PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tufail, S; Owais, M; Kazmi, S; Balyan, R; Khalsa, JK; Faisal, SM; Sherwani, MA; Gatoo, MA; Umar, MS; Zubair, S				Tufail, Saba; Owais, Mohammad; Kazmi, Shadab; Balyan, Renu; Khalsa, Jasneet Kaur; Faisal, Syed Mohd; Sherwani, Mohd Asif; Gatoo, Manzoor Ahmad; Umar, Mohd Saad; Zubair, Swaleha			Amyloid Form of Ovalbumin Evokes Native Antigen-specific Immune Response in the Host PROSPECTIVE IMMUNO-PROPHYLACTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL APLASIA; FIBRILS; PROTEIN; STABILITY; INSIGHTS; PROVIDES; PH	Amyloids are highly organized protein aggregates that arise from inappropriately folded versions of proteins or polypeptides under both physiological as well as simulated ambiences. Once thought to be irreversible assemblies, amyloids have begun to expose their more dynamic and reversible attributes depending upon the intrinsic properties of the precursor protein/peptide and experimental conditions such as temperature, pressure, structural modifications in proteins, or presence of chemicals in the reaction mixture. It has been repeatedly proposed that amyloids undergo transformation to the bioactive peptide/protein forms under specific conditions. In the present study, amyloids assembled from the model protein ovalbumin (OVA) were found to release the precursor protein in a slow and steady manner over an extended time period. Interestingly, the released OVA from amyloid depot was found to exhibit biophysical characteristics of native protein and reacted with native-OVA specific monoclonal as well as polyclonal antibodies. Moreover, antibodies generated upon immunization of OVA amyloidal aggregates or fibrils were found to recognize the native form of OVA. The study suggests that amyloids may act as depots for the native form of the protein and therefore can be exploited as vaccine candidates, where slow antigen release over extended time periods is a pre-requisite for the development of desired immune response.	[Sherwani, Mohd Asif; Umar, Mohd Saad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Balyan, Renu; Khalsa, Jasneet Kaur] Natl Inst Immunol, New Delhi 110067, India; [Gatoo, Manzoor Ahmad] Aligarh Muslim Univ, JNMC, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Aligarh Muslim University; Aligarh Muslim University	Owais, M (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com; swalehazubair@yahoo.com	Sherwani, Mohammad Asif/AAQ-2949-2021; Syed, Mohammad Faisal/AAM-7496-2020; Sherwani, Mohammad/AAR-6089-2021; Khalsa, Jasneet/AAZ-7112-2020	Sherwani, Mohammad Asif/0000-0001-5317-1557; Syed, Mohammad Faisal/0000-0002-3968-7810; Khalsa, Jasneet/0000-0003-4656-8454; Kazmi, Shadab/0000-0002-1860-0624; Mohammad, Owais/0000-0001-7377-7388; Balyan, Renu/0000-0002-9378-040X	Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF)	Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF)	Supported by the Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF).	Ahmad N, 2006, BIOCHIMIE, V88, P1391, DOI 10.1016/j.biochi.2006.04.017; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889; Atif SM, 2006, FEBS LETT, V580, P2183, DOI 10.1016/j.febslet.2006.03.015; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dwivedi V, 2009, VACCINE, V27, P473, DOI 10.1016/j.vaccine.2008.10.054; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Legge FS, 2009, J PHYS CHEM B, V113, P14006, DOI 10.1021/jp903842u; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Locatelli F, 2007, PERITON DIALYSIS INT, V27, pS303; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mankar S, 2011, NANO REV EXP, V2, DOI 10.3402/nano.v2i0.6032; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Tanaka N, 2011, J BIOL CHEM, V286, P5884, DOI 10.1074/jbc.M110.176396; Torrent J, 2006, PROTEIN PEPTIDE LETT, V13, P271, DOI 10.2174/092986606775338371; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Yamaguchi K, 2013, BIOCHEMISTRY-US, V52, P6797, DOI 10.1021/bi400698u; Yang M, 2009, BIOCHEM BIOPH RES CO, V378, P203, DOI 10.1016/j.bbrc.2008.11.037	54	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4131	4148		10.1074/jbc.M113.540989	http://dx.doi.org/10.1074/jbc.M113.540989			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512377	Green Published, hybrid			2022-12-26	WOS:000349458400026
J	Dimri, M; Cho, JH; Kang, M; Dimri, GP				Dimri, Manjari; Cho, Joon-Ho; Kang, Mingu; Dimri, Goberdhan P.			PLK1 Inhibition Down-regulates Polycomb Group Protein BMI1 via Modulation of the miR-200c/141 Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Biology; Cell Growth; Cellular Regulation; Cellular Senescence; Gene Regulation; microRNA (miRNA); Polycomb	CANCER STEM-CELLS; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; IN-VIVO; TUMOR-SUPPRESSOR; SELF-RENEWAL; LIFE-SPAN; KINASE 1; SENESCENCE; EXPRESSION	Background: BMI1 regulates cancer stem cell phenotype and is overexpressed in cancer cells. Results: PLK1 regulates BMI1 expression and its inhibitors suppress BMI1 expression, and induce premature senescence. Conclusion: BMI1 acts downstream of PLK1, and its expression is strongly inhibited by PLK1 inhibitor BI 2536. Significance: PLK1 inhibitors can be used to suppress growth of breast cancer cells overexpressing BMI1. The polycomb group protein BMI1 is an important regulator of cancer stem cell (CSC) phenotype and is often overexpressed in cancer cells. Its overexpression leads to increase in CSC fraction and therapy resistance in tumors. BMI1 functions via polycomb repressive complex 1 (PRC1)-mediated gene silencing and also via PRC1-independent transcriptional activities. At present, very little is known about the therapy reagents that can efficiently inhibit BMI1 expression, and the CSC phenotype. Here, we report that the polo-like kinase 1 (PLK1) regulates BMI1 expression, and that its inhibition can efficiently down-regulate BMI1 expression and PRC1 activity, and induce premature senescence in breast cancer cells. We also show that the exogenous BMI1 overexpression mitigates anti-oncogenic effects of PLK1 inhibition and overcomes senescence induction by PLK1 inhibitors. We further show that PLK1 inhibition down-regulates BMI1 by upregulating the miRNA-200c/141 cluster, which encodes miR-200c and miR-141, both of which are known to post-transcriptionally downregulate BMI1 expression. Thus, our data suggest that PLK1 inhibitors can be successfully used to inhibit growth of tumors in which PcG protein BMI1 is overexpressed or the PRC1 activity is deregulated.	[Dimri, Manjari; Cho, Joon-Ho; Kang, Mingu; Dimri, Goberdhan P.] George Washington Univ, Med Ctr, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA	George Washington University	Dimri, M (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, 2300 Eye St, Washington, DC 20037 USA.	gdimri@gwu.edu; mdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021	KANG, MINGU/0000-0001-6574-6661	NCI, National Institutes of Health [R01 CA094150]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 CA094150 from the NCI, National Institutes of Health (to G. P. D.).	Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dimri G. P., 2004, SCI AGING KNOWLEDGE, V2004, ppe40; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jin M, 2014, CANCER RES, V74, P4183, DOI 10.1158/0008-5472.CAN-14-0404; Kim HJ, 2013, J GERONTOL A-BIOL, V68, P1145, DOI 10.1093/gerona/glt017; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005	51	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3033	3044		10.1074/jbc.M114.615179	http://dx.doi.org/10.1074/jbc.M114.615179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505268	Green Published, hybrid			2022-12-26	WOS:000349310700040
J	Prasad, M; Kaur, J; Pawlak, KJ; Bose, M; Whittal, RM; Bose, HS				Prasad, Manoj; Kaur, Jasmeet; Pawlak, Kevin J.; Bose, Mahuya; Whittal, Randy M.; Bose, Himangshu S.			Mitochondria-associated Endoplasmic Reticulum Membrane (MAM) Regulates Steroidogenic Activity via Steroidogenic Acute Regulatory Protein (StAR)-Voltage-dependent Anion Channel 2 (VDAC2) Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Mitochondrial Metabolism; Progesterone; Steroidogenesis; Voltage-dependent Anion Channel (VDAC)	LIPOID ADRENAL-HYPERPLASIA; CHOLESTEROL TRAFFICKING; GEL-ELECTROPHORESIS; STAR; ER; IMPORT; CELLS; BIOGENESIS; TRANSPORT; MECHANISM	Background: Steroidogenic acute regulatory protein (StAR) fosters cholesterol into the adrenal and gonadal mitochondria to initiate steroidogenesis. Results: Voltage-dependent anion channel 2 (VDAC2) knockdown ablated pregnenolone synthesis and StAR processing into the mitochondria. Conclusion: Interaction between StAR and VDAC2 is critical for steroidogenesis. Significance: VDAC2 is a crucial regulator for initiating steroidogenesis. Steroid hormones are essential for carbohydrate metabolism, stress management, and reproduction and are synthesized from cholesterol in mitochondria of adrenal glands and gonads/ovaries. In acute stress or hormonal stimulation, steroidogenic acute regulatory protein (StAR) transports substrate cholesterol into the mitochondria for steroidogenesis by an unknown mechanism. Here, we report for the first time that StAR interacts with voltage-dependent anion channel 2 (VDAC2) at the mitochondria-associated endoplasmic reticulum membrane (MAM) prior to its translocation to the mitochondrial matrix. In the MAM, StAR interacts with mitochondrial proteins Tom22 and VDAC2. However, Tom22 knockdown by siRNA had no effect on pregnenolone synthesis. In the absence of VDAC2, StAR was expressed but not processed into the mitochondria as a mature 30-kDa protein. VDAC2 interacted with StAR via its C-terminal 20 amino acids and N-terminal amino acids 221-229, regulating the mitochondrial processing of StAR into the mature protein. In the absence of VDAC2, StAR could not enter the mitochondria or interact with MAM-associated proteins, and therefore steroidogenesis was inhibited. Furthermore, the N terminus was not essential for StAR activity, and the N-terminal deletion mutant continued to interact with VDAC2. The endoplasmic reticulum-targeting prolactin signal sequence did not affect StAR association with the MAM and thus its mitochondrial targeting. Therefore, VDAC2 controls StAR processing and activity, and MAM is thus a central location for initiating mitochondrial steroidogenesis.	[Prasad, Manoj; Kaur, Jasmeet; Pawlak, Kevin J.; Bose, Himangshu S.] Mercer Univ, Sch Med, Savannah, GA 31404 USA; [Bose, Mahuya] Univ Florida, Florida Biologix, Ctr Excellence Hlth Regenerat Biotechnol, Alachua, FL 32615 USA; [Bose, Mahuya] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Bose, Himangshu S.] Mem Univ Med Ctr, Anderson Canc Inst, Savannah, GA 31404 USA	Mercer University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alberta	Bose, HS (corresponding author), Mercer Univ, Sch Med, Div Biomed Sci, Dept Biochem, Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Pawlak, Kevin/HDO-6979-2022	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; American Heart Association; March of Dimes; Anderson Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes(March of Dimes); Anderson Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.). This work was also supported initially by the American Heart Association and the March of Dimes.; Supported by the Anderson Cancer Institute.	Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Bose HS, 2011, J PROTEINS PROTEOM, V2, P1; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bose M, 2008, ELECTROPHORESIS, V29, P753, DOI 10.1002/elps.200700782; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; CAPPONI AM, 1988, J BIOL CHEM, V263, P16113; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hunte C., 2003, MEMBRANE PROTEIN PUR; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; NICCHITTA CV, 1989, J CELL BIOL, V108, P789, DOI 10.1083/jcb.108.3.789; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Rajapaksha M, 2013, BIOCHEMISTRY-US, V52, P7242, DOI 10.1021/bi401125v; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; STERN JB, 1985, ARCH BIOCHEM BIOPHYS, V237, P244, DOI 10.1016/0003-9861(85)90275-9; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang XJ, 1998, ENDOCRINOLOGY, V139, P3903, DOI 10.1210/en.139.9.3903; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	50	91	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2604	2616		10.1074/jbc.M114.605808	http://dx.doi.org/10.1074/jbc.M114.605808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505173	Green Published, hybrid			2022-12-26	WOS:000349310700007
J	Yang, L; Katchman, A; Weinberg, RL; Abrams, J; Sannad, T; Wan, E; Pitt, GS; Marx, SO				Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Pitt, Geoffrey S.; Marx, Steven O.			The PDZ Motif of the alpha(1C) Subunit Is Not Required for Surface Trafficking and Adrenergic Modulation of Ca(V)1.2 Channel in the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; C-TERMINAL DOMAIN; CALCIUM-CHANNELS; CA2+ CHANNEL; CARDIAC MYOCYTES; ANCHORING PROTEIN; HIPPOCAMPAL-NEURONS; CARBOXYL-TERMINUS; SIGNALING COMPLEX; SKELETAL-MUSCLE	Voltage-gated Ca2+ channels play a key role in initiating muscle excitation-contraction coupling, neurotransmitter release, gene expression, and hormone secretion. The association of Ca(V)1.2 with a supramolecular complex impacts trafficking, localization, turnover, and, most importantly, multifaceted regulation of its function in the heart. Several studies hint at an important role for the C terminus of the alpha(1C) subunit as a hub for multidimensional regulation of Ca(V)1.2 channel trafficking and function. Recent studies have demonstrated an important role for the four-residue PDZ binding motif at the C terminus of alpha(1C) in interacting with scaffold proteins containing PDZ domains, in the subcellular localization of Ca(V)1.2 in neurons, and in the efficient signaling to cAMP-response element-binding protein in neurons. However, the role of the alpha(1C) PDZ ligand domain in the heart is not known. To determine whether the alpha(1C) PDZ motif is critical for Ca(V)1.2 trafficking and function in cardiomyocytes, we generated transgenic mice with inducible expression of an N-terminal FLAG epitope-tagged dihydropyridine-resistant alpha(1C) with the PDZ motif deleted (Delta PDZ). These mice were crossed with alpha-myosin heavy chain reverse transcriptional transactivator transgenic mice, and the double-transgenic mice were fed doxycycline. The Delta PDZ channels expressed, trafficked to the membrane, and supported robust excitation-contraction coupling in the presence of nisoldipine, a dihydropyridine Ca2+ channel blocker, providing functional evidence that they appropriately target to dyads. The Delta PDZ Ca2+ channels were appropriately regulated by isoproterenol and forskolin. These data indicate that the alpha(1C) PDZ motif is not required for surface trafficking, localization to the dyad, or adrenergic stimulation of Ca(V)1.2 in adult cardiomyocytes.	[Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Marx, Steven O.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Med, New York, NY 10032 USA; [Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Marx, Steven O.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Pharmacol, New York, NY 10032 USA; [Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA	Columbia University; Columbia University; Duke University	Marx, SO (corresponding author), Columbia Univ Coll Phys & Surg, Div Cardiol, Ctr PH 3, 630 W 168th St, New York, NY 10032 USA.	sm460@columbia.edu	Pitt, Geoffrey/L-4927-2019	Weinberg, Richard/0000-0001-8563-1554; Samad, Tahmina/0000-0001-8455-0998	NHLBI/National Institutes of Health [R01HL113136, R01 HL121253, T32 HL007854]; American Heart Association; Arlene and Arnold Goldstein Family Foundation; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007854, R01HL121253, R01HL113136] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Arlene and Arnold Goldstein Family Foundation; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Grants R01HL113136, R01 HL121253, and T32 HL007854. This work was also supported by an American Heart Association Founder's Affiliate grant-in-aid and by the Arlene and Arnold Goldstein Family Foundation. Supported by a fellowship from the Sarnoff Cardiovascular Research Foundation.; Supported by a fellowship from the Sarnoff Cardiovascular Research Foundation.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; BEELER GW, 1970, J PHYSIOL-LONDON, V207, P191, DOI 10.1113/jphysiol.1970.sp009056; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Domes K, 2011, J BIOL CHEM, V286, P33863, DOI 10.1074/jbc.M111.252312; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Ganesan AN, 2005, BIOCHEM BIOPH RES CO, V329, P749, DOI 10.1016/j.bbrc.2005.02.015; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hambleton M, 2007, AM J PHYSIOL-HEART C, V293, pH3768, DOI 10.1152/ajpheart.00486.2007; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Korb D., 2013, ISRN CELL BIOL, V2013, P1; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Lin CS, 2013, J BIOL CHEM, V288, P29403, DOI 10.1074/jbc.M113.470708; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; Maximov A, 2002, J NEUROSCI, V22, P6939; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shy D, 2014, CIRCULATION, V130, P147, DOI 10.1161/CIRCULATIONAHA.113.007852; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Weick JP, 2003, J NEUROSCI, V23, P3446; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Yang L, 2013, CIRC RES, V113, P871, DOI 10.1161/CIRCRESAHA.113.301926; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	59	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2166	2174		10.1074/jbc.M114.602508	http://dx.doi.org/10.1074/jbc.M114.602508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505241	Green Published, hybrid			2022-12-26	WOS:000348588000021
J	Chiu, CY; Tsai, MH; Yao, TC; Tu, YL; Hua, MC; Yeh, KW; Huang, JL				Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long			Urinary LTE4 Levels as a Diagnostic Marker for IgE-Mediated Asthma in Preschool Children: A Birth Cohort Study	PLOS ONE			English	Article							TOTAL SERUM IGE; CYSTEINYL LEUKOTRIENES; ANTILEUKOTRIENES; INFLAMMATION; MONTELUKAST; ASSOCIATION; EXCRETION; MODIFIERS; ALLERGIES; SKIN	Objectives: Leukotrienes play a central pathophysiological role in allergic asthma. The aim of this study was to investigate the utility of measuring urinary leukotriene E-4 (LTE4) levels in the diagnosis of atopic diseases in early childhood. Methods: Children aged 0 through 4 years from a birth cohort in the Prediction of Allergies in Taiwanese Children (PATCH) study were enrolled. Urinary LTE4 levels were measured and its association between total serum IgE levels, allergen-specific IgE sensitization and atopic diseases were assessed. Results: A total of 182 children were regular followed up at clinics for a four-year follow-up period. Urinary LTE4 levels appeared to be elevated in children with total serum IgE levels exceeding 100 kU/L, allergen-specific IgE sensitization after 2 years of age. Elevation of urinary LTE4 levels (>= 500 pg/mg of creatinine) significantly discriminated high serum total IgE levels (>= 100 kU/L) at age 2 (P=0.027). A higher level of total serum IgE or urinary LTE4 was significantly associated with the risk of developing allergic rhinitis and asthma at age 3. A significantly higher urinary LTE4 level was found in children with a combination of IgE sensitization and asthma at age 4. Conclusions: Urinary LTE4 levels appear to be highly associated with IgE sensitization and its related allergic airway diseases after age 2. The measurement of urinary LTE4 (>= 500 pg/mg of creatinine) could not only be a non-invasive method for atopic predisposition but also potentially provide a strategy for the diagnosis and management of asthma in preschool children.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp Keelung, Dept Pediat, Taoyuan, Taiwan; [Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Taoyuan, Taiwan; [Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung] Chang Gung Mem Hosp, Div Pediat Pulmonol, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Div Allergy Asthma & Rheumatol, Dept Pediat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yeh, KW (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	kwyeh@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Chiu, CY/Q-4238-2019; Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-52]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-52 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, CLIN EXP ALLERGY, V40, P85, DOI 10.1111/j.1365-2222.2009.03386.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; GERGEN PJ, 1992, ANN ALLERGY, V68, P507; Green SA, 2004, THORAX, V59, P100, DOI 10.1136/thorax.2003.006825; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Halvorsen R, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/460737; KUMLIN M, 1992, AM REV RESPIR DIS, V146, P96, DOI 10.1164/ajrccm/146.1.96; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Martinez FD, 2002, PEDIATRICS, V109, P362; Montuschi P, 2010, CLIN EXP ALLERGY, V40, P1732, DOI 10.1111/j.1365-2222.2010.03630.x; Montuschi P, 2008, MINI-REV MED CHEM, V8, P647, DOI 10.2174/138955708784567395; Montuschi P, 2007, DRUG DISCOV TODAY, V12, P404, DOI 10.1016/j.drudis.2007.03.004; Montuschi P, 2006, J ALLERGY CLIN IMMUN, V118, P347, DOI 10.1016/j.jaci.2006.04.010; Montuschi P, 2014, J CHROMATOGR B, V964, P12, DOI 10.1016/j.jchromb.2014.02.059; Peters-Golden M, 2006, CLIN EXP ALLERGY, V36, P689, DOI 10.1111/j.1365-2222.2006.02498.x; Price DB, 2003, THORAX, V58, P211, DOI 10.1136/thorax.58.3.211; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Satwani Hema, 2009, JPMA Journal of the Pakistan Medical Association, V59, P698; Severien C, 2000, EUR RESPIR J, V16, P588, DOI 10.1034/j.1399-3003.2000.16d03.x; SEYMOUR JL, 1987, J AM ACAD DERMATOL, V17, P988, DOI 10.1016/S0190-9622(87)70288-6; SMITH CM, 1992, EUR RESPIR J, V5, P693; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Togias Alkis G., 2000, Journal of Allergy and Clinical Immunology, V106, pS247; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115216	10.1371/journal.pone.0115216	http://dx.doi.org/10.1371/journal.pone.0115216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521113	gold, Green Published, Green Submitted			2022-12-26	WOS:000348845600026
J	Anchan, RM; Lachke, SA; Gerami-Naini, B; Lindsey, J; Ng, N; Naber, C; Nickerson, M; Cavallesco, R; Rowan, S; Eaton, JL; Xi, QC; Maas, RL				Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Naber, Catherine; Nickerson, Michael; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.			Pax6- and Six3-Mediated Induction of Lens Cell Fate in Mouse and Human ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LENTOID BODIES; ECTOPIC EYES; GENE; EXPRESSION; MUTATIONS; ANIRIDIA; DIFFERENTIATION; MORPHOGENESIS; REQUIREMENT	Embryonic stem (ES) cells provide a potentially useful in vitro model for the study of in vivo tissue differentiation. We used mouse and human ES cells to investigate whether the lens regulatory genes Pax6 and Six3 could induce lens cell fate in vitro. To help assess the onset of lens differentiation, we derived a new mES cell line (Pax6-GFP mES) that expresses a GFP reporter under the control of the Pax6 P0 promoter and lens ectoderm enhancer. Pax6 or Six3 expression vectors were introduced into mES or hES cells by transfection or lentiviral infection and the differentiating ES cells analyzed for lens marker expression. Transfection of mES cells with Pax6 or Six3 but not with other genes induced the expression of lens cell markers and up-regulated GFP reporter expression in Pax6-GFP mES cells by 3 days post-transfection. By 7 days post-transfection, mES cell cultures exhibited a. 10-fold increase over controls in the number of colonies expressing gamma A-crystallin, a lens fiber cell differentiation marker. RT-PCR and immunostaining revealed induction of additional lens epithelial or fiber cell differentiation markers including Foxe3, Prox1, alpha- and beta-crystallins, and Tdrd7. Moreover, gamma A-crystallin-or Prox1-expressing lentoid bodies formed by 30 days in culture. In hES cells, Pax6 or Six3 lentiviral vectors also induced lens marker expression. mES cells that express lens markers reside close to but are distinct from the Pax6 or Six3 transduced cells, suggesting that the latter induce nearby undifferentiated ES cells to adopt a lens fate by non-cell autonomous mechanisms. In sum, we describe a novel mES cell GFP reporter line that is useful for monitoring induction of lens fate, and demonstrate that Pax6 or Six3 is sufficient to induce ES cells to adopt a lens fate, potentially via non-cell autonomous mechanisms. These findings should facilitate investigations of lens development.	[Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Naber, Catherine; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Naber, Catherine; Nickerson, Michael; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Anchan, Raymond M.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Nickerson, Michael] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Med, Div Reprod Endocrinol & Infertil, Boston, MA 02115 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Delaware	Anchan, RM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	ranchan@partners.org; maas@genetics.med.harvard	Rowan, Sheldon/AAA-3271-2019	Rowan, Sheldon/0000-0002-1123-6743; Lachke, Salil/0000-0001-8845-010X	National Institutes of Health [T32 HD040135, K12 HD001255, NEI R01 EY10123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040135] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants T32 HD040135 and K12 HD001255 to RMA and NEI R01 EY10123 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Brown A, 1998, NUCLEIC ACIDS RES, V26, P259, DOI 10.1093/nar/26.1.259; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Chow RL, 1999, DEVELOPMENT, V126, P4213; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; Donner AL, 2006, SEMIN CELL DEV BIOL, V17, P676, DOI 10.1016/j.semcdb.2006.10.005; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Lachke SA, 2012, INVEST OPHTH VIS SCI, V53, P1617, DOI 10.1167/iovs.11-8839; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lengner CJ, 2010, ANN NY ACAD SCI, V1192, P38, DOI 10.1111/j.1749-6632.2009.05213.x; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; MARTHA A, 1994, AM J HUM GENET, V54, P801; Negre O, 2011, BLOOD, V117, P5321, DOI 10.1182/blood-2010-01-263582; Oliver G, 1996, MECH DEVELOP, V60, P233, DOI 10.1016/S0925-4773(96)00632-6; Ooto S, 2003, INVEST OPHTH VIS SCI, V44, P2689, DOI 10.1167/iovs.02-1168; Qiu XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032612; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Takahashi Masayo, 2006, V330, P417; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115106	10.1371/journal.pone.0115106	http://dx.doi.org/10.1371/journal.pone.0115106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517354	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600041
J	Chen, YY; Chen, JC; Lin, YC; Kitikiew, S; Li, HF; Bai, JC; Tseng, KC; Lin, BW; Liu, PC; Shi, YZ; Kuo, YH; Chang, YH				Chen, Yu-Yuan; Chen, Jiann-Chu; Lin, Yong-Chin; Kitikiew, Suwaree; Li, Hui-Fang; Bai, Jia-Chin; Tseng, Kuei-Chi; Lin, Bo-Wei; Liu, Po-Chun; Shi, Yin-Ze; Kuo, Yi-Hsuan; Chang, Yu-Hsuan			Endogenous Molecules Induced by a Pathogen-Associated Molecular Pattern (PAMP) Elicit Innate Immunity in Shrimp	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; PROPHENOLOXIDASE SYSTEM; HEMOCYTES; ACTIVATION; RESPONSES; PROTEINS; INVITRO; ASTACUS; GENES; DAMPS	Invertebrates rely on an innate immune system to combat invading pathogens. The system is initiated in the presence of cell wall components from microbes like lipopolysaccharide (LPS), beta-1,3-glucan (beta G) and peptidoglycan (PG), altogether known as pathogen-associated molecular patterns (PAMPs), via a recognition of pattern recognition protein (PRP) or receptor (PRR) through complicated reactions. We show herein that shrimp hemocytes incubated with LPS, beta G, and PG caused necrosis and released endogenous molecules (EMs), namely EM-L, EM-beta, and EM-P, and found that shrimp hemocytes incubated with EM-L, EM-beta, and EM-P caused changes in cell viability, degranulation and necrosis of hemocytes, and increased phenoloxidase (PO) activity and respiratory burst (RB) indicating activation of immunity in vitro. We found that shrimp receiving EM-L, EM-beta, and EM-P had increases in hemocyte count and other immune parameters as well as higher phagocytic activity toward a Vibrio pathogen, and found that shrimp receiving EM-L had increases in proliferation cell ratio and mitotic index of hematopoietic tissues (HPTs). We identified proteins of EMs deduced from SDS-PAGE and LC-ESI-MS/MS analyses. EM-L and EM-P contained damage-associated molecular patterns (DAMPs) including HMGBa, HMGBb, histone 2A (H2A), H2B, and H4, and other proteins including proPO, Rab 7 GPTase, and Rab 11 GPTase, which were not observed in controls (EM-C, hemocytes incubated in shrimp salt solution). We concluded that EMs induced by PAMPs contain DAMPs and other immune molecules, and they could elicit innate immunity in shrimp. Further research is needed to identify which individual molecule or combined molecules of EMs cause the results, and determine the mechanism of action in innate immunity.	[Chen, Yu-Yuan; Chen, Jiann-Chu; Lin, Yong-Chin; Kitikiew, Suwaree; Li, Hui-Fang; Bai, Jia-Chin; Tseng, Kuei-Chi; Lin, Bo-Wei; Liu, Po-Chun; Shi, Yin-Ze; Kuo, Yi-Hsuan; Chang, Yu-Hsuan] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan	National Taiwan Ocean University	Chen, JC (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan.	jcchen@mail.ntou.edu.tw		Shi, Yin-Ze/0000-0001-5142-985X	National Science Council, Taiwan [NSC 100-2313-B-019-010-My 3, NSC101-2313-B-019-002]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This research was supported by grants from the National Science Council (NSC 100-2313-B-019-010-My 3 and NSC101-2313-B-019-002), Taiwan, and partially supported by the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2013, FISH SHELLFISH IMMUN, V34, P990, DOI 10.1016/j.fsi.2012.08.019; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cardenas W, 2004, FISH SHELLFISH IMMUN, V17, P223, DOI 10.1016/j.fsi.2003.03.001; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chen YY, 2014, FISH SHELLFISH IMMUN, V36, P352, DOI 10.1016/j.fsi.2013.12.004; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P1550, DOI 10.1016/j.humimm.2013.08.275; Gazzola D, 2014, FOOD CHEM, V155, P132, DOI 10.1016/j.foodchem.2014.01.032; Giulianini PG, 2007, MICRON, V38, P49, DOI 10.1016/j.micron.2006.03.019; HernandezLopez J, 1996, COMP BIOCHEM PHYS C, V113, P61, DOI 10.1016/0742-8413(95)02033-0; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jearaphunt M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004059; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JOHANSSON MW, 1995, BIOCHEM BIOPH RES CO, V216, P1079, DOI 10.1006/bbrc.1995.2731; Kitikiew S, 2013, FISH SHELLFISH IMMUN, V34, P280, DOI 10.1016/j.fsi.2012.11.016; Li GQ, 2013, SEMIN CANCER BIOL, V23, P380, DOI 10.1016/j.semcancer.2013.08.002; Lin YongChin, 2013, PLoS ONE, V8, pe69722, DOI 10.1371/journal.pone.0069722; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Rao YL, 2013, DEV COMP IMMUNOL, V41, P164, DOI 10.1016/j.dci.2013.06.002; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Vera-Jimenez NJ, 2013, MOL IMMUNOL, V55, P231, DOI 10.1016/j.molimm.2013.01.016; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Xian JA, 2009, AQUACULTURE, V298, P139, DOI 10.1016/j.aquaculture.2009.10.008; Yang CR, 2013, DEV COMP IMMUNOL, V39, P133, DOI 10.1016/j.dci.2012.11.008; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	38	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115232	10.1371/journal.pone.0115232	http://dx.doi.org/10.1371/journal.pone.0115232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517999	Green Submitted, Green Published, gold			2022-12-26	WOS:000347215600055
J	da Costa, RS; Bicca-Marques, JC				da Costa, Renata Souza; Bicca-Marques, Julio Cesar			Owl Monkeys (Aotus nigriceps and A. infulatus) Follow Routes Instead of Food-Related Cues during Foraging in Captivity	PLOS ONE			English	Article							TAMARINS SAGUINUS-IMPERATOR; WILD; INFORMATION; FUSCICOLLIS; CALLICEBUS; DECISIONS; PRIMATES	Foraging at night imposes different challenges from those faced during daylight, including the reliability of sensory cues. Owl monkeys (Aotus spp.) are ideal models among anthropoids to study the information used during foraging at low light levels because they are unique by having a nocturnal lifestyle. Six Aotus nigriceps and four A. infulatus individuals distributed into five enclosures were studied for testing their ability to rely on olfactory, visual, auditory, or spatial and quantitative information for locating food rewards and for evaluating the use of routes to navigate among five visually similar artificial feeding boxes mounted in each enclosure. During most experiments only a single box was baited with a food reward in each session. The baited box changed randomly throughout the experiment. In the spatial and quantitative information experiment there were two baited boxes varying in the amount of food provided. These baited boxes remained the same throughout the experiment. A total of 45 sessions (three sessions per night during 15 consecutive nights) per enclosure was conducted in each experiment. Only one female showed a performance suggestive of learning of the usefulness of sight to locate the food reward in the visual information experiment. Subjects showed a chance performance in the remaining experiments. All owl monkeys showed a preference for one box or a subset of boxes to inspect upon the beginning of each experimental session and consistently followed individual routes among feeding boxes.	[da Costa, Renata Souza; Bicca-Marques, Julio Cesar] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Bicca-Marques, JC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	jcbicca@pucrs.br	Bicca-Marques, Júlio César/F-7487-2012	Bicca-Marques, Júlio César/0000-0002-5400-845X	Brazilian National Research Council [303154/2009-8, 303306/2013-0]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding from Brazilian National Research Council (RSC: Master's studentship; JCBM: PQ # 303154/2009-8 and 303306/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES M., 2007, BIOESTAT; BEECHER MD, 1974, J COMP PHYSIOL PSYCH, V86, P898, DOI 10.1037/h0036416; Bicca-Marques JC, 2005, INT J PRIMATOL, V26, P1321, DOI 10.1007/s10764-005-8855-9; Bicca-Marques JC, 2005, J COMP PSYCHOL, V119, P343, DOI 10.1037/0735-7036.119.3.343; Bicca-Marques JC, 2004, AM J PRIMATOL, V62, P171, DOI 10.1002/ajp.20014; Bicca-Marques JC, 2003, AM J PRIMATOL, V60, P139, DOI 10.1002/ajp.10101; Bicca-Marques JC, 2007, PRIMATOLOGIA BRASIL, P401; Bolen RH, 1997, J COMP PSYCHOL, V111, P152; Cant J.G.H., 1984, P304; Carlstead Kathy, 1996, P317; Castauo JH., 2010, PRIMATOLOGIA COLOMBI, P69; Donati Giuseppe, 2006, Journal of Anthropological Sciences, V84, P7; Fernandez-Duque E., 2012, International Zoo Yearbook, V46, P80, DOI 10.1111/j.1748-1090.2011.00156.x; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Ford Susan M., 1994, P1; Garber PA, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P201; Garber PA, 1997, FOLIA PRIMATOL, V68, P236, DOI 10.1159/000157250; GARBER PA, 1987, ANNU REV ANTHROPOL, V16, P339; Garber PA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P261; Garber PA, 2010, SPATIAL COGNITION SP, P180; Gomes DF, 2012, AM J PRIMATOL, V74, P58, DOI 10.1002/ajp.21009; Hayek LAC, 1996, MEASURING MONITORING, P343; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; Kamil Alan C., 1994, P11; King J.E., 1982, P327; Leigh S., 1999, READINGS BIOL BASES, P71; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Martin R.D., 1990, PRIMATE ORIGINS EVOL; McGuigan FG, 1994, BIOL PSYCHOL CYBEMET; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Wright Patricia C., 1994, P97; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5	33	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115188	10.1371/journal.pone.0115188	http://dx.doi.org/10.1371/journal.pone.0115188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517894	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600052
J	Hromadnikova, I; Kotlabova, K; Hympanova, L; Doucha, J; Krofta, L				Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie; Doucha, Jindrich; Krofta, Ladislav			First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension	PLOS ONE			English	Article							PLACENTA-SPECIFIC MICRORNAS; HUMAN CHORIONIC-GONADOTROPIN; FREE FETAL DNA; MATERNAL PLASMA; HYPERMETHYLATED RASSF1A; PRENATAL-DIAGNOSIS; GROWTH RESTRICTION; ANGIOGENIC FACTORS; PREGNANT-WOMEN; PREECLAMPSIA	Objective: The objective of the study was to evaluate risk assessment for gestational hypertension based on the profile of circulating placental specific C19MC microRNAs in early pregnancy. Study design: The prospective longitudinal cohort study of women enrolled at first trimester screening at 10 to 13 weeks was carried out (n=267). Relative quantification of placental specific C19MC microRNAs (miR-516-5p, miR-517*, miR-518b, miR-520a*, miR-520h, miR-525 and miR-526a) was determined in 28 normal pregnancies and 18 pregnancies which developed gestational hypertension using real-time PCR and a comparative Ct method relative to synthetic C. elegans microRNA (cel-miR-39). Results: Increased extracellular C19MC microRNA plasmatic levels (miR-516-5p, p<0.001; miR-517*, p-0.007; miR-520h, p<0.001; miR-518b, p=0.002) were detected in patients destined to develop gestational hypertension. MiR-520h had the best predictive performance with a PPV of 84.6% at a 7.1% false positive rate. The combination of miR-520h and miR-518b was able to predict 82.6% of women at the same false positive rate. The overall predictive capacity of single miR-518b (73.3% at 14.3% FPR), miR-516-5p (70.6% at 17.9% FPR) and miR-517* (57.9% at 28.6% FPR) biomarkers was lower. Conclusion: The study brought interesting finding that the up-regulation of miR516-5p, miR-517*, miR-520h and miR-518b is associated with a risk of later development of gestational hypertension. First trimester screening of extracellular miR-520h alone or in combination with miR-518b identified a significant proportion of women with subsequent gestational hypertension.	[Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie] Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague 10000, Czech Republic; [Hympanova, Lucie; Krofta, Ladislav] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague 14700, Czech Republic; [Doucha, Jindrich] Charles Univ Prague, Fac Med 2, Clin Obstet & Gynecol, Prague 15006, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague	Hromadnikova, I (corresponding author), Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Ruska 87, Prague 10000, Czech Republic.	Ilona.Hromadnikova@lf3.cuni.cz	Hympanova, Lucie/AAS-7474-2020; Hromadnikova, Ilona/E-1957-2017; Hympanova, Lucie/GRJ-1255-2022	Hympanova, Lucie/0000-0002-9002-9231; Hromadnikova, Ilona/0000-0002-4396-3304; Hympanova, Lucie/0000-0002-9002-9231; Kotlabova, Katerina/0000-0002-8824-4653	Grant Agency of Czech Republic [304/12/1352]; Charles University research program [PRVOUK P32]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Charles University research program	The work was exclusively supported by the Grant Agency of Czech Republic (no. 304/12/1352) and partially supported by the Charles University research program PRVOUK P32 (www.gacr.cz) (IH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asvold BO, 2014, ACTA OBSTET GYN SCAN, V93, P454, DOI 10.1111/aogs.12363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Byrne BM, 2003, HYPERTENS PREGNANCY, V22, P157, DOI 10.1081/PRG-120021062; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chambers AE, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-113; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Ciarmela P, 2010, EUR J OBSTET GYN R B, V148, P144, DOI 10.1016/j.ejogrb.2009.10.026; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Faas BHW, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60534-X; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Hromadnikova I, 2005, J HISTOCHEM CYTOCHEM, V53, P301, DOI 10.1369/jhc.4A6372.2005; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/186041; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Hromadnikova I, 2010, DNA CELL BIOL, V29, P295, DOI 10.1089/dna.2009.0971; Hromadnikova I, 2009, DNA CELL BIOL, V28, P351, DOI 10.1089/dna.2009.0855; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Karahasanovic A, 2014, CLIN CHEM LAB MED, V52, P521, DOI 10.1515/cclm-2013-0338; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau TW, 2002, CLIN CHEM, V48, P2141; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P184; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYPERTENSION PREGNAN; Neale DM, 2005, J PERINAT MED, V33, P471, DOI 10.1515/JPM.2005.085; Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3; Nishikawa S, 2000, LIFE SCI, V67, P1447, DOI 10.1016/S0024-3205(00)00736-0; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Rijnders RJP, 2001, OBSTET GYNECOL, V98, P374, DOI 10.1016/S0029-7844(01)01480-6; Robinson R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.011; Schmitz U., 2013, MICRORNA CANC REGULA; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sekizawa A, 2003, AM J OBSTET GYNECOL, V188, P480, DOI 10.1067/mob.2003.27; Sezer SD, 2013, GYNECOL ENDOCRINOL, V29, P797, DOI 10.3109/09513590.2013.801437; Smid M, 2001, ANN NY ACAD SCI, V945, P132; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Sziller I, 2005, MOL HUM REPROD, V11, P207, DOI 10.1093/molehr/gah151; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; Tsui DWY, 2007, PRENATAL DIAG, V27, P1212, DOI 10.1002/pd.1897; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Whitehead CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078487; Whitley GSJ, 2007, AM J PATHOL, V170, P1903, DOI 10.2353/ajpath.2007.070006; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287; World Health Organization, 2011, WHO REC PREV TREATM; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Yi KW, 2014, PLACENTA, V35, P64, DOI 10.1016/j.placenta.2013.09.008; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	73	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e113735	10.1371/journal.pone.0113735	http://dx.doi.org/10.1371/journal.pone.0113735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502889	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100007
J	Lin, L; Pan, S; Zhao, JQ; Liu, C; Wang, PG; Fu, L; Xu, XL; Jin, ML; Zhang, AD				Lin, Lan; Pan, Shan; Zhao, Jianqing; Liu, Cheng; Wang, Pingan; Fu, Lei; Xu, Xinlin; Jin, Meilin; Zhang, Anding			HSPD1 Interacts with IRF3 to Facilitate Interferon-Beta Induction	PLOS ONE			English	Article							REGULATORY FACTOR-3 ACTIVATION; ANTIVIRAL RESPONSE; PROTEIN; PHOSPHORYLATION; ADAPTER; MAVS; UBIQUITINATION; ASSOCIATION; SYNTHASE; SENSOR	The production of IFN-I (IFN-alpha/beta) is one of the earliest and most important host-protective responses. Interferon regulatory factor 3 (IRF3) is a critical transcriptional factor in the IFN-beta signaling pathway. Although significant progress has been achieved in the regulation of IRF3, the process may be more complicated than previously considered. In the present study, heat shock protein 60 (HSP60, HSPD1) was identified as a novel IRF3-interacting protein. Overexpression of HSPD1 facilitated the phosphorylation and dimerization of IRF3 and enhanced IFN-beta induction induced by SeV infection. In contrast, knockdown of endogenous HSPD1 significantly inhibited the signaling pathway. Furthermore, HSPD1 enhanced activation of the IFN-beta promoter mediated by RIG-I, MDA-5, MAVS, TBK1 and IKK epsilon but not IRF3/5D, a mock phosphorylated form of IRF3. The present study indicated that HSPD1 interacted with IRF3 and it contributed to the induction of IFN-beta.	[Lin, Lan; Pan, Shan; Jin, Meilin; Zhang, Anding] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Lin, Lan; Pan, Shan; Zhao, Jianqing; Wang, Pingan; Fu, Lei; Xu, Xinlin; Jin, Meilin; Zhang, Anding] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Liu, Cheng] Liaocheng Univ, Coll Agr, Liaocheng, Shandong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Liaocheng University	Zhang, AD (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	andye8019@mail.hzau.edu.cn			National Natural Science Foundation of China [31172328, 31272544]; 973 program [2012CB518805]; Program for New Century Excellent Talents in University; fundamental research funds for the central university [2011PY006, 2014PY016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); fundamental research funds for the central university	This work was supported by the National Natural Science Foundation of China (31172328, 31272544), the 973 program (2012CB518805), Program for New Century Excellent Talents in University, and the fundamental research funds for the central university (2011PY006; 2014PY016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Bergstroem B, 2010, J BIOL CHEM, V285, P24904, DOI 10.1074/jbc.M109.084822; Chen KR, 2012, J BIOL CHEM, V287, P32216, DOI 10.1074/jbc.C112.394346; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Gu LL, 2013, MOL CELL BIOL, V33, P2004, DOI 10.1128/MCB.01603-12; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Lee YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056284, 10.1371/journal.pone.0063255]; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang YT, 2012, J BIOL CHEM, V287, P34626, DOI 10.1074/jbc.M112.390401; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang AP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009936; Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114874	10.1371/journal.pone.0114874	http://dx.doi.org/10.1371/journal.pone.0114874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506707	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100028
J	Ben-David, BM; Eidels, A; Donkin, C				Ben-David, Boaz M.; Eidels, Ami; Donkin, Chris			Effects of Aging and Distractors on Detection of Redundant Visual Targets and Capacity: Do Older Adults Integrate Visual Targets Differently than Younger Adults?	PLOS ONE			English	Article							DIFFUSION-MODEL ANALYSIS; INFORMATION-PROCESSING RATES; SAME-DIFFERENT JUDGMENTS; AGE-RELATED-CHANGES; COLOR-WORD STROOP; WORKLOAD CAPACITY; SELECTIVE ATTENTION; DIVIDED ATTENTION; SENSORY ORIGIN; RECOGNITION	In the redundant target effect, participants respond faster with two (redundant) targets. We compared the magnitude of this effect in younger and older adults, with and without distractors, in a simple visual-detection task. We employed additional measures that allow non-parametric assessment of performance (Townsend's capacity coefficient) and parametric estimates (Linear Ballistic Accumulator model). Older participants' latencies were slower, especially in the presence of distractors, and their calculated capacity indicators increased with distractors. Parametric estimates indicated that these increases were generated by the older adults' increased difficulty in inhibiting the distractors, and not the results of either improved detection of redundant-targets, or of a generalized slowing of processing.	[Ben-David, Boaz M.] Interdisciplinary Ctr IDC Herzliya, Sch Psychol, Herzliyya, Israel; [Ben-David, Boaz M.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Ben-David, Boaz M.] Toronto Rehabil Inst, Toronto, ON, Canada; [Ben-David, Boaz M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Eidels, Ami] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Donkin, Chris] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Reichman University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Newcastle; University of New South Wales Sydney	Ben-David, BM (corresponding author), Interdisciplinary Ctr IDC Herzliya, Sch Psychol, Herzliyya, Israel.	boaz.ben.david@idc.ac.il		Ben-David, Boaz/0000-0002-0392-962X; Donkin, Chris/0000-0002-4285-8537; Eidels, Ami/0000-0003-4301-6072	Natural Sciences and Engineering Research Council of Canada [RGBPIN 9952]; Keats Endowment Research Fund; Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-CIG); Australian Research Council's Discovery Projects funding scheme [DP130100124]; Australian Research Council Discovery Early Career Award [DE130100129]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Keats Endowment Research Fund; Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-CIG); Australian Research Council's Discovery Projects funding scheme(Australian Research Council); Australian Research Council Discovery Early Career Award(Australian Research Council)	This work was supported by: 1) The Natural Sciences and Engineering Research Council of Canada (RGBPIN 9952) awarded to B. A. Schneider, who was the post-doctoral advisor for BBD at the time of data collection (www.nserccrsng.gc.ca/index_eng.asp). 2) The Keats Endowment Research Fund awarded to AE (http://www.newcastle.edu.au/Resources/News/2008/01/Keats%20endow%20research%20fund.pdf). 3) BBD was partially supported by the Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-2012-CIG) (ec.europa.eu/research/mariecurieactions/about-mca/.../cig/index_en.htm). 4) CD's contribution to this research was supported under Australian Research Council's Discovery Projects funding scheme (DP130100124), (www.arc.gov.au/ncgp/dp/dp_default.htm). 5) CD's work was also supported by an Australian Research Council Discovery Early Career Award (DE130100129) (www.arc.gov.au/ncgp/decra.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGOM D, 2014, OXFORD HANDBOOK OF C; ALLEN PA, 1993, J GERONTOL, V48, pP189, DOI 10.1093/geronj/48.4.P189; ALLEN PA, 1994, J GERONTOL, V49, pP213, DOI 10.1093/geronj/49.5.P213; ALLEN PA, 1992, J GERONTOL, V47, pP69, DOI 10.1093/geronj/47.2.P69; Ben-David BM, 2014, J ALZHEIMERS DIS, V38, P923, DOI 10.3233/JAD-131244; Ben-David BM, 2012, HEARING RES, V290, P55, DOI 10.1016/j.heares.2012.04.022; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Ben-David BM, 2011, J SPEECH LANG HEAR R, V54, P243, DOI 10.1044/1092-4388(2010/09-0233); Ben-David BM, 2010, AGING NEUROPSYCHOL C, V17, P730, DOI 10.1080/13825585.2010.510553; Ben-David BM, 2009, AGING NEUROPSYCHOL C, V16, P505, DOI 10.1080/13825580902855862; Ben-David BM, 2009, J EXP PSYCHOL HUMAN, V35, P958, DOI 10.1037/a0014511; Bertone A, 2007, J CLIN EXP NEUROPSYC, V29, P467, DOI 10.1080/13803390600770793; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Bucur B, 2005, PSYCHOL AGING, V20, P435, DOI 10.1037/0882-7974.20.3.435; Bucur B, 2005, J GERONTOL B-PSYCHOL, V60, pP279, DOI 10.1093/geronb/60.5.P279; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Eidels A, 2011, J MATH PSYCHOL, V55, P176, DOI 10.1016/j.jmp.2010.11.003; Eidels A, 2010, PSYCHON B REV, V17, P763, DOI 10.3758/PBR.17.6.763; Eidels A, 2010, COGNITION, V114, P129, DOI 10.1016/j.cognition.2009.08.008; Eidels A, 2008, J EXP PSYCHOL HUMAN, V34, P1441, DOI 10.1037/a0012320; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; HARTLEY AA, 1993, PSYCHOL AGING, V8, P371, DOI 10.1037/0882-7974.8.3.371; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Houpt JW, 2012, J MATH PSYCHOL, V56, P341, DOI 10.1016/j.jmp.2012.05.004; Hugenschmidt CE, 2010, INFORM FUSION, V11, P12, DOI 10.1016/j.inffus.2009.04.004; KRUEGER LE, 1978, PSYCHOL REV, V85, P278, DOI 10.1037/0033-295X.85.4.278; KRUEGER LE, 1987, PERCEPT PSYCHOPHYS, V41, P329, DOI 10.3758/BF03208234; KRUEGER LE, 1985, PERCEPT PSYCHOPHYS, V37, P266, DOI 10.3758/BF03207574; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Madden DJ, 2004, ADV CELL AGING GERON, V15, P41; McDowd J., 2000, HDB AGING COGNITION, P221; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; MILLER J, 1991, J EXP PSYCHOL HUMAN, V17, P160, DOI 10.1037/0096-1523.17.1.160; MYERSON J, 1992, PSYCHOL AGING, V7, P257, DOI 10.1037/0882-7974.7.2.257; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Plude DJ, 1986, PSYCHOL AGING, V1, P4, DOI 10.1037/0882-7974.1.1.4; Raab D., 1962, T NEW YORK ACADEMY S, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Ratcliff R, 2004, PSYCHOL AGING, V19, P278, DOI 10.1037/0882-7974.19.2.278; Ratcliff R, 2004, J MEM LANG, V50, P408, DOI 10.1016/j.jml.2003.11.002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2006, PSYCHON B REV, V13, P626, DOI 10.3758/BF03193973; Ratcliff R, 2006, PSYCHOL AGING, V21, P353, DOI 10.1037/0882-7974.21.2.353; Ratcliff R, 2010, COGNITIVE PSYCHOL, V60, P127, DOI 10.1016/j.cogpsych.2009.09.001; RAVEN JC, 1958, GUIDE TO USING THE M; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Schneider B.A., 2000, HDB AGING COGNITION, P155; Townsend JT, 2011, PSYCHON B REV, V18, P659, DOI 10.3758/s13423-011-0106-9; Townsend JT, 1995, J MATH PSYCHOL, V39, P321, DOI 10.1006/jmps.1995.1033; van Lieshout P, 2014, J FLUENCY DISORD, V40, P93, DOI 10.1016/j.jfludis.2014.02.003; Verhaeghen P, 2011, CURR DIR PSYCHOL SCI, V20, P174, DOI 10.1177/0963721411408772; Vetter Sebastian, 2010, Occupational Ergonomics, V9, P99, DOI 10.3233/OER-2010-0175; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067	53	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113551	10.1371/journal.pone.0113551	http://dx.doi.org/10.1371/journal.pone.0113551			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25501850	Green Submitted, Green Published			2022-12-26	WOS:000346375400010
J	Hou, XS; McMillan, M; Coumans, JVF; Poljak, A; Raftery, MJ; Pereg, L				Hou, Xingsheng; McMillan, Mary; Coumans, Joelle V. F.; Poljak, Anne; Raftery, Mark J.; Pereg, Lily			Cellular Responses during Morphological Transformation in Azospirillum brasilense and Its flcA Knockout Mutant	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; FUNGUS THIELAVIOPSIS-BASICOLA; ESCHERICHIA-COLI K-12; N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; AUREUS STRESS TOLERANCE; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; MEMBRANE-PROTEINS; OXIDATIVE STRESS; OUTER-MEMBRANE	FlcA is a response regulator controlling flocculation and the morphological transformation of Azospirillum cells from vegetative to cyst-like forms. To understand the cellular responses of Azospirillum to conditions that cause morphological transformation, proteins differentially expressed under flocculation conditions in A. brasilense Sp7 and its flcA knockout mutant were investigated. Comparison of 2-DE protein profiles of wild-type (Sp7) and a flcA deletion mutant (Sp7-flcA Delta) revealed a total of 33 differentially expressed 2-DE gel spots, with 22 of these spots confidently separated to allow protein identification. Analysis of these spots by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and MASCOT database searching identified 48 proteins (>= 10% emPAI in each spot). The functional characteristics of these proteins included carbon metabolism (beta-ketothiolase and citrate synthase), nitrogen metabolism (Glutamine synthetase and nitric oxide synthase), stress tolerance (superoxide dismutase, Alkyl hydroperoxidase and ATP-dependent Clp protease proteolytic subunit) and morphological transformation (transducer coupling protein). The observed differences between Sp7 wild-type and flcA(-) strains enhance our understanding of the morphological transformation process and help to explain previous phenotypical observations. This work is a step forward in connecting the Azospirillum phenome and genome.	[Hou, Xingsheng; McMillan, Mary; Coumans, Joelle V. F.; Pereg, Lily] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Hou, Xingsheng] Shanxi Med Univ, Dept Microbiol & Immunol, Taiyuan, Shanxi, Peoples R China; [Coumans, Joelle V. F.] Univ New England, Sch Rural Med, Armidale, NSW, Australia; [Poljak, Anne; Raftery, Mark J.] Univ New S Wales, Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Poljak, Anne] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New England; Shanxi Medical University; University of New England; University of New South Wales Sydney; University of New South Wales Sydney	Pereg, L (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	lily.pereg@une.edu.au	Coumans, Joelle/D-9793-2011	Coumans, Joelle/0000-0001-6642-5202; Poljak, Anne/0000-0001-9953-1984; McMillan, Mary/0000-0002-2336-3985	University of New England; Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province [2014-95]	University of New England; Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province	L.P. received a Faculty of the Sciences Internal Research Grant, from the University of New England. X.H. was supported by a UNERA International Fee & Stipend Scholarship from the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Xingsheng Hou received funding under the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (No. 2014-95) for the period 01/2014 to 12/2015.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ARMSTRONGBUISSERET L, 1995, MICROBIOL-SGM, V141, P1655, DOI 10.1099/13500872-141-7-1655; ASSMUS B, 1995, APPL ENVIRON MICROB, V61, P1013, DOI 10.1128/AEM.61.3.1013-1019.1995; Bellenger K, 2002, J BACTERIOL, V184, P5654, DOI 10.1128/JB.184.20.5654-5660.2002; Berleman JE, 2005, MOL MICROBIOL, V56, P1457, DOI 10.1111/j.1365-2958.2005.04646.x; Bible A, 2012, J BACTERIOL, V194, P3343, DOI 10.1128/JB.00310-12; Bible AN, 2008, J BACTERIOL, V190, P6365, DOI 10.1128/JB.00734-08; BONNEFOY V, 1992, MOL MICROBIOL, V6, P3595; BOZOUKLIAN H, 1986, ANN INST PASTEUR MIC, V137B, P3, DOI 10.1016/S0769-2609(86)80089-8; Burdman S, 1998, MICROBIOL-SGM, V144, P1989, DOI 10.1099/00221287-144-7-1989; Burdman S, 2000, FEMS MICROBIOL LETT, V189, P259, DOI 10.1111/j.1574-6968.2000.tb09240.x; Burdman S, 2000, CRIT REV MICROBIOL, V26, P91, DOI 10.1080/10408410091154200; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castellen P, 2009, EUR J SOIL BIOL, V45, P100, DOI 10.1016/j.ejsobi.2008.09.010; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Coumans JVF, 2011, ENVIRON MICROBIOL, V13, P576, DOI 10.1111/j.1462-2920.2010.02358.x; Coumans JVF, 2010, PROTEOMICS, V10, P1573, DOI 10.1002/pmic.200900301; Coumans JVF, 2009, PROTEOMICS, V9, P335, DOI 10.1002/pmic.200800251; DAMERAU K, 1993, J BACTERIOL, V175, P53, DOI 10.1128/JB.175.1.53-63.1993; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; DEZAMAROCZY M, 1993, J BACTERIOL, V175, P2507, DOI 10.1128/JB.175.9.2507-2515.1993; DEZAMAROCZY M, 1990, MOL GEN GENET, V224, P421, DOI 10.1007/BF00262437; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; Frees D, 1999, MOL MICROBIOL, V31, P79, DOI 10.1046/j.1365-2958.1999.01149.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Frees D, 2012, J PROTEOME RES, V11, P95, DOI 10.1021/pr200956s; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Genevaux P, 1999, ARCH MICROBIOL, V172, P1, DOI 10.1007/s002030050732; Gerk LP, 2000, APPL ENVIRON MICROB, V66, P2175, DOI 10.1128/AEM.66.5.2175-2184.2000; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; GREENBERG JT, 1988, EMBO J, V7, P2611, DOI 10.1002/j.1460-2075.1988.tb03111.x; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hashimoto W, 2005, BIOCHEMISTRY-US, V44, P13783, DOI 10.1021/bi050873b; Herschkovitz Y, 2005, MICROB ECOL, V50, P277, DOI 10.1007/s00248-004-0148-x; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; Kadouri D, 2003, APPL ENVIRON MICROB, V69, P3244, DOI 10.1128/AEM.69.6.3244-3250.2003; Kadouri D, 2002, APPL ENVIRON MICROB, V68, P2943, DOI 10.1128/AEM.68.6.2943-2949.2002; KATUPITIYA S, 1995, APPL ENVIRON MICROB, V61, P1987, DOI 10.1128/AEM.61.5.1987-1995.1995; Kock H, 2004, J BACTERIOL, V186, P5856, DOI 10.1128/JB.186.17.5856-5864.2004; KRAMER GF, 1987, J BACTERIOL, V169, P2259, DOI 10.1128/jb.169.5.2259-2266.1987; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Lee AI, 1999, J BACTERIOL, V181, P5309, DOI 10.1128/JB.181.17.5309-5316.1999; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Lim H, 2003, J AM SOC MASS SPECTR, V14, P957, DOI 10.1016/S1044-0305(03)00144-2; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Malhotra M, 2008, NITRIC OXIDE S UNPUB; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mothes G, 1996, ARCH MICROBIOL, V166, P405, DOI 10.1007/BF01682987; Mothes G, 1998, ARCH MICROBIOL, V169, P360, DOI 10.1007/s002030050583; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Otani M, 2001, J BACTERIOL, V183, P6282, DOI 10.1128/JB.183.21.6282-6287.2001; Pereg Gerk L, 1998, MOL PLANT MICROBE IN, V11, P177; Priebe GP, 2004, INFECT IMMUN, V72, P4224, DOI 10.1128/IAI.72.7.4224-4232.2004; QADRI F, 1988, J CLIN MICROBIOL, V26, P1343, DOI 10.1128/JCM.26.7.1343-1348.1988; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; RABIN RS, 1992, P NATL ACAD SCI USA, V89, P8419, DOI 10.1073/pnas.89.18.8419; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; SADASIVAN L, 1987, J BACTERIOL, V169, P1670, DOI 10.1128/jb.169.4.1670-1677.1987; SADASIVAN L, 1985, J BACTERIOL, V163, P716, DOI 10.1128/JB.163.2.716-723.1985; Salonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077894; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; SCHULMAN H, 1977, J BIOL CHEM, V252, P6299; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; SUTCLIFFE JG, 1978, NUCLEIC ACIDS RES, V5, P2721, DOI 10.1093/nar/5.8.2721; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Thomsen LE, 2002, MICROBIOL-SGM, V148, P2727, DOI 10.1099/00221287-148-9-2727; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; Valverde A, 2006, FEMS MICROBIOL LETT, V265, P186, DOI 10.1111/j.1574-6968.2006.00482.x; Van Dommelen A, 2003, APPL ENVIRON MICROB, V69, P5699, DOI 10.1128/AEM.69.9.5699-5701.2003; von Lohneysen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034237; Wang G, 1998, LETT APPL MICROBIOL, V26, P31, DOI 10.1046/j.1472-765X.1998.00264.x; Wasim M, 2009, MICROBIOL-SGM, V155, P1192, DOI 10.1099/mic.0.022541-0; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	91	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114435	10.1371/journal.pone.0114435	http://dx.doi.org/10.1371/journal.pone.0114435			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502569	Green Published, gold			2022-12-26	WOS:000346375400031
J	Liang, JW; Shi, ZZ; Shen, TY; Che, X; Wang, Z; Shi, SS; Xu, X; Cai, Y; Zhao, P; Wang, CF; Zhou, ZX; Wang, MR				Liang, Jian-Wei; Shi, Zhi-Zhou; Shen, Tian-Yun; Che, Xu; Wang, Zheng; Shi, Su-Sheng; Xu, Xin; Cai, Yan; Zhao, Ping; Wang, Cheng-Feng; Zhou, Zhi-Xiang; Wang, Ming-Rong			Identification of Genomic Alterations in Pancreatic Cancer Using Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; SIGNALING PATHWAY; TUMOR GRADE; EXPRESSION; GROWTH; HMGA2; DELETION; APOBEC3B; AKT2; GENE	Background: Genomic aberration is a common feature of human cancers and also is one of the basic mechanisms that lead to overexpression of oncogenes and underexpression of tumor suppressor genes. Our study aims to identify frequent genomic changes in pancreatic cancer. Materials and Methods: We used array comparative genomic hybridization (array CGH) to identify recurrent genomic alterations and validated the protein expression of selected genes by immunohistochemistry. Results: Sixteen gains and thirty-two losses occurred in more than 30% and 60% of the tumors, respectively. High-level amplifications at 7q21.3-q22.1 and 19q13.2 and homozygous deletions at 1p33-p32.3, 1p22.1, 1q22, 3q27.2, 6p22.3, 6p21.31, 12q13.2, 17p13.2, 17q21.31 and 22q13.1 were identified. Especially, amplification of AKT2 was detected in two carcinomas and homozygous deletion of CDKN2C in other two cases. In 15 independent validation samples, we found that AKT2 (19q13.2) and MCM7 (7q22.1) were amplified in 6 and 9 cases, and CAMTA2 (17p13.2) and PFN1 (17p13.2) were homozygously deleted in 3 and 1 cases. AKT2 and MCM7 were overexpressed, and CAMTA2 and PFN1 were underexpressed in pancreatic cancer tissues than in morphologically normal operative margin tissues. Both GISTIC and Genomic Workbench software identified 22q13.1 containing APOBEC3A and APOBEC3B as the only homozygous deletion region. And the expression levels of APOBEC3A and APOBEC3B were significantly lower in tumor tissues than in morphologically normal operative margin tissues. Further validation showed that overexpression of PSCA was significantly associated with lymph node metastasis, and overexpression of HMGA2 was significantly associated with invasive depth of pancreatic cancer. Conclusion: These recurrent genomic changes may be useful for revealing the mechanism of pancreatic carcinogenesis and providing candidate biomarkers.	[Liang, Jian-Wei; Che, Xu; Wang, Zheng; Zhao, Ping; Wang, Cheng-Feng; Zhou, Zhi-Xiang] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Shi, Zhi-Zhou; Shen, Tian-Yun] Kunming Univ Sci & Technol, Fac Med, Kunming, Peoples R China; [Shi, Su-Sheng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, Dept Pathol, Beijing 100730, Peoples R China; [Xu, Xin; Cai, Yan; Wang, Ming-Rong] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, ZZ (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming, Peoples R China.	zhizhoushi@126.com; wangmr2015@126.com		Shen, Tianyun/0000-0003-4300-5349	National Science and Technology Major Project of China [2012ZX09506001, 2011YQ17006710]; National Natural Science Foundation of China [81241086]; Yunnan Provincial Research Foundation for Basic Research, China [2013FD012]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Research Foundation for Basic Research, China	This work was supported by National Science and Technology Major Project of China (2012ZX09506001, 2011YQ17006710), and National Natural Science Foundation of China (81241086), and the Yunnan Provincial Research Foundation for Basic Research, China (Grant No. 2013FD012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Aumayr K, 2013, APPL IMMUNOHISTOCHEM; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Boyd KD, 2011, CLIN CANCER RES, V17, P7776, DOI 10.1158/1078-0432.CCR-11-1791; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chen D, 2012, INT J MOL SCI, V13, P1186, DOI 10.3390/ijms13011186; Ding X, 2014, CELL PROLIFERAT, V47, P146, DOI 10.1111/cpr.12096; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kitoh H, 2005, J GASTROENTEROL, V40, P511, DOI 10.1007/s00535-005-1577-0; Kulkarni MS, 2002, LEUKEMIA, V16, P127, DOI 10.1038/sj.leu.2402328; Lehnen NC, 2013, HISTOPATHOLOGY, V63, P157, DOI 10.1111/his.12115; Leonard B, 2013, CANC RES; Leone PE, 2008, CLIN CANCER RES, V14, P6033, DOI 10.1158/1078-0432.CCR-08-0347; Miwa W, 1996, BIOCHEM BIOPH RES CO, V225, P968, DOI 10.1006/bbrc.1996.1280; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; Pham P, 2013, J BIOL CHEM, V288, P29294, DOI 10.1074/jbc.M113.504175; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Shi XH, 2009, CANCER GENE THER, V16, P227, DOI 10.1038/cgt.2008.82; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Tanno S, 2001, CANCER RES, V61, P589; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Xi YN, 2014, ASIAN PAC J TROP MED, V7, P289, DOI 10.1016/S1995-7645(14)60040-7; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhou J, 2012, ASIAN PAC J CANCER P, V13, P719, DOI 10.7314/APJCP.2012.13.2.719	34	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114616	10.1371/journal.pone.0114616	http://dx.doi.org/10.1371/journal.pone.0114616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502777	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700033
J	Lu, Q; Yu, MX; Shen, CY; Chen, XP; Feng, T; Yao, YC; Li, JR; Li, H; Tu, WW				Lu, Qiao; Yu, Meixing; Shen, Chongyang; Chen, Xiaoping; Feng, Ting; Yao, Yongchao; Li, Jinrong; Li, Hong; Tu, Wenwei			Negligible Immunogenicity of Induced Pluripotent Stem Cells Derived from Human Skin Fibroblasts	PLOS ONE			English	Article							REGULATORY T-CELLS; NAIVE PRECURSORS; GENERATION; INDUCTION; ENGRAFT; GAMMA	Human induced pluripotent stem cells (hiPSCs) have potential applications in cell replacement therapy and regenerative medicine. However, limited information is available regarding the immunologic features of iPSCs. In this study, expression of MHC and T cell co-stimulatory molecules in hiPSCs, and the effects on activation, proliferation and cytokine production in allogeneic human peripheral blood mononuclear cells were examined. We found that no-integrate hiPSCs had no MHC-II and T cell co-stimulatory molecules expressions but had moderate level of MHC-I and HLA-G expressions. In contrast to human skin fibroblasts (HSFs) which significantly induced allogeneic T cell activation and proliferation, hiPSCs failed to induce allogeneic CD45(+) lymphocyte and CD8(+) T cell activation and proliferation but could induce a low level of allogeneic CD4(+) T cell proliferation. Unlike HSFs which induced allogeneic lymphocytes to produce high levels of IFN-gamma, TNF-alpha and IL-17, hiPSCs only induced allogeneic lymphocytes to produce IL-2 and IL-10, and promote IL-10-secreting regulatory Tcell (Treg) generation. Our study suggests that the integration-free hiPSCs had low or negligible immunogenicity, which may result from their induction of IL-10-secreting Treg.	[Lu, Qiao; Yu, Meixing; Shen, Chongyang; Feng, Ting; Li, Jinrong; Li, Hong; Tu, Wenwei] Sichuan Univ, Joint Res Ctr, West China Univ Hosp 2, Chengdu 610041, Sichuan, Peoples R China; [Lu, Qiao; Yu, Meixing; Shen, Chongyang; Feng, Ting; Li, Jinrong; Li, Hong; Tu, Wenwei] Sichuan Univ, Univ Hong Kong, Fac Med, Chengdu 610041, Sichuan, Peoples R China; [Lu, Qiao] Hubei Univ Nationalities, Dept Pediat, Univ Hosp, Enshi 445000, Hubei, Peoples R China; [Chen, Xiaoping; Yao, Yongchao] Chinese Acad Sci, Lab Pathogen Biol, State Key Lab Resp Dis, Ctr Infect & Immun,Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Li, Hong] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth De, West China Univ Hosp 2, Minist Educ, Chengdu 610041, Sichuan, Peoples R China; [Tu, Wenwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China	Sichuan University; Sichuan University; University of Hong Kong; Hubei Minzu University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Sichuan University; University of Hong Kong	Li, H (corresponding author), Sichuan Univ, Joint Res Ctr, West China Univ Hosp 2, Chengdu 610041, Sichuan, Peoples R China.	lh3985@gmail.com; wwtu@hkucc.hku.hk	Shen, Chongyang/W-8463-2019		National Natural Science Foundation of China (NSFC); Research Grants Council (RGC) of Hong Kong [N_HKU 747/11]; National Natural Science Foundation of China [81170606]; Doctoral Fund of Ministry of Education of China [20120181110087]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported in part by the grants from National Natural Science Foundation of China (NSFC) and the Research Grants Council (RGC) of Hong Kong Joint Research Scheme (N_HKU 747/11), National Natural Science Foundation of China (No. 81170606), and Doctoral Fund of Ministry of Education of China (No. 20120181110087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Audus KL, 2002, J PHARMACOL EXP THER, V301, P402, DOI 10.1124/jpet.301.2.402; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chadha R, 2011, TRANSPLANTATION, V91, P939, DOI 10.1097/TP.0b013e3182126eeb; Chan PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067969; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Falsini B, 2012, LANCET, V379, P2050, DOI 10.1016/S0140-6736(12)60890-3; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Itoh S, 2010, J CLIN IMMUNOL, V30, P235, DOI 10.1007/s10875-009-9366-9; Janeway CA, 1999, IMMUNOL RES, V19, P107, DOI 10.1007/BF02786480; Kim EM, 2013, BLOOD, V121, P5167, DOI 10.1182/blood-2012-11-467753; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Liu PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069617; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pick M, 2012, STEM CELLS, V30, P2700, DOI 10.1002/stem.1242; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Schuerwegh AJ, 1999, CYTOKINE, V11, P783, DOI 10.1006/cyto.1998.0483; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Song M, 2012, ARCH PHARM RES, V35, P245, DOI 10.1007/s12272-012-0205-9; Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tu WW, 2008, BLOOD, V112, P2554, DOI 10.1182/blood-2008-04-152041; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Wunderlich S, 2012, CELL REPROGRAM, V14, P471, DOI 10.1089/cell.2012.0041; Xi JY, 2011, STEM CELLS DEV, V20, P821, DOI 10.1089/scd.2010.0398; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329	48	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114949	10.1371/journal.pone.0114949	http://dx.doi.org/10.1371/journal.pone.0114949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503995	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700075
J	Balakrishna, AM; Basak, S; Manimekalai, MSS; Gruber, G				Balakrishna, Asha Manikkoth; Basak, Sandip; Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard			Crystal Structure of Subunits D and F in Complex Gives Insight into Energy Transmission of the Eukaryotic V-ATPase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; H+-ATPASE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; EPSILON-SUBUNIT; V-1 ATPASE; F-1-ATPASE; RESOLUTION; V-1-ATPASE; MODEL	Eukaryotic V1VO-ATPases hydrolyze ATP in the V-1 domain coupled to ion pumping in V-O. A unique mode of regulation of V-ATPases is the reversible disassembly of V-1 and V-O, which reduces ATPase activity and causes silencing of ion conduction. The subunits D and F are proposed to be key in these enzymatic processes. Here, we describe the structures of two conformations of the subunit DF assembly of Saccharomyces cerevisiae (ScDF) V-ATPase at 3.1 angstrom resolution. Subunit D (ScD) consists of a long pair of alpha-helices connected by a short helix ((79)IGYQVQE(85)) as well as a beta-hairpin region, which is flanked by two flexible loops. The long pair of helices is composed of the N-terminal alpha-helix and the C-terminal helix, showing structural alterations in the two ScDF structures. The entire subunit F (ScF) consists of an N-terminal domain of four beta-strands (beta 1-beta 4) connected by four alpha-helices (alpha 1-alpha 4). alpha 1 and beta 2 are connected via the loop (26)GQITPETQEK(35), which is unique in eukaryotic V-ATPases. Adjacent to the N-terminal domain is a flexible loop, followed by a C-terminal alpha-helix (alpha 5). A perpendicular and extended conformation of helix alpha 5 was observed in the two crystal structures and in solution x-ray scattering experiments, respectively. Fitted into the nucleotide-bound A(3)B(3) structure of the related A-ATP synthase from Enterococcus hirae, the arrangements of the ScDF molecules reflect their central function in ATPase-coupled ion conduction. Furthermore, the flexibility of the terminal helices of both subunits as well as the loop (26)GQITPETQEK(35) provides information about the regulatory step of reversible V1VO disassembly.	[Balakrishna, Asha Manikkoth; Basak, Sandip; Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Basak, sandip/B-8007-2018; Manikkoth Balakrishna, Asha/AFP-1973-2022	Basak, sandip/0000-0003-4018-8020; Manikkoth Balakrishna, Asha/0000-0001-5239-9015	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan. We thank the staff at the Synchrotron Radiation Protein Crystallography Facility (supported by the National Research Program for Genomic Medicine) at beam line 13B1 for expert help with data collection. We sincerely thank Dr. Kamariah Neelagandan for data collection at the 13B1 National Synchrotron Radiation Research Center, Taiwan. We are grateful to Prof. R. Kraut and Dr. G. Tria from the School of Biological Sciences, Nanyang Technological University, for reading the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basak S, 2013, J BIOL CHEM, V288, P11930, DOI 10.1074/jbc.M113.461533; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Guinier A., 1955, SMALL ANGLE SCATTERI, P5; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kluge C, 2003, J BIOENERG BIOMEMBR, V35, P377, DOI 10.1023/A:1025737117382; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Muench SP, 2014, J MOL BIOL, V426, P286, DOI 10.1016/j.jmb.2013.09.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P187, DOI 10.1007/s10863-011-9342-y; Rishikesan S, 2010, BBA-BIOMEMBRANES, V1798, P1961, DOI 10.1016/j.bbamem.2010.06.012; Rishikesan S, 2009, BBA-BIOENERGETICS, V1787, P242, DOI 10.1016/j.bbabio.2009.01.010; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Suzuki T, 2014, NAT CHEM BIOL, V10, P930, DOI [10.1038/nchembio.1635, 10.1038/NCHEMBIO.1635]; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilkens S, 2001, CELL BIOCHEM BIOPHYS, V34, P191, DOI 10.1385/CBB:34:2:191; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	63	34	35	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3183	3196		10.1074/jbc.M114.622688	http://dx.doi.org/10.1074/jbc.M114.622688			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505269	hybrid, Green Published			2022-12-26	WOS:000349456000001
J	Monsellier, E; Redeker, V; Ruiz-Arlandis, G; Bousset, L; Melki, R				Monsellier, Elodie; Redeker, Virginie; Ruiz-Arlandis, Gemma; Bousset, Luc; Melki, Ronald			Molecular Interaction between the Chaperone Hsc70 and the N-terminal Flank of Huntingtin Exon 1 Modulates Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein (HSP); Huntington Disease; Mass Spectrometry (MS); Molecular Chaperone; Neurodegenerative Disease; Polyglutamine; Protein Aggregation	FIBRILLAR ALPHA-SYNUCLEIN; INTERMEDIATE CAG REPEATS; AMYLOID-LIKE FIBRILS; POLYGLUTAMINE AGGREGATION; MUTANT HUNTINGTIN; ATAXIN-3 FIBRILLOGENESIS; INTRANUCLEAR INCLUSIONS; SUBSTRATE-SPECIFICITY; DISEASE PATHOLOGY; DNAK CHAPERONE	Background: Hsc70 has an alleviating effect on the toxicity of polyglutamine (polyQ)-containing proteins in vivo. Results: Hsc70 binds specifically the N-terminal flank of huntingtin exon 1. Conclusion: Hsc70 interaction with huntingtin exon 1 N-terminal flank affects the conformation of the resulting assemblies. Significance: We identify the surface interfaces between Hsc70 and huntingtin exon 1, which allows the design of future therapeutic tools. The aggregation of polyglutamine (polyQ)-containing proteins is at the origin of nine neurodegenerative diseases. Molecular chaperones prevent the aggregation of polyQ-containing proteins. The exact mechanism by which they interact with polyQ-containing, aggregation-prone proteins and interfere with their assembly is unknown. Here we dissect the mechanism of interaction between a huntingtin exon 1 fragment of increasing polyQ lengths (HttEx1Qn), the aggregation of which is tightly associated with Huntington's disease, and molecular chaperone Hsc70. We show that Hsc70, together with its Hsp40 co-chaperones, inhibits HttEx1Qn aggregation and modifies the structural, seeding, and infectious properties of the resulting fibrils in a polyQ-independent manner. We demonstrate that Hsc70 binds the 17-residue-long N-terminal flank of HttEx1Qn, and we map Hsc70-HttEx1Qn surface interfaces at the residue level. Finally, we show that this interaction competes with homotypic interactions between the N termini of different HttEx1Qn molecules that trigger the aggregation process. Our results lay the foundations of future therapeutic strategies targeting huntingtin aggregation in Huntington disease.	[Monsellier, Elodie; Redeker, Virginie; Ruiz-Arlandis, Gemma; Bousset, Luc; Melki, Ronald] CNRS, Neurosci Paris Saclay Inst, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Monsellier, E (corresponding author), CNRS, Neurosci Paris Saclay Inst, Ave Terrasse, F-91198 Gif Sur Yvette, France.	monsellier@lebs.cnrs-gif.fr; melki@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018; Monsellier, Elodie/GRF-5106-2022	Redeker, Virginie/0000-0003-2694-8388; Monsellier, Elodie/0000-0001-7944-7531; bousset, luc/0000-0002-0433-4337	Agence Nationale de la Recherche [ANR-11-BSV8-021-01]; CNRS; Human Frontier Science Program; European Community [264508]; Fondation Bettencourt-Schueller	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); European Community(European Commission); Fondation Bettencourt-Schueller	This work was supported by Agence Nationale de la Recherche Grant ANR-11-BSV8-021-01, CNRS, the Human Frontier Science Program, the European Community's Seventh Framework Program FP7/2010, Marie Curie Actions Grant 264508, and a "Coup d'Elan a la Recherche Francaise" award from Fondation Bettencourt-Schueller.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Groen JL, 2010, J NEUROL NEUROSUR PS, V81, P228, DOI 10.1136/jnnp.2008.170902; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Ha AHD, 2011, POSTGRAD MED, V123, P116, DOI 10.3810/pgm.2011.09.2466; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Jayaraman M, 2012, BIOCHEMISTRY-US, V51, P2706, DOI 10.1021/bi3000929; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Kenney C, 2007, MOVEMENT DISORD, V22, P127, DOI 10.1002/mds.21195; Killoran A, 2013, NEUROLOGY, V80, P2022, DOI 10.1212/WNL.0b013e318294b304; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Kurouski D, 2013, FEBS LETT, V587, P1638, DOI 10.1016/j.febslet.2013.03.038; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Redeker V, 2010, FEBS J, V277, P5112, DOI 10.1111/j.1742-4658.2010.07915.x; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tagawa K, 2007, J NEUROSCI, V27, P868, DOI 10.1523/JNEUROSCI.4522-06.2007; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	70	62	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2560	2576		10.1074/jbc.M114.603332	http://dx.doi.org/10.1074/jbc.M114.603332			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505179	Green Published, hybrid			2022-12-26	WOS:000349310700004
J	Jeannot, K; Diancourt, L; Vaux, S; Thouverez, M; Ribeiro, A; Coignard, B; Courvalin, P; Brisse, S				Jeannot, Katy; Diancourt, Laure; Vaux, Sophie; Thouverez, Michelle; Ribeiro, Amandina; Coignard, Bruno; Courvalin, Patrice; Brisse, Sylvain			Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France	PLOS ONE			English	Article							PREVALENT OXA CARBAPENEMASES; ANTIBIOTIC-RESISTANCE; STRAINS; OUTBREAK; CLONE; IDENTIFICATION; HOSPITALS; EMERGENCE; EVOLUTION; PCR	Carbapenem-resistant Acinetobacter baumannii have emerged globally. The objective of this study was to investigate the epidemiology, clonal diversity and resistance mechanisms of imipenem non-susceptible A. baumannii isolates in France. Between December 2010 and August 2011, 132 notifications were collected, including 37 outbreaks corresponding to 242 cases (2 to 55 per cluster). Multilocus sequence typing, pulsed-field gel electrophoresis (PFGE) and characterisation of carbapenemase-encoding genes were performed on 110 non-repetitive isolates. Gene bla(OXA-23) was the most frequently detected (82%), followed by bla(OXA-24) (11%) and bla(OXA-58) (7%). Eleven sequence types (ST) were distinguished, among which sequence types ST1, ST2 (64%), ST20, ST25, ST85 and ST107. Isolates from epidemiological clusters had the same ST and resistance genes, indicating probable transmission within centres. In contrast, PFGE types of isolates differed among centres, arguing against transmission among centers. This study provides the first epidemiological snapshot of the population of A. baumannii with reduced susceptibility to carbapenems from France, and further underlines the predominance of international clones.	[Jeannot, Katy; Ribeiro, Amandina; Courvalin, Patrice] Inst Pasteur, Ctr Natl Reference Resistance Antibiot, Unite Agents Antibacteriens, Paris, France; [Diancourt, Laure; Brisse, Sylvain] Inst Pasteur, Paris, France; [Vaux, Sophie] French Inst Publ Hlth Surveillance InVS, St Maurice, France; [Thouverez, Michelle] CHRU Jean Minjoz, Lab Epidemiol & Hyg Hosp, Besancon, France; [Brisse, Sylvain] CNRS, UMR3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute of Public Health Surveillance; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brisse, S (corresponding author), Inst Pasteur, Paris, France.	Sylvain.Brisse@pasteur.fr	Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Jeannot, katy/0000-0002-4634-8550; Vaux, Sophie/0000-0001-6648-6320; DIANCOURT, Laure/0000-0002-9670-3274	Institut Pasteur; French Ministry of Health through the French Institute for Public Health Surveillance	Institut Pasteur(European Commission); French Ministry of Health through the French Institute for Public Health Surveillance	This work was supported by the Institut Pasteur and the French Ministry of Health through the French Institute for Public Health Surveillance (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Alsultan AA, 2013, J MED MICROBIOL, V62, P885, DOI 10.1099/jmm.0.057216-0; [Anonymous], 2013, RESEAU ALERTE INVEST; Bonnin RA, 2013, EXPERT REV ANTI-INFE, V11, P571, DOI [10.1586/ERI.13.38, 10.1586/eri.13.38]; Bonnin RA, 2013, EMERG INFECT DIS, V19, P822, DOI 10.3201/eid1905.121618; Bourdon N, 2011, J ANTIMICROB CHEMOTH, V66, P713, DOI 10.1093/jac/dkq524; Coignard B, 2006, EUROSURVEILLANCE, V11; D'Arezzo S, 2011, J ANTIMICROB CHEMOTH, V66, P54, DOI 10.1093/jac/dkq407; Decousser JW, 2013, EURO SURVEILL, V18; Desenclos JC, 2009, EUROSURVEILLANCE, V14, P1; Di Popolo A, 2011, CLIN MICROBIOL INFEC, V17, P197, DOI 10.1111/j.1469-0691.2010.03254.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Endo S, 2012, J ANTIMICROB CHEMOTH, V67, P1623, DOI 10.1093/jac/dks094; European Centre for Disease Prevention and Control, EUR ANT RES SURV NET; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; Heritier C, 2005, J ANTIMICROB CHEMOTH, V55, P115, DOI 10.1093/jac/dkh500; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Higgins PG, 2009, J ANTIMICROB CHEMOTH; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Koh TH, 2012, EPIDEMIOL INFECT, V140, P535, DOI 10.1017/S0950268811001129; Liakopoulos A., 2012, EURO SURVEILL, V17; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Naas T, 2006, EMERG INFECT DIS, V12, P1214, DOI 10.3201/eid1708.051547; National_ Committee_ for_ Clinical_ Laboratory_ Standards, 2010, PERF STAND ANT SUS S; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; TANKOVIC J, 1994, J CLIN MICROBIOL, V32, P2677, DOI 10.1128/JCM.32.11.2677-2681.1994; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vaux S, 2011, B EPIDEMIOLOGIQUE HE, V31-32, P355; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	39	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115452	10.1371/journal.pone.0115452	http://dx.doi.org/10.1371/journal.pone.0115452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517732	gold, Green Published			2022-12-26	WOS:000347215600067
J	Kawamoto, R; Ninomiya, D; Hasegawa, Y; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T				Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru			Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Elderly Persons	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; RISK; LIPOPROTEIN; ANTIOXIDANT; MEN	Chronic kidney disease (CKD) is a major public health problem. However, few studies have examined the significance of serum bilirubin as a risk factor for the development of CKD in the general Japanese population. The subjects comprised 413 men (mean age: 79 +/- 9 years; (range, 60-100 years) and 637 women (mean age: 81 +/- 8 years; range, 60-106 years) who visited the medical department of Seiyo Municipal Nomura Hospital. We examined the relationship between increased serum bilirubin and renal function that was evaluated by estimated glomerular filtration rate (eGFR) using CKD-EPI equations modified by a Japanese coefficient. Stepwise multiple regression analysis with eGFR as the objective variable, and adjusted risk factors as the explanatory variables, showed that serum bilirubin (beta=0.11, P<0.001) was significantly and independently associated with eGFR, in addition to gender, age, prevalence of antihypertensive medication, triglycerides, prevalence of antidiabetic medication, and serum uric acid. Compared with stages 1+2 (eGFR >= 60.0 ml/min/1.73 m(2)), mean multivariate-adjusted odds ratio {95% (confidence interval (CI)} for hypobilirubinemia (first quartile, <0.52 mg/dL) was 3.52 (range: 1.88-6.59). Next, to control potential confounding factors, data were further stratified by gender, age, medication (antihypertensive, antidyslipidemic, and antidiabetic agents), and prevalence of cardiovascular disease. The standardized coefficient for eGFR was significant in both groups, and there was no interaction between the groups. Our data demonstrated an independent positive association between serum bilirubin and eGFR in both genders. Low serum bilirubin level would be useful as a potential risk factor for renal function.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo, Ehime, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan.	rykawamo@m.ehime.ca.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for the Development of the Community	Foundation for the Development of the Community	This study was supported, in part, by a grant-in-aid from the Foundation for the Development of the Community (2014). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Ishizaka N, 2007, HYPERTENS RES, V30, P1035, DOI 10.1291/hypres.30.1035; Kalkan GY, 2014, ANGIOLOGY, V65, P308, DOI 10.1177/0003319713507627; Kawamoto R, 2014, PLOS ONE IN PRESS; Kumar A, 2007, J TROP PEDIATRICS, V53, P69, DOI 10.1093/tropej/fml060; Levey AS, 2007, AM J KIDNEY DIS, V49, P175, DOI 10.1053/j.ajkd.2006.12.013; Mazzone GL, 2009, BIOCHEM BIOPH RES CO, V386, P338, DOI 10.1016/j.bbrc.2009.06.029; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Ollinger R, 2007, CELL CYCLE, V6, P39, DOI 10.4161/cc.6.1.3700; Ohnaka K, 2010, EXPERT REV ENDOCRINO, V5, P891, DOI [10.1586/eem.10.65, 10.1586/EEM.10.65]; Ryu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0075178; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Schwertner HA, 2000, ATHEROSCLEROSIS, V150, P381, DOI 10.1016/S0021-9150(99)00387-1; Shin HS, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-29; Stec DE, 2013, AM J HYPERTENS, V26, P918, DOI 10.1093/ajh/hpt038; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Targher G, 2009, KIDNEY INT, V75, P863, DOI 10.1038/ki.2008.677; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Vera T, 2010, AM J PHYSIOL-REG I, V299, pR1044, DOI 10.1152/ajpregu.00316.2010; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024	26	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115294	10.1371/journal.pone.0115294	http://dx.doi.org/10.1371/journal.pone.0115294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514359	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300050
J	Kelly, NI; Alzaid, A; Nash, GW; Gamperl, AK				Kelly, Nick I.; Alzaid, Abdullah; Nash, Gordon W.; Gamperl, A. Kurt			Metabolic Depression in Cunner (Tautogolabrus adspersus) Is Influenced by Ontogeny, and Enhances Thermal Tolerance	PLOS ONE			English	Article							COD GADUS-MORHUA; JUVENILE ATLANTIC COD; ANOXIA TOLERANCE; AEROBIC SCOPE; BODY-MASS; TEMPERATURE; FISH; RESPONSES; ANIMALS; WINTER	To examine the effect of ontogeny on metabolic depression in the cunner (Tautogolabrus adspersus), and to understand how ontogeny and the ability to metabolically depress influence this species' upper thermal tolerance: 1) the metabolic rate of 9 degrees C-acclimated cunner of three size classes [0.2-0.5 g, young of the year (YOY); 3-6 g, small; and 80-120 g, large (adult)] was measured during a 2 degrees C per day decrease in temperature; and 2) the metabolic response of the same three size classes of cunner to an acute thermal challenge [2 degrees C h(-1) from 10 degrees C until Critical Thermal Maximum, CTMax] was examined, and compared to that of the Atlantic cod (Gadus morhua). The onset-temperature for metabolic depression in cunner increased with body size, i.e. from 5 degrees C in YOY cunner to 7 degrees C in adults. In contrast, the extent of metabolic depression was similar to 80% (Q(10)=similar to 15) for YOY fish similar to 65% (Q(10)=similar to 8) for small fish and similar to 55% (Q(10)=similar to 5) for adults, and this resulted in the metabolic scaling exponent (b) gradually increasing from 0.84 to 0.92 between 9 degrees C to 1 degrees C. All size classes of cunner had significantly (approximately 60%) lower routine metabolic rates at 10 degrees C than Atlantic cod. However, there was no species' difference in the temperature-induced maximum metabolic rate, and this resulted in factorial metabolic scope values that were more than two-fold greater for cunner, and CTMax values that were 6-9 degrees C higher (similar to 21 vs. 28 degrees C). These results: 1) show that ontogeny influences the temperature of initiation and the extent of metabolic depression in cunner, but not O-2 consumption when in a hypometabolic state; and 2) suggest that the evolution of cold-induced metabolic depression in this northern wrasse species has not resulted in a trade-off with upper thermal tolerance, but instead, an enhancement of this species' metabolic plasticity.	[Kelly, Nick I.; Alzaid, Abdullah; Nash, Gordon W.; Gamperl, A. Kurt] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Memorial University Newfoundland	Gamperl, AK (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada.	kgamperl@mun.ca			Natural Sciences and Research Council of Canada	Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Natural Sciences and Research Council of Canada (http://www.nserc-crsng.gc.ca) provided funding for this research to AKG through their Discovery Grants program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster PJ, 1989, BIOL REP, V82; BEAMISH FWH, 1970, J FISH RES BOARD CAN, V27, P1209, DOI 10.1139/f70-143; Benfey TJ, 1997, ENVIRON BIOL FISH, V49, P259, DOI 10.1023/A:1007361231325; Bigelow HB, 1953, FISHES GULF MAINE; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Cargnelli LM, 1997, T AM FISH SOC, V126, P153, DOI 10.1577/1548-8659(1997)126<0153:NFELIE>2.3.CO;2; Carline RF, 2001, T AM FISH SOC, V130, P1211, DOI 10.1577/1548-8659(2001)130&lt;1211:CTMOWA&gt;2.0.CO;2; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Corkum CP, 2009, J EXP ZOOL PART A, V311A, P231, DOI 10.1002/jez.520; COSTA IAS, 2007, THESIS MEMORIAL U NE; Costa IASF, 2013, PHYSIOL BIOCHEM ZOOL, V86, P233, DOI 10.1086/669538; Curran MC, 1992, THESIS MIT; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; DEW C B, 1976, Chesapeake Science, V17, P101, DOI 10.2307/1351052; Gollock MJ, 2006, J EXP BIOL, V209, P2961, DOI 10.1242/jeb.02319; GREEN JM, 1971, CAN J ZOOLOG, V49, P1497, DOI 10.1139/z71-218; GUPPY M, 1994, COMP BIOCHEM PHYS B, V109, P175, DOI 10.1016/0305-0491(94)90001-9; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hansen SL, 2009, J FISH BIOL, V74, P1355, DOI 10.1111/j.1095-8649.2008.02169.x; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Huang QD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082837; Kemp JOG, 2009, AFR ZOOL, V44, P151, DOI 10.3377/004.044.0203; Kerfoot JR, 2012, J EXP ZOOL PART A, V317A, P266, DOI 10.1002/jez.1720; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Lewis JM, 2007, AM J PHYSIOL-REG I, V293, pR474, DOI 10.1152/ajpregu.00594.2006; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Ospina AF, 2004, ENVIRON BIOL FISH, V70, P339, DOI 10.1023/B:EBFI.0000035429.39129.34; Peck MA, 2003, CAN J FISH AQUAT SCI, V60, P929, DOI 10.1139/F03-079; Perez-Casanova JC, 2008, J FISH BIOL, V72, P899, DOI 10.1111/j.1095-8649.2007.01763.x; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Recsetar MS, 2012, T AM FISH SOC, V141, P1433, DOI 10.1080/00028487.2012.694830; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Rome Lawrence C., 1992, P183; SAUNDERS RL, 1963, J FISH RES BOARD CAN, V20, P373, DOI 10.1139/f63-031; Sayer MDJ, 1996, J FISH BIOL, V49, P64, DOI 10.1111/j.1095-8649.1996.tb00005.x; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Scott WB, 1988, ATLANTIC FISHES CANA; Spaas JT, 1960, HYDROBIOLOGIA, V15, P75; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; WALSH PJ, 1983, PHYSIOL ZOOL, V56, P532, DOI 10.1086/physzool.56.4.30155876; Wang T, 2007, SCIENCE, V315, P49, DOI 10.1126/science.1137359	48	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114765	10.1371/journal.pone.0114765	http://dx.doi.org/10.1371/journal.pone.0114765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514755	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000349146300021
J	Zhao, F; Malm, SW; Hinchman, AN; Li, H; Beeks, CG; Klimecki, WT				Zhao, Fei; Malm, Scott W.; Hinchman, Alyssa N.; Li, Hui; Beeks, Connor G.; Klimecki, Walter T.			Arsenite-Induced Pseudo-Hypoxia Results in Loss of Anchorage-Dependent Growth in BEAS-2B Pulmonary Epithelial Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; DRINKING-WATER; NEOPLASTIC TRANSFORMATION; HYDROXYLASE; HIF-1-ALPHA; EXPOSURE; GENES; ADIPOGENESIS; GLYCOLYSIS; METABOLISM	Epidemiology studies have established a strong link between lung cancer and arsenic exposure. Currently, the role of disturbed cellular energy metabolism in carcinogenesis is a focus of scientific interest. Hypoxia inducible factor-1 alpha (HIF-1A) is a key regulator of energy metabolism, and it has been found to accumulate during arsenite exposure under oxygen-replete conditions. We modeled arsenic-exposed human pulmonary epithelial cells in vitro with BEAS-2B, a non-malignant lung epithelial cell line. Constant exposure to 1 mu M arsenite (As) resulted in the early loss of anchorage-dependent growth, measured by soft agar colony formation, beginning at 6 weeks of exposure. This arsenite exposure resulted in HIF-1A accumulation and increased glycolysis, similar to the physiologic response to hypoxia, but in this case under oxygen-replete conditions. This "pseudo-hypoxia" response was necessary for the maximal acquisition of anchorage-independent growth in arsenite-exposed BEAS-2B. The HIF-1A accumulation and induction in glycolysis was sustained throughout a 52 week course of arsenite exposure in BEAS-2B. There was a time-dependent increase in anchorage-independent growth during the exposure to arsenite. When HIF-1A expression was stably suppressed, arsenite-induced glycolysis was abrogated, and the anchorage-independent growth was reduced. These findings establish that arsenite exerts a hypoxia-mimetic effect, which plays an important role in the subsequent gain of malignancy-associated phenotypes.	[Zhao, Fei; Malm, Scott W.; Hinchman, Alyssa N.; Li, Hui; Beeks, Connor G.; Klimecki, Walter T.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Arizona	Klimecki, WT (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	klimecki@pharmacy.arizona.edu	; Zhao, Fei/D-1857-2014	Li, Hui/0000-0001-5578-7259; Malm, Scott/0000-0002-3376-3421; Zhao, Fei/0000-0002-2149-1457	National Institutes of Health and National Institute of Environmental Health Sciences [ES 04940, ES00694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, R03ES023921, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health and National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health and National Institute of Environmental Health Sciences, grants ES 04940 and ES00694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; AMSTAD P, 1988, MOL CARCINOGEN, V1, P151, DOI 10.1002/mc.2940010303; Aposhian H, 1989, REV BIOCHEM TOXICOL, V10, P265; Bolt AM, 2010, TOXICOL LETT, V199, P153, DOI 10.1016/j.toxlet.2010.08.017; Carpenter RL, 2011, BIOCHEM BIOPH RES CO, V414, P533, DOI 10.1016/j.bbrc.2011.09.102; Ganapathy S, 2014, J BIOL CHEM, V289, P5340, DOI 10.1074/jbc.M113.531020; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guo HR, 2004, CANCER EPIDEM BIOMAR, V13, P638; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hou YY, 2013, ENVIRON HEALTH PERSP, V121, P237, DOI 10.1289/ehp.1205731; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Li GW, 2011, J CELL PHYSIOL, V226, P3225, DOI 10.1002/jcp.22683; Li Q, 2006, TOXICOL APPL PHARM, V213, P245, DOI 10.1016/j.taap.2005.11.006; Li YN, 2014, TOXICOL LETT, V224, P165, DOI 10.1016/j.toxlet.2013.10.029; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazurek S, 1999, J CELL PHYSIOL, V181, P136; McNeill LA, 2002, BIOORG MED CHEM LETT, V12, P1547, DOI 10.1016/S0960-894X(02)00219-6; Moran LA., 2012, PRINCIPLES BIOCH; Ribeiro CAD, 2008, ENVIRON TOXICOL PHAR, V25, P304, DOI 10.1016/j.etap.2007.10.033; PIZER LI, 1963, J BIOL CHEM, V238, P3934; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Stueckle TA, 2012, TOXICOL APPL PHARM, V261, P204, DOI 10.1016/j.taap.2012.04.003; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; Xu Y, 2013, TOXICOL APPL PHARM, V272, P542, DOI 10.1016/j.taap.2013.06.017; Zhang T, 2012, TOXICOL SCI, V130, P298, DOI 10.1093/toxsci/kfs240; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	41	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114549	10.1371/journal.pone.0114549	http://dx.doi.org/10.1371/journal.pone.0114549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513814	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300015
J	Zubillaga, M; Skewes, O; Soto, N; Rabinovich, JE; Colchero, F				Zubillaga, Maria; Skewes, Oscar; Soto, Nicolas; Rabinovich, Jorge E.; Colchero, Fernando			Bayesian Inference on the Effect of Density Dependence and Weather on a Guanaco Population from Chile	PLOS ONE			English	Article							VICUGNA-VICUGNA; TIME-SERIES; MODEL; CLIMATE; DYNAMICS; MANAGEMENT; SURVIVAL; DROUGHT; HARVEST; ELK	Understanding the mechanisms that drive population dynamics is fundamental for management of wild populations. The guanaco (Lama guanicoe) is one of two wild camelid species in South America. We evaluated the effects of density dependence and weather variables on population regulation based on a time series of 36 years of population sampling of guanacos in Tierra del Fuego, Chile. The population density varied between 2.7 and 30.7 guanaco/km(2), with an apparent monotonic growth during the first 25 years; however, in the last 10 years the population has shown large fluctuations, suggesting that it might have reached its carrying capacity. We used a Bayesian state-space framework and model selection to determine the effect of density and environmental variables on guanaco population dynamics. Our results show that the population is under density dependent regulation and that it is currently fluctuating around an average carrying capacity of 45,000 guanacos. We also found a significant positive effect of previous winter temperature while sheep density has a strong negative effect on the guanaco population growth. We conclude that there are significant density dependent processes and that climate as well as competition with domestic species have important effects determining the population size of guanacos, with important implications for management and conservation.	[Zubillaga, Maria; Rabinovich, Jorge E.] Univ Nacl La Plata, Ctr Estudios Parasitol & Vectores CEPAV, CONICET CCT La Plata, La Plata, Argentina; [Colchero, Fernando] Univ Southern Denmark, Dept Math & Comp Sci IMADA, DK-5230 Odense, Denmark; [Colchero, Fernando] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging MaxO, DK-5230 Odense, Denmark; [Skewes, Oscar] Univ Concepcion, Dept Ciencias Pecuarias, Chillan, Chile; [Soto, Nicolas] Serv Agr Ganadero, Dept Prot Recursos Nat, Santiago, Chile	University of Southern Denmark; University of Southern Denmark; Universidad de Concepcion	Zubillaga, M (corresponding author), Univ Nacl La Plata, Ctr Estudios Parasitol & Vectores CEPAV, CONICET CCT La Plata, La Plata, Argentina.	mariazubillaga22@gmail.com; colchero@imada.sdu.dk	Rabinovich, Jorge E./AAI-2536-2019; Colchero, Fernando/A-9368-2015	Rabinovich, Jorge E./0000-0002-3792-742X; Colchero, Fernando/0000-0001-8613-4568				Abrams PA, 2009, AM NAT, V174, P321, DOI 10.1086/603627; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Bank MS, 2002, J ZOOL, V258, P215, DOI 10.1017/S0952836902001334; Bardsen BJ, 2012, J ANIM ECOL, V81, P364, DOI 10.1111/j.1365-2656.2011.01913.x; Bateman AW, 2012, J ANIM ECOL, V81, P628, DOI 10.1111/j.1365-2656.2011.01934.x; Bonacic C, 2002, ORYX, V36, P118, DOI 10.1017/S0030605302000182; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Case T. J, 2000, ILLUSTRATED GUIDE TH; Caughley G, 1980, ANAL VERTEBRATE POPU; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Davis D.E., 1987, MANUAL TECNICAS GEST, P233; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; FRANKLIN WL, 1994, WILDLIFE SOC B, V22, P253; Franklin WL, 1997, WILDLIFE SOC B, V25, P65; Fujita H, 1982, IDIA, V397/400, P1; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A., 2004, BAYESIAN DATA ANAL; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; HORN HS, 1968, ECOLOGY, V49, P776, DOI 10.2307/1935548; Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753; Koons DN, 2012, J MAMMAL, V93, P475, DOI 10.1644/11-MAMM-A-281.1; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; McCullough DR, 1999, J MAMMAL, V80, P1130, DOI 10.2307/1383164; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOUSSALLI E, 1986, CAN J FISH AQUAT SCI, V43, P135, DOI 10.1139/f86-014; Novaro AJ, 2009, MAMMALIA, V73, P148, DOI 10.1515/MAMM.2009.016; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Patterson BR, 2002, OECOLOGIA, V130, P62, DOI 10.1007/s004420100783; RABINOVICH JE, 1985, ECOL MODEL, V30, P275, DOI 10.1016/0304-3800(85)90071-7; Rabinvich J.E., 1991, P337; Raedeke KJ, 1978, GUANACO MAGALLANES; Rey A, 2012, SMALL RUMINANT RES, V107, P92, DOI 10.1016/j.smallrumres.2012.05.009; Sarno RJ, 1999, J APPL ECOL, V36, P937, DOI 10.1046/j.1365-2664.1999.00449.x; Sarno RJ, 1999, J MAMMAL, V80, P1158, DOI 10.2307/1383166; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; Serrano E, 2008, BIOL LETTERS, V4, P512, DOI 10.1098/rsbl.2008.0221; Shaw AK, 2012, J MAMMAL, V93, P658, DOI 10.1644/11-MAMM-A-257.1; SKOGLAND T, 1986, J WILDLIFE MANAGE, V50, P314, DOI 10.2307/3801919; Soto N, 2010, DISTRIBUCION ABUNDAN; Stewart KM, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)167[1:HOBNAE]2.0.CO;2; Taper ML, 2002, J WILDLIFE MANAGE, V66, P106, DOI 10.2307/3802877; Team. RDC, 2007, R LANG ENV STAT COMP; Telleria JL, 1986, MANUAL CENSO VERTEBR; Zubillaga M, 2014, F1000RESEARCH	51	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115307	10.1371/journal.pone.0115307	http://dx.doi.org/10.1371/journal.pone.0115307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514510	Green Published, gold			2022-12-26	WOS:000349146300051
J	Falk, MK; Singh, A; Faber, C; Nissen, MH; Hviid, T; Sorensen, TL				Falk, Mads Kruger; Singh, Amardeep; Faber, Carsten; Nissen, Mogens Holst; Hviid, Thomas; Sorensen, Torben Lykke			CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD	PLOS ONE			English	Article							MACULAR DEGENERATION; SUBRETINAL MICROGLIA; RETINAL MICROGLIA; ANIMAL-MODEL; T-CELLS; EXPRESSION; PATHOGENESIS; CHEMOKINE; ACCUMULATION; MONOCYTES	Purpose: The chemokine receptors CX3CR1 and CCR2 have been implicated in the development of age-related macular degeneration (AMD). The evidence is mainly derived from experimental cell studies and murine models of AMD. The purpose of this study was to investigate the association between expression of CX3CR1 and CCR2 on different leukocyte subsets and AMD. Furthermore we measured the plasma levels of ligands CX3CL1 and CCL2. Methods: Patients attending our department were asked to participate in the study. The diagnosis of AMD was based on clinical examination and multimodal imaging techniques. Chemokine plasma level and chemokine receptor expression were measured by flow-cytometry. Results: A total of 150 participants were included. We found a significantly lower expression of CX3CR1 on CD8(+) T cells in the neovascular AMD group compared to the control group (p=0.04). We found a significant positive correlation between CCR2 and CX3CR1 expression on CD8(+) cells (r=0.727, p=0.0001). We found no difference in plasma levels of CX3CL1 and CCL2 among the groups. Conclusions: Our results show a down regulation of CX3CR1 on CD8(+) cells; this correlated to a low expression of CCR2 on CD8(+) cells. Further studies are needed to elucidate the possible role of this cell type in AMD development.	[Falk, Mads Kruger; Singh, Amardeep; Sorensen, Torben Lykke] Univ Copenhagen, Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark; [Falk, Mads Kruger; Singh, Amardeep; Hviid, Thomas; Sorensen, Torben Lykke] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Faber, Carsten; Nissen, Mogens Holst] Univ Copenhagen, Fac Hlth Sci, Dept Microbiol Immunol & Int Hlth, Copenhagen, Denmark; [Hviid, Thomas] Univ Copenhagen, Hosp Roskilde, Dept Clin Biochem, Ctr Immune Regulat & Reprod Immunol, Roskilde, Denmark; [Faber, Carsten] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Falk, MK (corresponding author), Univ Copenhagen, Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark.	madskrugerfalk@gmail.com	Nissen, Mogens/B-4825-2008; Faber, Carsten/I-4150-2013; Faber, Carsten/N-3210-2019; Singh, Amardeep/ABI-4544-2020	Nissen, Mogens/0000-0001-7729-8667; Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; 	Danish Eye Health Society (Vaern om Synet); Danish Eye Research foundation; Synoptik Foundation; Region Zealand's Research Fund	Danish Eye Health Society (Vaern om Synet); Danish Eye Research foundation; Synoptik Foundation; Region Zealand's Research Fund	This study was supported by the Danish Eye Health Society (Vaern om Synet) - www.vos.dk, the Danish Eye Research foundation - www.dkblind.dk, Region Zealand's Research Fund -http://www.regionsjaelland.dk/sundhed/forskning/praktisk%20om%20forskning/sider/den-regionale-forskningsfond.aspx, and the Synoptik Foundation http://synoptik-fonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bloch SB, 2013, ACTA OPHTHALMOL, V91, P42, DOI 10.1111/j.1755-3768.2011.02268.x; Burgisser P, 2007, CYTOM PART A, V71A, P632, DOI 10.1002/cyto.a.20414; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Faber C, 2013, OPHTHALMOLOGY, V120, P2310, DOI 10.1016/j.ophtha.2013.04.014; Falk MK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-22; Falk MK, 2014, INVEST OPHTHALMOL VI; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Grunin M, 2012, INVEST OPHTH VIS SCI, V53, P5292, DOI 10.1167/iovs.11-9165; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mizutani T, 2013, INVEST OPHTH VIS SCI, V54, P1564, DOI 10.1167/iovs.11-9095; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Raoul W, 2010, J NEUROINFLAMM, V7, P87; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Singh A, 2013, OPHTHALMOLOGY, V120, P1029, DOI 10.1016/j.ophtha.2012.11.002; Singh A, 2012, AM J OPHTHALMOL, V154, P193, DOI 10.1016/j.ajo.2012.01.036; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1	42	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e112473	10.1371/journal.pone.0112473	http://dx.doi.org/10.1371/journal.pone.0112473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503251	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100004
J	Schirutschke, H; Gladrow, L; Norkus, C; Parmentier, SP; Hohenstein, B; Hugo, CPM				Schirutschke, Holger; Gladrow, Lars; Norkus, Christian; Parmentier, Simon Paul; Hohenstein, Bernd; Hugo, Christian P. M.			A New Apparatus for Standardized Rat Kidney Biopsy	PLOS ONE			English	Article							MODEL	Survival biopsies are frequently applied in rat kidney disease models, but several drawbacks such as surgical kidney trauma, bleeding risk and variable loss of kidney tissue are still unsolved. Therefore, we developed an easy-to-use core biopsy instrument and evaluated whether two consecutive kidney biopsies within the same kidney can be carried out in a standardized manner. On day 0, 18 Lewis rats underwent a right nephrectomy and 9 of these rats a subsequent first biopsy of the left kidney (Bx group). 9 control rats had a sham biopsy of the left kidney (Ctrl group). On day 7, a second kidney biopsy/sham biopsy was performed. On day 42, all animals were sacrificed and their kidneys were removed for histology. Biopsy cylinders contained 57 +/- 28 glomeruli per transversal section, representing an adequate sample size. PAS staining showed that the biopsy depth was limited to the renal cortex whereas surgical tissue damage was limited to the area immediately adjacent to the taken biopsy cylinder. On day 42, the reduction of functional renal mass after two biopsies was only 5.2% and no differences of body weight, blood pressure, proteinuria, serum creatinine, glomerulosclerosis, interstitial fibrosis or number of ED-1 positive macrophages were found between both groups. In summary, our apparatus offers a safe method to perform repetitive kidney biopsies with minimal trauma and sufficient sample size and quality even in experimental disease models restricted to one single kidney.	[Schirutschke, Holger; Parmentier, Simon Paul; Hohenstein, Bernd; Hugo, Christian P. M.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Div Nephrol, D-01062 Dresden, Germany; [Gladrow, Lars; Norkus, Christian] Tech Univ Dresden, Inst Engn Mech, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Schirutschke, H (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Div Nephrol, D-01062 Dresden, Germany.	Holger.Schirutschke@uniklinikum-dresden.de			Deutsche Forschungsgemeinschaft [HU 600/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (grant no. HU 600/6-1, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	IRUELAARISPE L, 1995, AM J PATHOL, V147, P1715; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Keller K, 2006, NEPHROL DIAL TRANSPL, V21, P2724, DOI 10.1093/ndt/gfl340; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; MORRISON AB, 1962, LAB INVEST, V11, P321; Nangaku M, 1997, KIDNEY INT, V52, P182, DOI 10.1038/ki.1997.318; Wittmann S, 2008, NEPHRON EXP NEPHROL, V108, P45, DOI 10.1159/000116112; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417	8	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115368	10.1371/journal.pone.0115368	http://dx.doi.org/10.1371/journal.pone.0115368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506931	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100071
J	Feuillie, C; Merheb, MM; Gillet, B; Montagnac, G; Daniel, I; Hanni, C				Feuillie, Cecile; Merheb, Maxime M.; Gillet, Benjamin; Montagnac, Gilles; Daniel, Isabelle; Haenni, Catherine			Detection of DNA Sequences Refractory to PCR Amplification Using a Biophysical SERRS Assay (Surface Enhanced Resonant Raman Spectroscopy)	PLOS ONE			English	Article							ANCIENT DNA; ENZYMATIC AMPLIFICATION; SPECIES IDENTIFICATION; NONENZYMATIC DETECTION; DEOXYRIBONUCLEIC-ACID; ABASIC SITE; SCATTERING; POLYMERASE; DAMAGE; NANOPARTICLES	The analysis of ancient or processed DNA samples is often a great challenge, because traditional Polymerase Chain Reaction - based amplification is impeded by DNA damage. Blocking lesions such as abasic sites are known to block the bypass of DNA polymerases, thus stopping primer elongation. In the present work, we applied the SERRS-hybridization assay, a fully non-enzymatic method, to the detection of DNA refractory to PCR amplification. This method combines specific hybridization with detection by Surface Enhanced Resonant Raman Scattering (SERRS). It allows the detection of a series of double-stranded DNA molecules containing a varying number of abasic sites on both strands, when PCR failed to detect the most degraded sequences. Our SERRS approach can quickly detect DNA molecules without any need for DNA repair. This assay could be applied as a pre-requisite analysis prior to enzymatic reparation or amplification. A whole new set of samples, both forensic and archaeological, could then deliver information that was not yet available due to a high degree of DNA damage.	[Feuillie, Cecile; Montagnac, Gilles; Daniel, Isabelle] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Lab Geol Lyon,UMR 5276, F-69364 Lyon 07, France; [Merheb, Maxime M.; Gillet, Benjamin; Haenni, Catherine] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,UMR 5242, F-69364 Lyon 07, France; [Gillet, Benjamin; Haenni, Catherine] Ecole Normale Super Lyon, CNRS, Plateforme Natl Paleogenet PALGENE, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Feuillie, C (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	cecile.feuillie@gmail.com	Montagnac, Gilles/S-6440-2019; Daniel, Isabelle/D-2677-2012; Gillet, Benjamin/ABD-6704-2020	Montagnac, Gilles/0000-0001-9938-0282; Daniel, Isabelle/0000-0002-1448-7919; 	Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque"; Interdisciplinary program of Ecole Normale Superieure de Lyon; Region Rhone-Alpes CIBLE	Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque"; Interdisciplinary program of Ecole Normale Superieure de Lyon; Region Rhone-Alpes CIBLE(Region Auvergne-Rhone-Alpes)	The project was supported by the Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque", the Interdisciplinary program of Ecole Normale Superieure de Lyon and by the Region Rhone-Alpes CIBLE 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007; Barnes I, 2000, J ARCHAEOL SCI, V27, P91, DOI 10.1006/jasc.1999.0440; Beaulieu M, 2001, NUCLEIC ACIDS RES, V29, P1114, DOI 10.1093/nar/29.5.1114; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brotherton P, 2008, FORENS SCI INT-GEN S, V1, P19, DOI 10.1016/j.fsigss.2007.10.111; d'Abbadie M, 2007, NAT BIOTECHNOL, V25, P939, DOI 10.1038/nbt1321; Fajardo V, 2006, J AGR FOOD CHEM, V54, P1144, DOI 10.1021/jf051766r; Faulds K, 2004, ANAL CHEM, V76, P412, DOI 10.1021/ac035060c; Faulds K, 2007, ANGEW CHEM INT EDIT, V46, P1829, DOI 10.1002/anie.200604265; Feuillie C, 2012, ANAL BIOANAL CHEM; Feuillie C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017847; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graham D, 1997, ANAL CHEM, V69, P4703, DOI 10.1021/ac970657b; Graham D, 2008, CHEM SOC REV, V37, P1042, DOI 10.1039/b707941a; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hill HD, 2007, ANAL CHEM, V79, P9218, DOI 10.1021/ac701626y; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Jensen L, 2006, J PHYS CHEM A, V110, P5973, DOI 10.1021/jp0610867; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Maher RC, 2002, CHEM PHYS LETT, V352, P378, DOI 10.1016/S0009-2614(01)01474-9; McDonald JP, 2006, NUCL ACIDS RES, V34; Monaghan PB, 2007, ANAL CHEM, V79, P2844, DOI 10.1021/ac061769i; Moretti T, 1998, BIOTECHNIQUES, V25, P716; Newman ME, 2002, J ARCHAEOL SCI, V29, P77, DOI 10.1006/jasc.2001.0688; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Rizzi E, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-21; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Sikorsky JA, 2007, BIOCHEM BIOPH RES CO, V355, P431, DOI 10.1016/j.bbrc.2007.01.169; Song CX, 2014, ANAL CHIM ACTA, V827, P74, DOI 10.1016/j.aca.2014.04.006; Storhoff JJ, 2004, BIOSENS BIOELECTRON, V19, P875, DOI 10.1016/j.bios.2003.08.014; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wolf C, 1999, J AGR FOOD CHEM, V47, P1350, DOI 10.1021/jf9808426; Wozney KM, 2012, FORENSIC SCI INT, V219, P106, DOI 10.1016/j.forsciint.2011.12.006; Zhao XJ, 2003, J AM CHEM SOC, V125, P11474, DOI 10.1021/ja0358854	47	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114148	10.1371/journal.pone.0114148	http://dx.doi.org/10.1371/journal.pone.0114148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502338	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400022
J	Giles, GE; Mahoney, CR; Brunye, TT; Taylor, HA; Kanarek, RB				Giles, Grace E.; Mahoney, Caroline R.; Brunye, Tad T.; Taylor, Holly A.; Kanarek, Robin B.			Stress Effects on Mood, HPA Axis, and Autonomic Response: Comparison of Three Psychosocial Stress Paradigms	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; HEALTHY-YOUNG MEN; WORKING-MEMORY; CORTISOL RESPONSES; MATH-ANXIETY; COGNITIVE PERFORMANCE; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; MENSTRUAL-CYCLE; HEART-RATE	Extensive experimental psychology research has attempted to parse the complex relationship between psychosocial stress, mood, cognitive performance, and physiological changes. To do so, it is necessary to have effective, validated methods to experimentally induce psychosocial stress. The Trier Social Stress Test (TSST) is the most commonly used method of experimentally inducing psychosocial stress, but it is resource intensive. Less resource intense psychosocial stress tasks include the Socially Evaluative Cold Pressor Task (SECPT) and a computerized mental arithmetic task (MAT). These tasks effectively produce a physiological and psychological stress response and have the benefits of requiring fewer experimenters and affording data collection from multiple participants simultaneously. The objective of this study was to compare the magnitude and duration of these three experimental psychosocial stress induction paradigms. On each of four separate days, participants completed either a control non-stressful task or one of the three experimental stressors: the TSST, SECPT, or MAT. We measured mood, working memory performance, salivary cortisol and alpha-amylase (AA), and heart rate. The TSST and SECPT exerted the most robust effects on mood and physiological measures. TSST effects were generally evident immediately post-stress as well as 10- and 20-minutes after stress cessation, whereas SECPT effects were generally limited to the duration of the stressor. The stress duration is a key determinant when planning a study that utilizes an experimental stressor, as researchers may be interested in collecting dependent measures prior to stress cessation. In this way, the TSST would allow the investigator a longer window to administer tasks of interest.	[Giles, Grace E.; Mahoney, Caroline R.; Brunye, Tad T.; Taylor, Holly A.; Kanarek, Robin B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Giles, GE (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	grace.giles@tufts.edu						Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Backhaus J, 2004, PSYCHONEUROENDOCRINO, V29, P1184, DOI 10.1016/j.psyneuen.2004.01.010; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; Banderet LE, 1989, BRAIN RES B, V22, P851; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Brunye TT, 2013, LEARN INDIVID DIFFER, V27, P1, DOI 10.1016/j.lindif.2013.06.008; Childs E, 2006, PSYCHOPHYSIOLOGY, V43, P366, DOI 10.1111/j.1469-8986.2006.00414.x; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Hamada Toshihiko, 2006, Rinsho Byori, V54, P329; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Kanarek RB, 2004, PSYCHOPHARMACOLOGY, V173, P57, DOI 10.1007/s00213-003-1699-0; Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Kudielka BM, 2004, INT J BEHAV MED, V11, P116, DOI 10.1207/s15327558ijbm1102_8; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kuhlmann S, 2005, PSYCHOPHARMACOLOGY, V183, P65, DOI 10.1007/s00213-005-0143-z; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; Lieberman HR, 1996, AVIAT SPACE ENVIR MD, V67, P841; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Maheu FS, 2005, PROG NEURO-PSYCHOPH, V29, P1281, DOI 10.1016/j.pnpbp.2005.08.012; Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224; McNair D., 1971, MANUAL PROFILE MOOD; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Porcelli AJ, 2008, PHYSIOL BEHAV, V95, P282, DOI 10.1016/j.physbeh.2008.04.027; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; Robinson SJ, 2008, STRESS, V11, P115, DOI 10.1080/10253890701559970; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schoofs D, 2009, BEHAV NEUROSCI, V123, P1066, DOI 10.1037/a0016980; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2007, LEARN MEMORY, V14, P109, DOI 10.1101/lm.435807; Schwabe L, 2010, PSYCHONEUROENDOCRINO, V35, P977, DOI 10.1016/j.psyneuen.2009.12.010; Smeets T, 2006, BEHAV NEUROSCI, V120, P1204, DOI 10.1037/0735-7044.120.6.1204; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Uhart M, 2006, PSYCHONEUROENDOCRINO, V31, P642, DOI 10.1016/j.psyneuen.2006.02.003; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Weerda R, 2010, HUM BRAIN MAPP, V31, P1418, DOI 10.1002/hbm.20945; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013; Wolf OT, 2001, PSYCHONEUROENDOCRINO, V26, P711, DOI 10.1016/S0306-4530(01)00025-7	60	51	53	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113618	10.1371/journal.pone.0113618	http://dx.doi.org/10.1371/journal.pone.0113618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502466	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400012
J	Zhou, X; Han, DW; Xu, RL; Li, SH; Wu, HW; Qu, CX; Wang, F; Wang, XY; Zhao, YC				Zhou, Xin; Han, Dewu; Xu, Ruiling; Li, Suhong; Wu, Huiwen; Qu, Chongxiao; Wang, Feng; Wang, Xiangyu; Zhao, Yuanchang			A Model of Metabolic Syndrome and Related Diseases with Intestinal Endotoxemia in Rats Fed a High Fat and High Sucrose Diet	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOSE-TISSUE; BLOOD-PRESSURE; NONALCOHOLIC STEATOHEPATITIS; LIVER-DISEASE; MICE; INFLAMMATION; DYSFUNCTION; FRUCTOSE	Aim: We sought develop and characterize a diet-induced model of metabolic syndrome and its related diseases. Methods: The experimental animals (Spague-Dawley rats) were randomly divided into two groups, and each group was fed a different feed for 48 weeks as follows: 1) standard control diet (SC), and 2) a high sucrose and high fat diet (HSHF). The blood, small intestine, liver, pancreas, and adipose tissues were sampled for analysis and characterization. Results: Typical metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD), and type II diabetes (T2DM) were common in the HSHF group after a 48 week feeding period. The rats fed HSHF exhibited signs of obesity, dyslipidemia, hyperglycaemia, glucose intolerance, and insulin resistance (IR). At the same time, these animals had significantly increased levels of circulating LPS, TNF alpha, and IL-6 and increased ALP in their intestinal tissue homogenates. These animals also showed a significant reduction in the expression of occluding protein. The HSHF rats showed fatty degeneration, inflammation, fibrosis, cirrhosis, and lipid accumulation when their liver pathologies were examined. The HSHF rats also displayed increased islet diameters from 12 to 24 weeks, while reduced islet diameters occurred from 36 to 48 weeks with inflammatory cell infiltration and islet fat deposition. The morphometry of adipocytes in HSHF rats showed hypertrophy and inflammatory cell infiltration. HSHF CD68 analysis showed macrophage infiltration and significant increases in fat and pancreas size. HSHF Tunel analysis showed significant increases in liver and pancreas cell apoptosis. Conclusions: This work demonstrated the following: 1) a characteristic rat model of metabolic syndrome (MS) can be induced by a high sucrose and high fat diet, 2) this model can be used to research metabolic syndrome and its related diseases, such as NAFLD and T2DM, and 3) intestinal endotoxemia (IETM) may play an important role in the pathogenesis of MS and related diseases, such as NAFLD and T2DM.	[Zhou, Xin; Han, Dewu; Xu, Ruiling; Wu, Huiwen; Wang, Feng; Zhao, Yuanchang] Shanxi Med Univ, Dept Pathophysiol, Taiyuan 030001, Shanxi, Peoples R China; [Li, Suhong] Shanxi Tumor Hosp, Dept Pathol, Taiyuan 030013, Shanxi, Peoples R China; [Wu, Huiwen] Shanxi Med Univ, Fenyang Coll, Ctr Sci & Technol, Fenyang 032200, Shanxi, Peoples R China; [Qu, Chongxiao] Shanxi Prov Peoples Hosp, Dept Pathol, Taiyuan 030012, Shanxi, Peoples R China; [Wang, Xiangyu] Shanxi Med Univ, Dept Oral Med, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University	Han, DW (corresponding author), Shanxi Med Univ, Dept Pathophysiol, Taiyuan 030001, Shanxi, Peoples R China.	DewuHan@126.com			Dr. Start Fund of Shanxi Medical University; 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University; Youth Science and Technology Research Fund; Basic research projects in Shanxi [2014021040-3]	Dr. Start Fund of Shanxi Medical University; 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University; Youth Science and Technology Research Fund; Basic research projects in Shanxi	The authors gratefully acknowledge the financial support by the Dr. Start Fund of Shanxi Medical University in 2012, the 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University, the Youth Science and Technology Research Fund, Basic research projects in Shanxi (Grant No. 2014021040-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila MB, 2003, NUTRITION, V19, P347, DOI 10.1016/S0899-9007(02)00934-6; Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Aschner P, 2010, EXPERT REV CARDIOVAS, V8, P407, DOI [10.1586/erc.10.13, 10.1586/ERC.10.13]; Bauduceau B, 2007, DIABETES METAB, V33, P333, DOI 10.1016/j.diabet.2007.04.001; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Church T, 2011, PROG CARDIOVASC DIS, V53, P412, DOI 10.1016/j.pcad.2011.03.013; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; [郭江红 GUO Jiang-hong], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P1009; Han DW, 2002, WORLD J GASTROENTERO, V8, P961, DOI 10.3748/wjg.v8.i6.961; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsieh PS, 2008, EUR J CLIN INVEST, V38, P640, DOI 10.1111/j.1365-2362.2008.01991.x; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; KANAREK RB, 1987, AM J PHYSIOL, V253, pR158, DOI 10.1152/ajpregu.1987.253.1.R158; Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858; Kim SM, 2010, J CLIN BIOCHEM NUTR, V47, P12, DOI 10.3164/jcbn.09-124; Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Le KA, 2006, CURR OPIN CLIN NUTR, V9, P469, DOI 10.1097/01.mco.0000232910.61612.4d; Li H, 2001, CHINESE J PATHOPHYSI, V17, P353; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Palanisamy N, 2010, CAN J PHYSIOL PHARM, V88, P28, DOI 10.1139/Y09-110; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Santure M, 2002, BRIT J PHARMACOL, V137, P185, DOI 10.1038/sj.bjp.0704864; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sweazea KL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-48; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Zhang HY, 2007, WORLD J GASTROENTERO, V13, P3500, DOI 10.3748/wjg.v13.i25.3500; Zhao LF, 2000, WORLD CHIN J DIGESTO, V8, P1145; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	49	54	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115148	10.1371/journal.pone.0115148	http://dx.doi.org/10.1371/journal.pone.0115148			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502558	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700094
J	Farke, AA; Maxwell, WD; Cifelli, RL; Wedel, MJ				Farke, Andrew A.; Maxwell, W. Desmond; Cifelli, Richard L.; Wedel, Mathew J.			A Ceratopsian Dinosaur from the Lower Cretaceous of Western North America, and the Biogeography of Neoceratopsia	PLOS ONE			English	Article							2 MEDICINE FORMATION; CLOVERLY FORMATION; EARLY EVOLUTION; GEOGRAPHIC RANGE; CHINA; PROVINCE; EUROPE; AGE; USA; ORNITHISCHIA	The fossil record for neoceratopsian (horned) dinosaurs in the Lower Cretaceous of North America primarily comprises isolated teeth and postcrania of limited taxonomic resolution, hampering previous efforts to reconstruct the early evolution of this group in North America. An associated cranium and lower jaw from the Cloverly Formation (?middle-late Albian, between 104 and 109 million years old) of southern Montana is designated as the holotype for Aquilops americanus gen. et sp. nov. Aquilops americanus is distinguished by several autapomorphies, including a strongly hooked rostral bone with a midline boss and an elongate and sharply pointed antorbital fossa. The skull in the only known specimen is comparatively small, measuring 84 mm between the tips of the rostral and jugal. The taxon is interpreted as a basal neoceratopsian closely related to Early Cretaceous Asian taxa, such as Liaoceratops and Auroraceratops. Biogeographically, A. americanus probably originated via a dispersal from Asia into North America; the exact route of this dispersal is ambiguous, although a Beringian rather than European route seems more likely in light of the absence of ceratopsians in the Early Cretaceous of Europe. Other amniote clades show similar biogeographic patterns, supporting an intercontinental migratory event between Asia and North America during the late Early Cretaceous. The temporal and geographic distribution of Upper Cretaceous neoceratopsians (leptoceratopsids and ceratopsoids) suggests at least intermittent connections between North America and Asia through the early Late Cretaceous, likely followed by an interval of isolation and finally reconnection during the latest Cretaceous.	[Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA; [Maxwell, W. Desmond] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Farke, Andrew A.; Maxwell, W. Desmond; Cifelli, Richard L.; Wedel, Mathew J.] Sam Noble Oklahoma Museum Nat Hist, Norman, OK USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA	University of the Pacific; Western University of Health Sciences	Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA.	afarke@webb.org		Farke, Andrew/0000-0002-6930-2002	National Science Foundation [DEB 9401094, 9870173]; National Geographic Society [5918-97]; American Chemical Society (PRF) [38572-AC8]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); American Chemical Society (PRF)(American Chemical Society)	Funding was received from the National Science Foundation (DEB 9401094, 9870173, http://www.nsf.gov); National Geographic Society (5918-97, http://www.nationalgeographic.com/); and American Chemical Society (PRF #38572-AC8, http://www.acs.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Blakey R, 2014, PALEOGEOGRAPHY LIB R; Brown B, 1914, B AM MUS NAT HIST, V33, P567; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Burton D., 2006, GEOLOGICAL SOC AM AB, V38, P52; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Carpenter K., 1998, NEW MEXICO MUSEUM NA, V14, P249; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, IDAHO MUSEUM NATURAL, V14, P297; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; Chinnery-Allgeier Brenda J., 2010, P387; Cifelli RL, 2014, ACTA PALAEONTOL POL, V59, P31, DOI 10.4202/app.2012.0089; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Cifelli RL, J VERTEBRAT IN PRESS; COOMBS WP, 1982, PALAEONTOLOGY, V25, P89; Cragin F. W, 1894, COLORADO COLL STUDIE, V5, P49; Cuenca Bescos G, J VERTEBRAT IN PRESS; Cuenca-Bescos G, 2003, ACTA PALAEONTOL POL, V48, P575; D'emic M, 2008, J VERTEBR PALEONTOL, V28, p68A; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dong Zhiming, 1997, P68; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Estep J.W., 1998, NEW MEXICO MUSEUM NA, V14, P297; Farke AA, 2010, J VERTEBR PALEONTOL, V30, P1486, DOI 10.1080/02724634.2010.501436; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gao KQ, 2000, B AM MUS NAT HIST, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Handa N, 2012, PALEONTOL RES, V16, P179, DOI 10.2517/1342-8144-16.3.179; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hay O.P., 1902, USGS BULL, V179, P1, DOI DOI 10.5962/BHL.TITLE.20094; Hay WW, 1999, GEOL S AM S, P1; He HY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025274; Hochuli PA, 2006, J GEOL SOC LONDON, V163, P587, DOI 10.1144/0016-764905-135; Huxley T. H., 1869, GEOLOGICAL SOC LONDO, V204, P3; JACOBS LL, 1991, NEWSL STRATIGR, V24, P35; Jin LY, 2009, ACTA GEOL SIN-ENGL, V83, P200, DOI 10.1111/j.1755-6724.2009.00023.x; KAUFFMAN E. G., 1984, JURASSIC CRETACEOUS, P273; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirkland James I., 2010, P117; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Lambe L. M., 1902, CONTRIBUTIONS CANADI, V3, P23; LAMBE LM, 1904, OTTAWA NATURALIST, V18, P81; Lamsdell JC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-98; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Ludvigson GA, 2010, J SEDIMENT RES, V80, P955, DOI 10.2110/jsr.2010.086; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; MARSH OC, 1890, AM J SCI, V39, P81; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Meyers J.H., 1992, BASIN RES, V4, P315, DOI [10.1111/j.1365-2117.1992.tb00051.x, DOI 10.1111/J.1365-2117.1992.TB00051.X]; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; NESSOV LA, 1989, THEORETICAL APPL ASP, P144; Nopsca BF, 1923, FORSCHRITTE GEOLOGIE, V2, P1; Nydam RL, 2013, PALAEOBIO PALAEOENV, V93, P535, DOI 10.1007/s12549-013-0129-5; Oreska MPJ, 2013, J VERTEBR PALEONTOL, V33, P264, DOI 10.1080/02724634.2012.717567; Osborn H. F., 1923, American Museum Novitates, V95, P1; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; OSTROM JH, 1970, PEABODY MUSEUM NATUR, V35, P1; Owen R, 1842, 11 M BRIT ASS ADV SC, V1841, P66; Pereda-Suberbiola Javier, 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V232, P133; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Russell Dale E., 1995, Historical Biology, V10, P3; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Sames B, 2011, MICROPALEONTOLOGY, V57, P345; Sames B, 2011, MICROPALEONTOLOGY, V57, P291; Sames B, 2010, EARTH-SCI REV, V101, P207, DOI 10.1016/j.earscirev.2010.05.001; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno Paul C., 2010, P21; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Sues HD, 2009, NATURWISSENSCHAFTEN, V96, P645, DOI 10.1007/s00114-009-0518-9; Sun G, 2011, NATURE, V471, P625, DOI 10.1038/nature09811; Sweetman SC, 2006, PALAEONTOLOGY, V49, P889, DOI 10.1111/j.1475-4983.2006.00564.x; Sweetman SC, 2008, PALAEONTOLOGY, V51, P1367, DOI 10.1111/j.1475-4983.2008.00816.x; Tanoue Kyo, 2010, P234; Tanoue K, 2009, CAN J EARTH SCI, V46, P425, DOI 10.1139/E09-030; Tsubamoto T, 2004, ACTA PALAEONTOL POL, V49, P329; Weishampel D.B., 1989, Journal of Vertebrate Paleontology, V9, P56; Wolfe Douglas G., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P303; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You H, 2010, NEW PERSPECTIVES HOR, P68; You HL, 2007, ACTA GEOL SIN-ENGL, V81, P898; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P593; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; Zaleha MJ, 2006, GEOL SOC AM BULL, V118, P886, DOI 10.1130/B25715.1; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, HIST BIOL, V23, P317, DOI 10.1080/08912963.2010.543952; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681	111	42	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e112055	10.1371/journal.pone.0112055	http://dx.doi.org/10.1371/journal.pone.0112055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494182	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400008
J	Tagirov, M; Rutkowska, J				Tagirov, Makhsud; Rutkowska, Joanna			Sexual Dimorphism in the Early Embryogenesis in Zebra Finches	PLOS ONE			English	Article							DOSAGE COMPENSATION; BOVINE EMBRYOS; DEVELOPMENTAL RATES; GROWTH-HORMONE; EXPRESSION; GENES; DIFFERENTIATION; METABOLISM; FEMALE; STAGE	Sex-specific gene expression before the onset of gonadogensis has been documented in embryos of mammals and chickens. In several mammalian species, differences in gene expression are accompanied by faster growth of preimplantation male embryos. Here we asked whether avian embryos before gonadal differentiation are also sex-dimorphic in size and what genes regulate their growth. We used captive zebra finches (Taeniopygia guttata) whose freshly laid eggs were artificially incubated for 36-40 hours. Analyses controlling for the exact time of incubation of 81 embryos revealed that males were larger than females in terms of Hamburger and Hamilton stage and number of somites. Expression of 15 genes involved in cell cycle regulation, growth, metabolic activity, steroidogenic pathway and stress modulation were measured using RT-PCR in 5 male and 5 female embryos incubated for exactly 36 h. We found that in the presence of equal levels of the growth hormone itself, the faster growth of male embryos is most likely achieved by the overexpression of the growth hormone receptor gene and three other genes responsible for cell cycle regulation and metabolism, all of them located on the Z chromosome. Autosomal genes did not show sex-specific expression, except for the steroidogenic factor 1 which was expressed only in female embryos. To our knowledge this is the first report of sexual size dimorphism before gonadogenesis in birds. The finding suggests that faster growth of early male embryos is conserved through the mammalian and bird phyla, irrespective of their differential sex chromosome systems.	[Tagirov, Makhsud] Ukrainian Acad Agrarian Sci, Poultry Res Inst, Borky, Ukraine; [Rutkowska, Joanna] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	National Academy of Agrarian Sciences of Ukraine; State Poultry Research Station of the National Academy of Agrarian Sciences of Ukraine; Jagiellonian University	Rutkowska, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	joanna.rutkowska@uj.edu.pl	Rutkowska, Joanna/ABD-6205-2021; Rutkowska, Joanna/A-8309-2008	Rutkowska, Joanna/0000-0003-0396-1790; Rutkowska, Joanna/0000-0003-0396-1790; Tagirov, Makhsud/0000-0001-5720-0802	Polish National Science Center [2012/07/B/NZ8/01293];  [757/K/ZDS/004151]	Polish National Science Center; 	The study was financially supported by the grant from the Polish National Science Center (2012/07/B/NZ8/01293) to J.R. and the 757/K/ZDS/004151, http://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2013, DEV DYNAM, V242, P371, DOI 10.1002/dvdy.23936; AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312; Bernardi ML, 1996, HUM REPROD, V11, P621, DOI 10.1093/HUMREP/11.3.621; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Carre GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023959; CASSAR G, 1994, J REPROD FERTIL, V101, P317, DOI 10.1530/jrf.0.1010317; Feng YP, 2009, ACTA BIOCH BIOPH SIN, V41, P285, DOI 10.1093/abbs/gmp012; Ganuza M, 2012, EMBO J, V31, P2498, DOI 10.1038/emboj.2012.94; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Graves JAM, 2014, CHROMOSOME RES, V22, P45, DOI 10.1007/s10577-014-9409-9; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; Gutierrez-Adan A, 2006, REPROD DOMEST ANIM, V41, P54, DOI 10.1111/j.1439-0531.2006.00769.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey S, 2000, J ENDOCRINOL, V166, P489, DOI 10.1677/joe.0.1660489; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jost, 1947, ARCH ANAT MICR MORPH, V36, P271; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; McQueen HA, 2001, CURR BIOL, V11, P253, DOI 10.1016/S0960-9822(01)00070-7; Menezo YJR, 1999, FERTIL STERIL, V72, P221, DOI 10.1016/S0015-0282(99)00256-3; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; PEIPPO J, 1995, MOL REPROD DEV, V40, P56, DOI 10.1002/mrd.1080400108; PERGAMENT E, 1994, HUM REPROD, V9, P1730, DOI 10.1093/oxfordjournals.humrep.a138783; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; RAY PF, 1995, J REPROD FERTIL, V104, P165; RIEGER D, 1992, THERIOGENOLOGY, V37, P75, DOI 10.1016/0093-691X(92)90248-P; Smith CA, 1999, GEN COMP ENDOCR, V113, P187, DOI 10.1006/gcen.1998.7214; Soderstrom K, 2007, J NEUROSCI METH, V164, P116, DOI 10.1016/j.jneumeth.2007.04.007; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; TSUNODA Y, 1985, GAMETE RES, V12, P301, DOI 10.1002/mrd.1120120308; VALDIVIA RPA, 1993, MOL REPROD DEV, V35, P121, DOI 10.1002/mrd.1080350204; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Wallenfang MR, 2002, P NATL ACAD SCI USA, V99, P5527, DOI 10.1073/pnas.082618399; XU KP, 1992, MOL REPROD DEV, V31, P249, DOI 10.1002/mrd.1080310404; YADAV BR, 1993, MOL REPROD DEV, V36, P434, DOI 10.1002/mrd.1080360405; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	42	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114625	10.1371/journal.pone.0114625	http://dx.doi.org/10.1371/journal.pone.0114625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493645	gold, Green Submitted, Green Published			2022-12-26	WOS:000346611400061
J	Keklikoglou, I; Hosaka, K; Bender, C; Bott, A; Koerner, C; Mitra, D; Will, R; Woerner, A; Muenstermann, E; Wilhelm, H; Cao, Y; Wiemann, S				Keklikoglou, I.; Hosaka, K.; Bender, C.; Bott, A.; Koerner, C.; Mitra, D.; Will, R.; Woerner, A.; Muenstermann, E.; Wilhelm, H.; Cao, Y.; Wiemann, S.			MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes	ONCOGENE			English	Article							NF-KAPPA-B; HUMAN-ENDOTHELIAL-CELLS; TUMOR LYMPHANGIOGENESIS; DUCTAL ADENOCARCINOMA; PROMOTES ANGIOGENESIS; TRANSCRIPTION FACTOR; CANCER; GROWTH; SUPPRESSOR; EXPRESSION	Recent advances in cancer biology have emerged important roles for microRNAs (miRNAs) in regulating tumor responses. However, their function in mediating intercellular communication within the tumor microenvironment is thus far poorly explored. Here, we found miR-206 to be abrogated in human pancreatic ductal adenocarcinoma (PDAC) specimens and cell lines. We show that miR-206 directly targets the oncogenes KRAS and annexin a2 (ANXA2), thereby acting as tumor suppressor in PDAC cells by blocking cell cycle progression, cell proliferation, migration and invasion. Importantly, we identified miR-206 as a negative regulator of oncogenic KRAS-induced nuclear factor-kappa B transcriptional activity, resulting in a concomitant reduction of the expression and secretion of pro-angiogenic and pro-inflammatory factors including the cytokine interleukin-8, the chemokines (C-X-C motif) ligand 1 and (C-C motif) ligand 2, and the granulocyte macrophage colony-stimulating factor. We further show that miR-206 abrogates the expression and secretion of the potent pro-lymphangiogenic factor vascular endothelial growth factor C in pancreatic cancer cells through an NF-kappa B-independent mechanism. By using in vitro and in vivo approaches, we reveal that re-expression of miR-206 in PDAC cells is sufficient to inhibit tumor blood and lymphatic vessel formation, thus leading to a significant delay of tumor growth and progression. Taken together, our study sheds light onto the role of miR-206 as a pleiotropic modulator of different hallmarks of cancer, and as such raising the intriguing possibility that miR-206 may be an attractive candidate for miRNA-based anticancer therapies.	[Keklikoglou, I.; Bender, C.; Bott, A.; Koerner, C.; Mitra, D.; Woerner, A.; Muenstermann, E.; Wilhelm, H.; Wiemann, S.] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Keklikoglou, I.] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland; [Hosaka, K.; Cao, Y.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Will, R.] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Cao, Y.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Cao, Y.] Glenfield Gen Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Cao, Y.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Linkoping University	Keklikoglou, I (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	ioanna.keklikoglou@epfl.ch; s.wiemann@dkfz-heidelberg.de	Wiemann, Stefan/E-4424-2013	Wiemann, Stefan/0000-0003-4683-3174; Keklikoglou, Ioanna/0000-0003-1219-6912	German Federal Ministry of Education and Research (NGFN grant) [01GS0816]; Deutsche Forschungsgemeinschaft (DIP project) [WI3499/1-1]	German Federal Ministry of Education and Research (NGFN grant); Deutsche Forschungsgemeinschaft (DIP project)	We thank Prof George Mosialos and Dr Joerg Hoheisel for kindly providing us with the 3xKBL and pCMV-p65 vectors, and the BxPC-3, MiaPaca-2, Colo357, Capan-1 and CFPAC-1 cell lines, respectively. We thank Dr Christoph Roesli for providing us with the HPNE and HPDE cell lines and the DKFZ Genomics and Proteomics Core Facility for performing excellent services. This work was supported with funding from the German Federal Ministry of Education and Research (NGFN grant 01GS0816) and the Deutsche Forschungsgemeinschaft (DIP project WI3499/1-1).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brownstein C, 2004, BLOOD, V103, P317, DOI 10.1182/blood-2003-04-1304; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Cao RH, 2012, P NATL ACAD SCI USA, V109, P15894, DOI 10.1073/pnas.1208324109; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hofmann I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044146; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Sarkar S, 2011, GASTROENTEROLOGY, V140, P583, DOI 10.1053/j.gastro.2010.08.054; Seckinger A, 2012, BLOOD, V120, P1087, DOI 10.1182/blood-2012-03-415588; Sharma M, 2012, EXP MOL PATHOL, V92, P175, DOI 10.1016/j.yexmp.2011.10.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stupack Dwayne G, 2002, Sci STKE, V2002, ppe7, DOI 10.1126/stke.2002.119.pe7; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Wang CY, 2012, J BIOL CHEM, V287, P32512, DOI 10.1074/jbc.M112.351957; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang WX, 1999, CLIN CANCER RES, V5, P119; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390	47	99	100	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4867	4878		10.1038/onc.2014.408	http://dx.doi.org/10.1038/onc.2014.408			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25500542	Green Published, hybrid			2022-12-26	WOS:000361050000007
J	Wang, L; Song, G; Chang, X; Tan, W; Pan, J; Zhu, X; Liu, Z; Qi, M; Yu, J; Han, B				Wang, L.; Song, G.; Chang, X.; Tan, W.; Pan, J.; Zhu, X.; Liu, Z.; Qi, M.; Yu, J.; Han, B.			The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway	ONCOGENE			English	Article							THIOREDOXIN; PROTEIN; EXPRESSION; INHIBITORS; OVEREXPRESSION; TRANSITION; PROGNOSIS; BIOLOGY; DOMAIN; CELLS	Castration-resistant prostate cancer (CRPC) continues to be a major clinical problem and the mechanisms behind it remain unclear. Thioredoxin domain-containing protein 5 (TXNDC5) is involved in protein folding and chaperone activity, and its overexpression has been reported in multiple malignancies. In the current study, we demonstrated that TXNDC5 is up-regulated following long-term androgen-deprivation treatment (ADT) and is highly overexpressed in CRPC tumors compared with hormone-naive prostate cancer (PCa) cases. Functionally, in vitro and in vivo studies demonstrated that TXNDC5 overexpression promotes the growth of both androgen-dependent and castration-resistant PCa xenografts. Mechanistically, TXNDC5 directly interacts with the AR protein to increase its stability and thus enhances its transcriptional activity. TXDNC5-mediated CRPC growth can be fully abolished by AR inhibition, suggesting TXDNC5 up-regulation as an escape pathway for aberrant AR re-activation and CRPC growth in the milieu of low androgen. Indeed, we found that TXNDC5 is increased by ADT-induced hypoxia through HIF-1 alpha in an miR-200b-dependent manner. Overall, we defined an important role of TXNDC5 in CRPC and further investigations are needed to screen TXNDC5 antagonists as a novel therapeutic approaches to treat PCa patients with CRPC.	[Wang, L.; Tan, W.; Liu, Z.; Qi, M.; Han, B.] Shandong Univ, Sch Med, Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Wang, L.; Pan, J.] Shandong Acad Med Sci, Key Lab Rare & Uncommon Dis Shandong Prov, Res Ctr Med Biotechnol, Jinan, Peoples R China; [Song, G.] Shandong Acad Med Sci, Inst Basic Med, Jinan, Peoples R China; [Chang, X.] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, Jinan 250012, Shandong, Peoples R China; [Zhu, X.] Shandong Inst Med & Hlth Informat, Jinan, Peoples R China; [Liu, Z.; Han, B.] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Yu, J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Northwestern University; Feinberg School of Medicine	Han, B (corresponding author), Shandong Univ, Sch Med, Dept Pathol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	boh@sdu.edu.cn			National Natural Science Foundation of China [81302239, 81300426]; Foundation for Scientific and Technological Achievements of Jinan [201302046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Scientific and Technological Achievements of Jinan	We thank Professor Yaoqin Gong and Professor Huiqing Yuan from Shandong University Medical School for their critical reading of the manuscript. AR expression and PSA-Luc vectors were kindly provided by Professor Huiqing Yuan. This work was supported by the National Natural Science Foundation of China (Grant No. 81302239 and No. 81300426) and the Foundation for Scientific and Technological Achievements of Jinan (Grant No. 201302046).	Baumann C, 2012, ACTAS UROL ESP, V36, P1, DOI 10.1016/j.acuro.2011.07.017; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Dvorzhinski D, 2004, PROTEOMICS, V4, P3268, DOI 10.1002/pmic.200400847; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Galluzzi L, 2009, MOL CELL, V36, P176, DOI 10.1016/j.molcel.2009.10.003; Gulerez IE, 2012, ACTA CRYSTALLOGR F, V68, P378, DOI 10.1107/S1744309112005866; Han B, 2009, MODERN PATHOL, V22, P1176, DOI 10.1038/modpathol.2009.79; Hsieh CL, 2008, J MOL ENDOCRINOL, V41, P13, DOI 10.1677/JME-07-0158; Hsu FN, 2011, AM J PHYSIOL-ENDOC M, V300, pE902, DOI 10.1152/ajpendo.00610.2010; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Inoue T, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/647987; Leo S, 2011, CHEMOTHERAPY, V57, P115, DOI 10.1159/000323581; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Messaoudi S, 2008, ANTI-CANCER AGENT ME, V8, P761, DOI 10.2174/187152008785914824; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Pal SK, 2013, EXPERT OPIN PHARMACO, V14, P679, DOI 10.1517/14656566.2013.775251; Ramanathan RK, 2012, INVEST NEW DRUG, V30, P1591, DOI 10.1007/s10637-011-9739-9; Ranasinghe WKB, 2014, CANCER MED-US, V3, P245, DOI 10.1002/cam4.189; Ranasinghe WKB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054251; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sharifi N, 2013, ENDOCRINOLOGY, V154, P4010, DOI 10.1210/en.2013-1466; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Thoenes L, 2010, J PROTEOMICS, V73, P1342, DOI 10.1016/j.jprot.2010.02.019; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Wang L, 2014, PROSTATE, V74, P647, DOI 10.1002/pros.22783; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053301; Wang L, 2010, INT J BIOL SCI, V6, P454; Wang YT, 2014, INT J NEUROPSYCHOPH, V17, P469, DOI 10.1017/S1461145713001429; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; Wei Q, 2007, PROSTATE CANCER P D, V10, P167, DOI 10.1038/sj.pcan.4500933; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x; Zhao LY, 2014, CANCER EPIDEM BIOMAR, V23, P1047, DOI 10.1158/1055-9965.EPI-13-0696; Zhu XJ, 2011, ORAL ONCOL, V47, P609, DOI 10.1016/j.oraloncology.2011.05.006	40	32	34	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4735	4745		10.1038/onc.2014.401	http://dx.doi.org/10.1038/onc.2014.401			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25500540				2022-12-26	WOS:000360931500007
J	Hurlstone, MJ; Lewandowsky, S; Newell, BR; Sewell, B				Hurlstone, Mark J.; Lewandowsky, Stephan; Newell, Ben R.; Sewell, Brittany			The Effect of Framing and Normative Messages in Building Support for Climate Policies	PLOS ONE			English	Article							PLANNED BEHAVIOR; LOSS AVERSION; SOCIAL NORMS; CONSERVATION; ATTITUDES; IDEOLOGY; FAIRNESS; RANK	Deep cuts in greenhouse gas emissions are required to mitigate climate change. However, there is low willingness amongst the public to prioritise climate policies for reducing emissions. Here we show that the extent to which Australians are prepared to reduce their country's CO2 emissions is greater when the costs to future national income are framed as a "foregone-gain''-incomes rise in the future but not by as much as in the absence of emission cuts-rather than as a "loss''-incomes decrease relative to the baseline expected future levels (Studies 1 & 2). The provision of a normative message identifying Australia as one of the world's largest CO2 emitters did not increase the amount by which individuals were prepared to reduce emissions (Study 1), whereas a normative message revealing the emission policy preferences of other Australians did (Study 2). The results suggest that framing the costs of reducing emissions as a smaller increase in future income and communicating normative information about others' emission policy preferences are effective methods for leveraging public support for emission cuts.	[Hurlstone, Mark J.; Lewandowsky, Stephan; Sewell, Brittany] Univ Western Australia, Sch Psychol, Crawley, Australia; [Hurlstone, Mark J.] CSIRO, Ctr Environm & Life Sci, Floreat, Australia; [Lewandowsky, Stephan] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Newell, Ben R.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Bristol; University of New South Wales Sydney	Hurlstone, MJ (corresponding author), Univ Western Australia, Sch Psychol, Crawley, Australia.	mark.hurlstone@uwa.edu.au	Hurlstone, Mark/H-5091-2014; Lewandowsky, Stephan/L-4272-2019	Lewandowsky, Stephan/0000-0003-1655-2013; Newell, Benjamin/0000-0003-1898-205X; Hurlstone, Mark/0000-0001-9920-6284	National Climate Change Adaptation Research Facility (NCCARF) of Australia; Australian Research Council [LP120100224, FT110100151]; Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation	National Climate Change Adaptation Research Facility (NCCARF) of Australia; Australian Research Council(Australian Research Council); Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation	The research was supported by a grant from the National Climate Change Adaptation Research Facility (NCCARF) of Australia awarded to the second author and grants from the Australian Research Council (LP120100224, FT110100151) to the second and third authors. Preparation of this paper was supported by funding from the Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2000, J APPL SOC PSYCHOL, V30, P2439, DOI 10.1111/j.1559-1816.2000.tb02444.x; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; Boyce CJ, 2010, PSYCHOL SCI, V21, P471, DOI 10.1177/0956797610362671; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown GDA, 2008, IND RELAT, V47, P355, DOI 10.1111/j.1468-232X.2008.00525.x; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Fox J, 2008, APPL REGRESSION ANAL; Gilovich TD, 2010, HDB SOCIAL PSYCHOL, V2, P15; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Gromet DM, 2013, P NATL ACAD SCI USA, V110, P9314, DOI 10.1073/pnas.1218453110; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hatfield-Dodds S, 2010, 910 CCEP AUSTR NAT U; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; International Energy Agency, 2010, CO2 EM FUEL COMB HIG; IPCC, 2007, CONTRIBUTION WORKING; Johnson D, 2008, AUSTR LOW POLLUTION; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kleiner M, 2007, SPATIAL VISION, V10, P437; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; LEVIN IP, 1988, J CONSUM RES, V15, P374, DOI 10.1086/209174; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Manning M, 2009, BRIT J SOC PSYCHOL, V48, P649, DOI 10.1348/014466608X393136; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Melrose KL, 2013, J BEHAV DECIS MAKING, V26, P174, DOI 10.1002/bdm.1754; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Nolan JM, 2008, PERSONALITY SOCIAL P, V34, P84; O'Connor RE, 2002, SOC SCI QUART, V83, P1, DOI 10.1111/1540-6237.00067; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Schroder T, 2008, J APPL SOC PSYCHOL, V38, P135; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Stewart N, 2009, PSYCHOL SCI, V20, P39, DOI 10.1111/j.1467-9280.2008.02255.x; Terry DJ, 1996, PERS SOC PSYCHOL B, V22, P776, DOI 10.1177/0146167296228002; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Thaler R.H., 2021, NUDGE FINAL EDITION; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Tranter B, 2011, ENVIRON POLIT, V20, P78, DOI 10.1080/09644016.2011.538167; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	60	30	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114335	10.1371/journal.pone.0114335	http://dx.doi.org/10.1371/journal.pone.0114335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25501009	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100011
J	Rodriguez-Campello, A; Jimenez-Conde, J; Ois, A; Cuadrado-Godia, E; Giralt-Steinhauer, E; Schroeder, H; Romeral, G; Llop, M; Soriano-Tarraga, C; Garralda-Anaya, M; Roquer, J				Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Schroeder, Helmut; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat; Roquer, Jaume			Dietary Habits in Patients with Ischemic Stroke: A Case-Control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; WHOLE-GRAIN; PHYSICAL-ACTIVITY; RISK; CONSUMPTION; PREVENTION; PATTERNS; FRUIT	Background and Aims: Diet appears to have some role in stroke development. The objective of our study was to describe the dietary habits in patients admitted with acute ischemic stroke and compare selected dietary components with healthy controls. Adherence to healthy diet behaviors was also assessed. Methods: A case-control study of consecutive patients with acute ischemic stroke admitted to the Neurology Department of Hospital del Mar from 2007 to 2010. Patients were matched by age and sex with control subjects. A previously validated nutritional survey was administered to patients and controls. Demographic data, vascular risk factors, caloric intake and dietary nutrients were evaluated. Intention to follow a healthy diet was also assessed in both groups. Results: A total of 300 acute ischemic stroke patients and 300 controls with evaluation of dietary habits. No differences were observed in vascular risk factors, except smoking habit, diabetes and ischemic heart disease. Stroke patients reported a higher caloric intake: 2444.8(1736.8-3244.5) vs 2208.7(1753.1-2860.7) Kcal, p=0.001. After adjusting for energy intake, patients had higher intake of proteins (p<0.001; OR 1.02), total cholesterol (p=0.001; OR 1.04), and breaded foods (p=0.001; OR 1.94) and lower consumption of probiotic yogurt (p=0.002; OR 0.88). Compared to patients, control participants indicated greater intention to eat vegetables (p=0.002; OR 1.5) and whole foods (p=0.000; OR 2.4) and reduce their intake of salt (p=0.002; OR 1.7), fat (p=0.000; OR 3.7) and sweets (p=0.004; OR 1.7) than patients. Conclusion: We observed different dietary patterns between stroke patients and controls. Stroke patients have a higher caloric intake and are less concerned about maintaining healthy nutritional	[Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Schroeder, Helmut; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat; Roquer, Jaume] IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Neurovasc Res Grp, Stroke Unit,Dept Neurol, Barcelona, Spain; [Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Cuadrado-Godia, Elisa; Roquer, Jaume] Univ Pompeu Fabra, DCEXS, Barcelona, Spain; [Schroeder, Helmut] IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Program Res Inflammatory & Cardiovasc Disorders R, Cardiovasc Risk & Nutr Res Grp CARIN ULEC, Barcelona, Spain; [Schroeder, Helmut] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Rodriguez-Campello, A (corresponding author), IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Neurovasc Res Grp, Stroke Unit,Dept Neurol, Barcelona, Spain.	92269@hospitaldelmar.cat	Campello, Ana Rodriguez/AAP-7757-2021; Ois, A/AAE-7583-2022; Schroder, Helmut/G-2586-2015; Roquer, Jaume/G-8919-2017; TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Ois, A/X-2922-2019; JIMENEZ-CONDE, JORDI/C-1941-2012; Stefanadis, Christodoulos/ABH-2232-2020	Campello, Ana Rodriguez/0000-0001-8621-1420; Ois, A/0000-0002-1375-5950; Schroder, Helmut/0000-0003-2231-5081; Roquer, Jaume/0000-0001-5992-2606; Ois, A/0000-0002-1375-5950; Stefanadis, Christodoulos/0000-0001-5974-6454; Giralt Steinhauer, Eva/0000-0002-7463-0983; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Soriano Tarraga, Carolina/0000-0002-5635-273X	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER) [RD12/0042/0020]; Recercaixa'13 [JJ086116]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER); Recercaixa'13	This study was partly funded in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER, RD12/0042/0020). Additional support provided by Recercaixa'13 (JJ086116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Benitez-Arciniega AA, 2011, PUBLIC HEALTH NUTR, V14, P2015, DOI 10.1017/S1368980011001212; Bernstein AM, 2012, STROKE, V43, P637, DOI 10.1161/STROKEAHA.111.633404; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Ding EL, 2006, SEMIN NEUROL, V26, P11, DOI 10.1055/s-2006-933305; Drewnowski A, 2001, J Nutr Health Aging, V5, P75; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hankey GJ, 2012, LANCET NEUROL, V11, P66, DOI 10.1016/S1474-4422(11)70265-4; Hoevenaar-Blom MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045458; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kaluza J, 2012, STROKE, V43, P2556, DOI 10.1161/STROKEAHA.112.663286; Kastorini CM, 2012, ATHEROSCLEROSIS, V225, P187, DOI 10.1016/j.atherosclerosis.2012.08.004; Kokubo Y, 2012, CURR OPIN NEUROL, V25, P11, DOI 10.1097/WCO.0b013e32834eb58e; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Liu SM, 2000, JAMA-J AM MED ASSOC, V284, P1534, DOI 10.1001/jama.284.12.1534; Mahe G, 2010, J VASC SURG, V52, P62, DOI 10.1016/j.jvs.2010.02.258; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; Masia R, 1998, J EPIDEMIOL COMMUN H, V52, P707, DOI 10.1136/jech.52.11.707; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Oude Griep LM, 2011, STROKE, V42, P3190, DOI 10.1161/STROKEAHA.110.611152; Panagiotakos D, 2009, NUTR METAB CARDIOVAS, V19, P253, DOI 10.1016/j.numecd.2008.06.005; Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006; Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060; Riccioni G, 2012, INT J MOL SCI, V13, P1524, DOI 10.3390/ijms13021524; Schroder H, 2001, CLIN NUTR, V20, P429, DOI 10.1054/clnu.2001.0460; Schulze MB, 2006, BRIT J NUTR, V95, P860, DOI 10.1079/BJN20061731; Shay CM, 2012, EUR J NUTR, V51, P917, DOI 10.1007/s00394-011-0268-2; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383	32	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114716	10.1371/journal.pone.0114716	http://dx.doi.org/10.1371/journal.pone.0114716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506934	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100023
J	Yang, Y; Song, HL; Zhang, W; Wu, BJ; Fu, NN; Zheng, WP; Don, C; Shen, ZY				Yang, Yang; Song, Hong-Li; Zhang, Wen; Wu, Ben-Juan; Fu, Nan-Nan; Zheng, Wei-Ping; Don, Chong; Shen, Zhong-Yang			Reduction of Acute Rejection by Bone Marrow Mesenchymal Stem Cells during Rat Small Bowel Transplantation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALLOGRAFT-REJECTION; STROMAL CELLS; FACTOR-ALPHA; T-CELLS; KIDNEY-TRANSPLANTATION; TIGHT JUNCTION; FAS LIGAND; EXPRESSION; IMMUNOSUPPRESSION	Background: Bone marrow mesenchymal stem cells (BMMSCs) have shown immunosuppressive activity in transplantation. This study was designed to determine whether BMMSCs could improve outcomes of small bowel transplantation in rats. Methods: Heterotopic small bowel transplantation was performed from Brown Norway to Lewis rats, followed by infusion of BMMSCs through the superficial dorsal veins of the penis. Controls included rats infused with normal saline (allogeneic control), isogeneically transplanted rats (BN-BN) and nontransplanted animals. The animals were sacrificed after 1, 5, 7 or 10 days. Small bowel histology and apoptosis, cytokine concentrations in serum and intestinal grafts, and numbers of T regulatory (Treg) cells were assessed at each time point. Results: Acute cellular rejection occurred soon after transplantation and became aggravated over time in the allogeneic control rats, with increase in apoptosis, inflammatory response, and T helper (Th)1/Th2 and Th17/Treg-related cytokines. BMMSCs significantly attenuated acute cellular rejection, reduced apoptosis and suppressed the concentrations of interleukin (IL)-2, IL-6, IL-17, IL-23, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma while upregulating IL-10 and transforming growth factor (TGF)-beta expression and increasing Treg levels. Conclusion: BMMSCs improve the outcomes of allogeneic small bowel transplantation by attenuating the inflammatory response and acute cellular rejection. Treatment with BMMSCs may overcome acute cellular rejection in small bowel transplantation.	[Yang, Yang; Zhang, Wen; Wu, Ben-Juan; Fu, Nan-Nan] Tianjin Med Univ, Tianjin Cent Hosp 1, Tianjin, Peoples R China; [Song, Hong-Li; Zheng, Wei-Ping; Don, Chong; Shen, Zhong-Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Shen, ZY (corresponding author), Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China.	hlsong26@sina.com			Natural Science Foundation of China [81270528, 81170444, 81441022]; Natural Science Foundation of Tianjin, China [08JCYBJC08400, 11JCZDJC27800, 12JCZDJC25200]; Technology Foundation of Health Bureau in Tianjin, China [2011KY11]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); Technology Foundation of Health Bureau in Tianjin, China	This work was supported by Natural Science Foundation of China (Nos. 81270528, 81170444 and 81441022), Natural Science Foundation of Tianjin, China (grant no. 08JCYBJC08400, grant no. 11JCZDJC27800, grant no. 12JCZDJC25200), and Technology Foundation of Health Bureau in Tianjin, China (grant no. 2011KY11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Abu-Elmagd KM, 2009, ANN SURG, V250, P567, DOI 10.1097/SLA.0b013e3181b67725; Abu-Elmagd KM, 2009, TRANSPL INT, V22, P96, DOI 10.1111/j.1432-2277.2008.00785.x; Adams AB, 2002, AM J TRANSPLANT, V2, P12, DOI 10.1034/j.1600-6143.2002.020104.x; Beinhauer BG, 2004, EUR J IMMUNOL, V34, P74, DOI 10.1002/eji.200324550; Benghiat FS, 2005, TRANSPLANTATION, V79, P648, DOI 10.1097/01.TP.0000155179.61445.78; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; FARMER DG, 1994, J SURG RES, V57, P138, DOI 10.1006/jsre.1994.1121; Fishbein TM, 2009, NEW ENGL J MED, V361, P998, DOI 10.1056/NEJMra0804605; Fishbein TM, 2004, J SURG RES, V119, P51, DOI 10.1016/j.jss.2003.12.028; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hu AB, 2012, DIGEST LIVER DIS, V44, P988, DOI 10.1016/j.dld.2012.08.002; IMAGAWA DK, 1990, TRANSPLANTATION, V50, P189, DOI 10.1097/00007890-199008000-00003; Josien R, 1998, TRANSPLANTATION, V66, P887, DOI 10.1097/00007890-199810150-00013; Koksoy S, 2005, TRANSPLANTATION, V79, P1492, DOI 10.1097/01.TP.0000159870.01567.02; Kroemer A, 2008, J IMMUNOL, V180, P7818, DOI 10.4049/jimmunol.180.12.7818; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee K, 2004, J IMMUNOL, V172, P6539, DOI 10.4049/jimmunol.172.11.6539; Lee SS, 2007, FASEB J, V21, P3450, DOI 10.1096/fj.07-8472com; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Manilay JO, 1998, CURR OPIN IMMUNOL, V10, P532, DOI 10.1016/S0952-7915(98)80219-7; Mazar J, 2009, J BIOL CHEM, V284, P22022, DOI 10.1074/jbc.M109.032235; Perez-Basterrechea M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073526; Perico N, 2013, TRANSPL INT, V26, P867, DOI 10.1111/tri.12132; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pondrom Sue, 2010, Am J Transplant, V10, P438, DOI 10.1111/j.1600-6143.2009.03057.x; QUAN D, 1994, TRANSPLANTATION, V58, P808, DOI 10.1097/00007890-199410150-00011; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Shen ZY, 2013, WORLD J GASTROENTERO, V19, P3583, DOI 10.3748/wjg.v19.i23.3583; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Sonnino R E, 1988, J Invest Surg, V1, P55, DOI 10.3109/08941938809141076; Sonnino R E, 1988, J Invest Surg, V1, P181, DOI 10.3109/08941938809141104; SONNINO RE, 1986, J PEDIATR SURG, V21, P1073, DOI 10.1016/0022-3468(86)90011-4; Tzvetanov IG, 2010, CURR OPIN ORGAN TRAN, V15, P346, DOI 10.1097/MOT.0b013e3283398fa4; van Emmerik N, 1994, Transpl Int, V7 Suppl 1, pS623; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wang M, 2007, TRANSPL P, V39, P289, DOI 10.1016/j.transproceed.2006.10.200; Wang Y, 2009, TRANSPL P, V41, P4352, DOI 10.1016/j.transproceed.2009.08.072; Webber A, 2011, TRANSPLANTATION, V91, P1057, DOI 10.1097/TP.0b013e3182145306; Wiggins MC, 2000, TRANSPL IMMUNOL, V8, P211, DOI 10.1016/S0966-3274(00)00027-7; Wu H, 2013, MOL THER, V21, P1778, DOI 10.1038/mt.2013.147; Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F; YAMATAKA A, 1993, SURG TODAY, V23, P984, DOI 10.1007/BF00308974	48	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114528	10.1371/journal.pone.0114528	http://dx.doi.org/10.1371/journal.pone.0114528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25500836	Green Submitted, gold, Green Published			2022-12-26	WOS:000346607100015
J	Chitale, VS; Behera, MD; Roy, PS				Chitale, Vishwas Sudhir; Behera, Mukund Dev; Roy, Partha Sarthi			Future of Endemic Flora of Biodiversity Hotspots in India	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; RANGE SHIFTS; CONSERVATION; RICHNESS; AREAS	India is one of the 12 mega biodiversity countries of the world, which represents 11% of world's flora in about 2.4% of global land mass. Approximately 28% of the total Indian flora and 33% of angiosperms occurring in India are endemic. Higher human population density in biodiversity hotspots in India puts undue pressure on these sensitive eco-regions. In the present study, we predict the future distribution of 637 endemic plant species from three biodiversity hotspots in India; Himalaya, Western Ghats, Indo-Burma, based on A1B scenario for year 2050 and 2080. We develop individual variable based models as well as mixed models in MaxEnt by combining ten least co-related bioclimatic variables, two disturbance variables and one physiography variable as predictor variables. The projected changes suggest that the endemic flora will be adversely impacted, even under such a moderate climate scenario. The future distribution is predicted to shift in northern and northeastern direction in Himalaya and Indo-Burma, while in southern and south-western direction in Western Ghats, due to cooler climatic conditions in these regions. In the future distribution of endemic plants, we observe a significant shift and reduction in the distribution range compared to the present distribution. The model predicts a 23.99% range reduction and a 7.70% range expansion in future distribution by 2050, while a 41.34% range reduction and a 24.10% range expansion by 2080. Integration of disturbance and physiography variables along with bioclimatic variables in the models improved the prediction accuracy. Mixed models provide most accurate results for most of the combinations of climatic and non-climatic variables as compared to individual variable based models. We conclude that a) regions with cooler climates and higher moisture availability could serve as refugia for endemic plants in future climatic conditions; b) mixed models provide more accurate results, compared to single variable based models.	[Chitale, Vishwas Sudhir; Behera, Mukund Dev] Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci, Kharagpur, W Bengal, India; [Chitale, Vishwas Sudhir] Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal; [Roy, Partha Sarthi] Univ Hyderabad, Univ Ctr Earth & Space Sci, Hyderabad 500134, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Hyderabad	Chitale, VS (corresponding author), Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci, Kharagpur, W Bengal, India.	vschitale@iitkgp.ac.in		Behera, Mukunda/0000-0002-9976-6270				Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chitale VS, 2012, CURR SCI INDIA, V102, P1126; Chitale V.S., 2014, NAT INDIA, DOI [10.1038/nindia.2014.21, DOI 10.1038/NINDIA.2014.21]; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; Forest Survey of India (FSI) Website, 2011, PND STAT FOR REP; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, ECOL MODEL, V246, P86, DOI 10.1016/j.ecolmodel.2012.07.028; Irwin Sheeba J., 2011, Rheedea, V21, P87; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Kuussaari M, 2007, AGR ECOSYST ENVIRON, V122, P366, DOI 10.1016/j.agee.2007.02.008; Lele N, 2009, ENVIRON MONIT ASSESS, V156, P159, DOI 10.1007/s10661-008-0472-6; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Ni J, 2011, REG ENVIRON CHANGE, V11, pS49, DOI 10.1007/s10113-010-0170-0; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parry ML, 2007, IPCC CLIM CHANG IMP; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; Roy PS, 2013, CURR SCI INDIA, V105, P774; Roy P.S., 2012, BIODIVERSITY CHARACT, P140; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Tingley MW, 2013, NATURE, V500, P271, DOI 10.1038/500271a; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; US Geological Survey, SHUTTL RAD TOP MISS; Velho N, 2012, BIOL CONSERV, V148, P210, DOI 10.1016/j.biocon.2012.01.022; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	51	43	53	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115264	10.1371/journal.pone.0115264	http://dx.doi.org/10.1371/journal.pone.0115264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501852	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400089
J	Mao, K; Jiang, LB; Bo, WH; Xu, F; Wu, RL				Mao, Ke; Jiang, Libo; Bo, Wenhao; Xu, Fang; Wu, Rongling			Cloning of the Cryptochrome-Encoding PeCRY1 Gene from Populus euphratica and Functional Analysis in Arabidopsis	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; UNSTRUCTURED PROTEINS; SIGNALING MECHANISM; MOLECULAR-CLONING; HYPOCOTYL GROWTH; THALIANA; EXPRESSION; RECEPTOR; ELONGATION; AUXIN	Cryptochromes are photolyase-like blue/UV-A light receptors that evolved from photolyases. In plants, cryptochromes regulate various aspects of plant growth and development. Despite of their involvement in the control of important plant traits, however, most studies on cryptochromes have focused on lower plants and herbaceous crops, and no data on cryptochrome function are available for forest trees. In this study, we isolated a cryptochrome gene, PeCRY1, from Euphrates poplar (Populus euphratica), and analyzed its structure and function in detail. The deduced PeCRY1 amino acid sequence contained a conserved N-terminal photolyase-homologous region (PHR) domain as well as a C-terminal DQXVP-acidic-STAES (DAS) domain. Secondary and tertiary structure analysis showed that PeCRY1 shares high similarity with AtCRY1 from Arabidopsis thaliana. PeCRY1 expression was upregulated at the mRNA level by light. Using heterologous expression in Arabidopsis, we showed that PeCRY1 overexpression rescued the cry1 mutant phenotype. In addition, PeCRY1 overexpression inhibited hypocotyl elongation, promoted root growth, and enhanced anthocyanin accumulation in wild-type background seedlings grown under blue light. Furthermore, we examined the interaction between PeCRY1 and AtCOP1 using a bimolecular fluorescence complementation (BiFc) assay. Our data provide evidence for the involvement of PeCRY1 in the control of photomorphogenesis in poplar.	[Mao, Ke; Jiang, Libo; Bo, Wenhao; Xu, Fang; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China	Beijing Forestry University	Wu, RL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China.	rwu@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare [201404102]; Changjiang Scholars Award; "Thousand-person Plan" Award;  [NSF/IOS-0923975]	Special Fund for Forest Scientific Research in the Public Welfare; Changjiang Scholars Award; "Thousand-person Plan" Award(Chinese Academy of Sciences); 	This work is supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404102), NSF/IOS-0923975, Changjiang Scholars Award, and "Thousand-person Plan" Award (http://www.1000plan.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1998, NATURE, V392, P720, DOI 10.1038/33701; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2005, PLANTA, V220, P498, DOI 10.1007/s00425-004-1418-z; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chatterjee M, 2006, PLANT PHYSIOL, V141, P61, DOI 10.1104/pp.105.076323; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hoffman PD, 1996, MOL GEN GENET, V253, P259, DOI 10.1007/s004380050321; Imaizumi T, 2002, PLANT CELL, V14, P373, DOI 10.1105/tpc.010388; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li YY, 2013, PLANT PHYSIOL BIOCH, V67, P169, DOI 10.1016/j.plaphy.2013.02.031; Li YY, 2013, PLANT CELL REP, V32, P555, DOI 10.1007/s00299-013-1387-4; Lin C., 1996, PLANT PHYSIOL, V110, P1047; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; MANDOLI DF, 1990, PLANT CELL ENVIRON, V13, P287, DOI 10.1111/j.1365-3040.1990.tb01313.x; Matsumoto N, 2003, PLANT PHYSIOL, V133, P1494, DOI 10.1104/pp.103.025759; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Ninu L, 1999, PLANT J, V18, P551, DOI 10.1046/j.1365-313X.1999.00466.x; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Partch CL, 2005, METHOD ENZYMOL, V393, P726, DOI 10.1016/S0076-6879(05)93038-3; Platten JD, 2005, PLANT PHYSIOL, V139, P1472, DOI 10.1104/pp.105.067462; Platten JD, 2005, PLANT MOL BIOL, V59, P683, DOI 10.1007/s11103-005-0828-z; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Sharma P, 2014, PLANT CELL ENVIRON, V37, P961, DOI 10.1111/pce.12212; SOMERS DE, 1995, PLANT PHYSIOL, V107, P523, DOI 10.1104/pp.107.2.523; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Sorce C, 2008, J PLANT PHYSIOL, V165, P482, DOI 10.1016/j.jplph.2007.03.012; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Zhang YC, 2006, PLANT J, V46, P971, DOI 10.1111/j.1365-313X.2006.02753.x	68	8	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115201	10.1371/journal.pone.0115201	http://dx.doi.org/10.1371/journal.pone.0115201			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503486	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400081
J	Zhang, JM; Zhou, SY; Zhou, Y; Feng, F; Wang, QM; Zhu, XL; Ai, HS; Huang, XJ; Zhang, XH				Zhang, Jiamin; Zhou, Shiyuan; Zhou, Yi; Feng, Feier; Wang, Qianming; Zhu, Xiaolu; Ai, Huisheng; Huang, Xiaojun; Zhang, Xiaohui			Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; IN-VITRO; STROMAL CELLS; INJURY; TISSUE; IRRADIATION; DIFFERENTIATION; TRANSPLANTATION; FIBROSIS	Liver damage caused by radiotherapy is associated with a high mortality rate, but no established treatment exists. Adipose-derived mesenchymal stem cells (ADSCs) are capable of migration to injured tissue sites, where they aid in the repair of the damage. Hepatocyte growth factor (HGF) is critical for damage repair due to its anti-apoptotic, anti-fibrotic and cell regeneration-promoting effects. This study was performed to investigate the therapeutic effects of HGF-overexpressing ADSCs on radiation-induced liver damage (RILD). ADSCs were infected with a lentivirus encoding HGF and HGF-shRNA. Sprague-Dawley (SD) rats received 60Gy of irradiation to induce liver injury and were immediately given either saline, ADSCs, ADSCs + HGF or ADSCs + shHGF. Two days after irradiation, a significant reduction in apoptosis was observed in the HGF-overexpressing ADSC group compared with the RILD group, as assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Scanning electron microscopy showed chromatin condensation after irradiation, which was ameliorated in the group that received ADSCs and was reversed in the group that received HGF-overexpressing ADSCs. HGF-overexpressing ADSCs ameliorated radiation-induced liver fibrosis through down regulation of alpha-SMA and fibronectin. Hepatocyte regeneration was significantly improved in rats treated with ADSCs compared with rats from the RILD group), as assessed by Ki-67 immunohistochemistry. Rats that received HGF-overexpressing ADSCs showed an even greater level of hepatocyte regeneration. HGF-overexpressing ADSCs completely blocked the radiation-induced increase in the enzymes ALT and AST. The effect of mitigating RILD was compromised in the ADSC + shHGF group compared with the ADSC group. Altogether, these results suggest that HGF-overexpressing ADSCs can significantly improve RILD in a rat model, which may serve as a valuable therapeutic alternative.	[Zhang, Jiamin; Zhou, Shiyuan; Zhou, Yi; Feng, Feier; Wang, Qianming; Zhu, Xiaolu; Huang, Xiaojun; Zhang, Xiaohui] Peking Univ, Inst Hematol, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China; [Ai, Huisheng] Acad Mil Med Sci, Affiliated Hosp, Dept Hematol, Beijing, Peoples R China	Peking University; Academy of Military Medical Sciences - China	Huang, XJ (corresponding author), Peking Univ, Inst Hematol, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China.	zhangxh100@sina.com; zhangxhrmyy@126.com	Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643	National Key Technology Support Program [2012BAI38B03]; National Natural Science Foundation of China [81270643, 81470343]; Seeding Grant for Medicine and Engineering Sciences of Peking University [2141000008]; Beijing Natural Science Foundation [7132194]; Specialized Research Fund for the Doctoral Program of Higher Education [20120001110026]	National Key Technology Support Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seeding Grant for Medicine and Engineering Sciences of Peking University; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by The National Key Technology Support Program (No. 2012BAI38B03), the National Natural Science Foundation of China (No. 81270643 and No. 81470343), and a Seeding Grant for Medicine and Engineering Sciences of Peking University (No. 2141000008). This work was also supported in part by the Beijing Natural Science Foundation (No. 7132194) and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120001110026). All these funds were received by Xiaohui Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2004, J HEPATOL, V41, P905, DOI 10.1016/j.jhep.2004.08.022; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Barshishat-Kupper M, 2014, IEEE NETW OP MAN S N, P1; Beitnes JO, 2012, CELL TRANSPLANT, V21, P1697, DOI 10.3727/096368911X627462; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Chi CH, 2005, WORLD J GASTROENTERO, V11, P1496; Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; DESMET V, 1995, PATHOL RES PRACT, V191, P513, DOI 10.1016/S0344-0338(11)80870-8; FAJARDO LF, 1978, AM J SURG PATHOL, V2, P159, DOI 10.1097/00000478-197806000-00005; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Francois S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/151679; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hu SY, 2009, ACTA PHARMACOL SIN, V30, P1415, DOI 10.1038/aps.2009.133; Hu Shun-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P602; Imaeda M, 2014, J RADIAT RES, V55, P665, DOI 10.1093/jrr/rru005; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kubo N, 2012, J GASTROEN HEPATOL, V27, P165, DOI 10.1111/j.1440-1746.2011.06798.x; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Liang L, 2009, HEPATOL RES, V39, P822, DOI 10.1111/j.1872-034X.2009.00506.x; Liu XL, 2014, INT J CLIN EXP PATHO, V7, P174; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; Motawi TMK, 2014, CELL BIOCHEM BIOPHYS, V68, P111, DOI 10.1007/s12013-013-9698-1; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; OGATA KIKUAKI, 1963, TOKUSHIMA JOUR EXPTL MED, V9, P240; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Pan RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194498; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Ren ML, 2012, CELL TRANSPLANT, V21, P2711, DOI 10.3727/096368912X654966; Saito Y, 2013, J SURG RES, V180, P162, DOI 10.1016/j.jss.2012.10.009; Sato M, 2000, BIOCHEM PHARMACOL, V59, P681, DOI 10.1016/S0006-2952(99)00359-7; Seo KW, 2014, CELL BIOL INT, V38, P106, DOI 10.1002/cbin.10186; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Song YS, 2012, CELL TRANSPLANT, V21, P1641, DOI 10.3727/096368912X637488; Spahr L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053719; Tholpady SS, 2003, ANAT REC PART A, V272A, P398, DOI 10.1002/ar.a.10039; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang YL, 2013, TRANSPL P, V45, P3198, DOI 10.1016/j.transproceed.2013.07.061; WHARTON JT, 1973, AM J ROENTGENOL, V117, P73, DOI 10.2214/ajr.117.1.73; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Yang JJ, 2012, CELL BIOCHEM FUNCT, V30, P505, DOI 10.1002/cbf.2829; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	56	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114670	10.1371/journal.pone.0114670	http://dx.doi.org/10.1371/journal.pone.0114670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501583	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400044
J	Ismail, F; Couvin, D; Farakhin, I; Rahman, ZA; Rastogi, N; Suraiya, S				Ismail, Fazli; Couvin, David; Farakhin, Izzah; Rahman, Zaidah Abdul; Rastogi, Nalin; Suraiya, Siti			Study of Mycobacterium tuberculosis Complex Genotypic Diversity in Malaysia Reveals a Predominance of Ancestral East-African-Indian Lineage with a Malaysia-Specific Signature	PLOS ONE			English	Article							BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANT; STRAINS; SPOLIGOTYPES; RUSSIA; FAMILY	Background: Tuberculosis (TB) still constitutes a major public health problem in Malaysia. The identification and genotyping based characterization of Mycobacterium tuberculosis complex (MTBC) isolates causing the disease is important to determine the effectiveness of the control and surveillance programs. Objectives: This study intended a first assessment of spoligotyping-based MTBC genotypic diversity in Malaysia followed by a comparison of strains with those prevailing in neighboring countries by comparison with an international MTBC genotyping database. Methods: Spoligotyping was performed on a total of 220 M. tuberculosis clinical isolates collected in Kelantan and Kuala Lumpur. The results were compared with the SITVIT2 international database of the Pasteur Institute of Guadeloupe. Results: Spoligotyping revealed 77 different patterns: 22 corresponded to orphan patterns while 55 patterns containing 198 isolates were assigned a Spoligo International Type (SIT) designation in the database (the latter included 6 newly created SITs). The eight most common SITs grouped 141 isolates (5 to 56 strains per cluster) as follows: SIT1/Beijing, n = 56, 25.5%; SIT745/EAI1-SOM, n = 33, 15.0%; SIT591/EAI6-BGD1, n = 13, 5.9%; SIT256/EAI5, n = 12, 5.5%; SIT236/EAI5, n = 10, 4.6%; SIT19/EAI2-Manila, n = 9, 4.1%; SIT89/EAI2-Nonthaburi, n = 5, 2.3%; and SIT50/H3, n = 3, 1.4%. The association between city of isolation and lineages was statistically significant; Haarlem and T lineages being higher in Kuala Lumpur (p < 0.01). However, no statistically significant differences were noted when comparing drug resistance vs. major lineages, nor between gender and clades. Conclusions: The ancestral East-African-Indian (EAI) lineage was most predominant followed by the Beijing lineage. A comparison of strains with those prevailing in neighboring countries in South Asia, East Asia and South East Asia underlined the phylogeographical specificity of SIT745 for Malaysia, and its probable ongoing evolution with locally evolved strains sharing a specific signature characterized by absence of spacers 37, 38, and 40. Pending complementary genotyping confirmation, we propose that SIT745/EAI-SOM is tentatively reclassified as SIT745/EAI-MYS.	[Ismail, Fazli; Farakhin, Izzah; Rahman, Zaidah Abdul; Suraiya, Siti] Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Kota Baharu, Kelantan, Malaysia; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO, Supranat TB Reference Lab, Abymes, Guadeloupe, France	Universiti Sains Malaysia; World Health Organization	Suraiya, S (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Kota Baharu, Kelantan, Malaysia.	ssuraiya@usm.my	Rahman, Zaidah Abdul/AAD-1505-2020; Suraiya, Siti/D-7701-2016; RASTOGI, NALIN/AAP-1958-2020	Rahman, Zaidah Abdul/0000-0002-6612-8360; RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023	USM Research University Grant [1001/PPSP/853001]; Universiti Sains Malaysia; European Social Funds through the Regional Council of Guadeloupe, France	USM Research University Grant; Universiti Sains Malaysia(Universiti Sains Malaysia); European Social Funds through the Regional Council of Guadeloupe, France	This study was supported by USM Research University Grant (1001/PPSP/853001). Fazli Ismail was awarded a USM Fellowship by Universiti Sains Malaysia. David Couvin was awarded a Ph.D. fellowship by the European Social Funds through the Regional Council of Guadeloupe, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; Dale JW, 1999, J CLIN MICROBIOL, V37, P1265, DOI 10.1128/JCM.37.5.1265-1268.1999; David H, 1989, METHODES LAB MYCOBAC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Iyawoo K, 2004, TUBERCULOSIS, V84, P4, DOI 10.1016/j.tube.2003.08.014; JAGIELSKI T, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/645802; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Nissapatorn V, 2007, SE ASIAN J TROP MED, V38, P231; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yorsangsukkamol J, 2009, TUBERCULOSIS, V89, P304, DOI 10.1016/j.tube.2009.05.001	32	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114832	10.1371/journal.pone.0114832	http://dx.doi.org/10.1371/journal.pone.0114832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502956	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700057
J	Liu, XD; Yang, JJ; Fang, D; Cai, J; Wan, Y; Xing, GG				Liu, Xiao-Dan; Yang, Jing-Jing; Fang, Dong; Cai, Jie; Wan, You; Xing, Guo-Gang			Functional Upregulation of Nav1.8 Sodium Channels on the Membrane of Dorsal Root Ganglia Neurons Contributes to the Development of Cancer-Induced Bone Pain	PLOS ONE			English	Article							ACTION-POTENTIAL ELECTROGENESIS; NR2B-CONTAINING NMDA RECEPTORS; PRIMARY AFFERENT NEURONS; RESISTANT NA+ CURRENT; NEUROPATHIC PAIN; INFLAMMATORY PAIN; SENSORY NEURONS; DRG NEURONS; RAT MODEL; EXPRESSION	We have previously reported that enhanced excitability of dorsal root ganglia (DRG) neurons contributes to the development of bone cancer pain, which severely decreases the quality of life of cancer patients. Nav1.8, a tetrodotoxin-resistant (TTX-R) sodium channel, contributes most of the sodium current underlying the action potential upstroke and accounts for most of the current in later spikes in a train. We speculate that the Nav1.8 sodium channel is a potential candidate responsible for the enhanced excitability of DRG neurons in rats with bone cancer pain. Here, using electrophysiology, Western blot and behavior assays, we documented that the current density of TTX-R sodium channels, especially the Nav1.8 channel, increased significantly in DRG neurons of rats with cancer-induced bone pain. This increase may be due to an increased expression of Nav1.8 on the membrane of DRG neurons. Accordantly, blockade of Nav1.8 sodium channels by its selective blocker A-803467 significantly alleviated the cancer-induced mechanical allodynia and thermal hyperalgesia in rats. Taken together, these results suggest that functional upregulation of Nav1.8 channels on the membrane of DRG neurons contributes to the development of cancer-induced bone pain.	[Liu, Xiao-Dan; Yang, Jing-Jing; Fang, Dong; Cai, Jie; Xing, Guo-Gang] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Liu, Xiao-Dan; Cai, Jie; Wan, You; Xing, Guo-Gang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Beijing 100871, Peoples R China; [Xing, Guo-Gang] Minist Educ, Key Lab Neurosci, Beijing, Peoples R China; [Xing, Guo-Gang] Minist Hlth, Beijing, Peoples R China	Peking University; Peking University	Xing, GG (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Beijing 100871, Peoples R China.	ywan@hsc.pku.edu.cn; ggxing@bjmu.edu.cn	cai, jie/HHS-0606-2022; Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [81371237, 31171063, 81072951]; Beijing Natural Science Foundation [7112079]; special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China [201302013-01]; "973" Program of the Ministry of Science and Technology of China [2013CB531905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China; "973" Program of the Ministry of Science and Technology of China(National Basic Research Program of China)	The present work was supported by grants from the National Natural Science Foundation of China (81371237, 31171063,81072951), the Beijing Natural Science Foundation (7112079), the special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China (201302013-01) and the "973" Program of the Ministry of Science and Technology of China (2013CB531905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Berta T, 2008, MOL CELL NEUROSCI, V37, P196, DOI 10.1016/j.mcn.2007.09.007; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Blair NT, 2002, J NEUROSCI, V22, P10277; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; Fang X, 2002, J NEUROSCI, V22, P7425; Geng SJ, 2010, EXP NEUROL, V222, P256, DOI 10.1016/j.expneurol.2010.01.003; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jimenez-Andrade JM, 2010, ANN NY ACAD SCI, V1198, P173, DOI 10.1111/j.1749-6632.2009.05429.x; Joshi SK, 2009, J PAIN, V10, P306, DOI 10.1016/j.jpain.2008.09.007; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Liu M, 2013, PAIN, V154, P1551, DOI 10.1016/j.pain.2013.04.022; Matsutomi T, 2006, PFLUG ARCH EUR J PHY, V453, P83, DOI 10.1007/s00424-006-0104-3; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Miao XR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-216; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Moldovan M, 2013, EUR J PHARMACOL, V708, P105, DOI 10.1016/j.ejphar.2013.03.001; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Qiu F, 2012, NEUROSCI LETT, V512, P61, DOI 10.1016/j.neulet.2012.01.069; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rugiero F, 2003, J NEUROSCI, V23, P2715; Rush AM, 2004, BRAIN RES, V1023, P264, DOI 10.1016/j.brainres.2004.07.042; Zhao J, 2010, LIFE SCI, V87, P120, DOI 10.1016/j.lfs.2010.05.015; Zheng Q, 2013, PAIN, V154, P434, DOI 10.1016/j.pain.2012.12.005; Zheng Q, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-24; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	40	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114623	10.1371/journal.pone.0114623	http://dx.doi.org/10.1371/journal.pone.0114623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503076	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700034
J	Wang, X; Qian, YJ; Zhou, Q; Ye, P; Duan, N; Huang, XF; Zhu, YN; Li, JJ; Hu, LP; Zhang, WY; Han, XD; Wang, WM				Wang, Xiang; Qian, Ya-jie; Zhou, Qian; Ye, Pei; Duan, Ning; Huang, Xiao-feng; Zhu, Ya-nan; Li, Jing-jing; Hu, Li-ping; Zhang, Wei-yun; Han, Xiao-dong; Wang, Wen-mei			Caspase-12 Silencing Attenuates Inhibitory Effects of Cigarette Smoke Extract on NOD1 Signaling and hBDs Expression in Human Oral Mucosal Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; GENE-EXPRESSION; MACROPHAGES; INFECTIONS; INDUCTION; RESPONSES; CANCER; HEALTH; TISSUE	Cigarette smoke exposure is associated with increased risk of various diseases. Epithelial cells-mediated innate immune responses to infectious pathogens are compromised by cigarette smoke. Although many studies have established that cigarette smoke exposure affects the expression of Toll-liked receptor (TLR), it remains unknown whether the nucleotide-binding oligomerization domaincontaining protein 1 (NOD1) expression is affected by cigarette smoke exposure. In the study, we investigated effects of cigarette smoke extract (CSE) on NOD1 signaling in an immortalized human oral mucosal epithelial (Leuk-1) cell line. We first found that CSE inhibited NOD1 expression in a dose-dependent manner. Moreover, CSE modulated the expression of other crucial molecules in NOD1 signaling and human b defensin (hBD) 1, 2 and 3. We found that RNA interferenceinduced Caspase-12 silencing increased NOD1 and phospho-NF-kappa B (p-NF-kappa B) expression and down-regulated RIP2 expression. The inhibitory effects of CSE on NOD1 signaling can be attenuated partially through Caspase-12 silencing. Intriguingly, Caspase-12 silencing abrogated inhibitory effects of CSE on hBD1, 3 expression and augmented induced effect of CSE on hBD2 expression. Caspase-12 could play a vital role in the inhibitory effects of cigarette smoke on NOD1 signaling and hBDs expression in oral mucosal epithelial cells.	[Wang, Xiang; Qian, Ya-jie; Ye, Pei; Duan, Ning; Li, Jing-jing; Wang, Wen-mei] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Qian; Zhu, Ya-nan] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Endodont, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Xiao-feng] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Li-ping] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Han, Xiao-dong] Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Zhang, Wei-yun; Han, Xiao-dong] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Zhang, Wei-yun; Han, Xiao-dong] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Han, XD (corresponding author), Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing 210008, Jiangsu, Peoples R China.	hanxd@nju.edu.cn; wenmei-wang@hotmail.com	Wang, Xiang/F-8467-2014; han, xiao/HDN-9782-2022	Wang, Xiang/0000-0002-2135-8576; 	National Natural Scientific Foundation of China [81070839, 81273121]; Jiangsu Province's Outstanding Medical Academic Leader program [LJ201110]; Medical Science and technology development Foundation, Nanjing Department of Health [ZKX10030]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Outstanding Medical Academic Leader program; Medical Science and technology development Foundation, Nanjing Department of Health	This work was supported by the National Natural Scientific Foundation of China (No. 81070839 & No. 81273121), Jiangsu Province's Outstanding Medical Academic Leader program (No. LJ201110), and Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (No. ZKX10030).	Alberg AJ, 2008, DRUG TODAY, V44, P895, DOI 10.1358/dot.2008.44.12.1308898; Aldhous MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024715; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Baboni FB, 2009, MYCOPATHOLOGIA, V168, P227, DOI 10.1007/s11046-009-9217-5; Bogefors J, 2012, FEMS IMMUNOL MED MIC, V65, P431, DOI 10.1111/j.1574-695X.2012.00959.x; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chung WO, 2007, CURR PHARM DESIGN, V13, P3073, DOI 10.2174/138161207782110435; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Di Cello F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-90; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Gan GX, 2011, CELL PHYSIOL BIOCHEM, V28, P725, DOI 10.1159/000335766; He P, 2009, NEUROTOXICOLOGY, V30, P10, DOI 10.1016/j.neuro.2008.10.004; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kim SR, 2009, BIOMED CHROMATOGR, V23, P273, DOI 10.1002/bmc.1110; Kimball JR, 2006, ARCH ORAL BIOL, V51, P775, DOI 10.1016/j.archoralbio.2006.05.007; Kitaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038038; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Li YF, 2013, DIS MARKERS, V34, P247, DOI [10.1155/2013/983568, 10.3233/DMA-130967]; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Moraitis D, 2005, CANCER RES, V65, P664; Pace E, 2014, TOXICOL IN VITRO, V28, P292, DOI 10.1016/j.tiv.2013.11.004; Pace E, 2013, TOXICOL LETT, V223, P198, DOI 10.1016/j.toxlet.2013.09.013; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Patil AJ, 2009, CURR EYE RES, V34, P672, DOI 10.1080/02713680903015892; Rao SVK, 2013, ASIAN PAC J CANCER P, V14, P5567, DOI 10.7314/APJCP.2013.14.10.5567; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Sarioglu S, 2011, APPL IMMUNOHISTO M M, V19, P470, DOI 10.1097/PAI.0b013e318214e543; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Semlali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052614; Sharma A, 2008, INVEST OPHTH VIS SCI, V49, P5111, DOI 10.1167/iovs.08-2060; Shi JX, 2012, RESP PHYSIOL NEUROBI, V181, P154, DOI 10.1016/j.resp.2012.02.011; Shibata Y, 2008, RESPIROLOGY, V13, P1061, DOI 10.1111/j.1440-1843.2008.01362.x; Soysa NS, 2005, ORAL DIS, V11, P268, DOI 10.1111/j.1601-0825.2005.01115.x; Sugawara Y, 2006, J DENT RES, V85, P524, DOI 10.1177/154405910608500609; Suzuki Y, 2011, BURNS, V37, P109, DOI 10.1016/j.burns.2010.08.004; Todt JC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-33; Uchiyama R, 2014, ARCH IMMUNOL THER EX; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Wang Q, 2013, CARCINOGENESIS, V34, P2119, DOI 10.1093/carcin/bgt143; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895; Wang X, 2014, INT J CLIN EXP PATHO, V7, P1677; Wolgin M, 2012, J DENT, V40, P949, DOI 10.1016/j.jdent.2012.07.017; Yuan FJ, 2013, EXP TOXICOL PATHOL, V65, P1011, DOI 10.1016/j.etp.2013.02.004; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhao XP, 2007, BIOCHEM BIOPH RES CO, V359, P896, DOI 10.1016/j.bbrc.2007.05.175	53	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115053	10.1371/journal.pone.0115053	http://dx.doi.org/10.1371/journal.pone.0115053			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503380	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700087
J	Hudjetz, S; Lennartz, G; Kramer, K; Ross-Nickoll, M; Gergs, A; Preuss, TG				Hudjetz, Silvana; Lennartz, Gottfried; Kraemer, Klara; Ross-Nickoll, Martina; Gergs, Andre; Preuss, Thomas G.			Modeling Wood Encroachment in Abandoned Grasslands in the Eifel National Park - Model Description and Testing	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; BROOM CYTISUS-SCOPARIUS; SPATIALLY EXPLICIT; LAND-USE; SPECIES COMPOSITION; TREE REGENERATION; MOUNTAIN FORESTS; LANDSCAPE MODEL; SEED DISPERSAL; DYNAMICS MODEL	The degradation of natural and semi-natural landscapes has become a matter of global concern. In Germany, semi-natural grasslands belong to the most species-rich habitat types but have suffered heavily from changes in land use. After abandonment, the course of succession at a specific site is often difficult to predict because many processes interact. In order to support decision making when managing semi-natural grasslands in the Eifel National Park, we built the WoodS-Model (Woodland Succession Model). A multimodeling approach was used to integrate vegetation dynamics in both the herbaceous and shrub/tree layer. The cover of grasses and herbs was simulated in a compartment model, whereas bushes and trees were modelled in an individual-based manner. Both models worked and interacted in a spatially explicit, raster-based landscape. We present here the model description, parameterization and testing. We show highly detailed projections of the succession of a semi-natural grassland including the influence of initial vegetation composition, neighborhood interactions and ungulate browsing. We carefully weighted the single processes against each other and their relevance for landscape development under different scenarios, while explicitly considering specific site conditions. Model evaluation revealed that the model is able to emulate successional patterns as observed in the field as well as plausible results for different population densities of red deer. Important neighborhood interactions such as seed dispersal, the protection of seedlings from browsing ungulates by thorny bushes, and the inhibition of wood encroachment by the herbaceous layer, have been successfully reproduced. Therefore, not only a detailed model but also detailed initialization turned out to be important for spatially explicit projections of a given site. The advantage of the WoodS-Model is that it integrates these many mutually interacting processes of succession.	[Hudjetz, Silvana; Kraemer, Klara; Ross-Nickoll, Martina; Gergs, Andre; Preuss, Thomas G.] Rhein Westfal TH Aachen, Inst Environm Res Biol 5, D-52074 Aachen, Germany; [Hudjetz, Silvana; Lennartz, Gottfried] Rhein Westfal TH Aachen, Res Inst Ecosyst Anal & Assessment Gaiac, D-52072 Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Hudjetz, S (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res Biol 5, Worringerweg 1, D-52074 Aachen, Germany.	silvana.hudjetz@gaiac.rwth-aachen	RoÃ-NIckoll, Martina/HGE-9656-2022; Preuss, Thomas G./A-7926-2009	Preuss, Thomas G./0000-0001-6249-6003	MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia); LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection); German National Academic Foundation	MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia); LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection); German National Academic Foundation	The development of the model was supported by the MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia) and the LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection) and by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bakker ES, 2004, J APPL ECOL, V41, P571, DOI 10.1111/j.0021-8901.2004.00908.x; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Bergquist J, 2009, SCAND J FOREST RES, V24, P308, DOI 10.1080/02827580903117420; Bithell M, 2007, ECOL MODEL, V200, P59, DOI 10.1016/j.ecolmodel.2006.07.031; BOSSARD CC, 1990, ECOLOGY, V71, P2370, DOI 10.2307/1938647; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Brouwer E, 2005, VLIZ SPECIAL PUBLICA, P229; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Bugmann H., 1994, THESIS SWISS FEDERAL; BUGMANN H, 2005, FORUM WISSEN, P41; Burschel P, 1997, GRUNDRISS WALDBAUS L, V2nd; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; CANHAM CD, 1994, CAN J FOREST RES, V24, P817, DOI 10.1139/x94-107; CBD, 2010, 4 CBD; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Commission of the European Communities, 2009, COMP REP CONS STAT H; Didion M, 2009, FOREST ECOL MANAG, V258, pS44, DOI 10.1016/j.foreco.2009.06.006; Diemer M, 2001, APPL VEG SCI, V4, P237, DOI 10.1111/j.1654-109X.2001.tb00492.x; Dierschke H., 2002, KULTURGRASLAND; Eiberle K., 1989, Schweizerische Zeitschrift fur Forstwesen, V140, P1031; Ellenberg H, 1996, VEGETATION MITTELEUR; Engler S, 2010, THESIS RWTH AACHEN U; Frost I, 1997, OIKOS, V79, P53, DOI 10.2307/3546089; GBO3, 2010, GLOB BIOD OUTL 3 EX; Gebert C, 2001, MAMMAL REV, V31, P189, DOI 10.1046/j.1365-2907.2001.00090.x; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Gillet F, 2008, ECOL MODEL, V217, P1, DOI 10.1016/j.ecolmodel.2008.05.013; Glavac V, 1996, VEGETATIONSOKOLOGIE; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gross LJ, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P467; Hardtle W, 2008, WALDER TIEFLANDES MI; Harmer R, 2001, J APPL ECOL, V38, P1094, DOI 10.1046/j.1365-2664.2001.00664.x; Harmer R, 2001, BIOL CONSERV, V101, P291, DOI 10.1016/S0006-3207(01)00072-6; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Heilburg I, 2010, THESIS RWTH AACHEN U; Hejcman M, 2004, GRASSLAND SCI EUROPE, V9, P213; Holst PJ, 2004, AUST J EXP AGR, V44, P553, DOI 10.1071/EA97041; Isselstein J., 2005, Agronomy Research, V3, P139; JARVIS PG, 1964, OIKOS, V15, P56, DOI 10.2307/3564748; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kalen C, 2004, FOREST ECOL MANAG, V187, P149, DOI 10.1016/S0378-1127(03)00316-5; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kleyer M, 2007, BASIC APPL ECOL, V8, P293, DOI 10.1016/j.baae.2007.04.001; Kochy M, 2000, OIKOS, V91, P385, DOI 10.1034/j.1600-0706.2000.910219.x; Kochy M, 2008, REG ENVIRON CHANGE, V8, P73, DOI 10.1007/s10113-008-0048-6; Kramer K, 2006, FOREST ECOL MANAG, V226, P238, DOI 10.1016/j.foreco.2006.01.037; Kramer K, 2003, FOREST ECOL MANAG, V181, P205, DOI 10.1016/S0378-1127(03)00134-8; Kramer K, 2011, THESIS RWTH AACHEN U; Kramer K, 2009, AUSWIRKUNG VERSCHIED; Kratochwil A, 2001, OKOLOGIE LEBENSGEMEI; Kuiters AT, 2003, FOREST ECOL MANAG, V181, P239, DOI 10.1016/S0378-1127(03)00136-1; Kunstler G, 2007, DIVERS DISTRIB, V13, P799, DOI 10.1111/j.1472-4642.2007.00404.x; Lassig R., 1995, SCHWEIZERISCHE Z FOR, V146, P893; Lennartz G, 2006, ABSCHLUSSBERICHT MOD; Lenth R., 2019, Journal of Statistical Software, V60, P1; LIEFFERS VI, 1993, CAN J FOREST RES, V23, P2070, DOI 10.1139/x93-258; Lischke H, 2006, ECOL MODEL, V199, P409, DOI 10.1016/j.ecolmodel.2005.11.046; LOAGUE K, 1991, Journal of Contaminant Hydrology, V7, P51, DOI 10.1016/0169-7722(91)90038-3; Manzano P, 2005, SEED SCI RES, V15, P21, DOI 10.1079/SSR2004192; Meyer SE, 2008, WOODY PLANT SEED MAN, P466; Miller G. R., 1998, Scottish Forestry, V52, P138; Ministerium fur Ernahrung und landlichen Raum Baden-Wurttemberg, 2001, SCHATZH BEARB DURCH; Moog D, 2002, APPL VEG SCI, V5, P99, DOI 10.1111/j.1654-109X.2002.tb00539.x; Muller J, 1998, BRACHESUKZESSIONEN P, P103; Nationalparkverwaltung Eifel Nationalparkplan Eifel Band, BESTANDSANA IN PRESS, V2; Nothdurft A, 2007, THESIS GEORG AUGUST; Odom DIS, 2003, ECOL ECON, V44, P119, DOI 10.1016/S0921-8009(02)00259-8; Olff H, 1999, PLANT BIOLOGY, V1, P127, DOI 10.1111/j.1438-8677.1999.tb00236.x; Palmer SCF, 2004, FOREST ECOL MANAG, V192, P251, DOI 10.1016/j.foreco.2004.01.038; Pardey A, 2008, NATIONALPARK EIFEL N, V1; Paynter Q, 1998, J APPL ECOL, V35, P582, DOI 10.1046/j.1365-2664.1998.3540582.x; Paynter Q, 2003, J APPL ECOL, V40, P470, DOI 10.1046/j.1365-2664.2003.00817.x; Paynter Quentin, 2000, Plant Protection Quarterly, V15, P149; Peringer A, ECOLOGY SOC IN PRESS; Peringer A, 2011, ECOL MODEL, V222, P3120, DOI 10.1016/j.ecolmodel.2011.05.025; Peters DPC, 2002, ECOL MODEL, V152, P5, DOI 10.1016/S0304-3800(01)00460-4; PETRAK M, 1985, Z JAGDWISS, V31, P73, DOI 10.1007/BF02246115; Petrak M, 2005, HABITAT USE RED DEER, P435; Petrak Michael, 2006, Decheniana, V159, P123; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; POTT R, 1991, HUDELANDSCHAFTEN NOR; Prach K, 2006, PRESLIA, V78, P469; Pretzsch H, 2008, ANN BOT-LONDON, V101, P1065, DOI 10.1093/aob/mcm246; PRETZSCH H., 2001, MODELLIERUNG WALDWAC; Prevosto B, 2004, ACTA OECOL, V25, P73, DOI 10.1016/j.actao.2003.11.005; Rammig A, 2007, EUR J FOREST RES, V126, P49, DOI 10.1007/s10342-005-0088-0; Rammig A, 2006, FOREST ECOL MANAG, V222, P123, DOI 10.1016/j.foreco.2005.10.042; Rammig A, 2005, THESIS SWISS FEDERAL; Rammig A, 2007, FOREST ECOL MANAG, V242, P142, DOI 10.1016/j.foreco.2007.01.036; Reif A., 2007, WALDOEKOLOGIE ONLINE, V5, P79; Renaud PC, 2003, FOREST ECOL MANAG, V181, P31, DOI 10.1016/S0378-1127(03)00126-9; Rickebusch S, 2007, FOREST ECOL MANAG, V246, P251, DOI 10.1016/j.foreco.2007.04.030; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Schmidt W, 2004, ASUNGSKAPAZITAT WALD, pA; Schreiber K, 2000, METHODEN LANDSCHAFTS; Schreiber KF, 1997, FORSTWISS CENTRALBL, V116, P243, DOI 10.1007/BF02766901; Schulte J, 1998, JAGER LEHRBUCH JAGER; Schumacher S, 2004, ECOL MODEL, V180, P175, DOI 10.1016/j.ecolmodel.2003.12.055; SCHUMACHER S, 2004, THESIS SWISS FEDERAL; Schumacher S, 2006, LANDSCAPE ECOL, V21, P539, DOI 10.1007/s10980-005-2165-7; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Schupp EW, 1998, US FOR SERV RMRS-P, P66; Siehoff S, 2011, THESIS RWTH AACHEN U; Siehoff S, 2011, ECOL MODEL, V222, P3854, DOI 10.1016/j.ecolmodel.2011.10.003; Smit C, 2011, J VEG SCI, V22, P377, DOI 10.1111/j.1654-1103.2011.01264.x; SMITH J M B, 1991, Plant Protection Quarterly, V6, P73; Smith R, 1998, PLANT ECOL, V139, P203, DOI 10.1023/A:1009750216223; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Syphard AD, 2007, ENVIRON MODELL SOFTW, V22, P1641, DOI 10.1016/j.envsoft.2007.01.004; TARREGA R, 1992, VEGETATIO, V102, P139, DOI 10.1007/BF00044730; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tischler B, 2006, THESIS RWTH AACHEN U; Turner JH, 1933, B MISCELLANEOUS INFO, P257; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Wersch C, 2010, THESIS RWTH AACHEN U; Vandenberghe C, 2008, OIKOS, V117, P415, DOI 10.1111/j.2007.0030-1299.16264.x; Vincenot CE, 2011, ECOL MODEL, V222, P210, DOI 10.1016/j.ecolmodel.2010.09.029; Waloff N, 1968, ADV ECOLOGICAL RES; Ward BC, 2004, TECHNICAL REPORT; Watt AS, 1919, J ECOL, V7, P173, DOI 10.2307/2255275; Weber HE, 2008, GEBUSCHE HECKEN KRAU; Weisberg PJ, 2005, ECOL MODEL, V185, P213, DOI 10.1016/j.ecolmodel.2004.12.004; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; [No title captured]	129	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113827	10.1371/journal.pone.0113827	http://dx.doi.org/10.1371/journal.pone.0113827			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494057	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400021
J	Navara, KJ				Navara, Kristen J.			Low Gestational Weight Gain Skews Human Sex Ratios towards Females	PLOS ONE			English	Article							OFFSPRING SEX; MATERNAL WEIGHT; PREGNANT-WOMEN; ENERGY-INTAKE; BIRTH; MECHANISMS; ADJUSTMENT; SELECTION; DIET	Background: Human males are more vulnerable to adverse conditions than females starting early in gestation and continuing throughout life, and previous studies show that severe food restriction can influence the sex ratios of human births. It remains unclear, however, whether subtle differences in caloric intake during gestation alter survival of fetuses in a sex-specific way. I hypothesized that the ratio of male to female babies born should vary with the amount of weight gained during gestation. I predicted that women who gain low amounts of weight during gestation should produce significantly more females, and that, if gestational weight gain directly influences sex ratios, fetal losses would be more likely to be male when women gain inadequate amounts of weight during pregnancy. Methods: I analyzed data collected from over 68 million births over 23 years to test for a relationship between gestational weight gain and natal sex ratios, as well as between gestational weight gain and sex ratios of fetal deaths at five gestational ages. Results: Gestational weight gain and the proportion of male births were positively correlated; a lower proportion of males was produced by women who gained less weight and this strong pattern was exhibited in four human races. Further, sex ratios of fetal losses at 6 months of gestation were significantly male-biased when mothers had gained low amounts of weight during pregnancy, suggesting that low caloric intake during early fetal development can stimulate the loss of male fetuses. Conclusion: My data indicate that human sex ratios change in response to resource availability via sex-specific fetal loss, and that a pivotal time for influences on male survival is early in fetal development, at 6 months of gestation.	Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Navara, KJ (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	knavara@uga.edu						Bergmann MM, 1997, INT J OBESITY, V21, P1010, DOI 10.1038/sj.ijo.0800509; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Brawarsky P, 2005, INT J GYNECOL OBSTET, V91, P125, DOI 10.1016/j.ijgo.2005.08.008; Bulik CM, 2008, ACTA OBSTET GYN SCAN, V87, P979, DOI 10.1080/00016340802334385; BURGOYNE PS, 1993, DEVELOPMENT, V117, P341; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Cagnacci A, 2004, HUM REPROD, V19, P442, DOI 10.1093/humrep/deh071; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Caulfield LE, 1996, OBSTET GYNECOL, V87, P760, DOI 10.1016/0029-7844(96)00023-3; Centers for Disease Control and Prevention, 2014, DAT VIT STAT BIRTH D; de Zegher F, 1999, HORM RES, V51, P258, DOI 10.1159/000023382; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Evdokimova V. N., 2000, Ontogenez, V31, P251; Graffelman J, 1999, HUM REPROD, V14, P2917, DOI 10.1093/humrep/14.11.2917; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; Hernandez-Julian R, 2013, 7692 IZA; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Khashan AS, 2010, EPIDEMIOLOGY, V21, P913, DOI 10.1097/EDE.0b013e3181f3327c; KHOURY MJ, 1984, AM J HUM GENET, V36, P1103; Kirchengast S, 2009, J LIFE SCI, V1, P63, DOI DOI 10.1080/09751270.2009.11885136; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Lagiou P, 2004, EUR J CLIN NUTR, V58, P231, DOI 10.1038/sj.ejcn.1601771; Langley-Evans AJ, 2003, J R SOC PROMO HEALTH, V123, P210, DOI 10.1177/146642400312300409; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; Meikle DB, 1998, AM NAT, V124, P173; Navara KJ, 2013, INTEGR COMP BIOL, V53, P877, DOI 10.1093/icb/ict081; Navara KJ, 2010, J COMP PHYSIOL B, V180, P785, DOI 10.1007/s00360-010-0483-9; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; Nonaka K, 1999, HUM BIOL, V71, P875; Olafsdottir AS, 2006, INT J OBESITY, V30, P492, DOI 10.1038/sj.ijo.0803184; Olson CM, 2004, AM J OBSTET GYNECOL, V191, P530, DOI 10.1016/j.ajog.2004.01.027; RAY PF, 1995, J REPROD FERTIL, V104, P165; Rosenfeld CS, 2012, REPROD FERT DEVELOP, V24, P45, DOI 10.1071/RD11906; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SKJERVOLD H, 1979, Z TIERZ ZUCHTUNGSBIO, V95, P293; Song SG, 2012, P ROY SOC B-BIOL SCI, V279, P2883, DOI 10.1098/rspb.2012.0320; Stuebe Am, 2009, AM J OBSTET GYNECOL, V201; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; van Bodegom David, 2013, Evolution Medicine and Public Health, P37, DOI 10.1093/emph/eot002; van Schaik C.P., 1991, American Naturalist, V138, P1555, DOI 10.1086/285300; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Villamor E, 2008, FERTIL STERIL, V89, P1240, DOI 10.1016/j.fertnstert.2007.07.1371; WHO, 2014, GLOB DAT BOD MASS IN; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; Young SS, 2009, P R SOC B, V276, P1211, DOI 10.1098/rspb.2008.1405	48	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114304	10.1371/journal.pone.0114304	http://dx.doi.org/10.1371/journal.pone.0114304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493647	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400040
J	Gill-Thind, JK; Dhankher, P; D'Oyley, JM; Sheppard, TD; Millar, NS				Gill-Thind, JasKiran K.; Dhankher, Persis; D'Oyley, Jarryl M.; Sheppard, Tom D.; Millar, Neil S.			Structurally Similar Allosteric Modulators of alpha 7 Nicotinic Acetylcholine Receptors Exhibit Five Distinct Pharmacological Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; TRANSMEMBRANE SITE; CHANNEL DOMAIN; AMINO-ACIDS; IN-VITRO; AGONIST; SUBUNIT; EXPRESSION; BINDING; DESENSITIZATION	Activation of nicotinic acetylcholine receptors (nAChRs) is associated with the binding of agonists such as acetylcholine to an extracellular site that is located at the interface between two adjacent receptor subunits. More recently, there has been considerable interest in compounds, such as positive and negative allosteric modulators (PAMs and NAMs), that are able to modulate nAChR function by binding to distinct allosteric sites. Here we examined a series of compounds differing only in methyl substitution of a single aromatic ring. This series of compounds includes a previously described alpha 7-selective allosteric agonist, cis-cis-4-p-tolyl-3a, 4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4MP-TQS), together with all other possible combinations of methyl substitution at a phenyl ring (18 additional compounds). Studies conducted with this series of compounds have revealed five distinct pharmacological effects on alpha 7 nAChRs. These five effects can be summarized as: 1) nondesensitizing activation (allosteric agonists), 2) potentiation associated with minimal effects on receptor desensitization (type I PAMs), 3) potentiation associated with reduced desensitization (type II PAMs), 4) noncompetitive antagonism (NAMs), and 5) compounds that have no effect on orthosteric agonist responses but block allosteric modulation (silent allosteric modulators (SAMs)). Several lines of experimental evidence are consistent with all of these compounds acting at a common, transmembrane allosteric site. Notably, all of these chemically similar compounds that have been classified as nondesensitizing allosteric agonists or as nondesensitizing (type II) PAMs are cis-cis-diastereoisomers, whereas all of the NAMs, SAMs, and type I PAMs are cis-trans-diastereoisomers. Our data illustrate the remarkable pharmacological diversity of allosteric modulators acting on nAChRs.	[Gill-Thind, JasKiran K.; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Dhankher, Persis; D'Oyley, Jarryl M.; Sheppard, Tom D.] UCL, Dept Chem, London WC1H 0AJ, England	University of London; University College London; University of London; University College London	Millar, NS (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	n.millar@ucl.ac.uk	Sheppard, Tom D./C-2383-2008	Sheppard, Tom D./0000-0002-3455-1164	Biotechnology and Biological Sciences Research Council [BB/F017146/1]; Biotechnology and Biological Sciences Research Council; Eli Lilly; University College London Ph.D. Programme in Drug Discovery; Engineering and Physical Sciences Research Council [EP/E052789/1]; EPSRC [EP/E052789/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly(Eli Lilly); University College London Ph.D. Programme in Drug Discovery; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F017146/1.; Supported by a Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering Ph.D. studentship that was co-funded by the Biotechnology and Biological Sciences Research Council and Eli Lilly.; Supported by PhD studentships associated with the University College London Ph.D. Programme in Drug Discovery.; Supported by Engineering and Physical Sciences Research Council Advanced Research Fellowship Grant EP/E052789/1.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; Becker C, 2004, [No title captured], Patent No. [2004/098600, 2004098600]; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Burford NT, 2013, P NATL ACAD SCI USA, V110, P10830, DOI 10.1073/pnas.1300393110; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dhankher P, 2014, SYNLETT, V25, P381, DOI 10.1055/s-0033-1340302; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Harkness PC, 2001, NEUROPHARMACOLOGY, V41, P79, DOI 10.1016/S0028-3908(01)00042-9; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Mantione E, 2012, FUTURE MED CHEM, V4, P2217, DOI [10.4155/FMC.12.172, 10.4155/fmc.12.172]; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Noblin DJ, 2012, ASSAY DRUG DEV TECHN, V10, P457, DOI 10.1089/adt.2011.443; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Papke RL, 2014, J BIOL CHEM, V289, P4515, DOI 10.1074/jbc.M113.524603; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Thakur GA, 2013, J MED CHEM, V56, P8943, DOI 10.1021/jm401267t; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809	46	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3552	3562		10.1074/jbc.M114.619221	http://dx.doi.org/10.1074/jbc.M114.619221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25516597	hybrid, Green Published			2022-12-26	WOS:000349456000029
J	Konitsiotis, AD; Jovanovic, B; Ciepla, P; Spitaler, M; Lanyon-Hogg, T; Tate, EW; Magee, AI				Konitsiotis, Antonio D.; Jovanovic, Biljana; Ciepla, Paulina; Spitaler, Martin; Lanyon-Hogg, Thomas; Tate, Edward W.; Magee, Anthony I.			Topological Analysis of Hedgehog Acyltransferase, a Multipalmitoylated Transmembrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND O-ACYLTRANSFERASES; SONIC-HEDGEHOG; SACCHAROMYCES-CEREVISIAE; LIPID MODIFICATIONS; S-ACYLTRANSFERASES; COMPLETE GENOMES; PALMITOYLATION; MEMBRANE; PREDICTION; CALNEXIN	Hedgehog proteins are secreted morphogens that play critical roles in development and disease. During maturation of the proteins through the secretory pathway, they are modified by the addition of N-terminal palmitic acid and C-terminal cholesterol moieties, both of which are critical for their correct function and localization. Hedgehog acyltransferase(HHAT) is the enzyme in the endoplasmic reticulum that palmitoylates Hedgehog proteins, is a member of a small subfamily of membrane-bound O-acyltransferase proteins that acylate secreted proteins, and is an important drug target in cancer. However, little is known about HHAT structure and mode of function. We show that HHAT is comprised of ten transmembrane domains and two reentrant loops with the critical His and Asp residues on opposite sides of the endoplasmic reticulum membrane. We further show that HHAT is palmitoylated on multiple cytosolic cysteines that maintain protein structure within the membrane. Finally, we provide evidence that mutation of the conserved His residue in the hypothesized catalytic domain results in a complete loss ofHHATpalmitoylation, providing novel insights into how the protein may function in vivo.	[Konitsiotis, Antonio D.; Jovanovic, Biljana; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, London SW7 2AZ, England; [Spitaler, Martin] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, FILM, London SW7 2AZ, England; [Ciepla, Paulina; Lanyon-Hogg, Thomas; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Ciepla, Paulina; Tate, Edward W.; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Tate, EW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	e.tate@imperial.ac.uk; t.magee@imperial.ac.uk	Magee, Anthony/V-8345-2019	Lanyon-Hogg, Thomas/0000-0002-7092-8096; Spitaler, Martin/0000-0002-8833-638X; Ciepla, Paulina/0000-0002-5139-9635; Tate, Edward/0000-0003-2213-5814	Pancreatic Cancer Research Fund; Cancer Research UK; NHLI Foundation; Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training [EP/F500416/1]; EPSRC [EP/J021199/1] Funding Source: UKRI; MRC [G0400710] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [978583] Funding Source: researchfish; Cancer Research UK [16402] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J021199/1] Funding Source: researchfish; Medical Research Council [G0400710] Funding Source: researchfish	Pancreatic Cancer Research Fund; Cancer Research UK(Cancer Research UK); NHLI Foundation; Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Pancreatic Cancer Research Fund and Cancer Research UK grants (to A. I. M. and E. W. T.).; Supported by a Ph.D. studentship from the NHLI Foundation. Present address: Dept. of Biosciences and Nutrition, Karolinska Institutet, 14157 Huddinge, Sweden.; Supported by a Ph.D. studentship from the Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training (Grant EP/F500416/1).	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Heal WP, 2011, CHEM COMMUN, V47, P4081, DOI 10.1039/c0cc04710d; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; JOSEPH M, 1995, J BIOL CHEM, V270, P19439, DOI 10.1074/jbc.270.33.19439; Konitsiotis AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089899; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Law RJ, 2002, CURR BIOL, V12, pR250, DOI 10.1016/S0960-9822(02)00784-4; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Tsirigos KD, 2012, PROTEOMICS, V12, P2282, DOI 10.1002/pmic.201100495; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037	42	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3293	3307		10.1074/jbc.M114.614578	http://dx.doi.org/10.1074/jbc.M114.614578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505265	Green Published, hybrid			2022-12-26	WOS:000349456000010
J	Tyson, GH; Halavaty, AS; Kim, H; Geissler, B; Agard, M; Satchell, KJ; Cho, W; Anderson, WF; Hauser, AR				Tyson, Gregory H.; Halavaty, Andrei S.; Kim, Hyunjin; Geissler, Brett; Agard, Mallory; Satchell, Karla J.; Cho, Wonhwa; Anderson, Wayne F.; Hauser, Alan R.			A Novel Phosphatidylinositol 4,5-Bisphosphate Binding Domain Mediates Plasma Membrane Localization of ExoU and Other Patatin-like Phospholipases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Bacterial Toxin; Crystal Structure; Phosphatidylinositol Signaling; Phospholipase; Pseudomonas aeruginosa (P; aeruginosa)	AERUGINOSA CYTOTOXIN EXOU; III SECRETION SYSTEM; BACTERIAL PROTEIN TOXINS; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; STRUCTURE VALIDATION; HOST-CELLS; EMBL-EBI; IDENTIFICATION; ACTIVATION	Background: The Pseudomonas aeruginosa cytotoxin ExoU localizes to the plasma membrane in eukaryotic cells. Results: ExoU and related proteins utilize a conserved four-helical bundle to bind the lipid phosphatidylinositol 4,5-bisphosphate for localization. Conclusion: The membrane localization domain of ExoU represents a novel phosphoinositide binding domain. Significance: This is the first report of a four-helical bundle with specificity for phosphatidylinositol 4,5-bisphosphate. Bacterial toxins require localization to specific intracellular compartments following injection into host cells. In this study, we examined the membrane targeting of a broad family of bacterial proteins, the patatin-like phospholipases. The best characterized member of this family is ExoU, an effector of the Pseudomonas aeruginosa type III secretion system. Upon injection into host cells, ExoU localizes to the plasma membrane, where it uses its phospholipase A(2) activity to lyse infected cells. The targeting mechanism of ExoU is poorly characterized, but it was recently found to bind to the phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), a marker for the plasma membrane of eukaryotic cells. We confirmed that the membrane localization domain (MLD) of ExoU had a direct affinity for PI(4,5)P-2, and we determined that this binding was required for ExoU localization. Previously uncharacterized ExoU homologs from Pseudomonas fluorescens and Photorhabdus asymbiotica also localized to the plasma membrane and required PI(4,5)P-2 for this localization. A conserved arginine within the MLD was critical for interaction of each protein with PI(4,5)P-2 and for localization. Furthermore, we determined the crystal structure of the full-length P. fluorescens ExoU and found that it was similar to that of P. aeruginosa ExoU. Each MLD contains a four-helical bundle, with the conserved arginine exposed at its cap to allow for interaction with the negatively charged PI(4,5)P-2. Overall, these findings provide a structural explanation for the targeting of patatin-like phospholipases to the plasma membrane and define the MLD of ExoU as a member of a new class of PI(4,5)P-2 binding domains.	[Tyson, Gregory H.; Geissler, Brett; Agard, Mallory; Satchell, Karla J.; Hauser, Alan R.] Northwestern Univ, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Hauser, Alan R.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Halavaty, Andrei S.; Anderson, Wayne F.] Northwestern Univ, Dept Biochem, Chicago, IL 60611 USA; [Halavaty, Andrei S.; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Kim, Hyunjin; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hauser, AR (corresponding author), Northwestern Univ, Dept Microbiol & Immunol, 303 E Chicago Ave, Chicago, IL 60611 USA.	ahauser@northwestern.edu	Satchell, Karla/GSN-3100-2022	Tyson, Gregory/0000-0002-2729-5035	National Institutes of Health [AI053674, AI075191, AI099269, AI04831, AI088286, AI092825, AI051490]; American Heart Association [12PRE8660003]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075191, R01AI099269, K24AI104831, R21AI088286, R01AI053674, R01AI092825, R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI053674, AI075191, AI099269, AI04831, and AI088286 (to A. R. H.) and AI092825 and AI051490 (to K. J. S.). This work was also supported by American Heart Association Grant 12PRE8660003 (to G. H. T.).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Chen S, 2011, J BIOL CHEM, V286, P15067, DOI 10.1074/jbc.M111.224493; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2010, CELL SIGNAL, V22, P1097, DOI 10.1016/j.cellsig.2010.03.003; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Costa SCP, 2009, INFECT IMMUN, V77, P1022, DOI 10.1128/IAI.01064-08; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kim H, 2013, J LIPID RES, V54, P3531, DOI 10.1194/jlr.D041376; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Berre L, 2006, PROSTAG OTH LIPID M, V81, P113, DOI 10.1016/j.prostaglandins.2006.08.004; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabin SDP, 2006, INFECT IMMUN, V74, P2552, DOI 10.1128/IAI.74.5.2552-2561.2006; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Rabin SDP, 2003, INFECT IMMUN, V71, P4144, DOI 10.1128/IAI.71.7.4144-4150.2003; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Sato H, 2005, J BACTERIOL, V187, P1192, DOI 10.1128/JB.187.3.1192-1195.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; Schorr M, 2001, CURR BIOL, V11, P1421, DOI 10.1016/S0960-9822(01)00449-3; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; Varivarn K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-92; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wiradjaja F, 2007, J BIOL CHEM, V282, P16295, DOI 10.1074/jbc.M701038200; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhu WH, 2013, CELL MICROBIOL, V15, P1783, DOI 10.1111/cmi.12157	81	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2919	2937		10.1074/jbc.M114.611251	http://dx.doi.org/10.1074/jbc.M114.611251			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505182	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000349310700031
J	Qiao, YB; Wang, R; Yang, XF; Tang, K; Jing, NH				Qiao, Yunbo; Wang, Ran; Yang, Xianfa; Tang, Ke; Jing, Naihe			Dual Roles of Histone H3 Lysine 9 Acetylation in Human Embryonic Stem Cell Pluripotency and Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Background: H3K9Ac is an epigenetic mark representing transcriptionally active chromatin. Results: Inhibition of HDAC activity promotes pluripotency maintenance at the initiation of hESC differentiation and inhibits neural differentiation during neural commitment stage. Conclusion: H3K9Ac plays dual roles in hESC pluripotency maintenance and neural differentiation through regulating different targets. Significance: This work provides insight into the epigenetic mechanisms underlying neural differentiation of hESCs associated with histone acetylation patterns.	[Qiao, Yunbo; Wang, Ran; Yang, Xianfa; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Yang, Xianfa] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Nanchang University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn		Yang, Xianfa/0000-0002-6843-8055	"Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [91219303, 31430058]	"Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01010201, National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and National Natural Science Foundation of China Grants 91219303 and 31430058.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fang F, 2014, STEM CELLS, V32, P1805, DOI 10.1002/stem.1705; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2006, ACS CHEM BIOL, V1, P69, DOI 10.1021/cb6000894; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Qiao YB, 2012, CELL RES, V22, P1546, DOI 10.1038/cr.2012.122; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tulpule Asmin, 2009, V482, P35, DOI 10.1007/978-1-59745-060-7_3; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	54	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2508	2520		10.1074/jbc.M114.603761	http://dx.doi.org/10.1074/jbc.M114.603761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7PX	25519907	Green Published, hybrid			2022-12-26	WOS:000434590200001
J	Cassim, N; Coetzee, LM; Schnippel, K; Glencross, DK				Cassim, Naseem; Coetzee, Lindi M.; Schnippel, Kathryn; Glencross, Deborah K.			Estimating Implementation and Operational Costs of an Integrated Tiered CD4 Service including Laboratory and Point of Care Testing in a Remote Health District in South Africa	PLOS ONE			English	Article							EXTERNAL QUALITY ASSESSMENT; ANTIRETROVIRAL THERAPY; ART INITIATION; HIV; PERFORMANCE; ENUMERATION	Background: An integrated tiered service delivery model (ITSDM) has been proposed to provide 'full-coverage' of CD4 services throughout South Africa. Five tiers are described, defined by testing volumes and number of referring health-facilities. These include: (1) Tier-1/decentralized point-of-care service (POC) in a single site; Tier-2/POC-hub servicing processing <30-40 samples from 8-10 health-clinics; Tier-3/Community laboratories servicing similar to 50 health-clinics, processing <150 samples/day; high-volume centralized laboratories (Tier-4 and Tier-5) processing <300 or >600 samples/day and serving >100 or >200 health-clinics, respectively. The objective of this study was to establish costs of existing and ITSDM-tiers 1, 2 and 3 in a remote, under-serviced district in South Africa. Methods: Historical health-facility workload volumes from the Pixley-ka-Seme district, and the total volumes of CD4 tests performed by the adjacent district referral CD4 laboratories, linked to locations of all referring clinics and related laboratory-to-result turn-around time (LTR-TAT) data, were extracted from the NHLS Corporate-Data-Warehouse for the period April-2012 to March-2013. Tiers were costed separately (as a cost-per-result) including equipment, staffing, reagents and test consumable costs. A one-way sensitivity analyses provided for changes in reagent price, test volumes and personnel time. Results: The lowest cost-per-result was noted for the existing laboratory-based Tiers-4 and 5 ($6.24 and $5.37 respectively), but with related increased LTR-TAT of >24-48 hours. Full service coverage with TAT <6-hours could be achieved with placement of twenty-seven Tier-1/POC or eight Tier-2/POC-hubs, at a cost-per-result of $32.32 and $15.88 respectively. A single district Tier-3 laboratory also ensured 'full service coverage' and <24 hour LTR-TAT for the district at $7.42 per-test. Conclusion: Implementing a single Tier-3/community laboratory to extend and improve delivery of services in Pixley-ka-Seme, with an estimated local similar to 12-24-hour LTR-TAT, is similar to$2 more than existing referred services per-test, but 2-4 fold cheaper than implementing eight Tier-2/POC-hubs or providing twenty-seven Tier1/POCT CD4 services.	[Cassim, Naseem; Coetzee, Lindi M.; Glencross, Deborah K.] Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa; [Glencross, Deborah K.] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Schnippel, Kathryn] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Med, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Glencross, DK (corresponding author), Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/AFU-5522-2022; Cassim, Naseem/GLR-4911-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X; Schnippel, Kathryn/0000-0003-0757-4325	National Health Laboratory Service; National Priority Programmes division	National Health Laboratory Service; National Priority Programmes division	The authors thank Glynis Davis (Alere) and Ank Gowans (Beckman Coulter) for relevant equipment information and pricing. The authors acknowledge the assistance and support of the National Health Laboratory Service, the National Priority Programmes division including Prof. W. Stevens and Drs S. Carmona and L. Berrie, as well as the CD4 training staff, Mrs. S. Mojalefa and Mrs. S. Drury. The authors also acknowledge assistance from team of the NHLS CDW and all staff across all the NHLS CD4 laboratories, as well as the NHLS COO, Dr. N. Sangweni, for her support for this work.	Black Samantha, 2013, S Afr Med J, V103, P557, DOI 10.7196/samj.6565; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Cassim N, 2012, 1 AFR SOC LAB MED AS; Cassim N, 2012, AFR SOC LAB MED 1 IN; Cassim N, 2014, AFR SOC LAB MED 2 IN; Coetzee LM, 2014, 8 HIV INT M LUS ZAMB; Coetzee LM, 2013, UNPUB; Department of Public Service and Administration, 2013, APP C DPSA CIRC 2 20; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fajardo E, 2014, HIGH FREQUENCY INVAL; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glencross DK, 2012, AFR SOC LAB MED 1 IN; Glencross DK, 2014, PLOS ONE IN PRESS; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Husereau Don, 2013, J Med Econ, V16, P713, DOI 10.3111/13696998.2013.784591; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Lawrie D, 2010, CYTOM PART B-CLIN CY, V78B, P201, DOI 10.1002/cyto.b.20520; Magoro MT, 2013, COMMUNICATION; Medecins Sans Frontiers, 2013, NEW ROOTS S AFR CHAL; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mwau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107410; National Department of Health, 2013, REV ANT TREATM GUID; National Department of Health, 2013, NO CAP PIXL KA SEM D; National Department of Health, 2012, BUS PLAN NAT HLTH IN; National Health Laboratory Service, 2013, ANN REPORT; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Smith H, 2012, GEOGRAPHIC LOCATION; St John Andrew, 2013, Clin Biochem Rev, V34, P61; Standard Bank of South Africa (SBSA), 2013, FOR CLOS IND RAT 28; Statistics South Africa (STASSA), 2013, STAT PLAC NO CAP	37	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115420	10.1371/journal.pone.0115420	http://dx.doi.org/10.1371/journal.pone.0115420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517412	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600065
J	Watson, MK; Stern, AW; Labelle, AL; Joslyn, S; Fan, TM; Leister, K; Kohles, M; Marshall, K; Mitchell, MA				Watson, Megan K.; Stern, Adam W.; Labelle, Amber L.; Joslyn, Stephen; Fan, Timothy M.; Leister, Katie; Kohles, Micah; Marshall, Kemba; Mitchell, Mark A.			Evaluating the Clinical and Physiological Effects of Long Term Ultraviolet B Radiation on Guinea Pigs (Cavia porcellus)	PLOS ONE			English	Article							VITAMIN-D; DENTAL DISEASE; SKIN; ENHANCEMENT; METABOLISM; EXPOSURE; SUNLIGHT	Vitamin D is an important hormone in vertebrates. Most animals acquire this hormone through their diet, secondary to exposure to ultraviolet B (UVB) radiation, or a combination thereof. The objectives for this research were to evaluate the clinical and physiologic effects of artificial UVB light supplementation on guinea pigs (Cavia porcellus) and to evaluate the long-term safety of artificial UVB light supplementation over the course of six months. Twelve juvenile acromelanic Hartley guinea pigs were randomly assigned to one of two treatment groups: Group A was exposed to 12 hours of artificial UVB radiation daily and Group B received only ambient fluorescent light for 12 hours daily. Animals in both groups were offered the same diet and housed under the same conditions. Blood samples were collected every three weeks to measure blood chemistry values, parathyroid hormone, ionized calcium, and serum 25-hydroxyvitamin D-3 (25-OHD3) levels. Serial ophthalmologic examinations, computed tomography scans, and dual energy x-ray absorptiometry scans were performed during the course of the study. At the end of the study the animals were euthanized and necropsied. Mean +/- SD serum 25-OHD3 concentrations differed significantly in the guinea pigs (p<0.0001) between the UVB supplementation group (101.49 +/- 21.81 nmol/L) and the control group (36.33 +/- 24.42 nmol/L). An increased corneal thickness in both eyes was also found in the UVB supplementation compared to the control group (right eye [OD]: p<0.0001; left eye [OS]: p<0.0001). There were no apparent negative clinical or pathologic side effects noted between the groups. This study found that exposing guinea pigs to UVB radiation long term significantly increased their circulating serum 25-OHD3 levels, and that this increase was sustainable over time. Providing guinea pigs exposure to UVB may be an important husbandry consideration that is not currently recommended.	[Watson, Megan K.; Labelle, Amber L.; Joslyn, Stephen; Fan, Timothy M.; Leister, Katie; Mitchell, Mark A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Stern, Adam W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Kohles, Micah] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Kohles, Micah] Oxbow Anim Hlth, Murdock, NE USA; [Marshall, Kemba] PetSmart, Phoenix, AZ USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln	Mitchell, MA (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	mmitch@illinois.edu	, Adam/AAY-4010-2021	, Adam/0000-0002-6794-6592; Fan, Timothy/0000-0003-2510-7050	PetSmart Charities; Oxbow Animal Health; Fluker Farms (Port Allen, LA)	PetSmart Charities; Oxbow Animal Health; Fluker Farms (Port Allen, LA)	PetSmart Charities provided funding for this project. Dr. Kemba Marshall was included as a co-author as a member of the team that designed the study, provided additional resources, and helped with the preparation of the manuscript. Oxbow Animal Health provided funding for this project. Dr. Micah Kohles was included as a coauthor as a member of the team that designed the study, provided additional resources, and helped with the preparation of the manuscript. Fluker Farms (Port Allen, LA) was a sponsor that contributed funding but played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; [Anonymous], 1995, NUTR REQUIREMENTS LA; Balasubramanian D, 2000, J OCUL PHARMACOL TH, V16, P285, DOI 10.1089/jop.2000.16.285; Bergauer K. L., 1991, INT CONTACT LENS CLI, V18, P182; BROMMAGE R, 1988, BONE, V9, P131, DOI 10.1016/8756-3282(88)90002-6; Cafaro TA, 2009, VET OPHTHALMOL, V12, P234, DOI 10.1111/j.1463-5224.2009.00708.x; DORN CR, 1971, J NATL CANCER I, V46, P1073; Emerson JA, 2014, AM J VET RES, V75, P380, DOI 10.2460/ajvr.75.4.380; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Harcourt-Brown FM, 2007, J EXOT PET MED, V16, P146, DOI 10.1053/j.jepm.2007.06.003; Hazewinkel HAW, 2002, MOL CELL ENDOCRINOL, V197, P23, DOI 10.1016/S0303-7207(02)00275-7; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; HOLICK MF, 1990, J NUTR, V120, P1464, DOI 10.1093/jn/120.suppl_11.1464; HOLICK MF, 1995, P NATL ACAD SCI USA, V92, P3124, DOI 10.1073/pnas.92.8.3124; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2006, PRIMER METABOLIC BON, P129; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2014, Adv Exp Med Biol, V810, P1; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jekl V, 2013, J SMALL ANIM PRACT, V54, P481, DOI 10.1111/jsap.12124; Jensen JA, 2013, COMPARATIVE MED, V63, P156; Kadoya K, 2005, BRIT J DERMATOL, V153, P607, DOI 10.1111/j.1365-2133.2005.06716.x; KLIGMAN AM, 1986, J AM ACAD DERMATOL, V15, P836, DOI 10.1016/S0190-9622(86)70242-9; Kraus C, 2004, OIKOS, V105, P489, DOI 10.1111/j.0030-1299.2004.12941.x; Lebas F, 2010, WORLD RABBIT SCI, V8, P185; Lin YP, 2012, CURR EYE RES, V37, P871, DOI 10.3109/02713683.2012.688235; Mitchell MA., 2009, MANUAL EXOTIC PET PR, P456, DOI 10.1016/B978-1-4160-0119-5.X5001-X; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Pigiere F, 2012, J ARCHAEOL SCI, V39, P1020, DOI 10.1016/j.jas.2011.11.021; *Quesenberry KE., 2012, FERRETS RABBITS RODE, P279, DOI DOI 10.1016/B978-1-4160-6621-7-00022-1; Rivas AE, 2014, J EXOT PET MED, V23, P270, DOI 10.1053/j.jepm.2014.05.012; SchmidtGayk H, 1997, SCAND J CLIN LAB INV, V57, P35; Shepherd AJ, 2008, JAVMA-J AM VET MED A, V232, P695, DOI 10.2460/javma.232.5.695; Stockham S. L., 2008, FUNDAMENTALS VET CLI, P593; STUMPF WE, 1979, SCIENCE, V206, P1188, DOI 10.1126/science.505004; Van Saun RJ, 2009, VET CLIN N AM-FOOD A, V25, P797, DOI 10.1016/j.cvfa.2009.07.013; Wang C, 2011, LEVEL SET BASED SEGM; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605; Zigman S, 1995, OPTOMETRY VISION SCI, V72, P899, DOI 10.1097/00006324-199512000-00008	40	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114413	10.1371/journal.pone.0114413	http://dx.doi.org/10.1371/journal.pone.0114413			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517408	Green Published, gold			2022-12-26	WOS:000347215600017
J	Palomo, J; Marchiol, T; Piotet, J; Fauconnier, L; Robinet, M; Reverchon, F; Le Bert, M; Togbe, D; Buijs-Offerman, R; Stolarczyk, M; Quesniaux, VFJ; Scholte, BJ; Ryffel, B				Palomo, Jennifer; Marchiol, Tiffany; Piotet, Julie; Fauconnier, Louis; Robinet, Marieke; Reverchon, Flora; Le Bert, Marc; Togbe, Dieudonnee; Buijs-Offerman, Ruvalic; Stolarczyk, Marta; Quesniaux, Valerie F. J.; Scholte, Bob J.; Ryffel, Bernhard			Role of IL-1 beta in Experimental Cystic Fibrosis upon P. aeruginosa Infection	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MUCOID PSEUDOMONAS-AERUGINOSA; ACUTE LUNG INFECTION; MURINE MODEL; MICE; INFLAMMATION; EXPRESSION; DISEASE; CFTR; RECOGNITION	Cystic fibrosis is associated with increased inflammatory responses to pathogen challenge. Here we revisited the role of IL-1 beta in lung pathology using the experimental F508del-CFTR murine model on C57BL/6 genetic background (Cftr(tm1eur) or d/d), on double deficient for d/d and type 1 interleukin-1 receptor (d/d X IL-1R1(-/-)), and antibody neutralization. At steady state, young adult d/d mice did not show any signs of spontaneous lung inflammation. However, IL-1R1 deficiency conferred partial protection to repeated P. aeruginosa endotoxins/LPS lung instillation in d/d mice, as 50% of d/d mice succumbed to inflammation, whereas all d/d x IL-1R1(-/-) double mutants survived with lower initial weight loss and less pulmonary collagen and mucus production, suggesting that the absence of IL-1R1 signaling is protective in d/d mice in LPS-induced lung damage. Using P. aeruginosa acute lung infection we found heightened neutrophil recruitment in d/d mice with higher epithelial damage, increased bacterial load in BALF, and augmented IL-1 beta and TNF-alpha in parenchyma as compared to WT mice. Thus, F508del-CFTR mice show enhanced IL-1 beta signaling in response to P. aeruginosa. IL-1 beta antibody neutralization had no effect on lung homeostasis in either d/d or WT mice, however P. aeruginosa induced lung inflammation and bacterial load were diminished by IL-1 beta antibody neutralization. In conclusion, enhanced susceptibility to P. aeruginosa in d/d mice correlates with an excessive inflammation and with increased IL-1 beta production and reduced bacterial clearance. Further, we show that neutralization of IL-1 beta in d/d mice through the double mutation d/d x IL-1R1(-/-) and in WT via antibody neutralization attenuates inflammation. This supports the notion that intervention in the IL-1R1/IL-1 beta pathway may be detrimental in CF patients.	[Palomo, Jennifer; Piotet, Julie; Reverchon, Flora; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Palomo, Jennifer; Piotet, Julie; Reverchon, Flora; Quesniaux, Valerie F. J.; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Marchiol, Tiffany; Fauconnier, Louis; Robinet, Marieke; Togbe, Dieudonnee] Artimmune, Orleans, France; [Buijs-Offerman, Ruvalic; Stolarczyk, Marta; Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Ryffel, Bernhard] IDM, Inst Infect Dis & Mol Med, Cape Town, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Erasmus University Rotterdam; Erasmus MC; University of Cape Town	Scholte, BJ (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	b.scholte@erasmusmc.nl; bryffel@cnrs-orleans.fr	Le Bert, Marc/AAR-4577-2021; Togbe, Dieudonnee/AAE-1135-2020	Le Bert, Marc/0000-0002-5945-3800; Togbe, Dieudonnee/0000-0001-6658-414X; Marchiol, Tiffany/0000-0003-0714-1191; Reverchon, Flora/0000-0003-1642-4775	French association "Vaincre La Mucoviscidose'' [10IM1016]; ERASMUS Medical Center of Rotterdam (The Netherlands); Region Centre (Respig project); CNRS of Orleans (France); Dutch CF foundation NCFS; Dutch Lung foundation [Longfonds 3.3.10.027]	French association "Vaincre La Mucoviscidose''; ERASMUS Medical Center of Rotterdam (The Netherlands); Region Centre (Respig project)(Region Centre-Val de Loire); CNRS of Orleans (France); Dutch CF foundation NCFS; Dutch Lung foundation	This study was part of the European project no10IM1016 financed by the French association "Vaincre La Mucoviscidose'', supported by the ERASMUS Medical Center of Rotterdam (The Netherlands), and by Region Centre (Respig project) and CNRS of Orleans (France). RBO was supported by the Dutch CF foundation NCFS; MS was supported by the Dutch Lung foundation (Longfonds 3.3.10.027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Mohamed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039888; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; CFF, 2012, PAT REG ANN DAT REP; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Faure E, 2014, AM J RESP CRIT CARE; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Gaspar MC, 2013, EUR J CLIN MICROBIOL; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Hudock KM, 2012, AM J RESP CELL MOL, V47, P436, DOI 10.1165/rcmb.2012-0104OC; Kanangat S, 1999, INFECT IMMUN, V67, P2834, DOI 10.1128/IAI.67.6.2834-2840.1999; Laval J, 2013, J IMMUNOL, V190, P6043, DOI 10.4049/jimmunol.1201755; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Lubamba B, 2012, J CYST FIBROS, V11, P266, DOI 10.1016/j.jcf.2012.03.003; Meduri GU, 2002, CRIT CARE, V6, P24, DOI 10.1186/cc1450; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Moreno-Vinasco L., 2014, AM J RESP CELL MOL B; Nojiri T., 2014, PULM PHARM THER; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Secher T, 2011, J ANTIMICROB CHEMOTH, V66, P1100, DOI 10.1093/jac/dkr038; Shikama Y, 2014, J CELL PHYSL; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Stick S, 2013, EUR RESPIR J, V42, P527, DOI 10.1183/09031936.00108212; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tirkos S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-51; Tsay TB, 2013, CYTOKINE, V63, P58, DOI 10.1016/j.cyto.2013.04.002; Turner NA, 2011, INT J BIOCHEM CELL B, V43, P1450, DOI 10.1016/j.biocel.2011.06.008; van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC; van Heeckeren AM, 2004, INFECT IMMUN, V72, P1479, DOI 10.1128/IAI.72.3.1479-1486.2004; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Villeret B, 2013, AM J CLIN EXP IMMUNO, V2, P107; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Winfield RD, 2006, SURG CLIN N AM, V86, P317, DOI 10.1016/j.suc.2005.12.007; Zhou Y, 2013, J INNATE IMMUN, V5, P219, DOI 10.1159/000346568	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114884	10.1371/journal.pone.0114884	http://dx.doi.org/10.1371/journal.pone.0114884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500839	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400059
J	Baron, DM; Kaindl, U; Haudek-Prinz, VJ; Bayer, E; Rohrl, C; Gerner, C; Marian, B				Baron, David M.; Kaindl, Ulrike; Haudek-Prinz, Verena J.; Bayer, Editha; Roehrl, Clemens; Gerner, Christopher; Marian, Brigitte			Autonomous Inhibition of Apoptosis Correlates with Responsiveness of Colon Carcinoma Cell Lines to Ciglitazone	PLOS ONE			English	Article							COLORECTAL-CANCER; PPAR-GAMMA; NUCLEAR RECEPTORS; GENE-EXPRESSION; DNA-DAMAGE; PROTEIN; ACTIVATION; MICE; IDENTIFICATION; INFLAMMATION	Colorectal cancer is a leading cause of mortality worldwide. Resistance to therapy is common and often results in patients succumbing to the disease. The mechanisms of resistance are poorly understood. Cells basically have two possibilities to survive a treatment with potentially apoptosis-inducing substances. They can make use of their existing proteins to counteract the induced reactions or quickly upregulate protective factors to evade the apoptotic signal. To identify protein patterns involved in resistance to apoptosis, we studied two colorectal adenocarcinoma cell lines with different growth responses to low-molar concentrations of the thiazolidinedione Ciglitazone: HT29 cells underwent apoptosis, whereas SW480 cells increased cell number. Fluorescence detection and autoradiography scans of 2D-PAGE gels were performed in both cell lines to assess protein synthesis and turnover, respectively. To verify the data we performed shotgun analysis using the same treatment procedure as in 2D-experiments. Biological functions of the identified proteins were mainly associated with apoptosis regulation, chaperoning, intrinsic inflammation, and DNA repair. The present study suggests that different growth response of two colorectal carcinoma cell lines after treatment with Ciglitazone results from cell- specific protein synthesis and differences in protein regulation.	[Baron, David M.; Kaindl, Ulrike; Bayer, Editha; Roehrl, Clemens; Marian, Brigitte] Med Univ Vienna, Inst Canc Res, Clin Internal Med 1, Dept Med 1, Vienna, Austria; [Baron, David M.] Med Univ Vienna, Dept Anesthesia Gen Intens Care & Pain Management, Vienna, Austria; [Haudek-Prinz, Verena J.; Gerner, Christopher] Univ Vienna, Fac Chem, Inst Analyt Chem, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna	Gerner, C (corresponding author), Univ Vienna, Fac Chem, Inst Analyt Chem, Vienna, Austria.	christopher.gerner@univie.ac.at		Rohrl, Clemens/0000-0002-1192-0748; Gerner, Christopher/0000-0003-4964-0642	Austrian National Bank [10630]	Austrian National Bank	This study was funded by the Austrian National Bank project 10630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle P, 2008, WORLD CANC REPORT; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; FUJITA T, 1983, DIABETES, V32, P804, DOI 10.2337/diabetes.32.9.804; Gelman L, 1999, CELL MOL LIFE SCI, V55, P932, DOI 10.1007/s000180050345; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GRISS J, 2009, J PROTEOM BIOINFORM, V2, P167, DOI DOI 10.4172/JPB.1000074; Gundacker N, 2006, ELECTROPHORESIS, V27, P2712, DOI 10.1002/elps.200500964; Gundacker NC, 2009, J PROTEOME RES, V8, P2799, DOI 10.1021/pr8011039; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Koch S, 2013, MUCOSAL IMMUNOL, V6, P136, DOI 10.1038/mi.2012.57; Krasikova YS, 2013, J BIOL CHEM, V288, P10936, DOI 10.1074/jbc.M112.444026; KYRIAZIS AP, 1978, CANCER RES, V38, P3186; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Maxia C, 2008, J CELL MOL MED, V12, P2372, DOI 10.1111/j.1582-4934.2008.00256.x; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Miyazaki M, 2005, CANCER SCI, V96, P695, DOI 10.1111/j.1349-7006.2005.00093.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Resch U, 2008, BIOCHEM BIOPH RES CO, V375, P156, DOI 10.1016/j.bbrc.2008.07.142; Rohrl C, 2011, J CANCER RES CLIN, V137, P29, DOI 10.1007/s00432-010-0856-1; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sagynaliev E, 2005, PROTEOMICS, V5, P3066, DOI 10.1002/pmic.200402107; Sanjuan X, 1997, GASTROENTEROLOGY, V113, P1906, DOI 10.1016/S0016-5085(97)70010-6; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schellerer VS, 2014, ONCOL REP, V31, P255, DOI 10.3892/or.2013.2860; Segal NH, 2009, ANNU REV MED, V60, P207, DOI 10.1146/annurev.med.60.041807.132435; Seike M, 2004, PROTEOMICS, V4, P2776, DOI 10.1002/pmic.200300795; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tormanen-Napankangas U, 2001, INT J CANCER, V93, P192, DOI 10.1002/ijc.1315; Traxler E, 2004, PROTEOMICS, V4, P1314, DOI 10.1002/pmic.200300774; URBAN T, 1993, J NATL CANCER I, V85, P2008, DOI 10.1093/jnci/85.24.2008; Wenzel U, 2004, PROTEOMICS, V4, P2160, DOI 10.1002/pmic.200300726; Yadav N, 2014, MITOCHONDRION, V16, P18, DOI 10.1016/j.mito.2013.11.005; Yang LL, 2003, CANCER RES, V63, P831; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379; Yang YX, 2006, PROTEOMICS, V6, P2009, DOI 10.1002/pmic.200402031; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Young LC, 2007, CARCINOGENESIS, V28, P2131, DOI 10.1093/carcin/bgm153; Zhang Y-T, 2005, EUROPEAN J GASTROENT, V7, P725; Zhang YT, 2005, WORLD J GASTROENTERO, V11, P4679, DOI 10.3748/wjg.v11.i30.4679; Zou TT, 2004, AM J PHYSIOL-CELL PH, V286, pC1009, DOI 10.1152/ajpcell.00480.2003	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114158	10.1371/journal.pone.0114158	http://dx.doi.org/10.1371/journal.pone.0114158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502518	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700016
J	Carpi, S; Fogli, S; Giannetti, A; Adinolfi, B; Tombelli, S; Da Pozzo, E; Vanni, A; Martinotti, E; Martini, C; Breschi, MC; Pellegrino, M; Nieri, P; Baldini, F				Carpi, Sara; Fogli, Stefano; Giannetti, Ambra; Adinolfi, Barbara; Tombelli, Sara; Da Pozzo, Eleonora; Vanni, Alessia; Martinotti, Enrica; Martini, Claudia; Breschi, Maria Cristina; Pellegrino, Mario; Nieri, Paola; Baldini, Francesco			Theranostic Properties of a Survivin-Directed Molecular Beacon in Human Melanoma Cells	PLOS ONE			English	Article							TARGETING SURVIVIN; APOPTOSIS PROTEINS; MESSENGER-RNA; CANCER; EXPRESSION; GENE; COMBINATION; SUPPRESSANT; CHALLENGES; INHIBITORS	Survivin is an inhibitor of apoptosis overexpressed in different types of tumors and undetectable in most terminally differentiated normal tissues. In the current study, we sought to evaluate the in vitro theranostic properties of a molecular beaconoligodeoxynucleotide (MB) that targets survivin mRNA. We used laser scanning confocal microscopy to study MB delivery in living cells and real-time PCR and western blot to assess selective survivin-targeting in human malignant melanoma cells. We further assess the pro-apoptotic effect of MB by measuring internucleosomal DNA fragmentation, dissipation of mitochondrial membrane potential (MMP) and changes in nuclear morphology. Transfection of MB into A375 and 501 Mel cells generated high signal intensity from the cytoplasm, while no signal was detected in the extracellular environment and in survivin-negative cells (i. e., human melanocytes and monocytes). MB time dependently decreased survivin mRNA and protein expression in melanoma cells with the maximum effect reached at 72 h. Treatment of melanoma cells with MB induced apoptosis by significant changes in MMP, accumulation of histone-complexed DNA fragments in the cytoplasm and nuclear condensation. MB also enhanced the pro-apoptotic effect of standard chemotherapeutic drugs tested at clinically relevant concentrations. The MB tested in the current study conjugates the ability of imaging with the pharmacological silencing activity against survivin mRNA in human melanoma cells and may represent an innovative approach for cancer diagnosis and treatment.	[Carpi, Sara; Fogli, Stefano; Adinolfi, Barbara; Da Pozzo, Eleonora; Vanni, Alessia; Martinotti, Enrica; Martini, Claudia; Breschi, Maria Cristina; Nieri, Paola] Univ Pisa, Dept Pharm, Pisa, Italy; [Giannetti, Ambra; Tombelli, Sara; Baldini, Francesco] IFAC CNR, Inst Appl Phys Nello Carrara, Florence, Italy; [Pellegrino, Mario] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisica Applicata "Nello Carrara" (IFAC-CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Carpi, S (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	sara.carpi@for.unipi.it	Giannetti, Ambra/Q-2681-2015; Fogli, Stefano/AAB-5874-2022; Nieri, Paola/K-5814-2016; carpi, sara/AAG-7683-2021; Da Pozzo, Eleonora/M-2215-2015; Tombelli, Sara/H-6430-2013; Baldini, Francesco/C-2210-2015; Fogli, Stefano/AAC-1939-2019; Martini, Claudia/AAC-4089-2019; Da Pozzo, Eleonora/AAW-8186-2020	Giannetti, Ambra/0000-0002-0002-2977; Fogli, Stefano/0000-0002-7845-2598; Da Pozzo, Eleonora/0000-0003-4762-8949; Tombelli, Sara/0000-0003-1660-9833; Baldini, Francesco/0000-0002-2689-5952; Martini, Claudia/0000-0001-9379-3027; Da Pozzo, Eleonora/0000-0003-4762-8949; Carpi, Sara/0000-0002-3291-9009; Adinolfi, barbara/0000-0002-0603-6333	regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3); national flagship project NANOMAX; Association against Melanoma Onlus (Italy)	regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3); national flagship project NANOMAX; Association against Melanoma Onlus (Italy)	This work was supported by the regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3), by the national flagship project NANOMAX, and by Association against Melanoma Onlus (Italy). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Carrasco RA, 2011, MOL CANCER THER, V10, P221, DOI 10.1158/1535-7163.MCT-10-0756; Chen N, 2009, HUM PATHOL, V40, P950, DOI 10.1016/j.humpath.2008.12.001; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Giannetti A, 2013, ANAL BIOANAL CHEM, V405, P6181, DOI 10.1007/s00216-013-7086-8; Groner B, 2014, BIODRUGS, V28, P27, DOI 10.1007/s40259-013-0058-x; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Han SX, 2013, ARCH IMMUNOL THER EX, V61, P139, DOI 10.1007/s00005-012-0209-7; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Ikeguchi M, 2002, APOPTOSIS, V7, P23, DOI 10.1023/A:1013556727182; Kaneko N, 2013, BIOL PHARM BULL, V36, P1921, DOI 10.1248/bpb.b13-00515; Kolpashchikov DM, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/928783; Li G, 2013, ASIAN PAC J CANCER P, V14, P4943, DOI 10.7314/APJCP.2013.14.9.4943; Li HC, 2006, EXP EYE RES, V83, P176, DOI 10.1016/j.exer.2005.11.024; McKenzie JA, 2013, CARCINOGENESIS, V34, P2137, DOI 10.1093/carcin/bgt155; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Neri T, 2012, CARDIOVASC RES, V94, P537, DOI 10.1093/cvr/cvs125; Nitin N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh063; Peng XH, 2005, CANCER RES, V65, P1909, DOI 10.1158/0008-5472.CAN-04-3196; Pennati M, 2008, EXPERT OPIN THER TAR, V12, P463, DOI 10.1517/14728222.12.4.463 ; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Santangelo P, 2006, ANN BIOMED ENG, V34, P39, DOI 10.1007/s10439-005-9003-6; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Shi WL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0893-8; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; Sullivan RJ, 2014, BRIT J DERMATOL, V170, P36, DOI 10.1111/bjd.12698; Szafer-Glusman E, 2011, MOL BIOL CELL, V22, P3779, DOI 10.1091/mbc.E11-06-0569; Takeuchi H, 2005, INT J CANCER, V117, P1032, DOI 10.1002/ijc.21267; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang Q, 2013, THERANOSTICS, V3, P395, DOI 10.7150/thno.5935; World Health Organization, SKIN CANC; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yang H, 2008, J INT MED RES, V36, P734, DOI 10.1177/147323000803600416; Zheng WE, 2012, J BUON, V17, P284; Zhou L, 2013, ACTA BIOMATER, V9, P6019, DOI 10.1016/j.actbio.2012.12.030	41	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114588	10.1371/journal.pone.0114588	http://dx.doi.org/10.1371/journal.pone.0114588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501971	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700032
J	van Deurzen, I; van Oorschot, W; van Ingen, E				van Deurzen, Ioana; van Oorschot, Wim; van Ingen, Erik			The Link between Inequality and Population Health in Low and Middle Income Countries: Policy Myth or Social Reality?	PLOS ONE			English	Article							WEALTHIER ALWAYS HEALTHIER; INFANT-MORTALITY; POVERTY; ANEMIA; HOSPITALIZATION; ASSOCIATION	An influential policy idea states that reducing inequality is beneficial for improving health in the low and middle income countries (LMICs). Our study provides an empirical test of this idea: we utilized data collected by the Demographic and Health Surveys between 2000 and 2011 in as much as 52 LMICs, and we examined the relationship between household wealth inequality and two health outcomes: anemia status (of the children and their mothers) and the women' experience of child mortality. Based on multi-level analyses, we found that higher levels of household wealth inequality related to worse health, but this effect was strongly reduced when we took into account the level of individuals' wealth. However, even after accounting for the differences between individuals in terms of household wealth and other characteristics, in those LMICs with higher household wealth inequality more women experienced child mortality and more children were tested with anemia. This effect was partially mediated by the country's level and coverage of the health services and infrastructure. Furthermore, we found higher inequality to be related to a larger health gap between the poor and the rich in only one of the three examined samples. We conclude that an effective way to improve the health in the LMICs is to increase the wealth among the poor, which in turn also would lead to lower overall inequality and potential investments in public health infrastructure and services.	[van Deurzen, Ioana; van Ingen, Erik] Tilburg Univ, Dept Sociol, NL-5000 LE Tilburg, Netherlands; [van Oorschot, Wim] Leuven Univ, Dept Sociol, Leuven, Belgium	Tilburg University; KU Leuven	van Deurzen, I (corresponding author), Tilburg Univ, Dept Sociol, NL-5000 LE Tilburg, Netherlands.	i.a.vandeurzen@uvt.nl		van Ingen, Erik/0000-0003-3896-8079; Pop, Ioana/0000-0003-0747-6581				Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beckfield J, 2004, J HEALTH SOC BEHAV, V45, P231, DOI 10.1177/002214650404500301; Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; Bourguignon F, 2000, J DEV ECON, V62, P285, DOI 10.1016/S0304-3878(00)00086-9; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; deBenoist B, 2008, WORLDWIDE PREVALENCE; Deininger K., 2000, ASSET DISTRIBUTION I; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Easterly W, 2007, J DEV ECON, V84, P755, DOI 10.1016/j.jdeveco.2006.11.002; Ellison GTH, 2002, SOC SCI MED, V54, P561, DOI 10.1016/S0277-9536(01)00052-1; Fay M, 2005, WORLD DEV, V33, P1267, DOI 10.1016/j.worlddev.2005.03.001; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; GALOR O, 1993, REV ECON STUD, V60, P35, DOI 10.2307/2297811; Grantham-McGregor S, 2001, J NUTR S; Gravelle H, 1998, BMJ-BRIT MED J, V316, P382, DOI 10.1136/bmj.316.7128.382; Huynh M, 2005, INT J EPIDEMIOL, V34, P888, DOI 10.1093/ije/dyi092; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Kawachi I, 1999, HEALTH SERV RES, V34, P215; Kruk ME, 2008, AM J PUBLIC HEALTH, V98, P142, DOI 10.2105/AJPH.2006.104265; La Ferrara E, 2002, J PUBLIC ECON, V85, P235, DOI 10.1016/S0047-2727(01)00102-5; Larrea C, 2005, SOC SCI MED, V60, P165, DOI 10.1016/j.socscimed.2004.04.024; Li SL, 2004, KIDNEY INT, V65, P1864, DOI 10.1111/j.1523-1755.2004.00584.x; Lynch J, 2000, SOC SCI MED, V51, P1001, DOI 10.1016/S0277-9536(00)00080-0; Macinko JA, 2003, MED CARE RES REV, V60, P407, DOI 10.1177/1077558703257169; Marmot MG, 1998, MILBANK Q, V76, P403, DOI 10.1111/1468-0009.00097; McGuire JW, 2006, WORLD DEV, V34, P405, DOI 10.1016/j.worlddev.2005.08.004; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; OXFAM, 2013, COST IN WEALTH INC E; Perotti Roberto, 1996, J ECON GROWTH, V1, P149, DOI DOI 10.1007/BF00138861; Pickett KE, 2007, BJM; Pop IA, 2013, SOC INDIC RES, V113, P1025, DOI 10.1007/s11205-012-0125-6; Rajan K, 2013, SOC SCI MED, V88, P98, DOI 10.1016/j.socscimed.2013.04.004; Rajan R., 2010, FAULT LINES HIDDEN F; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; Riva E, 2009, HAEMATOL-HEMATOL J, V94, P22, DOI 10.3324/haematol.13449; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rutstein SO, 2006, GUIDE DHS STAT; Save The Children, 2012, BORN EQ RED IN COULD; Simms C, 2007, BITTEREST PILL ALL C; Smits J, 2014, INT WEALTH INDEX IWI; Szwarcwald CL, 2002, SOC SCI MED, V55, P2083, DOI 10.1016/S0277-9536(01)00353-7; The World Health Organization, 2008, CLOS GAP GEN HLTH EQ; UN, 2006, FAST FACTS FAC POV; United Nations, 2012, UN SYST TASK TEAM PO; WDI, 2012, WORLD DEV IND; WENNEMO I, 1993, SOCIOL HEALTH ILL, V15, P429, DOI 10.1111/1467-9566.ep11372773; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2009, SPIRIT LEVEL MORE EQ	52	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115109	10.1371/journal.pone.0115109	http://dx.doi.org/10.1371/journal.pone.0115109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25501652	Green Published, gold			2022-12-26	WOS:000347146700092
J	Wu, MM; Xiao, H; Ren, WK; Yin, J; Hu, JY; Duan, JL; Liu, G; Tan, B; Xiong, X; Oso, AO; Adeola, O; Yao, K; Yin, YL; Li, TJ				Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin; Liu, Gang; Tan, Bie; Xiong, Xia; Oso, Abimbola Oladele; Adeola, Olayiwola; Yao, Kang; Yin, Yulong; Li, Tiejun			An NMR-Based Metabolomic Approach to Investigate the Effects of Supplementation with Glutamic Acid in Piglets Challenged with Deoxynivalenol	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; COMPOSITE ANTIMICROBIAL PEPTIDES; MYCOTOXIN DEOXYNIVALENOL; ENTEROCYTE MASS; METABONOMIC APPROACH; INTESTINAL FAILURE; PLASMA CITRULLINE; FEED INGREDIENTS; SYSTEMS BIOLOGY; AMINO-ACID	Deoxynivalenol (DON) has various toxicological effects in humans and pigs that result from the ingestion of contaminated cereal products. This study was conducted to investigate the protective effects of dietary supplementation with glutamic acid on piglets challenged with DON. A total of 20 piglets weaned at 28 d of age were randomly assigned to receive 1 of 4 treatments (5 piglets/treatment): 1) basal diet, negative control (NC); 2) basal diet +4 mg/kg DON (DON); 3) basal diet +2% (g/g) glutamic acid (GLU); 4) basal diet +4 mg/kg DON +2% glutamic acid (DG). A 7-d adaptation period was followed by 30 days of treatment. A metabolite analysis using nuclear magnetic resonance spectroscopy (H-1-NMR)-based metabolomic technology and the determination of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities for plasma, as well as the activity of Caspase-3 and the proliferation of epithelial cells were conducted. The results showed that contents of low-density lipoprotein, alanine, arginine, acetate, glycoprotein, trimethylamine-N-oxide (TMAO), glycine, lactate, and urea, as well as the glutamate/creatinine ratio were higher but high-density lipoprotein, proline, citrate, choline, unsaturated lipids and fumarate were lower in piglets of DON treatment than that of NC treatment (P<0.05). Compared with DON treatment, dietary supplementation with glutamic acid increased the plasma concentrations of proline, citrate, creatinine, unsaturated lipids, and fumarate, and decreased the concentrations of alanine, glycoprotein, TMAO, glycine, and lactate, as well as the glutamate/creatinine ratio (P<0.05). Addition glutamic acid to DON treatment increased the plasma activities of SOD and GSH-Px and the proliferating cell nuclear antigen (PCNA) labeling indexes for the jejunum and ileum (P<0.05). These novel findings indicate that glutamic acid has the potential to repair the injuries associated with oxidative stress as well as the disturbances of energy and amino acid metabolism induced by DON.	[Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin; Liu, Gang; Tan, Bie; Xiong, Xia; Yao, Kang; Yin, Yulong; Li, Tiejun] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg,Sci Observing &, Hunan Prov Engn Res Ctr Hlthy Livestock,Minist Ag, Changsha, Hunan, Peoples R China; [Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Oso, Abimbola Oladele] Coll Anim Sci & Livestock Prod, Dept Anim Nutr, Abeokuta, Ogun State, Nigeria; [Adeola, Olayiwola] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xiong, X (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg,Sci Observing &, Hunan Prov Engn Res Ctr Hlthy Livestock,Minist Ag, Changsha, Hunan, Peoples R China.	xx@isa.ac.cn; yaokang@isa.ac.cn	YIN, Jie/H-3578-2019; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liu, Gang/0000-0002-9475-5134; OSO, ABIMBOLA/0000-0001-9107-0933	Research Subject of State Science and Technology Support Program [2013BAD21B04]; National Natural Science Foundation of China [31272463, 31072042]; Hunan Provincial Natural Science Foundation of China [12JJ2020, 13JJ2034]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2011T2S15]	Research Subject of State Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	This research was jointly supported by grants from the Research Subject of State Science and Technology Support Program (No. 2013BAD21B04), the National Natural Science Foundation of China (No. 31272463 and 31072042), Hunan Provincial Natural Science Foundation of China (No. 12JJ2020 and 13JJ2034) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (Grant No. 2011T2S15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad WA, 2010, FOOD ADDIT CONTAM A, V27, P510, DOI 10.1080/19440040903571747; Bensassi F, 2009, TOXICOLOGY, V264, P104, DOI 10.1016/j.tox.2009.07.020; Binder EM, 2007, ANIM FEED SCI TECH, V137, P265, DOI 10.1016/j.anifeedsci.2007.06.005; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2012, AMINO ACIDS, V43, P1485, DOI 10.1007/s00726-012-1221-2; Bracarense APFL, 2012, BRIT J NUTR, V107, P1776, DOI 10.1017/S0007114511004946; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; COLE E, 1995, CLIN TRANSPLANT, V9, P282; Constantinou MA, 2004, ANAL CHIM ACTA, V511, P303, DOI 10.1016/j.aca.2004.02.012; Cornell HJ, 2007, AMINO ACIDS, V33, P43, DOI 10.1007/s00726-006-0420-0; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Dinu D, 2011, TOXICON, V57, P1023, DOI 10.1016/j.toxicon.2011.04.006; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Foxall PJD, 1996, THER DRUG MONIT, V18, P498, DOI 10.1097/00007691-199608000-00032; Gabriel AS, 2013, AMINO ACIDS, V45, P451, DOI 10.1007/s00726-012-1371-2; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Griffin JL, 2003, CURR OPIN CHEM BIOL, V7, P648, DOI 10.1016/j.cbpa.2003.08.008; Guan S, 2011, J FOOD AGRIC ENVIRON, V9, P163; Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001; Halawa A, 2013, ARCH ANIM NUTR, V67, P134, DOI 10.1080/1745039X.2013.776327; Hauet T, 2000, J SURG RES, V93, P1, DOI 10.1006/jsre.2000.5885; HE P, 1993, J ANIM SCI, V71, P963, DOI 10.2527/1993.714963x; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Prelusky Dan B., 1994, Natural Toxins, V2, P97, DOI 10.1002/nt.2620020302; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezzi S, 2007, J PROTEOME RES, V6, P513, DOI 10.1021/pr060522z; Rhoads JM, 2005, J PEDIATR-US, V146, P542, DOI 10.1016/j.jpeds.2004.12.027; Sahu SC, 2010, J APPL TOXICOL, V30, P566, DOI 10.1002/jat.1527; Saxena V, 2006, NMR BIOMED, V19, P521, DOI 10.1002/nbm.1034; Schollenberger M, 2002, INT J FOOD MICROBIOL, V72, P85, DOI 10.1016/S0168-1605(01)00627-4; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Sugita Y, 2007, AMINO ACIDS, V33, P253, DOI 10.1007/s00726-007-0532-1; Volkl A, 2004, J BASIC MICROB, V44, P147, DOI 10.1002/jobm.200310353; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Xiao H, 2013, J ANIM SCI, V91, P4750, DOI 10.2527/jas.2013-6427; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Xu MH, 2003, WORLD J GASTROENTERO, V9, P1246, DOI 10.3748/wjg.v9.i6.1246; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Young VR, 2000, J NUTR, V130, p892S, DOI 10.1093/jn/130.4.892S; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	58	21	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113687	10.1371/journal.pone.0113687	http://dx.doi.org/10.1371/journal.pone.0113687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502722	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700009
J	Blackard, JT; Ma, G; Welge, JA; King, CC; Taylor, LE; Mayer, KH; Klein, RS; Celentano, DD; Sobel, JD; Jamieson, DJ; Gardner, L				Blackard, Jason T.; Ma, Gang; Welge, Jeffrey A.; King, Caroline C.; Taylor, Lynn E.; Mayer, Kenneth H.; Klein, Robert S.; Celentano, David D.; Sobel, Jack D.; Jamieson, Denise J.; Gardner, Lytt			GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection	PLOS ONE			English	Article							C/HEPATITIS-G VIRUS; MOTHER-TO-INFANT; ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; DISEASE PROGRESSION; SEXUAL TRANSMISSION; LIVER-DISEASE; US WOMEN; COINFECTION; PREVALENCE	Background: GB virus C (GBV-C) may have a beneficial impact on HIV disease progression; however, the epidemiologic characteristics of this virus are not well characterized. Behavioral factors and gender may lead to differential rates of GBV-C infection; yet, studies have rarely addressed GBV-C infections in women or racial/ethnic minorities. Therefore, we evaluated GBV-C RNA prevalence and genotype distribution in a large prospective study of high-risk women in the US. Results: 438 hepatitis C virus (HCV) seropositive women, including 306 HIV-infected and 132 HIV-uninfected women, from the HIV Epidemiologic Research Study were evaluated for GBV-C RNA. 347 (79.2%) women were GBV-C RNA negative, while 91 (20.8%) were GBV-C RNA positive. GBV-C positive women were younger than GBV-C negative women. Among 306 HIV-infected women, 70 (22.9%) women were HIV/GBV-C co-infected. Among HIV-infected women, the only significant difference between GBV-negative and GBV-positive women was age (mean 38.4 vs. 35.1 years; p<0.001). Median baseline CD4 cell counts and plasma HIV RNA levels were similar. The GBV-C genotypes were 1 (n=31; 44.3%), 2 (n=36; 51.4%), and 3 (n=3; 4.3%). The distribution of GBV-C genotypes in co-infected women differed significantly by race/ethnicity. However, median CD4 cell counts and log(10) HIV RNA levels did not differ by GBV-C genotype. GBV-C incidence was 2.7% over a median follow-up of 2.9 (IQR: 1.5, 4.9) years, while GBV-C clearance was 35.7% over a median follow-up of 2.44 (1.4, 3.5) years. 4 women switched genotypes. Conclusions: Age, injection drug use, a history of sex for money or drugs, and number of recent male sex partners were associated with GBV-C infection among all women in this analysis. However, CD4 cell count and HIV viral load of HIV/HCV/GBV-C co-infected women were not different although race was associated with GBV-C genotype.	[Blackard, Jason T.; Ma, Gang] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45220 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45221 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [King, Caroline C.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Taylor, Lynn E.] Brown Univ, Miriam Hosp, Providence, RI USA; [Taylor, Lynn E.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Klein, Robert S.] Mt Sinai Sch Med, Mt Sinai St Lukes Hosp, Div Infect Dis, New York, NY USA; [Klein, Robert S.] Mt Sinai Sch Med, Mt Sinai Roosevelt Hosp, New York, NY USA; [Celentano, David D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; [Gardner, Lytt] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Icahn School of Medicine at Mount Sinai; Mount Sinai West; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University; Centers for Disease Control & Prevention - USA	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45220 USA.	jason.blackard@uc.edu		Taylor, Lynn/0000-0002-0472-8125; Jamieson, Denise/0000-0003-2597-1201	National Institute on Allergy and Infectious Diseases [AI081564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institute on Allergy and Infectious Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute on Allergy and Infectious Diseases (award AI081564 to JTB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde R, 2010, VIRUS RES, V151, P148, DOI 10.1016/j.virusres.2010.04.008; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Berzsenyi MD, 2009, J GASTROEN HEPATOL, V24, P1407, DOI 10.1111/j.1440-1746.2009.05920.x; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Berzsenyi MD, 2005, J CLIN VIROL, V33, P243, DOI 10.1016/j.jcv.2005.01.002; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Birk M, 2002, AIDS, V16, P2482, DOI 10.1097/00002030-200212060-00017; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Frey SE, 2002, CLIN INFECT DIS, V34, P1033, DOI 10.1086/339206; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Handelsman E, 2007, HIV MED, V8, P561, DOI 10.1111/j.1468-1293.2007.00510.x; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hino K, 1998, ARCH VIROL, V143, P65, DOI 10.1007/s007050050268; Kao JH, 1997, J MED VIROL, V52, P381, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;381::AID-JMV6&gt;3.0.CO;2-Y; Kaye S, 2005, CLIN INFECT DIS, V40, P876, DOI 10.1086/428123; Larkin MA, 2007, BIOINFORMATICS, V2007, P21, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lefrere JJ, 2000, TRANSFUSION, V40, P602, DOI 10.1046/j.1537-2995.2000.40050602.x; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Mayer KH, 2003, JAIDS-J ACQ IMM DEF, V33, P614, DOI 10.1097/00126334-200308150-00011; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2003, J MED VIROL, V70, P141, DOI 10.1002/jmv.10375; Ohto H, 2000, TRANSFUSION, V40, P725, DOI 10.1046/j.1537-2995.2000.40060725.x; Quiros-Roldan E, 2002, AIDS, V16, P1430, DOI 10.1097/00002030-200207050-00019; Rodriguez B, 2003, J INFECT DIS, V187, P504, DOI 10.1086/368206; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; Sawayama Y, 1999, DIGEST DIS SCI, V44, P1937, DOI 10.1023/A:1026664428194; Schlueter V, 1996, J CLIN MICROBIOL, V34, P2660, DOI 10.1128/JCM.34.11.2660-2664.1996; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Sheng WH, 2007, CLIN INFECT DIS, V44, P584, DOI 10.1086/511037; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Smith SM, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-38; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Stover CT, 2003, J INFECT DIS, V187, P1388, DOI 10.1086/374649; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Viazov S, 1997, J HEPATOL, V27, P85, DOI 10.1016/S0168-8278(97)80284-X; Weintrob AC, 2004, CLIN INFECT DIS, V38, pE46, DOI 10.1086/382079; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Zanetti AR, 1998, J MED VIROL, V54, P107, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;107::AID-JMV7&gt;3.0.CO;2-A; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114467	10.1371/journal.pone.0114467	http://dx.doi.org/10.1371/journal.pone.0114467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493916	gold, Green Published			2022-12-26	WOS:000346611400047
J	Blasi, MF; Boitani, L				Blasi, Monica F.; Boitani, Luigi			Complex Social Structure of an Endangered Population of Bottlenose Dolphins (Tursiops truncatus) in the Aeolian Archipelago (Italy)	PLOS ONE			English	Article							ASSOCIATION PATTERNS; ALLIANCE FORMATION; PREDATION RISK; SHARK PREDATION; GROUP-SIZE; ADUNCUS; BEHAVIOR; BAY; SARASOTA; ECOLOGY	We investigated social structure and association patterns for a small population of Mediterranean bottlenose dolphins, Tursiops truncatus, inhabiting the Aeolian Archipelago (southern Italy). Specifically we evaluate the role of sex and age composition, residency patterns and interaction with trammel nets on this social organization. Association data for 23 regularly sighted individuals were obtained from summer photoidentification surveys collected from 2005-2012. Using a combined cluster and social network analysis approach, we found associations between dolphins were hierarchically structured, where two mixed-sex social units were subdivided into smaller temporarily dynamic groups. We found non-random and long-term preferred associations in the population; however, the degree of social cohesion, residence pattern and interaction with trammel nets differed considerably between the two social units. Six of eight females occurred in the more resident social unit-1; in addition, social unit-1 individuals had significantly stronger associations, higher preferred associates, lived in larger groups and occurred less frequently with trammel nets. Nine of eleven males were clustered in social unit-2 and five of these males, interacting with trammel nets, formed small groups and preferred associations. We propose that female and male groups associate in the study area during the breeding season and that some males choose to interact with reproductive females forming a distinct but interrelated social unit. Other males may be associating in a larger fission-fusion network, which consists of dolphins that appear to temporarily join the network from the coastal population. We cannot exclude that some males specialized in trammel net foraging, suggesting that this foraging technique may favor a solitary lifestyle. Large group sizes and high degree of social cohesion for females could be an indication of greater protection and more efficiency in detecting, deterring or repelling anthropogenic pressures. Most likely dolphins' social organization depends on a combination of socio-ecological, demographic and anthropogenic factors.	[Blasi, Monica F.] Filicudi WildLife Conservat, I-98055 Lipari, ME, Italy; [Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol, I-00185 Rome, Italy	Sapienza University Rome	Blasi, MF (corresponding author), Filicudi WildLife Conservat, I-98055 Lipari, ME, Italy.	blasimf@yahoo.com						Allen SJ, 2005, THESIS MACQUARIE U S; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Barros Nelio B., 1995, Bulletin of Marine Science, V57, P278; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 1997, MAR MAMMAL SCI, V13, P650, DOI 10.1111/j.1748-7692.1997.tb00089.x; Bearzi G, 2009, MAMMAL REV, V39, P92, DOI 10.1111/j.1365-2907.2008.00133.x; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Blasi MF, 2013, EUROPEAN RES CETAC E, V06, P255; Blasi Monica F., 2012, Endangered Species Research, V17, P269, DOI 10.3354/esr00422; BRAGER S, 1994, J MAMMAL, V75, P431, DOI 10.2307/1382564; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; COCKCROFT VG, 1989, S AFR J ZOOL, V24, P305; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor Richard C., 1992, P415; CORKERON P J, 1987, Aquatic Mammals, V13, P109; Corkeron P.J., 1990, P329; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; De Smgura AG, J MAR BIOL ASS UK, V88, P1185; Duffield DA, 1991, REPORTS INT WHALING, V13, P155; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Eisfeld SM, 2003, THESIS U WALES BANGO; Fearnbach H, 2012, MAR MAMMAL SCI, V28, P402, DOI 10.1111/j.1748-7692.2011.00481.x; Foley A, 2010, AQUAT MAMM, V36, P372, DOI 10.1578/AM.36.4.2010.372; Forcada J, 2004, MAR ECOL PROG SER, V275, P275, DOI 10.3354/meps275275; Freund RJ, 1986, SAS SYSTEM REGRESSIO; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Gero S, 2005, CAN J ZOOL, V83, P1566, DOI 10.1139/Z05-155; Gowans S, 2008, ADV MAR BIOL, V53, P195, DOI 10.1016/S0065-2881(07)53003-8; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holme P, 2007, PHYSICA A, V373, P821, DOI 10.1016/j.physa.2006.04.066; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; JOLLIFFE IT, 1972, J ROY STAT SOC C-APP, V21, P160; Krause J, 2002, LIVING GROUPS; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lauriano G., 2004, Journal of Cetacean Research and Management, V6, P165; Lauriano G, 2009, J MAR BIOL ASSOC UK, V89, P921, DOI 10.1017/S0025315409000393; Lewis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058162; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Lopez BD, 2008, BEHAV ECOL SOCIOBIOL, V62, P887, DOI 10.1007/s00265-007-0512-1; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1998, ANIM BEHAV, V55, P1097, DOI 10.1006/anbe.1997.0637; MANTEL N, 1967, CANCER RES, V27, P209; Miokovik Danijela, 1999, Natura Croatica, V8, P61; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Owen ECG, 2002, CAN J ZOOL, V80, P2072, DOI 10.1139/z02-195; Pace DS, 2012, BEHAV ECOL, V23, P254, DOI 10.1093/beheco/arr180; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Patterson AP, 1998, P ROY SOC LOND B BIO, V265, P167; Rogers CA, 2004, MAR MAMMAL SCI, V20, P688, DOI 10.1111/j.1748-7692.2004.tb01188.x; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Sall JP, 1981, A102 SAS I INC; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Schroeder J.P., 1990, P435; Scott M.D., 1990, P235; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; TOLLEY KA, 1995, J MAMMAL, V76, P1190, DOI 10.2307/1382611; Wells R.S., 1991, P199; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WHITE FJ, 1992, AM J PRIMATOL, V26, P203, DOI 10.1002/ajp.1350260306; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Whitehead H, 2008, COMPILED VERSION SOC, P73; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Wilson Ben, 1993, European Research on Cetaceans, V7, P54; Wiszniewski J, 2012, J MAMMAL, V93, P239, DOI 10.1644/10-MAMM-A-366.1; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; Wrangham RW, 1986, ECOLOGICAL ASPECTS S; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	102	22	23	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114849	10.1371/journal.pone.0114849	http://dx.doi.org/10.1371/journal.pone.0114849			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494331	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400079
J	Witkowski, A; Barka, F; Mann, DG; Li, CL; Weisenborn, JLF; Ashworth, MP; Kurzydlowski, KJ; Zglobicka, I; Dobosz, S				Witkowski, Andrzej; Barka, Frederik; Mann, David G.; Li, Chunlian; Weisenborn, Jascha L. F.; Ashworth, Matt P.; Kurzydlowski, Krzysztof J.; Zglobicka, Izabela; Dobosz, Slawomir			A Description of Biremis panamae sp nov., a New Diatom Species from the Marine Littoral, with an Account of the Phylogenetic Position of Biremis DG Mann et EJ Cox (Bacillariophyceae)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; AUXOSPORE FORMATION; LIFE-HISTORY; GENUS; SYSTEMATICS; MORPHOLOGY; INCUNABULA; ISLAND	Here we present a formal description of Biremis panamae Barka, Witkowski et Weisenborn sp. nov., which was isolated from the marine littoral environment of the Pacific Ocean coast of Panama. The description is based on morphology (light and electron microscopy) and the rbcL, psbC and SSU sequences of one clone of this species. The new species is included in Biremis due to its morphological features; i.e. two marginal rows of foramina, chambered striae, and girdle composed of numerous punctate copulae. The new species also possesses a striated valve face which is not seen in most known representatives of marine littoral Biremis species. In this study we also present the relationship of Biremis to other taxa using morphology, DNA sequence data and observations of auxosporulation. Our results based on these three sources point to an evolutionary relationship between Biremis, Neidium and Scoliopleura. The unusual silicified incunabular caps present in them are known otherwise only in Muelleria, which is probably related to the Neidiaceae and Scoliotropidaceae. We also discuss the relationship between Biremis and the recently described Labellicula and Olifantiella.	[Witkowski, Andrzej; Li, Chunlian; Dobosz, Slawomir] Univ Szczecin, Fac Geosci, Palaeoceanol Unit, PL-70383 Szczecin, Poland; [Barka, Frederik] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Mann, David G.] Inst Food & Agr Res & Technol IRTA, E-43540 San Carlos de la Rapita, Catalunya, Spain; [Weisenborn, Jascha L. F.] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60438 Frankfurt, Germany; [Ashworth, Matt P.] Univ Texas Austin, Biol Labs, Sect Integrat Biol, Austin, TX 78712 USA; [Kurzydlowski, Krzysztof J.; Zglobicka, Izabela] Warsaw Univ Technol, Fac Engn & Mat Sci, Warsaw, Poland	University of Szczecin; Goethe University Frankfurt; IRTA; Goethe University Frankfurt; University of Texas System; University of Texas Austin; Warsaw University of Technology	Witkowski, A (corresponding author), Univ Szczecin, Fac Geosci, Palaeoceanol Unit, Mickiewicza 18, PL-70383 Szczecin, Poland.	witkowsk@univ.szczecin.pl	Mann, David G/I-9018-2014	Mann, David G/0000-0003-0522-6802; Zglobicka, Izabela/0000-0002-4432-9196; Kurzydlowski, Krzysztof/0000-0003-3875-4820; Witkowski, Andrzej/0000-0003-1714-218X	National Science Centre in Cracow [2012/04/A/ST10/00544]	National Science Centre in Cracow	AW and CL received support from grant No. 2012/04/A/ST10/00544 from the National Science Centre in Cracow, programme Maestro (http://www.ncn.gov.pl/?language5en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVERSON AJ, 2006, THESIS U TEXAS AUSTI; [Anonymous], 2014, TRACER V1 6; Cleve P.T., 1896, BIHANG KUNGLIGA SVEN, V22, P1; CLEVE PT, 1895, KONGLIGA SVENSKA VET, V27, P1, DOI DOI 10.5962/BHL.TITLE.68663; COX EJ, 1990, OUVRAGE DEDIE MEMOIR, P63; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Edlund M. B., 2006, ADV PHYCOLOGICAL STU, P213; Edlund MB, 2001, DIATOM RES, V16, P295; GEITLER L, 1973, OSTERR BOT Z, V122, P299, DOI 10.1007/BF01376232; GIFFEN M H, 1980, Bacillaria, V3, P129; GIFFEN MH, 1976, BOT MAR, V19, P379, DOI 10.1515/botm.1976.19.6.379; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Herwig W. E., 2011, ADV LIGHT PHOTOMICRO, V185, P12; Hustedt Friedrich, 1942, INTERNAT REV GES HYDROBIOL U HYDROGR, V42, P1, DOI 10.1002/iroh.19420420102; Jones HM, 2005, EUR J PHYCOL, V40, P61, DOI 10.1080/09670260400024675; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Krammer K., 1986, SUSSWASSERFLORA MITT, V2; Krammer K., 2000, DIATOMS EUROPE DIATO; Mann D.G., 1980, P 6 S REC FOSS DIAT, P279; Mann David G., 1996, P249; Mann DG, 2014, EUR J PHYCOL, V49, P276, DOI 10.1080/09670262.2014.915063; Mann DG, 2013, PHYCOLOGIA, V52, P204, DOI 10.2216/12-077.1; Mann DG, 2011, J PHYCOL, V47, P1368, DOI 10.1111/j.1529-8817.2011.01058.x; Mann DG, 2009, FOTTEA, V9, P211, DOI 10.5507/fot.2009.022; Mann DG, 2005, PHYCOLOGIA, V44, P335, DOI 10.2216/0031-8884(2005)44[335:AMSARI]2.0.CO;2; MANN DG, 1984, BRIT PHYCOL J, V19, P319, DOI 10.1080/00071618400650371; MANN DG, 1993, HYDROBIOLOGIA, V269, P11, DOI 10.1007/BF00027999; MANN DG, 1995, PHYCOLOGIA, V34, P74, DOI 10.2216/i0031-8884-34-1-74.1; Mereschkowsky C., 1902, SCRIPTA BOT HORTI U, V21, P1; Park R.A., 1992, THESIS U EDINBURGH E; Poulickova A, 2006, J PHYCOL, V42, P872, DOI 10.1111/j.1529-8817.2006.00235.x; Riaux-Gobin C, 2012, FOTTEA, V12, P199, DOI 10.5507/fot.2012.015; Riaux-Gobin C, 2009, PHYCOL RES, V57, P178, DOI 10.1111/j.1440-1835.2009.00537.x; Ronquist F., 2012, SYST BIOL; Round F. E., 1990, DIATOMS BIOL MORPHOL; SABBE K, 1995, BOT MAR, V38, P379, DOI 10.1515/botm.1995.38.1-6.379; Sato S, 2013, PHYCOLOGIA, V52, P225, DOI 10.2216/12-072.1; Schrader H.-J., 1971, NOVA HEDWIGIA, V22, P915; Simonsen R., 1992, BIBLIOTHECA DIATOMOL, V24, P1; Spaulding S. A., 1997, Diatom Research, V12, P95; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Van de Vijver B, 2005, CRYPTOGAMIE ALGOL, V26, P125; Van de Vijver B, 2010, PHYCOLOGIA, V49, P22, DOI 10.2216/09-27.1; Vyverman W, 1997, PHYCOLOGIA, V36, P91, DOI 10.2216/i0031-8884-36-2-91.1; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7	46	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114508	10.1371/journal.pone.0114508	http://dx.doi.org/10.1371/journal.pone.0114508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494095	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400049
J	Zorn-Kruppa, M; Houdek, P; Wladykowski, E; Engelke, M; Bartok, M; Mewes, KR; Moll, I; Brandner, JM				Zorn-Kruppa, Michaela; Houdek, Pia; Wladykowski, Ewa; Engelke, Maria; Bartok, Melinda; Mewes, Karsten R.; Moll, Ingrid; Brandner, Johanna M.			Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories	PLOS ONE			English	Article							EYE IRRITATION TEST; SLUG MUCOSAL IRRITATION; PERMEABILITY TEST; TIERED APPROACH; CELL-CULTURES; VALIDATION; OPACITY; EXTENT; IDENTIFICATION; PREVALIDATION	The depth of injury (DOI) is a mechanistic correlate to the ocular irritation response. Attempts to quantitatively determine the DOI in alternative tests have been limited to ex vivo animal eyes by fluorescent staining for biomarkers of cell death and viability in histological cross sections. It was the purpose of this study to assess whether DOI could also be measured by means of cell viability detected by the MTT assay using 3-dimensional (3D) reconstructed models of cornea and conjunctiva. The formazan-free area of metabolically inactive cells in the tissue after topical substance application is used as the visible correlate of the DOI. Areas of metabolically active or inactive cells are quantitatively analyzed on cryosection images with ImageJ software analysis tools. By incorporating the total tissue thickness, the relative MTT-DOI (rMTT-DOI) was calculated. Using the rMTT-DOI and human reconstructed cornea equivalents, we developed a prediction model based on suitable viability cut-off values. We tested 25 chemicals that cover the whole range of eye irritation potential based on the globally harmonized system of classification and labelling of chemicals (GHS). Principally, the MTT-DOI test method allows distinguishing between the cytotoxic effects of the different chemicals in accordance with all 3 GHS categories for eye irritation. Although the prediction model is slightly over-predictive with respect to non-irritants, it promises to be highly valuable to discriminate between severe irritants (Cat. 1), and mild to moderate irritants (Cat. 2). We also tested 3D conjunctiva models with the aim to specifically address conjunctiva-damaging substances. Using the MTT-DOI method in this model delivers comparable results as the cornea model, but does not add additional information. However, the MTT-DOI method using reconstructed cornea models already provided good predictability that was superior to the already existing established in vitro/ex vivo methods.	[Zorn-Kruppa, Michaela; Houdek, Pia; Wladykowski, Ewa; Moll, Ingrid; Brandner, Johanna M.] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, D-20246 Hamburg, Germany; [Engelke, Maria; Bartok, Melinda] Jacobs Univ Bremen gGmbH, D-28759 Bremen, Germany; [Mewes, Karsten R.] Henkel AG & Co KGaA, D-40589 Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Jacobs University; Henkel	Zorn-Kruppa, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, D-20246 Hamburg, Germany.	m.zorn-kruppa@uke.de			German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ [0316010]	German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ(Federal Ministry of Education & Research (BMBF))	The study was funded by German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ/grant number: 0316010. URL: http://www.bmbf.de (MZ-K ME MB KM JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2008, TOXICOL IN VITRO, V22, P1285, DOI 10.1016/j.tiv.2008.02.018; Adriaens E, 2005, TOXICOL IN VITRO, V19, P79, DOI 10.1016/j.tiv.2004.06.004; Adriaens E, 2014, ARCH TOXICOL, V88, P701, DOI 10.1007/s00204-013-1156-8; ANDERSEN I, 1983, SCAND J WORK ENV HEA, V9, P405, DOI 10.5271/sjweh.2393; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Ayaki M, 2008, CLIN EXP OPHTHALMOL, V36, P553, DOI 10.1111/j.1442-9071.2008.01803.x; Barile FA, 2010, J PHARMACOL TOXICOL, V61, P136, DOI 10.1016/j.vascn.2010.01.001; BARROSO J, 2014, AUF SOT M PHOEN 23 2, P23; Barroso J., 2013, IN VITR TEST IND PLA; CHANG RSM, 1954, P SOC EXP BIOL MED, V87, P440; Dohlman CH, 2011, CORNEA, V30, P613, DOI 10.1097/ICO.0b013e3182012a4f; Doucet O, 2006, TOXICOL IN VITRO, V20, P499, DOI 10.1016/j.tiv.2005.09.005; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; ECHEVERRIA D, 1989, BRIT J IND MED, V46, P483; Engelke M, 2013, TOXICOL IN VITRO, V27, P458, DOI 10.1016/j.tiv.2012.07.011; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P415, DOI 10.1089/jop.2008.0140; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P113, DOI 10.1089/jop.2008.0098; ESKES C, 2004, REPORT ESTABLISHING; Eskes C, 2014, TOXICOL IN VITRO, V28, P1046, DOI 10.1016/j.tiv.2014.02.009; *EUR UN RISK ASS R, 2003, 108883 CAS, V30; European Center for Ecotoxicology and Toxicology of Chemicals-ECETOC, 1998, 482 ECETOC; GAUTHERON P, 1992, FUND APPL TOXICOL, V18, P442, DOI 10.1016/0272-0590(92)90142-5; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; GUILLOT JP, 1982, FOOD CHEM TOXICOL, V20, P573, DOI 10.1016/S0278-6915(82)80066-5; Hahne M, 2012, J PHARM SCI-US, V101, P2976, DOI 10.1002/jps.23190; Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P43, DOI 10.14573/altex.2010.1.43; Hayashi K, 2012, TOXICOL IN VITRO, V26, P1199, DOI 10.1016/j.tiv.2012.06.008; HOWELL SL, 1974, J CELL SCI, V15, P591; Huhtala A, 2008, TOPICS MULTIFUNCTION, V1, P1; ICCVAM, 2006, NIH PUBLICATION, V07-4519, P1; *ICCVAM, 2007, NIH PUBL; Jeon HS, 2012, CYTOKINE, V59, P280, DOI 10.1016/j.cyto.2012.04.006; Jester JV, 2010, TOXICOL IN VITRO, V24, P597, DOI 10.1016/j.tiv.2009.10.010; Jester JV, 2006, CUTAN OCUL TOXICOL, V25, P41, DOI 10.1080/15569520500536626; Jester JV, 1998, INVEST OPHTH VIS SCI, V39, P922; Jester JV, 1998, INVEST OPHTH VIS SCI, V39, P2610; Jester JV, 2001, TOXICOL IN VITRO, V15, P115, DOI 10.1016/S0887-2333(00)00065-5; Kaluzhny Y, 2011, ATLA-ALTERN LAB ANIM, V39, P339, DOI 10.1177/026119291103900409; Katoh M, 2013, TOXICOL IN VITRO, V27, P2184, DOI 10.1016/j.tiv.2013.08.008; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kojima H, 2014, J APPL TOXICOL, V34, P766, DOI 10.1002/jat.2937; Kolle SN, 2011, ATLA-ALTERN LAB ANIM, V39, P365, DOI 10.1177/026119291103900410; Manzer AK, 2009, ALTEX-ALTERN TIEREXP, V26, P33; Maurer JK, 2002, REGUL TOXICOL PHARM, V36, P106, DOI 10.1006/rtph.2002.1551; McNamee P, 2009, REGUL TOXICOL PHARM, V54, P197, DOI 10.1016/j.yrtph.2009.04.004; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; *OECD, 2013, OECD GUID TEST CHRM; OECD, 1995, GUID TEST CHEM, DOI [10.1787/9789264069787-en, DOI 10.1787/9789264203709-EN]; OECD, 2012, OECD GUID T IN PRESS; Organization for Economic Cooperation and Development (OECD), 2012, OECD GUID TEST CHEM, DOI DOI 10.1787/9789264076228-EN; Paladino G, 2004, TISSUE CELL, V36, P323, DOI 10.1016/j.tice.2004.05.003; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; PRINSEN MK, 1993, FOOD CHEM TOXICOL, V31, P69, DOI 10.1016/0278-6915(93)90182-X; RAABE HA, 2008, LINZ C 2008 S, V2008; Ramirez-Miranda A, 2011, MOL VIS, V17, P1652; Sakaguchi H, 2011, TOXICOL IN VITRO, V25, P796, DOI 10.1016/j.tiv.2011.01.015; Scheel J, 2011, TOXICOL IN VITRO, V25, P1435, DOI 10.1016/j.tiv.2011.04.017; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scott L, 2010, TOXICOL IN VITRO, V24, P1, DOI 10.1016/j.tiv.2009.05.019; Seaman CW, 2010, TOXICOL IN VITRO, V24, P1862, DOI 10.1016/j.tiv.2010.03.004; Seeber JW, 2008, ATLA-ALTERN LAB ANIM, V36, P569, DOI 10.1177/026119290803600512; Spielmann H, 1996, ATLA-ALTERN LAB ANIM, V24, P741; SUGAI S, 1990, Journal of Toxicological Sciences, V15, P245; Takahashi Y, 2011, TOXICOL IN VITRO, V25, P1425, DOI 10.1016/j.tiv.2011.04.012; Takahashi Y, 2010, CUTAN OCUL TOXICOL, V29, P77, DOI 10.3109/15569521003587327; UN, 2011, GLOB HARM SYST CLASS; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; Van Goethem F, 2010, TOXICOL IN VITRO, V24, P1854, DOI 10.1016/j.tiv.2010.04.012; Verstraelen S, 2013, TOXICOL IN VITRO, V27, P1298, DOI 10.1016/j.tiv.2013.02.018; VONBURG R, 1993, J APPL TOXICOL, V13, P441, DOI 10.1002/jat.2550130612; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046; Zorn-Kruppa M, 2005, ATLA-ALTERN LAB ANIM, V33, P37, DOI 10.1177/026119290503300107; Zorn-Kruppa M, 2004, ALTEX-ALTERN TIEREXP, V21, P129; Zuang V, 2005, ATLA-ALTERN LAB ANIM, V33, P1	75	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114181	10.1371/journal.pone.0114181	http://dx.doi.org/10.1371/journal.pone.0114181			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494045	Green Published, gold			2022-12-26	WOS:000346611400035
J	Villalba, MI; Canul-Tec, JC; Luna-Martinez, OD; Sanchez-Alcala, R; Olamendi-Portugal, T; Rudino-Pinera, E; Rojas, S; Sanchez-Lopez, R; Fernandez-Velasco, DA; Becerril, B				Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Sanchez-Lopez, Rosana; Fernandez-Velasco, Daniel A.; Becerril, Baltazar			Site-directed Mutagenesis Reveals Regions Implicated in the Stability and Fiber Formation of Human lambda 3r Light Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Antibody; Fibril; Mutagenesis in Vitro; Thermodynamics	PRIMARY AL AMYLOIDOSIS; PROTEIN; SEQUENCE; AGGREGATION; KAPPA; PREDICTION; MUTATIONS; SYSTEM	Background: 6a and 3r are the most implicated germ lines in light chain amyloidosis. Results: Mutagenesis at N-terminal, loop 40-60, and CDR3 regions affected 3r fibrillogenesis. Conclusion: Changes at residues 7, 48, and 91 increased fibril formation while changes at residues 8 and 40 reverted fibrillogenesis. Significance: Characterization of light chain germ lines helps to identify key regions implicated in amyloidosis. Light chain amyloidosis (AL) is a disease that affects vital organs by the fibrillar aggregation of monoclonal light chains. 3r germ line is significantly implicated in this disease. In this work, we contrasted the thermodynamic stability and aggregation propensity of 3mJL2 (nonamyloidogenic) and 3rJL2 (amyloidogenic) 3 germ lines. Because of an inherent limitation (extremely low expression), Cys at position 34 of the 3r germ line was replaced by Tyr reaching a good expression yield. A second substitution (W91A) was introduced in 3r to obtain a better template to incorporate additional mutations. Although the single mutant (C34Y) was not fibrillogenic, the second mutation located at CDR3 (W91A) induced fibrillogenesis. We propose, for the first time, that CDR3 (position 91) affects the stability and fiber formation of human 3r light chains. Using the double mutant (3rJL2/YA) as template, other variants were constructed to evaluate the importance of those substitutions into the stability and aggregation propensity of 3 light chains. A change in position 7 (P7D) boosted 3rJL2/YA fibrillogenic properties. Modification of position 48 (I48M) partially reverted 3rJL2/YA fibril aggregation. Finally, changes at positions 8 (P8S) or 40 (P40S) completely reverted fibril formation. These results confirm the influential roles of N-terminal region (positions 7 and 8) and the loop 40-60 (positions 40 and 48) on AL. X-ray crystallography revealed that the three-dimensional topology of the single and double 3r mutants was not significantly altered. This mutagenic approach helped to identify key regions implicated in 3 AL.	[Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Med, Mexico City 04510, DF, Mexico; [Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Bioproc, Mexico City 04510, DF, Mexico; [Sanchez-Lopez, Rosana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Biol Plants, Mexico City 04510, DF, Mexico; [Fernandez-Velasco, Daniel A.] Univ Nacl Autonoma Mexico, Fac Med, Lab Phys Chem & Prot Engn, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Fernandez-Velasco, DA (corresponding author), Ave Univ 3000 Colonia UNAM, Mexico City 04510, DF, Mexico.	fdaniel@unam.mx		Rudino-Pinera, Enrique/0000-0001-8170-6379; SANCHEZ-LOPEZ, ROSANA/0000-0002-1628-7240; Canul Tec, Juan Carlos/0000-0003-0513-545X	National Institutes of Health [GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]; Consejo Nacional de Ciencia y Tecnologia [185179, 177224]; CONACyT [102370]; Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica [IN204611]; PAPIIT [IN217510, UNAM]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica; PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-0080 (to X6A Beamline). This work was also supported in part by U.S. Department of Energy Contract DE-AC02-98CH10886 to the National Synchrotron Light Source at Brookhaven National Laboratory.; Recipient of Scholarship 185179 from the Consejo Nacional de Ciencia y Tecnologia.; Recipient of Scholarship 177224 from the Consejo Nacional de Ciencia y Tecnologia.; Supported by CONACyT Project 102370 and Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica IN204611.; Supported by PAPIIT IN217510, UNAM.	Abe M, 1998, CLIN EXP IMMUNOL, V111, P457; Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dealwis C, 2004, CURR DRUG TARGETS, V5, P159, DOI 10.2174/1389450043490550; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farner NL, 1999, J IMMUNOL, V162, P2137; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Huang DB, 1996, ACTA CRYSTALLOGR D, V52, P1058, DOI 10.1107/S090744499600813X; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LOPEZDECASTRO JA, 1978, BIOCHEMISTRY-US, V17, P1718, DOI 10.1021/bi00602a021; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; Milardi D, 1997, BIOPHYS CHEM, V69, P43, DOI 10.1016/S0301-4622(97)00071-9; Muller AMS, 2006, ONCOLOGIST, V11, P824, DOI 10.1634/theoncologist.11-7-824; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nowak M, 2004, PROTEINS, V55, P11, DOI 10.1002/prot.10606; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stevens F J, 1995, Methods Mol Biol, V51, P51; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Williams SC, 1996, J MOL BIOL, V264, P220, DOI 10.1006/jmbi.1996.0636	55	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2577	2592		10.1074/jbc.M114.629550	http://dx.doi.org/10.1074/jbc.M114.629550			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505244	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000349310700005
J	Ahonen, SJ; Arumilli, M; Seppala, E; Hakosalo, O; Kaukonen, MK; Komaromy, AM; Lohi, H				Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Komaromy, Andras M.; Lohi, Hannes			Increased Expression of MERTK Associated with a Unique Form of Canine Retinopathy	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; INHERITED RETINAL DYSTROPHY; CONE-ROD DYSTROPHY; LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; APOPTOTIC CELLS; NONSENSE MUTATION; SITE MUTATION; GENE; GENOME	Progressive retinal degenerations are among the most common causes of blindness both in human and in dogs. Canine progressive retinal atrophy (PRA) resembles human retinitis pigmentosa (RP) and is typically characterized by a progressive loss of rod photoreceptors followed by a loss of cone function. The disease gradually progress from the loss of night and day vision to a complete blindness. We have recently described a unique form of retinopathy characterized by the multifocal gray/brown discoloration and thinning of the retina in the Swedish Vallhund (SV) breed. We aimed to identify the genetic cause by performing a genome wide association analysis in a cohort of 18 affected and 10 healthy control dogs using Illumina's canine 22k SNP array. We mapped the disease to canine chromosome 17 (p=7.7 x 10(-5)) and found a 6.1 Mb shared homozygous region in the affected dogs. A combined analysis of the GWAS and replication data with additional 60 dogs confirmed the association (p=4.3 x 10(-8), OR=11.2 for homozygosity). A targeted resequencing of the entire associated region in four cases and four controls with opposite risk haplotypes identified several variants in the coding region of functional candidate genes, such as a known retinopathy gene, MERTK. However, none of the identified coding variants followed a compelling case- or breed- specific segregation pattern. The expression analyses of four candidate genes in the region, MERTK, NPHP1, ANAPC1 and KRCC1, revealed specific upregulation of MERTK in the retina of the affected dogs. Collectively, these results indicate that the retinopathy is associated with overexpression of MERTK, however further investigation is needed to discover the regulatory mutation for the better understanding of the disease pathogenesis. Our study establishes a novel gain-of-function model for the MERTK biology and provides a therapy model for retinopathy MERTK inhibitors. Meanwhile, a marker-based genetic counseling can be developed to revise breeding programs.	[Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; Michigan State University; University of Pennsylvania	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Arumilli, Meharji/0000-0003-4072-0996; Kaukonen, Maria/0000-0002-2146-4694; Ahonen, Saija/0000-0003-3313-784X	Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation [ERCStG-260997]; Academy of Finland; Biocentrum Helsinki; University of Helsinki Research Funds; NIH [K12-EY15398, R01-EY019304]; NATIONAL EYE INSTITUTE [R01EY019304, K12EY015398] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki Research Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study has been supported partly by the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation, ERCStG-260997, the Academy of Finland, Biocentrum Helsinki, University of Helsinki Research Funds, private donations, and NIH grants K12-EY15398 and R01-EY019304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguirre G D, 1998, Mol Vis, V4, P23; Ahonen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072122; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Brea-Fernandez AJ, 2008, BRIT J OPHTHALMOL, V92, P1419, DOI 10.1136/bjo.2008.139204; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooper AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106610; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Downs LL, 2012, TRAV GENRE SOC, P169; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Goldstein O, 2010, MOL VIS, V16, P1549; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Issa PC, 2009, BRIT J OPHTHALMOL, V93, P920, DOI 10.1136/bjo.2008.147397; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jorgensen PM, 2001, GENE, V262, P51, DOI 10.1016/S0378-1119(00)00511-4; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Knubel KH, 2014, ONCOTARGET, V5, P1338, DOI 10.18632/oncotarget.1793; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Ksantini M, 2012, EUR J OPHTHALMOL, V22, P647, DOI 10.5301/ejo.5000096; Kukekova AV, 2009, CANINE RD3 MUTATION; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mackay DS, 2010, MOL VIS, V16, P369; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Migdall-Wilson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031635; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nguyen KQN, 2014, J BIOL CHEM, V289, P25737, DOI 10.1074/jbc.M114.570838; Ostergaard E, 2011, MOL VIS, V17, P1485; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shahzadi A, 2010, BRIT J OPHTHALMOL, V94, P1094, DOI 10.1136/bjo.2009.171892; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Siemiatkowska AM, 2011, MOL VIS, V17, P3013; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tanaka-Matakatsu M, 2007, DEV BIOL, V309, P222, DOI 10.1016/j.ydbio.2007.07.007; Thompson DA, 2002, AM J HUM GENET, V70, P224, DOI 10.1086/338455; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Vilboux T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-10; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	75	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114552	10.1371/journal.pone.0114552	http://dx.doi.org/10.1371/journal.pone.0114552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517981	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600022
J	Chang, MC; Chang, HH; Chan, CP; Yeung, SY; Hsien, HC; Lin, BR; Yeh, CY; Tseng, WY; Tseng, SK; Jeng, JH				Chang, Mei-Chi; Chang, Hsiao-Hua; Chan, Chiu-Po; Yeung, Sin-Yuet; Hsien, Hsiang-Chi; Lin, Bor-Ru; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei			p-Cresol Affects Reactive Oxygen Species Generation, Cell Cycle Arrest, Cytotoxicity and Inflammation/Atherosclerosis-Related Modulators Production in Endothelial Cells and Mononuclear Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PLASMINOGEN-ACTIVATOR RECEPTOR; DENTAL-PULP CELLS; FUNCTION IN-VITRO; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASES; UREMIC TOXICITY; ORGAN DAMAGE; INFLAMMATION; DYSFUNCTION	Aims: Cresols are present in antiseptics, coal tar, some resins, pesticides, and industrial solvents. Cresol intoxication leads to hepatic injury due to coagulopathy as well as disturbance of hepatic circulation in fatal cases. Patients with uremia suffer from cardiovascular complications, such as atherosclerosis, thrombosis, hemolysis, and bleeding, which may be partly due to p-cresol toxicity and its effects on vascular endothelial and mononuclear cells. Given the role of reactive oxygen species (ROS) and inflammation in vascular thrombosis, the objective of this study was to evaluate the effect of p-cresol on endothelial and mononuclear cells. Methods: EA. hy926 (EAHY) endothelial cells and U937 cells were exposed to different concentrations of p-cresol. Cytotoxicity was evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and trypan blue dye exclusion technique, respectively. Cell cycle distribution was analyzed by propidium iodide flow cytometry. Endothelial cell migration was studied by wound closure assay. ROS level was measured by 2',7'-dichlorofluorescein diacetate (DCF) fluorescence flow cytometry. Prostaglandin F-2 alpha (PGF(2 alpha)), plasminogen activator inhibitor-1 (PAI-1), soluble urokinase plasminogen activator receptor (suPAR), and uPA production were determined by Enzyme-linked immunosorbant assay (ELISA). Results: Exposure to 100-500 mu M p-cresol decreased EAHY cell number by 30-61%. P-cresol also decreased the viability of U937 mononuclear cells. The inhibition of EAHY and U937 cell growth by p-cresol was related to induction of S-phase cell cycle arrest. Closure of endothelial wounds was inhibited by p-cresol (> 100 mu M). P-cresol (> 50 mu M) also stimulated ROS production in U937 cells and EAHY cells but to a lesser extent. Moreover, p-cresol markedly stimulated PAI-1 and suPAR, but not PGF(2 alpha), and uPA production in EAHY cells. Conclusions: p-Cresol may contribute to atherosclerosis and thrombosis in patients with uremia and cresol intoxication possibly due to induction of ROS, endothelial/mononuclear cell damage and production of inflammation/atherosclerosis-related molecules.	[Chang, Mei-Chi] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Chang, Hsiao-Hua; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Dept Dent, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Chang, Hsiao-Hua; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei] Natl Taiwan Univ, Sch Dent, Coll Med, Taipei 10764, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet; Hsien, Hsiang-Chi] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chan, CP (corresponding author), Chang Gung Mem Hosp, Dept Dent, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	smallpig86778231@yahoo.com.tw; jhjeng@ntu.edu.tw	Tseng, Wan-Yu/V-4444-2019	TSENG, WAN-YU/0000-0002-9012-3703; LIN, BOR-RU/0000-0001-9545-7393	National Science Council, Taiwan, R.O.C. [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002]; Chang Gung Memorial Hospital [CMRPF-3B0191, CMRPG-3B0192, NMRPF3C0061, NMRPF3C0091, NMRPF3B0071]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from National Science Council, Taiwan, R.O.C. (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, and NSC-101-2320-B-255-002) and Chang Gung Memorial Hospital (CMRPF-3B0191, CMRPG-3B0192, NMRPF3C0061, NMRPF3C0091, and NMRPF3B0071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bifulco K, 2013, MOL CANCER THER, V12, P1981, DOI 10.1158/1535-7163.MCT-13-0077; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Buckley JR, 1904, J AM DENT ASSOC, V3, P764; Cerini C, 2004, THROMB HAEMOSTASIS, V92, P140, DOI 10.1160/th03-07-0491; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang MC, 2002, BRIT J PHARMACOL, V135, P619, DOI 10.1038/sj.bjp.0704492; Chang MC, 2011, ATHEROSCLEROSIS, V219, P559, DOI 10.1016/j.atherosclerosis.2011.09.031; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Chillon J. -M., 2009, Annales Pharmaceutiques Francaises, V67, P234, DOI 10.1016/j.pharma.2009.04.001; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; de Carvalho JTG, 2011, ARTIF ORGANS, V35, pE27, DOI 10.1111/j.1525-1594.2010.01116.x; Dietz Dennis, 1991, Toxic Rep Ser, V9, P1; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; Enocsson H, 2013, TRANSL RES, V162, P287, DOI 10.1016/j.trsl.2013.07.003; Faure V, 2006, INT IMMUNOL, V18, P1453, DOI 10.1093/intimm/dxl077; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Galle J, 2003, KIDNEY BLOOD PRESS R, V26, P65, DOI 10.1159/000070986; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Ghiadoni L, 2004, J NEPHROL, V17, P512; Glorieux G, 2009, SEMIN DIALYSIS, V22, P423, DOI 10.1111/j.1525-139X.2009.00593.x; Gunthner T, 2009, SEMIN DIALYSIS, V22, P428, DOI 10.1111/j.1525-139X.2009.00594.x; Himmelfarb J, 2009, SEMIN DIALYSIS, V22, P636, DOI 10.1111/j.1525-139X.2009.00659.x; Hirsh J., 1974, PHYSL PHARM, P99; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kamijo Y, 2003, ARCH PATHOL LAB MED, V127, P364; Kawakami K, 2009, IMMUNOPHARM IMMUNOT, V31, P304, DOI 10.1080/08923970802680299; Ketteler M, 2006, KIDNEY INT, V70, pS5, DOI 10.1038/sj.ki.5001996; Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174; MADYASTHA KM, 1992, DRUG METAB DISPOS, V20, P295; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Merino A, 2008, CONTRIB NEPHROL, V161, P83, DOI 10.1159/000130412; MYERS DR, 1978, J AM DENT ASSOC, V96, P805, DOI 10.14219/jada.archive.1978.0187; Noh H, 2014, STEM CELLS, V32, P2443, DOI 10.1002/stem.1738; Ochodnicky P, 2006, J NEPHROL, V19, P246; OHARA P, 1993, J ENDODONT, V19, P498, DOI 10.1016/S0099-2399(06)81490-1; RAGHUNATH PN, 1995, ARTERIOSCL THROM VAS, V15, P1432, DOI 10.1161/01.ATV.15.9.1432; RANLY DM, 1988, ENDOD DENT TRAUMATOL, V4, P70; Recht PA, 2004, ATHEROSCLEROSIS, V173, P321, DOI 10.1016/j.atherosclerosis.2003.11.023; Sahin G, 2007, BLOOD PURIFICAT, V25, P309, DOI 10.1159/000106103; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; SEQUEIRA DJ, 1992, BIOCHEM PHARMACOL, V44, P1171, DOI 10.1016/0006-2952(92)90382-S; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Sloand EA, 2008, EXP HEMATOL, V36, P1616, DOI 10.1016/j.exphem.2008.06.016; Tseng SK, 2012, CLIN ORAL INVEST, V16, P1267, DOI 10.1007/s00784-011-0604-1; Tseng SK, 2014, J DENT SCI IN PRESS; VANHOLDER R, 1995, KIDNEY INT, V47, P510, DOI 10.1038/ki.1995.64; Vanholder R, 1999, NEPHROL DIAL TRANSPL, V14, P2813, DOI 10.1093/ndt/14.12.2813; Westrick RJ, 2007, CURR DRUG TARGETS, V8, P996, DOI 10.2174/138945007781662328; Wratten ML, 1999, BLOOD PURIFICAT, V17, P134, DOI 10.1159/000014385; Xu YC, 1996, KIDNEY INT, V50, P2011, DOI 10.1038/ki.1996.523; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; Yuhki K, 2010, INT ANGIOL, V29, P19; Zhang GQ, 2008, FRONT BIOSCI-LANDMRK, V13, P5462, DOI 10.2741/3093; Zhu JZ, 2012, NEPHROL DIAL TRANSPL, V27, P4323, DOI 10.1093/ndt/gfs382	62	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114446	10.1371/journal.pone.0114446	http://dx.doi.org/10.1371/journal.pone.0114446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517907	Green Submitted, gold, Green Published			2022-12-26	WOS:000347215600020
J	Ma, N; Yuan, JZ; Li, M; Li, J; Zhang, LY; Liu, LX; Naeem, MS; Zhang, CL				Ma, Ni; Yuan, Jinzhan; Li, Ming; Li, Jun; Zhang, Liyan; Liu, Lixin; Naeem, Muhammad Shahbaz; Zhang, Chunlei			Ideotype Population Exploration: Growth, Photosynthesis, and Yield Components at Different Planting Densities in Winter Oilseed Rape (Brassica napus L.)	PLOS ONE			English	Article							SEED YIELD; GRAIN-YIELD; OIL CONTENT; EFFICIENCY; QUALITY; TRAITS; CANOPY; MAIZE	Rapeseed is one of the most important edible oil crops in the world and the seed yield has lagged behind the increasing demand driven by population growth. Winter oilseed rape (Brassica napus L.) is widely cultivated with relatively low yield in China, so it is necessary to find the strategies to improve the expression of yield potential. Planting density has great effects on seed yield of crops. Hence, field experiments were conducted in Wuhan in the Yangtze River basin with one conventional variety (Zhongshuang 11, ZS11) and one hybrid variety (Huayouza 9, HYZ9) at five planting densities (27.0x10(4), 37.5x10(4), 48.0x10(4), 58.5x10(4), 69.0x10(4) plants ha(-1)) during 2010-2012 to investigate the yield components. The physiological traits for high-yield and normal-yield populations were measured during 2011-2013. Our results indicated that planting densities of 58.5x10(4) plants ha-1 in ZS11 and 48.0x10(4) plants ha(-1) in HYZ9 have significantly higher yield compared with the density of 27.0x10(4) plants ha(-1)for both varieties. The ideal silique numbers for ZS11 and HYZ9 were similar to 0.9x10(4) (n m(-2)) and,16104 (n m(-2)), respectively, and ideal primary branches for ZS11 and HYZ9 were similar to 250 (n m(-2)) and,300 (n m(-2)), respectively. The highest leaf area index (LAI) and silique wall area index (SAI) was similar to 5.0 and 7.0, respectively. Moreover, higher leaf net photosynthetic rate (Pn) and water use efficiency (WUE) were observed in the high-yield populations. A significantly higher level of silique wall photosynthesis and rapid dry matter accumulation were supposed to result in the maximum seed yield. Our results suggest that increasing the planting density within certain range is a feasible approach for higher seed yield in winter rapeseed in China.	[Ma, Ni; Yuan, Jinzhan; Li, Ming; Li, Jun; Zhang, Liyan; Liu, Lixin; Naeem, Muhammad Shahbaz; Zhang, Chunlei] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Crop Cultivat & Physiol, Key Lab Oil Crop Biol,Minist Agr, Wuhan, Peoples R China; [Li, Ming] Huazhong Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Middle Rea, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, CL (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Crop Cultivat & Physiol, Key Lab Oil Crop Biol,Minist Agr, Wuhan, Peoples R China.	zhangchunlei@caas.cn	Zhang, Li/GWM-7501-2022; Naeem, Muhammad Shahbaz/B-4892-2013	Naeem, Muhammad Shahbaz/0000-0002-2996-1927; Li, Ming/0000-0001-9962-6545	National Natural Science Foundation of China [31071372, 31271671]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (Nos. 31071372, 31271671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelgasim EH, 1991, ADV PLANT BREEDING, V2, P254; Adamsen FJ, 2005, IND CROP PROD, V21, P293, DOI 10.1016/j.indcrop.2004.04.012; Brahim K, 1998, IND CROP PROD, V9, P63, DOI 10.1016/S0926-6690(98)00015-6; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; CLARKE JM, 1978, CAN J PLANT SCI, V58, P1103, DOI 10.4141/cjps78-167; Diepenbrock W, 2000, FIELD CROP RES, V67, P35, DOI 10.1016/S0378-4290(00)00082-4; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hiltbrunner J, 2007, FIELD CROP RES, V102, P163, DOI 10.1016/j.fcr.2007.03.009; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Leach JE, 1999, J AGR SCI, V132, P173, DOI 10.1017/S0021859698006091; Lopez-Bellido FJ, 2005, EUR J AGRON, V23, P359, DOI 10.1016/j.eja.2005.02.002; Ma N, 2012, J INTEGR AGR, V11, P1297; MARSHALL DR, 1991, FIELD CROP RES, V26, P171, DOI 10.1016/0378-4290(91)90034-S; Masoni A, 2007, EUR J AGRON, V26, P179, DOI 10.1016/j.eja.2006.09.006; MOCK JJ, 1975, EUPHYTICA, V24, P613, DOI 10.1007/BF00132898; Momoh EJJ, 2001, J AGRON CROP SCI, V186, P253, DOI 10.1046/j.1439-037x.2001.00476.x; Murchie EH, 2002, J EXP BOT, V53, P2217, DOI 10.1093/jxb/erf064; Peltonen-Sainio P, 2008, FIELD CROP RES, V108, P101, DOI 10.1016/j.fcr.2008.04.006; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; RAO MSS, 1991, J AGR SCI-CAMBRIDGE, V117, P189, DOI 10.1017/S0021859600065278; Rathke GW, 2006, AGR ECOSYST ENVIRON, V117, P80, DOI 10.1016/j.agee.2006.04.006; Sieling K, 1997, EUR J AGRON, V6, P215, DOI 10.1016/S1161-0301(96)02049-7; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tandon JP, 2004, PLANT BREEDING: MENDELIAN TO MOLECULAR APPROACHES, P585; THURLING N, 1991, FIELD CROP RES, V26, P201, DOI 10.1016/0378-4290(91)90036-U; Tollenaar M, 2006, MAYDICA, V51, P399; Virk P. S., 2004, International Rice Research Notes, V29, P5; [王汉中 WANG Hanzhong], 2007, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V29, P101; [王汉中 Wang Hanzhong], 2002, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V24, P82; Weiner J, 2010, EVOL APPL, V3, P473, DOI 10.1111/j.1752-4571.2010.00144.x; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008	34	20	28	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114232	10.1371/journal.pone.0114232	http://dx.doi.org/10.1371/journal.pone.0114232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517990	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600015
J	Tenggardjaja, KA; Bowen, BW; Bernardi, G				Tenggardjaja, Kimberly A.; Bowen, Brian W.; Bernardi, Giacomo			Vertical and Horizontal Genetic Connectivity in Chromis verater, an Endemic Damselfish Found on Shallow and Mesophotic Reefs in the Hawaiian Archipelago and Adjacent Johnston Atoll	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-GENETICS; CORAL ECOSYSTEMS; CONTROL-REGION; DNA; PHYLOGEOGRAPHY; ECOLOGY; EVOLUTION; TRANSPORT; PATTERNS	Understanding vertical and horizontal connectivity is a major priority in research on mesophotic coral ecosystems (30-150 m). However, horizontal connectivity has been the focus of few studies, and data on vertical connectivity are limited to sessile benthic mesophotic organisms. Here we present patterns of vertical and horizontal connectivity in the Hawaiian Islands-Johnston Atoll endemic threespot damselfish, Chromis verater, based on 319 shallow specimens and 153 deep specimens. The mtDNA markers cytochrome b and control region were sequenced to analyze genetic structure: 1) between shallow (<30 m) and mesophotic (30-150 m) populations and 2) across the species' geographic range. Additionally, the nuclear markers rhodopsin and internal transcribed spacer 2 of ribosomal DNA were sequenced to assess connectivity between shallow and mesophotic populations. There was no significant genetic differentiation by depth, indicating high levels of vertical connectivity between shallow and deep aggregates of C. verater. Consequently, shallow and deep samples were combined by location for analyses of horizontal connectivity. We detected low but significant population structure across the Hawaiian Archipelago (overall cytochrome b: Phi(ST)=0.009, P=0.020; control region: Phi(ST)=0.012, P=0.009) and a larger break between the archipelago and Johnston Atoll (cytochrome b: Phi(ST)=0.068, P<0.001; control region: Phi(ST)=0.116, P<0.001). The population structure within the archipelago was driven by samples from the island of Hawaii at the southeast end of the chain and Lisianski in the middle of the archipelago. The lack of vertical genetic structure supports the refugia hypothesis that deep reefs may constitute a population reservoir for species depleted in shallow reef habitats. These findings represent the first connectivity study on a mobile organism that spans shallow and mesophotic depths and provide a reference point for future connectivity studies on mesophotic fishes.	[Tenggardjaja, Kimberly A.; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of California System; University of California Santa Cruz; University of Hawaii System	Tenggardjaja, KA (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ktenggar@ucsc.edu	Bernardi, Giacomo/F-6346-2011	Bernardi, Giacomo/0000-0002-8249-4678	National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship; Raney Fund for Ichthyology; Sigma Xi; American Academy of Underwater Sciences Kathy Johnston Scholarship; Lerner Gray Memorial Fund; Myers Trust; Friends of the Long Marine Lab; National Science Foundation [OCE-0453167, OCE-0929031]; NOAA National Marine Sanctuaries Program MOA grant [2005-008/66882]; Hawai'i Sea Grant [NA05OAR4171048]	National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship; Raney Fund for Ichthyology; Sigma Xi; American Academy of Underwater Sciences Kathy Johnston Scholarship; Lerner Gray Memorial Fund; Myers Trust; Friends of the Long Marine Lab; National Science Foundation(National Science Foundation (NSF)); NOAA National Marine Sanctuaries Program MOA grant; Hawai'i Sea Grant	This study arose from fieldwork and lab work supported by the National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship (http://fosterscholars.noaa.gov/), the Raney Fund for Ichthyology (http://www.amphilsoc.org/grants/lewisandclark), Sigma Xi Grants-in-Aid of Research (http ://www.sigmaxi.org/programs/grants-in-aid), the American Academy of Underwater Sciences Kathy Johnston Scholarship (http://www.aausfoundation.org/#!scholarships), the Lerner Gray Memorial Fund (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships),the Myers Trust, and the Friends of the Long Marine Lab (all to KAT). Additionally, this study was supported by National Science Foundation grants (http://www.nsf.gov; grants OCE-0453167 and OCE-0929031 to BWB), NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov) MOA grant 2005-008/66882 (R. J. Toonen) and Hawai'i Sea Grant (http://seagrant.soest.hawaii.edu/) NA05OAR4171048 (BWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Andrews KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091665; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Benjamini Y, 2001, ANN STAT, V29, P1165; Blyth-Skyrme VJ, 2013, MESOPHOTIC CORAL ECO; Boland R, 2011, AM SOC LIMN OC AQ SC; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Costantini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061546; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DiBattista JD, 2011, J MAR BIOL, DOI DOI 10.1155/2011/839134; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gomes G, 2012, AN ACAD BRAS CIENC, V84, P979, DOI 10.1590/S0001-37652012000400013; GOSLINE WILLIAM A., 1955, PACIFIC SCI, V9, P442; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoover JP, 2007, HAWAIIS FISHES GUIDE; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jordan DS, 1912, DESCRIPTINS 2 NEW SP; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; KENYON JC, 1992, CORAL REEFS, V11, P37, DOI 10.1007/BF00291933; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; LEE WJ, 1995, J MOL EVOL, V41, P54; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Luck DG, 2013, PEERJ, V1, DOI 10.7717/peerj.132; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; McMillan WO, 1997, J MOL EVOL, V45, P473, DOI 10.1007/PL00006252; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mundy Bruce C., 2005, Bishop Museum Bulletins in Zoology, V6, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palumbi Stephen R., 1996, P205; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Presa P, 2002, MOL BIOL EVOL, V19, P2161, DOI 10.1093/oxfordjournals.molbev.a004041; Puglise KA, 2009, MESOPHOTIC CORAL ECO; Pyle RL, 1996, NAT HIST, V105, P59; Ramon ML, 2008, MAR BIOL, V153, P1207, DOI 10.1007/s00227-007-0894-7; Randall JE, 1998, SHORE FISHES HAWAII; Rivera M.A.J., 2011, J MAR BIOL; Roberts CM, 2003, ECOL APPL, V13, pS199; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Swerdloff SN, 1970, THESIS U HAWAII; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toonen Robert J, 2011, J Mar Biol, V2011, DOI 10.1155/2011/460173; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x	68	43	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115493	10.1371/journal.pone.0115493	http://dx.doi.org/10.1371/journal.pone.0115493			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517964	gold, Green Published			2022-12-26	WOS:000347215600069
J	Budini, F; McManus, LM; Berchicci, M; Menotti, F; Macaluso, A; Di Russo, F; Lowery, MM; De Vito, G				Budini, Francesco; McManus, Lara M.; Berchicci, Marika; Menotti, Federica; Macaluso, Andrea; Di Russo, Francesco; Lowery, Madeleine M.; De Vito, Giuseppe			Alpha Band Cortico-Muscular Coherence Occurs in Healthy Individuals during Mechanically-Induced Tremor	PLOS ONE			English	Article							CEREBRAL OSCILLATORY NETWORK; TASK-DEPENDENT MODULATION; MONKEY MOTOR CORTEX; CORTICOMUSCULAR COHERENCE; PHYSIOLOGICAL TREMOR; ISOMETRIC CONTRACTION; RECURRENT INHIBITION; REFLEX RESPONSES; EXTENSOR MUSCLES; HUMAN HAND	The present work aimed at investigating the effects of mechanically amplified tremor on cortico-muscular coherence (CMC) in the alpha band. The study of CMC in this specific band is of particular interest because this coherence is usually absent in healthy individuals and it is an aberrant feature in patients affected by pathological tremors; understanding its mechanisms is therefore important. Thirteen healthy volunteers (23 +/- 4 years) performed elbow flexor sustained contractions both against a spring load and in isometric conditions at 20% of maximal voluntary isometric contraction (MVC). Spring stiffness was selected to induce instability in the stretch reflex servo loop. 64 EEG channels, surface EMG from the biceps brachii muscle and force were simultaneously recorded. Contractions against the spring resulted in greater fluctuations of the force signal and EMG amplitude compared to isometric conditions (p<.05). During isometric contractions CMC was systematically found in the beta band and sporadically observed in the alpha band. However, during the contractions against the spring load, CMC in the alpha band was observed in 12 out of 13 volunteers. Partial directed coherence (PDC) revealed an increased information flow in the EMG to EEG direction in the alpha band (p<.05). Therefore, coherence in the alpha band between the sensory-motor cortex and the biceps brachii muscle can be systematically induced in healthy individuals by mechanically amplifying tremor. The increased information flow in the EMG to EEG direction may reflect enhanced afferent activity from the muscle spindles. These results may contribute to the understanding of the presence of alpha band CMC in tremor related pathologies by suggesting that the origin of this phenomenon may not only be at cortical level but may also be affected by spinal circuit loops.	[Budini, Francesco; Berchicci, Marika; Menotti, Federica; Macaluso, Andrea; Di Russo, Francesco] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Budini, Francesco; De Vito, Giuseppe] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [McManus, Lara M.; Lowery, Madeleine M.] Univ Coll Dublin, Sch Elect Elect & Commun Engn, Dublin 2, Ireland; [Di Russo, Francesco] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy	Foro Italico University of Rome; University College Dublin; University College Dublin; IRCCS Santa Lucia	Macaluso, A (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	andrea.macaluso@uniroma4.it	Macaluso, Andrea/K-1101-2014; Di Russo, Francesco/N-6686-2015; De Vito, Giuseppe/J-4499-2012; Lowery, Madeleine/K-6153-2012; McManus, Lara/AAV-1552-2020	Macaluso, Andrea/0000-0001-9029-6156; Di Russo, Francesco/0000-0002-3127-9433; De Vito, Giuseppe/0000-0002-6855-9180; Lowery, Madeleine/0000-0001-6743-360X; McManus, Lara/0000-0002-2255-7382; Budini, Francesco/0000-0002-1729-3853; , Marika/0000-0001-8470-191X	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	FB was financially supported for his PhD by a grant from the "Irish Research Council for Science, Engineering and Technology". LMM was financially supported for her PhD by a grant from the "Irish Research Council for Science, Engineering and Technology". http://research.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; BROWN TIH, 1982, J PHYSIOL-LONDON, V332, P113, DOI 10.1113/jphysiol.1982.sp014404; Budini F, 2014, J ELECTROMYOGR KINES, V24, P412, DOI 10.1016/j.jelekin.2014.02.003; BULLER NP, 1980, J PHYSIOL-LONDON, V303, P337, DOI 10.1113/jphysiol.1980.sp013289; Campfens SF, 2013, EXP BRAIN RES, V228, P141, DOI 10.1007/s00221-013-3545-x; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Durbaba R, 2005, EXP BRAIN RES, V163, P295, DOI 10.1007/s00221-004-2165-x; Durbaba R, 2013, J APPL PHYSIOL, V114, P1647, DOI 10.1152/japplphysiol.00917.2011; Freriks B, 1999, EUROPEAN RECOMMENDAT, P1; FROMM C, 1977, BRAIN RES, V120, P459, DOI 10.1016/0006-8993(77)90399-7; Graham P, 1993, NEURAL NETWORKS, V6, P947; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hari R, 1999, NEUROREPORT, V10, pR1; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; JOYCE GC, 1974, J PHYSIOL-LONDON, V240, P375, DOI 10.1113/jphysiol.1974.sp010615; Kilner JM, 1999, J PHYSIOL-LONDON, V516, P559, DOI 10.1111/j.1469-7793.1999.0559v.x; Kilner JM, 2000, J NEUROSCI, V20, P8838; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; LIPPOLD OCJ, 1957, J PHYSIOL-LONDON, V137, P473, DOI 10.1113/jphysiol.1957.sp005828; Macaluso A, 2003, J APPL PHYSIOL, V95, P2544, DOI 10.1152/japplphysiol.00416.2003; MATTHEWS PBC, 1980, J PHYSIOL-LONDON, V302, P427; Mayston MJ, 2001, J PHYSIOL-LONDON, V530, P551, DOI 10.1111/j.1469-7793.2001.0551k.x; McClelland VM, 2012, EXP BRAIN RES, V219, P275, DOI 10.1007/s00221-012-3087-7; Menotti F, 2014, NEUROMUSCULAR DISORD, V24, P516, DOI 10.1016/j.nmd.2014.03.010; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Nakazawa K, 1997, EXP BRAIN RES, V116, P20, DOI 10.1007/PL00005740; Pollok B, 2004, J PHYSIOL-LONDON, V554, P871, DOI 10.1113/jphysiol.2003.051235; POMPEIANO O, 1975, ARCH ITAL BIOL, V113, P238; Raethjen J, 2007, J NEUROPHYSIOL, V97, P3219, DOI 10.1152/jn.00477.2006; Riddle CN, 2005, J PHYSIOL-LONDON, V566, P625, DOI 10.1113/jphysiol.2005.089607; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; Schelter B, 2006, J PHYSIOLOGY-PARIS, V99, P37, DOI 10.1016/j.jphysparis.2005.06.006; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Ushiyama J, 2011, J APPL PHYSIOL, V110, P1233, DOI 10.1152/japplphysiol.01194.2010; Ushiyama J, 2010, J APPL PHYSIOL, V109, P1086, DOI 10.1152/japplphysiol.00869.2009; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; Williams ER, 2010, P NATL ACAD SCI USA, V107, P11098, DOI 10.1073/pnas.0913373107; Williams ER, 2009, J NEUROSCI, V29, P6616, DOI 10.1523/JNEUROSCI.0272-09.2009	40	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115012	10.1371/journal.pone.0115012	http://dx.doi.org/10.1371/journal.pone.0115012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514444	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300027
J	Li, CW; Chen, DH; Zhong, JT; Bin Lin, Z; Peng, H; Lu, HG; Yang, Y; Yin, J; Li, TY				Li, Chun Wei; Chen, De Hua; Zhong, Jia Tao; Bin Lin, Zhi; Peng, Hua; Lu, Han Gui; Yang, Yan; Yin, Jia; Li, Tian Ying			Epidemiological Characterization and Risk Factors of Allergic Rhinitis in the General Population in Guangzhou City in China	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ASTHMA AND/OR RHINITIS; CHANGING PREVALENCE; SENSITIZATIONS; CHALLENGE; EXPOSURE; CHILDREN	The prevalence of allergic rhinitis (AR) in China has increased with an apparent geographic variation. The current study aims to investigate the AR prevalence/classification, diagnosis/treatment conditions, trigger factors, and risk factors in the general population of Guangzhou, the third biggest city in China. A cross-sectional survey was performed in the citizens in Guangzhou from December 2009 to March 2010 by using a stratified multistage cluster sampling method. All subjects were asked to complete a comprehensive questionnaire via a face to face interview. A total of 9,899 questionnaires were valid. The prevalence rate of AR in the general population of Guangzhou was 6.24%, with a significant higher prevalence in urban area (8.32%) versus rural area (3.43%). Among the AR subjects, most (87%) were diagnosed with intermittent AR and 87% suffered from moderate-severe symptoms. High percentages of the AR patients did not have previously physician-based diagnosis (34%) or specific medical treatment (55%). Morning time, winter season, and cold air were the most common trigger factors of AR. Family history of AR, current living place, living place during babyhood, smoking, home renovation, and pet ownership were the significant risk factors associated with AR prevalence in the population. The study demonstrated comprehensive epidemiological and clinical information about the AR in Guangzhou population. Change of living environment and lifestyles had strong impacts on the prevalence of AR. Public health policies should help the patients benefit from a proper diagnosis/treatment and specifically target the local risk factors, in order to control the AR incidence.	[Li, Chun Wei] Natl Univ Singapore, Dept Otolaryngol, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Chen, De Hua; Bin Lin, Zhi; Li, Tian Ying] Sun Yat Sen Univ, Dept Allergy, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Chen, De Hua; Zhong, Jia Tao; Bin Lin, Zhi; Peng, Hua; Lu, Han Gui; Li, Tian Ying] Sun Yat Sen Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Jia] Chinese Acad Med Sci, Dept Allergy, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Yin, Jia] Peking Union Med Coll, Beijing 100021, Peoples R China	National University of Singapore; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yin, J (corresponding author), Chinese Acad Med Sci, Dept Allergy, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	doctorying@126.com; litianying@yeah.net	yang, yang/GWB-9426-2022; Lang, Ming/HIK-0758-2022; Peng, Gloria/GWI-6523-2022		Industry Funds of the Ministry of Health of the People's Republic of China [200802001]	Industry Funds of the Ministry of Health of the People's Republic of China	This study was supported by a grant from Industry Funds of the Ministry of Health of the People's Republic of China (No. 200802001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Diaz-Sanchez D, 2006, J ALLERGY CLIN IMMUN, V118, P441, DOI 10.1016/j.jaci.2006.04.047; Kusunoki Takashi, 2009, Allergology International, V58, P543, DOI 10.2332/allergolint.09-OA-0085; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Lee SY, 2013, ASIA PAC ALLERGY, V3, P145, DOI [10.5415/apallergy.2013.3.3.145, 10.5415/apallergy.2013.3.1.15]; Leynaert B, 2001, AM J RESP CRIT CARE, V164, P1829, DOI 10.1164/ajrccm.164.10.2103137; Li J, 2009, ALLERGY, V64, P1083, DOI 10.1111/j.1398-9995.2009.01967.x; Li J, 2012, AM J RHINOL ALLERGY, V26, P85, DOI 10.2500/ajra.2012.26.3751; Liu MM, 2013, J EPIDEMIOL, V23, P280, DOI 10.2188/jea.JE20120175; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Sheikh Aziz, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P232, DOI 10.1097/01.moo.0000122311.13359.30; Sly RM, 1999, ANN ALLERG ASTHMA IM, V82, P233, DOI 10.1016/S1081-1206(10)62603-8; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tang XF, 2012, J INVEST ALLERG CLIN, V22, P55; WANG JH, 1995, J ALLERGY CLIN IMMUN, V96, P669, DOI 10.1016/S0091-6749(95)70266-0; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306	19	27	27	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114950	10.1371/journal.pone.0114950	http://dx.doi.org/10.1371/journal.pone.0114950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514026	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300024
J	Denil, SLIJ; Rietzschel, ER; De Buyzere, ML; Van daele, CM; Segers, P; De Bacquer, D; Van Criekinge, W; Bekaert, S; Gillebert, TC; De Meyer, T				Denil, Simon L. I. J.; Rietzschel, Ernst R.; De Buyzere, Marc L.; Van daele, Caroline M.; Segers, Patrick; De Bacquer, Dirk; Van Criekinge, Wim; Bekaert, Sofie; Gillebert, Thierry C.; De Meyer, Tim		Asklepios Investigators	On Cross-Sectional Associations of Leukocyte Telomere Length with Cardiac Systolic, Diastolic and Vascular Function: The Asklepios Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; PROGNOSTIC VALUE; PULSE PRESSURE; RISK; STIFFNESS	Background: Systemic telomere length has been associated with measures of diastolic function, vascular stiffness and left ventricular mass mainly in smaller, patient-specific settings and not in a general population. In this study we describe the applicability of these findings in a large, representative population. Methods and Results: Peripheral blood leukocyte telomere length (PBL TL) was measured using telomere restriction fragment analysis in the young to middle-aged (>2500 volunteers, similar to 35 to 55 years old) Asklepios study population, free from overt cardiovascular disease. Subjects underwent extensive echocardiographic, hemodynamic and biochemical phenotyping. After adjusting for relevant confounders (age, sex, systolic blood pressure, heart rate, body mass index and use of antihypertensive drugs) we found no associations between PBL TL and left ventricular mass index (P = 0.943), ejection fraction (P = 0.933), peak systolic septal annular motion (P = 0.238), pulse wave velocity (P = 0.971) or pulse pressure (P = 0.999). In contrast, our data showed positive associations between PBL TL and parameters of LV filling: the transmitral flow early (E) to late (A) velocity ratio (E/Aratio; P < 0.001), the ratio of early (e') to late (a') mitral annular velocities (e'/a'-ratio; P = 0.012) and isovolumic relaxation time (P = 0.015). Interestingly, these associations were stronger in women than in men and were driven by associations between PBL TL and the late diastolic components (A and a'). Conclusions: In a generally healthy, young to middle-aged population, PBL TL is not related to LV mass or systolic function, but might be associated with an altered LV filling pattern, especially in women.	[Denil, Simon L. I. J.; Van Criekinge, Wim; De Meyer, Tim] Univ Ghent, Dept Math Modelling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium; [Rietzschel, Ernst R.; De Buyzere, Marc L.; Van daele, Caroline M.; Gillebert, Thierry C.] Univ Ghent, Dept Cardiovasc Dis, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Segers, Patrick] Univ Ghent, IbiTech BioMMeda, B-9000 Ghent, Belgium; [De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Bekaert, Sofie] Ghent Univ Hosp, Clin Res Ctr Ghent, Bimetra, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital	De Meyer, T (corresponding author), Univ Ghent, Dept Math Modelling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium.	Tim.DeMeyer@UGent.be	De Bacquer, Dirk/HGU-3191-2022; Stefanadis, Christodoulos/ABH-2232-2020; Gillebert, Thierry C/F-5551-2014; Segers, Patrick/AAA-7844-2020; De Meyer, Tim/D-3892-2011	Stefanadis, Christodoulos/0000-0001-5974-6454; Gillebert, Thierry C/0000-0002-3832-919X; Segers, Patrick/0000-0003-3870-3409; De Meyer, Tim/0000-0003-2994-9693; De Bacquer, Dirk/0000-0002-3202-7238	Research Foundation Flanders (FWO) [G.0427.03, G.0838.10N]; agency for Innovation by Science and Technology (IWT) [SB101371]	Research Foundation Flanders (FWO)(FWO); agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The Asklepios Study is supported by Research Foundation Flanders (FWO, http://www. fwo.be/en/) research grants G.0427.03 and G.0838.10N. SD is supported by the agency for Innovation by Science and Technology (IWT, http://www.iwt.be/english/welcome) grant SB101371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2005, CIRCULATION, V112, P1428, DOI 10.1161/CIRCULATIONAHA.104.508465; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bhella PS, 2011, CIRC-CARDIOVASC IMAG, V4, P482, DOI 10.1161/CIRCIMAGING.110.960575; BRECKER SJD, 1992, BRIT HEART J, V68, P567; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Chirinos JA, 2009, HYPERTENSION, V54, P558, DOI 10.1161/HYPERTENSIONAHA.109.131870; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; De Meyer T, 2011, AGEING RES REV, V10, P297, DOI 10.1016/j.arr.2010.11.001; De Meyer T, 2009, EUR HEART J, V30, P3074, DOI 10.1093/eurheartj/ehp324; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Ha JW, 2004, J AM SOC ECHOCARDIOG, V17, P428, DOI 10.1016/j.echo.2004.02.007; Huber M, 2012, J MOL MED, V90, P1059, DOI 10.1007/s00109-012-0874-3; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Masi S, 2014, EUR HEART J; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nawrot Tim S, 2010, Front Biosci (Elite Ed), V2, P1164; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rietzschel ER, 2007, EUR J CARDIOV PREV R, V14, P179, DOI 10.1097/HJR.0b013e328012c380; STODDARD MF, 1989, J AM COLL CARDIOL, V13, P327, DOI 10.1016/0735-1097(89)90507-X; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang YY, 2011, AGING MALE, V14, P27, DOI 10.3109/13685538.2010.529196; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118	48	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115071	10.1371/journal.pone.0115071	http://dx.doi.org/10.1371/journal.pone.0115071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506937	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100047
J	Lawlor, DA; Benn, M; Zuccolo, L; De Silva, NMG; Tybjaerg-Hansen, A; Smith, GD; Nordestgaard, BG				Lawlor, Debbie A.; Benn, Marianne; Zuccolo, Luisa; De Silva, N. Maneka G.; Tybjaerg-Hansen, Anne; Smith, George Davey; Nordestgaard, Borge G.			ADH1B and ADH1C Genotype, Alcohol Consumption and Biomarkers of Liver Function: Findings from a Mendelian Randomization Study in 58,313 European Origin Danes	PLOS ONE			English	Article							K(M) ALDEHYDE DEHYDROGENASE; GENE; DISEASE; POPULATION; RISK; ASSOCIATIONS; DEPENDENCE; ADIPOSITY; LINKAGE	Background: The effect of alcohol consumption on liver function is difficult to determine because of reporting bias and potential residual confounding. Our aim was to determine this effect using genetic variants to proxy for the unbiased effect of alcohol. Methods: We used variants in ADH1B and ADH1C genes as instrumental variables (IV) to estimate the causal effect of long-term alcohol consumption on alanine aminotransferase (ALT), gamma-glutamyl-transferase (gamma-GT),alkaline phosphatase (ALP), bilirubin and prothrombin action. Analyses were undertaken on 58,313 Danes (mean age 56). Results: In both confounder adjusted multivariable and genetic-IV analyses greater alcohol consumption, amongst those who drank any alcohol, was associated with higher ALT [mean difference per doubling of alcohol consumption: 3.4% (95% CI: 3.1, 3.7) from multivariable analyses and 3.7% (24.5, 11.9) from genetic-IV analyses] and c-GT [8.2% (7.8, 8.5) and 6.8% (22.8, 16.5)]. The point estimates from the two methods were very similar and statistically the results from the two methods were consistent with each other for effects with ALT and c- GT (both pdiff. 0.3). Results from the multivariable analyses suggested a weak inverse association of alcohol with ALP [21.5% (21.7, 21.3)], which differed from the strong positive effect found in genetic-IV analyses [11.6% (6.8, 16.4)] (p(diff)<0.0001). In both multivariable and genetic- IV analyses associations with bilirubin and protrombin action were weak and close to the null. Conclusions: Our results suggest that greater consumption of alcohol is related to poorer liver function as indicated by higher ALT, gamma-GT and ALP, but not to clotting or bilirubin.	[Lawlor, Debbie A.; Zuccolo, Luisa; De Silva, N. Maneka G.; Smith, George Davey] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.; Zuccolo, Luisa; De Silva, N. Maneka G.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Benn, Marianne; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Benn, Marianne; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth & Med Sci, Copenhagen, Denmark; [Benn, Marianne; Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	University of Bristol; University of Bristol; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Lawlor, DA (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Benn, Marianne/O-4164-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Davey Smith, George/A-7407-2013	Benn, Marianne/0000-0002-1701-595X; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nordestgaard, Borge/0000-0002-1954-7220; Zuccolo, Luisa/0000-0002-7049-3037	Herlev Hospital; Copenhagen County Research Fund; Danish Medical Research Council; UK Medical Research Council (MRC) [MC_UU_12013/5, MC_UU_12013/1]; UK MRC [G0601625]; MRC Population Health Scientist postdoctoral fellowship [G0902144]; Copenhagen University Hospital; Medical Research Council [MC_UU_12013/1, G0902144, MC_UU_12013/5, G0601625, G0501864] Funding Source: researchfish; MRC [MC_UU_12013/1, MC_UU_12013/5, G0501864, G0601625, G0902144] Funding Source: UKRI	Herlev Hospital; Copenhagen County Research Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Population Health Scientist postdoctoral fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Herlev Hospital, Copenhagen University Hospital, The Copenhagen County Research Fund, and The Danish Medical Research Council. DAL, LZ and GDS work in a Unit that receives funding from the UK Medical Research Council (MRC) (MC_UU_12013/5 and MC_UU_12013/1). The contributions of DAL to this paper were also supported by an additional grant from the UK MRC (G0601625). LZ is funded by an MRC Population Health Scientist postdoctoral fellowship (G0902144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Li DW, 2012, HUM GENET, V131, P1361, DOI 10.1007/s00439-012-1163-5; Li DW, 2011, BIOL PSYCHIAT, V70, P504, DOI 10.1016/j.biopsych.2011.02.024; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4; McCullough AJ, 1998, AM J GASTROENTEROL, V93, P2022; Morimoto K, 1996, ENVIRON HEALTH PERSP, V104, P563, DOI 10.2307/3432824; Murata CT, 2003, METABOLISM, V52, P1096, DOI 10.1016/S0026-0495(03)00183-5; Pierce BL, 2012, INT J EPIDEMIOL, V41, P1383, DOI 10.1093/ije/dys141; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Sethi AA, 2004, CLIN CHEM, V50, P443, DOI 10.1373/clinchem.2003.026047; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; SORENSEN TIA, 1989, LIVER, V9, P189; Takeshita T, 2000, HUM GENET, V106, P589, DOI 10.1007/s004390050029; TAKESHITA T, 1993, LANCET, V341, P837, DOI 10.1016/0140-6736(93)90620-V; Thomasson H R, 1995, Recent Dev Alcohol, V12, P163; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Tolstrup JS, 2009, AM J GASTROENTEROL, V104, P2182, DOI 10.1038/ajg.2009.370; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; Yang X, 1999, ALCOHOL CLIN EXP RES, V23, P751; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zuccolo L, 2009, HUM MOL GENET, V18, P4457, DOI 10.1093/hmg/ddp388	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114294	10.1371/journal.pone.0114294	http://dx.doi.org/10.1371/journal.pone.0114294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503943	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100010
J	Scribner, E; Saut, O; Province, P; Bag, A; Colin, T; Fathallah-Shaykh, HM				Scribner, Elizabeth; Saut, Olivier; Province, Paula; Bag, Asim; Colin, Thierry; Fathallah-Shaykh, Hassan M.			Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; NEWLY-DIAGNOSED GLIOBLASTOMA; TUMOR-CELL INVASION; ANTIANGIOGENIC THERAPY; RECURRENT GLIOBLASTOMA; PROGRESSION; BEVACIZUMAB; VEGF; MRI; PATTERNS	Glioblastoma multiforme (GBM) causes significant neurological morbidity and short survival times. Brain invasion by GBM is associated with poor prognosis. Recent clinical trials of bevacizumab in newly-diagnosed GBM found no beneficial effects on overall survival times; however, the baseline health-related quality of life and performance status were maintained longer in the bevacizumab group and the glucocorticoid requirement was lower. Here, we construct a clinical-scale model of GBM whose predictions uncover a new pattern of recurrence in 11/70 bevacizumab-treated patients. The findings support an exception to the Folkman hypothesis: GBM grows in the absence of angiogenesis by a cycle of proliferation and brain invasion that expands necrosis. Furthermore, necrosis is positively correlated with brain invasion in 26 newly-diagnosed GBM. The unintuitive results explain the unusual clinical effects of bevacizumab and suggest new hypotheses on the dynamic clinical effects of migration by active transport, a mechanism of hypoxia-driven brain invasion.	[Scribner, Elizabeth; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Saut, Olivier; Colin, Thierry] Univ Bordeaux, Dept Math, Talence, France; [Province, Paula; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Bag, Asim] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; UDICE-French Research Universities; Universite de Bordeaux; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA.	hfathall@uab.edu	Bag, Asim/G-8308-2019	Bag, Asim/0000-0001-6164-5863; Fathallah-Shaykh, Hassan/0000-0002-2690-7685	National Institutes of Health [R01GM096191]; French State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HF-S is supported by R01GM096191 from the National Institutes of Health. TC and OS are supported by the French State, managed by the French National Research Agency (ANR) in the frame of the "Investments for the future'' Programme IdEx Bordeaux - CPU (ANR-10-IDEX-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Ellingson BM, 2014, NEURO-ONCOLOGY, V16, P2, DOI 10.1093/neuonc/nou224; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim EY, 2014, J NEURO-ONCOL, V116, P291, DOI 10.1007/s11060-013-1290-4; Konukoglu E, 2010, MED IMAGE ANAL, V14, P111, DOI 10.1016/j.media.2009.11.005; Konukoglu E, 2010, IEEE T MED IMAGING, V29, P77, DOI 10.1109/TMI.2009.2026413; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin MI, 2004, CANCER CELL, V6, P529, DOI 10.1016/S1535-6108(04)00340-X; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Plasswilm L, 2000, PATHOBIOLOGY, V68, P99, DOI 10.1159/000055909; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Ribatti D., 2009, HIST RES TUMOR ANGIO; Saut O, 2014, B MATH BIOL, V76, P2306, DOI 10.1007/s11538-014-0007-y; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tan X, 2012, PLOS ONE, V7; Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075436; Weller M, 2013, NEURO-ONCOLOGY, V15, P971, DOI 10.1093/neuonc/not106; Wen PY, 2014, NEUROLOGY, V82, P1670, DOI 10.1212/WNL.0000000000000421; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WHITE CW, 1989, NEW ENGL J MED, V320, P1197, DOI 10.1056/NEJM198905043201807; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhang Z, 2014, J NEURO-ONCOL, V119, P207, DOI 10.1007/s11060-014-1478-2; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451; Zuniga RM, 2009, J NEURO-ONCOL, V91, P329, DOI 10.1007/s11060-008-9718-y	44	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115018	10.1371/journal.pone.0115018	http://dx.doi.org/10.1371/journal.pone.0115018			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506702	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100044
J	Abdelnabi, Z; Saleh, N; Baraghithi, S; Glebe, D; Azzeh, M				Abdelnabi, Zakeih; Saleh, Niveen; Baraghithi, Sabri; Glebe, Dieter; Azzeh, Maysa			Subgenotypes and Mutations in the S and Polymerase Genes of Hepatitis B Virus Carriers in the West Bank, Palestine	PLOS ONE			English	Article							SURFACE-ANTIGEN HBSAG; LIVER-TRANSPLANT RECIPIENTS; BLOOD-DONORS; HBV INFECTION; IMMUNE GLOBULIN; PERINATAL TRANSMISSION; REVERSE-TRANSCRIPTASE; VERTICAL TRANSMISSION; LAMIVUDINE THERAPY; DIAGNOSTIC IMPACT	The mutation rate and genetic variability of hepatitis B virus (HBV) are crucial factors for efficient treatment and successful vaccination against HBV. Until today, genetic properties of this virus among the Palestinian population remain unknown. Therefore, we performed genetic analysis of the overlapping S and polymerase genes of HBV, isolated from 40 Palestinian patients' sera. All patients were HBsAg positive and presented with a viral load above 105 HBV genome copies/ml. The genotyping results of the S gene demonstrated that HBV D1 was detected in 90% of the samples representing the most prominent subgenotype among Palestinians carrying HBV. Various mutations existed within the S gene; in five patients four known escape mutations including the common G145R and D144E were found. Furthermore, a ratio of 4.25 of non-synonymous to synonymous mutations in the S gene indicated a strong selection pressure on the HBs antigen loops of HBV strains circulating in those Palestinian patients. Although all patients were treatment-naive, with the exception of one, several mutations were found in the HBV polymerase gene, but none pointed to drug resistance. The study presented here is the first report to address subgenotypes and mutation analyses of HBV S and polymerase genes in Palestine.	[Abdelnabi, Zakeih; Saleh, Niveen; Azzeh, Maysa] Al Quds Univ, Med Res Ctr, Virol Res Lab, Abu Dies East Jerusalem, Israel; [Baraghithi, Sabri] Al Makassed Islamic Charitable Hosp MICH Cent Lab, East Jerusalem, Israel; [Glebe, Dieter] Univ Giessen, German Ctr Infect Res DZIF, Natl Reference Ctr Hepatitis B&D Viruses, Biomed Res Ctr,Inst Med Virol, D-35390 Giessen, Germany	German Center for Infection Research; Justus Liebig University Giessen	Azzeh, M (corresponding author), Al Quds Univ, Med Res Ctr, Virol Res Lab, Abu Dies East Jerusalem, Israel.	mazzeh@med.alquds.edu			German Research Foundation (DFG) [GL595/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by German Research Foundation (DFG) grant No. GL595/2-1.	Allain JP, 2013, TRANSFUSION, V53, P1405, DOI 10.1111/trf.12096; Antaki N, 2010, EPIDEMIOL INFECT, V138, P40, DOI 10.1017/S0950268809990288; Araujo NM, 2009, BRAZ J INFECT DIS, V13, P266, DOI 10.1590/S1413-86702009000400005; Asimina F, 2011, J MED VIROL, V83, P245, DOI 10.1002/jmv.21969; Baig Saeeda, 2009, BMC Res Notes, V2, P1, DOI 10.1186/1756-0500-2-1; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; BEASLEY RP, 1983, LANCET, V2, P1099; Ben-Ari Z, 2003, TRANSPLANT P, V35, P609, DOI 10.1016/S0041-1345(03)00008-3; BROWN SE, 1984, LANCET, V2, P184; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013; Chang MH, 2010, ANTIVIR THER, V15, P463, DOI 10.3851/IMP1555; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Costantini A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-310; COUROUCEPAUTY AM, 1974, VOX SANG, V27, P533, DOI 10.1111/j.1423-0410.1974.tb02451.x; Cox LE, 2011, J MED VIROL, V83, P1321, DOI 10.1002/jmv.22118; Cuestas ML, 2006, J CLIN MICROBIOL, V44, P2191, DOI 10.1128/JCM.00057-06; El Chaar M, 2012, J CLIN MICROBIOL, V50, P3159, DOI 10.1128/JCM.01251-12; Garmiri P, 2011, J MED VIROL, V83, P948, DOI 10.1002/jmv.21772; Geipel A, 2011, PHANOTYPISCHE CHARAK; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Ghany MG, 1998, HEPATOLOGY, V27, P213, DOI 10.1002/hep.510270133; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; GUERRERO E, 1990, MOL IMMUNOL, V27, P435, DOI 10.1016/0161-5890(90)90168-Y; Gunther S, 1999, ADV VIRUS RES, V52, P25, DOI 10.1016/S0065-3527(08)60298-5; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Harder KM, 2011, VACCINE, V29, P9303, DOI 10.1016/j.vaccine.2011.10.028; HINO K, 1995, DIGEST DIS SCI, V40, P566, DOI 10.1007/BF02064370; HOWARD CR, 1988, VIRAL HEPATITIS LIVE, P1094; Hu YL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-221; Jursch CA, 2002, MED MICROBIOL IMMUN, V190, P189, DOI 10.1007/s00430-001-0103-0; KARTHIGESU VD, 1994, J GEN VIROL, V75, P443, DOI 10.1099/0022-1317-75-2-443; Katsoulidou A, 2009, J MED VIROL, V81, P815, DOI 10.1002/jmv.21499; Khaled IAE, 2011, MOL BIOL REP, V38, P4353, DOI 10.1007/s11033-010-0562-8; Kim JH, 2010, J KOREAN MED SCI, V25, P257, DOI 10.3346/jkms.2010.25.2.257; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Lee JM, 2011, WORLD J GASTROENTERO, V17, P283, DOI 10.3748/wjg.v17.i3.283; Locarinin S, 2004, MOL VIROLOGY, V24; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Ma Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-315; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Masaadeh HA, 2008, WORLD J GASTROENTERO, V14, P7231, DOI 10.3748/wjg.14.7231; Mathet VL, 2006, J CLIN MICROBIOL, V44, P3435, DOI 10.1128/JCM.00866-06; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Mele A, 2001, J INFECT DIS, V184, P905, DOI 10.1086/323396; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Norouzi M, 2012, IRAN J PUBLIC HEALTH, V41, P104; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Olinger CM, 2007, MED MICROBIOL IMMUN, V196, P247, DOI 10.1007/s00430-007-0050-5; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Plitt SS, 2007, CAN J PUBLIC HEALTH, V98, P194, DOI 10.1007/BF03403711; Pollicino T, 2009, ANTIVIR THER, V14, P649; Ragheb M, 2012, J MED VIROL, V84, P587, DOI 10.1002/jmv.23234; Sayan M, 2012, ANN HEPATOL, V11, P849, DOI 10.1016/S1665-2681(19)31409-7; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Spada E, 2011, J INFECTION, V62, P165, DOI 10.1016/j.jinf.2010.11.014; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Weber B, 2005, J CLIN VIROL, V32, P102, DOI 10.1016/j.jcv.2004.10.008; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Willis BC, 2010, PEDIATRICS, V125, P704, DOI 10.1542/peds.2009-1831; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094864; Yu JW, 2011, LIVER INT, V31, P499, DOI 10.1111/j.1478-3231.2011.02450.x; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-74; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	74	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113821	10.1371/journal.pone.0113821	http://dx.doi.org/10.1371/journal.pone.0113821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503289	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400016
J	Cao, YB; Xiao, GL; Qiu, XB; Ye, S; Lin, TY				Cao, Yabing; Xiao, Guangli; Qiu, Xibin; Ye, Sheng; Lin, Tongyu			Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; EML4-ALK FUSION GENE; INHIBITOR	Introduction: We report the efficacy and safety of crizotinib treatment among Chinese patients with advanced-stage NSCLC. Methods: We retrospectively analyzed patients with EML4-ALK positive advanced NSCLC who were treated with crizotinib from May 2012 to Aug 2013. Baseline clinical parameters, treatment protocol, response to therapy and survival were noted. The primary goal was to evaluate the efficacy of crizotinib in patients who were previously treated patients or who had poor ECOG performance status (PS). Results: Forty patients were evaluable for safety and efficacy. Median age was 43 years, 100% had adenocarcinoma and stage IV disease, and 42.5% were female. Six patients received frontline treatment with crizotinib, 17 patients had 1 prior treatment, and 17 patients had more than 2 lines of prior treatment. Patients received a median of 5 cycles of treatment (range 1-15 cycles). After the first cycle, 92.5% (37/40) patients archived partial remission (PR). At the end of the follow-up period, the overall PR rate was 70% (28/40), and progression of disease (PD) occurred in 30% of patients (12/40). The median PFS was 28 weeks (95% CI 15.4 to 40.5 weeks), and median OS was 40 weeks (95% CI 38.6 to 49.3 weeks). The most frequent treatment-related AEs were vomiting (47.5%), vision disorder (27.5%) and increased ALT/AST (42%); most toxicities were Grade 1/2. Observed treatment-related Grade 3/4 AEs included increased ALT/AST (10%) and vomiting (5%). The EML4-ALK fusion rate and number of prior chemotherapy cycles did not appear to significantly affect the efficacy of crizotinib. However, PS 0-2 patients had improved PFS (50 weeks vs. 24 weeks, p=0.015). Conclusions: Crizotinib was safe, well-tolerated, and effective in Chinese patients with pre-treated ALK-rearranged NSCLC. QOL was improved and PS appears to have an effect on the efficacy of crizotinib, but prior treatment and ALK fusion rate do not.	[Cao, Yabing; Xiao, Guangli; Qiu, Xibin] Kiang Wu Hosp, Dept Oncol, Macau 999999, Peoples R China; [Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510080, Guangdong, Peoples R China; [Lin, Tongyu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol Southern China, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Cao, YB (corresponding author), Kiang Wu Hosp, Dept Oncol, Estr Repouso, Macau 999999, Peoples R China.	sumscaoyabing@hotmail.com	Cao, Yabing/X-1168-2018					Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Liu Biao, 2012, Chinese Journal of Pathology, V41, P505, DOI 10.3760/cma.j.issn.0529-5807.2012.08.001; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945	10	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114008	10.1371/journal.pone.0114008	http://dx.doi.org/10.1371/journal.pone.0114008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501361	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400021
J	Ulanet, DB; Couto, K; Jha, A; Choe, S; Wang, A; Woo, HK; Steadman, M; DeLaBarre, B; Gross, S; Driggers, E; Dorsch, M; Hurov, JB				Ulanet, Danielle B.; Couto, Kiley; Jha, Abhishek; Choe, Sung; Wang, Amanda; Woo, Hin-Koon; Steadman, Mya; DeLaBarre, Byron; Gross, Stefan; Driggers, Edward; Dorsch, Marion; Hurov, Jonathan B.			Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition	PLOS ONE			English	Article							BREAST-CANCER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TUMOR-CELLS; STEM-CELLS; GROWTH; METABOLISM; TRANSITION; EXPRESSION; EMT; DIFFERENTIATION	Recent work has highlighted glutaminase (GLS) as a key player in cancer cell metabolism, providing glutamine-derived carbon and nitrogen to pathways that support proliferation. There is significant interest in targeting GLS for cancer therapy, although the gene is not known to be mutated or amplified in tumors. As a result, identification of tractable markers that predict GLS dependence is needed for translation of GLS inhibitors to the clinic. Herein we validate a small molecule inhibitor of GLS and show that non-small cell lung cancer cells marked by low E-cadherin and high vimentin expression, hallmarks of a mesenchymal phenotype, are particularly sensitive to inhibition of the enzyme. Furthermore, lung cancer cells induced to undergo epithelial to mesenchymal transition (EMT) acquire sensitivity to the GLS inhibitor. Metabolic studies suggest that the mesenchymal cells have a reduced capacity for oxidative phosphorylation and increased susceptibility to oxidative stress, rendering them unable to cope with the perturbations induced by GLS inhibition. These findings elucidate selective metabolic dependencies of mesenchymal lung cancer cells and suggest novel pathways as potential targets in this aggressive cancer type.	[Ulanet, Danielle B.; Couto, Kiley; Jha, Abhishek; Choe, Sung; Wang, Amanda; Woo, Hin-Koon; Steadman, Mya; DeLaBarre, Byron; Gross, Stefan; Driggers, Edward; Dorsch, Marion; Hurov, Jonathan B.] Agios Pharmaceut, Cambridge, MA 02139 USA	Agios Pharmaceuticals	Hurov, JB (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	jonathan.hurov@agios.com		Choe, Sung/0000-0001-9140-4198; Jha, Abhishek/0000-0001-9161-0450	Agios Pharmaceuticals	Agios Pharmaceuticals	All work was funded by Agios Pharmaceuticals. The funders, through its employees, who are the authors of this manuscript, had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRODIE AE, 1990, ARCH BIOCHEM BIOPHYS, V276, P212, DOI 10.1016/0003-9861(90)90028-W; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; EAGLE H, 1956, J BIOL CHEM, V218, P607; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gorowiec MR, 2012, FREE RADICAL BIO MED, V52, P1024, DOI 10.1016/j.freeradbiomed.2011.12.020; Grant CM., 2008, J BIOL-LONDON, V7, P1, DOI DOI 10.1186/jbiol63; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mates JM, 2013, CURR MOL MED, V13, P514; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Qie S, 2013, J CELL BIOCH; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shen CH, 2011, J BUON, V16, P733; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Simpson NE, 2012, BREAST CANCER RES TR, V133, P959, DOI 10.1007/s10549-011-1871-x; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sobhakumari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048175; Soeters PB, 2012, ANN NUTR METAB, V60, P17, DOI 10.1159/000334880; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; VAIDYANATHAN VV, 1993, MOL CELL BIOCHEM, V129, P57, DOI 10.1007/BF00926576; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMS WJ, 1958, J BIOL CHEM, V232, P229; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107	49	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115144	10.1371/journal.pone.0115144	http://dx.doi.org/10.1371/journal.pone.0115144			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502225	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400076
J	Eipeldauer, S; Thomas, A; Hoechtl-Lee, L; Kecht, M; Binder, H; Koettstorfer, J; Gregori, M; Sarahrudi, K				Eipeldauer, Stefan; Thomas, Anita; Hoechtl-Lee, Leonard; Kecht, Mathias; Binder, Harald; Koettstorfer, Julia; Gregori, Markus; Sarahrudi, Kambiz			Is Sonic Hedgehog Involved in Human Fracture Healing? - A Prospective Study on Local and Systemic Concentrations of SHH	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DIFFERENTIATION; OSTEOGENESIS; TGF-BETA-1; EXPRESSION; GENES; MODEL	Introduction: Sonic Hedgehog (SHH) is a new signalling pathway in bone repair. Evidence exist that SHH pathway plays a significant role in vasculogenesis and limb development during embryogenesis. Some in vitro and animal studies has already proven its potential for bone regeneration. However, no data on the role of SHH in the human fracture healing have been published so far. Methods: Seventy-five patients with long bone fractures were included into the study and divided in 2 groups. First group contained 69 patients with normal fracture healing. Four patients with impaired fracture healing formed the second group. 34 volunteers donated blood samples as control. Serum samples were collected over a period of 1 year following a standardized time schedule. In addition, SHH levels were measured in fracture haematoma and serum of 16 patients with bone fractures. Results: Fracture haematoma and patients serum both contained lower SHH concentrations compared to control serum. The comparison between the patients' serum SHH level and the control serum revealed lower levels for the patients at all measurement time points. Significantly lower concentrations were observed at weeks 1 and 2 after fracture. SHH levels were slightly decreased in patients with impaired fracture healing without statistical significance. Conclusion: This is the first study to report local and systemic concentration of SHH in human fracture healing and SHH serum levels in healthy adults. A significant reduction of the SHH levels during the inflammatory phase of fracture healing was found. SHH concentrations in fracture haematoma and serum were lower than the concentration in control serum for the rest of the healing period. Our findings indicate that there is no relevant involvement of SHH in human fracture healing. Fracture repair process seem to reduce the SHH level in human. Further studies are definitely needed to clarify the underlying mechanisms.	[Eipeldauer, Stefan; Hoechtl-Lee, Leonard; Kecht, Mathias; Binder, Harald; Koettstorfer, Julia; Gregori, Markus; Sarahrudi, Kambiz] Med Univ Vienna, Univ Clin Traumatol, Vienna, Austria; [Thomas, Anita] Med Univ Vienna, Dept Gender Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Sarahrudi, K (corresponding author), Med Univ Vienna, Univ Clin Traumatol, Vienna, Austria.	kambiz.sarahrudi@meduniwien.ac.at		Starlinger, Julia/0000-0001-7462-5730; Binder, Harald/0000-0002-9212-7214; Thomas, Anita/0000-0002-1679-3098				Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; BECK LS, 1993, J BONE MINER RES, V8, P753; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Dohle E, 2010, TISSUE ENG PT A, V16, P1235, DOI [10.1089/ten.tea.2009.0493, 10.1089/ten.TEA.2009.0493]; Dohle E, 2011, EUR CELLS MATER, V21, P144, DOI 10.22203/eCM.v021a12; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; GAZIT D, 1990, ENDOCRINOLOGY, V126, P2607, DOI 10.1210/endo-126-5-2607; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Horikiri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076785; Koyama E, 1996, DEV DYNAM, V207, P344, DOI 10.1002/(SICI)1097-0177(199611)207:3<344::AID-AJA11>3.0.CO;2-4; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691; Miyaji T, 2003, HISTOCHEM CELL BIOL, V119, P233, DOI 10.1007/s00418-003-0501-z; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Park SH, 2003, J ORTHOP TRAUMA, V17, P2, DOI 10.1097/00005131-200301000-00002; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sarahrudi K, 2011, INJURY, V42, P833, DOI 10.1016/j.injury.2011.03.055; Sarahrudi K, 2010, J ORTHOP RES, V28, P671, DOI 10.1002/jor.21048; Sarahrudi K, 2009, J ORTHOP RES, V27, P1293, DOI 10.1002/jor.20906; Schmidmaier G, 2002, BONE, V31, P165, DOI 10.1016/S8756-3282(02)00798-6; Song K, 2011, INJURY, V42, P796, DOI 10.1016/j.injury.2011.02.003; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Tielinen L, 2002, BIOMATERIALS, V23, P3817, DOI 10.1016/S0142-9612(02)00105-9; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Warzecha J, 2013, EXP THER MED, V5, P1035, DOI 10.3892/etm.2013.923; Watanabe Y, 1998, DEVELOPMENT, V125, P2631; Weiss S, 2002, J BONE MINER RES, V17, P1280, DOI 10.1359/jbmr.2002.17.7.1280; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114668	10.1371/journal.pone.0114668	http://dx.doi.org/10.1371/journal.pone.0114668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501422	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700042
J	Das, ML; Rowland, M; Austin, JW; De Lazzari, E; Picado, A				Das, Murari Lal; Rowland, Mark; Austin, James W.; De Lazzari, Elisa; Picado, Albert			Do Size and Insecticide Treatment Matter? Evaluation of Different Nets against Phlebotomus argentipes, the Vector of Visceral Leishmaniasis in Nepal	PLOS ONE			English	Article							DELTAMETHRIN-IMPREGNATED BEDNETS; BED-NETS; INDIAN SUBCONTINENT; DIPTERA PSYCHODIDAE; RANDOMIZED-TRIAL; ENDEMIC FOCI; ELIMINATION; SANDFLIES; BIHAR; BANGLADESH	In the Indian subcontinent, Leishmania donovani, the parasite causing visceral leishmaniasis (VL) is transmitted by the sand fly vector Phlebotomus argentipes. Long lasting insecticide treated nets (LN) have been postulated as alternative or complement to Indoor Residual Spraying but there are few field studies evaluating the entomological efficacy of different nets against this vector. We conducted two crossover trials in a VL endemic area in Nepal to compare the barrier effect of (1) LN with different mesh sizes (156 holes/inch(2) vs 625 holes/inch(2)) and (2) alpha-cypermethrin treated LN and untreated nets having the same mesh size (156 holes/inch(2)). Each crossover trial had two arms consisting of a sequence of two different nets for 8 nights. We used 10 cattle sheds per trial. A cow placed under the net was used as bait. CDC light traps placed inside the nets were used to evaluate the number of P. argentipes crossing the net barrier. Negative binomial generalized estimating equation (GEE) population-averaged models adjusted by night and sequence were used to estimate the barrier effect of the different nets. The crossover trials conducted in a rural village in Morang district (South-eastern Nepal) demonstrated that reducing the size of the holes in treated nets (625 holes/inch(2)) increased the barrier effect of LN by 77% (95% confidence interval (CI): 56%-88%) compared with treated nets with larger holes (156 holes/inch(2)). Treating nets with alpha-cypermethrin reduced the number of P. argentipes captured inside the nets by 77% (95% CI: 27%-93%) compared with untreated nets. The effectiveness and acceptability of finer mesh pyrethroid treated LN should be tested for VL prevention in a randomized controlled trial.	[Das, Murari Lal] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Austin, James W.] BASF Corp, Res Triangle Pk, NC USA; [De Lazzari, Elisa; Picado, Albert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain	B.P. Koirala Institute of Health Sciences; University of London; London School of Hygiene & Tropical Medicine; BASF; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Picado, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	albert.picado@cresib.cat	Das, Murari/AAK-9157-2021	De Lazzari, Elisa/0000-0003-2614-6545; Das, Murari/0000-0001-6816-2389; Picado, Albert/0000-0001-7344-628X	Royal Society of Tropical Medicine and Hygiene [46]	Royal Society of Tropical Medicine and Hygiene	This work was supported by the Royal Society of Tropical Medicine and Hygiene (Small Grants 2013 - Grant number 46) https://rstmh.org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Burniston I, 2010, J MED ENTOMOL, V47, P902, DOI 10.1603/ME09184; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Garlapati RB, 2012, J MED ENTOMOL, V49, P515, DOI 10.1603/ME11115; Kasili S, 2010, J VECTOR DIS, V47, P1; LEWIS DJ, 1987, SYST ENTOMOL, V12, P163, DOI 10.1111/j.1365-3113.1987.tb00194.x; MAJORI G, 1989, MED VET ENTOMOL, V3, P441, DOI 10.1111/j.1365-2915.1989.tb00253.x; Maroli M, 1991, Parassitologia, V33 Suppl, P399; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Mondal D, 2010, TROP MED INT HEALTH, V15, P1382, DOI 10.1111/j.1365-3156.2010.02635.x; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Palit A, 2005, INT J ENVIRON HEAL R, V15, P449, DOI 10.1080/09603120500392525; Picado A, 2012, INDIAN J MED RES, V136, P22; Picado A, 2012, T ROY SOC TROP MED H, V106, P150, DOI 10.1016/j.trstmh.2011.10.014; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2009, MEM I OSWALDO CRUZ, V104, P1183, DOI 10.1590/S0074-02762009000800018; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Reed JF, 2004, ANN EMERG MED, V43, P54, DOI 10.1016/S0196-0644(03)00661-9; Senn S, 2002, CROSS OVER TRIALS CL; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x; WHOPES - WHO Pesticide Evaluation Scheme, 2012, 15 WHOPES WORK GROUP; World Health Organization, 2005, GUID LAB FIELD TEST	27	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114915	10.1371/journal.pone.0114915	http://dx.doi.org/10.1371/journal.pone.0114915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494099	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000346611400084
J	Shafique, RH; Klimov, PB; Inam, M; Chaudhary, FR; OConnor, BM				Shafique, Rubaba Hamid; Klimov, Pavel B.; Inam, Muhammad; Chaudhary, Farhana Riaz; OConnor, Barry M.			Group 1 Allergen Genes in Two Species of House Dust Mites, Dermatophagoides farinae and D-pteronyssinus (Acari: Pyroglyphidae): Direct Sequencing, Characterization and Polymorphism	PLOS ONE			English	Article							DER-P-I; MAJOR ALLERGEN; IGE ANTIBODIES; F-I; SPECIFICITY; DER-P-1; BINDING; QUANTIFICATION; EXPRESSION; TASSER	Group 1 allergens of Dermatophagoides farinae (Der f 1) and D. pteronyssinus (Der p 1) dominate overall allergic responses in house dust mite allergy patients. The need for accurate identification and characterization of representative variants of group 1 allergens in any given geographic locality has been emphasized for development of appropriate allergen extracts. Regional amino acid sequence polymorphism has been described but the extent of this polymorphism is not well understood. Such data are completely absent for the USA and many other countries. Most previous studies used cDNA libraries generated by reverse transcriptase (RT-PCR) and/or primers amplifying shorter fragments of this gene. Using novel species-specific primers and direct PCR, we document group 1 allergen gene sequence polymorphism in populations of D. farinae and D. pteronyssinus from the USA and Pakistan. We report two novel introns (nt pos 87 and 291) in both species, and the absence of intron 3 in Der p 1. Thirteen silent and one novel non-synonymous mutation (Tryptophan W-197 to Arginine R-197) were detected in D. farinae. The potential medical significance of the latter mutation is discussed. Two haplotypes of the Der f 1 gene were identified, haplotype 1 (63%) was more frequent than haplotype 2 (18%). Polymorphism in Der f 1 displayed geographical localization, since both haplotypes were present in mite populations from Pakistan whereas haplotype 1 was observed only in the USA. In Der p 1, a silent mutation at nt (aa) position 1011(149) and four non-synonymous mutations at positions 589(50), 935(124), 971(136), 1268(215) were observed. These mutations were reported from many other geographic regions, suggesting that polymorphism in the Der p 1 gene is panmictic. The extent of polymorphism in both genes is substantially lower than that reported previously (0.10-0.16% vs 0.31-0.49%), indicating the need for careful evaluation of potential polymerase errors in studies utilizing RT-PCR.	[Shafique, Rubaba Hamid; Chaudhary, Farhana Riaz] Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Dept Zool, Rawalpindi, Pakistan; [Klimov, Pavel B.; OConnor, Barry M.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Klimov, Pavel B.] Tyumen State Univ, Fac Biol, Tyumen, Russia; [Inam, Muhammad] Univ Punjab, Dept Zool, Physiol Lab, Lahore, Pakistan	Arid Agriculture University; University of Michigan System; University of Michigan; Tyumen State University; University of Punjab	Shafique, RH (corresponding author), Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Dept Zool, Rawalpindi, Pakistan.	rubaba_hamid@hotmail.com	Klimov, Pavel B/E-4017-2010	Shafique, Rubaba Hamid/0000-0001-7380-2141; Inam, Muhammad/0000-0003-3789-5015	Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan; US National Science Foundation grant [DEB-0613769]; cooperative agreement of the Ministry of Education and Science of the Russian Federation [6.1933.2014/K, 1933]; US National Pediculosis Association (NPA) [20142016]; Marty Bloomberg	Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan; US National Science Foundation grant(National Science Foundation (NSF)); cooperative agreement of the Ministry of Education and Science of the Russian Federation; US National Pediculosis Association (NPA); Marty Bloomberg	This work was supported by the Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan to Rubaba Hamid Shafique, a US National Science Foundation grant DEB-0613769 to BMOC, cooperative agreement of the Ministry of Education and Science of the Russian Federation No. 6.1933.2014/K (project code 1933), 20142016, the US National Pediculosis Association (NPA) and Marty Bloomberg to PBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLIAN LG, 1991, EXP APPL ACAROL, V10, P167, DOI 10.1007/BF01198649; ARLIAN LG, 1983, J MED ENTOMOL, V20, P99, DOI 10.1093/jmedent/20.1.99; BEBENEK K, 1993, COLD SPRING HARBOR M, V23, P85; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHAPMAN MD, 1978, CLIN EXP IMMUNOL, V34, P126; Chruszcz M, 2012, J BIOL CHEM, V287, P7388, DOI 10.1074/jbc.M111.311159; CHUA KY, 1993, INT ARCH ALLERGY IMM, V101, P364, DOI 10.1159/000236478; Chua KY, 1996, CLIN EXP ALLERGY, V26, P829, DOI 10.1111/j.1365-2222.1996.tb00615.x; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Cui Y, 2008, BRAZ J MED BIOL RES, V41, P380, DOI 10.1590/S0100-879X2008000500006; Cui YB, 2008, INT J ACAROL, V34, P3, DOI 10.1080/01647950808683703; DILWORTH RJ, 1991, CLIN EXP ALLERGY, V21, P25, DOI 10.1111/j.1365-2222.1991.tb00800.x; DREBORG S, 1992, ALLERGY, V47, P418, DOI 10.1111/j.1398-9995.1992.tb02082.x; Hales BJ, 2002, CLIN EXP ALLERGY, V32, P1461, DOI 10.1046/j.1365-2745.2002.01500.x; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Hewitt CRA, 1997, CLIN EXP ALLERGY, V27, P201, DOI 10.1111/j.1365-2222.1997.tb00694.x; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hill MR, 1998, ALLERGY, V53, P18, DOI 10.1111/j.1398-9995.1998.tb04991.x; Jeong KY, 2012, EXP APPL ACAROL, V58, P35, DOI 10.1007/s10493-012-9553-x; KENT NA, 1992, INT ARCH ALLERGY IMM, V99, P150, DOI 10.1159/000236349; Klimov PB, 2013, SYST BIOL, V62, P411, DOI 10.1093/sysbio/syt008; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LIND P, 1988, J IMMUNOL, V140, P4256; Milian Evelyn, 2004, P R Health Sci J, V23, P47; NISHIYAMA C, 1993, INT ARCH ALLERGY IMM, V101, P159, DOI 10.1159/000236514; Olsson S, 1998, CLIN EXP ALLERGY, V28, P984, DOI 10.1046/j.1365-2222.1998.00375.x; Park JW, 2002, CLIN EXP ALLERGY, V32, P1042, DOI 10.1046/j.1365-2222.2002.01421.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piboonpocanun S, 2006, CLIN EXP ALLERGY, V36, P510, DOI 10.1111/j.1365-2222.2006.02464.x; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 1998, PRIMER3; Simpson RJ, 1988, PROTEIN SEQ DATA ANA, V2, P17; Smith WA, 2001, J ALLERGY CLIN IMMUN, V107, P985, DOI 10.1067/mai.2001.114652; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Thomas Wayne R, 2004, Chang Gung Med J, V27, P563; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Thomas WR, 2007, PROTEIN PEPTIDE LETT, V14, P943, DOI 10.2174/092986607782541169; Thomas WR, 1997, INT ARCH ALLERGY IMM, V113, P96, DOI 10.1159/000237516; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; van Ree R, 2007, J ALLERGY CLIN IMMUN, V119, P270, DOI 10.1016/j.jaci.2006.10.033; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114636	10.1371/journal.pone.0114636	http://dx.doi.org/10.1371/journal.pone.0114636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494056	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400063
J	Campeotto, I; Zhang, Y; Mladenov, MG; Freemont, PS; Grundling, A				Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Freemont, Paul S.; Grundling, Angelika			Complex Structure and Biochemical Characterization of the Staphylococcus aureus Cyclic Diadenylate Monophosphate (c-di-AMP)-binding Protein PstA, the Founding Member of a New Signal Transduction Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Bioinformatics; Crystal Structure; Nucleotide; Staphylococcus aureus (S; aureus); Complex	C-DI-AMP; CRYSTAL-STRUCTURES; GMP-AMP; SEQUENCE; BINDING; 2ND-MESSENGER; MECHANISM; REVEALS; CYANOBACTERIA; CONSERVATION	Background: PstA is a cyclic di-AMP receptor and PII-like signal transduction protein. Results: Apo-PstA and complex crystal structures reveal a novel cyclic di-AMP-binding mode and induced conformational changes. Conclusion: PstA has a similar fold but distinct signal transduction properties from classic PII proteins, which function in nitrogen metabolism. Significance: Identification of common features allows for rational prediction of cyclic di-AMP-binding sites. Signaling nucleotides are integral parts of signal transduction systems allowing bacteria to cope with and rapidly respond to changes in the environment. The Staphylococcus aureus PII-like signal transduction protein PstA was recently identified as a cyclic diadenylate monophosphate (c-di-AMP)-binding protein. Here, we present the crystal structures of the apo- and c-di-AMP-bound PstA protein, which is trimeric in solution as well as in the crystals. The structures combined with detailed bioinformatics analysis revealed that the protein belongs to a new family of proteins with a similar core fold but with distinct features to classical PII proteins, which usually function in nitrogen metabolism pathways in bacteria. The complex structure revealed three identical c-di-AMP-binding sites per trimer with each binding site at a monomer-monomer interface. Although distinctly different from other cyclic-di-nucleotide-binding sites, as the half-binding sites are not symmetrical, the complex structure also highlighted common features for c-di-AMP-binding sites. A comparison between the apo and complex structures revealed a series of conformational changes that result in the ordering of two anti-parallel -strands that protrude from each monomer and allowed us to propose a mechanism on how the PstA protein functions as a signaling transduction protein.	[Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Grundling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Grundling, Angelika] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, South Kensington Campus,Sir Ernst Chain Bldg, London SW7 2AZ, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk	ZHANG, YONG/H-1959-2011; ZHANG, YONG/J-3689-2019	ZHANG, YONG/0000-0003-2968-0081; ZHANG, YONG/0000-0003-2968-0081; Campeotto, Ivan/0000-0002-0814-619X; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; EMBO Long Term Fellowship [ALTF 721-2013]; MRC [MR/J006874/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371, Wellcome Trust Grant 100289 (to A. G.), and the EMBO Long Term Fellowship ALTF 721-2013 (to Y. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; Nichols CE, 2006, ACTA CRYSTALLOGR F, V62, P494, DOI 10.1107/S1744309106015430; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Read RJ, 2013, ACTA CRYSTALLOGR D, V69, P176, DOI 10.1107/S0907444912045374; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sakai H, 2005, J STRUCT BIOL, V149, P99, DOI 10.1016/j.jsb.2004.08.007; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2003, ACTA CRYSTALLOGR D, V59, P2183, DOI 10.1107/S0907444903019589; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zheng C, 2013, ENZYME MICROB TECH, V52, P319, DOI 10.1016/j.enzmictec.2013.03.007	46	42	44	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2888	2901		10.1074/jbc.M114.621789	http://dx.doi.org/10.1074/jbc.M114.621789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505271	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000349310700029
J	Deng, SS; Wu, LY; Wang, YC; Cao, PR; Xu, L; Li, QR; Liu, M; Zhang, L; Jiang, YJ; Yang, XY; Sun, SN; Tan, MJ; Qian, M; Zang, Y; Feng, LY; Li, J				Deng, Si-Si; Wu, Le-Yu; Wang, Ya-Chao; Cao, Peng-Rong; Xu, Lei; Li, Qian-Ru; Liu, Meng; Zhang, Lun; Jiang, Yue-Jing; Yang, Xiao-Yu; Sun, Sheng-Nan; Tan, Min-jia; Qian, Min; Zang, Yi; Feng, Linyin; Li, Jia			Protein Kinase A Rescues Microtubule Affinity-regulating Kinase 2-induced Microtubule Instability and Neurite Disruption by Phosphorylating Serine 409	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Microtubule; Microtubule-associated Protein (MAP); Neurite Outgrowth; Protein Kinase A (PKA); Tau Protein (Tau); MARK2	UBIQUITIN-ASSOCIATED DOMAINS; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; NEURONAL POLARITY; MARK/PAR-1; FAMILY; OUTGROWTH; TOXICITY; DIFFERENTIATION; ESTABLISHMENT	Background: MARK2 and PKA are both involved in the regulation of microtubule stability. Results: PKA significantly inhibits MARK2 by phosphorylating serine 409 and rescues MARK2-induced microtubule instability and neurite disruption. Conclusion: PKA functions as an upstream inhibitor of MARK2 by directly interacting and phosphorylating it. Significance: The results identify a novel interaction between PKA and MARK2, providing new insight into the signal networks of both. Microtubule affinity-regulating kinase 2 (MARK2)/PAR-1b and protein kinase A (PKA) are both involved in the regulation of microtubule stability and neurite outgrowth, but whether a direct cross-talk exists between them remains unclear. Here, we found the disruption of microtubule and neurite outgrowth induced by MARK2 overexpression was blocked by active PKA. The interaction between PKA and MARK2 was confirmed by coimmunoprecipitation and immunocytochemistry both in vitro and in vivo. PKA was found to inhibit MARK2 kinase activity by phosphorylating a novel site, serine 409. PKA could not reverse the microtubule disruption effect induced by a serine 409 to alanine (Ala) mutant of MARK2 (MARK2 S409A). In contrast, mutation of MARK2 serine 409 to glutamic acid (Glu) (MARK2 S409E) did not affect microtubule stability and neurite outgrowth. We propose that PKA functions as an upstream inhibitor of MARK2 in regulating microtubule stability and neurite outgrowth by directly interacting and phosphorylating MARK2.	[Deng, Si-Si; Cao, Peng-Rong; Xu, Lei; Li, Qian-Ru; Liu, Meng; Zhang, Lun; Jiang, Yue-Jing; Zang, Yi; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Wu, Le-Yu; Yang, Xiao-Yu; Feng, Linyin] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Dept Neuropharmacol, Shanghai 201203, Peoples R China; [Sun, Sheng-Nan; Tan, Min-jia] Chinese Acad Sci, Shanghai Inst Mat Med, Chem Prote Ctr, Shanghai 201203, Peoples R China; [Sun, Sheng-Nan; Tan, Min-jia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wang, Ya-Chao; Qian, Min; Li, Jia] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China Normal University	Zang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, 189 Guo Shoujing Rd, Shanghai 201203, Peoples R China.	yzang@simm.ac.cn; lyfeng@simm.ac.cn; jli@simm.ac.cn	Ya-chao, Wang/AAB-8162-2020; YANG, Xiaoyu/AFF-7937-2022; Zang, Yi/C-5683-2014; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Tan, Minjia/C-4491-2014	YANG, Xiaoyu/0000-0003-2508-4805; Zang, Yi/0000-0001-9835-922X; Tan, Minjia/0000-0002-6784-9653; Wang, Ya-chao/0000-0003-3709-5368	National Science Fund for Distinguished Young Scholars [81125023]; Program of Shanghai Subject Chief Scientist Grant [13XD1404300]; National Natural Science Foundation of China [81173033, 81123004]; Open Project Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University [SKLN-MKF201407]; Chinese Academy of Science "strategic leader in science and technology projects" [XDA01040303, XDA01040304]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program of Shanghai Subject Chief Scientist Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University; Chinese Academy of Science "strategic leader in science and technology projects"	This work was supported by National Science Fund for Distinguished Young Scholars Grant 81125023, Program of Shanghai Subject Chief Scientist Grant 13XD1404300, National Natural Science Foundation of China Grants 81173033 and 81123004, the Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University Grant SKLN-MKF201407, and Chinese Academy of Science "strategic leader in science and technology projects" Grants XDA01040303 and XDA01040304.	Aglah C, 2008, NEUROPHARMACOLOGY, V55, P8, DOI 10.1016/j.neuropharm.2008.04.005; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Birukova AA, 2004, AM J PHYSIOL-LUNG C, V287, pL86, DOI 10.1152/ajplung.00441.2003; Carlyle BC, 2014, P NATL ACAD SCI USA, V111, P5036, DOI 10.1073/pnas.1322360111; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dehmelt L, 2005, GENOME BIOL, V6; Diegelmann S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-76; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Gu GJ, 2013, J ALZHEIMERS DIS, V33, P699, DOI 10.3233/JAD-2012-121357; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hayashi Kenji, 2011, Bioarchitecture, V1, P261; Hayashi K, 2012, CELL STRUCT FUNCT, V37, P21; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Sapir T, 2008, J NEUROSCI, V28, P5710, DOI 10.1523/JNEUROSCI.0911-08.2008; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Wu PR, 2011, CELL DEATH DIFFER, V18, P1507, DOI 10.1038/cdd.2011.2; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	48	7	7	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3149	3160		10.1074/jbc.M114.629873	http://dx.doi.org/10.1074/jbc.M114.629873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512381	hybrid, Green Published			2022-12-26	WOS:000349310700049
J	Hirsch, PE; Cayon, D; Svanback, R				Hirsch, Philipp Emanuel; Cayon, David; Svanback, Richard			Plastic Responses of a Sessile Prey to Multiple Predators: A Field and Experimental Study	PLOS ONE			English	Article							MUSSEL DREISSENA-POLYMORPHA; ROACH RUTILUS-RUTILUS; ZEBRA MUSSELS; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSES; BLUE MUSSEL; NICHE WIDTH; TRADE-OFF; SHELL; CRAYFISH	Background: Theory predicts that prey facing a combination of predators with different feeding modes have two options: to express a response against the feeding mode of the most dangerous predator, or to express an intermediate response. Intermediate phenotypes protect equally well against several feeding modes, rather than providing specific protection against a single predator. Anti-predator traits that protect against a common feeding mode displayed by all predators should be expressed regardless of predator combination, as there is no need for trade-offs. Principal Findings: We studied phenotypic anti-predator responses of zebra mussels to predation threat from a handling-time-limited (crayfish) and a gape-size-limited (roach) predator. Both predators dislodge mussels from the substrate but diverge in their further feeding modes. Mussels increased expression of a nonspecific defense trait (attachment strength) against all combinations of predators relative to a control. In response to roach alone, mussels showed a tendency to develop a weaker and more elongated shell. In response to crayfish, mussels developed a harder and rounder shell. When exposed to either a combination of predators or no predator, mussels developed an intermediate phenotype. Mussel growth rate was positively correlated with an elongated weaker shell and negatively correlated with a round strong shell, indicating a trade-off between anti-predator responses. Field observations of prey phenotypes revealed the presence of both anti-predator phenotypes and the trade-off with growth, but intra-specific population density and bottom substrate had a greater influence than predator density. Conclusions: Our results show that two different predators can exert both functionally equivalent and inverse selection pressures on a single prey. Our field	[Hirsch, Philipp Emanuel; Cayon, David; Svanback, Richard] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Evolut, Uppsala, Sweden	Uppsala University	Hirsch, PE (corresponding author), Univ Basel, Program Man Soc Environm MGU, Basel, Switzerland.	philipp.hirsch@unibas.ch		Hirsch, Philipp Emanuel/0000-0002-6927-2368	Malmens stiftelse; VR	Malmens stiftelse; VR(Swedish Research Council)	This study was funded by grants form the Malmens stiftelse to PEH and from VR to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; [Anonymous], 1992, WATER QUALITY MEASUR; Bagenal T.B., 1978, IBP HDB, P101; Beadman HA, 2003, MAR BIOL, V142, P487, DOI 10.1007/s00227-002-0977-4; BOULDING EG, 1984, J EXP MAR BIOL ECOL, V76, P201, DOI 10.1016/0022-0981(84)90189-8; Bourdeau PE, 2012, OIKOS, V121, P1175, DOI 10.1111/j.1600-0706.2012.20235.x; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; Bouwma P, 2001, ANIM BEHAV, V61, P771, DOI 10.1006/anbe.2000.1649; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; Cheung SG, 2004, MAR BIOL, V144, P675, DOI 10.1007/s00227-003-1233-2; Czarnoleski M, 2005, EVOL ECOL RES, V7, P821; Czarnoleski M, 2003, EVOL ECOL RES, V5, P571; Czarnoleski M, 2011, ANIM BEHAV, V82, P543, DOI 10.1016/j.anbehav.2011.06.008; Czarnoleski M, 2010, FUND APPL LIMNOL, V176, P269, DOI 10.1127/1863-9135/2010/0176-0269; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Douhan B, 2007, HACKANDE SJOFAGLER E, P16; Doyle S, 2010, J EXP MAR BIOL ECOL, V394, P98, DOI 10.1016/j.jembe.2010.07.023; Egea-Serrano A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3266; Eklov P, 2000, OIKOS, V88, P250, DOI 10.1034/j.1600-0706.2000.880203.x; Eriksson L., 2006, MULTI MEGAVARIATE 1; Forsberg C, 1998, ADV LIMNOLOGY; Freeman AS, 2009, OIKOS, V118, P758, DOI 10.1111/j.1600-0706.2008.17176.x; Gons H. J., 1986, HYDROBIOL B, V20, P109, DOI [10.1007/BF02291156, DOI 10.1007/BF02291156]; Hagen NT, 2002, MAR BIOL, V140, P365, DOI 10.1007/s002270100694; HELLER J, 1976, J ZOOL, V179, P201; Herzog Q, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-113; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hirsch PE, 2013, OECOLOGIA, V172, P245, DOI 10.1007/s00442-013-2611-1; Hoverman JT, 2007, OECOLOGIA, V154, P551, DOI 10.1007/s00442-007-0847-3; Howes D., 1999, BRIT COLUMBIA ESTUAR; Hughes RN, 1995, J EXP MAR BIOL ECOL, V193, P225, DOI 10.1016/0022-0981(95)00119-0; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kobak J, 2011, AQUAT ECOL, V45, P357, DOI 10.1007/s10452-011-9359-7; Kobak J, 2010, HYDROBIOLOGIA, V644, P195, DOI 10.1007/s10750-010-0113-2; Kobak J, 2009, FUND APPL LIMNOL, V174, P193, DOI 10.1127/1863-9135/2009/0174-0193; Laurila A, 2006, OECOLOGIA, V147, P585, DOI 10.1007/s00442-005-0301-3; Lei J, 1996, CAN J FISH AQUAT SCI, V53, P29, DOI 10.1139/cjfas-53-1-29; Leonard GH, 1999, ECOLOGY, V80, P1; Lesku JA, 2008, BEHAV BRAIN RES, V189, P298, DOI 10.1016/j.bbr.2008.01.006; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; MICHELI F, 1995, J ANIM ECOL, V64, P63, DOI 10.2307/5827; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Molloy Daniel P., 1997, Reviews in Fisheries Science, V5, P27; Morrison TW, 1997, J GREAT LAKES RES, V23, P177, DOI 10.1016/S0380-1330(97)70895-5; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; Naddafi R, 2010, J N AM BENTHOL SOC, V29, P444, DOI 10.1899/09-071.1; Nagelkerke LAJ, 1996, CAN J FISH AQUAT SCI, V53, P2847, DOI 10.1139/cjfas-53-12-2847; Newell RIE, 2007, MAR BIOL, V152, P449, DOI 10.1007/s00227-007-0706-0; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Perry WL, 1997, CAN J FISH AQUAT SCI, V54, P120, DOI 10.1139/cjfas-54-1-120; PREJS A, 1990, OECOLOGIA, V83, P378, DOI 10.1007/BF00317563; Ray WJ, 1997, ENVIRON BIOL FISH, V50, P267, DOI 10.1023/A:1007379220052; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; RHOADS DC, 1970, LETHAIA, V3, P143, DOI 10.1111/j.1502-3931.1970.tb01854.x; Schreiber S, 1998, ERGEB LIMNOL, V51, P169; SEED R, 1968, J MAR BIOL ASSOC UK, V48, P561, DOI 10.1017/S0025315400019159; Selin NI, 2003, RUSS J MAR BIOL, V29, P230; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Smith LD, 2000, MAR BIOL, V136, P461, DOI 10.1007/s002270050705; Spencer M, 2008, ECOLOGY, V89, P1134, DOI 10.1890/07-0941.1; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Teplitsky C, 2004, ECOLOGY, V85, P2888, DOI 10.1890/03-3043; Toomey MB, 2002, J N AM BENTHOL SOC, V21, P468, DOI 10.2307/1468483; Touchon JC, 2011, BEHAV ECOL, V22, P169, DOI 10.1093/beheco/arq192; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Urban MC, 2007, P NATL ACAD SCI USA, V104, P14377, DOI 10.1073/pnas.0704645104; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; West-Eberhard Mary Jane, 2003, pi; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x	79	3	3	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115192	10.1371/journal.pone.0115192	http://dx.doi.org/10.1371/journal.pone.0115192			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517986	Green Submitted, Green Published, gold			2022-12-26	WOS:000347215600054
J	Krebs, SJ; McBurney, SP; Kovarik, DN; Waddell, CD; Jaworski, JP; Sutton, WF; Gomes, MM; Trovato, M; Waagmeester, G; Barnett, SJ; DeBerardinis, P; Haigwood, NL				Krebs, Shelly J.; McBurney, Sean P.; Kovarik, Dina N.; Waddell, Chelsea D.; Jaworski, J. Pablo; Sutton, William F.; Gomes, Michelle M.; Trovato, Maria; Waagmeester, Garret; Barnett, Susan J.; DeBerardinis, Piergiuseppe; Haigwood, Nancy L.			Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; DEHYDROGENASE MULTIENZYME COMPLEX; INTERMOLECULAR DISULFIDE BOND; MONOCLONAL-ANTIBODIES; IMMUNOLOGICAL CHARACTERIZATION; BACILLUS-STEAROTHERMOPHILUS; VARIABLE REGIONS; VACCINE EFFICACY; PASSIVE TRANSFER	Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env). However, the generation of neutralizing Abs (NAbs) targeting these regions through vaccination has proven to be difficult. One conserved region of particular interest is the membrane proximal external region (MPER) of Env located within the gp41 ectodomain. In order to direct the immune response to this region, the MPER and gp41 ectodomain were expressed separately as N-terminal fusions to the E2 protein of Geobacillus stearothermophilus. The E2 protein acts as a scaffold by self-assembling into 60-mer particles, displaying up to 60 copies of the fused target on the surface. Rabbits were immunized with E2 particles displaying MPER and/or the gp41 ectodomain in conjunction with DNA encoding full-length gp160. Only vaccines including E2 particles displaying MPER elicited MPER-specific Ab responses. NAbs were elicited after two immunizations that largely targeted the V3 loop. To overcome V3 immunodominance in the DNA component, E2 particles displaying MPER were used in conjunction with gp160 DNA lacking hypervariable regions V2, V3, or combined V1V2V3. All rabbits had HIV binding Ab responses and NAbs following the second vaccination. Using HIV-2/HIV-1 MPER chimeric viruses as targets, NAbs were detected in 12/16 rabbits after three immunizations. Low levels of NAbs specific for Tier 1 and 2 viruses were observed in all groups. This study provides evidence that co-immunizing E2 particles displaying MPER and gp160 DNA can focus Ab responses toward conserved regions of Env.	[Krebs, Shelly J.; McBurney, Sean P.; Waddell, Chelsea D.; Jaworski, J. Pablo; Sutton, William F.; Gomes, Michelle M.; Waagmeester, Garret; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Trovato, Maria; DeBerardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Kovarik, Dina N.; Haigwood, Nancy L.] Seattle Biomed Res Inst, Viral Vaccines Program, Seattle, WA 98109 USA; [Barnett, Susan J.] Novartis Vaccines & Diagnost, Emeryville, CA USA	Oregon Health & Science University; Oregon National Primate Research Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Center for Infectious Disease Research; Novartis	Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	haigwoon@ohsu.edu	Jaworski, Juan/ABA-4503-2020; De Berardinis, Piergiuseppe/HCI-0893-2022; Haigwood, Nancy Logan/AAV-7484-2020; De Berardinis, Piergiuseppe/AAX-1049-2020; Krebs, Shelly/D-8015-2016	Jaworski, Juan/0000-0002-1311-060X; De Berardinis, Piergiuseppe/0000-0001-6579-1729; Haigwood, Nancy/0000-0002-1477-9575; Gomes, Michelle/0000-0003-4809-2664; Krebs, Shelly/0000-0003-1136-1760; Trovato, Maria/0000-0002-3831-6073	National Institutes of Health [R01AI AI074379]; Ruth L. Kirschstein National Research Service [T32A1074494, F32AI104689];  [P51 OD-011092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI106489, R01AI074379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health R01AI AI074379 to NLH, P51 OD-011092 for ONPRC support, and the Ruth L. Kirschstein National Research Service Awards T32A1074494 to SJK and F32AI104689 to SPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Caivano A, 2010, VIROLOGY, V407, P296, DOI 10.1016/j.virol.2010.08.026; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Domingo GJ, 1999, EUR J BIOCHEM, V266, P1136, DOI 10.1046/j.1432-1327.1999.00966.x; Domingo GJ, 2001, J MOL BIOL, V305, P259, DOI 10.1006/jmbi.2000.4311; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Jaworski JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031464; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; LESSARD IAD, 1995, BIOCHEM J, V306, P727, DOI 10.1042/bj3060727; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lu S, 1998, AIDS RES HUM RETROV, V14, P151, DOI 10.1089/aid.1998.14.151; Lu S, 1998, CURR TOP MICROBIOL, V226, P161; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; PERHAM RN, 1995, METHOD ENZYMOL, V251, P436, DOI 10.1016/0076-6879(95)51147-4; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; PLANELLES V, 1991, AIDS RES HUM RETROV, V7, P889, DOI 10.1089/aid.1991.7.889; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; UNAIDS, 2008, REP GLOB AIDS EP; Wahome N, 2012, CHEM BIOL DRUG DES, V80, P349, DOI 10.1111/j.1747-0285.2012.01423.x; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 2011, VACCINE, V29, P8542, DOI 10.1016/j.vaccine.2011.09.032; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072205; Zhou MK, 2013, EUR J IMMUNOL, V43, P499, DOI 10.1002/eji.201242974; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	67	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113463	10.1371/journal.pone.0113463	http://dx.doi.org/10.1371/journal.pone.0113463			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514675	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300005
J	Becker, L; Kling, E; Schiller, E; Zeh, R; Schrewe, A; Holter, SM; Mossbrugger, I; Calzada-Wack, J; Strecker, V; Wittig, I; Dumitru, I; Wenz, T; Bender, A; Aichler, M; Janik, D; Neff, F; Walch, A; Quintanilla-Fend, L; Floss, T; Bekeredjian, R; Gailus-Durner, V; Fuchs, H; Wurst, W; Meitinger, T; Prokisch, H; de Angelis, MH; Klopstock, T				Becker, Lore; Kling, Eva; Schiller, Evelyn; Zeh, Ramona; Schrewe, Anja; Hoelter, Sabine M.; Mossbrugger, Ilona; Calzada-Wack, Julia; Strecker, Valentina; Wittig, Ilka; Dumitru, Iulia; Wenz, Tina; Bender, Andreas; Aichler, Michaela; Janik, Dirk; Neff, Frauke; Walch, Axel; Quintanilla-Fend, Leticia; Floss, Thomas; Bekeredjian, Raffi; Gailus-Durner, Valerie; Fuchs, Helmut; Wurst, Wolfgang; Meitinger, Thomas; Prokisch, Holger; de Angelis, Martin Hrabe; Klopstock, Thomas			MTO1-Deficient Mouse Model Mirrors the Human Phenotype Showing Complex I Defect and Cardiomyopathy	PLOS ONE			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; RESPIRATORY-CHAIN DEFICIENCY; OXIDATIVE-PHOSPHORYLATION; DISEASE; RNA; TRANSLATION; MUTATIONS; CELLS; GENE; QUANTIFICATION	Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients.	[Becker, Lore; Schiller, Evelyn; Zeh, Ramona; Bender, Andreas; Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Becker, Lore; Kling, Eva; Schiller, Evelyn; Zeh, Ramona; Schrewe, Anja; Hoelter, Sabine M.; Mossbrugger, Ilona; Calzada-Wack, Julia; Janik, Dirk; Neff, Frauke; Bekeredjian, Raffi; Gailus-Durner, Valerie; Fuchs, Helmut; Wurst, Wolfgang; de Angelis, Martin Hrabe; Klopstock, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm & Hlth, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Schiller, Evelyn; Zeh, Ramona; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Schrewe, Anja; Bekeredjian, Raffi] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Hoelter, Sabine M.; Floss, Thomas; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Mossbrugger, Ilona; Calzada-Wack, Julia; Janik, Dirk; Neff, Frauke; Quintanilla-Fend, Leticia] Helmholtz Zentrum Munchen, Inst Pathol, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Strecker, Valentina; Wittig, Ilka] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Dumitru, Iulia; Wenz, Tina] Univ Cologne, Inst Genet, Cologne, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Inst Pathol, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wurst, Wolfgang; Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang; de Angelis, Martin Hrabe; Klopstock, Thomas] German Ctr Vertigo & Balance Disorders, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Meitinger, Thomas] Deutsch Forschungszentrum Herz Kreislauferkrankun, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Wittig, Ilka; Wenz, Tina; Prokisch, Holger; Klopstock, Thomas] German Network Mitochondrial Disorders mitoNET, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Klopstock, T (corresponding author), Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany.	Thomas.Klopstock@med.uni-muenchen.de	Aichler, Michaela/B-5356-2014; Hölter, Sabine M./N-5868-2014; Gailus-Durner, Valerie/M-7337-2014; Walch, Axel/B-4554-2012; de Angelis, Martin Hrabe/F-5531-2012; Becker, Lore/AAJ-1203-2020; Meitinger, Thomas/O-1318-2015	Hölter, Sabine M./0000-0003-4878-5241; Walch, Axel/0000-0001-5578-4023; de Angelis, Martin Hrabe/0000-0002-7898-2353; Becker, Lore/0000-0002-6890-4984; Meitinger, Thomas/0000-0002-8838-8403; Bender, Andreas/0000-0002-6328-7104; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305; Prokisch, Holger/0000-0003-2379-6286	German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants (mitoNET) [01GM1113A-C]; National Genome Research Net (NGFN-Plus) [01GS0850, 01GS0851, 01GS0854]; German Center for Vertigo and Balance Disorders [01EO0901]; EU grants (EUMODIC) [LSHG-2006-037188, 211404, 01KX1012]; Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 815]; Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project [EXC 115]; Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association	German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants (mitoNET); National Genome Research Net (NGFN-Plus); German Center for Vertigo and Balance Disorders; EU grants (EUMODIC); Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project; Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association	This work was supported by German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants to the German Network for Mitochondrial Disorders (mitoNET, 01GM1113A-C), the National Genome Research Net (NGFN-Plus, No. 01GS0850, 01GS0851, 01GS0854) the German Center for Vertigo and Balance Disorders (no. 01EO0901) and by EU grants (EUMODIC, LSHG-2006-037188 and Infrafrontier Contracts No. 211404 and 01KX1012 to the GMC). In addition, T. W. is supported by the Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft, and I. W. by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815, Project Z1 (Redox-Proteomics) and by the Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project EXC 115. W. W. was also funded by the Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffini E, 2013, HUMAN MUTATION; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chouchani ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094157; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Ghezzi D, 2012, AM J HUMAN GENETICS; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2013, AM J HUMAN GENETICS; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li RH, 2003, BBA-GENE STRUCT EXPR, V1629, P53, DOI 10.1016/S0167-4781(03)00160-X; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Pearce S, 2012, MOL CELLULAR NEUROSC; Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z; Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; Vauti F, 2007, GENE, V389, P174, DOI 10.1016/j.gene.2006.11.004; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang KC, 2014, FREE RADICAL BIO MED, V71, P351, DOI 10.1016/j.freeradbiomed.2014.03.033; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	41	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114918	10.1371/journal.pone.0114918	http://dx.doi.org/10.1371/journal.pone.0114918			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506927	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100034
J	Tozbikian, G; Brogi, E; Kadota, K; Catalano, J; Akram, M; Patil, S; Ho, AY; Reis, JS; Weigelt, B; Norton, L; Adusumilli, PS; Wen, HY				Tozbikian, Gary; Brogi, Edi; Kadota, Kyuichi; Catalano, Jeffrey; Akram, Muzaffar; Patil, Sujata; Ho, Alice Y.; Reis-Filho, Jorge S.; Weigelt, Britta; Norton, Larry; Adusumilli, Prasad S.; Wen, Hannah Yong			Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival	PLOS ONE			English	Article							PROLONGED PATIENT SURVIVAL; HUMAN T-CELLS; PHASE-I; MONOCLONAL-ANTIBODY; HIGH-AFFINITY; CANCER; MARKERS; RECEPTOR; TISSUE; OVEREXPRESSION	Mesothelin is a cell surface associated antigen expressed on mesothelial cells and in some malignant neoplasms. Mesothelin-targeted therapies are in phase I/II clinical trials. The clinicopathologic and prognostic significance of mesothelin expression in triple negative breast carcinomas (TNBC) has not been fully assessed. We evaluated the expression of mesothelin and of basal markers in tissue microarrays of 226 TNBC and 88 non-TNBC and assessed the clinicopathologic features of mesothelin-expressing breast carcinomas. Furthermore, we investigated the impact of mesothelin expression on the disease-free and overall survival of patients with TNBC. We found that mesothelin expression is significantly more frequent in TNBC than in non-TNBC (36% vs 16%, respectively; p=0.0006), and is significantly correlated with immunoreactivity for basal keratins, but not for EGFR. Mesothelin-positive and mesothelin-negative TNBC were not significantly different by patients' race, tumor size, histologic grade, tumor subtype, lymphovascular invasion and lymph node metastases. Patients with mesothelin-positive TNBC were older than patients with mesothelin-negative TNBC, developed more distant metastases with a shorter interval, and had significantly lower overall and disease-free survival. Based on our results, patients with mesothelin-positive TNBC could benefit from mesothelin-targeted therapies.	[Tozbikian, Gary; Brogi, Edi; Catalano, Jeffrey; Akram, Muzaffar; Reis-Filho, Jorge S.; Weigelt, Britta; Wen, Hannah Yong] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Kadota, Kyuichi; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Patil, Sujata] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Ho, Alice Y.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wen, HY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	weny@mskcc.org	Kadota, Kyuichi/AAY-2676-2021	Kadota, Kyuichi/0000-0002-6835-453X; Norton, Larry/0000-0003-3701-9250; Tozbikian, Gary/0000-0002-5941-5652	Department of Defense (DOC) Breast Cancer Research Program [BC132124]	Department of Defense (DOC) Breast Cancer Research Program(United States Department of Defense)	This work was supported by the Department of Defense (DOC) Breast Cancer Research Program (BC132124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Einama T, 2012, BRIT J CANCER, V107, P137, DOI 10.1038/bjc.2012.235; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Fan D, 2002, MOL CANCER THER, V1, P595; Frierson HF, 2003, HUM PATHOL, V34, P605, DOI 10.1016/S0046-8177(03)00177-1; Glass JP, 2011, INT J SURG PATHOL, V19, P588, DOI 10.1177/1066896911409575; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Kachala SS, 2014, CLIN CANCER RES, V20, P1020, DOI 10.1158/1078-0432.CCR-13-1862; Kawamata F, 2012, INT J ONCOL, V41, P2109, DOI 10.3892/ijo.2012.1662; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Parinyanitikul N, 2013, CLIN BREAST CANCER, V13, P378, DOI 10.1016/j.clbc.2013.05.001; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Rizk NP, 2012, CANCER EPIDEM BIOMAR, V21, P482, DOI 10.1158/1055-9965.EPI-11-0993; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Servais EL, 2012, CLIN CANCER RES, V18, P2478, DOI 10.1158/1078-0432.CCR-11-2614; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swierczynski SL, 2004, HUM PATHOL, V35, P357, DOI 10.1016/j.humpath.2003.10.012; Tchou J, 2012, BREAST CANCER RES TR, V133, P799, DOI 10.1007/s10549-012-2018-4; Thike AA, 2010, AM J SURG PATHOL, V34, P956, DOI 10.1097/PAS.0b013e3181e02f45; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yen MJ, 2006, CLIN CANCER RES, V12, P827, DOI 10.1158/1078-0432.CCR-05-1397	55	60	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114900	10.1371/journal.pone.0114900	http://dx.doi.org/10.1371/journal.pone.0114900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506917	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100030
J	Gokyu, M; Kobayashi, H; Nanbara, H; Sudo, T; Ikeda, Y; Suda, T; Izumi, Y				Gokyu, Misa; Kobayashi, Hiroaki; Nanbara, Hiromi; Sudo, Takeaki; Ikeda, Yuichi; Suda, Tomonari; Izumi, Yuichi			Thrombospondin-1 Production Is Enhanced by Porphyromonas gingivalis Lipopolysaccharide in THP-1 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INFLAMMATORY T-CELLS; VIRULENCE FACTORS; HUMAN MONOCYTES; GROWTH-FACTOR; IN-VIVO; PERIODONTITIS; DEFICIENCY; ACTIVATION; EXPRESSION	Periodontitis is a chronic inflammatory disease caused by gram-negative anaerobic bacteria. Monocytes and macrophages stimulated by periodontopathic bacteria induce inflammatory mediators that cause tooth-supporting structure destruction and alveolar bone resorption. In this study, using a DNA microarray, we identified the enhanced gene expression of thrombospondin-1 (TSP-1) in human monocytic cells stimulated by Porphyromonas gingivalis lipopolysaccharide (LPS). TSP-1 is a multifunctional extracellular matrix protein that is upregulated during the inflammatory process. Recent studies have suggested that TSP-1 is associated with rheumatoid arthritis, diabetes mellitus, and osteoclastogenesis. TSP-1 is secreted from neutrophils, monocytes, and macrophages, which mediate immune responses at inflammatory regions. However, TSP-1 expression in periodontitis and the mechanisms underlying TSP-1 expression in human monocytic cells remain unknown. Here using real-time RT-PCR, we demonstrated that TSP-1 mRNA expression level was significantly upregulated in inflamed periodontitis gingival tissues and in P. gingivalis LPS-stimulated human monocytic cell line THP-1 cells. TSP-1 was expressed via Toll-like receptor (TLR) 2 and TLR4 pathways. In P. gingivalis LPS stimulation, TSP-1 expression was dependent upon TLR2 through the activation of NF-kappa B signaling. Furthermore, IL-17F synergistically enhanced P. gingivalis LPS-induced TSP-1 production. These results suggest that modulation of TSP-1 expression by P. gingivalis plays an important role in the progression and chronicity of periodontitis. It may also contribute a new target molecule for periodontal therapy.	[Gokyu, Misa; Kobayashi, Hiroaki; Nanbara, Hiromi; Sudo, Takeaki; Ikeda, Yuichi; Suda, Tomonari; Izumi, Yuichi] Tokyo Med & Dent Univ, Biomatrix Dept, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Kobayashi, H (corresponding author), Tokyo Med & Dent Univ, Biomatrix Dept, Grad Sch Med & Dent Sci, Tokyo, Japan.	h-kobayashi.peri@tmd.ac.jp	Sudo, Takeaki/AAH-9035-2019; Ikeda, Yuichi/AAA-3536-2020	Gokyu, Misa/0000-0003-1482-9218; Ikeda, Yuichi/0000-0001-7557-658X	JSPS KAKENHI [25463213, 25293424, 26861805]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25463213, 25293424, 26861805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Costalonga M, 2009, J PERIODONTAL RES, V44, P537, DOI 10.1111/j.1600-0765.2008.01152.x; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Fordham JB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00512; Gorska R, 2003, J CLIN PERIODONTOL, V30, P1046, DOI 10.1046/j.0303-6979.2003.00425.x; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P1780, DOI 10.1002/art.1780401009; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; JAFFE EA, 1985, BLOOD, V65, P79; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jandik KA, 2008, J PERIODONTAL RES, V43, P524, DOI 10.1111/j.1600-0765.2007.01064.x; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Kukreja A, 2009, BLOOD, V114, P3413, DOI 10.1182/blood-2009-03-211920; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026656; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Manns JM, 2006, ARTHRITIS RHEUM, V54, P2415, DOI 10.1002/art.22021; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Mize TW, 2014, J PERIODONT IN PRESS; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rico MC, 2008, TRANSL RES, V152, P95, DOI 10.1016/j.trsl.2008.06.002; Salajegheh M, 2007, J NEUROIMMUNOL, V187, P166, DOI 10.1016/j.jneuroim.2007.04.022; Shaker OG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/174764; SHAPIRA L, 1994, ORAL MICROBIOL IMMUN, V9, P112, DOI 10.1111/j.1399-302X.1994.tb00044.x; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Vallejo AN, 2000, J IMMUNOL, V164, P2947, DOI 10.4049/jimmunol.164.6.2947; Vallejo AN, 2003, J IMMUNOL, V171, P1732, DOI 10.4049/jimmunol.171.4.1732; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Yang KY, 2009, J AUTOIMMUN, V32, P94, DOI 10.1016/j.jaut.2008.12.004; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006	45	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115107	10.1371/journal.pone.0115107	http://dx.doi.org/10.1371/journal.pone.0115107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501558	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400073
J	Radwan, ZH; Wang, XB; Waqar, F; Pirim, D; Niemsiri, V; Hokanson, JE; Hamman, RF; Bunker, CH; Barmada, MM; Demirci, FY; Kamboh, MI				Radwan, Zaheda H.; Wang, Xingbin; Waqar, Fahad; Pirim, Dilek; Niemsiri, Vipavee; Hokanson, John E.; Hamman, Richard F.; Bunker, Clareann H.; Barmada, M. Michael; Demirci, F. Yesim; Kamboh, M. Ilyas			Comprehensive Evaluation of the Association of APOE Genetic Variation with Plasma Lipoprotein Traits in US Whites and African Blacks	PLOS ONE			English	Article							HUMAN APOLIPOPROTEIN-E; SAN-LUIS-VALLEY; CHOLESTEROL TRANSPORT; E POLYMORPHISM; A-I; POPULATION; DISEASE; RISK; PROFILES; VARIANTS	Although common APOE genetic variation has a major influence on plasma LDL-cholesterol, its role in affecting HDL-cholesterol and triglycerides is not well established. Recent genome-wide association studies suggest that APOE also affects plasma variation in HDL-cholesterol and triglycerides. It is thus important to resequence the APOE gene to identify both common and uncommon variants that affect plasma lipid profile. Here, we have sequenced the APOE gene in 190 subjects with extreme HDL-cholesterol levels selected from two well-defined epidemiological samples of U.S. non-Hispanic Whites (NHWs) and African Blacks followed by genotyping of identified variants in the entire datasets (623 NHWs, 788 African Blacks) and association analyses with major lipid traits. We identified a total of 40 sequence variants, of which 10 are novel. A total of 32 variants, including common tagSNPs (>= 5% frequency) and all uncommon variants (<5% frequency) were successfully genotyped and considered for genotype-phenotype associations. Other than the established associations of APOE*2 and APOE*4 with LDL-cholesterol, we have identified additional independent associations with LDL-cholesterol. We have also identified multiple associations of uncommon and common APOE variants with HDL-cholesterol and triglycerides. Our comprehensive sequencing and genotype-phenotype analyses indicate that APOE genetic variation impacts HDL-cholesterol and triglycerides in addition to affecting LDL-cholesterol.	[Radwan, Zaheda H.; Wang, Xingbin; Waqar, Fahad; Pirim, Dilek; Niemsiri, Vipavee; Barmada, M. Michael; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	kamboh@pitt.edu	PIRIM, DILEK/ABA-4957-2020	PIRIM, DILEK/0000-0002-0522-9432; Demirci, F. Yesim/0000-0001-6907-9843; Kamboh, M. Ilyas/0000-0002-3453-1438; Barmada, M Michael/0000-0002-3604-6460	National Heart, Lung and Blood Institute (NHLBI) [HL084613]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084613] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanji AO, 2007, METABOLISM, V56, P484, DOI 10.1016/j.metabol.2006.11.006; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; DAS HK, 1985, J BIOL CHEM, V260, P6240; De Blasi S, 2009, EXP GERONTOL, V44, P224, DOI 10.1016/j.exger.2008.11.005; Demirci FY, 2010, ANN NUTR METAB, V56, P59, DOI 10.1159/000268019; Dumanis SB, 2013, J NEUROCHEM, V124, P4, DOI 10.1111/j.1471-4159.2012.07908.x; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; HAVEL RJ, 1983, J CLIN INVEST, V72, P379, DOI 10.1172/JCI110978; Johansen CT, 2012, CURR ATHEROSCLER REP, V14, P227, DOI 10.1007/s11883-012-0243-2; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kamboh MI, 1997, AM J EPIDEMIOL, V146, P1011, DOI 10.1093/oxfordjournals.aje.a009229; Ken-Dror G, 2010, MOL MED, V16, P389, DOI 10.2119/molmed.2010.00044; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lucatelli JF, 2011, NEUROCHEM RES, V36, P1533, DOI 10.1007/s11064-011-0481-7; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Medina-Urrutia AX, 2004, HUM BIOL, V76, P605, DOI 10.1353/hub.2004.0059; MIETTINEN TA, 1992, ARTERIOSCLER THROMB, V12, P1044, DOI 10.1161/01.ATV.12.9.1044; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nikodemova M, 2013, SLEEP, V36, P873, DOI 10.5665/sleep.2714; Ordovas JM, 2008, J PERIODONTOL, V79, P1508, DOI 10.1902/jop.2008.080232; Ozturk Z, 2010, METAB SYNDR RELAT D, V8, P531, DOI 10.1089/met.2010.0034; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Savitz J, 2006, BRAIN RES REV, V51, P125, DOI 10.1016/j.brainresrev.2005.10.006; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANDENMAAGDENBERG AMJM, 1993, AM J HUM GENET, V52, P937; Viitanen L, 2001, J MOL MED-JMM, V79, P732, DOI 10.1007/s001090100265; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	51	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114618	10.1371/journal.pone.0114618	http://dx.doi.org/10.1371/journal.pone.0114618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502880	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000346375400041
J	Tarafdar, PK; Vedantam, LV; Sankhala, RS; Purushotham, P; Podile, AR; Swamy, MJ				Tarafdar, Pradip K.; Vedantam, Lakshmi Vasudev; Sankhala, Rajeshwer S.; Purushotham, Pallinti; Podile, Appa Rao; Swamy, Musti J.			Oligomerization, Conformational Stability and Thermal Unfolding of Harpin, HrpZ(Pss) and Its Hypersensitive Response-Inducing C-Terminal Fragment, C-214-HrpZ(Pss)	PLOS ONE			English	Article							KEY FUNCTIONAL REGION; HEAT-CAPACITY CHANGE; ERWINIA-AMYLOVORA; PROTEIN; XANTHOMONAS; ELICITOR; IDENTIFICATION; AGGREGATION; EXPRESSION; MEMBRANES	HrpZ-a harpin from Pseudomonas syringae-is a highly thermostable protein that exhibits multifunctional abilities e.g., it elicits hypersensitive response (HR), enhances plant growth, acts as a virulence factor, and forms pores in plant plasma membranes as well as artificial membranes. However, the molecular mechanism of its biological activity and high thermal stability remained poorly understood. HR inducing abilities of non-overlapping short deletion mutants of harpins put further constraints on the ability to establish structure-activity relationships. We characterized HrpZ(Pss) from Pseudomonas syringae pv. syringae and its HR inducing C-terminal fragment with 214 amino acids (C-214-HrpZ(Pss)) using calorimetric, spectroscopic and microscopic approaches. Both C-214-HrpZ(Pss) and HrpZPss were found to form oligomers. We propose that leucine-zipper-like motifs may take part in the formation of oligomeric aggregates, and oligomerization could be related to HR elicitation. CD, DSC and fluorescence studies showed that the thermal unfolding of these proteins is complex and involves multiple steps. The comparable conformational stability at 25 degrees C (similar to 10.0 kcal/mol) of HrpZ(Pss) and C-214-HrpZ(Pss) further suggest that their structures are flexible, and the flexibility allows them to adopt proper conformation for multifunctional abilities.	[Tarafdar, Pradip K.; Sankhala, Rajeshwer S.; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India; [Vedantam, Lakshmi Vasudev; Purushotham, Pallinti; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Swamy, MJ (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjswamy1@gmail.com	Swamy, Musti/B-9418-2009; Podile, Appa Rao/W-5077-2018	Swamy, Musti/0000-0002-3108-3633; Pallinti, Purushotham Naidu/0000-0002-5565-1762; Podile, Appa Rao/0000-0003-3208-765X	Department of Science & Technology (India); Council of Scientific and Industrial Research (India); Indian Council of Medical Research (ICMR); University Grants Commission (India); CAS; DST (India)	Department of Science & Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grants Commission (India)(University Grants Commission, India); CAS(Chinese Academy of Sciences); DST (India)(Department of Science & Technology (India))	This work was supported by a research project from Department of Science & Technology (India) to MJS. PKT and RSS thank Council of Scientific and Industrial Research (India) for Senior Research Fellowships. LVV was supported by a Senior Research Fellowship from Indian Council of Medical Research (ICMR). The authors thank the University Grants Commission (India) for their support through the UPE (to University of Hyderabad), and CAS (to School of Chemistry and School of Life Sciences) programs, and DST (India) for the support through the FIST II program to the School of Chemistry and the Department of Plant Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 1996, MOL MICROBIOL, V19, P715, DOI 10.1046/j.1365-2958.1996.415946.x; Anil K, 2014, J PLANT PATHOL, V96, P57; [Anonymous], 2008, BMC BIOINFORMATICS; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Chen CH, 1998, PHYSIOL MOL PLANT P, V52, P139, DOI 10.1006/pmpp.1997.0120; Choi MS, 2013, MOL PLANT MICROBE IN, V26, P1115, DOI 10.1094/MPMI-02-13-0050-CR; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Koklic T, 2009, BIOPHYS J, V97, P2232, DOI 10.1016/j.bpj.2009.07.043; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P530; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lidon-Moya MC, 2005, PROTEIN SCI, V14, P2387, DOI 10.1110/ps.041324305; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Melo AM, 2013, J PHYS CHEM B, V117, P2906, DOI 10.1021/jp310396v; Mukherjee A, 1997, MOL PLANT MICROBE IN, V10, P462, DOI 10.1094/MPMI.1997.10.4.462; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Pace CN, 1999, PROTEIN SCI, V8, P1500, DOI 10.1110/ps.8.7.1500; Pike SM, 1998, PHYSIOL MOL PLANT P, V53, P39, DOI 10.1006/pmpp.1998.0167; Riechmann L, 2005, J MOL BIOL, V348, P1261, DOI 10.1016/j.jmb.2005.03.029; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; Shrestha R, 2008, MOL CELLS, V25, P30; Tarafdar PK, 2013, BIOCHIMIE, V95, P2437, DOI 10.1016/j.biochi.2013.09.006; Tarafdar PK, 2009, BBA-PROTEINS PROTEOM, V1794, P1684, DOI 10.1016/j.bbapap.2009.07.023; Wang XY, 2007, MOL BIOL REP, V34, P189, DOI 10.1007/s11033-006-9034-6; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e109871	10.1371/journal.pone.0109871	http://dx.doi.org/10.1371/journal.pone.0109871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502017	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400002
J	Bruno, G; Barutta, F; Landi, A; Perin, PC; Gruden, G				Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella			NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PROBRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; KIDNEY-DISEASE; TYPE-2; ASSOCIATION; PREDICTION; COMPLICATIONS; ALBUMINURIA; HEART	Background: Few data are available to assess whether a low-moderate reduction in estimated glomerular filtration rates (eGFR) has a role per se on cardiovascular (CV) mortality or other biomarkers such as NT-proBNP allow to explain such association. Methods and Findings: In a prospective study including 1,645 type 2 diabetic subjects of the population-based Casale Monferrato Study, who had no clinical evidence of heart failure and eGFR >45 ml/min/1.73 m(2), we examined 6 years CV mortality. Multivariate Cox proportional hazards modeling were used to estimate the effect of NT-proBNP on the association between eGFR and mortality, independently of baseline CV risk factors, albumin excretion rate (AER) and C-reactive protein (CRP). During follow-up, 327 people died (149 of CV diseases) out of 8334.5 person-years. Compared to eGFR >= 90 ml/min/1.73 m(2), values of 60-89 and 45-59 ml/min/1.73 m(2) conferred a fully adjusted hazard ratios (HRs) of CV mortality of 1.74 (1.08-2.82) and 1.95 (1.03-3.68), respectively. After further adjustment for NT-proBNP, however, HRs were no longer significant (HRs 1.42, 0.83-2.42 and 1.22, 0.59-2.51). In this model, HR for logNT-proBNP was 1.84 (1.52-2.22). Adding NT-proBNP to the model improved the C-statistic of CV mortality from 0.79 (0.76-0.83) to 0.84 (0.81-0.87), yielded an IDI of 0.03 (p = 0.02), and a NRI of 0.44 (p = 0.016). Conclusions: In diabetic people a modest reduction in renal function increased 6-year CV mortality independently of albuminuria. This association, however, was mainly explained by the effect of NT-proBNP, that remained the strongest prognostic marker for a worse CV outcome, even after adjustment for other CV risk factors and pre-existing CVD.	[Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Turin, Italy	University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it		BRUNO, Graziella/0000-0002-3011-8304				Amin AP, 2013, AM J KIDNEY DIS, V61, pS12, DOI 10.1053/j.ajkd.2013.01.005; Bruno G, 2007, DIABETOLOGIA, V50, P941, DOI 10.1007/s00125-007-0616-1; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Bruno G, 2013, DIABETES CARE, V36, P2677, DOI 10.2337/dc13-0353; Bruno G, 2009, DIABETES, V58, P926, DOI 10.2337/db08-0900; Das SR, 2008, AM J CARDIOL, V102, P1394, DOI 10.1016/j.amjcard.2008.07.018; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; Delles C, 2011, DIABETOLOGIA, V54, P4, DOI 10.1007/s00125-010-1942-2; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Echouffo-Tcheugui JB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001344; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gruden G, 2014, DIABETES CARE, V37, P2899, DOI 10.2337/dc14-0669; Gruden G, 2012, DIABETES CARE, V35, P1931, DOI 10.2337/dc12-0089; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Pagano E, 2013, DIABETOLOGIA, V56, P1726, DOI 10.1007/s00125-013-2933-x; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163	19	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114855	10.1371/journal.pone.0114855	http://dx.doi.org/10.1371/journal.pone.0114855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503636	Green Published, gold			2022-12-26	WOS:000347146700060
J	Cumming, O; Elliott, M; Overbo, A; Bartram, J				Cumming, Oliver; Elliott, Mark; Overbo, Alycia; Bartram, Jamie			Does Global Progress on Sanitation Really Lag behind Water? An Analysis of Global Progress on Community- and Household-Level Access to Safe Water and Sanitation	PLOS ONE			English	Article							REPORTED DIARRHEAL DISEASE; DRINKING-WATER; DISTANCE; HEALTH; METAANALYSIS; ASSOCIATION; POOR; HOME	Safe drinking water and sanitation are important determinants of human health and wellbeing and have recently been declared human rights by the international community. Increased access to both were included in the Millennium Development Goals under a single dedicated target for 2015. This target was reached in 2010 for water but sanitation will fall short; however, there is an important difference in the benchmarks used for assessing global access. For drinking water the benchmark is community-level access whilst for sanitation it is household-level access, so a pit latrine shared between households does not count toward the Millennium Development Goal (MDG) target. We estimated global progress for water and sanitation under two scenarios: with equivalent household-and community-level benchmarks. Our results demonstrate that the "sanitation deficit" is apparent only when household-level sanitation access is contrasted with community-level water access. When equivalent benchmarks are used for water and sanitation, the global deficit is as great for water as it is for sanitation, and sanitation progress in the MDG-period (1990-2015) outstrips that in water. As both drinking water and sanitation access yield greater benefits at the household-level than at the community-level, we conclude that any post-2015 goals should consider a household-level benchmark for both.	[Cumming, Oliver] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect Trop Dis, London WC1, England; [Elliott, Mark] Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL USA; [Elliott, Mark; Overbo, Alycia; Bartram, Jamie] Univ N Carolina, Water Inst, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of London; London School of Hygiene & Tropical Medicine; University of Alabama System; University of Alabama Tuscaloosa; University of North Carolina; University of North Carolina Chapel Hill	Cumming, O (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect Trop Dis, London WC1, England.	oliver.cumming@lshtm.ac.uk; jbartram@email.unc.edu	Elliott, Mark/N-1574-2019	Elliott, Mark/0000-0002-7835-0612; Cumming, Oliver/0000-0002-5074-8709; Bartram, Jamie/0000-0002-6542-6315; Overbo, Alycia/0000-0002-1274-1258	UK Aid from the Department of International Development (DFID), Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium	UK Aid from the Department of International Development (DFID), Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium	This research was partially funded by UK Aid from the Department of International Development (DFID) as part of the Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium (www.SHAREresearch.org). However, the views expressed do not necessarily reflect the Department's official policies. There are no additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram J, INT J ENV R IN PRESS; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Biran A, 2011, TROP MED INT HEALTH, V16, P854, DOI 10.1111/j.1365-3156.2011.02764.x; Cairncross S., 1993, ENV HLTH ENG TROPICS, V2nd; Campbell O, GETTING BASICS RIGHT; Chant S, 2013, ENVIRON URBAN, V25, P9, DOI 10.1177/0956247813477809; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; DESA U, 2011, ESPWP220 UN DEP EC S; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Heijnen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093300; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; ICFInternational, 2004, DEM HLTH SURV; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luh J, 2013, INT J HYG ENVIR HEAL, V216, P662, DOI 10.1016/j.ijheh.2012.12.007; Onda K, 2014, INT J HYG ENVIR HEAL, V217, P379, DOI 10.1016/j.ijheh.2013.07.017; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Subaiya S, 2011, AM J TROP MED HYG, V84, P504, DOI 10.4269/ajtmh.2011.10-0591a; UN, 2013, REP HIGH LEV PAN EM; UNGA, 2010, RIGHT WAT; Unicef, 2012, MULT IND CLUST SURV; UNNC, 2013, DEP UN CHIEF CALLS U; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; White G., 1972, DRAWERS WATER; WHO/UNICEF, 2012, PROGR SAN DRINK WAT; WHO/UNICEF, 2013, PROGR SAN DRINK WAT; Wolf J, 2013, J WATER HEALTH, V11, P64, DOI 10.2166/wh.2012.107; Yang H, 2013, ENVIRON SCI TECHNOL, V47, P1222, DOI 10.1021/es303345p	32	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114699	10.1371/journal.pone.0114699	http://dx.doi.org/10.1371/journal.pone.0114699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502659	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700046
J	Garcia, NS; Hutchins, DA				Garcia, Nathan S.; Hutchins, David A.			Light-Limited Growth Rate Modulates Nitrate Inhibition of Dinitrogen Fixation in the Marine Unicellular Cyanobacterium Crocosphaera watsonii	PLOS ONE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; TRICHODESMIUM ERYTHRAEUM; CULTURES; SENSITIVITY; PHOSPHORUS; AMMONIUM; RATIOS; CO2; REQUIREMENTS	Biological N-2 fixation is the dominant supply of new nitrogen (N) to the oceans, but is often inhibited in the presence of fixed N sources such as nitrate (NO3-). Anthropogenic fixed N inputs to the ocean are increasing, but their effect on marine N-2 fixation is uncertain. Thus, global estimates of new oceanic N depend on a fundamental understanding of factors that modulate N source preferences by N-2-fixing cyanobacteria. We examined the unicellular diazotroph Crocosphaera watsonii (strain WH0003) to determine how the light-limited growth rate influences the inhibitory effects of fixed N on N-2 fixation. When growth (mu) was limited by low light (mu=0.23 d(-1)), short-term experiments indicated that 0.4 mu M NH4+ reduced N-2-fixation by similar to 90% relative to controls without added NH4+. In fast-growing, high-light-acclimated cultures (mu=0.68 d(-1)), 2.0 mu M NH4+ was needed to achieve the same effect. In long-term exposures to NO3-, inhibition of N-2 fixation also varied with growth rate. In high-light-acclimated, fast-growing cultures, NO3- did not inhibit N-2-fixation rates in comparison with cultures growing on N-2 alone. Instead NO3- supported even faster growth, indicating that the cellular assimilation rate of N-2 alone (i.e. dinitrogen reduction) could not support the light-specific maximum growth rate of Crocosphaera. When growth was severely light-limited, NO3- did not support faster growth rates but instead inhibited N-2-fixation rates by 55% relative to controls. These data rest on the basic tenet that light energy is the driver of photoautotrophic growth while various nutrient substrates serve as supports. Our findings provide a novel conceptual framework to examine interactions between N source preferences and predict degrees of inhibition of N-2 fixation by fixed N sources based on the growth rate as controlled by light.	[Garcia, Nathan S.; Hutchins, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Garcia, NS (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	n8garcia@gmail.com	Hutchins, David A/D-3301-2013	Hutchins, David A/0000-0002-6637-756X	National Science Foundation (NSF) Division of Ocean Sciences (OCE) [0962309, 1260490]; Directorate For Geosciences [1260490] Funding Source: National Science Foundation	National Science Foundation (NSF) Division of Ocean Sciences (OCE)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Grant support was provided by the National Science Foundation (NSF) Division of Ocean Sciences (OCE) 0962309 and 1260490 to D. Hutchins (DAH) and F. Fu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Brauer VS, 2013, ISME J, V7, P2105, DOI 10.1038/ismej.2013.103; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; Capone DG, 2007, NATURE, V445, P159, DOI 10.1038/445159a; Capone DG, 2013, NAT GEOSCI, V6, P711, DOI 10.1038/NGEO1916; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dekaezemacker J, 2011, MAR ECOL PROG SER, V438, P33, DOI 10.3354/meps09297; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski P. G., 1983, NITROGEN MARINE ENV, P839; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; FLYNN KJ, 1990, ARCH MICROBIOL, V153, P574, DOI 10.1007/BF00245267; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia NS, 2013, LIMNOL OCEANOGR, V58, P1501, DOI 10.4319/lo.2013.58.4.1501; Garcia NS, 2013, EUR J PHYCOL, V48, P128, DOI 10.1080/09670262.2013.773383; Garcia NS, 2011, J PHYCOL, V47, P1292, DOI 10.1111/j.1529-8817.2011.01078.x; GARCIA NS, 2014, ISME, DOI DOI 10.1038/ISMEJ.2014.104; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2013, NAT GEOSCI, V6, P790, DOI [10.1038/NGEO1858, 10.1038/ngeo1858]; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Knapp AN, 2012, AQUAT MICROB ECOL, V66, P223, DOI 10.3354/ame01577; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Masuda T, 2013, LIMNOL OCEANOGR, V58, P2029, DOI 10.4319/lo.2013.58.6.2029; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; OHKI K, 1991, ARCH MICROBIOL, V156, P335, DOI 10.1007/BF00248706; RAVEN JA, 1992, NEW PHYTOL, V121, P19, DOI 10.1111/j.1469-8137.1992.tb01088.x; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Sohm JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048315; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Ward BA, 2013, LIMNOL OCEANOGR, V58, P2059, DOI 10.4319/lo.2013.58.6.2059; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	45	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114465	10.1371/journal.pone.0114465	http://dx.doi.org/10.1371/journal.pone.0114465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503244	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700027
J	Huang, YS; Bertrand, V; Bozukova, D; Pagnoulle, C; Labrugere, C; De Pauw, E; De Pauw-Gillet, MC; Durrieu, MC				Huang, Yi-Shiang; Bertrand, Virginie; Bozukova, Dimitriya; Pagnoulle, Christophe; Labrugere, Christine; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire; Durrieu, Marie-Christine			RGD Surface Functionalization of the Hydrophilic Acrylic Intraocular Lens Material to Control Posterior Capsular Opacification	PLOS ONE			English	Article							EPITHELIAL-CELL MIGRATION; POLYETHYLENE TEREPHTHALATE SURFACES; MESENCHYMAL STEM-CELL; INTRA OCULAR LENS; OPTIC EDGE; HYDROPHOBIC RECOVERY; IN-VITRO; ADHESION; TRANSITION; PEPTIDES	Posterior Capsular Opacification (PCO) is the capsule fibrosis developed on implanted IntraOcular Lens (IOL) by the de-differentiation of Lens Epithelial Cells (LECs) undergoing Epithelial Mesenchymal Transition (EMT). Literature has shown that the incidence of PCO is multifactorial including the patient's age or disease, surgical technique, and IOL design and material. Reports comparing hydrophilic and hydrophobic acrylic IOLs have shown that the former has more severe PCO. On the other hand, we have previously demonstrated that the adhesion of LECs is favored on hydrophobic compared to hydrophilic materials. By combining these two facts and contemporary knowledge in PCO development via the EMT pathway, we propose a biomimetically inspired strategy to promote LEC adhesion without dedifferentiation to reduce the risk of PCO development. By surface grafting of a cell adhesion molecule (RGD peptide) onto the conventional hydrophilic acrylic IOL material, the surface-functionalized IOL can be used to reconstitute a capsule-LEC-IOL sandwich structure, which has been considered to prevent PCO formation in literature. Our results show that the innovative biomaterial improves LEC adhesion, while also exhibiting similar optical (light transmittance, optical bench) and mechanical (haptic compression force, IOL injection force) properties compared to the starting material. In addition, compared to the hydrophobic IOL material, our bioactive biomaterial exhibits similar abilities in LEC adhesion, morphology maintenance, and EMT biomarker expression, which is the crucial pathway to induce PCO. The in vitro assays suggest that this biomaterial has the potential to reduce the risk factor of PCO development.	[Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Chem, Liege, Belgium; [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Biomed & Preclin Sci, Mass Spectrometry Lab, Liege, Belgium; [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Mammalian Cell Culture Lab GIGA R, Liege, Belgium; [Huang, Yi-Shiang; Durrieu, Marie-Christine] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CBMN UMR5248, Pessac, France; [Bozukova, Dimitriya; Pagnoulle, Christophe] PhysIOL SA, Dept Res & Dev, Liege, Belgium; [Labrugere, Christine] Univ Bordeaux, PLACAMAT, Plateforme Aquitaine Caracterisat Mat, Pessac, France	University of Liege; University of Liege; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	De Pauw-Gillet, MC (corresponding author), Univ Liege, Dept Chem, Liege, Belgium.	marie-claire.depauw@ulg.ac.be; marie-christine.durrieu@inserm.fr	DURRIEU, Marie-Christine/I-4358-2016	DURRIEU, Marie-Christine/0000-0003-0583-9289; De Pauw, Edwin/0000-0003-3475-1315	project LINOLA from Walloon region, Belgium [1117465]; PhysIOL	project LINOLA from Walloon region, Belgium; PhysIOL	This study was financed by project LINOLA (1117465) from Walloon region, Belgium (http://recherchetechnologie.wallonie.be/). YSH and MCG received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DB and CP are employees of PhysIOL. PhysIOL provided support in the form of salaries for authors DB and CP, as well as the materials and installations for performing part of the research activities (i.e. plasma equipment, optical bench, haptic compression force measuring equipment), and had additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1; Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6; Agarwal A, 2011, PHACOEMULSIFICATION; Amoozgar B, 2013, J BIOACT COMPAT POL, V28, P637, DOI 10.1177/0883911513504855; Anderson JM, 2001, ANN REV MATER RES, V31, P30; Bartouilh de Taillac L, 2004, COMPOS SCI TECHNOL, V64, P827, DOI 10.1016/j.compscitech.2003.09.011; Behar-Cohen F., 2001, J FR OPHTALMOL, V24, P9; Bertrand V, 2014, J CATARACT REFR SURG, V40, P1536, DOI 10.1016/j.jcrs.2014.01.035; Bhattacharya SD, 2012, SURGERY, V152, P449, DOI 10.1016/j.surg.2012.06.011; Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037; Bozukova D, 2013, J CATARACT REFR SURG, V39, P1404, DOI 10.1016/j.jcrs.2013.01.050; Bozukova D, 2010, MAT SCI ENG R, V69, P63, DOI 10.1016/j.mser.2010.05.002; Briggs D., 1999, SURFACE ANAL POLYM X; Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI 10.1089/ten.TEA.2010.0199; Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30; Celine Chollet SL, 2006, J LASER MICRO NANOEN, V1, P5; Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045; Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149; Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012; Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Daniele Tognetto LT, 2002, J CATARACT REFR SURG, V28, P8; Das RK ZO, 2013, ACS NANO, V7, P11; De Giglio E, 2011, J BIOACT COMPAT POL, V26, P420, DOI 10.1177/0883911511410460; Dick HB, 2000, OPHTHALMOLOGY, V107, P241, DOI 10.1016/S0161-6420(99)00082-2; Dimitriya Bozukova CP, 2007, BIOMACROMOLECULES, V8, P9; Eisele G, 2014, J NEURO-ONCOL, V117, P141, DOI 10.1007/s11060-014-1365-x; Fine IH, 2007, J CATARACT REFR SURG, V33, P94, DOI 10.1016/j.jcrs.2006.09.016; Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; Gonzalez-Chomon C, 2011, MATERIALS, V4, P1927, DOI 10.3390/ma4111927; Guelcher S. A., 2005, INTRO BIOMATERIALS; Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024; Heatley CJ, 2005, J CATARACT REFR SURG, V31, P718, DOI 10.1016/j.jcrs.2004.08.060; Hongling Liu GF, 2010, IN VITRO STUDY, V16, P8; Huang X, 2013, J OCUL PHARMACOL TH, V29, P208, DOI 10.1089/jop.2012.0184; Hyeon II Lee MKK, 2007, J KOREAN MED SCI, V22, P6; James F., 2002, J CATARACT REFR SURG, V28, P7; Juila M, 1999, EYE, V13, P5; Kanokpanont S, 2013, INT J BIOL MACROMOL, V55, P88, DOI 10.1016/j.ijbiomac.2013.01.003; Katayama Y KS, 2007, OPHTHALMIC RES, P6; Kavoussi SC, 2011, J CATARACT REFR SURG, V37, P2194, DOI 10.1016/j.jcrs.2011.05.049; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817; Kohnen T, 2008, OPHTHALMOLOGY, V115, P1308, DOI 10.1016/j.ophtha.2008.01.002; Latz C, 2000, GRAEF ARCH CLIN EXP, V238, P696, DOI 10.1007/s004170000153; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Legeais JM, 2001, J FR OPHTALMOL, V24, P309; Lei Y ZO, 2013, SMALL, V9, P10; Lei YF, 2012, J MATER SCI-MATER M, V23, P2761, DOI 10.1007/s10856-012-4736-x; Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163; Liliana Werner J-ML, 1999, J BIOMED MATER RES, V46, P8; Lim H, 2001, J VAC SCI TECHNOL A, V19, P1490, DOI 10.1116/1.1382650; Lingli Li LL, 2011, J CONTROL RELEASE, V152, P2; Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0; Linnola RJ, 1997, J CATARACT REFR SURG, V23, P4; Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P12; Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P15; Liu HL, 2009, GRAEF ARCH CLIN EXP, V247, P801, DOI 10.1007/s00417-008-1007-0; Luensmann D, 2009, J CATARACT REFR SURG, V35, P2000, DOI 10.1016/j.jcrs.2009.05.052; Manju S, 2010, PHARM DEV TECHNOL, V15, P379, DOI 10.3109/10837450903262025; Matsushima H, 2006, J CATARACT REFR SURG, V32, P1035, DOI 10.1016/j.jcrs.2006.02.042; Morarescu D, 2010, BIOMATERIALS, V31, P2399, DOI 10.1016/j.biomaterials.2009.11.108; Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6; Nagamoto T, 2009, ARCH OPHTHALMOL-CHIC, V127, P471, DOI 10.1001/archophthalmol.2009.63; Niranjan Awasthi SG, 2009, ARCH OPHTHALMOL-CHIC, V127, P8; Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0; Nishi O, 2012, J CATARACT REFR SURG, V38, P924, DOI 10.1016/j.jcrs.2012.03.005; Nixon DR, 2006, AM J OPHTHALMOL, V142, P557, DOI 10.1016/j.ajo.2006.05.049; Pagnoulle C, 2012, J CATARACT REFR SURG, V38, P1271, DOI 10.1016/j.jcrs.2012.02.041; Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5; Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037; Porte-Durrieu MC LC, 1999, J BIOMED MATER RES, V46, P8; Poulin S, 2006, APPL SURF SCI, V252, P6738, DOI 10.1016/j.apsusc.2006.02.233; POWER W, 1993, DOC OPHTHALMOL, V84, P351, DOI 10.1007/BF01215449; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Puleo DA, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1; Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/fon.11.8, 10.2217/FON.11.8]; Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o; Ruoslahti E PM, 1987, SCIENCE, V238, P7; Ryu JJ, 2013, INT J ORAL MAX IMPL, V28, P963, DOI 10.11607/jomi.2421; Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004; Sheardown H, 2003, CELLS PROTEINS MAT F; Spalton D, 2012, BRIT J OPHTHALMOLOGY, V2012; Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261; Sun CB, 2014, COLLOID SURFACE B, V113, P33, DOI 10.1016/j.colsurfb.2013.08.024; Susanne Krag TTA, 2003, INVEST OPHTH VIS SCI, V44, P6; Tatsuo Arita L-RL, 1990, INVESTIGATIVE OPHTHA, V31; Tognetto D, 2003, OPHTHALMOLOGY, V110, P1935, DOI 10.1016/S0161-6420(03)00736-X; Wadajkar AS, 2014, ISRN DENT, V2014, P4; Wang GQ, 2012, INT J OPHTHALMOL-CHI, V5, P84, DOI 10.3980/j.issn.2222-3959.2012.01.17; Wang GQ, 2010, INT J OPHTHALMOL-CHI, V3, P141, DOI 10.3980/j.issn.2222-3959.2010.02.11; Werner JP, 1999, J FR OPHTALMOL, V22, P492; Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132; Werner L, 2010, J CATARACT REFR SURG, V36, P1398, DOI 10.1016/j.jcrs.2010.06.003; Werner LP, 1998, J FR OPHTALMOL, V21, P515; Wright A, 2005, CUTAN OCUL TOXICOL, V24, P53, DOI 10.1081/CUS-200046191; Xu ZX, 2011, BIOPOLYMERS, V95, P682, DOI 10.1002/bip.21635; Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398; Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zouani OF LY, 2013, SMALL, V9, P6; Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986; Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042; Zuk A, 1994, DEV DYNAM, V201, P16	108	15	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114973	10.1371/journal.pone.0114973	http://dx.doi.org/10.1371/journal.pone.0114973			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501012	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700079
J	Morgan, MM; Reid, RA; Saville, KA				Morgan, Michael M.; Reid, Rachel A.; Saville, Kimber A.			Functionally Selective Signaling for Morphine and Fentanyl Antinociception and Tolerance Mediated by the Rat Periaqueductal Gray	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; N-TERMINAL KINASE; DESENSITIZATION; AGONIST; PROTEIN; PHOSPHORYLATION; MICROINJECTION; ACTIVATION; DEPENDENCE; EFFICACY	Functionally selective signaling appears to contribute to the variability in mechanisms that underlie tolerance to the antinociceptive effects of opioids. The present study tested this hypothesis by examining the contribution of G protein-coupled receptor kinase (GRK)/Protein kinase C (PKC) and C-Jun N-terminal kinase (JNK) activation on both the expression and development of tolerance to morphine and fentanyl microinjected into the ventrolateral periaqueductal gray of the rat. Microinjection of morphine or fentanyl into the periaqueductal gray produced a dose-dependent increase in hot plate latency. Microinjection of the nonspecific GRK/PKC inhibitor Ro 32-0432 into the periaqueductal gray to block muopioid receptor phosphorylation enhanced the antinociceptive effect of morphine but had no effect on fentanyl antinociception. Microinjection of the JNK inhibitor SP600125 had no effect on morphine or fentanyl antinociception, but blocked the expression of tolerance to repeated morphine microinjections. In contrast, a microinjection of Ro 32-0432 blocked the expression of fentanyl, but not morphine tolerance. Repeated microinjections of Ro 32-0432 blocked the development of morphine tolerance and inhibited fentanyl antinociception whether rats were tolerant or not. Repeated microinjections of SP600125 into the periaqueductal gray blocked the development of tolerance to both morphine and fentanyl microinjections. These data demonstrate that the signaling molecules that contribute to tolerance vary depending on the opioid and methodology used to assess tolerance (expression vs. development of tolerance). This signaling difference is especially clear for the expression of tolerance in which JNK contributes to morphine tolerance and GRK/PKC contributes to fentanyl tolerance.	[Morgan, Michael M.; Reid, Rachel A.; Saville, Kimber A.] Washington State Univ, Dept Psychol, Vancouver, WA 98686 USA	Washington State University	Morgan, MM (corresponding author), Washington State Univ, Dept Psychol, Vancouver, WA 98686 USA.	mmmorgan@vancouver.wsu.edu			National Institute on Drug Abuse [DA015498]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015498] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse (http://www.drugabuse.gov/) grant # DA015498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bobeck EN, 2012, J PAIN, V13, P799, DOI 10.1016/j.jpain.2012.05.005; Bobeck EN, 2009, PAIN, V147, P210, DOI 10.1016/j.pain.2009.09.008; BODNAR RJ, 1990, BRAIN RES, V529, P324, DOI 10.1016/0006-8993(90)90845-3; Buntin-Mushock C, 2005, ANESTH ANALG, V100, P1740, DOI 10.1213/01.ANE.0000152191.29311.9B; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; do K Kim, 2011, J NEUROCHEM, V116, P1077; Doll C, 2012, BRIT J PHARMACOL, V167, P1259, DOI 10.1111/j.1476-5381.2012.02080.x; Eidson LN, 2013, J NEUROSCI, V33, P15952, DOI 10.1523/JNEUROSCI.1609-13.2013; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Fan XL, 2003, NEUROSCIENCE, V122, P997, DOI 10.1016/j.neuroscience.2003.08.062; Fossum EN, 2008, BRAIN RES, V1204, P53, DOI 10.1016/j.brainres.2008.02.022; Gunn A, 2011, J PAIN, V12, P222, DOI 10.1016/j.jpain.2010.06.011; Hull LC, 2010, J PHARMACOL EXP THER, V332, P1127, DOI 10.1124/jpet.109.161455; JACQUET YF, 1974, SCIENCE, V185, P1055, DOI 10.1126/science.185.4156.1055; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Lamberts JT, 2013, J NEUROSCI, V33, P4369, DOI 10.1523/JNEUROSCI.5470-12.2013; Lane DA, 2005, BRAIN RES, V1047, P65, DOI 10.1016/j.brainres.2005.04.001; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Morgan MM, 2006, PHARMACOL BIOCHEM BE, V85, P214, DOI 10.1016/j.pbb.2006.08.003; Morgan MM, 2009, BRAIN RES, V1295, P59, DOI 10.1016/j.brainres.2009.07.100; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rivero G, 2012, MOL PHARMACOL, V82, P178, DOI 10.1124/mol.112.078659; Smith FL, 2002, BRAIN RES, V958, P28, DOI 10.1016/S0006-8993(02)03394-2; Smith FL, 2006, PHARMACOL RES, V54, P474, DOI 10.1016/j.phrs.2006.09.007; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tortorici V, 1999, BEHAV NEUROSCI, V113, P833, DOI 10.1037/0735-7044.113.4.833; TRUJILLO KA, 1995, NEUROPSYCHOPHARMACOL, V13, P301, DOI 10.1038/sj.npp.1380296; Wagley Y, 2013, BBA-MOL CELL RES, V1833, P1476, DOI 10.1016/j.bbamcr.2013.02.017; Zhang L, 1996, J BIOL CHEM, V271, P11449, DOI 10.1074/jbc.271.19.11449	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114269	10.1371/journal.pone.0114269	http://dx.doi.org/10.1371/journal.pone.0114269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503060	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700019
J	Patton, DF; Katsuyama, AM; Pavlovski, I; Michalik, M; Patterson, Z; Parfyonov, M; Smit, AN; Marchant, EG; Chung, J; Abizaid, A; Storch, KF; de la Iglesia, H; Mistlberger, RE				Patton, Danica F.; Katsuyama, Angela M.; Pavlovski, Ilya; Michalik, Mateusz; Patterson, Zachary; Parfyonov, Maksim; Smit, Andrea N.; Marchant, Elliott G.; Chung, John; Abizaid, Alfonso; Storch, Kai-Florian; de la Iglesia, Horacio; Mistlberger, Ralph E.			Circadian Mechanisms of Food Anticipatory Rhythms in Rats Fed Once or Twice Daily: Clock Gene and Endocrine Correlates	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; SUPRACHIASMATIC NUCLEUS; BRAIN-AREAS; PHASE-SHIFT; 2 MEALS; EXPRESSION; OSCILLATORS; ENTRAINMENT; TEMPERATURE; GHRELIN	Circadian clocks in many brain regions and peripheral tissues are entrained by the daily rhythm of food intake. Clocks in one or more of these locations generate a daily rhythm of locomotor activity that anticipates a regular mealtime. Rats and mice can also anticipate two daily meals. Whether this involves 1 or 2 circadian clocks is unknown. To gain insight into how the circadian system adjusts to 2 daily mealtimes, male rats in a 12:12 light-dark cycle were fed a 2 h meal either 4 h after lights-on or 4 h after lights-off, or a 1 h meal at both times. After 30 days, brain, blood, adrenal and stomach tissue were collected at 6 time points. Multiple clock genes from adrenals and stomachs were assayed by RT-PCR. Blood was assayed for corticosterone and ghrelin. Bmal1 expression was quantified in 14 brain regions by in situ hybridization. Clock gene rhythms in adrenal and stomach from day-fed rats oscillated in antiphase with the rhythms in night-fed rats, and at an intermediate phase in rats fed twice daily. Corticosterone and ghrelin in 1-meal rats peaked at or prior to the expected mealtime. In 2-meal rats, corticosterone peaked only prior the nighttime meal, while ghrelin peaked prior to the daytime meal and then remained elevated. The olfactory bulb, nucleus accumbens, dorsal striatum, cerebellum and arcuate nucleus exhibited significant daily rhythms of Bmal1 in the night-fed groups that were approximately in antiphase in the day-fed groups, and at intermediate levels (arrhythmic) in rats anticipating 2 daily meals. The dissociations between anticipatory activity and the peripheral clocks and hormones in rats anticipating 2 daily meals argue against a role for these signals in the timing of behavioral rhythms. The absence of rhythmicity at the tissue level in brain regions from rats anticipating 2 daily meals support behavioral evidence that circadian clock cells in these tissues may reorganize into two populations coupled to different meals.	[Patton, Danica F.; Pavlovski, Ilya; Michalik, Mateusz; Parfyonov, Maksim; Smit, Andrea N.; Marchant, Elliott G.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Katsuyama, Angela M.; Chung, John; de la Iglesia, Horacio] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Patterson, Zachary; Abizaid, Alfonso] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [Storch, Kai-Florian] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Simon Fraser University; University of Washington; University of Washington Seattle; Carleton University; McGill University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Parfyonov, Maksim/AAP-7478-2020	Parfyonov, Maksim/0000-0003-0582-0852	NSERC Postgraduate Scholarship; NSERC Undergraduate Summer Research Awards; NSERC Canada [RGPIN341538, RGPIN155172]; NSF [IOS1145796]	NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Summer Research Awards; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF))	DFP was supported by an NSERC Postgraduate Scholarship (http://www.nserc.gc.ca). MM and MP were supported by NSERC Undergraduate Summer Research Awards (http://www.nserc.gc.ca). AA was supported by NSERC Canada operating grant RGPIN341538 (http://www.nserc.gc.ca). HI was supported by NSF IOS1145796 (www.nsf.gov). REM was supported by NSERC Canada operating grant RGPIN155172 (http://www.nserc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Antle MC, 2000, J NEUROSCI, V20, P9326; Barclay JL, 2012, PROG BRAIN RES, V199, P163, DOI 10.1016/B978-0-444-59427-3.00030-7; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; BOLLES RC, 1973, J COMP PHYSIOL PSYCH, V83, P510, DOI 10.1037/h0034666; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Dailey MJ, 2012, ENDOCRINOLOGY, V153, P132, DOI 10.1210/en.2011-1464; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dattolo T, 2014, SOC RES BIOL RHYTHMS, V14, P219; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; de la Iglesia Horacio O, 2007, Methods Mol Biol, V362, P513; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gallardo CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095990; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Hirao A, 2010, AM J PHYSIOL-GASTR L, V299, pG1045, DOI 10.1152/ajpgi.00330.2010; HONMA KI, 1984, AM J PHYSIOL, V246, pR721, DOI 10.1152/ajpregu.1984.246.5.R721; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, ESSAYS BIOCHEM, V49, P119, DOI [10.1042/BSE0490119, 10.1042/bse0490119]; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mordel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058457; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Natsubori A, 2013, EUR J NEUROSCI, V37, P251, DOI 10.1111/ejn.12034; Nolasco N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047779; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Pendergast JS, 2012, P NATL ACAD SCI USA, V109, P14218, DOI 10.1073/pnas.1206213109; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Reddy AB, 2014, ANNU REV BIOCHEM, V83, P165, DOI 10.1146/annurev-biochem-060713-035623; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Webb IC, 2014, BEHAV NEUROSCI, V128, P304, DOI 10.1037/a0035885; Zizzari P, 2011, J NEUROENDOCRINOL, V23, P804, DOI 10.1111/j.1365-2826.2011.02183.x	79	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e112451	10.1371/journal.pone.0112451	http://dx.doi.org/10.1371/journal.pone.0112451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502949	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700005
J	Velada, I; Ragonezi, C; Arnholdt-Schmitt, B; Cardoso, H				Velada, Isabel; Ragonezi, Carla; Arnholdt-Schmitt, Birgit; Cardoso, Helia			Reference Genes Selection and Normalization of Oxidative Stress Responsive Genes upon Different Temperature Stress Conditions in Hypericum perforatum L.	PLOS ONE			English	Article							REAL-TIME PCR; ALTERNATIVE OXIDASE GENE; ST-JOHNS-WORT; RT-PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; HEAT-STRESS; ARABIDOPSIS-THALIANA; ANTIOXIDANT ENZYMES; SALICYLIC-ACID	Reverse transcription-quantitative real-time PCR (RT-qPCR) is a widely used technique for gene expression analysis. The reliability of this method depends largely on the suitable selection of stable reference genes for accurate data normalization. Hypericum perforatum L. (St. John's wort) is a field growing plant that is frequently exposed to a variety of adverse environmental stresses that can negatively affect its productivity. This widely known medicinal plant with broad pharmacological properties (anti-depressant, anti-tumor, anti-inflammatory, antiviral, antioxidant, anti-cancer, and antibacterial) has been overlooked with respect to the identification of reference genes suitable for RT-qPCR data normalization. In this study, 11 candidate reference genes were analyzed in H. perforatum plants subjected to cold and heat stresses. The expression stability of these genes was assessed using GeNorm, NormFinder and BestKeeper algorithms. The results revealed that the ranking of stability among the three algorithms showed only minor differences within each treatment. The best-ranked reference genes differed between cold- and heat-treated samples; nevertheless, TUB was the most stable gene in both experimental conditions. GSA and GAPDH were found to be reliable reference genes in cold-treated samples, while GAPDH showed low expression stability in heat-treated samples. 26SrRNA and H2A had the highest stabilities in the heat assay, whereas H2A was less stable in the cold assay. Finally, AOX1, AOX2, CAT1 and CHS genes, associated with plant stress responses and oxidative stress, were used as target genes to validate the reliability of identified reference genes. These target genes showed differential expression profiles over time in treated samples. This study not only is the first systematic analysis for the selection of suitable reference genes for RT-qPCR studies in H. perforatum subjected to temperature stress conditions, but may also provide valuable information about the roles of genes associated with temperature stress responses.	[Velada, Isabel; Ragonezi, Carla; Arnholdt-Schmitt, Birgit; Cardoso, Helia] Univ Evora, IIFA, ICAAM, EU Marie Curie Chair, P-7006554 Evora, Portugal	University of Evora	Cardoso, H (corresponding author), Univ Evora, IIFA, ICAAM, EU Marie Curie Chair, Ap 94, P-7006554 Evora, Portugal.	hcardoso@uevora.pt	Cardoso, Hélia/O-7562-2018; Ragonezi, Carla/AAF-4418-2020; Velada, Isabel/M-2742-2016	Cardoso, Hélia/0000-0003-3688-607X; Ragonezi, Carla/0000-0002-1822-5473; Velada, Isabel/0000-0002-1590-3769	Portuguese Foundation for Science and Technology [PTDC/AGR-GPL/099263/2008]; program POPH Operational Program for Human Potential [C2008-UE/ICAM/06]; FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE; National Funds through FCT under the Strategic Projects [PEst-C/AGR/UI0115/2011, PEst-OE/AGR/UI0115/2014]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); program POPH Operational Program for Human Potential; FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE; National Funds through FCT under the Strategic Projects	This work was supported by the Portuguese Foundation for Science and Technology within the frame of the project PTDC/AGR-GPL/099263/2008 and the program POPH Operational Program for Human Potential (Ciencia 2007 to BA and Ciencia 2008 to HC: C2008-UE/ICAM/06). This work is funded by FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE, and National Funds through FCT under the Strategic Projects PEst-C/AGR/UI0115/2011 and PEst-OE/AGR/UI0115/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnholdt-Schmitt B, 2006, TRENDS PLANT SCI, V11, P281, DOI 10.1016/j.tplants.2006.05.001; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Borowski JM, 2014, PLANTA, P1; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Cansev A, 2011, HORTIC ENVIRON BIOTE, V52, P113, DOI 10.1007/s13580-011-0126-4; Caraci F, 2011, CURR DRUG METAB, V12, P570; Cardoso H. G., 2013, DIAGNOSTICS PLANT BR, V21, P467, DOI DOI 10.1007/978-94-007-5687-8_21; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chaitanya KV, 2002, PLANT GROWTH REGUL, V36, P175, DOI 10.1023/A:1015092628374; Chen Y, 2006, S AFR J BOT, V72, P272, DOI 10.1016/j.sajb.2005.09.004; Costa JH, 2014, MITOCHONDRION, V19, P172, DOI 10.1016/j.mito.2014.04.007; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Dechorgnat J, 2012, PLOS ONE, V7; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Demidenko N V., 2011, PLOS ONE, V6; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Everaert BR, 2011, PLOS ONE, V6; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Ferreira AO, 2009, PHYSIOL PLANTARUM, V137, P520, DOI 10.1111/j.1399-3054.2009.01291.x; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fiorani F, 2005, PLANT PHYSIOL, V139, P1795, DOI 10.1104/pp.105.070789; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Gadzovska S, 2013, PLANT CELL TISS ORG, V113, P25, DOI 10.1007/s11240-012-0248-0; Gong XW, 2014, 2014 48TH ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS (CISS); Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; He YL, 2005, CROP SCI, V45, P988, DOI 10.2135/cropsci2003.0678; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoenemann C, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-8; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jiang YW, 2001, J EXP BOT, V52, P341, DOI 10.1093/jexbot/52.355.341; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kuk YI, 2003, CROP SCI, V43, P2109, DOI 10.2135/cropsci2003.2109; Kumar R. R., 2012, International Journal of Plant Physiology and Biochemistry, V4, P83; Li CR, 2013, GENET MOL RES, V12, P5424, DOI 10.4238/2013.November.11.4; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Liu MX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084408, 10.1371/journal.pone.0108012, 10.1371/journal.pone.0102344]; Locato V, 2008, PLANT CELL ENVIRON, V31, P1606, DOI 10.1111/j.1365-3040.2008.01867.x; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo XY, 2014, SCI HORTIC-AMSTERDAM, V165, P281, DOI 10.1016/j.scienta.2013.10.030; Ma NL, 2013, INT J MOL SCI, V14, P7515, DOI 10.3390/ijms14047515; Ma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064666; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Matsumura T, 2002, PHYSIOL PLANTARUM, V116, P317, DOI 10.1034/j.1399-3054.2002.1160306.x; McClung CR, 1997, FREE RADICAL BIO MED, V23, P489, DOI 10.1016/S0891-5849(97)00109-3; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moller IM, 2001, PLANT MITOCHONDRIA O; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orendi G, 2001, PLANT SCI, V161, P301, DOI 10.1016/S0168-9452(01)00409-5; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Popov VN, 1997, FEBS LETT, V415, P87, DOI 10.1016/S0014-5793(97)01099-5; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Rivera-Vega L, 2012, PLANT MOL BIOL REP, V30, P242, DOI 10.1007/s11105-011-0340-3; Sairam RK, 2000, BIOL PLANTARUM, V43, P245, DOI 10.1023/A:1002756311146; Sato Y, 2001, J EXP BOT, V52, P145, DOI 10.1093/jexbot/52.354.145; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sirvent TM, 2003, J CHEM ECOL, V29, P2667, DOI 10.1023/B:JOEC.0000008011.77213.64; Skyba M, 2012, J PLANT PHYSIOL, V169, P955, DOI 10.1016/j.jplph.2012.02.017; Sugie A, 2006, GENES GENET SYST, V81, P349, DOI 10.1266/ggs.81.349; Umbach AL, 2002, BBA-BIOENERGETICS, V1554, P118, DOI 10.1016/S0005-2728(02)00219-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Watanabe CK, 2008, PLANT CELL ENVIRON, V31, P1190, DOI 10.1111/j.1365-3040.2008.01834.x; Xia W, 2014, BOTANY, V92, P179, DOI 10.1139/cjb-2013-0212; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zeng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097039; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	105	30	31	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115206	10.1371/journal.pone.0115206	http://dx.doi.org/10.1371/journal.pone.0115206			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503716	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700097
J	Xu, HL; Zhang, WP; Zhang, T; Li, J; Wu, X; Dong, LY				Xu, Hongle; Zhang, Wenpan; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao			Determination of Ploidy Level and Isolation of Genes Encoding Acetyl-CoA Carboxylase in Japanese Foxtail (Alopecurus japonicus)	PLOS ONE			English	Article							ACCASE-INHIBITING HERBICIDES; COENZYME-A CARBOXYLASE; NUCLEAR-DNA CONTENT; ACETOLACTATE SYNTHASE; MOLECULAR-BASIS; CARBOXYLTRANSFERASE DOMAIN; CONFER RESISTANCE; TRIBENURON-METHYL; SITE MUTATIONS; POPULATIONS	Ploidy level is important in biodiversity studies and in developing strategies for isolating important plant genes. Many herbicide-resistant weed species are polyploids, but our understanding of these polyploid weeds is limited. Japanese foxtail, a noxious agricultural grass weed, has evolved herbicide resistance. However, most studies on this weed have ignored the fact that there are multiple copies of target genes. This may complicate the study of resistance mechanisms. Japanese foxtail was found to be a tetraploid by flow cytometer and chromosome counting, two commonly used methods in the determination of ploidy levels. We found that there are two copies of the gene encoding plastidic acetyl-CoA carboxylase (ACCase) in Japanese foxtail and all the homologous genes are expressed. Additionally, no difference in ploidy levels or ACCase gene copy numbers was observed between an ACCase-inhibiting herbicide-resistant and a herbicide-sensitive population in this study.	[Xu, Hongle; Zhang, Wenpan; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Xu, Hongle; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao] Nanjing Agr Univ, Minist Agr, Key Lab Integrated Pest Management Crops East Chi, Beijing, Peoples R China; [Zhang, Wenpan] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Res Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Dong, LY (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	dly@njau.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [201303031]; Ph. D. Programs Foundation of Ministry of Education of China [20120097110038]; Natural Science Foundation for Young Scientists of Jiangsu Province [BK2012360]	Special Fund for Agro-scientific Research in the Public Interest; Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation for Young Scientists of Jiangsu Province	This research was supported by Special Fund for Agro-scientific Research in the Public Interest (201303031), Ph. D. Programs Foundation of Ministry of Education of China (20120097110038) and the Natural Science Foundation for Young Scientists of Jiangsu Province (BK2012360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Amsellem L, 2001, PLANT SYST EVOL, V228, P171, DOI 10.1007/s006060170027; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Bi YL, 2013, J PESTIC SCI, V38, P74, DOI 10.1584/jpestics.D12-075; Christoffers MJ, 2002, GENOME, V45, P1049, DOI 10.1139/G02-080; Clayton WD, GRASSBASE ONLINE WOR; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui HL, 2012, PESTIC BIOCHEM PHYS, V102, P229, DOI 10.1016/j.pestbp.2012.01.007; Cui HL, 2011, WEED SCI, V59, P376, DOI 10.1614/WS-D-10-00099.1; Cui HL, 2008, WEED SCI, V56, P775, DOI 10.1614/WS-08-058.1; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, PLANT PHYSIOL, V137, P794, DOI 10.1104/pp.104.046144; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Gherekhloo J, 2012, WEED RES, V52, P367, DOI 10.1111/j.1365-3180.2012.00919.x; Green AF, 2013, BIOL INVASIONS, V15, P2219, DOI 10.1007/s10530-013-0446-7; Hanson L, 2001, ANN BOT-LONDON, V87, P251, DOI 10.1006/anbo.2000.1325; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Iwakami S, 2012, PEST MANAG SCI, V68, P1098, DOI 10.1002/ps.3287; Jang SR, 2013, NEW PHYTOL, V197, P1110, DOI 10.1111/nph.12117; Jin T, 2011, PESTIC BIOCHEM PHYS, V100, P160, DOI 10.1016/j.pestbp.2011.03.005; Kaundun SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058012; Kaundun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039759; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; Kaundun SS, 2006, WEED RES, V46, P34, DOI 10.1111/j.1365-3180.2006.00487.x; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Lamego FP, 2009, WEED SCI, V57, P474, DOI 10.1614/WS-09-056.1; Liu WT, 2013, PESTIC BIOCHEM PHYS, V107, P50, DOI 10.1016/j.pestbp.2013.05.003; Liu WT, 2013, WEED SCI, V61, P390, DOI 10.1614/WS-D-12-00200.1; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Mohamed IA, 2012, WEED SCI, V60, P167, DOI 10.1614/WS-D-11-00111.1; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Puri A, 2007, WEED SCI, V55, P578, DOI 10.1614/WS-07-034.1; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Scarabel L, 2010, PEST MANAG SCI, V66, P337, DOI 10.1002/ps.1883; SIEBER VK, 1979, BOT J LINN SOC, V79, P343, DOI 10.1111/j.1095-8339.1979.tb01822.x; Sun JA, 2011, AGR SCI CHINA, V10, P86, DOI 10.1016/S1671-2927(11)60310-6; Tang HW, 2012, PEST MANAG SCI, V68, P1241, DOI 10.1002/ps.3285; Tang W, 2014, PESTIC BIOCHEM PHYS, V108, P16, DOI 10.1016/j.pestbp.2013.11.001; Uchino A, 2007, WEED BIOL MANAG, V7, P89, DOI 10.1111/j.1445-6664.2007.00240.x; Wang Y, 2009, HORTSCIENCE, V44, P2049, DOI 10.21273/HORTSCI.44.7.2049; Warwick SI, 2010, WEED SCI, V58, P244, DOI 10.1614/WS-D-09-00083.1; Xu HL, 2014, PEST MANAG SCI, V70, P1894, DOI 10.1002/ps.3753; Xu HL, 2013, PESTIC BIOCHEM PHYS, V107, P25, DOI 10.1016/j.pestbp.2013.04.008; Yang CH, 2007, WEED SCI, V55, P537, DOI 10.1614/WS-07-016.1; Yu Q, 2013, HEREDITY, V110, P220, DOI 10.1038/hdy.2012.69; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	56	16	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114712	10.1371/journal.pone.0114712	http://dx.doi.org/10.1371/journal.pone.0114712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503308	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700048
J	Volonte, D; Zou, HF; Bartholomew, JN; Liu, ZM; Morel, PA; Galbiati, F				Volonte, Daniela; Zou, Huafei; Bartholomew, Janine N.; Liu, Zhongmin; Morel, Penelope A.; Galbiati, Ferruccio			Oxidative Stress-induced Inhibition of Sirt1 by Caveolin-1 Promotes p53-dependent Premature Senescence and Stimulates the Secretion of Interleukin 6 (IL-6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; HUMAN FIBROBLASTS; IN-VIVO; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAFFOLDING DOMAIN; GENE-EXPRESSION; AGING PRIMATES; HUMAN-CELLS; DNA-DAMAGE	Oxidative stress can induce premature cellular senescence. Senescent cells secrete various growth factors and cytokines, such as IL-6, that can signal to the tumor microenvironment and promote cancer cell growth. Sirtuin 1 (Sirt1) is a class III histone deacetylase that regulates a variety of physiological processes, including senescence. We found that caveolin-1, a structural protein component of caveolar membranes, is a direct binding partner of Sirt1, as shown by the binding of the scaffolding domain of caveolin-1 (amino acids 82-101) to the caveolin-binding domain of Sirt1 (amino acids 310-317). Our data show that oxidative stress promotes the sequestration of Sirt1 into caveolar membranes and the interaction of Sirt1 with caveolin-1, which lead to inhibition of Sirt1 activity. Reactive oxygen species stimulation promotes acetylation of p53 and premature senescence in wild-type but not caveolin-1 null mouse embryonic fibroblasts (MEFs). Either down-regulation of Sirt1 expression or re-expression of caveolin-1 in caveolin-1 null MEFs restores reactive oxygen species-induced acetylation of p53 and premature senescence. In addition, overexpression of caveolin-1 induces stress induced premature senescence in p53 wildtype but not p53 knockout MEFs. Phosphorylation of caveolin-1 on tyrosine 14 promotes the sequestration of Sirt1 into caveolar membranes and activates p53/senescence signaling. We also identified IL-6 as a caveolin-1-specific cytokine that is secreted by senescent fibroblasts following the caveolin-1-mediated inhibition of Sirt1. The caveolin-1-mediated secretion of IL-6 by senescent fibroblasts stimulates the growth of cancer cells. Therefore, by inhibiting Sirt1, caveolin-1 links free radicals to the activation of the p53/senescence pathway and the protumorigenic properties of IL-6.	[Volonte, Daniela; Zou, Huafei; Bartholomew, Janine N.; Liu, Zhongmin; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Morel, Penelope A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020; Morel, Penelope Anne/AAI-6239-2020	Morel, Penelope Anne/0000-0002-1743-3676	NIA/National Institutes of Health [R01-AG030636]; NHLBI/National Institutes of Health [R56-HL124747]; American Heart Association [13GRNT16560012, 12SDG8800012]; University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL124747, R01HL124747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030636] Funding Source: NIH RePORTER	NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA/National Institutes of Health Grant R01-AG030636 and NHLBI/National Institutes of Health Grant R56-HL124747. This work was also supported by American Heart Association Grant 13GRNT16560012 and the University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer (to F. G.) and by American Heart Association Grant 12SDG8800012 (to D. V.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Jagannadham MV, 2002, BIOCHEM BIOPH RES CO, V298, P203, DOI 10.1016/S0006-291X(02)02426-9; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	54	73	77	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4202	4214		10.1074/jbc.M114.598268	http://dx.doi.org/10.1074/jbc.M114.598268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512378	hybrid, Green Published			2022-12-26	WOS:000349458400031
J	Goupil, E; Fillion, D; Clement, S; Luo, XY; Devost, D; Sleno, R; Petrin, D; Saragovi, HU; Thorin, E; Laporte, SA; Hebert, TE				Goupil, Eugenie; Fillion, Dany; Clement, Stephanie; Luo, Xiaoyan; Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Saragovi, H. Uri; Thorin, Eric; Laporte, Stephane A.; Hebert, Terence E.			Angiotensin II Type I and Prostaglandin F2 alpha Receptors Cooperatively Modulate Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Angiotensin II; G Protein; G Protein-coupled Receptor (GPCR); Prostaglandin; Dimerization	PROTEIN-COUPLED RECEPTORS; A GPCR DIMERS; BETA(2)-ADRENERGIC RECEPTOR; CROSS-TALK; PHARMACOLOGICAL CHARACTERIZATION; ERK1/2 ACTIVATION; OXYTOCIN RECEPTOR; OPIOID RECEPTORS; DRUG DISCOVERY; BLOOD-PRESSURE	Background: Evidence suggests that FP modulates AT1R physiological responses. Results: In heterologous and native systems, both receptors allosterically modulated each other's function. Conclusion: This is likely via the agency of an AT1R/FP heterodimer. Significance: This may have implications in hypertension management. The angiotensin II type I (AT1R) and the prostaglandin F2 (PGF2) F prostanoid (FP) receptors are both potent regulators of blood pressure. Physiological interplay between AT1R and FP has been described. Abdominal aortic ring contraction experiments revealed that PGF2-dependent activation of FP potentiated angiotensin II-induced contraction, whereas FP antagonists had the opposite effect. Similarly, PGF2-mediated vasoconstriction was symmetrically regulated by co-treatment with AT1R agonist and antagonist. The underlying canonical G(q) signaling via production of inositol phosphates mediated by each receptor was also regulated by antagonists for the other receptor. However, binding to their respective agonists, regulation of receptor-mediated MAPK activation and vascular smooth muscle cell growth were differentially or asymmetrically regulated depending on how each of the two receptors were occupied by either agonist or antagonist. Physical interactions between these receptors have never been reported, and here we show that AT1R and FP form heterodimeric complexes in both HEK 293 and vascular smooth muscle cells. These findings imply that formation of the AT1R/FP dimer creates a novel allosteric signaling unit that shows symmetrical and asymmetrical signaling behavior, depending on the outcome measured. AT1R/FP dimers may thus be important in the regulation of blood pressure.	[Goupil, Eugenie; Fillion, Dany; Clement, Stephanie; Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Saragovi, H. Uri; Laporte, Stephane A.; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 2B2, Canada; [Laporte, Stephane A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0CT, Canada; [Saragovi, H. Uri] Montreal Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Luo, Xiaoyan; Thorin, Eric] Inst Cardiol Montreal, Ctr Rech, Montreal, PQ H1T 1C8, Canada	McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Universite de Montreal; Institut de Cardiologie de Montreal	Laporte, SA (corresponding author), McGill Univ, Dept Med, 3640 Univ St,Ste W315, Montreal, PQ H3A 2B2, Canada.	stephane.laporte@mcgill.ca; terence.hebert@mcgill.ca	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021; Thorin, Eric/K-3978-2013	Laporte, Stephane/0000-0002-0633-543X; Thorin, Eric/0000-0001-5827-8935; Goupil, Eugenie/0000-0001-5554-8717	Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR) [CTP 79848]; Canadian Institutes of Health Research [MOP-36379, MOP-74603]	Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by in part Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR) CTP 79848 (to T. E. H. and S. A. L., co-investigators) and Canadian Institutes of Health Research Grants MOP-36379 (to T. E. H.) and MOP-74603 (to S. A. L.).	Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Berk BC, 1999, J AM SOC NEPHROL, V10, pS62; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Bourguet CB, 2011, J MED CHEM, V54, P6085, DOI 10.1021/jm200608k; Bouvier M, 2014, J PHYSIOL-LONDON, V592, P2439, DOI 10.1113/jphysiol.2014.272252; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DORN GW, 1992, J BIOL CHEM, V267, P24897; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Fujino H, 2000, MOL PHARMACOL, V57, P353; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Goupil E, 2013, METHOD CELL BIOL, V117, P165, DOI 10.1016/B978-0-12-408143-7.00009-8; Goupil E, 2013, BRIT J PHARMACOL, V168, P1101, DOI 10.1111/bph.12040; Goupil E, 2012, MOL ENDOCRINOL, V26, P1189, DOI 10.1210/me.2011-1245; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Griffin BW, 1998, J PHARMACOL EXP THER, V286, P411; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Lavoie C, 2003, CAN J PHYSIOL PHARM, V81, P186, DOI 10.1139/Y02-167; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; LEE PY, 1988, INVEST OPHTH VIS SCI, V29, P1474; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Makino S, 2007, SEMIN REPROD MED, V25, P60, DOI 10.1055/s-2006-956776; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Siddiquee K, 2013, BRIT J PHARMACOL, V168, P1104, DOI 10.1111/j.1476-5381.2012.02192.x; Speth RC, 2001, METH MOLEC MED, V51, P275, DOI 10.1385/1-59259-087-X:275; Thorin E, 1998, BRIT J PHARMACOL, V125, P1188, DOI 10.1038/sj.bjp.0702199; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Wrzal PK, 2012, CELL SIGNAL, V24, P342, DOI 10.1016/j.cellsig.2011.09.020; Wrzal PK, 2012, CELL SIGNAL, V24, P333, DOI 10.1016/j.cellsig.2011.09.019; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	56	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3137	3148		10.1074/jbc.M114.631119	http://dx.doi.org/10.1074/jbc.M114.631119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512374	Green Published, hybrid			2022-12-26	WOS:000349310700048
J	Perez-Canamas, M; Hernandez, C				Perez-Canamas, Miryam; Hernandez, Carmen			Key Importance of Small RNA Binding for the Activity of a Glycine-Tryptophan (GW) Motif-containing Viral Suppressor of RNA Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; Host-Pathogen Interaction; Nucleolus; Plant Virus; RNA Virus; GW; WG Motifs; Pelargonium Line Pattern Virus; Coat Protein; sRNA Binding; Viral Suppressor of RNA Silencing	SMALL INTERFERING RNA; LINE-PATTERN-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; LONG-DISTANCE MOVEMENT; NECROTIC-MOSAIC-VIRUS; CITRUS-TRISTEZA-VIRUS; DICER-LIKE PROTEINS; COAT PROTEIN; ANTIVIRAL DEFENSE; 2B PROTEIN	Background: GW/WG motif-containing viral suppressors of RNA silencing (VSRs) have been proposed to act through interaction with Argonaute (AGO) proteins. Results: The activity of a GW motif-containing VSR was found to rely on small RNA binding capability rather than on AGO interaction. Conclusion: Overlapping signals in VSRs may lead to misinterpretation of relevant molecular traits. Significance: Knowing primary target(s) of VSRs is critical for better understanding of the host-virus arms race. Viruses express viral suppressors of RNA silencing (VSRs) to counteract RNA silencing-based host defenses. Although virtually all stages of the antiviral silencing pathway can be inhibited by VSRs, small RNAs (sRNAs) and Argonaute (AGO) proteins seem to be the most frequent targets. Recently, GW/WG motifs of some VSRs have been proposed to dictate their suppressor function by mediating interaction with AGO(s). Here we have studied the VSR encoded by Pelargonium line pattern virus (family Tombusviridae). The results show that p37, the viral coat protein, blocks RNA silencing. Site-directed mutagenesis of some p37 sequence traits, including a conserved GW motif, allowed generation of suppressor-competent and -incompetent molecules and uncoupling of the VSR and particle assembly capacities. The engineered mutants were used to assess the importance of p37 functions for viral infection and the relative contribution of diverse molecular interactions to suppressor activity. Two main conclusions can be drawn: (i) the silencing suppression and encapsidation functions of p37 are both required for systemic Pelargonium line pattern virus infection, and (ii) the suppressor activity of p37 relies on the ability to bind sRNAs rather than on interaction with AGOs. The data also caution against potential misinterpretations of results due to overlap of sequence signals related to distinct protein properties. This is well illustrated by mutation of the GW motif in p37 that concurrently affects nucleolar localization, efficient interaction with AGO1, and sRNA binding capability. These concomitant effects could have been overlooked in other GW motif-containing suppressors, as we exemplify with the orthologous p38 of turnip crinkle virus.	[Perez-Canamas, Miryam; Hernandez, Carmen] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Perez-Canamas, M (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Ciudad Politecn Innovac,Ed 8E,Camino Vera S-N, E-46022 Valencia, Spain.	cahernan@ibmcp.upv.es	Hernandez, C./R-2047-2018	Hernandez, C./0000-0003-1192-6223; Perez-Canamas, Miryam/0000-0002-0767-277X	Ministerio de Economia y Competitividad (MINECO, Spain) [BFU2012-36095]	Ministerio de Economia y Competitividad (MINECO, Spain)	This work was supported by Grant BFU2012-36095 from the Ministerio de Economia y Competitividad (MINECO, Spain) ( to C. H.).	Alonso M, 2005, EUR J PLANT PATHOL, V112, P95, DOI 10.1007/s10658-005-0803-1; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cao MX, 2010, J VIROL, V84, P7793, DOI 10.1128/JVI.02643-09; Castano A, 2007, ACTA VIROL, V51, P271; Castano A, 2005, ARCH VIROL, V150, P949, DOI 10.1007/s00705-004-0464-y; Castano A, 2009, VIROLOGY, V386, P417, DOI 10.1016/j.virol.2009.01.017; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Chiba S, 2013, MOL PLANT MICROBE IN, V26, P168, DOI 10.1094/MPMI-06-12-0142-R; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Csorba T, 2010, PLANT J, V62, P463, DOI 10.1111/j.1365-313X.2010.04163.x; Cuellar WJ, 2008, J GEN VIROL, V89, P573, DOI 10.1099/vir.0.83471-0; DALMAY T, 1992, MOL PLANT MICROBE IN, V5, P379, DOI 10.1094/MPMI-5-379; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Gonzalez I, 2012, RNA, V18, P771, DOI 10.1261/rna.031260.111; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Ivars P, 2004, EUR J PLANT PATHOL, V110, P275, DOI 10.1023/B:EJPP.0000019798.87567.22; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim SH, 2007, P NATL ACAD SCI USA, V104, P11115, DOI 10.1073/pnas.0704632104; Kinard GR, 2002, ACTA HORTIC, P17, DOI 10.17660/ActaHortic.2002.568.1; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mangwende T, 2009, VIROLOGY, V384, P38, DOI 10.1016/j.virol.2008.10.034; Marques NT, 2012, EUR J PLANT PATHOL, V133, P229, DOI 10.1007/s10658-011-9877-0; Martinez-Turino S, 2009, J GEN VIROL, V90, P519, DOI 10.1099/vir.0.006098-0; Martinez-Turino S, 2011, VIROLOGY, V413, P310, DOI 10.1016/j.virol.2011.03.001; Meng CY, 2006, J GEN VIROL, V87, P451, DOI 10.1099/vir.0.81578-0; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Pickford AS, 2003, CELL MOL LIFE SCI, V60, P871, DOI 10.1007/s00018-003-2245-2; Powers JG, 2008, VIROLOGY, V381, P277, DOI 10.1016/j.virol.2008.09.004; Powers JG, 2008, MOL PLANT MICROBE IN, V21, P879, DOI 10.1094/MPMI-21-7-0879; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Reade R, 2003, VIRUS RES, V91, P171, DOI 10.1016/S0168-1702(02)00251-4; Rochon D., 2012, 9 INT COMM TAX VIR, P1111; Rubino L, 1997, J GEN VIROL, V78, P1219, DOI 10.1099/0022-1317-78-6-1219; Ruiz-Ruiz S, 2013, MOL PLANT MICROBE IN, V26, P306, DOI 10.1094/MPMI-08-12-0201-R; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Senshu H, 2009, J GEN VIROL, V90, P1014, DOI 10.1099/vir.0.008243-0; SIT TL, 1995, VIROLOGY, V206, P38, DOI 10.1016/S0042-6822(95)80017-4; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; VAEWHONGS AA, 1995, VIROLOGY, V212, P607, DOI 10.1006/viro.1995.1518; Valli A, 2008, J VIROL, V82, P974, DOI 10.1128/JVI.01664-07; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang YZ, 2004, J GEN VIROL, V85, P3135, DOI 10.1099/vir.0.80250-0; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Xu AX, 2013, MOL PLANT PATHOL, V14, P803, DOI 10.1111/mpp.12051; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	94	37	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3106	3120		10.1074/jbc.M114.593707	http://dx.doi.org/10.1074/jbc.M114.593707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505185	Green Published, hybrid			2022-12-26	WOS:000349310700046
J	Lu, ZP; Chen, Y; Aponte, AM; Battaglia, V; Gucek, M; Sack, MN				Lu, Zhongping; Chen, Yong; Aponte, Angel M.; Battaglia, Valentina; Gucek, Marjan; Sack, Michael N.			Prolonged Fasting Identifies Heat Shock Protein 10 as a Sirtuin 3 Substrate ELUCIDATING A NEW MECHANISM LINKING MITOCHONDRIAL PROTEIN ACETYLATION TO FATTY ACID OXIDATION ENZYME FOLDING AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA DEHYDROGENASE; MUSCLE INSULIN-RESISTANCE; ACID OXIDATION; SKELETAL-MUSCLE; LYSINE ACETYLATION; UREA CYCLE; DEACETYLATION; DEGRADATION; HSP60; METABOLISM	Although Sirtuin 3 (SIRT3), a mitochondrially enriched deacetylase and activator of fat oxidation, is down-regulated in response to high fat feeding, the rate of fatty acid oxidation and mitochondrial protein acetylation are invariably enhanced in this dietary milieu. These paradoxical data implicate that additional acetylation modification-dependent levels of regulation may be operational under nutrient excess conditions. Because the heat shock protein (Hsp) Hsp10-Hsp60 chaperone complex mediates folding of the fatty acid oxidation enzyme mediumchain acyl-CoA dehydrogenase, we tested whether acetylation-dependent mitochondrial protein folding contributes to this regulatory discrepancy. We demonstrate that Hsp10 is a functional SIRT3 substrate and that, in response to prolonged fasting, SIRT3 levels modulate mitochondrial protein folding. Acetyl mutagenesis of Hsp10 lysine 56 alters Hsp10-Hsp60 binding, conformation, and protein folding. Consistent with Hsp10-Hsp60 regulation of fatty acid oxidation enzyme integrity, medium-chain acyl-CoA dehydrogenase activity and fat oxidation are elevated by Hsp10 acetylation. These data identify acetyl modification of Hsp10 as a nutrient-sensing regulatory node controlling mitochondrial protein folding and metabolic function.	[Lu, Zhongping; Sack, Michael N.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Chen, Yong; Aponte, Angel M.; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Lu, Zhongping; Battaglia, Valentina] George Washington Univ, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Lu, Zhongping; Battaglia, Valentina] Vet Affairs Med Ctr, Washington, DC 20422 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lu, ZP (corresponding author), George Washington Univ, Vet Affairs Med Ctr, Washington, DC 20052 USA.	luz@gwu.edu	chen, yong/E-2432-2011	chen, yong/0000-0003-1528-3456	NHLBI/National Institutes of Health Intramural Research Program [HL006047-01]; NHLBI/National Institutes of Health K22 Award [K22HL109236]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, K22HL109236, ZICHL005903, ZIAHL006047] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI/National Institutes of Health K22 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Intramural Research Program HL006047-01 and by NHLBI/National Institutes of Health K22 Award K22HL109236.	Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Bie AS, 2011, CELL STRESS CHAPERON, V16, P633, DOI 10.1007/s12192-011-0275-5; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Corydon TJ, 2005, MOL GENET METAB, V85, P260, DOI 10.1016/j.ymgme.2005.04.003; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Sack MN, 2009, J MOL CELL CARDIOL, V46, P842, DOI 10.1016/j.yjmcc.2009.02.001; SAIJO T, 1994, J BIOL CHEM, V269, P4401; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073457; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Webster BR, 2014, BBA-MOL CELL BIOL L, V1841, P525, DOI 10.1016/j.bbalip.2014.02.001; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	44	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2466	2476		10.1074/jbc.M114.606228	http://dx.doi.org/10.1074/jbc.M114.606228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505263	Green Published, hybrid			2022-12-26	WOS:000348588000048
J	Porcari, R; Proukakis, C; Waudby, CA; Bolognesi, B; Mangione, PP; Paton, JFS; Mullin, S; Cabrita, LD; Penco, A; Relini, A; Verona, G; Vendruscolo, M; Stoppini, M; Tartaglia, GG; Camilloni, C; Christodoulou, J; Schapira, AHV; Bellotti, V				Porcari, Riccardo; Proukakis, Christos; Waudby, Christopher A.; Bolognesi, Benedetta; Mangione, P. Pattizia; Paton, Jack F. S.; Mullin, Stephen; Cabrita, Lisa D.; Penco, Amanda; Relini, Annalisa; Verona, Guglielmo; Vendruscolo, Michele; Stoppini, Monica; Gaetano Tartaglia, Gian; Camilloni, Carlo; Christodoulou, John; Schapira, Anthony H. V.; Bellotti, Vittorio			The H50Q Mutation Induces a 10-fold Decrease in the Solubility of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; SECONDARY STRUCTURE; AGGREGATION RATES; AMYLOID FIBRILS; GLOBULAR-PROTEINS; LEWY BODIES; IN-VITRO; NMR; PREDICTION	The conversion of alpha-synuclein from its intrinsically disordered monomeric state into the fibrillar cross-beta aggregates characteristically present in Lewy bodies is largely unknown. The investigation of alpha-synuclein variants causative of familial forms of Parkinson disease can provide unique insights into the conditions that promote or inhibit aggregate formation. It has been shown recently that a newly identified pathogenic mutation of alpha-synuclein, H50Q, aggregates faster than the wild-type. We investigate here its aggregation propensity by using a sequence-based prediction algorithm, NMRchemical shift analysis of secondary structure populations in the monomeric state, and determination of thermodynamic stability of the fibrils. Our data show that the H50Q mutation induces only a small increment in polyproline II structure around the site of the mutation and a slight increase in the overall aggregation propensity. We also find, however, that the H50Q mutation strongly stabilizes alpha-synuclein fibrils by 5.0 +/- 1.0 kJ mol(-1), thus increasing the supersaturation of monomeric alpha-synuclein within the cell, and strongly favors its aggregation process. We further show that wild-type alpha-synuclein can decelerate the aggregation kinetics of the H50Q variant in a dose-dependent manner when coaggregating with it. These last findings suggest that the precise balance of alpha-synuclein synthesized from the wild-type and mutant alleles may influence the natural history and heterogeneous clinical phenotype of Parkinson disease.	[Porcari, Riccardo; Mangione, P. Pattizia; Verona, Guglielmo; Bellotti, Vittorio] UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Proukakis, Christos; Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Bolognesi, Benedetta; Gaetano Tartaglia, Gian] Ctr Genom Regulat, Barcelona 08003, Spain; [Bolognesi, Benedetta; Gaetano Tartaglia, Gian] Univ Pompeu Fabra, Barcelona 08003, Spain; [Mangione, P. Pattizia; Verona, Guglielmo; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Waudby, Christopher A.; Paton, Jack F. S.; Mullin, Stephen; Cabrita, Lisa D.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Vendruscolo, Michele; Camilloni, Carlo] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, I-16146 Genoa, Italy	University of London; University College London; University of London; University College London; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Pavia; University of London; University College London; University of Cambridge; University of Genoa	Christodoulou, J (corresponding author), UCL, Dept Struct & Mol Biol, Mortimer St, London WC1E 6BT, England.	j.christodoulou@ucl.ac.uk; v.bellotti@ucl.ac.uk	Schapira, Anthony H V/A-1245-2010; Verona, Guglielmo/AAH-9802-2019; bolognesi, benedetta/J-6961-2014; proukakis, christos/ABE-3447-2020; Waudby, Christopher/AAT-1736-2021; Mullin, Stephen/V-6313-2019; Vendruscolo, Michele/F-5901-2012; Relini, Annalisa/AHC-3105-2022; Camilloni, Carlo/A-4395-2009; Tartaglia, Gian Gaetano/K-1229-2014	Schapira, Anthony H V/0000-0002-3018-3966; Verona, Guglielmo/0000-0001-8100-3876; bolognesi, benedetta/0000-0002-6632-947X; proukakis, christos/0000-0001-6423-6539; Waudby, Christopher/0000-0001-7810-3753; Mullin, Stephen/0000-0002-1936-394X; Vendruscolo, Michele/0000-0002-3616-1610; Camilloni, Carlo/0000-0002-9923-8590; Christodoulou, John/0000-0002-6710-3843; Paton, Julian/0000-0001-7410-2913; RELINI, ANNALISA/0000-0002-4040-9279; Mangione, Palma/0000-0003-0260-1400; Cabrita, Lisa/0000-0003-2963-8078; Tartaglia, Gian Gaetano/0000-0001-7524-6310	United Kingdom Medical Research Council [MR/K000187/1]; Italian Ministry of University and Research [FIRB RBFR109EOS]; Cariplo Foundation [2011-2096]; Istituto Nazionale di Biostrutture e Biosistemi; Spanish Ministry of Economy and Competitiveness [SAF2011-26211]; European Research Council; Marie Curie Action; Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; Wellcome Trust Investigator Award [097806/Z/11/Z]; University College London Amyloidosis Research Fund; University College London Wolfson Drug Discovery Unit Funds; University College London Hospital National Institute for Health Research Biomedical Research Centre; UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme; MRC [MC_U117533887, MR/K000187/1] Funding Source: UKRI; Medical Research Council [MC_U117533887, MR/K000187/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10237] Funding Source: researchfish; Parkinson&quot;s UK [G-1104] Funding Source: researchfish; The Francis Crick Institute [10029] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation(Fondazione Cariplo); Istituto Nazionale di Biostrutture e Biosistemi; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Marie Curie Action(European Commission); Wellcome Trust/MRC Joint Call in Neurodegeneration Award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); University College London Amyloidosis Research Fund; University College London Wolfson Drug Discovery Unit Funds; University College London Hospital National Institute for Health Research Biomedical Research Centre; UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); The Francis Crick Institute	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1 and Italian Ministry of University and Research Project FIRB RBFR109EOS (to V. B.); the Cariplo Foundation Project 2011-2096 (to M. S.); Istituto Nazionale di Biostrutture e Biosistemi (to V. B. and M. S.); Spanish Ministry of Economy and Competitiveness Grant SAF2011-26211 and European Research Council Starting Grant (to G. G. T.); Marie Curie Action (to B. B.); Wellcome Trust/MRC Joint Call in Neurodegeneration Award WT089698 (to A. H. V. S.); the Wellcome Trust Investigator Award (097806/Z/11/Z to J. C. and J. F. S. P. studentship); the University College London Amyloidosis Research Fund; the University College London Wolfson Drug Discovery Unit Funds and the University College London Hospital National Institute for Health Research Biomedical Research Centre. Core support for the Wolfson Drug Discovery Unit is provided by the UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Camilloni C, 2013, J PHYS CHEM B, V117, P10737, DOI 10.1021/jp405614j; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chi YC, 2014, J BIOL CHEM, V289, P15474, DOI 10.1074/jbc.M113.544049; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kobayashi H, 2003, BRAIN, V126, P32, DOI 10.1093/brain/awg010; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tartaglia GG, 2007, STRUCTURE, V15, P139, DOI 10.1016/j.str.2006.12.007; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Voutsinas GE, 2010, HUM MUTAT, V31, P685, DOI 10.1002/humu.21248; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waudby CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072286; Waudby CA, 2012, J AM CHEM SOC, V134, P11312, DOI 10.1021/ja304912c; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349; Zanzoni A, 2013, NUCLEIC ACIDS RES, V41, P9987, DOI 10.1093/nar/gkt794; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	62	48	48	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2395	2404		10.1074/jbc.M114.610527	http://dx.doi.org/10.1074/jbc.M114.610527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505181	Green Published, hybrid			2022-12-26	WOS:000348588000042
J	Runavot, JL; Guo, XY; Willats, WGT; Knox, JP; Goubet, F; Meulewaeter, F				Runavot, Jean-Luc; Guo, Xiaoyuan; Willats, William G. T.; Knox, J. Paul; Goubet, Florence; Meulewaeter, Frank			Non-Cellulosic Polysaccharides from Cotton Fibre Are Differently Impacted by Textile Processing	PLOS ONE			English	Article							CELL-WALL; ARABINOGALACTAN-PROTEIN; MONOCLONAL-ANTIBODIES; CRYSTALLINITY CHANGES; FABRICS; FUNCTIONALIZATION; ELONGATION; EXTRACTION; GENERATION; LOCATION	Cotton fibre is mainly composed of cellulose, although non-cellulosic polysaccharides play key roles during fibre development and are still present in the harvested fibre. This study aimed at determining the fate of non-cellulosic polysaccharides during cotton textile processing. We analyzed non-cellulosic cotton fibre polysaccharides during different steps of cotton textile processing using GC-MS, HPLC and comprehensive microarray polymer profiling to obtain monosaccharide and polysaccharide amounts and linkage compositions. Additionally, in situ detection was used to obtain information on polysaccharide localization and accessibility. We show that pectic and hemicellulosic polysaccharide levels decrease during cotton textile processing and that some processing steps have more impact than others. Pectins and arabinose-containing polysaccharides are strongly impacted by the chemical treatments, with most being removed during bleaching and scouring. However, some forms of pectin are more resistant than others. Xylan and xyloglucan are affected in later processing steps and to a lesser extent, whereas callose showed a strong resistance to the chemical processing steps. This study shows that non-cellulosic polysaccharides are differently impacted by the treatments used in cotton textile processing with some hemicelluloses and callose being resistant to these harsh treatments.	[Runavot, Jean-Luc; Goubet, Florence; Meulewaeter, Frank] Bayer CropSci NV, Innovat Ctr, Ghent, Belgium; [Guo, Xiaoyuan; Willats, William G. T.] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	Bayer AG; Bayer CropScience; University of Copenhagen; University of Leeds	Meulewaeter, F (corresponding author), Bayer CropSci NV, Innovat Ctr, Technol Pk 38, Ghent, Belgium.	Frank.meulewaeter@bayer.com	Knox, Paul/H-4577-2012; Runavot, Jean-Luc/F-6930-2012	Knox, Paul/0000-0002-9231-6891; Meulewaeter, Frank/0000-0002-3589-6471; Runavot, Jean-Luc/0000-0001-5451-2616	European Union [263916]	European Union(European Commission)	This work was supported by the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (grant agreement No. 263916). This paper reflects the authors' views only. The European Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim ES, 2013, CARBOHYD POLYM, V92, P1844, DOI 10.1016/j.carbpol.2012.11.045; Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Agrawal Pramod B., 2007, Biotechnology Journal, V2, P306, DOI 10.1002/biot.200600169; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Allen S, 2013, J BIOL CHEM, V288, P11093, DOI 10.1074/jbc.M113.452763; [Anonymous], 2005, BIODEGRADABLE SUSTAI; Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315; Battan B, 2012, INDIAN J MICROBIOL, V52, P222, DOI 10.1007/s12088-011-0118-1; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Colom X, 2002, EUR POLYM J, V38, P2225, DOI 10.1016/S0014-3057(02)00132-5; Denizli A, 2001, J BIOCHEM BIOPH METH, V49, P391, DOI 10.1016/S0165-022X(01)00209-3; Dinand E, 2002, CELLULOSE, V9, P7, DOI 10.1023/A:1015877021688; Fang L, 2013, CARBOHYD POLYM, V91, P363, DOI 10.1016/j.carbpol.2012.08.049; Filpponen I, 2012, BIOMACROMOLECULES, V13, P736, DOI 10.1021/bm201661k; Gabrielii I, 2000, CARBOHYD POLYM, V43, P367, DOI 10.1016/S0144-8617(00)00181-8; Guillon F, 2004, J CEREAL SCI, V40, P167, DOI 10.1016/j.jcs.2004.06.004; HAIGLER CH, 2012, FRONT PLANT SCI; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Ibrahim NA, 2012, CARBOHYD POLYM, V90, P908, DOI 10.1016/j.carbpol.2012.06.019; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kljun A, 2011, BIOMACROMOLECULES, V12, P4121, DOI 10.1021/bm201176m; Kohler A, 2000, BIOTECHNIQUES, V28, P1084, DOI 10.2144/00286bm06; Kumar V, 1999, INT J PHARM, V177, P173, DOI 10.1016/S0378-5173(98)00340-8; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Li A, 2013, PLANTA, V237, P1585, DOI 10.1007/s00425-013-1868-2; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Montazer M, 2012, COLLOID SURFACE B, V89, P196, DOI 10.1016/j.colsurfb.2011.09.015; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peng F, 2012, BIOTECHNOL ADV, V30, P879, DOI 10.1016/j.biotechadv.2012.01.018; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Rajendran R, 2011, Pak J Biol Sci, V14, P519, DOI 10.3923/pjbs.2011.519.525; Schindler W. D., 2004, CHEM FINISH TEXT; Seagull R. W., 2000, Journal of Cotton Science, V4, P97; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Sun XF, 2005, J AGR FOOD CHEM, V53, P860, DOI 10.1021/jf040456q; TANG F, 2014, FIELD CROPS RES; Tokumoto H, 2003, J PLANT PHYSIOL, V160, P1411, DOI 10.1078/0176-1617-01066; Tokumoto H, 2002, PLANT CELL PHYSIOL, V43, P411, DOI 10.1093/pcp/pcf048; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vismara E, 2009, J HAZARD MATER, V170, P798, DOI 10.1016/j.jhazmat.2009.05.042; Wakelyn PJ, 2007, INT FIBER SCI TECHNO, V17; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	51	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115150	10.1371/journal.pone.0115150	http://dx.doi.org/10.1371/journal.pone.0115150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517975	Green Published, gold			2022-12-26	WOS:000347215600046
J	Putcha, N; Puhan, MA; Drummond, MB; Han, MK; Regan, EA; Hanania, NA; Martinez, CH; Foreman, M; Bhatt, SP; Make, B; Ramsdell, J; Demeo, DL; Barr, RG; Rennard, SI; Martinez, F; Silverman, EK; Crapo, J; Wise, RA; Hansel, NN				Putcha, Nirupama; Puhan, Milo A.; Drummond, M. Bradley; Han, MeiLan K.; Regan, Elizabeth A.; Hanania, Nicola A.; Martinez, Carlos H.; Foreman, Marilyn; Bhatt, Surya P.; Make, Barry; Ramsdell, Joe; DeMeo, Dawn L.; Barr, R. Graham; Rennard, Stephen I.; Martinez, Fernando; Silverman, Edwin K.; Crapo, James; Wise, Robert A.; Hansel, Nadia N.			A Simplified Score to Quantify Comorbidity in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; GEORGES RESPIRATORY QUESTIONNAIRE; HEALTH; RISK; MORBIDITY; VALIDATION; INDEX; INFORMATION; PREVALENCE	Importance: Comorbidities are common in COPD, but quantifying their burden is difficult. Currently there is a COPD-specific comorbidity index to predict mortality and another to predict general quality of life. We sought to develop and validate a COPD-specific comorbidity score that reflects comorbidity burden on patient-centered outcomes. Materials and Methods: Using the COPDGene study (GOLD II-IV COPD), we developed comorbidity scores to describe patient-centered outcomes employing three techniques: 1) simple count, 2) weighted score, and 3) weighted score based upon statistical selection procedure. We tested associations, area under the Curve (AUC) and calibration statistics to validate scores internally with outcomes of respiratory disease-specific quality of life (St. George's Respiratory Questionnaire, SGRQ), six minute walk distance (6MWD), modified Medical Research Council (mMRC) dyspnea score and exacerbation risk, ultimately choosing one score for external validation in SPIROMICS. Results: Associations between comorbidities and all outcomes were comparable across the three scores. All scores added predictive ability to models including age, gender, race, current smoking status, pack-years smoked and FEV1 (p<0.001 for all comparisons). Area under the curve (AUC) was similar between all three scores across outcomes: SGRQ (range 0.7624-0.7676), MMRC (0.7590-0.7644), 6MWD (0.7531-0.7560) and exacerbation risk (0.6831-0.6919). Because of similar performance, the comorbidity count was used for external validation. In the SPIROMICS cohort, the comorbidity count performed well to predict SGRQ (AUC 0.7891), MMRC (AUC 0.7611), 6MWD (AUC 0.7086), and exacerbation risk (AUC 0.7341). Conclusions: Quantifying comorbidity provides a more thorough understanding of the risk for patient-centered outcomes in COPD. A comorbidity count performs well to quantify comorbidity in a diverse population with COPD.	[Putcha, Nirupama; Drummond, M. Bradley; Wise, Robert A.; Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Puhan, Milo A.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Han, MeiLan K.; Martinez, Carlos H.] Univ Michigan, Ann Arbor, MI 48109 USA; [Regan, Elizabeth A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Foreman, Marilyn] Morehouse Sch Med, Atlanta, GA 30310 USA; [Bhatt, Surya P.] Univ Alabama Birmingham, Birmingham, AL USA; [Make, Barry; Crapo, James] Natl Jewish Hlth, Pulm & Crit Care, Denver, CO USA; [Ramsdell, Joe] Univ Calif San Diego, San Diego, CA 92103 USA; [DeMeo, Dawn L.; Silverman, Edwin K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Dept Epidemiol, Med Ctr, New York, NY USA; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Omaha, NE USA; [Martinez, Fernando] New York Presbyterian Weill Cornell Med Coll, New York, NY USA	Johns Hopkins University; University of Zurich; University of Michigan System; University of Michigan; National Jewish Health; Baylor College of Medicine; Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; University of Nebraska System; University of Nebraska Medical Center; Cornell University	Putcha, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	Nputcha1@jhmi.edu	Puhan, Milo/ABE-6298-2020; Hanania, Nicola A/C-5875-2016	Puhan, Milo/0000-0003-4721-1879; Hanania, Nicola A/0000-0003-3087-9530; Foreman, Marilyn/0000-0002-9405-7475; Wise, Robert/0000-0002-8353-2349; Drummond, Michael/0000-0002-6968-4610	institutional training grant at Johns Hopkins University - National Heart, Lung, and Blood Institute (NHLBI) [T32HL007534]; Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award); COPD Foundation; AstraZeneca Pharmaceuticals LP through COPDGene(R) Industry Advisory Board; Novartis Pharmaceuticals Corporation through COPDGene(R) Industry Advisory Board; Pfizer through COPDGene(R) Industry Advisory Board; Siemens through COPDGene(R) Industry Advisory Board; Sunovion Inc through COPDGene(R) Industry Advisory Board; NHLBI of the National Institutes of Health [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN2682009000019C, HHSN268200900020C];  [2R01HL089897];  [2R01HL089856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089856, T32HL007534, R01HL089897, K23HL103192] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	institutional training grant at Johns Hopkins University - National Heart, Lung, and Blood Institute (NHLBI); Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award); COPD Foundation; AstraZeneca Pharmaceuticals LP through COPDGene(R) Industry Advisory Board; Novartis Pharmaceuticals Corporation through COPDGene(R) Industry Advisory Board; Pfizer through COPDGene(R) Industry Advisory Board; Siemens through COPDGene(R) Industry Advisory Board; Sunovion Inc through COPDGene(R) Industry Advisory Board; NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NP is a postdoctoral research fellow supported by the institutional training grant at Johns Hopkins University, funded the National Heart, Lung, and Blood Institute (NHLBI) [T32HL007534]. She obtained further support for this specific project through the Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award). The COPDGene (R) Study is funded by 2R01HL089897 (PI: James Crapo) and 2R01HL089856 (PI: Edwin Silverman). This work is also supported by the COPD Foundation. AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation, Pfizer, Siemens and Sunovion Inc are ongoing supporters of the project through the COPDGene (R) Industry Advisory Board. The SPIROMICS study is funded by the NHLBI of the National Institutes of Health, contract and grant numbers: HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN2682009000019C, and HHSN268200900020C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Della Porta MG, 2011, HAEMATOL-HEMATOL J, V96, P441, DOI 10.3324/haematol.2010.033506; Desai MM, 2001, AM J EPIDEMIOL, V153, P299, DOI 10.1093/aje/153.3.299; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Frei A, 2014, J CLIN EPIDEMIOL, V67, P904, DOI 10.1016/j.jclinepi.2014.03.005; GRANT I, 1982, ARCH INTERN MED, V142, P1470, DOI 10.1001/archinte.142.8.1470; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; PAGANINIHILL A, 1993, AM J EPIDEMIOL, V138, P101, DOI 10.1093/oxfordjournals.aje.a116832; Putcha N, 2013, COPD, V10, P324, DOI 10.3109/15412555.2012.744963; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Schunemann HJ, 2003, J CLIN EPIDEMIOL, V56, P1170, DOI 10.1016/S0895-4356(03)00115-X; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; St Germaine-Smith C, 2011, EPILEPSIA, V52, P2161, DOI 10.1111/j.1528-1167.2011.03292.x; StataCorp, 2011, STAT STAT SOFTW REL, P173; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van Manen JG, 2001, RESP MED, V95, P496, DOI 10.1053/rmed.2001.1077; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463; Yeo J, 2006, AGE AGEING, V35, P33, DOI 10.1093/ageing/afj002	31	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114438	10.1371/journal.pone.0114438	http://dx.doi.org/10.1371/journal.pone.0114438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514500	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300011
J	Zhang, RL; Zhang, JP; Wang, QQ				Zhang, Rui-Li; Zhang, Jing-Ping; Wang, Qian-Qiu			Recombinant Treponema pallidum Protein Tp0965 Activates Endothelial Cells and Increases the Permeability of Endothelial Cell Monolayer	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIGHT JUNCTION; LEUKOCYTE TRANSMIGRATION; NEISSERIA-MENINGITIDIS; MOLECULAR-MECHANISMS; FIBRONECTIN-BINDING; ADHESION MOLECULES; MEMBRANE-PROTEIN; RHO-KINASE; F-ACTIN	The recombinant Treponema pallidum protein Tp0965 (rTp0965), one of the many proteins derived from the genome of T. pallidum subsp. pallidum, shows strong immunogenicity and immunoreactivity. In this study, we investigated the effects of rTp0965 on the endothelial barrier. Treatment of human umbilical vein endothelial cells (HUVECs) with rTp0965 resulted in increased levels of ICAM-1, E-selectin, and MCP-1 mRNA and protein expression. These increases contributed to the adhesion and chemataxis of monocytes (THP-1 cells) to HUVECs preincubated with rTp0965. In addition, rTp0965 induced reorganization of F-actin and decreased expression of claudin-1 in HUVECs. Interestingly, inhibition of the RhoA/ROCK signal pathway protected against rTp0965-induced higher endothelial permeability as well as transendothelial migration of monocytes. These data indicate that Tp0965 protein may play an important role in the immunopathogenesis of syphilis.	[Zhang, Rui-Li] Nanjing Med Univ, Wuxi Affiliated Hosp 2, Dept Dermatol, Wuxi, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] China Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention	Wang, QQ (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.	doctorwqq@163.com	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617	Natural Science Foundation of Jiangsu Province, China [BK2010136]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	Funding for this work was provided by the Natural Science Foundation of Jiangsu Province, China No BK2010136. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; Backert S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-72; Beekhuizen H, 1997, J IMMUNOL, V158, P774; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Brautigam CA, 2012, J BACTERIOL, V194, P6771, DOI 10.1128/JB.01494-12; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cameron CE, 2004, J BACTERIOL, V186, P7019, DOI 10.1128/JB.186.20.7019-7022.2004; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6; Daniel AE, 2013, J INNATE IMMUN, V5, P324, DOI 10.1159/000348828; David M, 2012, CELL CYCLE, V11, P3003, DOI 10.4161/cc.21088; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Elsheikha HM, 2010, FEMS MICROBIOL REV, V34, P532, DOI 10.1111/j.1574-6976.2010.00215.x; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gavrilin MA, 2005, BIOCHEM BIOPH RES CO, V327, P533, DOI 10.1016/j.bbrc.2004.12.037; Gjestland T, 1955, Acta Derm Venereol Suppl (Stockh), V35, P3; Gopalakrishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC102, DOI 10.1152/ajpcell.00583.2002; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Grin EI, 1953, WHO MONOGRAPHY SERIE; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; Hirano S, 2004, CELL BIOL TOXICOL, V20, P1, DOI 10.1023/B:CBTO.0000021019.50889.aa; Houston S, 2011, INFECT IMMUN, V79, P1386, DOI 10.1128/IAI.01083-10; Hudson LC, 2010, HIV AIDS-RES PALLIAT, V2, P7; Imhof BA, 1997, HORM METAB RES, V29, P614, DOI 10.1055/s-2007-979112; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Kim SJ, 2013, KOREAN J INTERN MED, V28, P231, DOI 10.3904/kjim.2013.28.2.231; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee KH, 2000, YONSEI MED J, V41, P623, DOI 10.3349/ymj.2000.41.5.623; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Long FQ, 2012, CHINESE MED J-PEKING, V125, P1920, DOI 10.3760/cma.j.issn.0366-6999.2012.11.015; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; Puavilai Siripen, 1993, Journal of the Medical Association of Thailand, V76, P85; RIVIERE GR, 1989, INFECT IMMUN, V57, P2267, DOI 10.1128/IAI.57.8.2267-2271.1989; Rocha N, 2004, J EUR ACAD DERMATOL, V18, P517, DOI 10.1111/j.1468-3083.2004.00960.x; SAMSO M, 1995, EUR J BIOCHEM, V232, P818, DOI 10.1111/j.1432-1033.1995.818zz.x; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Simoneau B, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-18; Smurova K M, 2011, Tsitologiia, V53, P359; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tacke F, 2009, DEUT MED WOCHENSCHR, V134, P1645, DOI 10.1055/s-0029-1233994; Tani Kenji, 2001, Journal of Medical Investigation, V48, P133; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Tu CL, 2011, J INVEST DERMATOL, V131, P1119, DOI 10.1038/jid.2010.414; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vieira ML, 2013, INFECT IMMUN, V81, P1764, DOI 10.1128/IAI.00020-13; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wang ZJ, 2011, IUBMB LIFE, V63, P659, DOI 10.1002/iub.485; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006	70	13	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115134	10.1371/journal.pone.0115134	http://dx.doi.org/10.1371/journal.pone.0115134			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514584	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300036
J	Hoo, R; Lam, JH; Huot, L; Pant, A; Li, R; Hot, D; Alonso, S				Hoo, Regina; Lam, Jian Hang; Huot, Ludovic; Pant, Aakanksha; Li, Rui; Hot, David; Alonso, Sylvie			Evidence for a Role of the Polysaccharide Capsule Transport Proteins in Pertussis Pathogenesis	PLOS ONE			English	Article							ESCHERICHIA-COLI K1; 2-COMPONENT SENSOR PROTEIN; ATP-BINDING COMPONENT; BORDETELLA-PERTUSSIS; BIOFILM FORMATION; BVGAS PHOSPHORELAY; BPS POLYSACCHARIDE; ABC-TRANSPORTER; POLYSIALIC ACID; IN-VIVO	Polysaccharide (PS) capsules are important virulence determinants for many bacterial pathogens. Bordetella pertussis, the agent of whooping cough, produces a surface associated microcapsule but its role in pertussis pathogenesis remained unknown. Here we showed that the B. pertussis capsule locus is expressed in vivo in murine lungs and that absence of the membrane-associated protein KpsT, involved in the transport of the PS polymers across the envelope, but not the surface-exposed PS capsule itself, affects drastically B. pertussis colonization efficacy in mice. Microarray analysis revealed that absence of KpsT in B. pertussis resulted in global down-regulation of gene expression including key virulence genes regulated by BvgA/S, the master two-component system. Using a BvgS phase-locked mutant, we demonstrated a functional link between KpsT and BvgA/S-mediated signal transduction. Whereas pull-down assays do not support physical interaction between BvgS sensor and any of the capsule locus encoded proteins, absence of KpsT impaired BvgS oligomerization, necessary for BvgS function. Furthermore, complementation studies indicated that instead of KpsT alone, the entire PS capsule transport machinery spanning the cell envelope likely plays a role in BvgS-mediated signal transduction. Our work thus provides the first experimental evidence of a role for a virulence-repressed gene in pertussis pathogenesis.	[Hoo, Regina; Lam, Jian Hang; Pant, Aakanksha; Li, Rui; Alonso, Sylvie] Natl Univ Singapore, Dept Microbiol, Immunol Programme, Yong Loo Lin Sch Med,Ctr Life Sci 03 05, 28 Med Dr, Singapore 117597, Singapore; [Huot, Ludovic; Hot, David] Inst Pasteur, CIIL, U1019, UMR8204, F-59019 Lille, France	National University of Singapore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Alonso, S (corresponding author), Natl Univ Singapore, Dept Microbiol, Immunol Programme, Yong Loo Lin Sch Med,Ctr Life Sci 03 05, 28 Med Dr, Singapore 117597, Singapore.	micas@nus.edu.sg	; Hot, David/M-6775-2016	Pant, Aakanksha/0000-0002-1123-2638; Hoo, Regina/0000-0002-0295-9472; Hot, David/0000-0002-2361-0616	Singapore Ministry of Education [MOE2009-T2-2-014]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Singapore Ministry of Education (MOE2009-T2-2-014 grant allocated to SA.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2001, INFECT IMMUN, V69, P6038, DOI 10.1128/IAI.69.10.6038-6043.2001; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; BEATTIE DT, 1992, INFECT IMMUN, V60, P571, DOI 10.1128/IAI.60.2.571-577.1992; BEIER D, 1995, J MOL BIOL, V248, P596, DOI 10.1006/jmbi.1995.0245; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; DOMENICO P, 1994, INFECT IMMUN, V62, P4495, DOI 10.1128/IAI.62.10.4495-4499.1994; Dupre E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-172; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Eguchi Y, 2007, P NATL ACAD SCI USA, V104, P18712, DOI 10.1073/pnas.0705768104; ELZER PH, 1995, PLASMID, V33, P51, DOI 10.1006/plas.1995.1006; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gokhale RS, 1996, BIOCHEMISTRY-US, V35, P7150, DOI 10.1021/bi952890e; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Ho SY, 2008, INFECT IMMUN, V76, P111, DOI 10.1128/IAI.00795-07; Hot D, 2003, MOL GENET GENOMICS, V269, P475, DOI 10.1007/s00438-003-0851-1; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lippa AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000788; Lonnstedt I, 2002, STAT SINICA, V12, P31; Maeda S, 2006, J BIOL CHEM, V281, P37868, DOI 10.1074/jbc.M608680200; MAKINO S, 1981, J BIOCHEM-TOKYO, V89, P651, DOI 10.1093/oxfordjournals.jbchem.a133242; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Merkel TJ, 2003, J BACTERIOL, V185, P6902, DOI 10.1128/JB.185.23.6902-6912.2003; MILLER JF, 1992, J BACTERIOL, V174, P970, DOI 10.1128/jb.174.3.970-979.1992; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; Otto M, 2006, CURR TOP MICROBIOL, V306, P251; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PAVELKA MS, 1994, J BIOL CHEM, V269, P20149; Perraud AL, 2000, BBA-PROTEIN STRUCT M, V1478, P341, DOI 10.1016/S0167-4838(00)00052-2; PIGEON RP, 1994, MOL MICROBIOL, V14, P871, DOI 10.1111/j.1365-2958.1994.tb01323.x; Raffatellu M, 2006, INFECT IMMUN, V74, P19, DOI 10.1128/IAI.74.1.19-27.2006; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; ROY CR, 1991, J BACTERIOL, V173, P2385, DOI 10.1128/JB.173.7.2385-2392.1991; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Shukla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035984; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Soufi A, 2006, J MOL BIOL, V358, P943, DOI 10.1016/j.jmb.2006.02.020; Steffen P, 1996, EMBO J, V15, P102, DOI 10.1002/j.1460-2075.1996.tb00338.x; Stenson TH, 2005, INFECT IMMUN, V73, P5995, DOI 10.1128/IAI.73.9.5995-6004.2005; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STRAUSS EJ, 1995, CURR BIOL, V5, P706, DOI 10.1016/S0960-9822(95)00139-4; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Veal-Carr WL, 2005, MOL MICROBIOL, V55, P788, DOI 10.1111/j.1365-2958.2004.04418.x; Williams CL, 2007, J BACTERIOL, V189, P1974, DOI 10.1128/JB.01684-06; Zu T, 1996, MOL MICROBIOL, V21, P557, DOI 10.1111/j.1365-2958.1996.tb02564.x	72	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115243	10.1371/journal.pone.0115243	http://dx.doi.org/10.1371/journal.pone.0115243			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501560	gold, Green Published			2022-12-26	WOS:000346375400087
J	Bordonaro, M; Drago, E; Atamna, W; Lazarova, DL				Bordonaro, Michael; Drago, Eric; Atamna, Wafa; Lazarova, Darina L.			Comprehensive Suppression of All Apoptosis-Induced Proliferation Pathways as a Proposed Approach to Colorectal Cancer Prevention and Therapy	PLOS ONE			English	Article							AZD6244 ARRY-142886; BETA-CATENIN; WNT ACTIVITY; CELL-DEATH; INHIBITOR; COFFEE; RISK; COMBINATION; ANTITUMOR; BUTYRATE	Mutations in the WNT/beta-catenin pathway are present in the majority of all sporadic colorectal cancers (CRCs), and histone deacetylase inhibitors induce apoptosis in CRC cells with such mutations. This apoptosis is counteracted by (1) the signaling heterogeneity of CRC cell populations, and (2) the survival pathways induced by mitogens secreted from apoptotic cells. The phenomena of signaling heterogeneity and apoptosis-induced survival constitute the immediate mechanisms of resistance to histone deacetylase inhibitors, and probably other chemotherapeutic agents. We explored the strategy of augmenting CRC cell death by inhibiting all survival pathways induced by the pro-apoptotic agent LBH589, a histone deacetylase inhibitor: AKT, JAK/STAT, and ERK signaling. The apoptosis-enhancing ability of a cocktail of synthetic inhibitors of proliferation was compared to the effects of the natural product propolis. We utilized colorectal adenoma, drug-sensitive and drug-resistant colorectal carcinoma cells to evaluate the apoptotic potential of the combination treatments. The results suggest that an effective approach to CRC combination therapy is to combine apoptosis-inducing drugs (e.g., histone deacetylase inhibitors, such as LBH589) with agents that suppress all compensatory survival pathways induced during apoptosis (such as the cocktail of inhibitors of apoptosis-associated proliferation). The same paradigm can be applied to a CRC prevention approach, as the apoptotic effect of butyrate, a diet-derived histone deacetylase inhibitor, is augmented by other dietary agents that modulate survival pathways (e.g., propolis and coffee extract). Thus, dietary supplements composed by fermentable fiber, propolis, and coffee extract may effectively counteract neoplastic growth in the colon.	[Bordonaro, Michael; Drago, Eric; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Atamna, Wafa] Calif Northstate Univ, Coll Med, Elk Grove, CA 95757 USA	Geisinger Commonwealth School of Medicine	Lazarova, DL (corresponding author), Commonwealth Med Coll, Dept Basic Sci, 525 Pine St, Scranton, PA 18509 USA.	dlazarova@tcmedc.org			National Institutes of Health [1R15CA152852-01]; NATIONAL CANCER INSTITUTE [R15CA152852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (1R15CA152852-01, Lazarova). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Ruiz RB, 2014, MATURITAS, V77, P202, DOI 10.1016/j.maturitas.2013.11.010; Bergmann A, 2010, INT J RADIAT BIOL, V53, P95; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Bordonaro M, 2011, EXP CELL RES, V317, P1368, DOI 10.1016/j.yexcr.2011.03.019; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Dent P, 2009, DRUG RESIST UPDATE, V12, P65, DOI 10.1016/j.drup.2009.03.001; Drago E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073151; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Holt SV, 2012, BRIT J CANCER, V106, P858, DOI 10.1038/bjc.2012.8; Huang D, 2008, WORLD J GASTROENTERO, V14, P1823, DOI 10.3748/wjg.14.1823; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022; Kautenburger T, 2005, J CANCER RES CLIN, V131, P692, DOI 10.1007/s00432-005-0013-4; Lazarova D, 2014, J CANCER, V5, P203, DOI 10.7150/jca.8569; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Murugaesu N, 2013, AM J PATHOL, V182, P1962, DOI 10.1016/j.ajpath.2013.02.026; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Richter M, 2002, EUR J CANCER, V38, P1937, DOI 10.1016/S0959-8049(02)00158-2; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Schiller C, 2005, ALIMENT PHARM THER, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shen T, 2010, BIOL PHARM BULL, V33, P128, DOI 10.1248/bpb.33.128; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328; Sobocanec S, 2011, PHYTOMEDICINE, V18, P852, DOI 10.1016/j.phymed.2011.01.015; Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Suzuki I, 2002, CANCER BIOTHER RADIO, V17, P553, DOI 10.1089/108497802760804781; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Wang ZJ, 2013, WORLD J GASTROENTERO, V19, P2683, DOI 10.3748/wjg.v19.i17.2683; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ INT RE; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	45	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115068	10.1371/journal.pone.0115068	http://dx.doi.org/10.1371/journal.pone.0115068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500581	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700091
J	Gabbe, BJ; Simpson, PM; Lyons, RA; Ameratunga, S; Harrison, JE; Derrett, S; Polinder, S; Davie, G; Rivara, FP				Gabbe, Belinda J.; Simpson, Pam M.; Lyons, Ronan A.; Ameratunga, Shanthi; Harrison, James E.; Derrett, Sarah; Polinder, Suzanne; Davie, Gabrielle; Rivara, Frederick P.			Association between the Number of Injuries Sustained and 12-Month Disability Outcomes: Evidence from the Injury-VIBES Study	PLOS ONE			English	Article							SEVERE MULTIPLE INJURIES; QUALITY-OF-LIFE; TRAUMA REGISTRY; MAJOR TRAUMA; FUNCTIONAL CONSEQUENCES; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH-STATUS; BRAIN-INJURY; DISEASE	Objective: To determine associations between the number of injuries sustained and three measures of disability 12-months post-injury for hospitalised patients. Methods: Data from 27,840 adult (18+ years) participants, hospitalised for injury, were extracted for analysis from the Validating and Improving injury Burden Estimates (Injury-VIBES) Study. Modified Poisson and linear regression analyses were used to estimate relative risks and mean differences, respectively, for a range of outcomes (Glasgow Outcome Scale-Extended, GOS-E; EQ-5D and 12-item Short Form health survey physical and mental component summary scores, PCS-12 and MCS-12) according to the number of injuries sustained, adjusted for age, sex and contributing study. Findings: More than half (54%) of patients had an injury to more than one ICD-10 body region and 62% had sustained more than one Global Burden of Disease injury type. The adjusted relative risk of a poor functional recovery (GOS-E<7) and of reporting problems on each of the items of the EQ-5D increased by 5-10% for each additional injury type, or body region, injured. Adjusted mean PCS-12 and MCS-12 scores worsened with each additional injury type, or body region, injured by 1.3-1.5 points and 0.5 points, respectively. Conclusions: Consistent and strong relationships exist between the number of injury types and body regions injured and 12-month functional and health status outcomes. Existing composite measures of anatomical injury severity such as the NISS or ISS, which use up to three diagnoses only, may be insufficient for characterising or accounting for multiple injuries in disability studies. Future studies should consider the impact of multiple injuries to avoid under-estimation of injury burden.	[Gabbe, Belinda J.; Simpson, Pam M.; Lyons, Ronan A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.; Lyons, Ronan A.] Swansea Univ, Ctr Improvement Populat Hlth E Records Res, Swansea, W Glam, Wales; [Lyons, Ronan A.] Publ Hlth Wales NHS Trust, Cardiff, S Glam, Wales; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand; [Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA 5001, Australia; [Derrett, Sarah; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Hlth & Social Serv, Palmerston North, New Zealand; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Monash University; Swansea University; University of Auckland; Flinders University South Australia; University of Otago; Massey University; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gabbe, BJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu	Harrison, James/B-8958-2009	Harrison, James/0000-0001-9893-8491; Davie, Gabrielle/0000-0001-5466-5364; Lyons, Ronan/0000-0001-5225-000X; Gabbe, Belinda/0000-0001-7096-7688; Derrett, Sarah/0000-0003-2867-0498; Ameratunga, Shanthi/0000-0001-8042-2251	National Health and Medical Research Council (NHMRC) of Australia [GNT1021861]; Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand; Department of Health, State Government of Victoria; TAC through the Institute for Safety, Compensation and Recovery Research; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention [R49/CCR316840]; National Institutes of Health [R01/AG20361]; NHMRC [APP1048731]; Transport Accident Commission (TAC); MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand; Department of Health, State Government of Victoria; TAC through the Institute for Safety, Compensation and Recovery Research; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission (TAC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Injury-VIBES project is funded by the National Health and Medical Research Council (NHMRC) of Australia (GNT1021861, www.nhmrc.gov.au). The POIS study is funded by the Health Research Council of New Zealand (2007-2013, www.hrc.govt.nz), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010, acc.co.nz). The Victorian State Trauma Registry is a Department of Health, State Government of Victoria and Transport Accident Commission (TAC) funded project (www.tac.vic.gov.au, www.health.vic.gov.au). The Victorian Orthopaedic Trauma Outcomes Registry is funded by the TAC through the Institute for Safety, Compensation and Recovery Research (www.iscrr.com.au). The NSCOT was funded by the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention (Grant R49/CCR316840, www.cdc.gov/Injury) and the National Institutes of Health (Grant #R01/AG20361, www.nih.gov). Belinda Gabbe is supported by a Career Development Fellowship from the NHMRC (APP1048731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2009, J TRAUMA, V67, P883, DOI 10.1097/TA.0b013e3181ae6409; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Edwards ER, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2005.02.027; Gabbe BJ, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-040936; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Holtslag HR, 2007, INJURY, V38, P280, DOI 10.1016/j.injury.2006.10.026; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Macpherson AK, 2003, J TRAUMA, V55, P454, DOI 10.1097/01.TA.0000042158.79688.51; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Putz C, 2011, SPINAL CORD, V49, P721, DOI 10.1038/sc.2010.181; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Scivoletto G, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-42; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Soberg HL, 2007, J TRAUMA, V62, P471, DOI 10.1097/TA.0b013e31802e95f4; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Ware J., 1998, SF 12 SCORE SF 12 PH; Weninger P, 2008, J TRAUMA, V65, P799, DOI 10.1097/TA.0b013e3181820dae; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113467	10.1371/journal.pone.0113467	http://dx.doi.org/10.1371/journal.pone.0113467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501651	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700008
J	Kim, DK; Lillehoj, HS; Jang, SI; Lee, SH; Hong, YH; Cheng, HH				Kim, Duk Kyung; Lillehoj, Hyun S.; Jang, Seung I.; Lee, Sung Hyen; Hong, Yeong Ho; Cheng, Hans H.			Transcriptional Profiles of Host-Pathogen Responses to Necrotic Enteritis and Differential Regulation of Immune Genes in Two Inbreed Chicken Lines Showing Disparate Disease Susceptibility	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS; BROILER-CHICKENS; EIMERIA-MAXIMA; RISK-FACTORS; EXPRESSION; RESISTANCE; INFECTION; PROTEINS; TENELLA; CELLS	Necrotic enteritis (NE) is an important intestinal infectious disease of commercial poultry flocks caused by Clostridium perfringens. Using an experimental model of NE involving co-infection with C. perfringens and Eimeria maxima, transcriptome profiling and functional genomics approaches were applied to identify the genetic mechanisms that might regulate the host response to this disease. Microarray hybridization identified 1,049 transcripts whose levels were altered (601 increased, 448 decreased) in intestinal lymphocytes from C. perfringens/E. maxima co-infected Ross chickens compared with uninfected controls. Five biological functions, all related to host immunity and inflammation, and 11 pathways were identified from this dataset. To further elucidate the role of host genetics in NE susceptibility, two inbred chicken lines, ADOL line 6 and line 7 which share an identical B-2 major histocompatibility complex haplotype but differ in their susceptibility to virus infection, were compared for clinical symptoms and the expression levels of a panel of immune-related genes during experimental NE. Line 6 chickens were more susceptible to development of experimental NE compared with line 7, as revealed by decreased body weight gain and increased E. maxima oocyst shedding. Of 21 immune-related genes examined, 15 were increased in C. perfringens/E. maxima co-infected line 6 vs. line 7 chickens. These results suggest that immune pathways are activated in response to experimental NE infection and that genetic determinants outside of the chicken B complex influence resistance to this disease.	[Kim, Duk Kyung; Lillehoj, Hyun S.; Jang, Seung I.; Lee, Sung Hyen] Agr Res Serv, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA; [Kim, Duk Kyung] Hankyong Natl Univ, Anim Genom & Breeding Ctr, Ansong 456749, Gyeonggi, South Korea; [Lee, Sung Hyen] Natl Acad Agr Sci, Rural Dev Adm, Wanju Gun 565851, Jeollabuk Do, South Korea; [Hong, Yeong Ho] Chung Ang Univ, Dept Anim Sci & Technol, Ansong 456756, South Korea; [Cheng, Hans H.] Agr Res Serv, Avian Dis & Oncol Lab, USDA, E Lansing, MI 48823 USA	United States Department of Agriculture (USDA); Hankyong National University; Rural Development Administration (RDA); Chung Ang University; United States Department of Agriculture (USDA)	Lillehoj, HS (corresponding author), Agr Res Serv, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA.	Hyun.Lillehoj@ars.usda.gov		Hong, Yeong Ho/0000-0002-4510-7851; Cheng, Hans/0000-0003-2071-4644	ARS CRIS; Next-Generation BioGreen 21 Program [PJ008084, PJ008196]; project 'Investigation of the functional activity and the development of functional foods of Allium hookeri' [PJ010490]; Rural Development Administration, Republic of Korea	ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); project 'Investigation of the functional activity and the development of functional foods of Allium hookeri'; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by ARS CRIS, partially by grants from the Next-Generation BioGreen 21 Program (No. PJ008084 and No. PJ008196) and the project 'Investigation of the functional activity and the development of functional foods of Allium hookeri (PJ010490)', Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; BUMSTEAD JM, 1995, PARASITOLOGY, V111, P143, DOI 10.1017/S003118200006488X; BUMSTEAD N, 1987, BRIT POULTRY SCI, V28, P705, DOI 10.1080/00071668708417006; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Dagvadorj J, 2010, IMMUNOLOGY, V129, P97, DOI 10.1111/j.1365-2567.2009.03154.x; Feng Zhi-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1338; Gobel TWF, 2001, INT IMMUNOL, V13, P757, DOI 10.1093/intimm/13.6.757; Hermans PG, 2007, AVIAN PATHOL, V36, P43, DOI 10.1080/03079450601109991; Jang SI, 2012, VACCINE, V30, P5401, DOI 10.1016/j.vaccine.2012.06.007; Ji ZZ, 2011, CHINESE MED J-PEKING, V124, P177, DOI 10.3760/cma.j.issn.0366-6999.2011.02.004; Jia Y, 2013, J CELL PHYSIOL, V228, P476, DOI 10.1002/jcp.24156; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kang H, 2012, BIOCHEM BIOPH RES CO, V423, P188, DOI 10.1016/j.bbrc.2012.05.114; Kim DK, 2012, AVIAN DIS, V56, P670, DOI 10.1637/10069-013112-Reg.1; Kim DK, 2013, BRIT J NUTR, V109, P76, DOI 10.1017/S0007114512000530; Langers AMJ, 2008, BRIT J CANCER, V98, P1820, DOI 10.1038/sj.bjc.6604380; Lee KW, 2011, POULTRY SCI, V90, P1381, DOI 10.3382/ps.2010-01319; Lee K, 2011, RES VET SCI, V91, pE80, DOI 10.1016/j.rvsc.2011.01.017; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee SH, 2009, VET PARASITOL, V163, P123, DOI 10.1016/j.vetpar.2009.04.020; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Liu HC, 2001, ANIM GENET, V32, P351, DOI 10.1046/j.1365-2052.2001.00798.x; McShane LM, 2003, J MAMMARY GLAND BIOL, V8, P359, DOI 10.1023/B:JOMG.0000010035.57912.5a; Min WG, 2005, MOL BIOTECHNOL, V30, P143, DOI 10.1385/MB:30:2:143; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Olkowski AA, 2008, RES VET SCI, V85, P543, DOI 10.1016/j.rvsc.2008.02.007; Park SS, 2008, AVIAN DIS, V52, P14, DOI 10.1637/7997-041707-Reg; Sarson AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-260; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Timbermont L, 2009, COMP IMMUNOL MICROB, V32, P503, DOI 10.1016/j.cimid.2008.07.001; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Yoo J, 2009, VET IMMUNOL IMMUNOP, V132, P318, DOI 10.1016/j.vetimm.2009.06.003; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; Zhou H, 2009, POULTRY SCI, V88, P1023, DOI 10.3382/ps.2008-00343; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	37	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114960	10.1371/journal.pone.0114960	http://dx.doi.org/10.1371/journal.pone.0114960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25504150	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700076
J	Miller, KD; Roque, R; Clegg, CH				Miller, Keith D.; Roque, Richard; Clegg, Christopher H.			Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier	PLOS ONE			English	Article							T-CELL RESPONSES; EPITOPE DENSITY; SWISS-MODEL; IMMUNOGENICITY; PEPTIDE; AFFINITY; SUPPRESSION; STRATEGIES; ADJUVANTS; EFFICACY	Tobacco addiction represents one of the largest public health problems in the world and is the leading cause of cancer and heart disease, resulting in millions of deaths a year. Vaccines for smoking cessation have shown considerable promise in preclinical models, although functional antibody responses induced in humans are only modestly effective in preventing nicotine entry into the brain. The challenge in generating serum antibodies with a large nicotine binding capacity is made difficult by the fact that this drug is non-immunogenic and must be conjugated as a hapten to a protein carrier. To circumvent the limitations of traditional carriers like keyhole limpet hemocyanin (KLH), we have synthesized a short trimeric coiled-coil peptide (TCC) that creates a series of B and T cell epitopes with uniform stoichiometry and high density. Here we compared the relative activities of a TCC-nic vaccine and two control KLH-nic vaccines using Alum as an adjuvant or GLA-SE, which contains a synthetic TLR4 agonist formulated in a stable oil-in-water emulsion. The results showed that the TCC's high hapten density correlated with a better immune response in mice as measured by anti-nicotine Ab titer, affinity, and specificity, and was responsible for a reduction in anti-carrier immunogenicity. The Ab responses achieved with this synthetic vaccine resulted in a nicotine binding capacity in serum that could prevent >90% of a nicotine dose equivalent to three smoked cigarettes (0.05 mg/kg) from reaching the brain.	[Miller, Keith D.; Roque, Richard; Clegg, Christopher H.] TRIA Biosci Corp, Seattle, WA 98102 USA		Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA 98102 USA.	cclegg@triabio.com			National Institute on Drug Abuse, National Institutes of Health [R43DA033845]; NATIONAL INSTITUTE ON DRUG ABUSE [R43DA033845] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute on Drug Abuse, National Institutes of Health Grant R43DA033845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boylan NJ, 2013, BIOCONJUGATE CHEM, V24, P1008, DOI 10.1021/bc4000564; Brimijoin S, 2013, EXPERT REV VACCINES, V12, P323, DOI [10.1586/erv.13.1, 10.1586/ERV.13.1]; Carpenter MJ, 2013, DRUGS, V73, P407, DOI 10.1007/s40265-013-0038-y; Chandrudu S, 2013, MOLECULES, V18, P4373, DOI 10.3390/molecules18044373; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Clegg CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088979; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; de Villiers SHL, 2013, VACCINE, V31, P6185, DOI 10.1016/j.vaccine.2013.10.051; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hartmann-Boyce J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007072.pub2; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hu K, 2012, BIOSCI TRENDS, V6, P52, DOI 10.5582/bst.2012.v6.2.52; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Kim MT, 2014, BIOCONJUGATE CHEM, V25, P1223, DOI 10.1021/bc5000109; KLAUS GGB, 1974, CELL IMMUNOL, V14, P226, DOI 10.1016/0008-8749(74)90208-1; Komegae EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071185; La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Liu WL, 2005, EUR J IMMUNOL, V35, P505, DOI 10.1002/eji.200425749; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; McCluskie MJ, 2013, 19 ANN M SOC RES NIC; Micklatcher C, 1999, CURR OPIN CHEM BIOL, V3, P724, DOI 10.1016/S1367-5931(99)00031-9; Moreno AY, 2009, PHARMACOL BIOCHEM BE, V92, P199, DOI 10.1016/j.pbb.2009.01.015; Pedersen MK, 2006, J IMMUNOL METHODS, V311, P198, DOI 10.1016/j.jim.2006.02.008; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pobre K, 2014, VACCINE, V32, P1423, DOI 10.1016/j.vaccine.2014.01.047; Polosa R, 2011, TRENDS PHARMACOL SCI, V32, P281, DOI 10.1016/j.tips.2010.12.008; Pryde DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076557; Raupach T, 2012, DRUGS, V72, P1; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Sant AJ, 2007, EXPERT REV VACCINES, V6, P357, DOI 10.1586/14760584.6.3.357; Sant AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00340; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; Suzuki K, 1998, PROTEIN ENG, V11, P1051, DOI 10.1093/protein/11.11.1051; Tonstad S, 2013, NICOTINE TOB RES, V15, P1492, DOI 10.1093/ntr/ntt003; U. S. Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	53	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114366	10.1371/journal.pone.0114366	http://dx.doi.org/10.1371/journal.pone.0114366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494044	Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400042
J	Torma, F; Koltai, E; Nagy, E; Ziaaldini, MM; Posa, A; Koch, LG; Britton, SL; Boldogh, I; Radak, Z				Torma, Ferenc; Koltai, Erika; Nagy, Eniko; Ziaaldini, Mohammad Mosaferi; Posa, Aniko; Koch, Lauren G.; Britton, Steven L.; Boldogh, Istvan; Radak, Zsolt			Exercise Increases Markers of Spermatogenesis in Rats Selectively Bred for Low Running Capacity	PLOS ONE			English	Article							TESTIS-SPECIFIC GENE; OUTER DENSE FIBERS; OXIDATIVE STRESS; SEMEN QUALITY; SIRT1; P53; ACTIVATION; PROTEIN; PGC-1-ALPHA; DISORDERS	The oxidative stress effect of exercise training on testis function is under debate. In the present study we used a unique rat model system developed by artificial selection for low and high intrinsic running capacity (LCR and HCR, respectively) to evaluate the effects of exercise training on apoptosis and spermatogenesis in testis. Twentyfour 13-month-old male rats were assigned to four groups: control LCR (LCR-C), trained LCR (LCR-T), control HCR (HCR-C), and trained HCR (HCR-T). Ten key proteins connecting aerobic exercise capacity and general testes function were assessed, including those that are vital for mitochondrial biogenesis. The VO2 max of LCR-C group was about 30% lower than that of HCR-C rats, and the SIRT1 levels were also significantly lower than HCR-C. Twelve weeks of training significantly increased maximal oxygen consumption in LCR by nearly 40% whereas HCR remained unchanged. LCR-T had significantly higher levels of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1 alpha), decreased levels of reactive oxygen species and increased acetylated p53 compared to LCR-C, while training produced no significant changes for these measures in HCR rats. BAX and Blc-2 were not different among all four groups. The levels of outer dense fibers -1 (Odf-1), a marker of spermatogenesis, increased in LCR-T rats, but decreased in HCR-TR rats. Moreover, exercise training increased the levels of lactate dehydrogenase C (LDHC) only in LCR rats. These data suggest that rats with low inborn exercise capacity can increase whole body oxygen consumption and running exercise capacity with endurance training and, in turn, increase spermatogenesis function via reduction in ROS and heightened activity of p53 in testes.	[Torma, Ferenc; Koltai, Erika; Nagy, Eniko; Ziaaldini, Mohammad Mosaferi; Radak, Zsolt] Semmelweis Univ, Res Inst Sport Sci, H-1085 Budapest, Hungary; [Posa, Aniko] Univ Szeged, Fac Sci & Informat, Dept Physiol Anat & Neurosci, Szeged, Hungary; [Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Sealy Ctr Mol Med, Galveston, TX 77555 USA	Semmelweis University; Szeged University; University of Michigan System; University of Michigan; University of Texas System; University of Texas Medical Branch Galveston	Radak, Z (corresponding author), Semmelweis Univ, Res Inst Sport Sci, H-1085 Budapest, Hungary.	radak@tf.hu	Ziaaldini, Mohammad Mosaferi/AAE-4262-2019	Ziaaldini, Mohammad Mosaferi/0000-0001-7193-663X; Posa, Aniko/0000-0003-2167-2888; Radak, Zsolt/0000-0003-1297-6804	National Center for Research Resources [R24RR017718]; Office of Research Infrastructure Programs/OD grant from the National Institutes of Health [R24OD010950]; National Institutes of Health [R01 DK077200, R01GM104194]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010950] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The LCR-HCR rat model system was funded by the National Center for Research Resources grant R24RR017718 and is currently supported by the Office of Research Infrastructure Programs/OD grant R24OD010950 (to LGK and SLB) from the National Institutes of Health. SLB was also supported by National Institutes of Health grants R01 DK077200 and R01GM104194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYERS JWT, 1985, FERTIL STERIL, V43, P917; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chigurupati S, 2008, J ENDOCRINOL, V199, P333, DOI 10.1677/JOE-08-0306; Coussens M, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0001571, 10.1371/journal.pone.0002640]; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; HACKNEY AC, 1988, MED SCI SPORT EXER, V20, P60, DOI 10.1249/00005768-198802000-00009; Hart N, 2014, DOSE-RESPONSE, V12, P57, DOI 10.2203/dose-response.13-010.Radak; Hart N, 2013, FOOD CHEM TOXICOL, V61, P53, DOI 10.1016/j.fct.2013.01.051; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lindemann CB, 1996, CELL MOTIL CYTOSKEL, V34, P258, DOI 10.1002/(SICI)1097-0169(1996)34:4<258::AID-CM1>3.0.CO;2-4; Manna I, 2003, ACTA PHYSIOL SCAND, V178, P33, DOI 10.1046/j.1365-201X.2003.01095.x; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; O'Bryan MK, 1998, MOL REPROD DEV, V50, P313, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;313::AID-MRD7&gt;3.0.CO;2-M; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Schalles U, 1998, DEV BIOL, V199, P250, DOI 10.1006/dbio.1998.8931; Sharpe RM, 2000, BRIT MED BULL, V56, P630, DOI 10.1258/0007142001903436; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P245, DOI 10.1016/j.bbrc.2012.06.084; Vaamonde D, 2009, FERTIL STERIL, V92, P1941, DOI 10.1016/j.fertnstert.2008.09.010; van Leeuwen I, 2009, ADV CANCER RES, V102, P171, DOI 10.1016/S0065-230X(09)02005-3; WHEELER GD, 1984, JAMA-J AM MED ASSOC, V252, P514, DOI 10.1001/jama.252.4.514; Wu L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.008	38	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114075	10.1371/journal.pone.0114075	http://dx.doi.org/10.1371/journal.pone.0114075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493948	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400028
J	Park, H; Huang, X; Lu, CM; Cairo, MS; Zhou, XZ				Park, Haein; Huang, Xin; Lu, Changming; Cairo, Mitchell S.; Zhou, Xianzheng			MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cytokine; Dendritic Cell; Differentiation; MicroRNA (miRNA); NF-kappa B (NF-B); TNF Receptor-associated Factor (TRAF); IL-1 Receptor-associated Kinases (IRAK); miR-146	NF-KAPPA-B; T-CELL; IMMUNE-RESPONSE; ACTIVATION; EXPRESSION; MATURATION; MIR-146A; CANCER; MICE; INTERLEUKIN-12	Background: MicroRNA (miR)-146a and miR-146b (miR-146a/b) expression is induced upon human monocyte differentiation into dendritic cells (DCs). Results: miR-146a/b negatively regulates DC apoptosis and cytokine production. Conclusion: The miR-146a/b-TRAF6/IRAK1-NF-B axis is responsible for DC apoptosis. Significance: Our data reveal a novel negative feedback regulation in DCs and may have implications in the pathogenesis and treatment of autoimmune diseases. We have previously reported 27 differentially expressed microRNAs (miRNAs) during human monocyte differentiation into immature dendritic cells (imDCs) and mature DCs (mDCs). However, their roles in DC differentiation and function remain largely elusive. Here, we report that microRNA (miR)-146a and miR-146b modulate DC apoptosis and cytokine production. Expression of miR-146a and miR-146b was significantly increased upon monocyte differentiation into imDCs and mDCs. Silencing of miR-146a and/or miR-146b in imDCs and mDCs significantly prevented DC apoptosis, whereas overexpressing miR-146a and/or miR-146b increased DC apoptosis. miR-146a and miR-146b expression in imDCs and mDCs was inversely correlated with TRAF6 and IRAK1 expression. Furthermore, siRNA silencing of TRAF6 and/or IRAK1 in imDCs and mDCs enhanced DC apoptosis. By contrast, lentivirus overexpression of TRAF6 and/or IRAK1 promoted DC survival. Moreover, silencing of miR-146a and miR-146b expression had little effect on DC maturation but enhanced IL-12p70, IL-6, and TNF- production as well as IFN- production by IL-12p70-mediated activation of natural killer cells, whereas miR-146a and miR-146b overexpression in mDCs reduced cytokine production. Silencing of miR-146a and miR-146b in DCs also down-regulated NF-B inhibitor IB and increased Bcl-2 expression. Our results identify a new negative feedback mechanism involving the miR-146a/b-TRAF6/IRAK1-NF-B axis in promoting DC apoptosis.	[Park, Haein; Huang, Xin; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA; [Park, Haein; Huang, Xin; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Lu, Changming] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth, Birmingham, AL 35233 USA	New York Medical College; New York Medical College; New York Medical College; New York Medical College; New York Medical College; University of Alabama System; University of Alabama Birmingham	Zhou, XZ (corresponding author), New York Med Coll, 40 Sunshine Cottage Rd,Vosburgh Pavil,Rm 320, Valhalla, NY 10595 USA.	xianzheng_zhou@nymc.edu			National Institutes of Health [AI092220]; Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI092220 (to X. Z.). This work was also supported by the Pediatric Cancer Research Foundation (to M. S. C.).	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baseler WA, 2012, AM J PHYSIOL-CELL PH, V303, pC1244, DOI 10.1152/ajpcell.00137.2012; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Karrich JJ, 2013, BLOOD, V122, P3001, DOI 10.1182/blood-2012-12-475087; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou XZ, 2003, HUM GENE THER, V14, P1089, DOI 10.1089/104303403322124800	45	171	190	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2831	2841		10.1074/jbc.M114.591420	http://dx.doi.org/10.1074/jbc.M114.591420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505246	hybrid, Green Published			2022-12-26	WOS:000349310700024
J	Wang, CK; Da, Y				Wang, Chunkao; Da, Yang			Quantitative Genetics Model as the Unifying Model for Defining Genomic Relationship and Inbreeding Coefficient	PLOS ONE			English	Article							WIDE ASSOCIATION; SELECTION; DEPRESSION; VARIANCE	The traditional quantitative genetics model was used as the unifying approach to derive six existing and new definitions of genomic additive and dominance relationships. The theoretical differences of these definitions were in the assumptions of equal SNP effects (equivalent to across-SNP standardization), equal SNP variances (equivalent to within-SNP standardization), and expected or sample SNP additive and dominance variances. The six definitions of genomic additive and dominance relationships on average were consistent with the pedigree relationships, but had individual genomic specificity and large variations not observed from pedigree relationships. These large variations may allow finding least related genomes even within the same family for minimizing genomic relatedness among breeding individuals. The six definitions of genomic relationships generally had similar numerical results in genomic best linear unbiased predictions of additive effects (GBLUP) and similar genomic REML (GREML) estimates of additive heritability. Predicted SNP dominance effects and GREML estimates of dominance heritability were similar within definitions assuming equal SNP effects or within definitions assuming equal SNP variance, but had differences between these two groups of definitions. We proposed a new measure of genomic inbreeding coefficient based on parental genomic co-ancestry coefficient and genomic additive correlation as a genomic approach for predicting offspring inbreeding level. This genomic inbreeding coefficient had the highest correlation with pedigree inbreeding coefficient among the four methods evaluated for calculating genomic inbreeding coefficient in a Holstein sample and a swine sample.	[Wang, Chunkao; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Da, Y (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	yda@umn.edu			United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-67015-30333]; Agricultural Experiment Station at the University of Minnesota [MN-16-043]; National Research Initiative Competitive [2008-35205-18846]; USDA National Institute of Food and Agriculture; Holstein Association USA	United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); National Research Initiative Competitive(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Holstein Association USA	This research was supported by United States Department of Agriculture (USDA) National Institute of Food and Agriculture Grant no. 2011-67015-30333 and by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota. The Holstein SNP data were supported by National Research Initiative Competitive Grant no. 2008-35205-18846 from the USDA National Institute of Food and Agriculture and by a financial contribution from Holstein Association USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GENETICS ANAL QUANTI; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Da Y, 2013, PLANT ANIMAL GENOME; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garbe J., 2008, PEDIGRAPH SOFTWARE T; Garbe JR, 2008, MINIINBRED COMPUTER; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Ma L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-536; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Wang CK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-270; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	21	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114484	10.1371/journal.pone.0114484	http://dx.doi.org/10.1371/journal.pone.0114484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517971	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600021
J	Huang, K; Kiefer, C; Kamal, A				Huang, Keven; Kiefer, Christine; Kamal, Adeela			Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTOR; HUMAN T-LYMPHOCYTES; CELL LUNG-CANCER; ENDOTHELIAL-CELLS; UP-REGULATION; HIV-1 ENTRY; TRANSCRIPTIONAL REGULATION; TYROSINE PHOSPHORYLATION; FUNCTIONAL EXPRESSION	The G-protein coupled chemokine (C-X-C motif) receptor CXCR4 is linked to cancer, HIV, and WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome. While CXCR4 is reported to be overexpressed in multiple human cancer types and many hematological cancer cell lines, we have observed poor in vitro cell surface expression of CXCR4 in many solid tumor cell lines. We explore further the possible factors and pathways involved in regulating CXCR4 expression. Here, we showed that MEK-ERK signaling pathway and NFAT3 transcriptional factor plays a novel role in regulating CXCR4 expression. When cultured as 3D spheroids, HeyA8 ovarian tumor cells showed a dramatic increase in surface CXCR4 protein levels as well as mRNA transcripts. Furthermore, HeyA8 3D spheroids showed a decrease in phospho-ERK levels when compared to adherent cells. The treatment of adherent HeyA8 cells with an inhibitor of the MEK-ERK pathway, U0126, resulted in a significant increase in surface CXCR4 expression. Additional investigation using the PCR array assay comparing adherent to 3D spheroid showed a wide range of transcription factors being up-regulated, most notably a> 20 fold increase in NFAT3 transcription factor mRNA. Finally, chromatin immunoprecipitation (ChIP) analysis showed that direct binding of NFAT3 on the CXCR4 promoter corresponds to increased CXCR4 expression in HeyA8 ovarian cell line. Taken together, our results suggest that high phospho-ERK levels and NFAT3 expression plays a novel role in regulating CXCR4 expression.	[Huang, Keven; Kamal, Adeela] MedImmune, Dept Oncol Res, Gaithersburg, MD 20878 USA; [Kiefer, Christine] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Huang, K (corresponding author), MedImmune, Dept Oncol Res, Gaithersburg, MD 20878 USA.	huangke@medimmune.com		Kiefer, Christine/0000-0003-0823-9502	MedImmune	MedImmune(AstraZenecaMedimmune)	MedImmune funded the work mentioned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Baal N, 2009, LAB INVEST, V89, P152, DOI 10.1038/labinvest.2008.126; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Cristillo AD, 2003, MOL IMMUNOL, V40, P539, DOI 10.1016/S0161-5890(03)00169-X; Cristillo AD, 2002, FASEB J, V16, DOI 10.1096/fj.01-0744com; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Feng YK, 2011, EUR J CANCER, V47, P2353, DOI 10.1016/j.ejca.2011.05.006; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; GOLD MR, 1994, ADV IMMUNOL, V55, P221; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Han YL, 2001, BRAIN RES, V888, P1, DOI 10.1016/S0006-8993(00)02924-3; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Huang YC, 2007, BIOCHEM PHARMACOL, V74, P1702, DOI 10.1016/j.bcp.2007.08.025; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kress TR, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-1; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lincz LF, 1997, DIFFERENTIATION, V61, P261, DOI 10.1046/j.1432-0436.1997.6140261.x; Luo C, 1996, MOL CELL BIOL, V16, P3955; MILLER FR, 1989, CANCER RES, V49, P6091; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Moriuchi M, 1997, J IMMUNOL, V159, P4322; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; WEISS A, 1984, J IMMUNOL, V133, P123; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	57	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115249	10.1371/journal.pone.0115249	http://dx.doi.org/10.1371/journal.pone.0115249			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514788	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300046
J	Brehm, MA; Kempen, JCE; van der Kooi, AJ; de Groot, IJM; van den Bergen, JC; Verschuuren, JJGM; Niks, EH; Harlaar, J				Brehm, Merel-Anne; Kempen, Jiska C. E.; van der Kooi, Anneke J.; de Groot, Imelda J. M.; van den Bergen, Janneke C.; Verschuuren, Jan J. G. M.; Niks, Erik H.; Harlaar, Jaap			Age-Related Longitudinal Changes in Metabolic Energy Expenditure during Walking in Boys with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							COST; GAIT; CHILDREN; OXYGEN; DISEASE; SPEED	Objective: The aim of this study was to evaluate age-related changes in metabolic walking energy expenditure in ambulant boys affected by Duchenne muscular dystrophy over a follow-up period of 12 months. Methods: At baseline (T1) and 12 months later (T2), metabolic walking energy expenditure was assessed during a 6-minute walk test at comfortable speed in 14 ambulant boys with Duchenne (age range: 6.0-12.5 years, mean 8.2). Outcome measures derived from the assessment included the 6-minute comfortable walking distance (m) and net-nondimensional energy cost relative to speed-matched control cost (SMC-EC, %). Statistical comparisons were made using a two-way repeated measures ANOVA (factors: time (T1 versus T2) and age (<8 years of age (yoa) versus >= 8 yoa)). Results: Over the course of the study, a significant decrease of -28m (-8.2%, p=0.043) was noted in the walked distance at comfortable speed. Besides, SMC-EC increased with 4.4%, although this change was not significant (p=0.452). Regarding age groups, boys below 8 yoa showed a smaller annual decrease in the walked distance (-15 m) compared to boys above 8 yoa (-37 m). SMC-EC increased with 10% in the older boys, while in the younger boys it decreased (-2.1%). The main effect of age group on walking distance and SMC-EC however was not significant (p>0.158), and also there were no interaction effects (p>0.248). Conclusions: The results of our small study suggest that the natural course of walking performance in ambulant boys with Duchenne is characterized by a decrease in comfortable walking distance and an increase in walking energy cost. The rate of energy cost seems to increase with age, while walking distance decreases, which is opposite from the trend in typically developing children.	[Brehm, Merel-Anne; Kempen, Jiska C. E.; Harlaar, Jaap] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Brehm, Merel-Anne; Kempen, Jiska C. E.; Harlaar, Jaap] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst, Amsterdam, Netherlands; [Brehm, Merel-Anne] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [van der Kooi, Anneke J.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [de Groot, Imelda J. M.] Radboud Univ Nijmegen Med Ctr, Dept Rehabil, Nijmegen, Netherlands; [van den Bergen, Janneke C.; Verschuuren, Jan J. G. M.; Niks, Erik H.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brehm, MA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands.	m.a.brehm@amc.uva.nl	Brehm, Merel-Anne/AAK-7419-2020; Niks, Erik H/M-3520-2016; Brehm, Merel-Anne/K-8638-2017; de Groot, I.J.M./L-4339-2015	Brehm, Merel-Anne/0000-0002-3425-4661; Niks, Erik H/0000-0001-5892-5143; Brehm, Merel-Anne/0000-0002-3425-4661; Verschuuren, Jan/0000-0002-4572-1501; van der Kooi, Anneke/0000-0002-5261-5512; Harlaar, Jaap/0000-0003-2889-271X	Prosensa Therapeutics BV	Prosensa Therapeutics BV	This study was funded by Prosensa Therapeutics BV. The funder contributed to discussions regarding the study protocol and study execution. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	BarOr O, 1996, MED SCI SPORT EXER, V28, P421, DOI 10.1097/00005768-199604000-00005; Bendixen RM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-43; Brehm MA, 2006, ARCH PHYS MED REHAB, V87, P136, DOI 10.1016/j.apmr.2005.08.123; Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0966-6362(03)00097-3; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; European Medical Agency, 2013, GUID CLIN INV MED PR; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Henricson E, 2013, PLOS CURR, V5, DOI [10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06, DOI 10.1371/CURRENTS.MD.9E17658B007EB79FCD6F723089F79E06]; HSU JD, 1993, CLIN ORTHOP RELAT R, P122; Kempen JCE, 2014, NEUROMUSCULAR DISORD, V24, P216, DOI 10.1016/j.nmd.2013.11.015; Marconi V, 2012, EUR J PHYS REHAB MED, V48, P403; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Morgan DW, 2004, EUR J APPL PHYSIOL, V91, P30, DOI 10.1007/s00421-003-0945-9; PRIEDE IG, 1977, NATURE, V267, P610, DOI 10.1038/267610a0; Schwartz MH, 2006, GAIT POSTURE, V24, P14, DOI 10.1016/j.gaitpost.2005.06.014; SUTHERLAND DH, 1981, DEV MED CHILD NEUROL, V23, P3; Thomas SS, 2011, J PEDIATR REHAB MED, V4, P225, DOI 10.3233/PRM-2011-0178; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; Van de Walle P, 2010, GAIT POSTURE, V31, P495, DOI 10.1016/j.gaitpost.2010.02.008; WATERS RL, 1983, DEV MED CHILD NEUROL, V25, P184; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0	30	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115200	10.1371/journal.pone.0115200	http://dx.doi.org/10.1371/journal.pone.0115200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506914	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100058
J	Wiech, K; Edwards, R; Moseley, GL; Berna, C; Ploner, M; Tracey, I				Wiech, Katja; Edwards, Robert; Moseley, Graham Lorimer; Berna, Chantal; Ploner, Markus; Tracey, Irene			Dissociable Neural Mechanisms Underlying the Modulation of Pain and Anxiety? An fMRI Pilot Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; PERCEIVED CONTROLLABILITY; PLACEBO ANALGESIA; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; VOLUNTARY SUPPRESSION; BRAIN RESPONSES; VISCERAL PAIN; EMOTION; CONNECTIVITY	The down-regulation of pain through beliefs is commonly discussed as a form of emotion regulation. In line with this interpretation, the analgesic effect has been shown to co-occur with reduced anxiety and increased activity in the ventrolateral prefrontal cortex (VLPFC), which is a key region of emotion regulation. This link between pain and anxiety modulation raises the question whether the two effects are rooted in the same neural mechanism. In this pilot fMRI study, we compared the neural basis of the analgesic and anxiolytic effect of two types of threat modulation: a "behavioral control'' paradigm, which involves the ability to terminate a noxious stimulus, and a "safety signaling'' paradigm, which involves visual cues that signal the threat (or absence of threat) that a subsequent noxious stimulus might be of unusually high intensity. Analgesia was paralleled by VLPFC activity during behavioral control. Safety signaling engaged elements of the descending pain control system, including the rostral anterior cingulate cortex that showed increased functional connectivity with the periaqueductal gray and VLPFC. Anxiety reduction, in contrast, scaled with dorsolateral prefrontal cortex activation during behavioral control but had no distinct neural signature during safety signaling. Our pilot data therefore suggest that analgesic and anxiolytic effects are instantiated in distinguishable neural mechanisms and differ between distinct stress-and pain-modulatory approaches, supporting the recent notion of multiple pathways subserving top-down modulation of the pain experience. Additional studies in larger cohorts are needed to follow up on these preliminary findings.	[Wiech, Katja; Tracey, Irene] Univ Oxford, John Radcliffe Hosp, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Wiech, Katja; Moseley, Graham Lorimer; Berna, Chantal; Tracey, Irene] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Edwards, Robert] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Chestnut Hill, MA USA; [Moseley, Graham Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Moseley, Graham Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Berna, Chantal] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Ploner, Markus] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	University of Oxford; University of Oxford; Harvard University; Brigham & Women's Hospital; University of South Australia; Neuroscience Research Australia; University of Oxford; Technical University of Munich	Wiech, K (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Headley Way, Oxford OX3 9DU, England.	katja.wiech@ndcn.ox.ac.uk	Ploner, Markus/C-3281-2013; Moseley, Lorimer/A-7095-2009	Ploner, Markus/0000-0002-7767-7170; Moseley, Lorimer/0000-0002-3750-4945; Tracey, Irene/0000-0003-4134-6115; Berna, Chantal/0000-0001-8258-7412	Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO); National Health & Medical Research Council of Australia [571090]; MRC [G0700399] Funding Source: UKRI; Medical Research Council [G0700399] Funding Source: researchfish; National Center for Complementary & Integrative Health [P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051315, R01AR064367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034982] Funding Source: NIH RePORTER	Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The contribution of KW was supported by an Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO). GLM was supported by the National Health & Medical Research Council of Australia (571090). The authors wish to acknowledge the Medical Research Council Great Britain and Northern Ireland and Wellcome Trust (FMRIB Centre and IT), and the International Association for the Study of Pain (RE, IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Borckardt JJ, 2011, PAIN, V152, P182, DOI 10.1016/j.pain.2010.10.018; Campbell CM, 2009, TRANSL RES, V153, P97, DOI 10.1016/j.trsl.2008.12.002; Christianson JP, 2008, J NEUROSCI, V28, P13703, DOI 10.1523/JNEUROSCI.4270-08.2008; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Flaten MA, 2011, PHILOS T R SOC B, V366, P1818, DOI 10.1098/rstb.2010.0407; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Hubbard CS, 2011, PAIN, V152, P1632, DOI 10.1016/j.pain.2011.03.001; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lee HF, 2012, PAIN, V153, P1301, DOI 10.1016/j.pain.2012.03.018; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Mohr C, 2012, EUR J PAIN, V16, P496, DOI 10.1016/j.ejpain.2011.07.010; Moseley GL, 2007, PAIN, V133, P64, DOI 10.1016/j.pain.2007.03.002; Moseley GL, 2004, EUR J PAIN, V8, P39, DOI 10.1016/S1090-3801(03)00063-6; Moseley GL, 2003, AUST J PHYSIOTHER, V49, P263, DOI 10.1016/S0004-9514(14)60142-2; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Pellino TA, 1998, J PAIN SYMPTOM MANAG, V15, P110, DOI 10.1016/S0885-3924(97)00255-8; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Porto PR, 2009, J NEUROPSYCH CLIN N, V21, P114, DOI 10.1176/appi.neuropsych.21.2.114; Rokke PD, 2004, J BEHAV MED, V27, P343, DOI 10.1023/B:JOBM.0000042409.81856.5c; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; SCHARFF L, 1995, HEADACHE, V35, P527, DOI 10.1111/j.1526-4610.1995.hed3509527.x; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Skinner EA, 2011, OXFORD HDB STRESS HL; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; WEISENBERG M, 1985, PAIN, V23, P187, DOI 10.1016/0304-3959(85)90059-4; Wiech K, 2008, PAIN, V139, P467, DOI 10.1016/j.pain.2008.07.030; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006	54	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e110654	10.1371/journal.pone.0110654	http://dx.doi.org/10.1371/journal.pone.0110654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502237	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000346607100001
J	Degerman, S; Domellof, M; Landfors, M; Linder, J; Lundin, M; Haraldsson, S; Elgh, E; Roos, G; Forsgren, L				Degerman, Sofie; Domellof, Magdalena; Landfors, Mattias; Linder, Jan; Lundin, Mathias; Haraldsson, Susann; Elgh, Eva; Roos, Goran; Forsgren, Lars			Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism	PLOS ONE			English	Article							AGING-ASSOCIATED ALTERATION; LEWY BODY; DISEASE; PATHOGENESIS; CRITERIA; CELLS	Telomere length (TL) is regarded as a marker of cellular aging due to the gradual shortening by each cell division, but is influenced by a number of factors including oxidative stress and inflammation. Parkinson's disease and atypical forms of parkinsonism occur mainly in the elderly, with oxidative stress and inflammation in afflicted cells. In this study the relationship between blood TL and prognosis of 168 patients with idiopathic parkinsonism (136 Parkinson's disease [PD], 17 Progressive Supranuclear Palsy [PSP], and 15 Multiple System Atrophy [MSA]) and 30 controls was investigated. TL and motor and cognitive performance were assessed at baseline (diagnosis) and repeatedly up to three to five years follow up. No difference in TL between controls and patients was shown at baseline, nor any significant difference in TL stability or attrition during follow up. Interestingly, a significant relationship between TL at diagnosis and cognitive phenotype at follow up in PD and PSP patients was found, with longer mean TL at diagnosis in patients that developed dementia within three years.	[Degerman, Sofie; Landfors, Mattias; Haraldsson, Susann; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Domellof, Magdalena; Linder, Jan; Forsgren, Lars] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Lundin, Mathias] Umea Univ, Dept Stat, S-90187 Umea, Sweden; [Elgh, Eva] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Degerman, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofie.degerman@umu.se		Degerman, Sofie/0000-0002-2783-0712	Swedish Research Council; Swedish Parkinson Foundation; Swedish Parkinson's Disease Association; Swedish Cancer Society; Umea University; Foundation for Clinical Neuroscience at Umea University Hospital; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Parkinson's Disease Association; Swedish Cancer Society(Swedish Cancer Society); Umea University; Foundation for Clinical Neuroscience at Umea University Hospital; Vasterbotten County Council	This work was supported by grants from the Swedish Research Council (LF, GR), the Swedish Parkinson Foundation (LF), the Swedish Parkinson's Disease Association (LF), the Swedish Cancer Society (GR), Umea University (LF, GR), the Foundation for Clinical Neuroscience at Umea University Hospital (LF), and Vasterbotten County Council (ALF) (LF, GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Domellof ME, 2013, THESIS UMEA U MED; Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125; Emre Murat, 2007, Handb Clin Neurol, V83, P401, DOI 10.1016/S0072-9752(07)83018-1; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Hudson G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.022; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665; Maeda T, 2009, J GERONTOL A-BIOL, V64, P949, DOI 10.1093/gerona/glp070; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Saunders JAH, 2012, J NEUROIMMUNE PHARM, V7, P927, DOI 10.1007/s11481-012-9402-z; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schurks M, 2014, EUR J NEUROL, V21, P93, DOI 10.1111/ene.12252; Svenson U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055543; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7	27	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113387	10.1371/journal.pone.0113387	http://dx.doi.org/10.1371/journal.pone.0113387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501556	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400009
J	Mayer, C; Metscher, BD; Muller, GB; Mitteroecker, P				Mayer, Christine; Metscher, Brian D.; Mueller, Gerd B.; Mitteroecker, Philipp			Studying Developmental Variation with Geometric Morphometric Image Analysis (GMIA)	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EVOLUTION; VISUALIZATION; EPIGENETICS; CONSTRAINTS; PLASTICITY; SHAPE	The ways in which embryo development can vary across individuals of a population determine how genetic variation translates into adult phenotypic variation. The study of developmental variation has been hampered by the lack of quantitative methods for the joint analysis of embryo shape and the spatial distribution of cellular activity within the developing embryo geometry. By drawing from the strength of geometric morphometrics and pixel/voxel-based image analysis, we present a new approach for the biometric analysis of two-dimensional and three-dimensional embryonic images. Well-differentiated structures are described in terms of their shape, whereas structures with diffuse boundaries, such as emerging cell condensations or molecular gradients, are described as spatial patterns of intensities. We applied this approach to microscopic images of the tail fins of larval and juvenile rainbow trout. Inter-individual variation of shape and cell density was found highly spatially structured across the tail fin and temporally dynamic throughout the investigated period.	[Mayer, Christine; Metscher, Brian D.; Mueller, Gerd B.; Mitteroecker, Philipp] Univ Vienna, Fac Life Sci, Dept Theoret Biol, A-1090 Vienna, Austria	University of Vienna	Mitteroecker, P (corresponding author), Univ Vienna, Fac Life Sci, Dept Theoret Biol, Althanstr 14, A-1090 Vienna, Austria.	philipp.mitteroecker@univie.ac.at	Metscher, Brian/I-1238-2019; Mitteroecker, Philipp/A-1591-2012	Metscher, Brian/0000-0002-6514-4406; Mitteroecker, Philipp/0000-0002-5308-3837; Syrowatka, Christine/0000-0002-0315-5142	Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	This study was supported by the Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna, to PM (http://lifesciences.univie.ac.at/). This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookstein F., 1994, PSYCOLOQUY, V5; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Bookstein FL, 2014, EVOL BIOL; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hallgrimsson B, 2011, EPIGENETICS: LINKING GENOTYPE AND PHENOTYPE IN DEVELOPMENT AND EVOLUTION, P1; Hallgrimsson B, 2008, INTEGR COMP BIOL, V48, P373, DOI 10.1093/icb/icn076; Huttegger SM, 2011, EVOL BIOL, V38, P335, DOI 10.1007/s11692-011-9123-x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; LANITIS A, 1995, IMAGE VISION COMPUT, V13, P393, DOI 10.1016/0262-8856(95)99726-H; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Low FM, 2012, EVOL BIOL, V39, P650, DOI 10.1007/s11692-011-9157-0; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Martinez-Abadias N, 2012, EVOL BIOL, V39, P554, DOI 10.1007/s11692-012-9210-7; Metscher BD, 2011, DEV DYNAM, V240, P2301, DOI 10.1002/dvdy.22733; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2012, EVOL BIOL, V39, P536, DOI 10.1007/s11692-012-9178-3; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P377, DOI 10.1007/s11692-009-9075-6; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mitteroecker P, 2009, EVOLUTION, V63, P727, DOI 10.1111/j.1558-5646.2008.00587.x; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Muller GB, 2003, VIENNA SEE THEOR BIO; Newman SA, 2000, J EXP ZOOL, V288, P304, DOI 10.1002/1097-010X(20001215)288:4&lt;304::AID-JEZ3&gt;3.0.CO;2-G; O'Higgins P, 2012, EVOL BIOL, V39, P521, DOI 10.1007/s11692-012-9173-8; Pigliucci Massimo, 2010, EVOLUTION EXTENDED S, DOI DOI 10.1016/j.tree.2008.04.005; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; SENSEN CW, 2009, ADV IMAGING BIOL MED; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi; Zhang D, 2005, LECT NOTES COMPUT SC, V3497; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	46	13	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115076	10.1371/journal.pone.0115076	http://dx.doi.org/10.1371/journal.pone.0115076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500820	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400070
J	Olivieri, L; Gardebien, F				Olivieri, Lilian; Gardebien, Fabrice			Structure-Affinity Properties of a High-Affinity Ligand of FKBP12 Studied by Molecular Simulations of a Binding Intermediate	PLOS ONE			English	Article							X-RAY STRUCTURES; DYNAMICS SIMULATIONS; COMPUTATIONAL ANALYSIS; PROTEIN; COMPLEXES; FK506; RAPAMYCIN; IMMUNOPHILIN; INHIBITORS; DESIGN	With a view to explaining the structure-affinity properties of the ligands of the protein FKBP12, we characterized a binding intermediate state between this protein and a high-affinity ligand. Indeed, the nature and extent of the intermolecular contacts developed in such a species may play a role on its stability and, hence, on the overall association rate. To find the binding intermediate, a molecular simulation protocol was used to unbind the ligand by gradually decreasing the biasing forces introduced. The intermediate was subsequently refined with 17 independent stochastic boundary molecular dynamics simulations that provide a consistent picture of the intermediate state. In this state, the core region of the ligand remains stable, notably because of the two anchoring oxygen atoms that correspond to recurrent motifs found in all FKBP12 ligand core structures. Besides, the non-core regions participate in numerous transient intermolecular and intramolecular contacts. The dynamic aspect of most of the contacts seems important both for the ligand to retain at least a part of its configurational entropy and for avoiding a trapped state along the binding pathway. Since the transient and anchoring contacts contribute to increasing the stability of the intermediate, as a corollary, the dissociation rate constant k(-1) of this intermediate should be decreased, resulting in an increase of the affinity constant K-a. The present results support our previous conclusions and provide a coherent rationale for explaining the prevalence in high-affinity ligands of (i) the two oxygen atoms found in carbonyl or sulfonyl groups of dissimilar core structures and of (ii) symmetric or pseudo-symmetric mobile groups of atoms found as non-core moieties. Another interesting aspect of the intermediate is the distortion of the flexible 80 s loop of the protein, mainly in its tip region, that promotes the accessibility to the bound state.	[Gardebien, Fabrice] INSERM, DSIMB, U1134, F-75015 Paris, France; Univ Reunion, Fac Sci & Technol, UMR S 1134, F-97715 St Denis 05, Reunion, France; Inst Natl Transfus Sanguine, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; University of La Reunion	Gardebien, F (corresponding author), INSERM, DSIMB, U1134, F-75015 Paris, France.	Fabrice.Gardebien@univ-reunion.fr		Gardebien, Fabrice/0000-0002-2019-010X	French Ministry of Research; Laboratory of Excellence GR-Ex [ANR-11-LABX-0051]; French National Research Agency [ANR-11-IDEX-0005-02]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Laboratory of Excellence GR-Ex; French National Research Agency(French National Research Agency (ANR))	L. Olivieri was the recipient of a doctoral fellowship from the French Ministry of Research. This study was supported by grants from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. The labex GR-Ex is funded by the program 'Investissements d'avenir' of the French National Research Agency, reference ANR-11-IDEX-0005-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Burkhard P, 2000, J MOL BIOL, V295, P953, DOI 10.1006/jmbi.1999.3411; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Curcio R, 2005, PROTEIN SCI, V14, P2499, DOI 10.1110/ps.041280705; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; DeCenzo MT, 1996, PROTEIN ENG, V9, P173, DOI 10.1093/protein/9.2.173; Frisch M. J., 2004, GAUSSIAN03; Hamilton GS, 1997, BIOORG MED CHEM LETT, V7, P1785, DOI 10.1016/S0960-894X(97)00304-1; Herdegen Thomas, 2000, Trends in Pharmacological Sciences, V21, P3, DOI 10.1016/S0165-6147(99)01407-8; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Ivery MTG, 1997, BIOORGAN MED CHEM, V5, P217, DOI 10.1016/S0968-0896(96)00229-5; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Lamb ML, 1998, J MED CHEM, V41, P3928, DOI 10.1021/jm980062o; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lemons DS, 1997, AM J PHYS, V65, P1079, DOI 10.1119/1.18725; Li AJ, 1998, J MOL BIOL, V275, P677, DOI 10.1006/jmbi.1997.1484; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Mittag T, 2004, J AM CHEM SOC, V126, P9017, DOI 10.1021/ja0392519; Olivieri L, 2014, J MOL GRAPH MODEL, V49, P118, DOI 10.1016/j.jmgm.2014.02.003; Olivieri L, 2011, J CHEM THEORY COMPUT, V7, P725, DOI 10.1021/ct100394d; Paci E, 2001, J MOL BIOL, V314, P589, DOI 10.1006/jmbi.2001.5103; Peters GH, 1999, PROTEIN ENG, V12, P747, DOI 10.1093/protein/12.9.747; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROSEN MK, 1992, ANGEW CHEM INT EDIT, V31, P384, DOI 10.1002/anie.199203841; ROSEN MK, 1993, J AM CHEM SOC, V115, P821, DOI 10.1021/ja00055a082; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sun F, 2003, BIOPHYS J, V85, P3194, DOI 10.1016/S0006-3495(03)74737-7; Swegat W, 2003, BIOPHYS J, V84, P1493, DOI 10.1016/S0006-3495(03)74962-5; Szep S, 2009, PROTEINS, V74, P603, DOI 10.1002/prot.22176; Teplyakov A, 1996, EMBO J, V15, P3487, DOI 10.1002/j.1460-2075.1996.tb00717.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zacharias M, 2004, PROTEINS, V54, P759, DOI 10.1002/prot.10637; Zhao LQ, 2006, BIOORG MED CHEM LETT, V16, P4385, DOI 10.1016/j.bmcl.2006.05.044	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114610	10.1371/journal.pone.0114610	http://dx.doi.org/10.1371/journal.pone.0114610			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502559	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400039
J	Peng, L; Paulson, A; Li, H; Piekos, S; He, X; Li, LH; Zhong, XB				Peng, Lai; Paulson, Ariel; Li, Hua; Piekos, Stephanie; He, Xi; Li, Linheng; Zhong, Xiao-bo			Developmental Programming of Long Non-Coding RNAs during Postnatal Liver Maturation in Mice	PLOS ONE			English	Article							INTEGRATIVE ANNOTATION; REVEALS; MOUSE; DIFFERENTIATION; TRANSCRIPTION; QUANTIFICATION; ORGANOGENESIS; FRONTIER; GENOME; SEQ	The liver is a vital organ with critical functions in metabolism, protein synthesis, and immune defense. Most of the liver functions are not mature at birth and many changes happen during postnatal liver development. However, it is unclear what changes occur in liver after birth, at what developmental stages they occur, and how the developmental processes are regulated. Long non-coding RNAs (lncRNAs) are involved in organ development and cell differentiation. Here, we analyzed the transcriptome of lncRNAs in mouse liver from perinatal (day -2) to adult (day 60) by RNA-Sequencing, with an attempt to understand the role of lncRNAs in liver maturation. We found around 15,000 genes expressed, including about 2,000 lncRNAs. Most lncRNAs were expressed at a lower level than coding RNAs. Both coding RNAs and lncRNAs displayed three major ontogenic patterns: enriched at neonatal, adolescent, or adult stages. Neighboring coding and noncoding RNAs showed the trend to exhibit highly correlated ontogenic expression patterns. Gene ontology (GO) analysis revealed that some lncRNAs enriched at neonatal ages have their neighbor protein coding genes also enriched at neonatal ages and associated with cell proliferation, immune activation related processes, tissue organization pathways, and hematopoiesis; other lncRNAs enriched at adolescent ages have their neighbor protein coding genes associated with different metabolic processes. These data reveal significant functional transition during postnatal liver development and imply the potential importance of lncRNAs in liver maturation.	[Peng, Lai; Piekos, Stephanie; Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Paulson, Ariel; Li, Hua; He, Xi; Li, Linheng] Stowers Inst Med Res, Kansas City, MO USA	University of Connecticut; Stowers Institute for Medical Research	Zhong, XB (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	xiaobo.zhong@uconn.edu		Li, Linheng/0000-0001-9963-430X	National Institutes of Health National Institute for Environmental Health Sciences [R01ES-019487]; National Institutes of Health National Institute of General Medical Sciences [R01GM-087376]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087376] Funding Source: NIH RePORTER	National Institutes of Health National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health National Institute for Environmental Health Sciences [R01ES-019487 to X.B.Z.] and the National Institutes of Health National Institute of General Medical Sciences [R01GM-087376 to X.B.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen WD, 2011, BBA-MOL BASIS DIS, V1812, P888, DOI 10.1016/j.bbadis.2010.12.006; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jaeschke H., 2008, CASARETT DOULLS TOXI, P557, DOI [10.1036/0071470514, DOI 10.1036/0071470514]; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Li GB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780521; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peng L, 2013, DRUG METAB DISPOS, V41, P2175, DOI 10.1124/dmd.113.054635; Pineiro-Carrero VM, 2004, PEDIATRICS, V113, P1097; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Takeuchi M, 2006, HEMATOPOIESIS FETAF, P1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	31	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114917	10.1371/journal.pone.0114917	http://dx.doi.org/10.1371/journal.pone.0114917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503252	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700071
J	Zhu, X; Ma, Z; Wang, JJ; Chou, SL; Shan, AS				Zhu, Xin; Ma, Zhi; Wang, Jiajun; Chou, Shuli; Shan, Anshan			Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide	PLOS ONE			English	Article							BACTERIAL BIOFILM FORMATION; CATION-PI INTERACTIONS; ANTIBACTERIAL AGENTS; CELL SELECTIVITY; ANTIBIOTICS; DEFENSE; DESIGN; LL-37; RECOGNITION; INHIBITION	Here, we found that simple substitution of amino acids in the middle position of the hydrophobic face of an amphipathic peptide RI16 with tryptophan (T9W) considerably transformed into an antimicrobial peptide specifically targeting Pseudomonas aeruginosa. Minimal inhibitory concentration (MIC) results demonstrated that T9W had a strong and specifically antimicrobial activity against P. aeruginosa, including antibiotic-resistant strains, but was not active against Escherichia coli, Salmonella typhimurium, Staphylococcus aureus and Staphyfococcus epidermidis. Fluorescent spectroscopic assays indicated that T9W interacted with the membrane of P. aeruginosa, depolarizing the outer and the inner membrane of bacterial cells. Salt susceptibility assay showed that T9W still maintained its strong anti-pseudomonas activity in the presence of salts at physiological concentrations, and in hemolytic and MTT assays T9W also showed no toxicity against human blood cells and macrophages. In vivo assay demonstrated that T9W also displayed no toxicity to Chinese Kun Ming (KM) mice. Furthermore, the strong antibiofilm activity was also observed with the peptide T9W, which decreased the percentage of biomass formation in a dose-dependent manner. Overall, these findings indicated that design of single-pathogen antimicrobial agents can be achieved by simple amino acid mutation in naturally occurring peptide sequences and this study suggested a model of optimization/design of anti-pseudomonas drugs in which the tryptophan residue was a conserved element.	[Zhu, Xin; Ma, Zhi; Wang, Jiajun; Chou, Shuli; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Harbin, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Harbin, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105; Zhu, Xin/0000-0001-6556-4147	National Basic Research Program [2012CB124703]; National Key Research Program [2013BAD10B03]; National Natural Science Foundation of China [31072046, 31272453]	National Basic Research Program(National Basic Research Program of China); National Key Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Basic Research Program (Grant No. 2012CB124703), the National Key Research Program (2013BAD10B03) and the National Natural Science Foundation of China (Grant No. 31072046 and No. 31272453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Dong N, 2012, ANTIMICROB AGENTS CH, V56, P2994, DOI 10.1128/AAC.06327-11; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gopal R, 2013, AMINO ACIDS, V44, P645, DOI 10.1007/s00726-012-1388-6; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Lee JK, 2013, BBA-BIOMEMBRANES, V1828, P443, DOI 10.1016/j.bbamem.2012.09.005; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Oradd G, 2011, BBA-BIOMEMBRANES, V1808, P244, DOI 10.1016/j.bbamem.2010.08.015; Ouberai M, 2011, BBA-BIOMEMBRANES, V1808, P1716, DOI 10.1016/j.bbamem.2011.01.014; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pasupuleti M, 2009, BBA-GEN SUBJECTS, V1790, P800, DOI 10.1016/j.bbagen.2009.03.029; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Ravi HK, 2013, CHEM COMMUN, V49, P8821, DOI 10.1039/c3cc44912b; Rydberg HA, 2012, BIOCHEM BIOPH RES CO, V427, P261, DOI 10.1016/j.bbrc.2012.09.030; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Singh V, 2012, ANTIMICROB AGENTS CH, V56, P4360, DOI 10.1128/AAC.00544-12; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Spellberg B, 2013, NAT REV DRUG DISCOV, V12, P963, DOI 10.1038/nrd3957-c1; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wiradharma N, 2013, MACROMOL RAPID COMM, V34, P74, DOI 10.1002/marc.201200534; Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054; Wu GQ, 2008, CURR MICROBIOL, V57, P552, DOI 10.1007/s00284-008-9241-6; Xu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098935; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000; Zhu X, 2014, ACTA BIOMATER, V10, P244, DOI 10.1016/j.actbio.2013.08.043	48	26	29	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114605	10.1371/journal.pone.0114605	http://dx.doi.org/10.1371/journal.pone.0114605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494332	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400058
J	Azoulay-Alfaguter, I; Elya, R; Avrahami, L; Katz, A; Eldar-Finkelman, H				Azoulay-Alfaguter, I.; Elya, R.; Avrahami, L.; Katz, A.; Eldar-Finkelman, H.			Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth	ONCOGENE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RECEPTOR TYROSINE KINASES; TUBEROUS-SCLEROSIS; THERAPEUTIC TARGET; SIGNALING PATHWAY; MAMMALIAN TARGET; TUMOR-SUPPRESSOR; AMINO-ACIDS; INHIBITORS; DISEASE	There is controversy over the role of glycogen synthase kinase-3 (GSK-3) in cancer progression. Recent work has implicated GSK-3 in the regulation of mammalian target of rapamycin (mTOR), a known player in malignant transformation. Autophagy, a selfdegradation pathway, is inhibited by mTOR and is tightly associated with cell survival and tumor growth. Here we show that GSK-3 suppresses autophagy via mTOR complex-1 (mTORC1) and lysosomal regulation. We show that overexpression of GSK-3 isoforms (GSK-3 alpha and GSK-3 alpha) activated mTORC1 and suppressed autophagy in MCF-7 human breast cancer cells as indicated by reduced beclin-1 levels and upregulation of sequestosome 1 (p62/SQSTM1). Further, overexpression of GSK-3 increased the number of autophagosomes and inhibited autophagic flux. This activity was directly related to reduced lysosomal acidification triggered by GSK-3 (in which GSK-3 beta has a stronger impact). We found that lysosomal acidification is reduced in MCF-7 cells that also exhibit increased levels of autophagosomes and p62/SQSTM1 and increased activity of mTORC1. Subsequently, treating cells with GSK-3 inhibitors restored lysosomal acidification, enhanced autophagic flux and inhibited mTORC1. Furthermore, GSK-3 inhibitors inhibited cell proliferation. We provide evidence that GSK3-mediated mTORC1 activity and GSK-3-mediated lysosomal acidification occur via distinct pathways, yet both mTORC1 and lysosomes control cell growth. Finally, we show that GSK-3-reduced lysosomal acidification inhibits endocytic clearance as demonstrated by reduced endocytic degradation of the epidermal growth factor receptor. Taken together, our study places GSK-3 as a key regulator coordinating cellular homeostasis. GSK-3 inhibitors may be useful in targeting mTORC1 and lysosomal acidification for cancer therapy.	[Azoulay-Alfaguter, I.; Elya, R.; Avrahami, L.; Katz, A.; Eldar-Finkelman, H.] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Eldar-Finkelman, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	heldar@post.tau.ac.il		Eldar-Finkelman, Hagit/0000-0002-8460-9686	Israel Science Foundation [341/10]; Finghort Fund for Cancer Research at Tel Aviv University	Israel Science Foundation(Israel Science Foundation); Finghort Fund for Cancer Research at Tel Aviv University	This research was supported by the Israel Science Foundation grant No. 341/10 and the Finghort Fund for Cancer Research at Tel Aviv University. We thank Dr Dan Klionsky and Dr Zvulun Elazar for their constructive comments.	Aguilar-Morante D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013879; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Azoulay-Alfaguter I, 2011, J BIOL CHEM, V286, P13470, DOI 10.1074/jbc.M110.127969; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Birch NW, 2010, CANCER CELL, V17, P529, DOI 10.1016/j.ccr.2010.05.017; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doherty L, 2006, NEUROLOGY, V67, P156, DOI 10.1212/01.wnl.0000223844.77636.29; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Fishman P, 2004, ONCOGENE, V23, P2465, DOI 10.1038/sj.onc.1207355; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gulen MF, 2012, IMMUNITY, V37, P800, DOI 10.1016/j.immuni.2012.08.019; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Harris RA, 2002, PROTEOMICS, V2, P212, DOI 10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Karyo R, 2010, MOL CELL NEUROSCI, V45, P449, DOI 10.1016/j.mcn.2010.08.004; Kim HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060383; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lauring J, 2013, J NATL COMPR CANC NE, V11, P670, DOI 10.6004/jnccn.2013.0086; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McCubrey James A., 2014, Advances in Biological Regulation, V54, P176, DOI 10.1016/j.jbior.2013.09.013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Patel S, 2008, CANCER CELL, V14, P351, DOI 10.1016/j.ccr.2008.10.013; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Proud CG., 2013, BIOCHEM SOC T, V39, P431; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rix LLR, 2014, ACS CHEM BIOL, V9, P353, DOI 10.1021/cb400660a; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Shin S, 2014, ONCOGENE, V33, P1690, DOI 10.1038/onc.2013.113; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Voss MH, 2011, HEMATOL ONCOL CLIN N, V25, P835, DOI 10.1016/j.hoc.2011.04.008; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wazir U, 2014, CANCER GENOM PROTEOM, V11, P167; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398; Zhu Q, 2011, PROSTATE, V71, P835, DOI 10.1002/pros.21300; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	89	70	72	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4613	4623		10.1038/onc.2014.390	http://dx.doi.org/10.1038/onc.2014.390			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25500539				2022-12-26	WOS:000360189300007
J	Guo, C; Li, YL; Gow, CH; Wong, M; Zha, JK; Yan, CX; Liu, HQ; Wang, YJ; Burris, TP; Zhang, JS				Guo, Chun; Li, Yali; Gow, Chien-Hung; Wong, Madeline; Zha, Jikun; Yan, Chunxia; Liu, Hongqi; Wang, Yongjun; Burris, Thomas P.; Zhang, Jinsong			The Optimal Corepressor Function of Nuclear Receptor Corepressor (NCoR) for Peroxisome Proliferator-activated Receptor gamma Requires G Protein Pathway Suppressor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; LIGAND-BINDING DOMAIN; PPAR-GAMMA; TRANSCRIPTIONAL REPRESSION; ADIPOCYTE DIFFERENTIATION; GENE-TRANSCRIPTION; CRYSTAL-STRUCTURE; ADIPOSE-TISSUE; CO-REPRESSOR; SUBUNIT GPS2	Repression of peroxisome proliferator-activated receptor gamma (PPAR gamma)-dependent transcription by the nuclear receptor corepressor (NCoR) is important for homeostatic expression of PPAR gamma target genes in vivo. The current model states that NCoR-mediated repression requires its direct interaction with PPAR gamma in the repressive conformation. Previous studies, however, have shown that DNA-bound PPAR gamma is incompatible with a direct, high-affinity association with NCoR because of the inherent ability of PPAR gamma to adopt the active conformation. Here we show that NCoR acquires the ability to repress active PPAR gamma-mediated transcription via G protein pathway suppressor 2 (GPS2), a component of the NCoR corepressor complex. Unlike NCoR, GPS2 can recognize and bind the active state of PPAR gamma. In GPS2-deficient mouse embryonic fibroblast cells, loss of GPS2 markedly reduces the corepressor function of NCoR for PPAR gamma, leading to constitutive activation of PPAR gamma target genes and spontaneous adipogenesis of the cells. GPS2, however, is dispensable for repression mediated by unliganded thyroid hormone receptor gamma or aPPAR gamma mutant unable to adopt the active conformation. This study shows that GPS2, although dispensable for the intrinsic repression function of NCoR, can mediate a novel corepressor repression pathway that allows NCoR to directly repress active PPAR gamma-mediated transcription, which is important for the optimal corepressor function of NCoR for PPAR gamma. Interestingly, GPS2-dependent repression specifically targets PPAR gamma but not PPAR alpha or PPAR delta. Therefore, GPS2 may serve as a unique target to manipulate PPAR gamma signaling in diseases.	[Guo, Chun; Wong, Madeline; Zha, Jikun; Wang, Yongjun; Burris, Thomas P.; Zhang, Jinsong] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Guo, Chun; Li, Yali; Gow, Chien-Hung; Yan, Chunxia; Zhang, Jinsong] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45267 USA; [Gow, Chien-Hung] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City 220, Taiwan; [Yan, Chunxia] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710049, Shaanxi, Peoples R China; [Liu, Hongqi] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biol, Infect & Immun Res Grp, Kunming 650018, Yunnan, Peoples R China	Saint Louis University; University System of Ohio; University of Cincinnati; Far Eastern Memorial Hospital; Xi'an Jiaotong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College	Zhang, JS (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	jinsongzhang@slu.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Zhang, Jinsong/0000-0002-8798-7316	National Institutes of Health [R21CA178513, R01MH093429]; Saint Louis University; University of Cincinnati Cancer Center; Chinese Scholarship Council; Institute of Medical Biology, Chinese Academy of Medical Science [IMB-201]; NATIONAL CANCER INSTITUTE [R21CA178513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; University of Cincinnati Cancer Center; Chinese Scholarship Council(China Scholarship Council); Institute of Medical Biology, Chinese Academy of Medical Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R21CA178513 (to J. Z.) and R01MH093429 (to T. P. B.). This work was also supported by a start-up fund from Saint Louis University (to J. Z.), by a University of Cincinnati Cancer Center Pilot grant (to J. Z.), by the Chinese Scholarship Council (to C. Y.), and by Institute of Medical Biology, Chinese Academy of Medical Science Grant IMB-201 (to H. L.).	Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Fozzatti L, 2011, P NATL ACAD SCI USA, V108, P17462, DOI 10.1073/pnas.1107474108; Gizard F, 2002, J BIOL CHEM, V277, P39144, DOI 10.1074/jbc.M205786200; Gizard F, 2001, J BIOL CHEM, V276, P33881, DOI 10.1074/jbc.M100113200; Glass CK, 2000, GENE DEV, V14, P121; Gow CH, 2014, NUCLEIC ACIDS RES, V42, P137, DOI 10.1093/nar/gkt855; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo C, 2012, J BIOL CHEM, V287, P12111, DOI 10.1074/jbc.M111.327023; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li P, 2013, DIABETES RES CLIN PR, V102, P35, DOI 10.1016/j.diabres.2013.08.009; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Oger F, 2014, J BIOL CHEM, V289, P708, DOI 10.1074/jbc.M113.526996; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zheng RD, 2013, PEDIATR RES, V73, P263, DOI 10.1038/pr.2012.190	76	15	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3666	3679		10.1074/jbc.M114.598797	http://dx.doi.org/10.1074/jbc.M114.598797			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519902	hybrid, Green Published			2022-12-26	WOS:000349456000039
J	Kumar, V; Weng, YC; Geldenhuys, WJ; Wang, D; Han, XQ; Messing, RO; Chou, WH				Kumar, Varun; Weng, Yi-Chinn; Geldenhuys, Werner J.; Wang, Dan; Han, Xiqian; Messing, Robert O.; Chou, Wen-Hai			Generation and Characterization of ATP Analog-specific Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENETIC SCREEN; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; INHIBITOR SELECTIVITY; PEPTIDE INHIBITOR; STRUCTURAL BASIS; ACTIVATION; SUBSTRATE; EPSILON; PKC	To better study the role of PKC delta in normal function and disease, we developed an ATP analog-specific (AS) PKC delta that is sensitive to specific kinase inhibitors and can be used to identify PKC delta substrates. ASPKC delta showed nearly 200 times higher affinity (K-m) and 150 times higher efficiency (k(cat)/K-m) than wild type (WT) PKC delta toward N-6-(benzyl)-ATP. AS PKC delta was uniquely inhibited by 1-(tert-butyl)-3-(1-naphthyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (1NA-PP1) and 1-(tert-butyl)-3-(2-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (2MB-PP1) but not by other 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine (PP1) analogs tested, whereas WT PKC delta was insensitive to all PP1 analogs. To understand the mechanisms for specificity and affinity of these analogs, we created in silico WT and AS PKC delta homology models based on the crystal structure of PKC delta. N6-(Benzyl)-ATP and ATP showed similar positioning within the purine binding pocket of AS PKC delta, whereas N6-(benzyl)-ATP was displaced from the pocket of WT PKC delta and was unable to interact with the glycine-rich loop that is required for phosphoryl transfer. The adenine rings of 1NA-PP1 and 2MB-PP1 matched the adenine ring of ATP when docked in AS PKC delta, and this interaction prevented the potential interaction of ATP with Lys-378, Glu-428, Leu-430, and Phe-633 residues. 1NA-PP1 failed to effectively dock within WT PKC delta. Other PP1 analogs failed to interact with either AS PKC delta or WT PKC delta. These results provide a structural basis for the ability of AS PKC delta to efficiently and specifically utilize N-6-(benzyl)-ATP as a phosphate donor and for its selective inhibition by 1NA-PP1 and 2MB-PP1. Such homology modeling could prove useful in designing molecules to target PKC delta and other kinases to understand their function in cell signaling and to identify unique substrates.	[Kumar, Varun; Weng, Yi-Chinn; Han, Xiqian; Chou, Wen-Hai] Kent State Univ, Dept Biol Sci, Sch Biomed Sci, Kent, OH 44242 USA; [Geldenhuys, Werner J.] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA; [Wang, Dan; Messing, Robert O.; Chou, Wen-Hai] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA; [Wang, Dan; Messing, Robert O.; Chou, Wen-Hai] Univ Calif San Francisco, Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Messing, Robert O.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Northeast Ohio Medical University (NEOMED); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin	Chou, WH (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	wchou2@kent.edu	Messing, Robert/D-3642-2015; Chou, Wen-Hai/H-1970-2016	Messing, Robert/0000-0002-5345-4431; Chou, Wen-Hai/0000-0002-7899-1129; Kumar, Varun/0000-0001-6867-494X	National Institutes of Health [R21 NS057195, R01 AA018316]; Kent State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kent State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS057195 (to W. H. C.) and R01 AA018316 (to R. O. M.). This work was also supported by a grant from the Kent State University start-up fund (to W. H. C.).	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; DECHATELET LR, 1976, BLOOD, V47, P545; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Qi ZH, 2007, J BIOL CHEM, V282, P33052, DOI 10.1074/jbc.M707233200; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Tanramluk D, 2009, CHEM BIOL DRUG DES, V74, P16, DOI 10.1111/j.1747-0285.2009.00832.x; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Wu DF, 2012, J CLIN INVEST, V122, P1306, DOI 10.1172/JCI61934; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	52	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1936	1951		10.1074/jbc.M114.598698	http://dx.doi.org/10.1074/jbc.M114.598698			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505183	Green Published, hybrid			2022-12-26	WOS:000348588000004
J	Gorham, JC; Clark, DR; Bresette, MJ; Bagley, DA; Keske, CL; Traxler, SL; Witherington, BE; Shamblin, BM; Nairn, CJ				Gorham, Jonathan C.; Clark, David R.; Bresette, Michael J.; Bagley, Dean A.; Keske, Carrie L.; Traxler, Steve L.; Witherington, Blair E.; Shamblin, Brian M.; Nairn, Campbell J.			Characterization of a Subtropical Hawksbill Sea Turtle (Eretmocheyles imbricata) Assemblage Utilizing Shallow Water Natural and Artificial Habitats in the Florida Keys	PLOS ONE			English	Article							FEEDING GROUNDS; CHELONIA-MYDAS; GREEN TURTLES; GROWTH-RATES; HOME-RANGE; AGGREGATION; MIGRATIONS; ECOLOGY; ISLAND; RATIO	In order to provide information to better inform management decisions and direct further research, vessel-based visual transects, snorkel transects, and in-water capture techniques were used to characterize hawksbill sea turtles in the shallow marine habitats of a Marine Protected Area (MPA), the Key West National Wildlife Refuge in the Florida Keys. Hawksbills were found in hardbottom and seagrass dominated habitats throughout the Refuge, and on man-made rubble structures in the Northwest Channel near Cottrell Key. Hawksbills captured (N=82) were exclusively juveniles and subadults with a straight standard carapace length (SSCL) ranging from 21.4 to 69.0cm with a mean of 44.1 cm (SD=10.8). Somatic growth rates were calculated from 15 recaptured turtles with periods at large ranging from 51 to 1188 days. Mean SSCL growth rate was 7.7 cm/year (SD=4.6). Juvenile hawksbills (, 50 cm SSCL) showed a significantly higher growth rate (9.2 cm/year, SD=4.5, N=11) than subadult hawksbills (50-70 cm SSCL, 3.6 cm/year, SD=0.9, N=4). Analysis of 740 base pair mitochondrial control region sequences from 50 sampled turtles yielded 12 haplotypes. Haplotype frequencies were significantly different compared to four other Caribbean juvenile foraging aggregations, including one off the Atlantic coast of Florida. Many-to-one mixed stock analysis indicated Mexico as the primary source of juveniles in the region and also suggested that the Refuge may serve as important developmental habitat for the Cuban nesting aggregation. Serum testosterone radioimmunoassay results from 33 individuals indicated a female biased sex ratio of 3.3 females: 1 male for hawksbills in the Refuge. This assemblage of hawksbills is near the northern limit of the species range, and is one of only two such assemblages described in the waters of the continental United States. Since this assemblage resides in an MPA with intensive human use, basic information on the assemblage is vital to resource managers charged with conservation and species protection in the MPA.	[Gorham, Jonathan C.; Clark, David R.; Bresette, Michael J.; Bagley, Dean A.; Keske, Carrie L.; Traxler, Steve L.; Witherington, Blair E.] Inwater Res Grp Inc, Jensen Beach, FL 34957 USA; [Shamblin, Brian M.; Nairn, Campbell J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Gorham, JC (corresponding author), Inwater Res Grp Inc, Jensen Beach, FL 34957 USA.	jgorham@inwater.org	Nairn, Campbell J/B-6547-2018	Nairn, Campbell J/0000-0002-1690-1730	Florida Sea Turtle Grants Program [09-021R, 10-031R]	Florida Sea Turtle Grants Program	This work was supported by grant numbers 09-021R and 10-031R from the Florida Sea Turtle Grants Program (http://www.helpingseaturtles.org/) to JCG. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois F. A., 2006, 26 ANN S SEA TURTL B; Amos AF, 1989, P 9 ANN WORKSH SEA T, P9; BJORNDAL KA, 1988, COPEIA, P555, DOI 10.2307/1445373; BJORNDAL KA, 1985, BIOL CONSERV, V34, P353, DOI 10.1016/0006-3207(85)90040-0; Bjorndal KA, 2010, MAR BIOL, V157, P135, DOI 10.1007/s00227-009-1304-0; Blanvillian G, 2007, HERPETOLOGICAL CONSE, V3, P21; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Boulon Jr R, 1983, SOME NOTES POPULATIO; Bowen BW, 1999, ECOLOGICAL APPL, V6, P566; Bresette Michael J., 2010, Endangered Species Research, V9, P105, DOI 10.3354/esr00245; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; CARR ARCHIE FAIRLY, 1940, UNIV FLORIDA PUBL BIOL SCI SER, V3, P1; De Sola C. R., 1935, Copeia Ann Arbor, V1935, P44, DOI 10.2307/1436641; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; DIEZ C.E., 1997, P 8 INT COR REEF S, V2, P1421, DOI DOI 10.1007/S00227-011-1681-Z; Diez CE, 2003, J HERPETOL, V37, P533, DOI 10.1670/56-02N; Diez CE, 2002, MAR ECOL PROG SER, V234, P301, DOI 10.3354/meps234301; Ehrhart Llewellyn M., 1999, P61; Geis A, 2003, J HERPETOL, V37, P400, DOI 10.1670/0022-1511(2003)037[0400:PSROJH]2.0.CO;2; Hart KM, 2013, MAR BIOL, V160, P2567, DOI 10.1007/s00227-013-2249-x; Hart KM, 2012, MAR ECOL PROG SER, V457, P193, DOI 10.3354/meps09744; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Meylan Anne, 2006, Chelonian Research Monographs, V3, P105; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; National Marine Fisheries Service and U. S. Fish and Wildlife Service, 2013, HAWKSB SEA TURTL ER; National Marine Fisheries Service US Fish and Wildlife Service., 1993, REC PLAN HAWKSB TURT; Nuttal SM, 2012, P 31 ANN S SEA TURTL; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Pella J, 2001, FISH B-NOAA, V99, P151; Pritchard CH, 1983, W ATL TURTL S; Shamblin BM, 2012, MOL ECOL, V21, P2330, DOI 10.1111/j.1365-294X.2012.05530.x; Tikochinski Y, 2012, MAR GENOM, V6, P17, DOI 10.1016/j.margen.2012.01.002; van Dam RP, 1998, J EXP MAR BIOL ECOL, V220, P15, DOI 10.1016/S0022-0981(97)00080-4; Vilaca ST, 2013, J EXP MAR BIOL ECOL, V446, P334, DOI 10.1016/j.jembe.2013.06.004; Wood LD, 2013, HERPETOL CONSERV BIO, V8, P258	38	19	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114171	10.1371/journal.pone.0114171	http://dx.doi.org/10.1371/journal.pone.0114171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517946	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600013
J	Badve, SV; Paul, SK; Klein, K; Clayton, PA; Hawley, CM; Brown, FG; Boudville, N; Polkinghorne, KR; McDonald, SP; Johnson, DW				Badve, Sunil V.; Paul, Sanjoy K.; Klein, Kerenaftali; Clayton, Philip A.; Hawley, Carmel M.; Brown, Fiona G.; Boudville, Neil; Polkinghorne, Kevan R.; McDonald, Stephen P.; Johnson, David W.			The Association between Body Mass Index and Mortality in Incident Dialysis Patients	PLOS ONE			English	Article							PERITONEAL-DIALYSIS; OBESITY PARADOX; HEMODIALYSIS-PATIENTS; SURVIVAL ADVANTAGE; SIZE; OUTCOMES; WEIGHT; FAT; INFLAMMATION; SURROGATES	Objectives: To study the body mass index (BMI) trajectory in patients with incident end-stage kidney disease and its association with all-cause mortality. Methods: This longitudinal cohort study included 17022 adult patients commencing hemodialysis [HD] (n=10860) or peritoneal dialysis [PD] (n=6162) between 2001 and 2008 and had >= 6-month follow-up and >= 2 weight measurements, using the Australia and New Zealand Dialysis and Transplant Registry data. The association of time-varying BMI with all-cause mortality was explored using multivariate Cox regression models. Results: The median follow-up was 2.3 years. There was a non-linear change in the mean BMI (kg/m2) over time, with an initial decrease from 27.6 (95% confidence interval [CI]: 27.5, 27.7) to 26.7 (95% CI: 26.6, 26.9) at 3-month, followed by increments to 27.1 (95% CI: 27, 27.2) at 1-year and 27.2 (95% CI: 26.8, 27.1) at 3-year, and a gradual decrease subsequently. The BMI trajectory was significantly lower in HD patients who died than those who survived, although this pattern was not observed in PD patients. Compared to the reference time-varying BMI category of 25.1-28 kg/m(2), the mortality risks of both HD and PD patients were greater in all categories of time-varying BMI <25 kg/m(2). The mortality risks were significantly lower in all categories of time-varying BMI >28.1 kg/m(2) among HD patients, but only in the category 28.1-31 kg/m(2) among PD patients. Conclusions: BMI changed over time in a non-linear fashion in incident dialysis patients. Time-varying measures of BMI were significantly associated with mortality risk in both HD and PD patients.	[Badve, Sunil V.; Hawley, Carmel M.; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia; [Paul, Sanjoy K.; Klein, Kerenaftali] QIMR Berghofer Med Res Inst, Clin Trials Biostat Unit, Brisbane, Qld, Australia; [Clayton, Philip A.] Royal Prince Alfred Hosp, Dept Renal Med, Sydney, NSW, Australia; [Brown, Fiona G.; Polkinghorne, Kevan R.] Monash Med Ctr, Dept Nephrol & Med, Melbourne, Vic, Australia; [Brown, Fiona G.; Polkinghorne, Kevan R.] Monash Univ, Melbourne, Vic 3004, Australia; [Boudville, Neil] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [McDonald, Stephen P.] Univ Adelaide, Australia & New Zealand Dialysis & Transplant Reg, Cent Northern Adelaide Renal & Transplant Serv, Adelaide, SA, Australia	QIMR Berghofer Medical Research Institute; University of Sydney; Monash University; Monash University; University of Western Australia; University of Adelaide	Paul, SK (corresponding author), QIMR Berghofer Med Res Inst, Clin Trials Biostat Unit, Brisbane, Qld, Australia.	Sanjoy.paul@qimrberghofer.edu.au	Hawley, Carmel Mary/C-4905-2011; Boudville, Neil/H-8864-2014; Badve, Sunil/F-9049-2010; Clayton, Philip A/D-5613-2011; Paul, Sanjoy K/F-8199-2010; Johnson, David/F-2897-2011	Hawley, Carmel Mary/0000-0002-1392-5649; Badve, Sunil/0000-0003-2269-312X; Clayton, Philip A/0000-0001-9190-6753; Paul, Sanjoy K/0000-0003-0848-7194; Polkinghorne, Kevan/0000-0002-9851-002X; Boudville, Neil/0000-0002-5884-640X; Johnson, David/0000-0001-5491-3460	Merck; Novo Nordisk; Pfizer; Amylin Pharmaceuticals; Hospira; Amgen; Shire; Genzyme; Fresenius; Baxter; Baxter ANZ PD Academy; Roche; Janssen Cilag; Amgen Australia; Janssen-Cilag Pty Ltd; Boehringer-Ingelheim	Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Amylin Pharmaceuticals(Bristol-Myers Squibb); Hospira; Amgen(Amgen); Shire; Genzyme(Sanofi-AventisGenzyme Corporation); Fresenius; Baxter; Baxter ANZ PD Academy; Roche(Roche Holding); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen Australia(Amgen); Janssen-Cilag Pty Ltd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer-Ingelheim(Boehringer Ingelheim)	Drs. Badve, Klein and Clayton have reported that they have no potential conflicts of interest relevant to the contents of this paper to disclose. Dr. Paul has acted as a consultant and speaker for Novartis and Amylin Pharmaceuticals, LLC. He has received grants in support of investigator and investigator initiated clinical studies from Merck, Novo Nordisk and Pfizer, Amylin Pharmaceuticals and Hospira. Dr. Hawley has received consultancy fees from Amgen, Shire, Genzyme and Fresenius; research grant from Baxter and payment for lectures from Amgen and Shire. Dr. Brown has served as a member of the Fresenius ANZ Clinical Advisory Board and has received payment for lectures from Baxter ANZ PD Academy. Dr. Boudville has received research grant and payment for lectures from Roche; and travel grants from Roche, Amgen and Janssen Cilag. Dr. Polkinghorne has received payment for lectures from Amgen Australia and Janssen-Cilag Pty Ltd; and travel grants from Amgen Australia. Dr. McDonald has received consultancy fees from Amgen and Shire; research grants from Amgen; and travel grants from Amgen. Dr. Johnson has received consultancy fees from Baxter, Shire and Amgen; research grants from Baxter, Fresenius, Amgen, Janssen Cilag and Roche; payment for lectures from Baxter, Fresenius, Amgen, Shire and Boehringer-Ingelheim; payment for development of educational presentations from Baxter, Shire, Boehringer-Ingelheim and Lilley; and travel grants from Baxter, Fresenius, Shire, Amgen and Roche. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Ayala ER, 2004, NEPHROL DIAL TRANSPL, V19, P421, DOI 10.1093/ndt/gfg559; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Campbell KL, 2010, J RENAL NUTR, V20, P414, DOI 10.1053/j.jrn.2010.04.003; Chazot C, 2009, NEPHROL DIAL TRANSPL, V24, P2871, DOI 10.1093/ndt/gfp168; Cho KH, 2010, NEPHROL DIAL TRANSPL, V25, P593, DOI 10.1093/ndt/gfp473; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Mutsert R, 2009, CONTRIB NEPHROL, V163, P124, DOI 10.1159/000223790; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Fernstrom A, 1998, PERITON DIALYSIS INT, V18, P166; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Johnson DW, 2000, PERITON DIALYSIS INT, V20, P715; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384; Kalantar-Zadeh K, 2010, MAYO CLIN PROC, V85, P991, DOI 10.4065/mcp.2010.0336; Kotanko P, 2009, BLOOD PURIFICAT, V27, P38, DOI 10.1159/000167007; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Lievense H, 2012, NEPHROL DIAL TRANSPL, V27, P3631, DOI 10.1093/ndt/gfs131; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Molnar MZ, 2011, AM J TRANSPLANT, V11, P725, DOI 10.1111/j.1600-6143.2011.03468.x; National Health Medical Research Council (Australia), 2003, CLIN PRACT GUID MAN; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pellicano R, 2011, CLIN J AM SOC NEPHRO, V6, P1668, DOI 10.2215/CJN.06790810; Pliakogiannis T, 2007, INT UROL NEPHROL, V39, P281, DOI 10.1007/s11255-006-9142-1; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Snyder JJ, 2003, KIDNEY INT, V64, P1838, DOI 10.1046/j.1523-1755.2003.00287.x; Stack AG, 2004, KIDNEY INT, V65, P2398, DOI 10.1111/j.1523-1755.2004.00654.x; Stenvinkel P, 2000, J AM SOC NEPHROL, V11, P1303, DOI 10.1681/ASN.V1171303; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vashistha T, 2014, AM J KIDNEY DIS, V63, P612, DOI 10.1053/j.ajkd.2013.07.021; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	41	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114897	10.1371/journal.pone.0114897	http://dx.doi.org/10.1371/journal.pone.0114897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513810	Green Published, gold			2022-12-26	WOS:000349146300023
J	Braesch-Andersen, S; Beckman, L; Paulie, S; Kumagai-Braesch, M				Braesch-Andersen, Sten; Beckman, Lena; Paulie, Staffan; Kumagai-Braesch, Makiko			ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma	PLOS ONE			English	Article							APOLIPOPROTEIN-D; ALZHEIMERS-DISEASE; GENETIC-VARIATION; PERIPHERAL-NERVE; CANCER CELLS; HUMAN-PLASMA; HIGH-DENSITY; CHOLESTEROL ACYLTRANSFERASE; OXIDATIVE STRESS; MESSENGER-RNA	Apolipoprotein (Apo) D is an important protein produced in many parts of the body. It is necessary for the development and repair of the brain and protection from oxidative stress. The purpose of this study was to investigate the extent to which apoD interacts with lipoproteins in human plasma. By using detergent-free ELISA, we show that immobilized monoclonal antibodies against apoD very efficiently bind to low density lipoprotein (LDL) from plasma; this binding is as equally efficient as binding to an anti-apoB monoclonal antibody. Adding detergent to the plasma inhibited the binding, suggesting that the binding is dependent on the presence of intact lipoprotein particles. Reversing the system by using immobilized anti-apoB revealed that the affinity of apoD for LDL is rather low, suggesting that multiple bindings are needed for a durable connection. Biosensor experiments using purified lipoproteins also showed that purified apoD and high density lipoprotein 3 (HDL3), a lipoprotein fraction rich in apoD, were both able to bind LDL very efficiently, indicating that the HDL3-LDL interaction may be a physiological consequence of the affinity of apoD for LDL. Furthermore, we found that apoD increases the binding of HDL to actively growing T24 bladder carcinoma cells but not to quiescent, contact-inhibited, confluent T24 cells. This result is especially intriguing given that the T24 supernatant only contained detectable levels of apoD after growth inhibition, raising the possibility that alternating the expression of apoD and a putative apoD-receptor could give direction to the flow of lipids. In the current paper, we conclude that apoD mediates binding of HDL to LDL and to growing T24 carcinomas, thereby highlighting the importance of apoD in lipid metabolism.	[Braesch-Andersen, Sten; Beckman, Lena; Paulie, Staffan] Mabtech, Nacka Strand, Sweden; [Beckman, Lena] Karolinska Univ, Huddinge Hosp, Dept Endocrinol Metab & Diabet, Huddinge Hosp,Metab Unit, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Div Transplantat Surg, CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Braesch-Andersen, S (corresponding author), Mabtech, Nacka Strand, Sweden.	sten@mabtech.com		Kumagai-Braesch, Makiko/0000-0001-6011-0744				Bajo-Graneras R, 2013, INT J COLORECTAL DIS, V28, P751, DOI 10.1007/s00384-012-1616-2; BALBIN M, 1990, BIOCHEM J, V271, P803, DOI 10.1042/bj2710803; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; BON GB, 1981, J LIPID RES, V22, P998; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; Chen Y, 2008, BRAIN RES, V1233, P196, DOI 10.1016/j.brainres.2008.07.018; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Desai PP, 2003, AM J MED GENET B, V116B, P98, DOI 10.1002/ajmg.b.10798; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; FIELDING PE, 1980, P NATL ACAD SCI-BIOL, V77, P3327, DOI 10.1073/pnas.77.6.3327; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Helisalmi S, 2004, J NEUROL, V251, P951, DOI 10.1007/s00415-004-0470-8; HOLMQUIST L, 1989, J BIOCHEM BIOPH METH, V19, P93, DOI 10.1016/0165-022X(89)90054-7; Jimenez-Palomares M, 2011, METABOLISM, V60, P1767, DOI 10.1016/j.metabol.2011.04.013; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; LopezBoado YS, 1997, CANCER RES, V57, P4091; Mehdi H, 1999, HUM GENET, V105, P63, DOI 10.1007/s004390051065; MILLER NE, 1977, J CLIN INVEST, V60, P78, DOI 10.1172/JCI108772; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Muffat J, 2010, CELL CYCLE, V9, P269, DOI 10.4161/cc.9.2.10433; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perdomo G, 2009, AGING-US, V1, P17; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Shao B, 2009, J LIPID RES, V50, P599, DOI 10.1194/jlr.E900001-JLR200; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; SUGIMOTO K, 1994, J STEROID BIOCHEM, V51, P167, DOI 10.1016/0960-0760(94)90090-6; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; Yoshikawa M, 1997, CLIN BIOCHEM, V30, P221, DOI 10.1016/S0009-9120(97)00031-3	37	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115180	10.1371/journal.pone.0115180	http://dx.doi.org/10.1371/journal.pone.0115180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513803	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300039
J	Shiraki, T; Aoyama, T; Yokoyama, C; Hayakawa, Y; Tanaka, T; Nishigaki, K; Sawamura, T; Minatoguchi, S				Shiraki, Takeru; Aoyama, Takuma; Yokoyama, Chiharu; Hayakawa, Yuka; Tanaka, Toshiki; Nishigaki, Kazuhiko; Sawamura, Tatsuya; Minatoguchi, Shinya			LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OX-LDL RECEPTOR-1; VASCULAR ENDOTHELIAL-CELLS; HIGH-CHOLESTEROL DIET; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; OXIDIZED LDL; ATHEROSCLEROTIC LESIONS; MEDIATED ARTERIOGENESIS; NAD(P)H OXIDASE	LOX-1, lectin-like oxidized low-density lipoprotein (LDL) receptor-1, is a single transmembrane receptor mainly expressed on endothelial cells. LOX-1 mediates the uptake of oxidized LDL, an early step in atherosclerosis; however, little is known about whether LOX-1 is involved in angiogenesis during tissue ischemia. Therefore, we examined the role of LOX-1 in ischemia-induced angiogenesis in the hindlimbs of LOX-1 knockout (KO) mice. Angiogenesis was evaluated in a surgically induced hindlimb ischemia model using laser Doppler blood flowmetry (LDBF) and histological capillary density (CD) and arteriole density (AD). After right hindlimb ischemia, the ischemic/nonischemic hindlimb blood flow ratio was persistently lower in LOX-1 KO mice than in wild-type (WT) mice. CD and AD were significantly smaller in LOX-1 KO mice than in WT mice on postoperative day 14. Immunohistochemical analysis revealed that the number of macrophages infiltrating ischemic tissues was significantly smaller in LOX-1 KO mice than in WT mice. The number of infiltrated macrophages expressing VEGF was also significantly smaller in LOX-1 KO mice than in WT mice. Western blot analysis and ROS production assay revealed that LOX-KO mice show significant decrease in Nox2 expression, ROS production and HIF-1 alpha expression, the phosphorylation of p38 MAPK and NF-kappa B p65 subunit as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and LOX-1 itself in ischemic muscles, which is supposed to be required for macrophage infiltration expressing angiogenic factor VEGF. Reduction of VEGF expression successively suppressed the phosphorylation of Akt and eNOS, which accelerated angiogenesis, in the ischemic leg of LOX-1 KO mice. Our findings indicate that LOX-1 plays an important role in ischemia-induced angiogenesis by 1) Nox2-ROS-NF-kappa B activation, 2) upregulated expression of adhesion molecules: VCAM-1 and LOX-1 and 3) promoting macrophage infiltration, which expresses angiogenic factor VEGF.	[Shiraki, Takeru; Aoyama, Takuma; Yokoyama, Chiharu; Hayakawa, Yuka; Tanaka, Toshiki; Nishigaki, Kazuhiko; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 390, Japan	Gifu University; National Cerebral & Cardiovascular Center - Japan; Shinshu University	Aoyama, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	TKMAOYAMA@aol.com	Sawamura, Tatsuya/E-7103-2010					Aoyama T, 2000, FEBS LETT, V467, P217, DOI 10.1016/S0014-5793(00)01154-6; Aoyama T, 1999, BIOCHEM J, V339, P177, DOI 10.1042/0264-6021:3390177; Aoyama T, 1999, J MOL CELL CARDIOL, V31, P2101, DOI 10.1006/jmcc.1999.1041; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Diebold I, 2012, J CELL SCI, V125, P956, DOI 10.1242/jcs.094060; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Honjo M, 2003, P NATL ACAD SCI USA, V100, P1274, DOI 10.1073/pnas.0337528100; Hu CP, 2008, CARDIOVASC RES, V79, P287, DOI 10.1093/cvr/cvn110; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Hu C, 2008, J MOL CELL CARDIOL, V44, P76, DOI 10.1016/j.yjmcc.2007.10.009; Hu CP, 2007, CARDIOVASC RES, V76, P292, DOI 10.1016/j.cardiores.2007.07.003; Inomata Y, 2009, INVEST OPHTH VIS SCI, V50, P3970, DOI 10.1167/iovs.07-1177; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kanata S, 2006, BIOCHEM BIOPH RES CO, V348, P1003, DOI 10.1016/j.bbrc.2006.07.133; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; Kawamura I, 2010, AM J PHYSIOL-HEART C, V299, pH372, DOI 10.1152/ajpheart.00035.2010; Kume N, 1998, CIRC RES, V83, P322, DOI 10.1161/01.RES.83.3.322; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moriwaki H, 1998, ARTERIOSCL THROM VAS, V18, P1541, DOI 10.1161/01.ATV.18.10.1541; Nishimura S, 2004, OSTEOARTHR CARTILAGE, V12, P568, DOI 10.1016/j.joca.2004.04.005; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Sangle GV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1243, DOI 10.1152/ajpendo.90415.2008; Sasaki K, 2002, J CLIN INVEST, V109, P603, DOI 10.1172/JCI200213055; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; White SJ, 2010, CARDIOVASC PATHOL; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Zhang FX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/691023	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114542	10.1371/journal.pone.0114542	http://dx.doi.org/10.1371/journal.pone.0114542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514797	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300014
J	Geuss, LR; Wu, DC; Ramamoorthy, D; Alford, CD; Suggs, LJ				Geuss, Laura R.; Wu, Douglas C.; Ramamoorthy, Divya; Alford, Corinne D.; Suggs, Laura J.			Paramagnetic Beads and Magnetically Mediated Strain Enhance Cardiomyogenesis in Mouse Embryoid Bodies	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; CYCLIC STRAIN; CARDIAC DIFFERENTIATION; MECHANICAL CONTROL; INTEGRINS; INHIBITION; EXPRESSION; ADHESION; DELIVERY; STRESS	Mechanical forces play an important role in proper embryologic development, and similarly such forces can directly impact pluripotency and differentiation of mouse embryonic stem cells (mESC) in vitro. In addition, manipulation of the embryoid body (EB) microenvironment, such as by incorporation of microspheres or microparticles, can similarly influence fate determination. In this study, we developed a mechanical stimulation regimen using permanent neodymium magnets to magnetically attract cells within an EB. Arginine-Glycine-Aspartic Acid (RGD)-conjugated paramagnetic beads were incorporated into the interior of the EBs during aggregation, allowing us to exert force on individual cells using short-term magnetization. EBs were stimulated for one hour at different magnetic field strengths, subsequently exerting a range of force intensity on the cells at different stages of early EB development. Our results demonstrated that following exposure to a 0.2 Tesla magnetic field, ESCs respond to magnetically mediated strain by activating Protein Kinase A (PKA) and increasing phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) expression. The timing of stimulation can also be tailored to guide ESC differentiation: the combination of bone morphogenetic protein 4 (BMP4) supplementation with one hour of magnetic attraction on Day 3 enhances cardiomyogenesis by increasing contractile activity and the percentage of sarcomeric a-actin-expressing cells compared to control samples with BMP4 alone. Interestingly, we also observed that the beads alone had some impact on differentiation by increasingly slightly, albeit not significantly, the percentage of cardiomyocytes. Together these results suggest that magnetically mediated strain can be used to enhance the percentage of mouse ESC-derived cardiomyocytes over current differentiation protocols.	[Geuss, Laura R.; Wu, Douglas C.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Ramamoorthy, Divya; Alford, Corinne D.; Suggs, Laura J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Suggs, LJ (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	suggs@utexas.edu	Wu, Douglas/ABF-2497-2020	Wu, Douglas/0000-0001-6179-3110; /0000-0002-1419-8017; Ramamoorthy, Divya/0000-0001-9438-0419	National Science Foundation Career Award grant [CBET-0845239]	National Science Foundation Career Award grant(National Science Foundation (NSF))	The National Science Foundation Career Award grant awarded to LS (grant no. CBET-0845239) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079; Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4; Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Dawson J, 2011, IN VITRO CELL DEV-AN, V47, P653, DOI 10.1007/s11626-011-9453-0; Geuss LR, 2013, BIOTECHNOL PROGR, V29, P1089, DOI 10.1002/btpr.1794; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050; Heo JS, 2011, J CELL BIOCHEM, V112, P1880, DOI 10.1002/jcb.23108; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Laboureau J, 2004, EXP DERMATOL, V13, P70, DOI 10.1111/j.0906-6705.2004.00117.x; Lee MY, 2011, BIOCHEM BIOPH RES CO, V416, P51, DOI 10.1016/j.bbrc.2011.10.140; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sargent CY, 2009, TISSUE ENG PT A, V15, P331, DOI 10.1089/ten.tea.2008.0145; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Tahaa MF, 2008, INT J CARDIOL, V127, P78, DOI 10.1016/j.ijcard.2007.04.173; Toh YC, 2011, FASEB J, V25, P1208, DOI 10.1096/fj.10-168971; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080; VONSWEENEY NO, 2004, CARDIOVASC RES, V63, P625, DOI DOI 10.1016/J.CARDIORES.2004.05.008; Wan CR, 2011, ANN BIOMED ENG, V39, P1840, DOI 10.1007/s10439-011-0275-8; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yanada S, 2006, J BIOMED MATER RES A, V77A, P773, DOI 10.1002/jbm.a.30635; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113982	10.1371/journal.pone.0113982	http://dx.doi.org/10.1371/journal.pone.0113982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501004	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400020
J	Lederer, H; Muggli, B; Speich, R; Treder, U; Stricker, H; Goede, J; Ulrich, S; Stampfli, SF; Breitenstein, A				Lederer, Heidi; Muggli, Bettina; Speich, Rudolf; Treder, Ula; Stricker, Hans; Goede, Jeroen; Ulrich, Silvia; Stampfli, Simon F.; Breitenstein, Alexander			Haemosiderin-Laden Sputum Macrophages for Diagnosis in Pulmonary Veno-Occlusive Disease	PLOS ONE			English	Article							CLINICAL MANAGEMENT; HYPERTENSION; HEMORRHAGE; EDEMA	Aims: Pulmonary veno-occlusive disease (PVOD) is a rare condition of pulmonary arterial hypertension (PAH), in which post-capillary veins are affected. Since the therapeutic approach in PVOD differs from other forms of PAH, it is crucial to establish the diagnosis. Due to the fact that affected patients are often hemodynamically unstable, minimal invasive procedures are necessary for the diagnostic work-up. Chronic alveolar haemorrhage has been observed during bronchoalveolar lavage in PVOD cases. This study therefore investigates whether signs of alveolar haemorrhage can also be found in the sputum of these patients. Methods and Results: Six patients suffering from PVOD were included in this analysis. As controls, patients with idiopathic PAH (n=11), chronic thromboembolic PH (n=9) and with sclerodermia-associated PH (n=10) were assessed. Sputum from every patient was obtained by a non-invasive manner. The amount of haemosiderin-laden macrophages was determined using the Golde score. There were statistically significant more haemosiderin-laden macrophages in the sputum of patients suffering from PVOD as compared to the other groups (P<0.05). Assuming a cut-off of 200 on the Golde score, all of the 6 PVOD patients surpassed this value compared with only 1 out of the 30 cases with precapillary PH. Thus, sensitivity and specificity with respect to the diagnosis of PVOD was 100% and 97%, respectively. Conclusion: The content of haemosiderin-laden macrophages in the sputum of patients suffering from PVOD is significantly higher as compared to other forms of PH and may be useful in the non-invasive diagnostic work-up of these patients.	[Lederer, Heidi; Speich, Rudolf; Treder, Ula; Ulrich, Silvia; Breitenstein, Alexander] Univ Zurich Hosp, Clin Internal Med, Zurich Pulm Hypertens Program, CH-8091 Zurich, Switzerland; [Muggli, Bettina; Stampfli, Simon F.; Breitenstein, Alexander] Univ Zurich Hosp, Univ Heart Ctr, CH-8091 Zurich, Switzerland; [Stricker, Hans] Osped La Carita, Locarno, Switzerland; [Goede, Jeroen] Univ Zurich Hosp, Dept Hematol, CH-8091 Zurich, Switzerland; [Breitenstein, Alexander] St Bartholomews Hosp, Barts Hlth NHS Trust, Dept Cardiol, London, England	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Barts Health NHS Trust; University of London; Queen Mary University London	Breitenstein, A (corresponding author), Univ Zurich Hosp, Clin Internal Med, Zurich Pulm Hypertens Program, CH-8091 Zurich, Switzerland.	alexander.breitenstein@usz.ch		Stampfli, Simon F./0000-0003-3690-8216; Ulrich, Silvia/0000-0002-5250-5022	Actelion Switzerland	Actelion Switzerland	Dr. Breitenstein received educational funding from Actelion Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P749, DOI 10.1590/S1806-37132008000900015; Chaisson NF, 2013, CHEST, V144, P1346, DOI 10.1378/chest.12-2396; Creagh-Brown BC, 2008, THORAX, V63, P933, DOI 10.1136/thx.2007.088831; ELLIOTT CG, 1988, RESPIRATION, V53, P262; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GOLDE DW, 1975, BMJ-BRIT MED J, V2, P166, DOI 10.1136/bmj.2.5964.166; Holcomb BW, 2000, CHEST, V118, P1671, DOI 10.1378/chest.118.6.1671; Huertas A, 2011, EXPERT REV RESP MED, V5, P217, DOI [10.1586/ers.11.15, 10.1586/ERS.11.15]; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Lang IM, 2014, CIRCULATION, V130, P508, DOI 10.1161/CIRCULATIONAHA.114.009309; Lantuejoul S, 2006, AM J SURG PATHOL, V30, P850, DOI 10.1097/01.pas.0000209834.69972.e5; Mandel J, 2000, AM J RESP CRIT CARE, V162, P1964, DOI 10.1164/ajrccm.162.5.9912045; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; Palmer SM, 1998, CHEST, V113, P237, DOI 10.1378/chest.113.1.237; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Rabillier A, 2006, EUR RESPIR J, V27, P108, DOI 10.1183/09031936.06.00054105; Resten A, 2004, AM J ROENTGENOL, V183, P65, DOI 10.2214/ajr.183.1.1830065; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SHACKELFORD GD, 1977, AM J ROENTGENOL, V128, P643, DOI 10.2214/ajr.128.4.643; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Zamanian RT, 2014, CIRC RES, V115, P131, DOI 10.1161/CIRCRESAHA.115.303827	22	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115219	10.1371/journal.pone.0115219	http://dx.doi.org/10.1371/journal.pone.0115219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501010	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000346375400085
J	Sante, T; Vergult, S; Volders, PJ; Kloosterman, WP; Trooskens, G; De Preter, K; Dheedene, A; Speleman, F; De Meyer, T; Menten, B				Sante, Tom; Vergult, Sarah; Volders, Pieter-Jan; Kloosterman, Wigard P.; Trooskens, Geert; De Preter, Katleen; Dheedene, Annelies; Speleman, Frank; De Meyer, Tim; Menten, Bjorn			ViVar: A Comprehensive Platform for the Analysis and Visualization of Structural Genomic Variation	PLOS ONE			English	Article							READ ALIGNMENT; DATABASE; REARRANGEMENTS; SEQUENCES; TOOL	Structural genomic variations play an important role in human disease and phenotypic diversity. With the rise of high-throughput sequencing tools, mate-pair/paired-end/single-read sequencing has become an important technique for the detection and exploration of structural variation. Several analysis tools exist to handle different parts and aspects of such sequencing based structural variation analyses pipelines. A comprehensive analysis platform to handle all steps, from processing the sequencing data, to the discovery and visualization of structural variants, is missing. The ViVar platform is built to handle the discovery of structural variants, from Depth Of Coverage analysis, aberrant read pair clustering to split read analysis. ViVar provides you with powerful visualization options, enables easy reporting of results and better usability and data management. The platform facilitates the processing, analysis and visualization, of structural variation based on massive parallel sequencing data, enabling the rapid identification of disease loci or genes. ViVar allows you to scale your analysis with your work load over multiple (cloud) servers, has user access control to keep your data safe and is easy expandable as analysis techniques advance.	[Sante, Tom; Vergult, Sarah; Volders, Pieter-Jan; De Preter, Katleen; Dheedene, Annelies; Speleman, Frank; Menten, Bjorn] Univ Ghent, Fac Med & Hlth Sci, Ctr Med Genet, B-9000 Ghent, Belgium; [Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Trooskens, Geert; De Meyer, Tim] Univ Ghent, Fac Biosci Engn, BioBix, B-9000 Ghent, Belgium	Ghent University; Utrecht University; Utrecht University Medical Center; Ghent University	Menten, B (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Ctr Med Genet, B-9000 Ghent, Belgium.	bjorn.menten@UGent.be	Volders, Pieter-Jan/I-1567-2019; De Preter, Katleen/I-7135-2013; speleman, frank/AAR-5184-2020; Menten, Björn/B-3072-2013; De Meyer, Tim/D-3892-2011	Volders, Pieter-Jan/0000-0002-2685-2637; De Preter, Katleen/0000-0002-7726-5096; speleman, frank/0000-0002-6628-8559; De Meyer, Tim/0000-0003-2994-9693; Vergult, Sarah/0000-0002-0816-6262	Special Research Fund (BOF) from Ghent University; Research Foundation - Flanders (FWO); Special Research Fund of Ghent University	Special Research Fund (BOF) from Ghent University; Research Foundation - Flanders (FWO)(FWO); Special Research Fund of Ghent University(Ghent University)	Sarah Vergult is supported by a postdoctoral grant from the Special Research Fund (BOF) from Ghent University. Katleen De Preter is supported by a postdoctoral grant from the Research Foundation - Flanders (FWO). This article presents research results of the Belgian program of Interuniversity Poles of attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming (IUAP). The authors would like to acknowledge the N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership funded by the Special Research Fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bressler R, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-15; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; McKenna A., 2010, GENOME RES; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Brien TM, 2010, IEEE T VIS COMPUT GR, V16, P918, DOI 10.1109/TVCG.2010.163; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pavlopoulos GA, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt254; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Vergult S, 2013, EUR J HUM GENET; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	29	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113800	10.1371/journal.pone.0113800	http://dx.doi.org/10.1371/journal.pone.0113800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503062	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400015
J	Yilmazer, A; Tian, B; Kostarelos, K				Yilmazer, Acelya; Tian, Bowen; Kostarelos, Kostas			Development of Dual-Activity Vectors by Co-Envelopment of Adenovirus and SiRNA in Artificial Lipid Bilayers	PLOS ONE			English	Article							GENE DELIVERY; ANTITUMOR-ACTIVITY; IN-VITRO; RNA; LIPOPLEXES; LIPOSOMES; THERAPY; VIRUSES; GROWTH; PDNA	Gene therapy with human adenovirus type 5 (Ad5) has been extensively explored for the treatment of diseases resistant to traditional therapies. Intravenous administration leads to rapid clearance from blood circulation and high liver accumulation, which restrict the use of Ad-based vectors in clinical gene therapy protocols that involve systemic administration. We have previously proposed that such limitations can be improved by engineering artificial lipid envelopes around Ad and designed a variety of artificial lipid bilayer envelopes around the viral capsid. In this study, we sought to explore further opportunities that the artificially enveloped virus constructs could offer, by designing a previously unreported gene therapy vector by simultaneous envelopment of Ad and siRNA within the same lipid bilayer. Such a dual-activity vector can offer efficacious therapy for different genetic disorders where both turning on and switching off genes would be needed. Dynamic light scattering, transmission electron microscopy and atomic force microscopy were used to characterize these vectors. Agarose gel electrophoresis, Ribo green and dot blot assays showed that siRNA and Ad virions can be enveloped together within lipid bilayers at high envelopment efficiency. Cellular uptake and in vitro transfection experiments were carried out to show the feasibility of combining siRNA-mediated gene silencing with viral gene transfer using these newly designed dual-activity vectors.	[Yilmazer, Acelya; Kostarelos, Kostas] UCL, Fac Life Sci, Nanomed Lab, London, England; [Tian, Bowen] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Kostarelos, Kostas] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Kostarelos, Kostas] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Yilmazer, Acelya] Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey	University of London; University College London; University of Nottingham; University of Manchester; University of Manchester; Ankara University	Kostarelos, K (corresponding author), UCL, Fac Life Sci, Nanomed Lab, London, England.	kostas.kostarelos@manchester.ac.uk	Yilmazer, Acelya/L-4562-2013; Kostarelos, Kostas/AAP-6879-2021	Yilmazer, Acelya/0000-0003-2712-7450; Kostarelos, Kostas/0000-0002-2224-6672	Turkish Ministry of Education; Engineering and Physical Sciences Research Council [EP/K005014/1] Funding Source: researchfish; EPSRC [EP/K005014/1] Funding Source: UKRI	Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a full-time PhD studentship by the Turkish Ministry of Education to AY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MT, 2010, MOL THER, V18, P171, DOI 10.1038/mt.2009.208; Bates K, 2013, ADV DRUG DELIVER REV, V65, P2023, DOI 10.1016/j.addr.2013.10.003; Bauzon M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00074; Cho SK, 2012, BIOMATERIALS, V33, P3316, DOI 10.1016/j.biomaterials.2012.01.027; Ciani L, 2004, BBA-BIOMEMBRANES, V1664, P70, DOI 10.1016/j.bbamem.2004.04.003; Eltoukhy AA, 2013, ADV MATER, V25, P1487, DOI 10.1002/adma.201204346; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kang HC, 2011, BIOMATERIALS, V32, P4914, DOI 10.1016/j.biomaterials.2011.03.042; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Ozpolat B, 2010, J INTERN MED, V267, P44, DOI 10.1111/j.1365-2796.2009.02191.x; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Pan QW, 2008, ACTA ONCOL, V47, P135, DOI 10.1080/02841860701403053; Rhinn H, 2009, BBA-GEN SUBJECTS, V1790, P219, DOI 10.1016/j.bbagen.2009.01.005; Shen W, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-81; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275; Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565; Tada Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/572609; Tagami T, 2007, INT J PHARM, V333, P62, DOI 10.1016/j.ijpharm.2006.09.057; Tran MA, 2009, PIGM CELL MELANOMA R, V22, P388, DOI 10.1111/j.1755-148X.2009.00581.x; Van den Bossche J, 2011, BIOMATERIALS, V32, P3085, DOI 10.1016/j.biomaterials.2010.12.043; Wiseman JW, 2003, GENE THER, V10, P1654, DOI 10.1038/sj.gt.3302050; Wong HH, 2010, VIRUSES-BASEL, V2, P78, DOI 10.3390/v2010078; Yilmazer A, 2013, BIOMATERIALS, V34, P1354, DOI 10.1016/j.biomaterials.2012.10.053; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhang Y, 2010, INT J PHARMACEUT, V390, P198, DOI 10.1016/j.ijpharm.2010.01.035; Zhang YA, 2006, CANCER RES, V66, P9736, DOI 10.1158/0008-5472.CAN-06-1617; Zheng JN, 2009, CANCER GENE THER, V16, P20, DOI 10.1038/cgt.2008.61; Zheng JN, 2009, CANCER BIOL THER, V8, P84, DOI 10.4161/cbt.8.1.7204	30	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114985	10.1371/journal.pone.0114985	http://dx.doi.org/10.1371/journal.pone.0114985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501573	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400065
J	Guillemin, ML; Valero, M; Faugeron, S; Nelson, W; Destombe, C				Guillemin, Marie-Laure; Valero, Myriam; Faugeron, Sylvain; Nelson, Wendy; Destombe, Christophe			Tracing the Trans-Pacific Evolutionary History of a Domesticated Seaweed (Gracilaria chilensis) with Archaeological and Genetic Data	PLOS ONE			English	Article							POPULATION-GROWTH; RHODOPHYTA; DNA; ECOLOGY; VERMICULOPHYLLA; CULTIVATION; NEUTRALITY; SIGNATURE; PROGRAM; TESTS	The history of a domesticated marine macroalga is studied using archaeological, phylogeographic and population genetic tools. Phylogeographic and population genetic analyses demonstrated that the cultivated red alga Gracilaria chilensis colonised the Chilean coast from New Zealand. Combining archaeological observations with phylogeographic data provided evidence that exchanges between New Zealand and Chile have occurred at least before the Holocene, likely at the end of the Last Glacial Maximum (LGM) and we suggest that migration probably occurred via rafting. Furthermore, the remarkably low microsatellite diversity found in the Chilean populations compared to those in New Zealand is consistent with a recent genetic bottleneck as a result of over-exploitation of natural populations and/or the process of domestication. Therefore, the aquaculture of this seaweed, based essentially on clonal propagation, is occurring from genetically depressed populations and may be driving the species to an extinction vortex in Chile.	[Guillemin, Marie-Laure] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Guillemin, Marie-Laure; Valero, Myriam; Faugeron, Sylvain; Destombe, Christophe] Univ Paris 06, Sorbonne Univ, CNRS, UMI 3614,Stn Biol Roscoff, F-296888 Roscoff, France; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Santiago, Chile; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, CeBiB, Santiago, Chile; [Nelson, Wendy] Univ Auckland, Sch Biol Sci, Natl Inst Water & Atmospher Res, Wellington 6241, New Zealand	Universidad Austral de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland	Guillemin, ML (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Casilla 567, Valdivia, Chile.	marielaure.guillemin@gmail.com	Valero, Myriam/M-6052-2019; Valero, Myriam/C-7550-2011	Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; nelson, wendy/0000-0003-0014-5560; Guillemin, Marie-Laure/0000-0001-5703-7662; Destombe, Christophe/0000-0001-5656-9659; Faugeron, Sylvain/0000-0001-7258-5229	European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT) [ICA4-CT- 2001-10021]; French National Research Agency [ANR-10-BTBR-04-02]; CONICYT; Comision Nacional de Investigacion Cientifica y Tecnologica; Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT) [1090360, 1130868]; Iniciativa Cientifica Milenio (ICM) [P10-033F]; European Network of Excellence 'Marine Genomics' (Algal Node); 'ARCUS' programme of the French Ministry of Foreign Affairs; International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI) [0803]; National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding [COBR1401]	European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT); French National Research Agency(French National Research Agency (ANR)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Comision Nacional de Investigacion Cientifica y Tecnologica; Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio (ICM); European Network of Excellence 'Marine Genomics' (Algal Node); 'ARCUS' programme of the French Ministry of Foreign Affairs; International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI); National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding	This research was supported by the European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT ICA4-CT- 2001-10021), research grants IDEAL G "Seaweed biotechnology and bioresources: a french challenge'' ANR-10-BTBR-04-02 from the French National Research Agency, CONICYT, Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT No 1090360 and No 1130868) and Iniciativa Cientifica Milenio (ICM P10-033F). Additional support came from the European Network of Excellence 'Marine Genomics' (Algal Node), from the 'ARCUS' programme of the French Ministry of Foreign Affairs, International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI No 0803), National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding (COBR1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adovasio J., 1997, MONTE VERDE LATE PLE, P221; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BIRD CJ, 1986, CAN J BOT, V64, P2928, DOI 10.1139/b86-387; BIRD CJ, 1990, J APPL PHYCOL, V2, P375, DOI 10.1007/BF02180928; Boo GH, 2014, AQUAT BOT, V119, P73, DOI 10.1016/j.aquabot.2014.08.004; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; BUSCHMANN AH, 1995, J APPL PHYCOL, V7, P291, DOI 10.1007/BF00004003; Buschmann AH, 2001, AQUACULTURE, V194, P203, DOI 10.1016/S0044-8486(00)00518-4; Buschmann AH, 2008, INT J ENVIRON POLLUT, V33, P432, DOI 10.1504/IJEP.2008.020571; Byrne Kellie, 2002, Phycological Research, V50, P295, DOI 10.1111/j.1440-1835.2002.tb00162.x; Cohen S, 2004, J PHYCOL, V40, P742, DOI 10.1111/j.1529-8817.2004.03203.x; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Erlandson JM, 2011, QUATERN INT, V239, P28, DOI 10.1016/j.quaint.2011.02.030; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fraser CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069138; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemin ML, 2008, EVOLUTION, V62, P1500, DOI 10.1111/j.1558-5646.2008.00373.x; Guillemin ML, 2005, MOL ECOL NOTES, V5, P155, DOI 10.1111/j.1471-8286.2005.00867.x; Gurgel CFD, 2004, J PHYCOL, V40, P748, DOI 10.1111/j.1529-8817.2004.03070.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones TC, 2008, AQUAT BOT, V88, P39, DOI 10.1016/j.aquabot.2007.08.017; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Leakey R.E., 1995, 6 EXTINCTION PATTERN; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lyons DA, 2009, DIVERS DISTRIB, V15, P762, DOI 10.1111/j.1472-4642.2009.00580.x; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; May V, 1948, CSIRO B, V235, P7; MCCARTHY C, 1997, CHROMAS; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nelson WA, 2012, NZ INVENTORY BIODIVE, V3, P327; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; POBLETE A, 1991, REV CHIL HIST NAT, V64, P335; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Redman CL, 1999, HUMAN IMPACT ANCIENT, P239; Rioux Paquette S., 2011, POPGENKIT USEFUL FUN; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHIEL DR, 1990, HYDROBIOLOGIA, V204, P25, DOI 10.1007/BF00040211; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiers B., 2022, INDEX HERBARIORUM GL; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Weinberger F, 2008, AQUAT BIOL, V3, P251, DOI 10.3354/ab00083; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Womersley H.B.S., 1996, MARINE BENTHIC FL 3B; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Zhou B, 2007, MOL PLANT MICROBE IN, V20, P63, DOI 10.1094/MPMI-20-0063	62	27	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114039	10.1371/journal.pone.0114039	http://dx.doi.org/10.1371/journal.pone.0114039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501717	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700014
J	Hurley, B; Lee, D; Mott, A; Wilton, M; Liu, J; Liu, YC; Angers, S; Coaker, G; Guttman, DS; Desveaux, D				Hurley, Brenden; Lee, Donghyuk; Mott, Adam; Wilton, Michael; Liu, Jun; Liu, Yulu C.; Angers, Stephane; Coaker, Gitta; Guttman, David S.; Desveaux, Darrell			The Pseudomonas syringae Type III Effector HopF2 Suppresses Arabidopsis Stomatal Immunity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHYTOTOXIN CORONATINE; TRIGGERED IMMUNITY; PV. PHASEOLICOLA; TOMATO DC3000; VIRULENCE; RESISTANCE; PATTERN; AVIRULENCE; SYSTEM	Pseudomonas syringae subverts plant immune signalling through injection of type III secreted effectors (T3SE) into host cells. The T3SE HopF2 can disable Arabidopsis immunity through Its ADP-ribosyltransferase activity. Proteomic analysis of HopF2 interacting proteins identified a protein complex containing ATPases required for regulating stomatal aperture, suggesting HopF2 may manipulate stomatal immunity. Here we report HopF2 can inhibit stomatal immunity independent of its ADP-ribosyltransferase activity. Transgenic expression of HopF2 in Arabidopsis inhibits stomatal closing in response to P. syringae and increases the virulence of surface inoculated P. syringae. Further, transgenic expression of HopF2 inhibits flg22 induced reactive oxygen species production. Intriguingly, ADP-ribosyltransferase activity is dispensable for inhibiting stomatal immunity and flg22 induced reactive oxygen species. Together, this implies HopF2 may be a bifunctional T3SE with ADP-ribosyltransferase activity required for inhibiting apoplastic immunity and an independent function required to inhibit stomatal immunity.	[Hurley, Brenden; Mott, Adam; Wilton, Michael; Guttman, David S.; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Lee, Donghyuk; Liu, Jun; Coaker, Gitta] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Liu, Yulu C.; Angers, Stephane] Univ Toronto, Dept Biochem, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Guttman, David S.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of California System; University of California Davis; University of Toronto; University of Toronto	Guttman, DS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON, Canada.	david.guttman@utoronto.ca; darrell.desveaux@utoronto.ca	Angers, Stephane/E-1432-2014; Guttman, David S/A-7839-2011; Liu, Yulu Cherry/AAC-6960-2019	Angers, Stephane/0000-0001-7241-9044; Guttman, David S/0000-0001-8479-3869; Liu, Yulu Cherry/0000-0003-4861-6915; Mott, Adam/0000-0001-9803-103X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Plant-Microbe Systems Biology; Queen Elizabeth II Graduate Scholarship in Science and Technology; Centre for the Analysis of Genome Evolution and Function; CFI; CIHR; Canada Research Chair program; NSF [MCB-1054298]; NIH [RO1GM092772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092772] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Plant-Microbe Systems Biology; Queen Elizabeth II Graduate Scholarship in Science and Technology; Centre for the Analysis of Genome Evolution and Function; CFI(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Sciences and Engineering Research Council of Canada awards (to B.H., D.S.G., and D.D.); a Canada Research Chair in Plant-Microbe Systems Biology (to D.D.) or Comparative Genomics (to D.S.G.); Queen Elizabeth II Graduate Scholarship in Science and Technology (B.H.); the Centre for the Analysis of Genome Evolution and Function (D.D., and D.S.G.). S.A. is supported by CFI, CIHR and the Canada Research Chair program. G.C., J.L., and D.L. were supported through NSF grant number MCB-1054298 and NIH grant number RO1GM092772 awarded to G.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Freeman BC, 2009, MOL PLANT MICROBE IN, V22, P857, DOI 10.1094/MPMI-22-7-0857; Geng XQ, 2014, PLANTA, V240, P1149, DOI 10.1007/s00425-014-2151-x; Gimenez-Ibanez S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001792; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hou SG, 2011, FEMS MICROBIOL LETT, V323, P35, DOI 10.1111/j.1574-6968.2011.02356.x; Keinath NF, 2010, J BIOL CHEM, V285, P39140, DOI 10.1074/jbc.M110.160531; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Lozano-Duran R, 2014, NEW PHYTOL, V202, P259, DOI 10.1111/nph.12651; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; MOORE RA, 1989, CAN J MICROBIOL, V35, P910, DOI 10.1139/m89-151; Morris CE, 2013, ANNU REV PHYTOPATHOL, V51, P85, DOI 10.1146/annurev-phyto-082712-102402; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Qi YP, 2011, J BIOL CHEM, V286, P31297, DOI 10.1074/jbc.M110.211615; Qi YP, 2009, PLANT J, V57, P932, DOI 10.1111/j.1365-313X.2008.03736.x; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Zeng WQ, 2010, PLANT PHYSIOL, V153, P1188, DOI 10.1104/pp.110.157016; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zhou JG, 2014, PLANT J, V77, P235, DOI 10.1111/tpj.12381	56	43	43	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114921	10.1371/journal.pone.0114921	http://dx.doi.org/10.1371/journal.pone.0114921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503437	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700072
J	Liu, X; Cui, T; Li, YY; Wang, YT; Wang, QH; Li, X; Bi, Y; Wei, XP; Liu, L; Li, TY; Chen, J				Liu, Xia; Cui, Ting; Li, Yingying; Wang, Yuting; Wang, Qinghong; Li, Xin; Bi, Yang; Wei, Xiaoping; Liu, Lan; Li, Tingyu; Chen, Jie			Vitamin A Supplementation in Early Life Enhances the Intestinal Immune Response of Rats with Gestational Vitamin A Deficiency by Increasing the Number of Immune Cells	PLOS ONE			English	Article							RETINOIC ACID; DENDRITIC CELLS; MOUSE MODEL; T-CELLS; GUT; CHILDREN; LYMPHOCYTES; EXPRESSION; TOLERANCE; INFECTION	Vitamin A is a critical micronutrient for regulating immunity in many organisms. Our previous study demonstrated that gestational or early-life vitamin A deficiency decreases the number of immune cells in offspring. The present study aims to test whether vitamin A supplementation can restore lymphocyte pools in vitamin A-deficient rats and thereby improve the function of their intestinal mucosa; furthermore, the study aimed to identify the best time frame for vitamin A supplementation. Vitamin A-deficient pregnant rats or their offspring were administered a low-dose of vitamin A daily for 7 days starting on gestational day 14 or postnatal day 1, day 14 or day 28. Serum retinol concentrations increased significantly in all four groups that received vitamin A supplementation, as determined by high-performance liquid chromatography. The intestinal levels of secretory immunoglobulin A and polymeric immunoglobulin receptor increased significantly with lipopolysaccharide challenge in the rats that received vitamin A supplementation starting on postnatal day 1. The rats in this group had higher numbers of CD8(+) intestinal intraepithelial lymphocytes, CD11(C)(+) dendritic cells in the Peyer's patches and CD4(+) CD25(+) T cells in the spleen compared with the vitamin A-deficient rats; flow cytometric analysis also demonstrated that vitamin A supplementation decreased the number of B cells in the mesenteric lymph nodes. Additionally, vitamin A supplementation during late gestation increased the numbers of CD8(+) intestinal intraepithelial lymphocytes and decreased the numbers of B lymphocytes in the mesenteric lymph nodes. However, no significant differences in lymphocyte levels were found between the rats in the other two vitamin A supplement groups and the vitamin A-deficient group. In conclusion, the best recovery of a subset of lymphocytes in the offspring of gestational vitamin A-deficient rats and the greatest improvement in the intestinal mucosal immune response are achieved when vitamin A supplementation occurs during the early postnatal period.	[Liu, Xia; Cui, Ting; Li, Yingying; Wang, Yuting; Bi, Yang; Wei, Xiaoping; Li, Tingyu; Chen, Jie] Chongqing Med Univ, Childrens Nutr Res Ctr,Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Minist Educ,Key Lab Child Dev & Disorders,Key Lab, Chongqing 400014, Peoples R China; [Wang, Qinghong; Li, Xin] Chongqing Med Univ, Childrens Hosp, Inst Pediat, Chongqing 400014, Peoples R China; [Liu, Lan] Univ Maryland, Sch Med, Dept Surg, Lab Intestinal Physiol & Pathol, Baltimore, MD 21201 USA	Chongqing Medical University; Chongqing Medical University; University System of Maryland; University of Maryland Baltimore	Chen, J (corresponding author), Chongqing Med Univ, Childrens Nutr Res Ctr,Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Minist Educ,Key Lab Child Dev & Disorders,Key Lab, CSTC2009 CA5002, Chongqing 400014, Peoples R China.	jchen010@cqmu.edu.cn	wang, qinghong/M-7969-2017	Li, Tingyu/0000-0002-1940-7076	National Nature Science of Foundation of China [81070286, 81470799]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-1001]; Science & Technology Project of Yuzhong District of Chongqing	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science & Technology Project of Yuzhong District of Chongqing	This work was supported by grants from National Nature Science of Foundation of China (81070286, 81470799) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2009-1001), as well as Science & Technology Project of Yuzhong District of Chongqing (2012) to Professor JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Alberg T, 2011, INHAL TOXICOL, V23, P268, DOI 10.3109/08958378.2011.566898; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Cao JY, 2013, ASIA PAC J CLIN NUTR, V22, P214, DOI 10.6133/apjcn.2013.22.2.10; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chen K, 2008, J NUTR SCI VITAMINOL, V54, P440, DOI 10.3177/jnsv.54.440; Donnen P, 1998, AM J CLIN NUTR, V68, P1254, DOI 10.1093/ajcn/68.6.1254; Frossard CP, 2004, J ALLERGY CLIN IMMUN, V114, P377, DOI 10.1016/j.jaci.2004.03.040; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Imdad A., 2010, COCHRANE DATABASE SY, P12; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Jiang W, 2012, J NEUROCHEM, V121, P932, DOI 10.1111/j.1471-4159.2012.07697.x; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Liu X, 2014, NUTRITION, V30, P350, DOI 10.1016/j.nut.2013.09.008; Long KZ, 2006, J NUTR, V136, P1365, DOI 10.1093/jn/136.5.1365; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Organization WH, 2009, GLOB PREV VIT DEF PO, P283; Ross AC, 2011, VITAM HORM, V86, P103, DOI 10.1016/B978-0-12-386960-9.00005-8; Sauvant P, 2012, CURR OPIN CLIN NUTR, V15, P310, DOI 10.1097/MCO.0b013e3283526968; Seguin-Devaux C, 2005, MOL CELL ENDOCRINOL, V245, P67, DOI 10.1016/j.mce.2005.10.006; Seo GY, 2013, J LEUKOCYTE BIOL, V94, P325, DOI 10.1189/jlb.0313128; Sheridan Brian S, 2010, Curr Gastroenterol Rep, V12, P513, DOI 10.1007/s11894-010-0148-6; Stock A, 2013, IMMUNOL CELL BIOL, V91, P240, DOI 10.1038/icb.2012.73; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; Takenouchi-Ohkubo N, 2004, CLIN EXP IMMUNOL, V135, P448, DOI 10.1111/j.1365-2249.2004.02398.x; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Wei H, 2009, J NUTR SCI VITAMINOL, V55, P208, DOI 10.3177/jnsv.55.208; World Health Organization, 1996, NUTR IND ASS VIT A D; Zhang X, 2011, J NUTR BIOCHEM, V22, P1112, DOI 10.1016/j.jnutbio.2010.09.010	37	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114934	10.1371/journal.pone.0114934	http://dx.doi.org/10.1371/journal.pone.0114934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503794	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700074
J	Masters, SH; Burstein, R; DeCenso, B; Moore, K; Haakenstad, A; Ikilezi, G; Achan, J; Osei, I; Garshong, B; Kisia, C; Njuguna, P; Babigumira, J; Kumar, S; Hanlon, M; Gakidou, E				Masters, Samuel H.; Burstein, Roy; DeCenso, Brendan; Moore, Kelsey; Haakenstad, Annie; Ikilezi, Gloria; Achan, Jane; Osei, Ivy; Garshong, Bertha; Kisia, Caroline; Njuguna, Pamela; Babigumira, Joseph; Kumar, Santosh; Hanlon, Michael; Gakidou, Emmanuela			Pharmaceutical Availability across Levels of Care: Evidence from Facility Surveys in Ghana, Kenya, and Uganda	PLOS ONE			English	Article							ESSENTIAL MEDICINES; AFFORDABILITY; ANTIMALARIALS; SERVICES; DISEASES; QUALITY; OUTLETS; CHOICE; ACCESS	Objective: In this study we use facility-level data from nationally representative surveys conducted in Ghana, Kenya, and Uganda to understand pharmaceutical availability within the three countries. Methods: In 2012, we conducted a survey to capture information on pharmaceuticals and other facility indicators from over 200 facilities in each country. We analyze data on the availability of pharmaceuticals and quantify its association with various facility-level indicators. We analyze both availability of essential medicines, as defined by the various essential medicine lists (EMLs) of each respective country, and availability of all surveyed pharmaceuticals deemed important for treatment of various high-burden diseases, including those on the EMLs. Results: We find that there is heterogeneity with respect to availability across the three countries with Ghana generally having better availability than Uganda and Kenya. To analyze the relationship between facility-level factors and pharmaceutical stock-out we use a binomial regression model. We find that the factors associated with stock-out vary by country, but across all countries both presence of a laboratory at the facility and presence of a vehicle at the facility are significantly associated with reduced stock-out. Conclusion: The results of this study highlight the poor availability of essential medicines across these three countries and suggest more needs to be done to strengthen the supply system so that stock remains uninterrupted.	[Masters, Samuel H.] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA; [Burstein, Roy; Haakenstad, Annie; Hanlon, Michael] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [DeCenso, Brendan] RTI Int, Durham, NC USA; [Ikilezi, Gloria; Achan, Jane] Infect Dis Res Collaborat, Kampala, Uganda; [Osei, Ivy; Garshong, Bertha] Ghana Hlth Serv, Accra, Ghana; [Kisia, Caroline; Njuguna, Pamela] Act Africa Help Int, Nairobi, Kenya; [Babigumira, Joseph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kumar, Santosh] Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA	University of North Carolina; University of North Carolina Chapel Hill; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Research Triangle Institute; Ghana Health Service; University of Washington; University of Washington Seattle; Texas State University System; Sam Houston State University	Masters, SH (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA.	masters@unc.edu	Babigumira, Joseph/T-4208-2019	Masters, Samuel/0000-0001-7581-8219				Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Buabeng KO, 2008, CLIN PHARMACOL THER, V84, P613, DOI 10.1038/clpt.2008.130; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cheraghali AM, 2009, PHARM WORLD SCI, V31, P209, DOI 10.1007/s11096-009-9282-3; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; DAVIS BL, 2013, EM APPR SPEECH ACQ, P1, DOI DOI 10.1186/1475-2875-12-135; Ghana National Drugs Program Ministry of Health, 2010, GHAN ESS MED LIST; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; IHME, 2014, HLTH SERV PROV KEN A; Institute for Health Metrics and Evaluation (IHME), 2013, ACC BOTTL COSTS EQ A; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; Kenya Ministry of Medical Services Kenya Ministry of Public Health & Sanitation, 2010, KEN ESS MED LIST; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Mugisha F, 2004, B WORLD HEALTH ORGAN, V82, P572; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tumwine Y, 2010, TROPICAL J PHARM RES, V9; Uganda Ministry of Health, 2011, UG ESS MED LIST; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; WHO, 2013, WHO MOD LISTS ESS ME; World Health Organization and Health Action International, 2003, MED PRIC NEW APPR ME; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056	29	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114762	10.1371/journal.pone.0114762	http://dx.doi.org/10.1371/journal.pone.0114762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25500832	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700051
J	Ewers, H; Tada, T; Petersen, JD; Racz, B; Sheng, M; Choquet, D				Ewers, Helge; Tada, Tomoko; Petersen, Jennifer D.; Racz, Bence; Sheng, Morgan; Choquet, Daniel			A Septin-Dependent Diffusion Barrier at Dendritic Spine Necks	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR DYNAMICS; SYNAPTIC-TRANSMISSION; MAMMALIAN SEPTINS; AMPA RECEPTORS; MEMBRANE; COMPARTMENTALIZATION; PROTEINS; NEURONS; PHOSPHORYLATION; MORPHOLOGY	Excitatory glutamatergic synapses at dendritic spines exchange and modulate their receptor content via lateral membrane diffusion. Several studies have shown that the thin spine neck impedes the access of membrane and solute molecules to the spine head. However, it is unclear whether the spine neck geometry alone restricts access to dendritic spines or if a physical barrier to the diffusion of molecules exists. Here, we investigated whether a complex of septin cytoskeletal GTPases localized at the base of the spine neck regulates diffusion across the spine neck. We found that, during development, a marker of the septin complex, Septin7 (Sept7), becomes localized to the spine neck where it forms a stable structure underneath the plasma membrane. We show that diffusion of receptors and bulk membrane, but not cytoplasmic proteins, is slower in spines bearing Sept7 at their neck. Finally, when Sept7 expression was suppressed by RNA interference, membrane molecules explored larger membrane areas. Our findings indicate that Sept7 regulates membrane protein access to spines.	[Ewers, Helge; Petersen, Jennifer D.; Choquet, Daniel] Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Ewers, Helge; Petersen, Jennifer D.; Choquet, Daniel] CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Tada, Tomoko; Sheng, Morgan] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02446 USA; [Tada, Tomoko; Sheng, Morgan] MIT, Dept Biol, Cambridge, MA 02446 USA; [Racz, Bence] Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, H-1078 Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Hungarian University of Agriculture & Life Sciences	Choquet, D (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France.	daniel.choquet@u-bordeaux2.fr	Ewers, Helge/ABF-3629-2021; Rácz, Bence/J-4220-2019; Petersen, Jennifer/GLU-9899-2022; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018	Ewers, Helge/0000-0003-3948-4332; Rácz, Bence/0000-0002-1933-5332; Petersen, Jennifer/0000-0003-1107-8535; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Sheng, Morgan/0000-0002-8703-5366	FEBS Long-Term Fellowship; Human Frontiers Short-Term Fellowship; Hungarian Scientific Research Fund Grant [OTKA K83830]; Hungarian Academy of Sciences; CNRS; ERC Advanced Grant	FEBS Long-Term Fellowship; Human Frontiers Short-Term Fellowship; Hungarian Scientific Research Fund Grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences); CNRS(Centre National de la Recherche Scientifique (CNRS)); ERC Advanced Grant(European Research Council (ERC))	H.E. was supported by a FEBS Long-Term Fellowship, T.T. by a Human Frontiers Short-Term Fellowship, and M.S. was an Investigator of the Howard Hughes Medical Institute. B.R. is supported by the Hungarian Scientific Research Fund Grant (OTKA K83830) and by the Janos Bolyai research fellowship by the Hungarian Academy of Sciences. D.C was supported by the CNRS and an ERC Advanced Grant. Morgan Sheng is an employee of Genentech, and Tomoko Tada is an employee of Otsuka Pharmaceutical, and both received funding in the form of salary from these companies. The electron microscopy of cultured neurons and confocal microscopy were done in the Bordeaux Imaging Center of the University of Bordeaux Segalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Barral Y, 2007, CURR BIOL, V17, pR961, DOI 10.1016/j.cub.2007.10.001; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	35	62	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113916	10.1371/journal.pone.0113916	http://dx.doi.org/10.1371/journal.pone.0113916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494357	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000346611400023
J	Cong, WN; Chadwick, W; Wang, R; Daimon, CM; Cai, H; Amma, J; Wood, WH; Becker, KG; Martin, B; Maudsley, S				Cong, Wei-Na; Chadwick, Wayne; Wang, Rui; Daimon, Caitlin M.; Cai, Huan; Amma, Jennifer; Wood, William H., III; Becker, Kevin G.; Martin, Bronwen; Maudsley, Stuart			Amitriptyline Improves Motor Function via Enhanced Neurotrophin Signaling and Mitochondrial Functions in the Murine N171-82Q Huntington Disease Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Brain-derived Neurotrophic Factor (BDNF); Huntington Disease; Mitochondria; Neurodegenerative Disease; Amitriptyline; Motor Function; mHTT	STRIATAL PROJECTION NEURONS; TRKB RECEPTOR; MOUSE MODEL; MUTANT HUNTINGTIN; UNCOUPLING PROTEIN-2; THERAPEUTIC TARGET; TRANSGENIC MOUSE; SLOWS DISEASE; HUMAN BRAIN; IN-VIVO	Background: Etiology of Huntington disease (HD) is related to the overproduction of mutant huntingtin (mHTT) protein. Results: Amitriptyline improved motor symptoms via decreasing mHTT protein expression, improving neurotrophin signaling, and enhancing mitochondrial functions in HD mice. Conclusion: Amitriptyline demonstrated beneficial effects in HD mice. Significance: Amitriptyline has therapeutic potential in treating HD. Huntington disease (HD) is a neurodegenerative disorder characterized by progressive motor impairment and cognitive alterations. Hereditary HD is primarily caused by the expansion of a CAG trinucleotide repeat in the huntingtin (Htt) gene, which results in the production of mutant huntingtin protein (mHTT) with an expanded amino-terminal polyglutamine (poly(Q)) stretch. Besides pathological mHTT aggregation, reduced brain-derived neurotrophic factor (BDNF) levels, impaired neurotrophin signaling, and compromised mitochondrial functions also contribute to the deleterious progressive etiology of HD. As a well tolerated Food and Drug Administration-approved antidepressant, amitriptyline (AMI) has shown efficacy in treating neurodegenerative murine models via potentiation of BDNF levels and amelioration of alterations in neurotrophin signaling pathways. In this study, we observed profound improvements in the motor coordination of AMI-treated N171-82Q HD model mice. The beneficial effects of AMI treatment were associated with its ability to reduce mHTT aggregation, potentiation of the BDNF-TrkB signaling system, and support of mitochondrial integrity and functionality. Our study not only provides preclinical evidence for the therapeutic potency of AMI in treating HD, but it also represents an important example of the usefulness of additional pharmacogenomic profiling of pre-existing drugs for novel therapeutic effects with often intractable pathological scenarios.	[Cong, Wei-Na; Wang, Rui; Daimon, Caitlin M.; Cai, Huan; Amma, Jennifer; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chadwick, Wayne; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Wood, William H., III; Becker, Kevin G.] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Maudsley, Stuart] Univ Antwerp, Inst Born Bunge, Dept Mol Genet VIB, Neurogenet Lab, B-2000 Antwerp, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Flanders Institute for Biotechnology (VIB); University of Antwerp	Martin, B (corresponding author), NIA, Metab Unit, NIH, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	bronwenmartin@gmail.com; stuart.maudsley@molgen.vib-ua.be	Wang, Rui/I-5643-2019; Maudsley, Stuart/Q-4782-2019; Cai, Huan/B-6578-2016; Maudsley, Stuart/AAV-9929-2021	Wang, Rui/0000-0001-7015-0272; Cai, Huan/0000-0001-7731-8891; Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	National Institutes of Health Intramural Research Program of the NIA; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIA.	Aidt F. H., 2013, PLOS CURR; Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Baydyuk M, 2013, J NEUROSCI, V33, P3363, DOI 10.1523/JNEUROSCI.3687-12.2013; Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Besusso D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3031; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Chadwick W., 2011, J SIGNAL TRANSDUCTIO, V2011; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062665; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; DEPINTO V, 1992, J BIOENERG BIOMEMBR, V24, P21, DOI 10.1007/BF00769526; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fjorback AW, 2011, FEBS J, V278, P493, DOI 10.1111/j.1742-4658.2010.07970.x; Franklin K. B., 2008, MOUSE BRAIN STEREOTA, P34; Gesty-Palmer D, 2013, MOL ENDOCRINOL, V27, P296, DOI 10.1210/me.2012-1091; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Hoffner G, 2002, BIOCHIMIE, V84, P273, DOI 10.1016/S0300-9084(02)01398-6; Iannaccone Martina, 2013, Recent Pat CNS Drug Discov, V8, P161; Ishii T, 2013, BBA-BIOENERGETICS, V1827, P588, DOI 10.1016/j.bbabio.2012.10.016; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; Lee BH, 2010, J CLIN PSYCHOPHARM, V30, P623, DOI 10.1097/JCP.0b013e3181f13f0b; Lee HY, 2012, CELL MOL NEUROBIOL, V32, P577, DOI 10.1007/s10571-012-9802-x; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Estrada-Sanchez AM, 2010, NEUROCHEM RES, V35, P1156, DOI 10.1007/s11064-010-0168-5; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Moltzen EK, 2006, CURR TOP MED CHEM, V6, P1801, DOI 10.2174/156802606778249810; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Plotkin JL, 2014, NEURON, V83, P178, DOI 10.1016/j.neuron.2014.05.032; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Rosenstock TR, 2010, CURR DRUG TARGETS, V11, P1218; Russell L, 2000, CELL STRUCT FUNCT, V25, P103, DOI 10.1247/csf.25.103; Ryu Hoon, 2005, Expert Opin Emerg Drugs, V10, P345, DOI 10.1517/14728214.10.2.345; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Yuste JE, 2012, NEUROPHARMACOLOGY, V63, P1258, DOI 10.1016/j.neuropharm.2012.07.031; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	87	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2728	2743		10.1074/jbc.M114.588608	http://dx.doi.org/10.1074/jbc.M114.588608			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505248	Green Published, hybrid			2022-12-26	WOS:000349310700016
J	Culp, DJ; Robinson, B; Cash, MN; Bhattacharyya, I; Stewart, C; Cuadra-Saenz, G				Culp, David J.; Robinson, Bently; Cash, Melanie N.; Bhattacharyya, Indraneel; Stewart, Carol; Cuadra-Saenz, Giancarlo			Salivary Mucin 19 Glycoproteins INNATE IMMUNE FUNCTIONS IN STREPTOCOCCUS MUTANS-INDUCED CARIES IN MICE AND EVIDENCE FOR EXPRESSION IN HUMAN SALIVA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Animal Model; Glycobiology; Infectious Disease; Innate Immunity; Microbiome; Mucin; Streptococcus	ORAL MICROBIAL COMMUNITIES; ACQUIRED ENAMEL PELLICLE; WHOLE SALIVA; O-GLYCOSYLATION; CROHNS-DISEASE; DENTAL-CARIES; MUC5B; MOUSE; EXPRESSION; GLAND	Background: We investigated murine salivary Muc19, in vivo and in vitro, to protect against dental infections. Results: Muc19 attenuates dental infections by Streptococcus mutans and promotes its aggregation. Evidence for human salivary MUC19 is presented. Conclusion: Murine Muc19 helps limit colonization via clearance of S. mutans. Significance: A role for Muc19 in clearance expands upon acknowledged innate immune functions of salivary gel-forming mucins. Saliva functions in innate immunity of the oral cavity, protecting against demineralization of teeth (i.e. dental caries), a highly prevalent infectious disease associated with Streptococcus mutans, a pathogen also linked to endocarditis and atheromatous plaques. Gel-forming mucins are a major constituent of saliva. Because Muc19 is the dominant salivary gel-forming mucin in mice, we studied Muc19(-/-) mice for changes in innate immune functions of saliva in interactions with S. mutans. When challenged with S. mutans and a cariogenic diet, total smooth and sulcal surface lesions are more than 2- and 1.6-fold higher in Muc19(-/-) mice compared with wild type, whereas the severity of lesions are up to 6- and 10-fold higher, respectively. Furthermore, the oral microbiota of Muc19(-/-) mice display higher levels of indigenous streptococci. Results emphasize the importance of a single salivary constituent in the innate immune functions of saliva. In vitro studies of S. mutans and Muc19 interactions (i.e. adherence, aggregation, and biofilm formation) demonstrate Muc19 poorly aggregates S. mutans. Nonetheless, aggregation is enhanced upon adding Muc19 to saliva from Muc19(-/-) mice, indicating Muc19 assists in bacterial clearance through formation of heterotypic complexes with salivary constituents that bind S. mutans, thus representing a novel innate immune function for salivary gel-forming mucins. In humans, expression of salivary MUC19 is unclear. We find MUC19 transcripts in salivary glands of seven subjects and demonstrate MUC19 glycoproteins in glandular mucous cells and saliva. Similarities and differences between mice and humans in the expression and functions of salivary gel-forming mucins are discussed.	[Culp, David J.; Robinson, Bently; Cash, Melanie N.; Cuadra-Saenz, Giancarlo] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Bhattacharyya, Indraneel; Stewart, Carol] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Culp, DJ (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, 1395 Ctr Dr,POB 100424, Gainesville, FL 32610 USA.	dculp@dental.ufl.edu	Bhattacharyya, Indraneel/U-7752-2019; Cash, Melanie/AAT-3751-2020		National Institutes of Health [DE16362, DE014730]; NIDCR [DE020147]; University of Florida Research Opportunity Fund Award [83064];  [T90DE021990]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016362, R21DE020147, R01DE014730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Florida Research Opportunity Fund Award; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE16362, DE014730, and DE020147 from NIDCR and Grant T90DE021990 (to G. C.). This work was also supported by University of Florida Research Opportunity Fund Award 83064 (to D. J. C.).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; Almiron M, 2013, CURR MICROBIOL, V67, P395, DOI 10.1007/s00284-013-0367-9; Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; AMERONGEN AVN, 1987, CARIES RES, V21, P297; AMERONGEN AVN, 1989, J BIOL BUCCALE, V17, P85; [Anonymous], ORAL HLTH AM REPORT; Aviles-Reyes A, 2014, MOL ORAL MICROBIOL, V29, P11, DOI 10.1111/mom.12041; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Banderas-Tarabay JA, 2002, ARCH MED RES, V33, P499, DOI 10.1016/S0188-4409(02)00395-8; BARLETTA RG, 1988, INFECT IMMUN, V56, P322, DOI 10.1128/IAI.56.2.322-330.1988; BARLETTA RG, 1989, INFECT IMMUN, V57, P992, DOI 10.1128/IAI.57.3.992-995.1989; BISGAARD M, 1986, ACTA PATH MICRO IM B, V94, P1; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; BOLSCHER J, 1995, BIOCHEM J, V309, P801, DOI 10.1042/bj3090801; Boro S, 2010, CURR MICROBIOL, V61, P357, DOI 10.1007/s00284-010-9619-0; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; BRADSHAW DJ, 1994, MICROBIOL-UK, V140, P3407, DOI 10.1099/13500872-140-12-3407; Brandtzaeg P., 2013, J ORAL MICROBIOL, DOI [10.3402/jom.v6.26102, DOI 10.3402/JOM.V6.26102]; Carlen A, 1996, ARCH ORAL BIOL, V41, P1133, DOI 10.1016/S0003-9969(96)00094-5; Castro I, 2013, AUTOIMMUN REV, V12, P567, DOI 10.1016/j.autrev.2012.10.018; Chen T., 2010, DATABASE, V2010; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chi AC, 2010, AM FAM PHYSICIAN, V82, P1381; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; CLARK WB, 1978, INFECT IMMUN, V19, P846, DOI 10.1128/IAI.19.3.846-853.1978; Clavel T, 2013, ARCH MICROBIOL, V195, P43, DOI 10.1007/s00203-012-0846-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornejo OE, 2013, MOL BIOL EVOL, V30, P881, DOI 10.1093/molbev/mss278; Culp DJ, 2011, BBA-MOL BASIS DIS, V1812, P1567, DOI 10.1016/j.bbadis.2011.09.006; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Culp DJ, 2004, PHYSIOL GENOMICS, V19, P303, DOI 10.1152/physiolgenomics.00161.2004; Das B, 2013, J BIOL CHEM, V288, P14742, DOI 10.1074/jbc.M113.468645; Das B, 2010, J HISTOCHEM CYTOCHEM, V58, P141, DOI 10.1369/jhc.2009.954891; Das B, 2009, J HISTOCHEM CYTOCHEM, V57, P383, DOI 10.1369/jhc.2008.952853; DENNY PA, 1982, HISTOCHEM J, V14, P403, DOI 10.1007/BF01011852; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Denny PC, 1996, GLYCOBIOLOGY, V6, P43, DOI 10.1093/glycob/6.1.43; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dijkema T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-91; EMILSON CG, 1976, J CLIN MICROBIOL, V4, P95; Flowers SA, 2013, MOL CELL PROTEOMICS, V12, P921, DOI 10.1074/mcp.M113.028878; GERKEN TA, 1992, BIOCHEMISTRY-US, V31, P639, DOI 10.1021/bi00118a002; Glantz PO, 1997, COLLOID SURFACE A, V123, P657, DOI 10.1016/S0927-7757(96)03817-4; Gozalo AS, 2010, J AM ASSOC LAB ANIM, V49, P480; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Hand AR, 1999, ARCH ORAL BIOL, V44, pS3, DOI 10.1016/S0003-9969(99)00042-4; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; Haukioja A, 2008, ORAL MICROBIOL IMMUN, V23, P336, DOI 10.1111/j.1399-302X.2008.00435.x; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Issa SMA, 2011, ELECTROPHORESIS, V32, P3554, DOI 10.1002/elps.201100374; JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P; JOHNSSON M, 1993, CRIT REV ORAL BIOL M, V4, P371, DOI 10.1177/10454411930040031601; Karn RC, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030275; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P1, DOI 10.1016/j.ijporl.2012.11.038; KEYES PAUL H., 1958, JOUR DENTAL RES, V37, P1088, DOI 10.1177/00220345580370060901; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; KOPEC LK, 1995, CARIES RES, V29, P507, DOI 10.1159/000262122; Kouznetsova I, 2010, CELL PHYSIOL BIOCHEM, V26, P375, DOI 10.1159/000320561; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Kumar V, 2013, INFLAMM BOWEL DIS, V19, P1254, DOI 10.1097/MIB.0b013e318281f454; Larson R.H., 1981, SPL SUPP MICROBIOL A, P195; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lee YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067919; Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7; Li J, 2003, ORAL MICROBIOL IMMUN, V18, P183, DOI 10.1034/j.1399-302X.2003.00065.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; LIGTENBERG AJM, 1990, ANTON LEEUW INT J G, V57, P97, DOI 10.1007/BF00403161; Ligtenberg AJM, 2000, ANTON LEEUW INT J G, V77, P21, DOI 10.1023/A:1002054810170; LIGTENBERG AJM, 1992, INFECT IMMUN, V60, P3878, DOI 10.1128/IAI.60.9.3878-3884.1992; Liu B, 2000, BIOCHEM J, V345, P557, DOI 10.1042/0264-6021:3450557; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Mothey D, 2014, FEMS MICROBIOL LETT, V350, P161, DOI 10.1111/1574-6968.12336; Moye ZD, 2014, APPL ENVIRON MICROB, V80, P972, DOI 10.1128/AEM.03579-13; MURRAY PA, 1992, INFECT IMMUN, V60, P31, DOI 10.1128/IAI.60.1.31-38.1992; Nakajima K, 2003, J HISTOCHEM CYTOCHEM, V51, P1689, DOI 10.1177/002215540305101213; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Nielsen PA, 1997, GLYCOBIOLOGY, V7, P413, DOI 10.1093/glycob/7.3.413; Offner G D, 2000, Adv Dent Res, V14, P69; Ozcan S, 2013, J PROTEOME RES, V12, P1090, DOI 10.1021/pr3008013; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pinkstaff C A, 1980, Int Rev Cytol, V63, P141, DOI 10.1016/S0074-7696(08)61759-3; PRAKOBPHOL A, 1993, CRIT REV ORAL BIOL M, V4, P325, DOI 10.1177/10454411930040031001; Prakobphol A, 2005, BIOCHEMISTRY-US, V44, P2216, DOI 10.1021/bi0480180; Radaelli E, 2010, J AM ASSOC LAB ANIM, V49, P69; Rayment SA, 2000, J DENT RES, V79, P1765; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; ROSAN B, 1982, INFECT IMMUN, V38, P1056, DOI 10.1128/IAI.38.3.1056-1059.1982; ROTHER P, 1963, ACTA HISTOCHEM, V15, P325; Rousseau K, 2008, BIOCHEM J, V413, P545, DOI 10.1042/BJ20080260; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; SLOMIANY A, 1978, J BIOL CHEM, V253, P7301; SLOMIANY BL, 1993, INT J BIOCHEM, V25, P935, DOI 10.1016/0020-711X(93)90250-I; Smith AMV, 2000, ARCH ORAL BIOL, V45, P277, DOI 10.1016/S0003-9969(99)00141-7; Sonesson M, 2008, ARCH ORAL BIOL, V53, P523, DOI 10.1016/j.archoralbio.2008.01.002; SUNDH B, 1993, ORAL SURG ORAL MED O, V76, P564, DOI 10.1016/0030-4220(93)90063-A; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; TABAK LA, 1985, ARCH ORAL BIOL, V30, P423, DOI 10.1016/0003-9969(85)90070-6; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tanzer JM, 2006, J DENT RES, V85, P369, DOI 10.1177/154405910608500417; Thomsson KA, 2002, GLYCOBIOLOGY, V12, P1, DOI 10.1093/glycob/12.1.1; Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; Troxler RF, 1997, GLYCOBIOLOGY, V7, P965, DOI 10.1093/glycob/7.7.965; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; VANDERHOEVEN JS, 1990, ANTON LEEUW INT J G, V57, P165, DOI 10.1007/BF00403951; Veerman ECI, 2003, GLYCOBIOLOGY, V13, P363, DOI 10.1093/glycob/cwg037; Watson GE, 1997, ARCH ORAL BIOL, V42, P161, DOI 10.1016/S0003-9969(96)00100-8; Wen ZT, 2001, PLASMID, V45, P31, DOI 10.1006/plas.2000.1498; Wickstrom C, 2008, ORAL MICROBIOL IMMUN, V23, P177, DOI 10.1111/j.1399-302X.2007.00407.x; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Zhu LX, 2011, AM J RESP CELL MOL, V45, P348, DOI 10.1165/rcmb.2010-0312OC; Zimmerman JN, 2013, INT J MOL SCI, V14, P920, DOI 10.3390/ijms14010920	126	36	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2993	3008		10.1074/jbc.M114.597906	http://dx.doi.org/10.1074/jbc.M114.597906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512380	Green Published, hybrid			2022-12-26	WOS:000349310700037
J	Tachibana, Y; Sakurai, T; Bai, H; Shiota, K; Nambo, Y; Nagaoka, K; Imakawa, K				Tachibana, Yurika; Sakurai, Toshihiro; Bai, Hanako; Shiota, Kunio; Nambo, Yasuo; Nagaoka, Kentaro; Imakawa, Kazuhiko			RNA-Seq Analysis of Equine Conceptus Transcripts during Embryo Fixation and Capsule Disappearance	PLOS ONE			English	Article							EXPRESSION; GENES; TIME; GLYCOPROTEINS; ENDOMETRIUM; PROTEINS; GIRDLE; CELLS; VEGF; TAU	Extensive studies have been conducted to characterize the unique phenomena of equine pregnancy. Most studies have focused on embryo transmigration when the embryo is covered with a mucin-like glycoprotein capsule and on the characterization of the chorionic girdle and chorionic gonadotropin (CG) secretion. However, the events preceding and following capsule disappearance have not been well studied. In this study, the mRNA expression in conceptus membranes at days 19, 21, and 25 (day 0=day of ovulation) was analyzed by RNA-seq (SOLiD3), and transcript levels on these three days and day 13 were confirmed by real-time PCR. Of the 26,416 equine genes registered, 20,436 transcripts were aligned to sequences in the Ensembl database, from which 4,625 transcripts were registered in both Ensembl and the KEGG pathway. Each of the 4,625 transcripts was examined through KEGG pathway analysis, and 12 transcripts of integrins (ITGs) and collagens (COLs) were confirmed through real-time PCR. Our data indicated that extracellular matrix (ECM)-related mRNAs were highly expressed in day 19, 21, and 25 conceptus membranes. In combination with previous results, which confirmed a lack of laminin and fibronectin transcript expression in the endometrium, these observations suggest that in contrast to attachment through focal adhesion, conceptus chorionic membrane ECMs function as a scaffold-like structure to possibly maintain the shape of the conceptus and a separation between chorionic membranes and the uterine luminal epithelium.	[Tachibana, Yurika; Sakurai, Toshihiro; Bai, Hanako; Imakawa, Kazuhiko] Univ Tokyo, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan; [Tachibana, Yurika; Shiota, Kunio] Univ Tokyo, Lab Cellular Biochem, Tokyo 1138657, Japan; [Tachibana, Yurika; Shiota, Kunio] Univ Tokyo, Anim Resource Ctr, Tokyo 1138657, Japan; [Nambo, Yasuo] Japan Racing Assoc, Hidaka Training & Res Ctr, Urakawa 0570171, Japan; [Nagaoka, Kentaro] Tokyo Univ Agr & Technol, Vet Physiol Lab, Dept Vet Med, Fuchu, Tokyo 1838509, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo University of Agriculture & Technology	Imakawa, K (corresponding author), Univ Tokyo, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Bai, Hanako/K-4769-2019; Imakawa, Kazuhiko/AAD-3211-2022; Nagaoka, Kentaro/C-2019-2013	Bai, Hanako/0000-0001-9940-1880; Nagaoka, Kentaro/0000-0003-1038-1380	Japan Racing Association (JRA) [2009-2010]	Japan Racing Association (JRA)	The grant (2009-2010) from Japan Racing Association (JRA) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2009, PLACENTA, V30, P1005, DOI 10.1016/j.placenta.2009.09.007; Allen WR, 2001, REPROD FERT DEVELOP, V13, P623, DOI 10.1071/RD01063; Allen WR, 2001, REPRODUCTION, V121, P513, DOI 10.1530/rep.0.1210513; ALLEN WR, 1972, J REPROD FERTIL, V29, P313, DOI 10.1530/jrf.0.0290313; ALLEN WR, 1973, ANAT REC, V177, P485, DOI 10.1002/ar.1091770403; [Anonymous], 1969, CIB FDN S FOET AUT L, DOI DOI 10.1002/9780470719688.CH2; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Mestre AM, 2009, BIOL REPROD, V80, P227, DOI 10.1095/biolreprod.108.070920; de Ruijter-Villani M, 2013, THERIOGENOLOGY, V80, P979, DOI 10.1016/j.theriogenology.2013.07.024; ENDERS AC, 1991, J REPROD FERTIL, P427; Furmento VA, 2014, PLACENTA, V35, P937, DOI 10.1016/j.placenta.2014.09.003; Gastal MO, 1996, THERIOGENOLOGY, V46, P1171, DOI 10.1016/S0093-691X(96)00288-9; Ginther O.J., 1992, REPROD BIOL MARE BAS; Ginther O.J., 1998, CATTLE BOOK 3, VVolume 46, P100; GINTHER OJ, 1993, THERIOGENOLOGY, V40, P1, DOI 10.1016/0093-691X(93)90336-4; GINTHER OJ, 1983, THERIOGENOLOGY, V19, P603, DOI 10.1016/0093-691X(83)90180-2; GINTHER OJ, 1983, THERIOGENOLOGY, V19, P613, DOI 10.1016/0093-691X(83)90181-4; Haneda S, 2009, DOMEST ANIM ENDOCRIN, V36, P209, DOI 10.1016/j.domaniend.2008.11.006; Hartt LS, 2005, REPRODUCTION, V130, P241, DOI 10.1530/rep.1.00596; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kikuchi M, 2011, J REPROD DEVELOP, V57, P203, DOI 10.1262/jrd.10-079K; Klein C, 2011, BIOL REPROD, V84, P872, DOI 10.1095/biolreprod.110.088732; Kostourou V, 2014, BBA-GEN SUBJECTS, V1840, P2403, DOI 10.1016/j.bbagen.2014.02.018; Lyu JY, 2013, J CELL BIOCHEM, V114, P1744, DOI 10.1002/jcb.24517; MCDOWELL KJ, 1990, J REPROD FERTIL, V89, P107, DOI 10.1530/jrf.0.0890107; Mohanty S, 2010, PLACENTA, V31, P144, DOI 10.1016/j.placenta.2009.11.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaoka K, 2003, BIOL REPROD, V68, P1413, DOI 10.1095/biolreprod.102.008912; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; Nambo Y, 2002, THERIOGENOLOGY, V57, P1707, DOI 10.1016/S0093-691X(02)00683-0; Neely D P, 1979, J Reprod Fertil Suppl, P181; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; ORIOL JG, 1993, J REPROD FERTIL, V99, P653, DOI 10.1530/jrf.0.0990653; ORIOL JG, 1993, MOL REPROD DEV, V34, P255, DOI 10.1002/mrd.1080340305; ORIOL JG, 1991, J REPROD FERTIL, P455; Sakurai T, 2009, BIOL REPROD, V80, P1223, DOI 10.1095/biolreprod.108.073916; Stout TAE, 2002, REPRODUCTION, V123, P261, DOI 10.1530/rep.0.1230261; Stout TAE, 2001, REPRODUCTION, V121, P771, DOI 10.1530/rep.0.1210771; Tachibana Y, 2013, J REPROD DEVELOP, V59, P85; Walter I, 2010, REPROD FERT DEVELOP, V22, P405, DOI 10.1071/RD08280; Wooding FBP, 2001, PLACENTA, V22, P749, DOI 10.1053/plac.2001.0707	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114414	10.1371/journal.pone.0114414	http://dx.doi.org/10.1371/journal.pone.0114414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514169	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300009
J	Yu, AL; Li, Y; Ni, YL; Yang, WB; Yang, DQ; Cui, ZY; Wang, ZL; Yin, YP				Yu, Anling; Li, Yong; Ni, Yingli; Yang, Weibing; Yang, Dongqing; Cui, Zhengyong; Wang, Zhenlin; Yin, Yanping			Differences of Starch Granule Distribution in Grains from Different Spikelet Positions in Winter Wheat	PLOS ONE			English	Article							SIZE-DISTRIBUTION; INFERIOR GRAINS; RICE CULTIVAR; A-GRANULE; GROWTH; POSTANTHESIS; ENDOSPERM; SUPERIOR; ENZYMES; STRENGTH	Wheat starch development is a complex process and is markedly difference by changes in spikelet spatial position. The present study deals with endosperm starch granule distribution and spatial position during filling development. The study was conducted with pure starch isolated from wheat (Triticum aestivum L.), Jimai20 and Shannong1391, at 7-35 days after anthesis (DAA). The results showed that grain number, spikelet weight and grain weight per spikelet in different spatial position showed parabolic changes. Upper spikelets had highest starch and amylose content followed by basal spikelets, then middle spikelets. The paper also suggested the volume percents of B-type and A-type granule in grain of middle spikelets were remarkably higher and lower than those of basal and upper spikelets, respectively. However, no significant difference occurred in the number percents of the two type granule. The ratio of amylase to amylopectin was positively correlated with the volume proportion of 22.8-42.8 mu m, but was negatively related to the volume proportion of <9.9 mu m. The results indicated that the formation and distribution of starch granules were affected significantly by spikelet position, and grains at upper and basal spikelet had the potential of increasing grain weight through increasing the volume of B-type granules.	[Yu, Anling; Li, Yong; Yang, Weibing; Yang, Dongqing; Cui, Zhengyong; Wang, Zhenlin; Yin, Yanping] Shandong Agr Univ, Natl Key Lab Crop Biol, Minist Sci & Technol, Agron Coll, Tai An, Shandong, Peoples R China; [Yu, Anling] Agr Prod Qual Inspect Ctr Jining, Jining, Shandong, Peoples R China; [Ni, Yingli] Agr Bur Rencheng Dist, Jining, Shandong, Peoples R China		Wang, ZL (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Minist Sci & Technol, Agron Coll, Tai An, Shandong, Peoples R China.	zlwang@sdau.edu.cn; ypyin@sdau.edu.cn			National Natural Science Foundation of China [31271661, 31271667]; Public Service Sector (Agriculture) Research Program of China [201203100]; Postdoctoral Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Sector (Agriculture) Research Program of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	The research was supported by the National Natural Science Foundation of China (31271661, 31271667), the Public Service Sector (Agriculture) Research Program of China (201203100) and Postdoctoral Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2002, CEREAL CHEM, V79, P458, DOI 10.1094/CCHEM.2002.79.3.458; Ahuja G, 2014, CARBOHYD POLYM, V114, P87, DOI 10.1016/j.carbpol.2014.08.004; Ames NP, 1999, VARIATION STARCH GRA; BECHTEL DB, 1990, CEREAL CHEM, V67, P59; Calderini DF, 2000, AUST J PLANT PHYSIOL, V27, P183; Chiotelli E, 2002, CEREAL CHEM, V79, P286, DOI 10.1094/CCHEM.2002.79.2.286; Dai ZM, 2010, RUSS J PLANT PHYSL+, V57, P74, DOI 10.1134/S1021443710010103; Dai ZhongMin, 2008, Acta Agronomica Sinica, V34, P795, DOI 10.3724/SP.J.1006.2008.00795; Dengate H. N., 1984, Advances in Cereal Science and Technology, V6, P49; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Jeng TL, 2003, J AGR SCI-CAMBRIDGE, V141, P303, DOI 10.1017/S0021859603003599; Jiang D, 2003, PLANT GROWTH REGUL, V41, P247, DOI 10.1023/B:GROW.0000007500.90240.7d; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kim HS, 2008, J CEREAL SCI, V48, P159, DOI 10.1016/j.jcs.2007.09.002; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Li W, 2010, J AGR SCI-CAMBRIDGE, V148, P183, DOI 10.1017/S0021859609990554; [李文阳 LI WenYang], 2009, [生态学报, Acta Ecologica Sinica], V29, P298; Liang TaiBo, 2008, Acta Agronomica Sinica, V34, P150, DOI 10.3724/SP.J.1006.2008.00150; MACLEOD LC, 1988, J CEREAL SCI, V8, P29, DOI 10.1016/S0733-5210(88)80046-8; MALOUF RB, 1992, CEREAL CHEM, V69, P164; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Ni Y, 2012, J AGR SCI, V150, P45, DOI 10.1017/S0021859611000475; Pan Jie, 2005, Acta Agronomica Sinica, V31, P431; Park SH, 2009, J CEREAL SCI, V49, P98, DOI 10.1016/j.jcs.2008.07.011; Park SH, 2004, CEREAL CHEM, V81, P699, DOI 10.1094/CCHEM.2004.81.6.699; PARKER ML, 1985, J CEREAL SCI, V3, P271, DOI 10.1016/S0733-5210(85)80001-1; Peng M, 1999, CEREAL CHEM, V76, P375, DOI 10.1094/CCHEM.1999.76.3.375; Peng MS, 2001, PLANT SCI, V161, P1055, DOI 10.1016/S0168-9452(01)00481-2; Raeker MO, 1998, CEREAL CHEM, V75, P721, DOI 10.1094/CCHEM.1998.75.5.721; Sahlstrom S, 2003, J CEREAL SCI, V37, P285, DOI 10.1006/jcrs.2002.0504; Sahlstrom S, 1998, J CEREAL SCI, V28, P157, DOI 10.1006/jcrs.1998.0192; Seib P.A., 1994, OYO TOSHITSU KAGAKU, V41, P49; Shinde SV, 2003, CEREAL CHEM, V80, P91, DOI 10.1094/CCHEM.2003.80.1.91; Sikder H. P., 1976, Indian Agriculturalist, V20, P133; Soh HN, 2006, CEREAL CHEM, V83, P513, DOI 10.1094/CC-83-0513; SOULAKA AB, 1985, J SCI FOOD AGR, V36, P709, DOI 10.1002/jsfa.2740360811; STAMP P H, 1976, Zeitschrift fuer Acker- und Pflanzenbau, V142, P264; Stoddard FL, 1999, CEREAL CHEM, V76, P139, DOI 10.1094/CCHEM.1999.76.1.139; Tan XS, 2012, ACTA AGRON SIN, V11, P1809; Vermeylen R, 2005, CARBOHYD POLYM, V62, P170, DOI 10.1016/j.carbpol.2005.07.021; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang F, 2006, PLANT GROWTH REGUL, V49, P1, DOI 10.1007/s10725-006-0017-3; Wang Y.-R., 1981, International Rice Research Newsletter, V6, P23; Wang Z, 2003, J AGRON CROP SCI, V189, P280, DOI 10.1046/j.1439-037X.2003.00041.x; Yan S, 2010, J AGR SCI-CAMBRIDGE, V148, P567, DOI 10.1017/S0021859610000407; Yan SuHui, 2008, Acta Agronomica Sinica, V34, P1092, DOI 10.3724/SP.J.1006.2008.01092; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JianChang, 2002, Agricultural Sciences in China, V1, P155; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yang JianChang, 1998, Scientia Agricultura Sinica, V31, P7; Yu S L, 1990, WHEAT SHANDONG PROVI; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang QY, 2000, J TRITICEAE CROPS, V20, P55	54	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114342	10.1371/journal.pone.0114342	http://dx.doi.org/10.1371/journal.pone.0114342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514032	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300008
J	Fang, CS; Zhang, JQ; Qi, D; Fan, XQ; Luo, JC; Liu, L; Tan, QY				Fang, Chunshu; Zhang, Jingqing; Qi, Di; Fan, Xiaoqing; Luo, Jianchun; Liu, Ling; Tan, Qunyou			Evodiamine Induces G2/M Arrest and Apoptosis via Mitochondrial and Endoplasmic Reticulum Pathways in H446 and H1688 Human Small-Cell Lung Cancer Cells	PLOS ONE			English	Article							MEDIATED APOPTOSIS; A549 CELLS; ER STRESS; IN-VITRO; GROWTH; COMPLEX; CYCLE; DERIVATIVES; ACTIVATION; INDUCTION	The goal of this study was to evaluate the ability of EVO to decrease cell viability and promote cell cycle arrest and apoptosis in small cell lung cancer (SCLC) cells. Lung cancer has the highest incidence and mortality rates among all cancers. Chemotherapy is the primary treatment for SCLC; however, the drugs that are currently used for SCLC are less effective than those used for non-small cell lung cancer (NSCLC). Therefore, it is necessary to develop new drugs to treat SCLC. In this study, the effects of evodiamine (EVO) on cell growth, cell cycle arrest and apoptosis were investigated in the human SCLC cell lines NCI-H446 and NCI-H1688. The results represent the first report that EVO can significantly inhibit the viability of both H446 and H1688 cells in dose-and time-dependent manners. EVO induced cell cycle arrest at G2/M phase, induced apoptosis by up-regulating the expression of caspase-12 and cytochrome C protein, and induced the expression of Bax mRNA and by down-regulating of the expression of Bcl-2 mRNA in both H446 and H1688 cells. However, there was no effect on the protein expression of caspase-8. Taken together, the inhibitory effects of EVO on the growth of H446 and H1688 cells might be attributable to G2/M arrest and subsequent apoptosis, through mitochondria-dependent and endoplasmic reticulum stress-induced pathways (intrinsic caspase-dependent pathways) but not through the death receptor-induced pathway (extrinsic caspase-dependent pathway). Our findings suggest that EVO is a promising novel and potent antitumor drug candidate for SCLC. Furthermore, the cell cycle, the mitochondria and the ER stress pathways are rational targets for the future development of an EVO delivery system to treat SCLC.	[Fang, Chunshu; Qi, Di; Fan, Xiaoqing; Liu, Ling; Tan, Qunyou] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Inst Surg Res, Chongqing, Peoples R China; [Zhang, Jingqing; Luo, Jianchun] Chongqing Med Univ, Med Engn Res Ctr, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University	Tan, QY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Inst Surg Res, Chongqing, Peoples R China.	tanqy001@163.com			Chongqing Science and Technology Committee, Chongqing, People's Republic of China [CSTC2012JJB10027]	Chongqing Science and Technology Committee, Chongqing, People's Republic of China	This study was supported by the grant CSTC2012JJB10027 from Chongqing Science and Technology Committee, Chongqing, People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091388; Cao R, 2013, J MED CHEM, V56, P3636, DOI 10.1021/jm4001665; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Cheng CY, 2010, MOL MED REP, V3, P645, DOI 10.3892/mmr_00000310; Choi AY, 2014, APOPTOSIS, V19, P682, DOI 10.1007/s10495-013-0955-y; Christodoulou MS, 2013, BIOORGAN MED CHEM, V21, P6920, DOI 10.1016/j.bmc.2013.09.030; Cui WY, 2014, TUMOR BIOL, V35, P5213, DOI 10.1007/s13277-014-1677-7; Dong GQ, 2012, J MED CHEM, V55, P7593, DOI 10.1021/jm300605m; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Fei ZH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/497456; Jiang JL, 2009, MOLECULES, V14, P1852, DOI 10.3390/molecules14051852; Ju YH, 2013, MOL MED REP, V8, P794, DOI 10.3892/mmr.2013.1584; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; Li L, 2012, CHINESE J CANCER RES, V24, P109, DOI 10.1007/s11670-012-0109-8; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lin Y, 2014, TUMOR BIOL, V35, P3305, DOI 10.1007/s13277-013-1433-4; Ling YH, 2008, MOL PHARMACOL, V74, P793, DOI 10.1124/mol.107.044396; Liu AJ, 2013, CHEM-BIOL INTERACT, V205, P20, DOI 10.1016/j.cbi.2013.06.004; Liu ZG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-494; Lu B, 2003, DRUG DELIV, V10, P87, DOI 10.1080/713840364; Lv C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.484; Meng J, 2012, ONCOL REP, V28, P384, DOI 10.3892/or.2012.1793; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Shyu KG, 2006, LIFE SCI, V78, P2234, DOI 10.1016/j.lfs.2005.09.027; Song SC, 2013, MOLECULES, V18, P15750, DOI 10.3390/molecules181215750; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Tan QY, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035102; Tan QY, 2012, INT J NANOMED, V7, P5385, DOI 10.2147/IJN.S36404; Tan QY, 2012, AAPS PHARMSCITECH, V13, P534, DOI 10.1208/s12249-012-9772-9; Tan YH, 2008, CLIN CANCER RES, V14, P1823, DOI 10.1158/1078-0432.CCR-07-1806; Tao L, 2014, TOXICOL LETT; Wang Y, 2013, J MED CHEM, V56, P9601, DOI 10.1021/jm4016312; Wei WT, 2012, INT J BIOL SCI, V8, P1, DOI 10.7150/ijbs.8.1; Wei YL, 2013, FOOD CHEM TOXICOL, V59, P118, DOI 10.1016/j.fct.2013.05.054; Wu SH, 2010, ANTICANCER RES, V30, P2125; Xiao F, 2012, MOL CELL BIOCHEM, V371, P65, DOI 10.1007/s11010-012-1423-7; Xu WS, 2014, PHYTOTHER RES, V28, P296, DOI 10.1002/ptr.4984; Xu WS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/426521; Xu Y, 2014, MOL CLIN ONCOL, V2, P3, DOI 10.3892/mco.2013.202; Yang CL, 2012, DNA CELL BIOL, V31, P139, DOI 10.1089/dna.2011.1300; Yang L, 2014, MOL MED REP, V9, P1147, DOI 10.3892/mmr.2014.1924; Yang LN, 2013, IUBMB LIFE, V65, P533, DOI 10.1002/iub.1161; Yoon JW, 2014, ONCOL REP, V31, P314, DOI 10.3892/or.2013.2840; Yu HX, 2014, CELL BIOCHEM BIOPHYS, V70, P63, DOI 10.1007/s12013-014-9910-y; Zhang T, 2014, INT J MOL SCI, V15, P3154, DOI 10.3390/ijms15023154; Zhang YL, 2013, AM J CHINESE MED, V41, P1137, DOI 10.1142/S0192415X13500778; Zhu GY, 2012, CHEM PHARM BULL, V60, P1029, DOI 10.1248/cpb.c12-00302	48	43	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115204	10.1371/journal.pone.0115204	http://dx.doi.org/10.1371/journal.pone.0115204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506932	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100059
J	Jo, H; Patterson, V; Stoessel, S; Kuan, CY; Hoh, J				Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Kuan, Chia-Yi; Hoh, Josephine			Protoporphyrins Enhance Oligomerization and Enzymatic Activity of HtrA1 Serine Protease	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; MACULAR DEGENERATION; FAMILY PROTEINS; QUALITY CONTROL; SERUM-ALBUMIN; CANCER; OXYGEN; GENE; THERAPY; TARGETS	High temperature requirement protein A1 (HtrA1), a secreted serine protease of the HtrA family, is associated with a multitude of human diseases. However, the exact functions of HtrA1 in these diseases remain poorly understood. We seek to unravel the mechanisms of HtrA1 by elucidating its interactions with chemical or biological modulators. To this end, we screened a small molecule library of 500 bioactive compounds to identify those that alter the formation of extracellular HtrA1 complexes in the cell culture medium. An initial characterization of two novel hits from this screen showed that protoporphyrin IX (PPP-IX), a precursor in the heme biosynthetic pathway, and its metalloporphyrin (MPP) derivatives fostered the oligomerization of HtrA1 by binding to the protease domain. As a result of the interaction with MPPs, the proteolytic activity of HtrA1 against Fibulin-5, a specific HtrA1 substrate in age-related macular degeneration (AMD), was increased. This physical interaction could be abolished by the missense mutations of HtrA1 found in patients with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Furthermore, knockdown of HtrA1 attenuated apoptosis induced by PPP-IX. These results suggest that PPP-IX, or its derivatives, and HtrA1 may function as co-factors whereby porphyrins enhance oligomerization and the protease activity of HtrA1, while active HtrA1 elevates the pro-apoptotic actions of porphyrin derivatives. Further analysis of this interplay may shed insights into the pathogenesis of diseases such as AMD, CARASIL and protoporphyria, as well as effective therapeutic development.	[Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Hoh, Josephine] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Hoh, Josephine] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Yale University; Yale University; Children's Healthcare of Atlanta (CHOA); Emory University	Hoh, J (corresponding author), Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	Josephine.hoh@yale.edu			Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	This work was funded by Rosebay Medical Foundation and Yale Medical School Dean's Research Fund. No URL is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SM, 2002, BIOPHYS J, V82, P1607, DOI 10.1016/S0006-3495(02)75512-4; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Beacham DW, 2010, J BIOMOL SCREEN, V15, P441, DOI 10.1177/1087057109359807; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Chow JM, 2008, TOXICOL LETT, V177, P97, DOI 10.1016/j.toxlet.2008.01.004; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kobuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050082; Korinek M, 2006, J FLUORESC, V16, P355, DOI 10.1007/s10895-005-0057-5; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Marchetti P, 1996, J IMMUNOL, V157, P4830; Nishimoto Y, 2011, NEUROLOGY, V76, P1353, DOI 10.1212/WNL.0b013e318215281d; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Polireddy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040005; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Tominaga TT, 1997, J INORG BIOCHEM, V65, P235, DOI 10.1016/S0162-0134(96)00137-7; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wang GF, 2014, EXP EYE RES, V119, P1, DOI 10.1016/j.exer.2013.11.009; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yushmanov VE, 1996, MAGN RESON IMAGING, V14, P255, DOI 10.1016/0730-725X(95)02103-Z; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	42	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115362	10.1371/journal.pone.0115362	http://dx.doi.org/10.1371/journal.pone.0115362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506911	gold, Green Submitted, Green Published			2022-12-26	WOS:000346607100070
J	Laufer, S; Mazuz, A; Nachmansson, N; Fellig, Y; Corn, BW; Bokstein, F; Ben Bashat, D; Abramovitch, R				Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Fellig, Yakov; Corn, Benjamin William; Bokstein, Felix; Ben Bashat, Dafna; Abramovitch, Rinat			Monitoring Brain Tumor Vascular Heamodynamic following Anti-Angiogenic Therapy with Advanced Magnetic Resonance Imaging in Mice	PLOS ONE			English	Article							RECURRENT MALIGNANT GLIOMAS; MRI; HYPEROXIA; GROWTH; BEVACIZUMAB; HYPERCAPNIA; SUSCEPTIBILITY; RESPONSES; EFFICACY; MODEL	Advanced MR imaging methods have an essential role in classification, grading, follow-up and therapeutic management in patients with brain tumors. With the introduction of new therapeutic options, the challenge for better tissue characterization and diagnosis increase, calling for new reliable non-invasive imaging methods. In the current study we evaluated the added value of a combined protocol of blood oxygen level dependent (BOLD) imaging during hyperoxic challenge (termed hemodynamic response imaging (HRI)) in an orthotopic mouse model for glioblastoma under anti-angiogenic treatment with B20-4.1.1, an anti-VEGF antibody. In glioblastoma tumors, the elevated HRI indicated progressive angiogenesis as further confirmed by histology. In the current glioblastoma model, B20-treatment caused delayed tumor progression with no significant changes in HRI yet with slightly reduced tumor vascularity as indicated by histology. Furthermore, fewer apoptotic cells and higher proliferation index were detected in the B20-treated tumors compared to control-treated tumors. In conclusion, HRI provides an easy, safe and contrast agent free method for the assessment of the brain hemodynamic function, an additionally important clinical information.	[Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, MRI MRS Lab HBRC, Jerusalem, Israel; [Fellig, Yakov] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Corn, Benjamin William] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Radiotherapy, IL-69978 Tel Aviv, Israel; [Bokstein, Felix] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Neurooncol Serv, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Abramovitch, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rinat@hadassah.org.il			James S. McDonnell Foundation [220020176]; Translational Research Program (RTOG) [U10 CA21661]; CCOP grant from the National Cancer Institute (NCI) [U10 CA37422]; NATIONAL CANCER INSTITUTE [U10CA037422, U10CA180822, UG1CA189867, U10CA021661, U10CA180868] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Translational Research Program (RTOG); CCOP grant from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the James S. McDonnell Foundation (grant number 220020176), http://www.jsmf.org/; and was also supported by the Translational Research Program (RTOG) grant U10 CA21661 and CCOP grant U10 CA37422 from the National Cancer Institute (NCI). This manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 1999, CANCER RES, V59, P5012; Abramovitch R, 2004, NEOPLASIA, V6, P480, DOI 10.1593/neo.03520; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Cabrera AR, 2013, INT J RADIAT ONCOL, V86, P873, DOI 10.1016/j.ijrobp.2013.04.029; Edrei Y, 2012, BRIT J CANCER, V107, P658, DOI 10.1038/bjc.2012.322; Gerstner ER, 2008, CURR OPIN NEUROL, V21, P728, DOI 10.1097/WCO.0b013e328318402a; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hsu YY, 2004, J MAGN RESON IMAGING, V19, P160, DOI 10.1002/jmri.10447; Huettel SA, 2004, NEUROIMAGE, V23, P402, DOI 10.1016/j.neuroimage.2004.04.031; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jalali S, 2014, NEURO-ONCOLOGY, V16, P868, DOI 10.1093/neuonc/nou040; Kiessling F, 2007, EUR RADIOL, V17, P2136, DOI 10.1007/s00330-006-0566-x; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; Milman Z, 2013, NEPHROL DIAL TRANSPL, V28, P1150, DOI 10.1093/ndt/gfs541; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2009, J NEURO-ONCOL, V92, P149, DOI 10.1007/s11060-008-9745-8; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pope WB, 2006, NEUROLOGY, V66, P1258, DOI 10.1212/01.wnl.0000208958.29600.87; Reijneveld JC, 2000, J NEUROL, V247, P597, DOI 10.1007/s004150070128; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Sela Y, 2011, IEEE T BIO-MED ENG, V58, P2574, DOI 10.1109/TBME.2011.2159501; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115093	10.1371/journal.pone.0115093	http://dx.doi.org/10.1371/journal.pone.0115093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506833	gold, Green Submitted, Green Published			2022-12-26	WOS:000346607100049
J	Tesson, SVM; Montresor, M; Procaccini, G; Kooistra, WHCF				Tesson, Sylvie V. M.; Montresor, Marina; Procaccini, Gabriele; Kooistra, Wiebe H. C. F.			Temporal Changes in Population Structure of a Marine Planktonic Diatom	PLOS ONE			English	Article							GENETIC-STRUCTURE; COMPUTER-PROGRAM; COASTAL WATERS; TYRRHENIAN SEA; SPRING BLOOM; TIME; BACILLARIOPHYCEAE; SOFTWARE; NAPLES; GULF	A prevailing question in phytoplankton research addresses changes of genetic diversity in the face of huge population sizes and apparently unlimited dispersal capabilities. We investigated population genetic structure of the pennate planktonic marine diatom Pseudo-nitzschia multistriata at the LTER station MareChiara in the Gulf of Naples (Italy) over four consecutive years and explored possible changes over seasons and from year to year. A total of 525 strains were genotyped using seven microsatellite markers, for a genotypic diversity of 75.05%, comparable to that found in other Pseudo-nitzschia species. Evidence from Bayesian clustering analysis (BA) identified two genetically distinct clusters, here interpreted as populations, and several strains that could not be assigned with >= 90% probability to either population, here interpreted as putative hybrids. Principal Component Analysis (PCA) recovered these two clusters in distinct clouds with most of the putative hybrids located in-between. Relative proportions of the two populations and the putative hybrids remained similar within years, but changed radically between 2008 and 2009 and between 2010 and 2011, when the 2008-population apparently became the dominant one again. Strains from the two populations are inter-fertile, and so is their offspring. Inclusion of genotypes of parental strains and their offspring shows that the majority of the latter could not be assigned to any of the two parental populations. Therefore, field strains classified by BA as the putative hybrids could be biological hybrids. We hypothesize that P. multistriata population dynamics in the Gulf of Naples follows a meta-population-like model, including establishment of populations by cell inocula at the beginning of each growth season and remixing and dispersal governed by moving and mildly turbulent water masses.	[Tesson, Sylvie V. M.; Montresor, Marina; Procaccini, Gabriele; Kooistra, Wiebe H. C. F.] Staz Zool Anton Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Tesson, SVM (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, POB 462, SE-40530 Gothenburg, Sweden.	sylvie.tesson@gu.se	Procaccini, Gabriele/AAA-7040-2019; Tesson, Sylvie VM/D-9018-2015; Procaccini, Gabriele/A-6618-2010	Procaccini, Gabriele/0000-0002-6179-468X; Tesson, Sylvie VM/0000-0002-0751-6953; Procaccini, Gabriele/0000-0002-6179-468X; Kooistra, Wiebe/0000-0002-8641-9739; Montresor, Marina/0000-0002-2475-1787	Stazione Zoologica Anton Dohrn (SZN); MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare); SZN PhD fellowship	Stazione Zoologica Anton Dohrn (SZN); MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare); SZN PhD fellowship	This research was funded by the Stazione Zoologica Anton Dohrn (SZN) and the MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare). ST has been supported by a SZN PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NG, 2009, J PHYCOL, V45, P1037, DOI 10.1111/j.1529-8817.2009.00746.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bagley MJ, 2000, MARINE BIOINVASIONS, P241; Belkhir K., 1996, 5171 CNRS UMR; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Casabianca S, 2011, P BIOL SCI, V279, P129; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Casteleyn G, 2009, MAR BIOL, V156, P1149, DOI 10.1007/s00227-009-1157-6; Congestri R, 2008, NATO SCI PEACE SEC A, P197, DOI 10.1007/978-1-4020-8480-5_7; Cornuet JM, 1996, GENETICS, V144, P2001; D'Alcala MR, 2004, SCI MAR, V68, P65; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; D'Alelio D, 2009, HARMFUL ALGAE, V8, P225, DOI 10.1016/j.hal.2008.05.004; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edler L., 2010, MICROSCOPIC MOL METH, P13, DOI DOI 10.1016/J.RESP.2011.02.009; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hanski I., 1999, METAPOPULATION ECOLO; Hartl D., 1989, PRINCIPLES POPULATIO; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Menna M, 2007, NUOVO CIMENTO C, V30, P605, DOI 10.1393/ncc/i2008-10270-0; Montresor M, 2013, MAR ECOL PROG SER, V484, P79, DOI 10.3354/meps10236; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Richlen ML, 2012, ECOL EVOL, V2, P2583, DOI 10.1002/ece3.373; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Rynearson TA, 2009, PROTIST, V160, P111, DOI 10.1016/j.protis.2008.10.003; Tesson SVM, 2013, PROTIST, V164, P89, DOI 10.1016/j.protis.2012.07.001; Tesson SVM, 2011, AM J BOT, V98, pE33, DOI 10.3732/ajb.1000430; Uttieri M, 2011, OCEAN DYNAM, V61, P779, DOI 10.1007/s10236-011-0401-z; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Zingone A, 2006, HARMFUL ALGAE, V5, P321, DOI 10.1016/j.hal.2005.09.002	45	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114984	10.1371/journal.pone.0114984	http://dx.doi.org/10.1371/journal.pone.0114984			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506926	Green Submitted, gold, Green Published			2022-12-26	WOS:000346607100038
J	Cooper, DL; Harirforoosh, S				Cooper, Dustin L.; Harirforoosh, Sam			Effect of Formulation Variables on Preparation of Celecoxib Loaded Polylactide-Co-Glycolide Nanoparticles	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SOLID LIPID NANOPARTICLES; PLGA-BASED NANOPARTICLES; ORAL DELIVERY-SYSTEM; WATER-SOLUBLE DRUG; RHEUMATOID-ARTHRITIS; IN-VITRO; BIODEGRADABLE NANOPARTICLES; PARTICLE-SIZE; ACUTE PAIN	Polymer based nanoparticle formulations have been shown to increase drug bioavailability and/or reduce drug adverse effects. Nonsteroidal anti-inflammatory drugs (e. g. celecoxib) reduce prostaglandin synthesis and cause side effects such as gastrointestinal and renal complications. The aim of this study was to formulate celecoxib entrapped poly lactide-co-glycolide based nanoparticles through a solvent evaporation process using didodecyldimethylammonium bromide or poly vinyl alcohol as stabilizer. Nanoparticles were characterized for zeta potential, particle size, entrapment efficiency, and morphology. Effects of stabilizer concentration (0.1, 0.25, 0.5, and 1% w/v), drug amount (5, 10, 15, and 20 mg), and emulsifier (lecithin) on nanoparticle characterization were examined for formula optimization. The use of 0.1, 0.25, and 0.5% w/v didodecyldimethylammonium bromide resulted in a more than 5-fold increase in zeta potential and a more than 1.5-fold increase in entrapment efficiency with a reduction in particle size over 35%, when compared to stabilizer free formulation. Nanoparticle formulations were also highly influenced by emulsifier and drug amount. Using 0.25% w/v didodecyldimethylammonium bromide NP formulations, peak zeta potential was achieved using 15 mg celecoxib with emulsifier (17.15 +/- 0.36 mV) and 20 mg celecoxib without emulsifier (25.00 +/- 0.18 mV). Peak NP size reduction and entrapment efficiency was achieved using 5 mg celecoxib formulations with (70.87 +/- 1.24 nm and 95.55 +/- 0.66%, respectively) and without (92.97 +/- 0.51 nm and 95.93 +/- 0.27%, respectively) emulsifier. In conclusion, formulations using 5 mg celecoxib with 0.25% w/v didodecyldimethylammonium bromide concentrations produced nanoparticles exhibiting enhanced size reduction and entrapment efficiency. Furthermore, emulsifier free formulations demonstrated improved zeta potential when compared to formulations containing emulsifier (p<0.01). Therefore, our results suggest the use of emulsifier free 5 mg celecoxib drug formulations containing 0.25% w/v didodecyldimethylammonium bromide for production of polymeric NPs that demonstrate enhanced zeta potential, small particle size, and high entrapment efficiency.	[Cooper, Dustin L.; Harirforoosh, Sam] E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA	East Tennessee State University	Harirforoosh, S (corresponding author), E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	harirfor@etsu.edu	Harirforoosh, Sam/J-9493-2013	Harirforoosh, Sam/0000-0002-2631-3756	Research and Development Committee Major Grant, East Tennessee State University	Research and Development Committee Major Grant, East Tennessee State University	This study was funded by a Research and Development Committee Major Grant, East Tennessee State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2002, DRUG SAFETY, V25, P537, DOI 10.2165/00002018-200225070-00007; Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531; Amrite A, 2010, EXPERT OPIN DRUG DEL, V7, P631, DOI 10.1517/17425241003663236; Ayalasomayajula SP, 2005, EUR J PHARMACOL, V511, P191, DOI 10.1016/j.ejphar.2005.02.019; Bachar M, 2012, J CONTROL RELEASE, V160, P164, DOI 10.1016/j.jconrel.2012.01.004; Bala I, 2006, J DRUG TARGET, V14, P27, DOI 10.1080/10611860600565987; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chen JB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04841; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Clemett D, 2000, DRUGS, V59, P957, DOI 10.2165/00003495-200059040-00017; Cooper DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087326; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Crosasso P, 2000, J CONTROL RELEASE, V63, P19, DOI 10.1016/S0168-3659(99)00166-2; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; De SJ, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050453; Dhanda DS, 2013, J CONTROL RELEASE, V168, P239, DOI 10.1016/j.jconrel.2013.03.027; Fisk ID, 2013, FOOD RES INT, V54, P861, DOI 10.1016/j.foodres.2013.08.024; Fitzpatrick FA, 2004, CURR PHARM DESIGN, V10, P577, DOI 10.2174/1381612043453144; Frampton JE, 2007, DRUGS, V67, P2433, DOI 10.2165/00003495-200767160-00008; Goldenberg MM, 1999, CLIN THER, V21, P1497, DOI 10.1016/S0149-2918(00)80005-3; Gomaa YA, 2014, EUR J PHARM BIOPHARM, V86, P145, DOI 10.1016/j.ejpb.2013.01.026; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Han CY, 2011, MOL DIVERS, V15, P857, DOI 10.1007/s11030-011-9317-2; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Harirforoosh S, 2013, J PHARM PHARM SCI, V16, P821, DOI 10.18433/J3VW2F; HILLS BA, 1983, J APPL PHYSIOL, V54, P420, DOI 10.1152/jappl.1983.54.2.420; Hoffmann U, 2006, TRANSPL INT, V19, P203, DOI 10.1111/j.1432-2277.2005.00261.x; Hu KL, 2012, INT J NANOMED, V7, P3537, DOI 10.2147/IJN.S32880; Immordino ML, 2006, INT J NANOMED, V1, P297; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Joshi M, 2008, INT J PHARMACEUT, V346, P124, DOI 10.1016/j.ijpharm.2007.05.060; Kenawi IM, 2008, J MOL STRUC-THEOCHEM, V851, P46, DOI 10.1016/j.theochem.2007.10.034; Labhasetwar V, 1998, J PHARM SCI, V87, P1229, DOI 10.1021/js980021f; Lakshmi K, 2013, Curr Drug Discov Technol, V10, P305; McCormack PL, 2011, DRUGS, V71, P2457, DOI 10.2165/11208240-000000000-00000; Mohammadi Z, 2012, ACTA PHARMACEUT, V62, P83, DOI 10.2478/v10007-012-0008-z; Morgen M, 2012, PHARM RES-DORDR, V29, P427, DOI 10.1007/s11095-011-0558-7; Mosqueira VCF, 2000, J PHARM SCI-US, V89, P614, DOI 10.1002/(SICI)1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7; Palamoor M, 2013, COLLOID SURFACE B, V112, P474, DOI 10.1016/j.colsurfb.2013.07.039; Parhi P, 2012, DRUG DISCOV TODAY, V17, P1044, DOI 10.1016/j.drudis.2012.05.010; Qiao JL, 2013, J POWER SOURCES, V237, P1, DOI 10.1016/j.jpowsour.2013.02.059; Rao DA, 2010, J PHARM SCI-US, V99, P2018, DOI 10.1002/jps.21970; Rodriguez M, 2006, FOOD RES INT, V39, P840, DOI 10.1016/j.foodres.2006.04.002; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Savjani KT, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/195727; Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Seibert K, 1997, ADV EXP MED BIOL, V400, P167; SEIBERT K, 1994, RECEPTOR, V4, P17; Shakeel F, 2009, PHARMAZIE, V64, P258, DOI 10.1691/ph.2009.8282; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013; Tan A, 2011, PHARM RES-DORDR, V28, P2273, DOI 10.1007/s11095-011-0458-x; Tan A, 2009, J CONTROL RELEASE, V134, P62, DOI 10.1016/j.jconrel.2008.10.014; Thakkar H, 2005, AAPS PHARMSCITECH, V6; Thakkar Hetal, 2007, Drugs R D, V8, P275, DOI 10.2165/00126839-200708050-00002; Nguyen TH, 2013, J CONTROL RELEASE, V167, P85, DOI 10.1016/j.jconrel.2013.01.012; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188; Xu YL, 2013, PAK J PHARM SCI, V26, P495; Yamamoto Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1791, DOI 10.1271/bbb.61.1791; Zainol S, 2012, INT J MOL SCI, V13, P13049, DOI 10.3390/ijms131013049; Zidar N, 2009, J CELL MOL MED, V13, P3753, DOI 10.1111/j.1582-4934.2008.00430.x	67	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113558	10.1371/journal.pone.0113558	http://dx.doi.org/10.1371/journal.pone.0113558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502102	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400011
J	Gan, M; Jiang, PZ; McLean, P; Kanekiyo, T; Bu, GJ				Gan, Ming; Jiang, Peizhou; McLean, Pamela; Kanekiyo, Takahisa; Bu, Guojun			Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Regulates the Stability and Function of GluA1 alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor in Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; AMYLOID-BETA; GLUTAMATE RECEPTORS; PLASMINOGEN-ACTIVATOR; PHOSPHORYLATION SITES; MEDIATED ENDOCYTOSIS; PKA PHOSPHORYLATION; HIPPOCAMPAL-NEURONS	The low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor abundantly expressed in neurons. Increasing evidence demonstrates that LRP1 regulates synaptic integrity and function at the post synapses, at least partially by regulating glutamate receptors. The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) are critical ionotropic glutamate receptors consisting of homotetramer or heterotetramer of GluA1-4 subunits and play an essential role in synaptic transmission and synaptic plasticity. Our previous work has shown that neuronal deletion of the Lrp1 gene in mice leads to decreased level of GluA1 and reduced long-term potentiation. To understand the underlying mechanism, we investigated the cellular and functional consequences of LRP1 deletion in primary neurons. Here, we show that LRP1 interacts with and regulates the cellular distribution and turnover of GluA1. LRP1 knockdown in mouse primary neurons led to accelerated turnover and decreased cell surface distribution of GluA1, which correspond to decreased phosphorylation of GluA1 at S845 and S831 sites. Decreased LRP1 expression also attenuated AMPA-evoked calcium influx and reduced GluA1-regulated neurite outgrowth and filopodia density. Our results reveal a novel mechanism by which LRP1 controls synaptic integrity and function, specifically by regulating GluA1 trafficking, phosphorylation and turnover. They further demonstrate that LRP1-GluA1 pathway may hold promises as a therapeutic target for restoring synaptic functions in neurodegenerative diseases.	[Gan, Ming; Jiang, Peizhou; McLean, Pamela; Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Mayo Clinic; Xiamen University	Kanekiyo, T (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	kanekiyo.takahisa@mayo.edu; bu.guojun@mayo.edu		McLean, Pamela/0000-0003-4870-5715	NIH [R01AG035355, R01AG027924, R01AG046205, P01AG030128, P01NS074969]; Cure Alzheimer's Fund; Alzheimer's Association NIRG; Mayo Clinic CRM Career Developmental Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046205, P01AG030128, RF1AG046205, R01AG027924, R01AG035355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Alzheimer's Association NIRG; Mayo Clinic CRM Career Developmental Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH (http://grants.nih.gov/grants/oer.htm) grants R01AG035355 (GB), R01AG027924 (GB), R01AG046205(GB), P01AG030128 (GB), P01NS074969 (GB), a grant from the Cure Alzheimer's Fund (http://www.curealzfund.org/) (GB), and Alzheimer's Association NIRG and Mayo Clinic CRM Career Developmental Award (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; BU GJ, 1994, J BIOL CHEM, V269, P18521; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chen W, 2009, NEUROSCIENCE, V159, P172, DOI 10.1016/j.neuroscience.2008.11.038; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coutinho-Budd J, 2012, J CELL SCI, V125, P3390, DOI 10.1242/jcs.098962; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gendron TF, 2004, EUR J PHARMACOL, V493, P45, DOI 10.1016/j.ejphar.2004.04.026; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Lin CH, 2012, J NEUROSCI, V32, P1826, DOI 10.1523/JNEUROSCI.3380-11.2012; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Maier W, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-25; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Metzger F, 1998, J NEUROSCI, V18, P1735; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; Prithviraj R, 2008, DEV NEUROBIOL, V68, P247, DOI 10.1002/dneu.20590; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sans N, 2003, J NEUROSCI, V23, P9367; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Stein V, 2003, J NEUROSCI, V23, P5503; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valastro B, 2001, NEUROBIOL AGING, V22, P9, DOI 10.1016/S0197-4580(00)00177-9; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhang C, 2008, PROG NEURO-PSYCHOPH, V32, P62, DOI 10.1016/j.pnpbp.2007.07.009; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	68	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113237	10.1371/journal.pone.0113237	http://dx.doi.org/10.1371/journal.pone.0113237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500815	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400007
J	Leferink, AM; Fratila, RM; Koenrades, MA; van Blitterswijk, CA; Velders, A; Moroni, L				Leferink, Anne M.; Fratila, Raluca M.; Koenrades, Maaike A.; van Blitterswijk, Clemens A.; Velders, Aldrik; Moroni, Lorenzo			An Open Source Image Processing Method to Quantitatively Assess Tissue Growth after Non-Invasive Magnetic Resonance Imaging in Human Bone Marrow Stromal Cell Seeded 3D Polymeric Scaffolds	PLOS ONE			English	Article							INTENSITY NONUNIFORMITY CORRECTION; IRON-OXIDE NANOPARTICLES; MESENCHYMAL STEM-CELLS; X-RAY MICROTOMOGRAPHY; ENGINEERED CONSTRUCTS; ARTICULAR-CARTILAGE; MRI; MICROSCOPY; SPECTROSCOPY; PERFUSION	Monitoring extracellular matrix (ECM) components is one of the key methods used to determine tissue quality in three-dimensional (3D) scaffolds for regenerative medicine and clinical purposes. This is even more important when multipotent human bone marrow stromal cells (hMSCs) are used, as it could offer a method to understand in real time the dynamics of stromal cell differentiation and eventually steer it into the desired lineage. Magnetic Resonance Imaging (MRI) is a promising tool to overcome the challenge of a limited transparency in opaque 3D scaffolds. Technical limitations of MRI involve non-uniform background intensity leading to fluctuating background signals and therewith complicating quantifications on the retrieved images. We present a post-imaging processing sequence that is able to correct for this non-uniform background intensity. To test the processing sequence we investigated the use of MRI for in vitro monitoring of tissue growth in three-dimensional poly(ethylene oxide terephthalate)-poly(butylene terephthalate) (PEOT/PBT) scaffolds. Results showed that MRI, without the need to use contrast agents, is a promising non-invasive tool to quantitatively monitor ECM production and cell distribution during in vitro culture in 3D porous tissue engineered constructs.	[Leferink, Anne M.; Koenrades, Maaike A.; van Blitterswijk, Clemens A.; Moroni, Lorenzo] Univ Twente, MIRA, Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Fratila, Raluca M.] Univ Twente, MIRA, Inst Biomed Technol & Tech Med, NeuroImaging Grp, NL-7500 AE Enschede, Netherlands; [van Blitterswijk, Clemens A.; Moroni, Lorenzo] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Complex Tissue Regenerat, Maastricht, Netherlands; [Velders, Aldrik] Univ Twente, MIRA, Inst Nanotechnol, Lab SupraMol Chem & Technol, NL-7500 AE Enschede, Netherlands; [Velders, Aldrik] Wageningen Univ, Dept BioNanotechnol Agrotechnol & Food Sci, NL-6700 AP Wageningen, Netherlands	University of Twente; University of Twente; Maastricht University; University of Twente; Wageningen University & Research	Moroni, L (corresponding author), Univ Twente, MIRA, Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.	l.moroni@utwente.nl	Leferink, Ir. A. M./G-5024-2012; Moroni, Lorenzo/D-2826-2014; v, a/ABA-6163-2021; Fratila, Raluca Maria/C-9014-2012	Leferink, Ir. A. M./0000-0002-3765-8450; Moroni, Lorenzo/0000-0003-1298-6025; Fratila, Raluca Maria/0000-0001-5559-8757; Velders, Aldrik/0000-0002-6925-854X	Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]	Netherlands Institute for Regenerative Medicine (NIRM)	This work was supported by the Netherlands Institute for Regenerative Medicine (NIRM) through the grant number FES0908 [http://www.regeneratieve-geneeskunde.nl/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2012, J R SOC INTERFACE, V9, P2321, DOI 10.1098/rsif.2012.0068; Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033; Baradez MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026104; Barbetta A, 2012, ANN I SUPER SANITA, V48, P10, DOI 10.4415/ANN_12_01_03; BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504; Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f; Burg KJL, 2002, J BIOMED MATER RES, V61, P380, DOI 10.1002/jbm.10146; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen WL, 2010, TISSUE ENG PART C-ME, V16, P913, DOI [10.1089/ten.tec.2009.0596, 10.1089/ten.TEC.2009.0596]; Chesnick IE, 2008, BIOPHYS J, V95, P2017, DOI 10.1529/biophysj.107.120923; Constantinidis I, 1998, TISSUE ENG, V4, P9, DOI 10.1089/ten.1998.4.9; Crowe JJ, 2011, CHEM ENG SCI, V66, P4138, DOI 10.1016/j.ces.2011.05.046; de Bruijn J D, 1999, Adv Dent Res, V13, P74; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fishbein KW, 2007, MAGN RESON MED, V57, P866, DOI 10.1002/mrm.21189; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Grootendorst DJ, 2013, CONTRAST MEDIA MOL I, V8, P83, DOI 10.1002/cmmi.1498; Hachani R, 2013, NANOSCALE, V5, P11362, DOI 10.1039/c3nr03861k; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0; Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P470, DOI [10.1089/ten.teb.2012.0755, 10.1089/ten.TEB.2012.0755]; Leferink AM, 2013, J TISSUE ENG REGENER; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Milles J, 2007, COMPUT MED IMAG GRAP, V31, P81, DOI 10.1016/j.compmedimag.2006.11.001; Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127; Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499; Mountain KM, 2011, MAGN RESON MED, V66, P520, DOI 10.1002/mrm.23036; Neves AA, 2006, TISSUE ENG, V12, P53, DOI 10.1089/ten.2006.12.53; Nissi MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1265, DOI 10.1016/j.joca.2006.06.002; Peptan IA, 2006, TISSUE ENG, V12, P843, DOI 10.1089/ten.2006.12.843; Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; TAUBIN G, 1995, SIGGRAPH 95 C P, P351, DOI 10.1145/218380.218473; Washburn NR, 2004, J BIOMED MATER RES A, V69A, P738, DOI 10.1002/jbm.a.30054; Xia Y, 2001, OSTEOARTHR CARTILAGE, V9, P393, DOI 10.1053/joca.2000.0405; Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515; Yang C.-Y., 2009, J APPL PHYS, V105; Zheng SK, 2010, CARTILAGE, V1, P55, DOI 10.1177/1947603509359784	40	7	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115000	10.1371/journal.pone.0115000	http://dx.doi.org/10.1371/journal.pone.0115000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502022	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400068
J	Mrzilkova, J; Koutela, A; Kutova, M; Patzelt, M; Ibrahim, I; Al-Kayssi, D; Bartos, A; Ripova, D; Cermakova, P; Zach, P				Mrzilkova, Jana; Koutela, Antonella; Kutova, Martina; Patzelt, Matej; Ibrahim, Ibrahim; Al-Kayssi, Dina; Bartos, Ales; Ripova, Daniela; Cermakova, Pavla; Zach, Petr			Hippocampal Spatial Position Evaluation on MRI for Research and Clinical Practice	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; VARIABILITY; FMRI; VOLUMETRICS; DIAGNOSIS; CRITERIA; TASK	In clinical practice as well as in many volumetric studies we use different reorientations of the brain position towards x and y axis on the magnetic resonance imaging (MRI) scans. In order to find out whether it has an overall effect on the resulting 2D data, manual hippocampal area measurements and rotation variability of the brain (in two reoriented axes) and the skull were performed in 23 Alzheimer's disease patients and 31 healthy controls. After the MRI scanning, native brain scans (nat) were reoriented into the two different artificial planes (anterior commissure - posterior commissure axis (AC-PC) and hippocampal horizontal long axis (hipp)). Hippocampal area and temporal horn of the lateral ventricle was measured manually using freeware Image J program. We found that 1) hippocampal area of nat images is larger compared to hipp images, area of the nat images is equal to the AC-PC images and area of the hipp images is smaller compared to AC-PC images, 2) hippocampal area together with the area of the temporal horn for nat images is larger compared to hipp images, area of the hipp images is smaller compared to the AC-PC images and area of the nat images is smaller compared to the AC-PC images. The conclusion is that the measured area of the hippocampus in the native MRI is almost the same as the area of MRI reoriented only into the AC-PC axis. Therefore, when performing 2D area studies of the hippocampus or in the clinical practice we recommend usage of not-reoriented MRI images or to reorient them into the AC-PC axis. Surprising finding was that rotation of both AC-PC and hipp line towards x-axis among patients varies up to 35 degrees and the same is true for the skull rotation so that it is not only a matter of the brain position.	[Mrzilkova, Jana; Koutela, Antonella; Kutova, Martina; Patzelt, Matej; Al-Kayssi, Dina; Zach, Petr] Charles Univ Prague, Fac Med 3, Inst Anat, Prague 10000 10, Czech Republic; [Bartos, Ales; Ripova, Daniela] Prague Psychiat Ctr, AD Ctr, Prague 18103 8, Czech Republic; [Bartos, Ales] Charles Univ Prague, Fac Med 3, Teaching Hosp Kralovske Vinohrady, Prague 10034 10, Czech Republic; [Cermakova, Pavla] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Dis Res Ctr, S-14186 Stockholm, Sweden; [Cermakova, Pavla] Int Clin Res Ctr, Brno 65691, Czech Republic; [Cermakova, Pavla] St Annes Univ Hosp, Brno 65691, Czech Republic; [Ibrahim, Ibrahim] Inst Clin & Expt Med, Dept Radiodiagnost & Intervent Radiol, Prague 14021 4, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Vinohrady; Karolinska Institutet; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Institute for Clinical & Experimental Medicine (IKEM)	Zach, P (corresponding author), Charles Univ Prague, Fac Med 3, Inst Anat, Ruska 87, Prague 10000 10, Czech Republic.	zach.petr@post.cz	Zach, Petr/D-8955-2016; Cermakova, Pavla/C-5890-2019; Bartos, Ales/C-4353-2019; Šanderová, Martina/D-1588-2018; Mrzilkova, Jana/C-3588-2018; Patzelt, Matej/S-1341-2017	Zach, Petr/0000-0003-1941-2972; Cermakova, Pavla/0000-0002-9282-9363; Bartos, Ales/0000-0002-8020-8252; Šanderová, Martina/0000-0001-6481-049X; Mrzilkova, Jana/0000-0002-9474-5040; Patzelt, Matej/0000-0001-8269-5499; Ibrahim, Ibrahim/0000-0003-3530-5165; Mrzilkova, Jana/0000-0003-0913-8041	Grant Agency of the Czech Republic [P 304/12/G069]; Research Project Charles University in Prague [PRVOUK 34]; Czech Republic [260045/SVV/2014, GAUK 1894214]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Project Charles University in Prague; Czech Republic(Czech Republic Government)	The study was supported by grant P 304/12/G069 from the Grant Agency of the Czech Republic and the Research Project Charles University in Prague, PRVOUK 34, project 260045/SVV/2014 of the Czech Republic and GAUK 1894214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FINLAY LM, 1980, ANGLE ORTHOD, V50, P312; Fleisher AS, 2008, NEUROLOGY, V70, P191, DOI 10.1212/01.wnl.0000287091.57376.65; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Hayashi T, 2009, MAGN RESON MED SCI, V8, P33, DOI 10.2463/mrms.8.33; Maller JJ, 2006, HIPPOCAMPUS, V16, P80, DOI 10.1002/hipo.20133; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mrzilkova J, 2012, DEMENT GERIATR COGN, V34, P224, DOI 10.1159/000343445; Oksengard AR, 2010, DEMENT GERIATR COGN, V30, P374, DOI 10.1159/000321121; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Soltysik DA, 2011, NEUROIMAGE, V56, P1329, DOI 10.1016/j.neuroimage.2011.03.023; Teipel SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P244, DOI 10.1016/j.pscychresns.2010.03.003; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506	18	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115174	10.1371/journal.pone.0115174	http://dx.doi.org/10.1371/journal.pone.0115174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502906	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400078
J	Kasper, E; Schuster, C; Machts, J; Kaufmann, J; Bittner, D; Vielhaber, S; Benecke, R; Teipel, S; Prudlo, J				Kasper, Elisabeth; Schuster, Christina; Machts, Judith; Kaufmann, Joern; Bittner, Daniel; Vielhaber, Stefan; Benecke, Reiner; Teipel, Stefan; Prudlo, Johannes			Microstructural White Matter Changes Underlying Cognitive and Behavioural Impairment in ALS - An In Vivo Study Using DTI	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DIFFUSION-TENSOR MRI; VERBAL FLUENCY; TRACT DAMAGE; RETRIEVAL; CRITERIA; MEMORY; NEURODEGENERATION; TRACTOGRAPHY; DYSFUNCTION	Background: A relevant fraction of patients with amyotrophic lateral sclerosis (ALS) exhibit a fronto-temporal pattern of cognitive and behavioural disturbances with pronounced deficits in executive functioning and cognitive control of behaviour. Structural imaging shows a decline in fronto-temporal brain areas, but most brain imaging studies did not evaluate cognitive status. We investigated microstructural white matter changes underlying cognitive impairment using diffusion tensor imaging (DTI) in a large cohort of ALS patients. Methods: We assessed 72 non-demented ALS patients and 65 matched healthy control subjects using a comprehensive neuropsychological test battery and DTI. We compared DTI measures of fiber tract integrity using tract-based spatial statistics among ALS patients with and without cognitive impairment and healthy controls. Neuropsychological performance and behavioural measures were correlated with DTI measures. Results: Patients without cognitive impairment demonstrated white matter changes predominantly in motor tracts, including the corticospinal tract and the body of corpus callosum. Those with impairments (ca. 30%) additionally presented significant white matter alterations in extra-motor regions, particularly the frontal lobe. Executive and memory performance and behavioural measures were correlated with fiber tract integrity in large association tracts. Conclusion: In non-demented cognitively impaired ALS patients, white matter changes measured by DTI are related to disturbances of executive and memory functions, including prefrontal and temporal regions. In a group comparison, DTI is able to observe differences between cognitively unimpaired and impaired ALS patients.	[Kasper, Elisabeth; Teipel, Stefan] Univ Rostock, Dept Psychosomat Med, D-18055 Rostock, Germany; [Schuster, Christina; Teipel, Stefan; Prudlo, Johannes] DZNE German Ctr Neurodegenerat Dis, Rostock, Germany; [Machts, Judith; Vielhaber, Stefan] DZNE German Ctr Neurodegenerat Dis, Magdeburg, Germany; [Kaufmann, Joern; Bittner, Daniel; Vielhaber, Stefan] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Benecke, Reiner; Prudlo, Johannes] Univ Rostock, Dept Neurol, D-18055 Rostock, Germany	University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University; University of Rostock	Kasper, E (corresponding author), Univ Rostock, Dept Psychosomat Med, D-18055 Rostock, Germany.	elisabeth.kasper@med.uni-rostock.de	Machts, Judith/J-2508-2019	Machts, Judith/0000-0002-8660-095X				Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; [Anonymous], 1992, WST WORTSCHATZTEST; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Barbagallo G, 2014, NEUROL SCI, V35, P911, DOI 10.1007/s10072-013-1626-z; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Baumler G., 1985, FARB WORT INTERFEREN; Bede P, 2012, J NEUROLOGY NEUROSUR; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Christidi F, 2013, BRAIN IMAGING BEHAV, P1; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Foerster BR, 2013, 25 YEARS NEUROIMAGIN; Glindmann R, 2002, BOGENHAUSENER SEMANT; Goldstein LH, 2011, J NEUROL, V258, P2186, DOI 10.1007/s00415-011-6088-8; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grace J, 2002, FRONTAL SYSTEMS BEHA; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Helmstaedter C, 2001, VERBALER VEM MERKFAH; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kohler J, 2003, PLANUNGSTEST PT; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Lange K.W., 2000, RWT REGENSBURGER WOR; Laun FB, 2009, MAGN RESON IMAGING, V27, P541, DOI 10.1016/j.mri.2008.08.011; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2013, NEUROLOGY; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niemann H., 2008, CVLT CALIFORNIA VERB; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pettit L, 2013, J NEUROL NEUROSUR PS, V84, pe1; Pettit LD, 2013, BRAIN; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Radiology ACo, 2005, PHANT TEST GUID ACR; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schuster C, NEUROBIOLOGY AGING; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Taylor LJ, J NEUROL NEUROSURG P; Trojsi F, 2013, AMYOTROPH LAT SCL FR, V14, P553, DOI 10.3109/21678421.2013.785569; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Wechsler D, 1987, WMS R WECHSLER MEMOR; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2011, AMYOTROPH LATERAL SC, V12, P52, DOI 10.3109/17482968.2010.521842	57	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114543	10.1371/journal.pone.0114543	http://dx.doi.org/10.1371/journal.pone.0114543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501028	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700030
J	Rohringer, S; Holnthoner, W; Hackl, M; Weihs, AM; Runzler, D; Skalicky, S; Karbiener, M; Scheideler, M; Proll, J; Gabriel, C; Schweighofer, B; Groger, M; Spittler, A; Grillari, J; Redl, H				Rohringer, Sabrina; Holnthoner, Wolfgang; Hackl, Matthias; Weihs, Anna M.; Ruenzler, Dominik; Skalicky, Susanna; Karbiener, Michael; Scheideler, Marcel; Proell, Johannes; Gabriel, Christian; Schweighofer, Bernhard; Groeger, Marion; Spittler, Andreas; Grillari, Johannes; Redl, Heinz			Molecular and Cellular Effects of In Vitro Shockwave Treatment on Lymphatic Endothelial Cells	PLOS ONE			English	Article							WAVE THERAPY; SECONDARY LYMPHEDEMA; RAT MODEL; LIFE-SPAN; TISSUE; PODOPLANIN; EXPRESSION; LYMPHANGIOGENESIS; INFLAMMATION; MECHANISMS	Extracorporeal shockwave treatment was shown to improve orthopaedic diseases and wound healing and to stimulate lymphangiogenesis in vivo. The aim of this study was to investigate in vitro shockwave treatment (IVSWT) effects on lymphatic endothelial cell (LEC) behavior and lymphangiogenesis. We analyzed migration, proliferation, vascular tube forming capability and marker expression changes of LECs after IVSWT compared with HUVECs. Finally, transcriptome- and miRNA analyses were conducted to gain deeper insight into the IVSWT-induced molecular mechanisms in LECs. The results indicate that IVSWT-mediated proliferation changes of LECs are highly energy flux density-dependent and LEC 2D as well as 3D migration was enhanced through IVSWT. IVSWT suppressed HUVEC 3D migration but enhanced vasculogenesis. Furthermore, we identified podoplanin(high) and podoplanin(low) cell subpopulations, whose ratios changed upon IVSWT treatment. Transcriptome- and miRNA analyses on these populations showed differences in genes specific for signaling and vascular tissue. Our findings help to understand the cellular and molecular mechanisms underlying shockwave-induced lymphangiogenesis in vivo.	[Rohringer, Sabrina; Holnthoner, Wolfgang; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Rohringer, Sabrina; Holnthoner, Wolfgang; Hackl, Matthias; Weihs, Anna M.; Ruenzler, Dominik; Skalicky, Susanna; Proell, Johannes; Gabriel, Christian; Spittler, Andreas; Grillari, Johannes; Redl, Heinz] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Weihs, Anna M.; Ruenzler, Dominik] Univ Appl Sci Tech Wien, Dept Biochem Engn, Vienna, Austria; [Hackl, Matthias; Skalicky, Susanna] TAmiRNA GmbH, Vienna, Austria; [Karbiener, Michael; Scheideler, Marcel] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Proell, Johannes; Gabriel, Christian] Red Cross Blood Transfus Serv, Linz, Austria; [Schweighofer, Bernhard; Groeger, Marion] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div, Vienna, Austria; [Groeger, Marion] Med Univ Vienna, Core Facil Imaging, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil, Flow Cytometry & Surg Res Labs, Vienna, Austria; [Grillari, Johannes] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria	Ludwig Boltzmann Institute; Technische Universitat Wien; Graz University of Technology; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna	Holnthoner, W (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, Vienna, Austria.	Wolfgang.Holnthoner@trauma.lbg.ac.at	Rünzler, Dominik/G-9393-2014; Gabriel, Christian/A-1689-2014; Scheideler, Marcel/B-3087-2015; Grillari, Johannes/B-2967-2011; Redl, Heinz/AAD-8157-2019	Rünzler, Dominik/0000-0002-6020-3411; Gabriel, Christian/0000-0003-2043-9320; Scheideler, Marcel/0000-0003-4650-7387; Grillari, Johannes/0000-0001-5474-6332; Rohringer, Sabrina/0000-0002-9019-283X; Weihs, Anna/0000-0003-4802-328X; Holnthoner, Wolfgang/0000-0001-6425-9028; Spittler, Andreas/0000-0003-2657-6836; Hackl, Matthias/0000-0002-4136-7293	EU Biodesign Program [262948]; Austrian research promotion agency FFG; Austrian research promotion agency [CFFG 818412]; City of Vienna (MA27) [06-06]; City of Vienna Competence team reacTissue Project (MA27) [12-06]; TAmiRNA GmbH	EU Biodesign Program; Austrian research promotion agency FFG; Austrian research promotion agency; City of Vienna (MA27); City of Vienna Competence team reacTissue Project (MA27); TAmiRNA GmbH	This study was funded by: EU Biodesign Program (262948) (www.biodesign.eu) to HR and WH, a Femtech student fellowship from the Austrian research promotion agency FFG (www.ffg.at) to SR, the NewTissue Project (CFFG 818412) from the Austrian research promotion agency and City of Vienna (MA27 #06-06) and the City of Vienna Competence team reacTissue Project (MA27 #12-06) to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MH and SS are employed by TAmiRNA GmbH. TAmiRNA GmbH provided support in the form of salaries for authors MH and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MWF, 2005, EXP CELL RES, V309, P121, DOI 10.1016/j.yexcr.2005.05.002; Chen YJ, 2004, BONE, V34, P466, DOI 10.1016/j.bone.2003.11.013; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067675; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Davis TA, 2009, INT WOUND J, V6, P11, DOI 10.1111/j.1742-481X.2008.00540.x; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gerdesmeyer L, 2003, JAMA-J AM MED ASSOC, V290, P2573, DOI 10.1001/jama.290.19.2573; Groger M, 2007, J INVEST DERMATOL, V127, P2893, DOI 10.1038/sj.jid.5701031; Groger M, 2004, J IMMUNOL, V173, P7161, DOI 10.4049/jimmunol.173.12.7161; Haupt G, 1997, J UROLOGY, V158, P4, DOI 10.1097/00005392-199707000-00003; Hofbauer P, 2014, CYTOTHERAPY, V16, P1238, DOI 10.1016/j.jcyt.2014.04.009; Holfeld J, 2014, J VISUALIZED EXPT, V86; Holfeld J, 2014, INFLAMMATION, V37, P65, DOI 10.1007/s10753-013-9712-1; Holnthoner W, 2015, J TISSUE ENG REGEN M, V9, P127, DOI 10.1002/term.1620; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kubo M, 2010, J VASC SURG, V52, P429, DOI 10.1016/j.jvs.2010.03.017; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P522, DOI 10.1111/j.1524-475X.2009.00504.x; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P80, DOI 10.1111/j.1524-475X.2008.00444.x; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Marin T, 2013, FREE RADICAL BIO MED, V64, P61, DOI 10.1016/j.freeradbiomed.2013.05.034; MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Rohringer S, 2014, ANGIOGENESIS, V17, P921, DOI 10.1007/s10456-014-9439-0; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schaden W, 2007, J SURG RES, V143, P1, DOI 10.1016/j.jss.2007.01.009; Schoppmann SF, 2004, MICROCIRCULATION, V11, P261, DOI 10.1080/10739680490425967; Serizawa F, 2011, EUR J VASC ENDOVASC, V42, P254, DOI 10.1016/j.ejvs.2011.02.029; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070; Teruyama K, 2001, FEBS LETT, V504, P1, DOI 10.1016/S0014-5793(01)02724-7; Verma K, 2013, ANGIOLOGY, V1, P2; Wang CJ, 2009, J SURG RES, V152, P96, DOI 10.1016/j.jss.2008.01.026; Wang CJ, 2006, AM J SPORT MED, V34, P592, DOI 10.1177/0363546505281811; Weihs AM, 2014, J BIOL CHEM, V289, P27090, DOI 10.1074/jbc.M114.580936; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yip HK, 2008, CIRC J, V72, P150, DOI 10.1253/circj.72.150; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114806	10.1371/journal.pone.0114806	http://dx.doi.org/10.1371/journal.pone.0114806			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502694	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700055
J	Wali, S; Gupta, R; Veselenak, RL; Li, YS; Yu, JJ; Murthy, AK; Cap, AP; Guentzel, MN; Chambers, JP; Zhong, GM; Rank, RG; Pyles, RB; Arulanandam, BP				Wali, Shradha; Gupta, Rishein; Veselenak, Ronald L.; Li, Yansong; Yu, Jieh-Juen; Murthy, Ashlesh K.; Cap, Andrew P.; Guentzel, M. Neal; Chambers, James P.; Zhong, Guangming; Rank, Roger G.; Pyles, Richard B.; Arulanandam, Bernard P.			Use of a Guinea Pig-Specific Transcriptome Array for Evaluation of Protective Immunity against Genital Chlamydial Infection following Intranasal Vaccination in Guinea Pigs	PLOS ONE			English	Article							TRACHOMATIS INFECTIONS; TRACT INFECTION; ANIMAL-MODELS; HOST RESPONSE; REPRODUCTIVE-TRACT; IFN-GAMMA; T-CELLS; IMMUNIZATION; AGENT; HEALTH	Guinea pigs have been used as a second animal model to validate putative anti-chlamydial vaccine candidates tested in mice. However, the lack of guinea pig-specific reagents has limited the utility of this animal model in Chlamydia sp. vaccine studies. Using a novel guinea pig-specific transcriptome array, we determined correlates of protection in guinea pigs vaccinated with Chlamydia caviae (C. caviae) via the intranasal route, previously reported by us and others to provide robust antigen specific immunity against subsequent intravaginal challenge. C. caviae vaccinated guinea pigs resolved genital infection by day 3 post challenge. In contrast, mock vaccinated animals continued to shed viable Chlamydia up to day 18 post challenge. Importantly, at day 80 post challenge, vaccinated guinea pigs experienced significantly reduced genital pathology - a sequelae of genital chlamydial infections, in comparison to mock vaccinated guinea pigs. Sera from vaccinated guinea pigs displayed antigen specific IgG responses and increased IgG1 and IgG2 titers capable of neutralizing GPIC in vitro.	[Wali, Shradha; Gupta, Rishein; Yu, Jieh-Juen; Guentzel, M. Neal; Chambers, James P.; Arulanandam, Bernard P.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Wali, Shradha; Gupta, Rishein; Yu, Jieh-Juen; Guentzel, M. Neal; Chambers, James P.; Arulanandam, Bernard P.] Univ Texas San Antonio, Ctr Excellence Infect Genom, San Antonio, TX 78249 USA; [Veselenak, Ronald L.; Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Veselenak, Ronald L.; Pyles, Richard B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Li, Yansong; Cap, Andrew P.] US Army Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Murthy, Ashlesh K.] Midwestern Univ, Dept Pathol, Downers Grove, IL 60148 USA; [Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Rank, Roger G.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72202 USA; [Rank, Roger G.] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Defense; United States Army; Midwestern University; University of Texas System; University of Texas Health San Antonio; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Arulanandam, BP (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, One UTSA Circle, San Antonio, TX 78249 USA.	Bernard.Arulanandam@utsa.edu		Wali, Shradha/0000-0002-6077-7618	National Institutes of Health [1RO1AI074860, 1R03AI092621-01]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI092621, R01AI074860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office of the Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1RO1AI074860, 1R03AI092621-01 and the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DW, 2011, J REPROD IMMUNOL, V91, P9, DOI 10.1016/j.jri.2011.06.100; Bannantine JP, 1999, MICROBIOL-UK, V145, P2077, DOI 10.1099/13500872-145-8-2077; BARRON AL, 1984, INFECT IMMUN, V44, P82, DOI 10.1128/IAI.44.1.82-85.1984; BARRON AL, 1988, SEX TRANSM DIS, V15, P169, DOI 10.1097/00007435-198807000-00013; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; BATTEIGER BE, 1993, J GEN MICROBIOL, V139, P2965, DOI 10.1099/00221287-139-12-2965; Beagley KW, 2000, J REPROD IMMUNOL, V48, P47, DOI 10.1016/S0165-0378(00)00069-3; Bell Jason D, 2011, Infect Dis Obstet Gynecol, V2011, P675360, DOI 10.1155/2011/675360; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown THT, 2012, VACCINE, V30, P350, DOI 10.1016/j.vaccine.2011.10.086; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Cong Y, 2007, VACCINE, V25, P3773, DOI 10.1016/j.vaccine.2007.02.010; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Duncan B, 1999, BRIT MED J, V318, P931, DOI 10.1136/bmj.318.7188.931; Edelstein Paul H, 2013, Methods Mol Biol, V954, P521, DOI 10.1007/978-1-62703-161-5_32; Eko FO, 2004, J IMMUNOL, V173, P3375, DOI 10.4049/jimmunol.173.5.3375; Enderle JL, 2014, CURR MICROBIOL, V68, P220, DOI 10.1007/s00284-013-0465-8; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Folger AT, 2013, MATERNAL CHILD HLTH; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Jain R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-520; JOHNSON AP, 1982, AM J PATHOL, V106, P132; Kashino SS, 2008, MICROBES INFECT, V10, P1469, DOI 10.1016/j.micinf.2008.08.010; Khan E R, 2011, Mymensingh Med J, V20, P362; LAFERRIERE C, 1993, J IMMUNOL METHODS, V163, P123, DOI 10.1016/0022-1759(93)90246-4; LAMONT HC, 1978, INFECT IMMUN, V19, P807, DOI 10.1128/IAI.19.3.807-813.1978; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZ H, 1977, LAB ANIM SCI, V27, P522; Mardh PA, 2001, EUR J CONTRACEP REPR, V6, P115, DOI 10.1080/713604211; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Morre SA, 2000, INFECT IMMUN, V68, P7209, DOI 10.1128/IAI.68.12.7209-7211.2000; Murphey C, 2006, CELL IMMUNOL, V242, P110, DOI 10.1016/j.cellimm.2006.10.002; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Murthy AK, 2011, VACCINE, V29, P2519, DOI 10.1016/j.vaccine.2011.01.074; Murthy AK, 2009, FEMS IMMUNOL MED MIC, V55, P271, DOI 10.1111/j.1574-695X.2008.00517.x; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Paterson TL, 1996, SEX TRANSM DIS, V23, P145, DOI 10.1097/00007435-199603000-00010; PENN CW, 1977, J GEN MICROBIOL, V100, P159, DOI 10.1099/00221287-100-1-159; Pitsouni E, 2007, INT J ANTIMICROB AG, V30, P213, DOI 10.1016/j.ijantimicag.2007.04.015; Popescu C, 1981, Arch Roum Pathol Exp Microbiol, V40, P241; Ralli-Jain P, 2010, VACCINE, V28, P7659, DOI 10.1016/j.vaccine.2010.09.040; RANK RG, 1994, METHOD ENZYMOL, V235, P83; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1992, AM J PATHOL, V140, P927; RANK RG, 1990, INFECT IMMUN, V58, P2599, DOI 10.1128/IAI.58.8.2599-2605.1990; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Sakthivel SK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-136; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Tifrea DF, 2013, INFECT IMMUN, V81, P1741, DOI 10.1128/IAI.00734-12; Tree JA, 2006, INFECT IMMUN, V74, P1436, DOI 10.1128/IAI.74.2.1436-1441.2006; Tseng CTK, 1998, INFECT IMMUN, V66, P5867, DOI 10.1128/IAI.66.12.5867-5875.1998; Vanrompay D, 2006, DRUGS TODAY, V42, P55; Veselenak RL, 2014, MOL BIOTECH IN PRESS; Volp K, 2001, IMMUNOL CELL BIOL, V79, P245, DOI 10.1046/j.1440-1711.2001.01005.x; Waight Maria T, 2013, J La State Med Soc, V165, P219; Wang Y, 2010, INFECT IMMUN, V78, P1670, DOI 10.1128/IAI.01339-09; WHITE HJ, 1979, INFECT IMMUN, V26, P728, DOI 10.1128/IAI.26.2.728-735.1979; Witherden DA, 2000, J IMMUNOL, V165, P1902, DOI 10.4049/jimmunol.165.4.1902; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11; Zhou HY, 2013, J INTERF CYTOK RES, V33, P115, DOI 10.1089/jir.2012.0099	73	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114261	10.1371/journal.pone.0114261	http://dx.doi.org/10.1371/journal.pone.0114261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502875	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700018
J	Chen, H; Wu, B; Nelson, DR; Wu, K; Liu, C				Chen, Haimei; Wu, Bin; Nelson, David R.; Wu, Kai; Liu, Chang			Computational Identification and Systematic Classification of Novel Cytochrome P450 Genes in Salvia miltiorrhiza	PLOS ONE			English	Article							TANSHINONE BIOSYNTHESIS; P450; ORGANIZATION; SUPERFAMILY; METABOLISM; PROTEINS; REVEALS; FAMILY	Salvia miltiorrhiza is one of the most economically important medicinal plants. Cytochrome P450 (CYP450) genes have been implicated in the biosynthesis of its active components. However, only a dozen full-length CYP450 genes have been described, and there is no systematic classification of CYP450 genes in S. miltiorrhiza. We obtained 77,549 unigenes from three tissue types of S. miltiorrhiza using RNA-Seq technology. Combining our data with previously identified CYP450 sequences and scanning with the CYP450 model from Pfam resulted in the identification of 116 full-length and 135 partial-length CYP450 genes. The 116 genes were classified into 9 clans and 38 families using standard criteria. The RNA-Seq results showed that 35 CYP450 genes were co-expressed with CYP76AH1, a marker gene for tanshinone biosynthesis, using r >= 0.9 as a cutoff. The expression profiles for 16 of 19 randomly selected CYP450 obtained from RNA-Seq were validated by qRT-PCR. Comparing against the KEGG database, 10 CYP450 genes were found to be associated with diterpenoid biosynthesis. Considering all the evidence, 3 CYP450 genes were identified to be potentially involved in terpenoid biosynthesis. Moreover, we found that 15 CYP450 genes were possibly regulated by antisense transcripts (r >= 0.9 or r <=-0.9). Lastly, a web resource (SMCYP450, http://www.herbalgenomics.org/samicyp450) was set up, which allows users to browse, search, retrieve and compare CYP450 genes and can serve as a centralized resource.	[Chen, Haimei; Wu, Bin; Wu, Kai; Liu, Chang] Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Chen, Haimei; Wu, Bin; Wu, Kai; Liu, Chang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Nelson, David R.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Tennessee System; University of Tennessee Health Science Center	Liu, C (corresponding author), Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu@implad.ac.cn	Liu, Chang/A-1148-2014	Nelson, David/0000-0003-0583-5421	National Science Foundation [81373912, 81202859, 81274015]; Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China [IRT1150]	National Science Foundation(National Science Foundation (NSF)); Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China	This work was supported by grants from the National Science Foundation to CLIU (No. 81373912), HMC (No. 81202859) and BW (No. 81274015); the Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China (IRT1150). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Babu PR, 2013, GENE, V513, P156, DOI 10.1016/j.gene.2012.10.040; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cheng TO, 2006, J AM COLL CARDIOL, V47, P1498, DOI 10.1016/j.jacc.2006.01.001; Di P, 2013, ACS CHEM BIOL, V8, P1537, DOI 10.1021/cb3006962; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-73; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kumar MS, 2014, PLANT SYST EVOL, DOI [10.1007/s00606-00014-01066-00600, DOI 10.1007/S00606-00014-01066-00600]; Leister D, 2005, PLANT FUNCTIONAL GEN, P595; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2014, PHYSL PLANT; Ma LJ, 2007, J CHROMATOGR B, V846, P139, DOI 10.1016/j.jchromb.2006.08.048; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Reddy SM, 2014, TREE GENET GENOMES, V10, P399; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Song J, 2012, ACTA PHYSIOL PLANT, V34, P1501, DOI 10.1007/s11738-012-0948-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JW, 2010, APPL MICROBIOL BIOT, V88, P437, DOI 10.1007/s00253-010-2797-7; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347; Zhao YJ, 2014, APPL MICROBIOL BIOT, V98, P2371, DOI 10.1007/s00253-013-5496-3; Zi JC, 2013, ORG BIOMOL CHEM, V11, P7650, DOI 10.1039/c3ob41885e	42	39	46	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115149	10.1371/journal.pone.0115149	http://dx.doi.org/10.1371/journal.pone.0115149			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493946	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400097
J	Donohue, E; Balgi, AD; Komatsu, M; Roberge, M				Donohue, Elizabeth; Balgi, Aruna D.; Komatsu, Masaaki; Roberge, Michel			Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; SINGLET OXYGEN; CIGARETTE-SMOKE; NITRIC-OXIDE; CHEMICAL MODULATORS; STRUCTURAL BASIS; FORMATION SITE; CELLS; INACTIVATION; ACTIVATION	Autophagy is a cellular catabolic process responsible for the degradation of cytoplasmic constituents, including organelles and long-lived proteins, that helps maintain cellular homeostasis and protect against various cellular stresses. Verteporfin is a benzoporphyrin derivative used clinically in photodynamic therapy to treat macular degeneration. Verteporfin was recently found to inhibit autophagosome formation by an unknown mechanism that does not require exposure to light. We report that verteporfin directly targets and modifies p62, a scaffold and adaptor protein that binds both polyubiquitinated proteins destined for degradation and LC3 on autophagosomal membranes. Western blotting experiments revealed that exposure of cells or purified p62 to verteporfin causes the formation of covalently crosslinked p62 oligomers by a mechanism involving low-level singlet oxygen production. Rose bengal, a singlet oxygen producer structurally unrelated to verteporfin, also produced crosslinked p62 oligomers and inhibited autophagosome formation. Co-immunoprecipitation experiments demonstrated that crosslinked p62 oligomers retain their ability to bind to LC3 but show defective binding to polyubiquitinated proteins. Mutations in the p62 PB1 domain that abolish self-oligomerization also abolished crosslinked oligomer formation. Interestingly, small amounts of crosslinked p62 oligomers were detected in untreated cells, and other groups noted the accumulation of p62 forms with reduced SDS-PAGE mobility in cellular and animal models of oxidative stress and aging. These data indicate that p62 is particularly susceptible to oxidative crosslinking and lead us to propose a model whereby oxidized crosslinked p62 oligomers generated rapidly by drugs like verteporfin or over time during the aging process interfere with autophagy.	[Donohue, Elizabeth; Balgi, Aruna D.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	University of British Columbia; Tokyo Metropolitan Institute of Medical Science	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722	Canadian Cancer Society Research Institute; University of British Columbia	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); University of British Columbia	This work was supported by a Canadian Cancer Society Research Institute Innovation Grant. ED was funded by a graduate fellowship from the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Alarcon E, 2009, PHOTOCH PHOTOBIO SCI, V8, P933, DOI 10.1039/b901056d; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; Bae SI, 2008, BIOCHEM PHARMACOL, V76, P1653, DOI 10.1016/j.bcp.2008.09.003; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brodowska K, 2014, EXP EYE RES, V124, P67, DOI 10.1016/j.exer.2014.04.011; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalsgaard TK, 2007, J AGR FOOD CHEM, V55, P10968, DOI 10.1021/jf071948g; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Donohue E, 2011, J BIOL CHEM, V286, P7290, DOI 10.1074/jbc.M110.139915; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Epperlein MM, 1996, INT J EXP PATHOL, V77, P197, DOI 10.1046/j.1365-2613.1996.9930331.x; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fateye B, 2012, PHOTOCHEM PHOTOBIOL, V88, P1265, DOI 10.1111/j.1751-1097.2012.01160.x; Ferrario A, 2007, CANCER RES, V67, P4989, DOI 10.1158/0008-5472.CAN-06-4785; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; FOOTE CS, 1984, METHOD ENZYMOL, V105, P36; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; GOOSEY JD, 1980, SCIENCE, V208, P1278, DOI 10.1126/science.7375939; Gornati R, 2013, TOXICOL LETT, V218, P118, DOI 10.1016/j.toxlet.2013.01.023; Granville D J, 2000, Curr Opin Drug Discov Devel, V3, P232; Granville DJ, 1999, AM J PATHOL, V155, P1021, DOI 10.1016/S0002-9440(10)65202-9; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; Henderson BW, 2007, CLIN CANCER RES, V13, P3156, DOI 10.1158/1078-0432.CCR-06-2950; HUNT DWC, 1995, PHOTOCHEM PHOTOBIOL, V61, P417, DOI 10.1111/j.1751-1097.1995.tb08633.x; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kessel D, 2006, AUTOPHAGY, V2, P289, DOI 10.4161/auto.2792; Kim SY, 2001, BIOCHIMIE, V83, P437, DOI 10.1016/S0300-9084(01)01258-5; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; LEVY JG, 1995, TRENDS BIOTECHNOL, V13, P14, DOI 10.1016/S0167-7799(00)88895-2; Lin HL, 2012, CHEM RES TOXICOL, V25, P2642, DOI 10.1021/tx3002753; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luo J, 2006, ANTIOXID REDOX SIGN, V8, P1307, DOI 10.1089/ars.2006.8.1307; LYONS MJ, 1958, NATURE, V181, P1003, DOI 10.1038/1811003a0; Men L, 2007, J PROTEOME RES, V6, P216, DOI 10.1021/pr0603809; Min D B, 2002, Compr Rev Food Sci Food Saf, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PACZKOWSKI J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P341, DOI 10.1016/0748-5514(85)90146-1; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Pittilo RM, 2000, INT J EXP PATHOL, V81, P219; Pogue BW, 2003, CANCER RES, V63, P1025; Pyo JO, 2013, DIABETES METAB J, V37, P333, DOI 10.4093/dmj.2013.37.5.333; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Renno RZ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1002, DOI 10.1001/archopht.122.7.1002; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salem AF, 2013, CELL CYCLE, V12, P818, DOI 10.4161/cc.23722; Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V35, P213, DOI 10.1016/S1011-1344(96)07300-9; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V34, P203, DOI 10.1016/1011-1344(96)07286-7; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Suto D, 2007, ARCH BIOCHEM BIOPHYS, V461, P151, DOI 10.1016/j.abb.2007.03.020; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; TOMITA M, 1969, BIOCHEMISTRY-US, V8, P5149, DOI 10.1021/bi00840a069; VERWEIJ H, 1982, PHOTOCHEM PHOTOBIOL, V35, P265, DOI 10.1111/j.1751-1097.1982.tb03845.x; Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26	105	49	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114964	10.1371/journal.pone.0114964	http://dx.doi.org/10.1371/journal.pone.0114964			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494214	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400085
J	Tagawa, M; Hamano, T; Nishi, H; Tsuchida, K; Hanafusa, N; Fukatsu, A; Iseki, K; Tsubakihara, Y				Tagawa, Miho; Hamano, Takayuki; Nishi, Hiroshi; Tsuchida, Kenji; Hanafusa, Norio; Fukatsu, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study	PLOS ONE			English	Article							REGULAR DIALYSIS TREATMENT; MAINTENANCE HEMODIALYSIS; PARATHYROID-HORMONE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; PRACTICE PATTERNS; SERUM-CALCIUM; RISK-FACTORS; DISEASE; MORTALITY	Background/Aims: The associations between phosphate, calcium, and intact parathyroid hormone (PTH) levels and composite cardiovascular end points have been studied. This study examined the associations of these markers with myocardial infarction (MI) and stroke separately. Methods: This is a longitudinal study on 65,849 hemodialysis patients from the Japan Renal Data Registry. Patients with prior events at baseline were excluded. Predictors were phosphate, albumin-corrected calcium, intact PTH, and calcium times phosphate product levels. Outcome was the first episode of MI or stroke during a 1-year observation period. Data were analyzed using multiple logistic regression analyses, adjusted for potential confounders. Results: There were 1,048, 651, and 2,089 events of incident MI, hemorrhagic, and ischemic stroke, respectively. Incident MI was associated with phosphate levels >= 6.5 mg/dL (odds ratio 1.49; confidence interval 1.23-1.80) compared with phosphate levels of 4.7-5.4 mg/dL and intact PTH levels>500 pg/mL (1.35; 1.03-1.79) compared with intact PTH levels of 151-300 pg/mL. Higher albumin-corrected calcium level was positively associated with MI (p=0.04 by trend analysis). Hemorrhagic stroke was associated only with intact PTH levels>500 pg/mL (1.54; 1.10-2.17). Incident ischemic stroke had no association with phosphate, calcium, or intact PTH levels. The association of calcium times phosphate product with outcomes was essentially the same pattern as that of phosphate and outcomes. Conclusions: MI was associated with phosphate, calcium, and intact PTH levels, whereas hemorrhagic stroke was associated only with intact PTH. Ischemic stroke was not associated with any of them. The potential distinct beneficial effect on MI and stroke by managing bone and mineral disease should be investigated in future studies.	[Tagawa, Miho] Kyoto Katsura Hosp, Dept Nephrol, Kyoto, Japan; [Hamano, Takayuki; Nishi, Hiroshi; Tsuchida, Kenji; Hanafusa, Norio; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Fukatsu, Atsushi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Kyoto University	Tagawa, M (corresponding author), Kyoto Katsura Hosp, Dept Nephrol, Kyoto, Japan.	tagawa_miho@yahoo.co.jp	Hamano, TAKAYUKI/AAZ-4837-2021; FUKATSU, ATSUSHI/R-7941-2019	Hamano, TAKAYUKI/0000-0002-2100-9106; 				[Anonymous], 2003, AM J KIDNEY DIS S13, V42, pS1; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Navarro-Gonzalez JF, 2009, CLIN J AM SOC NEPHRO, V4, P1646, DOI 10.2215/CJN.02420409; ONOYAMA K, 1986, JPN HEART J, V27, P685; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Takase B, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-61; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	29	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114678	10.1371/journal.pone.0114678	http://dx.doi.org/10.1371/journal.pone.0114678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494334	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400065
J	Cotter, K; Capecci, J; Sennoune, S; Huss, M; Maier, M; Martinez-Zaguilan, R; Forgac, M				Cotter, Kristina; Capecci, Joseph; Sennoune, Souad; Huss, Markus; Maier, Martin; Martinez-Zaguilan, Raul; Forgac, Michael			Activity of Plasma Membrane V-ATPases Is Critical for the Invasion of MDA-MB231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; AMINO-TERMINAL DOMAIN; CATHEPSIN-B; A3 ISOFORM; SUBUNIT ISOFORMS; PROTON PUMPS; METASTASIS; BINDING; PH; INHIBITION	The vacuolar (H+)-ATPases (V-ATPases) are a family of ATP-driven proton pumps that couple ATP hydrolysis with translocation of protons across membranes. Previous studies have implicated V-ATPases in cancer cell invasion. It has been proposed that V-ATPases participate in invasion by localizing to the plasma membrane and causing acidification of the extracellular space. To test this hypothesis, we utilized two separate approaches to specifically inhibit plasma membrane V-ATPases. First, we stably transfected highly invasive MDA-MB231 cells with a V5-tagged construct of the membrane-embedded c subunit of the V-ATPase, allowing for extracellular expression of the V5 epitope. We evaluated the effect of addition of a monoclonal antibody directed against the V5 epitope on both V-ATPase-mediated proton translocation across the plasma-membrane and invasion using an in vitro Matrigel assay. The addition of anti-V5 antibody resulted in acidification of the cytosol and a decrease in V-ATPase-dependent proton flux across the plasma membrane in transfected but not control (untransfected) cells. These results demonstrate that the anti-V5 antibody inhibits activity of plasma membrane V-ATPases in transfected cells. Addition of the anti-V5 antibody also inhibited in vitro invasion of transfected (but not untransfected) cells. Second, we utilized a biotin-conjugated form of the specific V-ATPase inhibitor bafilomycin. When bound to streptavidin, this compound cannot cross the plasma membrane. Addition of this compound to MDA-MB231 cells also inhibited in vitro invasion. These studies suggest that plasma membrane V-ATPases play an important role in invasion of breast cancer cells.	[Cotter, Kristina; Capecci, Joseph; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Cotter, Kristina; Capecci, Joseph; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Sennoune, Souad; Martinez-Zaguilan, Raul] Texas Tech Univ, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Huss, Markus] Univ Osnabruck, Div Anim Physiol, Dept Biol Chem, D-49069 Osnabruck, Germany; [Maier, Martin] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Tufts University; Tufts University; Texas Tech University System; Texas Tech University; University Osnabruck; Eberhard Karls University of Tubingen	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.).; Supported in part by a Sackler Families Collaborative Cancer Biology Award from Tufts University.	Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cai M., 2014, PLOS ONE, V9, DOI [10.1371/annotation/ca9f2d5b-93ab-4d7c-b577-cd045b343e53, DOI 10.1371/ANNOTATION/CA9F2D5B-93AB-4D7C-B577-CD045B343E53]; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; FENG Y, 1992, J BIOL CHEM, V267, P5817; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Liberman R, 2013, J BIOL CHEM, V288, P22798, DOI 10.1074/jbc.M113.460295; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Partridge J, 2009, JOVE-J VIS EXP, P1475; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Robey IF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/485196; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	55	72	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3680	3692		10.1074/jbc.M114.611210	http://dx.doi.org/10.1074/jbc.M114.611210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505184	Green Published, hybrid			2022-12-26	WOS:000349456000040
J	Wang, XZ; Maynard, JA				Wang, Xianzhe; Maynard, Jennifer A.			The Bordetella Adenylate Cyclase Repeat-in-Toxin (RTX) Domain Is Immunodominant and Elicits Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACELLULAR PERTUSSIS VACCINES; ESCHERICHIA-COLI; RESPIRATORY-INFECTION; MONOCLONAL-ANTIBODIES; PROTECTIVE ACTIVITY; HUMAN NEUTROPHILS; PHAGE DISPLAY; TARGET-CELLS; CYAA TOXIN; HIGH-LEVEL	The adenylate cyclase toxin (ACT) is a multifunctional virulence factor secreted by Bordetella species. Upon interaction of its C-terminal hemolysin moiety with the cell surface receptor alpha(M)beta(2) integrin, the N-terminal cyclase domain translocates into the host cell cytosol where it rapidly generates supraphysiological cAMP concentrations, which inhibit host cell anti-bacterial activities. Although ACT has been shown to induce protective immunity in mice, it is not included in any current acellular pertussis vaccines due to protein stability issues and a poor understanding of its role as a protective antigen. Here, we aimed to determine whether any single domain could recapitulate the antibody responses induced by the holo-toxin and to characterize the dominant neutralizing antibody response. We first immunized mice with ACT and screened antibody phage display libraries for binding to purified ACT. The vast majority of unique antibodies identified bound the C-terminal repeat-in-toxin (RTX) domain. Representative antibodies binding two nonoverlapping, neutralizing epitopes in the RTX domain prevented ACT association with J774A.1 macrophages and soluble alpha(M)beta(2) integrin, suggesting that these antibodies inhibit the ACT-receptor interaction. Sera from mice immunized with the RTX domain showed similar neutralizing activity as ACT-immunized mice, indicating that this domain induced an antibody response similar to that induced by ACT. These data demonstrate that RTX can elicit neutralizing antibodies and suggest it may present an alternative to ACT.	[Wang, Xianzhe] Univ Texas Austin, Dept Biochem, Austin, TX 78712 USA; [Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas Austin, 200 E Dean Keeton,MC0400, Austin, TX 78712 USA.	maynard@che.utexas.edu			National Institutes of Health [GM095638]; Welch Foundation [F-1767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095638 (to J. A. M.). This work was also supported by Welch Foundation Grant F-1767.	Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; BETSOU F, 1995, INFECT IMMUN, V63, P3309, DOI 10.1128/IAI.63.9.3309-3315.1995; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056; BREZIN C, 1987, FEMS MICROBIOL LETT, V42, P75, DOI 10.1016/0378-1097(87)90501-5; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Chenal-Francisque V, 2009, RES MICROBIOL, V160, P330, DOI 10.1016/j.resmic.2009.03.006; Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Cheung GYC, 2006, INFECT IMMUN, V74, P6797, DOI 10.1128/IAI.01104-06; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Eby JC, 2013, INFECT IMMUN, V81, P1390, DOI 10.1128/IAI.00110-13; Eby JC, 2012, INFECT IMMUN, V80, P850, DOI 10.1128/IAI.05979-11; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; FARFEL Z, 1990, J MED MICROBIOL, V32, P173, DOI 10.1099/00222615-32-3-173; Gallay J, 2004, EUR J BIOCHEM, V271, P821, DOI 10.1111/j.1432-1033.2004.03987.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Goldstein D, 1990, CLIN METHODS HIST PH; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GOYARD S, 1989, BIOCHEMISTRY-US, V28, P1964, DOI 10.1021/bi00431a002; Gray MC, 2004, MOL MICROBIOL, V53, P1709, DOI 10.1111/j.1365-2958.2004.04227.x; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; GUEIRARD P, 1993, INFECT IMMUN, V61, P4072, DOI 10.1128/IAI.61.10.4072-4078.1993; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; GUISO N, 1989, MICROB PATHOGENESIS, V7, P373, DOI 10.1016/0882-4010(89)90040-5; GUISO N, 1991, MICROB PATHOGENESIS, V11, P423, DOI 10.1016/0882-4010(91)90038-C; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Henderson MW, 2012, INFECT IMMUN, V80, P2061, DOI 10.1128/IAI.00148-12; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hormozi K, 1999, FEMS IMMUNOL MED MIC, V23, P273, DOI 10.1016/S0928-8244(98)00146-1; Karimova G., 2007, CSH PROTOC, V2007; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; Lim A, 2014, MICROBES INFECT, V16, P51, DOI 10.1016/j.micinf.2013.10.002; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; MONNERON A, 1988, BIOCHEMISTRY-US, V27, P536, DOI 10.1021/bi00402a005; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pojanapotha P, 2011, PROTEIN EXPRES PURIF, V75, P127, DOI 10.1016/j.pep.2010.07.012; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Powthongchin B, 2008, ARCH MICROBIOL, V189, P169, DOI 10.1007/s00203-007-0302-1; RAPTIS A, 1989, INFECT IMMUN, V57, P1725, DOI 10.1128/IAI.57.6.1725-1730.1989; ROGEL A, 1988, J BIOL CHEM, V263, P13310; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sutherland JN, 2011, CLIN VACCINE IMMUNOL, V18, P954, DOI 10.1128/CVI.00561-10; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Weingart CL, 2000, INFECT IMMUN, V68, P1735, DOI 10.1128/IAI.68.3.1735-1739.2000; Weingart CL, 2000, INFECT IMMUN, V68, P7152, DOI 10.1128/IAI.68.12.7152-7155.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilkins MR, 1999, METH MOL B, V112, P531; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	78	23	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3576	3591		10.1074/jbc.M114.585281	http://dx.doi.org/10.1074/jbc.M114.585281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505186	Green Published, hybrid			2022-12-26	WOS:000349456000031
J	Wang, RL; Yu, GR; He, NP; Wang, QF; Xia, FC; Zhao, N; Xu, ZW; Ge, JP				Wang, Ruili; Yu, Guirui; He, Nianpeng; Wang, Qiufeng; Xia, Fucai; Zhao, Ning; Xu, Zhiwei; Ge, Jianping			Elevation-Related Variation in Leaf Stomatal Traits as a Function of Plant Functional Type: Evidence from Changbai Mountain, China	PLOS ONE			English	Article							VACCINIUM-MYRTILLUS; DIFFERENT ALTITUDES; ATMOSPHERIC CO2; DENSITY; CONDUCTANCE; PHOTOSYNTHESIS; CLIMATE; DRIVEN; GROWTH; ADAPTATION	Understanding the variation in stomatal characteristics in relation to climatic gradients can reveal the adaptation strategies of plants, and help us to predict their responses to future climate changes. In this study, we investigated stomatal density (SD) and stomatal length (SL) in 150 plant species along an elevation gradient (540-2357 m) in Changbai Mountain, China, and explored the patterns and drivers of stomatal characteristics across species and plant functional types (PFTs: trees, shrubs, and herbs). The average values of SD and SL for all species combined were 156 mm(-2) and 35 mu m, respectively. SD was higher in trees (224 mm(-2)) than in shrubs (156 mm(-2)) or herbs (124 mm(-2)), and SL was largest in herbs (37 mu m). SD was negatively correlated with SL in all species and PFTs (P<0.01). The relationship between stomatal characteristics and elevation differed among PFTs. In trees, SD decreased and SL increased with elevation; in shrubs and herbs, SD initially increased and then decreased. Elevation-related differences in SL were not significant. PFT explained 7.20-17.6% of the total variation in SD and SL; the contributions of CO2 partial pressure (P-CO2), precipitation, and soil water content (SWC) were weak (0.02-2.28%). Our findings suggest that elevation-related patterns of stomatal characteristics in leaves are primarily a function of PFT, and highlight the importance of differences among PFTs in modeling gas exchange in terrestrial ecosystems under global climate change.	[Wang, Ruili; Yu, Guirui; He, Nianpeng; Wang, Qiufeng; Zhao, Ning; Xu, Zhiwei] Chinese Acad Sci, Synth Res Ctr Chinese Ecosystem Res Network, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Wang, Ruili; Zhao, Ning; Xu, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xia, Fucai] Beihua Univ, Coll Forestry, Jilin, Peoples R China; [Ge, Jianping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beihua University; Beijing Normal University	Yu, GR (corresponding author), Chinese Acad Sci, Synth Res Ctr Chinese Ecosystem Res Network, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yugr@igsnrr.ac.cn; henp@igsnrr.ac.cn	wang, qiufeng/C-1654-2013; 于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	Major Program of the National Natural Science Foundation of China [31290221]; Environmental Public Welfare Scientific Research Project [201209028]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050702]; Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Public Welfare Scientific Research Project; Chinese Academy of Sciences Strategic Priority Research Program; Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	This work was partially supported by the Major Program of the National Natural Science Foundation of China (No. 31290221), the Environmental Public Welfare Scientific Research Project (201209028), the Chinese Academy of Sciences Strategic Priority Research Program (XDA05050702), and the Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Haworth M, 2011, OECOLOGIA, V167, P11, DOI 10.1007/s00442-011-1969-1; Haworth M, 2010, ANN BOT-LONDON, V105, P411, DOI 10.1093/aob/mcp309; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holland N., 2009, Journal of Sustainable Forestry, V28, P63, DOI 10.1080/10549810802626142; Hovenden MJ, 2000, AUST J PLANT PHYSIOL, V27, P451, DOI 10.1071/PP99164; JAMES JC, 1994, J ECOL, V82, P297, DOI 10.2307/2261297; KELLY CK, 1995, FUNCT ECOL, V9, P422, DOI 10.2307/2390005; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; KORNER C, 1986, OECOLOGIA, V69, P577, DOI 10.1007/BF00410366; Korner C, 1999, ALPINE PLANT LIFE; Korner C, 2003, FUNCTIONAL PLANT ECO; Kouwenberg LLR, 2007, REV MINERAL GEOCHEM, V66, P215, DOI 10.2138/rmg.2007.66.9; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Li CY, 2004, TREES-STRUCT FUNCT, V18, P277, DOI 10.1007/s00468-003-0304-9; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; Miller-Rushing AJ, 2009, AM J BOT, V96, P1779, DOI 10.3732/ajb.0800410; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; Pato J, 2012, ECOSCIENCE, V19, P59, DOI 10.2980/19-1-3407; Premoli AC, 2007, AUST J BOT, V55, P585, DOI 10.1071/BT06026; Qiang WY, 2003, TREES-STRUCT FUNCT, V17, P258, DOI 10.1007/s00468-002-0235-x; R Development Core Team, 2012, R LANG ENV STAT COMP; Read QD, 2014, FUNCT ECOL, V28, P37, DOI 10.1111/1365-2435.12162; Reich PB, 2007, ECOL APPL, V17, P1982, DOI 10.1890/06-1803.1; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Santrucek J, 2014, ANN BOT-LONDON, V114, P191, DOI 10.1093/aob/mcu095; Schoettle AW, 2000, AM J BOT, V87, P1797, DOI 10.2307/2656832; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Taylor SH, 2012, NEW PHYTOL, V193, P387, DOI 10.1111/j.1469-8137.2011.03935.x; TERASHIMA I, 1995, ECOLOGY, V76, P2663, DOI 10.2307/2265838; Wang RZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026209; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771; [徐文铎 Xu Wenduo], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P162; Yang XX, 2014, BASIC APPL ECOL, V15, P122, DOI 10.1016/j.baae.2014.01.003; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhao N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095196; Zhou YM, 2012, TREES-STRUCT FUNCT, V26, P1389, DOI 10.1007/s00468-012-0713-8	49	33	38	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115395	10.1371/journal.pone.0115395	http://dx.doi.org/10.1371/journal.pone.0115395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517967	Green Submitted, gold, Green Published			2022-12-26	WOS:000347215600061
J	Bhutra, S; Lenkala, D; LaCroix, B; Ye, M; Huang, RS				Bhutra, Steven; Lenkala, Divya; LaCroix, Bonnie; Ye, Meng; Huang, R. Stephanie			Identifying and Validating a Combined mRNA and MicroRNA Signature in Response to Imatinib Treatment in a Chronic Myeloid Leukemia Cell Line	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; CHROMATIN IMMUNOPRECIPITATION; CANCER CELLS; EXPRESSION; GENE; INHIBITOR; METHYLATION; SUPPRESSION; RESISTANCE	Imatinib, a targeted tyrosine kinase inhibitor, is the gold standard for managing chronic myeloid leukemia (CML). Despite its wide application, imatinib resistance occurs in 20-30% of individuals with CML. Multiple potential biomarkers have been identified to predict imatinib response; however, the majority of them remain externally uncorroborated. In this study, we set out to systematically identify gene/microRNA (miRNA) whose expression changes are related to imatinib response. Through a Gene Expression Omnibus search, we identified two genome-wide expression datasets that contain expression changes in response to imatinib treatment in a CML cell line (K562): one for mRNA and the other for miRNA. Significantly differentially expressed transcripts/miRNAs post imatinib treatment were identified from both datasets. Three additional filtering criteria were applied 1) miRbase/miRanda predictive algorithm; 2) opposite direction of imatinib effect for genes and miRNAs; and 3) literature support. These criteria narrowed our candidate gene-miRNA to a single pair: IL8 and miR-493-5p. Using PCR we confirmed the significant up-regulation and down-regulation of miR-493-5p and IL8 by imatinib treatment, respectively in K562 cells. In addition, IL8 expression was significantly down-regulated in K562 cells 24 hours after miR-493-5p mimic transfection (p=0.002). Furthermore, we demonstrated significant cellular growth inhibition after IL8 inhibition through either gene silencing or by over-expression of miR-493-5p (p=0.0005 and p=0.001 respectively). The IL8 inhibition also further sensitized K562 cells to imatinib cytotoxicity (p<0.0001). Our study combined expression changes in transcriptome and miRNA after imatinib exposure to identify a potential gene-miRNA pair that is a critical target in imatinib response. Experimental validation supports the relationships between IL8 and miR-493-5p and between this gene-miRNA pair and imatinib sensitivity in a CML cell line. Our data suggests integrative analysis of multiple omic level data may provide new insight into biomarker discovery as well as mechanisms of imatinib resistance.	[Bhutra, Steven] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Lenkala, Divya; LaCroix, Bonnie; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ye, Meng; Huang, R. Stephanie] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China	University of Chicago; University of Chicago; Ningbo University	Huang, RS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu		Huang, R. Stephanie/0000-0002-9862-0368; LaCroix, Bonnie/0000-0002-6833-5267	NHLBI [5R25HL096383-05]; NIH/NIGMS grant [UO1GM61393, K08GM089941]; Natural Science Foundation of Ningbo City, China [2014A610235]; NIH/NCI grant [R21 CA139278]; University of Chicago Cancer Center Support Grant [P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the NIH [UL1RR024999]; NATIONAL CANCER INSTITUTE [R21CA139278, P30CA014599, P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL096383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941, U01GM061393] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIGMS grant; Natural Science Foundation of Ningbo City, China; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center Support Grant; Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the NHLBI 5R25HL096383-05, NIH/NIGMS grant UO1GM61393 and by Natural Science Foundation of Ningbo City (2014A610235), China. RSH also received support from NIH/NIGMS grant K08GM089941, NIH/NCI grant R21 CA139278, University of Chicago Cancer Center Support Grant (#P30 CA14599), Breast Cancer SPORE Career Development Award [CA125183] and the National Center for Advancing Translational Sciences of the NIH [UL1RR024999]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN NC, 1995, LANCET, V345, P1392, DOI 10.1016/S0140-6736(95)92596-1; AUER H, 2004, GEODATASETS BIOPROJE; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bournia VK, 2013, SEMIN ARTHRITIS RHEU, V42, P377, DOI 10.1016/j.semarthrit.2012.06.001; Chen Wei-wei, 2012, Zhonghua Yi Xue Za Zhi, V92, P1405; Ciarcia R, 2012, J CELL PHYSIOL, V227, P2798, DOI 10.1002/jcp.23029; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dickens D, 2013, PHARMACOGENET GENOM, V23, P314, DOI 10.1097/FPC.0b013e328360d10c; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Esposito N, 2011, BLOOD, V118, P3634, DOI 10.1182/blood-2011-03-341073; Frame D, 2007, AM J HEALTH-SYST PH, V64, pS16, DOI 10.2146/ajhp070483; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gromicho M, 2013, ONCOL REP, V29, P741, DOI 10.3892/or.2012.2153; Hayashi Y, 2013, LEUKEMIA, V27, P619, DOI 10.1038/leu.2012.258; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Jalkanen SE, 2012, EXP HEMATOL, V40, P705, DOI 10.1016/j.exphem.2012.05.010; John B, 2004, PLOS BIOL, V2, pe363, DOI [10.1371/journal.pbio.0020363, DOI 10.1371/J0URNAL.PBI0.0020363]; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Koon HB, 2014, J CLIN ONCOL, V32, P402, DOI 10.1200/JCO.2012.48.6365; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Li ZY, 2013, CHINESE J CANCER RES, V25, P600, DOI 10.3978/j.issn.1000-9604.2013.10.14; Liu YC, 2014, MOL CARCINOGEN, V53, P951, DOI 10.1002/mc.22061; Liu YH, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-14; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; Lucas CM, 2011, BLOOD, V117, P6660, DOI 10.1182/blood-2010-08-304477; Mauro M J, 2001, Curr Oncol Rep, V3, P223, DOI 10.1007/s11912-001-0054-z; Nardinelli L, 2012, ACTA HAEMATOL-BASEL, V127, P228, DOI 10.1159/000336610; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Ouerhani S, 2012, CANCER GENET-NY, V205, P436, DOI 10.1016/j.cancergen.2012.05.008; Pollack A., 2013, THE NEW YORK TIMES; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rokah OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035501; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sakai H, 2014, CANCER SCI, V105, P425, DOI 10.1111/cas.12380; Shibata M, 2011, LEUKEMIA RES, V35, P1205, DOI 10.1016/j.leukres.2011.01.012; Stella S, 2013, MOL CANCER THER, V12, P1085, DOI 10.1158/1535-7163.MCT-12-0550; Sunil Y, 2010, INT J COLORECTAL DIS, V25, P323, DOI 10.1007/s00384-009-0847-3; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Turrini E, 2012, PHARMACOGENET GENOM, V22, P198, DOI 10.1097/FPC.0b013e328350012b; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; von Bubnoff N, 2010, DTSCH ARZTEBL INT, V107, P114, DOI 10.3238/arztebl.2010.0114; Wang LH, 2012, EXP HEMATOL, V40, P811, DOI 10.1016/j.exphem.2012.05.013; Wilkinson K, 2003, BLOOD, V102, P4187, DOI 10.1182/blood-2003-04-1150; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yang H, 2012, INT J HEMATOL, V96, P65, DOI 10.1007/s12185-012-1106-x; Zhang J, 2012, INT J LAB HEMATOL, V34, P267, DOI 10.1111/j.1751-553X.2011.01389.x; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	50	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115003	10.1371/journal.pone.0115003	http://dx.doi.org/10.1371/journal.pone.0115003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506832	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100041
J	De Coninck, Z; Feyissa, IA; Ekstrom, AM; Marrone, G				De Coninck, Zaake; Feyissa, Ibrahim A.; Ekstrom, Anna Mia; Marrone, Gaetano			Improved HIV Awareness and Perceived Empowerment to Negotiate Safe Sex among Married Women in Ethiopia between 2005 and 2011	PLOS ONE			English	Article							COHABITING COUPLES; CONDOM USE; RISK	Introduction: The HIV prevalence rate in Ethiopia for married (or cohabiting) women is 3 times that found amongst women who have never been married. While marriage used to be seen as a protective factor against HIV, evidence suggests that this is no longer necessarily the case. This study analyses the trend and socio-demographic determinants of HIV awareness and safe sex negotiation among married women in Ethiopia between 2005 and 2011. Methods: Data from Ethiopian Demographic and Health Surveys conducted in 2005 and in 2011 were analysed. Socio-demographic variables as well as 'survey year' were selected to assess their interaction with selected HIV awareness and safe sex negotiation indicators. Multivariable regression analyses were performed. Odds ratios and confidence intervals were computed. Results: A significant increase in knowledge of HIV and ability to negotiate safer sex occurred between 2005 and 2011 reflecting a positive trend in gender empowerment amongst married Ethiopian women. Some of these advancements were striking, for instance respondents were 3.6 times more likely to have "Heard of AIDS'' in 2011 than in 2005. HIV awareness and safer sex negotiation were significantly associated with higher education, higher socioeconomic status, those who had heard of HIV, those of the Orthodox Christian faith, and (to some extent) those living in rural areas. Conclusion: HIV awareness has increased significantly in Ethiopia over the last decade but married women are still disproportionately susceptible to HIV. Community programmes, already effective in Ethiopia, also need to target this vulnerable sub-group of women.	[De Coninck, Zaake; Ekstrom, Anna Mia; Marrone, Gaetano] Karolinska Inst, Dept Publ Hlth Sci Global Hlth IHCAR, Stockholm, Sweden; [Feyissa, Ibrahim A.] WHO, Immunizat Unit, Expanded Program, Nairobi, Kenya; [Ekstrom, Anna Mia; Marrone, Gaetano] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; World Health Organization; Karolinska Institutet; Karolinska University Hospital	De Coninck, Z (corresponding author), Karolinska Inst, Dept Publ Hlth Sci Global Hlth IHCAR, Stockholm, Sweden.	zaake.deconinck@gmail.com		Marrone, Gaetano/0000-0002-2991-1663	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2012, UG DEM HLTH SURV 201; [Anonymous], 2013, 2012 TANZ POP HOUS C; Callegari L, 2008, SEX TRANSM DIS, V35, P624, DOI 10.1097/OLQ.0b013e31816b3208; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Erulkar AS, 2008, IMPROVING REPROD HLT; Federal Democratic Republic of Ethiopia, 1998, POL ON HIV AIDS; Federal HIV/AIDS Prevention and Control Office, 2010, ANN PERF REP MULT HI; Federal HIV/AIDS Prevention and Control Office, 2014, STRAT PLAN INT MULT; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; (ISTEEBU) IdSedEEdB (MSPLS) MdlSPedlLclSB International I, 2012, ENQ DEM SANT 2010; Jacubowski N, 2008, CULT HEALTH SEX, V10, P87, DOI 10.1080/13691050601058573; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Ministry of Health, 2004, ETH STRAT PLAN INT M; Mumtaz Z, 2004, CONDOM USE UGANDA ZI; Mundi Index, 2011, TOT FERT RAT CHILDR; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Oljira L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17349; Rombo DO, 2009, THESIS U MINNESOTA; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Teferra D., 2003, AFRICAN HIGHER ED IN; Tenkorang EY, 2012, ARCH SEX BEHAV, V41, P1353, DOI 10.1007/s10508-012-9960-4; UNAIDS, 2012, COUNTR PROGR REP HIV; Ung M, 2013, J BIOSOC SCI, V21, P1; Varam DS, 2010, J WOMENS HEALTH, V19, P815; World Bank, 2012, ETH COUNTR METADATA	30	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115453	10.1371/journal.pone.0115453	http://dx.doi.org/10.1371/journal.pone.0115453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506823	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100077
J	Lopez-Emparan, A; Quezada-Martinez, D; Zuniga-Bustos, M; Cifuentes, V; Iniguez-Luy, F; Federico, ML				Lopez-Emparan, Ada; Quezada-Martinez, Daniela; Zuniga-Bustos, Matias; Cifuentes, Victor; Iniguez-Luy, Federico; Laura Federico, Maria			Functional Analysis of the Brassica napus L. Phytoene Synthase (PSY) Gene Family	PLOS ONE			English	Article							CAROTENOID BIOSYNTHESIS; MACULAR PIGMENT; BETA-CAROTENE; ABSCISIC-ACID; KEY ENZYME; ARABIDOPSIS; GENOME; EXPRESSION; PATHWAY; EVOLUTION	Phytoene synthase (PSY) has been shown to catalyze the first committed and rate-limiting step of carotenogenesis in several crop species, including Brassica napus L. Due to its pivotal role, PSY has been a prime target for breeding and metabolic engineering the carotenoid content of seeds, tubers, fruits and flowers. In Arabidopsis thaliana, PSY is encoded by a single copy gene but small PSY gene families have been described in monocot and dicotyledonous species. We have recently shown that PSY genes have been retained in a triplicated state in the A- and C-Brassica genomes, with each paralogue mapping to syntenic locations in each of the three "Arabidopsis-like'' subgenomes. Most importantly, we have shown that in B. napus all six members are expressed, exhibiting overlapping redundancy and signs of subfunctionalization among photosynthetic and non photosynthetic tissues. The question of whether this large PSY family actually encodes six functional enzymes remained to be answered. Therefore, the objectives of this study were to: (i) isolate, characterize and compare the complete protein coding sequences (CDS) of the six B. napus PSY genes; (ii) model their predicted tridimensional enzyme structures; (iii) test their phytoene synthase activity in a heterologous complementation system and (iv) evaluate their individual expression patterns during seed development. This study further confirmed that the six B. napus PSY genes encode proteins with high sequence identity, which have evolved under functional constraint. Structural modeling demonstrated that they share similar tridimensional protein structures with a putative PSY active site. Significantly, all six B. napus PSY enzymes were found to be functional. Taking into account the specific patterns of expression exhibited by these PSY genes during seed development and recent knowledge of PSY suborganellar localization, the selection of transgene candidates for metabolic engineering the carotenoid content of oilseeds is discussed.	[Lopez-Emparan, Ada; Quezada-Martinez, Daniela; Iniguez-Luy, Federico; Laura Federico, Maria] CGNA, Agriaquaculture Nutr Genom Ctr, Genom & Bioinformat Unit, Temuco, La Araucania, Chile; [Lopez-Emparan, Ada; Zuniga-Bustos, Matias] Univ Talca, Inst Biol Vegetal & Biotecnol, Talca, Maule, Chile; [Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Region Metropol, Chile	Universidad de Talca; Universidad de Chile	Federico, ML (corresponding author), CGNA, Agriaquaculture Nutr Genom Ctr, Genom & Bioinformat Unit, Temuco, La Araucania, Chile.	maria.federico@cgna.cl		Quezada-Martinez, Daniela/0000-0003-0470-9925; Zuniga-Bustos, Matias/0000-0003-2448-9376	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090726]; Proyecto Fortalecimiento [R13F1001]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Araucania Regional Government [/CGNA/R10C1001]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Fortalecimiento; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Araucania Regional Government	This research was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1090726), Proyecto Fortalecimiento R13F1001, Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Regional Program and the Araucania Regional Government /CGNA/R10C1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; BARTLEY GE, 1992, J BIOL CHEM, V267, P5036; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bollag W, 1996, FASEB J, V10, P938, DOI 10.1096/fasebj.10.9.8801175; Busch M, 2002, PLANT PHYSIOL, V128, P439, DOI [10.1104/pp.128.2.439, 10.1104/pp.010573]; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dong JZ, 2004, PLANTA, V218, P483, DOI 10.1007/s00425-003-1124-2; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Farre G, 2011, TRENDS PLANT SCI, V16, P532, DOI 10.1016/j.tplants.2011.08.001; Federico ML, 2005, PLANT MOL BIOL, V57, P35, DOI 10.1007/s11103-004-6769-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; Gallagher CE, 2003, APPL MICROBIOL BIOT, V60, P713, DOI 10.1007/s00253-002-1182-6; Hammond BR, 1997, OPTOMETRY VISION SCI, V74, P499, DOI 10.1097/00006324-199707000-00017; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Huh JH, 2001, THEOR APPL GENET, V102, P524, DOI 10.1007/s001220051677; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kidwell Kimberlee K., 1992, P1; Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Maluf MP, 1997, J EXP BOT, V48, P1259, DOI 10.1093/jxb/48.6.1259; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Niu Y, 2009, MOL PLANT, V2, P1107, DOI 10.1093/mp/ssp042; O'Hara P, 2002, PLANT PHYSIOL, V129, P310, DOI 10.1104/pp.010956; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Ortiz-Monasterio JI, 2007, J CEREAL SCI, V46, P293, DOI 10.1016/j.jcs.2007.06.005; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Park JY, 2005, MOL GENET GENOMICS, V274, P579, DOI 10.1007/s00438-005-0041-4; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saez PL, 2013, PLANT SCI, V201, P12, DOI 10.1016/j.plantsci.2012.11.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012; Shumskaya M, 2012, PLANT CELL, V24, P3725, DOI 10.1105/tpc.112.104174; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; U. N., 1935, Japanese Journal of Botany, V7, P389; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2010, PLANT CELL, V22, P3348, DOI 10.1105/tpc.110.077560; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wurtzel ET, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00029; Yan JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095088; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	74	23	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114878	10.1371/journal.pone.0114878	http://dx.doi.org/10.1371/journal.pone.0114878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506829	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100029
J	Pereira, RV; Siler, JD; Bicalho, RC; Warnick, LD				Pereira, Richard Van Vleck; Siler, Julie D.; Bicalho, Rodrigo Carvalho; Warnick, Lorin D.			In Vivo Selection of Resistant E. coli after Ingestion of Milk with Added Drug Residues	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; LONG-TERM IMPACTS; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; TETRACYCLINE ANTIBIOTICS; SALMONELLA-ENTERICA; CLASS-1 INTEGRONS; STABILITY; GENES	Antimicrobial resistance represents a major global threat to modern medicine. In vitro studies have shown that very low concentrations of drugs, as frequently identified in the environment, and in foods and water for human and animal consumption, can select for resistant bacteria. However, limited information is currently available on the in vivo impact of ingested drug residues. The objective of our study was to evaluate the effect of feeding preweaned calves milk containing antimicrobial drug residues (below the minimum inhibitory concentration), similar to concentrations detected in milk commonly fed to dairy calves, on selection of resistant fecal E. coli in calves from birth to weaning. At birth, thirty calves were randomly assigned to a controlled feeding trial where: 15 calves were fed raw milk with no drug residues (NR), and 15 calves were fed raw milk with drug residues (DR) by adding ceftiofur, penicillin, ampicillin, and oxytetracycline at final concentrations in the milk of 0.1, 0.005, 0.01, and 0.3 mu g/ml, respectively. Fecal samples were rectally collected from each calf once a week starting at birth prior to the first feeding in the trial (pre-treatment) until 6 weeks of age. A significantly greater proportion of E. coli resistant to ampicillin, cefoxitin, ceftiofur, streptomycin and tetracycline was observed in DR calves when compared to NR calves. Additionally, isolates from DR calves had a significant decrease in susceptibility to ceftriaxone and ceftiofur when compared to isolates from NR calves. A greater proportion of E. coli isolates from calves in the DR group were resistant to 3 or more antimicrobial drugs when compared to calves in the ND group. These findings highlight the role that low concentrations of antimicrobial drugs have on the evolution and selection of resistance to multiple antimicrobial drugs in vivo.	[Pereira, Richard Van Vleck; Siler, Julie D.; Bicalho, Rodrigo Carvalho; Warnick, Lorin D.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Pereira, RV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rvp25@cornell.edu	Pereira, Richard/L-2684-2019	Pereira, Richard/0000-0003-2028-8761	Office of the Director, National Institutes of Health of the National Institutions of Health [T32ODO011000]; United States Department of Agriculture (USDA) [NYC-478400]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011000] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health of the National Institutions of Health; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the Office of the Director, National Institutes of Health of the National Institutions of Health under Award Number T32ODO011000. Research reported here was also supported the United States Department of Agriculture (USDA), under Hatch award number NYC-478400. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health, the National Institute of Food and Agriculture (NIFA), or the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev VG, 2006, RUSS J GEN CHEM+, V76, P317, DOI 10.1134/S1070363206020265; AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Arkin RL, 2005, FDA NEWSLETTER CVM R; BARR V, 1986, J ANTIMICROB CHEMOTH, V17, P409, DOI 10.1093/jac/17.4.409; Batchelor Miranda, 2005, Expert Rev Anti Infect Ther, V3, P403, DOI 10.1586/14787210.3.3.403; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Cha E, 2011, J DAIRY SCI, V94, P4476, DOI 10.3168/jds.2010-4123; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CLSI, 2012, M100D22 CLIN LAB STA; CLSI, 2008, PERFORMANCE STANDARD; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Du XD, 2005, FEMS MICROBIOL LETT, V245, P295, DOI 10.1016/j.femsle.2005.03.021; Elizondo-Salazar JA, 2010, J DAIRY SCI, V93, P5509, DOI 10.3168/jds.2010-3460; Flanders SA, 2014, JAMA INTERN MED, V174, P661, DOI 10.1001/jamainternmed.2014.897; Galimand A, 2005, ANTIMICROB AGENTS CH, V49, P2949, DOI 10.1128/AAC.49.7.2949-2953.2005; GEORGE AM, 1983, J BACTERIOL, V155, P531, DOI 10.1128/JB.155.2.531-540.1983; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Godden SM, 2005, JAVMA-J AM VET MED A, V226, P1547, DOI 10.2460/javma.2005.226.1547; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Hoelzer K, 2011, FOODBORNE PATHOG DIS, V8, P1281, DOI 10.1089/fpd.2011.0933; Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Karageorgou EG, 2010, J SEP SCI, V33, P2862, DOI 10.1002/jssc.201000385; Karageorgou EG, 2010, J SEP SCI, V33, P17; Khachatryan AR, 2004, APPL ENVIRON MICROB, V70, P752, DOI 10.1128/AEM.70.2.752-757.2004; Kim S, 2014, SCI TOTAL ENVIRON, V468, P813, DOI 10.1016/j.scitotenv.2013.08.100; Kitazono Y, 2012, J HAZARD MATER, V243, P112, DOI 10.1016/j.jhazmat.2012.10.009; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Li XL, 2011, J AGR FOOD CHEM, V59, P10176, DOI 10.1021/jf202325c; Lindgren M, 2009, SCAND J INFECT DIS, V41, P215, DOI 10.1080/00365540802651897; Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x; Lopez E, 2009, ANTIMICROB AGENTS CH, V53, P3411, DOI 10.1128/AAC.00358-09; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Maneewannakul K, 1996, ANTIMICROB AGENTS CH, V40, P1695, DOI 10.1128/AAC.40.7.1695; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Michnik A, 2004, INT J PHARM, V273, P149, DOI 10.1016/j.ijpharm.2004.01.002; Navarro PG, 2003, INT J BIOL MACROMOL, V33, P159, DOI 10.1016/S0141-8130(03)00081-3; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Pereira R. V., 2014, J DAIRY SCI; Pereira RVV, 2011, J DAIRY SCI, V94, P4556, DOI 10.3168/jds.2011-4337; Perlin MH, 2009, P ROY SOC B-BIOL SCI, V276, P3759, DOI 10.1098/rspb.2009.0997; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Riediker S, 2004, J CHROMATOGR A, V1054, P359, DOI [10.1016/j.chroma.2004.07.085, 10.1016/S0021-9673(04)01289-0]; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Roca M, 2011, J DAIRY SCI, V94, P1155, DOI 10.3168/jds.2010-3599; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Schenck FJ, 2000, FOOD ADDIT CONTAM, V17, P675, DOI 10.1080/02652030050083196; Schriks M, 2010, WATER RES, V44, P461, DOI 10.1016/j.watres.2009.08.023; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Silley P, 2012, REV SCI TECH OIE, V31, P33; Thuy DT, 2011, J ANTIMICROB CHEMOTH, V66, P531, DOI 10.1093/jac/dkq496; USDA, 2008, REF DAIR CATTL HLT 1; Wardwell Leslie H, 2011, Curr Infect Dis Rep, V13, P28, DOI 10.1007/s11908-010-0147-7; World Health Organization, 2014, ANT RES GLOB REP SUR; Wu KH, 2012, INT J ANTIMICROB AG, V40, P264, DOI 10.1016/j.ijantimicag.2012.05.017; Zwald AG, 2004, J DAIRY SCI, V87, P191, DOI 10.3168/jds.S0022-0302(04)73158-6	76	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115223	10.1371/journal.pone.0115223	http://dx.doi.org/10.1371/journal.pone.0115223			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506918	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100062
J	Tisato, V; Garrovo, C; Biffi, S; Petrera, F; Voltan, R; Casciano, F; Meroni, G; Agnoletto, C; Zauli, G; Secchiero, P				Tisato, Veronica; Garrovo, Chiara; Biffi, Stefania; Petrera, Francesca; Voltan, Rebecca; Casciano, Fabio; Meroni, Germana; Agnoletto, Chiara; Zauli, Giorgio; Secchiero, Paola			Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model	PLOS ONE			English	Article							SEGMENTAL ANTIGEN CHALLENGE; LATE ASTHMATIC RESPONSE; BONE-MARROW; T-CELLS; APOPTOSIS; LIGAND; EXPRESSION; NEUTROPHILS; MICE; ACTIVATION	Ovalbumin (OVA)-sensitized BALB/c mice were i.n. instilled with recombinant TNF-related apoptosis inducing ligand (TRAIL) 24 hours before OVA challenge. The total number of leukocytes and the levels of the chemokine CXCL-1/KC significantly increased in the bronchoalveolar lavage (BAL) fluids of allergic animals with respect to control littermates, but not in the BAL of mice i.n. pretreated with recombinant TRAIL before OVA challenge. In particular, TRAIL pretreatment significantly reduced the BAL percentage of both eosinophils and neutrophils. On the other hand, when TRAIL was administrated simultaneously to OVA challenge its effect on BAL infiltration was attenuated. Overall, the results show that the i.n. pretreatment with TRAIL down-modulated allergic airway inflammation.	[Tisato, Veronica; Voltan, Rebecca; Casciano, Fabio; Agnoletto, Chiara; Secchiero, Paola] Univ Ferrara, Dept Morphol Surg Expt Med, I-44100 Ferrara, Italy; [Tisato, Veronica; Voltan, Rebecca; Casciano, Fabio; Agnoletto, Chiara; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Garrovo, Chiara; Biffi, Stefania; Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Petrera, Francesca; Meroni, Germana] CBM Scrl, Area Sci Pk, Trieste, Italy	University of Ferrara; University of Ferrara; IRCCS Burlo Garofolo	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol Surg Expt Med, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Biffi, Stefania/C-6652-2015; Tisato, Veronica/K-4525-2016; Casciano, Fabio FC/H-3219-2015; Zauli, Giorgio/ABE-8001-2020; Agnoletto, Chiara/J-8575-2017; secchiero, paola/G-9689-2015	Biffi, Stefania/0000-0003-2257-2053; Casciano, Fabio FC/0000-0002-6431-3335; Agnoletto, Chiara/0000-0002-1363-5852; secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Garrovo, Chiara/0000-0003-1432-0147; Petrera, Francesca/0000-0003-2075-5219; Tisato, Veronica/0000-0001-8448-066X	Italian Ministry of Health [GR-2010-2310832]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by a grant from Italian Ministry of Health (GR-2010-2310832) to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Biffi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057150; Cao J, 2011, CYTOKINE, V56, P823, DOI 10.1016/j.cyto.2011.09.016; Collison A, 2014, AM J RESP CELL MOL, V51, P86, DOI 10.1165/rcmb.2013-0490OC; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Faustino L, 2014, MUCOSAL IMMUNOL; Liu LY, 2003, J ALLERGY CLIN IMMUN, V112, P556, DOI 10.1067/mai.2003.1700; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Milani D, 2003, J NEUROCHEM, V86, P126, DOI 10.1046/j.1471-4159.2003.01805.x; Nabe T, 2005, EUR J PHARMACOL, V521, P144, DOI 10.1016/j.ejphar.2005.08.015; Nabe T, 2011, LIFE SCI, V88, P1127, DOI 10.1016/j.lfs.2011.04.003; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; RE MC, 1993, AIDS, V7, P1049, DOI 10.1097/00002030-199308000-00004; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; Robertson NM, 2004, VITAM HORM, V67, P149; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Secchiero P, 2001, BLOOD, V98, P2220, DOI 10.1182/blood.V98.7.2220; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2013, CLIN CANCER RES, V19, P1949, DOI 10.1158/1078-0432.CCR-12-3027; Secchiero P, 2009, BLOOD, V113, P4300, DOI 10.1182/blood-2008-11-187708; Secchiero P, 2008, STEM CELLS, V26, P2955, DOI 10.1634/stemcells.2008-0512; Stein LH, 2009, J INNATE IMMUN, V1, P618, DOI 10.1159/000233235; VARNER AE, 2000, ASTHMA RHINITIS, P1172; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Weckmann M, 2011, PEDIAT ALLERG IMM-UK, V22, P25, DOI 10.1111/j.1399-3038.2010.01027.x; Xu NJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/290565; Yalcin AD, 2012, MED SCI MONITOR, V18, pPI11, DOI 10.12659/MSM.882504; Zauli G, 2005, J CELL PHYSIOL, V202, P900, DOI 10.1002/jcp.20202; Zauli G, 2008, J CELL PHYSIOL, V214, P117, DOI 10.1002/jcp.21165; Zauli G, 2011, CLIN CANCER RES, V17, P762, DOI 10.1158/1078-0432.CCR-10-2572; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771	40	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115387	10.1371/journal.pone.0115387	http://dx.doi.org/10.1371/journal.pone.0115387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506835	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100073
J	Wang, ZF; Chen, YP; Pan, JR				Wang, Zhifang; Chen, Yaping; Pan, Jinren			Trends of Acute Hepatitis B Notification Rates in Eastern China from 2005 to 2013	PLOS ONE			English	Article							VIRUS-INFECTIONS; VACCINATION; POPULATION; PREVALENCE	Zhejiang Province was a high endemicity for hepatitis B disease in the 1990' s. A number of measures implemented since then have begun to control and prevent hepatitis B. In 1992, hepatitis B vaccine came on the market. In 2002, hepatitis B vaccine was included in the national Expanded Programme on Immunization (EPI). Between 2007 and 2010, catch-up vaccination was implemented for children under 15. Since 2010, vaccination guidelines for high-risk groups have also been adopted. This study evaluated the impact of these control and prevention strategies on acute hepatitis B notification rates from 2005 through 2013. Data from the National Notifiable Disease Reporting System (NNDRS) revealed a steady downward trend in notification rates of acute hepatitis B. The most dramatic decline occurred among pre-adults, highlighting the benefits of EPI's policy of universal vaccination for children. However, the highest notification rates occurred among young adults of lower socio-economic status. These findings indicate the strong need to vaccinate young adults at risk for HBV infection as well as to collect risk-factor information in the NNDRS for monitoring and following up persons with acute hepatitis B.	[Wang, Zhifang; Chen, Yaping; Pan, Jinren] Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Wang, ZF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China.	zfwang@cdc.zj.cn		Pan, jinren/0000-0001-7062-0887	Medical Research Foundation of Zhejiang Province, China [2014KYB060]	Medical Research Foundation of Zhejiang Province, China	This study was supported by Medical Research Foundation of Zhejiang Province, China (Grant No. 2014KYB060). The funders had no role in study design, data collection and analysis, decision to publish, or prepare of the manuscript.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P441; [Anonymous], 2007, THESIS; Ay P, 2013, EURO SURVEILL, V18; Chan CY, 2004, J GASTROEN HEPATOL, V19, P121, DOI 10.1111/j.1440-1746.2004.03153.x; CHEN PW, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0056444; *CHIN CTR DIS CONT, 2011, NAT HEP B EP SURV RE; Cui FQ, 2013, VACCINE, V31, pJ29, DOI 10.1016/j.vaccine.2012.07.048; Hwang EW, 2011, N AM J MED SCI BOSTO, V4; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b; McMahon BJ, 1998, HEPATOLOGY, V28, P265, DOI 10.1002/hep.510280135; *NAT CTR HIV AIDA, 2011, NAT CTR HIV AIDS VIR; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; YAO J, 1997, DIS SURVEILLANCE, V12, P258; ZHANG GM, 2013, CHIN J VAC IMMUN, V19, P266	19	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114645	10.1371/journal.pone.0114645	http://dx.doi.org/10.1371/journal.pone.0114645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504088	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400042
J	Kim, J; Noh, JW; Park, J; Kwon, YD				Kim, Jinseok; Noh, Jin-Won; Park, Jumin; Kwon, Young Dae			Body Mass Index and Depressive Symptoms in Older Adults: A Cross-Lagged Panel Analysis	PLOS ONE			English	Article							GENERAL-POPULATION; JOLLY FAT; OBESITY; ASSOCIATION; PREVALENCE; OVERWEIGHT; DISORDER; WEIGHT; KOREA	Background: There are conflicting results about the association between body mass index (BMI) and depressive symptoms in older adults. The present study examined the relationship between weight and depressive symptoms over time in older adults in South Korea. Methods: We used data from three waves of the Korean Longitudinal Study of Aging and ran a series of cross-lagged panel models to test the reciprocal relationship between depressive symptoms and obesity in older Korean adults. We assumed a temporally stable relationship between depressive symptoms and obesity and, thus imposed equality constraints over time. Results: After controlling for the effect of depressive symptoms two years prior, underweight older adults had a higher depressive symptom score than those of normal weight. When controlling for obesity status from two years prior, older adults with higher levels of depressive symptoms were more likely to be underweight and less likely to be overweight than normal weight. The same patterns were observed in data from 2006 to 2008 and from 2008 to 2010. Conclusions: These results show that there is a correlation between depressive symptoms and weight status. In middle-aged and elderly Asian populations, depression can lead to weight loss rather than obesity, and underweight may develop depressive symptoms.	[Kim, Jinseok] Seoul Womens Univ, Dept Social Welf, Seoul, South Korea; [Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Songnam, South Korea; [Park, Jumin] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Kwon, Young Dae] Catholica Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholica Univ Korea, Catholica Inst Healthcare Management, Seoul, South Korea	Seoul Women's University; Eulji University; University System of Maryland; University of Maryland Baltimore; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholica Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukydl@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832				Andersen I, 2011, SCAND J PUBLIC HEALT, V39, P857, DOI 10.1177/1403494811424611; [Anonymous], 2013, OB OV; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251; Chang HH, 2012, AGING MENT HEALTH, V16, P173, DOI 10.1080/13607863.2011.605053; Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007; CRISP AH, 1980, J PSYCHOSOM RES, V24, P233, DOI 10.1016/0022-3999(80)90013-6; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626; Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43; Konttinen H, 2014, INT J OBESITY, V38, P668, DOI 10.1038/ijo.2013.151; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; McCrea R, 2011, INT J OBES LOND, V36, P414, DOI DOI 10.1038/IJ0.2011.65; Ohayon MM, 2007, J PSYCHIAT RES, V41, P207, DOI 10.1016/j.jpsychires.2006.10.006; Ohayon MM, 2006, J PSYCHIATR RES, V40, P30, DOI 10.1016/j.jpsychires.2005.02.003; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Puhl Rebecca, 2003, Eat Behav, V4, P53, DOI 10.1016/S1471-0153(02)00096-X; Sachs-Ericsson N, 2007, AM J GERIAT PSYCHIAT, V15, P815, DOI 10.1097/JGP.0b013e3180a725d6; Seidell Jacob C, 2005, Semin Vasc Med, V5, P3, DOI 10.1055/s-2005-871737; Shadish WR, 2002, EXPT QUASIEXPERIMENT, P506; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Yasamy M.T., 2012, DEPRESSION GLOBAL PU; Yu Nan-Wen, 2011, Chang Gung Med J, V34, P620; Zhong WJ, 2010, DEPRESS ANXIETY, V27, P846, DOI 10.1002/da.20666	30	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114891	10.1371/journal.pone.0114891	http://dx.doi.org/10.1371/journal.pone.0114891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25501372	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700063
J	Li, JW; Mo, M; Yu, KD; Chen, CM; Hu, Z; Hou, YF; Di, GH; Wu, J; Shen, ZZ; Shao, ZM; Liu, GY				Li, Jian-wei; Mo, Miao; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu			ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE REMISSION; OPEN-LABEL; PREOPERATIVE CHEMOTHERAPY; GUIDELINE RECOMMENDATIONS; ADJUVANT BREAST; SENTINEL; BIOPSY; TRIAL; MULTICENTER; PACLITAXEL	Purpose: The study was to estimate the likelihood of axillary downstaging and to identify the factors predicting a pathologically node negative status after neoadjuvant chemotherapy (NAC) with or without trastuzumab in HER2-positive breast cancer. Methods: Patients with HER2-positive, stage IIa-IIIc breast cancer were enrolled. Axillary status was evaluated by palpation and fine needle aspiration (FNA) before NAC. All patients received 4-6 cycles of PCrb (paclitaxel 80 mg/m(2) and carboplatin AUC=2 d1, 8, and 15 of a 28-day cycle, or paclitaxel 175 mg/m(2) and carboplatin AUC=6 every-3-week) and were non-randomly administered trastuzumab (2 mg/kg weekly or 6 mg/kg every-3-week) or not. After NAC, each patient underwent standard axillary lymph node dissection and breast-conserving surgery or mastectomy. And some patients received sentinel lymph node biopsy (SLNB) before axillary dissection. Results: Between November-2007 and June-2013, 255 patients were enrolled. Of them, 157 were confirmed as axillary node positive by FNA (group-A) and 98 as axillary node negative either by FNA or impalpable (group-B). After axillary dissection, the overall pathologically node negative rates (pNNR) were 52.9% in group-A and 69.4% in group-B. The ER-poor/HER2-positive subtype acquired the highest pNNR (79.6% in group-A and 87.9% in group-B, respectively) and the lowest rate of residual with >= 4 nodes involvement (1.9% and 3%, respectively) after PCrb plus trastuzumab. In multivariate analysis, trastuzumab added and ERpoor status were independent factors in predicting a higher pNNR in HER2-positive breast cancer. Forty-six tested patients showed that the ER-poor/HER2-positive subtype acquired a considerable high pNNR and axillary status with SLNB was well macthed with the axillary dissection. Conclusions: ER-poor/HER2-positive subtype of breast cancer is a potential candidate for undergoing sentinel lymph node biopsy instead of regional node dissection for accurate axillary evaluation after effective downstaging by neoadjuvant chemo-trastuzumab therapy.	[Li, Jian-wei; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Li, Jian-wei; Mo, Miao; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu] Fudan Univ, Coll Med, Dept Oncol, Shanghai 200433, Peoples R China; [Mo, Miao] Fudan Univ, Ctr Canc, Clin Stat Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, GY (corresponding author), Fudan Univ, Inst Canc, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	Liugy123@yahoo.com		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology, China [12DZ2260100]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Key Clinical Program of the Ministry of Health	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Shanghai United Developing Technology Project of Municipal Hospitals; Key Clinical Program of the Ministry of Health	This research is supported by the Shanghai Committee of Science and Technology, China (grant 12DZ2260100), and the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012). The research funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other potential confict of interest relevant to this article was reported.	Alvarado R, 2012, ANN SURG ONCOL, V19, P3177, DOI 10.1245/s10434-012-2484-2; Ashikaga T, 2010, J SURG ONCOL, V102, P111, DOI 10.1002/jso.21535; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Boughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chen XS, 2010, ANN ONCOL, V21, P961, DOI 10.1093/annonc/mdq041; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Fitzal F, 2011, BREAST CANCER RES TR, V127, P121, DOI 10.1007/s10549-010-1164-9; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Kuehn T, 2000, BREAST CANCER RES TR, V64, P275, DOI 10.1023/A:1026564723698; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Lee S, 2007, BREAST CANCER RES TR, V102, P283, DOI 10.1007/s10549-006-9330-9; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Newman EA, 2007, ANN SURG ONCOL, V14, P2946, DOI 10.1245/s10434-007-9403-y; Phillips T, 2007, APPL IMMUNOHISTO M M, V15, P325, DOI 10.1097/01.pai.0000213135.16783.bc; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; Regan MM, 2006, JNCI-J NATL CANCER I, V98, P1571, DOI 10.1093/jnci/djj415; Robidoux A, 2013, LANCET ONCOL, V14, P1183, DOI 10.1016/S1470-2045(13)70411-X; Rouzier R, 2002, J CLIN ONCOL, V20, P1304, DOI 10.1200/JCO.20.5.1304; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Straver ME, 2010, J CLIN ONCOL, V28, P731, DOI 10.1200/JCO.2008.21.7554; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yu KD, 2013, ONCOLOGIST, V18, P511, DOI 10.1634/theoncologist.2012-0057	33	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114646	10.1371/journal.pone.0114646	http://dx.doi.org/10.1371/journal.pone.0114646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25504233	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700039
J	Sekizuka, T; Kai, M; Nakanaga, K; Nakata, N; Kazumi, Y; Maeda, S; Makino, M; Hoshino, Y; Kuroda, M				Sekizuka, Tsuyoshi; Kai, Masanori; Nakanaga, Kazue; Nakata, Noboru; Kazumi, Yuko; Maeda, Shinji; Makino, Masahiko; Hoshino, Yoshihiko; Kuroda, Makoto			Complete Genome Sequence and Comparative Genomic Analysis of Mycobacterium massiliense JCM 15300 in the Mycobacterium abscessus Group Reveal a Conserved Genomic Island MmGI-1 Related to Putative Lipid Metabolism	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; CYSTIC-FIBROSIS; LUNG-DISEASE; MCE OPERONS; ALIGNMENT; VISUALIZATION; INFECTIONS; OUTBREAK; THERAPY; TOOL	Mycobacterium abscessus group subsp., such as M. massiliense, M. abscessus sensu stricto and M. bolletii, are an environmental organism found in soil, water and other ecological niches, and have been isolated from respiratory tract infection, skin and soft tissue infection, postoperative infection of cosmetic surgery. To determine the unique genetic feature of M. massiliense, we sequenced the complete genome of M. massiliense type strain JCM 15300 (corresponding to CCUG 48898). Comparative genomic analysis was performed among Mycobacterium spp. and among M. abscessus group subspp., showing that additional ss-oxidation-related genes and, notably, the mammalian cell entry (mce) operon were located on a genomic island, M. massiliense Genomic Island 1 (MmGI-1), in M. massiliense. In addition, putative anaerobic respiration system-related genes and additional mycolic acid cyclopropane synthetase-related genes were found uniquely in M. massiliense. Japanese isolates of M. massiliense also frequently possess the MmGI-1 (14/44, approximately 32%) and three unique conserved regions (26/44; approximately 60%, 34/44; approximately 77% and 40/44; approximately 91%), as well as isolates of other countries (Malaysia, France, United Kingdom and United States). The well-conserved genomic island MmGI-1 may play an important role in high growth potential with additional lipid metabolism, extra factors for survival in the environment or synthesis of complex membrane-associated lipids. ORFs on MmGI-1 showed similarities to ORFs of phylogenetically distant M. avium complex (MAC), suggesting that horizontal gene transfer or genetic recombination events might have occurred within MmGI-1 among M. massiliense and MAC.	[Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Kai, Masanori; Nakanaga, Kazue; Nakata, Noboru; Makino, Masahiko; Hoshino, Yoshihiko] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Maeda, Shinji] Japan AntiTB Assoc, Res Inst TB, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Sekizuka, T (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	sekizuka@niid.go.jp; yhoshino@niid.go.jp	Hoshino, Yoshihiko/B-5159-2019	Hoshino, Yoshihiko/0000-0002-3132-0715; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Japan Society for the Promotion of Science [25461178]; Ohyama Health Foundation; Ministry of Health, Labour, and Welfare, Japan [H25-Shinko-Ippan-015]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ohyama Health Foundation; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid (25461178) for Scientific Research (C) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), by a grant from the Ohyama Health Foundation (http://www.disclo-koeki.org/10a/01044/index.html) and by a Grant-in-Aid (H25-Shinko-Ippan-015) from the Ministry of Health, Labour, and Welfare, Japan (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Banerjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019280; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cho YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081560; Choo SW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04061; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joseph J, 2011, BIOINFORMATION, V6, P393, DOI 10.6026/97320630006393; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-21; Klepp LI, 2012, MICROBES INFECT, V14, P590, DOI 10.1016/j.micinf.2012.01.007; Klotz T, 1996, J UROLOGY, V155, P1488, DOI 10.1016/S0022-5347(01)66312-2; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nakanaga K, 2014, J CLIN MICROBIOL, V52, P251, DOI 10.1128/JCM.01327-13; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P613, DOI 10.1128/JCM.00817-10; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Otsuki T, 2012, J DERMATOL, V39, P569, DOI 10.1111/j.1346-8138.2011.01339.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pawlik A, 2013, MOL MICROBIOL, V90, P612, DOI 10.1111/mmi.12387; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Shahidi M, 2010, INVEST OPHTH VIS SCI, V51, P4766, DOI 10.1167/iovs.09-4710; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki R, 2010, J BIOL CHEM, V285, P34279, DOI 10.1074/jbc.M110.156281; Villanueva A, 1997, CLIN INFECT DIS, V24, P1147, DOI 10.1086/513656; Wang W, 2004, J R SOC INTERFACE, V1, P109, DOI 10.1098/rsif.2004.0013	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114848	10.1371/journal.pone.0114848	http://dx.doi.org/10.1371/journal.pone.0114848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503461	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700059
J	Sutela, S; Hahl, T; Tiimonen, H; Aronen, T; Ylioja, T; Laakso, T; Saranpaa, P; Chiang, V; Julkunen-Tiitto, R; Haggman, H				Sutela, Suvi; Hahl, Terhi; Tiimonen, Heidi; Aronen, Tuija; Ylioja, Tiina; Laakso, Tapio; Saranpaa, Pekka; Chiang, Vincent; Julkunen-Tiitto, Riitta; Haggman, Hely			Phenolic Compounds and Expression of 4CL Genes in Silver Birch Clones and Pt4CL1a Lines	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS PERTURBATIONS; COENZYME-A LIGASE; BETULA-PENDULA; 4-COUMARATE-COA LIGASE; SECONDARY CHEMISTRY; POPULUS-TRICHOCARPA; TRANSGENIC POPLARS; FIELD PERFORMANCE; SYSTEMS BIOLOGY; DOWN-REGULATION	A small multigene family encodes 4-coumarate:CoA ligases (4CLs) catalyzing the CoA ligation of hydroxycinnamic acids, a branch point step directing metabolites to a flavonoid or monolignol pathway. In the present study, we examined the effect of antisense Populus tremuloides 4CL (Pt4CL1) to the lignin and soluble phenolic compound composition of silver birch (Betula pendula) Pt4CL1a lines in comparison with non-transgenic silver birch clones. The endogenous expression of silver birch 4CL genes was recorded in the stems and leaves and also in leaves that were mechanically injured. In one of the transgenic Pt4CL1a lines, the ratio of syringyl (S) and guaiacyl (G) lignin units was increased. Moreover, the transcript levels of putative silver birch 4CL gene (Bp4CL1) were reduced and contents of cinnamic acid derivatives altered. In the other two Pt4CL1a lines changes were detected in the level of individual phenolic compounds. However, considerable variation was found in the transcript levels of silver birch 4CLs as well as in the concentration of phenolic compounds among the transgenic lines and non-transgenic clones. Wounding induced the expression of Bp4CL1 and Bp4CL2 in leaves in all clones and transgenic lines, whereas the transcript levels of Bp4CL3 and Bp4CL4 remained unchanged. Moreover, minor changes were detected in the concentrations of phenolic compounds caused by wounding. As an overall trend the wounding decreased the flavonoid content in silver birches and increased the content of soluble condensed tannins. The results indicate that by reducing the Bp4CL1 transcript levels lignin composition could be modified. However, the alterations found among the Pt4CL1a lines and the non-transgenic clones were within the natural variation of silver birches, as shown in the present study by the clonal differences in the transcripts levels of 4CL genes, soluble phenolic compounds and condensed tannins.	[Sutela, Suvi; Hahl, Terhi; Haggman, Hely] Univ Oulu, Dept Biol, Oulu, Finland; [Tiimonen, Heidi] Border & Coast Guard Acad, Finnish Border Guard, Imatra, Finland; [Aronen, Tuija] Finnish Forest Res Inst, Eastern Finland Reg Unit, Punkaharju Unit, Punkaharju, Finland; [Ylioja, Tiina; Laakso, Tapio; Saranpaa, Pekka] Finnish Forest Res Inst, Southern Finland Reg Unit, Vantaa Unit, FIN-01301 Vantaa, Finland; [Chiang, Vincent] N Carolina State Univ, Dept Forestry & Environm Resources, Forest Biotechnol Grp, Raleigh, NC 27695 USA; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu, Finland	University of Oulu; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of North Carolina; North Carolina State University; University of Eastern Finland	Sutela, S (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	suvi.sutela@oulu.fi	Saranpaa, Pekka T/C-2114-2008; Julkunen-Tiitto, Riitta/GRR-9781-2022	Saranpaa, Pekka T/0000-0002-1129-2315; Aronen, Tuija/0000-0001-5442-5002; Ylioja, Tiina/0000-0002-8840-7504; Sutela, Suvi/0000-0003-0426-0718	Academy of Finland [104532]; Jenny and Antti Wihuri Foundation; Niemi Foundation; Biological Society of Finland Vanamo; Natural History Society of Oulu	Academy of Finland(Academy of Finland); Jenny and Antti Wihuri Foundation; Niemi Foundation; Biological Society of Finland Vanamo; Natural History Society of Oulu	The research was funded by the Academy of Finland (Project 104532 to HH), Jenny and Antti Wihuri Foundation, and Niemi Foundation (to SS) and by the Biological Society of Finland Vanamo and Natural History Society of Oulu (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TA, 2008, AQUAT BOT, V89, P27, DOI 10.1016/j.aquabot.2008.02.001; ARONEN T, 1995, EUR J FOREST PATHOL, V25, P197; Aronen T., 2003, SUSTAINABLE FORESTRY, P149; Baraza E, 2004, CAN J BOT, V82, P357, DOI [10.1139/b04-004, 10.1139/B04-004]; Baraza E, 2010, ECOSCIENCE, V17, P156, DOI 10.2980/17-2-3286; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; BECKERANDRE M, 1991, J BIOL CHEM, V266, P8551; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Cabane M, 2012, ADV BOT RES, V61, P219, DOI 10.1016/B978-0-12-416023-1.00007-0; Chen HC, 2014, PLANT CELL, V26, P876, DOI 10.1105/tpc.113.119685; Chowdhury MEK, 2013, PLANT OMICS, V6, P254; Costa MA, 2005, PHYTOCHEMISTRY, V66, P2072, DOI 10.1016/j.phytochem.2005.06.022; de Bruxelles GL, 2001, CRIT REV PLANT SCI, V20, P487, DOI 10.1016/S0010-8545(02)00029-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gao H, 2012, J SYST EVOL, V50, P195, DOI 10.1111/j.1759-6831.2012.00187.x; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamberger B, 2004, P NATL ACAD SCI USA, V101, P2209, DOI 10.1073/pnas.0307307101; HAUFFE KD, 1991, PLANT CELL, V3, P435, DOI 10.1105/tpc.3.5.435; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hikosaka K, 2005, ANN BOT-LONDON, V95, P1025, DOI 10.1093/aob/mci111; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jia CH, 2004, CHINESE SCI BULL, V49, P905, DOI 10.1360/03wc0529; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin XQ, 2012, BIOL PLANTARUM, V56, P261, DOI 10.1007/s10535-012-0085-3; Julkunen-Tiitto R, 2001, J CHEM ECOL, V27, P779, DOI 10.1023/A:1010358120482; Kajita S, 1996, PLANT CELL PHYSIOL, V37, P957, DOI 10.1093/oxfordjournals.pcp.a029045; Kajita S, 1997, PLANT PHYSIOL, V114, P871, DOI 10.1104/pp.114.3.871; Kao YY, 2002, PLANT PHYSIOL, V130, P796, DOI 10.1104/pp.006262; Keinanen M, 1999, ECOLOGY, V80, P1970, DOI 10.1890/0012-9658(1999)080[1970:TOIPMO]2.0.CO;2; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar A, 2003, PLANT MOL BIOL, V51, P327, DOI 10.1023/A:1022004923982; Laitinen ML, 2000, J CHEM ECOL, V26, P1609, DOI 10.1023/A:1005582611863; Laitinen ML, 2005, J CHEM ECOL, V31, P697, DOI 10.1007/s10886-005-3539-7; Laitinen ML, 2004, OIKOS, V104, P316, DOI 10.1111/j.0030-1299.2004.12793.x; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lemmetyinen J, 2008, COMPENDIUM TRANSGENI, V9, P193; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lin JS, 2013, PLANT J, V75, P781, DOI 10.1111/tpj.12238; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Muilenburg VL, 2013, TREES-STRUCT FUNCT, V27, P851, DOI 10.1007/s00468-013-0839-3; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Pan X, 2013, MOL BIOL REP, V40, P2309, DOI 10.1007/s11033-012-2312-6; Pasonen HL, 2008, TREES-STRUCT FUNCT, V22, P413, DOI 10.1007/s00468-007-0202-7; Pasonen HL, 2009, PLANTA, V230, P973, DOI 10.1007/s00425-009-1005-4; Pasonen HL, 2005, SCAND J FOREST RES, V20, P385, DOI 10.1080/02827580500251432; Pasonen HL, 2004, THEOR APPL GENET, V109, P562, DOI 10.1007/s00122-004-1650-8; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rani A, 2009, FUNCT INTEGR GENOMIC, V9, P271, DOI 10.1007/s10142-008-0098-3; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Seiwa K, 1999, ANN BOT-LONDON, V83, P355, DOI 10.1006/anbo.1998.0831; Seppanen SK, 2007, APPL SOIL ECOL, V36, P100, DOI 10.1016/j.apsoil.2006.12.002; Soltani BM, 2006, PLANTA, V224, P1226, DOI 10.1007/s00425-006-0296-y; Soltis DE, 2003, PLANT PHYSIOL, V132, P1790, DOI 10.1104/pp.103.022509; Souza CD, 2008, NEW PHYTOL, V179, P987, DOI 10.1111/j.1469-8137.2008.02534.x; Stout AT, 2014, BIOMASS BIOENERG, V68, P228, DOI 10.1016/j.biombioe.2014.06.008; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Sutela S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-124; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian XM, 2013, PLANT PHYSIOL BIOCH, V65, P111, DOI 10.1016/j.plaphy.2013.01.010; Tiimonen H, 2008, SILVAE GENET, V57, P235, DOI 10.1515/sg-2008-0036; Tiimonen H, 2005, PLANTA, V222, P699, DOI 10.1007/s00425-005-0002-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valjakka M, 2000, TREE PHYSIOL, V20, P607; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Vihervuori L, 2008, ENVIRON ENTOMOL, V37, P1582, DOI 10.1603/0046-225X-37.6.1582; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3	87	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114434	10.1371/journal.pone.0114434	http://dx.doi.org/10.1371/journal.pone.0114434			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502441	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000347146700023
J	Mueller, K; Horstman, A; Moller, HE; Anwander, A; Lepsien, J; Schroeter, ML; Villringer, A; Pleger, B				Mueller, Karsten; Horstman, Annette; Moeller, Harald E.; Anwander, Alfred; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard			Obesity Associated Cerebral Gray and White Matter Alterations Are Interrelated in the Female Brain	PLOS ONE			English	Article							BODY-MASS INDEX; LEPTIN CONCENTRATIONS; DIFFUSION; CONNECTIVITY; REGISTRATION; PARCELLATION; TRACTOGRAPHY; ENHANCEMENT; SYSTEM; CORTEX	Obesity is known to affect the brain's gray matter (GM) and white matter (WM) structure but the interrelationship of such changes remains unclear. Here we used T1-weighted magnetic resonance imaging (MRI) in combination with voxel-based morphometry (VBM) and diffusion-tensor imaging (DTI) with tract-based spatial statistics (TBSS) to assess the relationship between obesity-associated alterations of gray matter density (GMD) and anisotropic water diffusion in WM, respectively. In a small cohort of lean to obese women, we confirmed previous reports of obesity-associated alterations of GMD in brain regions involved in executive control (i.e., dorsolateral prefrontal cortex, DLPFC) and habit learning (i.e., dorsal striatum). Gray matter density alterations of the DLPFC were negatively correlated with radial diffusivity in the entire corpus callosum. Within the genu of the corpus callosum we found a positive correlation with axial diffusivity. In posterior region and inferior areas of the body of the corpus callosum, axial diffusivity correlated negatively with altered GMD in the dorsal striatum. These findings suggest that, in women, obesity-related alterations of GMD in brain regions involved in executive control and habit learning might relate to alterations of associated WM fiber bundles within the corpus callosum.	[Mueller, Karsten; Horstman, Annette; Moeller, Harald E.; Anwander, Alfred; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Horstman, Annette; Villringer, Arno] Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany	Max Planck Society; Leipzig University	Mueller, K (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	karstenm@cbs.mpg.de	Möller, Harald/AAB-4679-2019; Anwander, Alfred/B-5874-2011; Horstmann, Annette/C-9083-2011; Moller, Harald E/A-1565-2008	Möller, Harald/0000-0002-5659-1925; Anwander, Alfred/0000-0002-4861-4808; Horstmann, Annette/0000-0001-6184-8484; Moller, Harald E/0000-0002-5659-1925; Villringer, Arno/0000-0003-2604-2404	BMBF(IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany) [FKZ 01E01001]; BMBF (Bernstein Focus, State Dependencies of Learning) [01GQ0975, 18GL4DW4]; BMBF (German FTLD Consortium) [FKZ 01GI1007A]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Parkinson's Disease Foundation [PDF-IRG-1307]; German Research Foundation (DFG) [1052A1, 1052A5, 1052A6]; LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union; European Regional Development Fund (ERFD); Free State of Saxony	BMBF(IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); BMBF (Bernstein Focus, State Dependencies of Learning)(Federal Ministry of Education & Research (BMBF)); BMBF (German FTLD Consortium)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Parkinson's Disease Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); Free State of Saxony	This work was supported by the BMBF (IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany, FKZ 01E01001to AH and AV; Bernstein Focus, State Dependencies of Learning 01GQ0975, Project 18GL4DW4 to BP; German FTLD Consortium, Grant No. FKZ 01GI1007A to MLS) and in part funded by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases. Furthermore, KM and MLS are supported by the Parkinson's Disease Foundation (Grant No. PDF-IRG-1307). The work of AH, BP, and AV is supported by the German Research Foundation (DFG) within the framework of the CRC 1052 'Obesity Mechanisms', Projects 1052A1, 1052A5 and 1052A6. AV and MLS are supported by LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERFD) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Cazettes F, 2011, BRAIN RES, V1373, P101, DOI 10.1016/j.brainres.2010.12.008; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; deWeijer B., 2011, EJNMMI RES, V37, P1, DOI DOI 10.1186/2191-219X-1-37; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Eisenstein SA, 2013, SYNAPSE, V67, P748, DOI 10.1002/syn.21680; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Labadie C, 2014, MAGN RESON MED, V71, P375, DOI 10.1002/mrm.24670; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Marshall JA, 2000, OBES RES, V8, P543, DOI 10.1038/oby.2000.70; Metzler-Baddeley C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059849; Muller DK, 2013, J MAGN RESON, V230, P88, DOI 10.1016/j.jmr.2013.01.013; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Pannacciulli N, 2007, NEUROSCI LETT, V412, P248, DOI 10.1016/j.neulet.2006.11.019; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Park KG, 2004, DIABETES RES CLIN PR, V63, P135, DOI 10.1016/j.diabres.2003.09.010; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	48	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114206	10.1371/journal.pone.0114206	http://dx.doi.org/10.1371/journal.pone.0114206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494174	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400036
J	Oliver, PM; Couper, PJ; Pepper, M				Oliver, Paul M.; Couper, Patrick J.; Pepper, Mitzy			Independent Transitions between Monsoonal and Arid Biomes Revealed by Systematic Revison of a Complex of Australian Geckos (Diplodactylus; Diplodactylidae)	PLOS ONE			English	Article							SPECIES-GROUP; PHYLOGENETIC ANALYSES; MOLECULAR PHYLOGENY; POPULATION-GROWTH; WESTERN-AUSTRALIA; DNA POLYMORPHISM; ZONE BIOTA; EVOLUTION; RADIATION; DIVERSIFICATION	How the widespread expansion and intensification of aridity through the Neogene has shaped the Austral biota is a major question in Antipodean biogeography. Lineages distributed across wide aridity gradients provide opportunities to examine the timing, frequency, and direction of transitions between arid and mesic regions. Here, we use molecular genetics and morphological data to investigate the systematics and biogeography of a nominal Australian gecko species (Diplodactylus conspicillatus sensu lato) with a wide distribution spanning most of the Australian Arid Zone (AAZ) and Monsoonal Tropics (AMT). Our data support a minimum of seven genetically distinct and morphologically diagnosable taxa; we thus redefine the type species, ressurrect three names from synonymy, and describe three new species. Our inferred phylogeny suggests the history and diversification of lineages in the AAZ and AMT are intimately linked, with evidence of multiple independent interchanges since the late Miocene. However, despite this shared history, related lineages in these two regions also show evidence of broadly contrasting intra-regional responses to aridification; vicarance and speciation in older and increasingly attenuated mesic regions, versus a more dynamic history including independent colonisations and recent range expansions in the younger AAZ.	[Oliver, Paul M.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Oliver, Paul M.] Museum Victoria, Dept Sci, Melbourne, Vic, Australia; [Oliver, Paul M.; Pepper, Mitzy] Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia; [Couper, Patrick J.] Queensland Museum, Brisbane, Qld 4101, Australia	University of Melbourne; Museum Victoria; Australian National University; Queensland Museum	Oliver, PM (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	Paul.oliver@anu.edu.au		Pepper, Mitzy/0000-0003-4828-9977; Oliver, Paul/0000-0003-4291-257X	Mckenzie Postdoctoral Fellowship at the University of Melbourne; Australian Research Council linage Grant; Australian Biological Resources Survey Grant; Queensland Museum; Australian Research Council grant	Mckenzie Postdoctoral Fellowship at the University of Melbourne; Australian Research Council linage Grant(Australian Research Council); Australian Biological Resources Survey Grant; Queensland Museum; Australian Research Council grant(Australian Research Council)	This work was supported by Mckenzie Postdoctoral Fellowship at the University of Melbourne to Paul Oliver, an Australian Research Council linage Grant to Paul Oliver, Mike Lee and Paul Doughty, an Australian Biological Resources Survey Grant to Mark Hutchinson, Mark Adams, Paul Oliver and Paul Doughty, and the Queensland Museum. MP's contributions were supported by an Australian Research Council grant to J. Scott Keogh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, EVOLUTION, V57, P2619; Allen Gerald R., 1998, Aqua (Graffignana), V3, P9; Alley NF, 1998, PALAEOGEOGR PALAEOCL, V144, P239, DOI 10.1016/S0031-0182(98)00120-5; [Anonymous], 2014, TRACER V1 6; Archer M., 1991, AUSTR LOST WORLD PRE; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Catullo RA, 2014, J BIOGEOGR, V41, P659, DOI 10.1111/jbi.12230; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Cogger H. G., 1983, ZOOLOGICAL CATALOGUE; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dolman G, 2008, MOL PHYLOGENET EVOL, V49, P782, DOI 10.1016/j.ympev.2008.09.021; Donnellan S., 1993, P121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eldridge MDB, 2011, AUST J ZOOL, V59, P270, DOI 10.1071/ZO12012; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Fujioka T, 2009, GEOLOGY, V37, P51, DOI 10.1130/G25042A.1; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Horner Paul, 2007, Beagle, P1; Jaensch R., 2009, FLOODPLAIN WETLANDS; Jennings WB, 2003, SYST BIOL, V52, P757, DOI 10.1080/10635150390250974; Kluge A. G., 1963, Memoirs of the Queensland Museum, V14, P77; KLUGE A. G., 1967, AUST J ZOOL, V15, P1007, DOI 10.1071/ZO9671007; Kuch U, 2005, NATURWISSENSCHAFTEN, V92, P121, DOI 10.1007/s00114-004-0602-0; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longman H. A., 1915, Memoirs of the Queensland Museum, V3; Lucas AHS, 1897, P ROYAL SOC VICTORIA, P54; MACDONALD J D, 1969, Emu, V69, P169; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Marin J, 2013, BIOL J LINN SOC, V110, P427, DOI 10.1111/bij.12132; Marin J, 2013, J BIOGEOGR, V40, P928, DOI 10.1111/jbi.12045; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Melville J, 2011, MOL PHYLOGENET EVOL, V58, P257, DOI 10.1016/j.ympev.2010.11.025; MERTENS ROBERT, 1967, SENCKENBERG BIOL, V48, P1; Oliver PM, 2007, AUST J ZOOL, V55, P197, DOI 10.1071/ZO07008; Oliver PM, 2014, J BIOGEOGR, V41, P2068, DOI 10.1111/jbi.12364; Oliver PM, 2012, WILDLIFE RES, V39, P429, DOI 10.1071/WR12024; Oliver PM, 2011, MOL PHYLOGENET EVOL, V59, P664, DOI 10.1016/j.ympev.2011.03.018; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PARKER H. W., 1926, ANN & MAG NAT HIST, V17, P665; Pepper M, 2006, MOL PHYLOGENET EVOL, V41, P539, DOI 10.1016/j.ympev.2006.05.028; Pepper M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078110; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P810, DOI 10.1016/j.ympev.2011.08.012; Pepper M, 2011, MOL ECOL, V20, P1529, DOI 10.1111/j.1365-294X.2011.05036.x; Pianka E., 1986, ECOLOGY NATURAL HIST; Powney GD, 2010, GLOBAL ECOL BIOGEOGR, V19, P386, DOI 10.1111/j.1466-8238.2009.00521.x; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Rollins LA, 2012, ECOL EVOL, V2, P1208, DOI 10.1002/ece3.259; Shea G, 2011, ZOOTAXA, P1; Sistrom M, 2013, MOL PHYLOGENET EVOL, V68, P135, DOI 10.1016/j.ympev.2013.03.007; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Smith L. A., 2007, Records of the Western Australian Museum, V23, P309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sternfield R, 1924, ABHANDLUNGEN SENCKEN, V38, P221; Storr GM, 1990, LIZARDS W AUSTR 3 GE; TAJIMA F, 1989, GENETICS, V123, P585; Toon A, 2007, MOL ECOL, V16, P2525, DOI 10.1111/j.1365-294X.2007.03289.x; Uetz P, 2013, REPTILE DATABASE; Wells R.W., 1983, Australian Journal of Herpetology, V1, P73; Williams K.J., 2010, HARNESSING CONTINENT	79	30	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111895	10.1371/journal.pone.0111895	http://dx.doi.org/10.1371/journal.pone.0111895			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493936	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400006
J	Jonas, KC; Fanelli, F; Huhtaniemi, IT; Hanyaloglu, AC				Jonas, Kim C.; Fanelli, Francesca; Huhtaniemi, Ilpo T.; Hanyaloglu, Aylin C.			Single Molecule Analysis of Functionally Asymmetric G Protein-coupled Receptor (GPCR) Oligomers Reveals Diverse Spatial and Structural Assemblies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTORS; FOLLICLE-STIMULATING-HORMONE; PHOTOACTIVATED LOCALIZATION MICROSCOPY; BETA(2) ADRENERGIC-RECEPTOR; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; BETA-2-ADRENERGIC RECEPTOR; LH RECEPTOR; CELLS; HOMODIMERIZATION	Formation of G protein-coupled receptors (GPCRs) into dimers and higher order oligomers represents a key mechanism in pleiotropic signaling, yet how individual protomers function within oligomers remains poorly understood. We present a super-resolution imaging approach, resolving single GPCR molecules to similar to 8 nm resolution in functional asymmetric dimers and oligomers using dual-color photoactivatable dyes and localization microscopy (PD-PALM). PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding deficient receptor (LHRB-) and a signaling-deficient (LHRS-) receptor, which only function via intermolecular cooperation, favored oligomeric over dimeric formation. PD-PALM imaging of trimers and tetramers revealed specific spatial organizations of individual protomers in complexes where the ratiometric composition of LHRB- to LHRS- modulated ligand-induced signal sensitivity. Structural modeling of asymmetric LHR oligomers strongly aligned with PD-PALM-imaged spatial arrangements, identifying multiple possible helix interfaces mediating inter-protomer associations. Our findings reveal that diverse spatial and structural assemblies mediating GPCR oligomerization may acutely fine-tune the cellular signaling profile.	[Jonas, Kim C.; Huhtaniemi, Ilpo T.; Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England; [Fanelli, Francesca] Univ Modena & Reggio Emilia, Dept Life Sci, Computat Struct Biol Lab, I-41100 Modena, Italy; [Huhtaniemi, Ilpo T.] Univ Turku, Dept Physiol, Inst Biomed, FIN-20520 Turku, Finland	Imperial College London; Universita di Modena e Reggio Emilia; University of Turku	Huhtaniemi, IT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, Du Cane Rd, London W12 0NN, England.	ilpo.huhtaniemi@imperial.ac.uk; a.hanyaloglu@imperial.ac.uk	Fanelli, Francesca/O-8807-2014	Fanelli, Francesca/0000-0002-7620-6895; Jonas, Kim/0000-0003-1891-2617; /0000-0003-4206-737X	Biotechnology and Biological Sciences Research Council [BB/1008004/1]; Wellcome Trust [082101/Z/07/Z]; Society for Endocrinology Early Career Grant; BBSRC [BB/I008004/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008004/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Society for Endocrinology Early Career Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/1008004/1, Wellcome Trust Program Grant 082101/Z/07/Z, and a Society for Endocrinology Early Career Grant.	Angelova K, 2011, CELL MOL LIFE SCI, V68, P1227, DOI 10.1007/s00018-010-0519-z; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Belov VN, 2010, ANGEW CHEM INT EDIT, V49, P3520, DOI 10.1002/anie.201000150; Breen SM, 2013, MOL ENDOCRINOL, V27, P1483, DOI 10.1210/me.2013-1130; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Casciari D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-340; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DEHEJIA A, 1982, J BIOL CHEM, V257, P13781; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; HUHTANIEMI IT, 1981, ENDOCRINOLOGY, V108, P1931, DOI 10.1210/endo-108-5-1931; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Ji Q, 2004, INT J CANCER, V112, P803, DOI 10.1002/ijc.20478; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jonas KC, 2013, METHOD CELL BIOL, V117, P433, DOI 10.1016/B978-0-12-408143-7.00023-2; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; Lee C, 2002, METHODS, V27, P318, DOI 10.1016/S1046-2023(02)00089-0; Lee CW, 2002, J BIOL CHEM, V277, P15795, DOI 10.1074/jbc.M111818200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LUBORSKY JL, 1984, ENDOCRINOLOGY, V115, P2217, DOI 10.1210/endo-115-6-2217; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; ROBERTS CJ, 1995, LANGMUIR, V11, P1822, DOI 10.1021/la00005a063; Rossy J, 2014, HISTOCHEM CELL BIOL, V141, P605, DOI 10.1007/s00418-014-1208-z; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Wolf-Ringwall AL, 2011, J BIOL CHEM, V286, P29818, DOI 10.1074/jbc.M111.250969; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	59	88	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3875	3892		10.1074/jbc.M114.622498	http://dx.doi.org/10.1074/jbc.M114.622498			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25516594	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000349458400001
J	Maier, LK; Stachler, AE; Saunders, SJ; Backofen, R; Marchfelder, A				Maier, Lisa-Katharina; Stachler, Aris-Edda; Saunders, Sita J.; Backofen, Rolf; Marchfelder, Anita			An Active Immune Defense with a Minimal CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) RNA and without the Cas6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUIDED SURVEILLANCE COMPLEX; HALOFERAX-VOLCANII; TARGET RECOGNITION; ANTIVIRAL DEFENSE; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; SEED SEQUENCE; SYSTEM; PROKARYOTES; DNA	The prokaryotic immune system CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) is a defense system that protects prokaryotes against foreign DNA. The short CRISPR RNAs (crRNAs) are central components of this immune system. In CRISPR-Cas systems type I and III, crRNAs are generated by the endonuclease Cas6. We developed a Cas6b-independent crRNA maturation pathway for the Haloferax type I-B system in vivo that expresses a functional crRNA, which we termed independently generated crRNA (icrRNA). The icrRNA is effective in triggering degradation of an invader plasmid carrying the matching protospacer sequence. The Cas6b-independent maturation of the icrRNA allowed mutation of the repeat sequence without interfering with signals important for Cas6b processing. We generated 23 variants of the icrRNA and analyzed them for activity in the interference reaction. icrRNAs with deletions or mutations of the 3' handle are still active in triggering an interference reaction. The complete 3' handle could be removed without loss of activity. However, manipulations of the 5' handle mostly led to loss of interference activity. Furthermore, we could show that in the presence of an icrRNA a strain without Cas6b (Delta cas6b) is still active in interference..	[Maier, Lisa-Katharina; Stachler, Aris-Edda; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Saunders, Sita J.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, D-79110 Freiburg, Germany; [Backofen, Rolf] Univ Freiburg, Cluster Excellence, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ulm University; University of Freiburg; University of Freiburg	Marchfelder, A (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Marchfelder, Anita/0000-0002-1382-1794; Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323	German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680 [DFG MA1538/17-1, BA2168/5-1]	German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680(German Research Foundation (DFG))	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680 "Unravelling the prokaryotic immune system" (grant DFG MA1538/17-1 and BA2168/5-1).	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bikard D., 2013, 1000PRIME, DOI 10.12703/P5-47; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2013, CRISPR CAS SYSTEMS, P115; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dupuis M, 2013, CRISPR CAS SYSTEMS R, P171; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Holzle A, 2012, BIOCHIMIE, V94, P940, DOI 10.1016/j.biochi.2011.12.002; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Stoll B., 2013, BIOLOGY; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	56	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4192	4201		10.1074/jbc.M114.617506	http://dx.doi.org/10.1074/jbc.M114.617506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512373	Green Published, hybrid			2022-12-26	WOS:000349458400030
J	Chan, ACK; Blair, KM; Liu, YJ; Frirdich, E; Gaynor, EC; Tanner, ME; Salama, NR; Murphy, MEP				Chan, Anson C. K.; Blair, Kris M.; Liu, Yanjie; Frirdich, Emilisa; Gaynor, Erin C.; Tanner, Martin E.; Salama, Nina R.; Murphy, Michael E. P.			Helical Shape of Helicobacter pylori Requires an Atypical Glutamine as a Zinc Ligand in the Carboxypeptidase Csd4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SHAPE; PEPTIDOGLYCAN; SEQUENCE; CONSERVATION; HYDROLASES; MECHANISM	Peptidoglycan modifying carboxypeptidases (CPs) are important determinants of bacterial cell shape. Here, we report crystal structures of Csd4, a three-domain protein from the human gastric pathogen Helicobacter pylori. The catalytic zinc in Csd4 is coordinated by a rare His-Glu-Gln configuration that is conserved among most Csd4 homologs, which form a distinct subfamily of CPs. Substitution of the glutamine to histidine, the residue found in prototypical zinc carboxypeptidases, resulted in decreased enzyme activity and inhibition by phosphate. Expression of the histidine variant at the native locus in a H. pylori csd4 deletion strain did not restore the wild-type helical morphology. Biochemical assays show that Csd4 can cleave a tripeptide peptidoglycan substrate analog to release m-DAP. Structures of Csd4 with this substrate analog or product bound at the active site reveal determinants of peptidoglycan specificity and the mechanism to cleave an isopeptide bond to release m-DAP. Our data suggest that Csd4 is the archetype of a new CP subfamily with a domain scheme that differs from this large family of peptide-cleaving enzymes.	[Chan, Anson C. K.; Frirdich, Emilisa; Gaynor, Erin C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Blair, Kris M.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Blair, Kris M.; Salama, Nina R.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Liu, Yanjie; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Murphy, Michael/R-6805-2017; Salama, Nina Reda/AAG-2437-2019	Murphy, Michael/0000-0003-2589-0014; Salama, Nina Reda/0000-0003-2762-1424; Chan, Anson/0000-0001-6625-8942; Blair, Kris/0000-0002-2887-5592	National Institutes of Health [RO1A1094839, T32CA009657]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research [MOP-68981]; National Science Foundation [DGE-1256082]; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1A1094839 and T32CA009657. This work was also supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants (to M. E. P. M. and M. E. T.) and Canadian Institutes of Health Research Operating Grant MOP-68981 (to E. G.). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (to K. B.) under Grant DGE-1256082. Support for infrastructure for structural biology was provided by the Canadian Foundation for Innovation (to M. E. P. M.). The research described in this paper was performed using Beamlines 08B1-1 and 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Abdullah MR, 2014, MOL MICROBIOL, V93, P1183, DOI 10.1111/mmi.12729; Agnihotri G, 2011, J MED CHEM, V54, P1490, DOI 10.1021/jm101535e; Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frey P. A., 2007, ENZYMATIC REACTION M; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; GARNIER M, 1985, EUR J BIOCHEM, V148, P539, DOI 10.1111/j.1432-1033.1985.tb08873.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hor L, 2013, BIOCHIMIE, V95, P1949, DOI 10.1016/j.biochi.2013.06.026; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hoyland CN, 2014, STRUCTURE, V22, P949, DOI 10.1016/j.str.2014.04.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2014, ACTA CRYSTALLOGR D, V70, P2800, DOI 10.1107/S1399004714018732; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maqbool A, 2012, BIOCHEM J, V448, P329, DOI 10.1042/BJ20121164; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ridderstrom M, 1998, J BIOL CHEM, V273, P21623, DOI 10.1074/jbc.273.34.21623; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Terry K, 2005, INFECT IMMUN, V73, P803, DOI 10.1128/IAI.73.2.803-811.2005; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	43	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3622	3638		10.1074/jbc.M114.624734	http://dx.doi.org/10.1074/jbc.M114.624734			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505267	hybrid, Green Published			2022-12-26	WOS:000349456000035
J	Fisher, LR; Godfrey, MH; Owens, DW				Fisher, Leah R.; Godfrey, Matthew H.; Owens, David W.			Incubation Temperature Effects on Hatchling Performance in the Loggerhead Sea Turtle (Caretta caretta)	PLOS ONE			English	Article							CLIMATE-CHANGE; NEST TEMPERATURES; SNAPPING TURTLES; CHELONIA-MYDAS; GREEN TURTLES; PHENOTYPE; ENVIRONMENT; NORTHERN; RATIOS; FLUCTUATIONS	Incubation temperature has significant developmental effects on oviparous animals, including affecting sexual differentiation for several species. Incubation temperature also affects traits that can influence survival, a theory that is verified in this study for the Northwest Atlantic loggerhead sea turtle (Caretta caretta). We conducted controlled laboratory incubations and experiments to test for an effect of incubation temperature on performance of loggerhead hatchlings. Sixty-eight hatchlings were tested in 2011, and 31 in 2012, produced from eggs incubated at 11 different constant temperatures ranging from 27 degrees C to 33 degrees C. Following their emergence from the eggs, we tested righting response, crawling speed, and conducted a 24-hour long swim test. The results support previous studies on sea turtle hatchlings, with an effect of incubation temperature seen on survivorship, righting response time, crawling speed, change in crawl speed, and overall swim activity, and with hatchlings incubated at 27 degrees C showing decreased locomotor abilities. No hatchlings survived to be tested in both years when incubated at 32 degrees C and above. Differences in survivorship of hatchlings incubated at high temperatures are important in light of projected higher sand temperatures due to climate change, and could indicate increased mortality from incubation temperature effects.	[Fisher, Leah R.; Owens, David W.] Univ Charleston South Carolina, Coll Charleston, Charleston, SC 29424 USA; [Godfrey, Matthew H.] North Carolina Wildlife Resources Commiss, Beaufort, NC USA; [Godfrey, Matthew H.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	College of Charleston; Duke University	Fisher, LR (corresponding author), Univ Charleston South Carolina, Coll Charleston, Charleston, SC 29424 USA.	lrfisher22@gmail.com			PADI Foundation [5040, 6344]; Lerner Gray Memorial Fund of the American Museum of Natural History; Charleston Scientific and Cultural Society; Slocum-Lunz Foundation; National Oceanic and Atmospheric Administration Section 6 cooperative research grant [NA10NMF4720035]	PADI Foundation; Lerner Gray Memorial Fund of the American Museum of Natural History; Charleston Scientific and Cultural Society; Slocum-Lunz Foundation; National Oceanic and Atmospheric Administration Section 6 cooperative research grant	This research was funded to LRF by the PADI Foundation (#5040, #6344; http://www.padifoundation.org/), the Lerner Gray Memorial Fund of the American Museum of Natural History (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships), the Charleston Scientific and Cultural Society (no website), the Slocum-Lunz Foundation (no website). The research was also funded in part to MHG by a National Oceanic and Atmospheric Administration Section 6 cooperative research grant (NA10NMF4720035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; Booth DT, 2013, MAR BIOL, V160, P127, DOI 10.1007/s00227-012-2070-y; Booth DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Booth DT, 2004, INT CONGR SER, V1275, P226, DOI 10.1016/j.ics.2004.08.057; Booth DT, 2001, AUST J ZOOL, V49, P389, DOI 10.1071/ZO01006; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Burgess EA, 2006, CORAL REEFS, V25, P341, DOI 10.1007/s00338-006-0116-7; Chu CT, 2008, AUST J ZOOL, V56, P57, DOI 10.1071/ZO08004; Conover David O., 2004, P11; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; DeGregorio BA, 2011, CHELONIAN CONSERV BI, V10, P54, DOI 10.2744/CCB-0880.1; Delmas V, 2007, BIOL J LINN SOC, V91, P99, DOI 10.1111/j.1095-8312.2007.00780.x; Doody J. Sean, 1999, Chelonian Conservation and Biology, V3, P529; FOLEY AM, 1998, THESIS U S FLORIDA T; Freedberg S, 2004, EVOL ECOL RES, V6, P739; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Glen F, 2004, GLOBAL CHANGE BIOL, V10, P2036, DOI 10.1111/j.1529-8817.2003.00865.x; Glen F, 2003, J MAR BIOL ASSOC UK, V83, P1183, DOI 10.1017/S0025315403008464h; Godfrey Matthew H., 1997, Chelonian Conservation and Biology, V2, P581; GYURIS E, 1994, CORAL REEFS, V13, P137, DOI 10.1007/BF00301189; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M., 2007, CLIMATE CHANGE GREAT, P465; Hanson J, 1998, CAN J ZOOL, V76, P1850, DOI 10.1139/cjz-76-10-1850; Harbour Jerry, 2009, BASICS PERFORMANCE M; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; HOSIER PE, 1981, ENVIRON CONSERV, V8, P158, DOI 10.1017/S0376892900027284; HUTCHISON VICTOR H., 1965, HERPETOLOGICA, V20, P233; Ischer T, 2009, MAR BIOL, V156, P1399, DOI 10.1007/s00227-009-1180-7; JANZEN FJ, 1993, PHYSIOL ZOOL, V66, P349, DOI 10.1086/physzool.66.3.30163697; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Layton J, 2011, THESIS U ALABAMA BIR; LeBlanc AM, 2012, CHELONIAN CONSERV BI, V11, P108, DOI 10.2744/CCB-0915.1; LIMPUS CJ, 2006, ROUNDTABLE MIGRATORY; Lohmann Kenneth J., 1997, P107; Marcovaldi MA, 1997, CAN J ZOOL, V75, P755, DOI 10.1139/z97-097; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Maulany RI, 2012, MAR BIOL, V159, P2651, DOI 10.1007/s00227-012-2022-6; Maulany RI, 2012, COPEIA, P738, DOI 10.1643/CH-12-088; Micheli-Campbell MA, 2011, J ZOOL, V285, P266, DOI 10.1111/j.1469-7998.2011.00840.x; Micheli-Campbell MA, 2012, J ZOOL, V288, P143, DOI 10.1111/j.1469-7998.2012.00934.x; Miller J.D., 1985, Biology of Reptilia, V14, P269; MILLER J.D., 2003, LOGGERHEAD SEA TURTL, P125, DOI DOI 10.1086/431100; Mrosovsky N, 2002, CAN J ZOOL, V80, P2118, DOI 10.1139/Z02-204; MROSOVSKY N, 1988, CAN J ZOOL, V66, P661, DOI 10.1139/z88-098; O'Steen S, 1998, J EXP BIOL, V201, P439; Read T, 2012, AUST J ZOOL, V60, P402, DOI 10.1071/ZO12079; Reece SE, 2002, EVOL ECOL RES, V4, P737; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Sandoval S, 2011, J THERM BIOL, V36, P138, DOI 10.1016/j.jtherbio.2010.12.007; Shine R, 1997, ECOLOGY, V78, P2559; Sim EL, 2014, COPEIA, P63, DOI 10.1643/CP-13-041; Steyermark AC, 2001, COPEIA, P1050, DOI 10.1643/0045-8511(2001)001[1050:BTAMIA]2.0.CO;2; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Wibbels T, 2003, CRC MAR BIOL SER, P103; WITHERINGTON BE, 1992, J HERPETOL, V26, P226, DOI 10.2307/1564869; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Wood A, 2014, J EXP MAR BIOL ECOL, V451, P105, DOI 10.1016/j.jembe.2013.11.005; WYNEKEN J, 1992, COPEIA, P478, DOI 10.2307/1446208	59	56	57	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114880	10.1371/journal.pone.0114880	http://dx.doi.org/10.1371/journal.pone.0114880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517114	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600032
J	Kummell, SB; Frey, E				Kuemmell, Susanna B.; Frey, Eberhard			Range of Movement in Ray I of Manus and Pes and the Prehensility of the Autopodia in the Early Permian to Late Cretaceous Non-Anomodont Synapsida	PLOS ONE			English	Article							MARSUPIALS MAYULESTES-FEROX; PUCADELPHYS-ANDINUS; PALEOBIOLOGY; ANATOMY	The mobility of ray I was analysed in seventy-eight Early Permian to Late Cretaceous specimens of non-mammalian Synapsida and one extant mammal. In all non-mammaliamorph Synapsida investigated, ray I formed a digital arcade. The first phalanx was maximally extendable to the zero position in the metapodiophalangeal joint I. Metapodiale I was the functional equivalent to a basal phalanx of digits II-V. In contrast, there was no digital arcade in ray I in Mesozoic Mammaliamorpha. Phalanx 1 I was dorsally extendable and metapodiale I was functionally part of the metapodium. During the propulsion phase, autopodial rotation occurred in the majority of Synapsida with abducted limb posture. Regarding ray I, the reduction of autopodial rotation can be estimated, e. g., from the decrease of lateral rotation and medial abduction of the first phalanx in the metapodiophalangeal joint I. Autopodial rotation was high in Titanophoneus and reduced in derived Cynodontia. In Mammaliamorpha the mobility of the first ray suggests autopodial rolling in an approximately anterior direction. Most non-mammaliamorph Therapsida and probably some Mesozoic Mammaliamorpha had prehensile autopodia with an opposable ray I. In forms with a pronounced relief of the respective joints, ray I could be opposed to 90 degrees against ray III. A strong transverse arch in the row of distalia supported the opposition movement of ray I and resulted in a convergence of the claws of digits II-V just by flexing those digits. A tight articular coherence in the digital joints of digits II-V during strong flexion supported a firm grip capacity. Usually the grip capacity was more pronounced in the manus than in the pes. Prehensile autopodia of carnivorous Therapsida may have been utilized to hold prey while biting, thus helping to avoid fractures of the laterally compressed fangs.	[Kuemmell, Susanna B.] Univ Witten Herdecke, Inst Evolutionary Biol & Morphol, Ctr Biomed Educ & Res, Fac Hlth,Sch Med, Witten, Germany; [Frey, Eberhard] Staatl Museum Nat Kunde Karlsruhe, Karlsruhe, Germany	Witten Herdecke University	Kummell, SB (corresponding author), Univ Witten Herdecke, Inst Evolutionary Biol & Morphol, Ctr Biomed Educ & Res, Fac Hlth,Sch Med, Witten, Germany.	susanna.kuemmell@uni-wh.de			Rudolf Steiner-Fonds; Gemeinschaftsbank fur Leihen und Schenken; Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung	Rudolf Steiner-Fonds; Gemeinschaftsbank fur Leihen und Schenken; Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung	Rudolf Steiner-Fonds, Gemeinschaftsbank fur Leihen und Schenken, Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung (SK). Center for Biomedical Education and Research, University Witten/Herdecke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Attenborough D, 1984, WUNDERWELT NATUR ERD; Attenborough D, 1990, WUNDERWELT NATUR KIN; Benninghoff A., 1994, ANATOMIE MAKROSKOPIS; Benninghoff A, 1957, LEHRBUCH ANATOMIE ME, VI; Boonstra L. D., 1964, Annals of the South African Museum, V48, P121; Boonstra L. D., 1966, Annals of the South African Museum, V50, P1; BOONSTRA LIEUWE DIRK, 1965, ANN S AFRICAN MUS, V48, P237; BRINKMAN D, 1980, CAN J ZOOL, V58, P2187, DOI 10.1139/z80-301; Camp C.L., 1956, MEM U CALIF, V13, P255; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; Cartmill M., 1974, P45; Chudinov P.K., 1983, Trudy Paleontologicheskogo Instituta, V202, P1; Colbert E. H., 1948, Bulletin of the American Museum of Natural History, V89, P357; CRUICKSHANK AR, 1967, J ZOOL, V153, P163; De Valais S, 2009, ZOOTAXA, P1; FCAT, 1998, TERM AN INT AN TERM, P292; FOURIE H, 2001, THESIS U WITWATERSRA; Gand Georges, 2000, Palaeovertebrata (Montpellier), V29, P1; Granger W, 1930, B AM MUS NAT HIST, V56, P601; Grzimek B, 1987, GRZIMEKS ENZYKLOPADI, VI-V; Hu Yaoming, 1998, Vertebrata Palasiatica, V36, P102; Huttenlocker A, 2009, ZOOL J LINN SOC-LOND, V157, P865, DOI 10.1111/j.1096-3642.2009.00538.x; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; Jenkins F.A. Jr., 1974, P85; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Kemp T.S., 1986, Journal of Vertebrate Paleontology, V6, P215; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Z, 2006, ACTA PALAEONTOL POL, V51, P393; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KING GM, 1985, ZOOL J LINN SOC-LOND, V84, P263, DOI 10.1111/j.1096-3642.1985.tb01801.x; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Krebs B, 1991, BERLINER GEOWISSEN A, V133, P5; Kuhne W.G., 1956, LIASSIC THERAPSID OL, P149; Kummell SB, 2009, THESIS WITTEN HERDEC; Kummell Susanna B., 2012, Palaeobiodiversity Palaeoenvironments, V92, P171, DOI 10.1007/s12549-012-0076-6; Kummer B, 2005, BIOMECHANIK FORM FUN; Leonardi G., 1994, ANNOTATED ATLAS S AM; Napier J. R., 1961, Symposia of the Zoological Society of London, P115; Napier J. R., 1993, HANDS; ORLOV Yu. A., 1958, TR PALEONTOL INST AKAD NAUK SSSR, V72, P1; Platzer W, 1999, DTV ATLAS ANATOMIE, V1; Rauber A, 1987, ANATOMIE MENSCHEN LE, VI; Romer Alfred S., 1944, BULL MUS COMP ZOOL HARVARD UNIV, V93, P465; Schilling N, 1999, Z SAUGETIERKD, V64, P129; Sereno Paul C., 2006, P315; Van Valkenburgh Blaire, 2002, Paleontological Society Papers, V8, P267; Voigt S, 2005, TETRAPODENICHNOFAUNA; WATSON D. M. S., 1931, PROC ZOOL SOC LONDON, V1931, P1163	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113911	10.1371/journal.pone.0113911	http://dx.doi.org/10.1371/journal.pone.0113911			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517726	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600011
J	Beliveau, E; Lessard, V; Guillemette, G				Beliveau, Eric; Lessard, Vincent; Guillemette, Gaetan			STIM1 Positively Regulates the Ca2+ Release Activity of the Inositol 1,4,5-risphosphate Receptor in Bovine Aortic Endothelial Cells	PLOS ONE			English	Article							CALCIUM SENSOR STIM1; 1,4,5-TRISPHOSPHATE RECEPTOR; ACTIVATION; ENTRY; POLYCYSTIN-2; CHANNELS; ORAI1; WAVES	The endothelium is actively involved in many functions of the cardiovascular system, such as the modulation of arterial pressure and the maintenance of blood flow. These functions require a great versatility of the intracellular Ca2+ signaling that resides in the fact that different signals can be encoded by varying the frequency and the amplitude of the Ca2+ response. Cells use both extracellular and intracellular Ca2+ pools to modulate the intracellular Ca2+ concentration. In non-excitable cells, the inositol 1,4,5-trisphosphate receptor (IP3R), located on the endoplasmic reticulum (ER), is responsible for the release of Ca2+ from the intracellular store. The proteins STIM1 and STIM2 are also located on the ER and they are involved in the activation of a store-operated Ca2+ entry (SOCE). Due to their Ca2+ sensor property and their close proximity with IP(3)Rs on the ER, STIMs could modulate the activity of IP3R. In this study, we showed that STIM1 and STIM2 are expressed in bovine aortic endothelial cells and they both interact with IP3R. While STIM2 appears to play a minor role, STIM1 plays an important role in the regulation of agonist-induced Ca2+ mobilization in BAECs by a positive effect on both the SOCE and the IP3R-dependent Ca2+ release.	[Beliveau, Eric; Lessard, Vincent; Guillemette, Gaetan] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	gaetan.guillemette@usherbrooke.ca			Canadian Institutes of Health Research; Fondation des Maladies du Coeur du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation des Maladies du Coeur du Quebec	Funding from Canadian Institutes of Health Research (GG) and Fondation des Maladies du Coeur du Quebec (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Antigny F, 2012, J BIOL CHEM, V287, P5917, DOI 10.1074/jbc.M111.295733; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Beliveau E, 2011, J CELL BIOCHEM, V112, P3722, DOI 10.1002/jcb.23301; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Briand SI, 1999, J CELL BIOCHEM, V75, P587, DOI 10.1002/(SICI)1097-4644(19991215)75:4<587::AID-JCB5>3.0.CO;2-Q; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hirano K, 2009, J CELL BIOCHEM, V108, P499, DOI 10.1002/jcb.22279; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lopez E, 2012, J PHYSIOL BIOCHEM, V68, P619, DOI 10.1007/s13105-012-0163-1; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Pani B, 2012, FRONT BIOSCI-LANDMRK, V17, P805, DOI 10.2741/3958; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tran Q. -K., 2006, V176, P145; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605	36	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114718	10.1371/journal.pone.0114718	http://dx.doi.org/10.1371/journal.pone.0114718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506690	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100024
J	Hotzel, MJ; Longo, C; Balcao, LF; Cardoso, CS; Costa, JHC				Hoetzel, Maria J.; Longo, Cibele; Balcao, Lucas F.; Cardoso, Clarissa S.; Costa, Joao H. C.			A Survey of Management Practices That Influence Performance and Welfare of Dairy Calves Reared in Southern Brazil	PLOS ONE			English	Article							LACTATION BIOLOGY SYMPOSIUM; FEEDING-BEHAVIOR; ANIMAL-WELFARE; MILK REPLACER; HERD REPLACEMENTS; EARLY SEPARATION; HOLSTEIN CALVES; CROSS-SUCKING; CALF; COLOSTRUM	Here we report dairy calf management practices used by 242 smallholder family farmers in the South of Brazil. Data were collected via a semi-structured questionnaire with farmers, inspection of the production environment and an indepth interview with a sample of 26 farmers. Herds had an average of 22.3 lactating cows and an average milk production of 12.7 L/cow/day. Calves were dehorned in 98% of the farms, with a hot iron in 95%. Male calves were castrated in 71% of the farms; methods were surgery (68%), emasculator (29%), or rubber rings (3%). No pain control was used for these interventions. In 51% of the farms all newborn male calves were reared, sold or donated to others; in 35% all newborn males were killed on the farm. Calves were separated from the dam up to 12 h after birth in 78% of the farms, and left to nurse colostrum from the dam without intervention in 55% of the farms. The typical amount of milk fed to calves was 4 L/day until a median age of 75 days. In 40% of the farms milk was provided in a bucket, in 49% with bottles, and in 11% calves suckled from a cow. Solid feeding in the milk-feeding period started at a median age of 10 days. Calves were housed individually in 70% of the farms; in 81% of the farms calves were housed in indoor pens, in 6% in outdoor hutches and in 13% they were kept on pasture. Diarrhoea was reported as the main cause of calf mortality in 71% of the farms. Farmers kept no records of calf disease, mortality, or use of medicines. Changing the scenario identified in this survey is essential to support the sustainable development of dairy production, an activity of great economic and social relevance for the region.	[Hoetzel, Maria J.; Longo, Cibele; Balcao, Lucas F.; Cardoso, Clarissa S.; Costa, Joao H. C.] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil.	mjhotzel@cca.ufsc.br	Balcão, Lucas/F-2802-2017; Costa, Joao H. C./M-6660-2014; Costa, Joao H. C./ABD-4749-2021; Hötzel, Maria José/H-6975-2014; Cardoso, Clarissa Silva/J-7473-2018	Balcão, Lucas/0000-0002-9572-7039; Costa, Joao H. C./0000-0001-9311-4741; Costa, Joao H. C./0000-0001-9311-4741; Hötzel, Maria José/0000-0003-1034-3202; Cardoso, Clarissa Silva/0000-0002-4668-4052	MCT/CNPq/CT-Agronegocio/MAPA-SDC [505862/2008-5]; CNPq [562908/2010-2]; MEC/CAPES [23038.006958/2010-62]; CNPq (National Council for Scientific and Technological Development, Brazil); CAPES (Ministry of Education, Brazil)	MCT/CNPq/CT-Agronegocio/MAPA-SDC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MEC/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by MCT/CNPq/CT-Agronegocio/MAPA-SDC 40/2008, grant number 505862/2008-5, CNPq 22/2010 - Inter-institutional Network of the Agroecological Dairy Productive Chain, grant number 562908/2010-2, MEC/CAPES 029/2010, grant number 23038.006958/2010-62. MJH was supported by CNPq (National Council for Scientific and Technological Development, Brazil; http://www.cnpq.br/) CL, LFB and JHCC were supported by CAPES (Ministry of Education, Brazil; http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby MC, 2001, APPL ANIM BEHAV SCI, V74, P191, DOI 10.1016/S0168-1591(01)00171-X; AVMA, 2013, GUID EUTH ANIM 2013; Babu LK, 2004, APPL ANIM BEHAV SCI, V87, P177, DOI 10.1016/j.applanim.2004.01.006; Balcao LF, 2012, TIPOLOGIA ATIVIDADE; Balcao LF, 2011, 38 C BRAS MED VET FL; Ballou M. A., 2013, Professional Animal Scientist, V29, P116; Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Bergman MA, 2014, J DAIRY SCI, V97, P4269, DOI 10.3168/jds.2013-7766; Borderas TF, 2009, J DAIRY SCI, V92, P2843, DOI 10.3168/jds.2008-1886; Cardoso C. S., 2014, 3 BRAZ C BIOET AN WE, P196; Cardoso CS, 2014, SUSTENTABILIDADE PEC; Chua B, 2002, J DAIRY SCI, V85, P360, DOI 10.3168/jds.S0022-0302(02)74082-4; Costa JHC, 2013, J DAIRY SCI, V96, P307, DOI 10.3168/jds.2012-5906; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Dos Santos OV, 2006, ESTUDO CADEIA LEITE; Duve LR, 2012, J DAIRY SCI, V95, P6571, DOI 10.3168/jds.2011-5170; EDWARDS SA, 1982, ANIM BEHAV, V30, P525, DOI 10.1016/S0003-3472(82)80065-1; Ellis KA, 2009, ANIM WELFARE, V18, P267; EPAGRI/CEPA, 2012, SINT AN AGR SANT CAT; Fernandes COM, 2012, PRODUCAO LEITE BASE, P335; Flower FC, 2003, ANIM WELFARE, V12, P339; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Franklin ST, 2003, J DAIRY SCI, V86, P2145, DOI 10.3168/jds.S0022-0302(03)73804-1; Fulwider WK, 2008, J DAIRY SCI, V91, P1686, DOI 10.3168/jds.2007-0631; Gaillard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090205; Gjerris M, 2011, J AGR ENVIRON ETHIC, V24, P331, DOI 10.1007/s10806-010-9270-6; Godden S, 2008, VET CLIN N AM-FOOD A, V24, P19, DOI 10.1016/j.cvfa.2007.10.005; Gottardo F, 2011, J DAIRY SCI, V94, P5724, DOI 10.3168/jds.2011-4443; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Hotzel MJ, 2013, J DAIRY SCI, V96, P1535, DOI 10.3168/jds.2012-5780; Hotzel MJ, 2014, DILEMMAS IN ANIMAL WELFARE, P67, DOI 10.1079/9781780642161.0067; Honorato LA, 2014, J DAIRY SCI, V97, P1319, DOI 10.3168/jds.2012-6532; IBGE, 2009, CENS AGR; Jensen MB, 2006, J DAIRY SCI, V89, P4778, DOI 10.3168/jds.S0022-0302(06)72527-9; Jensen MB, 2006, J DAIRY SCI, V89, P201, DOI 10.3168/jds.S0022-0302(06)72084-7; Jung J, 2001, APPL ANIM BEHAV SCI, V72, P201, DOI 10.1016/S0168-1591(01)00110-1; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Le Cozler Y, 2012, J AGR SCI-CAMBRIDGE, V150, P518, DOI 10.1017/S0021859612000032; Lidfors LM, 1996, APPL ANIM BEHAV SCI, V49, P269, DOI 10.1016/0168-1591(96)01053-2; Lopes F. C. F., 2010, MANUAL BOVINOCULTURA, P351; Lorenzon J, 2005, ESTUDO COMPARATIVO R, P4; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; McGuirk SM, 2004, VET CLIN N AM-FOOD A, V20, P593, DOI 10.1016/j.cvfa.2004.06.005; MDA, 2014, POL SET LEIT; Mello MA, 2003, BASE AGRICOLA OESTE, P15; Mellor DJ, 2004, VET J, V168, P118, DOI 10.1016/j.tvjl.2003.08.004; Mezzadri FP, 2013, CULTURA ANAL CONJUNT; Mior LC, 2010, COLOQUIO INT DESENVO, P487; Moallem U, 2010, J DAIRY SCI, V93, P2639, DOI 10.3168/jds.2009-3007; Morrison SJ, 2012, ANIMAL, V6, P909, DOI 10.1017/S1751731111002163; Morrison SJ, 2009, ANIMAL, V3, P1570, DOI 10.1017/S1751731109990437; Pettersson K, 2001, ACTA VET SCAND, V42, P465, DOI 10.1186/1751-0147-42-465; Poletto R., 2012, Animal Frontiers, V2, P22, DOI 10.2527/af.2012-0045; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Robson C., 1993, REAL WORLD RES RESOU; Roth BA, 2009, APPL ANIM BEHAV SCI, V119, P143, DOI 10.1016/j.applanim.2009.03.004; Rushen J., 2008, WELFARE CATTLE, VVolume 5; SANTOS G. T., 2010, BOVINOCULTURA LEITEI, P47; Silva JCPM, 2011, MANEJO BEZERRAS LEIT; Sneddon J, 2010, J AGR ENVIRON ETHIC, V23, P371, DOI 10.1007/s10806-009-9216-z; Soberon F, 2013, J ANIM SCI, V91, P706, DOI 10.2527/jas.2012-5834; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Spers Renata Giovinazzo, 2013, Rev. Adm. (São Paulo), V48, P254, DOI 10.5700/rausp1086; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Stanek S, 2014, J DAIRY SCI, V97, P3973, DOI 10.3168/jds.2013-7325; Trotz-Williams LA, 2008, J DAIRY SCI, V91, P3840, DOI 10.3168/jds.2007-0898; USDA, 2008, PART 3 REF DAIR CATT; Uys JL, 2011, J S AFR VET ASSOC, V82, P47; Vasseur E, 2012, ANIM WELFARE, V21, P77, DOI 10.7120/096272812799129439; Vasseur E, 2010, J DAIRY SCI, V93, P1307, DOI 10.3168/jds.2009-2429; Veissier I, 2013, APPL ANIM BEHAV SCI, V147, P11, DOI 10.1016/j.applanim.2013.05.002; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Vieira AD, 2012, J DAIRY SCI, V95, P3218, DOI 10.3168/jds.2011-4821; Vieira AD, 2010, J DAIRY SCI, V93, P3079, DOI 10.3168/jds.2009-2516; Vieira AD, 2008, APPL ANIM BEHAV SCI, V109, P180, DOI 10.1016/j.applanim.2007.03.006; von Keyserlingk MAG, 2013, J DAIRY SCI, V96, P5405, DOI 10.3168/jds.2012-6354; Von Keyserlingk MAG, 2010, 3 BOEHR ING EXP FOR, P7; Von Keyserlingk MAG, J AGR ENV ETHICS, DOI s10.1007/s10806-10014-19518-10807; Zucali M, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e26	81	51	52	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114995	10.1371/journal.pone.0114995	http://dx.doi.org/10.1371/journal.pone.0114995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506692	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100040
J	Barnes, AD; Emberson, RM; Krell, FT; Didham, RK				Barnes, Andrew D.; Emberson, Rowan M.; Krell, Frank-Thorsten; Didham, Raphael K.			The Role of Species Traits in Mediating Functional Recovery during Matrix Restoration	PLOS ONE			English	Article							DUNG BEETLE COMMUNITIES; FOREST FRAGMENTATION; HABITAT RESTORATION; ECOSYSTEM SERVICES; RESPONSE FUNCTIONS; LAND-USE; BIODIVERSITY; CONSEQUENCES; FRAMEWORK; ECOLOGY	Reversing anthropogenic impacts on habitat structure is frequently successful through restoration, but the mechanisms linking habitat change, community reassembly and recovery of ecosystem functioning remain unknown. We test for the influence of edge effects and matrix habitat restoration on the reassembly of dung beetle communities and consequent recovery of dung removal rates across tropical forest edges. Using path modelling, we disentangle the relative importance of community-weighted trait means and functional trait dispersion from total biomass effects on rates of dung removal. Community trait composition and biomass of dung beetle communities responded divergently to edge effects and matrix habitat restoration, yielding opposing effects on dung removal. However, functional dispersion-used in this study as a measure of niche complementarity-did not explain a significant amount of variation in dung removal rates across habitat edges. Instead, we demonstrate that the path to functional recovery of these altered ecosystems depends on the trait-mean composition of reassembling communities, over and above purely biomass-dependent processes that would be expected under neutral theory. These results suggest that any ability to manage functional recovery of ecosystems during habitat restoration will demand knowledge of species' roles in ecosystem processes.	[Barnes, Andrew D.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Barnes, Andrew D.] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Emberson, Rowan M.] Lincoln Univ, Dept Ecol, Lincoln, New Zealand; [Krell, Frank-Thorsten] Denver Museum Nat & Sci, Dept Zool, Denver, CO USA; [Didham, Raphael K.] CSIRO Land & Water Flagship, Ctr Environm & Life Sci, Floreat, WA, Australia; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Canterbury; University of Gottingen; Lincoln University - New Zealand; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Barnes, AD (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 1, New Zealand.	abarnes@gwdg.de	Barnes, Andrew/C-6643-2014; Krell, Frank-Thorsten/A-8633-2009; Didham, Raphael K/B-5953-2011; Barnes, Andrew/AAQ-9592-2020	Barnes, Andrew/0000-0002-6499-381X; Krell, Frank-Thorsten/0000-0001-6065-0812; Barnes, Andrew/0000-0002-6499-381X				Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Baker SC, 2006, J INSECT CONSERV, V10, P269, DOI 10.1007/s10841-006-0016-8; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Barnes AD, 2014, BIOL CONSERV, V170, P28, DOI 10.1016/j.biocon.2013.12.006; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cadotte M, 2013, ECOL LETT, V16, P1234, DOI 10.1111/ele.12161; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapman HM, 2004, ORYX, V38, P282, DOI 10.1017/S0030605304000511; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Chown SL, 2002, COMP BIOCHEM PHYS B, V131, P587, DOI 10.1016/S1096-4959(02)00017-9; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Davis A. L. V., 2008, AFRICAN DUNG BEETLE; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ernest SKM, 2009, ECOL LETT, V12, P507, DOI 10.1111/j.1461-0248.2009.01305.x; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hubbell Stephen P., 2001, V32, pi; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Malmivaara-Lamsa M, 2008, SOIL BIOL BIOCHEM, V40, P1612, DOI 10.1016/j.soilbio.2008.01.013; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Moir ML, 2005, FOREST ECOL MANAG, V217, P294, DOI 10.1016/j.foreco.2005.06.012; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075819; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Quintero I, 2005, ECOLOGY, V86, P3303, DOI 10.1890/04-1960; R Development Core Team, 2013, LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Spector S, 2003, BIOTROPICA, V35, P394; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tsbikae BP, 2008, ENVIRON ENTOMOL, V37, P431, DOI 10.1603/0046-225X(2008)37[431:TAOADB]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Watts CH, 2008, BIOL CONSERV, V141, P568, DOI 10.1016/j.biocon.2007.12.008; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wu XW, 2011, ECOL MONOGR, V81, P313, DOI 10.1890/10-0808.1; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	58	17	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115385	10.1371/journal.pone.0115385	http://dx.doi.org/10.1371/journal.pone.0115385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502448	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400092
J	Ghosh, R; Kumar, A; Vaziri, A				Ghosh, Ranajay; Kumar, Aloke; Vaziri, Ashkan			Type-IV Pilus Deformation Can Explain Retraction Behavior	PLOS ONE			English	Article							TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; BIOGENESIS; MOTOR; TRANSFORMATION; DYNAMICS; PROTEIN; GENE; DNA	Polymeric filament like type IV Pilus (TFP) can transfer forces in excess of 100 pN during their retraction before stalling, powering surface translocation(twitching). Single TFP level experiments have shown remarkable nonlinearity in the retraction behavior influenced by the external load as well as levels of PilT molecular motor protein. This includes reversal of motion near stall forces when the concentration of the PilT protein is loweblack significantly. In order to explain this behavior, we analyze the coupling of TFP elasticity and interfacial behavior with PilT kinetics. We model retraction as reaction controlled and elongation as transport controlled process. The reaction rates vary with TFP deformation which is modeled as a compound elastic body consisting of multiple helical strands under axial load. Elongation is controlled by monomer transport which suffer entrapment due to excess PilT in the cell periplasm. Our analysis shows excellent agreement with a host of experimental observations and we present a possible biophysical relevance of model parameters through a mechano-chemical stall force map.	[Ghosh, Ranajay; Vaziri, Ashkan] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Kumar, Aloke] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada	Northeastern University; University of Alberta	Vaziri, A (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	vaziri@coe.neu.edu			United States National Science Foundation CMMI Grant [1149750]	United States National Science Foundation CMMI Grant	RG and AV were supported by United States National Science Foundation CMMI Grant-1149750. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crowther LJ, 2004, MOL MICROBIOL, V52, P67, DOI 10.1111/j.1365-2958.2003.03963.x; Drake SL, 1995, MOL MICROBIOL, V18, P975, DOI 10.1111/j.1365-2958.1995.18050975.x; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Jin F, 2011, P NATL ACAD SCI USA, V108, P12617, DOI 10.1073/pnas.1105073108; Linden M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021908; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Newton R. G., 1982, THEOR MATH PHYS+; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; Park K, 2011, APPL MECH REV, V64, DOI 10.1115/1.4023110; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; Rudel T, 1995, NEISSERIA PILC PROTE; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114613	10.1371/journal.pone.0114613	http://dx.doi.org/10.1371/journal.pone.0114613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502696	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400040
J	McCormack, A; Edmondson-Jones, M; Mellor, D; Dawes, P; Munro, KJ; Moore, DR; Fortnum, H				McCormack, Abby; Edmondson-Jones, Mark; Mellor, Duane; Dawes, Piers; Munro, Kevin J.; Moore, David R.; Fortnum, Heather			Association of Dietary Factors with Presence and Severity of Tinnitus in a Middle-Aged UK Population	PLOS ONE			English	Article							HEARING-LOSS; RISK; PREVALENCE	Objective: The impact of dietary factors on tinnitus has received limited research attention, despite being a considerable concern among people with tinnitus and clinicians. The objective was to examine the link between dietary factors and presence and severity of tinnitus. Design: This study used the UK Biobank resource, a large cross-sectional study of adults aged 40-69. 171,722 eligible participants were asked questions specific to tinnitus (defined as noises such as ringing or buzzing in the head or ears). Dietary factors included portions of fruit and vegetables per day, weekly fish consumption (oily and non-oily), bread type, cups of caffeinated coffee per day, and avoidance of dairy, eggs, wheat and sugar. We controlled for lifestyle, noise exposure, hearing, personality and comorbidity factors. Results: Persistent tinnitus, defined as present at least a lot of the time, was elevated with increased: (i) fruit/vegetable intake (OR=1.01 per portion/day), (ii) bread (wholemeal/wholegrain, OR=1.07; other bread, 1.20) and (iii) dairy avoidance (OR=1.27). Persistent tinnitus was reduced with: (i) fish consumption (non-oily, OR=0.91; oily, 0.95), (ii) egg avoidance (OR=0.87) and (iii) caffeinated coffee consumption (OR=0.99 per cup/day). Reports of "bothersome'' tinnitus (moderate-severe handicap) increased with wholemeal/wholegrain bread intake (OR=0.86). Reports of less frequent transient tinnitus increased with dairy avoidance (OR=1.18) and decreased with caffeinated coffee (OR=0.98 per cup/day) and brown bread (OR=0.94). Conclusions: This is the first population study to report the association between dietary factors and tinnitus. Although individually dietary associations are mostly modest, particular changes in diet, such as switching between foodstuffs, may result in stronger associations. These findings offer insights into possible dietary associations with tinnitus, and this may be useful when discussing management options in combination with other lifestyle changes and therapies.	[McCormack, Abby; Edmondson-Jones, Mark; Fortnum, Heather] NIHR Nottingham, Hearing Biomed Res Unit, Nottingham, England; [Edmondson-Jones, Mark; Fortnum, Heather] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2RD, England; [McCormack, Abby] MRC Inst Hearing Res, Nottingham, England; [Mellor, Duane] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England; [Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Munro, Kevin J.] Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester Acad Hlth Sci, Manchester, Lancs, England; [Moore, David R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of Nottingham; University of Nottingham; University of Manchester; Oxford University Hospitals NHS Foundation Trust; University of Manchester; Cincinnati Children's Hospital Medical Center	Edmondson-Jones, M (corresponding author), NIHR Nottingham, Hearing Biomed Res Unit, 113 Ropewalk, Nottingham, England.	mark.edmondson-jones@nottingham.ac.uk	Mellor, Duane/Q-2184-2019; munro, kevin j/A-2899-2015; Mellor, Duane/H-1262-2012	munro, kevin j/0000-0001-6543-9098; Mellor, Duane/0000-0002-1369-3868; Dawes, Piers/0000-0003-3180-9884; Hunter, Abby/0000-0002-6533-6918	National Institute for Health Research; National Institute for Health Research (NIHR); Intramural Programme of the Medical Research Council [U135097130]; Medical Research Council [MC_qA137853] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Intramural Programme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Nottingham Hearing Biomedical Research Unit is funded by the National Institute for Health Research. This paper presents independent research funded in part by the National Institute for Health Research (NIHR). This research was facilitated by the NIHR Manchester Biomedical Research Centre, and DRM was supported by the Intramural Programme of the Medical Research Council (Grant U135097130). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Cancado Trindade A.A., 2013, EJERCICIO FUNCION JU, V3rd, P1; Claire LS, 2010, INT J AUDIOL, V49, P24, DOI 10.3109/14992020903160884; Davis A, 2000, TINNITUS HDB, V1, P6; Dawes P., 2014, EAR HEARING; El Refaie A, 2004, INT J AUDIOL, V43, P410; Erlandsson SI, 2000, BRIT J AUDIOL, V34, P11, DOI 10.3109/03005364000000114; ERLANDSSON SI, 1992, AUDIOLOGY, V31, P168; Glicksman JT, 2014, AM J MED, V127, P739, DOI 10.1016/j.amjmed.2014.02.033; Gopinath B, 2011, J NUTR HEALTH AGING, V15, P896, DOI 10.1007/s12603-011-0119-0; Gopinath B, 2011, J NUTR, V141, P1355, DOI 10.3945/jn.111.138610; Gopinath B, 2010, J NUTR, V140, P2207, DOI 10.3945/jn.110.128462; Gopinath B, 2010, AM J CLIN NUTR, V92, P416, DOI 10.3945/ajcn.2010.29370; Hall D. A., 2013, Clinical Investigation, V3, P21, DOI 10.4155/cli.12.129; Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004; Hoare J, 2004, NATL DIET NUTR SURVE; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Houston DK, 1999, AM J CLIN NUTR, V69, P564; McCormack A, 2014, J PSYCHOSOM RES, V76, P56, DOI 10.1016/j.jpsychores.2013.08.018; McFerran D, 2013, FOOD DRINK TINNITUS; Shargorodsky J, 2010, OTOLARYNG HEAD NECK, V142, P231, DOI 10.1016/j.otohns.2009.10.049; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Spankovich C, 2011, J AM ACAD AUDIOL, V22, P49, DOI 10.3766/jaaa.22.1.6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Weber JH, 2008, Z PSYCHOSOM MED PSYC, V54, P227, DOI 10.13109/zptm.2008.54.3.227; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	27	28	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114711	10.1371/journal.pone.0114711	http://dx.doi.org/10.1371/journal.pone.0114711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503070	Green Published, Green Accepted, gold			2022-12-26	WOS:000346375400046
J	Miyata, K; Kudo, K				Miyata, Kohei; Kudo, Kazutoshi			Mutual Stabilization of Rhythmic Vocalization and Whole-Body Movement	PLOS ONE			English	Article							REDUCED TIMING VARIABILITY; AUDITORY-STIMULATION; PARKINSONS-DISEASE; PHASE-TRANSITIONS; STREET DANCERS; GAIT; INTERFERENCE; PERFORMANCE; ORGANIZATION; EXECUTION	The current study investigated the rhythmic coordination between vocalization and whole-body movement. Previous studies have reported that spatiotemporal stability in rhythmic movement increases when coordinated with a rhythmic auditory stimulus or other effector in a stable coordination pattern. Therefore, the present study conducted two experiments to investigate (1) whether there is a stable coordination pattern between vocalization and whole-body movement and (2) whether a stable coordination pattern reduces variability in whole-body movement and vocalization. In Experiment 1, two coordination patterns between vocalizations and whole-body movement (hip, knee, and ankle joint flexion-on-the-voice vs. joint extension-on-the-voice) in a standing posture were explored at movement frequencies of 80, 130, and 180 beats per minute. At higher movement frequencies, the phase angle in the extension-on-the-voice condition deviated from the intended phase angle. However, the angle of the flexion-on-the-voice was maintained even when movement frequency increased. These results suggest that there was a stable coordination pattern in the flexion-on-the-voice condition. In Experiment 2, variability in whole-body movement and voice-onset intervals was compared between two conditions: one related to tasks performed in the flexion-on-the-voice coordination (coordination condition) that was a stable coordination pattern, and the other related to tasks performed independently (control condition). The results showed that variability in whole-body movement and voice-onset intervals was smaller in the coordination condition than in the control condition. Overall, the present study revealed mutual stabilization between rhythmic vocalization and whole-body movement via coordination within a stable pattern, suggesting that coupled action systems can act as a single functional unit or coordinative structure.	[Miyata, Kohei; Kudo, Kazutoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	University of Tokyo	Miyata, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	still.kzn@gmail.com	Kudo, Kazutoshi/GVT-3733-2022	Kudo, Kazutoshi/0000-0002-3199-9449; Miyata, Kohei/0000-0002-5412-8240	Japanese Ministry of Education, Culture, Sports, Science and Technology [24650382]; Sasakawa Scientific Research Grant from The Japan Science Society [25-611]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant from The Japan Science Society	This research was supported by Grant-in-Aid for Challenging Exploratory Research (No. 24650382) awarded to KK from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/) and by the Sasakawa Scientific Research Grant (No. 25-611) awarded to MK from The Japan Science Society (http://www.jss.or.jp/ikusei/ sasakawa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Batschelet E, 1981, CIRCULAR STAT BIOL; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Buchanan JJ, 1997, BIOL CYBERN, V76, P257, DOI 10.1007/s004220050338; Drewing K, 2003, Q J EXP PSYCHOL-A, V56, P329, DOI 10.1080/02724980244000396; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Helmuth LL, 1996, J EXP PSYCHOL HUMAN, V22, P278, DOI 10.1037/0096-1523.22.2.278; HICKS RE, 1975, J COMP PHYSIOL PSYCH, V89, P50, DOI 10.1037/h0076385; Hiscock M, 1995, BRAIN COGNITION, V29, P307, DOI 10.1006/brcg.1995.1284; HISCOCK M, 1986, NEUROPSYCHOLOGIA, V24, P691, DOI 10.1016/0028-3932(86)90008-4; Hoffmann CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045206; INHOFF AW, 1990, BRAIN COGNITION, V13, P59, DOI 10.1016/0278-2626(90)90040-U; Kelso J.A.S., 1983, PRODUCTION SPEECH, P137, DOI [10.1007/978-1-4613-8202-7_7, DOI 10.1007/978-1-4613-8202-7_7]; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kelso JAS, 1981, B PSYCHON SOC, V18; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Maitra KK, 2003, OTJR-OCCUP PART HEAL, V23, P35, DOI 10.1177/153944920302300105; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miura A, 2013, NEUROSCI LETT, V544, P157, DOI 10.1016/j.neulet.2013.04.005; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006; Muto T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-58; Park JH, 2009, NEUROREHABILITATION, V25, P123, DOI 10.3233/NRE-2009-0507; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Pellecchia GL, 2001, J MOTOR BEHAV, V33, P9, DOI 10.1080/00222890109601898; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Seyal M, 1999, CLIN NEUROPHYSIOL, V110, P424, DOI 10.1016/S1388-2457(98)00019-4; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Treffner P, 2002, HUM MOVEMENT SCI, V21, P641, DOI 10.1016/S0167-9457(02)00178-1; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	38	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115495	10.1371/journal.pone.0115495	http://dx.doi.org/10.1371/journal.pone.0115495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502730	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400094
J	Rhiel, L; Krah, S; Gunther, R; Becker, S; Kolmar, H; Hock, B				Rhiel, Laura; Krah, Simon; Guenther, Ralf; Becker, Stefan; Kolmar, Harald; Hock, Bjoern			REAL-Select: Full-Length Antibody Display and Library Screening by Surface Capture on Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DIRECTED EVOLUTION; PROTEIN-A; HETEROLOGOUS PROTEINS; AFFINITY MATURATION; ESCHERICHIA-COLI; BINDING; FRAGMENTS; EXPRESSION; PHAGE	We describe a novel approach named REAL-Select for the non-covalent display of IgG-molecules on the surface of yeast cells for the purpose of antibody engineering and selection. It relies on the capture of secreted native full-length antibodies on the cell surface via binding to an externally immobilized ZZ domain, which tightly binds antibody Fc. It is beneficial for high-throughput screening of yeast-displayed IgG-libraries during antibody discovery and development. In a model experiment, antibody-displaying yeast cells were isolated from a 1: 1,000,000 mixture with control cells confirming the maintenance of genotype-phenotype linkage. Antibodies with improved binding characteristics were obtained by affinity maturation using REAL-Select, demonstrating the ability of this system to display antibodies in their native form and to detect subtle changes in affinity by flow cytometry. The biotinylation of the cell surface followed by functionalization with a streptavidin-ZZ fusion protein is an approach that is independent of the genetic background of the antibody-producing host and therefore can be expected to be compatible with other eukaryotic expression hosts such as P. pastoris or mammalian cells.	[Rhiel, Laura; Guenther, Ralf; Becker, Stefan; Hock, Bjoern] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany; [Krah, Simon; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany	Merck KGaA; EMD Serono Inc.; Technical University of Darmstadt	Kolmar, H (corresponding author), Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany.	Kolmar@Biochemie-TUD.de; Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993				Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Blaise L, 2004, GENE, V342, P211, DOI 10.1016/j.gene.2004.08.014; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; HORWITZ AH, 1988, P NATL ACAD SCI USA, V85, P8678, DOI 10.1073/pnas.85.22.8678; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Mazor Y, 2010, FEBS J, V277, P2291, DOI 10.1111/j.1742-4658.2010.07645.x; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NILSSON J, 1994, EUR J BIOCHEM, V224, P103, DOI 10.1111/j.1432-1033.1994.tb20000.x; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Rakestraw JA, 2011, PROTEIN ENG DES SEL, V24, P525, DOI 10.1093/protein/gzr008; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Schreuder MP, 1996, TRENDS BIOTECHNOL, V14, P115, DOI 10.1016/0167-7799(96)10017-2; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Traxlmayr MW, 2013, PROTEIN ENG DES SEL, V26, P255, DOI 10.1093/protein/gzs102; Ueda M, 2000, BIOTECHNOL ADV, V18, P121, DOI 10.1016/S0734-9750(00)00031-8; van den Beucken T, 2003, FEBS LETT, V546, P288, DOI 10.1016/S0014-5793(03)00602-1; VanderVaart JM, 1997, APPL ENVIRON MICROB, V63, P615, DOI 10.1128/AEM.63.2.615-620.1997; Vanhoefer U, 2004, J CLIN ONCOL, V22, P175, DOI 10.1200/JCO.2004.05.114; Wang Z, 2005, PROTEIN ENG DES SEL, V18, P337, DOI 10.1093/protein/gzi036; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005	35	16	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114887	10.1371/journal.pone.0114887	http://dx.doi.org/10.1371/journal.pone.0114887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501029	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400060
J	Szelinger, S; Malenica, I; Corneveaux, JJ; Siniard, AL; Kurdoglu, AA; Ramsey, KM; Schrauwen, I; Trent, JM; Narayanan, V; Huentelman, MJ; Craig, DW				Szelinger, Szabolcs; Malenica, Ivana; Corneveaux, Jason J.; Siniard, Ashley L.; Kurdoglu, Ahmet A.; Ramsey, Keri M.; Schrauwen, Isabelle; Trent, Jeffrey M.; Narayanan, Vinodh; Huentelman, Matthew J.; Craig, David W.			Characterization of X Chromosome Inactivation Using Integrated Analysis of Whole-Exome and mRNA Sequencing	PLOS ONE			English	Article							MENTAL-RETARDATION; GENE-EXPRESSION; METHYLATION; FRAMEWORK; PATTERNS; GENOME; SEQ; IDENTIFICATION; DUPLICATION; ALIGNMENT	In females, X chromosome inactivation (XCI) is an epigenetic, gene dosage compensatory mechanism by inactivation of one copy of X in cells. Random XCI of one of the parental chromosomes results in an approximately equal proportion of cells expressing alleles from either the maternally or paternally inherited active X, and is defined by the XCI ratio. Skewed XCI ratio is suggestive of non-random inactivation, which can play an important role in X-linked genetic conditions. Current methods rely on indirect, semi-quantitative DNA methylation-based assay to estimate XCI ratio. Here we report a direct approach to estimate XCI ratio by integrated, family-trio based whole-exome and mRNA sequencing using phase-by-transmission of alleles coupled with allele-specific expression analysis. We applied this method to in silico data and to a clinical patient with mild cognitive impairment but no clear diagnosis or understanding molecular mechanism underlying the phenotype. Simulation showed that phased and unphased heterozygous allele expression can be used to estimate XCI ratio. Segregation analysis of the patient's exome uncovered a de novo, interstitial, 1.7 Mb deletion on Xp22.31 that originated on the paternally inherited X and previously been associated with heterogeneous, neurological phenotype. Phased, allelic expression data suggested an 83: 20 moderately skewed XCI that favored the expression of the maternally inherited, cytogenetically normal X and suggested that the deleterious affect of the de novo event on the paternal copy may be offset by skewed XCI that favors expression of the wild-type X. This study shows the utility of integrated sequencing approach in XCI ratio estimation.	[Szelinger, Szabolcs; Malenica, Ivana; Corneveaux, Jason J.; Siniard, Ashley L.; Kurdoglu, Ahmet A.; Ramsey, Keri M.; Schrauwen, Isabelle; Narayanan, Vinodh; Huentelman, Matthew J.; Craig, David W.] Translat Genom Res Inst, Ctr Rare Childhood Disorders, Phoenix, AZ 85004 USA; [Szelinger, Szabolcs] Arizona State Univ, Coll Liberal Arts & Sci, Mol & Cellular Biol Interdisciplinary Grad Progra, Tempe, AZ USA; [Schrauwen, Isabelle] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Trent, Jeffrey M.] Translat Genom Res Inst, Genet Basis Human Dis Div, Phoenix, AZ USA; [Narayanan, Vinodh] Barrow Neurol Inst, Phoenix, AZ 85013 USA	Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; University of Antwerp; Translational Genomics Research Institute; Barrow Neurological Institute	Craig, DW (corresponding author), Translat Genom Res Inst, Ctr Rare Childhood Disorders, Phoenix, AZ 85004 USA.	dcraig@tgen.org	Malenica, Ivana/J-2007-2019; Craig, David Wesley/K-6961-2019; Schrauwen, Isabelle/H-5908-2019	Malenica, Ivana/0000-0002-7404-8088; Craig, David Wesley/0000-0003-2040-1955; Schrauwen, Isabelle/0000-0001-7310-6082; Narayanan, Vinodh/0000-0002-0658-3847	TGen's Salt River Project (SRP) Graduate Student Support Program; FWO Vlaanderen; Stardust Foundation; TGen Foundation	TGen's Salt River Project (SRP) Graduate Student Support Program; FWO Vlaanderen(FWO); Stardust Foundation; TGen Foundation	SS is supported by TGen's Salt River Project (SRP) Graduate Student Support Program; IS is supported by FWO Vlaanderen. This study was funded by The Stardust Foundation, and multiple anonymous private donors via the TGen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Biliya S, 2010, EXP BIOL MED, V235, P139, DOI 10.1258/ebm.2009.009251; Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244; Bordes L, 2007, COMPUT STAT DATA AN, V51, P5429, DOI 10.1016/j.csda.2006.08.015; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desai V, 2011, CLIN GENET, V79, P176, DOI 10.1111/j.1399-0004.2010.01451.x; Disteche CM, 1999, P NATL ACAD SCI USA, V96, P14180, DOI 10.1073/pnas.96.25.14180; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hardcastle TJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-135; Hunter DR, 2007, ANN STAT, V35, P224, DOI 10.1214/009053606000001118; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li F, 2010, EUR J MED GENET, V53, P93, DOI 10.1016/j.ejmg.2010.01.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; Orstavik KH, 2009, HUM GENET, V126, P363, DOI 10.1007/s00439-009-0670-5; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROZOWSKY J, 2011, MOL SYSTEMS BIOL, V7, P1, DOI DOI 10.1038/MSB.2011.54; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Sun W, 2012, BIOMETRICS, V68, P1, DOI 10.1111/j.1541-0420.2011.01654.x; Swierczek SI, 2008, BLOOD, V112, P3186, DOI 10.1182/blood-2008-03-143925; Swierczek SI, 2012, BLOOD, V119, pE100, DOI 10.1182/blood-2011-11-390351; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhou YH, 2011, BIOINFORMATICS, V27, P2672, DOI 10.1093/bioinformatics/btr449	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113036	10.1371/journal.pone.0113036	http://dx.doi.org/10.1371/journal.pone.0113036			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503791	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400005
J	Videnska, P; Sedlar, K; Lukac, M; Faldynova, M; Gerzova, L; Cejkova, D; Sisak, F; Rychlik, I				Videnska, Petra; Sedlar, Karel; Lukac, Maja; Faldynova, Marcela; Gerzova, Lenka; Cejkova, Darina; Sisak, Frantisek; Rychlik, Ivan			Succession and Replacement of Bacterial Populations in the Caecum of Egg Laying Hens over Their Whole Life	PLOS ONE			English	Article							SEROVAR ENTERITIDIS INFECTION; SALMONELLA COLONIZATION; COMPETITIVE-EXCLUSION; MICROBIOTA; CHICKENS; DIVERSITY; COMMUNITY; BUTYRATE; CELLS	In this study we characterised the development of caecal microbiota in egg laying hens over their commercial production lifespan, from the day of hatching until 60 weeks of age. Using pyrosequencing of V3/V4 variable regions of 16S rRNA genes for microbiota characterisation, we were able to define 4 different stages of caecal microbiota development. The first stage lasted for the first week of life and was characterised by a high prevalence of Enterobacteriaceae (phylum Proteobacteria). The second stage lasted from week 2 to week 4 and was characterised by nearly an absolute dominance of Lachnospiraceae and Ruminococcaceae (both phylum Firmicutes). The third stage lasted from month 2 to month 6 and was characterised by the succession of Firmicutes at the expense of Bacteroidetes. The fourth stage was typical for adult hens in full egg production aged 7 months or more and was characterised by a constant ratio of Bacteroidetes and Firmicutes formed by equal numbers of the representatives of both phyla.	[Videnska, Petra; Lukac, Maja; Faldynova, Marcela; Gerzova, Lenka; Cejkova, Darina; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel] Brno Univ Technol, CS-61090 Brno, Czech Republic	Czech Veterinary Research Institute; Brno University of Technology	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022; Cejkova, Darina/AAA-5820-2022; Sedlar, Karel/K-1120-2014	, Ivan/0000-0001-7995-6483; Cejkova, Darina/0000-0002-6989-6330; Sedlar, Karel/0000-0002-8269-4020	Czech Ministry of Education [MZE0002716202, CZ.1.05/2.1.00/01.0006-ED0006/01/01]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the projects MZE0002716202 and HealthyGut of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Hoszowski A, 1997, COMP IMMUNOL MICROB, V20, P111, DOI 10.1016/S0147-9571(96)00042-2; Juricova H, 2013, APPL ENVIRON MICROB, V79, P745, DOI 10.1128/AEM.02628-12; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Methner U, 1999, INT J FOOD MICROBIOL, V49, P35, DOI 10.1016/S0168-1605(99)00051-3; Methner U, 1997, INT J FOOD MICROBIOL, V35, P223, DOI 10.1016/S0168-1605(96)01236-6; Nordentoft S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110076; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	38	107	115	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115142	10.1371/journal.pone.0115142	http://dx.doi.org/10.1371/journal.pone.0115142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501990	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400075
J	Domingues, CSB; Waldman, EA				Bruniera Domingues, Carmen-Silvia; Waldman, Eliseu Alves			Causes of Death among People Living with AIDS in the Pre- and Post-HAART Eras in the City of S(a)over-tildeo Paulo, Brazil	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; ACTIVE ANTIRETROVIRAL THERAPY; SURVEYS ANRS EN19; RIO-DE-JANEIRO; INTERNATIONAL CLASSIFICATION; MORTALITY-RATES; PERSISTENT ROLE; UNITED-STATES; DISEASES; CANCERS	Objective: We examine the trend in causes of death among people living with AIDS in the city of S (a) over tildeo Paulo, Brazil, in the periods before and after the introduction of highly active antiretroviral therapy (HAART), and we investigate potential disparities across districts of residence. Methods: Descriptive study of three periods: pre-HAART (1991-1996); early post-HAART (1997-1999); and late post-HAART (2000-2006). The data source was the S (a) over tildeo Paulo State STD/AIDS Program and S (a) over tildeo Paulo State Data Analysis Foundation. Causes of death were classified by the ICD-9 (1991-1995) and ICD-10 (1996-2006). We estimated age-adjusted mortality rates for leading underlying causes of death and described underlying and associated causes of death according to sociodemographic characteristics and area of residence. We used Pearson's chi-square test or Fisher's exact test to compare categorical variables. Areas of residence were categorized using a socioeconomic index. To analyze trends we apply generalized linear model with Poisson regression. Results: We evaluated 32,808 AIDS-related deaths. Between the pre- and late post-HAART periods, the proportion of deaths whose underlying causes were non-AIDS-related diseases increased from 0.2% to 9.6% (p < 0.001): from 0.01% to 1.67% (p < 0.001) for cardiovascular diseases; 0.01% to 1.62% (p < 0.001) for bacterial/unspecified pneumonia; and 0.03% to 1.46% (p < 0.001) for non-AIDS-defining cancers. In the late post-HAART period, the most common associated causes of death were bacterial/unspecified pneumonia (35.94%), septicemia (33.46%), cardiovascular diseases (10.11%) and liver diseases (8.0%); and common underlying causes, besides AIDS disease, included non-AIDS-defining cancers in high-income areas, cardiovascular diseases in middle-income areas and assault in low-income areas. Conclusions: The introduction of HAART has shifted the mortality profile away from AIDS-related conditions, suggesting changes in the pattern of morbidity, but heterogeneously according to area of residence. There is a need for public policies aimed at adapting health care services to address the new scenario.	[Bruniera Domingues, Carmen-Silvia] Referral & Training Ctr, Sao Paulo State Dept Hlth STD & AIDS, Sao Paulo State Program STDs & AIDS, Sao Paulo, Brazil; [Bruniera Domingues, Carmen-Silvia; Waldman, Eliseu Alves] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Waldman, EA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.	eawaldma@usp.br	Waldman, Eliseu A/I-9401-2012	Waldman, Eliseu A/0000-0001-7807-6898	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development) [309502/2003-9]	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development)	Financial support for this research was provided by a grant from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development; Grant no. 309502/2003-9 to EAW). The funder had no role in the data collection, data analysis, preparation of the manuscript or decision to publish. No additional external funding was received for this study.	Adih William K, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P5, DOI 10.1177/1545109710384505; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766; Crabtree-Ramirez B, 2014, JAIDS-J ACQ IMM DEF, V67, pS96, DOI 10.1097/QAI.0000000000000261; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Ferreira MP, 2006, SAO PAULO PERSPECT, V20, P5; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Gopal M, 2009, CURR CARDIOL REV, V5, P149, DOI 10.2174/157340309788166705; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003; Hessamfar-Bonarek M, 2010, INT J EPIDEMIOL, V39, P135, DOI 10.1093/ije/dyp300; Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Rezende ELLF, 2010, BRAZ J INFECT DIS, V14, P558, DOI [10.1016/S1413-8670(10)70112-4, 10.1590/S1413-86702010000600003]; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Martinez E, 2009, CURR OPIN INFECT DIS, V22, P28, DOI 10.1097/QCO.0b013e328320a849; Melo VH, 2014, J LOW GENIT TRACT DI, V18, P128, DOI 10.1097/LGT.0b013e31829ee855; Ministerio da Saude do Brasil Secretaria de Politicas de Saude Coordenacao Nacional de DST e Aids, 2002, VIG HIV BRAS NOV DIR; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Departamento de DST Aids e Hepatites Virais, 2010, B EPIDEMIOLOGICO AID, VVI, P8; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Programa Nacional de DST e Aids, 2004, CRIT DEF CAS AIDS AD; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2011, AIDS RES HUM RETROV, V27, P25, DOI 10.1089/aid.2010.0089; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Prefeitura da Cidade de Sao Paulo, 2002, SECR MUN DES TRAB SO; Prefeitura da Cidade de Sao Paulo. Secretaria Municipal de Saude, 2010, B EPIDEMIOLOGICO AID, VXIV, P17; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Santo AH, 2000, REV SAUDE PUBL, V34, P21, DOI 10.1590/S0034-89102000000100005; Santo AH, 1999, REV BRASIL EPIDEMIOL, P90; Santos SS, 2013, J INT AIDS SOC, V16, P17344; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Simard EP, 2010, CLIN INFECT DIS, V51, P957, DOI 10.1086/656416; Suarez LC, 2006, REV ESP SALUD PUBLIC, V80, P157, DOI [10.1590/s1135-57272006000200005, 10.1590/S1135-57272006000200005]; Peres MFT, 2011, REV PANAM SALUD PUBL, V29, P17, DOI 10.1590/S1020-49892011000100003; Waldvogel BC, 2010, DADOS REPENSAR AIDS, P9; Waldvogel Bernadette Cunha, 2006, Rev. bras. estud. popul., V23, P187, DOI 10.1590/S0102-30982006000100011	42	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114661	10.1371/journal.pone.0114661	http://dx.doi.org/10.1371/journal.pone.0114661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500837	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700041
J	Song, P; Wei, HH; Cao, ZY; Wang, P; Zhu, GP				Song, Ping; Wei, Huanhuan; Cao, Zhengyu; Wang, Peng; Zhu, Guoping			Single Arginine Mutation in Two Yeast Isocitrate Dehydrogenases: Biochemical Characterization and Functional Implication	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; COMPARTMENTAL LOCALIZATION; IDH1; 2-HYDROXYGLUTARATE; INSIGHTS; REVEAL	Isocitrate dehydrogenase ( IDH), a housekeeping gene, has drawn the attention of cancer experts. Mutation of the catalytic Arg132 residue of human IDH1 (HcIDH) eliminates the enzyme's wild-type isocitrate oxidation activity, but confer the mutant an ability of reducing alpha-ketoglutarate (alpha-KG) to 2-hydroxyglutarate (2-HG). To examine whether an analogous mutation in IDHs of other eukaryotes could cause similar effects, two yeast mitochondrial IDHs, Saccharomyces cerevisiae NADP+IDH1 (ScIDH1) and Yarrowia lipolytica NADP(+)-IDH (YIIDH), were studied. The analogous Arg residues (Arg148 of ScIDH1 and Arg141 of YIIDH) were mutated to His. The K-m values of ScIDH1 R148H and YIIDH R141H for isocitrate were determined to be 2.4-fold and 2.2-fold higher, respectively, than those of the corresponding wild-type enzymes. The catalytic efficiencies (k(cat)/K-m) of ScIDH1 R148H and YIIDH R141H for isocitrate oxidation were drastically reduced by 227-fold and 460-fold, respectively, of those of the wild-type enzymes. As expected, both ScIDH1 R148H and YIIDH R141H acquired the neomorphic activity of catalyzing alpha-KG to 2-HG, and the generation of 2-HG was confirmed using gas chromatography/time of flight-mass spectrometry (GC/TOF-MS). Kinetic analysis showed that ScIDH1 R148H and YIIDH R141H displayed 5.2-fold and 3.3-fold higher affinities, respectively, for alpha-KG than the HcIDH R132H mutant. The catalytic efficiencies of ScIDH1 R148H and YIIDH R141H for a-KG were 5.5-fold and 4.5-fold, respectively, of that of the HcIDH R132H mutant. Since the HcIDH Arg132 mutation is associated with the tumorigenesis, this study provides fundamental information for further research on the physiological role of this IDH mutation in vivo using yeast.	[Song, Ping; Wei, Huanhuan; Cao, Zhengyu; Wang, Peng; Zhu, Guoping] Anhui Normal Univ, Inst Mol Biol & Biotechnol, Wuhu 241000, Anhui, Peoples R China	Anhui Normal University	Wang, P (corresponding author), Anhui Normal Univ, Inst Mol Biol & Biotechnol, 1 Beijing East Rd, Wuhu 241000, Anhui, Peoples R China.	wangpeng1219@gmail.com; gpz1996@yahoo.com	Wang, Peng/I-8770-2018	Wang, Peng/0000-0002-5598-0996	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 31400003]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424110004]; Natural Science Foundation of Anhui Province of China [1308085QC67]; Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China [KJ2013A128]	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China	This research was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005, 31400003), Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424110004), the Natural Science Foundation of Anhui Province of China (1308085QC67), and the Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China (KJ2013A128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Contreras-Shannon V, 2004, ARCH BIOCHEM BIOPHYS, V423, P235, DOI 10.1016/j.abb.2003.12.038; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guaragnella N, 2014, FEMS YEAST RES, V14, P2, DOI 10.1111/1567-1364.12094; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Li X, 2013, APPL BIOCHEM BIOTECH, V171, P403, DOI 10.1007/s12010-013-0373-1; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lu Q, 2008, ARCH BIOCHEM BIOPHYS, V472, P17, DOI 10.1016/j.abb.2008.01.025; Lu Q, 2010, ARCH BIOCHEM BIOPHYS, V493, P125, DOI 10.1016/j.abb.2009.10.011; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Pereira C, 2012, FEBS J, V279, P697, DOI 10.1111/j.1742-4658.2012.08477.x; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Shin SW, 2008, BIOCHEM BIOPH RES CO, V366, P1012, DOI 10.1016/j.bbrc.2007.12.067; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yang ES, 2011, BMB REP, V44, P312, DOI 10.5483/BMBRep.2011.44.5.312; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	30	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115025	10.1371/journal.pone.0115025	http://dx.doi.org/10.1371/journal.pone.0115025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502799	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700085
J	Yu, SH; Huang, CY; Lee, SD; Hsu, MF; Wang, RY; Kao, CL; Kuo, CH				Yu, Szu-Hsien; Huang, Chih-Yang; Lee, Shin-Da; Hsu, Ming-Fen; Wang, Ray-Yau; Kao, Chung-Lan; Kuo, Chia-Hua			Decreased Eccentric Exercise-Induced Macrophage Infiltration in Skeletal Muscle after Supplementation with a Class of Ginseng-Derived Steroids	PLOS ONE			English	Article							FACTOR-KAPPA-B; PANAX-GINSENG; REGENERATION; HYPERTROPHY; IMPROVEMENT; MODULATION; GROWTH; CELLS	Dammarane steroids (DS) are a class of chemical compounds present in Panax ginseng. Here, we evaluated the effect of 10 weeks of DS supplementation on inflammatory modulation in the soleus muscle following eccentric exercise (EE)induced muscle damage (downhill running). Eighty rats were randomized into 4 groups of DS supplementation (saline, 20, 60, 120 mg/kg body weight). Inflammatory markers were measured at rest and again 1 h after EE. At rest, NFkB signaling, TNF-alpha and IL-6 mRNAs, 3-nitrotyrosine, glutathione peroxidase, and GCS (glutamylcysteine synthetase) levels were significantly elevated in the skeletal muscle of DS-treated rats in a dose-dependent manner. Additionally, there were no detectable increases in the number of necrotic muscle fibers or CD68(+) M1 macrophages. However, muscle strength, centronucleation, IL-10 mRNA expression, and the number of CD163(+) M2 macrophages increased significantly over controls with DS treatment in rat soleus muscle. Under EE-challenged conditions, significant increases in muscle fiber necrosis, CD68(+) M1 macrophage distribution, and 3-nitrotyrosine were absent in rats that received low and medium doses (20 and 60 mg/kg) of DS treatment, suggesting that DS possess anti-inflammatory action protecting against a muscle-damaging challenge. However, this protective activity was diminished when a high dose of DS (120 mg/kg) was administered, suggesting that DS possess hormetic properties. In conclusion, our study provides new evidence suggesting that DS is an ergogenic component of ginseng that potentiate inflammation at baseline but that produce anti-inflammatory effects on skeletal muscle following muscle-damaging exercise. Furthermore, high doses should be avoided in formulating ginseng-based products.	[Yu, Szu-Hsien; Hsu, Ming-Fen; Kuo, Chia-Hua] Univ Taipei, Lab Exercise Biochem, Taipei, Taiwan; [Yu, Szu-Hsien] Natl Ilan Univ, Dept Leisure Ind & Hlth Promot, Taipei, Yilan Cty, Taiwan; [Huang, Chih-Yang; Lee, Shin-Da; Kao, Chung-Lan] China Med Univ, Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang; Lee, Shin-Da] Asia Univ, Dept Hlth & Biotechnol, Taichung, Taiwan; [Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan	University of Taipei; National Ilan University; China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University	Kuo, CH (corresponding author), Univ Taipei, Lab Exercise Biochem, Taipei, Taiwan.	kch@utaipei.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Kuo, Chia-Hua/0000-0002-1731-4984	National Science Council of Taiwan; Pegasus Pharmaceuticals [101-2622-H-154-001-CC2]; University of Taipei, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Pegasus Pharmaceuticals; University of Taipei, Taiwan	This study was supported in part by National Science Council of Taiwan, Pegasus Pharmaceuticals (101-2622-H-154-001-CC2), http://www.ppginco.com/eng/aboutus/index.html, and the University of Taipei, Taiwan, www.utaipei.edu.tw. The funders had no role in study design, data collection and analysis, manuscript preparation, or decision to publish.	Adori C, 2010, BEHAV BRAIN RES, V206, P299, DOI 10.1016/j.bbr.2009.09.031; Bahrke MS, 2000, SPORTS MED, V29, P113, DOI 10.2165/00007256-200029020-00004; Bucci LR, 2000, AM J CLIN NUTR, V72, p624S, DOI 10.1093/ajcn/72.2.624S; Chen CY, 2010, CHINESE J PHYSIOL, V53, P62, DOI 10.4077/CJP.2010.AMK078; de Oliveira ACC, 2001, COMP BIOCHEM PHYS C, V130, P369, DOI 10.1016/S1532-0456(01)00262-9; de Oliveira ACC, 2005, J ETHNOPHARMACOL, V97, P211, DOI 10.1016/j.jep.2004.10.029; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Gumieniczek A, 2001, CLIN CHIM ACTA, V314, P39, DOI 10.1016/S0009-8981(01)00680-5; Howell JM, 2014, NEUROMUSCULAR DISORD, V24, P167, DOI 10.1016/j.nmd.2013.10.003; Jensen KT, 2008, J ORTHOP RES, V26, P816, DOI 10.1002/jor.20600; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; Kim WK, 2013, EUR J PHARMACOL, V702, P285, DOI 10.1016/j.ejphar.2013.01.048; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; Monda M, 2009, J MUSCLE RES CELL M, V30, P139, DOI 10.1007/s10974-009-9182-0; Novak ML, 2009, AM J PHYSIOL-REG I, V296, pR1132, DOI 10.1152/ajpregu.90874.2008; Park IH, 2002, CHEM PHARM BULL, V50, P538, DOI 10.1248/cpb.50.538; Park SH, 2010, TOXICOLOGY, V278, P131, DOI 10.1016/j.tox.2010.04.003; Przybyla B, 2006, EXP GERONTOL, V41, P320, DOI 10.1016/j.exger.2005.12.007; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Scholz D, 2004, BIOORG MED CHEM LETT, V14, P2983, DOI 10.1016/j.bmcl.2004.02.104; Sievenpiper JL, 2004, J AM COLL NUTR, V23, P248, DOI 10.1080/07315724.2004.10719368; Sievenpiper JL, 2003, EUR J CLIN NUTR, V57, P243, DOI 10.1038/sj.ejcn.1601550; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Song SB, 2012, J GINSENG RES, V36, P146, DOI 10.5142/jgr.2012.36.2.146; STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290, DOI 10.1152/jappl.1994.77.1.290; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Ungaro R, 2009, AM J PHYSIOL-GASTR L, V296, pG1167, DOI 10.1152/ajpgi.90496.2008; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang Y, 2012, HORM METAB RES, V44, P33, DOI 10.1055/s-0031-1295416; Zhao JM, 2011, BIOORG MED CHEM LETT, V21, P1027, DOI 10.1016/j.bmcl.2010.12.035; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064	38	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114649	10.1371/journal.pone.0114649	http://dx.doi.org/10.1371/journal.pone.0114649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500579	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700040
J	Klein, C; Betz, J; Hirschbuehl, M; Fuchs, C; Schmiedtova, B; Engelbrecht, M; Mueller-Paul, J; Rosenberg, R				Klein, Christoph; Betz, Juliane; Hirschbuehl, Martin; Fuchs, Caroline; Schmiedtova, Barbara; Engelbrecht, Martina; Mueller-Paul, Julia; Rosenberg, Raphael			Describing Art - An Interdisciplinary Approach to the Effects of Speaking on Gaze Movements during the Beholding of Paintings	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL-ATTENTION; LANGUAGE; PERCEPTION; MEDIATION; OBJECTS	Ever since the Renaissance speaking about paintings has been a fundamental approach for beholders, especially experts. However, it is unclear whether and how speaking about art modifies the way we look at it and this was not yet empirically tested. The present study investigated to the best of our knowledge for the first time in what way speaking modifies the patterns of fixations and gaze movements while looking at paintings. Ninety nine university students looked at four paintings selected to cover different art historical typologies for periods of 15 minutes each while gaze movement data were recorded. After 10 minutes, the participants of the experimental group were asked open questions about the painting. Speaking dramatically reduced the duration of fixations and painting area covered by fixations while at the same time increasing the frequencies of fixations, gaze length and the amount of repeated transitions between fixation clusters. These results suggest that the production of texts as well-organised sequences of information, structures the gazes of art beholders by making them quicker, more focused and better connected.	[Klein, Christoph; Mueller-Paul, Julia] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Klein, Christoph] Univ Freiburg, Dept Child & Adolescent Psychiat Psychotherapy &, D-79106 Freiburg, Germany; [Betz, Juliane; Hirschbuehl, Martin; Engelbrecht, Martina] Heidelberg Univ, Inst European Art Hist, Heidelberg, Germany; [Hirschbuehl, Martin; Fuchs, Caroline; Rosenberg, Raphael] Univ Vienna, Dept Art Hist, Vienna, Austria; [Hirschbuehl, Martin; Fuchs, Caroline; Rosenberg, Raphael] Univ Vienna, Cognit Res Platform, Vienna, Austria; [Schmiedtova, Barbara] Heidelberg Univ, Inst German Foreign Language Philol, Heidelberg, Germany	Bangor University; University of Freiburg; Ruprecht Karls University Heidelberg; University of Vienna; University of Vienna; Ruprecht Karls University Heidelberg	Klein, C (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	c.klein@bangor.ac.uk	Kabongo, Jean Claude/ABC-5756-2021	Mertins, Barbara/0000-0002-0271-0431	Deutsche Forschungsgemeinschaft (DFG) [RO 2281/3-1]; Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	Research was supported by the Deutsche Forschungsgemeinschaft (DFG, RO 2281/3-1). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Altmann GTM, 2009, COGNITION, V111, P55, DOI 10.1016/j.cognition.2008.12.005; Athanasopoulos P, 2008, APPL PSYCHOLINGUIST, V29, P105, DOI 10.1017/S0142716408080053; Billman D, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P615; Billman D, 1998, PROCEEDINGS OF THE TWENTIETH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P156; Boehm G., 1995, BESCHREIBUNGSKUNST K; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; de Piles R., 1677, CONVERSATIONS CONNAI; Doni AF, 1552, MARMI; Engelbrecht M, 2010, IMAGE, P11; Felibien A, 1666, ENTRETIENS VIE OUVRA; FISK AD, 1987, CURR PSYCHOL RES REV, V5, P315; Gauvin HS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00818; Gennari SP, 2002, COGNITION, V83, P49, DOI 10.1016/S0010-0277(01)00166-4; Griffin ZM, 2006, BRAIN LANG, V99, P272, DOI 10.1016/j.bandl.2005.08.003; Griffin ZM, 2011, MENT LEX, V6, P53, DOI 10.1075/ml.6.1.03gri; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Ho C, 2005, NEUROSCI LETT, V389, P35, DOI 10.1016/j.neulet.2005.07.003; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Holsanova J., 2008, DISCOURSE VISION COG; Kase O, 2010, WORTEN SEHEN LERNEN; Kathmann N, 1999, PSYCHOPHYSIOLOGY, V36, P158, DOI 10.1017/S0048577299981167; Klein C, 2008, BRAIN COGNITION, V68, P215, DOI 10.1016/j.bandc.2008.08.012; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Levinson SC, 2002, COGNITION, V84, P155, DOI 10.1016/S0010-0277(02)00045-8; Meyer AS, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P253, DOI 10.1016/B978-044451020-4/50015-3; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Molnar F., 1981, ADV INTRINSIC MOTIVA, P385, DOI 10.1007/978-1-4613-3195-7_16; MOLNAR F, 1987, EYE MOVEMENTS PHYSL, P363; Naigles LR, 1998, PSYCHOL SCI, V9, P363, DOI 10.1111/1467-9280.00069; NODINE CF, 1993, LEONARDO, V26, P219, DOI 10.2307/1575815; Papafragou A, 2008, COGNITION, V108, P155, DOI 10.1016/j.cognition.2008.02.007; Piai V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00832; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; ROSENBERG R, 1995, Z KUNSTGESCHICHTE, V58, P297, DOI 10.2307/1482816; Rosenberg R, 2008, KUNSTHISTORISCHES JB, V6, P127; Rosenberg R, 2014, JB BAYERISCHEN AKAD, V27, P78; Salverda AP, 2011, J EXP PSYCHOL HUMAN, V37, P1122, DOI 10.1037/a0023101; SIGMAN M, 1991, COGNITIVE DEV, V6, P47, DOI 10.1016/0885-2014(91)90005-X; Slobin D., 1996, RETHINKING LINGUISTI, P70, DOI DOI 10.1016/S0378-2166(97)83851-9; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; Vogt S, 2007, PERCEPTION, V36, P91, DOI 10.1068/p5262; Wade NJ, 2005, MOVING TABLET EYE OR; Welzel Barbara, 1997, GESELLIGKEIT GESELLS, P495; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e102439	10.1371/journal.pone.0102439	http://dx.doi.org/10.1371/journal.pone.0102439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AW9YP	25494170	Green Published, gold			2022-12-26	WOS:000346611400001
J	Zhang, XS; Pebody, R; De Angelis, D; White, PJ; Charlett, A; McCauley, JW				Zhang, Xu-Sheng; Pebody, Richard; De Angelis, Daniela; White, Peter J.; Charlett, Andre; McCauley, John W.			The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment	PLOS ONE			English	Article							A H1N1 VIRUS; CROSS-PROTECTION; INFECTION; IMMUNITY; DYNAMICS; VACCINES; LIVE; TRANSMISSION; A(H1N1)PDM09; PATTERNS	Background: One pathway through which pandemic influenza strains might emerge is reassortment from coinfection of different influenza A viruses. Seasonal influenza vaccines are designed to target the circulating strains, which intuitively decreases the prevalence of coinfection and the chance of pandemic emergence due to reassortment. However, individual-based analyses on 2009 pandemic influenza show that the previous seasonal vaccination may increase the risk of pandemic A(H1N1) pdm09 infection. In view of pandemic influenza preparedness, it is essential to understand the overall effect of seasonal vaccination on pandemic emergence via reassortment. Methods and Findings: In a previous study we applied a population dynamics approach to investigate the effect of infection-induced cross-immunity on reducing such a pandemic risk. Here the model was extended by incorporating vaccination for seasonal influenza to assess its potential role on the pandemic emergence via reassortment and its effect in protecting humans if a pandemic does emerge. The vaccination is assumed to protect against the target strains but only partially against other strains. We find that a universal seasonal vaccine that provides full-spectrum cross-immunity substantially reduces the opportunity of pandemic emergence. However, our results show that such effectiveness depends on the strength of infection-induced cross-immunity against any novel reassortant strain. If it is weak, the vaccine that induces cross-immunity strongly against non-target resident strains but weakly against novel reassortant strains, can further depress the pandemic emergence; if it is very strong, the same kind of vaccine increases the probability of pandemic emergence. Conclusions: Two types of vaccines are available: inactivated and live attenuated, only live attenuated vaccines can induce heterosubtypic immunity. Current vaccines are effective in controlling circulating strains; they cannot always help restrain pandemic emergence because of the uncertainty of the oncoming reassortant strains, however. This urges the development of universal vaccines for prevention of pandemic influenza.	[Zhang, Xu-Sheng; White, Peter J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England; [Zhang, Xu-Sheng; White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London, England; [Pebody, Richard] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Resp Dis, London, England; [De Angelis, Daniela; Charlett, Andre] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Stat Unit, London, England; [De Angelis, Daniela] Univ Forvie Site, MRC, Biostat Unit, Cambridge, England; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, NIHR Hlth Protect Res Unit Modelling Methodol, London, England; [McCauley, John W.] Natl Inst Med Res, MRC, London NW7 1AA, England	Public Health England; Imperial College London; Public Health England; Public Health England; MRC Biostatistics Unit; University of Cambridge; Imperial College London; MRC National Institute for Medical Research	Zhang, XS (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England.	xu-sheng.zhang@phe.gov.uk		De Angelis, Daniela/0000-0001-6619-6112; Pebody, Richard/0000-0002-9069-2885; Zhang, Xu-Sheng/0000-0002-6596-4500	Public Health England; MRC [MR/K010174/1]; UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE) [HPRU-2012-10080]; MRC NIMR programme [u117512723]; Medical Research Council [MC_U105260556, MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; MRC [MC_U105260556] Funding Source: UKRI	Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE); MRC NIMR programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Public Health England. PJW thanks the MRC for Centre funding [grant number MR/K010174/1], and also thanks the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) for funding [grant number HPRU-2012-10080]. JWM was supported by MRC NIMR programme No. u117512723. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen JR, 2014, P NATL ACAD SCI USA, V111, P2476, DOI 10.1073/pnas.1323954111; Coburn BJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S6; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; DAVIES JR, 1986, J HYG-CAMBRIDGE, V96, P345, DOI 10.1017/S0022172400066092; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, GLOBAL PATTERNS SEAS; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gilbert SC, 2013, INFLUENZA OTHER RESP, V7, P750, DOI 10.1111/irv.12013; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girard MP, 2008, VACCINE, V26, P3969, DOI [10.1016/j.vaccine.2008.04.051, 10.1016/j.vaccine.2008.03.006]; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Gregory V, 2002, VIROLOGY, V300, P1, DOI 10.1006/viro.2002.1513; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; HOSKINS TW, 1976, LANCET, V1, P105; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kafatos G, 2013, INFLUENZA OTHER RESP, V7, P1175, DOI 10.1111/irv.12163; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Kelly H, 2009, Euro Surveill, V14; Kelly H, 2012, VACCINE, V30, P2037, DOI 10.1016/j.vaccine.2011.11.060; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007366; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Liu W, 2010, CLIN INFECT DIS, V50, P1359, DOI 10.1086/652143; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; MASUREL N, 1969, B WORLD HEALTH ORGAN, V41, P461; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Mercer GN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S11; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Pebody R, 2011, EUROSURVEILLANCE, V16, P8; Perera RAPM, 2011, EMERG INFECT DIS, V17, P1897, DOI 10.3201/eid1710.110629; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pitzer VE, 2011, P NATL ACAD SCI USA, V108, P19353, DOI 10.1073/pnas.1110507108; Plosker GL, 2012, DRUGS, V72, P1543, DOI 10.2165/11209650-000000000-00000; Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rabadan R, 2008, INFLUENZA OTHER RESP, V2, P9, DOI 10.1111/j.1750-2659.2007.00030.x; Restif O, 2007, J R SOC INTERFACE, V4, P143, DOI 10.1098/rsif.2006.0167; Rios-Doria D, 2009, J THEOR BIOL, V261, P584, DOI 10.1016/j.jtbi.2009.08.020; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Worobey M, 2014, P NATL ACAD SCI USA, V111, P8107, DOI 10.1073/pnas.1324197111; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x; Xiao YY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-589; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Yin JK, 2012, VACCINE, V30, P3209, DOI 10.1016/j.vaccine.2012.02.048; Zhang XS, 2013, EPIDEMICS-NETH, V5, P20, DOI 10.1016/j.epidem.2012.10.003	77	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114637	10.1371/journal.pone.0114637	http://dx.doi.org/10.1371/journal.pone.0114637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494180	gold, Green Submitted, Green Published			2022-12-26	WOS:000346611400064
J	Scarlett, K; Pattabiraman, V; Barnett, P; Liu, D; Anderson, LM				Scarlett, Kisha; Pattabiraman, Vaishnavi; Barnett, Petrina; Liu, Dong; Anderson, Leonard M.			The Proangiogenic Effect of Iroquois Homeobox Transcription Factor Irx3 in Human Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; ANGIOGENESIS; NOTCH; EXPRESSION; MORPHOGENESIS; ACTIVATION; MIGRATION; APOPTOSIS; HEART; ROLES	Angiogenesis is a dynamic process required for embryonic development. However, postnatal vascular growth is characteristic of multiple disease states. Despite insights into the multistep process in which adhesion molecules, extracellular matrix proteins, growth factors, and their receptors work in concert to form new vessels from the preexisting vasculature, there remains a lack of insight of the nuclear transcriptional mechanisms that occur within endothelial cells (ECs) in response to VEGF. Iroquois homeobox gene 3 (Irx3) is a transcription factor of the Iroquois family of homeobox genes. Irx homeodomain transcription factors are involved in the patterning and development of several tissues. Irx3 is known for its role during embryogenesis in multiple organisms. However, the expression and function of Irx3 in human postnatal vasculature remains to be investigated. Here we show that Irx3 is expressed in human microvascular endothelial cells, and expression is elevated by VEGF stimulation. Genetic Irx3 gain and loss of function studies in human microvascular endothelial cells resulted in the modulation of EC migration during wound healing, chemotaxis and invasion, and tubulogenesis. Additionally, we observed increased delta-like ligand 4 (Dll4) expression, which suggests an increase in EC tip cell population. Finally, siRNA screening studies revealed that transient knockdown of Hey1, a downstream Notch signaling mediator, resulted in increased Irx3 expression in response to VEGF treatment. Strategies to pharmacologically regulate Irx3 function in adult endothelial cells may provide new therapies for angiogenesis.	[Scarlett, Kisha; Pattabiraman, Vaishnavi; Liu, Dong; Anderson, Leonard M.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Liu, Dong; Anderson, Leonard M.] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Barnett, Petrina] Clark Atlanta Univ, Canc Ctr Therapeut Dev, Atlanta, GA 30314 USA	Morehouse School of Medicine; Morehouse School of Medicine; Clark Atlanta University	Anderson, LM (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.	landerson@msm.edu	Pattabiraman, Vaishnavi/K-1924-2019		National Institutes of Health [K01 HL084760-01, 5R25 HL003676, 5G12 MD007602]; National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant [EEC-9731643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003676, K01HL084760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 HL084760-01 (to L. M. A.), 5R25 HL003676 (to G. H. G.), and 5G12 MD007602 (to V. M. R.). This work was also supported by the National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant EEC-9731643 (to L. M. A.).	Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; Benedito R, 2013, EXP CELL RES, V319, P1281, DOI 10.1016/j.yexcr.2013.01.010; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Cardona Sandra M, 2013, Methods Mol Biol, V1013, P1, DOI 10.1007/978-1-62703-426-5_1; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chen W, 2008, J BIOL CHEM, V283, P16293, DOI 10.1074/jbc.M801803200; Cheng Z, 2011, HUM GENET, V130, P657, DOI 10.1007/s00439-011-0996-7; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Doi T, 2011, J PEDIATR SURG, V46, P62, DOI 10.1016/j.jpedsurg.2010.09.059; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Folkman J, 1983, Symp Fundam Cancer Res, V36, P201; Gaborit N, 2012, DEVELOPMENT, V139, P4007, DOI 10.1242/dev.081703; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Gorski DH, 2000, CIRC RES, V87, P865, DOI 10.1161/01.RES.87.10.865; Hamik A, 2006, ARTERIOSCLER THROMB, V26, P1926; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kachgal S, 2012, CELL ADHES MIGR, V6, P457, DOI 10.4161/cam.22164; Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372; Kieran M. W., 2012, COLD SPRING HARB PER, V12, P1; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Lecaudey V, 2005, J COMP NEUROL, V492, P289, DOI 10.1002/cne.20765; Li DY, 2014, DEV CELL, V29, P233, DOI 10.1016/j.devcel.2014.03.001; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; Myrthue A, 2008, CLIN CANCER RES, V14, P3562, DOI 10.1158/1078-0432.CCR-07-4649; Padua MB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.117002; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Robertshaw E, 2013, P NATL ACAD SCI USA, V110, pE3919, DOI 10.1073/pnas.1304311110; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Shah G, 2008, J SURG RES, V149, P171, DOI 10.1016/j.jss.2008.03.016; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sotillos S, 2006, MECH DEVELOP, V123, P241, DOI 10.1016/j.mod.2005.12.002; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tung JJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006601; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	52	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6303	6315		10.1074/jbc.M114.601146	http://dx.doi.org/10.1074/jbc.M114.601146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25512384	hybrid, Green Published			2022-12-26	WOS:000350732500036
J	Driesbaugh, KH; Buzza, MS; Martin, EW; Conway, GD; Kao, JPY; Antalis, TM				Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Kao, Joseph P. Y.; Antalis, Toni M.			Proteolytic Activation of the Protease-activated Receptor (PAR)-2 by the Glycosylphosphatidylinositol-anchored Serine Protease Testisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTICULAR GERM-CELLS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; LIPID RAFTS; FLUORESCENT INDICATORS; SIGNAL-TRANSDUCTION; THROMBIN RECEPTOR; FACTOR VIIA; IN-VITRO; PROTEINASE	Protease-activated receptors (PARs) are a family of seven-transmembrane, G-protein-coupled receptors that are activated by multiple serine proteases through specific N-terminal proteolytic cleavage and the unmasking of a tethered ligand. The majority of PAR-activating proteases described to date are soluble proteases that are active during injury, coagulation, and inflammation. Less investigation, however, has focused on the potential for membrane-anchored serine proteases to regulate PAR activation. Testisin is a unique trypsin-like serine protease that is tethered to the extracellular membrane of cells through a glycophosphatidylinositol (GPI) anchor. Here, we show that the N-terminal domain of PAR-2 is a substrate for testisin and that proteolytic cleavage of PAR-2 by recombinant testisin activates downstream signaling pathways, including intracellular Ca2+ mobilization and ERK1/2 phosphorylation. When testisin and PAR-2 are co-expressed in HeLa cells, GPI-anchored testisin specifically releases the PAR-2 tethered ligand. Conversely, knockdown of endogenous testisin in NCI/ADR-Res ovarian tumor cells reduces PAR-2 N-terminal proteolytic cleavage. The cleavage of PAR-2 by testisin induces activation of the intracellular serum-response element and NF kappa B signaling pathways and the induction of IL-8 and IL-6 cytokine gene expression. Furthermore, the activation of PAR-2 by testisin results in the loss and internalization of PAR-2 from the cell surface. This study reveals a new biological substrate for testisin and is the first demonstration of the activation of a PAR by a serine protease GPI-linked to the cell surface.	[Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Kao, Joseph P. Y.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 West Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Kao, Joseph/0000-0002-8875-2180; Martin, Erik/0000-0003-3979-2378	National Institutes of Health [HL084387, HL118390, DK081376, T32 HL07698]; American Heart Association [10PRE3640012]; Women's Board of the American Heart Association Greater Washington Region; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084387, T32HL007954, T32HL007698, R01HL118390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Women's Board of the American Heart Association Greater Washington Region; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084387 (to T. M. A.), HL118390 (to T. M. A.), DK081376 (to T. M. A.), and T32 HL07698 (to K. H. D.). This work was also supported by American Heart Association Predoctoral Fellowship 10PRE3640012 (to K. H. D.) and the Women's Board of the American Heart Association Greater Washington Region.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028018; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Awasthi V, 2007, ARTERIOSCL THROM VAS, V27, P1447, DOI 10.1161/ATVBAHA.107.143438; Bocheva G, 2009, J INVEST DERMATOL, V129, P1816, DOI 10.1038/jid.2008.449; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Del Rosso M, 2002, CLIN EXP METASTAS, V19, P193, DOI 10.1023/A:1015531321445; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; Jahan I, 2007, ANN ONCOL, V18, P1506, DOI 10.1093/annonc/mdm190; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; Kaufmann R, 2011, J CANCER RES CLIN, V137, P965, DOI 10.1007/s00432-010-0961-1; Kawano N, 2010, BIOL REPROD, V83, P359, DOI 10.1095/biolreprod.109.083089; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Liu CY, 2013, ARCH BIOCHEM BIOPHYS, V535, P234, DOI 10.1016/j.abb.2013.02.013; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; MINTA A, 1989, J BIOL CHEM, V264, P8171; Miyata H, 2012, CYTOSKELETON, V69, P207, DOI 10.1002/cm.21012; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Osuga Yutaka, 2012, Front Biosci (Schol Ed), V4, P1201; Pendurthi UR, 2008, THROMB RES, V122, pS14, DOI 10.1016/S0049-3848(08)70012-4; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Sales K. U., 2014, ONCOGENE, DOI [10.1038/pmc/2013.563, DOI 10.1038/PMC/2013.563]; Scarman AL, 2001, EUR J BIOCHEM, V268, P1250, DOI 10.1046/j.1432-1327.2001.01986.x; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shigemasa K, 2000, J SOC GYNECOL INVEST, V7, P358, DOI 10.1016/S1071-5576(00)00086-1; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Sorensen BB, 2003, BLOOD, V102, P1708, DOI 10.1182/blood-2003-01-0157; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tang T, 2005, CANCER RES, V65, P868; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Versteeg HH, 2004, ONCOGENE, V23, P410, DOI 10.1038/sj.onc.1207066; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weidinger S, 2003, HUM REPROD, V18, P2519, DOI 10.1093/humrep/deg476; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; Yeom SY, 2010, FEBS LETT, V584, P1469, DOI 10.1016/j.febslet.2010.02.072; Yoshida N, 2007, INT J MOL MED, V19, P335; YU JX, 1994, J BIOL CHEM, V269, P18843	61	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3529	3541		10.1074/jbc.M114.628560	http://dx.doi.org/10.1074/jbc.M114.628560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519908	Green Published, hybrid			2022-12-26	WOS:000349456000027
J	Nilsen, NJ; Vladimer, GI; Stenvik, J; Orning, MPA; Zeid-Kilani, MV; Bugge, M; Bergstroem, B; Conlon, J; Husebye, H; Hise, AG; Fitzgerald, KA; Espevik, T; Lien, E				Nilsen, Nadra J.; Vladimer, Gregory I.; Stenvik, Jorgen; Orning, M. Pontus A.; Zeid-Kilani, Maria V.; Bugge, Marit; Bergstroem, Bjarte; Conlon, Joseph; Husebye, Harald; Hise, Amy G.; Fitzgerald, Katherine A.; Espevik, Terje; Lien, Egil			A Role for the Adaptor Proteins TRAM and TRIF in Toll-like Receptor 2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCIBLE GENES; DOMAIN-CONTAINING ADAPTER; CUTTING EDGE; IFN-BETA; TRANSCRIPTION FACTORS; REGULATORY FACTOR-3; INTERFERON RESPONSE; LIPOTEICHOIC ACID; RNA HELICASE	Toll-like receptors (TLRs) are involved in sensing invading microbes by host innate immunity. TLR2 recognizes bacterial lipoproteins/lipopeptides, and lipopolysaccharide activates TLR4. TLR2 and TLR4 signal via the Toll/interleukin-1 receptor adaptors MyD88 and MAL, leading to NF-kappa B activation. TLR4 also utilizes the adaptors TRAM and TRIF, resulting in activation of interferon regulatory factor (IRF) 3. Here, we report a new role for TRAM and TRIF in TLR2 regulation and signaling. Interestingly, we observed that TLR2-mediated induction of the chemokine Ccl5 was impaired in TRAM or TRIF deficient macrophages. Inhibition of endocytosis reduced Ccl5 release, and the data also suggested that TRAM and TLR2 co-localize in early endosomes, supporting the hypothesis that signaling may occur from an intracellular compartment. Ccl5 release following lipoprotein challenge additionally involved the kinase Tbk-1 and Irf3, as well as MyD88 and Irf1. Induction of Interferon-beta and Ccl4 by lipoproteins was also partially impaired in cells lacking TRIF cells. Our results show a novel function of TRAM and TRIF in TLR2-mediated signal transduction, and the findings broaden our understanding of how Toll/interleukin-1 receptor adaptor proteins may participate in signaling downstream from TLR2.	[Nilsen, Nadra J.; Stenvik, Jorgen; Orning, M. Pontus A.; Zeid-Kilani, Maria V.; Bugge, Marit; Bergstroem, Bjarte; Husebye, Harald; Fitzgerald, Katherine A.; Espevik, Terje; Lien, Egil] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; [Nilsen, Nadra J.; Espevik, Terje] Norwegian Univ Sci & Technol, KG Jebsen Ctr Myeloma Res, N-7489 Trondheim, Norway; [Vladimer, Gregory I.; Orning, M. Pontus A.; Conlon, Joseph; Fitzgerald, Katherine A.; Lien, Egil] Univ Massachusetts, Sch Med, Program Innate Immun, Dept Med,Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hise, Amy G.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Hise, Amy G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University; Case Western Reserve University	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Program Innate Immun, Dept Med,Div Infect Dis & Immunol, 364 Plantat St,Lazare Res Bldg 311, Worcester, MA 01605 USA.	Egil.Lien@umassmed.edu	Vladimer, Gregory/X-4547-2018; Nilsen, Nadra/G-5592-2017; Fitzgerald, Katherine/ABE-6317-2020; Bergstrøm, Bjarte/H-8159-2016	Vladimer, Gregory/0000-0003-4205-7585; Nilsen, Nadra/0000-0003-0407-1060; Bergstrøm, Bjarte/0000-0002-5042-6697; Orning, Pontus/0000-0002-6177-6916; Fitzgerald, Kate/0000-0003-3175-609X; Husebye, Harald/0000-0002-8828-1059	National Institutes of Health [R01 AI57538, AI095213]; Research Council of Norway; Norwegian Cancer Society; Commission of the European Communities [QLK2-2000-00336]; Cancer Fund from St. Olavs Hospital, Trondheim, Norway; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Commission of the European Communities(European Commission); Cancer Fund from St. Olavs Hospital, Trondheim, Norway; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI57538 (to E. L.) and AI095213 (to G. I. V.). This work was also supported by the Research Council of Norway, the Norwegian Cancer Society, Commission of the European Communities Grant QLK2-2000-00336 (RTD Program "Quality of Life and Management of Living Resources" and "Hospath"), and by the Cancer Fund from St. Olavs Hospital, Trondheim, Norway.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heine H, 1999, J IMMUNOL, V162, P6971; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hirschfield GM, 2003, J IMMUNOL, V171, P6046, DOI 10.4049/jimmunol.171.11.6046; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lin RT, 1999, MOL CELL BIOL, V19, P959; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Petnicki-Ocwieja T, 2013, INFECT IMMUN, V81, P402, DOI 10.1128/IAI.00890-12; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Schjetne KW, 2003, J IMMUNOL, V171, P32, DOI 10.4049/jimmunol.171.1.32; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	50	73	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3209	3222		10.1074/jbc.M114.593426	http://dx.doi.org/10.1074/jbc.M114.593426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505250	Green Published, hybrid			2022-12-26	WOS:000349456000003
J	Shao, C; Ahmad, N; Hodges, K; Kuang, SH; Ratliff, T; Liu, XQ				Shao, Chen; Ahmad, Nihal; Hodges, Kurt; Kuang, Shihuan; Ratliff, Tim; Liu, Xiaoqi			Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INTERMITTENT ANDROGEN SUPPRESSION; ANTIDIABETIC DRUG; BREAST-CANCER; CLINICAL-EXPERIENCE; MAMMALIAN TARGET; CELL METABOLISM; BI 2536; GROWTH; PHOSPHORYLATION	The widely used anti-diabetic drug metformin has been shown to exert strong antineoplastic actions in numerous tumor types, including prostate cancer (PCa). In this study, we show that BI2536, a specific Plk1 inhibitor, acted synergistically with metformin in inhibiting PCa cell proliferation. Furthermore, we also provide evidence that Plk1 inhibition makes PCa cells carrying WT p53 much more sensitive to low-dose metformin treatment. Mechanistically, we found that co-treatment with BI2536 and metformin induced p53-dependent apoptosis and further activated the p53/Redd-1 pathway. Moreover, we also show that BI2536 treatment inhibited metformin-induced glycolysis and glutamine anaplerosis, both of which are survival responses of cells against mitochondrial poisons. Finally, we confirmed the cell-based observations using both cultured cell-derived and patient-derived xenograft studies. Collectively, our findings support another promising therapeutic strategy by combining two well tolerated drugs against PCa proliferation and the progression of androgen-dependent PCa to the castration-resistant stage.	[Shao, Chen; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ratliff, Tim; Liu, Xiaoqi] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Hodges, Kurt] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887; Kuang, Shihuan/0000-0001-9180-3180	National Institutes of Health [R01CA157429, R01AR059130, P30 CA023168]; National Science Foundation [MCB-1049693]; American Cancer Society [RSG-13-073]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA157429, P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157429 (to X. L.) and R01AR059130 (to N. A.). This work was also supported by National Science Foundation Grant MCB-1049693 and American Cancer Society Grant RSG-13-073 (to X. L.) and by the China Scholarship Council (to C. S.). Xenograft data were acquired by a Purdue Center for Cancer Research facility supported by National Institutes of Health Grant P30 CA023168.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bruchovsky N, 2000, MOL UROL, V4, P191; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Deeraksa A, 2013, ONCOGENE, V32, P2973, DOI 10.1038/onc.2012.309; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Gleave M, 1998, PROSTATE CANCER P D, V1, P289, DOI 10.1038/sj.pcan.4500260; Goldenberg SL, 1999, MOL UROL, V3, P287; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Hou XZ, 2013, PROSTATE, V73, P1352, DOI 10.1002/pros.22683; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Liu AY, 2004, PROSTATE, V60, P98, DOI 10.1002/pros.20031; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu XS, 2011, J BIOL CHEM, V286, P35795, DOI 10.1074/jbc.C111.269050; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; McInnes C, 2011, DRUG DISCOV TODAY, V16, P619, DOI 10.1016/j.drudis.2011.05.002; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Segal ED, 2011, BIOCHEM BIOPH RES CO, V414, P694, DOI 10.1016/j.bbrc.2011.09.134; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Sogame Y, 2009, BIOPHARM DRUG DISPOS, V30, P476, DOI 10.1002/bdd.684; Spratt DE, 2013, EUR UROL, V63, P709, DOI 10.1016/j.eururo.2012.12.004; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2024	2033		10.1074/jbc.M114.596817	http://dx.doi.org/10.1074/jbc.M114.596817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505174	Green Published, hybrid			2022-12-26	WOS:000348588000010
J	Nasel, C; Kalcher, K; Boubela, R; Moser, E				Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald			Improved Quantification of Cerebral Hemodynamics Using Individualized Time Thresholds for Assessment of Peak Enhancement Parameters Derived from Dynamic Susceptibility Contrast Enhanced Magnetic Resonance Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW; PERFUSION; STROKE; MISMATCH; REPERFUSION; DIFFUSION; MAPS	Purpose: Assessment of cerebral ischemia often employs dynamic susceptibility contrast enhanced magnetic resonance imaging (DSC-MRI) with evaluation of various peak enhancement time parameters. All of these parameters use a single time threshold to judge the maximum tolerable peak enhancement delay that is supposed to reliably differentiate sufficient from critical perfusion. As the validity of this single threshold approach still remains unclear, in this study, (1) the definition of a threshold on an individual patient-basis, nevertheless (2) preserving the comparability of the data, was investigated. Methods: The histogram of time-to-peak (TTP) values derived from DSC-MRI, the so-called TTP-distribution curve (TDC), was modeled using a double-Gaussian model in 61 patients without severe cerebrovascular disease. Particular modelbased zf-scores were used to describe the arterial, parenchymal and venous bolustransit phase as time intervals I-a,I-p,I-v. Their durations (delta I-a,I-p,I-v), were then considered as maximum TTP-delays of each phase. Results: Mean-R2 for the model-fit was 0.967. Based on the generic zf-scores the proposed bolus transit phases could be differentiated. The I-p-interval reliably depicted the parenchymal bolus-transit phase with durations of 3.4 s-10.1 s (median = 4.3s), where an increase with age was noted (similar to 30 ms/year). Conclusion: Individual threshold-adjustment seems rational since regular bolustransit durations in brain parenchyma obtained from the TDC overlap considerably with recommended critical TTP-thresholds of 4 s-8 s. The parenchymal transit time derived from the proposed model may be utilized to individually correct TTP-thresholds, thereby potentially improving the detection of critical perfusion.	[Nasel, Christian] Karl Landsteiner Univ Hlth Sci, Univ Hosp Tulln, Dept Radiol, Tulln, Austria; [Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Nasel, C (corresponding author), Karl Landsteiner Univ Hlth Sci, Univ Hosp Tulln, Dept Radiol, Tulln, Austria.	christian.nasel@meduniwien.ac.at	Moser, Ewald/B-3666-2013	Moser, Ewald/0000-0001-8278-9583; Nasel, Christian/0000-0002-1418-7924; Boubela, Roland/0000-0002-2870-0282; Kalcher, Klaudius/0000-0003-4558-7987				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Carroll TJ, 2002, J CEREBR BLOOD F MET, V22, P1149, DOI 10.1097/00004647-200209000-00013; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; FRALEY C, 2006, 504 U WASH DEP STAT; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Grun B, 2008, J STAT SOFTW, V28, P1; Hales PW, 2014, J CEREBR BLOOD F MET, V34, P776, DOI 10.1038/jcbfm.2014.17; Ibaraki Masanobu, 2005, Magn Reson Med Sci, V4, P27, DOI 10.2463/mrms.4.27; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; Kane I, 2007, STROKE, V38, P3158, DOI 10.1161/STROKEAHA.107.483842; Krayenbuahl HA., 1982, CEREBRAL ANGIOGRAPHY; Kreitner KF, 2005, ROFO-FORTSCHR RONTG, V177, P646, DOI 10.1055/s-2005-858091; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Ma H, 2012, INT J STROKE, V7, P74, DOI 10.1111/j.1747-4949.2011.00730.x; Nasel C, 2000, AM J NEURORADIOL, V21, P1195; Nasel C, 2005, EUR J RADIOL, V55, P219, DOI 10.1016/j.ejrad.2004.11.008; Nasel C, 2004, AM J NEURORADIOL, V25, P945; Nasel C, 2001, AM J NEURORADIOL, V22, P1056; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Perthen JE, 2002, MAGN RESON MED, V47, P61, DOI 10.1002/mrm.10020; R Core Team, 2018, R LANG ENV STAT COMP; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Shih LC, 2003, STROKE, V34, P1425, DOI 10.1161/01.STR.0000072998.70087.E9; Sobesky J, 2004, STROKE, V35, P2843, DOI 10.1161/01.STR.0000147043.29399.f6; Thijs VN, 2004, STROKE, V35, P94, DOI 10.1161/01.STR.0000106136.15163.73; WICHURA MJ, 1988, J R STAT SOC C-APPL, V37, P477, DOI 10.2307/2347330; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; Zaro-Weber O, 2010, STROKE, V41, P2817, DOI 10.1161/STROKEAHA.110.594432; Zaro-Weber O, 2009, STROKE, V40, P2413, DOI 10.1161/STROKEAHA.108.540914	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114999	10.1371/journal.pone.0114999	http://dx.doi.org/10.1371/journal.pone.0114999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521121	Green Published, Green Submitted, gold			2022-12-26	WOS:000348845600014
J	Suzuki, Y; Konno, U; Fukuda, A; Komatsu, DD; Hirota, A; Watanabe, K; Togo, Y; Morikawa, N; Hagiwara, H; Aosai, D; Iwatsuki, T; Tsunogai, U; Nagao, S; Ito, K; Mizuno, T				Suzuki, Yohey; Konno, Uta; Fukuda, Akari; Komatsu, Daisuke D.; Hirota, Akinari; Watanabe, Katsuaki; Togo, Yoko; Morikawa, Noritoshi; Hagiwara, Hiroki; Aosai, Daisuke; Iwatsuki, Teruki; Tsunogai, Urumu; Nagao, Seiya; Ito, Kazumasa; Mizuno, Takashi			Biogeochemical Signals from Deep Microbial Life in Terrestrial Crust	PLOS ONE			English	Article							ANAEROBIC OXIDATION; TONO AREA; HYDROGEN; GROUNDWATER; FRACTURE; METHANE; CARBON; TEMPERATURE; ECOSYSTEMS; ISOTOPES	In contrast to the deep subseafloor biosphere, a volumetrically vast and stable habitat for microbial life in the terrestrial crust remains poorly explored. For the long-term sustainability of a crustal biome, high-energy fluxes derived from hydrothermal circulation and water radiolysis in uranium-enriched rocks are seemingly essential. However, the crustal habitability depending on a low supply of energy is unknown. We present multi-isotopic evidence of microbially mediated sulfate reduction in a granitic aquifer, a representative of the terrestrial crust habitat. Deep meteoric groundwater was collected from underground boreholes drilled into Cretaceous Toki granite (central Japan). A large sulfur isotopic fractionation of 20-60% diagnostic to microbial sulfate reduction is associated with the investigated groundwater containing sulfate below 0.2 mM. In contrast, a small carbon isotopic fractionation (<30 parts per thousand) is not indicative of methanogenesis. Except for 2011, the concentrations of H-2 ranged mostly from 1 to 5 nM, which is also consistent with an aquifer where a terminal electron accepting process is dominantly controlled by ongoing sulfate reduction. High isotopic ratios of mantle-derived He-3 relative to radiogenic He-4 in groundwater and the flux of H-2 along adjacent faults suggest that, in addition to low concentrations of organic matter (<70 mu M), H-2 from deeper sources might partly fuel metabolic activities. Our results demonstrate that the deep biosphere in the terrestrial crust is metabolically active and playing a crucial role in the formation of reducing groundwater even under low-energy fluxes.	[Suzuki, Yohey; Watanabe, Katsuaki] Univ Tokyo, Grad Sch Sci, Dept Plant Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Yohey; Konno, Uta; Fukuda, Akari; Hirota, Akinari; Togo, Yoko; Morikawa, Noritoshi; Ito, Kazumasa] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Komatsu, Daisuke D.; Tsunogai, Urumu] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fukuda, Akari; Hagiwara, Hiroki; Aosai, Daisuke; Iwatsuki, Teruki; Mizuno, Takashi] Japan Atom Energy Agcy, Mizunami, Gifu 5096132, Japan; [Nagao, Seiya] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University; Japan Atomic Energy Agency; Kanazawa University	Suzuki, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Plant Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yohey-suzuki@eps.s.u-tokyo.ac.jp	Togo, Yoko/M-3411-2018; Tsunogai, Urumu/C-8303-2011; Morikawa, Noritoshi/L-9386-2016	Togo, Yoko/0000-0001-8353-4953; Tsunogai, Urumu/0000-0002-1517-3284; Morikawa, Noritoshi/0000-0002-7179-6769; Mizuno, Takashi/0000-0002-7338-1487	Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan	Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan	The main part of this research project has been conducted as the regulatory supporting research funded by the Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan. The funders supervised study design and approved this work for publication.	Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; [Anonymous], 2006, GWB ESSENTIALS GUIDE; Apps JA, 1993, 1570 US GEOL SURV; Banwart S, 1996, J CONTAM HYDROL, V21, P115, DOI 10.1016/0169-7722(95)00037-2; Bottrell SH, 2000, CHEM GEOL, V169, P461, DOI 10.1016/S0009-2541(00)00222-9; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Chapelle F, 2001, GROUND WATER MICROBI; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Gascoyne M, 1997, J GEOPHYS RES-SOL EA, V102, P573, DOI 10.1029/96JB02857; HARVEY RW, 1989, ENVIRON SCI TECHNOL, V23, P51, DOI 10.1021/es00178a005; Hasegawa T, 2010, RES DEV GROUNDWAT 12; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Hoek J, 2006, GEOCHIM COSMOCHIM AC, V70, P5831, DOI 10.1016/j.gca.2006.07.031; Iizuka T, 2007, PRECAMBRIAN RES, V153, P179, DOI 10.1016/j.precamres.2006.11.017; Iwatsuki T, 2005, APPL GEOCHEM, V20, P2283, DOI 10.1016/j.apgeochem.2005.09.002; Iwatsuki T, 2002, APPL GEOCHEM, V17, P1241, DOI 10.1016/S0883-2927(01)00129-9; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Konno U, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026115; Kunimaru T, 2012, MIZUNAMI UNDERGROUND, P2012; Larowe DE, 2008, GEOBIOLOGY, V6, P436, DOI 10.1111/j.1472-4669.2008.00170.x; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Metcalfe R, 2006, GEOCHEM-EXPLOR ENV A, V6, P13, DOI 10.1144/1467-7873/05-080; Mizuno Takashi, 2013, Transactions of the Atomic Energy Society of Japan, V12, P89, DOI 10.3327/taesj.J12.008; Morikawa N, 2004, LIMNOLOGY, V5, P61, DOI 10.1007/s10201-004-0118-5; Morikawa N, 2008, GEOCHEM J, V42, P61, DOI 10.2343/geochemj.42.61; Nagao S, 2003, WATER RES, V37, P4159, DOI 10.1016/S0043-1354(03)00377-4; Niwa M, 2011, PURE APPL GEOPHYS, V168, P887, DOI 10.1007/s00024-010-0167-0; OHMOTO H, 1982, GEOCHIM COSMOCHIM AC, V46, P1727, DOI 10.1016/0016-7037(82)90113-2; Parkhurst D.L, 1999, WATER RESOUR INVESTI; PARSONS B, 1982, J GEOPHYS RES, V87, P289, DOI 10.1029/JB087iB01p00289; Pedersen K, 2012, FEMS MICROBIOL ECOL, V81, P217, DOI 10.1111/j.1574-6941.2012.01370.x; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; RYE RO, 1981, GEOCHIM COSMOCHIM AC, V45, P1941, DOI 10.1016/0016-7037(81)90024-7; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Tsunogai U, 2000, GEOCHIM COSMOCHIM AC, V64, P2439, DOI 10.1016/S0016-7037(00)00374-4; Wang GZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3479, DOI 10.1016/j.gca.2008.04.024; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	43	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113063	10.1371/journal.pone.0113063	http://dx.doi.org/10.1371/journal.pone.0113063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517230	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600001
J	Wang, SK; Ma, W; Wang, SM; Yi, XR; Jia, HY; Xue, FZ				Wang, Shu-Kang; Ma, Wei; Wang, Shumei; Yi, Xiang-Ren; Jia, Hong-Ying; Xue, Fuzhong			Obesity and Its Relationship with Hypertension among Adults 50 Years and Older in Jinan, China	PLOS ONE			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; METABOLIC RISK; BLOOD-PRESSURE; PREVALENCE; HEALTH; ASSOCIATION; POPULATION	Background: The relationship between obesity and hypertension varies with geographical area, race and definitions of obesity. Our study aimed to investigate the prevalence of obesity using standard Chinese criteria based on the body mass index (BMI) and the waist circumference (WC) and to examine the association between obesity and hypertension among middle-aged and elderly people in Jinan city. Methods: This cross-sectional study examined 1,870 subjects from the blocks randomly selected from among the 6 communities of Jinan, China in 2011-2012. The Student's t-test was used to compare numerical data, and the chi(2) test was used to compare categorical data. Multivariate logistic regression analyses were performed to assess the effects of general and central obesity on hypertension after adjusting for age or for education level, smoking, alcohol consumption, and continuous age. Results: The prevalence of general obesity among people age 50 years and older was 21.1% (17.0% for males and 23.1% for females), and the prevalence of central obesity was 77.8% for men and 78.7% for women. For men, compared with a normal BMI, the ORs and 95% CIs for overweight and general obesity were 1.853 (1.252, 2.744) and 3.422 (1.894, 6.182), respectively, after adjusting for age, smoking, alcohol consumption and educational level. Compared with a normal WC, the ORs and 95% CIs for central obesity were 2.334 (1.573, 3.465) and 2.318 (1.544, 3.479), respectively, for men. For women, compared with a normal BMI, the ORs and 95% CIs were 1.942 (1.473, 2.599) and 4.011 (2.817, 5.712), respectively, after adjusting for age, smoking, alcohol consumption and educational level. Compared with a normal WC, the ORs and 95% CIs for central obesity were 2.488 (1.865, 3.319) and 2.379 (1.773, 3.192), respectively, for women. Conclusions: The relationship between hypertension and general obesity was stronger than the relationship between hypertension and either overweight or central obesity in both genders.	[Wang, Shu-Kang; Ma, Wei; Wang, Shumei; Xue, Fuzhong] Shandong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yi, Xiang-Ren] Shandong Univ, Coll Phys Educ, Jinan 250100, Peoples R China; [Jia, Hong-Ying] Shandong Univ, Hosp 2, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Xue, FZ (corresponding author), Shandong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Ma, Wei/L-2374-2019; Ma, Wei/C-4748-2019; Xue, Fuzhong/AAG-4808-2020	Ma, Wei/0000-0002-8092-3280; Ma, Wei/0000-0002-8092-3280; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Fund of China [81102191]; Independent Innovation Foundation of Shandong University [2012JC035]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by grants from the National Natural Science Fund (No. 81102191) of China and the Independent Innovation Foundation of Shandong University 2012JC035.	[Anonymous], 1995, WHO TECH REP SER, V854, P1; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Jie, 2005, Zhonghua Yi Xue Za Zhi, V85, P2830; Chen TJ, 2011, ACTA PAEDIATR, V100, P1583, DOI 10.1111/j.1651-2227.2011.02397.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coorperative Meta-analysis Group of China Obesity Task Force, 2003, CHIN J EPIDEMIOL, V23, P5; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004138; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Harris MM, 2000, OBES RES, V8, P516, DOI 10.1038/oby.2000.64; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; HUANG ZD, 1994, J HYPERTENS, V12, P1103; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jiang Yong, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P816; Ladabaum U, 2014, AM J MED, V14, P00191; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lopatynski Jerzy, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P413; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oda E, 2009, INTERNAL MED, V48, P497, DOI 10.2169/internalmedicine.48.1765; Pajunen P, 2011, OBESITY, V19, P848, DOI 10.1038/oby.2010.236; Park JK, 2013, HYPERTENS RES, V36, P444, DOI 10.1038/hr.2012.194; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Salvetti G, 2008, OBES METAB-MILAN, V4, P202; Shidfar F, 2012, CARDIOVASC J AFR, V23, P442, DOI 10.5830/CVJA-2012-038; Wakabayashi I, 2012, GENDER MED, V9, P267, DOI 10.1016/j.genm.2012.05.004; World Health Organization,, 1998, WHO TECHN REP SER; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhai Yi, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P621; Zhang YX, 2013, ANN HUM BIOL, V40, P294, DOI 10.3109/03014460.2013.772654; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5	36	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114424	10.1371/journal.pone.0114424	http://dx.doi.org/10.1371/journal.pone.0114424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517735	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600019
J	Orlowski, G; Karg, J; Karg, G				Orlowski, Grzegorz; Karg, Jerzy; Karg, Grzegorz			Functional Invertebrate Prey Groups Reflect Dietary Responses to Phenology and Farming Activity and Pest Control Services in Three Sympatric Species of Aerially Foraging Insectivorous Birds	PLOS ONE			English	Article							SWALLOWS HIRUNDO-RUSTICA; BARN SWALLOWS; AGRICULTURAL LANDSCAPES; INSECT PESTS; ABUNDANCE; FOOD; BIODIVERSITY; DIVERSITY; SPILLOVER; PASSERINE	Farming activity severely impacts the invertebrate food resources of farmland birds, with direct mortality to populations of above-ground arthropods thorough mechanical damage during crop harvests. In this study we assessed the effects of phenological periods, including the timing of harvest, on the composition and biomass of prey consumed by three species of aerial insectivorous birds. Common Swifts Apus apus, Barn Swallows Hirundo rustica and House Martins Delichon urbica breed sympatrically and most of their diet is obtained from agricultural sources of invertebrate prey, especially from oil-seed rape crops. We categorized invertebrate prey into six functional groups, including oil-seed rape pests; pests of other arable crops; other crop-provisioned taxa; coprophilous taxa; and taxa living in non-crop and mixed crop/non-crop habitats. Seasonality impacted functional groups differently, but the general direction of change (increase/decrease) of all groups was consistent as indexed by prey composition of the three aerial insectivores studied here. After the oil-seed rape crop harvest (mid July), all three species exhibited a dietary shift from oil-seed rape insect pests to other aerial invertebrate prey groups. However, Common Switfts also consumed a relative large quantity of oil-seed rape insect pests in the late summer (August), suggesting that they could reduce pest insect emigration beyond the host plant/crop. Since these aerially foraging insectivorous birds operate in specific conditions and feed on specific pest resources unavailable to foliage/ground foraging avian predators, our results suggest that in some crops like oil-seed rape cultivations, the potential integration of the insectivory of aerial foraging birds into pest management schemes might provide economic benefits. We advise further research into the origin of airborne insects and the role of aerial insectivores as agents of the biological control of crop insect pests, especially the determination of depredation rates and the cascading effects of insectivory on crop damage and yield.	[Orlowski, Grzegorz; Karg, Grzegorz] Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland; [Karg, Jerzy] Univ Zielona Gora, Fac Biol Sci, Nat Conservat Dept, Zielona Gora, Poland	Polish Academy of Sciences; University of Zielona Gora	Orlowski, G (corresponding author), Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland.	orlog@poczta.onet.pl		Orlowski, Grzegorz/0000-0001-9431-6521				Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; [Anonymous], ROCZ AKAD ROL POZ; Bell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054202; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bhar R., 1998, CONSERV ECOL, V2, P3; BRYANT DM, 1982, ANIM BEHAV, V30, P845, DOI 10.1016/S0003-3472(82)80158-9; BRYANT DM, 1973, J ANIM ECOL, V42, P539, DOI 10.2307/3123; Cramp S, 1998, COMPLETE BIRDS W PAL; DABROWSKA-PROT E, 1976, Polish Ecological Studies, V2, P87; Evans KL, 2007, AGR ECOSYST ENVIRON, V122, P267, DOI 10.1016/j.agee.2007.01.015; Evans KL, 2003, BIRD STUDY, V50, P8, DOI 10.1080/00063650309461284; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; FERGUSON AW, 1999, ASP APPL BIOL, V53, P1; Fuentes-Montemayor E, 2013, AGR ECOSYST ENVIRON, V172, P6, DOI 10.1016/j.agee.2013.03.019; Gagic V, 2011, P ROY SOC B-BIOL SCI, V278, P2946, DOI 10.1098/rspb.2010.2645; Gamez-Virues S, 2007, AUST J ENTOMOL, V46, P325, DOI 10.1111/j.1440-6055.2007.00608.x; Gruebler MU, 2008, AGR ECOSYST ENVIRON, V123, P75, DOI 10.1016/j.agee.2007.05.001; Gruebler MU, 2010, J APPL ECOL, V47, P1340, DOI 10.1111/j.1365-2664.2010.01873.x; Henderson I, 2007, BIRD STUDY, V54, P371, DOI 10.1080/00063650709461497; Holland J, 2000, AGR ECOSYST ENVIRON, V78, P115, DOI 10.1016/S0167-8809(99)00123-1; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; JOHNSTON RD, 1993, FUNCT ECOL, V7, P255, DOI 10.2307/2390203; Jones GA, 2005, CONSERV BIOL, V19, P1234, DOI 10.1111/j.1523-1739.2005.00211.x; KARG J, 1975, Polish Ecological Studies, V1, P149; KARG J, 1980, Polish Ecological Studies, V6, P345; Kedziora A, 2012, BIODIVERSITY ENRICHMENT IN A DIVERSE WORLD, P281, DOI 10.5772/48653; Kelly JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076616; Kirk David A., 1996, Current Ornithology, V13, P175; Kochman J., 1985, PORADNIK OCHRONY ROS; KOZENA I, 1983, FOLIA ZOOL, V32, P41; Kragten S, 2011, BIRD CONSERV INT, V21, P1, DOI 10.1017/S0959270910000079; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; LACK D, 1955, J ANIM ECOL, V24, P120, DOI 10.2307/1882; Martin EA, 2013, P NATL ACAD SCI USA, V110, P5534, DOI 10.1073/pnas.1215725110; MOLLER AP, 1987, ANIM BEHAV, V35, P819, DOI 10.1016/S0003-3472(87)80118-5; Moller AP, 2001, J APPL ECOL, V38, P378, DOI 10.1046/j.1365-2664.2001.00593.x; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Moonen AC, 2008, AGR ECOSYST ENVIRON, V127, P7, DOI 10.1016/j.agee.2008.02.013; Nocera JJ, 2012, P ROY SOC B-BIOL SCI, V279, P3114, DOI 10.1098/rspb.2012.0445; Orlowski G, 2013, BIRD STUDY, V60, P475, DOI 10.1080/00063657.2013.839622; Orlowski G, 2013, BIRD STUDY, V60, P111, DOI 10.1080/00063657.2012.748717; Orlowski G, 2011, CENT EUR J BIOL, V6, P1023, DOI 10.2478/s11535-011-0070-4; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ryszkowski L., 1992, Ekologia Polska, V39, P171; RYSZKOWSKI L, 1977, EKOL POL-POL J ECOL, V25, P501; RYSZKOWSKI L, 1993, LANDSCAPE ECOLOGY AND AGROECOSYSTEMS, P71; Schneider G, 2013, BASIC APPL ECOL, V14, P614, DOI 10.1016/j.baae.2013.08.008; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Shortall CR, 2009, INSECT CONSERV DIVER, V2, P251, DOI 10.1111/j.1752-4598.2009.00062.x; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; StatSoft, 2006, STAT DAT AN SOFTW SY; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Threlfall CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038800; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Turner A., 2006, BARN SWALLOW; Turner A. K., 1980, THESIS U STIRLING ST; TURNER AK, 1982, ANIM BEHAV, V30, P862, DOI 10.1016/S0003-3472(82)80160-7; TURNER AK, 1982, J ANIM ECOL, V51, P29, DOI 10.2307/4308; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Waugh DR, 1978, THESIS U STIRLING ST; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whitaker DM, 2000, CAN J ZOOL, V78, P740, DOI 10.1139/cjz-78-5-740; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004	65	19	21	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114906	10.1371/journal.pone.0114906	http://dx.doi.org/10.1371/journal.pone.0114906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506696	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100032
J	Baldeon, RL; Weigelt, K; de Wit, H; Ozcan, B; van Oudenaren, A; Sempertegui, F; Sijbrands, E; Grosse, L; Freire, W; Drexhage, HA; Leenen, PJM				Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; Ozcan, Behiye; van Oudenaren, Adri; Sempertegui, Fernando; Sijbrands, Eric; Grosse, Laura; Freire, Wilma; Drexhage, Hemmo A.; Leenen, Pieter J. M.			Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; HUMAN RESISTIN; MICRORNAS; RECEPTOR; OBESITY; CANCER; EXPRESSION; ALPHA	Background: There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation. Aim: To determine a putative association between the levels of miR-146a and miR-155 in serum of T2D patients, clinical parameters and serological indicators of inflammation. Methods: We performed quantitative Real Time PCR (qPCR) of microRNAs from serum (56 Ecuadorian T2D ambulatory patients and 40 non-diabetic controls). In addition, we evaluated T2D-related serum cytokines. chemokines and growth factors using a commercially available multi-analyte cytometric bead array system. We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state. Results: The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients. The serum levels of miR-146a were significantly reduced in T2D patients as compared to these non-diabetic, but obese/dyslipidemic control group (mean patients 0.61, mean controls set at 1; p=0.042), those of miR-155 were normal. The serum levels of both microRNAs correlated to each other (r=0.478; p<0.001) and to leptin levels. The microRNAs did not correlate to BMI, glycemia and dyslipidemia. From the tested cytokines, chemokines and growth factors, we found IL-8 and HGF significantly raised in T2D patients versus non-diabetic controls (p=0.011 and 0.023 respectively). Conclusions: This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL- 8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.	[Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; van Oudenaren, Adri; Drexhage, Hemmo A.; Leenen, Pieter J. M.] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Ozcan, Behiye; Sijbrands, Eric] Univ Med Ctr, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Baldeon, Lucy R.; Sempertegui, Fernando] Cent Univ Ecuador, Dept Immunol, Quito, Ecuador; [Freire, Wilma] Univ San Francisco Quito, Inst Res Hlth & Nutr, Quito, Ecuador; [Grosse, Laura] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Drexhage, Hemmo A.] Cent Univ Ecuador, Prometeo Program SENESCYT, Quito, Ecuador; Univ Fuerzas Armadas, Quito, Ecuador	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universidad Central del Ecuador; University of Munster; Universidad Central del Ecuador	Baldeon, RL (corresponding author), Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands.	l.baldeonrojas@erasmusmc.nl	Sijbrands, Eric/A-1065-2009; Baldeon, Lucy/AAE-6323-2022; Leenen, Pieter JM/I-5839-2013	Sijbrands, Eric/0000-0001-8857-7389; Baldeon, Lucy/0000-0002-0447-0136; Leenen, Pieter JM/0000-0001-9860-2920; Grosse, Laura/0000-0001-6273-5035	Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands	Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands	This study was supported by grants from The Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands (www.diabetesfonds.nl; to PL and LB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Belmont P., 2013, ENSANUT ECU 2011 201, VI; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Costantini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039486; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; El-Ekiaby N, 2012, FEBS OPEN BIO, V2, P179, DOI 10.1016/j.fob.2012.07.005; Febbraio MA, 2014, TRENDS ENDOCRINOLOGY; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Hooper PL, 2009, CELL STRESS CHAPERON, V14, P113, DOI 10.1007/s12192-008-0073-x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; Liu Fen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P540; McClelland AD, 2014, CLIN SCI, V126, P95, DOI 10.1042/CS20130079; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Qu D, 2014, BRIT J PHARM; Rashid S, 2013, RHEUMATOL CURR RES, V3; Saiki A, 2006, INT J OBESITY, V30, P1676, DOI 10.1038/sj.ijo.0803316; Satani K, 2006, DIABETIC MED, V23, P617, DOI 10.1111/j.1464-5491.2006.01849.x; Scazzocchio B, 2009, J LIPID RES, V50, P832, DOI 10.1194/jlr.M800402-JLR200; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	53	81	86	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115209	10.1371/journal.pone.0115209	http://dx.doi.org/10.1371/journal.pone.0115209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500583	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400083
J	Alcolea, PJ; Alonso, A; Garcia-Tabares, F; Torano, A; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Torano, Alfredo; Larraga, Vicente			An Insight into the Proteome of Crithidia fasciculata Choanomastigotes as a Comparative Approach to Axenic Growth, Peanut Lectin Agglutination and Differentiation of Leishmania spp. Promastigotes	PLOS ONE			English	Article							GENE-EXPRESSION; TRYPANOSOMA-BRUCEI; VISCERAL LEISHMANIASIS; INFANTUM PROMASTIGOTES; LIFE-CYCLE; KINASE-C; GENOME; DNA; PROTEINS; STAGE	The life cycle of the trypanosomatid Crithidia fasciculata is monogenetic, as the unique hosts of these parasites are different species of culicids. The comparison of these non-pathogenic microorganisms evolutionary close to other species of trypanosomatids that develop digenetic life cycles and cause chronic severe sickness to millions of people worldwide is of outstanding interest. A ground-breaking analysis of differential protein abundance in Crithidia fasciculata is reported herein. The comparison of the outcome with previous gene expression profiling studies developed in the related human pathogens of the genus Leishmania has revealed substantial differences between the motile stages of these closely related organisms in abundance of proteins involved in catabolism, redox homeostasis, intracellular signalling, and gene expression regulation. As L. major and L. infantum agglutinate with peanut lectin and non-agglutinating parasites are more infective, the agglutination properties were evaluated in C. fasciculata. The result is that choanomastigotes are able to agglutinate with peanut lectin and a non-agglutinating subpopulation can be also isolated. As a difference with L. infantum, the non-agglutinating subpopulation over-expresses the whole machinery for maintenance of redox homeostasis and the translation factors eIF5a, EF1 alpha and EF2, what suggests a relationship between the lack of agglutination and a differentiation process.	[Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Dept Mol Microbiol & Biol Infect, Ctr Invest Biol, Madrid, Spain; [Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Serv Prote & Genom, Ctr Invest Biol, Madrid, Spain; [Torano, Alfredo] Inst Salud Carlos III, Serv Inmunol, Ctr Nacl Microbiol Virol & Inmunol Sanitarias, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Instituto de Salud Carlos III	Alcolea, PJ (corresponding author), CSIC, Dept Mol Microbiol & Biol Infect, Ctr Invest Biol, Madrid, Spain.	pjalcolea@cib.csic.es	Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Larraga, Vicente/0000-0003-1260-7400; Alonso Ayala, Ana Maria/0000-0002-1228-7331	Spanish Ministry of Science, MICINN [AGL2010-21806-C02-01]; RICET (RETICS-FIS, FEDER) collaborative network grant; Fundacion Ramon Areces contract [050204100014/OTT, 20100338]	Spanish Ministry of Science, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RICET (RETICS-FIS, FEDER) collaborative network grant; Fundacion Ramon Areces contract	PA thanks CENTRO DE INVESTIGACIONES BIOLOGICAS CSIC for two contracts of employment at a position included in the A1 group (respectively developed from January 16th to July 23rd 2008 and from October 16th 2008 to April 15th 2009). AA thanks CSIC for the Ph.D. contract 5072160068 W0SC000077 within the A1 group. This work has been partially defrayed by the grant AGL2010-21806-C02-01 (Spanish Ministry of Science, MICINN), RICET (RETICS-FIS, FEDER) collaborative network grant and the Fundacion Ramon Areces contract 050204100014/OTT code 20100338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Alcolea PJ, 2011, INT MICROBIOL, V14, P1, DOI 10.2436/20.1501.01.129; Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Alcolea PJ, 2010, INT J PARASITOL, V40, P1497, DOI 10.1016/j.ijpara.2010.05.013; Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Calderon-Arguedas Olger, 2006, Parasitologia Latinoamericana, V61, P32; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Chevalier N, 2000, EUR J BIOCHEM, V267, P1464, DOI 10.1046/j.1432-1327.2000.01145.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gualdron-Lopez M, 2013, BBA-MOL CELL RES, V1833, P3076, DOI 10.1016/j.bbamcr.2013.08.008; Gupta N, 1999, ACTA TROP, V73, P121, DOI 10.1016/S0001-706X(99)00020-0; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Hughes Austin L., 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-15; IBRAHIM EA, 1987, ACTA TROP, V44, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maslov DA, 2001, MEM I OSWALDO CRUZ, V96, P397, DOI 10.1590/S0074-02762001000300021; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; Olsen OW, 1974, ANIMAL PARASITES LIF; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Perez-Castineira JR, 2002, BIOCHEM BIOPH RES CO, V294, P567, DOI 10.1016/S0006-291X(02)00517-X; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Saxena A, 2003, MOL BIOCHEM PARASIT, V129, P103, DOI 10.1016/S0166-6851(03)00100-2; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Tetaud E, 1998, MOL BIOCHEM PARASIT, V96, P111, DOI 10.1016/S0166-6851(98)00120-0; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Warburg O, 1942, BIOCHEM Z, V310, P384; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WHO, 2010, CONTR LEISHM	50	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113837	10.1371/journal.pone.0113837	http://dx.doi.org/10.1371/journal.pone.0113837			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503511	Green Published, gold			2022-12-26	WOS:000347146700010
J	Betekhtin, A; Jenkins, G; Hasterok, R				Betekhtin, Alexander; Jenkins, Glyn; Hasterok, Robert			Reconstructing the Evolution of Brachypodium Genomes Using Comparative Chromosome Painting	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHLOROPLAST NDHF GENE; MODEL GRASS; ARABIDOPSIS-THALIANA; KARYOTYPE EVOLUTION; DISTACHYON; REARRANGEMENTS; BRASSICACEAE; PHYLOGENY; POACEAE	Brachypodium distachyon is a model for the temperate cereals and grasses and has a biology, genomics infrastructure and cytogenetic platform fit for purpose. It is a member of a genus with fewer than 20 species, which have different genome sizes, basic chromosome numbers and ploidy levels. The phylogeny and interspecific relationships of this group have not to date been resolved by sequence comparisons and karyotypical studies. The aims of this study are not only to reconstruct the evolution of Brachypodium karyotypes to resolve the phylogeny, but also to highlight the mechanisms that shape the evolution of grass genomes. This was achieved through the use of comparative chromosome painting (CCP) which hybridises fluorescent, chromosome-specific probes derived from B. distachyon to homoeologous meiotic chromosomes of its close relatives. The study included five diploids (B. distachyon 2n=10, B. sylvaticum 2n=18, B. pinnatum 2n=16; 2n=18, B. arbuscula 2n=18 and B. stacei 2n=20) three allotetraploids (B. pinnatum 2n=28, B. phoenicoides 2n=28 and B. hybridum 2n=30), and two species of unknown ploidy (B. retusum 2n=38 and B. mexicanum 2n=40). On the basis of the patterns of hybridisation and incorporating published data, we propose two alternative, but similar, models of karyotype evolution in the genus Brachypodium. According to the first model, the extant genome of B. distachyon derives from B. mexicanum or B. stacei by several rounds of descending dysploidy, and the other diploids evolve from B. distachyon via ascending dysploidy. The allotetraploids arise by interspecific hybridisation and chromosome doubling between B. distachyon and other diploids. The second model differs from the first insofar as it incorporates an intermediate 2n=18 species between the B. mexicanum or B. stacei progenitors and the dysploidic B. distachyon.	[Betekhtin, Alexander; Hasterok, Robert] Silesian Univ, Dept Plant Anat & Cytol, Fac Biol & Environm Protect, Katowice, Poland; [Jenkins, Glyn] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	University of Silesia in Katowice; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Hasterok, R (corresponding author), Silesian Univ, Dept Plant Anat & Cytol, Fac Biol & Environm Protect, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008; Betekhtin, Alexander/O-4619-2018	Betekhtin, Alexander/0000-0001-6146-1669; Hasterok, Robert/0000-0001-6667-2721	Polish National Science Centre [DEC-2012/04/A/NZ3/00572]; UPGOW project - European Social Fund	Polish National Science Centre; UPGOW project - European Social Fund	RH and AB acknowledge financial support from the Polish National Science Centre (grant no. DEC-2012/04/A/NZ3/00572). AB acknowledges scholarships from the UPGOW project financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Almeida C, 2013, THEOR APPL GENET, V126, P1909, DOI 10.1007/s00122-013-2106-9; Bishop R, 2010, BIOSCI HORIZONS, V3, P85, DOI DOI 10.1093/BIOHORIZONS/HZQ009; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Catalan P, 2000, PLANT SYST EVOL, V220, P1, DOI 10.1007/BF00985367; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; CATALAN P, 1995, BOT J LINN SOC, V117, P263, DOI 10.1006/bojl.1995.0018; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Fonseca A, 2013, GENOME, V56, P335, DOI 10.1139/gen-2013-0025; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hasterok R, 2002, FOLIA HISTOCHEM CYTO, V40, P319; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-20; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Henegariu O, 2000, NAT BIOTECHNOL, V18, P345, DOI 10.1038/73815; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jones N, 2005, NEW PHYTOL, V165, P391, DOI 10.1111/j.1469-8137.2004.01225.x; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lou QF, 2014, PLANT J, V78, P169, DOI 10.1111/tpj.12453; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2010, CYTOGENET GENOME RES, V129, P184, DOI 10.1159/000312951; Lysak MA, 2001, PLANT J, V28, P689, DOI 10.1046/j.1365-313x.2001.01194.x; Ma L, 2010, CHROMOSOME RES, V18, P841, DOI 10.1007/s10577-010-9166-3; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mandakova T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-367; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; MOORE G, 1995, CURR OPIN GENET DEV, V5, P717, DOI 10.1016/0959-437X(95)80003-N; Muller S, 1999, CHROMOSOMA, V108, P393, DOI 10.1007/s004120050391; Peters SA, 2012, PLANT J, V71, P602, DOI 10.1111/j.1365-313X.2012.05012.x; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Qi LL, 2010, FUNCT INTEGR GENOMIC, V10, P477, DOI 10.1007/s10142-010-0190-3; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2011, CR BIOL, V334, P205, DOI 10.1016/j.crvi.2010.12.014; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Schubert Ingo, 2001, Methods in Cell Science, V23, P57, DOI 10.1023/A:1013137415093; SHI Y, 1993, PLANT SYST EVOL, V188, P125; Szinay D, 2010, CYTOGENET GENOME RES, V129, P199, DOI 10.1159/000313502; Szinay D, 2012, NEW PHYTOL, V195, P688, DOI 10.1111/j.1469-8137.2012.04195.x; Tayale A, 2013, CYTOGENET GENOME RES, V140, P79, DOI 10.1159/000351318; TKACHUK DC, 1991, GENET ANAL-BIOMOL E, V8, P67, DOI 10.1016/1050-3862(91)90051-R; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Xie SL, 2010, GENOME, V53, P439, DOI [10.1139/g10-018, 10.1139/G10-018]	57	43	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115108	10.1371/journal.pone.0115108	http://dx.doi.org/10.1371/journal.pone.0115108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493646	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400096
J	Campuzano, O; Sarquella-Brugada, G; Mademont-Soler, I; Allegue, C; Cesar, S; Ferrer-Costa, C; Coll, M; Mates, J; Iglesias, A; Brugada, J; Brugada, R				Campuzano, Oscar; Sarquella-Brugada, Georgia; Mademont-Soler, Irene; Allegue, Catarina; Cesar, Sergi; Ferrer-Costa, Carles; Coll, Monica; Mates, Jesus; Iglesias, Anna; Brugada, Josep; Brugada, Ramon			Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology	PLOS ONE			English	Article							DELETION; DUPLICATIONS; PREVALENCE; DIAGNOSIS; VARIANTS; KCNH2	Background: Long QT Syndrome is an inherited channelopathy leading to sudden cardiac death due to ventricular arrhythmias. Despite that several genes have been associated with the disease, nearly 20% of cases remain without an identified genetic cause. Other genetic alterations such as copy number variations have been recently related to Long QT Syndrome. Our aim was to take advantage of current genetic technologies in a family affected by Long QT Syndrome in order to identify the cause of the disease. Methods: Complete clinical evaluation was performed in all family members. In the index case, a Next Generation Sequencing custom-built panel, including 55 sudden cardiac death-related genes, was used both for detection of sequence and copy number variants. Next Generation Sequencing variants were confirmed by Sanger method. Copy number variations variants were confirmed by Multiplex Ligation dependent Probe Amplification method and at the mRNA level. Confirmed variants and copy number variations identified in the index case were also analyzed in relatives. Results: In the index case, Next Generation Sequencing revealed a novel variant in TTN and a large deletion in KCNQ1, involving exons 7 and 8. Both variants were confirmed by alternative techniques. The mother and the brother of the index case were also affected by Long QT Syndrome, and family cosegregation was observed for the KCNQ1 deletion, but not for the TTN variant. Conclusions: Next Generation Sequencing technology allows a comprehensive genetic analysis of arrhythmogenic diseases. We report a copy number variation identified using Next Generation Sequencing analysis in Long QT Syndrome. Clinical and familiar correlation is crucial to elucidate the role of genetic variants identified to distinguish the pathogenic ones from genetic noise.	[Campuzano, Oscar; Mademont-Soler, Irene; Allegue, Catarina; Coll, Monica; Mates, Jesus; Iglesias, Anna; Brugada, Ramon] Univ Girona IdIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Sarquella-Brugada, Georgia; Cesar, Sergi; Brugada, Josep] Univ Barcelona, Hosp St Joan Deu, Arrhythmia Unit, Barcelona, Spain; [Ferrer-Costa, Carles] Gendiag SL, Barcelona, Spain; [Brugada, Ramon] Hosp Josep Trueta, Serv Cardiol, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Univ Girona IdIBGi, Cardiovasc Genet Ctr, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Cesar, Sergi/ABH-4429-2020; Sarquella-Brugada, Georgia/W-9278-2018	campuzano, oscar/0000-0001-5298-5276; Sarquella-Brugada, Georgia/0000-0002-6857-8904; BRUGADA, JOSEP/0000-0002-5662-8302; CESAR, SERGI/0000-0002-2798-1756; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159; Mademont-Soler, Irene/0000-0002-6501-9250	"La Caixa'' Foundation; Fundacio Privada Daniel Bravo Andreu	"La Caixa'' Foundation(La Caixa Foundation); Fundacio Privada Daniel Bravo Andreu	This study has been funding by "La Caixa'' Foundation and Fundacio Privada Daniel Bravo Andreu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barc Julien, 2011, J Am Coll Cardiol, V57, P40, DOI 10.1016/j.jacc.2010.08.621; Bisgaard AM, 2006, AM J MED GENET A, V140A, P644, DOI 10.1002/ajmg.a.31130; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Caselli R, 2008, AM J MED GENET A, V146A, P1195, DOI 10.1002/ajmg.a.32197; Darbar D, 2006, HEART RHYTHM, V3, P56, DOI 10.1016/j.hrthm.2005.10.029; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Eddy CA, 2008, HEART RHYTHM, V5, P1275, DOI 10.1016/j.hrthm.2008.05.033; Gurrieri F, 2013, EUR J HUM GENET, V21, P965, DOI 10.1038/ejhg.2012.280; Kirkpatrick B, 2013, J GENET COUNS, V22, P407, DOI 10.1007/s10897-013-9572-8; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Koopmann TT, 2006, HEART RHYTHM, V3, P52, DOI 10.1016/j.hrthm.2005.10.014; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Stattin EL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-95; Tester DJ, 2010, AM J CARDIOL, V106, P1124, DOI 10.1016/j.amjcard.2010.06.022; Xu HY, 2011, HUM MUTAT, V32, P1341, DOI 10.1002/humu.21601	18	24	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114894	10.1371/journal.pone.0114894	http://dx.doi.org/10.1371/journal.pone.0114894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494010	Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400083
J	Gerez, J; Tedesco, L; Bonfiglio, JJ; Fuertes, M; Barontini, M; Silberstein, S; Wu, Y; Renner, U; Paez-Pereda, M; Holsboer, F; Stalla, GK; Arzt, E				Gerez, J.; Tedesco, L.; Bonfiglio, J. J.; Fuertes, M.; Barontini, M.; Silberstein, S.; Wu, Y.; Renner, U.; Paez-Pereda, M.; Holsboer, F.; Stalla, G. K.; Arzt, E.			RSUME inhibits VHL and regulates its tumor suppressor function	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTOR; SUMO CONJUGATION; GENE-MUTATIONS; PROTEIN; SUMOYLATION; GROWTH; HIF; REQUIRES; BINDING; DEGRADATION	Somatic mutations or loss of von Hippel-Lindau (pVHL) happen in the majority of VHL disease tumors, which present a constitutively active Hypoxia Inducible Factor (HIF), essential for tumor growth. Recently described mechanisms for pVHL modulation shed light on the open question of the HIF/pVHL pathway regulation. The aim of the present study was to determine the molecular mechanism by which RSUME stabilizes HIFs, by studying RSUME effect on pVHL function and to determine the role of RSUME on pVHL-related tumor progression. We determined that RSUME sumoylates and physically interacts with pVHL and negatively regulates the assembly of the complex between pVHL, Elongins and Cullins (ECV), inhibiting HIF-1 and 2 alpha ubiquitination and degradation. We found that RSUME is expressed in human VHL tumors (renal clear-cell carcinoma (RCC), pheochromocytoma and hemangioblastoma) and by overexpressing or silencing RSUME in a pVHL-HIF-oxygen-dependent degradation stability reporter assay, we determined that RSUME is necessary for the loss of function of type 2 pVHL mutants. The functional RSUME/pVHL interaction in VHL-related tumor progression was further confirmed using a xenograft assay in nude mice. RCC clones, in which RSUME was knocked down and express either pVHL wt or type 2 mutation, have an impaired tumor growth, as well as HIF-2 alpha, vascular endothelial growth factor A and tumor vascularization diminution. This work shows a novel mechanism for VHL tumor progression and presents a new mechanism and factor for targeting tumor-related pathologies with pVHL/HIF altered function.	[Gerez, J.; Tedesco, L.; Bonfiglio, J. J.; Fuertes, M.; Silberstein, S.; Arzt, E.] Max Planck Gesell, Partner Inst, CONICET, Inst Invest Biomed Buenos Aires IBioBA, RA-2390 Buenos Aires, DF, Argentina; [Gerez, J.; Bonfiglio, J. J.; Silberstein, S.; Arzt, E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; [Barontini, M.] Hosp Ninos Dr Ricardo Gutierrez, Ctr Endocrinol Invest CEDIE, Buenos Aires, DF, Argentina; [Wu, Y.; Renner, U.; Paez-Pereda, M.; Holsboer, F.; Stalla, G. K.] Max Planck Inst Psychiat, Dept Clin Res, D-80804 Munich, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Max Planck Society	Arzt, E (corresponding author), Max Planck Gesell, Partner Inst, CONICET, Inst Invest Biomed Buenos Aires IBioBA, C1425FQD, RA-2390 Buenos Aires, DF, Argentina.	earzt@ibioba-mpsp-conicet.gov.ar	Wu, Yonghe/N-2269-2019; Bonfiglio, Juan José/B-5853-2013	Wu, Yonghe/0000-0001-9667-8198; Bonfiglio, Juan José/0000-0001-7767-0799; Paez-Pereda, Marcelo/0000-0001-6029-0706	Argentinian Instituto Nacional del Cancer (INC); BungeBorn Foundation; Max Planck Society, Germany; University of Buenos Aires; CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; FOCEM-Mercosur [COF 03/11]	Argentinian Instituto Nacional del Cancer (INC); BungeBorn Foundation; Max Planck Society, Germany(Max Planck Society); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); FOCEM-Mercosur	We thank Sergio Senin, Maria Antunica Noguerol, Jimena Druker and Mariana Haedo for technical help. We also thank the Argentinian Instituto Nacional del Cancer (INC) and Bunge&Born Foundation for financial support to Lucas Tedesco and Juan Jose Bonfiglio, respectively. This work was supported by grants from the Max Planck Society, Germany; the University of Buenos Aires; CONICET; the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina and FOCEM-Mercosur (COF 03/11).	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bergmann TK, 2013, ACTA ONCOL, V52, P871, DOI 10.3109/0284186X.2012.707787; Berra E, 2007, METHOD ENZYMOL, V435, P107, DOI 10.1016/S0076-6879(07)35006-4; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Brooks SA, 2014, EUR UROL, V66, P77, DOI 10.1016/j.eururo.2014.02.035; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Castro CP, 2003, ENDOCRINOLOGY, V144, P693, DOI 10.1210/en.2002-220891; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chien W, 2013, BRIT J CANCER, V109, P1795, DOI 10.1038/bjc.2013.531; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Druker J, 2013, MOL CELL BIOL, V33, P2116, DOI 10.1128/MCB.01470-12; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057795; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hacker KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003801; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Huang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076421; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Jonasch E, 2012, MOL CANCER RES, V10, P859, DOI 10.1158/1541-7786.MCR-12-0117; Juengel E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-161; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang X, 2010, ONCOGENE, V29, P5568, DOI 10.1038/onc.2010.297; Keefe SM, 2013, SEMIN ONCOL, V40, P421, DOI 10.1053/j.seminoncol.2013.05.006; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Knauth K, 2009, J BIOL CHEM, V284, P10514, DOI 10.1074/jbc.M809056200; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lolkema MP, 2005, J BIOL CHEM, V280, P22205, DOI 10.1074/jbc.M503220200; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Nunez-O'Mara A, 2013, BIOL CHEM, V394, P459, DOI 10.1515/hsz-2012-0319; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rathmell WK, 2010, CURR OPIN ONCOL, V22, P250, DOI 10.1097/CCO.0b013e328337a5d2; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Rechsteiner MP, 2011, CANCER RES, V71, P5500, DOI 10.1158/0008-5472.CAN-11-0757; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rojewska E, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-47; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schneider BP, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.1000; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shan B, 2012, ENDOCR-RELAT CANCER, V19, P13, DOI 10.1530/ERC-11-0211; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Willi-Monnerat S, 2008, MOL CELL NEUROSCI, V37, P845, DOI 10.1016/j.mcn.2008.01.009; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zimmer M, 2004, MOL CANCER RES, V2, P89	73	16	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4855	4866		10.1038/onc.2014.407	http://dx.doi.org/10.1038/onc.2014.407			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25500545				2022-12-26	WOS:000361050000006
J	Pierdomenico, AM; Recchiuti, A; Simiele, F; Codagnone, M; Mari, VC; Davi, G; Romano, M				Pierdomenico, Anna Maria; Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Davi, Giovanni; Romano, Mario			MicroRNA-181b Regulates ALX/FPR2 Receptor Expression and Proresolution Signaling in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE INFLAMMATORY RESPONSES; DOWN-REGULATION; ANNEXIN A1; LIPOXIN; RESOLUTION; ASPIRIN; MEDIATORS; FIBROSIS; GENE; A(4)	Regulatory mechanisms of ALX/FPR2, the lipoxin A(4) receptor, expression have considerable relevance in inflammation resolution. Because microRNAs (miRs) are emerging as key players in inflammation resolution, here we examined microRNA-mediated regulation of ALX/FPR2 (lipoxin A4 receptor/formyl peptide receptor 2) expression. By matching data from bioinformatic algorithms, we found 27 miRs predicted to bind the 3'-UTR of ALX/FPR2. Among these, we selected miR-181b because of its link with inflammation. Using a luciferase reporter system, we assessed miR-181b binding to ALX/FPR2 3'-UTR. Consistent with this, miR-181b overexpression in human macrophages significantly down-regulated ALX/FPR2 protein levels (-25%), whereas miR-181b knockdown gave a significant increase in ALX/FPR2 (+60%). miR-181b levels decreased during monocyte to macrophage differentiation (-50%), whereas ALX/FPR2 expression increased significantly (+60%). miR-181b overexpression blunted lipoxin A(4) (0.1-10 nM)-and resolvin D1 (0.01-10 nM)-stimulated phagocytic activity of macrophages. These results unravel novel regulatory mechanisms of ALX/FPR2 expression and ligand-evoked macrophages proresolution responses mediated by miR-181b, thus uncovering novel components of the endogenous inflammation resolution circuits.	[Pierdomenico, Anna Maria; Davi, Giovanni] Univ G DAnnunzio, Dept Med & Aging Sci, I-66013 Chieti, Italy; [Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Romano, Mario] Univ G DAnnunzio, Dept Med Oral & Technol Sci, I-66013 Chieti, Italy; [Pierdomenico, Anna Maria; Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Davi, Giovanni; Romano, Mario] Univ G dAnnunzio, Ctr Excellence Aging, I-66013 Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Romano, M (corresponding author), Univ G DAnnunzio, Ctr Excellence Aging, Via Luigi Polacchi 11-13, I-66013 Chieti, Italy.	mromano@unich.it	Romano, Mario/I-7986-2012; Recchiuti, Antonio/K-7670-2016	Romano, Mario/0000-0001-8512-1458; Recchiuti, Antonio/0000-0002-1409-5261; Pierdomenico, Anna Maria/0000-0002-1788-6106	Italian Cystic Fibrosis Foundation [17/2012, 19/2013]; Italian Ministry of the University and Research	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part Italian Cystic Fibrosis Foundation Grants FFC#17/2012 and FFC#19/2013 and Italian Ministry of the University and Research Grant PRIN 2010-2011 (to M. R.).	Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YH, 2011, BIOCELL, V35, pB43; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Peng ZF, 2013, J NEUROSCI RES, V91, P1349, DOI 10.1002/jnr.23255; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, BIOCHEM BIOPH RES CO, V118, P943, DOI 10.1016/0006-291X(84)91486-4; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Song J, 2013, BIOCHEM BIOPH RES CO, V431, P210, DOI 10.1016/j.bbrc.2012.12.133; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Visone R, 2012, ONCOTARGET, V3, P195; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x	54	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3592	3600		10.1074/jbc.M114.592352	http://dx.doi.org/10.1074/jbc.M114.592352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505240	Green Published, hybrid			2022-12-26	WOS:000349456000032
J	Diaz-Martinez, LA; Tian, W; Li, B; Warrington, R; Jia, LY; Brautigam, CA; Luo, XL; Yu, HT				Diaz-Martinez, Laura A.; Tian, Wei; Li, Bing; Warrington, Ross; Jia, Luying; Brautigam, Chad A.; Luo, Xuelian; Yu, Hongtao			The Cdc20-binding Phe Box of the Spindle Checkpoint Protein BubR1 Maintains the Mitotic Checkpoint Complex During Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; ASSEMBLY CHECKPOINT; SUBSTRATE RECRUITMENT; DEGRON RECOGNITION; AAA-ATPASE; APC/C; CDC20; MAD2; P31(COMET); BINDING	The spindle checkpoint ensures accurate chromosome segregation by monitoring kinetochore-microtubule attachment. Unattached or tensionless kinetochores activate the checkpoint and enhance the production of the mitotic checkpoint complex (MCC) consisting of BubR1, Bub3, Mad2, and Cdc20. MCC is a critical checkpoint inhibitor of the anaphase-promoting complex/cyclosome, a ubiquitin ligase required for anaphase onset. The N-terminal region of BubR1 binds to both Cdc20 and Mad2, thus nucleating MCC formation. The middle region of human BubR1 (BubR1M) also interacts with Cdc20, but the nature and function of this interaction are not understood. Here we identify two critical motifs within BubR1M that contribute to Cdc20 binding and anaphase-promoting complex/cyclosome inhibition: a destruction box (D box) and a phenylalanine-containing motif termed the Phe box. ABubR1 mutant lacking these motifs is defective in MCC maintenance in mitotic human cells but is capable of supporting spindle-checkpoint function. Thus, the BubR1M-Cdc20 interaction indirectly contributes to MCC homeostasis. Its apparent dispensability in the spindle checkpoint might be due to functional duality or redundant, competing mechanisms.	[Diaz-Martinez, Laura A.; Tian, Wei; Li, Bing; Warrington, Ross; Jia, Luying; Luo, Xuelian; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Brautigam, Chad A.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Warrington, Ross; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luo, XL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	xuelian.luo@utsouthwestern.edu; hongtao.yu@utsouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338; Yu, Hongtao/0000-0002-8861-049X; Diaz-Martinez, Laura/0000-0002-7226-7068; tian, wei/0000-0003-3207-375X	National Institutes of Health [GM085004]; Welch Foundation [1-1441]; Cancer Prevention and Research Institute of Texas [RP120717-P2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM085004 (to X. L.). This work was also supported by Welch Foundation Grant 1-1441 (to H. Y.) and Cancer Prevention and Research Institute of Texas Grant RP120717-P2 (to H. Y.).	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Diaz-Martinez LA, 2014, EMBO J, V33, P1960, DOI 10.15252/embj.201487826; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Han JS, 2014, P NATL ACAD SCI USA, V111, pE4185, DOI 10.1073/pnas.1416277111; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Heinrich S, 2013, NAT CELL BIOL, V15, P1328, DOI 10.1038/ncb2864; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Izawa D., 2014, NATURE, DOI [10.1038/nature13911, DOI 10.1038/NATURE13911]; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kang JS, 2008, MOL CELL, V32, P394, DOI 10.1016/j.molcel.2008.09.017; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Luo XL, 2012, CURR BIOL, V22, pR128, DOI 10.1016/j.cub.2012.01.018; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	57	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2431	2443		10.1074/jbc.M114.616490	http://dx.doi.org/10.1074/jbc.M114.616490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505175	Green Published, hybrid			2022-12-26	WOS:000348588000045
J	Schnitzler, A; Woimant, F; Tuppin, P; de Peretti, C				Schnitzler, Alexis; Woimant, France; Tuppin, Philippe; de Peretti, Christine			Prevalence of Self-Reported Stroke and Disability in the French Adult Population: A Transversal Study	PLOS ONE			English	Article							NURSING-HOME; YOUNG-ADULTS; AGE; EPIDEMIOLOGY; MORTALITY; BURDEN; GENDER; TRENDS	In France, the prevalence of stroke and the level of disability of stroke survivors are little known. The aim of this study was to evaluate functional limitations in adults at home and in institutions, with and without self-reported stroke. A survey named "the Disability Health survey'' was carried out in people's homes (DHH) and in institutions (DHI). Medical history and functional level (activities-of-daily-living, ADL and instrumented-activities-of-daily-living IADL) were collected through interviews. The modified Rankin score (mRS) and the level of dependence and disability were compared between participants with and without stroke. 33896 subjects responded. The overall prevalence of stroke was 1.6% (CI95% [1.4%-1.7%]). The mRS was over 2 for 34.4% of participants with stroke (28.7% of participants at home and 87.8% of participants in institutions) versus respectively 3.9%, 3.1% and 71.6% without stroke. Difficulty washing was the most frequently reported ADL for those with stroke (30.6% versus 3% for those without stroke). Difficulty with ADL and IADL increased with age but the relative risk was higher below the age of 60 (17 to 25) than over 85 years (1.5 to 2.2), depending on the ADL. In the overall population, 22.6% of those confined to bed or chair reported a history of stroke. These results thus demonstrate a high national prevalence of stroke. Older people are highly dependent, irrespective of stroke history and the relative risk of dependence in young subjects with a history of stroke is high compared with those without.	[Schnitzler, Alexis] Univ Versailles St Quentin EA 4497, Hop Raymond Poincare, Assistance Publ Hop Paris, Phys Med & Rehabil Dept, Garches, France; [Woimant, France] Agence Reg Sante Ile France, Paris, France; [Woimant, France] Caisse Natl Assurance Malad Travailleurs Salaries, Paris, France; [de Peretti, Christine] Inst Veille Sanit, St Maurice, France; [Woimant, France] Hop Lariboisiere, Assistance Publ Hop Paris, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Schnitzler, A (corresponding author), Univ Versailles St Quentin EA 4497, Hop Raymond Poincare, Assistance Publ Hop Paris, Phys Med & Rehabil Dept, Garches, France.	alexis.schnitzler@rpc.aphp.fr	Schnitzler, Alfons/Q-5520-2019	Schnitzler, Alfons/0000-0002-6414-7939				Bejot Y, 2009, EUR J NEUROL, V16, P324, DOI 10.1111/j.1468-1331.2008.02415.x; Bejot Y, 2010, CEREBROVASC DIS, V30, P346, DOI 10.1159/000319569; Black-Schaffer Randie M, 2004, Top Stroke Rehabil, V11, P23; Brown RD, 1999, STROKE, V30, P924, DOI 10.1161/01.STR.30.5.924; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; De Peretti C, 2012, B EPIDEMIOLOGIQUE HE; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Fearon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub3; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fisher RJ, 2011, STROKE, V42, P1392, DOI 10.1161/STROKEAHA.110.606285; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; JORGENSEN HS, 1995, STROKE, V26, P1178, DOI 10.1161/01.STR.26.7.1178; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Mishra NK, 2010, STROKE, V41, P2840, DOI 10.1161/STROKEAHA.110.586206; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Palazzo C, 2013, PLOS ONE, V7; Peretti C. de, 2010, Bulletin Epidemiologique Hebdomadaire, P501; Rousseaux M., 2009, Annals of Physical and Rehabilitation Medicine, V52, P224, DOI 10.1016/j.rehab.2009.01.002; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; World Health Organization, WORLD HLTH STAT; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	29	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115375	10.1371/journal.pone.0115375	http://dx.doi.org/10.1371/journal.pone.0115375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521057	Green Published, gold			2022-12-26	WOS:000348845600038
J	Rabhi, KK; Esancy, K; Voisin, A; Crespin, L; Le Corre, J; Tricoire-Leignel, H; Anton, S; Gadenne, C				Rabhi, Kaouther K.; Esancy, Kali; Voisin, Anouk; Crespin, Lucille; Le Corre, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe			Unexpected Effects of Low Doses of a Neonicotinoid Insecticide on Behavioral Responses to Sex Pheromone in a Pest Insect	PLOS ONE			English	Article							BLACK CUTWORM MOTH; GREEN PEACH APHID; ASIAN CORN-BORER; INDUCED HORMESIS; PARASITOID WASP; ACUTE TOXICITY; SUBLETHAL; REPRODUCTION; HONEYBEE; EXPOSURE	In moths, which include many agricultural pest species, males are attracted by female-emitted sex pheromones. Although integrated pest management strategies are increasingly developed, most insect pest treatments rely on widespread use of neurotoxic chemicals, including neonicotinoid insecticides. Residual accumulation of low concentrations of these insecticides in the environment is known to be harmful to beneficial insects such as honey bees. This environmental stress probably acts as an "info-disruptor'' by modifying the chemical communication system, and therefore decreases chances of reproduction in target insects that largely rely on olfactory communication. However, low doses of pollutants could on the contrary induce adaptive processes in the olfactory pathway, thus enhancing reproduction. Here we tested the effects of acute oral treatments with different low doses of the neonicotinoid clothianidin on the behavioral responses to sex pheromone in the moth Agrotis ipsilon using wind tunnel experiments. We show that low doses of clothianidin induce a biphasic effect on pheromone-guided behavior. Surprisingly, we found a hormetic-like effect, improving orientation behavior at the LD20 dose corresponding to 10 ng clothianidin. On the contrary, a negative effect, disturbing orientation behavior, was elicited by a treatment with a dose below the LD0 dose corresponding to 0.25 ng clothianidin. No clothianidin effect was observed on behavioral responses to plant odor. Our results indicate that risk assessment has to include unexpected effects of residues on the life history traits of pest insects, which could then lead to their adaptation to environmental stress.	[Rabhi, Kaouther K.; Esancy, Kali; Voisin, Anouk; Crespin, Lucille; Le Corre, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe] Univ Angers, INRA, Neuroethol RCIM, SFR QUASAV 4207,UPRES EA USC INRA 2647 1330, F-49071 Beaucouze, France	INRAE; Universite d'Angers	Gadenne, C (corresponding author), Univ Angers, INRA, Neuroethol RCIM, SFR QUASAV 4207,UPRES EA USC INRA 2647 1330, 42 Rue Georges Morel, F-49071 Beaucouze, France.	christophe.gadenne@angers.inra.fr	Tricoire-Leignel, Hélène/ABG-2320-2020	Tricoire-Leignel, Hélène/0000-0002-2881-2962	French National Funding Agency [ANR-12 ADAP-0012-01]; Region Pays de la Loire; Fulbright grant	French National Funding Agency; Region Pays de la Loire(Region Pays de la Loire); Fulbright grant	This work was supported by French National Funding Agency grant ANR-12 ADAP-0012-01 to H.T.-L., S.A., C.G. and a PhD grant to K.K.R., by the "Region Pays de la Loire" to S.A. and C.G. and by a Fulbright grant to K.E.	Ahmad S, 2013, INT J TROP INSECT SC, V33, P264, DOI 10.1017/S1742758413000246; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Anton S, 2007, ENTOMOL EXP APPL, V123, P1, DOI 10.1111/j.1570-7458.2007.00516.x; Anton S, 2011, P NATL ACAD SCI USA, V108, P3401, DOI 10.1073/pnas.1008840108; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Barbieri RF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2157; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Bues R., 1974, ANN ZOOL ECOL ANIM, V2, P79; Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Calabrese EJ, 2001, TOXICOL SCI, V62, P330, DOI 10.1093/toxsci/62.2.330; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Delpuech JM, 2005, ARCH ENVIRON CON TOX, V49, P186, DOI 10.1007/s00244-004-0158-1; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; GADENNE C, 1993, EXPERIENTIA, V49, P721, DOI 10.1007/BF01923960; Gemeno C, 1998, J CHEM ECOL, V24, P999, DOI 10.1023/A:1022398318465; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hu XP, 1998, J APPL ENTOMOL, V122, P37, DOI 10.1111/j.1439-0418.1998.tb01458.x; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Komeza N, 2001, ARCH ENVIRON CON TOX, V41, P436, DOI 10.1007/s002440010269; Kullik SA, 2011, J ECON ENTOMOL, V104, P484, DOI 10.1603/EC10360; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P671, DOI 10.1016/S0028-3908(99)00170-7; Laurino D, 2013, B INSECTOL, V66, P119; Laurino D, 2011, B INSECTOL, V64, P107; Li J, 2010, INSECT BIOCHEM MOLEC, V40, P17, DOI 10.1016/j.ibmb.2009.12.003; LINN C, 1985, PESTIC SCI, V16, P445; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Miao J, 2014, PEST MANAG SCI, V70, P55, DOI 10.1002/ps.3523; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morse JG, 1998, HUM EXP TOXICOL, V17, P266, DOI 10.1191/096032798678908738; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Rings RW, 1974, OHIO AGR RES DEV CTR, P1; ROELOFS WL, 1995, P NATL ACAD SCI USA, V92, P44, DOI 10.1073/pnas.92.1.44; Saber M, 2013, CROP PROT, V43, P14, DOI 10.1016/j.cropro.2012.09.011; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207; Sohrabi F, 2011, CROP PROT, V30, P1190, DOI 10.1016/j.cropro.2011.05.004; Sokal R.R., 2012, BIOMETRY; Suckling DM, 2014, PEST MANAG SCI, V70, P179, DOI 10.1002/ps.3670; Taillebois E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096669; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Wei H, 2004, PESTIC BIOCHEM PHYS, V80, P12, DOI 10.1016/j.pestbp.2004.05.001; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zhou HC, 2005, J CHEM ECOL, V31, P1645, DOI 10.1007/s10886-005-5804-1	62	30	35	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114411	10.1371/journal.pone.0114411	http://dx.doi.org/10.1371/journal.pone.0114411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517118	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600016
J	Si, MR; Long, MX; Chaudhry, MT; Xu, YX; Zhang, P; Zhang, L; Shen, XH				Si, Meiru; Long, Mingxiu; Chaudhry, Muhammad Tausif; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui			Functional Characterization of Corynebacterium glutamicum Mycothiol S-Conjugate Amidase	PLOS ONE			English	Article							N-ACETYL-1-D-MYO-INOSITYL-2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE DEACETYLASE MSHB; MYCOBACTERIUM-SMEGMATIS MUTANTS; SIGMA-FACTOR SIGH; BIOSYNTHESIS; TUBERCULOSIS; GENE; IDENTIFICATION; DETOXIFICATION; INHIBITORS; COFACTOR	The present study focuses on the genetic and biochemical characterization of mycothiol S-conjugate amidase (Mca) of Corynebacterium glutamicum. Recombinant C. glutamicum Mca was heterologously expressed in Escherichia coli and purified to apparent homogeneity. The molecular weight of native Mca protein determined by gel filtration chromatography was 35 kDa, indicating that Mca exists as monomers in the purification condition. Mca showed amidase activity with mycothiol S-conjugate of monobromobimane (MSmB) in vivo while mca mutant lost the ability to cleave MSmB. In addition, Mca showed limited deacetylase activity with N-acetyl-D-glucosamine (GlcNAc) as substrate. Optimum pH for amidase activity was between 7.5 and 8.5, while the highest activity in the presence of Zn2+ confirmed Mca as a zinc metalloprotein. Amino acid residues conserved among Mca family members were located in C. glutamicum Mca and site-directed mutagenesis of these residues indicated that Asp14, Tyr137, His139 and Asp141 were important for activity. The mca deletion mutant showed decreased resistance to antibiotics, alkylating agents, oxidants and heavy metals, and these sensitive phenotypes were recovered in the complementary strain to a great extent. The physiological roles of Mca in resistance to various toxins were further supported by the induced expression of Mca in C. glutamicum under various stress conditions, directly under the control of the stress-responsive extracytoplasmic function-sigma (ECF-s) factor SigH.	[Si, Meiru; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Si, Meiru; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Long, Mingxiu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Chaudhry, Muhammad Tausif] Pakistan Council Sci & Ind Res, Natl Phys & Stand Lab, Environm Analyt Lab, Islamabad, Pakistan	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; National Physical & Standards Laboratory (NPSL); PCSIR Laboratories Complex	Shen, XH (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	xihuishen@nwsuaf.edu.cn			National High Technology Research and Development Program of China (863 program) [2013AA102802]; National Natural Science Foundation of China [31270078, 31170100, 31170121]; Key Science and Technology R&D Program of Shaanxi Province, China [2014K02-12-01]; State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences [SKLMR-20120601]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology R&D Program of Shaanxi Province, China; State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences	This work was supported by the National High Technology Research and Development Program of China (863 program, grant 2013AA102802), National Natural Science Foundation of China (Nos. 31270078, 31170100 and 31170121), Key Science and Technology R&D Program of Shaanxi Province, China (2014K02-12-01) and the Opening Project of State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences (No. SKLMR-20120601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaeva EA, 2008, TOXICOL APPL PHARM, V231, P34, DOI 10.1016/j.taap.2008.03.017; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Busche T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-445; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y; Li M, 2007, ARCH BIOCHEM BIOPHYS, V458, P220, DOI 10.1016/j.abb.2006.12.010; Liu YB, 2013, ARCH MICROBIOL, V195, P419, DOI 10.1007/s00203-013-0889-3; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; Miller JH, 1992, SHORT COURSE BACTERI, V1; Nan BY, 2006, BBA-PROTEINS PROTEOM, V1764, P839, DOI 10.1016/j.bbapap.2005.10.023; Nan BY, 2010, MOL MICROBIOL, V75, P1484, DOI 10.1111/j.1365-2958.2010.07069.x; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Nicholas GM, 2002, BIOORG MED CHEM LETT, V12, P2487, DOI 10.1016/S0960-894X(02)00385-2; Nicholas GM, 2001, ORG LETT, V3, P1543, DOI 10.1021/ol015845+; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Rawat M, 2004, J BACTERIOL, V186, P6050, DOI 10.1128/jb.186.18.6050-6058.2004; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Si MR, 2014, APPL ENVIRON MICROB, V80, P1750, DOI 10.1128/AEM.03654-13; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Steffek M, 2003, BIOCHEMISTRY-US, V42, P12067, DOI 10.1021/bi030080u; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	38	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115075	10.1371/journal.pone.0115075	http://dx.doi.org/10.1371/journal.pone.0115075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514023	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300032
J	Morgan, AP; Crowley, JJ; Nonneman, RJ; Quackenbush, CR; Miller, CN; Ryan, AK; Bogue, MA; Paredes, SH; Yourstone, S; Carroll, IM; Kawula, TH; Bower, MA; Sartor, RB; Sullivan, PF				Morgan, Andrew P.; Crowley, James J.; Nonneman, Randal J.; Quackenbush, Corey R.; Miller, Cheryl N.; Ryan, Allison K.; Bogue, Molly A.; Paredes, Sur Herrera; Yourstone, Scott; Carroll, Ian M.; Kawula, Thomas H.; Bower, Maureen A.; Sartor, R. Balfour; Sullivan, Patrick F.			The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse	PLOS ONE			English	Article							INSULIN-RESISTANCE; FAT DEPOSITION; BODY-WEIGHT; SCHIZOPHRENIA; DRUGS; SEQUENCES; ECOLOGY; OBESITY	The second-generation antipsychotic olanzapine is effective in reducing psychotic symptoms but can cause extreme weight gain in human patients. We investigated the role of the gut microbiota in this adverse drug effect using a mouse model. First, we used germ-free C57BL/6J mice to demonstrate that gut bacteria are necessary and sufficient for weight gain caused by oral delivery of olanzapine. Second, we surveyed fecal microbiota before, during, and after treatment and found that olanzapine potentiated a shift towards an "obesogenic'' bacterial profile. Finally, we demonstrated that olanzapine has antimicrobial activity in vitro against resident enteric bacterial strains. These results collectively provide strong evidence for a mechanism underlying olanzapine-induced weight gain in mouse and a hypothesis for clinical translation in human patients.	[Morgan, Andrew P.; Crowley, James J.; Nonneman, Randal J.; Quackenbush, Corey R.; Ryan, Allison K.; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Miller, Cheryl N.; Kawula, Thomas H.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Paredes, Sur Herrera; Yourstone, Scott] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Carroll, Ian M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Morgan, Andrew P.; Paredes, Sur Herrera; Yourstone, Scott] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Bogue, Molly A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Bower, Maureen A.; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sullivan, PF (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	pfsulliv@med.unc.edu	Miller, Cheryl/M-7133-2019; Miller, Cheryl N/M-7579-2019; Paredes, Sur Herrera/I-8617-2019	Miller, Cheryl N/0000-0003-3665-704X; Paredes, Sur Herrera/0000-0001-9246-8337; Morgan, Andrew Parker/0000-0003-1942-4543; Crowley, James/0000-0001-9051-1557	National Institute of Mental Health [R21MH097173, K01MH094406]; National Institute of Diabetes, Digestive and Kidney Diseases [P30DK034987, P40OD010995, P30DK056350]; National Institute of General Medical Sciences [T32GM067553, T32GM008719]; Howard Hughes Medical Institute International Student Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, T32GM067553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094406, F30MH103925, R21MH097173] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: National Institute of Mental Health #R21MH097173 (JJC, PFS), #K01MH094406 (JJC); National Institute of Diabetes, Digestive and Kidney Diseases #P30DK034987, P40OD010995, P30DK056350 (RBS); National Institute of General Medical Sciences #T32GM067553, T32GM008719 (APM); and Howard Hughes Medical Institute International Student Research Fellowship (SHP). URLs: NIMH http://www.nimh.nih.gov/; NIDDK http://www.niddk. nih.gov/; NIGMS http://www.nigms.nih.gov/; HHMI https://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2011, LANCET, V377, P611, DOI 10.1016/S0140-6736(11)60211-0; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Capasso RM, 2008, SCHIZOPHR RES, V98, P287, DOI 10.1016/j.schres.2007.10.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2009, MAMM GENOME, V20, P395, DOI 10.1007/s00335-009-9204-7; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Davey KJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.83; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; Farwell WR, 2004, J GEN INTERN MED, V19, P1200, DOI 10.1111/j.1525-1497.2004.40126.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Jenkins AJ, 1998, J ANAL TOXICOL, V22, P605, DOI 10.1093/jat/22.7.605; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; KRISTIANSEN JEH, 1979, ACTA PATH MICRO IM B, V87, P317; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lieberman JA, 2006, ARCH GEN PSYCHIAT, V63, P1069, DOI 10.1001/archpsyc.63.10.1069; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Nixon JP, 2010, OBESITY, V18, P1652, DOI 10.1038/oby.2009.471; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Thorsing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064518; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Venables WN., 2002, MODERN APPL STAT S 4; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang CJ, 2006, BIOL PSYCHIAT, V60, P1309, DOI 10.1016/j.biopsych.2006.03.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhang G, 2007, J CHROMATOGR B, V858, P276, DOI 10.1016/j.jchromb.2007.08.007; Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58	58	103	105	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115225	10.1371/journal.pone.0115225	http://dx.doi.org/10.1371/journal.pone.0115225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506936	Green Submitted, gold, Green Published			2022-12-26	WOS:000346607100063
J	Sato, Y; Inoue, M; Yoshizawa, T; Yamagata, K				Sato, Yoshifumi; Inoue, Masahiro; Yoshizawa, Tatsuya; Yamagata, Kazuya			Moderate Hypoxia Induces beta-Cell Dysfunction with HIF-1-Independent Gene Expression Changes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; TUMOR HYPOXIA; APOPTOSIS; ACTIVATION; FAILURE; PROLIFERATION; PROGRESSION; HOMEOSTASIS; REGULATOR	Pancreatic beta-cell failure is central to the development and progression of type 2 diabetes. We recently demonstrated that beta-cells become hypoxic under high glucose conditions due to increased oxygen consumption and that the pancreatic islets of diabetic mice but not those of control mice are moderately hypoxic. However, the impact of moderate hypoxia on beta-cell number and function is unknown. In the present study, moderate hypoxia induced a hypoxic response in MIN6 cells, as evidenced by increased levels of HIF-1 alpha protein and target genes. Under these conditions, a selective downregulation of Mafa, Pdx1, Slc2a2, Ndufa5, Kcnj11, Ins1, Wfs1, Foxa2, and Neurod1, which play important roles in beta-cells, was also observed in both MIN6 cells and isolated pancreatic islets. Consistent with the altered expression of these genes, abnormal insulin secretion was detected in hypoxic MIN6 cells. Most of the hypoxia-induced gene downregulation in MIN6 cells was not affected by the suppression of HIF-1 alpha, suggesting a HIF-1-independent mechanism. Moderate hypoxia also induced apoptosis in MIN6 cells. These results suggest that hypoxia is a novel stressor of beta-cells and that hypoxic stress may play a role in the deterioration of beta-cell function.	[Sato, Yoshifumi; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan	Kumamoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto, Japan.	k-yamaga@kumamoto-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022	Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Banyu Life Science Foundation International; Takeda Science Foundation; Novo Nordisk Insulin Research Foundation	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk Insulin Research Foundation	This work was supported by a Grant-in-Aid for Young Scientists (B), a Grant-in-Aid for Scientific Research (B), a grant from Banyu Life Science Foundation International, a grant from Takeda Science Foundation, and a grant from Novo Nordisk Insulin Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Fujimoto K, 2010, J CLIN INVEST, V120, P4031, DOI 10.1172/JCI44011; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Samoszuk MK, 2004, J HISTOCHEM CYTOCHEM, V52, P837, DOI 10.1369/jhc.4B6248.2004; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	49	31	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114868	10.1371/journal.pone.0114868	http://dx.doi.org/10.1371/journal.pone.0114868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503986	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400057
J	Gordian, E; Li, J; Pevzner, Y; Mediavilla-Varela, M; Luddy, K; Ohaegbulam, K; Daniel, KG; Haura, EB; Munoz-Antonia, T				Gordian, Edna; Li, Jiannong; Pevzner, Yuri; Mediavilla-Varela, Melanie; Luddy, Kimberly; Ohaegbulam, Kim; Daniel, Kenyon G.; Haura, Eric B.; Munoz-Antonia, Teresita			Transforming Growth Factor beta Signaling Overcomes Dasatinib Resistance in Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; TGF-BETA; EPITHELIAL-CELLS; RECEPTOR KINASE; BREAST-CANCER; I RECEPTOR; PHASE-II; APOPTOSIS; EXPRESSION; INVASION	Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Despite recent advances in the development of targeted therapies, patients with advanced disease remain incurable, mostly because metastatic non-small cell lung carcinomas (NSCLC) eventually become resistant to tyrosine kinase inhibitors (TKIs). Kinase inhibitors have the potential for target promiscuity because the kinase super family is the largest family of druggable genes that binds to a common substrate (ATP). As a result, TKIs often developed for a specific purpose have been found to act on other targets. Drug affinity chromatography has been used to show that dasatinib interacts with the TGF beta type I receptor (T beta R-I), a serine-threonine kinase. To determine the potential biological relevance of this association, we studied the combined effects of dasatinib and TGFb on lung cancer cell lines. We found that dasatinib treatment alone had very little effect; however, when NSCLC cell lines were treated with a combination of TGF beta and dasatinib, apoptosis was induced. Combined TGF beta-1 + dasatinib treatment had no effect on the activity of Smad2 or other non-canonical TGF beta intracellular mediators. Interestingly, combined TGFb and dasatinib treatment resulted in a transient increase in p-Smad3 (seen after 3 hours). In addition, when NSCLC cells were treated with this combination, the pro-apoptotic protein BIM was up-regulated. Knockdown of the expression of Smad3 using Smad3 siRNA also resulted in a decrease in BIM protein, suggesting that TGF beta-1 + dasatinib- induced apoptosis is mediated by Smad3 regulation of BIM. Dasatinib is only effective in killing EGFR mutant cells, which is shown in only 10% of NSCLCs. Therefore, the observation that wild-type EGFR lung cancers can be manipulated to render them sensitive to killing by dasatinib could have important implications for devising innovative and potentially more efficacious treatment strategies for this disease.	[Gordian, Edna; Munoz-Antonia, Teresita] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Li, Jiannong; Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Pevzner, Yuri; Daniel, Kenyon G.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Mediavilla-Varela, Melanie] H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Luddy, Kimberly] H Lee Moffitt Canc Ctr & Res Inst, Canc Imaging & Metab Program, Tampa, FL 33612 USA; [Ohaegbulam, Kim] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Yeshiva University; Albert Einstein College of Medicine	Munoz-Antonia, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	teresita.Antonia@moffitt.org		Luddy, Kimberly/0000-0002-5172-221X	National Institutes of Health SPORE [P50 CA119997-02-S2]; NATIONAL CANCER INSTITUTE [P50CA119997] Funding Source: NIH RePORTER	National Institutes of Health SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health SPORE Grant P50 CA119997-02-S2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SUIT 2012 DESM MOL D; [Anonymous], 2013, SCHROD REL 2013 1 SI; [Anonymous], 2012, SUIT 2012 SCHROD SUI; [Anonymous], 2012, EP; [Anonymous], 2012, LIGPREP; [Anonymous], 2013, SCHROD REL 2013 1 MA; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DiVito KA, 2010, PIGM CELL MELANOMA R, V23, P795, DOI 10.1111/j.1755-148X.2010.00758.x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Ha Thi Huyen Trang, 2013, Biochim Biophys Acta, V1830, P3584, DOI 10.1016/j.bbagen.2013.03.006; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Saitoh M, 1996, J BIOL CHEM, V271, P2769, DOI 10.1074/jbc.271.5.2769; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhang ZF, 2010, ONCOTARGET, V1, P497	60	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114131	10.1371/journal.pone.0114131	http://dx.doi.org/10.1371/journal.pone.0114131			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501935	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700015
J	Hu, HF; Gao, ZY; Liu, LM; Liu, HH; Gao, JF; Xu, SZ; Li, W; Huang, L				Hu, Huaifei; Gao, Zhiyong; Liu, Liman; Liu, Haihua; Gao, Junfeng; Xu, Shengzhou; Li, Wei; Huang, Lu			Automatic Segmentation of the Left Ventricle in Cardiac MRI Using Local Binary Fitting Model and Dynamic Programming Techniques	PLOS ONE			English	Article							BORDER DETECTION; DISEASE	Segmentation of the left ventricle is very important to quantitatively analyze global and regional cardiac function from magnetic resonance. The aim of this study is to develop a novel algorithm for segmenting left ventricle on short-axis cardiac magnetic resonance images (MRI) to improve the performance of computer-aided diagnosis (CAD) systems. In this research, an automatic segmentation method for left ventricle is proposed on the basis of local binary fitting (LBF) model and dynamic programming techniques. The validation experiments are performed on a pool of data sets of 45 cases. For both endo- and epi-cardial contours of our results, percentage of good contours is about 93.5%, the average perpendicular distance are about 2 mm. The overlapping dice metric is about 0.91. The regression and determination coefficient between the experts and our proposed method on the LV mass is 1.038 and 0.9033, respectively; they are 1.076 and 0.9386 for ejection fraction (EF). The proposed segmentation method shows the better performance and has great potential in improving the accuracy of computer-aided diagnosis systems in cardiovascular diseases.	[Hu, Huaifei; Gao, Zhiyong; Liu, Liman; Liu, Haihua; Gao, Junfeng; Li, Wei] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Xu, Shengzhou] South Cent Univ Nationalities, Coll Comp Sci, Wuhan, Peoples R China; [Huang, Lu] Huazhong Univ Sci & Technol, Dept Radiol, Tongji Hosp, Wuhan 430074, Peoples R China	South Central Minzu University; South Central Minzu University; Huazhong University of Science & Technology	Liu, HH (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	liuhh@mail.scuec.edu.cn			National Natural Science Foundation of China [91320102, 61305044, 61302192, 81271659]; Natural Science Foundation of Hubei Province of China [2014CFB922]; State Ethnic Affairs Commission Foundation of China [CZQ13010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); State Ethnic Affairs Commission Foundation of China	The work is supported by National Natural Science Foundation of China (No. 91320102, 61305044, 61302192 and 81271659), Natural Science Foundation of Hubei Province of China (No. 2014CFB922), and State Ethnic Affairs Commission Foundation of China (No. CZQ13010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bayati M., 2013, ADV BREAST CANC RES, V02, P72, DOI [10.4236/ABCR.2013.23013, DOI 10.4236/ABCR.2013.23013, 10.4236/abcr.2013.23013]; Ammar M, 2012, J DIGIT IMAGING, V25, P294, DOI 10.1007/s10278-011-9404-z; Chen T, 2008, IEEE T MED IMAGING, V27, P1084, DOI 10.1109/TMI.2008.918327; Eslami A, 2012, MED IMAGE ANAL; Grosgeorge D, 2011, INT J COMPUT ASS RAD, V6, P573, DOI 10.1007/s11548-010-0532-6; Hadhoud MM, 2012, AM J BIOMEDICAL ENG, V2, P131, DOI DOI 10.5923/j.ajbe.20120203.07; Haggerty CM, 2013, J MAGNETIC RESONANCE; Hu HF, 2013, MAGN RESON IMAGING, V31, P575, DOI 10.1016/j.mri.2012.10.004; Huang S. Y., 2010, J STRENGTH COND RES, P1, DOI DOI 10.1007/S10278-010-9315-4; Kaus MR, 2004, MED IMAGE ANAL, V8, P245, DOI 10.1016/j.media.2004.06.015; Lee HY, 2010, IEEE T BIO-MED ENG, V57, P905, DOI 10.1109/TBME.2009.2014545; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Liu H, 2012, ACAD RADIOL, V19, P723, DOI 10.1016/j.acra.2012.02.011; Lu Y, 2011, J CARDIOVASC MAGN R, V13, P4; [路远景 LU Yuan-jing], 2009, [现代制造工程, Modern Manufacturing Engineering], P49; Nambakhsh C, 2013, MED IMAGE ANAL; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; O'Brien SP, 2011, IEEE T MED IMAGING, V30, P461, DOI 10.1109/TMI.2010.2086465; Otsu N, 1975, AUTOMATICA, V11, P285; Pednekar A, 2006, IEEE T BIO-MED ENG, V53, P1425, DOI 10.1109/TBME.2006.873684; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Plueimpitiwiriyawej C, 2005, IEEE T MED IMAGING, V24, P593, DOI 10.1109/TMI.2005.843740; Radau P, MIDAS J CARDIAC MR L; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Souto M, 2013, DIAGNOSTICS, V3, P271, DOI 10.3390/diagnostics3020271; Uzumcu M, 2006, INVEST RADIOL, V41, P52, DOI 10.1097/01.rli.0000194070.88432.24; Wijnhout J, 2009, MIDAS J, P43; Xu XY, 2011, PATTERN RECOGN LETT, V32, P956, DOI 10.1016/j.patrec.2011.01.021; Yeh JY, 2005, COMPUT METH PROG BIO, V79, P19, DOI 10.1016/j.cmpb.2004.10.010; Zhang HH, 2010, IEEE T MED IMAGING, V29, P350, DOI 10.1109/TMI.2009.2030799	30	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114760	10.1371/journal.pone.0114760	http://dx.doi.org/10.1371/journal.pone.0114760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500580	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700050
J	Li, YY; Wen, HY; Chen, LQ; Yin, TT				Li, Yuanyuan; Wen, Hongyu; Chen, Longqian; Yin, Tingting			Succession of Bacterial Community Structure and Diversity in Soil along a Chronosequence of Reclamation and Re-Vegetation on Coal Mine Spoils in China	PLOS ONE			English	Article							MICROBIAL COMMUNITY; RESTORATION; RECOVERY; DISTRIBUTIONS; DISTURBANCE; SEQUENCES; PATTERNS; IMPACT; CARBON	The growing concern about the effectiveness of reclamation strategies has motivated the evaluation of soil properties following reclamation. Recovery of belowground microbial community is important for reclamation success, however, the response of soil bacterial communities to reclamation has not been well understood. In this study, PCR-based 454 pyrosequencing was applied to compare bacterial communities in undisturbed soils with those in reclaimed soils using chronosequences ranging in time following reclamation from 1 to 20 year. Bacteria from the Proteobacteria, Chloroflexi, Actinobacteria, Acidobacteria, Planctomycetes and Bacteroidetes were abundant in all soils, while the composition of predominant phyla differed greatly across all sites. Long-term reclamation strongly affected microbial community structure and diversity. Initial effects of reclamation resulted in significant declines in bacterial diversity indices in younger reclaimed sites (1, 8-year-old) compared to the undisturbed site. However, bacterial diversity indices tended to be higher in older reclaimed sites (15, 20-year-old) as recovery time increased, and were more similar to predisturbance levels nearly 20 years after reclamation. Bacterial communities are highly responsive to soil physicochemical properties (pH, soil organic matter, Total N and P), in terms of both their diversity and community composition. Our results suggest that the response of soil microorganisms to reclamation is likely governed by soil characteristics and, indirectly, by the effects of vegetation restoration. Mixture sowing of gramineae and leguminosae herbage largely promoted soil geochemical conditions and bacterial diversity that recovered to those of undisturbed soil, representing an adequate solution for soil remediation and sustainable utilization for agriculture. These results confirm the positive impacts of reclamation and vegetation restoration on soil microbial diversity and suggest that the most important phase of microbial community recovery occurs between 15 and 20 years after reclamation.	[Li, Yuanyuan; Chen, Longqian] China Univ Min & Technol, Sch Environm Sci & Spatial Informat, Jiangsu Key Lab Resources & Environm Informat Eng, Xuzhou, Peoples R China; [Wen, Hongyu; Yin, Tingting] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Peoples R China; [Chen, Longqian] Univ Malaya, Fac Built Environm, Kuala Lumpur, Malaysia	China University of Mining & Technology; Jiangsu Normal University; Universiti Malaya	Chen, LQ (corresponding author), China Univ Min & Technol, Sch Environm Sci & Spatial Informat, Jiangsu Key Lab Resources & Environm Informat Eng, Xuzhou, Peoples R China.	longqianchencumt@163.com	li, yuanyuan/GZA-4435-2022		National Natural Science Foundation of China [51174207]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions [SZBF2011-6-B35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (51174207) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (SZBF2011-6-B35, http://www.nsfc.gov.cn/; http://www.nsfc.gov.cn/nsfc/cen/00/download.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Afrasayab S., 2002, PAK J BIOL SCI, V5, P792, DOI [10.3923/pjbs.2002.792.797, DOI 10.3923/PJBS.2002.792.797]; Anderson JD, 2008, APPL SOIL ECOL, V40, P387, DOI 10.1016/j.apsoil.2008.06.008; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Bastida F, 2013, SOIL BIOL BIOCHEM, V65, P12, DOI 10.1016/j.soilbio.2013.04.022; Bremner J.M., 1965, METHODS SOIL ANAL 2, P1149, DOI DOI 10.2134/AGRONMONOGR9.2.C32; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; CARSON PL, 1980, N DAK AGR EXP STA BU, P17; Chen LX, 2013, ENVIRON MICROBIOL, V15, P2431, DOI 10.1111/1462-2920.12114; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dangi SR, 2012, SOIL SCI SOC AM J, V76, P915, DOI 10.2136/sssaj2011.0288; Dimitriu PA, 2010, SOIL BIOL BIOCHEM, V42, P2289, DOI 10.1016/j.soilbio.2010.09.001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frost SM, 2001, ARID LAND RES MANAG, V15, P3, DOI 10.1080/15324980119429; Gasch C, 2014, APPL SOIL ECOL, V76, P102, DOI 10.1016/j.apsoil.2013.12.012; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Harris J.A., 1996, LAND RESTORATION REC; Huang LN, 2011, APPL ENVIRON MICROB, V77, P5540, DOI 10.1128/AEM.02458-10; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ingram LJ, 2005, SOIL SCI SOC AM J, V69, P1737, DOI 10.2136/sssaj2004.0371; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Keil D, 2011, FEMS MICROBIOL ECOL, V77, P95, DOI 10.1111/j.1574-6941.2011.01091.x; Kolton M, 2011, APPL ENVIRON MICROB, V77, P4924, DOI 10.1128/AEM.00148-11; Kuffner M, 2012, FEMS MICROBIOL ECOL, V82, P551, DOI 10.1111/j.1574-6941.2012.01420.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Lewis DE, 2012, MICROB ECOL, V64, P738, DOI 10.1007/s00248-012-0020-3; Lewis DE, 2010, MICROB ECOL, V59, P710, DOI 10.1007/s00248-009-9621-x; Li JG, 2014, GEODERMA, V226, P130, DOI 10.1016/j.geoderma.2014.02.003; Li JW, 2010, GEODERMA, V156, P60, DOI 10.1016/j.geoderma.2010.01.008; Li YY, 2014, J MICROBIOL BIOTECHN, V24, P313, DOI 10.4014/jmb.1309.09001; Mummey DL, 2002, SOIL BIOL BIOCHEM, V34, P1717, DOI 10.1016/S0038-0717(02)00158-X; Munshower FF., 1994, PRACTICAL HDB DISTUR; Nelson D. W., 1982, METHODS SOIL ANAL 2; [潘平 Pang Ping], 2003, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V20, P697; Poncelet DM, 2014, ENVIRON MONIT ASSESS, V186, P1917, DOI 10.1007/s10661-013-3505-8; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Rana S., 2007, 30 YEARS SMCRA, P653, DOI [DOI 10.21000/JASMR07010653, 10.21000/JASMR07010653]; Rastogi G, 2010, MICROB ECOL, V59, P94, DOI 10.1007/s00248-009-9598-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Sheoran V., 2010, INT J SOIL SEDIMENT, V3, P1; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Sun YG, 2011, CHINESE GEOGR SCI, V21, P403, DOI 10.1007/s11769-011-0482-0; Tait E, 2007, J EXP MAR BIOL ECOL, V342, P138, DOI 10.1016/j.jembe.2006.10.024; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang L.P., 2009, INT J MIN SCI TECHNO, V19, P479, DOI [10.1016/S1674-5264(09)60089-2, DOI 10.1016/S1674-5264(09)60089-2]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wick A.F., 2007, THESIS U WYOMING LAR; [武瑞平 WU Rui-ping], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1855; Xiao R, 2011, CONT SHELF RES, V31, P739, DOI 10.1016/j.csr.2011.01.013; Xu QF, 2010, J SOIL SEDIMENT, V10, P255, DOI 10.1007/s11368-009-0100-2; Ye RW, 2001, CURR OPIN MICROBIOL, V4, P307, DOI 10.1016/S1369-5274(00)00208-3; Zhao ZQ, 2012, ECOL ENG, V44, P147, DOI 10.1016/j.ecoleng.2012.03.018	58	37	40	9	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115024	10.1371/journal.pone.0115024	http://dx.doi.org/10.1371/journal.pone.0115024			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502754	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700084
J	Rauch, AV; ter Horst, L; Paul, VG; Bauer, J; Dannlowski, U; Konrad, C; Ohrmann, P; Kugel, H; Egloff, B; Arolt, V; Suslow, T				Rauch, Astrid Veronika; ter Horst, Lena; Paul, Victoria Gabriele; Bauer, Jochen; Dannlowski, Udo; Konrad, Carsten; Ohrmann, Patricia; Kugel, Harald; Egloff, Boris; Arolt, Volker; Suslow, Thomas			Influence of Repressive Coping Style on Cortical Activation during Encoding of Angry Faces	PLOS ONE			English	Article							VIGILANCE-AVOIDANCE THEORY; COGNITIVE AVOIDANCE; INDIVIDUAL-DIFFERENCES; EMOTIONAL MEMORY; HORMONAL CYCLE; TERM-MEMORY; FMRI; INFORMATION; THREAT; PERCEPTION	Background: Coping plays an important role for emotion regulation in threatening situations. The model of coping modes designates repression and sensitization as two independent coping styles. Repression consists of strategies that shield the individual from arousal. Sensitization indicates increased analysis of the environment in order to reduce uncertainty. According to the discontinuity hypothesis, repressors are sensitive to threat in the early stages of information processing. While repressors do not exhibit memory disturbances early on, they manifest weak memory for these stimuli later. This study investigates the discontinuity hypothesis using functional magnetic resonance imaging (fMRI). Methods: Healthy volunteers (20 repressors and 20 sensitizers) were selected from a sample of 150 students on the basis of the Mainz Coping Inventory. During the fMRI experiment, subjects evaluated and memorized emotional and neutral faces. Subjects performed two sessions of face recognition: immediately after the fMRI session and three days later. Results: Repressors exhibited greater activation of frontal, parietal and temporal areas during encoding of angry faces compared to sensitizers. There were no differences in recognition of facial emotions between groups neither immediately after exposure nor after three days. Conclusions: The fMRI findings suggest that repressors manifest an enhanced neural processing of directly threatening facial expression which confirms the assumption of hyper-responsivity to threatening information in repression in an early processing stage. A discrepancy was observed between high neural activation in encoding-relevant brain areas in response to angry faces in repressors and no advantage in subsequent memory for these faces compared to sensitizers.	[Rauch, Astrid Veronika; ter Horst, Lena; Paul, Victoria Gabriele; Bauer, Jochen; Ohrmann, Patricia; Arolt, Volker] Univ Munster, Dept Psychiat, Munster, Germany; [Dannlowski, Udo; Konrad, Carsten] Univ Marburg, Dept Psychiat, Marburg, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, Munster, Germany; [Egloff, Boris] Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany; [Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med, D-04109 Leipzig, Germany	University of Munster; Philipps University Marburg; University of Munster; Johannes Gutenberg University of Mainz; Leipzig University	Rauch, AV (corresponding author), Univ Munster, Dept Psychiat, Munster, Germany.	rauchast@ukmuenster.de	Egloff, Boris/G-2503-2013; Bauer, Jochen/AAW-4539-2021	Egloff, Boris/0000-0002-5736-9912; Bauer, Jochen/0000-0001-9345-2126; Suslow, Thomas/0000-0003-4560-0555; Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759	Deutsche Forschungsgemeinschaft (DFG) [RA 2009/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The Deutsche Forschungsgemeinschaft (DFG) supported part of this research (RA 2009/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; [Anonymous], 2007, COMPUTER SOFTWARE; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; BAUMEISTER RF, 1992, J PERS SOC PSYCHOL, V62, P851, DOI 10.1037/0022-3514.62.5.851; Beck A, 1987, BDI BECK DEPRESSION; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; Cutler SE, 1996, J PERS, V64, P379, DOI 10.1111/j.1467-6494.1996.tb00515.x; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Derakshan N, 2001, ANXIETY STRESS COPIN, V14, P285, DOI 10.1080/10615800108248358; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Egloff B, 1998, DIAGNOSTICA, V44, P189; Ekman P., 1984, APPROACHES EMOTION, V3, P344; Ekman P., 1976, PICTURES FACIAL AFFE; Fajkowska M, 2011, PERS INDIV DIFFER, V50, P961, DOI 10.1016/j.paid.2010.11.023; Fischer H, 2007, EMOTION, V7, P767, DOI 10.1037/1528-3542.7.4.767; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Fujiwara E, 2008, COGN AFFECT BEHAV NE, V8, P254, DOI 10.3758/CABN.8.3.254; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hock M, 1996, J PERS SOC PSYCHOL, V70, P1052, DOI 10.1037/0022-3514.70.5.1052; Hock M, 2004, EMOTION, V4, P65, DOI 10.1037/1528-3542.4.1.65; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Izard C. E., 1991, PSYCHOL EMOTIONS; Jackson MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003536; Keightley ML, 2011, SOC COGN AFFECT NEUR, V6, P24, DOI 10.1093/scan/nsq003; KOCHUNOV P, 2003, TALAIRACH DAEMON CLI; Kohlmann CW, 1996, PSYCHOL HEALTH, V11, P371, DOI 10.1080/08870449608400265; Krohne H. W. E., 1993, ATTENTION AVOIDANCE; Krohne HW, 2008, J RES PERS, V42, P1572, DOI 10.1016/j.jrp.2008.07.015; Krohne HW, 2000, COGNITIVE THER RES, V24, P297, DOI 10.1023/A:1005511320194; KROHNE HW, 1989, ADV BEHAV RES THER, V11, P235, DOI 10.1016/0146-6402(89)90027-1; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; Laux L., 1981, STATE TRAIT ANGSTINV; Lazarus R.S., 1984, EMOTION ADAPTATION; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Leube DT, 2001, NEUROREPORT, V12, P2773, DOI 10.1097/00001756-200108280-00035; Lundqvist D., 1998, KAROLINSKA DIRECTED; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Myers L, 2004, COGNITION EMOTION, V18, P495, DOI 10.1080/02699930341000419; Myers LB, 1998, J ABNORM PSYCHOL, V107, P141, DOI 10.1037/0021-843X.107.1.141; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Paul VG, 2012, SOC COGN AFFECT NEUR, V7, P980, DOI 10.1093/scan/nsr080; Pennebaker JW, 1993, INHIBITION PSYCHOSOM, P146; Peters JH, 2012, J PERS SOC PSYCHOL, V102, P200, DOI 10.1037/a0026080; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rauch AV, 2007, CEREB CORTEX, V17, P2526, DOI 10.1093/cercor/bhl158; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Rohrmann S, 2002, PSYCHOL HEALTH, V17, P583, DOI 10.1080/08870440290025795; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sander K, 2003, COGNITIVE BRAIN RES, V16, P441, DOI 10.1016/S0926-6410(03)00059-4; Schimmack U, 1997, J PERS SOC PSYCHOL, V73, P1064, DOI 10.1037/0022-3514.73.5.1064; Schwerdtfeger A, 2010, PSYCHOPHYSIOLOGY, V47, P786, DOI 10.1111/j.1469-8986.2010.00965.x; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Sergerie K, 2006, J COGNITIVE NEUROSCI, V18, P1359, DOI 10.1162/jocn.2006.18.8.1359; Shimamura AP, 2006, PSYCHON B REV, V13, P217, DOI 10.3758/BF03193833; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tewes U, 1991, HDB TESTANWEISUNG	62	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e112398	10.1371/journal.pone.0112398	http://dx.doi.org/10.1371/journal.pone.0112398			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502775	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700004
J	Henaut, Y; Corbara, B; Pelozuelo, L; Azemar, F; Cereghino, R; Herault, B; Dejean, A				Henaut, Yann; Corbara, Bruno; Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Herault, Bruno; Dejean, Alain			A Tank Bromeliad Favors Spider Presence in a Neotropical Inundated Forest	PLOS ONE			English	Article							JUMPING SPIDERS; ANT MIMICRY; VISUAL CUES; CUPIENNIUS; PREDATION; ARANEAE; PREY; STRATEGIES; CAPTURE; VISION	Tank bromeliads are good models for understanding how climate change may affect biotic associations. We studied the relationships between spiders, the epiphytic tank bromeliad, Aechmea bracteata, and its associated ants in an inundated forest in Quintana Roo, Mexico, during a drought period while, exceptionally, this forest was dry and then during the flooding that followed. We compared spider abundance and diversity between 'Aechmea-areas' and 'control-areas' of the same surface area. We recorded six spider families: the Dipluridae, Ctenidae, Salticidae, Araneidae, Tetragnathidae and Linyphiidae among which the funnel-web tarantula, Ischnothele caudata, the only Dipluridae noted, was the most abundant. During the drought period, the spiders were more numerous in the Aechmea-areas than in the control-areas, but they were not obligatorily associated with the Aechmea. During the subsequent flooding, the spiders were concentrated in the A. bracteata patches, particularly those sheltering an ant colony. Also, a kind of specificity existed between certain spider taxa and ant species, but varied between the drought period and subsequent flooding. We conclude that climatic events modulate the relationship between A. bracteata patches and their associated fauna. Tank bromeliads, previously considered only for their ecological importance in supplying food and water during drought, may also be considered refuges for spiders during flooding. More generally, tank bromeliads have an important role in preserving non-specialized fauna in inundated forests.	[Henaut, Yann] Colegio Frontera Sur, Dept Conservac Biodiversidad, Quintana Roo, Chetumal, Mexico; [Corbara, Bruno] Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Corbara, Bruno] Univ Blaise Pascal, CNRS, Unite Mixte Rech 6023, Aubiere, France; [Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Dejean, Alain] Univ Toulouse 3, Lab Ecol Fonct & Environm, F-31062 Toulouse, France; [Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Dejean, Alain] CNRS, Unite Mixte Rech 5245, Lab Ecol Fonct & Environm, Toulouse, France; [Herault, Bruno] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech 93, Kourou, France; [Dejean, Alain] Ecol Forets Guyane, Kourou, France	El Colegio de la Frontera Sur (ECOSUR); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles	Henaut, Y (corresponding author), Colegio Frontera Sur, Dept Conservac Biodiversidad, Quintana Roo, Chetumal, Mexico.	yhenaut@ecosur.mx	Hérault, Bruno/B-2765-2011; Azémar, Frédéric/A-9041-2010	Hérault, Bruno/0000-0002-6950-7286; Azémar, Frédéric/0000-0002-3098-8676; Dejean, Alain/0000-0002-3561-2248; CORBARA, Bruno/0000-0003-4232-8234	French Agence Nationale pour la Recherche (RAINWEBS) [ANR-12-BSV7-0022-01]; internal fund of El Colegio de la Frontera Sur (ECOSUR)	French Agence Nationale pour la Recherche (RAINWEBS)(French National Research Agency (ANR)); internal fund of El Colegio de la Frontera Sur (ECOSUR)	All the financial support for this study was provided by the French Agence Nationale pour la Recherche (RAINWEBS ANR-12-BSV7-0022-01) and internal fund of El Colegio de la Frontera Sur (ECOSUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 1997, CENTRAL AMAZON FLOOD, P299, DOI 10.1007/978-3-662-03416-3_14; Allan RA, 1996, P ROY SOC B-BIOL SCI, V263, P69, DOI 10.1098/rspb.1996.0012; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; BARTH FG, 1988, OECOLOGIA, V77, P187, DOI 10.1007/BF00379185; Benzing D. H., 2008, VASCULAR EPIPHYTES G; Beutelspacher BCR, 1999, BROMELIACEAS COMO EC; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; COYLE FA, 1995, B AM MUS NAT HIST, P3; De Omena PM, 2008, BIOL J LINN SOC, V94, P653, DOI 10.1111/j.1095-8312.2008.01039.x; de Omena PM, 2010, BEHAV ECOL, V21, P690, DOI 10.1093/beheco/arq040; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Dejean A, 1997, J NAT HIST, V31, P1313, DOI 10.1080/00222939700770741; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027004; Dias Sidclay Calaça, 2004, Rev. Bras. Zool., V21, P789, DOI 10.1590/S0101-81752004000400011; Durkee CA, 2011, ENVIRON ENTOMOL, V40, P1223, DOI 10.1603/EN11057; Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Gillespie Rosemary G., 1993, Pacific Science, V47, P21; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Halaj J, 1997, OECOLOGIA, V109, P313, DOI 10.1007/s004420050089; Harwood JD, 2001, J APPL ECOL, V38, P88, DOI 10.1046/j.1365-2664.2001.00572.x; Henaut Y, 2001, ENTOMOL EXP APPL, V98, P1, DOI 10.1023/A:1018731906296; Henaut Y, 2014, ANIM COGN, V17, P185, DOI 10.1007/s10071-013-0651-x; Huang JN, 2011, P ROY SOC B-BIOL SCI, V278, P1356, DOI 10.1098/rspb.2010.1896; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; Kohonen T., 2001, SELF ORG MAPS; LAND MF, 1992, J EXP BIOL, V164, P227; McCracken SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085470; Nakaegawa T, 2014, THEOR APPL CLIMATOL, V116, P155, DOI 10.1007/s00704-013-0934-9; Nelson XJ, 2006, BEHAV ECOL, V17, P676, DOI 10.1093/beheco/ark017; Nelson XJ, 2014, BEHAV ECOL SOCIOBIOL, V68, P773, DOI 10.1007/s00265-014-1690-2; Nelson XJ, 2005, J ARACHNOL, V33, P813, DOI 10.1636/S04-12.1; Nelson XJ, 2004, NEW ZEAL J ZOOL, V31, P45, DOI 10.1080/03014223.2004.9518358; NENTWIG W, 1986, OECOLOGIA, V69, P571, DOI 10.1007/BF00410365; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Philander S.G., 1990, NINO NINA SO OSCILLA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raizer J, 2001, J ARACHNOL, V29, P227, DOI 10.1636/0161-8202(2001)029[0227:DTSCOA]2.0.CO;2; Romero GQ, 2004, BIOTROPICA, V36, P596, DOI 10.1111/j.1744-7429.2004.tb00353.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanders D, 2007, OECOLOGIA, V150, P611, DOI 10.1007/s00442-006-0538-5; Santos AJ, 2004, J ARACHNOL, V32, P188, DOI 10.1636/H03-01; Schmidt CA, 2014, ZOOTAXA, V3817, P1, DOI 10.11646/zootaxa.3817.1.1; SCHUSTER M, 1994, J ARACHNOL, V22, P32; Styrsky JD, 2014, ECOL EVOL, V4, P276, DOI 10.1002/ece3.930; Weihmann T, 2010, J COMP PHYSIOL A, V196, P421, DOI 10.1007/s00359-010-0527-3; Zhang SC, 2012, P ROY SOC B-BIOL SCI, V279, P1824, DOI 10.1098/rspb.2011.2193; Zschokke S, 2006, CAN J ZOOL, V84, P964, DOI 10.1139/Z06-074	50	15	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114592	10.1371/journal.pone.0114592	http://dx.doi.org/10.1371/journal.pone.0114592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494055	Green Published, gold			2022-12-26	WOS:000346611400056
J	Iejima, D; Itabashi, T; Kawamura, Y; Noda, T; Yuasa, S; Fukuda, K; Oka, C; Iwata, T				Iejima, Daisuke; Itabashi, Takeshi; Kawamura, Yuich; Noda, Toru; Yuasa, Shinsuke; Fukuda, Keiichi; Oka, Chio; Iwata, Takeshi			HTRA1 (High Temperature Requirement A Serine Peptidase 1) Gene Is Transcriptionally Regulated by Insertion/Deletion Nucleotides Located at the 3 ' End of the ARMS2 (Age-related Maculopathy Susceptibility 2) Gene in Patients with Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Photoreceptor; Retina; Retinal Degeneration; Transcription Regulation; ARMS2; EMSA; HTRA1; Age-related Macular Degeneration	POLYPOIDAL CHOROIDAL VASCULOPATHY; PROTEASE; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; POLYMORPHISM; VARIANT	Background: The biological function of insertion/deletion sequences associated with AMD has not been fully characterized. Results: The HTRA1 regulatory region contains an insertion/deletion sequence that is significantly up-regulated in retinal neuronal cell lines. Conclusion:HTRA1 expression is enhanced by a mutation in the insertion/deletion in the HTRA1 regulatory region. Significance: This is the characterization of the HTRA1 regulatory elements and the effect of insertion/deletion sequences associated with AMD. Dry age-related macular degeneration (AMD) accounts for over 85% of AMD cases in the United States, whereas Japanese AMD patients predominantly progress to wet AMD or polypoidal choroidal vasculopathy. Recent genome-wide association studies have revealed a strong association between AMD and an insertion/deletion sequence between the ARMS2 (age-related maculopathy susceptibility 2) and HTRA1 (high temperature requirement A serine peptidase 1) genes. Transcription regulator activity was localized in mouse retinas using heterozygous HtrA1 knock-out mice in which HtrA1 exon 1 was replaced with -galactosidase cDNA, thereby resulting in dominant expression of the photoreceptors. The insertion/deletion sequence significantly induced HTRA1 transcription regulator activity in photoreceptor cell lines but not in retinal pigmented epithelium or other cell types. A deletion construct of the HTRA1 regulatory region indicated that potential transcriptional suppressors and activators surround the insertion/deletion sequence. Ten double-stranded DNA probes for this region were designed, three of which interacted with nuclear extracts from 661W cells in EMSA. Liquid chromatography-mass spectrometry (LC-MS/MS) of these EMSA bands subsequently identified a protein that bound the insertion/deletion sequence, LYRIC (lysine-rich CEACAM1 co-isolated) protein. In addition, induced pluripotent stem cells from wet AMD patients carrying the insertion/deletion sequence showed significant up-regulation of the HTRA1 transcript compared with controls. These data suggest that the insertion/deletion sequence alters the suppressor and activator cis-elements of HTRA1 and triggers sustained up-regulation of HTRA1. These results are consistent with a transgenic mouse model that ubiquitously overexpresses HtrA1 and exhibits characteristics similar to those of wet AMD patients.	[Iejima, Daisuke; Itabashi, Takeshi; Kawamura, Yuich; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo 1528902, Japan; [Noda, Toru] Natl Hosp Org Tokyo Med Ctr, Div Ophthalmol, Tokyo 1528902, Japan; [Yuasa, Shinsuke; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Oka, Chio] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Iwata, T (corresponding author), Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo 1528902, Japan.	takeshi_iwata@kankakuki.go.jp	Fukuda, Keiichi/L-3777-2013	Itabashi, Takeshi/0000-0002-2222-3446; Yuasa, Shinsuke/0000-0001-5593-7552	Japanese Ministry of Health, Labor, and Welfare [10103254]; National Hospital Organization of Japan [09005752]; Japan Society for the Promotion of Science [23890258]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japanese Ministry of Health, Labor, and Welfare Grant 10103254 and National Hospital Organization of Japan Grant 09005752 (to T. I.). This work was also supported by Japan Society for the Promotion of Science Grant 23890258 (to D. I.).	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Ferrer-Vaquer A, 2008, DEV DYNAM, V237, P1893, DOI 10.1002/dvdy.21597; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Huang Y, 2014, ONCOL LETT, V8, P493, DOI 10.3892/ol.2014.2231; Jiang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046058; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Nakayama M, 2014, INVEST OPHTH VIS SCI, V55, P6514, DOI 10.1167/iovs.14-14453; Noch E, 2011, CANCER BIOL THER, V11, P32, DOI 10.4161/cbt.11.1.13835; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okamoto H, 2006, MOL VIS, V12, P156; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Supanji, 2013, EXP EYE RES, V112, P79, DOI 10.1016/j.exer.2013.04.013; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wu XH, 2014, FEBS LETT, V588, P143, DOI 10.1016/j.febslet.2013.11.022; Xu YQ, 2014, J CELL BIOCHEM, V115, P1112, DOI 10.1002/jcb.24751; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhu F, 2010, HEPATOB PANCREAT DIS, V9, P508	40	16	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2784	2797		10.1074/jbc.M114.593384	http://dx.doi.org/10.1074/jbc.M114.593384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519903	Green Published, hybrid			2022-12-26	WOS:000349310700020
J	Jang, W; Kim, Y; Cui, S; Jo, J; Lee, BC; Lee, Y; Kwon, KS; Park, CS; Kim, C				Jang, Wijeong; Kim, Young; Cui, Shanyu; Jo, Juyeon; Lee, Byoung-Cheol; Lee, Yeonwoo; Kwon, Ki-Sun; Park, Chul-Seung; Kim, Changsoo			The Anoctamin Family Channel Subdued Mediates Thermal Nociception in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SENSOR; ION-CHANNEL; PAINLESS; RECEPTOR	Calcium-permeable and thermosensitive transient receptor potential (TRP) channels mediate the nociceptive transduction of noxious temperature in Drosophila nociceptors. However, the underlying molecular mechanisms are not completely understood. Here we find that Subdued, a calcium-activated chloride channel of the Drosophila anoctamin family, functions in conjunction with the thermo-TRPs in thermal nociception. Genetic analysis with deletion and the RNAi-mediated reduction of subdued show that subdued is required for thermal nociception in nociceptors. Further genetic analysis of subdued mutant and thermo-TRP mutants show that they interact functionally in thermal nociception. We find that Subdued expressed in heterologous cells mediates a strong chloride conductance in the presence of both heat and calcium ions. Therefore, our analysis suggests that Subdued channels may amplify the nociceptive neuronal firing that is initiated by thermo-TRP channels in response to thermal stimuli.	[Jang, Wijeong; Kim, Young; Jo, Juyeon; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Yongbong Dong 500757, Gwangju Si, South Korea; [Cui, Shanyu; Lee, Byoung-Cheol; Lee, Yeonwoo; Park, Chul-Seung] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Cui, Shanyu; Park, Chul-Seung] Gwangju Inst Sci & Technol, Natl Leading Res Lab Ion Channel, Kwangju 500712, South Korea; [Lee, Byoung-Cheol; Lee, Yeonwoo; Park, Chul-Seung] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Kim, Young; Kwon, Ki-Sun] Korea Res Inst Biosci & BioTechnol, Aging Res Ctr, Taejon, South Korea	Chonnam National University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, CS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	cspark@gist.ac.kr; changgk@chonnam.ac.kr		Park, Chul-Seung/0000-0003-0209-1412; Jo, Juyeon/0000-0001-8939-1623	National Leading Research Laboratories [2012R1A2A2A01014574]; Biomedical Technology Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2011-0030133]; National Research Foundation - Ministry of Education, Science, and Technology of Korea [2011-0028665, 2011-0001154]	National Leading Research Laboratories; Biomedical Technology Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; National Research Foundation - Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Leading Research Laboratories Grant 2012R1A2A2A01014574 and by Biomedical Technology Development Program Grant 2011-0030133 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (to C. K.) and by grants to the National Leading Research Laboratories (2011-0028665) and the Cell Dynamics Research Center (2011-0001154) from the National Research Foundation funded by the Ministry of Education, Science, and Technology of Korea (to C. S. P.).	Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Schnakenberg SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001192; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wong XM, 2013, ELIFE, V2, DOI 10.7554/eLife.00862; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; YANG MY, 1995, NEURON, V15, P45; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	21	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2521	2528		10.1074/jbc.M114.592758	http://dx.doi.org/10.1074/jbc.M114.592758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505177	Green Published, hybrid			2022-12-26	WOS:000348588000052
J	Dechmann, DKN; Wikelski, M; Varga, K; Yohannes, E; Fiedler, W; Safi, K; Burkhard, WD; O'Mara, MT				Dechmann, Dina K. N.; Wikelski, Martin; Varga, Katarina; Yohannes, Elisabeth; Fiedler, Wolfgang; Safi, Kamran; Burkhard, Wolf-Dieter; O'Mara, M. Teague			Tracking Post-Hibernation Behavior and Early Migration Does Not Reveal the Expected Sex-Differences in a "Female-Migrating'' Bat	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; NYCTALUS-NOCTULA; INSECTIVOROUS BAT; FORAGING BEHAVIOR; HABITAT USE; INDIVIDUAL SPECIALIZATION; TADARIDA-BRASILIENSIS; FLIGHT PERFORMANCE; LASIURUS-CINEREUS; MYOTIS-LUCIFUGUS	Long-distance migration is a rare phenomenon in European bats. Genetic analyses and banding studies show that females can cover distances of up to 1,600 km, whereas males are sedentary or migrate only short distances. The onset of this sex-biased migration is supposed to occur shortly after rousing from hibernation and when the females are already pregnant. We therefore predicted that the sexes are exposed to different energetic pressures in early spring, and this should be reflected in their behavior and physiology. We investigated this in one of the three Central European long-distance migrants, the common noctule (Nyctalus noctula) in Southern Germany recording the first individual partial migration tracks of this species. In contrast to our predictions, we found no difference between male and female home range size, activity, habitat use or diet. Males and females emerged from hibernation in similar body condition and mass increase rate was the same in males and females. We followed the first migration steps, up to 475 km, of radio-tagged individuals from an airplane. All females, as well as some of the males, migrated away from the wintering area in the same northeasterly direction. Sex differences in long-distance migratory behavior were confirmed through stable isotope analysis of hair, which showed greater variation in females than in males. We hypothesize that both sexes faced similarly good conditions after hibernation and fattened at maximum rates, thus showing no differences in their local behavior. Interesting results that warrant further investigation are the better initial condition of the females and the highly consistent direction of the first migratory step in this	[Dechmann, Dina K. N.; Wikelski, Martin; Fiedler, Wolfgang; Safi, Kamran; O'Mara, M. Teague] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Dechmann, Dina K. N.; Wikelski, Martin; Varga, Katarina; Yohannes, Elisabeth; Fiedler, Wolfgang; Safi, Kamran; O'Mara, M. Teague] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Dechmann, Dina K. N.; Wikelski, Martin; O'Mara, M. Teague] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Max Planck Society; University of Konstanz; Smithsonian Institution; Smithsonian Tropical Research Institute	Dechmann, DKN (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Am Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.	ddechmann@om.mpg.de	O'Mara, M. Teague/J-6090-2012; Fiedler, Wolfgang/AAG-4510-2021; Safi, Kamran/B-2079-2008	O'Mara, M. Teague/0000-0002-6951-1648; Fiedler, Wolfgang/0000-0003-1082-4161; Safi, Kamran/0000-0002-8418-6759				ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Alerstam T, 2009, J THEOR BIOL, V258, P530, DOI 10.1016/j.jtbi.2009.01.020; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; BARCLAY RMR, 1989, BEHAV ECOL SOCIOBIOL, V24, P31, DOI 10.1007/BF00300115; BECK A, 1995, MYOTIS, V32, P109; Berthold P, 2001, BIRD MIGRATION GEN S, P89; Best TL, 2003, SOUTHWEST NAT, V48, P590, DOI 10.1894/0038-4909(2003)048<0590:SFROMF>2.0.CO;2; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Catry Paulo, 2005, P351; Cryan PM, 2012, J MAMMAL, V93, P381, DOI 10.1644/11-MAMM-S-162.1; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Durell SEALD, 2000, WADER STUDY GROUP B, V100, P35; Dzal YA, 2012, J COMP PHYS B; Fleming TH, 2003, BAT ECOLOGY, P156; GEBHARD J, 1997, FLEDERMAUSE; GLOOR S, 1995, MYOTIS, V32, P231; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Haussler U, 2003, SAUGETIERE BADENWURT, P591; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Heise G., 1989, NYCTALUS, V3, P17; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; JONES G, 1995, J ZOOL, V237, P303, DOI 10.1111/j.1469-7998.1995.tb02764.x; Kolb A, 1955, SAUGETIERKUNDLICHE M, V3, P176; KURTA A, 1990, J MAMMAL, V71, P59, DOI 10.2307/1381316; KURTA A, 1987, PHYSIOL ZOOL, V60, P386, DOI 10.1086/physzool.60.4.30157900; Lam MMY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083452; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; McGuire LP, 2013, J EXP BIOL, V216, P800, DOI 10.1242/jeb.072868; McGuire LP, 2009, J MAMMAL, V90, P1290, DOI 10.1644/09-MAMM-S-084R.1; McWilliams Scott R., 2005, P67; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Mara MT, 2014, METHODS ECOL EVOL, V5, P311, DOI 10.1111/2041-210X.12172; O'SHEA T J, 1976, Southwestern Naturalist, V21, P321, DOI 10.2307/3669717; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Petit E, 2000, MOL ECOL, V9, P683, DOI 10.1046/j.1365-294x.2000.00896.x; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Privat KL, 2007, J ARCHAEOL SCI, V34, P1197, DOI 10.1016/j.jas.2006.10.008; Raikow DF, 2011, ECOL APPL, V21, P983, DOI 10.1890/09-1504.1; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rubin Esther S., 2005, P379; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Scott JE, 2006, J HUM EVOL, V51, P422, DOI 10.1016/j.jhevol.2006.06.001; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Shiel CB, 1999, J ZOOL, V249, P347, DOI 10.1111/j.1469-7998.1999.tb00770.x; Shine R, 2002, OECOLOGIA, V133, P45, DOI 10.1007/s00442-002-1012-7; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; van Toor ML, 2011, ANIM CONSERV, V14, P512, DOI 10.1111/j.1469-1795.2011.00454.x; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Waters D, 1999, J ZOOL, V249, P173, DOI 10.1111/j.1469-7998.1999.tb00755.x; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; WILLIAMS TC, 1973, J MAMMAL, V54, P807, DOI 10.2307/1379076; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	70	18	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114810	10.1371/journal.pone.0114810	http://dx.doi.org/10.1371/journal.pone.0114810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517947	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600029
J	Gallo, I; Rattazzi, L; Piras, G; Gobbetti, T; Panza, E; Perretti, M; Dalley, JW; D'Acquisto, F				Gallo, Irene; Rattazzi, Lorenza; Piras, Giuseppa; Gobbetti, Thomas; Panza, Elisabetta; Perretti, Mauro; Dalley, Jeffrey W.; D'Acquisto, Fulvio			Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SPECIES-TYPICAL BEHAVIORS; INNATE IMMUNE RECOGNITION; MURINE MICROGLIAL CELLS; CHEMOTACTIC PEPTIDE; ENVIRONMENTAL ENRICHMENT; PLASMA-CORTICOSTERONE; DENDRITIC CELLS; GUT MICROBIOTA; BINDING-SITES	Formyl peptide receptors (FPR) belong to a family of sensors of the immune system that detect microbe-associated molecules and inform various cellular and sensorial mechanisms to the presence of pathogens in the host. Here we demonstrate that Fpr2/3-deficient mice show a distinct profile of behaviour characterised by reduced anxiety in the marble burying and light-dark box paradigms, increased exploratory behaviour in an open-field, together with superior performance on a novel object recognition test. Pharmacological blockade with a formyl peptide receptor antagonist, Boc2, in wild type mice reproduced most of the behavioural changes observed in the Fpr2/3(-/)-mice, including a significant improvement in novel object discrimination and reduced anxiety in a light/dark shuttle test. These effects were associated with reduced FPR signalling in the gut as shown by the significant reduction in the levels of p-p38. Collectively, these findings suggest that homeostatic FPR signalling exerts a modulatory effect on anxiety-like behaviours. These findings thus suggest that therapies targeting FPRs may be a novel approach to ameliorate behavioural abnormalities present in neuropsychiatric disorders at the cognitive-emotional interface.	[Gallo, Irene; Rattazzi, Lorenza; Piras, Giuseppa; Gobbetti, Thomas; Perretti, Mauro; D'Acquisto, Fulvio] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Panza, Elisabetta] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Dalley, Jeffrey W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Dalley, Jeffrey W.] Univ Cambridge, Dept Psychiat, Cambridge, England	University of London; Queen Mary University London; University of Naples Federico II; University of Cambridge; University of Cambridge	D'Acquisto, F (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.	F.Dacquisto@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018	D'Acquisto, Fulvio/0000-0002-4513-1608; Dalley, Jeffrey/0000-0002-2282-3660				Alam A, 2014, MUCOSAL IMMUNOL, V7, P645, DOI 10.1038/mi.2013.84; Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Anton P, 1998, GUT, V42, P374, DOI 10.1136/gut.42.3.374; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aoki M, 2010, ZOOL SCI, V27, P783, DOI 10.2108/zsj.27.783; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Barr JL, 2011, NEUROSCIENCE, V182, P105, DOI 10.1016/j.neuroscience.2011.03.020; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Carpenter AC, 2012, DEV NEUROSCI-BASEL, V34, P250, DOI 10.1159/000336824; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2007, J IMMUNOL, V178, P1759, DOI 10.4049/jimmunol.178.3.1759; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; CONDO GT, 1991, PHYS REV D, V43, P2787, DOI 10.1103/PhysRevD.43.2787; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Costa-Pinto FA, 2010, NEUROIMMUNOMODULAT, V17, P196, DOI 10.1159/000258722; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cui YH, 2002, NEUROBIOL DIS, V10, P366, DOI 10.1006/nbdi.2002.0517; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Palma G, 2014, J PHYSL; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Derian CK, 1996, BIOCHEMISTRY-US, V35, P1265, DOI 10.1021/bi952087k; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Ganella DE, 2014, BRIT J PHARMACOL, V171, P4556, DOI 10.1111/bph.12643; Gao JL, 2011, BEHAV GENET, V41, P724, DOI 10.1007/s10519-011-9467-0; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gemperle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050195; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ihara S, 2013, NEUROSCIENCE, V254, P45, DOI 10.1016/j.neuroscience.2013.08.063; Jahng JW, 2011, HORM BEHAV, V59, P213, DOI 10.1016/j.yhbeh.2010.11.010; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kedia S, 2014, J NEUROSCI METHODS; Keitoku M, 1997, J MOL CELL CARDIOL, V29, P881, DOI 10.1006/jmcc.1996.0291; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lim H, 2012, BIOMOL THER, V20, P418, DOI 10.4062/biomolther.2012.20.4.418; Luisi R, 2009, J NEUROCHEM, V109, P168, DOI 10.1111/j.1471-4159.2009.05945.x; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Miceli F, 2009, NEUROBIOL DIS, V34, P501, DOI 10.1016/j.nbd.2009.03.009; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Mou HW, 2012, INFLAMMATION, V35, P656, DOI 10.1007/s10753-011-9358-9; Munger SD, 2009, NATURE, V459, P521, DOI 10.1038/459521a; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Onnela JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036106; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; Park S, 2014, BIOCHEM BIOPH RES CO, V450, P13, DOI 10.1016/j.bbrc.2014.05.049; PELLOW S, 1985, PHYSIOL BEHAV, V35, P587, DOI 10.1016/0031-9384(85)90145-3; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rane MJ, 1997, J IMMUNOL, V159, P5070; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saigo M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.091601; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Santos-Soto IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081459; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Sato T, 2010, FORENSIC SCI INT, V194, P77, DOI 10.1016/j.forsciint.2009.10.014; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Spurr L, 2011, INT IMMUNOPHARMACOL, V11, P55, DOI 10.1016/j.intimp.2010.10.006; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Strohle A, 2003, PHARMACOPSYCHIATRY, V36, pS207; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; van Gaalen MM, 2002, GENES BRAIN BEHAV, V1, P174, DOI 10.1034/j.1601-183X.2002.10305.x; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang QS, 2012, BEHAV BRAIN RES, V230, P167, DOI 10.1016/j.bbr.2012.01.051; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	90	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114626	10.1371/journal.pone.0114626	http://dx.doi.org/10.1371/journal.pone.0114626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517119	Green Submitted, Green Published, gold			2022-12-26	WOS:000347215600024
J	Mukai, K; Komatsu, E; Nakajima, Y; Urai, T; Nasruddin; Sugama, J; Nakatani, T				Mukai, Kanae; Komatsu, Emi; Nakajima, Yukari; Urai, Tamae; Nasruddin; Sugama, Junko; Nakatani, Toshio			The Effect of 17 beta-Estradiol on Cutaneous Wound Healing in Protein-Malnourished Ovariectomized Female Mouse Model	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; ALTERNATIVE ACTIVATION; INFLAMMATORY RESPONSES; AGED HUMANS; ESTROGEN; MICE; MACROPHAGES; SUPPLEMENTATION; MALNUTRITION; ALTERS	Cutaneous wound healing is delayed by protein malnutrition (PM). On the other hand, estrogen promotes cutaneous wound healing by its anti-inflammatory and cell proliferation effects. Therefore, we hypothesized that estrogen administration in protein-malnourished ovariectomized (OVX) female mice might improve the inflammatory response and promote cutaneous wound healing as well as normal nutrition. To test this hypothesis, we used full-thickness excisional wounds in Control SHAM, PM SHAM, PM OVX and PM OVX+17 beta-estradiol mice. The Control diet included 200 g/kg protein and the PM diet included 30 g/kg protein. The ratio of wound area in the Control SHAM group was significantly smaller than those in the three PM groups. In addition, microscopic findings also showed that the ratio of collagen fibers, the ratio of myofibroblasts and the number of new blood vessels in the Control SHAM group were significantly greater than those in the three PM groups. However, the number of Ym1-positive cells as an anti-inflammatory M2-like macrophage marker in the PM OVX+17 beta-estradiol group was significantly higher than those in the other three groups. These results indicate that the appearance of anti-inflammatory M2-like macrophages was promoted by estrogen administration; however, it could not promote cutaneous wound healing upon a low-protein diet. Therefore, it may be confirmed that nutrition is more important for promoting cutaneous wound healing than estrogen administration.	[Mukai, Kanae; Komatsu, Emi; Nakajima, Yukari; Urai, Tamae; Nasruddin] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Dept Clin Nursing, Kanazawa, Ishikawa, Japan; [Sugama, Junko; Nakatani, Toshio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Nakatani, T (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan.	nakatosi@staff.kanazawa-u.ac.jp	, Nasruddin/P-1610-2019; 中谷, 壽男/C-3220-2015	, Nasruddin/0000-0002-0872-6282; 中谷, 壽男/0000-0003-4949-5123	JSPS KAKENHI [25293430]; Kanazawa University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanazawa University	All of this work was supported by JSPS KAKENHI (Grant Number 25293430 to T. Nakatani) and research funding from Kanazawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RE, 1998, ARCH SURG-CHICAGO, V133, P1002, DOI 10.1001/archsurg.133.9.1002; [Anonymous], 2007, DERMATOTOXICOLOGY, DOI DOI 10.1201/9781420009774.CH33; Ansell DM, 2014, WOUND REPAIR REGEN, V22, P281, DOI 10.1111/wrr.12148; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Ashcroft GS, 1997, CELL TISSUE RES, V290, P581, DOI 10.1007/s004410050963; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Ashcroft GS, 1998, LAB INVEST, V78, P47; Brufani M, 2009, MOL PHARMACEUT, V6, P543, DOI 10.1021/mp800206b; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; CHANDRA RK, 1992, J NUTR, V122, P597, DOI 10.1093/jn/122.suppl_3.597; Emmerson E, 2009, ENDOCRINOLOGY, V150, P2749, DOI 10.1210/en.2008-1569; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hardman MJ, 2008, ENDOCRINOLOGY, V149, P551, DOI 10.1210/en.2007-1042; Herrick S, 1997, LAB INVEST, V77, P281; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Izawa S, 2006, CLIN NUTR, V25, P962, DOI 10.1016/j.clnu.2006.05.006; Langemo D, 2006, ADV SKIN WOUND CARE, V19, P303; Langemo D, 2006, ADV SKIN WOUND CARE, V19, P300; Langemo Diane, 2006, Adv Skin Wound Care, V19, P297, DOI 10.1097/00129334-200607000-00007; Li J, 2002, J NUTR, V132, P3286, DOI 10.1093/jn/132.11.3286; Lim Y, 2006, J NUTR BIOCHEM, V17, P328, DOI 10.1016/j.jnutbio.2005.08.004; Lima FD, 2013, EUR J NUTR, V52, P1343, DOI 10.1007/s00394-012-0443-0; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mercado AM, 2002, J NEUROIMMUNOL, V129, P74, DOI 10.1016/S0165-5728(02)00174-1; Mukai K, 2014, J HORM; Mukai K, 2014, J HORM, DOI 10.1371/journal.pone.0115564; Mukai K, 2016, INT WOUND J, V13, P636, DOI 10.1111/iwj.12336; Otranto M, 2009, APPL PHYSIOL NUTR ME, V34, P1023, DOI 10.1139/H09-100; Routley CE, 2009, WOUND REPAIR REGEN, V17, P42, DOI 10.1111/j.1524-475X.2008.00440.x; Sgonc R, 2013, GERONTOLOGY, V59, P159, DOI 10.1159/000342344; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Sindrilaru A, 2013, ADV WOUND CARE, V2, P357, DOI 10.1089/wound.2012.0407; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Tsuda K, 2010, INT WOUND J, V7, P135, DOI 10.1111/j.1742-481X.2010.00674.x	39	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115564	10.1371/journal.pone.0115564	http://dx.doi.org/10.1371/journal.pone.0115564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25518000	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600071
J	Liu, W; Wang, JY; Wang, TJ; Xie, HW				Liu, Wei; Wang, Jianying; Wang, Tengjiao; Xie, Hongwei			Construction and Analyses of Human Large-Scale Tissue Specific Networks	PLOS ONE			English	Article								Construction and analyses of tissue specific networks is crucial to unveil the function and organizational structure of biological systems. As a direct method to detect protein dynamics, human proteome-wide expression data provide an valuable resource to investigate the tissue specificity of proteins and interactions. By integrating protein expression data with large-scale interaction network, we constructed 30 tissue/cell specific networks in human and analyzed their properties and functions. Rather than the tissue specificity of proteins, we mainly focused on the tissue specificity of interactions to distill tissue specific networks. Through comparing our tissue specific networks with those inferred from gene expression data, we found our networks have larger scales and higher reliability. Furthermore, we investigated the similar extent of multiple tissue specific networks, which proved that tissues with similar functions tend to contain more common interactions. Finally, we found that the tissue specific networks differed from the static network in multiple topological properties. The proteins in tissue specific networks are interacting looser and the hubs play more important roles than those in the static network.	[Liu, Wei; Wang, Tengjiao; Xie, Hongwei] Natl Univ Def Technol, Coll Mech & Elect Engn & Automat, Changsha, Hunan, Peoples R China; [Wang, Jianying] Affiliated Hosp Mil Med Sci, Beijing, Peoples R China		Liu, W (corresponding author), Natl Univ Def Technol, Coll Mech & Elect Engn & Automat, Changsha, Hunan, Peoples R China.	angel_nudt@126.com	wang, tengjiao/E-2118-2015	wang, tengjiao/0000-0002-7790-7407	International Cooperation Project [2014DFB30010]; Chinese National Key Program of Basic Research [31171266]	International Cooperation Project; Chinese National Key Program of Basic Research	This work was supported by International Cooperation Project (2014DFB30010) and Chinese National Key Program of Basic Research (31171266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Emig D, 2011, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2011-5; Emig D, 2011, J PROTEOME RES, V10, P1893, DOI 10.1021/pr101132h; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Koyuturk M, 2010, WIRES SYST BIOL MED, V2, P277, DOI 10.1002/wsbm.61; Lopes TJS, 2011, BIOINFORMATICS, V27, P2414, DOI 10.1093/bioinformatics/btr414; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Schaefer MH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002860; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025394	19	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115074	10.1371/journal.pone.0115074	http://dx.doi.org/10.1371/journal.pone.0115074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513809	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300031
J	Chi, NF; Liu, HL; Yang, JT; Lin, JR; Liao, SL; Peng, BH; Lee, YT; Lee, TH				Chi, Nai-Fang; Liu, Ho-Ling; Yang, Jen-Tsung; Lin, Jr-Rung; Liao, Shu-Li; Peng, Bo-Han; Lee, Yen-Tung; Lee, Tsong-Hai			Neuroprotective Mechanism of BNG-1 against Focal Cerebral Ischemia: A Neuroimaging and Neurotrophin Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SCUTELLARIA-BAICALENSIS; DIFFUSION-PERFUSION; ACUTE STROKE; BLOOD-FLOW; IN-VIVO; RATS; BRAIN; EXPRESSION; HYPERPERFUSION	BNG-1 is a herb complex used in traditional Chinese medicine to treat stroke. In this study, we attempted to identify the neuroprotective mechanism of BNG-1 by using neuroimaging and neurotrophin analyses of a stroke animal model. Rats were treated with either saline or BNG-1 for 7 d after 60-min middle cerebral artery occlusion by filament model. The temporal change of magnetic resonance (MR) imaging of brain was studied using a 7 Tesla MR imaging (MRI) system and the temporal expressions of neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF) in brain were analyzed before operation and at 4 h, 2 d, and 7 d after operation. Compared with the saline group, the BNG-1 group exhibited a smaller infarction volume in the cerebral cortex in T2 image from as early as 4 h to 7 d, less edema in the cortex in diffusion weighted image from 2 to 7 d, earlier reduction of postischemic hyperperfusion in both the cortex and striatum in perfusion image at 4 h, and earlier normalization of the ischemic pattern in the striatum in susceptibility weighted image at 2 d. NT-3 and BDNF levels were higher in the BNG-1 group than the saline group at 7 d. We concluded that the protective effect of BNG-1 against cerebral ischemic injury might act through improving cerebral hemodynamics and recovering neurotrophin generation.	[Chi, Nai-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan; [Chi, Nai-Fang] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Liu, Ho-Ling] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Yang, Jen-Tsung] Chiayi Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Dept Neurosurg, Taoyuan, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Liao, Shu-Li] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Peng, Bo-Han] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Lee, Yen-Tung] En Chu Kong Hosp, Dept Tradit Chinese Med, New Taipei City, Taiwan; [Lee, Tsong-Hai] Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Taipei Medical University; Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; En Chu Kong Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan.	thlee@adm.cgmh.org.tw	Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; Lin, Jr-Rung/0000-0002-8522-6601	National Science Council, Taiwan [NSC 97-2314-B-182A-049, NSC 98-2314-B-182-054, NSC 99-2628-B-182-027, 103-2314-B-182A-030-MY2]; Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center) [CMRPG340203]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center)	This work was supported by the National Science Council, Taiwan (NSC 97-2314-B-182A-049, NSC 98-2314-B-182-054, NSC 99-2628-B-182-027, 103-2314-B-182A-030-MY2) and Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center CMRPG340203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, NEW ENGLAND J MED, V333, P1581; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; Bereczki D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000480.pub2; Bonoczk Peter, 2002, Eur J Ultrasound, V15, P85, DOI 10.1016/S0929-8266(02)00006-X; Chan S, 2011, CURR OPIN PHARMACOL, V11, P720, DOI 10.1016/j.coph.2011.09.002; Cheng FC, 2005, AM J CHINESE MED, V33, P61, DOI 10.1142/S0192415X05002667; Geisler BS, 2006, STROKE, V37, P1778, DOI 10.1161/01.STR.0000226738.97426.6f; Jeong JC, 2005, J ETHNOPHARMACOL, V98, P259, DOI 10.1016/j.jep.2004.12.034; Kidwell CS, 2001, NEUROLOGY, V57, P2015, DOI 10.1212/WNL.57.11.2015; Kim YO, 2001, J ETHNOPHARMACOL, V77, P183, DOI 10.1016/S0378-8741(01)00283-5; Lee JT, 2014, NEUROSCIENCE, V257, P31, DOI 10.1016/j.neuroscience.2013.10.066; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; Lee TH, 1998, STROKE, V29, P1687, DOI 10.1161/01.STR.29.8.1687; LEE TH, 1994, STROKE, V25, P1425, DOI 10.1161/01.STR.25.7.1425; Lee TH, 2008, BRAIN RES, V1187, P1, DOI 10.1016/j.brainres.2007.09.078; Lee TH, 2011, EXP NEUROL, V227, P314, DOI 10.1016/j.expneurol.2010.12.003; Li RL, 2010, CURR NEUROVASC RES, V7, P213, DOI 10.2174/156720210792231796; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Lu ZF, 2010, J ASIAN NAT PROD RES, V12, P265, DOI 10.1080/10286021003689791; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Mao QQ, 2010, J ETHNOPHARMACOL, V131, P182, DOI 10.1016/j.jep.2010.06.019; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; Medina AE, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00021; Oliveira GB, 2014, BRAIN RES, V1561, P23, DOI 10.1016/j.brainres.2014.03.005; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Park JS, 2012, J PHARMACOL EXP THER, V341, P59, DOI 10.1124/jpet.111.189035; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shin JW, 2012, AM J CHINESE MED, V40, P85, DOI 10.1142/S0192415X12500073; Tanabe H, 2006, PHYTOMEDICINE, V13, P334, DOI 10.1016/j.phymed.2005.02.001; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Xu XL, 2008, PHYTOTHER RES, V22, P389, DOI 10.1002/ptr.2332; Yan BC, 2014, J NEUROSCI RES, V92, P795, DOI 10.1002/jnr.23360; Ye RD, 2011, NEUROPHARMACOLOGY, V61, P815, DOI 10.1016/j.neuropharm.2011.05.029; Yin YY, 2010, AM J CHINESE MED, V38, P517, DOI 10.1142/S0192415X10008020; Yu XQ, 2008, LIFE SCI, V82, P68, DOI 10.1016/j.lfs.2007.10.019; Zhang L, 2009, YAKUGAKU ZASSHI, V129, P855, DOI 10.1248/yakushi.129.855	39	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114909	10.1371/journal.pone.0114909	http://dx.doi.org/10.1371/journal.pone.0114909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506838	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100033
J	Dubchak, I; Balasubramanian, S; Wang, S; Meyden, C; Sulakhe, D; Poliakov, A; Bornigen, D; Xie, BQ; Taylor, A; Ma, JZ; Paciorkowski, AR; Mirzaa, GM; Dave, P; Agam, G; Xu, JB; Al-Gazali, L; Mason, CE; Ross, ME; Maltsev, N; Gilliam, TC				Dubchak, Inna; Balasubramanian, Sandhya; Wang, Sheng; Meyden, Cem; Sulakhe, Dinanath; Poliakov, Alexander; Boernigen, Daniela; Xie, Bingqing; Taylor, Andrew; Ma, Jianzhu; Paciorkowski, Alex R.; Mirzaa, Ghayda M.; Dave, Paul; Agam, Gady; Xu, Jinbo; Al-Gazali, Lihadh; Mason, Christopher E.; Ross, M. Elizabeth; Maltsev, Natalia; Gilliam, T. Conrad			An Integrative Computational Approach for Prioritization of Genomic Variants	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; NEURAL-TUBE DEFECTS; VITAMIN B-12 RECEPTOR; GENE PRIORITIZATION; INTERACTION NETWORKS; PATHWAY GENES; DATABASE; CUBILIN; VISTA; ASSOCIATION	An essential step in the discovery of molecular mechanisms contributing to disease phenotypes and efficient experimental planning is the development of weighted hypotheses that estimate the functional effects of sequence variants discovered by high-throughput genomics. With the increasing specialization of the bioinformatics resources, creating analytical workflows that seamlessly integrate data and bioinformatics tools developed by multiple groups becomes inevitable. Here we present a case study of a use of the distributed analytical environment integrating four complementary specialized resources, namely the Lynx platform, VISTA RViewer, the Developmental Brain Disorders Database (DBDB), and the RaptorX server, for the identification of high-confidence candidate genes contributing to pathogenesis of spina bifida. The analysis resulted in prediction and validation of deleterious mutations in the SLC19A placental transporter in mothers of the affected children that causes narrowing of the outlet channel and therefore leads to the reduced folate permeation rate. The described approach also enabled correct identification of several genes, previously shown to contribute to pathogenesis of spina bifida, and suggestion of additional genes for experimental validations. The study demonstrates that the seamless integration of bioinformatics resources enables fast and efficient prioritization and characterization of genomic factors and molecular networks contributing to the phenotypes of interest.	[Dubchak, Inna] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Dubchak, Inna; Poliakov, Alexander] Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Balasubramanian, Sandhya; Sulakhe, Dinanath; Boernigen, Daniela; Xie, Bingqing; Taylor, Andrew; Maltsev, Natalia; Gilliam, T. Conrad] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Wang, Sheng; Boernigen, Daniela; Ma, Jianzhu; Xu, Jinbo] Toyota Technol Inst, Chicago, IL USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Sulakhe, Dinanath; Dave, Paul; Maltsev, Natalia; Gilliam, T. Conrad] Univ Chicago, Argonne Natl Lab, Computat Inst, Chicago, IL 60637 USA; [Xie, Bingqing; Agam, Gady] IIT, Dept Comp Sci, Chicago, IL 60616 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Mirzaa, Ghayda M.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Mirzaa, Ghayda M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Ross, M. Elizabeth] Weill Cornell Med Coll, Lab Neurogenet & Dev, New York, NY USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Chicago; Toyota Technological Institute - Chicago; Cornell University; Cornell University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Illinois Institute of Technology; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United Arab Emirates University; Cornell University	Dubchak, I (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA.	ildubchak@lbl.gov; maltsev@uchicago.edu	Mason, Christopher/HCH-3977-2022; Wang, Sheng/H-5989-2018; Wang, Sheng/O-3465-2015; Ma, Jianzhu/AAV-1904-2020	Wang, Sheng/0000-0003-4210-1670; Wang, Sheng/0000-0003-4210-1670; Meydan, Cem/0000-0002-0663-6216	National Heart, Lung and Blood Institute, National Institutes of Health [R01GM081080A]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Institute of Neurological Disorders and Stroke, National Institutes of Health [2R01NS050375-06]; National Institutes of Health (NIH) [R01HG006798, R01NS076465]; Irma T. Hirschl Charitable Trust; STARR Consortium [I7-A765]; Monique Weill-Caulier Charitable Trust; Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465, R01NS050375] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; STARR Consortium; Monique Weill-Caulier Charitable Trust; Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	ID was partially supported by National Heart, Lung and Blood Institute, National Institutes of Health, Grant R01GM081080A. The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy under Contract No. (DE-AC02-05CH11231); SB and NM were partially supported by National Institute of Neurological Disorders and Stroke, National Institutes of Health, Grant 2R01NS050375-06. The University of Chicago component of the project is grateful to Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation for their generous support of the project. This work was also supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Boucher Benjamin, 2013, Frontiers in Genetics, V4, P290, DOI 10.3389/fgene.2013.00290; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; Brudno M, 2007, NUCLEIC ACIDS RES, V35, pW669, DOI 10.1093/nar/gkm279; Burzynski GM, 2012, GENOME RES, V22, P2278, DOI 10.1101/gr.139717.112; Calabrese C, 2014, BIOINFORMATICS; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chandler AL, 2012, BIRTH DEFECTS RES A, V94, P864, DOI 10.1002/bdra.23068; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Copp AJ, 2013, WIRES DEV BIOL, V2, P213, DOI 10.1002/wdev.71; Cordero F, 2012, CURR TOP MED CHEM, V12, P1320, DOI 10.2174/156802612801319007; Doolin MT, 2002, AM J HUM GENET, V71, P1222, DOI 10.1086/344209; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franke B, 2009, BIRTH DEFECTS RES A, V85, P216, DOI 10.1002/bdra.20556; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Green Ridgely Fisk, 2013, Frontiers in Genetics, V4, P223, DOI 10.3389/fgene.2013.00223; Hamilton NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055434; Hong HX, 2013, SCI CHINA LIFE SCI, V56, P110, DOI 10.1007/s11427-013-4439-7; Infante CR, 2013, DEV BIOL, V374, P234, DOI 10.1016/j.ydbio.2012.11.017; Jager M, 2014, HUM MUTAT, V35, P548, DOI 10.1002/humu.22531; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Konneker T, 2008, AM J MED GENET B, V147B, P671, DOI 10.1002/ajmg.b.30802; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Li Xin, 2013, Frontiers in Genetics, V4, P67, DOI 10.3389/fgene.2013.00067; Liu J, 2014, J NEUROL SCI, V337, P61, DOI 10.1016/j.jns.2013.11.017; Lukashin I, 2011, BIOINFORMATICS, V27, P2595, DOI 10.1093/bioinformatics/btr440; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Marini NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028408; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Mirzaa GM, 2014, AM J MED GENET A, V164, P1503, DOI 10.1002/ajmg.a.36517; Mirzaa GM, 2014, AM J MED GENET A; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Morin I, 2003, MOL GENET METAB, V79, P197, DOI 10.1016/S1096-7192(03)00086-6; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Nitsch D, 2011, NUCLEIC ACIDS RES, V39, pW334, DOI 10.1093/nar/gkr289; Padmanabhan Rengasamy, 2006, Congenital Anomalies, V46, P55, DOI 10.1111/j.1741-4520.2006.00104.x; Pastrello C, 2014, BIOCHEM BIOPH RES CO, V445, P757, DOI 10.1016/j.bbrc.2014.01.151; Peng J, 2011, PROTEINS, V79, P1930, DOI 10.1002/prot.23016; Rady PL, 2001, MOL GENET METAB, V73, P285, DOI 10.1006/mgme.2001.3197; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Ross ME, 2010, WIRES SYST BIOL MED, V2, P471, DOI 10.1002/wsbm.72; Seoane JA, 2013, CURR TOP MED CHEM, V13, P591; Sifrim A, 2013, NAT METHODS, V10, P1083, DOI [10.1038/NMETH.2656, 10.1038/nmeth.2656]; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Sulakhe D, 2014, NUCLEIC ACIDS RES, V42, pD1007, DOI 10.1093/nar/gkt1166; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wahlstedt-Froberg V, 2003, PEDIATR NEPHROL, V18, P417, DOI 10.1007/s00467-003-1128-y; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Wang Shuoguo, 2013, Genomics & Informatics, V11, P191, DOI 10.5808/GI.2013.11.4.191; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x; Wu JX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004237; Xie B, 2012, PREDICTION CANDIDATE; Yao J, 2014, BIOINFORMATICS	69	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114903	10.1371/journal.pone.0114903	http://dx.doi.org/10.1371/journal.pone.0114903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506935	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100031
J	Rostoker, G; Griuncelli, M; Loridon, C; Magna, T; Janklewicz, P; Drahi, G; Dahan, H; Cohen, Y				Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile; Janklewicz, Philippe; Drahi, Gilles; Dahan, Herve; Cohen, Yves			Maximal Standard Dose of Parenteral Iron for Hemodialysis Patients: An MRI-Based Decision Tree Learning Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANEMIA MANAGEMENT; SUPPLEMENTATION; OVERLOAD; OUTCOMES; MORTALITY; PATTERNS; TIME	Background and Objectives: Iron overload used to be considered rare among hemodialysis patients after the advent of erythropoesis-stimulating agents, but recent MRI studies have challenged this view. The aim of this study, based on decision-tree learning and on MRI determination of hepatic iron content, was to identify a noxious pattern of parenteral iron administration in hemodialysis patients. Design, Setting, Participants and Measurements: We performed a prospective cross-sectional study from 31 January 2005 to 31 August 2013 in the dialysis centre of a French community-based private hospital. A cohort of 199 fit hemodialysis patients free of overt inflammation and malnutrition were treated for anemia with parenteral iron-sucrose and an erythropoesis-stimulating agent (darbepoetin), in keeping with current clinical guidelines. Patients had blinded measurements of hepatic iron stores by means of T1 and T2* contrast MRI, without gadolinium, together with CHi-squared Automatic Interaction Detection (CHAID) analysis. Results: The CHAID algorithm first split the patients according to their monthly infused iron dose, with a single cutoff of 250 mg/month. In the node comprising the 88 hemodialysis patients who received more than 250 mg/month of IV iron, 78 patients had iron overload on MRI (88.6%, 95% CI: 80% to 93%). The odds ratio for hepatic iron overload on MRI was 3.9 (95% CI: 1.81 to 8.4) with >250 mg/month of IV iron as compared to <250 mg/month. Age, gender (female sex) and the hepcidin level also influenced liver iron content on MRI. Conclusions: The standard maximal amount of iron infused per month should be lowered to 250 mg in order to lessen the risk of dialysis iron overload and to allow safer use of parenteral iron products.	[Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile] Gen Sante, Hop Prive Claude Galien, Div Nephrol & Dialysis, F-91480 Quincy Sous Senart, France; [Janklewicz, Philippe; Drahi, Gilles; Dahan, Herve; Cohen, Yves] Gen Sante, Div Radiol, Hop Prive Claude Galien, F-91480 Quincy Sous Senart, France		Rostoker, G (corresponding author), Gen Sante, Hop Prive Claude Galien, Div Nephrol & Dialysis, 20 Route Boussy, F-91480 Quincy Sous Senart, France.	rostotom@orange.fr	Rostoker, Guy/K-1432-2019	Rostoker, Guy/0000-0002-4383-3825	not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante	not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante	This study was sponsored by the not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante. The aim of the QRCT Association is to promote clinical, epidemiological and cognitive research at Claude Galien Hospital. QRCT paid for the software license of SPSS decision learning trees from IBM Bois-Colombes, France and for computers (iMac OS X).	ALI M, 1982, LANCET, V1, P652; [Anonymous], 2014, KDIGO CONTR C IR MAN; [Anonymous], 2006, AN MAN PEOP CHRON KI; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Barton JC., 2010, HDB IRON OVERLOAD DI; Besarab A, 2010, NAT REV NEPHROL, V6, P699, DOI 10.1038/nrneph.2010.139; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Canavese C, 2004, KIDNEY INT, V65, P1091, DOI 10.1111/j.1523-1755.2004.00480.x; Eduardo Toblli Jorge, 2012, Inflammation & Allergy Drug Targets, V11, P66; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Ferrari P, 2011, CLIN J AM SOC NEPHRO, V6, P77, DOI 10.2215/CJN.04190510; Fishbane S, 2014, NEPHROL DIAL TRANSPL, V29, P255, DOI 10.1093/ndt/gft269; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Ghoti H, 2012, EUR J HAEMATOL, V89, P87, DOI 10.1111/j.1600-0609.2012.01783.x; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KDOQI, 2006, Am J Kidney Dis, V47, pS16; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Moisen G. G., 2008, ENCY ECOLOGY, V1, P582; Pisoni RL, 2012, AM J KIDNEY DIS, V60, P160, DOI 10.1053/j.ajkd.2012.04.001; Rostoker G, 2012, AM J MED, V125, P991, DOI 10.1016/j.amjmed.2012.01.015; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009; Yamamoto H, 2011, SEMIN DIALYSIS, V24, P269, DOI 10.1111/j.1525-139X.2011.00938.x	29	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115096	10.1371/journal.pone.0115096	http://dx.doi.org/10.1371/journal.pone.0115096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506921	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100050
J	Ruggirello, M; Dolci, P; Cocolin, L				Ruggirello, Marianna; Dolci, Paola; Cocolin, Luca			Detection and Viability of Lactococcus lactis throughout Cheese Ripening	PLOS ONE			English	Article							CULTURE-INDEPENDENT METHODS; CARBOHYDRATE STARVATION; MICROBIAL DIVERSITY; ACID BACTERIA; PCR-DGGE; IDENTIFICATION; LACTOBACILLUS; EXTRACTION; STRATEGIES; DYNAMICS	Recent evidences highlighted the presence of Lactococcus lactis during late cheese ripening. For this reason, the role of this microorganism, well known as dairy starter, should be reconsidered throughout cheese manufacturing and ripening. Thus, the main objective of this study was to develop a RT-qPCR protocol for the detection, quantification and determination of the viability of L. lactis in ripened cheese samples by direct analysis of microbial nucleic acids. Standard curves were constructed for the specific quantification of L. lactis in cheese matrices and good results in terms of selectivity, correlation coefficient and efficiency were obtained. Thirty-three ripened cheeses were analyzed and, on the basis of RNA analysis, twelve samples showed 10(6) to 10(8) CFU of L. lactis per gram of product, thirteen from 10(3) to 10(5) CFU/g, and in eight cheeses, L. lactis was not detected. Traditional plating on M17 medium led to loads ranging from 10(5) to 10(9) CFU/g, including the cheese samples where no L. lactis was found by RT-qPCR. From these cheeses, none of the colonies isolated on M17 medium was identified as L. lactis species. These data could be interpreted as a lack of selectivity of M17 medium where colony growth is not always related to lactococcal species. At the same time, the absence or low abundance of L. lactis isolates on M17 medium from cheese where L. lactis was detected by RT-qPCR support the hypothesis that L. lactis starter populations are mainly present in viable but not culturable state during ripening and, for this reason, culture-dependent methods have to be supplemented with direct analysis of cheese.	[Ruggirello, Marianna; Dolci, Paola; Cocolin, Luca] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy	University of Turin	Dolci, P (corresponding author), Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy.	paola.dolci@unito.it	Cocolin, Luca/H-5091-2012	Cocolin, Luca/0000-0003-4799-7074; DOLCI, Paola/0000-0003-1847-2367				Achilleos C, 2013, FOOD MICROBIOL, V36, P286, DOI 10.1016/j.fm.2013.06.024; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Cocolin L, 2001, APPL ENVIRON MICROB, V67, P5113, DOI 10.1128/AEM.67.11.5113-5121.2001; Corroler D, 1998, APPL ENVIRON MICROB, V64, P4729; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; Desfosses-Foucault E, 2013, INT J FOOD MICROBIOL, V166, P117, DOI 10.1016/j.ijfoodmicro.2013.06.022; Dolci P, 2010, INT J FOOD MICROBIOL, V143, P71, DOI 10.1016/j.ijfoodmicro.2010.07.007; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; FEIRTAG JM, 1987, J DAIRY SCI, V70, P1779, DOI 10.3168/jds.S0022-0302(87)80214-X; Florez AB, 2006, INT J FOOD MICROBIOL, V110, P165, DOI 10.1016/j.ijfoodmicro.2006.04.016; Fortina MG, 2003, FOOD MICROBIOL, V20, P397, DOI 10.1016/S0740-0020(02)00149-1; Ganesan B, 2007, APPL ENVIRON MICROB, V73, P2498, DOI 10.1128/AEM.01832-06; Jany JL, 2008, FOOD MICROBIOL, V25, P839, DOI 10.1016/j.fm.2008.06.003; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Ke DB, 2000, J BACTERIOL, V182, P6913, DOI 10.1128/JB.182.24.6913-6920.2000; Mertens K, 2014, INT J FOOD MICROBIOL, V170, P29, DOI 10.1016/j.ijfoodmicro.2013.10.022; Ndoye B, 2011, DAIRY SCI TECHNOL, V91, P495, DOI 10.1007/s13594-011-0031-8; Neviani E, 2009, FOOD MICROBIOL, V26, P240, DOI 10.1016/j.fm.2009.01.004; Rantsiou K, 2008, INT J FOOD MICROBIOL, V126, P36, DOI 10.1016/j.ijfoodmicro.2008.04.031; Stuart MR, 1999, APPL ENVIRON MICROB, V65, P665; Taibi A, 2011, INT J FOOD MICROBIOL, V146, P263, DOI 10.1016/j.ijfoodmicro.2011.02.034; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Ulve VM, 2008, J APPL MICROBIOL, V105, P1327, DOI 10.1111/j.1365-2672.2008.03869.x; Ventura M, 2003, APPL ENVIRON MICROB, V69, P6908, DOI 10.1128/AEM.69.11.6908-6922.2003	24	28	28	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114280	10.1371/journal.pone.0114280	http://dx.doi.org/10.1371/journal.pone.0114280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503474	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100009
J	Haggerty, TJ; Dunn, IS; Rose, LB; Newton, EE; Pandolfi, F; Kurnick, JT				Haggerty, Timothy J.; Dunn, Ian S.; Rose, Lenora B.; Newton, Estelle E.; Pandolfi, Franco; Kurnick, James T.			Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells	PLOS ONE			English	Article							PHASE-II TRIAL; ANTITUMOR-ACTIVITY; BRAF INHIBITION; DOWN-MODULATION; HSP90 INHIBITOR; B-RAF; CANCER; IMMUNOTHERAPY; CHAPERONE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN	In an effort to enhance antigen-specific T cell recognition of cancer cells, we have examined numerous modulators of antigen-expression. In this report we demonstrate that twelve different Hsp90 inhibitors (iHsp90) share the ability to increase the expression of differentiation antigens and MHC Class I antigens. These iHsp90 are active in several molecular and cellular assays on a series of tumor cell lines, including eleven human melanomas, a murine B16 melanoma, and two human glioma-derived cell lines. Intra-cytoplasmic antibody staining showed that all of the tested iHsp90 increased expression of the melanocyte differentiation antigens Melan-A/MART-1, gp100, and TRP-2, as well as MHC Class I. The gliomas showed enhanced gp100 and MHC staining. Quantitative analysis of mRNA levels showed a parallel increase in message transcription, and a reporter assay shows induction of promoter activity for Melan-A/MART-1 gene. In addition, iHsp90 increased recognition of tumor cells by T cells specific for Melan-A/MART-1. In contrast to direct Hsp90 client proteins, the increased levels of full-length differentiation antigens that result from iHsp90 treatment are most likely the result of transcriptional activation of their encoding genes. In combination, these results suggest that iHsp90 improve recognition of tumor cells by T cells specific for a melanoma-associated antigen as a result of increasing the expressed intracellular antigen pool available for processing and presentation by MHC Class I, along with increased levels of MHC Class I itself. As these Hsp90 inhibitors do not interfere with T cell function, they could have potential for use in immunotherapy of cancer.	[Haggerty, Timothy J.; Dunn, Ian S.; Rose, Lenora B.; Newton, Estelle E.; Kurnick, James T.] CytoCure LLC, Beverly, MA USA; [Haggerty, Timothy J.; Kurnick, James T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA USA; [Pandolfi, Franco] Catholic Univ, Dept Internal Med, Rome, Italy	Harvard University; Harvard Medical School; Massachusetts General Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Pandolfi, F (corresponding author), Catholic Univ, Dept Internal Med, Rome, Italy.	pandolfi@rm.unicatt.it	Pandolfi, Franco/D-3025-2011; Kurnick, James/GRO-3944-2022	Pandolfi, Franco/0000-0003-3516-3961	National Institutes of Health [CA-165553]; International Cancer Research Scholarship; NATIONAL CANCER INSTITUTE [R43CA165553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Cancer Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported in part by a grant from the National Institutes of Health, CA-165553 (TJH, ISD, EEN, LBR, JTK), and by an International Cancer Research Scholarship to JTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Bae J, 2007, J IMMUNOL, V178, P7730, DOI 10.4049/jimmunol.178.12.7730; Bai L, 2011, APOPTOSIS, V16, P45, DOI 10.1007/s10495-010-0542-4; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Brandt GEL, 2008, J MED CHEM, V51, P6495, DOI 10.1021/jm8007486; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Castilleja A, 2001, MOL CELL BIOCHEM, V217, P21, DOI 10.1023/A:1007267814251; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn IS, 2007, J IMMUNOL, V179, P2134, DOI 10.4049/jimmunol.179.4.2134; Durda PJ, 2003, MOL CANCER RES, V1, P411; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fox BA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-214; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Haggerty TJ, 2012, ASSAY DRUG DEV TECHN, V10, P187, DOI 10.1089/adt.2011.0379; Haggerty TJ, 2011, CANCER IMMUNOL IMMUN, V60, P133, DOI 10.1007/s00262-010-0926-x; Hishii M, 1999, CLIN EXP IMMUNOL, V116, P388; Hishii M, 1997, P NATL ACAD SCI USA, V94, P1378, DOI 10.1073/pnas.94.4.1378; Houlihan JL, 2009, J IMMUNOL, V182, P7451, DOI 10.4049/jimmunol.0804296; Hurwitz AA, 2004, METH MOLEC MED, V102, P421; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; Kurnick JT, 2001, J IMMUNOL, V167, P1204, DOI 10.4049/jimmunol.167.3.1204; Kurnick JT, 2013, INT TRENDS IMMUNOLOG, V1, P5; Li YY, 2009, DRUG RESIST UPDATE, V12, P17, DOI 10.1016/j.drup.2008.12.002; Lundgren K, 2009, MOL CANCER THER, V8, P921, DOI 10.1158/1535-7163.MCT-08-0758; Maus MV, 2014, CLIN CANCER RES, V20, P3899, DOI 10.1158/1078-0432.CCR-14-0721; Mehta PP, 2011, CANCER LETT, V300, P30, DOI 10.1016/j.canlet.2010.09.002; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Pacey S, 2012, INVEST NEW; Pandolfi F, 2008, INT J IMMUNOPATH PH, V21, P493, DOI 10.1177/039463200802100302; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Rao A, 2012, CANCER RES, V72, P3196, DOI 10.1158/0008-5472.CAN-12-0538; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Shipp C, 2013, CELL STRESS CHAPERON, V18, P145, DOI 10.1007/s12192-012-0363-1; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Tarhini AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087705; Tian ZQ, 2004, BIOORGAN MED CHEM, V12, P5317, DOI 10.1016/j.bmc.2004.07.053; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Yeh S, 2009, OPHTHALMOLOGY, V116, P981, DOI 10.1016/j.ophtha.2008.12.004; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532	59	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114506	10.1371/journal.pone.0114506	http://dx.doi.org/10.1371/journal.pone.0114506			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503774	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400032
J	Sangartit, W; Kukongviriyapan, U; Donpunha, W; Pakdeechote, P; Kukongviriyapan, V; Surawattanawan, P; Greenwald, SE				Sangartit, Weerapon; Kukongviriyapan, Upa; Donpunha, Wanida; Pakdeechote, Poungrat; Kukongviriyapan, Veerapol; Surawattanawan, Praphassorn; Greenwald, Stephen E.			Tetrahydrocurcumin Protects against Cadmium-Induced Hypertension, Raised Arterial Stiffness and Vascular Remodeling in Mice	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NITRIC-OXIDE PRODUCTION; NATIONAL-HEALTH; ANTIOXIDANT; CURCUMIN; TOXICITY; DYSFUNCTION; EXPRESSION; MECHANISM; BLOOD	Background: Cadmium (Cd) is a nonessential heavy metal, causing oxidative damage to various tissues and associated with hypertension. Tetrahydrocurcumin (THU), a major metabolite of curcumin, has been demonstrated to be an antioxidant, anti-diabetic, anti-hypertensive and anti-inflammatory agent. In this study, we investigated the protective effect of THU against Cd-induced hypertension, raised arterial stiffness and vascular remodeling in mice. Methods: Male ICR mice received CdCl2 (100 mg/l) via drinking water for 8 weeks. THU was administered intragastrically at dose of 50 or 100 mg/kg/day concurrently with Cd treatment. Results: Administration of CdCl2 significantly increased arterial blood pressure, blunted vascular responses to vasoactive agents, increased aortic stiffness, and induced hypertrophic aortic wall remodeling by increasing number of smooth muscle cells and collagen deposition, decreasing elastin, and increasing matrix metalloproteinase (MMP)-2 and MMP-9 levels in the aortic medial wall. Supplementation with THU significantly decreased blood pressure, improved vascular responsiveness, and reversed the structural and mechanical alterations of the aortas, including collagen and elastin deposition. The reduction on the adverse response of Cd treatment was associated with upregulated eNOS and downregulated iNOS protein expressions, increased nitrate/nitrite level, alleviated oxidative stress and enhanced antioxidant glutathione. Moreover, THU also reduced the accumulation of Cd in the blood and tissues. Conclusions: Our results suggest that THU ameliorates cadmium-induced hypertension, vascular dysfunction, and arterial stiffness in mice through enhancing NO bioavailability, attenuating oxidative stress, improving vascular remodeling and decreasing Cd accumulation in other tissues. THU has a beneficial effect in moderating the vascular alterations associated with Cd exposure.	[Sangartit, Weerapon; Kukongviriyapan, Upa; Donpunha, Wanida; Pakdeechote, Poungrat] Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen 40002, Thailand; [Kukongviriyapan, Veerapol] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand; [Surawattanawan, Praphassorn] Govt Pharmaceut Org, Inst Res & Dev, Bangkok 10400, Thailand; [Greenwald, Stephen E.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Pathol Grp, London E1 1BB, England	Khon Kaen University; Khon Kaen University; University of London; Queen Mary University London	Kukongviriyapan, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen 40002, Thailand.	upa_ku@kku.ac.th	Greenwald, Stephen E/C-6928-2012	Sangartit, Weerapon/0000-0002-5058-2294; Greenwald, Stephen/0000-0002-8471-7070	Khon Kaen University Research Fund; Invitation Research Fund, Faculty of Medicine, Khon Kaen University; Thailand Research Fund; British Council PMI2, United Kingdom [Ref RC53]; Royal Golden Jubilee PhD Program [PHD/0292/2551]	Khon Kaen University Research Fund; Invitation Research Fund, Faculty of Medicine, Khon Kaen University; Thailand Research Fund(Thailand Research Fund (TRF)); British Council PMI2, United Kingdom; Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This work was supported by grants from the Khon Kaen University Research Fund, the Invitation Research Fund, Faculty of Medicine, Khon Kaen University, The Thailand Research Fund and the British Council PMI2 Connect Grant (Ref RC53), United Kingdom. WS was supported by a scholarship (PHD/0292/2551) from the Royal Golden Jubilee PhD Program, The Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOX PROF CADM, P1, DOI DOI 10.1039/C2EM30303E; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ali MS, 2009, PHARMAZIE, V64, P132, DOI 10.1691/ph.2008.8628; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castro MM, 2013, CURR DRUG TARGETS, V14, P335; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; Cohen RD, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/185845; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Donpunha W, 2011, BIOMETALS, V24, P105, DOI 10.1007/s10534-010-9379-0; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Eybl V, 2006, TOXICOLOGY, V225, P150, DOI 10.1016/j.tox.2006.05.011; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fowler BA, 2009, TOXICOL APPL PHARM, V238, P294, DOI 10.1016/j.taap.2009.05.004; Gaubin Y, 2000, BBA-MOL CELL RES, V1495, P4, DOI 10.1016/S0167-4889(99)00149-4; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Huang PL, 1998, AM J CARDIOL, V82, p57S, DOI 10.1016/S0002-9149(98)90437-4; Jackson ZS, 2002, CIRC RES, V90, P918, DOI 10.1161/01.RES.0000016481.87703.CC; Javanmard Shaghayegh Haghjooy, 2009, Pathophysiology, V16, P9, DOI 10.1016/j.pathophys.2008.11.003; Kirschvink N, 2005, TOXICOLOGY, V211, P36, DOI 10.1016/j.tox.2005.02.012; Kukongviriyapan U, 2014, NUTRIENTS, V6, P1194, DOI 10.3390/nu6031194; Kukongviriyapan U, 2012, CAN J PHYSIOL PHARM, V90, P1345, DOI [10.1139/Y2012-101, 10.1139/y2012-101]; Kundu S, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-19; Lambertucci RH, 2012, CELL PHYSIOL BIOCHEM, V30, P1169, DOI 10.1159/000343307; LANGEWOUTERS GJ, 1984, J BIOMECH, V17, P425, DOI 10.1016/0021-9290(84)90034-4; Lee BK, 2012, AM J IND MED, V55, P1060, DOI 10.1002/ajim.22078; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Lehoux S, 2004, CIRCULATION, V109, P1041, DOI 10.1161/01.CIR.0000115521.95662.7A; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Murugan P, 2007, J ETHNOPHARMACOL, V113, P479, DOI 10.1016/j.jep.2007.07.004; Murugan P, 2006, BASIC CLIN PHARMACOL, V99, P122, DOI 10.1111/j.1742-7843.2006.pto_447.x; Nakmareong S, 2012, HYPERTENS RES, V35, P418, DOI 10.1038/hr.2011.180; Nakmareong S, 2011, N-S ARCH PHARMACOL, V383, P519, DOI 10.1007/s00210-011-0624-z; Nwokocha CR, 2013, CARDIOVASC TOXICOL, V13, P357, DOI 10.1007/s12012-013-9216-0; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; ONER G, 1995, BIOL TRACE ELEM RES, V48, P111, DOI 10.1007/BF02789083; OSAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1609, DOI 10.1271/bbb.59.1609; Ozturk IM, 2009, TOXICOL MECH METHOD, V19, P308, DOI 10.1080/15376510802662751; Pari L, 2005, J PHARM PHARM SCI, V8, P115; Portes E, 2007, TETRAHEDRON, V63, P9092, DOI 10.1016/j.tet.2007.06.085; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Prozialeck WC, 2006, LIFE SCI, V79, P1493, DOI 10.1016/j.lfs.2006.05.007; Satarug S, 2005, TOXICOL LETT, V157, P57, DOI 10.1016/j.toxlet.2005.01.004; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Sompamit K, 2010, TOXICOL LETT, V198, P77, DOI 10.1016/j.toxlet.2010.04.007; Somparn P, 2007, BIOL PHARM BULL, V30, P74, DOI 10.1248/bpb.30.74; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sugiyama Y, 1996, BIOCHEM PHARMACOL, V52, P519, DOI 10.1016/0006-2952(96)00302-4; Tandon SK, 2003, TOXICOL LETT, V145, P211, DOI 10.1016/S0378-4274(03)00265-0; Tellez-Plaza M, 2008, ENVIRON HEALTH PERSP, V116, P51, DOI 10.1289/ehp.10764; Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009; Tzotzes V, 2007, BIOMETALS, V20, P83, DOI 10.1007/s10534-006-9017-z; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Watts SW, 2007, AM J PHYSIOL-HEART C, V292, pH2438, DOI 10.1152/ajpheart.00900.2006; Xu SP, 2006, CAN J CARDIOL, V22, P947, DOI 10.1016/S0828-282X(06)70314-2; Yeh TK, 2011, NANOTOXICOLOGY, V5, P91, DOI 10.3109/17435390.2010.502260; Yoopan N, 2008, TOXICOL LETT, V176, P157, DOI 10.1016/j.toxlet.2007.11.002; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	63	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114908	10.1371/journal.pone.0114908	http://dx.doi.org/10.1371/journal.pone.0114908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502771	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700069
J	Lansade, L; Valenchon, M; Foury, A; Neveux, C; Cole, SW; Laye, S; Cardinaud, B; Levy, F; Moisan, MP				Lansade, Lea; Valenchon, Mathilde; Foury, Aline; Neveux, Claire; Cole, Steve W.; Laye, Sophie; Cardinaud, Bruno; Levy, Frederic; Moisan, Marie-Pierre			Behavioral and Transcriptomic Fingerprints of an Enriched Environment in Horses (Equus caballus)	PLOS ONE			English	Article							TEMPERAMENT TRAIT; YOUNG HORSES; COGNITIVE BIAS; TIME; EXPRESSION; INFLAMMATION; INHIBITION; REACTIVITY; RESPONSES; WELFARE	The use of environmental enrichment (EE) has grown in popularity over decades, particularly because EE is known to promote cognitive functions and well-being. Nonetheless, little is known about how EE may affect personality and gene expression. To address this question in a domestic animal, 10-month-old horses were maintained in a controlled environment or EE for 12 weeks. The control horses (n=9) lived in individual stalls on wood shaving bedding. They were turned out to individual paddocks three times a week and were fed three times a day with pellets or hay. EE-treated horses (n=10) were housed in large individual stalls on straw bedding 7 hours per day and spent the remainder of the time together at pasture. They were fed three times a day with flavored pellets, hay, or fruits and were exposed daily to various objects, odors, and music. The EE modified three dimensions of personality: fearfulness, reactivity to humans, and sensory sensitivity. Some of these changes persisted >3 months after treatment. These changes are suggestive of a more positive perception of the environment and a higher level of curiosity in EE-treated horses, explaining partly why these horses showed better learning performance in a Go/No-Go task. Reduced expression of stress indicators indicated that the EE also improved well-being. Finally, whole-blood transcriptomic analysis showed that in addition to an effect on the cortisol level, the EE induced the expression of genes involved in cell growth and proliferation, while the control treatment activated genes related to apoptosis. Changes in both behavior and gene expression may constitute a psychobiological signature of the effects of enrichment and result in improved well-being. This study illustrates how the environment interacts with genetic information in shaping the individual at both the behavioral and molecular levels.	[Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] CNRS, Physiol Reprod & Comportements UMR7247, Nouzilly, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] Univ Tours, Tours, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] IFCE, Nouzilly, France; [Foury, Aline; Laye, Sophie] INRA, UMR 1286, Bordeaux, France; [Foury, Aline; Laye, Sophie] Univ Bordeaux, UMR 1286, Bordeaux, France; [Cole, Steve W.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cardinaud, Bruno] INSERM, U1035, Bordeaux, France; [Cardinaud, Bruno] Inst Polytech Bordeaux, Talence, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Los Angeles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lansade, L (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	lansade@tours.inra.fr	Moisan, Marie-Pierre/AAO-9971-2021; Laye, Sophie/AAX-2501-2020	Moisan, Marie-Pierre/0000-0001-7315-5319; Laye, Sophie/0000-0002-3843-1012; Valenchon, Mathilde/0000-0003-0226-8433; Foury, Aline/0000-0002-4552-3222	French Institute of horse and Riding (IFCE); department of animal genetics of the French National Institute for Agricultural Research (INRA)	French Institute of horse and Riding (IFCE); department of animal genetics of the French National Institute for Agricultural Research (INRA)	This study was supported by the French Institute of horse and Riding (IFCE) and by the department of animal genetics of the French National Institute for Agricultural Research (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrey E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-29; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2013, AM J PUBLIC HEALTH, V103, P84, DOI 10.2105/AJPH.2012.301183; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Fureix C, 2012, PLOS ONE, V7; Goodwin D, 2007, VET REC, V160, P548, DOI 10.1136/vr.160.16.548; Goodwin D, 2005, APPL ANIM BEHAV SCI, V90, P337, DOI 10.1016/j.applanim.2004.08.013; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; Houpt K, 2000, J EQUINE VET SCI, V20, P691, DOI 10.1016/S0737-0806(00)80155-0; Jorgensen GHM, 2011, APPL ANIM BEHAV SCI, V129, P100, DOI 10.1016/j.applanim.2010.11.004; Konig v. Borstel U., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138006; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064853; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pedersen GR, 2004, J EQUINE VET SCI, V24, P153, DOI 10.1016/j.jevs.2004.03.013; Petrosini L, 2009, BRAIN RES REV, V61, P221, DOI 10.1016/j.brainresrev.2009.07.002; Raabymagle P, 2006, J EQUINE VET SCI, V26, P11, DOI 10.1016/j.jevs.2005.11.015; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rivera E, 2002, APPL ANIM BEHAV SCI, V78, P235, DOI 10.1016/S0168-1591(02)00091-6; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Slavich GM, 2013, CLIN PSYCHOL SCI, V1, P331, DOI 10.1177/2167702613478594; Sondergaard E, 2004, APPL ANIM BEHAV SCI, V87, P105, DOI 10.1016/j.applanim.2003.12.010; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002; Young T, 2012, APPL ANIM BEHAV SCI, V140, P33, DOI 10.1016/j.applanim.2012.05.008	51	24	24	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114384	10.1371/journal.pone.0114384	http://dx.doi.org/10.1371/journal.pone.0114384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494179	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400043
J	Thiers, L; Louzao, M; Ridoux, V; Le Corre, M; Jaquemet, S; Weimerskirch, H				Thiers, Laurie; Louzao, Maite; Ridoux, Vincent; Le Corre, Matthieu; Jaquemet, Sebastien; Weimerskirch, Henri			Combining Methods to Describe Important Marine Habitats for Top Predators: Application to Identify Biological Hotspots in Tropical Waters	PLOS ONE			English	Article							SEABIRD COMMUNITY STRUCTURE; PRODUCTIVITY GRADIENT; MOZAMBIQUE CHANNEL; ISLAND; OCEAN; CONSERVATION; BIRD; PATTERNS; BEHAVIOR; EDDIES	In tropical waters resources are usually scarce and patchy, and predatory species generally show specific adaptations for foraging. Tropical seabirds often forage in association with sub-surface predators that create feeding opportunities by bringing prey close to the surface, and the birds often aggregate in large multispecific flocks. Here we hypothesize that frigatebirds, a tropical seabird adapted to foraging with low energetic costs, could be a good predictor of the distribution of their associated predatory species, including other seabirds (e.g. boobies, terns) and subsurface predators (e.g., dolphins, tunas). To test this hypothesis, we compared distribution patterns of marine predators in the Mozambique Channel based on a long-term dataset of both vessel- and aerial surveys, as well as tracking data of frigatebirds. By developing species distribution models (SDMs), we identified key marine areas for tropical predators in relation to contemporaneous oceanographic features to investigate multi-species spatial overlap areas and identify predator hotspots in the Mozambique Channel. SDMs reasonably matched observed patterns and both static (e.g. bathymetry) and dynamic (e.g. Chlorophyll a concentration and sea surface temperature) factors were important explaining predator distribution patterns. We found that the distribution of frigatebirds included the distributions of the associated species. The central part of the channel appeared to be the best habitat for the four groups of species considered in this study (frigatebirds, brown terns, boobies and sub-surface predators).	[Thiers, Laurie; Ridoux, Vincent; Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Stn Ecol Chize La Rochelle, UMR 7372, F-79360 Villiers En Bois, France; [Louzao, Maite] CO Xixon, Inst Espanol Oceanog, Xixon 33212, Spain; [Ridoux, Vincent] Univ La Rochelle, UMS 3462, CNRS, Observ PELAGIS, F-17000 La Rochelle, France; [Le Corre, Matthieu; Jaquemet, Sebastien] Univ Reunion, Lab ECOMAR, FRE 3560, CNRS, F-97744 St Denis 9, Reunion, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Spanish Institute of Oceanography; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); University of La Reunion	Thiers, L (corresponding author), CNRS, Ctr Etud Biol Chize, Stn Ecol Chize La Rochelle, UMR 7372, F-79360 Villiers En Bois, France.	thiers@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Louzao, Maite/N-5379-2014	Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144; Ridoux, Vincent/0000-0002-9779-9319	Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF); Conseil Regional Poitou Charentes; Fondation prince Albert 2 de Monaco; Juan de la Cierva (Ministerio de Cienciae Innovacion) [JCI-2010-07639]; Marie Curie Career Integration Grant [PCIG09-GA-2011-293774]	Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF); Conseil Regional Poitou Charentes(Region Nouvelle-Aquitaine); Fondation prince Albert 2 de Monaco; Juan de la Cierva (Ministerio de Cienciae Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Career Integration Grant	This study was funded partly by Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF). Laurie Thiers was funded by Conseil Regional Poitou Charentes and Fondation prince Albert 2 de Monaco. Maite Louzao was funded by a Juan de la Cierva post-doctoral contract (JCI-2010-07639, Ministerio de Cienciae Innovacion) and a Marie Curie Career Integration Grant (PCIG09-GA-2011-293774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ashmole N.P., 1971, P223; Asseid BS, 2006, AFR J MAR SCI, V28, P109, DOI 10.2989/18142320609504138; AU DWK, 1986, CONDOR, V88, P304, DOI 10.2307/1368877; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Ballance Lisa T., 2007, Marine Ornithology, V35, P127; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; De Monte S, 2012, J R SOC INTERFACE, V9, P3351, DOI 10.1098/rsif.2012.0509; Ford R. Glenn, 2004, Marine Ornithology, V32, P77; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hammond PS, 1995, LIFE, V92; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hyrenbach KD, 2007, DEEP-SEA RES PT I, V54, P1129, DOI 10.1016/j.dsr.2007.05.002; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jaquemet S, 2007, DEEP-SEA RES PT I, V54, P130, DOI 10.1016/j.dsr.2006.10.003; Jaquemet S, 2005, MAR BIOL, V147, P573, DOI 10.1007/s00227-005-1610-0; Jaquemet S, 2014, DEEP-SEA RES PT II, V100, P200, DOI 10.1016/j.dsr2.2013.10.027; Jaquemet S, 2004, MAR ECOL PROG SER, V268, P281, DOI 10.3354/meps268281; Kai ET, 2010, PROG OCEANOGR, V86, P214, DOI 10.1016/j.pocean.2010.04.010; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; Le Corre M, 2005, ESTUAR COAST SHELF S, V63, P421, DOI 10.1016/j.ecss.2004.11.013; Le Corre M, 2001, J ZOOL, V254, P239, DOI 10.1017/S0952836901000759; LeCorre M, 1997, REV ECOL-TERRE VIE, V52, P205; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Sabarros PS, 2009, MAR ECOL PROG SER, V395, P101, DOI 10.3354/meps08087; Schneider D.C., 1990, Polar Research, V8, P17, DOI 10.1111/j.1751-8369.1990.tb00370.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Spear LB, 2001, MAR ECOL PROG SER, V219, P275, DOI 10.3354/meps219275; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Ternon JF, 2014, DEEP-SEA RES PT II, V100, P10, DOI 10.1016/j.dsr2.2013.10.013; van Erkel AR, 1998, EUR J RADIOL, V27, P88, DOI 10.1016/S0720-048X(97)00157-5; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2; Weimerskirch H, 2005, MAR ECOL PROG SER, V288, P251, DOI 10.3354/meps288251; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wong SNP, 2014, J GEOPHYS RES-OCEANS, V119, P1691, DOI 10.1002/2013JC009198; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	62	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115057	10.1371/journal.pone.0115057	http://dx.doi.org/10.1371/journal.pone.0115057			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494047	Green Published, gold			2022-12-26	WOS:000346611400091
J	Bhat, AA; Pope, JL; Smith, JJ; Ahmad, R; Chen, X; Washington, MK; Beauchamp, RD; Singh, AB; Dhawan, P				Bhat, A. A.; Pope, J. L.; Smith, J. J.; Ahmad, R.; Chen, X.; Washington, M. K.; Beauchamp, R. D.; Singh, A. B.; Dhawan, P.			Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; E-CADHERIN EXPRESSION; DNA-METHYLATION; DOWN-REGULATION; TIGHT JUNCTION; UP-REGULATION; CANCER; INVASION; RAB25; METASTASIS	In normal colon, claudin-7 is one of the highly expressed claudin proteins and its knockdown in mice results in altered epithelial cell homeostasis and neonatal death. Notably, dysregulation of the epithelial homeostasis potentiates oncogenic transformation and growth. However, the role of claudin-7 in the regulation of colon tumorigenesis remains poorly understood. Using a large colorectal cancer (CRC) patient database and mouse models of colon cancer, we found claudin-7 expression to be significantly downregulated in cancer samples. Most notably, forced claudin-7 expression in poorly differentiated and highly metastatic SW620 colon cancer cells induced epithelial characteristics and inhibited their growth in soft agar and tumor growth in vivo. By contrast, knockdown of claudin-7 in HT-29 or DLD-1 cells induced epithelial-to-mesenchymal transition (EMT), colony formation, xenograft-tumor growth in athymic mice and invasion. Importantly, a claudin-7 signature gene profile generated by overlapping the DEGs (differentially expressed genes in a high-throughput transcriptome analysis using claudin-7-manipulated cells) with human claudin-7 signature genes identified high-risk CRC patients. Furthermore, Rab25, a colon cancer suppressor and regulator of the polarized cell trafficking constituted one of the highly upregulated DEGs in claudin-7 overexpressing cells. Notably, silencing of Rab25 expression counteracted the effects of claudin-7 expression and not only increased proliferation and cell invasion but also increased the expression of p-Src and mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 that were suppressed upon claudin-7 overexpression. Of interest, CRC cell lines, which exhibited decreased claudin-7 expression, also exhibited promoter DNA hypermethylation, a modification associated with transcriptional silencing. Taken together, our data demonstrate a previously undescribed role of claudin-7 as a colon cancer suppressor and suggest that loss of claudin-7 potentiates EMT to promote colon cancer, in a manner dependent on Rab25.	[Bhat, A. A.; Pope, J. L.; Ahmad, R.; Dhawan, P.] Vanderbilt Univ, Med Ctr, Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA; [Pope, J. L.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Smith, J. J.; Beauchamp, R. D.; Singh, A. B.; Dhawan, P.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Chen, X.; Singh, A. B.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Washington, M. K.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Beauchamp, R. D.; Dhawan, P.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Beauchamp, R. D.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Dhawan, P (corresponding author), Vanderbilt Univ, Med Ctr, Div Surg Oncol, Dept Surg,MCN, B-2211,1161 21st Ave South, Nashville, TN 37232 USA.	punita.dhawan@vanderbilt.edu	Bhat, Ajaz/V-3642-2019; Smith, Jesse Joshua/AAN-5440-2020	Bhat, Ajaz/0000-0003-3640-6275; Smith, Jesse Joshua/0000-0003-2538-5456; Beauchamp, Robert Daniel/0000-0002-8446-4114	VA-merit [BX002086, CA124977, DK088902, CA158472, CA069457]; GI Cancer SPORE grant [CA095103]; Vanderbilt DDRC [P30DK058404, VICC P30CA68485]; StarBRITE funds [VR1258]; NATIONAL CANCER INSTITUTE [R01CA124977, R01CA069457, P50CA095103, P30CA068485, R01CA158472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK088902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002086] Funding Source: NIH RePORTER	VA-merit; GI Cancer SPORE grant; Vanderbilt DDRC; StarBRITE funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We are thankful to John Neff and Jalal Hamaamen for their technical support. This work was supported by VA-merit BX002086 and CA124977 (to PD), DK088902 (to ABS), CA158472 (to XC and RDB), CA069457 (to RDB), GI Cancer SPORE grant CA095103, Vanderbilt DDRC P30DK058404, VICC P30CA68485 and StarBRITE funds (no. VR1258).	Bates RC, 2005, CANCER BIOL THER, V4, P365; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Boireau S, 2007, CARCINOGENESIS, V28, P246, DOI 10.1093/carcin/bgl120; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Cheng JM, 2010, INT J CANCER, V126, P2799, DOI 10.1002/ijc.24900; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Esteller M, 2001, CANCER RES, V61, P3225; Evron E, 2001, CANCER RES, V61, P2782; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Goldenring JR, 2011, BRIT J CANCER, V104, P33, DOI 10.1038/sj.bjc.6605983; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Issa JP, 2008, CANCER PREV RES, V1, P219, DOI 10.1158/1940-6207.CAPR-08-0029; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; Lourenco SV, 2010, HISTOPATHOLOGY, V57, P689, DOI 10.1111/j.1365-2559.2010.03685.x; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; Melchers LJ, 2013, ORAL ONCOL, V49, P998, DOI 10.1016/j.oraloncology.2013.07.008; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; Park GB, 2014, INVEST OPHTH VIS SCI, V55, P1770, DOI 10.1167/iovs.13-12988; Pope JL, 2014, GUT, V63, P622, DOI 10.1136/gutjnl-2012-304241; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyota M, 1999, CANCER RES, V59, P5438; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018; Yoshizawa K, 2013, ONCOL REP, V29, P445, DOI 10.3892/or.2012.2161	46	57	60	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4570	4580		10.1038/onc.2014.385	http://dx.doi.org/10.1038/onc.2014.385			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25500541	Green Accepted			2022-12-26	WOS:000360189300003
J	Ratti, F; Ramond, F; Moncollin, V; Simonet, T; Milan, G; Mejat, A; Thomas, JL; Streichenberger, N; Gilquin, B; Matthias, P; Khochbin, S; Sandri, M; Schaeffer, L				Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Milan, Giulia; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Gilquin, Benoit; Matthias, Patrick; Khochbin, Saadi; Sandri, Marco; Schaeffer, Laurent			Histone Deacetylase 6 Is a FoxO Transcription Factor-dependent Effector in Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; MOUSE MODEL; HDAC6; ACETYLATION; EXPRESSION; DISEASE; STRESS; IDENTIFICATION; POLYUBIQUITIN; DEGRADATION	Skeletal muscle atrophy is a severe condition of muscle mass loss. Muscle atrophy is caused by a down-regulation of protein synthesis and by an increase of protein breakdown due to the ubiquitin-proteasome system and autophagy activation. Upregulation of specific genes, such as the muscle-specific E3 ubiquitin ligase MAFbx, by FoxO transcription factors is essential to initiate muscle protein ubiquitination and degradation during atrophy. HDAC6 is a particular HDAC, which is functionally related to the ubiquitin proteasome system via its ubiquitin binding domain. We show that HDAC6 is up-regulated during muscle atrophy. HDAC6 activation is dependent on the transcription factor FoxO3a, and the inactivation of HDAC6 in mice protects against muscle wasting. HDAC6 is able to interact with MAFbx, a key ubiquitin ligase involved in muscle atrophy. Our findings demonstrate the implication of HDAC6 in skeletal muscle wasting and identify HDAC6 as a new downstream target of FoxO3a in stress response. This work provides new insights in skeletal muscle atrophy development and opens interesting perspectives on HDAC6 as a valuable marker of muscle atrophy and a potential target for pharmacological treatments.	[Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] Ecole Normale Super Lyon, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] CNRS, UMR 5239, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] Univ Lyon, Equipe Differenciat Neuromusculaire, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Schaeffer, Laurent] Univ Lyon 1, F-38706 La Tronche, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Schaeffer, Laurent] Hosp Civils Lyon, F-38706 La Tronche, France; [Gilquin, Benoit; Khochbin, Saadi] INSERM, U309, Inst Albert Bonniot, F-38706 La Tronche, France; [Matthias, Patrick] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Milan, Giulia; Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Milan, Giulia; Sandri, Marco] Dulbecco Telethon Inst, Venetian Inst Mol Med, I-35129 Padua, Italy	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Friedrich Miescher Institute for Biomedical Research; University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine	Schaeffer, L (corresponding author), ENS Lyon, CNRS, UMR 5239, 46 Allee Italie, F-69364 Lyon 07, France.	Laurent.Schaeffer@ens-lyon.fr	Khochbin, Saadi/M-8090-2013; Ratti, Francesca/AAB-2116-2019; MONCOLLIN, Vincent/R-1941-2017; Ramond, Francis/GVS-2149-2022; GILQUIN, Benoit/A-6234-2014	Khochbin, Saadi/0000-0002-0455-0857; MONCOLLIN, Vincent/0000-0002-4163-0231; schaeffer, laurent/0000-0001-6600-503X; GILQUIN, benoit/0000-0001-8138-7021	Association Francaise contre les Myopathies (AFM); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Institut National du Cancer (INCA)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France)	This work was supported by the Association Francaise contre les Myopathies (AFM), the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale, de la Recherche et de la Technologie, and the Institut National du Cancer (INCA).	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inui A, 2002, CA-CANCER J CLIN, V52, P72, DOI 10.3322/canjclin.52.2.72; Kanno K, 2012, ONCOL REP, V28, P867, DOI 10.3892/or.2012.1898; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Penet MF, 2011, CANCER RES, V71, P6948, DOI 10.1158/0008-5472.CAN-11-1095; Piccirillo R, 2012, EMBO J, V31, P3334, DOI 10.1038/emboj.2012.178; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2012, NAT CELL BIOL, V14, P786, DOI 10.1038/ncb2550; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Zuo QQ, 2012, ONCOL REP, V27, P819, DOI 10.3892/or.2011.1553	37	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4215	4224		10.1074/jbc.M114.600916	http://dx.doi.org/10.1074/jbc.M114.600916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25516595	Green Published, hybrid			2022-12-26	WOS:000349458400032
J	Hassan, C; Chabrol, E; Jahn, L; Kester, MGD; de Ru, AH; Drijfhout, JW; Rossjohn, J; Falkenburg, JHF; Heemskerk, MHM; Gras, S; van Veelen, PA				Hassan, Chopie; Chabrol, Eric; Jahn, Lorenz; Kester, Michel G. D.; de Ru, Arnoud H.; Drijfhout, Jan W.; Rossjohn, Jamie; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.; Gras, Stephanie; van Veelen, Peter A.			Naturally Processed Non-canonical HLA-A*02:01 Presented Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Immunology; Mass Spectrometry (MS); Peptide Conformation; Peptides; HLA-A*02:01; Human Leukocyte Antigen Class I; T-cell Immunity; Peptidomics	MHC CLASS-I; COMPLEX CLASS-I; CELL-RECEPTOR RECOGNITION; AMINO-ACIDS; LONG; SPECIFICITY; SELECTION; IMPACT; LENGTH; TCR	Background: The impact of long epitopes on T-cell immunity remains unclear. Results: We identified and characterized 15-mer epitopes restricted to HLA-A*02:01. Conclusion: HLA-A*02:01, in addition to the HLA-B family, can bind long epitopes that represent new antigenic targets for CD8(+) T-cells. Significance: The characterization of 15-mer epitopes restricted to HLA-A*02:01 expands our knowledge of the HLA-ligandome. Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acids (aa) in length. Although an increasing number of examples with lengthy (>11 aa) peptides, presented mostly by HLA-B alleles, have been reported. Here we characterize HLA-A*02:01 restricted, in addition to the HLA-B*0702 and HLA-B*4402 restricted, lengthy peptides (>11 aa) arising from the B-cell ligandome. We analyzed a number of 15-mer peptides presented by HLA-A*02:01, and confirmed pHLA-I formation by HLA folding and thermal stability assays. Surprisingly the binding affinity and stability of the 15-mer epitopes in complex with HLA-A*02:01 were comparable with the values observed for canonical length (8 to 11 aa) HLA-A*02:01-restricted peptides. We solved the structures of two 15-mer epitopes in complex with HLA-A*02:01, within which the peptides adopted distinct super-bulged conformations. Moreover, we demonstrate that T-cells can recognize the 15-mer peptides in the context of HLA-A*02:01, indicating that these 15-mer peptides represent immunogenic ligands. Collectively, our data expand our understanding of longer epitopes in the context of HLA-I, highlighting that they are not limited to the HLA-B family, but can bind the ubiquitous HLA-A*02:01 molecule, and play an important role in T-cell immunity.	[Hassan, Chopie; de Ru, Arnoud H.; Drijfhout, Jan W.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Jahn, Lorenz; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.] Leiden Univ, Med Ctr, Dept Hematol, NL-2333 ZA Leiden, Netherlands; [Chabrol, Eric; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University; Monash University; Cardiff University	Gras, S (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	stephanie.gras@monash.edu; p.a.van_veelen@lumc.nl	Drijfhout, Jan Wouter/ABA-6318-2021; Rossjohn, Jamie/F-9032-2013; Heemskerk, Mirjam H.M./ABI-2336-2020; hassan, cesare/H-2844-2012	Drijfhout, Jan Wouter/0000-0003-4808-5296; Rossjohn, Jamie/0000-0002-2020-7522; Heemskerk, Mirjam H.M./0000-0001-6320-9133; hassan, cesare/0000-0001-7167-1459; van Veelen, Peter/0000-0002-7898-9408; gras, stephanie/0000-0001-7416-038X; Jahn, Lorenz/0000-0002-9880-7026	Landsteiner Foundation for Blood Transfusion Research [LSBR0713]; Australian Research Council; National Health and Medical Research Council of Australia; National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship; Australian Research Council [FT120100416]	Landsteiner Foundation for Blood Transfusion Research; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Landsteiner Foundation for Blood Transfusion Research Grant LSBR0713 and the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by a National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship.; Supported by Australian Research Council Future Fellowship FT120100416.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bade-Doding C, 2011, HAEMATOL-HEMATOL J, V96, P110, DOI 10.3324/haematol.2010.030924; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell MJ, 2009, MOL IMMUNOL, V46, P1911, DOI 10.1016/j.molimm.2008.12.003; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Delano W.L, 2002, PYMOL USERS MANUAL; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Hombrink P, 2013, J IMMUNOL, V190, P3869, DOI 10.4049/jimmunol.1202351; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Liu YC, 2012, J BIOL CHEM, V287, P12267, DOI 10.1074/jbc.M112.344689; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rist MJ, 2013, J IMMUNOL, V191, P561, DOI 10.4049/jimmunol.1300292; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Tan TLR, 1997, J IMMUNOL METHODS, V205, P201, DOI 10.1016/S0022-1759(97)00086-0; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Wynn KK, 2008, BLOOD, V111, P4283, DOI 10.1182/blood-2007-11-122622; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	35	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2593	2603		10.1074/jbc.M114.607028	http://dx.doi.org/10.1074/jbc.M114.607028			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505266	Green Published, hybrid			2022-12-26	WOS:000349310700006
J	Kiefer, K; Carreras-Sureda, A; Garcia-Lopez, R; Rubio-Moscardo, F; Casas, J; Fabrias, G; Vicente, R				Kiefer, Kerstin; Carreras-Sureda, Amado; Garcia-Lopez, Roberto; Rubio-Moscardo, Fanny; Casas, Josefina; Fabrias, Gemma; Vicente, Ruben			Coordinated Regulation of the Orosomucoid-like Gene Family Expression Controls de Novo Ceramide Synthesis in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ceramide; Enzyme Inhibitor; Macrophage; Serine Palmitoyltransferase; Sphingolipid	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROTEINS MEDIATE; ORMDL3; HOMEOSTASIS; RISK; ORM2	Background: Knockdown of orosomucoid-like (ORMDL) proteins releases serine palmitoyltransferase (SPT) activity. Results: Significant changes in SPT activity were detected when all three ORMDLs were overexpressed. Sphingolipids do not modify SPT-ORMDL interaction but rearrange ORMDLs. Macrophages suppress ORMDLs to induce de novo ceramide synthesis. Conclusion: Coordinated ORMDL expression regulation strongly influences SPT activity. Significance: SPT-ORMDL complex presents transcriptional and post-translational regulation. The orosomucoid-like (ORMDL) protein family is involved in the regulation of de novo sphingolipid synthesis, calcium homeostasis, and unfolded protein response. Single nucleotide polymorphisms (SNPs) that increase ORMDL3 expression have been associated with various immune/inflammatory diseases, although the pathophysiological mechanisms underlying this association are poorly understood. ORMDL proteins are claimed to be inhibitors of the serine palmitoyltransferase (SPT). However, it is not clear whether individual ORMDL expression levels have an impact on ceramide synthesis. The present study addressed the interaction with and regulation of SPT activity by ORMDLs to clarify their pathophysiological relevance. We have measured ceramide production in HEK293 cells incubated with palmitate as a direct substrate for SPT reaction. Our results showed that a coordinated overexpression of the three isoforms inhibits the enzyme completely, whereas individual ORMDLs are not as effective. Immunoprecipitation and fluorescence resonance energy transfer (FRET) studies showed that mammalian ORMDLs form oligomeric complexes that change conformation depending on cellular sphingolipid levels. Finally, using macrophages as a model, we demonstrate that mammalian cells modify ORMDL genes expression levels coordinately to regulate the de novo ceramide synthesis pathway. In conclusion, we have shown a physiological modulation of SPT activity by general ORMDL expression level regulation. Moreover, because single ORMDL3 protein alteration produces an incomplete inhibition of SPT activity, this work argues against the idea that ORMDL3 pathophysiology could be explained by a simple on/off mechanism on SPT activity.	[Kiefer, Kerstin; Carreras-Sureda, Amado; Garcia-Lopez, Roberto; Rubio-Moscardo, Fanny; Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Casas, Josefina; Fabrias, Gemma] Inst Adv Chem Catalonia IQAC, Dept Biomed Chem, Res Unit Bioact Mol RUBAM, Barcelona 08034, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC)	Vicente, R (corresponding author), Univ Pompeu Fabra, Dr Aiguader 88, Barcelona 08003, Spain.	ruben.vicente@upf.edu	Rubio-Moscardó, Francisca/L-6247-2014; Casas, Josefina/L-7934-2014; García, Rubén Vicente/L-1097-2014	Rubio-Moscardó, Francisca/0000-0002-3609-9992; García, Rubén Vicente/0000-0003-0401-4808; Carreras Sureda, Amado/0000-0002-9032-5639; Fabrias, Gemma/0000-0001-7162-3772	Spanish Ministry of Economy and Competitiveness [SAF2010-16725, SAF2011-22444]; Fondo de Investigacion Sanitaria Red HERACLES [RD12/0042/0014]; Fondos Europeos de Desarrollo Regional; Generalitat de Catalunya [SGR2014]; Fundacio la Marato de TV3 [20134030]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria Red HERACLES(Instituto de Salud Carlos III); Fondos Europeos de Desarrollo Regional; Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3	This work was supported by Spanish Ministry of Economy and Competitiveness Grants SAF2010-16725 and SAF2011-22444, Fondo de Investigacion Sanitaria Red HERACLES Grant RD12/0042/0014, Fondos Europeos de Desarrollo Regional, Generalitat de Catalunya Grant SGR2014, and Fundacio la Marato de TV3 Grant 20134030.	Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Canals D, 2009, BIOORGAN MED CHEM, V17, P235, DOI 10.1016/j.bmc.2008.11.026; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Yu H, 2013, J LIPID RES, V54, P189, DOI 10.1194/jlr.M031427	24	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2822	2830		10.1074/jbc.M114.595116	http://dx.doi.org/10.1074/jbc.M114.595116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519910	Green Published, hybrid			2022-12-26	WOS:000349310700023
J	Yuan, L; Chen, ZB; Song, SS; Wang, S; Tian, CY; Xing, GC; Chen, XJ; Xiao, ZX; He, FC; Zhang, LQ				Yuan, Lin; Chen, Zhongbin; Song, Shanshan; Wang, Shan; Tian, Chunyan; Xing, Guichun; Chen, Xiaojuan; Xiao, Zhi-Xiong; He, Fuchu; Zhang, Lingqiang			p53 Degradation by a Coronavirus Papain-like Protease Suppresses Type I Interferon Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Interferon; Mouse Double Minute 2 Homolog (MDM2); p53; Virus; PLP2; Coronavirus	UBIQUITIN LIGASE SMURF1; RING-FINGER DOMAIN; IFN-ALPHA/BETA; SARS; ACTIVATION; INFECTION; DEUBIQUITINASE; REPLICATION; VIRUS; GENES	Background: The molecular mechanism of coronavirus PLPs suppressing the innate immune response remains unclear. Results: PLP2 induces the degradation of p53 through stabilizing MDM2, and IRF7 is a novel target gene of p53. Conclusion: PLP2 inhibits the p53-mediated production of type I IFN and apoptosis to ensure viral growth. Significance: We identify the mechanism with which coronavirus induces the low dosage IFN production. Infection by human coronaviruses is usually characterized by rampant viral replication and severe immunopathology in host cells. Recently, the coronavirus papain-like proteases (PLPs) have been identified as suppressors of the innate immune response. However, the molecular mechanism of this inhibition remains unclear. Here, we provide evidence that PLP2, a catalytic domain of the nonstructural protein 3 of human coronavirus NL63 (HCoV-NL63), deubiquitinates and stabilizes the cellular oncoprotein MDM2 and induces the proteasomal degradation of p53. Meanwhile, we identify IRF7 (interferon regulatory factor 7) as a bona fide target gene of p53 to mediate the p53-directed production of type I interferon and the innate immune response. By promoting p53 degradation, PLP2 inhibits the p53-mediated antiviral response and apoptosis to ensure viral growth in infected cells. Thus, our study reveals that coronavirus engages PLPs to escape from the innate antiviral response of the host by inhibiting p53-IRF7-IFN signaling.	[Yuan, Lin; Song, Shanshan; Wang, Shan; Tian, Chunyan; Xing, Guichun; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Prote, Beijing 100850, Peoples R China; [Yuan, Lin; Zhang, Lingqiang] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Liaoning Provin, Peoples R China; [Chen, Zhongbin; Chen, Xiaojuan] Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing 100850, Peoples R China; [Xiao, Zhi-Xiong] Sichuan Univ, Sch Life Sci, Chengdu 610065, Sichuan Provinc, Peoples R China	Academy of Military Medical Sciences - China; Dalian Medical University; Academy of Military Medical Sciences - China; Sichuan University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn		YUAN, LIN/0000-0001-5449-3435	National Basic Research Programs [2012CB910702, 2011CB910802, 2013CB910803]; National Natural Science Foundation [81201271, 31125010, 81221004]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by National Basic Research Programs 2012CB910702, 2011CB910802, and 2013CB910803 and National Natural Science Foundation Projects 81201271, 31125010, and 81221004.	Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chaudhuri R, 2011, J MOL BIOL, V414, P272, DOI 10.1016/j.jmb.2011.09.030; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nguyen ML, 2007, J VIROL, V81, P12985, DOI 10.1128/JVI.01485-07; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rivas C, 2010, VIRUSES-BASEL, V2, P298, DOI 10.3390/v2010298; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Zheng BJ, 2004, J INTERF CYTOK RES, V24, P388, DOI 10.1089/1079990041535610; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294	33	75	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3172	3182		10.1074/jbc.M114.619890	http://dx.doi.org/10.1074/jbc.M114.619890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505178	Green Published, hybrid			2022-12-26	WOS:000349310700051
J	MacNeil, JE; Williams, RN				MacNeil, Jami E.; Williams, Rod N.			Effects of Timber Harvests and Silvicultural Edges on Terrestrial Salamanders	PLOS ONE			English	Article							SOUTHERN APPALACHIAN SALAMANDERS; MISSOURI OZARK FORESTS; PLETHODONTID SALAMANDERS; ABUNDANCE; AMPHIBIANS; MANAGEMENT; POPULATIONS; STANDS; PERSISTENCE; MOUNTAINS	Balancing timber production and conservation in forest management requires an understanding of how timber harvests affect wildlife species. Terrestrial salamanders are useful indicators of mature forest ecosystem health due to their importance to ecosystem processes and sensitivity to environmental change. However, the effects of timber harvests on salamanders, though often researched, are still not well understood. To further this understanding, we used artificial cover objects to monitor the relative abundance of terrestrial salamanders for two seasons (fall and spring) pre-harvest and five seasons post-harvest in six forest management treatments, and for three seasons post-harvest across the edge gradients of six recent clearcuts. In total, we recorded 19,048 encounters representing nine species of salamanders. We observed declines in mean encounters of eastern red-backed salamanders (Plethodon cinereus) and northern slimy salamanders (P. glutinosus) from pre-to post-harvest in group selection cuts and in clearcuts. However, we found no evidence of salamander declines at shelterwoods and forested sites adjacent to harvests. Edge effects induced by recent clearcuts influenced salamanders for approximately 20 m into the forest, but edge influence varied by slope orientation. Temperature, soil moisture, and canopy cover were all correlated with salamander counts. Our results suggest silvicultural techniques that remove the forest canopy negatively affect salamander relative abundance on the local scale during the years immediately following harvest, and that the depth of edge influence of clearcuts on terrestrial salamanders is relatively shallow (<20 m). Small harvests (<4 ha) and techniques that leave the forest canopy intact may be compatible with maintaining terrestrial salamander populations across a forested landscape. Our results demonstrate the importance of examining species-specific responses and monitoring salamanders across multiple seasons and years. Long-term monitoring will be necessary to understand the full impacts of forest management on terrestrial salamanders.	[MacNeil, Jami E.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	MacNeil, JE (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	jami.macneil@gmail.com			Indiana Department of Natural Resources Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Indiana Department of Natural Resources Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Funding was provided by the Indiana Department of Natural Resources Division of Forestry and the Department of Forestry and Natural Resources, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2010, SALAMANDERS US CANAD; Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Ash AN, 1999, CONSERV BIOL, V13, P206, DOI 10.1046/j.1523-1739.1999.98257.x; ASH AN, 1994, CONSERV BIOL, V8, P300, DOI 10.1046/j.1523-1739.1994.08010300.x; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Biek R, 2002, NORTHWEST SCI, V76, P129; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bolen EG, 2003, WILDLIFE ECOLOGY MAN, P332; Bonin J., 1991, THESIS MCGILL U MONT; Brown JK, 1974, INT16 USDA FOR SERV; Burnham K. P., 1998, MODEL SELECTION INFE; BURTON TM, 1975, COPEIA, P541; BURY RB, 1988, MANAGEMENT AMPHIBIAN, P11; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Dale M.E., 1995, NE698 USDA FOR SERV; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; DEGRAAF RM, 1992, WILDLIFE SOC B, V20, P260; DeGraaf RM, 2002, FOREST SCI, V48, P351; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Duguay JP, 2002, FOREST SCI, V48, P331; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Fellers GM, 1994, MEASURING MONITORING, P149; Ford WM, 2002, FOREST ECOL MANAG, V155, P131, DOI 10.1016/S0378-1127(01)00553-9; Grialou JA, 2000, J WILDLIFE MANAGE, V64, P105, DOI 10.2307/3802979; Harpole DN, 1999, FOREST ECOL MANAG, V114, P349, DOI 10.1016/S0378-1127(98)00365-X; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Herbeck LA, 1999, CONSERV BIOL, V13, P623, DOI 10.1046/j.1523-1739.1999.98097.x; Hines, 2006, PROGRAM PRESENCE VER; Hyde EJ, 2001, J WILDLIFE MANAGE, V65, P624, DOI 10.2307/3803013; JAEGER RG, 1980, COPEIA, P265, DOI 10.2307/1444003; KALB RA, 2013, HARDWOOD ECOSYSTEM E, V108, P36; Karraker NE, 2006, BIOL CONSERV, V131, P132, DOI 10.1016/j.biocon.2006.02.013; KESSLER WB, 1992, ECOL APPL, V2, P221, DOI 10.2307/1941856; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Leopold A, 1930, GAME MANAGEMENT; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacNeil JE, 2013, HERPETOL CO IN PRESS; Maser C., 1979, WILDLIFE HABITATS MA, P78; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Morneault AE, 2004, FOREST ECOL MANAG, V199, P1, DOI 10.1016/j.foreco.2004.03.043; Moseley KR, 2009, ENVIRON MONIT ASSESS, V151, P425, DOI 10.1007/s10661-008-0286-6; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; National Drought Mitigation Center, US DROUGHT MON; Perry DA, 1998, ANNU REV ECOL SYST, V29, P435, DOI 10.1146/annurev.ecolsys.29.1.435; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Petranka JW, 1999, CONSERV BIOL, V13, P203, DOI 10.1046/j.1523-1739.1999.97376.x; Popescu VD, 2012, FOREST ECOL MANAG, V270, P163, DOI 10.1016/j.foreco.2012.01.027; POUGH FH, 1987, FOREST ECOL MANAG, V20, P1, DOI 10.1016/0378-1127(87)90146-0; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Roznik EA, 2012, J THERM BIOL, V37, P260, DOI 10.1016/j.jtherbio.2012.02.004; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; SHARITZ RR, 1992, ECOL APPL, V2, P226, DOI 10.2307/1941857; Summerville KS, 2009, FOREST ECOL MANAG, V259, P8, DOI 10.1016/j.foreco.2009.09.033; Temple SA, 1987, PREDATION TURTLE NES, V1987, P250; USDA Forest Service, 2007, USDA FOR SERV OV; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Willson John D., 2010, P229; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258; Zwolak R, 2009, FOREST ECOL MANAG, V258, P539, DOI 10.1016/j.foreco.2009.05.033	67	5	7	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114683	10.1371/journal.pone.0114683	http://dx.doi.org/10.1371/journal.pone.0114683			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517409	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600025
J	Wiseman, B; Kilburg, A; Chaptal, V; Reyes-Mejia, GC; Sarwan, J; Falson, P; Jault, JM				Wiseman, Benjamin; Kilburg, Arnaud; Chaptal, Vincent; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Falson, Pierre; Jault, Jean-Michel			Stubborn Contaminants: Influence of Detergents on the Purity of the Multidrug ABC Transporter BmrA	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MEMBRANE-PROTEIN CRYSTALLIZATION; SIZE-EXCLUSION CHROMATOGRAPHY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ATP-BINDING; STRUCTURAL-ANALYSIS; ACRB CONTAMINATION; PURIFICATION; SOFTWARE	Despite the growing interest in membrane proteins, their crystallization remains a major challenge. In the course of a crystallographic study on the multidrug ATP-binding cassette transporter BmrA, mass spectral analyses on samples purified with six selected detergents revealed unexpected protein contamination visible for the most part on overloaded SDS-PAGE. A major contamination from the outer membrane protein OmpF was detected in purifications with Foscholine 12 (FC12) but not with Lauryldimethylamine-N-oxide (LDAO) or any of the maltose-based detergents. Consequently, in the FC12 purified BmrA, OmpF easily crystallized over BmrA in a new space group, and whose structure is reported here. We therefore devised an optimized protocol to eliminate OmpF during the FC12 purification of BmrA. On the other hand, an additional band visible at similar to 110 kDa was detected in all samples purified with the maltose-based detergents. It contained AcrB that crystallized over BmrA despite its trace amounts. Highly pure BmrA preparations could be obtained using either a Delta acrAB E. coli strain and n-dodecyl-beta-D-maltopyranoside, or a classical E. coli strain and lauryl maltose neopentyl glycol for the overexpression and purification, respectively. Overall our results urge to incorporate a proteomics-based purity analysis into quality control checks prior to commencing crystallization assays of membrane proteins that are notoriously arduous to crystallize. Moreover, the strategies developed here to selectively eliminate obstinate contaminants should be applicable to the purification of other membrane proteins overexpressed in E. coli.	[Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] Univ Grenoble Alpes, Inst Biol Struct, F-38000 Grenoble, France; [Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] CEA Grenoble, DSV, IBS, F-38000 Grenoble, France; [Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] CNRS, IBS, UMR5075, F-38000 Grenoble, France; [Kilburg, Arnaud; Chaptal, Vincent; Falson, Pierre] Univ Lyon 1, Inst Biol & Chim Prot, Drug Resistance Mech & Modulat Team, CNRS,UMR5086, F-69367 Lyon, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Falson, P (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, 6 Rue Jules Horowitz, F-38000 Grenoble, France.	pierre.falson@ibcp.fr; jean-michel.jault@ibcp.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Wiseman, Benjamin/0000-0002-2994-5839; chaptal, vincent/0000-0003-2603-0294; Falson, Pierre/0000-0002-9760-4577	Ligue Contre le Cancer; region Rhone-Alpes; Ligue Nationale Contre le Cancer;  [ANR-EMMA-10-049-01];  [ANR-13-BSV5-0001-01];  [ANR-09-PIRI-0002-01];  [ANR-14-CE09-0024]	Ligue Contre le Cancer(Ligue nationale contre le cancer); region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ; ; ; 	PF was supported by the Ligue Contre le Cancer and by ANR-EMMA-10-049-01 and ANR-13-BSV5-0001-01. JMJ and PF were supported by the ANR-09-PIRI-0002-01 and the ANR-14-CE09-0024. Arnaud Kilburg is a recipient of a doctoral fellowship from 'region Rhone-Alpes' and Jonathan Sarwan was a recipient of a doctoral fellowship from the Ligue Nationale Contre le Cancer; their financial support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arachea BT, 2012, PROTEIN EXPRES PURIF, V86, P12, DOI 10.1016/j.pep.2012.08.016; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Camara-Artigas A, 2006, ACTA CRYSTALLOGR F, V62, P1087, DOI 10.1107/S174430910604200X; Caylor CL, 1999, PROTEINS, V36, P270, DOI 10.1002/(SICI)1097-0134(19990815)36:3<270::AID-PROT2>3.3.CO;2-E; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chung KY, 2012, J BIOL CHEM, V287, P36305, DOI 10.1074/jbc.M112.406371; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hohl M, 2012, NAT STRUCT MOL BIOL; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Jin MS, 2012, NATURE; Kang HJ, 2013, INT J BIOCHEM CELL B, V45, P636, DOI 10.1016/j.biocel.2012.12.018; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kefala G, 2010, PROTEIN SCI, V19, P1117, DOI 10.1002/pro.369; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lohkamp B, 2008, ACTA CRYSTALLOGR D, V64, P407, DOI 10.1107/S0907444908001091; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panwar P, 2012, ACTA CRYSTALLOGR D, V68, P1272, DOI 10.1107/S090744491202639X; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Pollock NL, 2014, BBA-BIOMEMBRANES, V1838, P134, DOI 10.1016/j.bbamem.2013.09.001; Psakis G, 2009, J STRUCT BIOL, V166, P107, DOI 10.1016/j.jsb.2008.12.007; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08	53	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114864	10.1371/journal.pone.0114864	http://dx.doi.org/10.1371/journal.pone.0114864			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517996	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600031
J	Brummett, BH; Babyak, MA; Williams, RB; Harris, KM; Jiang, R; Kraus, WE; Singh, A; Costa, PT; Georgiades, A; Siegler, IC				Brummett, Beverly H.; Babyak, Michael A.; Williams, Redford B.; Harris, Kathleen Mullan; Jiang, Rong; Kraus, William E.; Singh, Abanish; Costa, Paul T.; Georgiades, Anastasia; Siegler, Ilene C.			A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; HUMAN 5-HT2C RECEPTOR; SEROTONIN 2C RECEPTOR; CORTISOL RESPONSES; GENDER; CYS23SER; EXPOSURE	Psychosocial stress is well known to be positively associated with subsequent depressive symptoms. Cortisol response to stress may be one of a number of biological mechanisms that links psychological stress to depressive symptoms, although the precise causal pathway remains unclear. Activity of the x-linked serotonin 5-HTR2C receptor has also been shown to be associated with depression and with clinical response to antidepressant medications. We recently demonstrated that variation in a single nucleotide polymorphism on the HTR2C gene, rs6318 (Ser23Cys), is associated with different cortisol release and short-term changes in affect in response to a series of stress tasks in the laboratory. Based on this observation, we decided to examine whether rs6318 might moderate the association between psychosocial stress and subsequent depressive symptoms. In the present study we use cross-sectional data from a large population-based sample of young adult White men (N=2,366) and White women (N=2,712) in the United States to test this moderation hypothesis. Specifically, we hypothesized that the association between self-reported stressful life events and depressive symptoms would be stronger among homozygous Ser23 C females and hemizygous Ser23 C males than among Cys23 G carriers. In separate within-sex analyses a genotype-by-life stress interaction was observed for women (p=.022) but not for men (p=.471). Homozygous Ser23 C women who reported high levels of life stress had depressive symptom scores that were about 0.3 standard deviations higher than female Cys23 G carriers with similarly high stress levels. In contrast, no appreciable difference in depressive symptoms was observed between genotypes at lower levels of stress. Our findings support prior work that suggests a functional SNP on the HTR2C gene may confer an increased risk for depressive symptoms in White women with a history of significant life stress.	[Brummett, Beverly H.; Babyak, Michael A.; Williams, Redford B.; Jiang, Rong; Singh, Abanish; Costa, Paul T.; Georgiades, Anastasia; Siegler, Ilene C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Kraus, William E.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Kraus, William E.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Brummett, BH (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	brummett@duke.edu	Costa, Paul/AAH-6594-2019	Costa, Paul/0000-0003-4375-1712	National Heart Lung and Blood Institute [P01-HL036587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the the grant from the National Heart Lung and Blood Institute P01-HL036587. Redford Williams is the Principal Investigator on this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver KM, 2012, AM J ORTHOPSYCHIAT, V82, P260, DOI 10.1111/j.1939-0025.2012.01148.x; Blazer DG, 1998, PSYCHOL MED, V28, P1311, DOI 10.1017/S0033291798007648; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Brummett BH, 2008, BIOL PSYCHOL, V78, P200, DOI 10.1016/j.biopsycho.2008.03.002; Brummett BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082781; Brummett BH, 2012, BIOL PSYCHOL, V89, P94, DOI 10.1016/j.biopsycho.2011.09.013; Brummett BH, BIOL PSYCHO IN PRESS; Cooke BM, 2014, HORM BEHAV, V65, P416, DOI 10.1016/j.yhbeh.2014.03.004; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Drago A, 2009, AM J MED GENET B, V150B, P601, DOI 10.1002/ajmg.b.30864; Ensel W, 1996, MEASURING DEPRESSION, P51; Fentress HM, 2005, PHARMACOGENOMICS J, V5, P244, DOI 10.1038/sj.tpj.6500315; GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Harris CM, 2009, NATL LONGITUDINAL ST; Heim Christine, 2002, Semin Clin Neuropsychiatry, V7, P147, DOI 10.1053/scnp.2002.33127; Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007; Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955; Jahnsen JA, 2012, EUR J PHARMACOL, V684, P44, DOI 10.1016/j.ejphar.2012.03.043; Kidd T, 2014, BIOL PSYCHOL, V99, P34, DOI 10.1016/j.biopsycho.2014.02.010; Lerer B, 2001, VARIABILITY 5 HT2C R; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Lowry CA, 2002, J NEUROENDOCRINOL, V14, P911, DOI 10.1046/j.1365-2826.2002.00861.x; Mickey BJ, 2012, J NEUROSCI, V32, P9344, DOI 10.1523/JNEUROSCI.1260-12.2012; Netherton C, 2004, PSYCHONEUROENDOCRINO, V29, P125, DOI 10.1016/S0306-4530(02)00150-6; Okada M, 2004, MOL PSYCHIATR, V9, P55, DOI 10.1038/sj.mp.4001357; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Turner R, 1995, CHECKLIST MEASURMENT, P29	31	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114451	10.1371/journal.pone.0114451	http://dx.doi.org/10.1371/journal.pone.0114451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514629	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300012
J	Delvendahl, I; Gattinger, N; Berger, T; Gleich, B; Siebner, HR; Mall, V				Delvendahl, Igor; Gattinger, Norbert; Berger, Thomas; Gleich, Bernhard; Siebner, Hartwig R.; Mall, Volker			The Role of Pulse Shape in Motor Cortex Transcranial Magnetic Stimulation Using Full-Sine Stimuli	PLOS ONE			English	Article							INPUT-OUTPUT CURVE; CORTICAL EXCITABILITY; CURRENT DIRECTION; WAVE-FORMS; I-WAVES; RTMS; THRESHOLDS; EXCITATION; ACTIVATION; FREQUENCY	A full-sine (biphasic) pulse waveform is most commonly used for repetitive transcranial magnetic stimulation (TMS), but little is known about how variations in duration or amplitude of distinct pulse segments influence the effectiveness of a single TMS pulse to elicit a corticomotor response. Using a novel TMS device, we systematically varied the configuration of full-sine pulses to assess the impact of configuration changes on resting motor threshold (RMT) as measure of stimulation effectiveness with single-pulse TMS of the non-dominant motor hand area (M1). In young healthy volunteers, we (i) compared monophasic, half-sine, and full-sine pulses, (ii) applied two-segment pulses consisting of two identical half-sines, and (iii) manipulated amplitude, duration, and current direction of the first or second full-sine pulse half-segments. RMT was significantly higher using half-sine or monophasic pulses compared with full-sine. Pulses combining two half-sines of identical polarity and duration were also characterized by higher RMT than full-sine stimuli resulting. For full-sine stimuli, decreasing the amplitude of the half-segment inducing posterior-anterior oriented current in M1 resulted in considerably higher RMT, whereas varying the amplitude of the half-segment inducing anterior-posterior current had a smaller effect. These findings provide direct experimental evidence that the pulse segment inducing a posterior-anterior directed current in M1 contributes most to corticospinal pathway excitation. Preferential excitation of neuronal target cells in the posterior-anterior segment or targeting of different neuronal structures by the two half-segments can explain this result. Thus, our findings help understanding the mechanisms of neural stimulation by full-sine TMS.	[Delvendahl, Igor] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Gattinger, Norbert; Gleich, Bernhard] Tech Univ Munich, IMETUM, Zent Inst Med Tech, Garching, Germany; [Berger, Thomas] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Siebner, Hartwig R.] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark; [Siebner, Hartwig R.] Univ Copenhagen, Hvidovre Hosp, Dept Neurol, Copenhagen, Denmark; [Mall, Volker] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany	Leipzig University; Technical University of Munich; University of Freiburg; University of Copenhagen; University of Copenhagen; Technical University of Munich	Mall, V (corresponding author), Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany.	volker.mall@tum.de	Gleich, Bernhard/D-4803-2009; Berger, Thomas U/HGA-3594-2022; Delvendahl, Igor/A-7176-2013; Siebner, Hartwig R/G-4052-2016	Gleich, Bernhard/0000-0002-0574-7678; Delvendahl, Igor/0000-0002-6151-2363; 	Grant of Excellence "ContAct" from Lundbeckfonden [R59 A5399]; German Research Foundation [DFG MA 3306/4-1]; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Grant of Excellence "ContAct" from Lundbeckfonden; German Research Foundation(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	HRS was supported by a Grant of Excellence "ContAct" from Lundbeckfonden (R59 A5399); VM was supported by a grant from the German Research Foundation (DFG MA 3306/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2005, CLIN NEUROPHYSIOL, V116, P605, DOI 10.1016/j.clinph.2004.09.020; Arai N, 2007, CLIN NEUROPHYSIOL, V118, P2227, DOI 10.1016/j.clinph.2007.07.006; Awiszus F, 2003, CLIN NEUROPHYSIOL, P5613; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; Barker AT, 1991, ELECTROENCEPHALOGR S, P43227; Brockhardt, 2011, TMS MOTOR THRESHOLD; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; CLAUS D, 1990, ELECTROEN CLIN NEURO, V75, P342, DOI 10.1016/0013-4694(90)90112-W; Clay JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045983; COHEN LG, 1990, ELECTROEN CLIN NEURO, V75, P350, DOI 10.1016/0013-4694(90)90113-X; Corthout E, 2001, EXP BRAIN RES, V141, P128, DOI 10.1007/s002210100860; Delvendahl I, 2014, BRAIN STIMUL, V7, P49, DOI 10.1016/j.brs.2013.08.002; Di Lazzaro V, 2001, EXP BRAIN RES, V138, P268; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V718; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; EPSTEIN CM, 1990, NEUROLOGY, V40, P666, DOI 10.1212/WNL.40.4.666; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Gattinger N, 2012, IEEE T BIO-MED ENG, V59, P1962, DOI 10.1109/TBME.2012.2195180; George MS, 2009, BRAIN STIMUL, V2, P14, DOI 10.1016/j.brs.2008.06.001; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; JALINOUS R, 1991, J CLIN NEUROPHYSIOL, V8, P10, DOI 10.1097/00004691-199101000-00004; Jung NH, 2012, BMC NEUROSCI, V13139; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kammer T, 2010, CLIN NEUROPHYSIOL, V121, P376, DOI 10.1016/j.clinph.2009.12.002; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; Moller C, 2009, CLIN NEUROPHYSIOL, V120, P1003, DOI 10.1016/j.clinph.2009.03.001; Niehaus L, 2000, CLIN NEUROPHYSIOL, V111, P75, DOI 10.1016/S1388-2457(99)00198-4; Pechmann A, 2012, BRAIN STIMUL, V5, P148, DOI 10.1016/j.brs.2011.02.006; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Peterchev AV, 2008, IEEE T BIO-MED ENG, V55, P257, DOI 10.1109/TBME.2007.900540; Peterchev AV, 2013, CLIN NEUROPHYSIOL, V124, P1364, DOI 10.1016/j.clinph.2013.01.011; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Salvador R, 2011, CLIN NEUROPHYSIOL, V122, P748, DOI 10.1016/j.clinph.2010.09.022; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Silbert BI, 2013, CLIN NEUROPHYSIOL, V124, P708, DOI 10.1016/j.clinph.2012.09.018; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sommer M, 2013, BRAIN STIMUL, V6, P363, DOI 10.1016/j.brs.2012.07.003; Tings T, 2005, EXP BRAIN RES, V164, P323, DOI 10.1007/s00221-005-2253-6; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Weyh T, 2005, CLIN NEUROPHYSIOL, V116, P1477, DOI 10.1016/j.clinph.2005.02.002; Ziemann U, 2000, J CLIN NEUROPHYSIOL, V17, P397, DOI 10.1097/00004691-200007000-00005; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	54	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115247	10.1371/journal.pone.0115247	http://dx.doi.org/10.1371/journal.pone.0115247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514673	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300045
J	Ko, WC; Liu, CL; Lee, JJ; Liu, TP; Yang, PS; Hsu, YC; Cheng, SP				Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Hsu, Yi-Chiung; Cheng, Shih-Ping			Negative Association between Serum Parathyroid Hormone Levels and Urinary Perchlorate, Nitrate, and Thiocyanate Concentrations in US Adults: The National Health and Nutrition Examination Survey 2005-2006	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; RECEPTOR; SMOKING; DISEASE; EXPOSURE; RELEASE; DIETARY; GLANDS; GENDER	Objectives: Perchlorate, nitrate, and thiocyanate are well-known inhibitors of the sodium-iodide symporter and may disrupt thyroid function. This exploratory study investigated the association among urinary perchlorate, nitrate, and thiocyanate concentrations and parathyroid hormone (PTH) levels in the general U.S. population. Methods: We analyzed data on 4265 adults (aged 20 years and older) from the National Health and Nutrition Examination Survey in 2005 through 2006 to evaluate the relationship among urinary perchlorate, nitrate, and thiocyanate concentration and PTH levels and the presence of hyperparathyroidism cross-sectionally. Results: The geometric means and 95% confidence interval (95% CI) concentrations of urinary perchlorate, nitrate, and thiocyanate were 3.38 (3.15-3.62), 40363 (37512-43431), and 1129 (1029-1239) ng/mL, respectively. After adjusting for confounding variables and sample weights, creatinine-corrected urinary perchlorate was negatively associated with serum PTH levels in women (P=0.001), and creatinine-corrected urinary nitrate and thiocyanate were negatively associated with serum PTH levels in both sex groups (P=0.001 and P<0.001 for men, P=0.018 and P<0.001 for women, respectively). Similar results were obtained from sensitivity analyses performed for exposure variables unadjusted for creatinine with urinary creatinine added as a separate covariate. There was a negative relationship between hyperparathyroidism and urinary nitrate and thiocyanate [odds ratio (95% CI)=0.77 (0.60-0.98) and 0.69 (0.61-0.79), respectively]. Conclusions: A higher urinary concentration of perchlorate, nitrate, and thiocyanate is associated with lower serum PTH levels. Future studies are needed to determine the pathophysiological background of the observation.	[Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] MacKay Mem Hosp, Dept Surg, Taipei, Taiwan; [Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] Mackay Med Coll, Taipei, Taiwan; [Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Lee, Jie-Jen; Yang, Po-Sheng; Cheng, Shih-Ping] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan; [Lee, Jie-Jen; Yang, Po-Sheng; Cheng, Shih-Ping] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Yi-Chiung] Acad Sinica, Inst Stat, Taipei 115, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Taipei Medical University; Academia Sinica - Taiwan	Cheng, SP (corresponding author), MacKay Mem Hosp, Dept Surg, Taipei, Taiwan.	surg.mmh@gmail.com	Cheng, Shih-Ping/Q-3014-2018	Cheng, Shih-Ping/0000-0002-6301-5096	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-195-004]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grant from the Ministry of Science and Technology of Taiwan (MOST 103-2314-B-195-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafez AM, 2014, J ENDOCRINOL INVEST, V37, P455, DOI 10.1007/s40618-013-0043-8; Amstrup AK, 2010, CALCIFIED TISSUE INT, V87, P406, DOI 10.1007/s00223-010-9416-6; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basile C, 2006, NEPHROL DIAL TRANSPL, V21, P968, DOI 10.1093/ndt/gfi311; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Brown JM, 2014, HYPERTENSION, V63, P273, DOI 10.1161/HYPERTENSIONAHA.113.01910; Canadillas S, 2010, AM J PHYSIOL-RENAL, V298, pF1197, DOI 10.1152/ajprenal.00529.2009; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chang WH, 1997, AM J PHYSIOL-ENDOC M, V273, pE880, DOI 10.1152/ajpendo.1997.273.5.E880; Cheng SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/709024; Cheng SP, 2011, J SURG RES, V168, P82, DOI 10.1016/j.jss.2009.07.034; Cheng SP, 2011, MED HYPOTHESES, V76, P94, DOI 10.1016/j.mehy.2010.08.039; Cozzolino M, 2009, INT J ARTIF ORGANS, V32, P75, DOI 10.1177/039139880903200203; Fischer E, 2014, J CLIN ENDOCR METAB, V99, P965, DOI 10.1210/jc.2013-3214; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Goodman WG, 2008, KIDNEY INT, V74, P276, DOI 10.1038/sj.ki.5002287; Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551; LEWITUS Z, 1962, ENDOCRINOLOGY, V70, P295, DOI 10.1210/endo-70-3-295; Meir T, 2009, AM J PHYSIOL-RENAL, V297, pF1192, DOI 10.1152/ajprenal.00360.2009; Mervish N, 2012, J EXPO SCI ENV EPID, V22, P212, DOI 10.1038/jes.2011.44; Miller BS, 2008, WORLD J SURG, V32, P795, DOI 10.1007/s00268-007-9427-2; Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648; Paik JM, 2012, OSTEOPOROSIS INT, V23, P1727, DOI 10.1007/s00198-011-1776-x; Rapuri PB, 2000, BONE, V27, P429, DOI 10.1016/S8756-3282(00)00341-0; Rejnmark L, 2011, CLIN ENDOCRINOL, V74, P37, DOI 10.1111/j.1365-2265.2010.03894.x; RIDEFELT P, 1995, SURGERY, V117, P56, DOI 10.1016/S0039-6060(05)80230-2; RIDEFELT P, 1992, BIOCHEM BIOPH RES CO, V186, P556, DOI 10.1016/S0006-291X(05)80844-7; Rossi GP, 2012, HYPERTENSION, V60, P431, DOI 10.1161/HYPERTENSIONAHA.112.195891; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Scherer G, 2006, EXP TOXICOL PATHOL, V58, P101, DOI 10.1016/j.etp.2006.07.001; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P3245, DOI 10.1097/01.ASN.0000101240.47747.7F; Srinivasan A, 2009, INT J ENV RES PUB HE, V6, P1418, DOI 10.3390/ijerph6041418; Steinmaus C, 2013, ENVIRON RES, V123, P17, DOI 10.1016/j.envres.2013.01.005; Suh M, 2014, J EXPO SCI ENV EPID, V24, P579, DOI 10.1038/jes.2013.67; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; Tripepi G, 2012, J NEPHROL, V25, P75, DOI 10.5301/JN.2011.7740; Ward MH, 2010, EPIDEMIOLOGY, V21, P389, DOI 10.1097/EDE.0b013e3181d6201d; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; Wolff J, 1998, PHARMACOL REV, V50, P89; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115245	10.1371/journal.pone.0115245	http://dx.doi.org/10.1371/journal.pone.0115245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514572	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300044
J	Zhang, H; Shao, Z; Alibin, CP; Acosta, C; Anderson, HD				Zhang, Haining; Shao, Zongjun; Alibin, Caroline P.; Acosta, Crystal; Anderson, Hope D.			Liganded Peroxisome Proliferator-Activated Receptors (PPARs) Preserve Nuclear Histone Deacetylase 5 Levels in Endothelin-Treated Sprague-Dawley Rat Cardiac Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; NATRIURETIC-PEPTIDE GENE; MEF2 TRANSCRIPTION FACTOR; HYPERTROPHY IN-VITRO; CARDIOMYOCYTE HYPERTROPHY; DEPENDENT ACTIVATION; GAMMA; EXPRESSION; DIFFERENTIATION; SUPPRESSION	Ligand activation of peroxisome proliferator-activated receptors (PPARs) prevents cardiac myocyte hypertrophy, and we previously reported that diacylglycerol kinase zeta (DGK zeta) is critically involved. DGK zeta is an intracellular lipid kinase that catalyzes phosphorylation of diacylglycerol; by attenuating DAG signaling, DGK zeta suppresses protein kinase C (PKC) and G-protein signaling. Here, we investigated how PPAR-DGK zeta signaling blocks activation of the hypertrophic gene program. We focused on export of histone deacetylase 5 (HDAC5) from the nucleus, a key event during hypertrophy, since crosstalk occurs between PPARs and other members of the HDAC family. Using cardiac myocytes isolated from Sprague-Dawley rats, we determined that liganded PPARs disrupt endothelin-1 (ET1)-induced nuclear export of HDAC5 in a manner that is dependent on DGK zeta. When DGK zeta-mediated PKC inhibition was circumvented using a constitutively-active PKC epsilon mutant, PPARs failed to block ET1-induced nuclear retention of HDAC5. Liganded PPARs also prevented (i) activation of protein kinase D (the downstream effector of PKC), (ii) HDAC5 phosphorylation at 14-3-3 protein chaperone binding sites (serines 259 and 498), and (iii) physical interaction between HDAC5 and 14-3-3, all of which are consistent with blockade of nucleo-cytoplasmic shuttling of HDAC5. Finally, the ability of PPARs to prevent neutralization of HDAC5 activity was associated with transcriptional repression of hypertrophic genes. This occurred by first, reduced MEF2 transcriptional activity and second, augmented deacetylation of histone H3 associated with hypertrophic genes expressing brain natriuretic peptide, beta-myosin heavy chain, skeletal muscle alpha-actin, and cardiac muscle alpha-actin. Our findings identify spatial regulation of HDAC5 as a target for liganded PPARs, and to our knowledge, are the first to describe a mechanistic role for nuclear DGK zeta in cardiac myocytes. In conclusion, these results implicate modulation of HDAC5 as a mechanism by which liganded PPARs suppress the hypertrophic gene program.	[Zhang, Haining; Shao, Zongjun; Alibin, Caroline P.; Acosta, Crystal; Anderson, Hope D.] St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB R2H 2A6, Canada; [Acosta, Crystal] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0W3, Canada; [Anderson, Hope D.] Univ Manitoba, Fac Hlth Sci, Coll Pharm, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Anderson, HD (corresponding author), St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB R2H 2A6, Canada.	handerson@sbrc.ca		Anderson, Hope/0000-0001-6570-6678	Canadian Institutes of Health Research [MOP114888]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant awarded to HDA from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca, Grant Number: MOP114888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibin CP, 2008, J BIOL CHEM, V283, P10707, DOI 10.1074/jbc.M800035200; Anderson HDI, 2004, J BIOL CHEM, V279, P9287, DOI 10.1074/jbc.M309227200; Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Asakawa M, 2002, CIRCULATION, V105, P1240, DOI 10.1161/hc1002.105225; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bonofiglio D, 2008, ENDOCR-RELAT CANCER, V15, P545, DOI 10.1677/ERC-07-0272; Bonofiglio D, 2009, BREAST CANCER RES TR, V113, P423, DOI 10.1007/s10549-008-9944-1; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.M110.004317; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Huang YS, 2011, CARDIOVASC RES, V90, P267, DOI 10.1093/cvr/cvq401; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaneda R, 2005, CIRC RES, V97, P210, DOI 10.1161/01.RES.0000176028.18423.07; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kuwahara K, 2001, MOL CELL BIOL, V21, P2085, DOI 10.1128/MCB.21.6.2085-2097.2001; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7; Lee KS, 2009, J CELL BIOCHEM, V106, P823, DOI 10.1002/jcb.22038; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mathiyalagan P, 2014, CARDIOVASC RES, V103, P7, DOI 10.1093/cvr/cvu122; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Sheng L, 2008, CLIN EXP HYPERTENS, V30, P109, DOI 10.1080/10641960801945840; Takahashi H, 2005, CIRCULATION, V111, P1510, DOI 10.1161/01.CIR.0000159339.00703.22; Takahashi H, 2004, EUR J CLIN INVEST, V34, P85, DOI 10.1111/j.1365-2362.2004.01304.x; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; WOTTON D, 1993, J BIOL CHEM, V268, P17975; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115258	10.1371/journal.pone.0115258	http://dx.doi.org/10.1371/journal.pone.0115258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514029	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300048
J	Jeraldo, P; Kalari, K; Chen, XF; Bhavsar, J; Mangalam, A; White, B; Nelson, H; Kocher, JP; Chia, N				Jeraldo, Patricio; Kalari, Krishna; Chen, Xianfeng; Bhavsar, Jaysheel; Mangalam, Ashutosh; White, Bryan; Nelson, Heidi; Kocher, Jean-Pierre; Chia, Nicholas			IM-TORNADO: A Tool for Comparison of 16S Reads from Paired-End Libraries	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; MICROBIAL COMMUNITIES; DIVERSITY; INSIGHTS; DATABASE; FASTER	Motivation: 16S rDNA hypervariable tag sequencing has become the de facto method for accessing microbial diversity. Illumina paired-end sequencing, which produces two separate reads for each DNA fragment, has become the platform of choice for this application. However, when the two reads do not overlap, existing computational pipelines analyze data from read separately and underutilize the information contained in the paired-end reads. Results: We created a workflow known as Illinois Mayo Taxon Organization from RNA Dataset Operations (IM-TORNADO) for processing non-overlapping reads while retaining maximal information content. Using synthetic mock datasets, we show that the use of both reads produced answers with greater correlation to those from full length 16S rDNA when looking at taxonomy, phylogeny, and beta-diversity. Availability and Implementation: IM-TORNADO is freely available at http://sourceforge.net/projects/imtornado and produces BIOM format output for cross compatibility with other pipelines such as QIIME, mothur, and phyloseq.	[Jeraldo, Patricio; Nelson, Heidi; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, MN 55902 USA; [Jeraldo, Patricio; White, Bryan; Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Kalari, Krishna; Chen, Xianfeng; Bhavsar, Jaysheel; Kocher, Jean-Pierre] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Mangalam, Ashutosh] Mayo Clin, Dept Immunol, Rochester, MN USA; [White, Bryan] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Chia, Nicholas] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic	Chia, N (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55902 USA.	chia.nicholas@mayo.edu	Chen, Xianfeng/ABG-8256-2021; Jeraldo, Patricio/H-8178-2019; Mangalam, Ashutosh/I-8565-2017	Jeraldo, Patricio/0000-0003-0282-4217; Mangalam, Ashutosh/0000-0002-9926-2531; Kalari, Krishna/0000-0001-8944-8378; Chia, Nicholas/0000-0001-9652-691X	Mayo Clinic Center for Individualized Medicine Microbiome Program; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL CANCER INSTITUTE [R01CA179243] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine Microbiome Program; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Mayo Clinic Center for Individualized Medicine Microbiome Program. PJ was funded by the Mayo-Illinois Strategic Alliance for Technology-Based Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Rienzi Sara C, 2013, Elife, V2, pe01102, DOI 10.7554/eLife.01102; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lie AAY, 2014, APPL ENVIRON MICROB, V80, P4363, DOI 10.1128/AEM.00057-14; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015220; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	45	73	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114804	10.1371/journal.pone.0114804	http://dx.doi.org/10.1371/journal.pone.0114804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506826	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100025
J	Genuis, SJ; Liu, YN; Genuis, QIT; Martin, JW				Genuis, Stephen J.; Liu, Yanna; Genuis, Quentin I. T.; Martin, Jonathan W.			Phlebotomy Treatment for Elimination of Perfluoroalkyl Acids in a Highly Exposed Family: A Retrospective Case-Series	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE; HALF-LIFE; SERUM; BLOOD; WOMEN; PFOA; PERFLUOROHEXANESULFONATE; PERFLUOROCHEMICALS; ASSOCIATION; POPULATION	Background: Perfluoroalkyl acids (PFAAs) are a family of commonly used synthetic chemicals that have become widespread environmental contaminants. In human serum, perfluorohexane sulfonate (PFHxS), perflurooctane sulfonate (PFOS), and perfluorooctanoate (PFOA) are most frequently detected, in part owing to their long elimination half-lives of between 3.8 yrs (PFOA) and 8.5 yrs (PFHxS). These PFAAs also cross the placenta and have been associated with developmental toxicity, and some are considered likely human carcinogens. Interventions to eliminate PFAAs in highly contaminated individuals would reduce future health risks, but minimal research has been conducted on methods to facilitate accelerated human clearance of these persistent substances. Methods: Six patients with elevated serum concentrations from a single family were treated by intermittent phlebotomy over a 4-5 year period at intervals similar to, or less frequent than what is done for routine blood donation at Canadian Blood Services. The apparent elimination half-life (HLapp) for PFHxS, PFOS, and PFOA in this treated population was calculated in each patient and compared to the intrinsic elimination half-lives (HLin) from a literature reference population of untreated fluorochemical manufacturing plant retirees (n=26, age >55 yrs). Results: For all three PFAAs monitored during phlebotomy, HLapp in each of the family members (except the mother, who had a low rate of venesection) was significantly shorter than the geometric mean HL measured in the reference population, and in some cases were even shorter compared to the fastest eliminator in the reference population. Conclusion: This study suggests significantly accelerated PFAA clearance with regular phlebotomy treatment, but the small sample size and the lack of controls in this clinical intervention precludes drawing firm conclusions. Given the minimal risks of intermittent phlebotomy, this may be an effective and safe clinical intervention to diminish the body burden of PFAAs in highly exposed people.	[Genuis, Stephen J.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Liu, Yanna; Martin, Jonathan W.] Univ Alberta, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB, Canada; [Genuis, Quentin I. T.] Univ Alberta, Fac Med & Dent, MD Program, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Genuis, SJ (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.	sgenuis@ualberta.ca	Martin, Jonathan W/J-3824-2013	Martin, Jonathan W/0000-0001-6265-4294	China Scholarship Council	China Scholarship Council(China Scholarship Council)	The authors would like to thank Dr. Detlef Birkholz at the 'Centre of Excellence' at ALS Environmental for his expert assistance in laboratory testing. Yanna Liu acknowledges stipend support from the China Scholarship Council.	Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; [Anonymous], 2012, 4 NHANES; Arbuckle TE, 2014, ENVIRON INT, V68, P55, DOI 10.1016/j.envint.2014.02.010; Beesoon S, 2012, ENVIRON SCI TECHNOL, V46, P12960, DOI 10.1021/es3034654; Beesoon S, 2011, ENVIRON HEALTH PERSP, V119, P1659, DOI 10.1289/ehp.1003265; Centers for Disease Control and Prevention, 2013, 4 CDCP; Chen MH, 2013, EPIDEMIOLOGY, V24, P800, DOI 10.1097/EDE.0b013e3182a6dd46; Corsini E, 2014, TOXICOLOGY LETT; DeWitt JC, 2012, TOXICOL PATHOL, V40, P300, DOI 10.1177/0192623311428473; Doherty Steven, 2005, Emerg Med Australas, V17, P314, DOI 10.1111/j.1742-6723.2005.00752.x; Ducatman AM, 2012, COMMUNICATION; Frisbee SJ, 2009, ENVIRON HEALTH PERSP, V117, P1873, DOI 10.1289/ehp.0800379; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Genuis SJ, 2008, PUBLIC HEALTH, V122, P671, DOI 10.1016/j.puhe.2008.04.002; Genuis SJ, 2010, PUBLIC HEALTH, V124, P367, DOI 10.1016/j.puhe.2010.03.002; Genuis SJ, 2013, ISRN TOXICOLOGY; Genuis SK, 2006, J EVAL CLIN PRACT, V12, P49, DOI 10.1111/j.1365-2753.2005.00608.x; Genuis SJ, 2011, HUM EXP TOXICOL, V30, P3, DOI 10.1177/0960327110368417; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; GREENBLATT DJ, 1985, ANNU REV MED, V36, P421; Gregoraszczuk EL, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/828532; Hanssen L, 2010, J ENVIRON MONITOR, V12, P1355, DOI 10.1039/b924420d; Harada K, 2005, ENVIRON RES, V99, P253, DOI 10.1016/j.envres.2004.12.003; Health Canada, 2013, 2 HLTH CAN; Hu WY, 2003, COMP BIOCHEM PHYS C, V135, P77, DOI 10.1016/S1532-0456(03)00043-7; Huang QY, 2013, TOXICOL LETT, V223, P211, DOI 10.1016/j.toxlet.2013.09.002; Jandacek RJ, 2013, SCI WORLD J, DOI 10.1155/2013/205621; JOHNSON JD, 1984, FUND APPL TOXICOL, V4, P972, DOI 10.1016/0272-0590(84)90235-5; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Kaneko T, 2000, TOXICOLOGY, V143, P203, DOI 10.1016/S0300-483X(99)00170-5; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Kjeldsen LS, 2013, PERFLUORINATED COMPO; Klaunig JE, 2012, REPROD TOXICOL, V33, P410, DOI 10.1016/j.reprotox.2011.10.014; Kleszczynski K, 2009, TOXICOL APPL PHARM, V235, P182, DOI 10.1016/j.taap.2008.11.021; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Kwadijk CJ, 2014, ENV TOXICOLOGY CHEM; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee DH, 2012, ENVIRON INT, V47, P115, DOI 10.1016/j.envint.2012.06.009; Lee I, 2013, NEUROTOXICOLOGY; Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850; Lorber M, 2011, ORGANOHALOGEN COMPOU, V73, P943; Louis GMB, 2012, EPIDEMIOLOGY, V23, P799, DOI 10.1097/EDE.0b013e31826cc0cf; Martin JW, 2010, J ENVIRON MONITOR, V12, P1979, DOI 10.1039/c0em00295j; Nakayama Shoji, 2005, Environ Sci, V12, P293; Nicole W, 2013, ENVIRON HEALTH PERSP, V121, pA340, DOI 10.1289/ehp.121-A340; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Organisation for Economic Co-operation and Development, 2002, HAZ ASS PERFL SULF I; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Shi ZM, 2007, TOXICOL SCI, V98, P206, DOI 10.1093/toxsci/kfm070; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P229, DOI 10.1289/ehp.0900940; Tian MP, 2012, TOXICOLOGY, V296, P48, DOI 10.1016/j.tox.2012.03.003; Vallianatos EG, 2014, POISON SPRING, P1; Wong F, 2014, ENVIRON SCI TECHNOL, V48, P8807, DOI 10.1021/es500796y; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018; Zhang YF, 2013, ENVIRON SCI TECHNOL, V47, P10619, DOI 10.1021/es401905e	56	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114295	10.1371/journal.pone.0114295	http://dx.doi.org/10.1371/journal.pone.0114295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504057	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400025
J	Hero, JM; Butler, SA; Lollback, GW; Castley, JG				Hero, Jean-Marc; Butler, Sarah A.; Lollback, Gregory W.; Castley, James G.			Determinants of Tree Assemblage Composition at the Mesoscale within a Subtropical Eucalypt Forest	PLOS ONE			English	Article							VEGETATION-ENVIRONMENT RELATIONSHIPS; PLANT DIVERSITY PATTERNS; RAIN-FOREST; SPECIES-RICHNESS; HABITAT ASSOCIATIONS; NORTHERN-TERRITORY; SPATIAL PREDICTION; FUNCTIONAL TRAITS; LIFE FORMS; SOIL	A variety of environmental processes, including topography, edaphic and disturbance factors can influence vegetation composition. The relative influence of these patterns has been known to vary with scale, however, few studies have focused on environmental drivers of composition at the mesoscale. This study examined the relative importance of topography, catchment flow and soil in influencing tree assemblages in Karawatha Forest Park; a South-East Queensland subtropical eucalypt forest embedded in an urban matrix that is part of the Terrestrial Ecosystem Research Network South-East Queensland Peri-urban SuperSite. Thirty-three LTER plots were surveyed at the mesoscale (909 ha), where all woody stems >= 1.3 m high rooted within plots were sampled. Vegetation was divided into three cohorts: small (>= 1-10 cm DBH), intermediate (>= 10-30 cm DBH), and large (>= 30 cm DBH). Plot slope, aspect, elevation, catchment area and location and soil chemistry and structure were also measured. Ordinations and smooth surface modelling were used to determine drivers of vegetation assemblage in each cohort. Vegetation composition was highly variable among plots at the mesoscale (plots systematically placed at 500 m intervals). Elevation was strongly related to woody vegetation composition across all cohorts (R-2: 0.69-0.75). Other topographic variables that explained a substantial amount of variation in composition were catchment area (R-2: 0.43-0.45) and slope (R-2: 0.23-0.61). Soil chemistry (R-2: 0.09-0.75) was also associated with woody vegetation composition. While species composition differed substantially between cohorts, the environmental variables explaining composition did not. These results demonstrate the overriding importance of elevation and other topographic features in discriminating tree assemblage patterns irrespective of tree size. The importance of soil characteristics to tree assemblages was also influenced by topography, where ridge top sites were typically drier and had lower soil nutrient levels than riparian areas.	[Hero, Jean-Marc; Butler, Sarah A.; Lollback, Gregory W.; Castley, James G.] Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia	Griffith University	Lollback, GW (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia.	g.lollback@griffith.edu.au	Castley, James Guy/A-7056-2010	Castley, James Guy/0000-0002-8418-5828	Brisbane City Council; Griffith University; SEQ Catchments; TERN Australian SuperSite Network	Brisbane City Council; Griffith University(Griffith University); SEQ Catchments; TERN Australian SuperSite Network	Funded by the Brisbane City Council, Griffith University, SEQ Catchments and TERN Australian SuperSite Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar FC, 2013, J VEG SCI, V24, P628, DOI 10.1111/jvs.12009; Austin MP, 2009, J ECOL, V97, P496, DOI 10.1111/j.1365-2745.2009.01494.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; AUSTIN MP, 1985, ANNU REV ECOL SYST, V16, P39, DOI 10.1146/annurev.es.16.110185.000351; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Australian Biological Resources Study, 2000, FLOR AUSTR, V17a; Australian Biological Resources Study, 1995, FLORA AUSTR, V16; Austrheim G, 2002, PLANT ECOL, V161, P193, DOI 10.1023/A:1020315718720; Bale CL, 1998, FOREST ECOL MANAG, V110, P363, DOI 10.1016/S0378-1127(98)00300-4; BASNET K, 1992, BIOTROPICA, V24, P31, DOI 10.2307/2388471; Batek MJ, 1999, J BIOGEOGR, V26, P397, DOI 10.1046/j.1365-2699.1999.00292.x; Battaglia M, 1996, OECOLOGIA, V108, P518, DOI 10.1007/BF00333729; Beerling DJ, 1997, GLOBAL ECOL BIOGEOGR, V6; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bledsoe BP, 2000, WETLANDS, V20, P126, DOI 10.1672/0277-5212(2000)020[0126:VAHAEG]2.0.CO;2; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; de Castilho CV, 2010, BIOTROPICA, V42, P95, DOI 10.1111/j.1744-7429.2009.00543.x; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Debski I, 2000, J TROP ECOL, V16, P387, DOI 10.1017/S0266467400001474; Egan JL, 1996, AUST SYST BOT, V9, P205, DOI 10.1071/SB9960205; Eisenlohr PV, 2013, BIODIVERS CONSERV, V22, P2767, DOI 10.1007/s10531-013-0553-x; Eiserhardt WL, 2011, ANN BOT-LONDON, V108, P1391, DOI 10.1093/aob/mcr146; Fensham RJ, 2012, ECOL APPL, V22, P894, DOI 10.1890/11-1123.1; FENSHAM RJ, 1992, AUST J BOT, V40, P311, DOI 10.1071/BT9920311; Flora of Australia, 1981, FLOR AUSTR, V16; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Hager Tim, 2010, Cunninghamia, V11, P425; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hero JM, 2013, FOREST ECOL MANAG, V310, P547, DOI 10.1016/j.foreco.2013.08.062; Hero Jean-Marc, 2010, Australian Zoologist, V35, P216; Horton BM, 2013, FOREST ECOL MANAG, V302, P329, DOI 10.1016/j.foreco.2013.04.006; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Hutchinson TF, 1999, PLANT ECOL, V144, P177, DOI 10.1023/A:1009804020976; Kalra Y. P., 1991, Information Report - Northwest Region, Forestry Canada; Kooyman R, 2010, J ECOL, V98, P517, DOI 10.1111/j.1365-2745.2010.01642.x; Kordas G, 1993, VEGETATION KARAWATHA; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Leathwick JR, 2001, FUNCT ECOL, V15, P233, DOI 10.1046/j.1365-2435.2001.00504.x; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Legendre P., 2012, NUMERICAL ECOLOGY; Liu XP, 2012, ECOL ENG, V49, P193, DOI 10.1016/j.ecoleng.2012.06.040; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Mark AF, 2000, ARCT ANTARCT ALP RES, V32, P240, DOI 10.2307/1552522; Moeslund JE, 2013, NORD J BOT, V31, P129, DOI 10.1111/j.1756-1051.2013.00082.x; Nagy L., 2003, ALPINE BIODIVERSITY; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Neave HM, 1998, FOREST ECOL MANAG, V106, P259, DOI 10.1016/S0378-1127(97)00318-6; Nzegbule EC, 2013, TROP ECOL, V54, P205; O'Grady AP, 2000, AUST J BOT, V48, P629, DOI 10.1071/BT99022; Oksanen J., 2020, VEGAN COMMUNITY ECOL; OLIVEIRAFILHO AT, 1994, J TROP ECOL, V10, P483, DOI 10.1017/S0266467400008178; Olvera-Vargas M, 2010, PLANT ECOL, V211, P321, DOI 10.1007/s11258-010-9792-z; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; Pekin BK, 2012, AUSTRAL ECOL, V37, P330, DOI 10.1111/j.1442-9993.2011.02280.x; Pekin BK, 2009, FOREST ECOL MANAG, V258, P2136, DOI 10.1016/j.foreco.2009.08.013; Pollock LJ, 2012, ECOGRAPHY, V35, P716, DOI 10.1111/j.1600-0587.2011.07085.x; Queensland Herbarium, 2001, KEY EUC GREAT BRISB; R Core Team, 2021, R LANGUAGE ENV STAT; Rayment G.E., 1992, AUSTR LAB HDB SOIL W; Sanchez M, 2013, FLORA, V208, P184, DOI 10.1016/j.flora.2013.03.002; Siefert A, 2012, J VEG SCI, V23, P942, DOI 10.1111/j.1654-1103.2012.01401.x; Sklenar Petr, 2001, Diversity and Distributions, V7, P113, DOI 10.1046/j.1472-4642.2001.00101.x; Sukri RS, 2012, BIOTROPICA, V44, P595, DOI 10.1111/j.1744-7429.2011.00837.x; TITUS HJ, 1990, B TORREY BOT CLUB, V117, P429, DOI 10.2307/2996840; Vlam M, 2014, FOREST ECOL MANAG, V312, P108, DOI 10.1016/j.foreco.2013.10.016; Wardell-Johnson Grant W., 2007, Pacific Conservation Biology, V13, P47; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Wills KE, 2008, AUST J BOT, V56, P422, DOI 10.1071/BT07150; Zhang JT, 2013, MT RES DEV, V33, P170, DOI 10.1659/MRD-JOURNAL-D-11-00042.1	78	2	2	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114994	10.1371/journal.pone.0114994	http://dx.doi.org/10.1371/journal.pone.0114994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501866	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400067
J	King, LY; Johnson, KB; Zheng, H; Wei, L; Gudewicz, T; Hoshida, Y; Corey, KE; Ajayi, T; Ufere, N; Baumert, TF; Chan, AT; Tanabe, KK; Fuchs, BC; Chung, RT				King, Lindsay Y.; Johnson, Kara B.; Zheng, Hui; Wei, Lan; Gudewicz, Thomas; Hoshida, Yujin; Corey, Kathleen E.; Ajayi, Tokunbo; Ufere, Nneka; Baumert, Thomas F.; Chan, Andrew T.; Tanabe, Kenneth K.; Fuchs, Bryan C.; Chung, Raymond T.			Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis	PLOS ONE			English	Article							THAN-G POLYMORPHISM; GROWTH-FACTOR GENE; HEPATOCELLULAR-CARCINOMA; FUNCTIONAL POLYMORPHISM; RISK; PROGRESSION; EXPRESSION; SIGNATURE; RS738409; FIBROSIS	Single nucleotide polymorphisms (SNPs) in the epidermal growth factor (EGF, rs4444903), patatin-like phospholipase domain-containing protein 3 (PNPLA3, rs738409) genes, and near the interleukin-28B (IL28B, rs12979860) gene are linked to treatment response, fibrosis, and hepatocellular carcinoma (HCC) in chronic hepatitis C. Whether these SNPs independently or in combination predict clinical deterioration in hepatitis C virus (HCV)-related cirrhosis is unknown. We genotyped SNPs in EGF, PNPLA3, and IL28B from liver tissue from 169 patients with biopsy-proven HCV cirrhosis. We estimated risk of clinical deterioration, defined as development of ascites, encephalopathy, variceal hemorrhage, HCC, or liver-related death using Cox proportional hazards modeling. During a median follow-up of 6.6 years, 66 of 169 patients experienced clinical deterioration. EGF non-AA, PNPLA3 non-CC, and IL28B non-CC genotypes were each associated with increased risk of clinical deterioration in age, sex, and race-adjusted analysis. Only EGF non-AA genotype was independently associated with increased risk of clinical deterioration (hazard ratio [HR] 2.87; 95% confidence interval [CI] 1.31-6.25) after additionally adjusting for bilirubin, albumin, and platelets. Compared to subjects who had 0-1 unfavorable genotypes, the HR for clinical deterioration was 1.79 (95% CI 0.96-3.35) for 2 unfavorable genotypes and 4.03 (95% CI 2.13-7.62) for unfavorable genotypes for all three loci (P-trend<0.0001). In conclusion, among HCV cirrhotics, EGF non-AA genotype is independently associated with increased risk for clinical deterioration. Specific PNPLA3 and IL28B genotypes also appear to be associated with clinical deterioration. These SNPs have potential to identify patients with HCV-related cirrhosis who require more intensive monitoring for decompensation or future therapies preventing disease progression.	[King, Lindsay Y.; Johnson, Kara B.; Corey, Kathleen E.; Chan, Andrew T.; Chung, Raymond T.] Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA; [King, Lindsay Y.; Johnson, Kara B.; Corey, Kathleen E.; Ufere, Nneka; Chan, Andrew T.; Chung, Raymond T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wei, Lan; Tanabe, Kenneth K.; Fuchs, Bryan C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Gudewicz, Thomas] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [King, Lindsay Y.; Johnson, Kara B.; Zheng, Hui; Wei, Lan; Gudewicz, Thomas; Corey, Kathleen E.; Ufere, Nneka; Baumert, Thomas F.; Chan, Andrew T.; Tanabe, Kenneth K.; Fuchs, Bryan C.; Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA; [Hoshida, Yujin] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ajayi, Tokunbo] North Shore Med Ctr, Dept Med, Salem, MA USA; [Baumert, Thomas F.] Univ Strasbourg, INSERM, U1110, Strasbourg, France	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chung, RT (corresponding author), Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA.	rtchung@partners.org	Chan, Andrew T/P-8293-2014; Baumert, Thomas/ABF-4718-2020; Ufere, Nneka/AAB-2660-2022; Hoshida, Yujin/R-7513-2019	Chan, Andrew T/0000-0001-7284-6767; Baumert, Thomas/0000-0002-8864-2168; Ufere, Nneka/0000-0001-8255-9374; 	National Institutes of Health [DK078772, T32DK007191, DK098311]; National Cancer Institute [CA140861]; NATIONAL CANCER INSTITUTE [K01CA140861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311, K23DK099422, R01DK099558, T32DK007191, K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health DK078772 (RC), National Cancer Institute CA140861 (BF), National Institutes of Health T32DK007191 (LK and KJ), National Institutes of Health DK098311 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; [Anonymous], 1997, HEPATOLOGY, V26, pS2; [Anonymous], WHO TECHN REP SER, V889, P64; Charlton M, 2001, AM J TRANSPLANT, V1, P197, DOI 10.1034/j.1600-6143.2001.001003197.x; Cmet S, 2012, CLIN EXP IMMUNOL, V167, P296, DOI 10.1111/j.1365-2249.2011.04497.x; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2012, CYTOKINE, V57, P68, DOI 10.1016/j.cyto.2011.10.018; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Fuchs BC, 2013, HEPATOLOGY; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2010, GASTROENTEROLOGY, V138, P136, DOI 10.1053/j.gastro.2009.09.007; Guyot E, 2013, J HEPATOL, V58, P312, DOI 10.1016/j.jhep.2012.09.036; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Noureddin M, 2013, HEPATOLOGY; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Trepo E, 2013, HEPATOLOGY; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Yang ZP, 2012, GENET TEST MOL BIOMA, V16, P1086, DOI 10.1089/gtmb.2012.0050; Zhong JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032159; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	28	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114747	10.1371/journal.pone.0114747	http://dx.doi.org/10.1371/journal.pone.0114747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504078	gold, Green Published			2022-12-26	WOS:000346375400049
J	Zhong, X; Xu, HT; Chen, DK; Zhou, HJ; Hu, X; Cheng, G				Zhong, Xue; Xu, Hongtao; Chen, Dongke; Zhou, Haijian; Hu, Xin; Cheng, Gang			First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital	PLOS ONE			English	Article							EFFLUX PUMP ACRAB; ACINETOBACTER-BAUMANNII; MULTIDRUG-RESISTANCE; RAMA; EXPRESSION; SUSCEPTIBILITY; MECHANISMS; SOXS	Tigecycline is one of the few therapeutic options for treating infections caused by some multi-drug resistant pathogens, such as Klebsiella pneumoniae. However, tigecycline-resistant K. pneumoniae has been discovered recently in China. From 2009 to 2013, nine tigecycline-resistant K. pneumoniae isolates were identified in our hospital. Six of nine strains were identified before using tigecycline. To investigate the efflux-mediated resistance mechanisms of K. pneumoniae, the expression of efflux pump genes (acrA, acrB, tolC, oqxA and oqxB) and pump regulators (acrR, marA, soxS, rarA, rob and ramA) were examined by real-time RTPCR. Molecular typing of the tigecycline resistant strains was performed. ST11 was the predominant clone of K. pneumoniae strains, while ST1414 and ST1415 were novel STs. Efflux pump inhibitor (EPI)-carbonyl cyanide chlorophenylhydrazone (CCCP) was able to reverse the resistance patterns of 5 resistant K. pneumoniae strains. In comparison with strain A111, a tigecycline-susceptible strain (negative control), we found that the expression levels of efflux pump genes and pump regulators were higher in a majority of resistant strains. Higher expression levels of regulators rarA (2.41-fold, 9.55-fold, 28.44-fold and 18.31-fold, respectively) and pump gene oqxB (3.87-fold, 31.96-fold, 50.61-fold and 29.45-fold, respectively) were observed in four tigecycline resistant strains (A363, A361, A368, A373, respectively). Increased expression of acrB was associated with ramA and marA expression. To our knowledge, studies on tigecycline resistance mechanism in K. pneumoniae are limited especially in China. In our study, we found that both efflux pump AcrAB-TolC and OqxAB contributed to tigecycline resistance in K. pneumoniae isolates.	[Zhong, Xue; Cheng, Gang] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang, Liaoning, Peoples R China; [Zhong, Xue; Hu, Xin] Beijing Hosp, Dept Pharm, Beijing, Peoples R China; [Xu, Hongtao; Chen, Dongke] Beijing Hosp, Dept Clin Lab, Beijing, Peoples R China; [Zhou, Haijian] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Haijian] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Shenyang Pharmaceutical University; Beijing Hospital; Beijing Hospital; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Cheng, G (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang, Liaoning, Peoples R China.	chenggang63@hotmail.com						Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; Deng M., 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10. 1128/AAC. 01727-13 24165187; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Hornsey M, 2010, INT J ANTIMICROB AG, V35, P478, DOI 10.1016/j.ijantimicag.2010.01.011; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P6256, DOI 10.1128/AAC.01085-12; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Reid GE, 2007, PHARMACOTHERAPY, V27, P1198, DOI 10.1592/phco.27.8.1198; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Ruzin A, 2008, ANTIMICROB AGENTS CH, V52, P3430, DOI 10.1128/AAC.00591-08; Sheng ZK, 2014, ANTIMICROB AGENTS CH, V58, P6982, DOI 10.1128/AAC.03808-14; Stein GE, 2013, DIAGN MICR INFEC DIS, V75, P331, DOI 10.1016/j.diagmicrobio.2012.12.004; Sun Y, 2013, INT J ANTIMICROB AG, V41, P110, DOI 10.1016/j.ijantimicag.2012.09.005; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4466, DOI 10.1128/AAC.06224-11	21	58	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115185	10.1371/journal.pone.0115185	http://dx.doi.org/10.1371/journal.pone.0115185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503276	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400080
J	Isipradit, S; Sirimaharaj, M; Charukamnoetkanok, P; Thonginnetra, O; Wongsawad, W; Sathornsumetee, B; Somboonthanakij, S; Soomsawasdi, P; Jitawatanarat, U; Taweebanjongsin, W; Arayangkoon, E; Arame, P; Kobkoonthon, C; Pangputhipong, P				Isipradit, Saichin; Sirimaharaj, Maytinee; Charukamnoetkanok, Puwat; Thonginnetra, Oraorn; Wongsawad, Warapat; Sathornsumetee, Busaba; Somboonthanakij, Sudawadee; Soomsawasdi, Piriya; Jitawatanarat, Umapond; Taweebanjongsin, Wongsiri; Arayangkoon, Eakkachai; Arame, Punyawee; Kobkoonthon, Chinsuchee; Pangputhipong, Pannet			The First Rapid Assessment of Avoidable Blindness (RAAB) in Thailand	PLOS ONE			English	Article							CATARACT BLINDNESS; VISUAL IMPAIRMENT; GLOBAL BLINDNESS; LOW-VISION; PREVALENCE; POPULATION; DISTRICT	Background: The majority of vision loss is preventable or treatable. Population surveys are crucial for planning, implementation, and monitoring policies and interventions to eliminate avoidable blindness and visual impairments. This is the first rapid assessment of avoidable blindness (RAAB) study in Thailand. Methods: A cross-sectional study of a population in Thailand age 50 years old or over aimed to assess the prevalence and causes of blindness and visual impairments. Using the Thailand National Census 2010 as the sampling frame, a stratified four-stage cluster sampling based on a probability proportional to size was conducted in 176 enumeration areas from 11 provinces. Participants received comprehensive eye examination by ophthalmologists. Results: The age and sex adjusted prevalence of blindness (presenting visual acuity (VA),<20/400), severe visual impairment(VA, <20/200 but >= 20/400), and moderate visual impairment (VA <20/70 but >= 20/200) were 0.6% (95% CI: 0.5-0.8), 1.3% (95% CI: 1.0-1.6), 12.6% (95% CI: 10.8-14.5). There was no significant difference among the four regions of Thailand. Cataract was the main cause of vision loss accounted for 69.7% of blindness. Cataract surgical coverage in persons was 95.1% for cut off VA of 20/400. Refractive errors, diabetic retinopathy, glaucoma, and corneal opacities were responsible for 6.0%, 5.1%, 4.0%, and 2.0% of blindness respectively. Conclusion: Thailand is on track to achieve the goal of VISION 2020. However, there is still much room for improvement. Policy refinements and innovative interventions are recommended to alleviate blindness and visual impairments especially regarding the backlog of blinding cataract, management of non-communicative, chronic, age-related eye diseases such as glaucoma, age-related macular degeneration, and diabetic retinopathy, prevention of childhood blindness, and establishment of a robust eye health information system.	[Isipradit, Saichin; Sirimaharaj, Maytinee; Charukamnoetkanok, Puwat; Thonginnetra, Oraorn; Wongsawad, Warapat; Sathornsumetee, Busaba; Somboonthanakij, Sudawadee; Soomsawasdi, Piriya; Jitawatanarat, Umapond; Taweebanjongsin, Wongsiri; Arayangkoon, Eakkachai; Arame, Punyawee; Kobkoonthon, Chinsuchee; Pangputhipong, Pannet] Mettapracharak Wat Rai Khing Hosp, Sampran 73210, Nakornprathom, Thailand		Charukamnoetkanok, P (corresponding author), Mettapracharak Wat Rai Khing Hosp, 52 Moo 2 Rai Khing, Sampran 73210, Nakornprathom, Thailand.	drpuwat@yahoo.com			Department of Medical Services, Ministry of Public Health, Kingdom of Thailand	Department of Medical Services, Ministry of Public Health, Kingdom of Thailand	This work was supported by the Department of Medical Services, Ministry of Public Health, Kingdom of Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; Bachani D, 2000, Indian J Public Health, V44, P82; Bastawrous A, 2012, OPHTHALMOLOGY, V119, P432, DOI 10.1016/j.ophtha.2011.11.014; Beltranena F, 2007, OPHTHALMOLOGY, V114, P1558, DOI 10.1016/j.ophtha.2006.11.015; Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Jenchitr W, 2007, THAI J PUB HLTH OPHT, V21, P11; Konyama K, 1998, Community Eye Health, V11, P19; Kuper Hannah, 2006, Community Eye Health, V19, P68; Limburg H, 1998, Ophthalmic Epidemiol, V5, P211, DOI 10.1076/opep.5.4.211.4193; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Nirmalan PK, 2005, INVEST OPHTH VIS SCI, V46, P2308, DOI 10.1167/iovs.04-0830; Pararajasegaram R, 2011, COMMUNICATION; Saw SM, 2003, BRIT J OPHTHALMOL, V87, P1075, DOI 10.1136/bjo.87.9.1075; Schwab L, 2007, EYE CARE DEV NATIONS, P235; Smith AF, 1996, BRIT J OPHTHALMOL, V80, P276, DOI 10.1136/bjo.80.4.276; West S, 2001, B WORLD HEALTH ORGAN, V79, P244; WHO Programme for the Prevention of Blindness, 1990, WHOPBL9018; Wong TY, 2008, AM J OPHTHALMOL, V146, P656, DOI 10.1016/j.ajo.2008.07.048; World Health Organization, 2013, UN EYE HLTH GLOB ACT; Wu Min, 2007, Community Eye Health, V20, P10; Zainal M, 2002, BRIT J OPHTHALMOL, V86, P951, DOI 10.1136/bjo.86.9.951; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	32	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114245	10.1371/journal.pone.0114245	http://dx.doi.org/10.1371/journal.pone.0114245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502762	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700017
J	Moens, LN; Falk-Sorqvist, E; Asplund, AC; Bernatowska, E; Smith, CIE; Nilsson, M				Moens, Lotte N.; Falk-Sorqvist, Elin; Asplund, A. Charlotta; Bernatowska, Ewa; Smith, C. I. Edvard; Nilsson, Mats			Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach	PLOS ONE			English	Article							IMMUNE-DEFICIENCY; MUTATIONS; GLYCOSYLATION; DESIGN; PROBES	Primary Immunodeficiencies (PID) are genetically inherited disorders characterized by defects of the immune system, leading to increased susceptibility to infection. Due to the variety of clinical symptoms and the complexity of current diagnostic procedures, accurate diagnosis of PID is often difficult in daily clinical practice. Thanks to the advent of "next generation'' sequencing technologies and target enrichment methods, the development of multiplex diagnostic assays is now possible. In this study, we applied a selector-based target enrichment assay to detect disease-causing mutations in 179 known PID genes. The usefulness of this assay for molecular diagnosis of PID was investigated by sequencing DNA from 33 patients, 18 of which had at least one known causal mutation at the onset of the experiment. We were able to identify the disease causing mutations in 60% of the investigated patients, indicating that the majority of PID cases could be resolved using a targeted sequencing approach. Causal mutations identified in the unknown patient samples were located in STAT3, IGLL1, RNF168 and PGM3. Based on our results, we propose a stepwise approach for PID diagnostics, involving targeted resequencing, followed by whole transcriptome and/or whole genome sequencing if causative variants are not found in the targeted exons.	[Moens, Lotte N.; Falk-Sorqvist, Elin; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Asplund, A. Charlotta; Smith, C. I. Edvard] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Huddinge, Sweden; [Bernatowska, Ewa] Childrens Mem Hlth Inst, Dept Clin Immunol, Warsaw, Poland; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Children's Memorial Health Institute; Stockholm University	Smith, CIE (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Huddinge, Sweden.	edvard.smith@ki.se; mats.nilsson@scilifelab.se		SMITH, C. I. Edvard/0000-0003-1907-3392; Bernatowska, Ewa/0000-0002-0125-266X	FP7 project "European Genetic Disease Diagnostics''; EURO-GENE-SCAN [Health-F5-2008-223293]	FP7 project "European Genetic Disease Diagnostics''; EURO-GENE-SCAN	This study was funded by the FP7 project "European Genetic Disease Diagnostics'', with the acronym "EURO-GENE-SCAN'' (project number Health-F5-2008-223293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Berglof A, 2013, EXPERT REV CLIN IMMU, V9, P1205, DOI 10.1586/1744666X.2013.850030; Blundred RM, 2011, EXPERT REV CLIN IMMU, V7, P169, DOI [10.1586/ECI.10.93, 10.1586/eci.10.93]; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Etzioni A, 2014, PRIMARY IMMUNODEFICIENCY DISORDERS: A HISTORIC AND SCIENTIFIC PERSPECTIVE, P1; Evans BJ, 2013, GENET MED, V15, P915, DOI 10.1038/gim.2013.135; Freeman A., 2014, PRIMARY IMMUNODEFICI, P489; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; McCusker C., 2011, ALLERGY ASTHMA CL IM, V7, pS11, DOI [DOI 10.1186/1710-1492-7-S1-S11, 10.1186/1710-1492-7-S1-S11]; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Oliveira JB, 2010, J ALLERGY CLIN IMMUN, V125, pS297, DOI 10.1016/j.jaci.2009.08.043; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Shehata N, 2010, TRANSFUS MED REV, V24, pS28, DOI 10.1016/j.tmrv.2009.09.011; Stenberg J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-229; Stenberg J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni071; Stenberg J, 2009, BIOINFORMATICS, V25, P666, DOI 10.1093/bioinformatics/btp001; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Valencia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053083; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weiss MM, 2013, HUM MUTAT, V34, P1313, DOI 10.1002/humu.22368; Yu B, 2014, METHODS MOL BIOL, V1168, P195, DOI 10.1007/978-1-4939-0847-9_11; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	25	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114901	10.1371/journal.pone.0114901	http://dx.doi.org/10.1371/journal.pone.0114901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502423	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700066
J	Moonens, K; De Kerpel, M; Coddens, A; Cox, E; Pardon, E; Remaut, H; De Greve, H				Moonens, Kristof; De Kerpel, Maia; Coddens, Annelies; Cox, Eric; Pardon, Els; Remaut, Han; De Greve, Henri			Nanobody Mediated Inhibition of Attachment of F18 Fimbriae Expressing Escherichia coli	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; URINARY-TRACT-INFECTIONS; GALABIOSE DERIVATIVES; FIMH ANTAGONISTS; EDEMA DISEASE; F107 FIMBRIAE; ADHESIN FEDF; PIGS; RECEPTOR; BINDING	Post-weaning diarrhea and edema disease caused by F18 fimbriated E. coli are important diseases in newly weaned piglets and lead to severe production losses in farming industry. Protective treatments against these infections have thus far limited efficacy. In this study we generated nanobodies directed against the lectin domain of the F18 fimbrial adhesin FedF and showed in an in vitro adherence assay that four unique nanobodies inhibit the attachment of F18 fimbriated E. coli bacteria to piglet enterocytes. Crystallization of the FedF lectin domain with the most potent inhibitory nanobodies revealed their mechanism of action. These either competed with the binding of the blood group antigen receptor on the FedF surface or induced a conformational change in which the CDR3 region of the nanobody displaces the D ''-E loop adjacent to the binding site. This D ''-E loop was previously shown to be required for the interaction between F18 fimbriated bacteria and blood group antigen receptors in a membrane context. This work demonstrates the feasibility of inhibiting the attachment of fimbriated pathogens by employing nanobodies directed against the adhesin domain.	[Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Coddens, Annelies; Cox, Eric] Univ Ghent, Fac Vet Med, Dept Vet Immunol, B-9820 Merelbeke, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Ghent University	De Greve, H (corresponding author), VIB, Struct Biol Res Ctr, Brussels, Belgium.	hdegreve@vub.ac.be		Pardon, Els/0000-0002-2466-0172; Cox, Eric/0000-0003-4281-2990; Remaut, Han/0000-0002-9775-4102	VIB Young PI project; Odysseus program of the FWO-Vlaanderen; Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office [7/40]; FWO [G030411N]; Hercules Foundation [UABR/09/005]	VIB Young PI project; Odysseus program of the FWO-Vlaanderen; Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office; FWO(FWO); Hercules Foundation	K.M. was a doctoral fellow of the Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen. H.R. is supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen. E.P. is supported by grant 7/40 of the Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office. The authors are grateful to the beamline staff of the Swiss Light Source (SLS; Switzerland), Diamond Light Source (England) and Soleil (France) for support with data collection and processing. This research was granted by FWO project G030411N and equipment grant UABR/09/005 from the Hercules Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT TJ, 1989, J INFECT DIS, V159, P774, DOI 10.1093/infdis/159.4.774; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bertschinger H. U., 1994, P193; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Coddens A, 2009, J BIOL CHEM, V284, P9713, DOI 10.1074/jbc.M807866200; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cusumano CK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003021; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; De Kerpel M, 2006, ACTA CRYSTALLOGR F, V62, P1278, DOI 10.1107/S1744309106049281; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairbrother J. M., 2006, DIS SWINE, P649; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; IMBERECHTS H, 1992, INFECT IMMUN, V60, P1963, DOI 10.1128/IAI.60.5.1963-1971.1992; IMBERECHTS H, 1994, VET MICROBIOL, V40, P219, DOI 10.1016/0378-1135(94)90111-2; Jiang XH, 2012, J MED CHEM, V55, P4700, DOI 10.1021/jm300192x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Klein T, 2010, J MED CHEM, V53, P8627, DOI 10.1021/jm101011y; Lo AWH, 2013, CURR OPIN MICROBIOL, V16, P85, DOI 10.1016/j.mib.2013.02.003; Melkebeek V, 2013, VET IMMUNOL IMMUNOP, V152, P37, DOI 10.1016/j.vetimm.2012.09.024; Moonens K, 2012, MOL MICROBIOL, V86, P82, DOI 10.1111/j.1365-2958.2012.08174.x; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ohlsson J, 2002, CHEMBIOCHEM, V3, P772, DOI 10.1002/1439-7633(20020802)3:8<772::AID-CBIC772>3.0.CO;2-8; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Reineck P, 2010, ELECTROPHORESIS, V31, P279, DOI 10.1002/elps.200900505; Salminen A, 2007, J ANTIMICROB CHEMOTH, V60, P495, DOI 10.1093/jac/dkm251; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Schwardt O, 2011, BIOORGAN MED CHEM, V19, P6454, DOI 10.1016/j.bmc.2011.08.057; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Smeds A, 2001, INFECT IMMUN, V69, P7941, DOI 10.1128/IAI.69.12.7941-7945.2001; Tiels P, 2005, VET MICROBIOL, V110, P277, DOI 10.1016/j.vetmic.2005.08.004; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Verdonck F, 2007, VET IMMUNOL IMMUNOP, V120, P69, DOI 10.1016/j.vetimm.2007.06.018; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	48	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114691	10.1371/journal.pone.0114691	http://dx.doi.org/10.1371/journal.pone.0114691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502211	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700043
J	Otto, CC; Koehl, JL; Solanky, D; Haydel, SE				Otto, Caitlin C.; Koehl, Jennifer L.; Solanky, Dipesh; Haydel, Shelley E.			Metal Ions, Not Metal-Catalyzed Oxidative Stress, Cause Clay Leachate Antibacterial Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; ACID RESISTANCE; CADMIUM TOXICITY; SILVER IONS; IRON; SUPEROXIDE; COPPER; PH	Aqueous leachates prepared from natural antibacterial clays, arbitrarily designated CB-L, release metal ions into suspension, have a low pH (3.4-5), generate reactive oxygen species (ROS) and H2O2 , and have a high oxidation-reduction potential. To isolate the role of pH in the antibacterial activity of CB clay mixtures, we exposed three different strains of Escherichia coli O157:H7 to 10% clay suspensions. The clay suspension completely killed acid-sensitive and acid-tolerant E. coli O157: H7 strains, whereas incubation in a low-pH buffer resulted in a minimal decrease in viability, demonstrating that low pH alone does not mediate antibacterial activity. The prevailing hypothesis is that metal ions participate in redox cycling and produce ROS, leading to oxidative damage to macromolecules and resulting in cellular death. However, E. coli cells showed no increase in DNA or protein oxidative lesions and a slight increase in lipid peroxidation following exposure to the antibacterial leachate. Further, supplementation with numerous ROS scavengers eliminated lipid peroxidation, but did not rescue the cells from CB-L-mediated killing. In contrast, supplementing CB-L with EDTA, a broad-spectrum metal chelator, reduced killing. Finally, CB-L was equally lethal to cells in an anoxic environment as compared to the aerobic environment. Thus, ROS were not required for lethal activity and did not contribute to toxicity of CB-L. We conclude that clay-mediated killing was not due to oxidative damage, but rather, was due to toxicity associated directly with released metal ions.	[Otto, Caitlin C.; Koehl, Jennifer L.; Solanky, Dipesh; Haydel, Shelley E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85004 USA; [Haydel, Shelley E.] Arizona State Univ, Biodesign Inst Ctr Infect Dis & Vaccinol, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Haydel, SE (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85004 USA.	Shelley.Haydel@asu.edu		Haydel, Shelley/0000-0001-5542-5469	NIH National Center for Complementary and Alternative Medicine [AT004690]; Arizona Board of Regents Doctoral Research Grant; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004690] Funding Source: NIH RePORTER	NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Arizona Board of Regents Doctoral Research Grant; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by Public Health Service grant AT004690 awarded to SEH from the NIH National Center for Complementary and Alternative Medicine and an Arizona Board of Regents Doctoral Research Grant awarded to CCO. CCO was also partially supported by a graduate research fellowship from Science Foundation Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg E, 1996, INT J MINER PROCESS, V46, P73, DOI 10.1016/0301-7516(95)00058-5; ARIFOGLU M, 1992, TEXT RES J, V62, P94, DOI 10.1177/004051759206200206; AVERILLBATES DA, 1994, ARCH BIOCHEM BIOPHYS, V312, P52, DOI 10.1006/abbi.1994.1279; Berry ED, 2000, APPL ENVIRON MICROB, V66, P1493, DOI 10.1128/AEM.66.4.1493-1498.2000; Bird LJ, 2013, APPL ENVIRON MICROB, V79, P3619, DOI 10.1128/AEM.03944-12; Borda MJ, 2001, ASTROBIOLOGY, V1, P283, DOI 10.1089/15311070152757474; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cervantes-Cervantes MP, 2005, BIOL TRACE ELEM RES, V103, P229, DOI 10.1385/BTER:103:3:229; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5; Cunningham TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009456; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Harris D. C., 2010, QUANTITATIVE CHEM AN; Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jayasena T, 2007, NEUROSCI RES, V57, P454, DOI 10.1016/j.neures.2006.12.004; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lloyd DR, 1998, CHEM RES TOXICOL, V11, P420, DOI 10.1021/tx970156l; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; McCormick ML, 1998, J BACTERIOL, V180, P622, DOI 10.1128/JB.180.3.622-625.1998; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Otto CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064068; Otto CC, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-26; Pacheco CC, 2008, ARCH MICROBIOL, V189, P271, DOI 10.1007/s00203-007-0316-8; Popat SC, 2009, ENVIRON SCI TECHNOL, V43, P7856, DOI 10.1021/es901305x; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rowbury RJ, 1999, FEMS MICROBIOL LETT, V174, P49, DOI 10.1016/S0378-1097(99)00120-2; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Sandrin TR, 2002, ENVIRON TOXICOL CHEM, V21, P2075, DOI 10.1897/1551-5028(2002)021<2075:EOPOCT>2.0.CO;2; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Small PLC, 1998, TRENDS MICROBIOL, V6, P214, DOI 10.1016/S0966-842X(98)01285-2; STIM KP, 1993, J BACTERIOL, V175, P1221, DOI 10.1128/JB.175.5.1221-1234.1993; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Toyokuni S, 1997, LAB INVEST, V76, P365; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Waterman SR, 1998, APPL ENVIRON MICROB, V64, P3882; Williams LB, 2011, ENVIRON SCI TECHNOL, V45, P3768, DOI 10.1021/es1040688; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	63	16	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115172	10.1371/journal.pone.0115172	http://dx.doi.org/10.1371/journal.pone.0115172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502790	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700096
J	Sverdrup-Thygeson, A; Sogaard, G; Rusch, GM; Barton, DN				Sverdrup-Thygeson, Anne; Sogaard, Gunnhild; Rusch, Graciela M.; Barton, David N.			Spatial Overlap between Environmental Policy Instruments and Areas of High Conservation Value in Forest	PLOS ONE			English	Article							NORTHERN EUROPE; BIODIVERSITY; WOOD; RETENTION; INVENTORY	In order to safeguard biodiversity in forest we need to know how forest policy instruments work. Here we use a nationwide network of 9400 plots in productive forest to analyze to what extent large-scale policy instruments, individually and together, target forest of high conservation value in Norway. We studied both instruments working through direct regulation; Strict Protection and Landscape Protection, and instruments working through management planning and voluntary schemes of forest certification; Wilderness Area and Mountain Forest. As forest of high conservation value (HCV-forest) we considered the extent of 12 Biodiversity Habitats and the extent of Old-Age Forest. We found that 22% of productive forest area contained Biodiversity Habitats. More than 70% of this area was not covered by any large-scale instruments. Mountain Forest covered 23%, while Strict Protection and Wilderness both covered 5% of the Biodiversity Habitat area. A total of 9% of productive forest area contained Old-Age Forest, and the relative coverage of the four instruments was similar as for Biodiversity Habitats. For all instruments, except Landscape Protection, the targeted areas contained significantly higher proportions of HCV-forest than areas not targeted by these instruments. Areas targeted by Strict Protection had higher proportions of HCV-forest than areas targeted by other instruments, except for areas targeted by Wilderness Area which showed similar proportions of Biodiversity Habitats. There was a substantial amount of spatial overlap between the policy tools, but no incremental conservation effect of overlapping instruments in terms of contributing to higher percentages of targeted HCV-forest. Our results reveal that although the current policy mix has an above average representation of forest of high conservation value, the targeting efficiency in terms of area overlap is limited. There is a need to improve forest conservation and a potential to cover this need by better targeting high conservation value areas.	[Sverdrup-Thygeson, Anne] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Sverdrup-Thygeson, Anne; Barton, David N.] Norwegian Inst Nat Res NINA, Oslo, Norway; [Sogaard, Gunnhild] Norwegian Forest & Landscape Inst, As, Norway; [Rusch, Graciela M.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Norwegian University of Life Sciences; Norwegian Institute Nature Research; The Norwegian Forest & Landscape Institute; Norwegian Institute Nature Research	Sverdrup-Thygeson, A (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	anne.sverdrup-thygeson@nmbu.no	Sverdrup-Thygeson, Anne/I-2902-2017; Sverdrup-Thygeson, Anne/AAW-7779-2021	Sverdrup-Thygeson, Anne/0000-0002-3122-2250; Rusch, Graciela/0000-0003-3769-8345	European Union [244065]	European Union(European Commission)	The POLICYMIX project (http://policymix.nina.no) has received funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 244065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2012, ASSESSMENT EXISTING; Bollandsas OM, 2004, NULLOMRADER SKOGBRUK; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Directorate for Nature Management, 2010, NAT NORG 2010; Directorate for Nature Management, 1995, 61995 DN; Djupstrom LB, 2008, FOREST ECOL MANAG, V255, P3340, DOI 10.1016/j.foreco.2008.02.015; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fedrowitz K, 2014, J APPL ECOL, V51, P1669, DOI 10.1111/1365-2664.12289; Framstad E, 2010, 535 NINA; Gjerde I, 2010, NORWEGIAN FOREST HAB; Gjerde I, 2007, BIOL CONSERV, V137, P549, DOI 10.1016/j.biocon.2007.03.007; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Johansson T, 2013, FOREST ECOL MANAG, V303, P98, DOI 10.1016/j.foreco.2013.04.012; Kouki J, 2012, DIVERS DISTRIB, V18, P348, DOI 10.1111/j.1472-4642.2011.00839.x; Living Forests, 2007, LIV FOR STAND SUST F; Lovdata, 2006, 61995 DIR NAT MAN; Magnusson M, 2014, SCAND J FOREST RES, V29, P455, DOI 10.1080/02827581.2014.919353; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Nilsen J-EO, 2010, DATAGRUNNLAGET NATUR; Norwegian Agricultural Authority Directorate for Nature Management, 2010, SKOGS HENSYN INNGR N; Norwegian Environment Agency, 2014, M137 NORW ENV AG; R Core Team, 2021, R LANGUAGE ENV STAT; Rietbergen-McCracken J., 2007, HIGH CONSERVATION VA; Ring I, 2011, 22011 UFZ LEIPZ HELM; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Skjeggedal T, 2005, INNGREPSFRIE NATUROM; Sogaard G., 2012, EFFEKTER ULIKE MILJO; Storaunet KO, 2011, MENGDE UTVIKLING DOD; Sverdrup-Thygeson A, 2009, MILJOREGISTRERING SK; Sverdrup-Thygeson A, 2008, SCAND J FOREST RES, V23, P236, DOI 10.1080/02827580802158228; Sverdrup-Thygeson A, 2014, FOREST ECOL MANAG, V330, P8, DOI 10.1016/j.foreco.2014.06.036; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; The Office of the Auditor General of Norway, 2012, DOKUMENT, V3, P17; Timonen J, 2010, SCAND J FOREST RES, V25, P309, DOI 10.1080/02827581.2010.497160	37	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115001	10.1371/journal.pone.0115001	http://dx.doi.org/10.1371/journal.pone.0115001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502238	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000347146700080
J	Carrasco, A; Brown, TA; Lomber, SG				Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.			Spectral and Temporal Acoustic Features Modulate Response Irregularities within Primary Auditory Cortex Columns	PLOS ONE			English	Article							CAT PRIMARY; CEREBRAL-CORTEX; LAYER-III; FUNCTIONAL-ORGANIZATION; SOMATOSENSORY CORTICES; PROJECTION NEURONS; MACAQUE MONKEY; VISUAL-CORTEX; IN-VITRO; LAMINAR	Assemblies of vertically connected neurons in the cerebral cortex form information processing units (columns) that participate in the distribution and segregation of sensory signals. Despite well-accepted models of columnar architecture, functional mechanisms of inter-laminar communication remain poorly understood. Hence, the purpose of the present investigation was to examine the effects of sensory information features on columnar response properties. Using acute recording techniques, extracellular response activity was collected from the right hemisphere of eight mature cats (felis catus). Recordings were conducted with multichannel electrodes that permitted the simultaneous acquisition of neuronal activity within primary auditory cortex columns. Neuronal responses to simple (pure tones), complex (noise burst and frequency modulated sweeps), and ecologically relevant (con-specific vocalizations) acoustic signals were measured. Collectively, the present investigation demonstrates that despite consistencies in neuronal tuning (characteristic frequency), irregularities in discharge activity between neurons of individual A1 columns increase as a function of spectral (signal complexity) and temporal (duration) acoustic variations.	[Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Cerebral Syst Lab, London, ON, Canada; [Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lomber, SG (corresponding author), Univ Western Ontario, Cerebral Syst Lab, London, ON, Canada.	steve.lomber@uwo.ca	Carrasco, Andres/GVU-9039-2022; Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909; Carrasco, Andres/0000-0002-7217-8567	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Funding provided by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Anderson LA, 2009, BRAIN RES, V1252, P130, DOI 10.1016/j.brainres.2008.11.037; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Brodmann K, 1909, IHREN PRINZIPIEN DAR; BROWN KA, 1978, DEV PSYCHOBIOL, V11, P559, DOI 10.1002/dev.420110605; Carrasco A, 2011, J NEUROPHYSIOL, V106, P1166, DOI 10.1152/jn.00940.2010; Carrasco A, 2010, J NEUROSCI, V30, P1476, DOI 10.1523/JNEUROSCI.5708-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P8350, DOI 10.1523/JNEUROSCI.6001-08.2009; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; Christianson GB, 2011, J NEUROSCI, V31, P12837, DOI 10.1523/JNEUROSCI.2863-11.2011; CODE RA, 1985, J COMP NEUROL, V242, P485, DOI 10.1002/cne.902420404; DIAMOND IT, 1979, PROGR PSYCHOBIOLOGY, V8, P1; FAVOROV O, 1988, BRAIN RES REV, V13, P25, DOI 10.1016/0165-0173(88)90003-3; FAVOROV O, 1988, BRAIN RES REV, V13, P43, DOI 10.1016/0165-0173(88)90004-5; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P144, DOI 10.1152/jn.00807.2006; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Huetz C, 2011, HEARING RES, V271, P147, DOI 10.1016/j.heares.2010.01.010; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2008, J COMP NEUROL, V507, P1901, DOI 10.1002/cne.21614; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Mathers DA, 2007, NEUROPHARMACOLOGY, V52, P1160, DOI 10.1016/j.neuropharm.2006.12.004; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; MITANI A, 1985, J COMP NEUROL, V235, P430, DOI 10.1002/cne.902350403; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; OONISHI S, 1965, JPN J PHYSIOL, V15, P342; PHILLIPS DP, 1981, J NEUROPHYSIOL, V45, P48, DOI 10.1152/jn.1981.45.1.48; Prieto JJ, 1999, J COMP NEUROL, V404, P332, DOI 10.1002/(SICI)1096-9861(19990215)404:3<332::AID-CNE5>3.0.CO;2-R; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Reser DH, 2000, CEREB CORTEX, V10, P574, DOI 10.1093/cercor/10.6.574; ROMAND R, 1984, DEV PSYCHOBIOL, V17, P629, DOI 10.1002/dev.420170606; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; SCHWARK HD, 1992, EXP BRAIN RES, V91, P425; Shen JX, 1999, HEARING RES, V137, P174, DOI 10.1016/S0378-5955(99)00149-5; Sugimoto S, 1997, HEARING RES, V112, P175, DOI 10.1016/S0378-5955(97)00119-6; SZENTAGOTHAI J, 1975, BRAIN RES, V95, P475, DOI 10.1016/0006-8993(75)90122-5; Szymanski FD, 2011, J NEUROSCI, V31, P15787, DOI 10.1523/JNEUROSCI.1416-11.2011; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Essen D.C., 1985, P259; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00072; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Winer J.A., 1992, Springer Handbook of Auditory Research, V1, P222; WINER JA, 1984, J COMP NEUROL, V229, P476, DOI 10.1002/cne.902290404; WINER JA, 1984, J COMP NEUROL, V224, P535, DOI 10.1002/cne.902240405; WINER JA, 1984, J COMP NEUROL, V229, P512, DOI 10.1002/cne.902290406; WINER JA, 1985, J COMP NEUROL, V238, P10, DOI 10.1002/cne.902380103; Winer JA, 2001, J COMP NEUROL, V434, P379, DOI 10.1002/cne.1183; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	73	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114550	10.1371/journal.pone.0114550	http://dx.doi.org/10.1371/journal.pone.0114550			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494365	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400051
J	Liu, YJ; Zhang, WT; Yao, YZ; Ren, D				Liu, Yujia; Zhang, Weiting; Yao, Yunzhi; Ren, Dong			A New Fossil of Necrotauliidae (Insecta: Trichoptera) from the Jiulongshan Formation of China and Its Taxonomic Significance	PLOS ONE			English	Article							CADDISFLIES INSECTA; SOUTHERN ENGLAND; INNER-MONGOLIA; PHYLOGENY; EVOLUTION; LEPIDOPTERA; ORDER; AGE	Background: Acisarcuatus variradius gen. et sp. nov., an extinct new species representing a new genus, is described from the Middle Jurassic Jiulongshan Formation in Daohugou Village, Inner Mongolia, China. Methodology/Principal Findings: In this paper, we revised the diagnosis of Necrotauliidae Handlirsch, 1906. One new genus and species of Necrotauliidae is described. An analysis based on the fossil morphological characters clarified the taxonomic status of the new taxa. Conclusions/Significance: New fossil evidence supports the viewpoint that the family Necrotauliidae belongs to the Integripalpia.	[Liu, Yujia; Yao, Yunzhi; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China; [Zhang, Weiting] Shijiazhuang Univ Econ, Geosci Museum, Shijiazhuang 050031, Peoples R China	Capital Normal University; Hebei GEO University	Yao, YZ (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China.	yaoyz100@gmail.com			National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [31372242, 41272006, 31230065, 41402009]; Project of Outstanding Young Talents of Beijing Municipal Commission of Education [CITTCD201304163]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [131021]; General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China [KM201210028016]; Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project [KZ201310028033]; PhD Research Startup Foundation of Shijiazhuang University of Economics [BQ201319]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Outstanding Young Talents of Beijing Municipal Commission of Education; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China; Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project; PhD Research Startup Foundation of Shijiazhuang University of Economics	This research was funded by grants from the National Basic Research Program of China (973 Program) (No. 2012CB821900), The National Natural Science Foundation of China (Nos. 31372242, 41272006, 31230065, 41402009), the Project of Outstanding Young Talents of Beijing Municipal Commission of Education (No. CIT&TCD201304163), the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (No. 131021), the General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (No. KM201210028016), the Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project (grant KZ201310028033), and the PhD Research Startup Foundation of Shijiazhuang University of Economics (No. BQ201319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge Joerg, 2002, Nova Supplementa Entomologica, V15, P55; Ansorge Joerg, 2003, Acta Zoologica Cracoviensia, V46, P285; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gao Yan, 2012, Chinese Journal of Applied Entomology, V49, P543; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Grimaldi David, 2005, pi; Handlirsch A., 1906, HDB PALAONTOLOGEN ZO; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Hennig W., 1981, INSECT PHYLOGENY; Holzenthal RW, 2007, ZOOTAXA, P639; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Ivanov V.D., 2002, HIST INSECTS, P194; JARZEMBOWSKI E A, 1991, Proceedings of the Geologists' Association, V102, P93; Jarzembowski EA, 1995, CRETACEOUS RES, V16, P695, DOI 10.1006/cres.1995.1043; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; KUKALOVAPECK J, 1990, CAN J EARTH SCI, V27, P459, DOI 10.1139/e90-041; Lin Q.B., 1986, EARLY MESOZOIC FOSSI; Lin QB, 2006, PROG NAT SCI-MATER, V16, P309; Martynova OM, 1958, MAT K OSNOVAM PALEON, P69; Martynova OM, 1962, OSNOVY PALEONTOLOGII, V9, P294; Morse J.C., TRICHOPTERA WORLD CH; Morse JC, 1997, ANNU REV ENTOMOL, V42, P427, DOI 10.1146/annurev.ento.42.1.427; NOVOKSHONOV VG, 1992, ZOOL ZH, V71, P58; RIEK E. F., 1955, AUSTRALIAN JOUR ZOOL, V3, P654, DOI 10.1071/ZO9550654; ROSS HH, 1967, ANNU REV ENTOMOL, V12, P169, DOI 10.1146/annurev.en.12.010167.001125; SHIELDS O, 1988, J PALEONTOL, V62, P251, DOI 10.1017/S0022336000029899; SOHN JC, 2012, ZOOTAXA 0430, P1; Sukacheva I.D., 1982, Trudy Paleontologicheskogo Instituta, V197, P1; Sukacheva ID, 1985, T PALEONTOLOGICHESKO, P96; Sukatscheva I.D., 1976, Paleontological J, V10, P198; Sukatsheva I.D., 1968, YURSKIE NASEKOMYE KA, P175; SUKATSHEVA ID, 1980, ZH OBSHCH BIOL, V41, P457; Sukatsheva ID, 2001, CRETACEOUS RES, V22, P685, DOI 10.1006/cres.2001.0292; Tillyard RJ, 1926, P LINN SOC N S W, P265; Tillyard RJ., 1933, FOSSIL INSECTS, V3, P15; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Weaver III J.S., 1984, P 4 INT S TRICH, P413; Wiggins G. B., 1994, AQUATIC INSECTS CHIN, P260; WIGGINS GB, 1989, J N AM BENTHOL SOC, V8, P260, DOI 10.2307/1467330; WILLIAMS NE, 1988, PALAEOGEOGR PALAEOCL, V62, P493, DOI 10.1016/0031-0182(88)90069-7; Willmann R, 1989, ABH SENCKENB NAT, V544, P1; WOOTTON RJ, 1988, PALAEOGEOGR PALAEOCL, V62, P477, DOI 10.1016/0031-0182(88)90068-5	43	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114968	10.1371/journal.pone.0114968	http://dx.doi.org/10.1371/journal.pone.0114968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494387	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400086
J	Soares, SC; Lindstrom, B; Esteves, F; Ohman, A				Soares, Sandra C.; Lindstrom, Bjorn; Esteves, Francisco; Ohman, Arne			The Hidden Snake in the Grass: Superior Detection of Snakes in Challenging Attentional Conditions	PLOS ONE			English	Article							VISUAL-SEARCH; RAPID DETECTION; EVOLVED MODULE; HUMAN PULVINAR; FEAR; STIMULUS; EMOTION; LOAD; RECOGNITION; COMPETITION	Snakes have provided a serious threat to primates throughout evolution. Furthermore, bites by venomous snakes still cause significant morbidity and mortality in tropical regions of the world. According to the Snake Detection Theory (SDT Isbell, 2006; 2009), the vital need to detect camouflaged snakes provided strong evolutionary pressure to develop astute perceptual capacity in animals that were potential targets for snake attacks. We performed a series of behavioral tests that assessed snake detection under conditions that may have been critical for survival. We used spiders as the control stimulus because they are also a common object of phobias and rated negatively by the general population, thus commonly lumped together with snakes as "evolutionary fear-relevant''. Across four experiments (N=205) we demonstrate an advantage in snake detection, which was particularly obvious under visual conditions known to impede detection of a wide array of common stimuli, for example brief stimulus exposures, stimuli presentation in the visual periphery, and stimuli camouflaged in a cluttered environment. Our results demonstrate a striking independence of snake detection from ecological factors that impede the detection of other stimuli, which suggests that, consistent with the SDT, they reflect a specific biological adaptation. Nonetheless, the empirical tests we report are limited to only one aspect of this rich theory, which integrates findings across a wide array of scientific disciplines.	[Soares, Sandra C.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal; [Soares, Sandra C.] Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging & Life Sci, Coimbra, Portugal; [Soares, Sandra C.] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, P-4100 Oporto, Portugal; [Lindstrom, Bjorn; Ohman, Arne] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Esteves, Francisco] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Universidade de Aveiro; Universidade de Coimbra; Universidade do Porto; Karolinska Institutet; Mid-Sweden University	Soares, SC (corresponding author), Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal.	sandra.soares@ua.pt	Esteves, Francisco/I-1206-2012; Soares, Sandra C./K-5576-2013	Esteves, Francisco/0000-0002-5403-0091; Soares, Sandra C./0000-0002-0346-7840	Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education [SFRH/19513/2004, PTDC/PSI/73429/2006]; Operational Program of Science and Innovation; European Social Funding; Swedish Research Council; NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; U.S. National Institute of Mental [P50MH72850];  [421-2010-2117]	Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education; Operational Program of Science and Innovation; European Social Funding; Swedish Research Council(Swedish Research CouncilEuropean Commission); NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; U.S. National Institute of Mental; 	This study was supported by grants SFRH/19513/2004 (to SCS) and PTDC/PSI/73429/2006 (to SCS and FE), from the Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education (www.fct.pt), and co-financed by The Operational Program of Science and Innovation 2010 and the European Social Funding. The study also received financial support of AO from the Swedish Research Council; (Grant 421-2010-2117); The NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; and the U.S. National Institute of Mental (P50MH72850) to the Center for the Study of Emotion Attention at the University of Florida, Gainesville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAS S, 1969, COMPR PSYCHIAT, V10, P151, DOI 10.1016/0010-440X(69)90022-4; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Coss RG, 2000, BEHAVIOUR, V137, P315, DOI 10.1163/156853900502105; Cuthbert B. N, 2005, A6 U FLOR; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Fabre-Thorpe M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00243; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Forster S, 2008, VIS COGN, V16, P200, DOI 10.1080/13506280701465049; Fredrikson M, 1996, BEHAV RES THER, V34, P33, DOI 10.1016/0005-7967(95)00048-3; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; Greene H. W., 1997, SNAKES EVOLUTION MYS; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Headland TN, 2011, P NATL ACAD SCI USA, V108, pE1470, DOI 10.1073/pnas.1115116108; Isbell L.A., 2009, FRUIT TREE SERPENT; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Isbister GK, 2004, TOXICON, V43, P477, DOI 10.1016/j.toxicon.2004.02.002; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Leonard CJ, 2011, J VISION, V11, DOI 10.1167/11.13.11; Lim SL, 2008, NEUROPSYCHOLOGIA, V46, P1267, DOI 10.1016/j.neuropsychologia.2007.12.003; LoBue V, EMOTION; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; LoBue V, 2010, CURR DIR PSYCHOL SCI, V19, P375, DOI 10.1177/0963721410388801; LoBue V, 2011, VIS COGN, V19, P129, DOI 10.1080/13506285.2010.522216; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nyffeler M, 1999, J ARACHNOL, V27, P317; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 2008, HDB EMOTIONS, P709; Ohman A., 1985, THEORETICAL ISSUES B, V1, P123; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Ohman A, 2010, COGNITION EMOTION, V24, P1216, DOI 10.1080/02699930903166882; Ohman A, 2009, SCAND J PSYCHOL, V50, P543, DOI 10.1111/j.1467-9450.2009.00784.x; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rauschenberger R, 2006, J EXP PSYCHOL GEN, V135, P116, DOI 10.1037/0096-3445.135.1.116; Scharf I, 2006, AM NAT, V168, P350, DOI 10.1086/506921; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Soares SC, 2013, PSYCH J, V2, P11, DOI 10.1002/pchj.18; Soares SC, 2009, BEHAV RES THER, V47, P1032, DOI 10.1016/j.brat.2009.07.022; Soares SC, 2009, J ANXIETY DISORD, V23, P136, DOI 10.1016/j.janxdis.2008.05.002; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Van Strien JW, 2009, NEUROREPORT, V20, P445, DOI 10.1097/WNR.0b013e3283262e26; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016	65	54	55	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114724	10.1371/journal.pone.0114724	http://dx.doi.org/10.1371/journal.pone.0114724			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493937	gold, Green Published			2022-12-26	WOS:000346611400069
J	Alonso, AN; Perry, KJ; Regeimbal, JM; Regan, PM; Higgins, DE				Alonso, Almaris N.; Perry, Kyle J.; Regeimbal, James M.; Regan, Patrick M.; Higgins, Darren E.			Identification of Listeria monocytogenes Determinants Required for Biofilm Formation	PLOS ONE			English	Article							ALANYL-LIPOTEICHOIC ACID; MARINER-BASED TRANSPOSON; BACILLUS-SUBTILIS; VIRULENCE; MUTAGENESIS; EXPRESSION; HEMOLYSIN; SURFACES; SYSTEM; GROWTH	Listeria monocytogenes is a Gram-positive, food-borne pathogen of humans and animals. L. monocytogenes is considered to be a potential public health risk by the U.S. Food and Drug Administration (FDA), as this bacterium can easily contaminate ready-to-eat (RTE) foods and cause an invasive, life-threatening disease (listeriosis). Bacteria can adhere and grow on multiple surfaces and persist within biofilms in food processing plants, providing resistance to sanitizers and other antimicrobial agents. While whole genome sequencing has led to the identification of biofilm synthesis gene clusters in many bacterial species, bioinformatics has not identified the biofilm synthesis genes within the L. monocytogenes genome. To identify genes necessary for L. monocytogenes biofilm formation, we performed a transposon mutagenesis library screen using a recently constructed Himar1 mariner transposon. Approximately 10,000 transposon mutants within L. monocytogenes strain 10403S were screened for biofilm formation in 96-well polyvinyl chloride (PVC) microtiter plates with 70 Himar1 insertion mutants identified that produced significantly less biofilms. DNA sequencing of the transposon insertion sites within the isolated mutants revealed transposon insertions within 38 distinct genetic loci. The identification of mutants bearing insertions within several flagellar motility genes previously known to be required for the initial stages of biofilm formation validated the ability of the mutagenesis screen to identify L. monocytogenes biofilm-defective mutants. Two newly identified genetic loci, dltABCD and phoPR, were selected for deletion analysis and both Delta dltABCD and Delta phoPR bacterial strains displayed biofilm formation defects in the PVC microtiter plate assay, confirming these loci contribute to biofilm formation by L. monocytogenes.	[Alonso, Almaris N.; Perry, Kyle J.; Regeimbal, James M.; Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Alonso, Almaris N.; Regan, Patrick M.] US FDA, Winchester Engn & Analyt Ctr, Winchester, MA 01890 USA	Harvard University; Harvard Medical School; US Food & Drug Administration (FDA)	Alonso, AN (corresponding author), US FDA, Ctr Tobacco Prod, Off Sci, 10903 New Hampshire Ave,Bldg 32,Rm 5160, Silver Spring, MD 20993 USA.	Almaris.Alonso@fda.hhs.gov; dhiggins@hms.harvard.edu			United States Public Health Service Grant from the National Institutes of Health [AI53669]; FDA Office of Regulatory Affairs, Division of Field Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669] Funding Source: NIH RePORTER	United States Public Health Service Grant from the National Institutes of Health; FDA Office of Regulatory Affairs, Division of Field Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grant AI53669 from the National Institutes of Health (DEH) and has been funded in part by the FDA Office of Regulatory Affairs, Division of Field Science (ANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Alonso A.N., 2008, BIOFILMS, V5, P1, DOI [10.1017/S1479050508002238, DOI 10.1017/S1479050508002238]; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Blackman IC, 1996, J FOOD PROTECT, V59, P827, DOI 10.4315/0362-028X-59.8.827; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Chang YH, 2012, APPL MICROBIOL BIOT, V93, P2051, DOI 10.1007/s00253-011-3719-z; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Doyle M.P., 2013, FOOD MICROBIOLOGY FU; GAILLARD JL, 1986, INFECT IMMUN, V52, P50, DOI 10.1128/IAI.52.1.50-55.1986; Ghannoum M., 2004, MICROBIAL BIOFILMS; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Heilmann C., 2010, BACTERIAL SIGNALING, P7; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kocan M, 2006, J BACTERIOL, V188, P724, DOI 10.1128/JB.188.2.724-732.2006; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Ouyang Y, 2012, J BIOTECH RES, V4, P13; Perry KJ, 2013, J BACTERIOL, V195, P3331, DOI 10.1128/JB.00210-13; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Prouty AM, 2003, INFECT IMMUN, V71, P7154, DOI 10.1128/IAI.71.12.7154-7158.2003; Saar-Dover R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002891; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wassinger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070448; Wingender J., 1999, MICROBIAL EXTRACELLU; Young JM, 2012, ENVIRON MICROBIOL, V14, P594, DOI 10.1111/j.1462-2920.2011.02596.x; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09; Zhu XN, 2011, FOODBORNE PATHOG DIS, V8, P495, DOI 10.1089/fpd.2010.0697; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7	36	44	46	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113696	10.1371/journal.pone.0113696	http://dx.doi.org/10.1371/journal.pone.0113696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517120	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600008
J	Silveira, JW; Issy, AC; Castania, VA; Salmon, CEG; Nogueira-Barbosa, MH; Guimaraes, FS; Defino, HLA; Del Bel, E				Silveira, Joao W.; Issy, Ana Carolina; Castania, Vitor A.; Salmon, Carlos E. G.; Nogueira-Barbosa, Marcello H.; Guimaraes, Francisco S.; Defino, Helton L. A.; Del Bel, Elaine			Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration	PLOS ONE			English	Article							LOW-BACK-PAIN; MULTIPLE-SCLEROSIS; CONTROLLED-TRIAL; CONSTITUENT CANNABIDIOL; INFLAMMATORY CYTOKINES; PLANT CANNABINOIDS; ANTITUMOR-ACTIVITY; NEUROPATHIC PAIN; NUCLEUS PULPOSUS; NEEDLE PUNCTURE	Disc degeneration is a multifactorial process that involves hypoxia, inflammation, neoinnervation, accelerated catabolism, and reduction in water and glycosaminoglycan content. Cannabidiol is the main non-psychotropic component of the Cannabis sativa with protective and anti-inflammatory properties. However, possible therapeutic effects of cannabidiol on intervertebral disc degeneration have not been investigated yet. The present study investigated the effects of cannabidiol intradiscal injection in the coccygeal intervertebral disc degeneration induced by the needle puncture model using magnetic resonance imaging (MRI) and histological analyses. Disc injury was induced in the tail of male Wistar rats via a single needle puncture. The discs selected for injury were punctured percutaneously using a 21-gauge needle. MRI and histological evaluation were employed to assess the results. The effects of intradiscal injection of cannabidiol (30, 60 or 120 nmol) injected immediately after lesion were analyzed acutely (2 days) by MRI. The experimental group that received cannabidiol 120 nmol was resubmitted to MRI examination and then to histological analyses 15 days after lesion/cannabidiol injection. The needle puncture produced a significant disc injury detected both by MRI and histological analyses. Cannabidiol significantly attenuated the effects of disc injury induced by the needle puncture. Considering that cannabidiol presents an extremely safe profile and is currently being used clinically, these results suggest that this compound could be useful in the treatment of intervertebral disc degeneration.	[Silveira, Joao W.; Issy, Ana Carolina; Castania, Vitor A.; Del Bel, Elaine] Univ Sao Paulo, NAPNA, Sch Dent, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Dept Phys Philosophy, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Sch Sci, Ribeirao Preto, Brazil; [Nogueira-Barbosa, Marcello H.] Univ Sao Paulo, Sch Med, Div Radiol, Ribeirao Preto, Brazil; [Guimaraes, Francisco S.] Univ Sao Paulo, NAPNA, Sch Med, Dept Pharmacol, Ribeirao Preto, Brazil; [Defino, Helton L. A.] Univ Sao Paulo, Locomotor Apparat, Sch Med, Dept Biomech Med & Rehabil, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Del Bel, E (corresponding author), Univ Sao Paulo, NAPNA, Sch Dent, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, Brazil.	eadelbel@forp.usp.br	Guimaraes, Francisco Silveira/C-1059-2012; Issy, Ana Carolina/V-8077-2019; Del Bel, Elaine A/E-2308-2012; Del Bel, Elaine/ABH-1331-2020; Nogueira-Barbosa, Marcello H/D-7681-2012; Issy, Ana C/K-1878-2012; Salmon, Carlos Ernesto Garrido/C-6326-2012; Defino, Helton/O-1928-2013	Guimaraes, Francisco Silveira/0000-0003-4092-7778; Del Bel, Elaine A/0000-0002-4158-7376; Del Bel, Elaine/0000-0003-3483-8074; Nogueira-Barbosa, Marcello H/0000-0002-7436-5315; Salmon, Carlos Ernesto Garrido/0000-0003-1441-1524; Defino, Helton/0000-0003-4274-0130	CAPES/PNPD, Brazil	CAPES/PNPD, Brazil	This research was supported by CAPES/PNPD, Brazil. The equipment and drugs used in this work were acquired from FAPESP, CNPq, and CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2003, SPINE, V28, pS86, DOI 10.1097/00007632-200308011-00015; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Brady CM, 2004, MULT SCLER J, V10, P425, DOI 10.1191/1352458504ms1063oa; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Buttermann Glenn R, 2004, Spine J, V4, P495, DOI 10.1016/j.spinee.2004.03.024; CARLINI EA, 1981, J CLIN PHARMACOL, V21, pS417, DOI 10.1002/j.1552-4604.1981.tb02622.x; Carragee EJ, 2011, SPINE J, V11, P97, DOI 10.1016/j.spinee.2011.01.015; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Costa B, 2004, N-S ARCH PHARMACOL, V369, P294, DOI 10.1007/s00210-004-0871-3; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Durst R, 2007, AM J PHYSIOL-HEART C, V293, pH3602, DOI 10.1152/ajpheart.00098.2007; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Fouad AA, 2011, EUR J PHARMACOL, V670, P216, DOI 10.1016/j.ejphar.2011.08.048; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; Guimaraes FS, 2006, PSYCHOPHARMACOLOGY B, V100, P558; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9; Issy AC, 2013, BRAZ J MED BIOL RES, V46, P235, DOI 10.1590/1414-431X20122429; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Khot A, 2004, SPINE, V29, P833, DOI 10.1097/00007632-200404150-00002; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Kwiatkoski M, 2012, NEUROTOX RES, V21, P271, DOI 10.1007/s12640-011-9273-8; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Ludwinski FE, 2013, REGEN MED, V8, P75, DOI [10.2217/RME.12.108, 10.2217/rme.12.108]; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Mechoulam R, 2002, CHEM PHYS LIPIDS, V121, P35, DOI 10.1016/S0009-3084(02)00144-5; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Moreira FA, 2006, PROG NEURO-PSYCHOPH, V30, P1466, DOI 10.1016/j.pnpbp.2006.06.004; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P1368, DOI 10.1016/j.freeradbiomed.2011.02.021; Napimoga MH, 2009, INT IMMUNOPHARMACOL, V9, P216, DOI 10.1016/j.intimp.2008.11.010; Norcross JP, 2003, J ORTHOPAED RES, V21, P183, DOI 10.1016/S0736-0266(02)00098-0; PEARCE RH, 1991, J RHEUMATOL, V18, P42; Perez Matheus, 2013, Tropical Medicine & International Health, V18, P3424, DOI 10.1111/ejn.12341; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Rock EM, 2008, PSYCHOPHARMACOLOGY, V196, P389, DOI 10.1007/s00213-007-0970-1; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; SCHIEBLER ML, 1991, SPINE, V16, P635, DOI 10.1097/00007632-199106000-00007; SIMMONS JW, 1992, SPINE, V17, pS172, DOI 10.1097/00007632-199206001-00019; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Sun Z, 2013, MED HYPOTHESES, V81, P477, DOI 10.1016/j.mehy.2013.06.014; Sun Z, 2013, INT J CLIN EXP PATHO, V6, P1009; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Thompson JP, 1988, T ORTHOP RES SOC, V13, P1; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wei A, 2009, INT J BIOL SCI, V5, P388; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zhang YJ, 2008, AM J PHYS MED REHAB, V87, P694, DOI 10.1097/PHM.0b013e31817c1945; Zuardi AW, 2009, J PSYCHOPHARMACOL, V23, P979, DOI 10.1177/0269881108096519	62	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113161	10.1371/journal.pone.0113161	http://dx.doi.org/10.1371/journal.pone.0113161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517414	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600002
J	Lo, KL; Wang, LC; Chen, IJ; Liu, YC; Chung, MC; Lo, WS				Lo, Kuan-Lin; Wang, Long-Chi; Chen, I-Ju; Liu, Yu-Chen; Chung, Mei-Chu; Lo, Wan-Sheng			Transcriptional Consequence and Impaired Gametogenesis with High-Grade Aneuploidy in Arabidopsis thaliana	PLOS ONE			English	Article							GENE BALANCE HYPOTHESIS; TERTIARY TRISOMICS; CHROMOSOMAL INSTABILITY; PLANT-MITOCHONDRIA; TETRAD ANALYSIS; AURORA KINASES; CELL-DIVISION; DOWN-SYNDROME; COPY-NUMBER; T-DNA	Aneuploidy features a numerical chromosome variant that the number of chromosomes in the nucleus of a cell is not an exact multiple of the haploid number, which may have an impact on morphology and gene expression. Here we report a tertiary trisomy uncovered by characterizing a T-DNA insertion mutant (aur2-1/+) in the Arabidopsis (Arabidopsis thaliana) AURORA2 locus. Whole-genome analysis with DNA tiling arrays revealed a chromosomal translocation linked to the aur2-1 allele, which collectively accounted for a tertiary trisomy 2. Morphologic, cytogenetic and genetic analyses of aur2-1 progeny showed impaired male and female gametogenesis to various degrees and a tight association of the aur2-1 allele with the tertiary trisomy that was preferentially inherited. Transcriptome analysis showed overlapping and distinct gene expression profiles between primary and tertiary trisomy 2 plants, particularly genes involved in response to stress and various types of external and internal stimuli. Additionally, transcriptome and gene ontology analyses revealed an overrepresentation of nuclear-encoded organelle-related genes functionally involved in plastids, mitochondria and peroxisomes that were differentially expressed in at least three if not all Arabidopsis trisomics. These observations support a previous hypothesis that aneuploid cells have higher energy requirement to overcome the detrimental effects of an unbalanced genome. Moreover, our findings extend the knowledge of the complex nature of the T-DNA insertion event influencing plant genomic integrity by creating high-grade trisomy. Finally, gene expression profiling results provide useful information for future research to compare primary and tertiary trisomics for the effects of aneuploidy on plant cell physiology.	[Lo, Kuan-Lin; Chen, I-Ju; Liu, Yu-Chen; Chung, Mei-Chu; Lo, Wan-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Long-Chi] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University	Lo, WS (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	sunnylo@gate.sinica.edu.tw	liu, yuchen/GYQ-6286-2022		Ministry of Science and Technology (NSC) [101-2311-B-001-029-MY3]; Institute of Plant and Microbial Biology, Academia Sinica, Taiwan	Ministry of Science and Technology (NSC); Institute of Plant and Microbial Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This research was funded in part by grants from the Ministry of Science and Technology (NSC 101-2311-B-001-029-MY3) and Institute of Plant and Microbial Biology, Academia Sinica, Taiwan, to WSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla E. R, 2010, ARABIDOPSIS BOOK, V8, pe0127, DOI [DOI 10.1199/TAB.0127, 10.1199/tab.0127]; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2014, METHODS MOL BIOL, V1112, P25, DOI 10.1007/978-1-62703-773-0_2; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Braddock SR, 2000, AM J MED GENET, V92, P311, DOI 10.1002/1096-8628(20000619)92:5<311::AID-AJMG4>3.0.CO;2-7; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; Cataldo AM, 2003, J NEUROSCI, V23, P6788; CHAN CSM, 1993, GENETICS, V135, P677; Chang YC, 2009, J AM SOC HORTIC SCI, V134, P567, DOI 10.21273/JASHS.134.5.567; Chen YCS, 1996, DEVELOPMENT, V122, P3243; Chung MC, 2008, THEOR APPL GENET, V116, P745, DOI 10.1007/s00122-007-0705-z; Copenhaver GP, 2000, PLANT PHYSIOL, V124, P7, DOI 10.1104/pp.124.1.7; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eberhard S, 2002, PLANT J, V31, P149, DOI 10.1046/j.1365-313X.2002.01340.x; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KHUSH GS, 1967, CAN J GENET CYTOL, V9, P610, DOI 10.1139/g67-066; KOORNNEEF M, 1983, GENETICA, V61, P41, DOI 10.1007/BF00563230; Koornneef M, 2003, CHROMOSOME RES, V11, P183, DOI 10.1023/A:1022827624082; Kosterin OE, 2009, EUPHYTICA, V166, P109, DOI 10.1007/s10681-008-9843-x; KUMAR RS, 1985, CYTOLOGIA, V50, P433, DOI 10.1508/cytologia.50.433; LADIZINSKY G, 1990, EUPHYTICA, V51, P179; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; MATZKE MA, 1994, MOL GEN GENET, V245, P471, DOI 10.1007/BF00302260; Matzke MA, 2003, TRENDS GENET, V19, P253, DOI 10.1016/S0168-9525(03)00057-X; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; OHBA T, 1995, PLANT J, V7, P157, DOI 10.1046/j.1365-313X.1995.07010157.x; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Papp I, 1996, PLANT J, V10, P469, DOI 10.1046/j.1365-313X.1996.10030469.x; Park SK, 1998, DEVELOPMENT, V125, P3789; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; SEARS LMS, 1970, CAN J GENET CYTOL, V12, P217, DOI 10.1139/g70-032; Sheltzer JM, 2013, CANCER RES, V73, P6401, DOI 10.1158/0008-5472.CAN-13-0749; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Singh RJ., 1993, PLANT CYTOGENETICS; STANDRING LS, 1990, EUPHYTICA, V47, P71, DOI 10.1007/BF00040366; Storchova Z, 2012, ANEUPLOIDY HLTH DIS; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Van Damme D, 2011, PLANT CELL, V23, P4013, DOI 10.1105/tpc.111.089565; Vizir IY, 1999, J HERED, V90, P412, DOI 10.1093/jhered/90.3.412; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	70	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114617	10.1371/journal.pone.0114617	http://dx.doi.org/10.1371/journal.pone.0114617			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514186	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300017
J	Fu, JY; Han, BY; Xiao, Q				Fu, Jian-Yu; Han, Bao-Yu; Xiao, Qiang			Mitochondrial COI and 16sRNA Evidence for a Single Species Hypothesis of E-vitis, J-formosana and E-onukii in East Asia	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; LEAFHOPPER; CICADELLIDAE; PHYLOGENY; HEMIPTERA; TEA; ALEYRODIDAE; APHELINIDAE; HYMENOPTERA; EVOLUTION	Tea green leafhopper is one of the most damaging tea pests in main tea production regions of East Asia. For lack of recognized morphological characters, the dominant species of tea green leafhoppers in Mainland China, Taiwan and Japan have always been named as Empoasca vitis Gothe, Jacobiasca formosana Paoli and Empoasca onukii MATSUDA, respectively. Furthermore, nothing is known about the genetic relationships among them. In this study, we collected six populations from Mainland China, four populations from Japan and one population from Taiwan, and examined the genetic distances in the COI and 16sRNA regions of mtDNA among them. The results showed that the genetic distances based on single gene or the combined sequences among eleven leafhopper populations were 0.3-1.2%, which were all less than the species boundary of 2%. Moreover, there were at least two haplotypes shared by two distinct populations from different regions. The phylogenetic analysis based on single gene or combined sets also supported that tea green leafhoppers from Mainland China, Taiwan and Japan were closely related to each other, and there were at least two specimens from different regions clustered ahead of those from the same region. Therefore, we propose that the view of recognizing the dominant species of tea green leafhoppers in three adjacent tea production regions of East Asia as different species is unreliable or questionable and suggest that they are a single species.	[Fu, Jian-Yu; Xiao, Qiang] Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China; [Fu, Jian-Yu] Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China; [Han, Bao-Yu] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou 310018, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; China Jiliang University	Fu, JY (corresponding author), Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China.	mybatigoal@mail.tricaas.com; han-insect@263.net			National Natural Science Foundation of China [31470693, 31100503]; Zhejiang Province [2013C32086]; Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS [0032014014]; Natural Science Foundation of Zhejiang province, China [Y3080150]; Fundamental Research Funds of National Science and Technology [2013FY113200]; Key Innovation Team of Zhejiang Province [2011R09027-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province; Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS; Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds of National Science and Technology; Key Innovation Team of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (31470693, 31100503), the public technology application research of Zhejiang Province (2013C32086), the Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS, (0032014014), the Natural Science Foundation of Zhejiang province, China (Y3080150), the Fundamental Research Funds of National Science and Technology (2013FY113200), and the Key Innovation Team of Zhejiang Province (Grant No. 2011R09027-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Castalanelli MA, 2012, B ENTOMOL RES, V102, P17, DOI 10.1017/S0007485311000319; Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dietrich CH, 1997, MOL PHYLOGENET EVOL, V8, P139, DOI 10.1006/mpev.1997.0415; FANG QQ, 1993, MOL PHYLOGENET EVOL, V2, P119, DOI 10.1006/mpev.1993.1012; Fu JY, 2005, B SCI TECHNOL, V5, P550; Ge ZLZ (, 1988, J TEA BUSINESS, P15; Hazarika LK, 2009, ANNU REV ENTOMOL, V54, P267, DOI 10.1146/annurev.ento.53.103106.093359; Hicks AL, 1996, P ENTOMOL SOC WASH, V98, P145; Jin Miao, 2007, Acta Ecologica Sinica, V27, P3973, DOI 10.1016/S1872-2032(07)60083-3; Johnson DG, 2005, ANN ENTOMOL SOC AM, V98, P165, DOI 10.1603/0013-8746(2005)098[0165:POLSEE]2.0.CO;2; Li Le, 2013, Chinese Journal of Applied Entomology, V50, P675, DOI 10.7679/j.issn.2095-1353.2013.095; Lozier JD, 2009, B ENTOMOL RES, V99, P83, DOI 10.1017/S0007485308006147; Matsuda R., 1952, Oyo-Kontyu Tokyo, V8, P19; Mochizuki M., 1994, Bulletin of the National Research Institute of Vegetables, Ornamental Plants and Tea. Series B, P29; Monti MM, 2005, B ENTOMOL RES, V95, P401, DOI 10.1079/BER2005371; Mu D, 2012, INSECT SCI, V19, P229, DOI 10.1111/j.1744-7917.2011.01476.x; Oman P. W., 1990, Leafhoppers (Cicadellidae): A bibliography, generic check-list and index to the world literature 1956-1985.; Paoli G, 1932, MEMORIES ITALIA ENTO, P109; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith PT, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.41; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhang HH, 2004, TEA PESTS NONPOLLUTI, P3; Zhao DongXiang, 2000, Journal of Tea Science, V20, P101	31	23	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115259	10.1371/journal.pone.0115259	http://dx.doi.org/10.1371/journal.pone.0115259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506929	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100066
J	Gilbert, M; Koel, BF; Bestebroer, TM; Lewis, NS; Smith, DJ; Fouchier, RAM				Gilbert, Martin; Koel, Bjorn F.; Bestebroer, Theo M.; Lewis, Nicola S.; Smith, Derek J.; Fouchier, Ron A. M.			Serological Evidence for Non-Lethal Exposures of Mongolian Wild Birds to Highly Pathogenic Avian Influenza H5N1 Virus	PLOS ONE			English	Article							A VIRUSES; EXPERIMENTAL-INFECTION; MIGRATORY WATERFOWL; GENETIC EVOLUTION; NORTHERN EUROPE; ASIAN LINEAGE; HONG-KONG; ANTIBODIES; GEESE; DUCKS	Surveillance for highly pathogenic avian influenza viruses (HPAIV) in wild birds is logistically demanding due to the very low rates of virus detection. Serological approaches may be more cost effective as they require smaller sample sizes to identify exposed populations. We hypothesized that antigenic differences between classical Eurasian H5 subtype viruses (which have low pathogenicity in chickens) and H5N1 viruses of the Goose/Guangdong/96 H5 lineage (which are HPAIV) may be used to differentiate populations where HPAIVs have been circulating, from those where they have not. To test this we performed hemagglutination inhibition assays to compare the reactivity of serum samples from wild birds in Mongolia (where HPAIV has been circulating, n= 1,832)and Europe (where HPAIV has been rare or absent, n=497) to a panel of reference viruses including classical Eurasian H5 (of low pathogenicity), and five HPAIV H5N1 antigens of the Asian lineage A/Goose/Guangdong/1/96. Antibody titres were detected against at least one of the test antigens for 182 Mongolian serum samples (total seroprevalence of 0.10, n=1,832, 95% adjusted Wald confidence limits of 0.09-0.11) and 25 of the European sera tested (total seroprevalence of 0.05, n=497, 95% adjusted Wald confidence limits of 0.03-0.07). A bias in antibody titres to HPAIV antigens was found in the Mongolian sample set (22/182) that was absent in the European sera (0/25). Although the interpretation of serological data from wild birds is complicated by the possibility of exposure to multiple strains, and variability in the timing of exposure, these findings suggest that a proportion of the Mongolian population had survived exposure to HPAIV, and that serological assays may enhance the targeting of traditional HPAIV surveillance toward populations where isolation of HPAIV is more likely.	[Gilbert, Martin] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA; [Gilbert, Martin] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Koel, Bjorn F.; Bestebroer, Theo M.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Wildlife Conservation Society; University of Glasgow; Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Gilbert, M (corresponding author), Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA.	mgilbert@wcs.org	Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Gilbert, Martin/0000-0002-9930-4383	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH); Department of Health and Human Services [HHSN266200700007C, HHSN266200700010C]; Biotechnology and Biological Sciences Research Council [BB/F016786/1]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and the Department of Health and Human Services under contracts HHSN266200700007C and HHSN266200700010C. Further support was provided through a doctoral training grant to MG by the Biotechnology and Biological Sciences Research Council (BB/F016786/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Berhane Y, 2014, J WILDLIFE DIS, V50, P84, DOI 10.7589/2012-09-237; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; *BRIT TRUST ORN, 2012, MIGRATION MAPPING TO; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Daly JM, 1996, J GEN VIROL, V77, P661, DOI 10.1099/0022-1317-77-4-661; Dowdle W.A., 1979, DIAGNOSTIC PROCEDURE, V5th ed., P585; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *EMPR, 2012, H5N1 HPAI GLOBAL OVE, P1; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fransson T., 2010, EURING LIST LONGEVIT; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ishtiaq F, 2012, J WILDLIFE DIS, V48, P768, DOI 10.7589/0090-3558-48.3.768; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Kwon YK, 2010, VET PATHOL, V47, P495, DOI 10.1177/0300985809359602; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Nemeth NM, 2013, VET PATHOL, V50, P961, DOI 10.1177/0300985813490758; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; UNDERWOOD PA, 1982, J GEN VIROL, V62, P153, DOI 10.1099/0022-1317-62-1-153; Wallensten A, 2006, VACCINE, V24, P6734, DOI 10.1016/j.vaccine.2006.05.057; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; *WHO, 2011, UPDATED UNIFIED NOME	38	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e113569	10.1371/journal.pone.0113569	http://dx.doi.org/10.1371/journal.pone.0113569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502318	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000346607100006
J	Hill, CG; Jabbari, N; Matyunina, LV; McDonald, JF				Hill, Christopher G.; Jabbari, Neda; Matyunina, Lilya V.; McDonald, John F.			Functional and Evolutionary Significance of Human MicroRNA Seed Region Mutations	PLOS ONE			English	Article							EXPRESSION; SEQUENCE; TARGETS	MicroRNAs have emerged in recent years as important regulators of cell function in both normal and diseased cells. MiRNAs coordinately regulate large suites of target genes by mRNA degradation and/or translational inhibition. The mRNA target specificities of miRNAs in animals are primarily encoded within a 7 nt "seed region" mapping to positions 2-8 at the molecule's 5' end. We here combine computational analyses with experimental studies to explore the functional significance of sequence variation within the seed region of human miRNAs. The results indicate that a substitution of even a single nucleotide within the seed region changes the spectrum of mRNA targets by >50%. The high functional cost of even single nucleotide changes within seed regions is consistent with their high sequence conservation among miRNA families both within and between species and suggests processes that may underlie the evolution of miRNA regulatory control.	[McDonald, John F.] Georgia Inst Technol, Integrated Canc Res Ctr, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McDonald, JF (corresponding author), Georgia Inst Technol, Integrated Canc Res Ctr, Sch Biol, 315 Ferst Dr, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu		McDonald, John F/0000-0002-4263-8155; Jabbari, Neda/0000-0002-3252-0655	Ovarian Cancer Institute; Northside Hospital (Atlanta); Deborah Nash Endowment Fund; Josephine Robinson Family; J.D. Rhodes Trust	Ovarian Cancer Institute; Northside Hospital (Atlanta); Deborah Nash Endowment Fund; Josephine Robinson Family; J.D. Rhodes Trust	Funding for this project was provided by the Ovarian Cancer Institute, Northside Hospital (Atlanta), The Deborah Nash Endowment Fund, The Josephine Robinson Family, and The J.D. Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BUICK RN, 1985, CANCER RES, V45, P3668; Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hill CG, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-36; Jabbari N, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-12; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Nana-Sinkam SP, 2010, IDRUGS, V13, P843; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Shahab SW, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-33; Shahab SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022508; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	24	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115241	10.1371/journal.pone.0115241	http://dx.doi.org/10.1371/journal.pone.0115241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501359	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400086
J	Rizk, SM; El-Maraghy, SA; Nassar, NN				Rizk, Sherine M.; El-Maraghy, Shohda A.; Nassar, Noha N.			A Novel Role for SIRT-1 in L-Arginine Protection against STZ Induced Myocardial Fibrosis in Rats	PLOS ONE			English	Article							NF-KAPPA-B; TRANSFORMING GROWTH FACTOR-BETA(1); INSULIN-RESISTANCE; TNF-ALPHA; DIABETIC CARDIOMYOPATHY; CARDIAC FIBROBLASTS; COLLAGEN PRODUCTION; INDUCED APOPTOSIS; END-PRODUCTS; FAS LIGAND	Background: L-arginine (L-ARG) effectively protects against diabetic impediments. In addition, silent information regulator (SIRT-1) activators are emerging as a new clinical concept in treating diabetic complications. Accordingly, this study aimed at delineating a role for SIRT-1 in mediating L-ARG protection against streptozotocin (STZ) induced myocardial fibrosis. Methods: Male Wistar rats were allocated into five groups; (i) normal control rats received 0.1 M sodium citrate buffer (pH 4.5); (ii) STZ at the dose of 60 mg/kg dissolved in 0.1 M sodium citrate buffer (pH 4.5); (iii) STZ + sirtinol (Stnl; specific inhibitor of SIRT-1; 2 mg/Kg, i.p.); (iv) STZ + L-ARG given in drinking water (2.25%) or (v) STZ + L-ARG + Stnl. Results: L-ARG increased myocardial SIRT-1 expression as well as its protein content. The former finding was paralleled by L-ARG induced reduction in myocardial fibrotic area compared to STZ animals evidenced histopathologically. The reduction in the fibrotic area was accompanied by a decline in fibrotic markers as evident by a decrease in expression of collagen-1 along with reductions in myocardial TGF-beta, fibronectin, CTGF and BNP expression together with a decrease in TGF-beta and hydroxyproline contents. Moreover, L-ARG increased MMP-2 expression in addition to its protein content while decreasing expression of PAI-1. Finally, L-ARG protected against myocardial cellular death by reduction in NF kappa-B mRNA as well as TNF-alpha level in association with decline in Casp-3 and FAS expressions andCasp-3protein content in addition to reduction of FAS positive cells. However, co-administration of L-ARG and Stnl diminished the protective effect of L-ARG against STZ induced myocardial fibrosis. Conclusion: Collectively, these findings associate a role for SIRT-1 in L-ARG defense against diabetic cardiac fibrosis via equilibrating the balance between profibrotic and antifibrotic mediators.	[Rizk, Sherine M.; El-Maraghy, Shohda A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Nassar, Noha N.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Nassar, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	noha.nnassar@pharma.cu.edu.eg						Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006; BISSE E, 1985, J CHROMATOGR, V344, P81, DOI 10.1016/S0378-4347(00)82009-5; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Ortiz MD, 2013, NEUROCHEM RES, V38, P2570, DOI 10.1007/s11064-013-1172-3; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hutchinson KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072080; Huynh K, 2010, DIABETES, V59, P1512, DOI 10.2337/db09-1456; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; James LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070441; Jesmin S, 2005, MOL CELL BIOCHEM, V272, P63, DOI 10.1007/s11010-005-7635-3; Kain V, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-82; Kar Manoj, 1999, Indian Journal of Experimental Biology, V37, P190; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kiener PA, 1997, J IMMUNOL, V159, P1594; Kohda Y, 2008, J TOXICOL SCI, V33, P459, DOI 10.2131/jts.33.459; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225; Lijnen P, 2002, METHOD FIND EXP CLIN, V24, P333, DOI 10.1358/mf.2002.24.6.693065; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Liu CT, 2005, NUTRITION, V21, P615, DOI 10.1016/j.nut.2004.09.020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miguel-Carrasco JL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/726940; Luo L, 2013, J SURG RES, V179, pE255, DOI 10.1016/j.jss.2012.02.059; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Mendez JD, 2006, BIOMED PHARMACOTHER, V60, P26, DOI 10.1016/j.biopha.2005.08.004; Mohan IK, 1998, FREE RADICAL BIO MED, V25, P757, DOI 10.1016/S0891-5849(98)00129-4; Nagaya N, 2001, AM J RESP CRIT CARE, V163, P887, DOI 10.1164/ajrccm.163.4.2007116; Nelson DP, 2000, J CLIN INVEST, V105, P1199, DOI 10.1172/JCI8212; Pai MH, 2010, BRIT J NUTR, V104, P686, DOI 10.1017/S000711451000111X; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Perez Gutierrez RM, 2014, PHARM BIOL, P1; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Piatti P, 2001, DIABETES CARE, V24, P875, DOI 10.2337/diacare.24.5.875; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pulla VK, 2012, EXPERT OPIN THER TAR, V16, P819, DOI 10.1517/14728222.2012.703656; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sklavounou E, 2006, BIOCHEM BIOPH RES CO, V347, P420, DOI 10.1016/j.bbrc.2006.06.087; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Suboj P, 2012, EUR J PHARM SCI, V45, P581, DOI 10.1016/j.ejps.2011.12.012; Szulinska M, 2014, EUR REV MED PHARMACO, V18, P575; Takahashi T, 2007, INT HEART J, V48, P637, DOI 10.1536/ihj.48.637; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang WR, 2013, EXP CELL RES, V319, P1523, DOI 10.1016/j.yexcr.2013.04.007; Wang WR, 2013, APOPTOSIS, V18, P689, DOI 10.1007/s10495-013-0833-7; Way KJ, 2002, DIABETES, V51, P2709, DOI 10.2337/diabetes.51.9.2709; Westermann D, 2007, DIABETES, V56, P641, DOI 10.2337/db06-1163; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yang JH, 2011, ARCH MED RES, V42, P354, DOI 10.1016/j.arcmed.2011.07.005; Yang Y, 2013, FREE RADICAL BIO MED, V65, P667, DOI 10.1016/j.freeradbiomed.2013.07.007; Zagotta I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/793525; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140	68	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114560	10.1371/journal.pone.0114560	http://dx.doi.org/10.1371/journal.pone.0114560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501750	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400036
J	Eriksen, M; Lebreton, LCM; Carson, HS; Thiel, M; Moore, CJ; Borerro, JC; Galgani, F; Ryan, PG; Reisser, J				Eriksen, Marcus; Lebreton, Laurent C. M.; Carson, Henry S.; Thiel, Martin; Moore, Charles J.; Borerro, Jose C.; Galgani, Francois; Ryan, Peter G.; Reisser, Julia			Plastic Pollution in the World's Oceans: More than 5 Trillion Plastic Pieces Weighing over 250,000 Tons Afloat at Sea	PLOS ONE			English	Article							DENSITY POLYETHYLENE; MARINE DEBRIS; MICROPLASTICS; INGESTION; ACCUMULATION; TRANSPORT; CHEMICALS; ENVIRONMENT; BACTERIA; LIFE	Plastic pollution is ubiquitous throughout the marine environment, yet estimates of the global abundance and weight of floating plastics have lacked data, particularly from the Southern Hemisphere and remote regions. Here we report an estimate of the total number of plastic particles and their weight floating in the world's oceans from 24 expeditions (2007-2013) across all five sub-tropical gyres, costal Australia, Bay of Bengal and the Mediterranean Sea conducting surface net tows (N=680) and visual survey transects of large plastic debris (N=891). Using an oceanographic model of floating debris dispersal calibrated by our data, and correcting for wind-driven vertical mixing, we estimate a minimum of 5.25 trillion particles weighing 268,940 tons. When comparing between four size classes, two microplastic <4.75 mm and meso- and macroplastic >4.75 mm, a tremendous loss of microplastics is observed from the sea surface compared to expected rates of fragmentation, suggesting there are mechanisms at play that remove <4.75 mm plastic particles from the ocean surface.	[Eriksen, Marcus] Five Gyres Inst, Los Angeles, CA 90016 USA; [Lebreton, Laurent C. M.] Dumpk Data Sci, Wellington, New Zealand; [Carson, Henry S.] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA; [Carson, Henry S.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Thiel, Martin] Ctr Estudios Avanzados & Zonas Aridas, Coquimbo, Chile; [Moore, Charles J.] Algalita Marine Res & Educ, Long Beach, CA USA; [Borerro, Jose C.] eCoast Ltd, Raglan, New Zealand; [Galgani, Francois] IFREMER, Inst Francais Rech Exploitat Mer, Dept Oceanog & Dynam Ecosyst, Bastia, Corsica, France; [Ryan, Peter G.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7700 Rondebosch, South Africa; [Reisser, Julia] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Reisser, Julia] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia	University of Hawaii System; University Hawaii Hilo; Washington Department of Fish & Wildlife (WDFW); Universidad Catolica del Norte; Ifremer; University of Cape Town; University of Western Australia; University of Western Australia	Eriksen, M (corresponding author), Five Gyres Inst, Los Angeles, CA 90016 USA.	marcus@5gyres.org	galgani, francois/A-1973-2011; Reisser, Julia/K-2065-2013	galgani, francois/0000-0001-8770-6054; Reisser, Julia/0000-0002-1785-1042	Will J. Reid Foundation; Seaver Institute; IPRS; CSIRO's Flagship Postgraduate scholarship; Chilean Millennium Initiative [NC120030]	Will J. Reid Foundation; Seaver Institute; IPRS; CSIRO's Flagship Postgraduate scholarship; Chilean Millennium Initiative	Financial support from the Will J. Reid Foundation (HSC) and Seaver Institute (ME) made much of this work possible. J. Reisser is sponsored by an IPRS and a CSIRO's Flagship Postgraduate scholarship and M. Thiel was supported by the Chilean Millennium Initiative (grant NC120030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Barnes DKA, 2010, MAR ENVIRON RES, V70, P250, DOI 10.1016/j.marenvres.2010.05.006; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Black K.P., 1990, ACANTHASTER CORAL RE, P151, DOI [10.1007/978-3-642-46726-4_9, DOI 10.1007/978-3-642-46726-4_9]; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Goldstein M, 2013, PEERJ, V184, P2; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Hinojosa IA, 2009, MAR POLLUT BULL, V58, P341, DOI 10.1016/j.marpolbul.2008.10.020; Jantz LA, 2013, MAR POLLUT BULL, V69, P97, DOI 10.1016/j.marpolbul.2013.01.019; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lumpkin R, 2012, J ATMOS OCEAN TECH, V29, P300, DOI 10.1175/JTECH-D-11-00100.1; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Plastics Europe, 2013, PLAST FACTS 2013 AN; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Ryan PG, 2014, MAR POLLUT BULL, V79, P220, DOI 10.1016/j.marpolbul.2013.12.010; Ryan PG, 2013, MAR POLLUT BULL, V69, P128, DOI 10.1016/j.marpolbul.2013.01.016; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; SMITH SD, 1988, J GEOPHYS RES-OCEANS, V93, P15467, DOI 10.1029/JC093iC12p15467; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	42	2156	2252	122	2024	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111913	10.1371/journal.pone.0111913	http://dx.doi.org/10.1371/journal.pone.0111913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494041	Green Published, gold			2022-12-26	WOS:000346611400007
J	Guo, BB; Bellingham, SA; Hill, AF				Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.			The Neutral Sphingomyelinase Pathway Regulates Packaging of the Prion Protein into Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CELLS; APOPTOSIS; DISEASE; INFECTIVITY; ASSOCIATION; SECRETION; VESICLES; RELEASE; IDENTIFICATION	Prion diseases are a group of transmissible, fatal neurodegenerative disorders associated with the misfolding of the host-encoded prion protein, PrPC, into a disease-associated form, PrPSc. The transmissible prion agent is principally formed of PrPSc itself and is associated with extracellular vesicles known as exosomes. Exosomes are released from cells both in vitro and in vivo, and have been proposed as a mechanism by which prions spread intercellularly. The biogenesis of exosomes occurs within the endosomal system, through formation of intraluminal vesicles (ILVs), which are subsequently released from cells as exosomes. ILV formation is known to be regulated by the endosomal sorting complexes required for transport (ESCRT) machinery, although an alternative neutral sphingomyelinase (nSMase) pathway has been suggested to also regulate this process. Here, we investigate a role for the nSMase pathway in exosome biogenesis and packaging of PrP into these vesicles. Inhibition of the nSMase pathway using GW4869 revealed a role for the nSMase pathway in both exosome formation and PrP packaging. In agreement, targeted knockdown of nSMase1 and nSMase2 in mouse neurons using lentivirus-mediated RNAi also decreases exosome release, demonstrating the nSMase pathway regulates the biogenesis and release of exosomes. We also demonstrate that PrPC packaging is dependent on nSMase2, whereas the packaging of disease-associated PrPSc into exosomes occurs independently of nSMase2. These findings provide further insight into prion transmission and identify a pathway which directly assists exosome-mediated transmission of prions.	[Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Bellingham, SA (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	shayneb@unimelb.edu.au; a.hill@unimelb.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Guo, Belinda/0000-0003-2146-8561	Australian National Health and Medical Research Council (NHMRC) [628946, 1041413]; Australian Postgraduate Award; Faculty of Medicine, Dentistry and Health Sciences (MDHS); MDHS, The University of Melbourne; Australian Research Council [FT100100560]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Faculty of Medicine, Dentistry and Health Sciences (MDHS); MDHS, The University of Melbourne; Australian Research Council(Australian Research Council)	This study was funded by grants from the Australian National Health and Medical Research Council (NHMRC; Grants 628946 and 1041413). This work was also supported by an Australian Postgraduate Award and Faculty of Medicine, Dentistry and Health Sciences (MDHS) Top-Up Scholarship (to B. B. G.); a Bellberry Indigenous Health Fellowship (MDHS, The University of Melbourne) (to S. A. B.); an Australian Research Council (www.arc.gov.au) Future Fellowship (Grant FT100100560) (to A. F. H.). A. F. H is a shareholder of D-Gen Limited, which supplies an antibody used in the study.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Choi HS, 2014, BIOCHEM BIOPH RES CO, V448, P157, DOI 10.1016/j.bbrc.2014.04.069; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Garza-Licudine E, 2010, IEEE ENG MED BIO, P5736, DOI 10.1109/IEMBS.2010.5627861; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Mattei V, 2011, MOL BIOL CELL, V22, P4842, DOI 10.1091/mbc.E11-04-0348; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schatzl HM, 1997, J VIROL, V71, P8821; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	58	144	146	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3455	3467		10.1074/jbc.M114.605253	http://dx.doi.org/10.1074/jbc.M114.605253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505180	Green Published, hybrid			2022-12-26	WOS:000349456000021
J	Wong, SG; Grigg, JC; Le Brun, NE; Moore, GR; Murphy, MEP; Mauk, AG				Wong, Steve G.; Grigg, Jason C.; Le Brun, Nick E.; Moore, Geoffrey R.; Murphy, Michael E. P.; Mauk, A. Grant			The B-type Channel Is a Major Route for Iron Entry into the Ferroxidase Center and Central Cavity of Bacterioferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; CORE FORMATION; FERRITIN; BINDING; ELECTROSTATICS; MECHANISM; DIFFUSION; OXIDATION	Bacterioferritin is a bacterial iron storage and detoxification protein that is capable of forming a ferric oxyhydroxide mineral core within its central cavity. To do this, iron must traverse the bacterioferritin protein shell, which is expected to occur through one or more of the channels through the shell identified by structural studies. The size and negative electrostatic potential of the 24 B-type channels suggest that they could provide a route for iron into bacterioferritin. Residues at the B-type channel (Asn-34, Glu-66, Asp-132, and Asp-139) of E. coli bacterioferritin were substituted to determine if they are important for iron core formation. A significant decrease in the rates of initial oxidation of Fe(II) at the ferroxidase center and subsequent iron mineralization was observed for the D132F variant. The crystal structure of this variant shows that substitution of residue 132 with phenylalanine caused a steric blockage of the B-type channel and no other material structural perturbation. We conclude that the B-type channel is a major route for iron entry into both the ferroxidase center and the iron storage cavity of bacterioferritin.	[Wong, Steve G.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Grigg, Jason C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Le Brun, Nick E.; Moore, Geoffrey R.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of British Columbia; University of East Anglia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	grant.mauk@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Le Brun, Nick/0000-0001-9780-4061	Canadian Foundation for Innovation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NIGMS; BBSRC [BB/I021884/1, BB/D001943/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001943/1, BB/I021884/1] Funding Source: researchfish	Canadian Foundation for Innovation(Canada Foundation for Innovation); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The stopped-flow spectrometer and spectroscopic instrumentation were obtained with a grant from the Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken-Rogers H, 2004, J BIOL INORG CHEM, V9, P161, DOI 10.1007/s00775-003-0504-1; Antonyuk SV, 2011, BBA-PROTEINS PROTEOM, V1814, P778, DOI 10.1016/j.bbapap.2010.12.017; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; LEBRUN NE, 1993, FEBS LETT, V333, P197, DOI 10.1016/0014-5793(93)80404-I; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Lv CY, 2014, BIOCHEMISTRY-US, V53, P2232, DOI 10.1021/bi500066m; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE GR, 1994, BIOCHEM J, V304, P493, DOI 10.1042/bj3040493; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Wahlgren WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046992; Willies SC, 2009, J BIOL INORG CHEM, V14, P201, DOI 10.1007/s00775-008-0438-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SG, 2012, BIOCHEM J, V444, P553, DOI 10.1042/BJ20112200; Wong SG, 2009, J BIOL CHEM, V284, P18873, DOI 10.1074/jbc.M901747200; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119	41	17	17	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3732	3739		10.1074/jbc.M114.623082	http://dx.doi.org/10.1074/jbc.M114.623082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25512375	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000349456000044
J	Zhang, CB; Hwarng, G; Cooper, DE; Grevengoed, TJ; Eaton, JM; Natarajan, V; Harris, TE; Coleman, RA				Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E.; Grevengoed, Trisha J.; Eaton, James M.; Natarajan, Viswanathan; Harris, Thurl E.; Coleman, Rosalind A.			Inhibited Insulin Signaling in Mouse Hepatocytes Is Associated with Increased Phosphatidic Acid but Not Diacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; HEPATIC STEATOSIS; DEPENDENT ACTIVATION; PHOSPHOLIPASE D1; MTOR COMPLEX; RESISTANCE; ACYLTRANSFERASE; CELLS; MICE	Although an elevated triacylglycerol content in non-adipose tissues is often associated with insulin resistance, the mechanistic relationship remains unclear. The data support roles for intermediates in the glycerol-3-phosphate pathway of triacylglycerol synthesis: diacylglycerol (DAG), which may cause insulin resistance in liver by activating PKC epsilon, and phosphatidic acid (PA), which inhibits insulin action in hepatocytes by disrupting the assembly of mTOR and rictor. To determine whether increases in DAG and PA impair insulin signaling when produced by pathways other than that of de novo synthesis, we examined primary mouse hepatocytes after enzymatically manipulating the cellular content of DAG or PA. Overexpressing phospholipase D1 or phospholipase D2 inhibited insulin signaling and was accompanied by an elevated cellular content of total PA, without a change in total DAG. Overexpression of diacylglycerol kinase-theta inhibited insulin signaling and was accompanied by an elevated cellular content of total PA and a decreased cellular content of total DAG. Overexpressing glycerol-3-phosphate acyltransferase-1 or -4 inhibited insulin signaling and increased the cellular content of both PA and DAG. Insulin signaling impairment caused by overexpression of phospholipase D1/D2 or diacylglycerol kinase-theta was always accompanied by disassociation of mTOR/rictor and reduction of mTORC2 kinase activity. However, although the protein ratio of membrane to cytosolic PKC epsilon increased, PKC activity itself was unaltered. These data suggest that PA, but not DAG, is associated with impaired insulin action in mouse hepatocytes.	[Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E.; Grevengoed, Trisha J.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Eaton, James M.; Harris, Thurl E.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, 2301 MHRC,Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021	Grevengoed, Trisha/0000-0003-4433-3950	National Institutes of Health [DK56598, P01 HL98050]; American Diabetes Association [7-11-JF-21]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056598, R01DK101946, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK56598 (to R. A. C.) and P01 HL98050 (to V. N.) and American Diabetes Association Grant 7-11-JF-21 (to T. E. H.).	Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; DONNELLY R, 1995, ENDOCRINE, V3, P129, DOI 10.1007/BF02990064; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Epand RM, 2007, METHOD ENZYMOL, V434, P293, DOI 10.1016/S0076-6879(07)34016-0; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Goto K, 2008, TOHOKU J EXP MED, V214, P199, DOI 10.1620/tjem.214.199; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu BA, 2010, J LIPID RES, V51, P3207, DOI 10.1194/jlr.M007054; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Monetti M, 2011, P NATL ACAD SCI USA, V108, pE523, DOI 10.1073/pnas.1108505108; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Qu XQ, 1999, CLIN SCI, V97, P355, DOI 10.1042/cs0970355; RANDO RR, 1984, BIOCHEM BIOPH RES CO, V122, P818, DOI 10.1016/S0006-291X(84)80107-2; Rector RS, 2013, HEPATOLOGY, V57, P2213, DOI 10.1002/hep.26285; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; WALSH JP, 1992, METHOD ENZYMOL, V209, P153; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang CB, 2014, AM J PHYSIOL-ENDOC M, V307, pE305, DOI 10.1152/ajpendo.00034.2014; Zhang CB, 2013, CLIN LIPIDOL, V8, P659, DOI 10.2217/clp.13.67; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	50	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3519	3528		10.1074/jbc.M114.602789	http://dx.doi.org/10.1074/jbc.M114.602789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25512376	hybrid, Green Published			2022-12-26	WOS:000349456000026
J	Miyamoto, J; Mizukure, T; Park, SB; Kishino, S; Kimura, I; Hirano, K; Bergamo, P; Rossi, M; Suzuki, T; Arita, M; Ogawa, J; Tanabe, S				Miyamoto, Junki; Mizukure, Taichi; Park, Si-Bum; Kishino, Shigenobu; Kimura, Ikuo; Hirano, Kanako; Bergamo, Paolo; Rossi, Mauro; Suzuki, Takuya; Arita, Makoto; Ogawa, Jun; Tanabe, Soichi			A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Epithelial Cell; Microbiome; Tight Junction; Tumor Necrosis Factor (TNF); Caco-2; G Protein-coupled Receptor; Linoleic Acid; Metabolite	INFLAMMATORY-BOWEL-DISEASE; PROTEIN-COUPLED RECEPTOR; TIGHT JUNCTION BARRIER; PANCREATIC BETA-CELLS; NECROSIS-FACTOR-ALPHA; CHAIN FATTY-ACIDS; INSULIN-SECRETION; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; INDUCED COLITIS	Background: The physiological activity of gut microbial metabolites has recently attracted much attention. Results: A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid (HYA), ameliorates intestinal epithelial barrier impairments by regulating TNFR2 expression via the GPR40-MEK-ERK pathway. Conclusion: HYA-induced GPR40 signaling contributes to the intestinal homeostasis. Significance: Our findings indicate a novel function of GPR40 in the inflamed intestine. Gut microbial metabolites of polyunsaturated fatty acids have attracted much attention because of their various physiological properties. Dysfunction of tight junction (TJ) in the intestine contributes to the pathogenesis of many disorders such as inflammatory bowel disease. We evaluated the effects of five novel gut microbial metabolites on tumor necrosis factor (TNF)--induced barrier impairment in Caco-2 cells and dextran sulfate sodium-induced colitis in mice. 10-Hydroxy-cis-12-octadecenoic acid (HYA), a gut microbial metabolite of linoleic acid, suppressed TNF- and dextran sulfate sodium-induced changes in the expression of TJ-related molecules, occludin, zonula occludens-1, and myosin light chain kinase. HYA also suppressed the expression of TNF receptor 2 (TNFR2) mRNA and protein expression in Caco-2 cells and colonic tissue. In addition, HYA suppressed the protein expression of TNFR2 in murine intestinal epithelial cells. Furthermore, HYA significantly up-regulated G protein-coupled receptor (GPR) 40 expression in Caco-2 cells. It also induced [Ca2+](i) responses in HEK293 cells expressing human GPR40 with higher sensitivity than linoleic acid, its metabolic precursor. The barrier-recovering effects of HYA were abrogated by a GPR40 antagonist and MEK inhibitor in Caco-2 cells. Conversely, 10-hydroxyoctadacanoic acid, which is a gut microbial metabolite of oleic acid and lacks a carbon-carbon double bond at 12 position, did not show these TJ-restoring activities and down-regulated GPR40 expression. Therefore, HYA modulates TNFR2 expression, at least partially, via the GPR40-MEK-ERK pathway and may be useful in the treatment of TJ-related disorders such as inflammatory bowel disease.	[Miyamoto, Junki; Mizukure, Taichi; Suzuki, Takuya; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Park, Si-Bum; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Kimura, Ikuo; Hirano, Kanako] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo 1838509, Japan; [Bergamo, Paolo; Rossi, Mauro] CNR, Inst Food Sci, I-83100 Avellino, Italy; [Arita, Makoto] RIKEN, Lab Metabol, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Hiroshima University; Kyoto University; Kyoto University; Tokyo University of Agriculture & Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); RIKEN	Ogawa, J (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	ogawa@kais.kyoto-u.ac.jp; stanabe@hiroshima-u.ac.jp	Suzuki, Takuya/H-3750-2019; Tanabe, Soichi/R-6229-2019; 宮本, 潤基/ABG-8169-2020; Rossi, Mauro/AAC-2968-2021; Kimura, Ikuo/B-4193-2015; Rossi, Mauro/B-5930-2012; Bergamo, Paolo/F-7835-2013; Rossi, Mauro/R-1715-2019	Suzuki, Takuya/0000-0003-3709-543X; Rossi, Mauro/0000-0001-8631-1683; Bergamo, Paolo/0000-0002-1726-7911; Kishino, Shigenobu/0000-0002-4587-2422; Rossi, Mauro/0000-0002-0252-4321; Arita, Makoto/0000-0001-9902-0463	Japanese Ministry of Education, Science, Sports and Culture [KAKENHI 22380076, 25292074]; Bio-Oriented Technology Research Advancement Institution of Japan; NEDO Innovation Commercialization Venture Support Project; Agreement of Scientific Cooperation [CNR-JSPS 2010-11]; Grants-in-Aid for Scientific Research [14J06559] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; NEDO Innovation Commercialization Venture Support Project; Agreement of Scientific Cooperation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japanese Ministry of Education, Science, Sports and Culture Grants-in-aid KAKENHI 22380076 and 25292074 (to S. T.), the Bio-Oriented Technology Research Advancement Institution of Japan (to J. O.), NEDO Innovation Commercialization Venture Support Project (to collaboration of NITTO PHARMA and J. O.) and by Agreement of Scientific Cooperation Grant CNR-JSPS 2010-11 (to S. T. and M. R.).	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baker OJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1191, DOI 10.1152/ajpcell.00144.2008; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Cao ZX, 2013, GASTROENTEROLOGY, V144, P808, DOI 10.1053/j.gastro.2012.12.028; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; Del Guerra S, 2010, NUTR METAB CARDIOVAS, V20, P22, DOI 10.1016/j.numecd.2009.02.008; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Fukui A, 2012, AM J PHYSIOL-GASTR L, V303, pG927, DOI 10.1152/ajpgi.00236.2012; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hossain Z, 2008, MOL BIOSYST, V4, P1181, DOI 10.1039/b800402a; Inoue D, 2012, FEBS LETT, V586, P1547, DOI 10.1016/j.febslet.2012.04.021; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Martinasso G, 2010, CANCER LETT, V287, P62, DOI 10.1016/j.canlet.2009.05.036; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Miyauchi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079735; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Petit CSV, 2012, GASTROENTEROLOGY, V143, P122, DOI 10.1053/j.gastro.2012.03.029; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Srinivas SP, 2004, EXP EYE RES, V79, P543, DOI 10.1016/j.exer.2004.06.027; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tanabe S, 2013, INT REV IMMUNOL, V32, P511, DOI 10.3109/08830185.2013.839665; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052924; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263; Zenhom M, 2011, IMMUNOBIOLOGY, V216, P715, DOI 10.1016/j.imbio.2010.10.008	63	133	135	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2902	2918		10.1074/jbc.M114.610733	http://dx.doi.org/10.1074/jbc.M114.610733			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505251	Green Published, hybrid			2022-12-26	WOS:000349310700030
J	Heurich, M; Hilger, A; Kuchenhoff, H; Andren, H; Bufka, L; Krofel, M; Mattisson, J; Odden, J; Persson, J; Rauset, GR; Schmidt, K; Linnell, JDC				Heurich, Marco; Hilger, Anton; Kuechenhoff, Helmut; Andren, Henrik; Bufka, Ludek; Krofel, Miha; Mattisson, Jenny; Odden, John; Persson, Jens; Rauset, Geir R.; Schmidt, Krzysztof; Linnell, John D. C.			Activity Patterns of Eurasian Lynx Are Modulated by Light Regime and Individual Traits over a Wide Latitudinal Range	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; DEER CAPREOLUS-CAPREOLUS; ROE DEER; NATIONAL-PARK; HOME-RANGE; RED DEER; CIRCADIAN ACTIVITY; MOVEMENT PATTERNS; TROPHIC CASCADE; BEHAVIOR	The activity patterns of most terrestrial animals are regarded as being primarily influenced by light, although other factors, such as sexual cycle and climatic conditions, can modify the underlying patterns. However, most activity studies have been limited to a single study area, which in turn limit the variability of light conditions and other factors. Here we considered a range of variables that might potentially influence the activity of a large carnivore, the Eurasian lynx, in a network of studies conducted with identical methodology in different areas spanning latitudes from 49 degrees 7'N in central Europe to 70 degrees 00'N in northern Scandinavia. The variables considered both light conditions, ranging from a day with a complete day-night cycle to polar night and polar day, as well as individual traits of the animals. We analysed activity data of 38 individual free-ranging lynx equipped with GPS-collars with acceleration sensors, covering more than 11,000 lynx days. Mixed linear additive models revealed that the lynx activity level was not influenced by the daily daylight duration and the activity pattern was bimodal, even during polar night and polar day. The duration of the active phase of the activity cycle varied with the widening and narrowing of the photoperiod. Activity varied significantly with moonlight. Among adults, males were more active than females, and subadult lynx were more active than adults. In polar regions, the amplitude of the lynx daily activity pattern was low, likely as a result of the polycyclic activity pattern of their main prey, reindeer. At lower latitudes, the basic lynx activity pattern peaked during twilight, corresponding to the crepuscular activity pattern of the main prey, roe deer. Our results indicated that the basic activity of lynx is independent of light conditions, but is modified by both individual traits and the activity pattern of the locally most important prey.	[Heurich, Marco] Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Chair Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Hilger, Anton; Kuechenhoff, Helmut] Univ Munich, Stat Consulting Unit, Dept Stat, Munich, Germany; [Andren, Henrik; Persson, Jens; Rauset, Geir R.] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Kasperske Hory, Czech Republic; [Krofel, Miha] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Mattisson, Jenny; Odden, John; Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Freiburg; University of Munich; Swedish University of Agricultural Sciences; University of Ljubljana; Norwegian Institute Nature Research; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany.	marco.heurich@npv-bw.bayern.de	Schmidt, Krzysztof/L-6437-2013; Krofel, Miha/I-4495-2019; Andrén, Henrik/C-8995-2015; Linnell, John/V-4177-2019; Rauset, Geir Rune/F-8961-2016; Rauset, Geir Rune/AAF-5435-2021; Odden, John/F-6088-2019; Mattisson, Jenny/X-4750-2019; Heurich, Marco/O-4653-2014	Krofel, Miha/0000-0002-2010-5219; Linnell, John/0000-0002-8370-5633; Rauset, Geir Rune/0000-0002-6345-3029; Rauset, Geir Rune/0000-0002-6345-3029; Odden, John/0000-0002-6275-8648; Mattisson, Jenny/0000-0001-6032-5307; Heurich, Marco/0000-0003-0051-2930; Persson, Jens/0000-0003-1405-7561; Kuchenhoff, Helmut/0000-0002-6372-2487; Andren, Henrik/0000-0002-5616-2426; Schmidt, Krzysztof/0000-0002-9043-291X	EU; Bavarian Forest National Park Administration; Swedish Environmental Protection Agency; Norwegian Environmental agency; Research Council of Norway; Nature Protection Divisions of the County Governor's Offices in Finnmark; Troms; Buskerud; Oppland; Telemark; Vestfold (Norway); Reindeer Development Fund in Norway; Carnivore Management Boards in regions 2, 3 and 8 (Norway); World Wide Fund for Nature (Sweden); Swedish Research Council; private foundation Marie-Claire Cronstedts Stiftelse	EU(European Commission); Bavarian Forest National Park Administration; Swedish Environmental Protection Agency; Norwegian Environmental agency; Research Council of Norway(Research Council of Norway); Nature Protection Divisions of the County Governor's Offices in Finnmark; Troms; Buskerud; Oppland; Telemark; Vestfold (Norway); Reindeer Development Fund in Norway; Carnivore Management Boards in regions 2, 3 and 8 (Norway); World Wide Fund for Nature (Sweden); Swedish Research Council(Swedish Research CouncilEuropean Commission); private foundation Marie-Claire Cronstedts Stiftelse	Financial support was provided by the EU program Interreg IV (Ziel 3), the Bavarian Forest National Park Administration, the Swedish Environmental Protection Agency, the Norwegian Environmental agency, the Research Council of Norway, the Nature Protection Divisions of the County Governor's Offices in Finnmark, Troms, Buskerud, Oppland, Telemark and Vestfold (Norway), the Reindeer Development Fund in Norway, the Carnivore Management Boards in regions 2, 3 and 8 (Norway), the World Wide Fund for Nature (Sweden), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) and the private foundation Marie-Claire Cronstedts Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale SB, 2009, ISR J ECOL EVOL, V55, P315, DOI 10.1560/IJEE.55.4.315; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; Arnemo JM, 2011, BIOMEDICAL PROTOCOL; ASCHOFF J, 1954, NATURWISSENSCHAFTEN, V41, P49, DOI 10.1007/BF00634164; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beltran J, 1988, THESIS U SEVILLE; BELTRAN JF, 1994, J MAMMAL, V75, P382, DOI 10.2307/1382557; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOWDEN J, 1973, B ENTOMOL RES, V63, P129, DOI 10.1017/S0007485300050938; Breitenmoser U., 2008, LUCHS GROSSRAUBTIER; Broekhuis F, 2014, BEHAV ECOL, V25, P1268, DOI 10.1093/beheco/aru122; CEDERLUND G, 1989, HOLARCTIC ECOL, V12, P39; Curio E., 1976, ETHOLOGY PREDATION; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Gerkema MP, 2013, P ROYAL SOC B, V280; Guillet C, 1996, WILDLIFE BIOL, V2, P107, DOI 10.2981/wlb.1996.039; Harmsen BJ, 2011, MAMM BIOL, V76, P320, DOI 10.1016/j.mambio.2010.08.007; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Jedrzejewski W, 2002, ANN ZOOL FENN, V39, P29; Kamler JF, 2007, J MAMMAL, V88, P508, DOI 10.1644/06-MAMM-A-169R.1; KITCHENER A., 1991, NATURAL HIST WILD CA; Kolbe JA, 2007, J WILDLIFE MANAGE, V71, P1607, DOI 10.2193/2005-727; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Krofel M, 2013, ECOL RES, V28, P103, DOI 10.1007/s11284-012-1005-x; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Krop-Benesch A, 2011, ACTIVITY PATTERN USE, P139; Krop-Benesch A, 2012, ITALIAN J ZOOLOGY, V80, P1; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Loe LE, 2007, OECOLOGIA, V152, P617, DOI 10.1007/s00442-007-0681-7; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; Lu WQ, 2010, CURR BIOL, V20, P533, DOI 10.1016/j.cub.2010.01.042; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; Manfredi C, 2011, MAMM BIOL, V76, P313, DOI 10.1016/j.mambio.2011.01.009; Mattisson J, 2011, BIOL CONSERVATION; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; Pagon N, 2013, CHRONOBIOL INT, P1; PALOMARES F, 1988, J MAMMAL, V69, P635, DOI 10.2307/1381362; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; R Core Team, 2021, R LANGUAGE ENV STAT; Ray RR, 2014, ANIM BIODIV CONSERV, V37, P77; Reinhardt I, 1999, Z SAUGETIERKD, V64, P65; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schaller GB, 1972, WILDLIFE BEHAV ECOLO; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; Schmidt K, 1999, J ZOOL, V249, P417, DOI 10.1017/S0952836999009851; Schmidt K, 2008, ACTA THERIOL, V53, P1, DOI 10.1007/BF03194274; Sunquist ME, 2002, WILD CATS WORLD; Theuerkauf J, 2003, J MAMMAL, V84, P243, DOI 10.1644/1545-1542(2003)084<0243:DPADOW>2.0.CO;2; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Vogt K, 2014, BEHAV PROCESS, V106, P98, DOI 10.1016/j.beproc.2014.04.017; Wilson DE., 2015, HDB MAMMALS WORLD; Wolfl M, 1996, ACTA THERIOL, V41, P443; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zimmermann F, 2007, ORYX, V41, P358, DOI 10.1017/S0030605307000712	75	51	51	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114143	10.1371/journal.pone.0114143	http://dx.doi.org/10.1371/journal.pone.0114143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517902	gold, Green Accepted, Green Published			2022-12-26	WOS:000347215600012
J	Kuhn, S; Brick, TR; Muller, BCN; Gallinat, J				Kuehn, Simone; Brick, Timothy R.; Mueller, Barbara C. N.; Gallinat, Juergen			Is This Car Looking at You? How Anthropomorphism Predicts Fusiform Face Area Activation when Seeing Cars	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; PERCEPTION; EXPERTISE	Anthropomorphism encompasses the attribution of human characteristics to non-living objects. In particular the human tendency to see faces in cars has long been noticed, yet its neural correlates are unknown. We set out to investigate whether the fusiform face area (FFA) is associated with seeing human features in car fronts, or whether, the higher-level theory of mind network (ToM), namely temporoparietal junction (TPJ) and medial prefrontal cortex (MPFC) show a link to anthropomorphism. Twenty participants underwent fMRI scanning during a passive car-front viewing task. We extracted brain activity from FFA, TPJ and MPFC. After the fMRI session participants were asked to spontaneously list adjectives that characterize each car front. Five raters judged the degree to which each adjective can be applied as a characteristic of human beings. By means of linear mixed models we found that the implicit tendency to anthropomorphize individual car fronts predicts FFA, but not TPJ or MPFC activity. The results point to an important role of FFA in the phenomenon of ascribing human attributes to non-living objects. Interestingly, brain regions that have been associated with thinking about beliefs and mental states of others (TPJ, MPFC) do not seem to be related to anthropomorphism of car fronts.	[Kuehn, Simone; Brick, Timothy R.] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Mueller, Barbara C. N.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6500 HE Nijmegen, Netherlands; [Mueller, Barbara C. N.] Univ Munich, Dept Psychol, D-80802 Munich, Germany; [Gallinat, Juergen] Charite, Clin Psychiat & Psychotherapy, D-10115 Berlin, Germany; [Gallinat, Juergen] Univ Clin Hamburg Eppendorf, Clin & Policlin Psychiat & Psychotherapy, D-20246 Hamburg, Germany	Max Planck Society; Radboud University Nijmegen; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kuhn, S (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Lentzeallee 94, D-14195 Berlin, Germany.	kuehn@mpib-berlin.mpg.de	, Barbara/O-4912-2019; Kuehn, Simone/P-6145-2014; Brick, Timothy/C-9966-2015	, Barbara/0000-0003-1812-8531; Brick, Timothy/0000-0002-3339-9279; Kuhn, Simone/0000-0001-6823-7969				Bates D, 2012, LME4 LINEAR MIXED EF; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Brett M, 2002, PRESENTED AT THE 8TH; CORTI FJ, 2000, SYST BIOL, V49, P740, DOI DOI 10.1080/106351500750049806; Cullen H, 2014, SOC COGN AFFECT NEUR, V9, P1276, DOI 10.1093/scan/nst109; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Epley N, 2008, PSYCHOL SCI, V19, P114, DOI 10.1111/j.1467-9280.2008.02056.x; Farah M, 1998, PSYCHOL REV; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Guthrie S., 1993, FACES IN THE CLOUDS; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; MCGUGIN RW, 2012, HIGH RESOLUTION IMAG; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Satterthwaite FE, 1946, BIOMETRICS B; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Waytz A, 2010, PERSPECT PSYCHOL SCI, V5, P219, DOI 10.1177/1745691610369336; Windhager S, 2008, HUM NATURE-INT BIOS, V19, P331, DOI 10.1007/s12110-008-9047-z; Windhager S, 2012, EVOL HUM BEHAV, V33, P109, DOI 10.1016/j.evolhumbehav.2011.06.003; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075	29	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113885	10.1371/journal.pone.0113885	http://dx.doi.org/10.1371/journal.pone.0113885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517511	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600010
J	Wu, JY; Ding, ST; Li, QJ; Zhao, ZR; Sun, BN				Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian			First Occurrence of Platycladus from the Upper Miocene of Southwest China and Its Phytogeographic Implications	PLOS ONE			English	Article							ASIAN MONSOON; CUPRESSACEAE; OLIGOCENE; CLIMATE; CALOCEDRUS; PHYLOGENY; EVOLUTION; SEQUENCES; PLIOCENE; FOLIAGE	Platycladus Spach is native to Central China, but its natural occurrences are very difficult to establish. According to molecular phylogenetic data, this genus might have originated since the Oligocene, but no fossil record has been reported. Here, we describe eight foliage branches from the upper Miocene in western Yunnan, Southwest China as a new species, P. yunnanensis sp. nov., which is characterized by foliage branches spread in flattened sprays, and leaves decussate, imbricate, scale-like and dimorphic. The leaves are amphistomatic, and the stomata are elliptical or oblong, haplocheilic, and monocyclic type. Based on a detailed comparison with the extant genera of Cupressaceae sensu lato, our fossils are classified into the genus Platycladus. The occurrence of P. yunnanensis sp. nov. indicates that this genus had a more southernly natural distribution in the late Miocene than at present. Molecular phylogeny and fossil records support a pre-Oligocene common ancestor for the genera Platycladus, Microbiota and Calocedrus. The separation of the three taxa was most likely caused by the arid belt across Central China during the Oligocene. In addition, the cooling down of the global temperature and the strengthening of Asian monsoon since the Miocene will further promote the migration of these genera.	[Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian] Lanzhou Univ, Sch Earth Sci, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China; [Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Wu, Jing-Yu] Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Wu, JY (corresponding author), Lanzhou Univ, Sch Earth Sci, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China.	jywu@lzu.edu.cn	Wu, Jingyu/HHR-9058-2022		National Natural Science Foundation of China [41302009, 41172021, 41271024]; NSFC-RFBR [413111050]; China Postdoctoral Science Foundation [2011M500960]; Foundation of the State Key Laboratory of Paleobiology and Stratigraphy; Nanjing Institute of Geology and Paleontology; Chinese Academy of Sciences [133102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RFBR; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of the State Key Laboratory of Paleobiology and Stratigraphy; Nanjing Institute of Geology and Paleontology; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (41302009, 41172021, 41271024), the NSFC-RFBR (413111050), the China Postdoctoral Science Foundation (2011M500960), and the Foundation of the State Key Laboratory of Paleobiology and Stratigraphy, Nanjing Institute of Geology and Paleontology, Chinese Academy of Sciences (133102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], [No title captured]; Blokhina Nadezhda I., 2011, Acta Palaeobotanica, V51, P19; BRUNSFELD SJ, 1994, SYST BOT, V19, P253, DOI 10.2307/2419600; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen CH, 2009, BOT STUD, V50, P425; Chen W, 2000, ACTA BOT YUNNANICA, V23, P189; Clift PD, 2008, NAT GEOSCI, V1, P875, DOI 10.1038/ngeo351; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Farjon A., 2005, MONOGRAPH CUPRESSACE, P1; Fu L., 1999, FLORA CHINA, P62; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Ge H.-R., 1999, CENOZOIC COAL BEARIN, P1; [郭双兴 Guo Shuangxing], 2011, [古生物学报, Acta Palaeontologica Sinica], V50, P353; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; He WL, 2012, REV PALAEOBOT PALYNO, V176, P24, DOI 10.1016/j.revpalbo.2012.03.013; Kvacek Z, 2000, INT J PLANT SCI, V161, P331, DOI 10.1086/314245; Little DP, 2004, AM J BOT, V91, P1872, DOI 10.3732/ajb.91.11.1872; LIU TS, 1993, GLOBAL PLANET CHANGE, V7, P119; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Shi GL, 2012, AM J BOT, V99, P108, DOI 10.3732/ajb.1100331; Shi GL, 2011, REV PALAEOBOT PALYNO, V166, P325, DOI 10.1016/j.revpalbo.2011.06.005; Shi GL, 2010, REV PALAEOBOT PALYNO, V161, P179, DOI 10.1016/j.revpalbo.2010.04.002; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; WILSON ERNEST H., 1926, JOUR ARNOLD ARBORETUM, V7, P37; Working Group on Copper Geology of the Zhongtiao Mountains, 1978, COPPER GEOLOGY ZHONG, P1; Wu JY, 2009, REV PALAEOBOT PALYNO, V155, P32, DOI 10.1016/j.revpalbo.2008.12.015; Xia K, 2009, PALAEOGEOGR PALAEOCL, V276, P80, DOI 10.1016/j.palaeo.2009.02.024; Xing YW, 2012, PALAEOGEOGR PALAEOCL, V358, P19, DOI 10.1016/j.palaeo.2012.07.011; Xu JX, 2008, REV PALAEOBOT PALYNO, V148, P36, DOI 10.1016/j.revpalbo.2007.08.004; Yang ZY, 2012, MOL PHYLOGENET EVOL, V64, P452, DOI 10.1016/j.ympev.2012.05.004; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; [张仲石 Zhang Zhongshi], 2005, [第四纪研究, Quaternary Sciences], V25, P523; Zheng HB, 2004, GLOBAL PLANET CHANGE, V41, P147, DOI 10.1016/j.gloplacha.2004.01.003; Zhu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056489; Zhuo WR., 1990, YUNNAN GEOL, V9, P321	37	4	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115141	10.1371/journal.pone.0115141	http://dx.doi.org/10.1371/journal.pone.0115141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517767	Green Submitted, gold, Green Published			2022-12-26	WOS:000347215600044
J	Gan, L; Jiang, WD; Wu, P; Liu, Y; Jiang, J; Li, SH; Tang, L; Kuang, SY; Feng, L; Zhou, XQ				Gan, Lu; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Kuang, Sheng-Yao; Feng, Lin; Zhou, Xiao-Qiu			Flesh Quality Loss in Response to Dietary Isoleucine Deficiency and Excess in Fish: A Link to Impaired Nrf2-Dependent Antioxidant Defense in Muscle	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; TROUT ONCORHYNCHUS-MYKISS; ALPHA-TOCOPHERYL ACETATE; SALMON SALMO-SALAR; OXIDATIVE STRESS; ENZYME-ACTIVITIES; GRASS CARP; HOLDING CAPACITY; ATLANTIC SALMON; FILLET QUALITY	The present study explored the impact of dietary isoleucine (Ile) on fish growth and flesh quality and revealed a possible role of muscle antioxidant defense in flesh quality in relation to dietary Ile. Grass carp (weighing 256.8 +/- 3.5 g) were fed diets containing six graded levels of Ile (3.8, 6.6, 9.3, 12.5, 15.2 and 18.5 g/kg) for eight weeks. The results indicated that compared with Ile deficiency (3.8 g/kg diets) and excess (18.5 g/kg diets) groups, 9.3-15.2 g Ile/kg diet supplementations promoted fish growth and muscle fat deposition, whereas 6.6-15.2 g Ile/kg diets supplementation enhanced muscle nutrients (protein and total EAAs) deposition. Furthermore, muscle shear force, pH value, and hydroxyproline concentration were improved by 9.3-12.5, 9.3 and 9.3 g Ile/kg diet supplementations, respectively. However, muscle cooking loss, lactate content, and activities of cathepsin B and L were decreased by 6.6-15.2, 9.3-12.5, 9.3-12.5 and 9.3-15.2 g Ile/kg diet supplementations, respectively. Additionally, 6.6-15.2 and 6.6-12.5 g Ile/kg diet supplementations attenuated malondialdehyde and protein carbonyl contents, respectively. The activities of copper/zinc superoxide dismutase (Cu/Zn-SOD) and glutathione peroxidase (GPx), and glutathione content were enhanced by 6.6-9.3, 6.6-12.5 and 6.6-15.2 g Ile/kg diet supplementations, respectively. Moreover, the relative mRNA expressions of antioxidant enzymes, including Cu/Zn-SOD (6.6-12.5 g/kg diets) and GPx (12.5 g/kg diets), as well as antioxidant-related signaling molecules, including NF-E2-related factor 2 (Nrf2) (6.6-12.5 g/kg diets), target of rapamycin (6.6-12.5 g/kg diets), ribosomal S6 protein kinase 1 (9.3-12.5 g/kg diets) and casein kinase 2 (6.6-12.5 g/kg diets), were up-regulated when Ile diet supplementations were administered at these levels, respectively, whereas the relative mRNA expression of Kelch-like ECH-associated protein 1 was downregulated with 9.3 g Ile/kg diet supplementations. Collectively, the present study indicated that optimum isoleucine improved flesh quality, partly due to the activation of antioxidant defense through the Nrf2 signaling pathway.	[Gan, Lu; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Disease Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Tang, Ling; Kuang, Sheng-Yao] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Feng, L (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	fenglin@sicau.edu.cn; xqzhouqq@tom.com	liu, yang/HHY-8583-2022; jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007]; Science and Technology Support Program of Sichuan Province [2014NZ0003]; National 973 Project [2014CB138600]	National Department Public Benefit Research Foundation (Agriculture) of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Science and Technology Support Program of Sichuan Province; National 973 Project(National Basic Research Program of China)	This research was financially supported by the National Department Public Benefit Research Foundation (Agriculture) of China (201003020), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007), Science and Technology Support Program of Sichuan Province (2014NZ0003) and National 973 Project (2014CB138600). The authors would like to thank the personnel of these teams for their kind assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Acerete L, 2004, AQUACULTURE, V237, P167, DOI 10.1016/j.aquaculture.2004.03.018; Acerete L, 2009, AQUACULTURE, V287, P139, DOI 10.1016/j.aquaculture.2008.10.012; Ahmed I, 2006, BRIT J NUTR, V96, P450, DOI 10.1079/BJN20061845; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bahuaud D, 2010, FOOD CHEM, V118, P602, DOI 10.1016/j.foodchem.2009.05.028; Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; Bridi R, 2003, INT J DEV NEUROSCI, V21, P327, DOI 10.1016/S0736-5748(03)00074-1; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; Ayala MD, 2011, LWT-FOOD SCI TECHNOL, V44, P1098, DOI 10.1016/j.lwt.2010.09.014; Enser M, 1996, MEAT SCI, V42, P443, DOI 10.1016/0309-1740(95)00037-2; FAO, 2011, FAOSTAT AGR; FAUCONNEAU B, 1995, AQUACULTURE, V129, P265, DOI 10.1016/0044-8486(94)00309-C; Hosseini SV, 2010, FOOD CHEM, V118, P341, DOI 10.1016/j.foodchem.2009.04.131; Huang HM, 2004, FREE RADICAL BIO MED, V37, P1779, DOI 10.1016/j.freeradbiomed.2004.08.001; Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; KANETO A, 1972, ENDOCRINOLOGY, V91, P691, DOI 10.1210/endo-91-3-691; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kong FB, 2008, LWT-FOOD SCI TECHNOL, V41, P1210, DOI 10.1016/j.lwt.2007.07.020; Lai CC, 1996, J MOL CELL CARDIOL, V28, P1157, DOI 10.1006/jmcc.1996.0106; Lambertucci RH, 2007, MECH AGEING DEV, V128, P267, DOI 10.1016/j.mad.2006.12.006; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li X., 2013, J APPL MATH, P1; Lin YH, 2013, AQUACULTURE, V380, P47, DOI 10.1016/j.aquaculture.2012.11.034; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Losada V, 2005, FOOD CHEM, V93, P619, DOI 10.1016/j.foodchem.2004.09.041; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; Mercado N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088168; Mohammadzadeh M, 2012, CELL STRESS CHAPERON, V17, P553, DOI 10.1007/s12192-012-0331-9; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Obernier JA, 2006, ILAR J, V47, P364, DOI 10.1093/ilar.47.4.364; OFSTAD R, 1993, FOOD STRUCT, V12, P163; Okouchi M, 2006, CURR NEUROVASC RES, V3, P249, DOI 10.2174/156720206778792876; Olsen RE, 1998, AQUACULT NUTR, V4, P13, DOI 10.1046/j.1365-2095.1998.00099.x; Olsson GB, 2003, LEBENSM-WISS TECHNOL, V36, P125, DOI 10.1016/S0023-6438(02)00205-0; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; Peso-Echarri P, 2012, FOOD CHEM, V135, P699, DOI 10.1016/j.foodchem.2012.05.033; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Rodehutscord M, 1997, J NUTR, V127, P1166, DOI 10.1093/jn/127.6.1166; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; [尚晓迪 SHANG Xiao-di], 2009, [水产学报, Journal of Fisheries of China], V33, P813; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Talbott S., 2006, ANN M INT SOC SPORTS; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Tokur B, 2007, FOOD CHEM, V104, P754, DOI 10.1016/j.foodchem.2006.12.033; Wu T, 2008, FOOD CHEM, V110, P647, DOI 10.1016/j.foodchem.2008.02.058; Wu Y.P., 2014, AQUAC RES; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhang Xiao-dong, 2007, Journal of Zhejiang University-Science B, V8, P680, DOI 10.1631/jzus.2007.B0680; Zhou QC, 2012, AQUACULTURE, V350, P175, DOI 10.1016/j.aquaculture.2012.03.042	61	30	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115129	10.1371/journal.pone.0115129	http://dx.doi.org/10.1371/journal.pone.0115129			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514235	gold, Green Submitted, Green Published			2022-12-26	WOS:000349146300034
J	Prehna, G; Ramirez, BE; Lovering, AL				Prehna, Gerd; Ramirez, Benjamin E.; Lovering, Andrew L.			The Lifestyle Switch Protein Bd0108 of Bdellovibrio bacteriovorus Is an Intrinsically Disordered Protein	PLOS ONE			English	Article							NMR CHEMICAL-SHIFTS; IV PILI; STRUCTURE PREDICTION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; DIVERSE BACTERIA; DOMAIN; SERVER; GENE; SPECTROSCOPY	Bdellovibrio bacteriovorus is a delta-proteobacterium that preys upon Salmonella spp., E. coli, and other Gram-negative bacteria. Bdellovibrio can grow axenically (host-independent, HI, rare and mutation-driven) or subsist via a predatory lifecycle (host-dependent, HD, the usual case). Upon contact with prey, B. bacteriovorus enters the host periplasm from where it slowly drains the host cytosol of nutrients for its own replication. At the core of this mechanism is a retractile pilus, whose architecture is regulated by the protein Bd0108 and its interaction with the neighboring gene product Bd0109. Deletion of bd0108 results in negligible pilus formation, whereas an internal deletion (the one that instigates host-independence) causes mis-regulation of pilus length. These mutations, along with a suite of naturally occurring bd0108 mutant strains, act to control the entry to HI growth. To further study the molecular mechanism of predatory regulation, we focused on the apparent lifecycle switch protein Bd0108. Here we characterize the solution structure and dynamics of Bd0108 using nuclear magnetic resonance (NMR) spectroscopy complemented with additional biophysical methods. We then explore the interaction between Bd0108 and Bd0109 in detail utilizing isothermal titration calorimetry (ITC) and NMR spectroscopy. Together our results demonstrate that Bd0108 is an intrinsically disordered protein (IDP) and that the interaction with Bd0109 is of low affinity. Furthermore, we observe that Bd0108 retains an IDP nature while binding Bd0109. From our data we conclude that Bdellovibrio bacteriovorus utilizes an intrinsically disordered protein to regulate its pilus and control predation signaling.	[Prehna, Gerd; Ramirez, Benjamin E.] Univ Illinois, Struct Biol Ctr, Res Resources Ctr, Chicago, IL USA; [Prehna, Gerd] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Ramirez, Benjamin E.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Lovering, Andrew L.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Birmingham	Lovering, AL (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	a.lovering@bham.ac.uk		Prehna, Gerd/0000-0001-5539-7533; Lovering, Andrew/0000-0002-1856-7975	EMBO Young Investigator Award; BBSRC [BB/J015229/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015229/1] Funding Source: researchfish	EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an EMBO Young Investigator Award to ALL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Baer ML, 2004, INT J SYST EVOL MICR, V54, P1011, DOI 10.1099/ijs.0.02458-0; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Capeness MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079759; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Crossman LC, 2013, ISME J, V7, P148, DOI 10.1038/ismej.2012.90; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferguson MA, 2014, APPL ENV MICROBIOL; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hobley L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-670; HOENIGER JF, 1972, CAN J MICROBIOL, V18, P87, DOI 10.1139/m72-014; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Lambert C, 2006, CURR OPIN MICROBIOL, V9, P639, DOI 10.1016/j.mib.2006.10.002; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Milner DS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004253; Minet AD, 1999, J CELL SCI, V112, P2019; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Morehouse KA, 2011, J BACTERIOL, V193, P932, DOI 10.1128/JB.00941-10; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Passerini A, 2011, NUCLEIC ACIDS RES, V39, pW288, DOI 10.1093/nar/gkr365; Pasternak Z, 2014, ISME J, V8, P625, DOI 10.1038/ismej.2013.164; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Phulera S, 2013, BIOCHEMISTRY-US, V52, P4056, DOI 10.1021/bi400191z; Prehna G, 2012, J BIOL CHEM, V287, P32324, DOI 10.1074/jbc.M112.357210; Prehna G, 2012, STRUCTURE, V20, P1154, DOI 10.1016/j.str.2012.04.014; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reichmann D, 2013, CURR OPIN STRUC BIOL, V23, P436, DOI 10.1016/j.sbi.2013.02.006; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; RITTENBERG GM, 1979, CT-J COMPUT TOMOGR, V3, P140, DOI 10.1016/0149-936X(79)90005-5; Roschanski N, 2011, J BACTERIOL, V193, P1745, DOI 10.1128/JB.01343-10; Roux N, 2012, RES MICROBIOL, V163, P659, DOI 10.1016/j.resmic.2012.10.015; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Serre L, 2004, J MOL BIOL, V339, P161, DOI 10.1016/j.jmb.2004.03.022; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; Soranno A, 2014, P NATL ACAD SCI USA, V111, P4874, DOI 10.1073/pnas.1322611111; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TUDOR JJ, 1990, J BACTERIOL, V172, P2421, DOI 10.1128/jb.172.5.2421-2426.1990; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	74	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115390	10.1371/journal.pone.0115390	http://dx.doi.org/10.1371/journal.pone.0115390			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514156	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300057
J	Thomas, A; Hanel, B; Marott, JL; Buchvald, F; Mortensen, J; Nielsen, KG				Thomas, Astrid; Hanel, Birgitte; Marott, Jacob L.; Buchvald, Frederik; Mortensen, Jann; Nielsen, Kim G.			The Single-Breath Diffusing Capacity of CO and NO in Healthy Children of European Descent	PLOS ONE			English	Article							LUNG MEMBRANE CONDUCTANCE; HIGH-ALTITUDE NEWCOMERS; CAPILLARY BLOOD-VOLUME; CARBON-MONOXIDE; NITRIC-OXIDE; REFERENCE VALUES; HYPERTENSION; EQUATIONS; GASES; RATIO	Rationale: The diffusing capacity (D-L) of the lung can be divided into two components: the diffusing capacity of the alveolar membrane (Dm) and the pulmonary capillary volume (Vc). D-L is traditionally measured using a single-breath method, involving inhalation of carbon monoxide, and a breath hold of 8-10 seconds (D-L,(CO)). This method does not easily allow calculation of Dm and Vc. An alternative single-breath method (D-L,(CO),(NO)), involving simultaneous inhalation of carbon monoxide and nitric oxide, and traditionally a shorter breath hold, allows calculation of Dm and Vc and the D-L,(NO)/D-L,(CO) ratio in a single respiratory maneuver. The clinical utility of Dm, Vc, and D-L,(NO)/D-L,(CO) in the pediatric age range is currently unknown but also restricted by lack of reference values. Objectives: The aim of this study was to establish reference ranges for the outcomes of D-L,(CO),(NO) with a 5 second breath hold, including the calculated outcomes Dm, Vc, and the D-L,(NO)/D-L,(CO) ratio, as well as to establish reference values for the outcomes of the traditional D-L,(CO) method, with a 10 second breath hold in children. Methods: D-L,(CO),(NO) and D-L,(CO) were measured in healthy children, of European descent, aged 5-17 years using a Jaeger Masterscreen PFT. The data were analyzed using the Generalized Additive Models for Location Scale and Shape (GAMLSS) statistical method. Measurements and Main Results: A total of 326 children were eligible for diffusing capacity measurements, resulting in 312 measurements of D-L,(CO),(NO) and 297 of D-L,(CO), respectively. Reference equations were established for the outcomes of D-L,(CO),(NO) and D-L,(CO), including the calculated values: Vc, Dm, and the D-L,(NO)/D-L,(CO) ratio. Conclusion: These reference values are based on the largest sample of children to date and may provide a basis for future studies of their clinical utility in differentiating between alterations in the pulmonary circulation and changes in the alveolar membrane in pediatric patients.	[Thomas, Astrid; Hanel, Birgitte; Buchvald, Frederik; Nielsen, Kim G.] Univ Copenhagen, Rigshosp, Danish PCD & ChILD Ctr, CF Ctr Copenhagen,Pediat Pulm Serv,Dept Pediat &, DK-2100 Copenhagen, Denmark; [Marott, Jacob L.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Mortensen, Jann] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Univ Copenhagen, Rigshosp, Danish PCD & ChILD Ctr, CF Ctr Copenhagen,Pediat Pulm Serv,Dept Pediat &, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449; Mortensen, Jann/0000-0002-1399-8995	Dagmar Marshalls Foundation; Carpenter Johannes Foghs Foundation; John and Birthe Meyer Foundation; Director Jacob Madsens Foundation; Aase and Ejnar Danielsens Foundation	Dagmar Marshalls Foundation; Carpenter Johannes Foghs Foundation; John and Birthe Meyer Foundation; Director Jacob Madsens Foundation; Aase and Ejnar Danielsens Foundation	Dagmar Marshalls Foundation URL: N/A, Carpenter Johannes Foghs Foundation http://www.fogfond.dk, Aase and Ejnar Danielsens Foundation http://www.danielsensfond.dk, The John and Birthe Meyer Foundation URL: N/A, Director Jacob Madsens Foundation URL: N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; Borland C, 1996, THORAX, V51, P855, DOI 10.1136/thx.51.8.855; BORLAND CDR, 1989, EUR RESPIR J, V2, P56; Borland CDR, 2010, J APPL PHYSIOL, V108, P1052, DOI 10.1152/japplphysiol.00904.2009; Cook RD, 1982, RESIDUALS INFLUENCE; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Cotes JE, 1993, LUNG FUNCTION ASSESS, Vxi; Cotes JE, 2006, LUNG FUNCTION PHYSL, Vxi; Dressel H, 2008, CHEST, V133, P1149, DOI 10.1378/chest.07-2388; Dressel Holger, 2009, BMC Pulm Med, V9, P30, DOI 10.1186/1471-2466-9-30; Forster R.E., 1987, HDB PHYSL RESP SYSTE, P71; Fox Jr J., 2015, APPL REGRESSION ANAL; Glenet SN, 2007, J PHYSIOL-LONDON, V582, P767, DOI 10.1113/jphysiol.2007.133405; GUENARD H, 1987, RESP PHYSIOL, V70, P113, DOI 10.1016/S0034-5687(87)80036-1; Hector Dearton Thomas, 2013, BUSINESS TODAY; Hughes JMB, 2013, J APPL PHYSIOL, V115, P153, DOI 10.1152/japplphysiol.00581.2013; Hughes JMB, 2013, EUR RESPIR J, V41, P453, DOI 10.1183/09031936.00082112; JONES RS, 1961, Q J EXP PHYSIOL CMS, V46, P131, DOI 10.1113/expphysiol.1961.sp001525; Kim YJ, 2011, PEDIAT PULMONOLOGY, P469; Kim YJ, 2011, PEDIAT PULMONOLOGY; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Krogh M, 1915, J PHYSIOL-LONDON, V49, P271; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinot JB, 2013, J APPL PHYSIOL, V115, P157, DOI 10.1152/japplphysiol.01455.2012; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; Phansalkar AR, 2004, AM J RESP CRIT CARE, V169, P1034, DOI 10.1164/rccm.200309-1287OC; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rouatbi S, 2006, REV MAL RESPIR, V23, P211, DOI 10.1016/S0761-8425(06)71570-4; Rouatbi S, 2014, EGYPT J CHEST DIS TU, V63, P705, DOI 10.1016/j.ejcdt.2014.02.007; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van der Lee I, 2006, CHEST, V129, P378, DOI 10.1378/chest.129.2.378; van der Lee I, 2009, RESP MED, V103, P1892, DOI 10.1016/j.rmed.2009.06.005; VONWESTERNHAGEN F, 1978, LUNG, V154, P289; Welsch R, 1980, REGRESSION DIAGNOSTI; Williams D, 1987, APPL STAT, P181; Zavorsky GS, 2010, ACTA PHYSIOL, V198, P499, DOI 10.1111/j.1748-1716.2009.02059.x; Zavorsky GS, 2013, RESP PHYSIOL NEUROBI, V186, P103, DOI 10.1016/j.resp.2013.01.001	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113177	10.1371/journal.pone.0113177	http://dx.doi.org/10.1371/journal.pone.0113177			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514246	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300002
J	Verzola, D; Ratto, E; Villaggio, B; Parodi, EL; Pontremoli, R; Garibotto, G; Viazzi, F				Verzola, Daniela; Ratto, Elena; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca			Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; POST-HOC ANALYSIS; ENDOTHELIAL DYSFUNCTION; GLOMERULAR HYPERTENSION; MILD HYPERURICEMIA; NAD(P)H OXIDASE; RENAL OUTCOMES; PROLIFERATION; EXPRESSION; INFLAMMATION	Mild hyperuricemia has been linked to the development and progression of tubulointerstitial renal damage. However the mechanisms by which uric acid may cause these effects are poorly explored. We investigated the effect of uric acid on apoptosis and the underlying mechanisms in a human proximal tubule cell line (HK-2). Increased uric acid concentration decreased tubule cell viability and increased apoptotic cells in a dose dependent manner (up to a 7-fold increase, p<0.0001). Uric acid up-regulated Bax (+60% with respect to Ctrl; p<0.05) and down regulated X-linked inhibitor of apoptosis protein. Apoptosis was blunted by Caspase-9 but not Caspase-8 inhibition. Uric acid induced changes in the mitochondrial membrane, elevations in reactive oxygen species and a pronounced up-regulation of NOX 4 mRNA and protein (p<0.05). In addition, both reactive oxygen species production and apoptosis was prevented by the NADPH oxidase inhibitor DPI as well as by Nox 4 knockdown. URAT 1 transport inhibition by probenecid and losartan and its knock down by specific siRNA, blunted apoptosis, suggesting a URAT 1 dependent cell death. In summary, our data show that uric acid increases the permissiveness of proximal tubule kidney cells to apoptosis by triggering a pathway involving NADPH oxidase signalling and URAT 1 transport. These results might explain the chronic tubulointerstitial damage observed in hyperuricaemic states and suggest that uric acid transport in tubular cells is necessary for urate-induced effects.	[Verzola, Daniela; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca] Univ Genoa, Genoa, Italy; [Verzola, Daniela; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca] IRCCS Azienda Ospedaliera Univ San Martino IST, Ist Nazl Ric Cancro, Dept Internal Med, Genoa, Italy; [Ratto, Elena] IRCCS Azienda Ospedaliera Univ San Martino IST, Ist Nazl Ric Cancro, Clin Nefrol Dialisi & Trapianto, Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Viazzi, F (corresponding author), Univ Genoa, Genoa, Italy.	francesca.viazzi@unige.it	Viazzi, Francesca/AAB-2479-2019; Verzola, Daniela/U-2761-2019; Garibotto, Giacomo/AAB-1190-2019	Garibotto, Giacomo/0000-0001-6432-2429; VERZOLA, Daniela/0000-0002-2790-5876; Viazzi, Francesca/0000-0003-4219-7043; Parodi, Emanuele Luigi/0000-0002-7365-7287	Italian Ministero della Salute (Bando Giovane Ricercatore) [CUP G35J11000130001]	Italian Ministero della Salute (Bando Giovane Ricercatore)	This work was, in part, supported by grants from the Italian Ministero della Salute (Bando Giovane Ricercatore 2008, CUP G35J11000130001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Capellino S, 2008, CLIN EXP RHEUMATOL, V26, P903; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Lhotta K, 1998, NEPHRON, V79, P340, DOI 10.1159/000045060; Liu YH, 2009, KIDNEY INT, V76, P1125, DOI 10.1038/ki.2009.352; Lodha S, 2002, MOL MED, V8, P830, DOI 10.1007/BF03402088; Miao Y, 2011, HYPERTENSION, V58, P2, DOI 10.1161/HYPERTENSIONAHA.111.171488; Miyazaki H, 2004, TRENDS PHARMACOL SCI, V25, P654, DOI 10.1016/j.tips.2004.10.006; Morais C, 2005, NEPHROL DIAL TRANSPL, V20, P50, DOI 10.1093/ndt/gfh561; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Ohno I, 2001, NEPHRON, V87, P333, DOI 10.1159/000045939; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Quan H, 2011, CELL PHYSIOL BIOCHEM, V27, P91, DOI 10.1159/000325209; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sanchez-Nino MD, 2010, KIDNEY INT, V78, P737, DOI 10.1038/ki.2010.270; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Smink PA, 2012, J HYPERTENS, V30, P1022, DOI 10.1097/HJH.0b013e32835200f9; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; Viazzi F, 2007, AM J HYPERTENS, V20, P1276, DOI 10.1016/j.amjhyper.2007.08.010; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	53	83	88	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115210	10.1371/journal.pone.0115210	http://dx.doi.org/10.1371/journal.pone.0115210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514209	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300042
J	Hayden, TA; Holbrook, CM; Fielder, DG; Vandergoot, CS; Bergstedt, RA; Dettmers, JM; Krueger, CC; Cooke, SJ				Hayden, Todd A.; Holbrook, Christopher M.; Fielder, David G.; Vandergoot, Christopher S.; Bergstedt, Roger A.; Dettmers, John M.; Krueger, Charles C.; Cooke, Steven J.			Acoustic Telemetry Reveals Large-Scale Migration Patterns of Walleye in Lake Huron	PLOS ONE			English	Article							FRESH-WATER FISHES; GREAT-LAKES; STIZOSTEDION-VITREUM; CHINOOK SALMON; MOVEMENT; ERIE; POPULATION; SURVIVAL; MARK; MODELS	Fish migration in large freshwater lacustrine systems such as the Laurentian Great Lakes is not well understood. The walleye (Sander vitreus) is an economically and ecologically important native fish species throughout the Great Lakes. In Lake Huron walleye has recently undergone a population expansion as a result of recovery of the primary stock, stemming from changing food web dynamics. During 2011 and 2012, we used acoustic telemetry to document the timing and spatial scale of walleye migration in Lake Huron and Saginaw Bay. Spawning walleye (n=199) collected from a tributary of Saginaw Bay were implanted with acoustic tags and their migrations were documented using acoustic receivers (n=140) deployed throughout U.S. nearshore waters of Lake Huron. Three migration pathways were described using multistate mark-recapture models. Models were evaluated using the Akaike Information Criterion. Fish sex did not influence migratory behavior but did affect migration rate and walleye were detected on all acoustic receiver lines. Most (95%) tagged fish migrated downstream from the riverine tagging and release location to Saginaw Bay, and 37% of these fish emigrated from Saginaw Bay into Lake Huron. Remarkably, 8% of walleye that emigrated from Saginaw Bay were detected at the acoustic receiver line located farthest from the release location more than 350 km away. Most (64%) walleye returned to the Saginaw River in 2012, presumably for spawning. Our findings reveal that fish from this stock use virtually the entirety of U.S. nearshore waters of Lake Huron.	[Hayden, Todd A.; Dettmers, John M.] Great Lakes Fishery Commiss, Ann Arbor, MI 48105 USA; [Hayden, Todd A.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Holbrook, Christopher M.; Bergstedt, Roger A.] US Geol Survey, Hammond Bay Biol Stn, Millersburg, MI 49759 USA; [Fielder, David G.] Michigan Dept Nat Resources, Alpena, MI 49707 USA; [Vandergoot, Christopher S.] Ohio Dept Nat Resources, Sandusky Fish Res Unit, Sandusky, OH 44870 USA; [Krueger, Charles C.] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Carleton University; United States Department of the Interior; United States Geological Survey; Ohio Department of Natural Resources; Michigan State University	Hayden, TA (corresponding author), Great Lakes Fishery Commiss, 2100 Commonwealth Blvd Ste 100, Ann Arbor, MI 48105 USA.	thayden@usgs.gov	Cooke, Steven J/F-4193-2010	Cooke, Steven J/0000-0002-5407-0659	Great Lakes Fishery Commission [GL-00E23010-3]; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada	Great Lakes Fishery Commission; Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was funded by the Great Lakes Fishery Commission (http://www.glfc.org) by way of Great Lakes Restoration Initiative appropriations (GL-00E23010-3), Canada Research Chairs Program (SC), and the Natural Sciences and Engineering Research Council of Canada (SC).	BALDWIN NS, 1962, TECHNICAL REPORT NO; Barton BA, 2011, BIOLOGY, MANAGEMENT, AND CULTURE OF WALLEYE AND SAUGER, P199; BENCE JR, 2008, GREAT LAKES FISH COM, V801; Bowlby JN, 2011, AQUAT ECOSYST HEALTH, V14, P56, DOI 10.1080/14634988.2011.548298; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 2002, MODEL SELECTION AND; BURNHAM KP, 1987, DESIGN AND ANALYSIS; Cooke S.J., 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-5; COOKE SJ, 2011, TECHNICAL REPORT; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P11, DOI 10.1007/s11160-010-9184-4; CROWE WALTER R., 1962, TRANS AMER FISH SOC, V91, P350, DOI 10.1577/1548-8659(1962)91[350:HBIW]2.0.CO;2; DEMPSEY D, 2001, RUIN AND RECOVERY MI; Dettmers JM, 2012, FISHERIES, V37, P495, DOI 10.1080/03632415.2012.731875; DINGLE H, 1996, MIGRATION THE BIOLOG; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fielder DG, 2007, J GREAT LAKES RES, V33, P118, DOI 10.3394/0380-1330(2007)33[118:EAECST]2.0.CO;2; FIELDER DG, 2014, FISHERIES DIVISION R; FIELDER DG, 2014, 31 YEARS OF TAG RETU; FIELDER DG, 2014, REPORT; FULLER K, 2002, THE GREAT LAKES AN E, P1; GOWAN C, 1994, CAN J FISH AQUAT SCI, V51, P2626, DOI 10.1139/f94-262; Hanson K. C., 2008, REV FISH SCI, V16, P421, DOI DOI 10.1080/10641260802013866; Hayden TA, 2011, J GREAT LAKES RES, V37, P691, DOI 10.1016/j.jglr.2011.08.012; Henderson BA, 1996, CAN J FISH AQUAT SCI, V53, P127, DOI 10.1139/cjfas-53-1-127; HESTBECK JB, 1991, ECOLOGY, V72, P523, DOI 10.2307/2937193; HILE R, 1959, RESEARCH REPORT 51; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Jackson CH, 2011, J STAT SOFTW, V38, P1; Johnson JE, 2010, N AM J FISH MANAGE, V30, P518, DOI 10.1577/M09-094.1; Kershner MW, 1999, CAN J FISH AQUAT SCI, V56, P527, DOI 10.1139/cjfas-56-4-527; LAAKE J, 2013, PROGRAM MARK A GENTL; Landsman SJ, 2011, J GREAT LAKES RES, V37, P365, DOI 10.1016/j.jglr.2011.03.003; Lucas M. C., 2001, MIGRATION OF FRESHWA; Lucas MC, 2000, FISH FISH, V1, P283, DOI 10.1046/j.1467-2979.2000.00028.x; Madenjian CP, 2008, N AM J FISH MANAGE, V28, P263, DOI 10.1577/M07-012.1; Madenjian CP, 1998, CAN J FISH AQUAT SCI, V55, P1085, DOI 10.1139/cjfas-55-5-1085; Manly B.F.J., 1968, T SOC BRIT ENTOMOLOG, V18, P81; McParland TL, 1999, T AM FISH SOC, V128, P1055, DOI 10.1577/1548-8659(1999)128&lt;1055:GPSAMS&gt;2.0.CO;2; Melnychuk MC, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P339; Pangle KL, 2010, CAN J FISH AQUAT SCI, V67, P1475, DOI 10.1139/F10-076; Peake S, 2000, CAN J ZOOL, V78, P1686, DOI 10.1139/cjz-78-9-1686; Perry RW, 2010, N AM J FISH MANAGE, V30, P142, DOI 10.1577/M08-200.1; Pincock D.G., 2009, DETECTION PERFORMANC; R Core Team, 2021, R LANGUAGE ENV STAT; SCHNEIDER JC, 1977, J FISH RES BOARD CAN, V34, P1878, DOI 10.1139/f77-254; Seber G. A. F., 1982, THE ESTIMATION OF AN; Skalski JR, 2001, CAN J FISH AQUAT SCI, V58, P1987, DOI 10.1139/cjfas-58-10-1987; SPANGLER GR, 1977, J FISH RES BOARD CAN, V34, P1839, DOI 10.1139/f77-250; STEPHEN C, 2013, THE STATUS OF LAKE H, P21; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Stepien CA, 2012, T AM FISH SOC, V141, P660, DOI 10.1080/00028487.2012.683474; Tanner HA, 2002, SUSTAINING NORTH AMERICAN SALMON: PERSPECTIVES ACROSS REGIONS AND DISCIPLINES, P139; Vandergoot CS, 2011, N AM J FISH MANAGE, V31, P914, DOI 10.1080/02755947.2011.629717; Wang HY, 2007, T AM FISH SOC, V136, P539, DOI 10.1577/T06-012.1; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zhao YM, 2011, N AM J FISH MANAGE, V31, P379, DOI 10.1080/02755947.2011.571516	58	73	74	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114833	10.1371/journal.pone.0114833	http://dx.doi.org/10.1371/journal.pone.0114833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506913	gold, Green Published			2022-12-26	WOS:000346607100026
J	Yuan, LH; Zhang, XJ; Li, LM; Jiang, HY; Chen, JP				Yuan, Lihong; Zhang, Xiujuan; Li, Linmiao; Jiang, Haiying; Chen, Jinping			High-Throughput Sequencing of MicroRNA Transcriptome and Expression Assay in the Sturgeon, Acipenser schrenckii	PLOS ONE			English	Article							RNA-SEQ; DUPLICATION EVENTS; IDENTIFICATION; GENERATION; GENOMICS; TARGETS; DIFFERENTIATION; NORMALIZATION; KARYOTYPES; EVOLUTION	Sturgeons are considered as living fossils and have very high evolutionary, economical and conservation values. The multiploidy of sturgeon that has been caused by chromosome duplication may lead to the emergence of new microRNAs ( miRNAs) involved in the ploidy and physiological processes. In the present study, we performed the first sturgeon miRNAs analysis by RNA-seq high-throughput sequencing combined with expression assay of microarray and real-time PCR, and aimed to discover the sturgeon-specific miRNAs, confirm the expressed pattern of miRNAs and illustrate the potential role of miRNAs-targets on sturgeon biological processes. A total of 103 miRNAs were identified, including 58 miRNAs with strongly detected signals ( signal >500 and P <= 0.01), which were detected by microarray. Real-time PCR assay supported the expression pattern obtained by microarray. Moreover, co-expression of 21 miRNAs in all five tissues and tissue-specific expression of 16 miRNAs implied the crucial and particular function of them in sturgeon physiological processes. Target gene prediction, especially the enriched functional gene groups (369 GO terms) and pathways (37 KEGG) regulated by 58 miRNAs (P<0.05), illustrated the interaction of miRNAs and putative mRNAs, and also the potential mechanism involved in these biological processes. Our new findings of sturgeon miRNAs expand the public database of transcriptome information for this species, contribute to our understanding of sturgeon biology, and also provide invaluable data that may be applied in sturgeon breeding.	[Yuan, Lihong; Zhang, Xiujuan; Li, Linmiao; Jiang, Haiying; Chen, Jinping] South China Inst Endangered Animals, Guangdong Entomol Inst, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Chen, JP (corresponding author), South China Inst Endangered Animals, Guangdong Entomol Inst, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.	chenjp@gdei.gd.cn			Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences [rcjj201402]; Innovative Talent Fund of Guangdong Entomological Institute [GDEI-cxrc2013]; National Natural Science Fund of China [31301012]; Guangzhou Pearl River Scientific and Technological New Star Project [2012J2200003]	Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences; Innovative Talent Fund of Guangdong Entomological Institute; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Guangzhou Pearl River Scientific and Technological New Star Project	This work was funded by grants awarded to LH.Y under the Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences (rcjj201402) and the Innovative Talent Fund of Guangdong Entomological Institute (GDEI-cxrc2013). LH.Y is supported by the National Natural Science Fund of China (31301012) and the Guangzhou Pearl River Scientific and Technological New Star Project (2012J2200003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bemis WE, 1997, STURGEON BIODIVERSIT, V17, P5; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BIRSTEIN VJ, 1987, GENETICA, V72, P3, DOI 10.1007/BF00126973; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chen P, 2013, P NATL ACAD SCI USA, V110, P11511, DOI 10.1073/pnas.1310144110; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fontana F, 2008, GENOME, V51, P113, DOI [10.1139/G07-112, 10.1139/g07-112]; Fontana F, 2008, GENETICA, V132, P281, DOI 10.1007/s10709-007-9171-4; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hudish LI, 2013, DEV CELL, V27, P387, DOI 10.1016/j.devcel.2013.10.015; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0; Karaayvaz M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.193; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leary S, 2013, AVMA GUIDELINES EUTH; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ludwig A, 2001, GENETICS, V158, P1203; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Tarailo-Graovac M, 2009, CURRENT PROTOCOLS BI, V25; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu J, 2014, REPROD DOMEST ANIM, V49, P32, DOI 10.1111/rda.12217; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132	45	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115251	10.1371/journal.pone.0115251	http://dx.doi.org/10.1371/journal.pone.0115251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506840	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100065
J	Grande, V; Manassero, G; Vercelli, A				Grande, Valentina; Manassero, Giusi; Vercelli, Alessandro			Neuroprotective and Anti-Inflammatory Roles of the Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							KAINIC ACID; TUMOR-SUPPRESSOR; STATUS EPILEPTICUS; SYNAPTIC PLASTICITY; REACTIVE ASTROCYTES; NEURONAL APOPTOSIS; KAINATE RECEPTORS; CELLS; BRAIN; DEATH	Excitotoxic damage represents the major mechanism leading to cell death in many human neurodegenerative diseases such as ischemia, trauma and epilepsy. Caused by an excess of glutamate that acts on metabotropic and ionotropic excitatory receptors, excitotoxicity activates several death signaling pathways leading to an extensive neuronal loss and a consequent strong activation of astrogliosis. Currently, the search for a neuroprotective strategy is aimed to identify the level in the signaling pathways to block excitotoxicity avoiding the loss of important physiological functions and side effects. To this aim, PTEN can be considered an ideal candidate: downstream the excitatory receptors activated in excitotoxicity (whose inhibition was shown to be not clinically viable), it is involved in neuronal damage and in the first stage of the reactive astrogliosis in vivo. In this study, we demonstrated the involvement of PTEN in excitotoxicity through its pharmacological inhibition by dipotassium bisperoxo (picolinato) oxovanadate [bpv(pic)] in a model of temporal lobe epilepsy, obtained by intraperitoneal injection of kainate in 2-month-old C57BL/6J male mice. We have demonstrated that inhibition of PTEN by bpv(pic) rescues neuronal death and decreases the reactive astrogliosis in the CA3 area of the hippocampus caused by systemic administration of kainate. Moreover, the neurotoxin administration increases significantly the scanty presence of mitochondrial PTEN that is significantly decreased by the administration of the inhibitor 6 hr after the injection of kainate, suggesting a role of PTEN in mitochondrial apoptosis. Taken together, our results confirm the key role played by PTEN in the excitotoxic damage and the strong anti-inflammatory and neuroprotective potential of its inhibition.	[Grande, Valentina; Manassero, Giusi; Vercelli, Alessandro] Univ Turin, Dept Neurosci, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [Manassero, Giusi] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy	University of Turin; University of Genoa	Grande, V (corresponding author), Univ Turin, Dept Neurosci, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy.	valentina.grande@unito.it	Vercelli, Alessandro/A-1926-2012	Vercelli, Alessandro/0000-0002-5909-2128	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) PRIN grant, to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Blair PJ, 2012, J PHYSIOL-LONDON, V590, P1017, DOI 10.1113/jphysiol.2012.227868; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen ZG, 2005, J NEUROBIOL, V62, P207, DOI 10.1002/neu.20099; Cho JY, 2002, NEUROSCI LETT, V334, P131, DOI 10.1016/S0304-3940(02)01122-9; Choy MS, 2006, NEUROSCI LETT, V405, P120, DOI 10.1016/j.neulet.2006.06.037; Crossman AR, 2000, J ANAT, V196, P519, DOI 10.1046/j.1469-7580.2000.19640519.x; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Haberny KA, 2002, TOXICOL SCI, V68, P9, DOI 10.1093/toxsci/68.1.9; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jarrett SG, 2008, NEUROBIOL DIS, V30, P130, DOI 10.1016/j.nbd.2007.12.009; Lee HN, 2010, NEUROCHEM RES, V35, P114, DOI 10.1007/s11064-009-0036-3; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Lipton SA, 2008, NAT NEUROSCI, V11, P381, DOI 10.1038/nn0408-381; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marino S, 2002, DEVELOPMENT, V129, P3513; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sperow M, 2012, J PHYSIOL-LONDON, V590, P777, DOI 10.1113/jphysiol.2011.220236; Spigolon G, 2010, EUR J NEUROSCI, V31, P1261, DOI 10.1111/j.1460-9568.2010.07158.x; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sury MD, 2011, NEUROBIOL DIS, V41, P201, DOI 10.1016/j.nbd.2010.09.007; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010; Zu LY, 2011, AM J PHYSIOL-HEART C, V300, pH2177, DOI 10.1152/ajpheart.01138.2010	46	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114554	10.1371/journal.pone.0114554	http://dx.doi.org/10.1371/journal.pone.0114554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501575	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400035
J	Mykkanen, OT; Huotari, A; Herzig, KH; Dunlop, TW; Mykkanen, H; Kirjavainen, PV				Mykkanen, Otto T.; Huotari, Anne; Herzig, Karl-Heinz; Dunlop, Thomas W.; Mykkanen, Hannu; Kirjavainen, Pirkka V.			Wild Blueberries (Vaccinium myrtillus) Alleviate Inflammation and Hypertension Associated with Developing Obesity in Mice Fed with a High-Fat Diet	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; BLOOD-PRESSURE; AMELIORATES HYPERGLYCEMIA; GLUCOSE-INTOLERANCE; BERRY ANTHOCYANINS; INTERFERON-GAMMA; C57BL/6J MOUSE; WHOLE BERRIES; T-CELLS	Background: Low-grade metabolic inflammation and hypertension are primary mechanisms involved in obesity-associated adverse health effects. Berries, especially Nordic wild blueberries (hereafter referred to as bilberries), represent an important source of dietary anthocyanins, a group of polyphenols with potential beneficial effects to combat obesity-associated metabolic disturbances. Methods: The effects of 5% or 10% (w/w) of whole bilberries (BB) were studied on the development of obesity and its metabolic disturbances in C57BL mice fed with a high-fat diet (HFD) for three months. Cytokines, inflammatory cells, systolic blood pressure, glucose tolerance, insulin sensitivity, weight gain, body fat, food consumption and energy metabolism were assessed. Results: Bilberries ameliorated type 1 pro-inflammatory responsiveness induced by HFD. This was indicated by the altered cytokine profile and the reduced prevalence of interferon gamma - producing T-cells, in particular T helper type 1 cells. Bilberries also prevented the progression of obesity associated long term increase in systolic blood pressure in mice. Conclusions: Bilberries reduce the development of systemic inflammation and prevent the progression of chronic hypertension, thus supporting their potential role in alleviating the adverse health effects associated with developing obesity.	[Mykkanen, Otto T.; Mykkanen, Hannu; Kirjavainen, Pirkka V.] Univ Eastern Finland, Food & Hlth Res Ctr, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Huotari, Anne; Dunlop, Thomas W.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Herzig, Karl-Heinz] Univ Oulu, Med Ctr, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Univ Oulu, Med Ctr, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland; [Kirjavainen, Pirkka V.] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Mykkanen, OT (corresponding author), Univ Eastern Finland, Food & Hlth Res Ctr, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland.	otto.mykkanen@uef.fi	Kirjavainen, Pirkka/AAW-6833-2021; Kirjavainen, Pirkka/AAX-8069-2020	Kirjavainen, Pirkka/0000-0001-6119-8768; 	Academy of Finland [133431, 108478, 129568]; Graduate School of Applied Biosciences; Yrjo Jahnsson Foundation; Northern Savo Fund of Finnish Cultural Foundation; Olvi Foundation; University of Eastern Finland	Academy of Finland(Academy of Finland); Graduate School of Applied Biosciences; Yrjo Jahnsson Foundation; Northern Savo Fund of Finnish Cultural Foundation; Olvi Foundation; University of Eastern Finland	The work was supported by the Academy of Finland project #133431 (Effects of berry consumption on obesity-associated metabolic disorders) (http://www.aka.fi/), the Graduate School of Applied Biosciences (http://www.vetmed.helsinki.fi/abs/), Yrjo Jahnsson Foundation (http://www.yjs.fi/), The Northern Savo Fund of Finnish Cultural Foundation (https://www.skr.fi/), Olvi Foundation (http://www.olvisaatio.fi/), the University of Eastern Finland (http://www.uef.fi/) and in part by grants from the Academy of Finland (#108478 and #129568). Bilberries were kindly provided as gift from a local company, Joswola, Iisalmi, Finland and freeze dried within European networks project collaboration (ELLU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Aoqui C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-31; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Baumann M, 2009, J CLIN HYPERTENS, V11, P11, DOI 10.1111/j.1751-7176.2008.00057.x; Bell DR, 2006, J APPL PHYSIOL, V100, P1164, DOI 10.1152/japplphysiol.00626.2005; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; De Ciuceis C, 2014, IMMUNE MECH HYPERTEN; DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; Graf D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066690; H Xu, 2013, DRUG DISCOV TODAY DI, V10, P21, DOI DOI 10.1016/J.DDMEC.2013.03.006; Harrison David G, 2008, Curr Cardiol Rep, V10, P464; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Helmstadter A, 2010, PHARMAZIE, V65, P315, DOI 10.1691/ph.2010.9402; Heyman L, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/403041; Houston M, 2013, J CLIN HYPERTENS, V15, P752, DOI 10.1111/jch.12188; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Joseph SV, 2014, J AGR FOOD CHEM; Kalea AZ, 2010, J NUTR BIOCHEM, V21, P14, DOI 10.1016/j.jnutbio.2008.09.005; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karlsen A, 2010, EUR J NUTR, V49, P345, DOI 10.1007/s00394-010-0092-0; Kirjavainen PV, 2009, CLIN VACCINE IMMUNOL, V16, P29, DOI 10.1128/CVI.00323-08; Kirjavainen PV, 1999, CLIN DIAGN LAB IMMUN, V6, P799, DOI 10.1128/CDLI.6.6.799-802.1999; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Kolehmainen M, 2012, MOL NUTR FOOD RES, V56, P1501, DOI 10.1002/mnfr.201200195; Koponen JM, 2007, J AGR FOOD CHEM, V55, P1612, DOI 10.1021/jf062897a; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mendes A, 2003, FUND CLIN PHARMACOL, V17, P673, DOI 10.1046/j.1472-8206.2003.00198.x; MILLS E, 1993, AM J PHYSIOL, V264, pR73, DOI 10.1152/ajpregu.1993.264.1.R73; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Mykkanen OT, 2012, MOL VIS, V18, P2338; Nile SH, 2014, NUTRITION, V30, P134, DOI 10.1016/j.nut.2013.04.007; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ovaskainen ML, 2008, J NUTR, V138, P562; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Papadopoulos Dimitrios P, 2005, J Clin Hypertens (Greenwich), V7, P729, DOI 10.1111/j.1524-6175.2005.04888.x; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Riihinen K, 2008, FOOD CHEM, V110, P156, DOI 10.1016/j.foodchem.2008.01.057; Riso P, 2013, EUR J NUTR, V52, P949, DOI 10.1007/s00394-012-0402-9; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rodriguez-Mateos A, 2013, BRIT J NUTR, V109, P1746, DOI 10.1017/S0007114512003911; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Sautebin L, 2004, PLANTA MED, V70, P745, DOI 10.1055/s-2004-827206; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Shindo M, 2007, J NUTR SCI VITAMINOL, V53, P90, DOI 10.3177/jnsv.53.90; Stas SN, 2004, REV ENDOCR METAB DIS, V5, P221, DOI 10.1023/B:REMD.0000032410.75638.da; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takano H, 2007, TRENDS PHARMACOL SCI, V28, P512, DOI 10.1016/j.tips.2007.09.002; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Winer S, 2012, IMMUNOL CELL BIOL, V90, P755, DOI 10.1038/icb.2011.110; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang M, 2011, CURR MED CHEM, V18, P291, DOI 10.2174/092986711794088380	82	57	59	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114790	10.1371/journal.pone.0114790	http://dx.doi.org/10.1371/journal.pone.0114790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501421	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400051
J	Sabol, M; Trnski, D; Uzarevic, Z; Ozretic, P; Musani, V; Rafaj, M; Cindric, M; Levanat, S				Sabol, Maja; Trnski, Diana; Uzarevic, Zvonimir; Ozretic, Petar; Musani, Vesna; Rafaj, Maja; Cindric, Mario; Levanat, Sonja			Combination of Cyclopamine and Tamoxifen Promotes Survival and Migration of MCF-7 Breast Cancer Cells - Interaction of Hedgehog-Gli and Estrogen Receptor Signaling Pathways	PLOS ONE			English	Article							SONIC-HEDGEHOG; THERAPEUTIC TARGET; POOR-PROGNOSIS; EXPRESSION; PROTEIN; PROHIBITIN; ALPHA; PROLIFERATION; ACTIVATION; DNA	Hedgehog-Gli (Hh-Gli) signaling pathway is one of the new molecular targets found upregulated in breast tumors. Estrogen receptor alpha (ER alpha) signaling has a key role in the development of hormone-dependent breast cancer. We aimed to investigate the effects of inhibiting both pathways simultaneously on breast cancer cell survival and the potential interactions between these two signaling pathways. ER-positive MCF-7 cells show decreased viability after treatment with cyclopamine, a Hh-Gli pathway inhibitor, as well as after tamoxifen (an ER alpha inhibitor) treatment. Simultaneous treatment with cyclopamine and tamoxifen on the other hand, causes short-term survival of cells, and increased migration. We found upregulated Hh-Gli signaling under these conditions and protein profiling revealed increased expression of proteins involved in cell proliferation and migration. Therefore, even though Hh-Gli signaling seems to be a good potential target for breast cancer therapy, caution must be advised, especially when combining therapies. In addition, we also show a potential direct interaction between the Shh protein and ER alpha in MCF-7 cells. Our data suggest that the Shh protein is able to activate ER alpha independently of the canonical Hh-Gli signaling pathway. Therefore, this may present an additional boost for ER-positive cells that express Shh, even in the absence of estrogen.	[Sabol, Maja; Trnski, Diana; Ozretic, Petar; Musani, Vesna; Rafaj, Maja; Cindric, Mario; Levanat, Sonja] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Uzarevic, Zvonimir] Josip Juraj Strossmayer Univ Osijek, Fac Educ, Osijek, Croatia	Rudjer Boskovic Institute; University of JJ Strossmayer Osijek	Levanat, S (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia.	levanat@irb.hr	Sabol, Maja/G-4177-2011; Užarević, Zvonimir/AAC-8963-2021; Trnski, Diana/N-6816-2015; Musani, Vesna/K-7972-2019; Ozretić, Petar/G-5189-2014	Sabol, Maja/0000-0001-6968-2327; Ozretić, Petar/0000-0001-9757-6636; Musani, Vesna/0000-0001-9927-3727; Uzarevic, Zvonimir/0000-0001-9543-321X; Trnski, Diana/0000-0003-2441-8439	Croatian Ministry of Science, Education and Sports [098-0982464-2461]; European Union [316289 - InnoMol, FP7-REGPOT-2012-2013-1]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); European Union(European Commission)	This work was supported by funds from the Croatian Ministry of Science, Education and Sports, Grant No. 098-0982464-2461, and the European Union's Seventh Framework Programme for Research and Technological Development under grant agreement No. 316289 - InnoMol, FP7-REGPOT-2012-2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Antonioli P, 2009, J CHROMATOGR A, V1216, P3606, DOI 10.1016/j.chroma.2008.11.053; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; CHE J, 2013, ONCOL LETT; Chu YW, 1996, AM J PATHOL, V148, P63; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guay J, 1997, J CELL SCI, V110, P357; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jinawath A, 2007, J CANCER RES CLIN, V133, P271, DOI 10.1007/s00432-006-0166-9; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kameda C, 2010, BRIT J CANCER, V102, P738, DOI 10.1038/sj.bjc.6605517; Koga K, 2008, ANTICANCER RES, V28, P731; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Kwon SM, 2010, J ENDODONT, V36, P1332, DOI 10.1016/j.joen.2010.04.010; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Leovic D, 2012, HEAD NECK-J SCI SPEC, V34, P104, DOI 10.1002/hed.21696; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maurac I, 2012, INT J GYNECOL PATHOL, V31, P264, DOI 10.1097/PGP.0b013e31823b6f0f; Mazumdar M, 2010, CANCER RES, V70, DOI 10.1158/1538-7445.AM10-2940; Mimeault M, 2006, INT J CANCER, V118, P1022, DOI 10.1002/ijc.21440; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Panfoli I, 2012, EXPERT REV PROTEOMIC, V9, P627, DOI [10.1586/epr.12.63, 10.1586/EPR.12.63]; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Sabol M, 2012, INT J ONCOL, V41, P1411, DOI 10.3892/ijo.2012.1554; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sinha S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-84; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Teh MT, 2002, CANCER RES, V62, P4773; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Wicking C, 1998, ONCOGENE, V16, P1091, DOI 10.1038/sj.onc.1201644; Wolf I, 2007, BREAST CANCER RES TR, V105, P139, DOI 10.1007/s10549-006-9440-4; Xie JW, 1997, CANCER RES, V57, P2369; Xu ZB, 2011, SCI CHINA LIFE SCI, V54, P121, DOI 10.1007/s11427-010-4130-1; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3; Zhao JY, 2010, BREAST CANCER RES TR, V119, P39, DOI 10.1007/s10549-009-0323-3	56	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114510	10.1371/journal.pone.0114510	http://dx.doi.org/10.1371/journal.pone.0114510			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503972	gold, Green Published			2022-12-26	WOS:000346375400033
J	Schofield, AJ; Kingdom, FAA				Schofield, Andrew J.; Kingdom, Frederick A. A.			Texture Variations Suppress Suprathreshold Brightness and Colour Variations	PLOS ONE			English	Article							CHROMOLUMINANCE PATTERNS; RED-GREEN; LUMINANCE; CONTRAST; MECHANISMS; SENSITIVITY; LIGHTNESS; CONE; INFORMATION; ADAPTATION	Discriminating material changes from illumination changes is a key function of early vision. Luminance cues are ambiguous in this regard, but can be disambiguated by co-incident changes in colour and texture. Thus, colour and texture are likely to be given greater prominence than luminance for object segmentation, and better segmentation should in turn produce stronger grouping. We sought to measure the relative strengths of combined luminance, colour and texture contrast using a suprathreshhold, psychophysical grouping task. Stimuli comprised diagonal grids of circular patches bordered by a thin black line and contained combinations of luminance decrements with either violet, red, or texture increments. There were two tasks. In the Separate task the different cues were presented separately in a two-interval design, and participants indicated which interval contained the stronger orientation structure. In the Combined task the cues were combined to produce competing orientation structure in a single image. Participants had to indicate which orientation, and therefore which cue was dominant. Thus we established the relative grouping strength of each cue pair presented separately, and compared this to their relative grouping strength when combined. In this way we observed suprathreshold interactions between cues and were able to assess cue dominance at ecologically relevant signal levels. Participants required significantly more luminance and colour compared to texture contrast in the Combined compared to Separate conditions (contrast ratios differed by about 0.1 log units), showing that suprathreshold texture dominates colour and luminance when the different cues are presented in combination.	[Schofield, Andrew J.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Kingdom, Frederick A. A.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	University of Birmingham; McGill University	Schofield, AJ (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	a.j.schofield@bham.ac.uk		Schofield, Andrew J./0000-0002-0589-4678	Canadian Institute of Health Research [MOP 82755, MOP 123349]; Engineering and Physical Sciences Research Council [EP/F026269/1]; Royal Society Travel grant; EPSRC [EP/F026269/1] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Travel grant(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Canadian Institute of Health Research (www.cihr-irsc.gc.ca/e/193.html) grants MOP 82755 and MOP 123349 awarded to FK and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant (EP/F026269/1) and a Royal Society (www.royalsociety.org) Travel grant to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H, 1995, CHECKER SHADOW ILLUS; Amano K, 2014, J OPT SOC AM A, V31, pA254, DOI 10.1364/JOSAA.31.00A254; CHAPARRO A, 1994, VISION RES, V34, P751, DOI 10.1016/0042-6989(94)90214-3; Chen CC, 2000, VISION RES, V40, P773, DOI 10.1016/S0042-6989(99)00227-8; Chen CC, 2000, VISION RES, V40, P789, DOI 10.1016/S0042-6989(99)00228-X; Clery S, 2013, J VISION, V13, DOI 10.1167/13.5.16; COLE GR, 1993, J OPT SOC AM A, V10, P38, DOI 10.1364/JOSAA.10.000038; COLE GR, 1990, J OPT SOC AM A, V7, P128, DOI 10.1364/JOSAA.7.000128; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Georgeson MA, 2002, SPATIAL VISION, V16, P59, DOI 10.1163/15685680260433913; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; GUR M, 1992, VISION RES, V32, P1253, DOI 10.1016/0042-6989(92)90220-D; Johnson AP, 2005, J OPT SOC AM A, V22, P2050, DOI 10.1364/JOSAA.22.002050; Kingdom FAA, 2004, PERCEPTION, V33, P907, DOI 10.1068/p5264; Kingdom FAA, 2006, SPATIAL VISION, V19, P147, DOI 10.1163/156856806776923461; Kingdom FAA, 2005, VISION RES, V45, P1425, DOI 10.1016/j.visres.2004.11.023; Kingdom FAA, 2003, NAT NEUROSCI, V6, P641, DOI 10.1038/nn1060; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; Kingdom FAA, 2014, VISION RES, V95, P36, DOI 10.1016/j.visres.2013.12.004; Kingdom FAA, 2010, J VISION, V10, DOI 10.1167/10.10.13; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; LANDY MS, 1991, VISION RES, V31, P679, DOI 10.1016/0042-6989(91)90009-T; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Mamassian P, 2001, VISION RES, V41, P2653, DOI 10.1016/S0042-6989(01)00147-X; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; MULLEN KT, 1994, J OPT SOC AM A, V11, P3136, DOI 10.1364/JOSAA.11.003136; NOORLANDER C, 1983, J OPT SOC AM, V73, P1533, DOI 10.1364/JOSA.73.001533; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Prins N, 2009, PALMEDES MATLAB ROUT; Regan BC, 1997, DOC OPHTH P, V59, P261; RUBIN JM, 1982, BIOL CYBERN, V45, P215, DOI 10.1007/BF00336194; Sankeralli MJ, 1997, J OPT SOC AM A, V14, P906; Schofield AJ, 1999, VISION RES, V39, P2697, DOI 10.1016/S0042-6989(98)00284-3; Schofield AJ, 2006, VISION RES, V46, P3462, DOI 10.1016/j.visres.2006.03.014; Schofield AJ, 2010, J VISION, V10, DOI 10.1167/10.9.2; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STROMEYER CF, 1985, VISION RES, V25, P219, DOI 10.1016/0042-6989(85)90116-6; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114803	10.1371/journal.pone.0114803	http://dx.doi.org/10.1371/journal.pone.0114803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502555	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000346375400055
J	Dona, F; Houseley, J				Dona, Federico; Houseley, Jonathan			Unexpected DNA Loss Mediated by the DNA Binding Activity of Ribonuclease A	PLOS ONE			English	Article							BOVINE PANCREATIC RIBONUCLEASE; EMBRYONIC STEM-CELLS; PERICENTRIC HETEROCHROMATIN; SATELLITE REPEATS; MOUSE DEVELOPMENT; TRANSCRIPTION; METHYLATION; MECHANISM; PATHWAY	Ribonuclease A (RNase A) is widely used in molecular biology research both for analytical assays and for nucleic acid preparation. The catalytic mechanism of RNase A is well understood and absolutely precludes activity on DNA; however anecdotal reports of DNA degradation by RNase A are not uncommon. Here we describe a mechanism by which RNase A treatment can lead to apparent DNA degradation. This results from the surprising finding that RNase A remains functional in a phenol: chloroform mixture, to our knowledge the only enzyme that survives this highly denaturing solvent environment. Although RNase A does not cleave the DNA backbone it is capable of binding to DNA, forming stable RNase ADNA complexes that partition to the interphase or organic phase during phenol: chloroform purification. The unexpected survival of the RNase A DNA-binding activity in phenol means that these complexes are not dissolved and a substantial amount of RNase A- bound DNA is permanently removed from the aqueous phase and lost on phase separation. This effect will impact DNA recovery from multiple procedures and is likely to represent a source of sequence bias in genome- wide studies. Our results also indicate that the results of analytical studies performed using RNase A must be considered with care.	[Dona, Federico; Houseley, Jonathan] Babraham Inst, Epigenet Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Houseley, J (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	jon.houseley@babraham.ac.uk	Houseley, Jon/AAF-7409-2021	Dona, Federico/0000-0002-4232-4762; Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust [088335]; scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome; BBSRC [BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust [grant number 088335], FD was partially supported by a scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BenoreParsons M, 1997, BIOTECHNIQUES, V23, P128, DOI 10.2144/97231st04; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; FELSENFELD G, 1963, P NATL ACAD SCI USA, V50, P644, DOI 10.1073/pnas.50.4.644; FINDLAY D, 1961, NATURE, V190, P781, DOI 10.1038/190781a0; GAUBATZ JW, 1990, J BIOL CHEM, V265, P17753; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; GUTTE B, 1969, J AM CHEM SOC, V91, P501, DOI 10.1021/ja01030a050; HIRSCHMANN R, 1969, J AM CHEM SOC, V91, P507, DOI 10.1021/ja01030a055; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Jones W, 1920, AM J PHYSIOL, V52, P203, DOI 10.1152/ajplegacy.1920.52.1.203; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KARTHA G, 1967, NATURE, V213, P862, DOI 10.1038/213862a0; KUNITZ M., 1940, JOUR GEN PHYSIOL, V24, P15, DOI 10.1085/jgp.24.1.15; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MOORE S, 1973, SCIENCE, V180, P458, DOI 10.1126/science.180.4085.458; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Richards F M, 1972, Science, V178, P492, DOI 10.1126/science.178.4060.492; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SAUNDERS M, 1957, J AM CHEM SOC, V79, P3289, DOI 10.1021/ja01569a083; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; WYCKOFF HW, 1967, J BIOL CHEM, V242, P3984	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115008	10.1371/journal.pone.0115008	http://dx.doi.org/10.1371/journal.pone.0115008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502562	Green Published, gold			2022-12-26	WOS:000347146700082
J	Kwak, W; Song, KD; Oh, JD; Heo, KN; Lee, JH; Lee, WK; Yoon, SH; Kim, H; Cho, S; Lee, HK				Kwak, Woori; Song, Ki-Duk; Oh, Jae-Don; Heo, Kang-Nyeong; Lee, Jun-Heon; Lee, Woon Kyu; Yoon, Sook Hee; Kim, Heebal; Cho, Seoae; Lee, Hak-Kyo			Uncovering Genomic Features and Maternal Origin of Korean Native Chicken by Whole Genome Sequencing	PLOS ONE			English	Article							PROTEIN; GENE; EXPRESSION; GENERATION; ALIGNMENT; FORMAT; MODEL; SNPS; CELL	The Korean Native Chicken (KNC) is an important endemic biological resource in Korea. While numerous studies have been conducted exploring this breed, none have used next-generation sequencing to identify its specific genomic features. We sequenced five strains of KNC and identified 10.9 million SNVs and 1.3 million InDels. Through the analysis, we found that the highly variable region common to all 5 strains had genes like PCHD15, CISD1, PIK3C2A, and NUCB2 that might be related to the phenotypic traits of the chicken such as auditory sense, growth rate and egg traits. In addition, we assembled unaligned reads that could not be mapped to the reference genome. By assembling the unaligned reads, we were able to present genomic sequences characteristic to the KNC. Based on this, we also identified genes related to the olfactory receptors and antigen that are common to all 5 strains. Finally, through the reconstructed mitochondrial genome sequences, we performed phylogenomic analysis and elucidated the maternal origin of the artificially restored KNC. Our results revealed that the KNC has multiple maternal origins which are in agreement with Korea's history of chicken breed imports. The results presented here provide a valuable basis for future research on genomic features of KNC and further understanding of KNC's origin.	[Kwak, Woori; Cho, Seoae] C&K Genom, Seoul, South Korea; [Kwak, Woori] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Song, Ki-Duk; Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansong, South Korea; [Heo, Kang-Nyeong] Natl Inst Anim Sci, Poultry Sci Div, Cheonan, South Korea; [Lee, Woon Kyu] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Taejon, South Korea; [Lee, Woon Kyu] Inha Univ, Sch Med, Inha Res Inst Med Sci, Inchon, South Korea; [Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Hankyong National University; National Institute of Animal Science, Republic of Korea; Chungnam National University; Inha University; Seoul National University (SNU); Seoul National University (SNU)	Lee, HK (corresponding author), Hankyong Natl Univ, Genom Informat Ctr, Ansong, South Korea.	breedlee@empas.com	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Lee, Jun Heon/0000-0003-3996-9209	next generation BioGreen 21 Project of Rural Development Administration, Republic of Korea [PJ008196]	next generation BioGreen 21 Project of Rural Development Administration, Republic of Korea	This study was supported by next generation BioGreen 21 Project (PJ008196) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; Bolger AM, 2014, BIOINFORMATICS; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hall T., 2004, BIOEDIT VERSION 7 0; Hoque MR, 2011, ASIAN AUSTRAL J ANIM, V24, P1637, DOI 10.5713/ajas.2011.11144; Hoque MR, 2013, RECONSTRUCTION PHYLO; Horwitz GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008627; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kong HS, 2006, ASIAN AUSTRAL J ANIM, V19, P1546, DOI 10.5713/ajas.2006.1546; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2012, ASIAN AUSTRAL J ANIM, V25, P895, DOI 10.5713/ajas.2011.11374; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo J, 2007, DEV DYNAM, V236, P2331, DOI 10.1002/dvdy.21248; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mann K, 2007, PROTEOMICS, V7, P106, DOI 10.1002/pmic.200600635; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miao Y, 2012, HEREDITY; Oh JD, 2006, ASIAN AUSTRAL J ANIM, V19, P1065; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; PLOTREE D, 1989, PHYLIP PHYLOGENY INF; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tarailo-Graovac M., 2009, CURRENT PROTOCOLS BI; Wang XF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-351; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Yoon S, 2014, MOL CELLS, V37, P314, DOI 10.14348/molcells.2014.2360	34	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114763	10.1371/journal.pone.0114763	http://dx.doi.org/10.1371/journal.pone.0114763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501044	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700052
J	Vent-Schmidt, J; Waltz, X; Romana, M; Hardy-Dessources, MD; Lemonne, N; Billaud, M; Etienne-Julan, M; Connes, P				Vent-Schmidt, Jens; Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Lemonne, Nathalie; Billaud, Marie; Etienne-Julan, Maryse; Connes, Philippe			Blood Thixotropy in Patients with Sickle Cell Anaemia: Role of Haematocrit and Red Blood Cell Rheological Properties	PLOS ONE			English	Article							AGGREGATE STRENGTH; ALPHA-THALASSEMIA; DEFORMABILITY; EVOLUTION; DISEASE; CRISIS; RISK	We compared the blood thixotropic/shear-thinning properties and the red blood cells' (RBC) rheological properties between a group of patients with sickle cell anaemia (SS) and healthy individuals (AA). Blood thixotropy was determined by measuring blood viscosity with a capillary viscometer using a "loop" protocol: the shear rate started at 1 s(-1) and increased progressively to 922 s(-1) and then redecreased to the initial shear rate. Measurements were performed at native haematocrit for the two groups and at 25% and 40% haematocrit for the AA and SS individuals, respectively. RBC deformability was determined by ektacytometry and RBC aggregation properties by laser backscatter versus time. AA at native haematocrit had higher blood thixotropic index than SS at native haematocrit and AA at 25% haematocrit. At 40% haematocrit, SS had higher blood thixotropic index than AA. While RBC deformability and aggregation were lower in SS than in AA, the strength of RBC aggregates was higher in the former population. Our results showed that 1) anaemia is the main modulator of blood thixtropy and 2) the low RBC deformability and high RBC aggregates strength cause higher blood thixotropy in SS patients than in AA individuals at 40% haematocrit, which could impact blood flow in certain vascular compartments.	[Vent-Schmidt, Jens; Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Etienne-Julan, Maryse; Connes, Philippe] CHU Pointe A Pitre, Hop Ricou, Inserm UMR 1134, Pointe A Pitre 97157, Guadeloupe, France; [Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Etienne-Julan, Maryse; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, F-75015 Paris, France; [Waltz, Xavier] French West Indies & Guiana Univ, Dept Physiol, Lab ACTES EA 3596, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Billaud, Marie; Etienne-Julan, Maryse] CHU Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre 97157, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Connes, Philippe] Univ Lyon 1, Lab CRIS EA647, F-69100 Villeurbanne, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Institut Universitaire de France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Connes, P (corresponding author), CHU Pointe A Pitre, Hop Ricou, Inserm UMR 1134, Pointe A Pitre 97157, Guadeloupe, France.	pconnes@yahoo.fr	, Hardy-dessources/K-9189-2017; WALTZ, Xavier/M-3606-2016; Romana, Marc/K-6442-2017; Connes, Philippe/J-7835-2019	, Hardy-dessources/0000-0003-0861-3648; WALTZ, Xavier/0000-0002-0838-290X; Romana, Marc/0000-0002-8715-9836; Connes, Philippe/0000-0002-9232-0268; ETIENNE-JULAN, Maryse/0000-0003-1339-6545				BALLAS SK, 1988, BLOOD, V72, P1216; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; BALLAS SK, 1991, AM J HEMATOL, V36, P122, DOI 10.1002/ajh.2830360211; BARBEE JH, 1971, MICROVASC RES, V3, P6, DOI 10.1016/0026-2862(71)90002-1; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; CLARK MR, 1980, J CLIN INVEST, V65, P189, DOI 10.1172/JCI109650; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; Connes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079680; DINTENFASS L, 1962, Sogo Rinsho, V11, P233; EMBURY SH, 1984, J CLIN INVEST, V73, P116, DOI 10.1172/JCI111181; Franco M, 2013, BLOOD, V121, P546, DOI 10.1182/blood-2012-07-442467; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hierso R, 2014, BRIT J HAEMATOL, V166, P601, DOI 10.1111/bjh.12912; Lamarre Y, 2014, CLIN HEMORHEOL MICRO, V57, P63, DOI 10.3233/CH-131772; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LANDE WM, 1988, BLOOD, V72, P2056; Lemaire C, 2013, CLIN HEMORHEOL MICRO, V55, P205, DOI 10.3233/CH-2012-1622; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; MOHANDAS N, 1989, ANN NY ACAD SCI, V565, P327, DOI 10.1111/j.1749-6632.1989.tb24180.x; NASH GB, 1986, BLOOD, V67, P110; Stuart J, 1987, Baillieres Clin Haematol, V1, P747, DOI 10.1016/S0950-3536(87)80023-9; Thurston GB, 2004, CLIN HEMORHEOL MICRO, V30, P83; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Vaya A, 2014, CLIN HEMORHEOL MICRO; Vaya A, 2013, CLIN HEMORHEOL MICRO; Waltz X, 2012, CLIN HEMORHEOL MICRO, V52, P15, DOI 10.3233/CH-2012-1540	30	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114412	10.1371/journal.pone.0114412	http://dx.doi.org/10.1371/journal.pone.0114412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502228	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700022
J	Fujise, L; Yamashita, H; Suzuki, G; Sasaki, K; Liao, LM; Koike, K				Fujise, Lisa; Yamashita, Hiroshi; Suzuki, Go; Sasaki, Kengo; Liao, Lawrence M.; Koike, Kazuhiko			Moderate Thermal Stress Causes Active and Immediate Expulsion of Photosynthetically Damaged Zooxanthellae (Symbiodinium) from Corals	PLOS ONE			English	Article							REEF CORALS; STYLOPHORA-PISTILLATA; OXIDATIVE STRESS; SURFACE-AREA; NITRIC-OXIDE; MASS EXPULSION; CELL-DEATH; TEMPERATURE; MECHANISMS; PATTERNS	The foundation of coral reef biology is the symbiosis between corals and zooxanthellae (dinoflagellate genus Symbiodinium). Recently, coral bleaching, which often results in mass mortality of corals and the collapse of coral reef ecosystems, has become an important issue around the world as coral reefs decrease in number year after year. To understand the mechanisms underlying coral bleaching, we maintained two species of scleractinian corals (Acroporidae) in aquaria under non-thermal stress (27 degrees C) and moderate thermal stress conditions (30 degrees C), and we compared the numbers and conditions of the expelled Symbiodinium from these corals. Under non-thermal stress conditions corals actively expel a degraded form of Symbiodinium, which are thought to be digested by their host coral. This response was also observed at 30 degrees C. However, while the expulsion rates of Symbiodinium cells remained constant, the proportion of degraded cells significantly increased at 30 degrees C. This result indicates that corals more actively digest and expel damaged Symbiodinium under thermal stress conditions, likely as a mechanism for coping with environmental change. However, the increase in digested Symbiodinium expulsion under thermal stress may not fully keep up with accumulation of the damaged cells. There are more photosynthetically damaged Symbiodinium upon prolonged exposure to thermal stress, and corals release them without digestion to prevent their accumulation. This response may be an adaptive strategy to moderate stress to ensure survival, but the accumulation of damaged Symbiodinium, which causes subsequent coral deterioration, may occur when the response cannot cope with the magnitude or duration of environmental stress, and this might be a possible mechanism underlying coral bleaching during prolonged moderate thermal stress.	[Fujise, Lisa; Liao, Lawrence M.; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Yamashita, Hiroshi; Suzuki, Go] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Sasaki, Kengo] Western Reg Ind Res Ctr, Higashihiroshima, Hiroshima, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019; Liao, Lawrence Manzano/Y-9944-2018	Liao, Lawrence Manzano/0000-0001-5484-6560; Kazuhiko, Koike/0000-0001-5380-5839; Yamashita, Hiroshi/0000-0002-3909-5073	Ministry of Education, Culture, Sports, Science and Technology of Japan [24570028]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (No. 24570028) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WALL STREET J; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; Baird AH, 1998, CORAL REEFS, V17, P376, DOI 10.1007/s003380050142; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bhagooli R, 2004, MAR BIOL, V145, P329, DOI 10.1007/s00227-004-1309-7; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2000, MAR ECOL PROG SER, V195, P117, DOI 10.3354/meps195117; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Bythell JC, 2001, CORAL REEFS, V20, P193; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; EGANA AC, 1982, PAC SCI, V36, P61; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Fujise Lisa, 2013, Galaxea - Tokyo, V15, P29; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Glynn PW, 2001, B MAR SCI, V69, P79; GOREAU TF, 1964, SCIENCE, V145, P383, DOI 10.1126/science.145.3630.383; GOREAU TJ, 1994, AMBIO, V23, P176; Hawkins TD, 2014, CORAL REEFS, V33, P141, DOI 10.1007/s00338-013-1103-4; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hikosaka-Katayama T, 2012, ZOOL SCI, V29, P559, DOI 10.2108/zsj.29.559; Hill R, 2007, MAR ECOL PROG SER, V352, P137, DOI 10.3354/meps07159; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; HOEGHGULDBERG O, 1988, CORAL REEFS, V7, P113, DOI 10.1007/BF00300970; Holmes G, 2008, J EXP MAR BIOL ECOL, V365, P67, DOI 10.1016/j.jembe.2008.07.045; JAAP WC, 1979, B MAR SCI, V29, P414; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; KOBLUK DR, 1994, B MAR SCI, V54, P142; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Ladriere O, 2008, CAH BIOL MAR, V49, P215; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P157, DOI 10.4319/lo.1985.30.1.0157; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; NHK Online, 2013, NHK ONLINE      0830; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Podesta GP, 2001, B MAR SCI, V69, P43; Podesta GP, 1997, J GEOPHYS RES-OCEANS, V102, P15749, DOI 10.1029/96JC03557; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Reaka-Kudla Marjorie L., 1997, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; Rosenberg E, 1999, REEF ENCOUNTER, V25, P8; Shimpo Ryukyu, 2013, RYUKYU SHIMPO   0818; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilkinson C, 2008, STATUS CORAL REEFS W; Winter A, 1998, CORAL REEFS, V17, P377, DOI 10.1007/s003380050143; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z	70	46	49	4	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114321	10.1371/journal.pone.0114321	http://dx.doi.org/10.1371/journal.pone.0114321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493938	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400041
J	Phuyal, S; Skotland, T; Hessvik, NP; Simolin, H; Overbye, A; Brech, A; Parton, RG; Ekroos, K; Sandvig, K; Llorente, A				Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Simolin, Helena; Overbye, Anders; Brech, Andreas; Parton, Robert G.; Ekroos, Kim; Sandvig, Kirsten; Llorente, Alicia			The Ether Lipid Precursor Hexadecylglycerol Stimulates the Release and Changes the Composition of Exosomes Derived from PC-3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT; EXTRACELLULAR VESICLES; ETHANOLAMINE PLASMALOGEN; MULTIVESICULAR BODIES; MOLECULAR LIPIDOMICS; CHOLESTEROL; SECRETION; PLASMENYLETHANOLAMINE; PHOSPHOLIPIDS	Exosomes are vesicles released by cells after fusion of multi-vesicular bodies with the plasma membrane. In this study, we have investigated whether ether lipids affect the release of exosomes in PC-3 cells. To increase the cellular levels of ether lipids, the ether lipid precursor hexadecylglycerol was added to cells. Lipidomic analysis showed that this compound was in fact able to double the cellular levels of ether lipids in these cells. Furthermore, increased levels of ether lipids were also found in exosomes released by cells containing high levels of these lipids. Interestingly, as measured by nanoparticle tracking analysis, cells containing high levels of ether lipids released more exosomes than control cells, and these exosomes were similar in size to control exosomes. Moreover, silver staining and Western blot analyses showed that the protein composition of exosomes released in the presence of hexadecylglycerol was changed; the levels of some proteins were increased, and the levels of others were reduced. In conclusion, this study clearly shows that an increase in cellular ether lipids is associated with changes in the release and composition of exosomes.	[Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Overbye, Anders; Brech, Andreas; Sandvig, Kirsten; Llorente, Alicia] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway; [Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Overbye, Anders; Brech, Andreas; Sandvig, Kirsten; Llorente, Alicia] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway; [Simolin, Helena; Ekroos, Kim] Zora Biosci Oy, Espoo 02150, Finland; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4067, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4067, Australia; [Sandvig, Kirsten] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Queensland; University of Queensland; University of Oslo	Llorente, A (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway.	Alicia.Martinez.Llorente@rr-research.no	Llorente, Alicia/AAP-7349-2021; Parton, Robert/C-5673-2009	Llorente, Alicia/0000-0002-0045-071X; Brech, Andreas/0000-0002-9803-1774; Parton, Robert/0000-0002-7494-5248	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority; Research Council of Norway through its Centres of Excellence [179571]; National Health and Medical Research Council of Australia [1045092, 1058565]	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Research Council of Norway through its Centres of Excellence(Research Council of Norway); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Norwegian Cancer Society, the South-Eastern Norway Regional Health Authority, The Research Council of Norway through its Centres of Excellence funding scheme, Project Number 179571, and by Grant 1045092 and Fellowship 1058565 (to R. G. P.) from the National Health and Medical Research Council of Australia.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bergan J, 2014, CELL MOL LIFE SCI, V71, P4285, DOI 10.1007/s00018-014-1624-1; Bergan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075904; Biermann J, 1999, IUBMB LIFE, V48, P635, DOI 10.1080/152165499306531; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Edgar JR, 2014, TRAFFIC, V15, P197, DOI 10.1111/tra.12139; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Hahnel D, 1999, FREE RADICAL BIO MED, V27, P1087, DOI 10.1016/S0891-5849(99)00142-2; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huybrechts SJ, 2009, TRAFFIC, V10, P1722, DOI 10.1111/j.1600-0854.2009.00970.x; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kuczynski B, 2006, NEUROCHEM RES, V31, P639, DOI 10.1007/s11064-006-9061-7; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; LOHNER K, 1991, BIOCHIM BIOPHYS ACTA, V1061, P132, DOI 10.1016/0005-2736(91)90277-F; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; MORAND OH, 1988, J BIOL CHEM, V263, P11597; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sandvig K, 2014, PROG LIPID RES, V54, P1, DOI 10.1016/j.plipres.2014.01.001; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zhan YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077387; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	53	70	70	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4225	4237		10.1074/jbc.M114.593962	http://dx.doi.org/10.1074/jbc.M114.593962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25519911	Green Published, hybrid			2022-12-26	WOS:000349458400033
J	Lynch, TP; Morello, EB; Evans, K; Richardson, AJ; Rochester, W; Steinberg, CR; Roughan, M; Thompson, P; Middleton, JF; Feng, M; Sherrington, R; Brando, V; Tilbrook, B; Ridgway, K; Allen, S; Doherty, P; Hill, K; Moltmann, TC				Lynch, Tim P.; Morello, Elisabetta B.; Evans, Karen; Richardson, Anthony J.; Rochester, Wayne; Steinberg, Craig R.; Roughan, Moninya; Thompson, Peter; Middleton, John F.; Feng, Ming; Sherrington, Robert; Brando, Vittorio; Tilbrook, Bronte; Ridgway, Ken; Allen, Simon; Doherty, Peter; Hill, Katherine; Moltmann, Tim C.			IMOS National Reference Stations: A Continental-Wide Physical, Chemical and Biological Coastal Observing System	PLOS ONE			English	Article							PHYTOPLANKTON	Sustained observations allow for the tracking of change in oceanography and ecosystems, however, these are rare, particularly for the Southern Hemisphere. To address this in part, the Australian Integrated Marine Observing System (IMOS) implemented a network of nine National Reference Stations (NRS). The network builds on one long-term location, where monthly water sampling has been sustained since the 1940s and two others that commenced in the 1950s. In-situ continuously moored sensors and an enhanced monthly water sampling regime now collect more than 50 data streams. Building on sampling for temperature, salinity and nutrients, the network now observes dissolved oxygen, carbon, turbidity, currents, chlorophyll a and both phytoplankton and zooplankton. Additional parameters for studies of ocean acidification and bio-optics are collected at a sub-set of sites and all data is made freely and publically available. Our preliminary results demonstrate increased utility to observe extreme events, such as marine heat waves and coastal flooding; rare events, such as plankton blooms; and have, for the first time, allowed for consistent continental scale sampling and analysis of coastal zooplankton and phytoplankton communities. Independent water sampling allows for cross validation of the deployed sensors for quality control of data that now continuously tracks daily, seasonal and annual variation. The NRS will provide multi-decadal time series, against which more spatially replicated short-term studies can be referenced, models and remote sensing products validated, and improvements made to our understanding of how large-scale, long-term change and variability in the global ocean are affecting Australia's coastal seas and ecosystems. The NRS network provides an example of how a continental scaled observing systems can be developed to collect observations that integrate across physics, chemistry and biology.	[Lynch, Tim P.; Evans, Karen; Thompson, Peter; Sherrington, Robert; Tilbrook, Bronte; Ridgway, Ken; Allen, Simon] CSIRO, Oceans & Atmosphere, Hobart, Tas 7001, Australia; [Morello, Elisabetta B.; Richardson, Anthony J.; Rochester, Wayne] CSIRO, Oceans & Atmosphere, Brisbane, Qld 4102, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, St Lucia, Qld 4072, Australia; [Steinberg, Craig R.; Doherty, Peter] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Roughan, Moninya] Univ New S Wales, Sch Math, Sydney, NSW 2052, Australia; [Middleton, John F.] South Australian Res & Dev Inst, Urrbrae, SA 5022, Australia; [Feng, Ming] CSIRO, Oceans & Atmosphere, Wembly, WA 6014, Australia; [Brando, Vittorio] CSIRO, Land & Water, Canberra, ACT 2601, Australia; [Hill, Katherine; Moltmann, Tim C.] Univ Tasmania, Integrated Marine Observ Syst, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Australian Institute of Marine Science; University of New South Wales Sydney; South Australian Research & Development Institute (SARDI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Lynch, TP (corresponding author), CSIRO, Oceans & Atmosphere, GPO Box 1538, Hobart, Tas 7001, Australia.	Tim.Lynch@csiro.au	Lynch, Tim P/A-1463-2012; Rochester, Wayne A/K-1569-2018; Ridgway, Ken/AAA-4040-2019; Brando, Vittorio E/A-1321-2008; Richardson, Anthony J/B-3649-2010; Roughan, Moninya/B-5563-2009; Thompson, Peter A/A-2361-2012; Tilbrook, Bronte/W-4007-2019; Feng, Ming/F-5411-2010; evans, karen/D-7110-2012; Doherty, Peter J/K-5211-2015; Tilbrook, Bronte/A-1522-2012	Rochester, Wayne A/0000-0002-7315-9341; Brando, Vittorio E/0000-0002-2193-5695; Richardson, Anthony J/0000-0002-9289-7366; Roughan, Moninya/0000-0003-3825-7533; Thompson, Peter A/0000-0002-9504-5433; Tilbrook, Bronte/0000-0001-9385-3827; Feng, Ming/0000-0002-2855-7092; Doherty, Peter J/0000-0001-6863-0533; Tilbrook, Bronte/0000-0001-9385-3827; Moltmann, Tim/0000-0002-7060-2117; Evans, Karen/0000-0003-2205-4264	Australian Government through the National Collaborative Research Infrastructure Strategy; Education Investment Fund; Collaborative Research Infrastructure Scheme	Australian Government through the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund; Collaborative Research Infrastructure Scheme	Funding for the development of the extended NRS described here was provided by the Australian Government through the National Collaborative Research Infrastructure Strategy (2007-2011), the Education Investment Fund (2009-2013) and the Collaborative Research Infrastructure Scheme (2013-2014). Co-investment has been provided by the Queensland and New South Wales State Government, the Northern Territory Government, the Commonwealth Science and Industry Research Organisation, the Australian Institute of Marine Science, the Sydney Institute of Marine Science and the South Australian Research and Development Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Australian Bureau of Statistics, 2019, 3101 0 AUSTR DEM STA; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BURFORD MA, 1995, MAR ECOL PROG SER, V118, P255, DOI 10.3354/meps118255; BUSALACCHI A, 2010, ESA PUBLICATION WPP, V2, P10, DOI DOI 10.5270/OCEANOBS09.PP.10; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dexter P., 2010, TROUBLED WATERS OCEA, P161; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DUARTE CM, 1992, NATURE, V356, P190, DOI 10.1038/356190a0; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Findlay CS, 2000, MAR MICROPALEONTOL, V40, P417, DOI 10.1016/S0377-8398(00)00046-3; FREELAND H, 2010, ESA PUBLICATION WPP, V2; Geoscience Australia, 2004, GEODATA COAST 100K 2; Glenn S.M., 2000, OCEANOGRAPHY, V13, P24, DOI [10.5670/oceanog.2000.50, DOI 10.5670/OCEANOG.2000.50]; GREGG WW, 2007, DEEP SEA RES 2, V54, P1; GRIFFIN DA, 2004, DECADE SST SATELLITE; GUNN JJ, 2010, ESA PUBLICATION WPP, V2, P20, DOI DOI 10.5270/OCEANOBS09.PP.20; HALLEGRAEFF GM, 1993, AUST J MAR FRESH RES, V44, P325; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hayes D., 2005, COLLATION ANAL OCEAN; HEREDIA PC, 2014, J GEOPHYS RES-OCEANS, P119; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hill K, 2010, MAR TECHNOL SOC J, V44, P65, DOI 10.4031/MTSJ.44.6.13; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEQUERE C, 2010, ESA PUBLICATION WPP, V2, DOI DOI 10.5270/OCEANOBS09.CWP.56; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LYNCH T, 2010, ESA PUBLICATION WPP, V2, DOI DOI 10.5270/OCEANOBS09; LYNCH TP, 2011, SCI RATIONALE IMPLEM; Morello Elisabetta B., 2014, Methods in Oceanography, V9, P17, DOI 10.1016/j.mio.2014.09.001; Oke PR, 2012, J MARINE SYST, V105, P30, DOI 10.1016/j.jmarsys.2012.05.009; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; REVELANTE N, 1982, J PLANKTON RES, V4, P47, DOI 10.1093/plankt/4.1.47; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001921; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Solomon D.Q.S., 2007, CONTRIBUTION WORKING; Southward AJ, 2005, ADV MAR BIOL, V47, P1; SWADLING KM, 2013, AUSTRALIAN MARINE ZO; Taylor F.J.R., 1976, BIBLIOTHECA BOT, V132, P1; Thompson P. A., 2011, Journal of the Royal Society of Western Australia, V94, P161; Thompson PA, 2011, DEEP-SEA RES PT II, V58, P645, DOI 10.1016/j.dsr2.2010.10.003; Thompson PA, 2009, MAR ECOL PROG SER, V394, P1, DOI 10.3354/meps08297; UNESCO, 2005, 148 UNESCO GOOS; van den Honert RC, 2011, WATER-SUI, V3, P1149, DOI 10.3390/w3041149; Wilson D, 2009, OCEANS-IEEE, P2643; WOOD E. J. F., 1954, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V5, P171; J GEO RES; [No title captured], DOI DOI 10.5270/OCEANOBS09.CWP.17	53	56	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113652	10.1371/journal.pone.0113652	http://dx.doi.org/10.1371/journal.pone.0113652			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517905	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600005
J	Shen, SC; Shen, CI; Lin, H; Chen, CJ; Chang, CY; Chen, SM; Lee, HC; Lai, PS; Su, HL				Shen, Shih-Cheng; Shen, Ching-I; Lin, Ho; Chen, Chun-Jung; Chang, Chia-Yu; Chen, Sheng-Mei; Lee, Hsiu-Chin; Lai, Ping-Shan; Su, Hong-Lin			Susceptibility of Human Embryonic Stem Cell-Derived Neural Cells to Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							NEURONAL PROGENITOR CELLS; GLIAL ACTIVATION; RAT-BRAIN; DIFFERENTIATION; VIMENTIN; DEATH; PATHOGENESIS; CONTRIBUTES; FEATURES; TROPISM	Pluripotent human embryonic stem cells (hESCs) can be efficiently directed to become immature neuroepithelial precursor cells (NPCs) and functional mature neural cells, including neurotransmitter-secreting neurons and glial cells. Investigating the susceptibility of these hESCs-derived neural cells to neurotrophic viruses, such as Japanese encephalitis virus (JEV), provides insight into the viral cell tropism in the infected human brain. We demonstrate that hESC-derived NPCs are highly vulnerable to JEV infection at a low multiplicity of infection (MOI). In addition, glial fibrillary acid protein (GFAP)-expressing glial cells are also susceptible to JEV infection. In contrast, only a few mature neurons were infected at MOI 10 or higher on the third day post-infection. In addition, functional neurotransmitter-secreting neurons are also resistant to JEV infection at high MOI. Moreover, we discover that vimentin intermediate filament, reported as a putative neurovirulent JEV receptor, is highly expressed in NPCs and glial cells, but not mature neurons. These results indicate that the expression of vimentin in neural cells correlates to the cell tropism of JEV. Finally, we further demonstrate that membranous vimentin is necessary for the susceptibility of hESC-derived NPCs to JEV infection.	[Shen, Shih-Cheng; Lin, Ho; Chen, Sheng-Mei; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Shen, Ching-I; Lai, Ping-Shan] Natl Chung Hsing Univ, Dept Chem, Taichung 40227, Taiwan; [Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan; [Chen, Chun-Jung] Hung Kuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Chang, Chia-Yu; Lee, Hsiu-Chin] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Tunghai University; Hungkuang University; National Chung Hsing University	Su, HL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan.	suhonglin@nchu.edu.tw		Lin, Ho/0000-0001-7849-9137	National Science Council of Taiwan (NSC) [101-2811-B-005-015-MY3, 102-2628-B-005-007-MY3]; Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU) [1017604, 1027607]; Ministry of Education, Taiwan, Republic of China, under the ATU plan	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU); Ministry of Education, Taiwan, Republic of China, under the ATU plan	This work was supported by grants from the National Science Council of Taiwan (NSC 101-2811-B-005-015-MY3 and 102-2628-B-005-007-MY3) and the Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU 1017604 and 1027607). This research was also funded in part by the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0; Chen SM, 2013, CELL TRANSPLANT, DOI [10. 3727/ 096368913X096675179, DOI 10.3727/096368913X096675179]; Cheng EH, 2008, REPROD BIOMED ONLINE, V17, P436, DOI 10.1016/S1472-6483(10)60229-5; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Das S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017225; DESAI A, 1995, ACTA NEUROPATHOL, V89, P368, DOI 10.1007/BF00309631; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; HOULE J, 1983, DEV BRAIN RES, V9, P189, DOI 10.1016/0165-3806(83)90051-2; ISHII T, 1977, ACTA NEUROPATHOL, V38, P181, DOI 10.1007/BF00688063; JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676; Kumar S, 2009, BRAIN RES, V1268, P135, DOI 10.1016/j.brainres.2009.02.051; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Lin YL, 1996, VIRUS RES, V44, P45, DOI 10.1016/0168-1702(96)01343-3; LUKAS Z, 1989, HISTOCHEM J, V21, P693, DOI 10.1007/BF01002834; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; OGATA A, 1991, J VIROL, V65, P880, DOI 10.1128/JVI.65.2.880-886.1991; Raung SL, 2007, NEUROSCI LETT, V419, P263, DOI 10.1016/j.neulet.2007.04.036; Riaz SS, 2004, DEV BRAIN RES, V153, P39, DOI 10.1016/j.devbrainres.2004.07.006; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SCHNITZER J, 1984, DEV BRAIN RES, V15, P21, DOI 10.1016/0165-3806(84)90136-6; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Solomon T, 2004, ARCH VIROL, P161; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586; Tsueng G, 2011, J VIROL, V85, P5718, DOI 10.1128/JVI.02261-10; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114990	10.1371/journal.pone.0114990	http://dx.doi.org/10.1371/journal.pone.0114990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517725	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600035
J	Surma, S; Pakhomov, EA; Pitcher, TJ				Surma, Szymon; Pakhomov, Evgeny A.; Pitcher, Tony J.			Effects of Whaling on the Structure of the Southern Ocean Food Web: Insights on the "Krill Surplus'' from Ecosystem Modelling	PLOS ONE			English	Article							SEA-ICE EXTENT; ROSS SEA; WHALES; COMPETITION; INCREASES; SHETLAND; REVEALS; GEORGIA; DECLINE; BIOMASS	The aim of this study was to examine the ecological plausibility of the "krill surplus'' hypothesis and the effects of whaling on the Southern Ocean food web using mass-balance ecosystem modelling. The depletion trajectory and unexploited biomass of each rorqual population in the Antarctic was reconstructed using yearly catch records and a set of species-specific surplus production models. The resulting estimates of the unexploited biomass of Antarctic rorquals were used to construct an Ecopath model of the Southern Ocean food web existing in 1900. The rorqual depletion trajectory was then used in an Ecosim scenario to drive rorqual biomasses and examine the "krill surplus'' phenomenon and whaling effects on the food web in the years 1900-2008. An additional suite of Ecosim scenarios reflecting several hypothetical trends in Southern Ocean primary productivity were employed to examine the effect of bottom-up forcing on the documented krill biomass trend. The output of the Ecosim scenarios indicated that while the "krill surplus'' hypothesis is a plausible explanation of the biomass trends observed in some penguin and pinniped species in the mid-20th century, the excess krill biomass was most likely eliminated by a rapid decline in primary productivity in the years 1975-1995. Our findings suggest that changes in physical conditions in the Southern Ocean during this time period could have eliminated the ecological effects of rorqual depletion, although the mechanism responsible is currently unknown. Furthermore, a decline in iron bioavailability due to rorqual depletion may have contributed to the rapid decline in overall Southern Ocean productivity during the last quarter of the 20th century. The results of this study underscore the need for further research on historical changes in the roles of top-down and bottom-up forcing in structuring the Southern Ocean food web.	[Surma, Szymon; Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Pakhomov, Evgeny A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Surma, S (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	s.surma@fisheries.ubc.ca	Surma, Szymon/GOG-9811-2022	Surma, Szymon/0000-0002-0236-6757				Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2009, MAR MAMMAL SCI, V26, P1; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2014, TRENDS ECOL EVOL, V29, P309, DOI 10.1016/j.tree.2014.03.011; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Ballance LT, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P215; Boyce DG, 2014, PROG OCEANOGR, V122, P163, DOI 10.1016/j.pocean.2014.01.004; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Branch TA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P262; Brierley A.S., 1999, CCAMLR Science, V6, P47; Christensen LB, 2006, FISHERIES CTR RES RE, V14, P1; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; de la Mare WK, 2009, CLIMATIC CHANGE, V92, P461, DOI 10.1007/s10584-008-9473-2; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; FRASER WR, 1992, POLAR BIOL, V11, P525; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; LAWS RM, 1977, PHILOS T ROY SOC B, V279, P81, DOI 10.1098/rstb.1977.0073; Leaper R, 2008, SC60 IWC SCI COMM; Lee CS, 2011, J SPINAL DISORD TECH, V24, P183, DOI 10.1097/BSD.0b013e3181eb5214; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Mori M, 2006, CCAMLR SCI, V13, P217; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2007, ANTARCT SCI, V19, P291, DOI 10.1017/S0954102007000491; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Pinkerton MH, 2010, CCAMLR SCI, V17, P1; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Ruegg KC, 2010, MOL ECOL, V19, P281, DOI 10.1111/j.1365-294X.2009.04447.x; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smetacek V., 2008, IMPACTS GLOBAL WARMI, P45; Smith WO, 2014, GEOPHYS RES LETT, V41, P1624, DOI 10.1002/2014GL059311; Trathan PN, 2012, ECOGRAPHY, V35, P983, DOI 10.1111/j.1600-0587.2012.07330.x; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Williams TM, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P191	43	26	27	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114978	10.1371/journal.pone.0114978	http://dx.doi.org/10.1371/journal.pone.0114978			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517505	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600034
J	Sandberg, CJ; Vik-Mo, EO; Behnan, J; Helseth, E; Langmoen, IA				Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.			Transcriptional Profiling of Adult Neural Stem-Like Cells from the Human Brain	PLOS ONE			English	Article							PROGENITOR CELLS; SUBVENTRICULAR ZONE; IMMUNOHISTOCHEMICAL ANALYSIS; PROSPECTIVE IDENTIFICATION; NEUROTROPHIN RECEPTOR; HEMATOPOIETIC STEM; SELF-RENEWAL; EXPRESSION; FAMILY; SLITRK	There is a great potential for the development of new cell replacement strategies based on adult human neural stem-like cells. However, little is known about the hierarchy of cells and the unique molecular properties of stem-and progenitor cells of the nervous system. Stem cells from the adult human brain can be propagated and expanded in vitro as free floating neurospheres that are capable of self-renewal and differentiation into all three cell types of the central nervous system. Here we report the first global gene expression study of adult human neural stem-like cells originating from five human subventricular zone biopsies (mean age 42, range 33-60). Compared to adult human brain tissue, we identified 1,189 genes that were significantly up-and downregulated in adult human neural stem-like cells (1% false discovery rate). We found that adult human neural stem-like cells express stem cell markers and have reduced levels of markers that are typical of the mature cells in the nervous system. We report that the genes being highly expressed in adult human neural stem-like cells are associated with developmental processes and the extracellular region of the cell. The calcium signaling pathway and neuroactive ligand-receptor interactions are enriched among the most differentially regulated genes between adult human neural stem-like cells and adult human brain tissue. We confirmed the expression of 10 of themost up-regulated genes in adult human neural stem-like cells in an additional sample set that included adult human neural stem-like cells (n=6), foetal human neural stem cells (n=1) and human brain tissues (n=12). The NGFR, SLITRK6 and KCNS3 receptors were further investigated by immunofluorescence and shown to be heterogeneously expressed in spheres. These receptors could potentially serve as new markers for the identification and characterisation of neural stem-and progenitor cells or as targets for manipulation of cellular fate.	[Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.] Oslo Univ Hosp, Vilhelm Magnus Lab, Inst Surg Res, Oslo, Norway; [Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Langmoen, Iver A.] Oslo Univ Hosp, Canc Stem Cell Innovat Ctr CAST, Oslo, Norway; [Langmoen, Iver A.] Univ Oslo, Oslo, Norway; [Langmoen, Iver A.] Oslo Univ Hosp, Norwegian Stem Cell Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sandberg, CJ (corresponding author), Oslo Univ Hosp, Vilhelm Magnus Lab, Inst Surg Res, Oslo, Norway.	cesandbe@medisin.uio.no	Behnan, Jinan/C-9263-2009; Helseth, Eirik/AAH-2466-2020	Behnan, Jinan/0000-0001-5780-0971; Vik-Mo, Einar Osland/0000-0001-8303-4123				Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai JL, 2006, STEM CELLS DEV, V15, P232, DOI 10.1089/scd.2006.15.232; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chen Y, 2009, J INT MED RES, V37, P281, DOI 10.1177/147323000903700201; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dutta S, 2013, CNS NEUROSCI THER, V19, P5, DOI 10.1111/cns.12027; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giebel B, 2008, BIOL CHEM, V389, P813, DOI 10.1515/BC.2008.092; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Milde T, 2007, LEUKEMIA, V21, P824, DOI 10.1038/sj.leu.2404525; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Murrell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071334; Nash B, 2014, INT REV NEUROBIOL, V118, P105, DOI 10.1016/B978-0-12-801284-0.00005-1; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Rahman M, 2011, NEUROSURGERY, V68, P531, DOI 10.1227/NEU.0b013e3181ff9eb5; Rector Kyle, 2013, Methods Mol Biol, V976, P1, DOI 10.1007/978-1-62703-317-6_1; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sandberg CJ, 2013, EXP CELL RES, V319, P2230, DOI 10.1016/j.yexcr.2013.06.004; Singh SK, 2003, CANCER RES, V63, P5821; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; Valyi-Nagy K, 2012, MOL VIS, V18, P588; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; Vik-Mo EO, 2011, EXP CELL RES, V317, P1049, DOI 10.1016/j.yexcr.2010.12.022; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xue LP, 2014, CELL BIOCHEM BIOPHYS, V70, P1609, DOI 10.1007/s12013-014-0103-5	57	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114739	10.1371/journal.pone.0114739	http://dx.doi.org/10.1371/journal.pone.0114739			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514637	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300020
J	Estan, MC; Calvino, E; Calvo, S; Guillen-Guio, B; Boyano-Adanez, MD; de Blas, E; Rial, E; Aller, P				Cristina Estan, Maria; Calvino, Eva; Calvo, Susana; Guillen-Guio, Beatriz; del Carmen Boyano-Adanez, Maria; de Blas, Elena; Rial, Eduardo; Aller, Patricio			Apoptotic Efficacy of Etomoxir in Human Acute Myeloid Leukemia Cells. Cooperation with Arsenic Trioxide and Glycolytic Inhibitors, and Regulation by Oxidative Stress and Protein Kinase Activities	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; FATTY-ACID OXIDATION; ENERGY-METABOLISM; LEVEL; 2-DEOXYGLUCOSE; GLUTATHIONE; ACTIVATION; LONIDAMINE; DEPLETION; GROWTH	Fatty acid synthesis and oxidation are frequently exacerbated in leukemia cells, and may therefore represent a target for therapeutic intervention. In this work we analyzed the apoptotic and chemo-sensitizing action of the fatty acid oxidation inhibitor etomoxir in human acute myeloid leukemia cells. Etomoxir caused negligible lethality at concentrations up to 100 mu M, but efficaciously cooperated to cause apoptosis with the anti-leukemic agent arsenic trioxide (ATO, Trisenox), and with lower efficacy with other anti-tumour drugs (etoposide, cisplatin), in HL60 cells. Etomoxir-ATO cooperation was also observed in NB4 human acute promyelocytic cells, but not in normal (non-tumour) mitogen-stimulated human peripheral blood lymphocytes. Biochemical determinations in HL60 cells indicated that etomoxir (25-200 mu M) dose-dependently inhibited mitochondrial respiration while slightly stimulating glycolysis, and only caused marginal alterations in total ATP content and adenine nucleotide pool distribution. In addition, etomoxir caused oxidative stress (increase in intracellular reactive oxygen species accumulation, decrease in reduced glutathione content), as well as pro-apoptotic LKB-1/AMPK pathway activation, all of which may in part explain the chemo-sensitizing capacity of the drug. Etomoxir also cooperated with glycolytic inhibitors (2-deoxy-D-glucose, lonidamine) to induce apoptosis in HL60 cells, but not in NB4 cells. The combined etomoxir plus 2-deoxy-D-glucose treatment did not increase oxidative stress, caused moderate decrease in net ATP content, increased the AMP/ATP ratio with concomitant drop in energy charge, and caused defensive Akt and ERK kinase activation. Apoptosis generation by etomoxir plus 2-deoxy-D-glucose was further increased by co-incubation with ATO, which is apparently explained by the capacity of ATO to attenuate Akt and ERK activation. In summary, co-treatment with etomoxir may represent an interesting strategy to increase the apoptotic efficacy of ATO and (with some limitations) 2-deoxy-D-glucose which, although clinically important anti-tumour agents, exhibit low efficacy in monotherapy.	[Cristina Estan, Maria; Calvino, Eva; Calvo, Susana; Guillen-Guio, Beatriz; de Blas, Elena; Rial, Eduardo; Aller, Patricio] CSIC, Ctr Invest Biol, Madrid, Spain; [Calvo, Susana; del Carmen Boyano-Adanez, Maria] Univ Alcala, Dept Biol Sistemas, Fac Med & Ciencies Salud, Unidad Bioquim & Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Alcala	Rial, E (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid, Spain.	rial@cib.csic.es; aller@cib.csic.es	Calviño, Eva/H-9219-2015; Rial, Eduardo/A-4242-2008	Rial, Eduardo/0000-0001-8634-8902; Calvino Vanegas, Eva/0000-0003-0316-3035; Guillen-Guio, Beatriz/0000-0002-3703-1738	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion [SAF2010-20256]; Comunidad de Madrid [S2010/BMD-2402]; Consejo Superior de Investigaciones Cientificas	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Consejo Superior de Investigaciones Cientificas	This work was supported by grant SAF2010-20256 (to P.A.) from the Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion (http://www.mineco.gob.es/portal/site/mineco/idi), and by Grant S2010/BMD-2402 (to E.R.) from the Comunidad de Madrid (https://www.madrimasd.org). M.C.E. is the recipient of a JAE-Predoc fellowship from the Consejo Superior de Investigaciones Cientificas (http://www.csic.es/web/ guest/programa-jae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELALEEM S, 1994, HORM METAB RES, V26, P88, DOI 10.1055/s-2007-1000779; Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Amadori S, 2005, CURR MED RES OPIN, V21, P403, DOI 10.1185/030079904X20349; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; Cabrero A, 2002, J BIOL CHEM, V277, P10100, DOI 10.1074/jbc.M110321200; Calvino E, 2014, J PHARMACOL EXP THER, V348, P324, DOI 10.1124/jpet.113.206714; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; DEKORTE D, 1985, ANAL BIOCHEM, V147, P197, DOI 10.1016/0003-2697(85)90028-4; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Diaz Zuanel, 2005, Blood, V105, P1237; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Holubarsch CJF, 2007, CLIN SCI, V113, P205, DOI 10.1042/CS20060307; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Ko YH, 2012, J BIOENERG BIOMEMBR, V44, P163, DOI 10.1007/s10863-012-9417-4; Kritharis A, 2013, ANN HEMATOL, V92, P719, DOI 10.1007/s00277-013-1707-3; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; LANOTTE M, 1991, BLOOD, V77, P1080; Li JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074623; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Merrill CL, 2002, TOXICOL SCI, V68, P93, DOI 10.1093/toxsci/68.1.93; Miller WH, 2002, CANCER RES, V62, P3893; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Sanchez Y, 2010, J PHARMACOL EXP THER, V335, P114, DOI 10.1124/jpet.110.168344; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Tsunekawa-Imai N, 2013, LEUKEMIA RES, V37, P1132, DOI 10.1016/j.leukres.2013.05.017; Vickers AEM, 2006, TOXICOL IN VITRO, V20, P1173, DOI 10.1016/j.tiv.2006.01.021; Xi HB, 2013, BIOCHEM PHARMACOL, V85, P1463, DOI 10.1016/j.bcp.2013.02.037; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; Yi J, 2002, APOPTOSIS, V7, P209, DOI 10.1023/A:1015331229263; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	50	32	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115250	10.1371/journal.pone.0115250	http://dx.doi.org/10.1371/journal.pone.0115250			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506699	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100064
J	Giannini, M; Giannaccini, M; Sibillano, T; Giannini, C; Liu, D; Wang, ZG; Bau, A; Dente, L; Cuschieri, A; Raffa, V				Giannini, Marianna; Giannaccini, Martina; Sibillano, Teresa; Giannini, Cinzia; Liu, Dun; Wang, Zhigang; Bau, Andrea; Dente, Luciana; Cuschieri, Alfred; Raffa, Vittoria			Sheets of Vertically Aligned BaTiO3 Nanotubes Reduce Cell Proliferation but Not Viability of NIH-3T3 Cells	PLOS ONE			English	Article							PIEZOELECTRIC CERAMIC IMPLANTS; BARIUM-TITANATE; IN-VITRO; SURFACE-ROUGHNESS; CALCIUM-PHOSPHATE; ADHESION; GROWTH; DIFFERENTIATION; HYDROXYAPATITE; NANOPARTICLES	All biomaterials initiate a tissue response when implanted in living tissues. Ultimately this reaction causes fibrous encapsulation and hence isolation of the material, leading to failure of the intended therapeutic effect of the implant. There has been extensive bioengineering research aimed at overcoming or delaying the onset of encapsulation. Nanotechnology has the potential to address this problem by virtue of the ability of some nanomaterials to modulate interactions with cells, thereby inducing specific biological responses to implanted foreign materials. To this effect in the present study, we have characterised the growth of fibroblasts on nano-structured sheets constituted by BaTiO3, a material extensively used in biomedical applications. We found that sheets of vertically aligned BaTiO3 nanotubes inhibit cell cycle progression - without impairing cell viability - of NIH-3T3 fibroblast cells. We postulate that the 3D organization of the material surface acts by increasing the availability of adhesion sites, promoting cell attachment and inhibition of cell proliferation. This finding could be of relevance for biomedical applications designed to prevent or minimize fibrous encasement by uncontrolled proliferation of fibroblastic cells with loss of material-tissue interface underpinning long-term function of implants.	[Giannini, Marianna; Giannaccini, Martina; Cuschieri, Alfred; Raffa, Vittoria] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Sibillano, Teresa; Giannini, Cinzia] CNR, Inst Crystallog, I-70126 Bari, Italy; [Liu, Dun; Wang, Zhigang; Cuschieri, Alfred; Raffa, Vittoria] Univ Dundee, Inst Med Sci & Technol, Dundee, Scotland; [Bau, Andrea; Dente, Luciana; Raffa, Vittoria] Univ Pisa, Dept Biol, Pisa, Italy	Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Dundee; University of Pisa	Giannini, M (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.	marianna.giannini@sssup.it	Cuschieri, Alfred/O-4092-2019; Wang, Zhigang/A-5197-2013	Cuschieri, Alfred/0000-0003-0764-5947; Wang, Zhigang/0000-0001-8309-7888; GIANNINI, CINZIA/0000-0003-0983-2885; DENTE, LUCIANA/0000-0002-9617-0922; RAFFA, VITTORIA/0000-0002-4289-9937; GIANNACCINI, Martina/0000-0002-8485-1018	FIRB-MIUR - Italian Ministry of Education, Universities and Research [RBAP114AMK_006]; Italian MoH/Regione Toscana [RF-2009-1535329]; EPSRC [EP/H010033/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H010033/1] Funding Source: researchfish	FIRB-MIUR - Italian Ministry of Education, Universities and Research; Italian MoH/Regione Toscana; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by: FIRB-MIUR "Rete integrata per la Nano Medicina (RINAME)'', code RBAP114AMK_006, funded by Italian Ministry of Education, Universities and Research (http://www.istruzione.it/), to M. Saviano and D. Gatteschi; and "Single incision laparoscopy surgery study (SILS)'', project, code RF-2009-1535329, funded by Italian MoH/Regione Toscana, http://ricerca.cbim.it/index.html, to V. Raffa and A. Cuschieri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bacakova L, 2004, PHYSIOL RES, V53, pS35; Baxter FR, 2010, ANN BIOMED ENG, V38, P2079, DOI 10.1007/s10439-010-9977-6; Baxter FR, 2009, J MATER SCI-MATER M, V20, P1697, DOI 10.1007/s10856-009-3734-0; Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801; Chen YY, 2009, INORG CHEM, V48, P681, DOI 10.1021/ic8018887; Ciofani G, 2010, NANOSCALE RES LETT, V5, P1093, DOI 10.1007/s11671-010-9607-0; CRAWFORD GP, 1992, J CHEM PHYS, V96, P7788, DOI 10.1063/1.462376; Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Feng JQ, 1997, BIOMATERIALS, V18, P1531, DOI 10.1016/S0142-9612(97)00087-2; Gimenes R, 2004, P SOC PHOTO-OPT INS, V5385, P539, DOI 10.1117/12.548647; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hwang KS, 2002, J MATER SCI-MATER M, V13, P133, DOI 10.1023/A:1013671526975; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013; Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2; Massafera MP, 2011, ELECTROANAL, V23, P2534, DOI 10.1002/elan.201100239; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; PARK JB, 1980, J BIOMED MATER RES, V14, P269, DOI 10.1002/jbm.820140308; PARK JB, 1981, J BIOMED MATER RES, V15, P103, DOI 10.1002/jbm.820150114; Park YJ, 2002, BIOMATERIALS, V23, P3859, DOI 10.1016/S0142-9612(02)00123-0; Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Song HJ, 2007, MATER LETT, V61, P3473, DOI 10.1016/j.matlet.2006.11.100; Wada S, 2007, J KOREAN PHYS SOC, V51, P874, DOI 10.3938/jkps.51.874; Wang ZG, 2013, INT J MOL SCI, V14, P9111, DOI 10.3390/ijms14059111; Zagar K, 2011, MATER RES BULL, V46, P366, DOI 10.1016/j.materresbull.2010.12.012; Zagar K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/38/385501	30	1	2	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115183	10.1371/journal.pone.0115183	http://dx.doi.org/10.1371/journal.pone.0115183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506693	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100056
J	Letz, S; Haag, C; Schulze, E; Frank-Raue, K; Raue, F; Hofner, B; Mayr, B; Schofl, C				Letz, Saskia; Haag, Christine; Schulze, Egbert; Frank-Raue, Karin; Raue, Friedhelm; Hofner, Benjamin; Mayr, Bernhard; Schoefl, Christof			Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia	PLOS ONE			English	Article							PARATHYROID-HORMONE; ACTIVATING MUTATIONS; CA2+-SENSING RECEPTOR; CA2+ RECEPTOR; PHENOTYPES; SECRETION; DOMAIN; IDENTIFICATION; TRANSDUCTION; ANTAGONISTS	Introduction: Activating calcium sensing receptor (CaSR) mutations cause autosomal dominant hypocalcemia (ADH) characterized by low serum calcium, inappropriately low PTH and relative hypercalciuria. Four activating CaSR mutations cause additional renal wasting of sodium, chloride and other salts, a condition called Bartter syndrome (BS) type 5. Until today there is no specific medical treatment for BS type 5 and ADH. We investigated the effects of different allosteric CaSR antagonists (calcilytics) on activating CaSR mutants. Methods: All 4 known mutations causing BS type 5 and five ADH mutations were expressed in HEK 293T cells and receptor signalling was studied by measurement of intracellular free calcium in response to extracellular calcium ([Ca2+](o)). To investigate the effect of calcilytics, cells were stimulated with 3 mM [Ca2+](o) in the presence or absence of NPS-2143, ATF936 or AXT914. Results: All BS type 5 and ADH mutants showed enhanced signalling activity to [Ca2+](o) with left shifted dose response curves. In contrast to the amino alcohol NPS-2143, which was only partially effective, the quinazolinone calcilytics ATF936 and AXT914 significantly mitigated excessive cytosolic calcium signalling of all BS type 5 and ADH mutants studied. When these mutants were co-expressed with wild-type CaSR to approximate heterozygosity in patients, ATF936 and AXT914 were also effective on all mutants. Conclusion: The calcilytics ATF936 and AXT914 are capable of attenuating enhanced cytosolic calcium signalling activity of CaSR mutations causing BS type 5 and ADH. Quinazolinone calcilytics might therefore offer a novel treatment option for patients with activating CaSR mutations.	[Letz, Saskia; Mayr, Bernhard; Schoefl, Christof] Univ Klinikum Erlangen, Dept Med 1, Div Endocrinol & Diabet, Erlangen, Germany; [Hofner, Benjamin] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schofl, C (corresponding author), Univ Klinikum Erlangen, Dept Med 1, Div Endocrinol & Diabet, Erlangen, Germany.	christof.schoefl@uk-erlangen.de	Mayr, Bernhard M/F-6936-2012; Hofner, Benjamin/AGN-7505-2022; Raue, Friedhelm/AAC-4405-2020; Raue, Friedhelm/ABD-6150-2021	Mayr, Bernhard M/0000-0002-8973-4494; Hofner, Benjamin/0000-0003-2810-3186; Raue, Friedhelm/0000-0002-7700-1648	Friedrich-Alexander University Erlangen-Nuremberg [AZ 08.12.18.1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Friedrich-Alexander University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Christof Schofl was supported by institutional grants from the Friedrich-Alexander University Erlangen-Nuremberg (AZ 08.12.18.1). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Caltabiano S, 2009, J BONE MINER RES  S1, V24; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Fitzpatrick L, 2009, J BONE MINER RES S1, V24; Gonzales MC, 2013, ENDOCR PRACT, V19, pE24, DOI 10.4158/EP12132.CR; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Hu JX, 2005, J BIOL CHEM, V280, P5113, DOI 10.1074/jbc.M413403200; Hu JX, 2004, J BONE MINER RES, V19, P578, DOI 10.1359/JBMR.040106; John MR, 2014, BONE, V64, P204, DOI 10.1016/j.bone.2014.04.015; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Lia-Baldini AS, 2013, EUR J ENDOCRINOL, V168, pK27, DOI 10.1530/EJE-12-0714; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5313, DOI 10.1210/jc.86.11.5313; Liu XL, 2013, MOL NEUROBIOL, V48, P590, DOI 10.1007/s12035-013-8448-0; MacLeod RJ, 2013, BEST PRACT RES CL EN, V27, P385, DOI 10.1016/j.beem.2013.05.005; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Milliken GA., 1990, TECHNOMETRICS, V32, P219, DOI [10.1080/00401706.1990.10484638, DOI 10.1080/00401706.1990.10484638]; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Park SY, 2013, CLIN ENDOCRINOL, V78, P687, DOI 10.1111/cen.12056; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Raue F, 2011, CLIN ENDOCRINOL, V75, P760, DOI 10.1111/j.1365-2265.2011.04142.x; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Rus R, 2008, J CLIN ENDOCR METAB, V93, P4797, DOI 10.1210/jc.2008-1076; Sayer JA, 2003, CLIN ENDOCRINOL, V59, P419, DOI 10.1046/j.1365-2265.2003.01869.x; Szczawinska D, 2014, J CLIN ENDOCRINOL ME; Theman TA, 2009, J BONE MINER RES, V24, P964, DOI 10.1359/JBMR.081233; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Vezzoli G, 2006, J NEPHROL, V19, P525; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Widler L, 2011, FUTURE MED CHEM, V3, P535, DOI [10.4155/FMC.11.17, 10.4155/fmc.11.17]; Zhao XM, 1999, FEBS LETT, V448, P180, DOI 10.1016/S0014-5793(99)00368-3	36	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115178	10.1371/journal.pone.0115178	http://dx.doi.org/10.1371/journal.pone.0115178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506941	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100055
J	Onken, MD; Li, JM; Cooper, JA				Onken, Michael D.; Li, Jinmei; Cooper, John A.			Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration	PLOS ONE			English	Article							COLLABORATIVE OCULAR MELANOMA; VASCULOGENIC MIMICRY; ENDOTHELIAL BARRIER; EXPRESSION; MELANOGENESIS; MECHANISMS; TRANSMIGRATION; PLASTICITY; INHIBITORS; LEUKOCYTES	Uveal melanoma arises in the eye, and it spreads to distant organs in almost half of patients, leading to a fatal outcome. To metastasize, uveal melanoma cells must transmigrate into and out of the microvasculature, crossing the monolayer of endothelial cells that separates the vessel lumen from surrounding tissues. We investigated how human uveal melanoma cells cross the endothelial cell monolayer, using a cultured cell system with primary human endothelial cell monolayers on hydrogel substrates. We found that uveal melanoma cells transmigrate by a novel and unexpected mechanism. Uveal melanoma cells intercalate into the endothelial cell monolayer and flatten out, assuming a shape and geometry similar to those of endothelial cells in the monolayer. After an extended period of time in the intercalated state, the uveal melanoma cells round up and migrate underneath the monolayer. VCAM is present on endothelial cells, and anti-VCAM antibodies slowed the process of intercalation. Depletion of BAP1, a known suppressor of metastasis in patients, increased the amount of transmigration of uveal melanoma cells in transwell assays; but BAP1 depletion did not affect the rate of intercalation, based on movies of living cells. Our results reveal a novel route of transendothelial migration for uveal melanoma cells, and they provide insight into the mechanism by which loss of BAP1 promotes metastasis.	[Onken, Michael D.; Li, Jinmei; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Onken, MD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	mdonken@wustl.edu	Onken, Michael D/H-5620-2013; Cooper, John/D-4448-2014	Onken, Michael D/0000-0003-4082-1105; Cooper, John/0000-0002-0933-4571	National Institute of Health [GM38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM38542 from the National Institute of Health (http://grants.nih.gov) to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 1998, AM J OPHTHALMOL, V125, P745; Anastassiou G, 2002, EXP EYE RES, V74, P423, DOI 10.1006/exer.2002.1140; Baker JKL, 2001, MELANOMA RES, V11, P265, DOI 10.1097/00008390-200106000-00008; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Callejo SA, 2007, EYE, V21, P752, DOI 10.1038/sj.eye.6702322; Clarijs R, 2001, INVEST OPHTH VIS SCI, V42, P1422; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Keilholz U, 2004, CLIN CANCER RES, V10, P1605, DOI 10.1158/1078-0432.CCR-0610-3; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Mazzini C, 2014, CANCERS, V6, P323, DOI 10.3390/cancers6010323; Mihic-Probst D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033571; Mooren OL, 2014, MOL BIOL CELL; Mukherjee S, 2014, PLOS ONE IN PRESS; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2014, CYTOSKELETO IN PRESS; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Sage PT, 2009, FRONT BIOSCI-LANDMRK, V14, P5066, DOI 10.2741/3587; Singh AD, 2005, OPHTHALMOL CLIN N AM, V18, pviii; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Willson JKV, 2001, ARCH OPHTHALMOL-CHIC, V119, P670; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Woodward JKL, 2005, EYE, V19, P342, DOI 10.1038/sj.eye.6701471; Yonekawa Y, 2012, HEMATOL ONCOL CLIN N, V26, P1169, DOI 10.1016/j.hoc.2012.08.004; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115472	10.1371/journal.pone.0115472	http://dx.doi.org/10.1371/journal.pone.0115472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506912	gold, Green Published			2022-12-26	WOS:000346607100078
J	Song, H; Fares, M; Maguire, KR; Siden, A; Potacova, Z				Song, Hairong; Fares, Mona; Maguire, Kim R.; Siden, Ake; Potacova, Zuzana			Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; PROSTATE-CANCER; NONANTIBIOTIC PROPERTIES; DNA-DAMAGE; APOPTOSIS; INHIBITION; PROTEIN; PROLIFERATION; METASTASIS; LINES	Tetracycline analogues (TCNAs) have been shown to inhibit matrix metalloproteinases and to induce apoptosis in several cancer cell types. In the present study, the cytotoxic effects of TCNAs doxycycline (DOXY), minocycline (MINO) and chemically modified tetracycline-3 (COL-3) were investigated in the human acute myeloid leukemia HL-60 cell line. Cells were incubated with TCNAs in final concentrations of 0.5-100 mu g/ml for 24 h. Viability of the leukemic cells was inhibited in a concentration-dependent manner using resazurin assay. The estimated IC50s were 9.2 mu g/ml for DOXY, 9.9 mu g/ml for MINO and 1.3 mu g/ml for COL-3. All three TCNAs induced potent cytotoxic effects and cell death. Apoptosis, which was assessed by morphological changes and annexin V positivity, was concentration- and time-dependent following incubation with any one of the drugs. TCNAs induced DNA double strand breaks soon after treatment commenced as detected by gamma H2AX and western blot. The loss of mitochondrial membrane potential (Delta psi m), caspase activation and cleavage of PARP and Bcl-2 were observed; however, the sequence of events differed among the drugs. Pancaspase inhibitor Z-VAD-FMK improved survival of TCNAs-treated cells and decreased TCNAs-induced apoptosis. In summary, we demonstrated that TCNAs had a cytotoxic effect on the HL-60 leukemic cell line. Apoptosis was induced via mitochondria-mediated and caspase-dependent pathways in HL-60 cells by all three TCNAs. COL-3 exerted the strongest anti-proliferative and pro-apoptotic effects in concentrations that have been achieved in human plasma in reported clinical trials. These results indicate that there is a therapeutic potential of TCNAs in leukemia.	[Song, Hairong; Fares, Mona; Maguire, Kim R.; Potacova, Zuzana] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Clin Res Ctr Novum,Dept Lab Med, Stockholm, Sweden; [Siden, Ake] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Potacova, Z (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Clin Res Ctr Novum,Dept Lab Med, Stockholm, Sweden.	zuzana.potacova@ki.se			Swedish Childhood Cancer Foundation [PROJ04/085, PROJ04/098, PROJ06/121]	Swedish Childhood Cancer Foundation(European Commission)	This study was supported by grants from the Swedish Childhood Cancer Foundation ( PROJ04/085, PROJ04/098, PROJ06/121); http://www.barncancerfonden.se. COL-3 was generously provided by CollaGenex Pharmaceuticals Inc and Galderma R & D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Bachur NR, 1989, CANC MANAGEMENT MAN, P125; Belizario JE, 2007, BRAZ J MED BIOL RES, V40, P1011, DOI 10.1590/S0100-879X2006005000109; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Dalm D, 2010, J MOL BIOL, V398, P83, DOI 10.1016/j.jmb.2010.02.049; DALTON WT, 1988, BLOOD, V71, P242; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dezube BJ, 2006, J CLIN ONCOL, V24, P1389, DOI 10.1200/JCO.2005.04.2614; Fletcher A, 2011, LEUKEMIAS: PRINCIPLES AND PRACTICE OF THERAPY, P17; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Howlader N, 2009, J NATL CANCER I, V101, P533, DOI 10.1093/jnci/djn517; Juliusson G, 2012, BLOOD, V119, P3890, DOI 10.1182/blood-2011-12-379008; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Lichtman MA, 2013, BLOOD CELL MOL DIS, V50, P119, DOI 10.1016/j.bcmd.2012.10.005; Liu J, 1999, BIOCHEM BIOPH RES CO, V260, P562, DOI 10.1006/bbrc.1999.0929; Lokeshwar BL, 1999, ANN NY ACAD SCI, V878, P271, DOI 10.1111/j.1749-6632.1999.tb07690.x; Lokeshwar BL, 2002, INT J CANCER, V98, P297, DOI 10.1002/ijc.10168; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Nelson M L, 1998, Adv Dent Res, V12, P5; Noble W, 2009, PRION, V3, P78, DOI 10.4161/pri.3.2.8820; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Pollyea DA, 2011, BRIT J HAEMATOL, V152, P524, DOI 10.1111/j.1365-2141.2010.08470.x; Pourgholami MH, 2012, GYNECOL ONCOL, V125, P433, DOI 10.1016/j.ygyno.2012.01.006; Sagar J, 2010, ANTI-CANCER AGENT ME, V10, P556, DOI 10.2174/187152010793498645; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Seftor REB, 1998, CLIN EXP METASTAS, V16, P217, DOI 10.1023/A:1006588708131; Selzer MG, 1999, ANN NY ACAD SCI, V878, P678, DOI 10.1111/j.1749-6632.1999.tb07760.x; SEN S, 1993, LEUKEMIA RES, V17, P639, DOI 10.1016/0145-2126(93)90068-V; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Swerdlow SH, 2008, WHO CLASSIFICATION T; Syed S, 2004, CLIN CANCER RES, V10, P6512, DOI 10.1158/1078-0432.CCR-04-0804; Tolomeo M, 2001, BRIT J PHARMACOL, V133, P306, DOI 10.1038/sj.bjp.0704068; VANDENBOGERT C, 1985, LEUKEMIA RES, V9, P617, DOI 10.1016/0145-2126(85)90142-0; VANDENBOGERT C, 1986, CANCER RES, V46, P3283; Wang JYJ, 2001, ACTA ONCOL, V40, P689; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	43	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114457	10.1371/journal.pone.0114457	http://dx.doi.org/10.1371/journal.pone.0114457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502932	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100014
J	Wang, HB; Zhang, JQ; Lv, GY; Ma, JB; Ma, PK; Du, GY; Wang, ZL; Tian, JW; Fang, WS; Fu, FH				Wang, Hongbo; Zhang, Jianqiao; Lv, Guangyao; Ma, Jinbo; Ma, Pengkai; Du, Guangying; Wang, Zongliang; Tian, Jingwei; Fang, Weishuo; Fu, Fenghua			Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome	PLOS ONE			English	Article							HYDROPHOBIC DRUG-DELIVERY; IN-VITRO; PHASE-I; PACLITAXEL FORMULATION; COMPLEMENT ACTIVATION; CREMOPHOR-EL; DOXORUBICIN; CANCER; HYPERSENSITIVITY; ENCAPSULATION	Lx2-32c is a novel taxane that has been demonstrated to have robust antitumor activity against different types of tumors including several paclitaxel-resistant neoplasms. Since the delivery vehicles for taxane, which include cremophor EL, are all associated with severe toxic effects, liposome-based Lx2-32c has been developed. In the present study, the pharmacokinetics, biodistribution, antitumor efficacy and safety characteristics of liposome-based Lx2-32c were explored and compared with those of cremophor-based Lx2-32c. The results showed that liposome-based Lx2-32c displayed similar antitumor effects to cremophor-based Lx2-32c, but with significantly lower bone marrow toxicity and cardiotoxicity, especially with regard to the low ratio of hypersensitivity reaction. In comparing these two delivery modalities, targeting was superior using the Lx2-32c liposome formulation; it achieved significantly higher uptake in tumor than in bone marrow and heart. Our data thus suggested that the Lx2-32c liposome was a novel alternative formulation with comparable antitumor efficacy and a superior safety profiles to cremophor-based Lx2-32c, which might be related to the improved pharmacokinetic and biodistribution characteristics. In conclusion, the Lx2-32c liposome could be a promising alternative formulation for further development.	[Wang, Hongbo; Zhang, Jianqiao; Lv, Guangyao; Ma, Pengkai; Du, Guangying; Wang, Zongliang; Tian, Jingwei; Fu, Fenghua] Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China; [Fang, Weishuo] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Fang, Weishuo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jinbo] Binzhou Med Coll, Dept Clin Med, Yantai, Peoples R China; [Tian, Jingwei] Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai, Peoples R China	Ministry of Education, China; Yantai University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Binzhou Medical University	Wang, HB (corresponding author), Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China.	hongbowangyt@gmail.com; fufenghua@sohu.com	Tian, Jingwei/GPJ-9819-2022; Wang, Hongbo/AHC-7831-2022; 王, 洪波/A-6767-2019	Wang, Hongbo/0000-0001-8530-2339; 王, 洪波/0000-0001-8530-2339; Lv, Guang yao/0000-0002-6726-3089; Fang, Weishuo/0000-0002-0972-0640; qiao, jian/0000-0002-4941-7013	Taishan Scholar Project, Technology Development Program Projects of Shandong Province [2011YD18075]; Startup Project of Doctor scientific research in Yantai University [YX11B31, YX13B29]; National Natural Science Foundation of China [81202038, 30930108]; MOST Grant [2012ZX09103101-054]; State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.)	Taishan Scholar Project, Technology Development Program Projects of Shandong Province; Startup Project of Doctor scientific research in Yantai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST Grant; State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.)	This study was supported by the Taishan Scholar Project, Technology Development Program Projects of Shandong Province (2011YD18075), Startup Project of Doctor scientific research in Yantai University (YX11B31 and YX13B29), National Natural Science Foundation of China (No. 81202038 and 30930108) and MOST Grant (No. 2012ZX09103101-054). State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.) provided support in the form of a salary for author JT. The Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams J. D., 1992, J NATL CANC I MONOGR, P141; Chu Z, 2008, ANTI-CANCER DRUG, V19, P275, DOI 10.1097/CAD.0b013e3282f3fd2e; Crosasso P, 2000, J CONTROL RELEASE, V63, P19, DOI 10.1016/S0168-3659(99)00166-2; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; FORSSEN EA, 1983, CANCER TREAT REP, V67, P481; Hamaguchi T, 2007, BRIT J CANCER, V97, P170, DOI 10.1038/sj.bjc.6603855; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; MADHAVAN S, 1995, J NATL CANCER I, V87, P1556, DOI 10.1093/jnci/87.20.1556; Mita AC, 2007, CLIN CANCER RES, V13, P3293, DOI 10.1158/1078-0432.CCR-06-2496; Phillips WT, 2002, J PHARMACOL EXP THER, V303, P11, DOI 10.1124/jpet.102.037119; ROSA P, 1983, PHARMACOLOGY, V26, P221, DOI 10.1159/000137805; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Rowinsky M, 1997, ANNU REV MED, V48, P353; Sadzuka Y, 2002, TOXICOL LETT, V126, P83, DOI 10.1016/S0378-4274(01)00447-7; Stenner-Liewen F, 2006, CHIRURG, V77, P1118, DOI 10.1007/s00104-006-1262-8; Straub JA, 2005, PHARM RES-DORDR, V22, P347, DOI 10.1007/s11095-004-1871-1; Szebeni J, 1998, JNCI-J NATL CANCER I, V90, P300, DOI 10.1093/jnci/90.4.300; Wang H. B., 2014, SCI REPORTS, V4; Wang HB, 2008, CANCER LETT, V268, P89, DOI 10.1016/j.canlet.2008.03.051; Wang HB, 2013, MOL MED REP, V7, P947, DOI 10.3892/mmr.2013.1264; Wang L, 2007, BIOORG MED CHEM LETT, V17, P3191, DOI 10.1016/j.bmcl.2007.03.026; Weiszhar Z, 2012, EUR J PHARM SCI, V45, P492, DOI 10.1016/j.ejps.2011.09.016; Working PK, 1999, J PHARMACOL EXP THER, V289, P1128; Wyld L, 2007, EUR J CANCER, V43, P2253, DOI 10.1016/j.ejca.2007.07.035; Yang A-z, 2006, B CHIN CANC, V15, P862; Ye L, 2013, FOOD CHEM TOXICOL, V52, P200, DOI 10.1016/j.fct.2012.11.004; Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513	29	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114688	10.1371/journal.pone.0114688	http://dx.doi.org/10.1371/journal.pone.0114688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506928	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100019
J	Rajan, D; McCracken, CE; Kopleman, HB; Kyu, SY; Lee, FEH; Lu, XY; Anderson, LJ				Rajan, Devi; McCracken, Courtney E.; Kopleman, Hannah B.; Kyu, Shuya Y.; Lee, F. Eun-Hyung; Lu, Xiaoyan; Anderson, Larry J.			Human Rhinovirus Induced Cytokine/Chemokine Responses in Human Airway Epithelial and Immune Cells	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; BLOOD MONONUCLEAR-CELLS; ASTHMA EXACERBATIONS; MONOCYTIC CELLS; CHILDREN; EXPRESSION; RELEASE; IMMUNIZATION; REPLICATION; PREVALENCE	Infections with human rhinovirus (HRV) are commonly associated with acute upper and lower respiratory tract disease and asthma exacerbations. The role that HRVs play in these diseases suggests it is important to understand host-specific or virus-specific factors that contribute to pathogenesis. Since species A HRVs are often associated with more serious HRV disease than species B HRVs, differences in immune responses they induce should inform disease pathogenesis. To identify species differences in induced responses, we evaluated 3 species A viruses, HRV 25, 31 and 36 and 3 species B viruses, HRV 4, 35 and 48 by exposing human PBMCs to HRV infected Calu-3 cells. To evaluate the potential effect of memory induced by previous HRV infection on study responses, we tested cord blood mononuclear cells that should be HRV naive. There were HRV-associated increases (significant increase compared to mock-infected cells) for one or more HRVs for IP-10 and IL-15 that was unaffected by addition of PBMCs, for MIP-1 alpha, MIP-1 beta, IFN-alpha, and HGF only with addition of PBMCs, and for ENA-78 only without addition of PBMCs. All three species B HRVs induced higher levels, compared to A HRVs, of MIP-1 alpha and MIP-1 beta with PBMCs and ENA-78 without PBMCs. In contrast, addition of CBMCs had less effect and did not induce MIP-1 alpha, MIP-1 beta, or IFN-alpha nor block ENA-78 production. Addition of CBMCs did, however, increase IP-10 levels for HRV 35 and HRV 36 infection. The presence of an effect with PBMCs and no effect with CBMCs for some responses suggest differences between the two types of cells possibly because of the presence of HRV memory responses in PBMCs and not CBMCs or limited response capacity for the immature CBMCs relative to PBMCs. Thus, our results indicate that different HRV strains can induce different patterns of cytokines and chemokines; some of these differences may be due to differences in memory responses induced by past HRV infections, and other differences related to virus factors that can inform disease pathogenesis.	[Rajan, Devi; McCracken, Courtney E.; Kopleman, Hannah B.; Anderson, Larry J.] Emory Childrens Ctr, Dept Pediat, Atlanta, GA 30322 USA; [Kyu, Shuya Y.; Lee, F. Eun-Hyung] Emory Univ, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Lu, Xiaoyan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Anderson, LJ (corresponding author), Emory Childrens Ctr, Dept Pediat, Atlanta, GA 30322 USA.	larry.anderson@emory.edu			NIH - Children's Healthcare of Atlanta [1U19AI095227]; Immunology Core of Emory Children's Pediatric Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095227] Funding Source: NIH RePORTER	NIH - Children's Healthcare of Atlanta; Immunology Core of Emory Children's Pediatric Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH 1U19AI095227 grant, funding from Children's Healthcare of Atlanta, and the Immunology Core of Emory Children's Pediatric Research Center.	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Amineva SP, 2011, J GEN VIROL, V92, P2549, DOI 10.1099/vir.0.031302-0; Arakawa M, 2012, J MED MICROBIOL, V61, P410, DOI 10.1099/jmm.0.035006-0; Arden KE, 2010, J CLIN VIROL, V47, P219, DOI 10.1016/j.jcv.2010.01.001; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; COONEY MK, 1975, J IMMUNOL, V114, P635; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Glanville N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003669; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P216, DOI 10.1016/j.jaci.2007.02.025; Jin Y, 2009, J CLIN MICROBIOL, V47, P2895, DOI 10.1128/JCM.00745-09; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Johnston SL, 1998, J IMMUNOL, V160, P6172; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; McLean GR, 2012, ANTIVIR RES, V95, P193, DOI 10.1016/j.antiviral.2012.06.006; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Olsson S, 2003, CLIN EXP IMMUNOL, V132, P254, DOI 10.1046/j.1365-2249.2003.02148.x; Papadopoulos N G, 2000, Can Respir J, V7, P409; Papadopoulos NG, 2001, CLIN EXP ALLERGY, V31, P1060, DOI 10.1046/j.1365-2222.2001.01112.x; Persson T, 2003, CLIN EXP ALLERGY, V33, P531, DOI 10.1046/j.1365-2222.2003.01609.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rajan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066600; Saedisomeolia A, 2009, J NUTR BIOCHEM, V20, P577, DOI 10.1016/j.jnutbio.2008.06.001; Saedisomeolia A, 2009, BRIT J NUTR, V101, P533, DOI 10.1017/S0007114508025798; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Vlasak M, 2003, J VIROL, V77, P6923, DOI 10.1128/JVI.77.12.6923-6930.2003; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	44	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114322	10.1371/journal.pone.0114322	http://dx.doi.org/10.1371/journal.pone.0114322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500821	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400028
J	Hwang, BG; Ahn, S; Lee, SJ				Hwang, Bae Geun; Ahn, Sungsook; Lee, Sang Joon			Use of Gold Nanoparticles to Detect Water Uptake in Vascular Plants	PLOS ONE			English	Article							REFILLING PROCESS; EMBOLISM REPAIR; SAP FLOW; XYLEM; DYNAMICS; VESSELS; ROOTS; MAIZE	Direct visualization of water-conducting pathways and sap flows in xylem vessels is important for understanding the physiology of vascular plants and their sap ascent. Gold nanoparticles (AuNPs) combined with synchrotron X-ray imaging technique is a new promising tool for investigating plant hydraulics in opaque xylem vessels of vascular plants. However, in practical applications of AuNPs for real-time quantitative visualization of sap flows, their interaction with a vascular network needs to be verified in advance. In this study, the effect of AuNPs on the water-refilling function of xylem vessels is experimentally investigated with three monocot species. Discrepancy in the water uptakes starts to appear at about 20 min to 40 min after the supply of AuNP solution to the test plant by the possible gradual accumulation of AuNPs on the internal structures of vasculature. However conclusively, it is observed that the water-refilling speeds in individual xylem vessels are virtually unaffected by hydrophilically surface-modified AuNPs (diameter similar to 20 nm). Therefore, the AuNPs can be effectively used as flow tracers in the xylem vessels in the first 20 similar to 30 min without any physiological barrier. As a result, AuNPs are found to be useful for visualizing various fluid dynamic phenomena occurring in vascular plants.	[Hwang, Bae Geun; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang 790784, Gyeongbuk, South Korea; [Ahn, Sungsook] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang 790784, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Ctr Biofluid & Biomim Res, San31, Pohang 790784, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019		National Research Foundation of Korea - Korea government (MSIP) [2008-0061991]	National Research Foundation of Korea - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) grant funded by the Korea government (MSIP) (No. 2008-0061991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Ahn S, 2011, BIOMATERIALS, V32, P7191, DOI 10.1016/j.biomaterials.2011.05.023; Ahn S, 2010, ACS NANO, V4, P3753, DOI 10.1021/nn1003293; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Gasco A, 2006, PLANT CELL ENVIRON, V29, P1946, DOI 10.1111/j.1365-3040.2006.01570.x; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Im KS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711372; Kaufmann I, 2009, NEW PHYTOL, V184, P245, DOI 10.1111/j.1469-8137.2009.02919.x; Kim HK, 2010, NEW PHYTOL, V188, P1085, DOI 10.1111/j.1469-8137.2010.03424.x; Lee SJ, 2013, PLANTA, V238, P307, DOI 10.1007/s00425-013-1889-x; Lee SJ, 2010, BIOSENS BIOELECTRON, V25, P1571, DOI 10.1016/j.bios.2009.11.010; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Lee SJ, 2003, J APPL PHYS, V94, P3620, DOI 10.1063/1.1599981; NIST, XRAY MASS ATT COEFF; Sano Y, 2005, TREE PHYSIOL, V25, P269, DOI 10.1093/treephys/25.3.269; Scheenen TWJ, 2007, PLANT PHYSIOL, V144, P1157, DOI [10.1104/pp.106.089250, 10.1104/PP.106.089250]; Shane MW, 2000, ANN BOT-LONDON, V85, P613, DOI 10.1006/anbo.2000.1113; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Wyss HM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061402; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	21	4	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114902	10.1371/journal.pone.0114902	http://dx.doi.org/10.1371/journal.pone.0114902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502567	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700067
J	Jahandideh, F; Majumder, K; Chakrabarti, S; Morton, JS; Panahi, S; Kaufman, S; Davidge, ST; Wu, JP				Jahandideh, Forough; Majumder, Kaustav; Chakrabarti, Subhadeep; Morton, Jude S.; Panahi, Sareh; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping			Beneficial Effects of Simulated Gastro-Intestinal Digests of Fried Egg and Its Fractions on Blood Pressure, Plasma Lipids and Oxidative Stress in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							LONG-TERM INTAKE; WHITE HYDROLYSATE; ANTIOXIDANT ACTIVITY; VASCULAR REACTIVITY; MESENTERIC-ARTERIES; VIRGIN OLIVE; SERUM-LIPIDS; PEPTIDES; DIET; CHEMISTRY	Background: We have previously characterized several antihypertensive peptides in simulated digests of cooked eggs and showed blood pressure lowering property of fried whole egg digest. However, the long-term effects of this hydrolysate and its fractions on blood pressure are not known. Therefore, the objectives of the study were to determine the effects of long term administration of fried whole egg hydrolysate and its fractions (i.e. egg white and egg yolk) on regulation of blood pressure and associated factors in cardiovascular disease such as plasma lipid profile and tissue oxidative stress. Methods and Results: We used spontaneously hypertensive rats (SHR), an animal model of essential hypertension. Hydrolysates of fried egg and its fractions were prepared by simulated gastro-intestinal digestion with pepsin and pancreatin. 16-17 week old male SHRs were orally administered fried whole egg hydrolysate, non-hydrolyzed fried whole egg, egg white hydrolysate or egg yolk hydrolysates (either defatted, or not) daily for 18 days. Blood pressure (BP) and heart rate were monitored by telemetry. Animals were sacrificed at the end of the treatment for vascular function studies and evaluating plasma lipid profile and tissue oxidative stress. BP was reduced by feeding fried whole egg hydrolysate but not by the nonhydrolyzed product suggesting a critical role for in vitro digestion in releasing anti-hypertensive peptides. Egg white hydrolysate and defatted egg yolk hydrolysate (but not egg yolk hydrolysate) also had similar effects. Reduction in BP was accompanied by the restoration of nitric oxide (NO) dependent vasorelaxation and reduction of plasma angiotensin II. Fried whole egg hydrolysate also reduced plasma levels of triglyceride although it was increased by the non-hydrolyzed sample. Additionally the hydrolyzed preparations attenuated tissue oxidative stress. Conclusion: Our results demonstrate that fried egg hydrolysates exert antihypertensive effects, improve plasma lipid profile and attenuate tissue oxidative stress in vivo.	[Jahandideh, Forough; Majumder, Kaustav; Chakrabarti, Subhadeep; Panahi, Sareh; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Kaufman, Susan; Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	jwu3@ualberta.ca	Jahandideh, Forough/M-4648-2019; Wu, Jian/AAU-5221-2020; Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020	Jahandideh, Forough/0000-0001-9731-0854; Wu, Jian/0000-0001-9933-7364; Majumder, Kaustav/0000-0003-2094-7835; Davidge, Sandra/0000-0002-5559-4905; Wu, Jian/0000-0002-3394-1507	Egg Farmers of Canada (EFC); Egg Farmers of Alberta (EFA); Natural Sciences and Engineering Research Council (NSERC) of Canada	Egg Farmers of Canada (EFC); Egg Farmers of Alberta (EFA); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by grants from Egg Farmers of Canada (EFC), Egg Farmers of Alberta (EFA), and Natural Sciences and Engineering Research Council (NSERC) of Canada to J. Wu. S. T. Davidge is a Canada Research Chair in women's cardiovascular health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anton M, 2003, FOOD CHEM, V83, P175, DOI 10.1016/S0308-8146(03)00060-8; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bolterman RJ, 2005, HYPERTENSION, V46, P943, DOI 10.1161/01.HYP.0000174602.59935.d5; Boon CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055908; Chen C, 2012, AMINO ACIDS, V43, P457, DOI 10.1007/s00726-011-1102-0; Chockalingam A, 2008, CAN J CARDIOL, V24, P441, DOI 10.1016/S0828-282X(08)70617-2; Cohn JS, 2010, NUTRIENTS, V2, P116, DOI 10.3390/nu2020116; Cooke CLM, 2003, CARDIOVASC RES, V60, P635, DOI 10.1016/j.cardiores.2003.08.011; CURTIS KJ, 1978, J PHYSIOL-LONDON, V274, P409, DOI 10.1113/jphysiol.1978.sp012156; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; Duan X, 2014, J AGR FOOD CHEM; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Giachini FRC, 2008, EXPERT OPIN THER TAR, V12, P327, DOI 10.1517/14728222.12.3.327; Hermansen K, 2000, BRIT J NUTR, V83, pS113; Herrera MD, 2001, BRIT J NUTR, V86, P349, DOI 10.1079/BJN2001397; Huang W, 2010, J AGR FOOD CHEM; Kawase M, 2000, J DAIRY SCI, V83, P255, DOI 10.3168/jds.S0022-0302(00)74872-7; Khanna A, 2008, CURR OPIN NEPHROL HY, V17, P477, DOI 10.1097/MNH.0b013e3283069d72; KINGSLEY TR, 1988, LIPIDS, V23, P564, DOI 10.1007/BF02535598; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Majumder K, 2013, J AGR FOOD CHEM; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082829; Majumder K, 2013, J FUNCT FOODS, V5, P187, DOI 10.1016/j.jff.2012.10.004; Majumder K, 2011, FOOD CHEM, V126, P1614, DOI 10.1016/j.foodchem.2010.12.039; Manso MA, 2008, FOOD CHEM, V109, P361, DOI 10.1016/j.foodchem.2007.12.049; Matoba N, 1999, FEBS LETT, V452, P181, DOI 10.1016/S0014-5793(99)00587-6; Miguel M, 2005, BRIT J NUTR, V94, P731, DOI 10.1079/BJN20051570; Miguel M, 2006, J NUTR, V136, P1457, DOI 10.1093/jn/136.6.1457; Miguel M, 2006, LIFE SCI, V78, P2960, DOI 10.1016/j.lfs.2005.11.025; Milanovic JG, 2010, J HYPERTENS, V28, pE500; Mine Y, 2007, CURR PHARM DESIGN, V13, P875, DOI 10.2174/138161207780414278; Miura K, 2013, J HYPERTENS, V31, P1144, DOI 10.1097/HJH.0b013e3283604016; Moser Marvin, 2007, J Clin Hypertens (Greenwich), V9, P316, DOI 10.1111/j.1524-6175.2007.07152.x; Nimalaratne C, 2011, FOOD CHEM, V129, P155, DOI 10.1016/j.foodchem.2011.04.058; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Palacios LE, 2005, J AM OIL CHEM SOC, V82, P571, DOI 10.1007/s11746-005-1111-4; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Perona JS, 2004, CLIN NUTR, V23, P1113, DOI 10.1016/j.clnu.2004.02.004; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Rawendra RDS, 2013, J PROTEOMICS, V94, P359, DOI 10.1016/j.jprot.2013.10.006; Remanan MK, 2014, FOOD FUNCT, V5, P1464, DOI 10.1039/c4fo00204k; Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shahidi F, 2008, J AOAC INT, V91, P914; Shen SW, 2010, J AGR FOOD CHEM, V58, P7664, DOI 10.1021/jf101323y; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; Xiong X, 2001, HYPERTENS PREGNANCY, V20, P1; Yang F, 2012, LIPIDS, V47, P269, DOI 10.1007/s11745-011-3646-x; Yoshii H, 2001, COMP BIOCHEM PHYS C, V128, P27, DOI 10.1016/S1532-0456(00)00172-1; Yu ZP, 2011, J SCI FOOD AGR, V91, P921, DOI 10.1002/jsfa.4266; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	56	26	28	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115006	10.1371/journal.pone.0115006	http://dx.doi.org/10.1371/journal.pone.0115006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502445	gold, Green Published			2022-12-26	WOS:000347146700081
J	Bulatov, E; Martin, EM; Chatterjee, S; Knebel, A; Shimamura, S; Konijnenberg, A; Johnson, C; Zinn, N; Grandi, P; Sobott, F; Ciulli, A				Bulatov, Emil; Martin, Esther M.; Chatterjee, Sneha; Knebel, Axel; Shimamura, Satoko; Konijnenberg, Albert; Johnson, Clare; Zinn, Nico; Grandi, Paola; Sobott, Frank; Ciulli, Alessio			Biophysical Studies on Interactions and Assembly of Full-size E3 Ubiquitin Ligase SUPPRESSOR OF CYTOKINE SIGNALING 2 (SOCS2)-ELONGIN BC-CULLIN 5-RING BOX PROTEIN 2 (RBX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSIBLE SURFACE-AREAS; CULLIN-RING LIGASES; STRUCTURAL BASIS; CUL5-RBX2 MODULES; PROTEINS POP1P; HEAT-CAPACITY; BOX; COMPLEXES; NEDD8; ARCHITECTURE	The multisubunit cullin RINGE3 ubiquitin ligases (CRLs) target post-translationally modified substrates for ubiquitination and proteasomal degradation. The suppressors of cytokine signaling (SOCS) proteins play important roles in inflammatory processes, diabetes, and cancer and therefore represent attractive targets for therapeutic intervention. The SOCS proteins, among their other functions, serve as substrate receptors of CRL5 complexes. A member of the CRL family, SOCS2-EloBC-Cul5-Rbx2 (CRL5(SOCS2)), binds phosphorylated growth hormone receptor as its main substrate. Here, we demonstrate that the components of CRL5(SOCS2) can be specifically pulled from K562 human cell lysates using beads decorated with phosphorylated growth hormone receptor peptides. Subsequently, SOCS2-EloBC and full-length Cul5-Rbx2, recombinantly expressed in Escherichia coli and in Sf21 insect cells, respectively, were used to reconstitute neddylated and unneddylated CRL5(SOCS2) complexes in vitro. Finally, diverse biophysical methods were employed to study the assembly and interactions within the complexes. Unlike other E3 ligases, CRL5(SOCS2) was found to exist in a monomeric state as confirmed by size exclusion chromatography with inline multiangle static light scattering and native MS. Affinities of the protein-protein interactions within the multisubunit complex were measured by isothermal titration calorimetry. A structural model for full-size neddylated and unneddylated CRL5(SOCS2) complexes is supported by traveling wave ion mobility mass spectrometry data.	[Bulatov, Emil; Ciulli, Alessio] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Knebel, Axel; Johnson, Clare] Univ Dundee, Coll Life Sci, Phosphorylat & Ubiquitylat Unit, Med Res Council,Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Bulatov, Emil; Ciulli, Alessio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Martin, Esther M.; Chatterjee, Sneha; Konijnenberg, Albert; Sobott, Frank] Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium; [Shimamura, Satoko; Zinn, Nico; Grandi, Paola] Cellzome GmbH, D-69117 Heidelberg, Germany	University of Dundee; University of Dundee; University of Cambridge; University of Antwerp; GlaxoSmithKline; Cellzome GmbH	Ciulli, A (corresponding author), Univ Dundee, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	a.ciulli@dundee.ac.uk	Bulatov, Emil/C-1766-2015	Bulatov, Emil/0000-0003-2961-0032; Sobott, Frank/0000-0001-9029-1865; Knebel, Axel/0000-0002-9197-6054	United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship [BB/G023123/1]; European Research Council [ERC-2012-StG-311460 DrugE3CRLs]; Government of the Republic of Tatarstan; Wellcome Trust [100476/Z/12/Z]; Hercules Foundation-Flanders; BBSRC [BB/G023123/1, BB/G023123/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023123/1, BB/G023123/2] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Government of the Republic of Tatarstan; Wellcome Trust(Wellcome TrustEuropean Commission); Hercules Foundation-Flanders; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship BB/G023123/1 (to A. C.), European Research Council Starting Grant ERC-2012-StG-311460 DrugE3CRLs (to A. C.), and the Government of the Republic of Tatarstan (Ph.D. studentship to E. B.). Molecular biophysics was supported by Wellcome Trust strategic award 100476/Z/12/Z (to the University of Dundee). The Synapt G2 mass spectrometer was funded by a grant from the Hercules Foundation-Flanders.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Anderica-Romero AC, 2013, REDOX BIOL, V1, P366, DOI 10.1016/j.redox.2013.07.003; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hubbard S. J., 1993, NACCESS; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kershaw NJ, 2014, GROWTH FACTORS, V32, P1, DOI 10.3109/08977194.2013.877005; Kim YK, 2013, ACTA CRYSTALLOGR D, V69, P1587, DOI 10.1107/S0907444913011220; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Lee DW, 2012, ANAL BIOCHEM, V428, P64, DOI 10.1016/j.ab.2012.06.007; Li YF, 2010, J BIOL CHEM, V285, P13896, DOI 10.1074/jbc.M110.111518; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Salter JD, 2012, BIOCHEMISTRY-US, V51, P8702, DOI 10.1021/bi301244z; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Seibert V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-22; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thomas JC, 2013, BIOCHEMISTRY-US, V52, P5236, DOI 10.1021/bi400758h; van Geersdaele LK, 2013, ACTA CRYSTALLOGR D, V69, P1677, DOI 10.1107/S0907444913012687; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	55	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4178	4191		10.1074/jbc.M114.616664	http://dx.doi.org/10.1074/jbc.M114.616664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25505247	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000349458400029
J	Olson, DK; Frohlich, F; Christiano, R; Hannibal-Bach, HK; Ejsing, CS; Walther, TC				Olson, Daniel K.; Froehlich, Florian; Christiano, Romain; Hannibal-Bach, Hans K.; Ejsing, Christer S.; Walther, Tobias C.			Rom2-dependent Phosphorylation of Elo2 Controls the Abundance of Very Long-chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GTP-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; SPHINGOLIPID HOMEOSTASIS; EXCHANGE FACTOR; BUDDING YEAST; RHO1 GTPASE; ACTIVATION; LIPIDS; GENE	Sphingolipids are essential components of eukaryotic membranes, where they serve to maintain membrane integrity. They are important components of membrane trafficking and function in signaling as messenger molecules. Sphingolipids are synthesized de novo from very long-chain fatty acids (VLCFA) and sphingoid long-chain bases, which are amide linked to form ceramide and further processed by addition of various headgroups. Little is known concerning the regulation of VLCFA levels and how cells coordinate their synthesis with the availability of long-chain bases for sphingolipid synthesis. Here we show that Elo2, a key enzyme of VLCFA synthesis, is controlled by signaling of the guanine nucleotide exchange factor Rom2, initiating at the plasma membrane. This pathway controls Elo2 phosphorylation state and VLCFA synthesis. Our data identify a regulatory mechanism for coordinating VLCFA synthesis with sphingolipid metabolism and link signal transduction pathways from the plasma membrane to the regulation of lipids for membrane homeostasis.	[Olson, Daniel K.; Froehlich, Florian; Christiano, Romain; Walther, Tobias C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Olson, Daniel K.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06150 USA; [Hannibal-Bach, Hans K.; Ejsing, Christer S.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-0230 Odense, Denmark; [Walther, Tobias C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walther, Tobias C.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Yale University; University of Southern Denmark; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Walther, TC (corresponding author), 665 Huntington Ave,Bldg 1,Room 207, Boston, MA 02115 USA.	twalther@hsph.harvard.edu	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Walther, Tobias/0000-0003-1442-1327; Frohlich, Florian/0000-0001-8307-2189	National Institutes of Health [R01GM095982]; Yale Top scholar award; Lundbeckfonden [R44-A4342]; Danish Council for Independent Research Natural Sciences [09-072484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095982, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Top scholar award; Lundbeckfonden(Lundbeckfonden); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM095982 (to T. C. W.), a Yale Top scholar award (to T. C. W.), Lundbeckfonden Grant R44-A4342 (to C. S. E.), and Danish Council for Independent Research Natural Sciences Grant 09-072484 (to C. S. E.).	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Breslow DK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013326; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Frohlich F, 2013, MOL CELL PROTEOMICS, V12, P1995, DOI 10.1074/mcp.M112.025742; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Mizunuma M, 2001, EMBO J, V20, P1074, DOI 10.1093/emboj/20.5.1074; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Niles BJ, 2012, CELL CYCLE, V11, P3745, DOI 10.4161/cc.21752; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; REVARDEL E, 1995, BBA-GENE STRUCT EXPR, V1263, P261, DOI 10.1016/0167-4781(95)00124-Y; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SIKORSKI RS, 1989, GENETICS, V122, P19; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; THEWALT J, 1992, BIOCHEM BIOPH RES CO, V188, P1247, DOI 10.1016/0006-291X(92)91365-W; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yan GH, 2012, MOL CELL, V45, P743, DOI 10.1016/j.molcel.2012.01.028; Zimmermann C, 2013, CELL REP, V5, P1036, DOI 10.1016/j.celrep.2013.10.024	57	17	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4238	4247		10.1074/jbc.M114.629279	http://dx.doi.org/10.1074/jbc.M114.629279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25519905	Green Published, hybrid			2022-12-26	WOS:000349458400034
J	Liu, F; Zhou, Q; Zhou, J; Sun, H; Wang, Y; Zou, XQ; Feng, LL; Hou, ZY; Zhou, AW; Zhou, Y; Li, Y				Liu, Feng; Zhou, Qin; Zhou, Jie; Sun, Hao; Wang, Yan; Zou, Xiuqun; Feng, Lingling; Hou, Zhaoyuan; Zhou, Aiwu; Zhou, Yi; Li, Yong			14-3-3 tau Promotes Surface Expression of Cav2.2 (alpha 1B) Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Electrophysiology; Membrane Trafficking; Protein-Protein Interaction; Trafficking; 14-3-3tau; Cav 2; 2 Channel; Cav Auxiliary Subunits; Endoplasmic Reticulum Retention	BETA-SUBUNIT; CALCIUM-CHANNELS; ENDOPLASMIC-RETICULUM; CHARGE MOVEMENT; IONIC CURRENT; MODULATION; PROTEINS; RETENTION; TRANSPORT; BINDING	Background: The mechanism and dynamics of Cav channels trafficking remains mysterious. Results: 14-3-3 promotes Cav2.2 trafficking independent of Cav auxiliary subunits. Conclusion: 14-3-3 enhances Cav2.2 trafficking by masking the ER retention signal at its proximal C-terminal region. Significance: Uncovering the regulation of Cav2.2 trafficking may contribute to understanding the Cav2.2 surface expression and functional control under physiological and pathophysiological conditions. Surface expression of voltage-gated Ca2+ (Cav) channels is important for their function in calcium homeostasis in the physiology of excitable cells, but whether or not and how the 1 pore-forming subunits of Cav channels are trafficked to plasma membrane in the absence of the known Cav auxiliary subunits, and 2, remains mysterious. Here we showed that 14-3-3 proteins promoted functional surface expression of the Cav2.2 1B channel in transfected tsA-201 cells in the absence of any known Cav auxiliary subunit. Both the surface to total ratio of the expressed 1B protein and the current density of voltage step-evoked Ba2+ current were markedly suppressed by the coexpression of a 14-3-3 antagonist construct, pSCM138, but not its inactive control, pSCM174, as determined by immunofluorescence assay and whole cell voltage clamp recording, respectively. By contrast, coexpression with 14-3-3 significantly enhanced the surface expression and current density of the Cav2.2 1B channel. Importantly, we found that between the two previously identified 14-3-3 binding regions at the 1B C terminus, only the proximal region (amino acids 1706-1940), closer to the end of the last transmembrane domain, was retained by the endoplasmic reticulum and facilitated by 14-3-3 to traffic to plasma membrane. Additionally, we showed that the 14-3-3/Cav subunit coregulated the surface expression of Cav2.2 channels in transfected tsA-201 cells and neurons. Altogether, our findings reveal a previously unidentified regulatory function of 14-3-3 proteins in promoting the surface expression of Cav2.2 1B channels.	[Liu, Feng; Zhou, Qin; Zhou, Jie; Sun, Hao; Wang, Yan; Zou, Xiuqun; Feng, Lingling; Hou, Zhaoyuan; Zhou, Aiwu; Li, Yong] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol,Shanghai Key Lab Tum, Shanghai 200025, Peoples R China; [Zhou, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Shanghai Jiao Tong University; State University System of Florida; Florida State University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	liyong68@shsmu.edu.cn	Li, Yong/ABB-5588-2021	ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China [2010CB912001, 2014CB910303]; National Natural Science Foundation of China [81171230, 31371064, 30970937]; Major Research Plan of the National Natural Science Foundation of China [91132303]; Shanghai Pujiang Program Grant [11PJ1406100]; Shanghai Committee of Science and Technology [11DZ2260200]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program Grant; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Basic Research Program of China Grants 2010CB912001 and 2014CB910303 (to Y. L.), National Natural Science Foundation of China Grants 81171230, 31371064, and 30970937 (to Y. L.), Major Research Plan of the National Natural Science Foundation of China Grant 91132303 (to Tianle Xu and Y. L.), Shanghai Pujiang Program Grant 11PJ1406100 (to Y. L.), and Shanghai Committee of Science and Technology Grant 11DZ2260200.	Allouis M, 2006, CIRC RES, V98, P1538, DOI 10.1161/01.RES.0000229244.97497.2c; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Y, 2007, CHANNELS, V1; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Sun CC, 2013, J BIOL CHEM, V288, P24676, DOI 10.1074/jbc.M113.462069; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856	41	8	8	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2689	2698		10.1074/jbc.M114.567800	http://dx.doi.org/10.1074/jbc.M114.567800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25516596	Green Published, hybrid			2022-12-26	WOS:000349310700013
J	Welak, SR; Rentea, RM; Teng, RJ; Heinzerling, N; Biesterveld, B; Liedel, JL; Pritchard, KA; Fredrich, KM; Gourlay, DM				Welak, Scott R.; Rentea, Rebecca M.; Teng, Ru-Jeng; Heinzerling, Nathan; Biesterveld, Ben; Liedel, Jennifer L.; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.			Intestinal NADPH Oxidase 2 Activity Increases in a Neonatal Rat Model of Necrotizing Enterocolitis	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; NAD(P)H OXIDASE; SUPEROXIDE-PRODUCTION; ALKALINE-PHOSPHATASE; NOX FAMILY; EXPRESSION; SYNTHASE; MECHANISMS; PHYSIOLOGY	Necrotizing enterocolitis (NEC) is a complication of prematurity. The etiology is unknown, but is related to enteral feeding, ischemia, infection, and inflammation. Reactive oxygen species production, most notably superoxide, increases in NEC. NADPH oxidase (NOX) generates superoxide, but its activity in NEC remains unknown. We hypothesize that NOX-derived superoxide production increases in NEC. Newborn Sprague-Dawley rats were divided into control, formula-fed, formula/LPS, formula/hypoxia, and NEC (formula, hypoxia, and LPS). Intestinal homogenates were analyzed for NADPH-dependent superoxide production. Changes in superoxide levels on days 0-4 were measured. Inhibitors for nitric oxide synthase (L-NAME) and NOX2 (GP91-ds-tat) were utilized. RT-PCR for eNOS, NOX1, GP91(phox) expression was performed. Immunofluorescence studies estimated the co-localization of p47(phox) and GP91(phox) in control and NEC animals on D1, D2, and D4. NEC pups generated more superoxide than controls on D4, while all other groups were unchanged. NADPH-dependent superoxide production was greater in NEC on days 0, 3, and 4. GP91-ds-tat decreased superoxide production in both groups, with greater inhibition in NEC. L-NAME did not alter superoxide production. Temporally, superoxide production varied minimally in controls. In NEC, superoxide generation was decreased on day 1, but increased on days 3-4. GP91(phox) expression was higher in NEC on days 2 and 4. NOX1 and eNOS expression were unchanged from controls. GP91(phox) and p47(phox) had minimal co-localization in all control samples and NEC samples on D1 and D2, but had increased co-localization on D4. In conclusion, this study proves that experimentally-induced NEC increases small intestinal NOX activity. All components of NEC model are necessary for increased NOX activity. NOX2 is the major source, especially as the disease progresses.	[Welak, Scott R.; Teng, Ru-Jeng; Liedel, Jennifer L.] Med Coll Wisconsin, Dept Pediat, Div Neonatol, Milwaukee, WI 53226 USA; [Welak, Scott R.; Rentea, Rebecca M.; Teng, Ru-Jeng; Heinzerling, Nathan; Biesterveld, Ben; Liedel, Jennifer L.; Gourlay, David M.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Welak, Scott R.; Teng, Ru-Jeng; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.] Med Coll Wisconsin, Translat Vasc Biol Program, Milwaukee, WI 53226 USA; [Rentea, Rebecca M.; Heinzerling, Nathan; Biesterveld, Ben; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Liedel, Jennifer L.] Med Coll Wisconsin, Dept Pediat, Div Crit Care, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Welak, SR (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Neonatol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	swelak@mcw.edu	Biesterveld, Ben/AAM-1087-2021	Rentea, Rebecca/0000-0002-8689-5989	NHLBI NIH HHS [R01 HL112270] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdullah F, 2010, CLIN PEDIATR, V49, P166, DOI 10.1177/0009922809349161; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Aydemir C, 2011, J PEDIATR SURG, V46, P2096, DOI 10.1016/j.jpedsurg.2011.06.032; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Baregamian N, 2006, J SURG RES, V136, P31, DOI 10.1016/j.jss.2006.04.028; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; CLARK DA, 1988, AM J PATHOL, V130, P537; Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Heinzerling NP, 2014, J PEDIATR SURG, V49, P954, DOI 10.1016/j.jpedsurg.2014.01.031; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Hilburger EW, 2005, NEUROSCI LETT, V377, P16, DOI 10.1016/j.neulet.2004.11.066; Hink U, 2001, CIRC RES, V88, pE14; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Kelly N, 2004, SURGERY, V136, P557, DOI 10.1016/j.surg.2004.05.034; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; MUSEMECHE C, 1991, J PEDIATR SURG, V26, P1047, DOI 10.1016/0022-3468(91)90671-F; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P128, DOI 10.3109/14767058.2012.663197; Perrone S, 2010, EARLY HUM DEV, V86, P241, DOI 10.1016/j.earlhumdev.2010.03.008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rentea RM, 2012, J PEDIATR SURG, V47, P1135, DOI 10.1016/j.jpedsurg.2012.03.018; Rentea RM, 2013, EUR J PEDIATR SURG, V23, P39, DOI 10.1055/s-0032-1329704; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; Whitehouse JS, 2010, J SURG RES, V161, P1, DOI 10.1016/j.jss.2009.07.028; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Yang M, 2006, AM J HYPERTENS, V19, P587, DOI 10.1016/j.amjhyper.2005.11.017; Yasuda M, 2012, AM J PHYSIOL-GASTR L, V302, pG1133, DOI 10.1152/ajpgi.00535.2011	41	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115317	10.1371/journal.pone.0115317	http://dx.doi.org/10.1371/journal.pone.0115317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517730	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600059
J	Lin, YR; Chiu, JJ; Tsai, SY				Lin, Yi-Ru; Chiu, Jian-Jia; Tsai, Shang-Yueh			Feasibility and Reproducibility of Echo Planar Spectroscopic Imaging on the Quantification of Hepatic Fat	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; IN-VIVO; NONINVASIVE ASSESSMENT; CHEMICAL-SHIFT; LIVER-DISEASE; HUMAN BRAIN; ARRAY COIL; STEATOSIS; PREVALENCE	Objectives: 1H-MRS is widely regarded as the most accurate noninvasive method to quantify hepatic fat content (HFC). When practical period of breath holding, and acquisition of HFC over multiple liver areas is considered, a fast MR spectroscopic imaging technique is desired. The aim of this study is to examine the feasibility and reproducibility of echo planar spectroscopic imaging (EPSI) on the quantification of HFC in subject with various HFCs. Methods: Twenty two volunteers were examined in a 3T MR system. The acquisition time of proposed EPSI protocol was 18 seconds. The EPSI scans were repeated 8 times for each subject to test reproducibility. The peak of water and individual peaks of fat including methyl, methylene, and allylic peaks at 0.9, 1.3, and 2.0 ppm were fitted. Calculated amount of water and fat content were corrected for T2 relaxation. The total HFC was defined as the combination of individual peaks. Standard deviation (SD), coefficient of variance (COV) and fitting reliability of HFC quantified by LCModel were calculated. Results: Our results show that the SDs of total HFC for all subjects are less than 2.5%. Fitting reliability is mostly under 10% and positively correlates with COV. Subjects separated into three subgroups according to quantified total HFC show that improved fitting reliability and reproducibility can be achieved on subjects with higher total HFC. Conclusions: We have demonstrated feasibility of the proposed EPSI protocols on the quantification of HFC over a whole slice of liver with scan time in a single breath hold.	[Lin, Yi-Ru; Chiu, Jian-Jia] Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan; [Tsai, Shang-Yueh] Natl Chengchi Univ, Grad Inst Appl Phys, Taipei 11623, Taiwan	National Taiwan University of Science & Technology; National Chengchi University	Lin, YR (corresponding author), Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan.	yrlin@mail.ntust.edu.tw	Tsai, Shang-Yueh/O-2226-2013	Tsai, Shang-Yueh/0000-0002-6310-4750	Ministry of Science and Technology of Taiwan [100-2221-E-011-013-MY3, 01-2320-B-004-001-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan under grant no. 100-2221-E-011-013-MY3 (YRL) and 101-2320-B-004-001-MY2 (SYT) (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Friedrich-Rust M, 2010, J CLIN GASTROENTEROL, V44, P58, DOI 10.1097/MCG.0b013e3181a84b8d; Gambarota G, 2011, MAGN RESON MATER PHY, V24, P339, DOI 10.1007/s10334-011-0278-3; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Johnson NA, 2008, HEPATOLOGY, V47, P1513, DOI 10.1002/hep.22220; Kang BK, 2012, INVEST RADIOL, V47, P368, DOI 10.1097/RLI.0b013e31824baff3; Katz-Brull R, 2003, MAGNET RESON MED, V50, P461, DOI 10.1002/mrm.10560; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Lin FH, 2007, MAGN RESON MED, V57, P249, DOI 10.1002/mrm.21119; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; Marsman HA, 2011, J GASTROEN HEPATOL, V26, P356, DOI 10.1111/j.1440-1746.2010.06326.x; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Otazo R, 2007, MAGN RESON MED, V58, P1107, DOI 10.1002/mrm.21426; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Sharma P, 2009, J MAGN RESON IMAGING, V29, P629, DOI 10.1002/jmri.21682; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Tsai SY, 2008, MAGN RESON MED, V59, P989, DOI 10.1002/mrm.21545; Tsai SY, 2012, NEUROIMAGE, V63, P1020, DOI 10.1016/j.neuroimage.2012.07.039; van Werven JR, 2009, J MAGN RESON IMAGING, V30, P444, DOI 10.1002/jmri.21837	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114436	10.1371/journal.pone.0114436	http://dx.doi.org/10.1371/journal.pone.0114436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514348	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300010
J	Andreoni, C; Orsi, G; De Maria, C; Montemurro, F; Vozzi, G				Andreoni, Chiara; Orsi, Gianni; De Maria, Carmelo; Montemurro, Francesca; Vozzi, Giovanni			In Silico Models for Dynamic Connected Cell Cultures Mimicking Hepatocyte-Endothelial Cell-Adipocyte Interaction Circle	PLOS ONE			English	Article							FATTY-ACID UPTAKE; MULTICOMPARTMENTAL BIOREACTOR; LIPID-METABOLISM; MATHEMATICAL-MODEL; MODULAR BIOREACTOR; PATHWAYS; LIVER; SIMULATION; PROGRAM; GLUCOSE	The biochemistry of a system made up of three kinds of cell is virtually impossible to work out without the use of in silico models. Here, we deal with homeostatic balance phenomena from a metabolic point of view and we present a new computational model merging three single-cell models, already available from our research group: the first model reproduced the metabolic behaviour of a hepatocyte, the second one represented an endothelial cell, and the third one described an adipocyte. Multiple interconnections were created among these three models in order to mimic the main physiological interactions that are known for the examined cell phenotypes. The ultimate aim was to recreate the accomplishment of the homeostatic balance as it was observed for an in vitro connected three-culture system concerning glucose and lipid metabolism in the presence of the medium flow. The whole model was based on a modular approach and on a set of nonlinear differential equations implemented in Simulink, applying Michaelis-Menten kinetic laws and some energy balance considerations to the studied metabolic pathways. Our in silico model was then validated against experimental datasets coming from literature about the cited in vitro model. The agreement between simulated and experimental results was good and the behaviour of the connected culture system was reproduced through an adequate parameter evaluation. The developed model may help other researchers to investigate further about integrated metabolism and the regulation mechanisms underlying the physiological homeostasis.	[Andreoni, Chiara; Orsi, Gianni; De Maria, Carmelo; Montemurro, Francesca; Vozzi, Giovanni] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [De Maria, Carmelo; Vozzi, Giovanni] Univ Pisa, Dept Informat Engn, Pisa, Italy	University of Pisa; University of Pisa	Andreoni, C (corresponding author), Univ Pisa, Res Ctr E Piaggio, Pisa, Italy.	ing.chiara.andreoni@gmail.com	Vozzi, Giovanni/AAS-5320-2021; Vozzi, Giovanni/F-9787-2014; De Maria, Carmelo/AAC-8978-2021	Vozzi, Giovanni/0000-0002-9414-9994; De Maria, Carmelo/0000-0002-1368-3571				Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Berk PD, 1999, J BIOL CHEM, V274, P28626, DOI 10.1074/jbc.274.40.28626; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; CORNISHBOWDEN A, 1991, COMPUT APPL BIOSCI, V7, P89; Cutrone A, 2009, COMPUT METH PROG BIO, V94, P181, DOI 10.1016/j.cmpb.2008.12.004; De Maria C, 2008, COMPUT METH PROG BIO, V92, P121, DOI 10.1016/j.cmpb.2008.06.004; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; EHLDE M, 1995, COMPUT APPL BIOSCI, V11, P201; FIGARD PH, 1986, J LIPID RES, V27, P771; Garvey Thomas D., 2003, OMICS A Journal of Integrative Biology, V7, P411, DOI 10.1089/153623103322637715; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; GRUNDY SM, 1990, DM-DIS MON, V36, P641; Guzzardi MA, 2009, TISSUE ENG PT A, V15, P3635, DOI 10.1089/ten.TEA.2008.0695; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Iori E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034704; Kettner Carsten, 2007, In Silico Biology, V7, pS57; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kummer Ursula, 2007, In Silico Biology, V7, pS65; MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a; Maeda N, 2008, NAT CLIN PRACT ENDOC, V4, P627, DOI 10.1038/ncpendmet0980; Mathews CK, 1998, BIOCHIMICA; Mazzei D, 2008, IEEE T IND ELECTRON, V55, P3273, DOI 10.1109/TIE.2008.928122; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Micheloni A, 2014, COMPUTER METHODS BIO; Monti LD, 2000, METABOLISM, V49, P73, DOI 10.1016/S0026-0495(00)90763-7; Orsi G, 2011, COMPUT METHOD BIOMEC, V14, P837, DOI 10.1080/10255842.2010.497145; Orsi G, 2009, ENMET ENDOTHELIAL CE, P654; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Ring A, 2002, J LIPID RES, V43, P2095, DOI 10.1194/jlr.M200285-JLR200; Russell WMS., 1959, MED J AUSTRALIA; SAURO HM, 1993, COMPUT APPL BIOSCI, V9, P441; SAURO HM, 2000, ANIMATING CELLULAR M; Sidoli FR, 2004, CYTOTECHNOLOGY, V44, P27, DOI 10.1023/B:CYTO.0000043397.94527.84; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; SUGIHARA H, 1987, J LIPID RES, V28, P1038; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Valvano G, 2014, IEEE T BIO-MED ENG, V61, P224, DOI 10.1109/TBME.2013.2272942; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Vinci B, 2012, BIOTECHNOL J, V7, P117, DOI 10.1002/biot.201100177; Vinci B, 2010, BIOTECHNOL J, V5, P618, DOI 10.1002/biot.201000009; Vinci B, 2010, BIOTECHNOL J, V5, P232, DOI 10.1002/biot.200900074; Vozzi F, 2009, TISSUE ENG PT A, V15, P1291, DOI 10.1089/ten.tea.2008.0066; Wang G, 2009, ENDOCRINOL METAB, V297, pE271	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e111946	10.1371/journal.pone.0111946	http://dx.doi.org/10.1371/journal.pone.0111946			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502576	gold, Green Published			2022-12-26	WOS:000346607100002
J	Berard, V; Fiala, C; Cameron, S; Bombas, T; Parachini, M; Gemzell-Danielsson, K				Berard, Veronique; Fiala, Christian; Cameron, Sharon; Bombas, Teresa; Parachini, Mirella; Gemzell-Danielsson, Kristina			Instability of Misoprostol Tablets Stored Outside the Blister: A Potential Serious Concern for Clinical Outcome in Medical Abortion	PLOS ONE			English	Article							HYDROXYPROPYL METHYLCELLULOSE; MANAGEMENT; RECOMMENDATIONS; MIFEPRISTONE; COMBINATION; KINETICS; HEALTH; TRIAL	Introduction: Misoprostol (Cytotec) is recognised to be effective for many gynaecological indications including termination of pregnancy, management of miscarriage and postpartum haemorrhage. Although not licensed for such indications, it has been used for these purposes by millions of women throughout the world. Misoprostol tablets are most often packaged as multiple tablets within an aluminium strip, each within an individual alveolus. When an alveolus is opened, tablets will be exposed to atmospheric conditions. Objective: To compare the pharmaco technical characteristics (weight, friability), water content, misoprostol content and decomposition product content (type A misoprostol, type B misoprostol and 8-epi misoprostol) of misoprostol tablets Cytotec (Pfizer) exposed to air for periods of 1 hour to 720 hours (30 days), to those of identical non exposed tablets. Methods: Four hundred and twenty (420) tablets of Cytotec (Pfizer) were removed from their alveoli blister and stored at 25 degrees C/60% relative humidity. Water content, and misoprostol degradation products were assayed in tablets exposed from 1 to 720 hours (30 days). Comparison was made with control tablets (N=60) from the same batch stored in non-damaged blisters. Statistical analyses were carried out using Fisher's exact test for small sample sizes. Results: By 48 hours, exposed tablets demonstrated increased weight (+4.5%), friability (+1 300%), and water content (+80%) compared to controls. Exposed tablets also exhibited a decrease in Cytotec active ingredient dosage (-5.1% after 48 hours) and an increase in the inactive degradation products (+25% for type B, +50% for type A and +11% for 8-epi misoprostol after 48 hours) compared to controls. Conclusion: Exposure of Cytotec tablets to 'typical' European levels of air and humidity results in significant time-dependent changes in physical and biological composition that could impact adversely upon clinical efficacy. Health professionals should be made aware of the degradation of misoprostol with inappropriate storage of misoprostol tablets.	[Berard, Veronique] Univ Bourgogne, Dept Neurosci, Div MaNaPI, ICB CNRS, Dijon, France; [Fiala, Christian] Gynmed Clin, Vienna, Austria; [Cameron, Sharon] NHS Lothian, Chalmers Ctr, Edinburgh, Midlothian, Scotland; [Bombas, Teresa] Ctr Hosp Coimbra, Obstetr Serv, Coimbra, Portugal; [Bombas, Teresa] Univ Coimbra, Coimbra, Portugal; [Parachini, Mirella] San Filippo Neri Hosp, Rome, Italy; [Fiala, Christian; Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Fiala, Christian; Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Stockholm, Sweden	Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; San Filippo Neri Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Berard, V (corresponding author), Univ Bourgogne, Dept Neurosci, Div MaNaPI, ICB CNRS, Dijon, France.	vberard@u-bourgogne.fr		Fiala, Christian/0000-0001-6451-7349	Exelgyn	Exelgyn	The authors confirm that Sharon Cameron as well as Kristina Gemzell Danielsson are PLOS ONE Editorial Board members. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. Veronique Berard received funding from a commercial source "Exelgyn'' but this does not alter Veronique Berard's adherence to PLOS ONE policies on sharing data and materials.	Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X; Carr SA, 2012, APPR HEALTHC TECHN D, P1; Cervagem, 2005, SUMM PROD CHAR; Chung T, 1997, ACTA OBSTET GYN SCAN, V76, P248, DOI 10.1111/j.1600-0412.1997.tb07854.x; COLLINS PW, 1985, DIGEST DIS SCI, V30, pS114, DOI 10.1007/BF01309395; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Danielsson KG, 1999, OBSTET GYNECOL, V93, P275, DOI 10.1016/S0029-7844(98)00436-0; EDQM, 2013, PHARM EUR 7 6 DIR EV, P5107; EDQM, 2011, PHARM EUR 7 0 DIR EV, P291; Ellertson C, 2001, Curr Womens Health Rep, V1, P184; Exelgyn, 2013, SMPC MIF 200 MG TABL; Faucher P, 2005, Gynecol Obstet Fertil, V33, P220, DOI 10.1016/j.gyobfe.2005.02.021; Hamoda H, 2005, BJOG-INT J OBSTET GY, V112, P1102, DOI 10.1111/j.1471-0528.2005.00638.x; Herabutya Y, 1997, INT J GYNECOL OBSTET, V56, P263, DOI 10.1016/S0020-7292(96)02815-9; KARARLI TT, 1990, PHARMACEUT RES, V7, P1186, DOI 10.1023/A:1015996712794; Kararli TT, 2004, INT J GYNECOL OBSTET, V87, P281; Kulier R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002855.pub4; McCreath Wayne A., 2001, Obstetrics and Gynecology, V97, p67S, DOI 10.1016/S0029-7844(01)01306-0; National Abortion Federation, 2002, EARL MED AB MIF OTH; Newhall Elizabeth Pirruccello, 2000, American Journal of Obstetrics and Gynecology, V183, pS44; Shaw D, 2007, INT J GYNECOL OBSTET, V99, pS155, DOI 10.1016/j.ijgo.2007.09.002; Singh K, 1998, OBSTET GYNECOL, V92, P795, DOI 10.1016/S0029-7844(98)00281-6; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; TOLEDOVELASQUEZ D, 1992, J PHARM SCI, V81, P145, DOI 10.1002/jps.2600810209; Wagaarachchi PT, 2001, HUM REPROD, V16, P1849, DOI 10.1093/humrep/16.9.1849; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e112401	10.1371/journal.pone.0112401	http://dx.doi.org/10.1371/journal.pone.0112401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502819	Green Published, gold			2022-12-26	WOS:000346607100003
J	De Filette, M; Chabierski, S; Andries, O; Ulbert, S; Sanders, NN				De Filette, Marina; Chabierski, Stefan; Andries, Oliwia; Ulbert, Sebastian; Sanders, Niek N.			T Cell Epitope Mapping of the E-Protein of West Nile Virus in BALB/c Mice	PLOS ONE			English	Article							INFECTION; PREDICTION; IMMUNITY; IMMUNOPATHOLOGY; ENCEPHALITIS; PROTECTION; RESPONSES; ANTIGEN; HUMANS	West Nile virus (WNV) is a zoonotic virus, which is transmitted by mosquitoes. It is the causative agent of the disease syndrome called West Nile fever. In some human cases, a WNV infection can be associated with severe neurological symptoms. The immune response to WNV is multifactorial and includes both humoral and cellular immunity. T-cell epitope mapping of the WNV envelope (E) protein has been performed in C57BL/6 mice, but not in BALB/c mice. Therefore, we performed in BALB/c mice a T-cell epitope mapping using a series of peptides spanning the WNV envelope (E) protein. To this end, the WNV-E specific T cell repertoire was first expanded by vaccinating BALB/c mice with a DNA vaccine that generates subviral particles that resemble West Nile virus. Furthermore, the WNV structural protein was expressed in Escherichia coli as a series of overlapping 20-mer peptides fused to a carrier-protein. Cytokine-based ELISPOT assays using these purified peptides revealed positive WNV-specific T cell responses to peptides within the different domains of the E-protein.	[De Filette, Marina; Andries, Oliwia; Sanders, Niek N.] Univ Ghent, Fac Vet Sci, Lab Gene Therapy, B-9000 Merelbeke, Belgium; [Chabierski, Stefan; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany	Ghent University; Fraunhofer Gesellschaft	Sanders, NN (corresponding author), Univ Ghent, Fac Vet Sci, Lab Gene Therapy, B-9000 Merelbeke, Belgium.	Niek.Sanders@UGent.be		Sanders, Niek/0000-0003-4585-0343; Ulbert, Sebastian/0000-0001-5910-3643	European Union [261426]; Research Foundation Flanders	European Union(European Commission); Research Foundation Flanders(FWO)	This work was supported by the European Union under FP7 (MDF, SC, SU, NNS), Project 261426 (WINGS-West Nile Integrated Shield Project), and by the Research Foundation Flanders (OA, NNS) (http://www.fwo.be/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246; Chabierski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066507; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Heinz CM, 2000, 7 INT COMM TAX VIR; Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012; Jung KO, 2012, J VIROL, V86, P7616, DOI 10.1128/JVI.00166-12; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; SINIGAGLIA F, 1994, CURR OPIN IMMUNOL, V6, P52, DOI 10.1016/0952-7915(94)90033-7; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115343	10.1371/journal.pone.0115343	http://dx.doi.org/10.1371/journal.pone.0115343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506689	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100068
J	Li, Y; Qin, ZP; Guo, HX; Yang, HX; Zhang, GJ; Ji, SL; Zeng, TY				Li, Ye; Qin, Zhenping; Guo, Hongxia; Yang, Hanxiao; Zhang, Guojun; Ji, Shulan; Zeng, Tingying			Low-Temperature Synthesis of Anatase TiO2 Nanoparticles with Tunable Surface Charges for Enhancing Photocatalytic Activity	PLOS ONE			English	Article							TITANIUM-DIOXIDE; HYDROTHERMAL SYNTHESIS; ORGANIC CONTAMINANTS; RUTILE TIO2; DEGRADATION; TRANSFORMATION; NANOCRYSTALS; PARTICLES; NANOTUBES; HYDROGEN	In this work, the positively or negatively charged anatase TiO2 nanoparticles were synthesized via a low temperature precipitation-peptization process (LTPPP) in the presence of poly(ethyleneimine) (PEI) and poly(sodium4-styrenesulfonate) (PSS). X-ray diffraction (XRD) pattern and high-resolution transmission electron microscope (HRTEM) confirmed the anatase crystalline phase. The charges of the prepared TiO2, PEI-TiO2 and PSS-TiO2 nanoparticles were investigated by zeta potentials. The results showed that the zeta potentials of PEI-TiO2 nanoparticles can be tuned from +39.47 mV to +95.46 mV, and that of PSS-TiO2 nanoparticles can be adjusted from -56.63 mV to -119.32 mV. In comparison with TiO2, PSS-TiO2 exhibited dramatic adsorption and degradation of dye molecules, while the PEI modified TiO2 nanoparticles showed lower photocatalytic activity. The photocatalytic performances of these charged nanoparticles were elucidated by the results of UV-vis diffuse reflectance spectra (DRS) and the photoluminescence (PL) spectra, which indicated that the PSS-TiO2 nanoparticles showed a lower recombination rate of electron-hole pairs than TiO2 and PEI-TiO2.	[Li, Ye; Qin, Zhenping; Yang, Hanxiao; Zhang, Guojun; Ji, Shulan] Beijing Univ Technol, Coll Environm & Energy Engn, Beijing, Peoples R China; [Guo, Hongxia] Beijing Univ Technol, Coll Mat Sci & Engn, Beijing, Peoples R China; [Li, Ye; Guo, Hongxia; Ji, Shulan] Beijing Key Lab Green Catalysis & Separat, Beijing, Peoples R China; [Zeng, Tingying] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Beijing University of Technology; Beijing University of Technology; Massachusetts Institute of Technology (MIT)	Guo, HX (corresponding author), Beijing Univ Technol, Coll Mat Sci & Engn, Beijing, Peoples R China.	hxguo@bjut.edu.cn		Guo, Hongxia/0000-0003-0903-8382	National Natural Science Foundation of China [21176005]; National technology support program of China [2011BAE29B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National technology support program of China	This work was financially supported by National Natural Science Foundation of China (21176005), National technology support program of China (Project No., 2011BAE29B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosc F, 2003, CHEM MATER, V15, P2463, DOI 10.1021/cm031025a; Burunkaya E, 2013, APPL SURF SCI, V265, P317, DOI 10.1016/j.apsusc.2012.11.003; Cassaignon S, 2007, J MATER SCI, V42, P6689, DOI 10.1007/s10853-007-1496-y; Chen K, 2012, MAT SCI SEMICON PROC, V15, P20, DOI 10.1016/j.mssp.2011.05.007; Deshpande SB, 2006, MATER CHEM PHYS, V97, P207, DOI 10.1016/j.matchemphys.2005.02.014; Fernandez N. A, 1999, COLLOID SURF A, V148, P231, DOI DOI 10.1016/S0927-7757(98)00763-8; Finnegan MP, 2007, J PHYS CHEM C, V111, P1962, DOI 10.1021/jp063822c; FRANCESCA R, 2013, CATAL TODAY, V209, P28, DOI DOI 10.1016/J.CATT0D.2013.01.008; Gao JC, 2011, INTEGR FERROELECTR, V129, P169, DOI 10.1080/10584587.2011.576944; Gao YN, 2014, APPL SURF SCI, V294, P36, DOI 10.1016/j.apsusc.2013.12.107; Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003; Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648; IMAE T, 1991, COLLOID POLYM SCI, V269, P43, DOI 10.1007/BF00654658; Khataee AR, 2010, J MOL CATAL A-CHEM, V328, P8, DOI 10.1016/j.molcata.2010.05.023; Kim J, 2009, ENVIRON SCI TECHNOL, V43, P5488, DOI 10.1021/es900342q; Kumaresan L, 2010, IND ENG CHEM RES, V49, P1480, DOI 10.1021/ie901191z; Li GS, 2005, J AM CHEM SOC, V127, P8659, DOI 10.1021/ja050517g; Li KX, 2013, J HAZARD MATER, V250, P19, DOI 10.1016/j.jhazmat.2013.01.069; Liao DL, 2007, J PHOTOCH PHOTOBIO A, V187, P363, DOI 10.1016/j.jphotochem.2006.11.003; Liao DL, 2009, COLLOID SURFACE A, V348, P270, DOI 10.1016/j.colsurfa.2009.07.036; Libanori R, 2009, J SOL-GEL SCI TECHN, V49, P95, DOI 10.1007/s10971-008-1821-1; Liu N, 2014, CATAL TODAY, V225, P34, DOI 10.1016/j.cattod.2013.10.090; Lu OY, 2008, J MEMBRANE SCI, V310, P76, DOI 10.1016/j.memsci.2007.10.031; Mogilevsky G, 2008, J PHYS CHEM C, V112, P3239, DOI 10.1021/jp076899p; Nguyen TBL, 2011, J MATER SCI, V46, P5615, DOI 10.1007/s10853-011-5511-y; Ni M, 2007, RENEW SUST ENERG REV, V11, P401, DOI 10.1016/j.rser.2005.01.009; Nian JN, 2006, J PHYS CHEM B, V110, P4193, DOI 10.1021/jp0567321; Oliveira EGL, 2011, CHEM ENG J, V172, P96, DOI 10.1016/j.cej.2011.05.069; Park BJ, 2006, J ELECTROCERAM, V17, P1031, DOI 10.1007/s10832-006-9242-4; Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m; Priya DN, 2009, ACS APPL MATER INTER, V1, P2684, DOI 10.1021/am900566n; Qi KH, 2010, ACS APPL MATER INTER, V2, P3479, DOI 10.1021/am1005892; Song HJ, 2006, J PHYS CHEM A, V110, P6178, DOI 10.1021/jp061053r; Song MX, 2008, J RARE EARTH, V26, P693, DOI 10.1016/S1002-0721(08)60165-9; Tayade RJ, 2006, IND ENG CHEM RES, V45, P5231, DOI 10.1021/ie051362o; Thapa R, 2012, J MOL CATAL A-CHEM, V363, P223, DOI 10.1016/j.molcata.2012.06.013; VILLOSLADA IM, 2006, POLYMER, V47, P6496, DOI DOI 10.1016/J.P0LYMER.2006.07.059; Wang H, 2006, LANGMUIR, V22, P1526, DOI 10.1021/la051988j; Wang S, 2012, APPL SURF SCI, V263, P260, DOI 10.1016/j.apsusc.2012.09.040; Weng YX, 2003, J PHYS CHEM B, V107, P4356, DOI 10.1021/jp022534n; Wu XM, 2001, J SOLID STATE CHEM, V156, P220, DOI 10.1006/jssc.2000.8991; Xie MZ, 2010, J HAZARD MATER, V176, P139, DOI 10.1016/j.jhazmat.2009.11.008; Xu SB, 2012, SOL ENERG MAT SOL C, V96, P286, DOI 10.1016/j.solmat.2011.09.022; Yin HB, 2001, J MATER CHEM, V11, P1694, DOI 10.1039/b008974p; Zahng Qing-Hong, 2000, J INORG CHEM, P931; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Zhang WF, 2000, APPL PHYS B-LASERS O, V70, P261, DOI 10.1007/s003400050043; Zhang YC, 2013, APPL CATAL B-ENVIRON, V142, P249, DOI 10.1016/j.apcatb.2013.05.023	48	17	17	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114638	10.1371/journal.pone.0114638	http://dx.doi.org/10.1371/journal.pone.0114638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506839	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100016
J	Mancuso, P; Calleri, A; Gregato, G; Labanca, V; Quarna, J; Antoniotti, P; Cuppini, L; Finocchiaro, G; Eoli, M; Rosti, V; Bertolini, F				Mancuso, Patrizia; Calleri, Angelica; Gregato, Giuliana; Labanca, Valentina; Quarna, Jessica; Antoniotti, Pierluigi; Cuppini, Lucia; Finocchiaro, Gaetano; Eoli, Marica; Rosti, Vittorio; Bertolini, Francesco			A Subpopulation of Circulating Endothelial Cells Express CD109 and is Enriched in the Blood of Cancer Patients	PLOS ONE			English	Article							FLOW-CYTOMETRY; METRONOMIC CHEMOTHERAPY; IDENTIFICATION; ANGIOGENESIS; HETEROGENEITY; BEVACIZUMAB; RECEPTOR; GENES; INHIBITOR; VIABILITY	Background: The endothelium is not a homogeneous organ. Endothelial cell heterogeneity has been described at the level of cell morphology, function, gene expression, and antigen composition. As a consequence of the genetic, transcriptome and surrounding environment diversity, endothelial cells from different vascular beds have differentiated functions and phenotype. Detection of circulating endothelial cells (CECs) by flow cytometry is an approach widely used in cancer patients, and their number, viability and kinetic is a promising tool to stratify patient receiving anti-angiogenic treatment. Methodology/Principal Findings: Currently CECs are identified as positive for a nuclear binding antigen (DNA+), negative for the pan leukocyte marker CD45, and positive for CD31 and CD146. Following an approach recently validated in our laboratory, we investigated the expression of CD109 on CECs from the peripheral blood of healthy subject and cancer patients. The endothelial nature of these cells was validated by RT-PCR for the presence of m-RNA level of CDH5 (Ve-Cadherin) and CLDN5 (Claudin5), two endothelial specific transcripts. Before treatment, significantly higher levels of CD109+CECs and viable CD109+CECs were found in breast cancer patients and glioblastoma patients compared to healthy controls, and their number significantly decreased after treatment. Higher levels of endothelial specific transcripts expressed in developing endothelial cells CLEC14a, TMEM204, ARHGEF15, GPR116, were observed in sorted CD109+CECs when compared to sorted CD146+CECs, suggesting that these genes can play an important role not only during embryogenesis but also in adult angiogenesis. Interestingly, mRNA levels of TEM8 (identified as Antrax Toxin Receptor1, Antrax1) were expressed in CD109+CECs+ but not in CD146+CECs. Conclusion: Taken together our results suggest that CD109 represent a rare population of circulating tumor endothelial cells, that play a potentially useful prognostic role in patients with glioblastoma. The role of CD109 expression in cancer vessel-specific endothelial cells deserves to be further investigated by gene expression studies.	[Mancuso, Patrizia; Calleri, Angelica; Gregato, Giuliana; Labanca, Valentina; Quarna, Jessica; Antoniotti, Pierluigi; Bertolini, Francesco] European Inst Oncol, Lab Hematol Oncol, Milan, Italy; [Cuppini, Lucia; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C Besta, Dept Neurooncol, Milan, Italy; [Rosti, Vittorio] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Istituto Neurologico Besta; IRCCS Fondazione San Matteo	Mancuso, P (corresponding author), European Inst Oncol, Lab Hematol Oncol, Milan, Italy.	patrizia.mancuso@ieo.it	Rosti, Vittorio/K-1743-2018; bertolini, francesco/AAC-9780-2019; Eoli, Marica/K-7748-2016; Gregato, Giuliana/AAO-5668-2020; Finocchiaro, Gaetano/AAG-6791-2020; Calleri, Angelica/AAO-3747-2020	Rosti, Vittorio/0000-0003-4195-2289; bertolini, francesco/0000-0001-5660-3255; Eoli, Marica/0000-0003-4744-9377; Finocchiaro, Gaetano/0000-0003-3583-4040	AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Umberto Veronesi; Ministero della Salute	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Ministero della Salute(Ministry of Health, Italy)	Supported in part by AIRC (Associazione Italiana per la Ricerca sul Cancro), Fondazione Umberto Veronesi, and Ministero della Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Cuppini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074345; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P45, DOI 10.1160/TH06-04-0185; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawaishi M, 2009, J THORAC ONCOL, V4, P208, DOI 10.1097/JTO.0b013e318193030d; Keedy VL, 2007, CANCER SCI, V98, P1825, DOI 10.1111/j.1349-7006.2007.00620.x; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Mancuso P, 2006, BLOOD, V108, P452, DOI 10.1182/blood-2005-11-4570; Mancuso P, 2009, CLIN CANCER RES, V15, P267, DOI 10.1158/1078-0432.CCR-08-0432; Mehran R, 2014, CANCER RES, V74, P2731, DOI 10.1158/0008-5472.CAN-13-2044; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Mutin M, 1997, TISSUE ANTIGENS, V50, P449, DOI 10.1111/j.1399-0039.1997.tb02899.x; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Shaked Y, 2005, BLOOD, V106, P3058, DOI 10.1182/blood-2005-04-1422; St Croix B, 2000, SCIENCE, V289, P1197; Strijbos MH, 2008, BRIT J CANCER, V98, P1731, DOI 10.1038/sj.bjc.6604383; SUTHERLAND DR, 1991, BLOOD, V77, P84; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; van der Pol MA, 2003, CYTOM PART B-CLIN CY, V55B, P14, DOI 10.1002/cyto.b.10024	44	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114713	10.1371/journal.pone.0114713	http://dx.doi.org/10.1371/journal.pone.0114713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506915	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100022
J	Baskaran, K; Pugazhendhi, S; Ramakrishna, BS				Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.			Protective Association of Tumor Necrosis Factor Superfamily 15 (TNFSF15) Polymorphic Haplotype with Ulcerative Colitis and Crohn's Disease in an Indian Population	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENE; TL1A; EXPRESSION; VARIANTS; RISK	Background: Tumor necrosis factor superfamily (TNFSF) proteins are involved in the genesis of inflammatory bowel disease (IBD). We examined the association of seven single nucleotide polymorphisms (SNP) in the TNFSF15 gene with Crohn's disease (CD) and ulcerative colitis (UC) in the Indian population. Methods: Seven SNPs in the TNFSF15 gene (rs10114470, rs3810936, rs6478108, rs4263839, rs6478109, rs7848647 and rs7869487) were genotyped in 309 CD patients, 330 UC patients and 437 healthy controls using the Sequenom iPLEX MassArray platform. Disease associations were evaluated for allelotypes and for genotypes. Results: The minor T alleles and the TT genotypes of rs10114470 and rs3810936 were significantly protectively associated with both CD and UC. The CC genotype of rs6478108, AA genotype of rs4263839, the AA genotype of rs6478109, the TT genotype of rs7848647 and the CC genotype of rs7869487 were all protectively associated with CD but not with UC. Two haplotype blocks could be discerned, one where SNPs rs10114470 and rs3810936 were in tight LD (D' = 0.8) and the other where rs6478108, rs4263839, rs6478109, rs7848647 and rs7869487 were in tight LD (D' 0.92-1.00). The second block of haplotypes were not associated with CD or with UC. The first block of haplotypes was very significantly associated with both CD and UC. Conclusions: Strong associations exist between TNFSF15 gene polymorphisms and IBD (both CD and UC) in the Indian population.	[Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore 632004, Tamil Nadu, India; [Ramakrishna, Balakrishnan S.] SRM Inst Med Sci, Chennai 600026, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; SRM Institute of Science & Technology Chennai	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore 632004, Tamil Nadu, India.	wurama@hotmail.com	Srinivasan, Pugazhendhi/M-5184-2019; Ramakrishna, Balakrishnan/D-6808-2015	Srinivasan, Pugazhendhi/0000-0002-1748-1416; Ramakrishna, Balakrishnan/0000-0001-5090-9501				Ahuja V, 2010, J DIGEST DIS, V11, P134, DOI 10.1111/j.1751-2980.2010.00429.x; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cavallini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060136; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Foster A, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00034; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Montgomery SM, 1999, EUR J GASTROEN HEPAT, V11, P543, DOI 10.1097/00042737-199905000-00013; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; PROBERT CSJ, 1993, GUT, V34, P1547, DOI 10.1136/gut.34.11.1547; Pugazhendhi Srinivasan, 2008, Indian J Gastroenterol, V27, P201; Pugazhendhi S, 2013, GENE, V512, P309, DOI 10.1016/j.gene.2012.10.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin OY, 2006, J GASTROEN HEPATOL, V21, P1772, DOI 10.1111/j.1440-1746.2006.04674.x; Ramakrishna BS, 2012, INDIAN J GASTROENTER, V31, P307, DOI 10.1007/s12664-012-0259-0; Sood Ajit, 2007, Indian J Gastroenterol, V26, P285; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Zheng L, 2013, EUR J MICROBIOL IMMU, V3, P11, DOI 10.1556/EuJMI.3.2013.1.2	34	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114665	10.1371/journal.pone.0114665	http://dx.doi.org/10.1371/journal.pone.0114665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501099	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400043
J	Czorlich, P; Burkhardt, T; Knospe, V; Richard, G; Vettorazzi, E; Wagenfeld, L; Westphal, M; Regelsberger, J; Skevas, C				Czorlich, Patrick; Burkhardt, Till; Knospe, Volker; Richard, Gisbert; Vettorazzi, Eik; Wagenfeld, Lars; Westphal, Manfred; Regelsberger, Jan; Skevas, Christos			Ocular Ultrasound as an Easy Applicable Tool for Detection of Terson's Syndrome after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							ULTRASONOGRAPHY; SAFETY; VITRECTOMY; PREGNANCY; BRAIN	Introduction: Intraocular hemorrhage in patients suffering from aneurysmal subarachnoid hemorrhage is known as Terson's syndrome and is an underestimated but common pathology. We therefore designed a prospective single-blinded study to evaluate the validity of ocular ultrasound compared to the gold standard indirect funduscopy in the diagnosis of Terson's syndrome. Material and Methods: Fifty-two patients (104 eyes in total) suffering from aneurysmal subarachnoid hemorrhage were enrolled in this study. Two investigators independently performed a single-blinded ocular ultrasound using a standard intensive care ultrasound system to detect an intraocular hemorrhage. Indirect funduscopy following iatrogenic mydriasis served as the gold standard for confirmation or exclusion of an intraocular hemorrhage. Statistical analyses were performed to evaluate the sensitivity and specificity, positive and negative predictive values of the method as well as the learning curve of ocular ultrasound. Results: Indirect funduscopy detected Terson's syndrome in 11 of 52 (21.2%) respectively in 21 of 104 (20.2%) eyes in patients suffering from subarachnoid hemorrhage. Sensitivity and specificity increased with the number of ocular ultrasound examinations for both investigators, reaching 81.8% and 100% respectively. Positive and negative predictive values were different for both investigators (63.6% vs. 100% positive and 100% vs. 95.7% negative) but were both correlated to the amount of intraocular hemorrhage. A low Glasgow Coma scale (p=0.015) and high Hunt & Hess grade (p=0.003) was associated with a higher rate of Terson's syndrome. Conclusions: Ocular ultrasound using standard ultrasound equipment has been confirmed as a reliable, easy-to-handle bedside screening tool for detecting Terson's syndrome. Nevertheless funduscopy remains the gold standard to detect Terson's syndrome.	[Czorlich, Patrick; Burkhardt, Till; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Knospe, Volker; Richard, Gisbert; Wagenfeld, Lars; Skevas, Christos] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	p.czorlich@uke.de	Czorlich, Patrick/H-8934-2019; Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402				Bello SO, 2012, ANN AFR MED, V11, P1, DOI 10.4103/1596-3519.91006; Berrocal T, 1996, RADIOGRAPHICS, V16, P251, DOI 10.1148/radiographics.16.2.8966285; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1111/j.1553-2712.2003.tb01352.x; Czorlich P, 2015, NEUROSURG REV, V38, P129, DOI 10.1007/s10143-014-0564-4; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; FISHER CM, 1967, J NEUROL NEUROSUR PS, V30, P383, DOI 10.1136/jnnp.30.5.383; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; Frizzell RT, 1997, NEUROSURGERY, V41, P529, DOI 10.1097/00006123-199709000-00004; GARFINKLE AM, 1992, J NEUROSURG, V76, P766, DOI 10.3171/jns.1992.76.5.0766; Gauntt CD, 2007, J NEURO-OPHTHALMOL, V27, P193, DOI 10.1097/WNO.0b013e31814b22dc; Koskela E, 2014, J NEUROSURG, V120, P1172, DOI 10.3171/2014.2.JNS131248; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Leo M, 2011, ULTRASOUND CLIN, V6, P227; Litten M, 1881, BERL KLIN WOCHENSCHR, V18, P23; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Parchand S, 2014, SEMIN OPHTHALMOL, V29, P236, DOI 10.3109/08820538.2013.821506; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Rosa M, 2012, RADIOGRAPHICS, V32, P9; Rubowitz A, 2006, RETINA-J RET VIT DIS, V26, P230; Sharma T, 2002, OPHTHALMIC SURG LAS, V33, P195; Silverman RH, 2001, J ULTRAS MED, V20, P979; Skevas C, 2014, OPHTHALMOLOGY, V121, P1628, DOI 10.1016/j.ophtha.2014.02.015; Terson A, 1900, CLIN OPHTHALMOL, V6, P309; Torloni MR, 2009, ULTRASOUND OBST GYN, V33, P599, DOI 10.1002/uog.6328; WEINGEIST TA, 1986, OPHTHALMOLOGY, V93, P1435; Wietholter S, 1998, ZBL NEUROCHIR, V59, P166; Yoonessi R, 2010, ACAD EMERG MED, V17, P913, DOI 10.1111/j.1553-2712.2010.00809.x	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114907	10.1371/journal.pone.0114907	http://dx.doi.org/10.1371/journal.pone.0114907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502695	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700068
J	Lukovic, JA; Miletic, V; Pekmezovic, T; Trajkovic, G; Ratkovic, N; Aleksic, D; Grgurevic, A				Lukovic, Jasminka Adzic; Miletic, Vladimir; Pekmezovic, Tatjana; Trajkovic, Goran; Ratkovic, Nevena; Aleksic, Danijela; Grgurevic, Anita			Self-Medication Practices and Risk Factors for Self-Medication among Medical Students in Belgrade, Serbia	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; HEALTH-CARE; DRUG-USE; ALCOHOL; SEEKING; ANTIBIOTICS; ADOLESCENTS; ATTITUDES; BEHAVIOR	Introduction: Self-medication among future health care professionals can represent a serious threat to professionalism in medicine and it has potential to put at risk public trust into this profession. The aim of this research was to investigate prevalence and risk factors for self-medication among population of medical students, because it was previously shown that their attitudes towards pharmacotherapy could affect the way they could prescribe medication in the future. Material and Methods: Research was performed as a cross-sectional study and it included 1296 (84.1%) 1st, 3rd and 6th year students of School of Medicine, University of Belgrade. Students filled out a demographic and self-medication questionnaire created for the purpose of this research and the Physical Health Questionnaire - 9 (PHQ-9). Questions about self-medication were related to the period of the previous year. Results: Self-medication was reported by 79.9% students. The most frequently self-prescribed medications were analgesics (55.4%). Independent risk factors for self-medication were possession of home-pharmacies (OR=5.3, CI 95% 3.89-7.23), lower level of father's education (OR=1.6, CI 95% 1.18-2.25), consumption of alcoholic beverages (OR=1.5, CI 95% 1.13-2.08), less than 1 hour spent in physical activity per week (OR=1.4, CI 95% 1.00-2.02), female gender (OR=1.4, CI 95% 1.02-1.89), older age (OR=1.1, CI 95% 1.07-1.21) and higher PHQ-9 score (OR=1.09, CI 95% 1.05-1.12). Conclusions: Self-medication is an important issue among population of medical students. Prevalence of self-medication could be controlled through regulatory authorities and further education.	[Lukovic, Jasminka Adzic; Pekmezovic, Tatjana; Grgurevic, Anita] Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade, Serbia; [Miletic, Vladimir] Assoc Mental Hlth Promot, Belgrade, Serbia; [Trajkovic, Goran] Univ Belgrade, Sch Med, Inst Med Stat & Informat, Belgrade, Serbia; [Ratkovic, Nevena; Aleksic, Danijela] Clin Ctr Serbia, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Grgurevic, A (corresponding author), Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade, Serbia.	anita.grgurevic@gmail.com						Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Badiger S, 2012, AUSTRALAS MED J, V5, P217, DOI 10.4066/AMJ.2012.1007; Bertoldi AD, 2010, CAD SAUDE PUBLICA, V26, P1945, DOI 10.1590/S0102-311X2010001000011; Bertoldi AD, 2014, J ADOLESCENT HEALTH, V55, P175, DOI 10.1016/j.jadohealth.2014.02.010; Betancourt J, 2013, P R HEALTH SCI J, V32, P89; Brimstone R, 2007, MED EDUC, V41, P74, DOI 10.1111/j.1365-2929.2006.02649.x; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; da Silva MGC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-339; Demissie Z, 2014, MATERN CHIL IN PRESS; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; El Ezz N F A, 2011, J Prev Med Hyg, V52, P196; EPSTEIN AM, 1984, AM J MED, V77, P313, DOI 10.1016/0002-9343(84)90709-5; Eticha T, 2014, PLOS ONE, V12; Fayyazi Bordbar MR, 2014, SUBST USE M IN PRESS; Gardiner Paula, 2007, BMC Complement Altern Med, V7, P39, DOI 10.1186/1472-6882-7-39; Gazibara T, 2013, GERIATR NURS, V34, P486, DOI 10.1016/j.gerinurse.2013.08.002; Hofmeister EH, 2010, J VET MED EDUC, V37, P403, DOI 10.3138/jvme.37.4.403; James H, 2006, MED PRIN PRACT, V15, P270, DOI 10.1159/000092989; Kauffman SE, 1997, SOC WORK, V42, P231, DOI 10.1093/sw/42.3.231; Keel PK, 2007, J ABNORM PSYCHOL, V116, P422, DOI 10.1037/0021-843X.116.2.422; Kisic-Tepavcevic D, 2013, AM J DRUG ALCOHOL AB, V39, P130, DOI 10.3109/00952990.2012.746348; Klemenc-Ketis Z, 2010, INT J CLIN PHARM TH, V48, P705; Klemenc-Ketis Z, 2010, MED PRIN PRACT, V19, P395, DOI 10.1159/000316380; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kumar N, 2013, PLOS ONE, V28; Lazareck S, 2012, J CLIN PSYCHIAT, V73, pE588, DOI 10.4088/JCP.11m07345; Montgomery AJ, 2011, OCCUP MED-OXFORD, V61, P490, DOI 10.1093/occmed/kqr098; Pan H, 2012, PLOS ONE, V27; Pekmezovic T, 2011, QUAL LIFE RES, V20, P391, DOI 10.1007/s11136-010-9754-x; Roberts LW, 2000, ACAD MED, V75, P272, DOI 10.1097/00001888-200003000-00019; Roberts LW, 2001, COMPR PSYCHIAT, V42, P1, DOI 10.1053/comp.2001.19747; Sawalha AF, 2008, RES SOC ADMIN PHARM, V4, P164, DOI 10.1016/j.sapharm.2007.04.004; Ullah H, 2013, ACTA POL PHARM, V70, P919; Van der Veer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028038; WHO, 2011, WHO GLOB REP NONC DI WHO GLOB REP NONC DI; World Health Organization, 2000, REG GUID TEL PROD; Zafar Syed Nabeel, 2008, J Pak Med Assoc, V58, P214	38	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114644	10.1371/journal.pone.0114644	http://dx.doi.org/10.1371/journal.pone.0114644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25503967	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700038
J	Thomas, HR; Percival, SM; Yoder, BK; Parant, JM				Thomas, Holly R.; Percival, Stefanie M.; Yoder, Bradley K.; Parant, John M.			High-Throughput Genome Editing and Phenotyping Facilitated by High Resolution Melting Curve Analysis	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; CAENORHABDITIS-ELEGANS; REVERSE GENETICS; ZEBRAFISH; SYSTEM; CAS9; SPECIFICITY; DROSOPHILA; MUTATION	With the goal to generate and characterize the phenotypes of null alleles in all genes within an organism and the recent advances in custom nucleases, genome editing limitations have moved from mutation generation to mutation detection. We previously demonstrated that High Resolution Melting (HRM) analysis is a rapid and efficient means of genotyping known zebrafish mutants. Here we establish optimized conditions for HRM based detection of novel mutant alleles. Using these conditions, we demonstrate that HRM is highly efficient at mutation detection across multiple genome editing platforms (ZFNs, TALENs, and CRISPRs); we observed nuclease generated HRM positive targeting in 1 of 6 (16%) open pool derived ZFNs, 14 of 23 (60%) TALENs, and 58 of 77 (75%) CRISPR nucleases. Successful targeting, based on HRM of G0 embryos correlates well with successful germline transmission (46 of 47 nucleases); yet, surprisingly mutations in the somatic tail DNA weakly correlate with mutations in the germline F1 progeny DNA. This suggests that analysis of G0 tail DNA is a good indicator of the efficiency of the nuclease, but not necessarily a good indicator of germline alleles that will be present in the F1s. However, we demonstrate that small amplicon HRM curve profiles of F1 progeny DNA can be used to differentiate between specific mutant alleles, facilitating rare allele identification and isolation; and that HRM is a powerful technique for screening possible off-target mutations that may be generated by the nucleases. Our data suggest that micro-homology based alternative NHEJ repair is primarily utilized in the generation of CRISPR mutant alleles and allows us to predict likelihood of generating a null allele. Lastly, we demonstrate that HRM can be used to quickly distinguish genotype-phenotype correlations within F1 embryos derived from G0 intercrosses. Together these data indicate that custom nucleases, in conjunction with the ease and speed of HRM, will facilitate future high-throughput mutation generation and analysis needed to establish mutants in all genes of an organism.	[Thomas, Holly R.; Percival, Stefanie M.; Parant, John M.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cellular Dev & Integrated Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Parant, JM (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA.	Jparant@uab.edu			UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC) [P30 DK074038]; NIH Neurological disease and stroke [R21 NS092105]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065655, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092105] Funding Source: NIH RePORTER	UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC); NIH Neurological disease and stroke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BKY is supported by UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC, P30 DK074038). JMP is supported by NIH Neurological disease and stroke (R21 NS092105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Paul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059505; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2014, NAT METHODS; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Zhou LM, 2013, CLIN CHEM, V59, P1052, DOI 10.1373/clinchem.2013.202689	42	88	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114632	10.1371/journal.pone.0114632	http://dx.doi.org/10.1371/journal.pone.0114632			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503746	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700037
J	Huber, F; Meurer, M; Bunina, D; Kats, I; Maeder, CI; Stefl, M; Mongis, C; Knop, M				Huber, Florian; Meurer, Matthias; Bunina, Daria; Kats, Ilia; Maeder, Celine I.; Stefl, Martin; Mongis, Cyril; Knop, Michael			PCR Duplication: A One-Step Cloning-Free Method to Generate Duplicated Chromosomal Loci and Interference-Free Expression Reporters in Yeast	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; MODULES; TRANSFORMATION; GENES; OLIGONUCLEOTIDES; DISRUPTION; CASSETTES; VERSATILE	Here, we report on a novel PCR targeting-based strategy called 'PCR duplication' that enables targeted duplications of genomic regions in the yeast genome using a simple PCR-based approach. To demonstrate its application we first duplicated the promoter of the FAR1 gene in yeast and simultaneously inserted a GFP downstream of it. This created a reporter for promoter activity while leaving the FAR1 gene fully intact. In another experiment, we used PCR duplication to increase the dosage of a gene in a discrete manner, from 1x to 2x. Using TUB4, the gene encoding for the yeast gamma-tubulin, we validated that this led to corresponding increases in the levels of mRNA and protein. PCR duplication is an easy one-step procedure that can be adapted in different ways to permit rapid, disturbance-free investigation of various genomic regulatory elements without the need for ex vivo cloning.	[Huber, Florian; Meurer, Matthias; Bunina, Daria; Kats, Ilia; Maeder, Celine I.; Stefl, Martin; Mongis, Cyril; Knop, Michael] Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Knop, M (corresponding author), Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, D-69120 Heidelberg, Germany.	m.knop@zmbh.uni-heidelberg.de	Stefl, Martin/O-1316-2018	Stefl, Martin/0000-0001-8436-5581; Huber, Florian/0000-0001-8265-0856; Kats, Ilia/0000-0001-5220-5671; Bunina, Daria/0000-0002-5885-7440	DFG (Deutsche Forschungsgemeinschaft) [SFB1036]; CellNetworks Cluster of Excellence; Alexander von Humboldt Foundation; HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology); Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); CellNetworks Cluster of Excellence; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology); Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung	FH was supported by the SFB1036 of the DFG (Deutsche Forschungsgemeinschaft, www.dfg.de/en), MM and MS by the CellNetworks Cluster of Excellence (www.cellnetworks.uni-hd.de), MS in addition by the Alexander von Humboldt Foundation (www.humboldt-foundation.de/web/home.html), IK by the HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, www.hbigs.uni-heidelberg.de) and DB received funding from the Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung (www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HICKS JB, 1979, COLD SPRING HARB SYM, V43, P1305, DOI 10.1101/SQB.1979.043.01.149; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Horecka J, 2014, YEAST, V31, P103, DOI 10.1002/yea.2992; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maeder CI, 2007, METHOD MICROBIOL, V36, P55, DOI 10.1016/S0580-9517(06)36004-7; Morrow DM, 1997, GENETICS, V147, P371; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114590	10.1371/journal.pone.0114590	http://dx.doi.org/10.1371/journal.pone.0114590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493941	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000346611400055
J	Labbe, A; Ganopolsky, JG; Martoni, CJ; Prakash, S; Jones, ML				Labbe, Alain; Ganopolsky, Jorge G.; Martoni, Christopher J.; Prakash, Satya; Jones, Mitchell L.			Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN GUT MICROBIOME; ACID RECEPTOR; LIPID-METABOLISM; ASSOCIATION; DIVERSITY; DYSBIOSIS; ARTICLE; GLUCOSE; HEALTH	We performed an analysis to determine the importance of bile acid modification genes in the gut microbiome of inflammatory bowel disease and type 2 diabetic patients. We used publicly available metagenomic datasets from the Human Microbiome Project and the MetaHIT consortium, and determined the abundance of bile salt hydrolase gene (bsh), 7 alpha-dehydroxylase gene (adh) and 7-alpha hydroxysteroid dehydrogenase gene (hsdh) in fecal bacteria in diseased populations of Crohn's disease (CD), Ulcerative Colitis (UC) and Type 2 diabetes mellitus (T2DM). Phylum level abundance analysis showed a significant reduction in Firmicute-derived bsh in UC and T2DM patients but not in CD patients, relative to healthy controls. Reduction of adh and hsdh genes was also seen in UC and T2DM patients, while an increase was observed in the CD population as compared to healthy controls. A further analysis of the bsh genes showed significant differences in the correlations of certain Firmicutes families with disease or healthy populations. From this observation we proceeded to analyse BSH protein sequences and identified BSH proteins clusters representing the most abundant strains in our analysis of Firmicute bsh genes. The abundance of the bsh genes corresponding to one of these protein clusters was significantly reduced in all disease states relative to healthy controls. This cluster includes bsh genes derived from Lachospiraceae, Clostridiaceae, Erysipelotrichaceae and Ruminococcaceae families. This metagenomic analysis provides evidence of the importance of bile acid modifying enzymes in health and disease. It further highlights the importance of identifying gene and protein clusters, as the same gene may be associated with health or disease, depending on the strains expressing the enzyme, and differences in the enzymes themselves.	[Prakash, Satya; Jones, Mitchell L.] Fac Med, Dept Biomed Engn, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada; [Labbe, Alain; Ganopolsky, Jorge G.; Martoni, Christopher J.; Prakash, Satya; Jones, Mitchell L.] Micropharma Ltd, Montreal, PQ, Canada		Jones, ML (corresponding author), Fac Med, Dept Biomed Engn, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada.	mitchell.jones@mcgill.ca			Micropharma Limited	Micropharma Limited	Micropharma Limited funded this research.	Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Attinkara Ragam, 2012, BMC Res Notes, V5, P461, DOI 10.1186/1756-0500-5-461; Camilleri M, 2011, NEUROGASTROENT MOTIL, V23, P995, DOI 10.1111/j.1365-2982.2011.01772.x; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jess T, 2005, AM J GASTROENTEROL, V100, P2486, DOI 10.1111/j.1572-0241.2005.00224.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Knop FK, 2010, AM J PHYSIOL-ENDOC M, V299, pE10, DOI 10.1152/ajpendo.00137.2010; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; Popescu IR, 2010, FEBS LETT, V584, P2845, DOI 10.1016/j.febslet.2010.04.068; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renga B, 2010, BBA-MOL BASIS DIS, V1802, P363, DOI 10.1016/j.bbadis.2010.01.002; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Vrieze A, 2013, J HEPATOL; Wewalka M, 2014, J CLIN ENDOCR METAB; Wildenberg ME, 2011, GUT, V60, P432, DOI 10.1136/gut.2010.233304; Zarrinpar A, 2012, ALIMENT PHARM THER, V36, P909, DOI 10.1111/apt.12084	40	81	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115175	10.1371/journal.pone.0115175	http://dx.doi.org/10.1371/journal.pone.0115175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517115	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600048
J	Sandstrom, CAM; Prop, J; van der Jeugd, H; Loonen, MJJE				Sandstrom, Cecilia A. M.; Prop, Jouke; van der Jeugd, Henk; Loonen, Maarten J. J. E.			Baseline Immune Activity Is Associated with Date Rather than with Moult Stage in the Arctic-Breeding Barnacle Goose (Branta leucopsis)	PLOS ONE			English	Article							PARASITE POPULATION INTERACTIONS; ANNUAL-CYCLE; LIFE-HISTORY; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LEUKOCYTE PROFILES; PIED FLYCATCHERS; SEASONAL-CHANGES; GLOBAL PATTERNS; WING MOLT	Variation in immune defence in birds is often explained either by external factors such as food availability and disease pressure or by internal factors such as moult and reproductive effort. We explored these factors together in one sampling design by measuring immune activity over the time frame of the moulting period of Arctic-breeding barnacle geese (Branta leucopsis). We assessed baseline innate immunity by measuring levels of complement-mediated lysis and natural antibody-mediated agglutination together with total and differential leukocyte counts. Variation in immune activity during moult was strongly associated with calendar date and to a smaller degree with the growth stage of wing feathers. We suggest that the association with calendar date reflected temporal changes in the external environment. This environmental factor was further explored by comparing the immune activity of geese in the Arctic population with conspecifics in the temperate climate zone at comparable moult stages. In the Arctic environment, which has a lower expected disease load, geese exhibited significantly lower values of complement-mediated lysis, their blood contained fewer leukocytes, and levels of phagocytic cells and reactive leukocytes were relatively low. This suggests that lower baseline immune activity could be associated with lower disease pressure. We conclude that in our study species, external factors such as food availability and disease pressure have a greater effect on temporal variation of baseline immune activity than internal factors such as moult stage.	[Sandstrom, Cecilia A. M.; Prop, Jouke; Loonen, Maarten J. J. E.] Univ Groningen, Arctic Ctr, NL-9700 AS Groningen, Netherlands; [Sandstrom, Cecilia A. M.] Univ Groningen, NL-9747 AG Groningen, Netherlands; [van der Jeugd, Henk] Dutch Ctr Avian Migrat & Demog NIOO KNAW, Vogeltrekstn, NL-6700 AB Wageningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Sandstrom, CAM (corresponding author), Univ Groningen, Arctic Ctr, POB 716, NL-9700 AS Groningen, Netherlands.	c.a.m.sandstrom@rug.nl	van der Jeugd, Henk/S-3159-2019; van der Jeugd, Henk P/F-4891-2010; KNAW, NIOO-KNAW/A-4320-2012	van der Jeugd, Henk/0000-0002-5332-9526; van der Jeugd, Henk P/0000-0002-5332-9526; KNAW, NIOO-KNAW/0000-0002-3835-159X; Loonen, Maarten J.J.E./0000-0002-3426-4595	Netherlands Polar Program (HvdJ); Netherlands Organisation for Scientific Research [851.40.071, 851.30.21]; CAMS; Dutch Faunafonds	Netherlands Polar Program (HvdJ); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CAMS; Dutch Faunafonds	This work was carried out within the frame of the International Polar Year project BIRDHEALTH (MJJEL, JP, HvdJ, CAMS) and by the Netherlands Polar Program (HvdJ), funded by the Netherlands Organisation for Scientific Research (www.nwo.nl; grant 851.40.071 to MJJEL, 851.30.21 to HvdJ). The Faculty of Science, Rijksuniversiteit Groningen, financed CAMS and Dutch Faunafonds supported the field work in the temperate study population. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Ardia DR, 2007, ECOGRAPHY, V30, P23, DOI 10.1111/j.2006.0906-7590.04939.x; Ardia DR, 2008, AVIAN IMMUNOLOGY, P421, DOI 10.1016/B978-012370634-8.50025-1; BAKKER JP, 1993, HYDROBIOLOGIA, V265, P73, DOI 10.1007/BF00007263; BENNETT GF, 1992, CONDOR, V94, P289, DOI 10.2307/1368821; Black J.M., 2014, THE BARNACLE GOOSE; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2010, AUK, V127, P394, DOI 10.1525/auk.2010.09017; Buehler DM, 2009, J COMP PHYSIOL A, V195, P445, DOI 10.1007/s00359-009-0422-y; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; CECCHINI G, 1992, VET RES COMMUN, V16, P425, DOI 10.1007/BF01839019; Coulson SJ, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1448.1.2; Cramp S, 1977, BIRDS W PALEARCTIC; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Drent RH, 1998, NORSK POLARINST SKRI, P105; Dzubin A. E., 1992, MEASUREMENTS GEESE G; Eichhorn G, 2010, AUK, V127, P162, DOI 10.1525/auk.2009.09057; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fox AD, 2005, J AVIAN BIOL, V36, P538, DOI 10.1111/j.0908-8857.2005.03301.x; Gerlach Helga, 1994, P109; Gonzalez-Quevedo C, 2014, J ANIM ECOL, V83, P1091, DOI 10.1111/1365-2656.12214; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; Hegemann A, 2012, OECOLOGIA, V170, P605, DOI 10.1007/s00442-012-2339-3; Hegemann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036358; Hohman William L., 1992, P128; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Horrocks NPC, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00287.1; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Horrocks NPC, 2011, INTEGR COMP BIOL, V51, P563, DOI 10.1093/icb/icr011; Horrocks NPC, 2012, THESIS RIJKSUNIVERSI, P37; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Johansen B, 2014, INT J APPL EARTH OBS, V27, P20, DOI 10.1016/j.jag.2013.07.001; Jonker RM, 2013, MOL ECOL, V22, P5835, DOI 10.1111/mec.12548; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Klasing K.C., 2004, ACTA ZOOL SINICA, V50, P961; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loonen MJJE, 1997, ARDEA, V85, P177; Loonen MJJE, 1997, THESIS RIJKSUNIVERSI, P137; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Moller AP, 2006, OIKOS, V115, P463, DOI 10.1111/j.2006.0030-1299.15312.x; Moreno-Rueda G, 2010, J EVOLUTION BIOL, V23, P2229, DOI 10.1111/j.1420-9101.2010.02090.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Owen JC, 2011, J FIELD ORNITHOL, V82, P339, DOI 10.1111/j.1557-9263.2011.00338.x; OWEN M, 1979, CONDOR, V81, P42, DOI 10.2307/1367855; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Pinsky NA, 2003, CLIN DIAGN LAB IMMUN, V10, P19, DOI 10.1128/CDLI.10.1.19-21.2003; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Prop J, 2004, THESIS RIJKSUNIVERSI; R Development Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Samour Jaime, 2006, P587; Sandstrom CAM, 2013, VET PARASITOL, V194, P9, DOI 10.1016/j.vetpar.2012.12.027; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; Silverin B, 1999, J AVIAN BIOL, V30, P255, DOI 10.2307/3677351; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Van der Graaf AJ, 2006, THESIS RIJKSUNIVERSI, P149; van der Graaf SAJ, 2006, ARDEA, V94, P567; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; Zuur Alain F., 2009, P1	85	4	4	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114812	10.1371/journal.pone.0114812	http://dx.doi.org/10.1371/journal.pone.0114812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517982	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600030
J	Lamot, L; Borovecki, F; Bukovac, LT; Vidovic, M; Perica, M; Gotovac, K; Harjacek, M				Lamot, Lovro; Borovecki, Fran; Bukovac, Lana Tambic; Vidovic, Mandica; Perica, Marija; Gotovac, Kristina; Harjacek, Miroslav			Aberrant Expression of Shared Master-Key Genes Contributes to the Immunopathogenesis in Patients with Juvenile Spondyloarthritis	PLOS ONE			English	Article							ENTHESITIS-RELATED ARTHRITIS; INFLAMMATORY-BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; IDIOPATHIC ARTHRITIS; MICROARRAY ANALYSIS; RECEPTOR 4; PROFILES; HLA-B27; CLASSIFICATION; IDENTIFICATION	Association of juvenile spondyloarthritis (jSpA) with the HLA-B27 genotype is well established, but there is little knowledge of other genetic factors with a role in the development of the disease. To date, only a few studies have tried to find those associated genes by obtaining expression profiles, but with inconsistent results due to various patient selection criteria and methodology. The aim of the present study was to identify and confirm gene signatures and novel biomarkers in highly homogeneous cohorts of untreated and treated patients diagnosed with jSpA and other forms of juvenile idiopathic arthritis (JIA) according to ILAR criteria. For the purposes of the research, total RNA was isolated from whole blood of 45 children with jSpA and known HLA genotype, 11 children with oligo-and polyarticular forms of JIA, as well as 12 age and sex matched control participants without diagnosis of inflammatory disease. DNA microarray gene expression was performed in 11 patients with jSpA and in four healthy controls, along with bioinformatical analysis of retrieved data. Carefully selected differentially expressed genes where analyzed by qRT-PCR in all participants of the study. Microarray results and bioinformatical analysis revealed 745 differentially expressed genes involved in various inflammatory processes, while qRT-PCR analysis of selected genes confirmed data universality and specificity of expression profiles in jSpA patients. The present study indicates that jSpA could be a polygenic disease with a possible malfunction in antigen recognition and activation of immunological response, migration of inflammatory cells and regulation of the immune system. Among genes involved in these processes TLR4, NLRP3, CXCR4 and PTPN12 showed almost consistent expression in study patients diagnosed with jSpA. Those genes and their products could therefore potentially be used as novel biomarkers, possibly predictive of disease prognosis and response to therapy, or even as a target for new therapeutic approaches.	[Lamot, Lovro; Harjacek, Miroslav] Univ Zagreb, Sch Med, Dept Pediat, Zagreb 41001, Croatia; [Lamot, Lovro; Bukovac, Lana Tambic; Vidovic, Mandica; Perica, Marija; Harjacek, Miroslav] Childrens Hosp Srebrnjak, Div Pediat & Adolescent Rheumatol, Zagreb, Croatia; [Borovecki, Fran; Gotovac, Kristina] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Dept Funct Genom, Zagreb 41001, Croatia	University of Zagreb; University of Zagreb	Lamot, L (corresponding author), Univ Zagreb, Sch Med, Dept Pediat, Zagreb 41001, Croatia.	lovro.lamot@gmail.com	Lamot, Lovro/F-1041-2013	Lamot, Lovro/0000-0002-7939-115X; Harjacek, Miroslav/0000-0002-8322-9702	Ministry of Science, Education and Sports of the Republic of Croatia [108-1083107-0351]; Parkinson&quot;s UK [K-1206] Funding Source: researchfish	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was completely funded by the Ministry of Science, Education and Sports of the Republic of Croatia by grant 108-1083107-0351 (www.mzos.hr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2014, J IMMUNOL, V192, P5520, DOI 10.4049/jimmunol.1400343; [Anonymous], 2014, CELL SIGNAL BIOL; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; CEDOZ JP, 1995, J RHEUMATOL, V22, P1884; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Duan R, 2010, ANN RHEUM DIS, V69, P1724, DOI 10.1136/ard.2009.111690; Fantini MC, 2009, WORLD J GASTROENTERO, V15, P2472, DOI 10.3748/wjg.15.2472; Gu J, 2002, RHEUMATOLOGY, V41, P759, DOI 10.1093/rheumatology/41.7.759; Gu J, 2002, J RHEUMATOL, V29, P2159; Gu JR, 2009, ARTHRITIS RHEUM-US, V60, P3269, DOI 10.1002/art.24968; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Harjacek M, 2008, CLIN EXP RHEUMATOL, V26, P498; Harjacek M., 2011, CHALLENGES RHEUMATOL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YT, 2014, ANN APPL STAT, V8, P352, DOI 10.1214/13-AOAS690; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; May E, 2000, GASTROENTEROLOGY, V119, P1745, DOI 10.1053/gast.2000.20173; Myles A, 2012, RHEUMATOLOGY, V51, P1785, DOI 10.1093/rheumatology/kes151; Nurtdinov RN, 2010, NUCLEIC ACIDS RES, V38, pD726, DOI 10.1093/nar/gkp969; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Pimentel-Santos FM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3309; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Reveille John D, 2009, Curr Rheumatol Rep, V11, P340, DOI 10.1007/s11926-009-0049-6; REYNOLDS TL, 1988, J RHEUMATOL, V15, P1454; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Sampaio-Barros PD, 2003, J RHEUMATOL, V30, P2632; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sharma SM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2855; Sheng MHC, 2009, CELL MOL LIFE SCI, V66, P1946, DOI 10.1007/s00018-009-8811-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas GP, 2010, DISCOV MED, V10, P263; Thomas T, 2007, CELL CYCLE, V6, P696, DOI 10.4161/cc.6.6.4013; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wei FY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3930; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Yang ZX, 2007, CLIN EXP IMMUNOL, V149, P48, DOI 10.1111/j.1365-2249.2007.03396.x; Yuan XY, 2012, BRAZ J MED BIOL RES, V45, P1334, DOI 10.1590/S0100-879X2012007500163; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	48	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115416	10.1371/journal.pone.0115416	http://dx.doi.org/10.1371/journal.pone.0115416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506924	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000346607100074
J	Beta, M; Khetan, V; Chatterjee, N; Suganeswari, G; Rishi, P; Biswas, J; Krishnakumar, S				Beta, Madhu; Khetan, Vikas; Chatterjee, Nivedita; Suganeswari, Ganesan; Rishi, Pukhraj; Biswas, Jyotirmay; Krishnakumar, Subramanian			EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CELL-ADHESION-MOLECULE; EP-CAM; CLUSTER; CANCER; IDENTIFICATION; OVEREXPRESSION; MUTATIONS; PROFILE	The co-ordinated regulation of oncogenes along with miRNAs play crucial role in carcinogenesis. In retinoblastoma (RB), several miRNAs are known to be differentially expressed. Epithelial cell adhesion molecule (EpCAM) gene is involved in many epithelial cancers including, retinoblastoma (RB) tumorigenesis. EpCAM silencing effectively reduces the oncogenic miR-17-92 cluster. In order to investigate whether EpCAM has wider effect as an inducer or silencer of miRNAs, we performed a global microRNA expression profile in EpCAM siRNA knockdown Y79 cells. MicroRNA profiling in EpCAM silenced Y79 cells showed seventy-three significantly up regulated and thirty-six down regulated miRNAs. A subset of these miRNAs was also validated in tumors. Functional studies on Y79 and WERI-Rb-1 cells transfected with antagomirs against two miRNAs of miR-181c and miR-130b showed striking changes in tumor cell properties in RB cells. Treatment with anti-miR-181c and miR-130b showed significant decrease in cell viability and cell invasion. Increase in caspase-3 level was noticed in antagomir transfected cell lines indicating the induction of apoptosis. Possible genes altered by EpCAM influenced microRNAs were predicted by bioinformatic tools. Many of these belong to pathways implicated in cancer. The study shows significant influence of EpCAM on global microRNA expression. EpCAM regulated miR-181c and miR-130b may play significant roles in RB progression. EpCAM based targeted therapies may reduce carcinogenesis through several miRNAs and target genes.	[Beta, Madhu; Chatterjee, Nivedita; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, Kamalanayan Bajaj Res Inst, L&T Ocular Pathol Dept, Madras 600006, Tamil Nadu, India; [Khetan, Vikas; Suganeswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras 600006, Tamil Nadu, India; [Khetan, Vikas; Suganeswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Ocular Oncol Serv, Madras 600006, Tamil Nadu, India		Krishnakumar, S (corresponding author), Vis Res Fdn, Kamalanayan Bajaj Res Inst, L&T Ocular Pathol Dept, 18-41 Coll Rd, Madras 600006, Tamil Nadu, India.	drkrishnakumar_2000@yahoo.com	Rishi, Pukhraj/AAZ-5296-2020	Khetan, Vikas/0000-0003-4396-9877	Department of Biotechnology (DBT) [BT/PR12901/AGR/36/636/2009, BT/01/CEIB/11/V/16]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	The authors acknowledge the Department of Biotechnology (DBT) grant numbers BT/PR12901/AGR/36/636/2009 and BT/01/CEIB/11/V/16 for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Bellone S, 2009, INT J GYNECOL CANCER, V19, P860, DOI 10.1111/IGC.0b013e3181a8331f; Beta M, 2013, BIOINFORM BIOL INSIG, V7, P21, DOI 10.4137/BBI.S10501; Brunner A, 2008, ANTICANCER RES, V28, P125; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Dalgard CL, 2009, INVEST OPHTH VIS SCI, V50, P4542, DOI 10.1167/iovs.09-3520; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Hassan T, 2012, EXPERT REV ANTI-INFE, V10, P359, DOI [10.1586/ERI.11.175, 10.1586/eri.11.175]; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kandalam MM, 2012, MOL VIS, V18, P2279; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-41; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Madhavan J, 2007, INVEST OPHTH VIS SCI, V48, P4901, DOI 10.1167/iovs.07-0063; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Martin A, 2013, BIOCHEM BIOPH RES CO, V440, P599, DOI 10.1016/j.bbrc.2013.09.117; Matsuda T, 2014, ANN SURG ONCOL, V21, P356, DOI 10.1245/s10434-014-3579-8; Mitra M, 2010, MOL VIS, V16, P828; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; SERENALUNGAROTTI M, 1979, HUM GENET, V52, P269, DOI 10.1007/BF00278676; Singhal R, 2013, AGING-US, V5, P347, DOI 10.18632/aging.100558; Sithambaram D, 2011, HYBRIDOMA, V30, P511, DOI 10.1089/hyb.2011.0069; Sreenivasan S, 2012, CURR EYE RES, V37, P421, DOI 10.3109/02713683.2011.647224; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	43	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114800	10.1371/journal.pone.0114800	http://dx.doi.org/10.1371/journal.pone.0114800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502397	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400054
J	Melotti, P; Mafficini, A; Lebecque, P; Ortombina, M; Leal, T; Pintani, E; Pepermans, X; Sorio, C; Assael, BM				Melotti, Paola; Mafficini, Andrea; Lebecque, Patrick; Ortombina, Myriam; Leal, Teresinha; Pintani, Emily; Pepermans, Xavier; Sorio, Claudio; Assael, Baroukh Maurice			Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; LUNG-FUNCTION DECLINE; DISEASE SEVERITY; MODIFIER GENES; PSEUDOMONAS-AERUGINOSA; FEV1 DECLINE; CLINICAL-USE; CHILDREN; ASSOCIATION; MACROPHAGES	Macrophage migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine sustaining the acute response to gram-negative bacteria and a regulatory role for MIF in Cystic Fibrosis has been suggested by the presence of a functional, polymorphic, four-nucleotide repeat in this gene's promoter at position -794, with the 5-repeat allele displaying lower promoter activity. We aimed at assessing the association of this polymorphism with disease severity in a group of Cystic Fibrosis patients homozygous for F508del CFTR gene mutation. Genotype frequencies were determined in 189 Cystic Fibrosis and 134 control subjects; key clinical features of patients were recorded and compared among homozygous 5-allele patients and the other MIF genotypes. Patients homozygous for the 5-repeat allele of MIF promoter displayed a slower rate of lung function decline ( p=0.027) at multivariate survival analysis. Multiple regression analysis on age-normalized respiratory volume showed no association of the homozygous 5-repeat genotype with lung function under stable conditions and no correlation with P. aeruginosa chronic colonization. Therefore, only the Homozygous 5-repeat genotype at MIF -794 is associated with milder disease in F508del Cystic Fibrosis patients.	[Melotti, Paola; Ortombina, Myriam; Pintani, Emily; Assael, Baroukh Maurice] Univ & Hosp Trust Verona, Cyst Fibrosis Ctr, Verona, Italy; [Mafficini, Andrea; Sorio, Claudio] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Mafficini, Andrea; Sorio, Claudio] Univ & Hosp Trust Verona, Dept Pathol & Diagnost, Verona, Italy; [Lebecque, Patrick] Catholic Univ Louvain, Pediat Pulmonol & Cyst Fibrosis Unit, B-1200 Brussels, Belgium; [Leal, Teresinha] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium; [Pepermans, Xavier] Catholic Univ Louvain, Ctr Human Genet, B-1200 Brussels, Belgium	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Mafficini, A (corresponding author), Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy.	andrea.mafficini@univr.it	Sorio, Claudio/F-2764-2018; Melotti, Paola/J-6205-2018; Mafficini, Andrea/AAK-8158-2020	Sorio, Claudio/0000-0003-2739-4014; Melotti, Paola/0000-0002-5276-1595; Mafficini, Andrea/0000-0002-7471-3121; pepermans, xavier/0000-0001-6497-4443	ABCFoundation; Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus; FFC - Delegazione FFC di V.C.O. Verbania [06/2010]; Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla; Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio; Alessandra Boccanera; FFC - Donatori SMS Solidale [26/2011]; Delegazione FFC di Varese; Associazione Trentina FC onlus	ABCFoundation; Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus(Italian Cystic Fibrosis Research Foundation); FFC - Delegazione FFC di V.C.O. Verbania; Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla; Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio; Alessandra Boccanera; FFC - Donatori SMS Solidale; Delegazione FFC di Varese; Associazione Trentina FC onlus(Italian Cystic Fibrosis Research Foundation)	MO was supported by the ABCFoundation while AM by the Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus. The work is also supported by FFC grant# 06/2010, adopted by Delegazione FFC di V.C.O. Verbania, Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla, Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio, Alessandra Boccanera and FFC # 26/2011, adopted by Donatori SMS Solidale 2011, Delegazione FFC di Varese, Associazione Trentina FC onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Boyle Michael P, 2007, Proc Am Thorac Soc, V4, P52, DOI 10.1513/pats.200605-129JG; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Calandra T, 1996, J INFLAMM, V47, P39; Cooke G, 2009, BIOFACTORS, V35, P165, DOI 10.1002/biof.27; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dahlgren MK, 2012, J MED CHEM, V55, P10148, DOI 10.1021/jm301269s; Davies JC, 2005, PEDIATR PULM, V39, P383, DOI 10.1002/ppul.20198; De Boeck K, 2011, EUR RESPIR J, V37, P1091, DOI 10.1183/09031936.00077210; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GRASEMANN H, 2006, DIS MODIFIER GENES C, P50; Hansen Christine Ronne, 2005, J Cyst Fibros, V4, P35, DOI 10.1016/j.jcf.2004.09.001; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Konstan MW, 2011, PEDIATR PULM, V46, P545, DOI 10.1002/ppul.21388; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Lai HCJ, 2008, AM J CLIN NUTR, V88, P161, DOI 10.1093/ajcn/88.1.161; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; LESTER LA, 1994, PEDIATRICS, V93, P114; Long AD, 1999, GENOME RES, V9, P720; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Ren CL, 2008, J PEDIATR, V153, P746, DOI 10.1016/j.jpeds.2008.07.010; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Sorio C, 2009, J LEUKOCYTE BIOL, V86, P465, DOI 10.1189/jlb.0309120; Stotland PK, 2000, PEDIATR PULM, V30, P413, DOI 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114274	10.1371/journal.pone.0114274	http://dx.doi.org/10.1371/journal.pone.0114274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503271	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400024
J	Elvira-Recuenco, M; Iturritxa, E; Majada, J; Alia, R; Raposo, R				Elvira-Recuenco, Margarita; Iturritxa, Eugenia; Majada, Juan; Alia, Ricardo; Raposo, Rosa			Adaptive Potential of Maritime Pine (Pinus pinaster) Populations to the Emerging Pitch Canker Pathogen, Fusarium circinatum	PLOS ONE			English	Article							DISEASE RESISTANCE; GENETIC-VARIATION; 1ST REPORT; SUBGLUTINANS; TOLERANCE; RESPONSES; THREAT; SPP.; DIFFERENTIATION; SUSCEPTIBILITY	There is a concern on how emerging pests and diseases will affect the distribution range and adaptability of their host species, especially due to different conditions derived from climate change and growing globalization. Fusarium circinatum, which causes pitch canker disease in Pinus species, is an exotic pathogen of recent introduction in Spain that threatens its maritime pine (P. pinaster) stands. To predict the impact this disease will have on the species, we examine host resistance traits and their genetic architecture. Resistance phenotyping was done in a clonal provenance/progeny trial, using three-year-old cuttings artificially inoculated with the pathogen and maintained under controlled environmental conditions. A total number of 670 ramets were assessed, distributed in 10 populations, with a total of 47 families, 2 to 5 half-sibs per family, and 3-7 ramets per clone. High genetic variation was found at the three hierarchical levels studied: population, family and clone, being both additive and non-additive effects important. Narrow-sense and broad-sense heritability estimates were relatively high, with respective values of 0.43-0.58 and 0.51-0.8, depending on the resistance traits measured (lesion length, lesion length rate, time to wilting, and survival). These values suggest the species' high capacity of evolutionary response to the F. circinatum pathogen. A population originated in Northern Spain was the most resistant, while another from Morocco was the most susceptible. The total number of plants that did not show lesion development or presented a small lesion (length, 30 mm) was 224 out of 670, indicating a high proportion of resistant trees in the offspring within the analyzed populations. We found large differences among populations and considerable genetic variation within populations, which should allow, through natural or artificial selection, the successful adaptation of maritime pine to pitch canker disease.	[Elvira-Recuenco, Margarita; Raposo, Rosa] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Silviculture & Forest Management Dept, Madrid, Spain; [Iturritxa, Eugenia] Inst Vasco Invest & Desarrollo Agr NEIKER, Vitoria, Spain; [Majada, Juan] Forest & Wood Technol Res Ctr CETEMAS, Principado De Asturias, Spain; [Alia, Ricardo] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Forest Ecol & Genet Dept, Madrid, Spain; [Alia, Ricardo] Sustainable Forest Management Res Inst, Palencia, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Raposo, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Silviculture & Forest Management Dept, Madrid, Spain.	raposo@inia.es	, Eugenia/AAT-7521-2020; Elvira-Recuenco, Margarita/G-9977-2012; Majada, Juan/AAZ-2999-2021; Raposo, Rosa/A-3185-2012; Alia, Ricardo/B-5160-2011	Elvira-Recuenco, Margarita/0000-0001-6749-3346; Raposo, Rosa/0000-0002-4893-6874; Alia, Ricardo/0000-0002-9426-0967; Iturritxa, Eugenia/0000-0002-6390-5873	Ministerio de Economia y Competitividad [RTA 2012-00015, RTA2010-00120-C02]	Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by Projects RTA 2012-00015 and RTA2010-00120-C02, Ministerio de Economia y Competitividad (Subprograma de Proyectos de I+D orientado a los Recursos y Tecnologias Agrarias en coordinacion con las Comunidades Autonomas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H. M., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P326; Aranda I, 2010, TREE GENET GENOMES, V6, P169, DOI 10.1007/s11295-009-0238-5; Baker R, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1620; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Baradat P, 1997, ANN SCI FOREST, V54, P83, DOI 10.1051/forest:19970107; BARROWSBROADDUS J, 1983, PHYTOPATHOLOGY, V73, P882, DOI 10.1094/Phyto-73-882; BARROWSBROADDUS J, 1984, PHYTOPATHOLOGY, V74, P438, DOI 10.1094/Phyto-74-438; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Braganca H, 2009, PLANT DIS, V93, P1079, DOI 10.1094/PDIS-93-10-1079A; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2004, PLANT PATHOL, V53, P804, DOI 10.1111/j.1365-3059.2004.01079.x; Brown JKM, 2013, PLANT PATHOL, V62, P83, DOI 10.1111/ppa.12163; Burdon JJ, 2013, CURR OPIN PLANT BIOL, V16, P400, DOI 10.1016/j.pbi.2013.05.003; Burdon RD, 2001, CAN J FOREST RES, V31, P596, DOI 10.1139/cjfr-31-4-596; Carlucci A, 2007, PLANT DIS, V91, P1683, DOI 10.1094/PDIS-91-12-1683C; Chornesky EA, 2005, BIOSCIENCE, V55, P335, DOI 10.1641/0006-3568(2005)055[0335:SPFRTT]2.0.CO;2; Clarke D. D., 1986, Advances in Plant Pathology Volume 5., P161; CORRELL JC, 1991, PLANT DIS, V75, P676, DOI 10.1094/PD-75-0751A; Desprez-Loustau ML, 2006, ANN FOREST SCI, V63, P597, DOI 10.1051/forest:2006040; Dvorak WS, 2007, SOUTH HEMISPH FOR J, V69, P125, DOI 10.2989/SHFJ.2007.69.3.1.351; EPPO (European and Mediterranean Plant Protection Organization), 2006, 1 REP GIBB CIRC FRAN; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Falconer D. S., 1996, INTRO QUANTITATIVE G; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Garbelotto M, 2012, EUR J PLANT PATHOL, V133, P101, DOI 10.1007/s10658-011-9928-6; Gaspar MJ, 2013, PLOS ONE, P8; GIBBS JN, 1978, ANNU REV PHYTOPATHOL, V16, P287, DOI 10.1146/annurev.py.16.090178.001443; Gilmour A.R., 2012, ASREML USER GUIDE RE; Gonzalez-Martinez SC, 2004, FOREST ECOL MANAG, V197, P103, DOI 10.1016/j.foreco.2004.05.008; Gordon TR, 2011, FOREST PATHOL, V41, P227, DOI 10.1111/j.1439-0329.2010.00678.x; Gordon TR, 1998, HORTSCIENCE, V33, P868, DOI 10.21273/HORTSCI.33.5.868; Gordon TR, 2001, PLANT DIS, V85, P1128, DOI 10.1094/PDIS.2001.85.11.1128; Griffin GJ, 2000, J FOREST, V98, P22; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Hamilton MG, 2013, HEREDITY, V110, P372, DOI 10.1038/hdy.2012.106; Hodge GR, 2000, NEW FOREST, V19, P241, DOI 10.1023/A:1006613021996; Iturritxa E, 2013, FOREST PATHOL, V43, P488, DOI 10.1111/efp.12061; Iturritxa E, 2012, AUSTRALAS PLANT PATH, V41, P601, DOI 10.1007/s13313-012-0160-4; Iturritxa E, 2014, PLANT PATHO IN PRESS; Iturritxa E, 2011, FUNGAL BIOL-UK, V115, P288, DOI 10.1016/j.funbio.2010.12.014; Kayihan GC, 2005, THEOR APPL GENET, V110, P948, DOI 10.1007/s00122-004-1915-2; Kim KW, 2010, PLANT PATHOLOGY J, V26, P394, DOI 10.5423/PPJ.2010.26.4.394; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Lamy J-B, 2011, PLOS ONE, P6; Landeras E, 2005, PLANT DIS, V89, P1015, DOI 10.1094/PD-89-1015A; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Majada J, 2011, NEW FOREST, V41, P399, DOI 10.1007/s11056-010-9232-x; Martin-Rodrigues N, 2013, NEW PHYTOL, V198, P1215, DOI 10.1111/nph.12222; Martinez-Alonso C, 2012, NEW FOREST, V43, P651, DOI 10.1007/s11056-012-9333-9; Matheson A. C., 2006, Australian Forestry, V69, P101; McKinney LV, 2011, HEREDITY, V106, P788, DOI 10.1038/hdy.2010.119; Mitchell RG, 2012, NEW FOREST, V43, P473, DOI 10.1007/s11056-011-9293-5; Ouellette G, 2008, FOREST SYSTEMS, V13, P119; Pautasso M, 2012, EUR J PLANT PATHOL, V133, P295, DOI 10.1007/s10658-012-9936-1; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Perez-Sierra A, 2007, MYCOL RES, V111, P832, DOI 10.1016/j.mycres.2007.05.009; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Roux J, 2007, NEW FOREST, V33, P109, DOI 10.1007/s11056-006-9017-4; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; SAS, 2008, SAS US GUID; SCHOENEWEISS DF, 1975, ANNU REV PHYTOPATHOL, V13, P193, DOI 10.1146/annurev.py.13.090175.001205; Sokal R.R., 2012, BIOMETRY; Sorte CJB, 2013, ECOL LETT, V16, P261, DOI 10.1111/ele.12017; Stenlid J, 2011, FORESTS, V2, P486, DOI 10.3390/f2020486; Storer AJ, 1998, PLANT PATHOL, V47, P649, DOI 10.1046/j.1365-3059.1998.00288.x; Swei A, 2011, OECOLOGIA, V166, P91, DOI 10.1007/s00442-010-1796-9; Vivas M, 2012, FORESTRY, V85, P185, DOI 10.1093/forestry/cpr055; Wingfield MJ, 2008, AUSTRALAS PLANT PATH, V37, P319, DOI 10.1071/AP08036; Zas R, 2011, J ECOL, V99, P1316, DOI 10.1111/j.1365-2745.2011.01872.x	72	26	26	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114971	10.1371/journal.pone.0114971	http://dx.doi.org/10.1371/journal.pone.0114971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500822	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700078
J	Song, J; Shen, YJ; Zhang, J; Lian, QQ				Song, Jing; Shen, Yenji; Zhang, Jing; Lian, Qingquan			Mini Profile of Potential Anticancer Properties of Propofol	PLOS ONE			English	Article							CARCINOMA-CELLS; CANCER-CELLS; INHIBITS INVASION; RAS MUTATIONS; LUNG-CANCER; APOPTOSIS; PATHWAY; ACTIVATION; EXPRESSION; RAS/RAF/MEK/ERK	Background: Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered to induce and maintain anesthesia. It has been recently revealed that propofol has anticancer properties including direct and indirect suppression of the viability and proliferation of cancer cells by promoting apoptosis in some cancer cell lines. Methodology/Principal Findings: This study aimed to establish a profile to quantitatively and functionally evaluate the anticancer properties of propofol in three cancer cell lines: non-small cell lung carcinoma cell line A549, human colon carcinoma cell line LoVo, and human breast cancer cell line SK-BR-3. We demonstrated that the expression level of caspase-3, an apoptosis biomarker, significantly increased in a dose-dependent manner after 24-h stimulation with 100 mu M propofol in A549 cells, and slightly increased in LoVo cells. However, there was no change in caspase-3 expression in SK-BR-3 cells. High caspase-3 expression in A549 cells may be modulated by the ERK1/2 pathway because phosphorylated ERK1/2 dramatically reduced after propofol treatment. BAX, a major protein that promotes apoptosis in the regulation phase, was highly expressed in A549 cells after treatment with 25 mM propofol. Apoptosis induced by propofol may be associated with cancer cells carrying Kras mutations. Conclusions/Significance: Our results suggest that the anti-cancer effects of propofol, which are consistent with those of previous studies, are likely associated with the Kras mutation status. Only Kras mutation in Codon 12 instead of other Kras status has been demonstrated to play an important role in sensitizing the propofol-induced apoptosis in cancer cell lines from our study. These findings may enable us a detailed investigation of propofol/Kras-mediated cancer cell apoptosis in the future.	[Song, Jing] Montefiore Med Ctr, Dept Anesthesiol, New York, NY 10029 USA; [Shen, Yenji; Zhang, Jing; Lian, Qingquan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China; [Shen, Yenji; Zhang, Jing; Lian, Qingquan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China	Montefiore Medical Center; Wenzhou Medical University; Wenzhou Medical University	Song, J (corresponding author), Montefiore Med Ctr, Dept Anesthesiol, New York, NY 10029 USA.	jsong@montefiore.org			National Nature Science Foundation of China, NSFC [81271469]; National Science Foundation of Zhejiang Province [Z2101211]	National Nature Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation of Zhejiang Province	Dr. Lian received the following two funds for this study. 1) National Nature Science Foundation of China, NSFC (81271469) and 2) National Science Foundation of Zhejiang Province (Z2101211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetts Paul S, 2010, AANA J, V78, P237; Boch C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002560; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duldulao MP, 2013, ANN SURG ONCOL, V20, P2166, DOI 10.1245/s10434-013-2910-0; Gibson LF, 1999, BREAST CANCER RES TR, V55, P107, DOI 10.1023/A:1006175811676; Gu J, 2013, INT J MED SCI, V10, P599, DOI 10.7150/ijms.5151; Homburger JA, 2006, CURR OPIN ANESTHESIO, V19, P423, DOI 10.1097/01.aco.0000236143.61593.14; Huang H, 2014, BRIT J CANCER, V111, P1338, DOI 10.1038/bjc.2014.426; Kushida A, 2007, IMMUNOPHARM IMMUNOT, V29, P477, DOI 10.1080/08923970701675085; Lalier L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-153; Lee JY, 2010, KOREAN J ANESTHESIOL, V58, P277, DOI 10.4097/kjae.2010.58.3.277; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mammoto T, 2002, CANCER LETT, V184, P165, DOI 10.1016/S0304-3835(02)00210-0; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; Ren XF, 2010, ANAESTHESIA, V65, P478, DOI 10.1111/j.1365-2044.2010.06304.x; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schmitz KJ, 2007, VIRCHOWS ARCH, V450, P151, DOI 10.1007/s00428-006-0342-y; Siddiqui RA, 2005, BREAST CANCER RES, V7, pR645, DOI 10.1186/bcr1036; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Takamochi K, 2013, ONCOL LETT, V6, P1207, DOI 10.3892/ol.2013.1551; Tsuchiya M, 2002, ACTA ANAESTH SCAND, V46, P1068, DOI 10.1034/j.1399-6576.2002.460903.x; VACHTENHEIM J, 1995, CLIN CANCER RES, V1, P359; Wada H, 2007, ANESTHESIOLOGY, V106, P499, DOI 10.1097/00000542-200703000-00014; Xu YB, 2013, EUR REV MED PHARMACO, V17, P2486; Zhang J, 2013, CELL BIOL INT, V37, P227, DOI 10.1002/cbin.10034; Zhang LM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-66	32	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114440	10.1371/journal.pone.0114440	http://dx.doi.org/10.1371/journal.pone.0114440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502773	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700025
J	Tiwari, P; Danish, S; Madabhushi, A				Tiwari, Pallavi; Danish, Shabbar; Madabhushi, Anant			Identifying MRI Markers Associated with Early Response following Laser Ablation for Neurological Disorders: Preliminary Findings	PLOS ONE			English	Article							THERMAL THERAPY LITT; PROSTATE-CANCER; GLIOBLASTOMA-MULTIFORME; INDUCED THERMOTHERAPY; BREAST-CANCER; BRAIN; STANDARDIZATION; BIOMARKERS; CRITERIA; LESIONS	There is a renewed interest in MR-guided laser interstitial thermal therapy (LITT) as a minimally invasive alternative to craniotomy for local treatment of various brain tumors and epilepsy. LITT allows for focused delivery of laser energy monitored in real time by MRI, for precise ablation of the lesion. Although highly promising, the long-term effects of laser ablation as a viable treatment option for neurological disorders have yet to be rigorously studied and quantified. In this work, we present a quantitative framework for monitoring per-voxel thermal-induced changes post-LITT over time on multi parametric MRI. We demonstrate that voxel-by-voxel quantification of MRI markers over time can enable a careful and accurate (a) characterization of early LITT-related changes (if and when they are exaggerated and when they subside), and (b) identification and monitoring of MRI markers that potentially allow for better quantification of response to LITT therapy. The framework was evaluated on two distinct cohorts of patients (GBM, epilepsy), who were monitored post-LITT at regular time-intervals via multi-parametric MRI. On a cohort of six GBM studies we found that (a) it may be important for the initial treatment-related changes to subside to more reliably capture MRI markers relating to tumor recurrence, and (b) T1w MRI and T2-GRE may better differentiate changes that may correspond to tumor recurrence from patients with no recurrence, as compared to T2w-MRI, and FLAIR. Similarly, our preliminary analysis of four epilepsy studies suggests that (a) early LITT changes (attributed to swelling, edema) appear to subside within 4-weeks post-LITT, and (b) ADC may be more reflective of early treatment changes (up to 1 month), while T1w may be more reflective of early delayed treatment changes (1 month, 3 months), while T2-w and T2-FLAIR appeared to be more sensitive to late treatment related changes (6-months post-LITT) compared to the other MRI protocols under evaluation.	[Tiwari, Pallavi; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Danish, Shabbar] Rutgers RWJ Med Sch, Div Neurosurg, New Brunswick, NJ USA	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Tiwari, P (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	pxt130@case.edu	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399	National Cancer Institute of the Coulter Translational Award [RES508406]; National Institutes of Health [R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE [R01CA140772, R21CA179327, R01CA136535, R21CA167811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the Coulter Translational Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the Coulter Translational Award (RES508406), National Institutes of Health under award numbers R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01; the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the Ohio Third Frontier Technology development Grant, the CTSC Coulter Annual Pilot Grant, and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M, 2006, PATTERN RECOGNITION; Carpentier A, 2002, MED LASER APPL, V17, P147; Carpentier A, 2008, NEUROSURGERY, V63, P21, DOI [10.1227/01.NEU.0000311254.63848.72, 10.1227/01.neu.0000335007.07381.df]; Carpentier A, 2012, LASER SURG MED, V44, P361, DOI 10.1002/lsm.22025; Chan YL, 1999, RADIOLOGY, V213, P800, DOI 10.1148/radiology.213.3.r99dc07800; Curry DJ, 2012, EPILEPSY BEHAV, V24, P408, DOI 10.1016/j.yebeh.2012.04.135; Engel J., 1993, WHO SHOULD BE SURG C; Foltz WD, 2013, J MAGN RESON IMAGING, V37, P909, DOI 10.1002/jmri.23885; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jamin Y, 2013, RADIOLOGY, V266, P130, DOI 10.1148/radiol.12120128; Jethwa PR, 2012, NEUROSURGERY, V71, P133, DOI 10.1227/NEU.0b013e31826101d4; Khayal IS, 2010, NEURO-ONCOLOGY, V12, P908, DOI 10.1093/neuonc/noq049; King AD, 2013, AM J NEURORADIOL, V34, P1237, DOI 10.3174/ajnr.A3378; Li X, 2014, TRANSL ONCOL, V7, P14, DOI 10.1593/tlo.13748; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Mavroidis P, 2011, MED PHYS, V38, P2382, DOI 10.1118/1.3570613; Morrison PR, 1998, JMRI-J MAGN RESON IM, V8, P57, DOI 10.1002/jmri.1880080114; MullerLisse GU, 1996, RADIOLOGE, V36, P722, DOI 10.1007/s001170050134; Nasseri M, 2014, NEURO-ONCOLOGY, V16, P1146, DOI 10.1093/neuonc/not328; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Patel NV, 2013, LASER SURG MED, V45, P362, DOI 10.1002/lsm.22151; Schulze PC, 2004, ACTA NEUROCHIR, V146, P803, DOI 10.1007/s00701-004-0293-5; Schwabe B, 1997, J COMPUT ASSIST TOMO, V21, P818, DOI 10.1097/00004728-199709000-00031; Schwarzmaier HJ, 2006, EUR J RADIOL, V59, P208, DOI 10.1016/j.ejrad.2006.05.010; Sloan AE, 2013, J NEUROSURG, V118, P1202, DOI 10.3171/2013.1.JNS1291; Spath H., 2004, Mathematical Communications, V9, P27; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Thiesse P, 1997, J CLIN ONCOL, V15, P3507, DOI 10.1200/JCO.1997.15.12.3507; Tiwari P, 2012, NMR BIOMED, V25, P607, DOI 10.1002/nbm.1777; Tiwari P, 2013, MED IMAGE ANAL, V17, P219, DOI 10.1016/j.media.2012.10.004; Tiwari P, 2011, LECT NOTES COMPUT SC, V6963, P80, DOI 10.1007/978-3-642-23944-1_9; Verma R, 2008, ACAD RADIOL, V15, P966, DOI 10.1016/j.acra.2008.01.029; Wolz R, 2012, MED IMAGE ANAL, V16, P819, DOI 10.1016/j.media.2011.12.003	36	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114293	10.1371/journal.pone.0114293	http://dx.doi.org/10.1371/journal.pone.0114293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503713	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700020
J	Opatova, V; Arnedo, MA				Opatova, Vera; Arnedo, Miquel A.			Spiders on a Hot Volcanic Roof: Colonisation Pathways and Phylogeography of the Canary Islands Endemic Trap-Door Spider Titanidiops canariensis (Araneae, Idiopidae)	PLOS ONE			English	Article							WOODLOUSE-HUNTER SPIDERS; GENUS DYSDERA ARANEAE; BAYESIAN SPECIES DELIMITATION; HAPLOTYPE RECONSTRUCTION; MOLECULAR PHYLOGENETICS; POPULATION SUBDIVISION; DIVERGENCE TIMES; DNA-SEQUENCES; NORTH-AFRICA; MITOCHONDRIAL	Studies conducted on volcanic islands have greatly contributed to our current understanding of how organisms diversify. The Canary Islands archipelago, located northwest of the coast of northern Africa, harbours a large number of endemic taxa. Because of their low vagility, mygalomorph spiders are usually absent from oceanic islands. The spider Titanidiops canariensis, which inhabits the easternmost islands of the archipelago, constitutes an exception to this rule. Here, we use a multi-locus approach that combines three mitochondrial and four nuclear genes to investigate the origins and phylogeography of this remarkable trap-door spider. We provide a timeframe for the colonisation of the Canary Islands using two alternative approaches: concatenation and species tree inference in a Bayesian relaxed clock framework. Additionally, we investigate the existence of cryptic species on the islands by means of a Bayesian multi-locus species delimitation method. Our results indicate that T. canariensis colonised the Canary Islands once, most likely during the Miocene, although discrepancies between the timeframes from different approaches make the exact timing uncertain. A complex evolutionary history for the species in the archipelago is revealed, which involves two independent colonisations of Fuerteventura from the ancestral range of T. canariensis in northern Lanzarote and a possible back colonisation of southern Lanzarote. The data further corroborate a previously proposed volcanic refugium, highlighting the impact of the dynamic volcanic history of the island on the phylogeographic patterns of the endemic taxa. T. canariensis includes at least two different species, one inhabiting the Jandia peninsula and central Fuerteventura and one spanning from central Fuerteventura to Lanzarote. Our data suggest that the extant northern African Titanidiops lineages may have expanded to the region after the islands were colonised and, hence, are not the source of colonisation. In addition, T. maroccanus may harbour several cryptic species.	[Opatova, Vera] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; Univ Barcelona, Dept Biol Anim, Barcelona, Spain	University of Barcelona; University of Barcelona	Opatova, V (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	Vera.Opatova@gmail.com	Arnedo, Miquel/E-9086-2011; Opatova, Vera/F-3427-2019	Arnedo, Miquel/0000-0003-1402-4727; Opatova, Vera/0000-0002-4324-1344	Spanish Ministry of Science and Innovation (MICINN) [CGL 2009-07639, CGL2012-36863]; Generalitat de Catalunya [2009SGR1462]; ICREA Academia award from the Generalitat de Catalunya;  [AP 2008-01841]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia award from the Generalitat de Catalunya(ICREA); 	This project was funded by Spanish Ministry of Science and Innovation (MICINN) grants CGL 2009-07639 and CGL2012-36863 (both to MA) and additional financial support was provided by project 2009SGR1462 from the Generalitat de Catalunya. VO was supported by a graduate grant (AP 2008-01841). MA was further supported by an ICREA Academia award for excellence in research from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ancochea E, 1996, J VOLCANOL GEOTH RES, V70, P183, DOI 10.1016/0377-0273(95)00051-8; Andrus N, 2004, TAXON, V53, P333, DOI 10.2307/4135612; [Anonymous], 2021, SPLITS SPECIES LIMIT; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Arnedo MA, 2000, J ARACHNOL, V28, P261, DOI 10.1636/0161-8202(2000)028[0261:SOTGDA]2.0.CO;2; Arnedo MA, 2001, CLADISTICS, V17, P313, DOI 10.1111/j.1096-0031.2001.tb00129.x; Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Baele G, 2012, MOL BIOL EVOLUTION; Bidegaray-Batista L, 2011, BMC EVOLUTIONARY BIO, V11, P317; Bidegaray-Batista L, 2007, MOL ECOL, V16, P3198, DOI 10.1111/j.1365-294X.2007.03351.x; Bloor P, 2008, MOL ECOL, V17, P854, DOI 10.1111/j.1365-294X.2007.03575.x; Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; BORCHSENIUS F, 2009, FASTGAP 1 2; Brown RM, 2012, MOL PHYLOGENET EVOL, V65, P351, DOI 10.1016/j.ympev.2012.06.009; Brown RP, 2010, SYST BIOL, V59, P119, DOI 10.1093/sysbio/syp082; Burbrink FT, 2011, EVOLUTION, V65, P1851, DOI 10.1111/j.1558-5646.2011.01260.x; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2003, ESTUD GEOL-MADRID, V59, P277, DOI DOI 10.3989/EGEOL.03595-6104; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; Carracedo JC., 1993, REV ACAD CANARIA CIE, V4, P25; Carracedo JC, 2002, CANARY ISLANDS; Carranza S, 2002, MOL PHYLOGENET EVOL, V23, P244, DOI 10.1016/S1055-7903(02)00024-6; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Churchill Tracey B., 1992, Memoirs of the Queensland Museum, V32, P9; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Cox SC, 2010, MOL PHYLOGENET EVOL, V56, P747, DOI 10.1016/j.ympev.2010.03.020; COYLE FA, 1985, J ARACHNOL, V13, P137; COYLE FA, 1985, J ARACHNOL, V13, P291; Decae A.E., 1996, Bulletin of the British Arachnological Society, V10, P161; Dimitrov D, 2008, MOL PHYLOGENET EVOL, V48, P596, DOI 10.1016/j.ympev.2008.04.027; Drummond A.J., 2012, MOL BIOL EVOLUTION; Drummond A. J., 2010, GENEIOUS V 5 3; Eberhard WG, 2006, J ARACHNOL, V34, P254, DOI 10.1636/S03-54.1; Edwards SV, 2000, EVOLUTION, V54, P1839; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Emerson BC, 2000, EVOLUTION, V54, P2081, DOI 10.1111/j.0014-3820.2000.tb01251.x; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujita MK, 2012, TRENDS ECOLOGY EVOLU; Giribet G, 1999, MOL PHYLOGENET EVOL, V11, P296, DOI 10.1006/mpev.1998.0583; Gonzalez A.R., 2012, GEOL TODAY, P53, DOI DOI 10.1111/j.1365-2451.2012.00827.x; Greve C, 2010, MOL PHYLOGE IN PRESS; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020156, 10.1371/journal.pone.0026207]; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2013, MOL ECOL, V22, P508, DOI 10.1111/mec.12130; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ibanez JM, 2012, GEOPHYS J INT, V191, P659, DOI 10.1111/j.1365-246X.2012.05629.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jennings WB, 2005, EVOLUTION, V59, P2033; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kekkonen M, 2014, MOL ECOL RESOUR; Kohler CM, 2010, PALAEOGEOGR PALAEOCL, V285, P66, DOI 10.1016/j.palaeo.2009.10.025; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macias-Hernandez N, 2008, BIOL J LINN SOC, V94, P589, DOI 10.1111/j.1095-8312.2008.01007.x; Macias-Hernandez N, 2013, J HERED, V104, P341, DOI 10.1093/jhered/est008; Macias-Hernandez N, 2013, J ZOOL SYST EVOL RES, V51, P29, DOI 10.1111/jzs.12008; Macias-Hernandez N, 2010, SYST BIODIVERS, V8, P531, DOI 10.1080/14772000.2010.535865; Marino IAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028567; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; McGuire G, 2000, J COMPUT BIOL, V7, P159, DOI 10.1089/10665270050081432; Meco J., 2008, HIST GEOLOGICA CLIMA; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nogales M, 1998, J EVOLUTION BIOL, V11, P481, DOI 10.1007/s000360050101; Opatova V, 2014, INVERTEBR SYST, V28, P361, DOI 10.1071/IS14004; Opatova V, 2013, MOL PHYLOGENET EVOL, V69, P1135, DOI 10.1016/j.ympev.2013.08.002; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Packert M, 2013, MOL PHYLOGENET EVOL, V67, P458, DOI 10.1016/j.ympev.2013.02.010; Paez-Moscoso DJ, 2012, MOL PHYLOGENET EVOL, V65, P805, DOI 10.1016/j.ympev.2012.08.001; Pages M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031123; Pepper M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078110; Pinho C, 2007, MOL ECOL, V16, P1191, DOI 10.1111/j.1365-294X.2007.03230.x; Planas E, 2013, MOL PHYLOGENET EVOL, V67, P414, DOI 10.1016/j.ympev.2013.02.006; Platnick N. I., 2014, WORLD SPIDER CATALOG; Pons J, 2006, MOL ECOL NOTES, V6, P623, DOI 10.1111/j.1471-8286.2006.01353.x; Rambaut A., 2009, FIGTREE V1 3 1 COMPU; Rambaut A, 2009, TRACER V 1 5; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; RAVEN RJ, 1980, J ARACHNOL, V8, P251; Raven RJ, 1988, AM MUS NOVIT, V2929, P1; Raven Robert J., 1994, Memoirs of the Queensland Museum, V35, P291; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Gracia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030239; Sanmartin I, 2010, BIOL LETT; Santos X, 2012, J ZOOL SYST EVOL RES, V50, P210, DOI 10.1111/j.1439-0469.2012.00663.x; Santos-Guerra A., 2002, NATURALEZA ISLAS CAN, P185; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Satler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025355; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon E., 1909, Madrid Memorias de la Sociedad Espanola de Historia Natural, V6; Simon E, 1903, HIST NATURELLE ARAIG, P669; Sistrom M, 2013, MOL PHYLOGENET EVOL, V68, P135, DOI 10.1016/j.ympev.2013.03.007; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Stueben PE, 2010, ZOOL J LINN SOC-LOND, V160, P40, DOI 10.1111/j.1096-3642.2009.00609.x; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Thiv M, 2010, MOL PHYLOGENET EVOL, V54, P607, DOI 10.1016/j.ympev.2009.10.009; Vandergast AG, 2004, MOL ECOL, V13, P1729, DOI 10.1111/j.1365-294X.2004.02179.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Wunderlich J, 1995, BEITRAGE ARANEOLOGIE, V4, P385; Wunderlich J., 1992, BEITRAGE ARANEOLOGIE, V1, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	131	37	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115078	10.1371/journal.pone.0115078	http://dx.doi.org/10.1371/journal.pone.0115078			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494329	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400093
J	Philip, P; Chaufton, C; Orriols, L; Lagarde, E; Amoros, E; Laumon, B; Akerstedt, T; Taillard, J; Sagaspe, P				Philip, Pierre; Chaufton, Cyril; Orriols, Ludivine; Lagarde, Emmanuel; Amoros, Emmanuelle; Laumon, Bernard; Akerstedt, Torbjorn; Taillard, Jacques; Sagaspe, Patricia			Complaints of Poor Sleep and Risk of Traffic Accidents: A Population-Based Case-Control Study	PLOS ONE			English	Article							CRASHES; DRIVERS	Introduction: This study aimed to determine the sleepiness-related factors associated with road traffic accidents. Methods: A population based case-control study was conducted in 2 French agglomerations. 272 road accident cases hospitalized in emergency units and 272 control drivers matched by time of day and randomly stopped by police forces were included in the study. Odds ratios were calculated for the risk of road traffic accidents. Results: As expected, the main predictive factor for road traffic accidents was having a sleep episode at the wheel just before the accident (OR 9.97, CI 95%: 1.57-63.50, p < 0.05). The increased risk of traffic accidents was 3.35 times higher in subjects who reported very poor quality sleep during the last 3 months (CI 95%: 1.30-8.63, p < 0.05), 1.69 times higher in subjects reporting sleeping 6 hours or fewer per night during the last 3 months (CI 95%: 1.00-2.85, p < 0.05), 2.02 times higher in subjects reporting symptoms of anxiety or nervousness in the previous day (CI 95%: 1.03-3.97, p < 0.05), and 3.29 times higher in subjects reporting taking more than 2 medications in the last 24 h (CI 95%: 1.14-9.44, p < 0.05). Chronic daytime sleepiness measured by the Epworth Sleepiness Scale, expressed heavy snoring and nocturnal leg movements did not explain traffic accidents. Conclusion: Physicians should be attentive to complaints of poor sleep quality and quantity, symptoms of anxiety-nervousness and/ or drug consumption in regular car drivers.	[Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] Univ Bordeaux, USR SANPSY 3413, F-33000 Bordeaux, France; [Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] CNRS, SANPSY, USR 3413, F-33000 Bordeaux, France; [Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] CHU Pellegrin, F-33076 Bordeaux, France; [Orriols, Ludivine; Lagarde, Emmanuel] Univ Bordeaux, INSERM U897, ISPED, Equipe PPCT, F-33000 Bordeaux, France; [Amoros, Emmanuelle; Laumon, Bernard] IFSTTAR, UMRESTTE, TS2, F-69500 Bron, France; [Amoros, Emmanuelle; Laumon, Bernard] Univ Lyon 1, F-69008 Lyon, France; [Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Stockholm University	Philip, P (corresponding author), Univ Bordeaux, USR SANPSY 3413, F-33000 Bordeaux, France.	pr.philip@free.fr	Taillard, Jacques/H-5063-2018; PHILIP, Pierre/AAS-8889-2020; Lagarde, Emmanuel/F-7132-2013	Taillard, Jacques/0000-0001-9067-8189; PHILIP, Pierre/0000-0003-3267-634X; SAGASPE, Patricia/0000-0003-2845-1199; Lagarde, Emmanuel/0000-0001-8031-7400; Akerstedt, Torbjorn/0000-0001-8049-8504	DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France)	DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France)	This research was supported by a grant from DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Martiniuk ALC, 2010, J ADOLESCENT HEALTH, V47, P488, DOI 10.1016/j.jadohealth.2010.03.010; Motak L, 2014, ACCIDENT ANAL PREV, V67, P61, DOI 10.1016/j.aap.2014.02.009; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Roidl E, 2014, ACCIDENT ANAL PREV, V70, P282, DOI 10.1016/j.aap.2014.04.010; Sagaspe P, 2010, J SLEEP RES, V19, P578, DOI 10.1111/j.1365-2869.2009.00818.x; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Wickens CM, 2013, ACCIDENT ANAL PREV, V51, P84, DOI 10.1016/j.aap.2012.10.007	14	46	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114102	10.1371/journal.pone.0114102	http://dx.doi.org/10.1371/journal.pone.0114102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25494198	Green Published, gold			2022-12-26	WOS:000346611400030
J	Yoshihara, K; Wang, Q; Torres-Garcia, W; Zheng, S; Vegesna, R; Kim, H; Verhaak, RGW				Yoshihara, K.; Wang, Q.; Torres-Garcia, W.; Zheng, S.; Vegesna, R.; Kim, H.; Verhaak, R. G. W.			The landscape and therapeutic relevance of cancer-associated transcript fusions	ONCOGENE			English	Article							GENE FUSIONS; TYROSINE KINASE; BREAST-CANCER; IDENTIFICATION; GENOME; REARRANGEMENTS; ABERRATIONS; INHIBITION; RESOURCE; PATTERNS	Transcript fusions as a result of chromosomal rearrangements have been a focus of attention in cancer as they provide attractive therapeutic targets. To identify novel fusion transcripts with the potential to be exploited therapeutically, we analyzed RNA sequencing, DNA copy number and gene mutation data from 4366 primary tumor samples. To avoid false positives, we implemented stringent quality criteria that included filtering of fusions detected in RNAseq data from 364 normal tissue samples. Our analysis identified 7887 high confidence fusion transcripts across 13 tumor types. Our fusion prediction was validated by evidence of a genomic rearrangement for 78 of 79 fusions in 48 glioma samples where whole-genome sequencing data were available. Cancers with higher levels of genomic instability showed a corresponding increase in fusion transcript frequency, whereas tumor samples harboring fusions contained statistically significantly fewer driver gene mutations, suggesting an important role for tumorigenesis. We identified at least one in-frame protein kinase fusion in 324 of 4366 samples (7.4%). Potentially druggable kinase fusions involving ALK, ROS, RET, NTRK and FGFR gene families were detected in bladder carcinoma (3.3%), glioblastoma (4.4%), head and neck cancer (1.0%), low-grade glioma (1.5%), lung adenocarcinoma (1.6%), lung squamous cell carcinoma (2.3%) and thyroid carcinoma (8.7%), suggesting a potential for application of kinase inhibitors across tumor types. Inframe fusion transcripts involving histone methyltransferase or histone demethylase genes were detected in 111 samples (2.5%) and may additionally be considered as therapeutic targets. In summary, we described the landscape of transcript fusions detected across a large number of tumor samples and revealed fusion events with clinical relevance that have not been previously recognized. Our results support the concept of basket clinical trials where patients are matched with experimental therapies based on their genomic profile rather than the tissue where the tumor originated.	[Yoshihara, K.; Wang, Q.; Torres-Garcia, W.; Zheng, S.; Vegesna, R.; Kim, H.; Verhaak, R. G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Yoshihara, K.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Verhaak, R. G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genome Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Niigata University; University of Texas System; UTMD Anderson Cancer Center	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Dept Bioinformat & Computat Biol, 1400 Pressler St,Unit 1410, Houston, TX 77030 USA.	rverhaak@mdanderson.org	Verhaak, Roel/ABE-7058-2020; Yoshihara, Kosuke/AAU-9874-2020; Torres-Garcia, Wandaliz/L-6347-2017; Kim, Hoon/AAL-9283-2020	Yoshihara, Kosuke/0000-0002-2254-3378; Kim, Hoon/0000-0003-4244-6126	Mary K Chapman Foundation; Michael & Susan Dell Foundation; US National Cancer Institute (MD Anderson TCGA Genome Data Analysis Center) [CA143883, CA083639]; MD Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA083639, U24CA143883] Funding Source: NIH RePORTER	Mary K Chapman Foundation; Michael & Susan Dell Foundation; US National Cancer Institute (MD Anderson TCGA Genome Data Analysis Center); MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The results published here are in whole or part based upon data generated by The Cancer Genome Atlas project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at 'http://cancergenome.nih.gov'. This work was supported in part by the Mary K Chapman Foundation, the Michael & Susan Dell Foundation (honoring Lorraine Dell), US National Cancer Institute (MD Anderson TCGA Genome Data Analysis Center) grant numbers CA143883 and CA083639, and MD Anderson Cancer Center Support Grant P30 CA016672 (the Bioinformatics Shared Resource).	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cadot B, 2009, CANCER RES, V69, P6074, DOI 10.1158/0008-5472.CAN-08-2796; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gough SM, 2014, CANCER DISCOV, V4, P564, DOI 10.1158/2159-8290.CD-13-0419; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Kalyana-Sundaram S, 2012, NEOPLASIA, V14, P702, DOI 10.1593/neo.12914; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Lam ET, 2010, J CLIN ONCOL, V28, P2323, DOI 10.1200/JCO.2009.25.0068; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; NOWELL PC, 1960, SCIENCE, V132, P1497; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; R Core Team, 2021, R LANGUAGE ENV STAT; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113	53	296	300	1	39	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4845	4854		10.1038/onc.2014.406	http://dx.doi.org/10.1038/onc.2014.406			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25500544	Green Accepted			2022-12-26	WOS:000361050000005
J	Huang, R; Zhang, M; Rwere, F; Waskell, L; Ramamoorthy, A				Huang, Rui; Zhang, Meng; Rwere, Freeborn; Waskell, Lucy; Ramamoorthy, Ayyalusamy			Kinetic and Structural Characterization of the Interaction between the FMN Binding Domain of Cytochrome P450 Reductase and Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ELECTRON-TRANSFER; COENZYME BINDING; P450 REDUCTASE; NMR-SPECTROSCOPY; LIVER MICROSOMES; PARAMAGNETIC NMR; P-450 REDUCTASE; COMPLEX; MECHANISM	Cytochrome P450 reductase (CPR) is a diflavin enzyme that transfers electrons to many protein partners. Electron transfer from CPR to cyt c has been extensively used as a model reaction to assess the redox activity of CPR. CPR is composed of multiple domains, among which the FMN binding domain (FBD) is the direct electron donor to cyt c. Here, electron transfer and complex formation between FBD and cyt c are investigated. Electron transfer from FBD to cyt c occurs at distinct rates that are dependent on the redox states of FBD. When compared with full-length CPR, FBD reduces cyt c at a higher rate in both the semiquinone and hydroquinone states. The NMR titration experiments reveal the formation of dynamic complexes between FBD and cyt c on a fast exchange time scale. Chemical shift mapping identified residues of FBD involved in the binding interface with cyt c, most of which are located in proximity to the solvent-exposed edge of the FMN cofactor along with other residues distributed around the surface of FBD. The structural model of the FBD-cyt c complex indicates two possible orientations of complex formation. The major complex structure shows a salt bridge formation between Glu-213/Glu-214 of FBD and Lys-87 of cyt c, which may be essential for the formation of the complex, and a predicted electron transfer pathway mediated by Lys-13 of cyt c. The findings provide insights into the function of CPR and CPR-cyt c interaction on a structural basis.	[Huang, Rui; Zhang, Meng; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Rwere, Freeborn; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Rwere, Freeborn; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Huang, Rui/N-4022-2017; Rwere, Freeborn/ABF-3335-2021; Zhang, Meng/P-6278-2017	Huang, Rui/0000-0002-4064-6397; Rwere, Freeborn/0000-0002-7037-6850; Zhang, Meng/0000-0003-4497-3253; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [GM084018, GM095640, GM094209]; merit review grant from Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095640, R01GM084018, R01GM094209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); merit review grant from Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM094209. This work was also supported by a merit review grant from Veterans Affairs (to L. W.).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Goddard T. D., 2006, SPARKY 3; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2000, BIOCHEMISTRY-US, V39, P15990, DOI 10.1021/bi002135n; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Hervas M, 2013, FEBS J, V280, P1830, DOI 10.1111/febs.12207; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hubbard SJ., 1993, COMPUTER PROGRAM; Jang HH, 2010, BBA-PROTEINS PROTEOM, V1804, P1285, DOI 10.1016/j.bbapap.2010.02.003; Kurnikov IV., 2000, HARLEM MOL MODELING; LU AYH, 1968, J BIOL CHEM, V243, P1331; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; NADLER SG, 1988, ARCH BIOCHEM BIOPHYS, V261, P418, DOI 10.1016/0003-9861(88)90358-X; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; Ortiz de Montellano P. R, 2005, CYTOCHROME P450 STRU, P115; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; RODKEY FL, 1947, FED PROC, V6, P286; Sakamoto K, 2011, P NATL ACAD SCI USA, V108, P12271, DOI 10.1073/pnas.1108320108; Scanu S, 2012, CHEMBIOCHEM, V13, P1312, DOI 10.1002/cbic.201200073; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEM DS, 1994, BIOCHEMISTRY-US, V33, P12012, DOI 10.1021/bi00206a002; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SHEN SJ, 1994, BIOCHEMISTRY-US, V33, P8807, DOI 10.1021/bi00195a024; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Ubbink M, 2012, BIOCHEM SOC T, V40, P415, DOI 10.1042/BST20110698; Vincent B, 2012, J MOL BIOL, V420, P296, DOI 10.1016/j.jmb.2012.03.022; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; VORKINK WP, 1974, PHOTOCHEM PHOTOBIOL, V19, P205, DOI 10.1111/j.1751-1097.1974.tb06500.x; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Worrall JAR, 2003, BIOCHEMISTRY-US, V42, P7068, DOI 10.1021/bi0342968; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200; ZABINSKI-SNOPKO R M, 1981, Journal of Biological Physics, V9, P155, DOI 10.1007/BF01988248; Zhao Q, 1999, PROTEIN SCI, V8, P298	61	17	19	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4843	4855		10.1074/jbc.M114.582700	http://dx.doi.org/10.1074/jbc.M114.582700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25512382	hybrid, Green Published			2022-12-26	WOS:000350042000029
J	Kang, HJ; Wilkins, AD; Lichtarge, O; Wensel, TG				Kang, Hye Jin; Wilkins, Angela D.; Lichtarge, Olivier; Wensel, Theodore G.			Determinants of Endogenous Ligand Specificity Divergence among Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computational Biology; G Protein; Metabotropic Glutamate Receptor (mGluR); Molecular Evolution; Signal Transduction; G Protein-coupled Receptors	POSITIVE ALLOSTERIC MODULATORS; EVOLUTIONARY TRACE; BINDING-SITE; ACTIVATION; RESIDUES	Background: l-Glutamate and l-serine-O-phosphate (l-SOP) differentially regulate subtypes of metabotropic glutamate receptor (mGluR). Results: Evolutionary trace identified residues whose swapping between mGluR1 or mGluR7 and mGluR4 altered responses as predicted. Conclusion: Determinants for early and later functional divergence of mGluRs were identified. Significance: The structural and evolutionary origins of divergent mGluR specificities may aid in design of new therapeutics. To determine the structural origins of diverse ligand response specificities among metabotropic glutamate receptors (mGluRs), we combined computational approaches with mutagenesis and ligand response assays to identify specificity-determining residues in the group I receptor, mGluR1, and the group III receptors, mGluR4 and mGluR7. Among these, mGluR1 responds to l-glutamate effectively, whereas it binds weakly to another endogenous ligand, l-serine-O-phosphate (l-SOP), which antagonizes the effects of l-glutamate. In contrast, mGluR4 has in common with other group III mGluR that it is activated with higher potency and efficacy by l-SOP. mGluR7 differs from mGluR4 and other group III mGluR in that l-glutamate and l-SOP activate it with low potency and efficacy. Enhanced versions of the evolutionary trace (ET) algorithm were used to identify residues that when swapped between mGluR1 and mGluR4 increased the potency of l-SOP inhibition relative to the potency of l-glutamate activation in mGluR1 mutants and others that diminished the potency/efficacy of l-SOP for mGluR4 mutants. In addition, combining ET identified swaps from mGluR4 with one identified by computational docking produced mGluR7 mutants that respond with dramatically enhanced potency/efficacy to l-SOP. These results reveal that an early functional divergence between group I/II and group III involved variation at positions primarily at allosteric sites located outside of binding pockets, whereas a later divergence within group III occurred through sequence variation both at the ligand-binding pocket and at loops near the dimerization interface and interlobe hinge region. They also demonstrate the power of ET for identifying allosteric determinants of evolutionary importance.	[Kang, Hye Jin; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Wilkins, Angela D.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, BCM 125, Houston, TX 77030 USA.	twensel@bcm.edu		Kang, Hye Jin/0000-0001-9067-9050; Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [R01-GM066099, R01-EY011900, R01-EY007981, R01-GM079656, T90-DK070109]; National Science Foundation [MCB-0818353, CCF-0905536, DBI-1062455]; Welch Foundation [Q-0035]; Direct For Biological Sciences [1356569] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY011900, R01EY007981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, R01GM066099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM066099, R01-EY011900, R01-EY007981, R01-GM079656, and T90-DK070109. This work was also supported by National Science Foundation Grants MCB-0818353, CCF-0905536, and DBI-1062455 and by the Welch Foundation Grant Q-0035.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Kammermeier PJ, 2012, MOL PHARMACOL, V82, P438, DOI 10.1124/mol.112.078501; Kang HJ, 2014, J BIOL CHEM, V289, P29961, DOI 10.1074/jbc.M114.574483; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Mathiesen JM, 2003, BRIT J PHARMACOL, V138, P1026, DOI 10.1038/sj.bjp.0705159; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Sheffler DJ, 2008, NEUROPHARMACOLOGY, V55, P419, DOI 10.1016/j.neuropharm.2008.06.047; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wilkins AD, 2013, BIOINFORMATICS, V29, P2714, DOI 10.1093/bioinformatics/btt489; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2870	2878		10.1074/jbc.M114.622233	http://dx.doi.org/10.1074/jbc.M114.622233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519912	Green Published, hybrid			2022-12-26	WOS:000349310700027
J	Anderwald, CH; Tura, A; Gessl, A; Smajis, S; Bieglmayer, C; Marculescu, R; Luger, A; Pacini, G; Krebs, M				Anderwald, Christian-Heinz; Tura, Andrea; Gessl, Alois; Smajis, Sabina; Bieglmayer, Christian; Marculescu, Rodrig; Luger, Anton; Pacini, Giovanni; Krebs, Michael			Whole-Body Insulin Sensitivity Rather than Body-Mass-Index Determines Fasting and Post-Glucose-Load Growth Hormone Concentrations	PLOS ONE			English	Article							GH-RELEASING HORMONE; TOLERANCE TEST; RESISTANCE; SECRETION; OBESITY; METABOLISM; INFUSION; IMPACT; ADULTS; CLAMP	Background: Obese, non-acromegalic persons show lower growth hormone (GH) concentrations at fasting and reduced GH nadir during an oral glucose tolerance test (OGTT). However, this finding has never been studied with regard to whole-body insulin-sensitivity as a possible regulator. Methods: In this retrospective analysis, non-acromegalic (NonACRO, n=161) and acromegalic (ACRO, n=35), non-diabetic subjects were subdivided into insulin-sensitive (IS) and -resistant (IR) groups according to the Clamp-like Index (CLIX)-threshold of 5 mg.kg(-1).min(-1) from the OGTT. Results: Non-acromegalic IS (CLIX: 8.8 +/- 0.4 mg.kg(-1).min(-1)) persons with similar age and sex distribution, but lower (p<0.001) body-mass-index (BMI=25 +/- 0 kg/m(2), 84% females, 56 +/- 1 years) had 59% and 70%, respectively, higher (p<0.03) fasting GH and OGTT GH area under the curve concentrations than IR (CLIX: 3.5 +/- 0.1 mg.kg(-1).min(-1), p<0.001) subjects (BMI=29 +/- 1 kg/m(2), 73% females, 58 +/- 1 years). When comparing on average overweight non-acromegalic IS and IR with similar anthropometry (IS: BMI: 27 +/- 0 kg/m(2), 82% females, 58 +/- 2 years; IR: BMI: 27 +/- 0 kg/m(2), 71% females, 60 +/- 1 years), but different CLIX (IS: 8.7 +/- 0.9 vs. IR: 3.8 +/- 0.1 mg.kg(-1).min(-1), p<0.001), the results remained almost the same. In addition, when adjusted for OGTT-mediated glucose rise, GH fall was less pronounced in IR. In contrast, in acromegalic subjects, no difference was found between IS and IR patients with regard to fasting and post-glucose-load GH concentrations. Conclusions: Circulating GH concentrations at fasting and during the OGTT are lower in non-acromegalic insulin-resistant subjects. This study seems the first to demonstrate that insulin sensitivity rather than body-mass modulates fasting and post-glucose-load GH concentrations in non-diabetic non-acromegalic subjects.	[Anderwald, Christian-Heinz; Gessl, Alois; Smajis, Sabina; Luger, Anton; Krebs, Michael] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 2, Vienna, Austria; [Anderwald, Christian-Heinz; Tura, Andrea; Pacini, Giovanni] CNR, Metab Unit, Inst Biomed Engn, ISIB, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria; [Bieglmayer, Christian; Marculescu, Rodrig] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna	Anderwald, CH (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 2, Vienna, Austria.	christian-heinz.anderwald@meduniwien.ac.at	Marculescu, Rodrig/B-6474-2016; Anderwald, Christian Heinz/AAG-2271-2021	Marculescu, Rodrig/0000-0003-1772-6695; Anderwald, Christian Heinz/0000-0001-7485-0815; Krebs, Michael/0000-0002-9265-7274				Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Anderwald C, 2008, EUR J CLIN INVEST, V38, P227, DOI 10.1111/j.1365-2362.2008.01932.x; Anderwald CH, 2010, JOURNAL OF CLINICAL, V1, P61; Anderwald C, 2007, DIABETES CARE, V30, P2374, DOI 10.2337/dc07-0422; Anderwald C, 2011, DIABETES CARE, V34, P1475, DOI 10.2337/dc10-2266; Anderwald C, 2011, J CLIN ENDOCR METAB, V96, P515, DOI 10.1210/jc.2010-1398; Anderwald C, 2010, HEART, V96, P1191, DOI 10.1136/hrt.2009.177436; Anderwald C, 2009, ENDOCRINOLOGIST, V19, P302, DOI 10.1097/TEN.0b013e3181c0479d; Anderwald CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077326; Anderwald CH, 2012, DIABETES CARE, V35, P2580, DOI 10.2337/dc12-0197; Anderwald-Stadler M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1393, DOI 10.1152/ajpendo.00330.2007; Arafat AM, 2010, DIABETOLOGIA, V53, P1304, DOI 10.1007/s00125-010-1738-4; Arafat AM, 2008, J CLIN ENDOCR METAB, V93, P1254, DOI 10.1210/jc.2007-2084; Bredella MA, 2013, J CLIN ENDOCR METAB, V98, P3864, DOI 10.1210/jc.2013-2063; Chanson P, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-17; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; Grottoli S, 1997, J CLIN ENDOCR METAB, V82, P2261, DOI 10.1210/jc.82.7.2261; Iranmanesh A, 2012, J CLIN ENDOCR METAB, V97, P2172, DOI 10.1210/jc.2011-3317; Jessen N, 2005, AM J PHYSIOL-ENDOC M, V288, pE194, DOI 10.1152/ajpendo.00149.2004; Kim SK, 2012, J KOREAN MED SCI, V27, P177, DOI 10.3346/jkms.2012.27.2.177; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Plockinger U, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/268957; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Stadler M, 2009, DIABETOLOGIA, V52, P2435, DOI 10.1007/s00125-009-1520-7; Stadler M, 2010, DIABETES, V59, P215, DOI 10.2337/db09-0354; Tam CS, 2012, DIABETES CARE, V35, P1605, DOI 10.2337/dc11-2339; Tura A, 2011, AM J PHYSIOL-REG I, V300, pR941, DOI 10.1152/ajpregu.00650.2010; Verrua E, 2011, J CLIN ENDOCR METAB, V96, pE83, DOI 10.1210/jc.2010-1115; Vierhapper H, 2003, METABOLISM, V52, P181, DOI 10.1053/meta.2003.50036	34	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115184	10.1371/journal.pone.0115184	http://dx.doi.org/10.1371/journal.pone.0115184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517727	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600051
J	Agbor, AA; Bigna, JJR; Billong, SC; Tejiokem, MC; Ekali, GL; Plottel, CS; Noubiap, JJN; Abessolo, H; Toby, R; Koulla-Shiro, S				Agbor, Ako A.; Bigna, Jean Joel R.; Billong, Serges Clotaire; Tejiokem, Mathurin Cyrille; Ekali, Gabriel L.; Plottel, Claudia S.; Noubiap, Jean Jacques N.; Abessolo, Hortence; Toby, Roselyne; Koulla-Shiro, Sinata			Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaounde Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006-2013)	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 REPLICATION; RURAL SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; MORTALITY; ADULTS; MALAWI; IMPACT; AIDS; COINFECTION; DISTRICT	Background: Contributors to fatal outcomes in TB/HIV co-infected patients actively undergoing TB treatment are poorly characterized. The aim was to assess factors associated with death in TB/HIV co-infected patients during the initial 6 months of TB treatment. Methods: We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at the Yaounde Central Hospital, Cameroon. We reviewed medical records to identify hospitalized co-infected TB/HIV patients aged 15 years and older. Death was defined as any death occurring during TB treatment, as per the World Health Organization's recommendations. We conducted logistic regression analysis to identify factors associated with a fatal outcome. Magnitudes of associations were expressed by adjusted odds ratio (aOR) with 95% confidence interval. Results: The 337 patients enrolled had a mean age of 39.3 (standard deviation 10.3) years and 54.3% were female. TB treatment outcomes were distributed as follows: 205 (60.8%) treatment success, 99 (29.4%) deaths, 18 (5.3%) not evaluated, 14 (4.2%) lost to follow-up, and 1 (0.3%) failed. After exclusion of patients lost to follow-up and not evaluated, death in TB/HIV co-infected patients during TB treatment was associated with a TB diagnosis made before 2010 (aOR=2.50 [1.31-4.78]; p=0.006), the presence of other AIDS-defining diseases (aOR=2.73 [1.27-5.86]; p=0.010), non-AIDS comorbidities (aOR=3.35 [1.37-8.21]; p=0.008), not receiving cotrimoxazole prophylaxis (aOR=3.61 [1.71-7.63]; p=0.001), not receiving antiretroviral therapy (aOR=2.45 [1.18-5.08]; p=0.016), and CD4 cells count <50 cells/mm(3) (aOR=16.43 [1.05-258.04]; p=0.047). Conclusions: The TB treatment success rate among TB/HIV co-infected patients in our setting is low. Mortality was high among TB/HIV co-infected patients during TB treatment and is strongly associated with clinical and biological factors, highlighting the urgent need for specific interventions focused on enhancing patient outcomes.	[Agbor, Ako A.; Billong, Serges Clotaire; Koulla-Shiro, Sinata] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Bigna, Jean Joel R.] Minist Publ Hlth, Goulfey Hlth Dist Unit, Goulfey, Cameroon; [Billong, Serges Clotaire; Ekali, Gabriel L.] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Tejiokem, Mathurin Cyrille] Ctr Pasteur Cameroun, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon; [Plottel, Claudia S.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Plottel, Claudia S.] NYU, Sch Med, Dept Med, New York, NY USA; [Noubiap, Jean Jacques N.] Edea Reg Hosp, Internal Med Unit, Edea, Cameroon; [Abessolo, Hortence; Toby, Roselyne; Koulla-Shiro, Sinata] Yaounde Cent Hosp, Infect Dis Unit, Yaounde, Cameroon	University of Yaounde I; Centre Pasteur du Cameroun; New York University; NYU Langone Medical Center; New York University	Bigna, JJR (corresponding author), Minist Publ Hlth, Goulfey Hlth Dist Unit, POB 62 Kousseri, Goulfey, Cameroon.	bignarimjj@yahoo.fr	Bigna, Jean Joel/A-1781-2015; Loni Ekali, Gabriel/L-1799-2018	Bigna, Jean Joel/0000-0001-8018-6279; Loni Ekali, Gabriel/0000-0003-3693-5097; Noubiap, Jean Jacques/0000-0002-7722-9757; Plottel, Claudia S./0000-0001-6088-6534				Alvarez-Uria G, 2013, BIOIMPACTS, V3, P123, DOI 10.5681/bi.2013.025; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Banerjee A, 1997, T ROY SOC TROP MED H, V91, P707, DOI 10.1016/S0035-9203(97)90533-2; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; Connolly C, 1999, AIDS, V13, P1543, DOI 10.1097/00002030-199908200-00015; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Dou Zhi-hui, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1091; El-Sony AI, 2002, INT J TUBERC LUNG D, V6, P1058; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/518667; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Harries AD, 2000, SCOT MED J, V45, P47, DOI 10.1177/00369330000450S122; Harries AD, 2009, INT J TUBERC LUNG DI, V13; Hoffmann C, 2007, HIV MED, P389; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Kantipong P, 2012, HIV AIDS-RES PALLIAT, V4, P159, DOI 10.2147/HIV.S33535; Kirenga BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090614; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Kuaban C, 1997, E AFR MED J, V74, P474; Kuaban C, 2011, HLTH SCI DIS, V12; Little R. J. A., 1987, STAT ANAL MISSING DA; Marcy O, 2014, CLIN INFECT DIS, V59, P435, DOI 10.1093/cid/ciu283; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; National AIDS Control Committtee, 2010, NAT GUID MAN HIV INF; Programme National de lutte contre la Tuberculose, 2014, PLAN STRAT LUTT CONT; Programme National de lutte contre la Tuberculose, 2012, GUID PERS SANT; Quinn TC, 2001, B WORLD HEALTH ORGAN, V79, P1159; Rizzardi GP, 1999, INFECT DIS, P1; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sume G E, 2009, East Afr Med J, V86, P469; Sun Ding-yong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P181; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WHO GLOBAL TUBERCULO; Witor SZ, 1999, LANCET, V353, P1469; Yone EWP, 2012, REV PNEUMOL CLIN, V68, P338, DOI 10.1016/j.pneumo.2012.10.001; Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	47	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115211	10.1371/journal.pone.0115211	http://dx.doi.org/10.1371/journal.pone.0115211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506830	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100061
J	Gong, YN; Chen, GW; Chen, CJ; Kuo, RL; Shih, SR				Gong, Yu-Nong; Chen, Guang-Wu; Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru			Computational Analysis and Mapping of Novel Open Reading Frames in Influenza A Viruses	PLOS ONE			English	Article							MESSENGER-RNA; PB1-F2 PROTEIN; SEGMENT 2; TRANSLATION; INITIATION; GENE; AUG; IDENTIFICATION; MECHANISM; TYPE-1	The influenza A virus contains 8 segmented genomic RNAs and was considered to encode 10 viral proteins until investigators identified the 11th viral protein, PB1-F2, which uses an alternative reading frame of the PB1 gene. The recently identified PB1-N40, PA-N155 and PA-N182 influenza A proteins have shown the potential for using a leaking ribosomal scanning mechanism to generate novel open reading frames (ORFs). These novel ORFs provide examples of the manner in which the influenza A virus expands its coding capacity by using overlapping reading frames. In this study, we performed a computational search, based on a ribosome scanning mechanism, on all influenza A coding sequences to identify possible forward-reading ORFs that could be translated into novel viral proteins. We specified that the translated products had a prevalence >= 5% to eliminate sporadic ORFs. A total of 1,982 ORFs were thus identified and presented in terms of their locations, lengths and Kozak sequence strengths. We further provided an abridged list of ORFs by requiring every candidate an upstream start codon ( within the upstream third of the primary transcript), a strong Kozak consensus sequence and high prevalence (>= 95% and >= 50% for in-frame and alternative-frame ORFs, respectively). The PB1-F2, PB1-N40, PA-N155 and PA-N182 proteins all fulfilled our filtering criteria. Subject to these three stringent settings, we additionally named 16 novel ORFs for all influenza A genomes except for HA and NA, for which 43 HA and 11 NA ORFs from their respective subtypes were also recognized.	[Gong, Yu-Nong; Chen, Guang-Wu] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Chen, GW (corresponding author), Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	gwchen@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016; Chen, Guang-Wu/M-6768-2016	Chen, Chi-Jene/0000-0002-2292-7769; Gong, Yu-Nong/0000-0002-6799-1561; Chen, Guang-Wu/0000-0002-5322-4839; Shih, Shin-Ru/0000-0003-4874-401X	Ministry of Science and Technology, Taiwan [100-2221-E-182-056-MY3]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD260013]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	GWC received two grants from the Ministry of Science and Technology, Taiwan (No. 100-2221-E-182-056-MY3; http://www.most.gov.tw/) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (No. CMRPD260013; http://www.cgmh.org.tw) that partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Chen GW, 2004, EMERG INFECT DIS, V10, P630, DOI 10.3201/eid1004.030412; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DILLON PJ, 1989, J VIROL, V63, P974, DOI 10.1128/JVI.63.2.974-977.1989; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; Tam JS, 2002, VACCINE, V20, pS77, DOI 10.1016/S0264-410X(02)00137-8; Trifonov V., 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1006; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Xu H, 2010, CELL RES, V20, P445, DOI 10.1038/cr.2010.25; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zhirnov OP, 2007, DOKL BIOCHEM BIOPHYS, V414, P127, DOI 10.1134/S1607672907030106	34	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115016	10.1371/journal.pone.0115016	http://dx.doi.org/10.1371/journal.pone.0115016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506939	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100043
J	Pasiarski, M; Rolinski, J; Grywalska, E; Stelmach-Goldys, A; Korona-Glowniak, I; Gozdz, S; Hus, I; Malm, A				Pasiarski, Marcin; Rolinski, Jacek; Grywalska, Ewelina; Stelmach-Goldys, Agnieszka; Korona-Glowniak, Izabela; Gozdz, Stanislaw; Hus, Iwona; Malm, Anna			Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients - Preliminary Report	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; SEROLOGIC RESPONSE; PERIPHERAL-BLOOD; DIAGNOSIS; IGG; INFECTIONS; GUIDELINES; CELLS; SERUM	Background: Chronic lymphocytic leukemia (CLL) leads to significant immune system dysfunction. The predominant clinical presentation in 50% of patients involves recurrent, often severe, infections. Infections are also the most common (60-80%) cause of deaths in CLL patients. The scope of infections varies with the clinical stage of the disease. Treatment-naive patients typically present with respiratory tract infections caused by encapsulated bacteria Streptococcus pneumoniae and Haemophilus influenzae. Since 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended in the United States and some EU countries for pneumococcal infection prevention in patients with CLL (besides the long-standing standard, 23-valent pneumococcal polysaccharide vaccine, PPV23). The aim of this study was to compare the immune response to PCV13 in 24 previously untreated CLL patients and healthy subjects. Methods: Both groups were evaluated for: the levels of specific pneumococcal antibodies, the levels of IgG and IgG subclasses and selected peripheral blood lymphocyte subpopulations including the frequency of plasmablasts before and after immunization. Results: Adequate response to vaccination, defined as an at least two-fold increase in specific pneumococcal antibody titers versus pre-vaccination baseline titers, was found in 58.3% of CLL patients and 100% of healthy subjects. Both the CLL group and the control group demonstrated a statistically significant increase in the IgG2 subclass levels following vaccination (P=0.0301). After vaccination, the frequency of plasmablasts was significantly lower (P < 0.0001) in CLL patients in comparison to that in controls. Patients who responded to vaccination had lower clinical stage of CLL as well as higher total IgG, and IgG2 subclass levels. No significant vaccine-related side effects were observed. Conclusions: PCV13 vaccination in CLL patients is safe and induces an effective immune response in a considerable proportion of patients. To achieve an optimal vaccination response, the administration of PCV13 is recommended as soon as possible following CLL diagnosis.	[Pasiarski, Marcin; Stelmach-Goldys, Agnieszka] Holycross Canc Ctr, Dept Hematol, Kielce, Poland; [Rolinski, Jacek; Grywalska, Ewelina] Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland; [Rolinski, Jacek; Grywalska, Ewelina] St Johns Canc Ctr, Lublin, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Chemotherapy & Clin Oncol, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Hus, Iwona] Med Univ Lublin, Dept Clin Transplantol, Lublin, Poland; [Korona-Glowniak, Izabela; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, Lublin, Poland	Medical University of Lublin; Jan Kochanowski University; Medical University of Lublin; Medical University of Lublin	Rolinski, J (corresponding author), Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland.	jacek.rolinski@gmail.com	Kielce, SCO/O-6702-2016; Hus, Iwona/AAB-2809-2020; Gozdz, Stanislaw/D-3300-2013	Hus, Iwona/0000-0002-6096-4093; Rolinski, Jacek/0000-0003-4841-6120; Gozdz, Stanislaw/0000-0001-6902-3807; Korona-Glowniak, Izabela/0000-0003-1634-0387; Malm, Anna/0000-0003-1503-7634; Rolinski, Jacek Mariusz/0000-0001-5596-2651; Grywalska, Ewelina/0000-0002-0451-4741; Pasiarski, Marcin/0000-0002-8569-4261	Polish National Science Centre [UMO-2011/01/N/NZ6/01762, UMO-2012/05/B/NZ6/00792]	Polish National Science Centre	The study was subsidized from scientific grants No. UMO-2011/01/N/NZ6/01762 and No. UMO-2012/05/B/NZ6/00792 of the Polish National Science Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BL, 2006, ONCOLOGIST, V11, P21, DOI 10.1634/theoncologist.11-1-21; Bacterial Respiratory Pathogen Reference Laboratory at the University of Alabama at Birmingham (UAB) website, TRAIN MAN ENZ LINK I; Balmer P, 2003, CLIN EXP IMMUNOL, V133, P364, DOI 10.1046/j.1365-2249.2003.02232.x; CHOU MY, 1983, CANCER, V51, P1546, DOI 10.1002/1097-0142(19830415)51:8<1546::AID-CNCR2820510832>3.0.CO;2-A; Chovancova Z, 2011, VACCINE, V29, P4142, DOI 10.1016/j.vaccine.2011.03.087; Corscadden KJ, 2013, VACCINE, V31, P1393, DOI 10.1016/j.vaccine.2012.12.078; DAVEY FR, 1987, AM J CLIN PATHOL, V87, P60, DOI 10.1093/ajcp/87.1.60; Dearden Claire, 2008, Hematology Am Soc Hematol Educ Program, P450, DOI 10.1182/asheducation-2008.1.450; Dighiero G, 1998, NEW ENGL J MED, V338, P1506, DOI 10.1056/NEJM199805213382104; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Freeman JA, 2013, LEUKEMIA LYMPHOMA, V54, P99, DOI 10.3109/10428194.2012.706285; Garcia-Munoz R, 2012, ANN HEMATOL, V91, P981, DOI 10.1007/s00277-012-1460-z; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; GOLDBLATT D, 1992, J INFECT DIS, V166, P632, DOI 10.1093/infdis/166.3.632; GRIFFITHS H, 1992, CLIN EXP IMMUNOL, V89, P374; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Hartkamp A, 2001, VACCINE, V19, P1671, DOI 10.1016/S0264-410X(00)00409-6; He XS, 2011, J IMMUNOL METHODS, V365, P67, DOI 10.1016/j.jim.2010.12.008; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Linet MS, 2007, BRIT J HAEMATOL, V139, P672, DOI 10.1111/j.1365-2141.2007.06847.x; Lobetti-Bodoni C, 2013, EUR J INTERN MED, V24, P401, DOI 10.1016/j.ejim.2013.03.009; Lu CL, 2014, VACCINE, V32, P1031, DOI 10.1016/j.vaccine.2014.01.009; MOLICA S, 1994, LEUKEMIA LYMPHOMA, V13, P203, DOI 10.3109/10428199409056283; Molteni A, 2005, HAEMATOLOGICA, V90, P1145; Morrison VA, 1998, SEMIN ONCOL, V25, P98; Morrison Vicki A, 2007, Hematology Am Soc Hematol Educ Program, P332, DOI 10.1182/asheducation-2007.1.332; Nosari A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.070; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Obaro SK, 1996, IMMUNOL LETT, V49, P83, DOI 10.1016/0165-2478(95)02487-5; Oscier D, 2004, BRIT J HAEMATOL, V125, P294, DOI 10.1111/j.1365-2141.2004.04898.x; Pollyea DA, 2010, J CLIN ONCOL, V28, P2481, DOI 10.1200/JCO.2009.26.6908; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Ravandi F, 2006, CANCER IMMUNOL IMMUN, V55, P197, DOI 10.1007/s00262-005-0015-8; Safdar A, 2008, CANCER-AM CANCER SOC, V113, P383, DOI 10.1002/cncr.23561; Sigurdardottir ST, 2014, VACCINE, V32, P417, DOI 10.1016/j.vaccine.2013.11.029; Sinisalo M, 2003, LEUKEMIA LYMPHOMA, V44, P649, DOI 10.1080/1042819031000063408; Sinisalo M, 2001, BRIT J HAEMATOL, V114, P107, DOI 10.1046/j.1365-2141.2001.02882.x; Sinisalo M, 2007, VACCINE, V26, P82, DOI 10.1016/j.vaccine.2007.10.053; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Van der Velden AMT, 2007, EUR J HAEMATOL, V79, P47, DOI 10.1111/j.1600-0609.2007.00862.x; Yri OE, 2011, BLOOD, V118, P6769, DOI 10.1182/blood-2011-08-372649	43	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114966	10.1371/journal.pone.0114966	http://dx.doi.org/10.1371/journal.pone.0114966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506837	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100037
J	Cheng, LY; Sun, XM; Hu, CM; Jin, R; Sun, BS; Shi, YM; Cui, WG; Zhang, YG				Cheng, Liying; Sun, Xiaoming; Hu, Changmin; Jin, Rong; Sun, Baoshan; Shi, Yaoming; Cui, Wenguo; Zhang, Yuguang			In Vivo Early Intervention and the Therapeutic Effects of 20(S)-Ginsenoside Rg3 on Hypertrophic Scar Formation	PLOS ONE			English	Article							GINSENOSIDE RG3; CANCER CELLS; KELOIDS; EXPRESSION; MANAGEMENT; ACTIVATION; TOXICITY; GROWTH	Background: Intra-lesional injections of corticosteroids, interferon, and chemotherapeutic drugs are currently the most popular treatments of hypertrophic scar formation. However, these drugs can only be used after HS is formed, and not during the inflammatory phase of wound healing, which regulates the HS forming process. Objective: To investigate a new, effective, combining therapeutic and safe drug for early intervention and treatment for hypertrophic scars. Methods: Cell viability assay and flow cytometric analysis were studied in vitro. Animal studies were done to investigate the combining therapeutic effects of 20(S)ginsenoside Rg3 (Rg3) on the inflammatory phase of wound healing and HS formation. Results: In vitro studies showed that Rg3 can inhibit HS fibroblasts proliferation and induce HSF apoptosis in a concentration-dependent manner. In vivo studies demonstrated that Rg3 can limit the exaggerated inflammation, and do not delay the wound healing process, which indicates that Rg3 could be used as an early intervention to reduce HS formation. Topical injection of 4 mg/mL Rg3 can reduce HS formation by 34%. Histological and molecular studies revealed that Rg3 injection inhibits fibroblasts proliferation thus reduced the accumulation of collagen fibers, and down-regulates VEGF expression in the HS tissue. Conclusion: Rg3 can be employed as an early intervention and a combining therapeutic drug to reduce inflammation and HS formation as well.	[Cheng, Liying; Sun, Xiaoming; Jin, Rong; Sun, Baoshan; Shi, Yaoming; Zhang, Yuguang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China; [Hu, Changmin; Cui, Wenguo] Soochow Univ, Inst Orthoped, Suzhou 215006, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Cui, WG (corresponding author), Soochow Univ, Inst Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.	wgcui80@hotmail.com; zhangyg18@126.com	Hu, Changmin/N-3508-2017	Hu, Changmin/0000-0002-1472-9981	National Natural Science Foundation of China [81372703, 51373112]; Science and Technology Commission of Shanghai fund grant [11 nm0503400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai fund grant	This work was supported in part by National Natural Science Foundation of China (grant number: 81372703, 51373112) (http://www.nsfc.gov.cn/) and Science and Technology Commission of Shanghai fund grant (grant number: 11 nm0503400) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir HU, 2014, J THORAC DIS, V6, P66, DOI 10.3978/j.issn.2072-1439.2013.12.54; Alster TS, 2003, AM J CLIN DERMATOL, V4, P235, DOI 10.2165/00128071-200304040-00003; Bae JS, 2012, J NAT MED-TOKYO, V66, P476, DOI 10.1007/s11418-011-0609-8; Berman B, 1998, EUR J DERMATOL, V8, P591; Chen JX, 2008, MELANOMA RES, V18, P322, DOI 10.1097/CMR.0b013e32830b3536; Chen QJ, 2010, CELL PHYSIOL BIOCHEM, V26, P849, DOI 10.1159/000323994; CHEN S E, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P161; Coon JT, 2002, DRUG SAFETY, V25, P323, DOI 10.2165/00002018-200225050-00003; Cui Y, 2010, WORLD J GASTROENTERO, V16, P445, DOI 10.3748/wjg.v16.i4.445; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Goppold A, 2011, EUR J DERMATOL, V21, P262, DOI 10.1684/ejd.2010.1230; Haurani MJ, 2009, PLAST RECONSTR SURG, V123, P139, DOI 10.1097/PRS.0b013e3181904d1b; Hayashi T, 2012, DERMATOL SURG, V38, P893, DOI 10.1111/j.1524-4725.2012.02345.x; Jiang JW, 2011, WORLD J GASTROENTERO, V17, P3605, DOI 10.3748/wjg.v17.i31.3605; Joo SS, 2008, BIOL PHARM BULL, V31, P1392, DOI 10.1248/bpb.31.1392; Juckett G, 2009, AM FAM PHYSICIAN, V80, P253; Keum YS, 2003, MUTAT RES-FUND MOL M, V523, P75, DOI 10.1016/S0027-5107(02)00323-8; Kim JW, 2012, PHYTOTHER RES, V26, P1286, DOI 10.1002/ptr.3722; Kim SM, 2010, EUR J PHARMACOL, V631, P1, DOI 10.1016/j.ejphar.2009.12.018; Kwon HY, 2008, ARCH PHARM RES, V31, P171, DOI 10.1007/s12272-001-1137-y; LARRABEE WF, 1990, ARCH OTOLARYNGOL, V116, P1159; Levy LL, 2012, AM J CLIN DERMATOL, V13, P331, DOI 10.2165/11631410-000000000-00000; Liu JP, 2012, FOOD CHEM TOXICOL, V50, P3388, DOI 10.1016/j.fct.2012.07.004; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Sai K, 2006, NEUROTOXICOLOGY, V27, P458, DOI 10.1016/j.neuro.2005.12.008; Saray Y, 2005, INT J DERMATOL, V44, P777, DOI 10.1111/j.1365-4632.2005.02633.x; Seo YJ, 2008, ARCH PHARM RES, V31, P364, DOI [10.1007/s12272-001-1165-x, 10.1007/s00000-001-1165-x]; SHEN R, 2009, ZHONGHUA ZHENG XING, V19, P254; Shockman S, 2010, J DRUGS DERMATOL, V9, P1249; Slemp AE, 2006, CURR OPIN PEDIATR, V18, P396, DOI 10.1097/01.mop.0000236389.41462.ef; Slominski A, 2013, J CLIN ENDOCR METAB, V98, pE298, DOI 10.1210/jc.2012-3074; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; SLOMINSKI AT, 2011, J INVEST DERMATOL; Urioste SS, 1999, SEMIN CUTAN MED SURG, V18, P159, DOI 10.1016/S1085-5629(99)80040-6; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Williams CC, 2011, J FAM PRACTICE, V60, P757; Xie HT, 2005, J CHROMATOGR B, V818, P167, DOI 10.1016/j.jchromb.2004.12.028; Yoo HH, 2006, AM J CHINESE MED, V34, P137, DOI 10.1142/S0192415X06003709; Yuan HD, 2010, MOL MED REP, V3, P825, DOI 10.3892/mmr.2010.328; Yue Yi-gang, 2006, Zhonghua Shao Shang Za Zhi, V22, P427; Zhang CL, 2012, MOL MED REP, V5, P1295, DOI 10.3892/mmr.2012.808; Zhang GY, 2011, BRIT J DERMATOL, V164, P729, DOI 10.1111/j.1365-2133.2010.10130.x; Zhang QY, 2008, CANCER BIOTHER RADIO, V23, P647, DOI 10.1089/cbr.2008.0532	47	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113640	10.1371/journal.pone.0113640	http://dx.doi.org/10.1371/journal.pone.0113640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502572	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400013
J	Kaushik, P; Molinelli, EJ; Miller, ML; Wang, WQ; Korkut, A; Liu, WB; Ju, ZL; Lu, YL; Mills, G; Sander, C				Kaushik, Poorvi; Molinelli, Evan J.; Miller, Martin L.; Wang, Weiqing; Korkut, Anil; Liu, Wenbin; Ju, Zhenlin; Lu, Yiling; Mills, Gordon; Sander, Chris			Spatial Normalization of Reverse Phase Protein Array Data	PLOS ONE			English	Article							MICROARRAYS; NETWORKS; VALIDATION; ACTIVATION; PATHWAYS	Reverse phase protein arrays (RPPA) are an efficient, high-throughput, cost-effective method for the quantification of specific proteins in complex biological samples. The quality of RPPA data may be affected by various sources of error. One of these, spatial variation, is caused by uneven exposure of different parts of an RPPA slide to the reagents used in protein detection. We present a method for the determination and correction of systematic spatial variation in RPPA slides using positive control spots printed on each slide. The method uses a simple bi-linear interpolation technique to obtain a surface representing the spatial variation occurring across the dimensions of a slide. This surface is used to calculate correction factors that can normalize the relative protein concentrations of the samples on each slide. The adoption of the method results in increased agreement between technical and biological replicates of various tumor and cell-line derived samples. Further, in data from a study of the melanoma cell-line SKMEL-133, several slides that had previously been rejected because they had a coefficient of variation (CV) greater than 15%, are rescued by reduction of CV below this threshold in each case. The method is implemented in the R statistical programing language. It is compatible with MicroVigene and SuperCurve, packages commonly used in RPPA data analysis.	[Kaushik, Poorvi; Molinelli, Evan J.; Miller, Martin L.; Wang, Weiqing; Korkut, Anil; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Lu, Yiling; Mills, Gordon] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Liu, Wenbin; Ju, Zhenlin] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kaushik, P (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	pkaushik@cbio.mskcc.org		Miller, Martin L/0000-0003-3161-8690	National Cancer Institute, Systems Biology of Diversity in Cancer [1 U 54 CA148967]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE [P30CA016672, U54CA148967] Funding Source: NIH RePORTER	National Cancer Institute, Systems Biology of Diversity in Cancer; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this study was provided by the National Cancer Institute grant 1 U 54 CA148967, Systems Biology of Diversity in Cancer (C. Sander, PI). Additional support was provided by the Tri-Institutional Training Program in Computational Biology and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2009, PROTEOMICS, V9, P5562, DOI 10.1002/pmic.200900505; Aoki H, 2007, FASEB J, V21, P2918, DOI 10.1096/fj.06-6941com; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Bender C, 2010, BIOINFORMATICS, V26, pi596, DOI 10.1093/bioinformatics/btq385; Charboneau Lu, 2002, Briefings in Functional Genomics & Proteomics, V1, P305, DOI 10.1093/bfgp/1.3.305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Espina V, 2009, CLIN LAB MED, V29, P1, DOI 10.1016/j.cll.2009.03.001; Espina Virginia, 2008, V441, P113, DOI 10.1007/978-1-60327-047-2_8; Gulmann C, 2009, J PATHOL, V218, P514, DOI 10.1002/path.2561; Havelund BM, 2012, APPL IMMUNOHISTOCHEM; Kevin Coombes WL, 2012, SUPERCURVE; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lavezzari G, 2012, METHODS MOL BIOL, V795, P203, DOI 10.1007/978-1-61779-337-0_14; Liang C, 2004, IBCS 11 ANN INT C CH; Listgarten Jennifer, 2003, Appl Bioinformatics, V2, P219; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Martiny-Baron G, 2011, METHODS MOL BIOL, V785, P79, DOI 10.1007/978-1-61779-286-1_7; Molero C, 2009, PROTEOMICS, V9, P3652, DOI 10.1002/pmic.200800907; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nishizuka SS, 2011, METHODS MOL BIOL, V785, P65, DOI 10.1007/978-1-61779-286-1_6; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Silvestri A, 2010, LAB INVEST, V90, P787, DOI 10.1038/labinvest.2010.47; Strosznajder RP, 2005, MOL NEUROBIOL, V31, P149, DOI 10.1385/MN:31:1-3:149; Terfve C, 2012, ADV EXP MED BIOL, V736, P19, DOI 10.1007/978-1-4419-7210-1_2; Troncale S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038686; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Verdugo RA, 2009, NUCLEIC ACIDS RES, V37, P5610, DOI 10.1093/nar/gkp573; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e97213	10.1371/journal.pone.0097213	http://dx.doi.org/10.1371/journal.pone.0097213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501559	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400001
J	Poll, G; Li, S; Ohmayer, U; Hierlmeier, T; Milkereit, P; Perez-Fernandez, J				Poell, Gisela; Li, Shuang; Ohmayer, Uli; Hierlmeier, Thomas; Milkereit, Philipp; Perez-Fernandez, Jorge			In Vitro Reconstitution of Yeast tUTP/UTP A and UTP B Subcomplexes Provides New Insights into Their Modular Architecture	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; BIOGENESIS; TRANSCRIPTION; EXPRESSION; PROCESSOME; COMPLEXES; CELLS	Eukaryotic ribosome biogenesis is a multistep process involving more than 150 biogenesis factors, which interact transiently with pre-ribosomal particles to promote their maturation. Some of these auxiliary proteins have been isolated in complexes found separate from the ribosomal environment. Among them, are 3 large UTP subcomplexes containing 6 or 7 protein subunits which are involved in the early steps of ribosome biogenesis. The composition of the UTP subcomplexes and the network of binary interactions between protein subunits have been analyzed previously. To obtain further insights into the structural and biochemical properties of UTP subcomplexes, we established a heterologous expression system to allow reconstitution of the yeast tUTP/UTP A and UTP B subcomplexes from their candidate subunits. The results of a series of reconstitution experiments involving different combinations of protein subunits are in good agreement with most of the previously observed binary interactions. Moreover, in combination with additional biochemical analyses, several stable building blocks of the UTP subcomplexes were identified. Based on these findings, we present a refined model of the tUTP/UTP A and UTP B architecture.	[Poell, Gisela; Li, Shuang; Ohmayer, Uli; Hierlmeier, Thomas; Milkereit, Philipp; Perez-Fernandez, Jorge] Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany	University of Regensburg	Perez-Fernandez, J (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany.	jpfernandez@ur.de	Perez-Fernandez, Jorge/F-6937-2010	Perez-Fernandez, Jorge/0000-0002-0018-5493	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960 from the "Deutsche Forschungsgemeinschaft'' to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eswara MBK, 2009, MOL BIOL CELL, V20, P5007, DOI 10.1091/mbc.E09-06-0490; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Reiter A, 2011, MOL CELL BIOL, V31, P803, DOI 10.1128/MCB.01227-10; SAMBROOK J, 2000, MOL CLONING LAB MANU; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114898	10.1371/journal.pone.0114898	http://dx.doi.org/10.1371/journal.pone.0114898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501974	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400062
J	Rybakin, V; Westernberg, L; Fu, G; Kim, HO; Ampudia, J; Sauer, K; Gascoigne, NRJ				Rybakin, Vasily; Westernberg, Luise; Fu, Guo; Kim, Hee-Ok; Ampudia, Jeanette; Sauer, Karsten; Gascoigne, Nicholas R. J.			Allelic Exclusion of TCR alpha-Chains upon Severe Restriction of V alpha Repertoire	PLOS ONE			English	Article							T-CELL-RECEPTOR; POSITIVE SELECTION; EXPRESSION; GENES; INCLUSION; SURFACE	Development of thymocytes through the positive selection checkpoint requires the rearrangement and expression of a suitable T cell receptor (TCR) alpha-chain that can pair with the already-expressed beta-chain to make a TCR that is selectable. That is, it must have sufficient affinity for self MHC-peptide to induce the signals required for differentiation, but not too strong so as to induce cell death. Because both alleles of the alpha-chain continue to rearrange until a positively-selectable heterodimer is formed, thymocytes and T cells can in principle express dual alpha-chains. However, cell-surface expression of two TCRs is comparatively rare in mature T cells because of post-transcriptional regulatory mechanisms termed "phenotypic allelic exclusion". We produced mice transgenic for a rearranged beta-chain and for two unrearranged alpha-chains on a genetic background where endogenous alpha-chains could not be rearranged. Both V alpha 3.2 and V alpha 2 containing alpha-chains were efficiently positively selected, to the extent that a population of dual alpha-chain-bearing cells was not distinguishable from single alpha-chain-expressors. Surprisingly, V alpha 3.2-expressing cells were much more frequent than the V alpha 2 transgene-expressing cells, even though this V alpha 3.2-V beta 5 combination can reconstitute a known selectable TCR. In accord with previous work on the V alpha 3 repertoire, T cells bearing V alpha 3.2 expressed from the rearranged minilocus were predominantly selected into the CD8(+) T cell subpopulation. Because of the dominance of V alpha 3.2 expression over V alpha 2 expressed from the miniloci, the peripheral T cell population was predominantly CD8(+) cells.	[Rybakin, Vasily; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Rybakin, Vasily; Westernberg, Luise; Fu, Guo; Kim, Hee-Ok; Ampudia, Jeanette; Sauer, Karsten; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sauer, Karsten] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National University of Singapore; Scripps Research Institute; Scripps Research Institute	Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, 5 Sci Dr 2, Singapore 117545, Singapore.	micnrjg@nus.edu.sg	Rybakin, Vasily/J-6310-2019	Rybakin, Vasily/0000-0002-5093-1757	NIH [GM065230, GM048002]; National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048002, R01GM065230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM065230 and GM048002 and by National University of Singapore. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health, nor of NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This is TSRI manuscript number 24007.	ALAM SM, 1995, IMMUNITY, V3, P449; Alam SM, 1998, J IMMUNOL, V160, P3883; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Boyd R, 1998, J IMMUNOL, V161, P1718; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; Dave VP, 1999, J IMMUNOL, V162, P5764; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Gascoigne NRJ, 1999, SEMIN IMMUNOL, V11, P337, DOI 10.1006/smim.1999.0190; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; KOUSKOFF V, 1995, EUR J IMMUNOL, V25, P54, DOI 10.1002/eji.1830250111; Lacorazza HD, 2004, J IMMUNOL, V173, P5591, DOI 10.4049/jimmunol.173.9.5591; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Niederberger N, 2003, J IMMUNOL, V170, P4557, DOI 10.4049/jimmunol.170.9.4557; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PIRCHER H, 1992, EUR J IMMUNOL, V22, P399, DOI 10.1002/eji.1830220217; Sant'Angelo DB, 2001, P NATL ACAD SCI USA, V98, P6824, DOI 10.1073/pnas.121179998; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sim BC, 1998, J IMMUNOL, V160, P1204; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; Simmons KB, 2012, CELL IMMUNOL, V272, P124, DOI 10.1016/j.cellimm.2011.10.022; UTSUNOMIYA Y, 1989, J IMMUNOL, V143, P2602	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114320	10.1371/journal.pone.0114320	http://dx.doi.org/10.1371/journal.pone.0114320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500569	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400027
J	Meyers, K; Rodriguez, K; Moeller, RW; Gratch, I; Markowitz, M; Halkitis, PN				Meyers, Kathrine; Rodriguez, Kristina; Moeller, Robert W.; Gratch, Ilana; Markowitz, Martin; Halkitis, Perry N.			High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort Substudy	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; BISEXUAL MEN; SERODISCORDANT COUPLES; NEGATIVE GAY; PREVENTION; ACCEPTABILITY; ATTITUDES; BARRIERS; FACILITATORS; WILLINGNESS	Objective: In the context of continued high rates of condomless anal intercourse and HIV-1 infection, young men who have sex with men (YMSM) need additional effective and desirable HIV prevention tools. This study reports on the willingness of a racially-ethnically diverse cohort of YMSM to use a new biomedical prevention approach, a long-acting injectable pre-exposure prophylaxis (LAI-PrEP) agent. Methods: A cross-sectional study conducted between June-August 2013 recruited participants from an ongoing cohort study of YMSM in NYC. Participants included 197 YMSM, of whom 72.6% (n = 143) identified as men of color. Two outcomes were measured through computer-assisted self-interviews: 1) willingness to use long-acting injectable PrEP and 2) preference for route of administration of PrEP. In addition, concerns about perceived impacts of PrEP on health and risk behavior, access to health services, and stigma were investigated. Results: Over 80% (n = 159/197, p < 0.001) of participants stated they would be willing to use LAI-PrEP. With regards to preference for mode of delivery 79.2% (n = 156/197, p < 0.001) stated they would prefer an injection administered every three months over a daily pill or neither one. Conclusions: This study is the first to explore acceptability of LAI-PrEP in the US. A significant majority of participants expressed willingness to use LAI and the majority preferred LAI-PrEP. LAI-PrEP holds great promise in that it could circumvent the adherence challenges associated with daily dosing, especially if nested within appropriate psycho-behavioral support. Medical providers whose patients include YMSM at high risk for HIV infection should note the positive attitudes toward PrEP, and specifically LAI-PrEP.	[Meyers, Kathrine; Rodriguez, Kristina; Markowitz, Martin] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Moeller, Robert W.; Gratch, Ilana] Middlebury Coll, Middlebury, VT 05753 USA; [Halkitis, Perry N.] NYU, Ctr HIV Ident Behav & Prevent Studies, New York, NY 10003 USA; [Halkitis, Perry N.] NYU, Global Inst Publ Hlth, New York, NY USA; [Halkitis, Perry N.] NYU, Dept Populat Hlth, New York, NY USA	New York University; New York University; New York University	Halkitis, PN (corresponding author), NYU, Ctr HIV Ident Behav & Prevent Studies, New York, NY 10003 USA.	pnh1@nyu.edu	Moeller, Robert/AAV-6557-2020	Moeller, Robert/0000-0001-9218-4887	Aaron Diamond AIDS Research Center; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025537] Funding Source: NIH RePORTER	Aaron Diamond AIDS Research Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Aaron Diamond AIDS Research Center funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2012, RES COMB BIOM BEH AP; Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; CDC, 2012, HIV SURV REP; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Goodman E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e31; Grant RM, 2014, LANCET INFECT DIS; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Mansergh G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001286; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Mimiaga MJ, 2013, ARCH SEX BEHAV; Nodin N, 2008, AIDS CARE, V20, P106, DOI 10.1080/09540120701449096; NYC DOHMH, 2012, NEW YORK CIT HIV AID; Peinado J, 2013, J INT ASS PHYS AIDS; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Tangmunkongvorakul A, 2013, AIDS CARE, V25, P961, DOI 10.1080/09540121.2012.748871; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2012, AIDS BEHAV; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	31	58	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114700	10.1371/journal.pone.0114700	http://dx.doi.org/10.1371/journal.pone.0114700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502768	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700047
J	Puig-Oliveras, A; Ballester, M; Corominas, J; Revilla, M; Estelle, J; Fernandez, AI; Ramayo-Caldas, Y; Folch, JM				Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Estelle, Jordi; Fernandez, Ana I.; Ramayo-Caldas, Yuliaxis; Folch, Josep M.			A Co-Association Network Analysis of the Genetic Determination of Pig Conformation, Growth and Fatness	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; TYROSINE KINASES; COMPLEX TRAITS; CELL-ADHESION; MEAT QUALITY; NITRIC-OXIDE; PPAR-GAMMA; METABOLISM; MICE	Background: Several QTLs have been identified for major economically relevant traits in livestock, such as growth and meat quality, revealing the complex genetic architecture of these traits. The use of network approaches considering the interactions of multiple molecules and traits provides useful insights into the molecular underpinnings of complex traits. Here, a network based methodology, named Association Weight Matrix, was applied to study gene interactions and pathways affecting pig conformation, growth and fatness traits. Results: The co-association network analysis underpinned three transcription factors, PPARc, ELF1, and PRDM16 involved in mesoderm tissue differentiation. Fifty-four genes in the network belonged to growth-related ontologies and 46 of them were common with a similar study for growth in cattle supporting our results. The functional analysis uncovered the lipid metabolism and the corticotrophin and gonadotrophin release hormone pathways among the most important pathways influencing these traits. Our results suggest that the genes and pathways here identified are important determining either the total body weight of the animal and the fat content. For instance, a switch in the mesoderm tissue differentiation may determinate the age-related preferred pathways being in the puberty stage those related with the miogenic and osteogenic lineages; on the contrary, in the maturity stage cells may be more prone to the adipocyte fate. Hence, our results demonstrate that an integrative genomic co-association analysis is a powerful approach for identifying new connections and interactions among genes. Conclusions: This work provides insights about pathways and key regulators which may be important determining the animal growth, conformation and body proportions and fatness traits. Molecular information concerning genes and pathways here described may be crucial	[Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Ramayo-Caldas, Yuliaxis; Folch, Josep M.] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra 08193, Spain; [Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Ramayo-Caldas, Yuliaxis; Folch, Josep M.] Ctr Recerca Agrigen CRAG, Bellaterra 08193, Spain; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] INRA, GABI, UMR1313, F-78350 Jouy En Josas, France; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] AgroParisTech, GABI, UMR1313, F-78350 Jouy En Josas, France; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] CEA, LREG, Commissariat Energie Atom & Energies Alternat, F-78350 Jouy En Josas, France; [Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr Alimentaria INIA, Dept Genet Anim, Madrid 28040, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Puig-Oliveras, A (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra 08193, Spain.	anna.puig@cragenomica.es	Ballester, Maria/E-7201-2016; Corominas Galbany, Jordi/B-6356-2018; Folch, Josep M/I-4738-2015; Revilla, Manuel/U-9033-2018; Fernández, Ana Isabel/J-3265-2012; Devis, Maria Ballester/AAV-2467-2020; Estellé, Jordi/A-7976-2008; Caldas, Yuliaxis Ramayo/B-6337-2014; Puig Oliveras, Anna/M-5551-2015	Ballester, Maria/0000-0002-5413-4640; Corominas Galbany, Jordi/0000-0003-1736-1278; Folch, Josep M/0000-0003-3689-1303; Revilla, Manuel/0000-0002-0164-9317; Fernández, Ana Isabel/0000-0002-1509-5191; Devis, Maria Ballester/0000-0002-5413-4640; Estellé, Jordi/0000-0002-6241-1732; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Puig Oliveras, Anna/0000-0003-2551-9012	MICINN project [AGL2011-29821-C02]; Innovation Consolider-Ingenio Program [CSD2007-00036]; Universitat Autonoma de Barcelona [458-01-1/2011]; Spanish Ministerio de Educacion [BES-2009-018223]; Spanish Ministerio [AP2008-01450]; Generalitat de Catalunya [ECO/1639/2013]	MICINN project(Spanish Government); Innovation Consolider-Ingenio Program; Universitat Autonoma de Barcelona; Spanish Ministerio de Educacion(Spanish Government); Spanish Ministerio; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been funded by MICINN project AGL2011-29821-C02 (Ministerio de Economia y Competitividad), and by the Innovation Consolider-Ingenio 2010 Program (CSD2007-00036, Centre de Recerca en Agrigenomica). APO was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). JC was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009-018223), YRC by a Formacion del Profesorado Universitario (FPU) PhD grant from the Spanish Ministerio (AP2008-01450), and MR by a Formacio i Contractacio de Personal Investigador Novell (FI-DGR) PhD grant from Generalitat de Catalunya (ECO/1639/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Allen DB, 1996, ENDOCRIN METAB CLIN, V25, P699, DOI 10.1016/S0889-8529(05)70348-0; [Anonymous], 2008, FATS FATT AC HUM NUT; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baek K, 2013, ADIPOCYTE, V2, P50, DOI 10.4161/adip.22019; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Calero-Nieto FJ, 2010, NUCLEIC ACIDS RES, V38, P6363, DOI 10.1093/nar/gkq490; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chen Z, 2011, GENET MOL BIOL, V34, P56, DOI 10.1590/S1415-47572010005000107; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Cordani N, 2014, STEM CELLS, V32, P874, DOI 10.1002/stem.1587; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; Decrock E, 2013, BBA-MOL CELL RES, V1833, P1772, DOI 10.1016/j.bbamcr.2012.12.016; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Dube A, 2001, CIRC RES, V88, P237; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Fernandez A., 2007, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P43; Fernandez AI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-41; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gispert M, 2007, MEAT SCI, V77, P397, DOI 10.1016/j.meatsci.2007.04.006; Gjerlaug-Enger E, 2012, ANIMAL, V6, P9, DOI 10.1017/S1751731111001455; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Kantas D, 2014, J ANIM SCI, V92, P2251, DOI 10.2527/jas.2013-6924; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Laumet G, 2010, NEUROSCI LETT, V468, P1, DOI 10.1016/j.neulet.2009.10.040; Lee TK, 2014, PSYCHONEUROENDOCRINO, V47, P166, DOI 10.1016/j.psyneuen.2014.05.015; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mul D, 2008, EUR J ENDOCRINOL, V159, pS3, DOI 10.1530/EJE-08-0814; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; O'Gorman CW, 2010, J ANIM PHYSIOL AN N, V94, pE266, DOI 10.1111/j.1439-0396.2009.00968.x; Oettgen P, 1996, MOL CELL BIOL, V16, P5091; OWENS FN, 1993, J ANIM SCI, V71, P3138, DOI 10.2527/1993.71113138x; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2014, J ANIM SCI; Ramayo-Caldas Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-232; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter Antonio, 2013, Methods Mol Biol, V1019, P437, DOI 10.1007/978-1-62703-447-0_20; Rieusset J, 2004, MOL ENDOCRINOL, V18, P2363, DOI 10.1210/me.2003-0325; Rubinek T, 2005, ENDOCRINE, V28, P209, DOI 10.1385/ENDO:28:2:209; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1; Serrano MP, 2012, SPAN J AGR RES, V11; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stevens A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-547; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutton P, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-76; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Widmann P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-798; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xiang P, 2010, EXP HEMATOL, V38, P798, DOI 10.1016/j.exphem.2010.06.006	85	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114862	10.1371/journal.pone.0114862	http://dx.doi.org/10.1371/journal.pone.0114862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503799	Green Published, gold			2022-12-26	WOS:000347146700061
J	Nishimata, H; Ohara-Nemoto, Y; Baba, TT; Hoshino, T; Fujiwara, T; Shimoyama, Y; Kimura, S; Nemoto, TK				Nishimata, Haruka; Ohara-Nemoto, Yuko; Baba, Tomomi T.; Hoshino, Tomonori; Fujiwara, Taku; Shimoyama, Yu; Kimura, Shigenobu; Nemoto, Takayuki K.			Identification of Dipeptidyl-Peptidase (DPP)5 and DPP7 in Porphyromonas endodontalis, Distinct from Those in Porphyromonas gingivalis	PLOS ONE			English	Article							ROOT-CANAL INFECTIONS; BACTEROIDES-ENDODONTALIS; PREVOTELLA-INTERMEDIA; ESCHERICHIA-COLI; GENOME SEQUENCE; STRAIN W83; BACTERIA; PURIFICATION; FIBROBLASTS; EXPRESSION	Dipeptidyl peptidases (DPPs) that liberate dipeptides from the N-terminal end of oligopeptides are crucial for the growth of Porphyromonas species, anaerobic asaccharolytic gram negative rods that utilize amino acids as energy sources. Porphyromonas endodontalis is a causative agent of periapical lesions with acute symptoms and Asp/Glu-specific DPP11 has been solely characterized in this organism. In this study, we identified and characterized two P. endodontalis DPPs, DPP5 and DPP7. Cell-associated DPP activity toward Lys-Ala-4-methylcoumaryl-7-amide (MCA) was prominent in P. endodontalis ATCC 35406 as compared with the Porphyromonas gingivalis strains ATCC 33277, 16-1, HW24D1, ATCC 49417, W83, W50, and HNA99. The level of hydrolysis of Leu-Asp-MCA by DPP11, GlyPro- MCA by DPP4, and Met-Leu-MCA was also higher than in the P. gingivalis strains. MER236725 and MER278904 are P. endodontalis proteins belong to the S9- and S46-family peptidases, respectively. Recombinant MER236725 exhibited enzymatic properties including substrate specificity, and salt-and pH-dependence similar to P. gingivalis DPP5 belonging to the S9 family. However, the k(cat)/K-m figure (194 mu M(-1)sec(-1)) for the most potent substrate (Lys-Ala-MCA) was 18.4-fold higher as compared to the P. gingivalis entity (10.5 mu M(-1)sec(-1)). In addition, P. endodontalis DPP5 mRNA and protein contents were increased several fold as compared with those in P. gingivalis. Recombinant MER278904 preferentially hydrolyzed Met-Leu-MCA and exhibited a substrate specificity similar to P. gingivalis DPP7 belonging to the S46 family. In accord with the deduced molecular mass of 818 amino acids, a 105-kDa band was immunologically detected, indicating that P. endodontalis DPP7 is an exceptionally large molecule in the DPP7/DPP11/S46 peptidase family. The enhancement of four DPP activities was conclusively demonstrated in P. endodontalis, and remarkable Lys-Ala-MCA-hydrolysis was achieved by qualitative and quantitative potentiation of the DPP5 molecule.	[Nishimata, Haruka; Ohara-Nemoto, Yuko; Baba, Tomomi T.; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Oral Mol Biol, Nagasaki 852, Japan; [Nishimata, Haruka; Hoshino, Tomonori; Fujiwara, Taku] Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Pediat Dent, Nagasaki 852, Japan; [Shimoyama, Yu; Kimura, Shigenobu] Iwate Med Univ, Div Mol Microbiol, Yahaba, Iwate, Japan	Nagasaki University; Nagasaki University; Iwate Medical University	Nemoto, TK (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Oral Mol Biol, Nagasaki 852, Japan.	tnemoto@nagasaki-u.ac.jp		Nemoto, Takayuki K./0000-0002-5007-6260	Japan Society for the Promotion of Science [25462894, 24592809, 24592775]; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Grants-in-Aid for Scientific Research [24592775] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research (C) (#25462894, YON), (C) (#24592809, TKN), (C) (#24592775, SK) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) and a grant of the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2013 (YON) (http://www.mdp.nagasaki-u.ac.jp/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1985, J DENT RES, V64, P106, DOI 10.1177/00220345850640020201; Baba TT, 2013, CELL BIOCHEM FUNCT, V31, P652, DOI 10.1002/cbf.2951; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; BARUA PK, 1989, INFECT IMMUN, V57, P2522, DOI 10.1128/IAI.57.8.2522-2528.1989; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Cao H, 2012, INT ENDOD J, V45, P773, DOI 10.1111/j.1365-2591.2012.02035.x; Carmona C, 1987, NUCLEIC ACIDS RES, V15, P607; Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Flynn TR, 2012, J ORAL MAXIL SURG, V70, P1854, DOI 10.1016/j.joms.2011.09.009; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Gomes BPFA, 2005, ORAL MICROBIOL IMMUN, V20, P211, DOI 10.1111/j.1399-302X.2005.00214.x; Gomes BPFA, 2004, ORAL MICROBIOL IMMUN, V19, P71, DOI 10.1046/j.0902-0055.2003.00116.x; GRENIER D, 1994, MICROBIOL-SGM, V140, P873, DOI 10.1099/00221287-140-4-873; Hirai H, 1988, JPN J CONSERV DENT, V31, P616; Ho YC, 2007, J ENDODONT, V33, P437, DOI 10.1016/j.joen.2006.12.022; Kon A, 2002, DENT J IWATE MED U, V27, P187; Kurita-Ochiai T, 2008, J DENT RES, V87, P51, DOI 10.1177/154405910808700108; MURPHY RA, 1974, CAN J MICROBIOL, V20, P1061, DOI 10.1139/m74-164; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ohara-Nemoto Y, 2002, MICROB PATHOGENESIS, V33, P33, DOI 10.1006/mpat.2002.0515; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Ono T, 2008, ANAL BIOCHEM, V381, P74, DOI 10.1016/j.ab.2008.06.022; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rocas IN, 2011, J ENDODONT, V37, P1206, DOI 10.1016/j.joen.2011.05.026; Rosen G, 2001, ORAL MICROBIOL IMMUN, V16, P326, DOI 10.1034/j.1399-302X.2001.160602.x; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sebastian Y, 2013, SHOTGUN ASSEMBLY SEQ; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; SINGER RE, 1981, INFECT IMMUN, V32, P458, DOI 10.1128/IAI.32.2.458-463.1981; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; SUNDQVIST G, 1989, J ENDODONT, V15, P13, DOI 10.1016/S0099-2399(89)80092-5; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; VANSTEENBERGEN TJM, 1984, INT J SYST BACTERIOL, V34, P118, DOI 10.1099/00207713-34-2-118; VANWINKELHOFF AJ, 1985, J CLIN MICROBIOL, V22, P75, DOI 10.1128/JCM.22.1.75-79.1985; Vermout S, 2008, FEMS IMMUNOL MED MIC, V54, P299, DOI 10.1111/j.1574-695X.2008.00479.x; Yabuta M, 1995, APPL MICROBIOL BIOT, V44, P118	43	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114221	10.1371/journal.pone.0114221	http://dx.doi.org/10.1371/journal.pone.0114221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494328	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400037
J	Weng, YH; Yang, CY; Chiu, YW				Weng, Yi-Hao; Yang, Chun-Yuh; Chiu, Ya-Wen			Risk Assessment of Adverse Birth Outcomes in Relation to Maternal Age	PLOS ONE			English	Article							INTRAPARTUM STILLBIRTH; CESAREAN-SECTION; WEIGHT INFANTS; UNITED-STATES; POPULATION; ASSOCIATION; PREGNANCY; IMPACT; CHILDBEARING; ANTEPARTUM	Background: Although a number of studies have investigated correlations of maternal age with birth outcomes, an extensive assessment using age as a continuous variable is lacking. In the current study, we estimated age-specific risks of adverse birth outcomes in childbearing women. Method: National population-based data containing maternal and neonatal information were derived from the Health Promotion Administration, Taiwan. A composite adverse birth outcome was defined as at least anyone of stillbirth, preterm birth, low birth weight, macrosomia, neonatal death, congenital anomaly, and small for gestational age (SGA). Singletons were further analyzed for outcomes of live birth in relation to each year of maternal age. A log-binomial model was used to adjust for possible confounders of maternal and neonatal factors. Results: In total, 2,123,751 births between 2001 and 2010 were utilized in the analysis. The risk of a composite adverse birth outcome was significantly higher at extreme maternal ages. In specific, risks of stillbirth, neonatal death, preterm birth, congenital anomaly, and low birth weight were higher at the extremes of maternal age. Furthermore, risk of macrosomia rose proportionally with an increasing maternal age. In contrast, risk of SGA declined proportionally with an increasing maternal age. The log-binomial model showed greater risks at the maternal ages of <26 and > 30 years for a composite adverse birth outcome. Conclusions: Infants born to teenagers and women at advanced age possess greater risks for stillbirth, preterm birth, neonatal death, congenital anomaly, and low birth weight. Pregnancies at advanced age carry an additional risk for macrosomia, while teenage pregnancies carry an additional risk for SGA. The data suggest that the optimal maternal ages to minimize adverse birth outcomes are 26 similar to 30 years.	[Weng, Yi-Hao] Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Dept Pediat, Div Neonatol, Taipei, Taiwan; [Yang, Chun-Yuh] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Chiu, Ya-Wen] Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan; [Chiu, Ya-Wen] Taipei Med Univ, Hlth Policy & Care Res Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University	Chiu, YW (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan.	bettychiu@tmu.edu.tw			Taipei Medical University [TMU101-AE1-B68]; National Health Research Institutes [PH-101-PP-20]; National Science Council [NSC 102-2511-S-038-005]; Chang Gung Memorial Hospital [CMRPG1B0131]	Taipei Medical University; National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by research grants from Taipei Medical University (TMU101-AE1-B68), the National Health Research Institutes (PH-101-PP-20), National Science Council (NSC 102-2511-S-038-005), and Chang Gung Memorial Hospital (CMRPG1B0131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Joao Guilherme Bezerra, 2012, BMC Res Notes, V5, P531, DOI 10.1186/1756-0500-5-531; Arad I, 2001, EUR J OBSTET GYN R B, V94, P283, DOI 10.1016/S0301-2115(00)00308-0; Bae Jisuk, 2011, J Prev Med Public Health, V44, P111, DOI 10.3961/jpmph.2011.44.3.111; Bakker R, 2011, BJOG-INT J OBSTET GY, V118, P500, DOI 10.1111/j.1471-0528.2010.02823.x; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Buescher Paul A, 2006, N C Med J, V67, P16; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Goonewardene I. M. R., 2005, Ceylon Medical Journal, V50, P116; Gordon A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-12; Gortzak-Uzan L, 2001, J Matern Fetal Med, V10, P393; Gu SY, 2012, J BIOMED RES, V26, P235, DOI 10.7555/JBR.26.20120037; Hayward CE, 2012, AM J PHYSIOL-ENDOC M, V302, pE233, DOI 10.1152/ajpendo.00192.2011; da Silva CH, 2013, MATERN CHILD HLTH J, V17, P539, DOI 10.1007/s10995-012-1030-y; Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Hwang BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033949; Lin CM, 2004, J FORMOS MED ASSOC, V103, P297; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Machado CJ, 2006, J BIOSOC SCI, V38, P523, DOI 10.1017/S0021932005026660; Mousiolis A, 2013, J OBSTET GYNAECOL, V33, P28, DOI 10.3109/01443615.2012.730078; Muganyizi PS, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-30; NAEYE RL, 1983, OBSTET GYNECOL, V61, P210; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Phipps MG, 2002, AM J PUBLIC HEALTH, V92, P125, DOI 10.2105/AJPH.92.1.125; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Reichman NE, 1997, FAM PLANN PERSPECT, V29, P268, DOI 10.2307/2953415; Roy K. K., 2006, Indian Journal of Pediatrics, V73, P669, DOI 10.1007/BF02898441; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Schempf AH, 2007, PAEDIATR PERINAT EP, V21, P34, DOI 10.1111/j.1365-3016.2007.00785.x; Sugiura-Ogasawara M, 2009, AM J REPROD IMMUNOL, V62, P314, DOI 10.1111/j.1600-0897.2009.00741.x; Takimoto H, 2005, J OBSTET GYNAECOL RE, V31, P314, DOI 10.1111/j.1447-0756.2005.00294.x; Tough SC, 2002, PEDIATRICS, V109, P399, DOI 10.1542/peds.109.3.399; Vieira CL, 2012, J PEDIATR ADOL GYNEC, V25, P185, DOI 10.1016/j.jpag.2011.12.070; Wang Y, 2011, ARCH GYNECOL OBSTET, V284, P31, DOI 10.1007/s00404-010-1587-x; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Yadav Siddhartha, 2008, Mcgill J Med, V11, P141	44	71	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114843	10.1371/journal.pone.0114843	http://dx.doi.org/10.1371/journal.pone.0114843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494176	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400078
J	Fernandez, J; Portilho, DM; Danckaert, A; Munier, S; Becker, A; Roux, P; Zambo, A; Shorte, S; Jacob, Y; Vidalain, PO; Charneau, P; Clavel, F; Arhel, NJ				Fernandez, Juliette; Portilho, Debora M.; Danckaert, Anne; Munier, Sandie; Becker, Andreas; Roux, Pascal; Zambo, Anaba; Shorte, Spencer; Jacob, Yves; Vidalain, Pierre-Olivier; Charneau, Pierre; Clavel, Francois; Arhel, Nathalie J.			Microtubule-associated Proteins 1 (MAP1) Promote Human Immunodeficiency Virus Type I (HIV-1) Intracytoplasmic Routing to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIM5-ALPHA RESTRICTION FACTOR; REVERSE TRANSCRIPTION; DNA FLAP; PREINTEGRATION COMPLEX; DYNEIN LIGHT-CHAIN-8; NONDIVIDING CELLS; INFECTION; CYTOSKELETON; REPLICATION; IMPORT	After cell entry, HIV undergoes rapid transport toward the nucleus using microtubules and microfilaments. Neither the cellular cytoplasmic components nor the viral proteins that interact to mediate transport have yet been identified. Using a yeast two-hybrid screen, we identified four cytoskeletal components as putative interaction partners for HIV-1 p24 capsid protein: MAP1A, MAP1S, CKAP1, and WIRE. Depletion of MAP1A/MAP1S in indicator cell lines and primary human macrophages led to a profound reduction in HIV-1 infectivity as a result of impaired retrograde trafficking, demonstrated by a characteristic accumulation of capsids away from the nuclear membrane, and an overall defect in nuclear import. MAP1A/MAP1S did not impact microtubule network integrity or cell morphology but contributed to microtubule stabilization, which was shown previously to facilitate infection. In addition, we found that MAP1 proteins interact with HIV-1 cores both in vitro and in infected cells and that interaction involves MAP1 light chain LC2. Depletion of MAP1 proteins reduced the association of HIV-1 capsids with both dynamic and stable microtubules, suggesting that MAP1 proteins help tether incoming viral capsids to the microtubular network, thus promoting cytoplasmic trafficking. This work shows for the first time that following entry into target cells, HIV-1 interacts with the cytoskeleton via its p24 capsid protein. Moreover, our results support a role for MAP1 proteins in promoting efficient retrograde trafficking of HIV-1 by stimulating the formation of stable microtubules and mediating the association of HIV-1 cores with microtubules.	[Fernandez, Juliette; Portilho, Debora M.; Becker, Andreas; Zambo, Anaba; Clavel, Francois; Arhel, Nathalie J.] Hop St Louis, INSERM, U941, IUH, F-75010 Paris, France; [Danckaert, Anne; Roux, Pascal; Shorte, Spencer] Inst Pasteur, F-75015 Paris, France; [Munier, Sandie; Jacob, Yves] Univ Paris Diderot, Dept Virol, Unite Genet Mol Virus ARN, CNRS,UMR3569, F-75015 Paris, France; [Vidalain, Pierre-Olivier] Inst Pasteur, CNRS, UMR3569, Unite Genom Virale & Vaccinat, F-75015 Paris, France; [Charneau, Pierre] Inst Pasteur, Unite Virol Mol & Vaccinol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arhel, NJ (corresponding author), Hop St Louis, INSERM, U941, IUH, 1 Ave Claude Vellefaux, F-75010 Paris, France.	nathalie.arhel@inserm.fr	Vidalain, Pierre-Olivier/F-9778-2019; CHARNEAU, Pierre/M-1565-2017; fernandez, juliette/D-4600-2016; Munier, Sandie/F-6826-2016	Vidalain, Pierre-Olivier/0000-0003-3082-7407; CHARNEAU, Pierre/0000-0003-1184-5773; fernandez, juliette/0000-0003-2969-8150; Munier, Sandie/0000-0001-7819-128X; Arhel, Nathalie/0000-0001-5309-1725; Jacob, Yves/0000-0001-9125-2374; Shorte, Spencer/0000-0002-2125-8663				Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Atherton J, 2013, BIOL CELL, V105, P465, DOI 10.1111/boc.201300012; BARBOSA P, 1994, AIDS RES HUM RETROV, V10, P53, DOI 10.1089/aid.1994.10.53; Black LR, 2010, J VIROL, V84, P6564, DOI 10.1128/JVI.00210-10; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gallo DE, 2012, VIROLOGY, V422, P13, DOI 10.1016/j.virol.2011.09.015; Gaudin R, 2013, TRENDS CELL BIOL, V23, P652, DOI 10.1016/j.tcb.2013.09.004; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Iglesias C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-92; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shah VB, 2011, JOVE-J VIS EXP, DOI 10.3791/3384; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Zamborlini A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-63; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	51	54	56	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4631	4646		10.1074/jbc.M114.613133	http://dx.doi.org/10.1074/jbc.M114.613133			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25505242	hybrid, Green Published			2022-12-26	WOS:000350042000009
J	Hayashi, Y; Ishii, S; Urakubo, H				Hayashi, Yuichiro; Ishii, Shin; Urakubo, Hidetoshi			A Computational Model of Afterimage Rotation in the Peripheral Drift Illusion Based on Retinal ON/OFF Responses	PLOS ONE			English	Article							MOTION ILLUSION; ILLUSORY MOTION; LIGHT ADAPTATION; VISUAL-SYSTEM; LUMINANCE; TIME; THRESHOLDS; DECREMENTS; INCREMENTS; PERCEPTION	Human observers perceive illusory rotations after the disappearance of circularly repeating patches containing dark-to-light luminance. This afterimage rotation is a very powerful phenomenon, but little is known about the mechanisms underlying it. Here, we use a computational model to show that the afterimage rotation can be explained by a combination of fast light adaptation and the physiological architecture of the early visual system, consisting of ON-and OFF-type visual pathways. In this retinal ON/OFF model, the afterimage rotation appeared as a rotation of focus lines of retinal ON/OFF responses. Focus lines rotated clockwise on a light background, but counterclockwise on a dark background. These findings were consistent with the results of psychophysical experiments, which were also performed by us. Additionally, the velocity of the afterimage rotation was comparable with that observed in our psychophysical experiments. These results suggest that the early visual system (including the retina) is responsible for the generation of the afterimage rotation, and that this illusory rotation may be systematically misinterpreted by our high-level visual system.	[Hayashi, Yuichiro; Ishii, Shin; Urakubo, Hidetoshi] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishii, S (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Yoshida Honmachi 36-1, Kyoto 6068501, Japan.	ishii@i.kyoto-u.ac.jp; urakubo-h@sys.i.kyoto-u.ac.jp		Ishii, Shin/0000-0001-9385-8230; Urakubo, Hidetoshi/0000-0002-1816-0040	JSPS KAKENHI [26540154]; Strategic Research Program for Brain Sciences (SRPBS) from the MEXT of Japan; Platform for Dynamic Approaches to Living System from the MEXT of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences (SRPBS) from the MEXT of Japan; Platform for Dynamic Approaches to Living System from the MEXT of Japan	This work was supported by JSPS KAKENHI, No. 26540154; the Strategic Research Program for Brain Sciences (SRPBS) and the Platform for Dynamic Approaches to Living System, both from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2005, J VISION, V5, P1055, DOI 10.1167/5.11.10; Beer AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002741; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BURR DC, 1993, J OPT SOC AM A, V10, P1706, DOI 10.1364/JOSAA.10.001706; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; Egashira A, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON NETWORKING AND COMPUTING (ICNC 2012), P130, DOI 10.1109/ICNC.2012.27; EHRENSTEIN WH, 1983, J OPT SOC AM, V73, P419, DOI 10.1364/JOSA.73.000419; Faubert J, 1999, PERCEPTION, V28, P617, DOI 10.1068/p2825; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; GRAHAM N, 1992, VISION RES, V32, P1373, DOI 10.1016/0042-6989(92)90230-G; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; Hisakata R, 2008, VISION RES, V48, P1940, DOI 10.1016/j.visres.2008.06.015; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Hsieh P, 2006, VISION RES, V46, P970, DOI 10.1016/j.visres.2005.10.009; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Kitaoka A, 2007, PERCEPTION, V36, P1019, DOI 10.1068/p5362; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Kuriki I, 2008, J VIS, V8, P1; Lu ZL, 1996, VISION RES, V36, P559, DOI 10.1016/0042-6989(95)00139-5; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; MATHER G, 1991, VISION RES, V31, P1013, DOI 10.1016/0042-6989(91)90206-K; Murakami I, 2006, VISION RES, V46, P2421, DOI 10.1016/j.visres.2006.01.030; Naor-Raz G, 2000, PERCEPTION, V29, P325; Otero-Millan J, 2012, J NEUROSCI, V32, P6043, DOI 10.1523/JNEUROSCI.5823-11.2012; Pessoa L, 1998, TRENDS COGN SCI, V2, P422, DOI 10.1016/S1364-6613(98)01237-6; Petrov YA, 2002, J OPT SOC AM A, V19, P1107, DOI 10.1364/JOSAA.19.001107; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Poot L, 1997, J OPT SOC AM A, V14, P2499, DOI 10.1364/JOSAA.14.002499; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Snippe HP, 2000, VISUAL NEUROSCI, V17, P449, DOI 10.1017/S0952523800173110; Tomimatsu E, 2011, ATTEN PERCEPT PSYCHO, V73, P1823, DOI 10.3758/s13414-011-0131-9; Westheimer G, 2007, PROG RETIN EYE RES, V26, P636, DOI 10.1016/j.preteyeres.2007.07.003; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098	35	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115464	10.1371/journal.pone.0115464	http://dx.doi.org/10.1371/journal.pone.0115464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517906	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600068
J	Abed, RMM; Al-Kharusi, S; Prigent, S; Headley, T				Abed, Raeid M. M.; Al-Kharusi, Samiha; Prigent, Stephane; Headley, Tom			Diversity, Distribution and Hydrocarbon Biodegradation Capabilities of Microbial Communities in Oil-Contaminated Cyanobacterial Mats from a Constructed Wetland	PLOS ONE			English	Article							AEROBIC HETEROTROPHIC BACTERIA; RNA GENE DATABASE; NITROGEN-FIXATION; MARINE SEDIMENT; CRUDE-OIL; WATER; SULFATE; MICROORGANISMS; DEGRADATION; MICROALGAE	Various types of cyanobacterial mats were predominant in a wetland, constructed for the remediation of oil-polluted residual waters from an oil field in the desert of the south-eastern Arabian Peninsula, although such mats were rarely found in other wetland systems. There is scarce information on the bacterial diversity, spatial distribution and oil-biodegradation capabilities of freshwater wetland oil-polluted mats. Microbial community analysis by Automated Ribosomal Spacer Analysis (ARISA) showed that the different mats hosted distinct microbial communities. Average numbers of operational taxonomic units (OTUs(ARISA)) were relatively lower in the mats with higher oil levels and the number of shared OTUs(ARISA) between the mats was,60% in most cases. Multivariate analyses of fingerprinting profiles indicated that the bacterial communities in the wetland mats were influenced by oil and ammonia levels, but to a lesser extent by plant density. In addition to oil and ammonia, redundancy analysis (RDA) showed also a significant contribution of temperature, dissolved oxygen and sulfate concentration to the variations of the mats' microbial communities. Pyrosequencing yielded 282,706 reads with >90% of the sequences affiliated to Proteobacteria (41% of total sequences), Cyanobacteria (31%), Bacteriodetes (11.5%), Planctomycetes (7%) and Chloroflexi (3%). Known autotrophic (e.g. Rivularia) and heterotrophic (e. g. Azospira) nitrogen-fixing bacteria as well as purple sulfur and non-sulfur bacteria were frequently encountered in all mats. On the other hand, sequences of known sulfate-reducing bacteria (SRBs) were rarely found, indicating that SRBs in the wetland mats probably belong to yet-undescribed novel species. The wetland mats were able to degrade 53-100% of C-12-C-30 alkanes after 6 weeks of incubation under aerobic conditions. We conclude that oil and ammonia concentrations are the major key players in determining the spatial distribution of the wetland mats' microbial communities and that these mats contribute directly to the removal of hydrocarbons from oil field wastewaters.	[Abed, Raeid M. M.; Al-Kharusi, Samiha] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud 123, Oman; [Prigent, Stephane; Headley, Tom] BAUER Resources, Constructed Wetland Competence Ctr, Muscat, Oman	Sultan Qaboos University	Abed, RMM (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Biol, POB 36, Al Khoud 123, Oman.	rabed@mpi-bremen.de			Research Council (TRC) of Oman [RC/SCI/BIOL/11/01]	Research Council (TRC) of Oman	The Research Council (TRC) of Oman (grant No. RC/SCI/BIOL/11/01) https://home.trc.gov.om/tabid/40/language/en-US/Default.aspx.	Abed RMM, 2010, INT BIODETER BIODEGR, V64, P58, DOI 10.1016/j.ibiod.2009.10.008; Abed Raeid M. M., 2009, Algological Studies, V130, P69, DOI 10.1127/1864-1318/2009/0130-0069; Abed RMM, 2005, INT BIODETER BIODEGR, V55, P29, DOI 10.1016/j.ibiod.2004.07.001; Abed RMM, 2002, APPL ENVIRON MICROB, V68, P1674, DOI 10.1128/AEM.68.4.1674-1683.2002; Acosta-Gonzalez A, 2013, ENVIRON MICROBIOL, V15, P77, DOI 10.1111/j.1462-2920.2012.02782.x; Al-Awadhi H, 2007, APPL MICROBIOL BIOT, V77, P183, DOI 10.1007/s00253-007-1127-1; Alley BL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1639-5; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Balasooriya WK, 2008, HYDROL EARTH SYST SC, V12, P277, DOI 10.5194/hess-12-277-2008; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; BATTERTON JC, 1978, MAR ENVIRON RES, V1, P31, DOI 10.1016/0141-1136(78)90011-9; Baudisova D, 2009, PLANT SOIL ENVIRON, V55, P429, DOI 10.17221/131/2009-PSE; Berrendero E, 2008, INT J SYST EVOL MICR, V58, P447, DOI 10.1099/ijs.0.65273-0; Bottos EM, 2008, ENVIRON MICROBIOL, V10, P950, DOI 10.1111/j.1462-2920.2007.01516.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cerna B, 2009, HYDROBIOLOGIA, V627, P55, DOI 10.1007/s10750-009-9715-y; Chaillan F, 2006, CHEMOSPHERE, V62, P1574, DOI 10.1016/j.chemosphere.2005.06.050; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edlund A, 2006, APPL ENVIRON MICROB, V72, P6800, DOI 10.1128/AEM.00971-06; Ferro Dal, 2007, GLOBAL ONSHORE OFFSH; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; HEIJTHUIJSEN JHFG, 1986, FEMS MICROBIOL ECOL, V38, P57, DOI 10.1016/0378-1097(86)90042-X; Hopner T., 1996, MARINE WILDLIFE SANC, P85; Jackson CR, 2009, MICROB ECOL, V57, P402, DOI 10.1007/s00248-008-9409-4; Ji GD, 2002, ECOL ENG, V18, P459, DOI 10.1016/S0925-8574(01)00106-9; Kadlec R.H., 1996, TREATMENT WETLANDS; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI DOI 10.1201/9781420012514; Kleikemper J, 2002, APPL ENVIRON MICROB, V68, P1516, DOI 10.1128/AEM.68.4.1516-1523.2002; Knight R.L., 1992, CONSTRUCTED WETLANDS, P35; Komárek Jiøi, 2007, Hoehnea, V34, P49; Kraigher B, 2006, SOIL BIOL BIOCHEM, V38, P2762, DOI 10.1016/j.soilbio.2006.04.031; Lamers LPM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00156; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loy A, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P127, DOI 10.1007/978-90-481-9204-5_6; Megharaj M, 2000, ARCH ENVIRON CON TOX, V38, P439, DOI 10.1007/s002449910058; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Murray-Gulde C, 2003, WATER RES, V37, P705, DOI 10.1016/S0043-1354(02)00353-6; Musat F, 2004, OPHELIA, V58, P217, DOI 10.1080/00785236.2004.10410229; Musat F, 2006, ENVIRON MICROBIOL, V8, P1834, DOI 10.1111/j.1462-2920.2006.01069.x; O'BRIEN P Y, 1976, British Phycological Journal, V11, P115; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pagano M. C., 2013, British Journal of Environment and Climate Change, V3, P188; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radwan SS, 2000, ECOLOGY CYANOBACTERI, P307, DOI DOI 10.1007/0-306-46855-7_11; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rejmankova E, 2000, HYDROBIOLOGIA, V431, P135, DOI 10.1023/A:1004011318643; Rejmankova E, 2004, BIOGEOCHEMISTRY, V67, P353, DOI 10.1023/B:BIOG.0000015790.28584.ed; Rejmankova E, 2005, AQUAT BOT, V83, P87, DOI 10.1016/j.aquabot.2005.05.011; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Scott JT, 2007, BIOGEOCHEMISTRY, V84, P207, DOI 10.1007/s10533-007-9119-x; Sheppard PJ, 2012, J MICROBIOL BIOTECHN, V22, P1185, DOI 10.4014/jmb.1201.01049; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Shpiner R, 2009, WATER RES, V43, P4258, DOI 10.1016/j.watres.2009.06.004; SORKHOH N, 1992, NATURE, V359, P109, DOI 10.1038/359109a0; Stikker A, 1998, FUTURES, V30, P43, DOI 10.1016/S0016-3287(98)00005-6; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; van de Meene AML, 2007, J BACTERIOL, V189, P4196, DOI 10.1128/JB.01711-06; VANDERMEULEN J H, 1976, P107; Venables WN., 2002, MODERN APPL STAT S 4; Venieraki A, 2011, MICROB ECOL, V61, P277, DOI 10.1007/s00248-010-9747-x; Verhoeven JTA, 1999, ECOL ENG, V12, P5, DOI 10.1016/S0925-8574(98)00050-0; Wang S, 2012, WORLD J MICROB BIOT, V28, P493, DOI 10.1007/s11274-011-0840-1; White JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-152; Whitmire SL, 2005, J ENVIRON QUAL, V34, P2062, DOI 10.2134/jeq2004.0483; Widdel F, 1992, PROKARYOTES, P3353; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/w11-004, 10.1139/W11-004]; Winters K, 1977, POLLUTANT EFFECTS MA, P167	76	35	35	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114570	10.1371/journal.pone.0114570	http://dx.doi.org/10.1371/journal.pone.0114570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514025	Green Published, gold			2022-12-26	WOS:000349146300016
J	Skorheim, S; Razak, K; Bazhenov, M				Skorheim, Steven; Razak, Khaleel; Bazhenov, Maxim			Network Models of Frequency Modulated Sweep Detection	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; MECHANISMS UNDERLYING SELECTIVITY; BAT INFERIOR COLLICULUS; ECHO-LOCATING BATS; PALLID BAT; NEURAL MECHANISMS; SOUND DURATION; DIRECTION SELECTIVITY; COMPUTATIONAL MODELS; RESPONSE PROPERTIES	Frequency modulated (FM) sweeps are common in species-specific vocalizations, including human speech. Auditory neurons selective for the direction and rate of frequency change in FM sweeps are present across species, but the synaptic mechanisms underlying such selectivity are only beginning to be understood. Even less is known about mechanisms of experience-dependent changes in FM sweep selectivity. We present three network models of synaptic mechanisms of FM sweep direction and rate selectivity that explains experimental data: (1) The 'facilitation' model contains frequency selective cells operating as coincidence detectors, summing up multiple excitatory inputs with different time delays. (2) The 'duration tuned' model depends on interactions between delayed excitation and early inhibition. The strength of delayed excitation determines the preferred duration. Inhibitory rebound can reinforce the delayed excitation. (3) The 'inhibitory sideband' model uses frequency selective inputs to a network of excitatory and inhibitory cells. The strength and asymmetry of these connections results in neurons responsive to sweeps in a single direction of sufficient sweep rate. Variations of these properties, can explain the diversity of rate-dependent direction selectivity seen across species. We show that the inhibitory sideband model can be trained using spike timing dependent plasticity (STDP) to develop direction selectivity from a non-selective network. These models provide a means to compare the proposed synaptic and spectrotemporal mechanisms of FM sweep processing and can be utilized to explore cellular mechanisms underlying experience-or training-dependent changes in spectrotemporal processing across animal models. Given the analogy between FM sweeps and visual motion, these models can serve a broader function in studying stimulus movement across sensory epithelia.	[Skorheim, Steven; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Razak, Khaleel] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu			Direct For Biological Sciences [1252769] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Aubie B, 2009, J NEUROSCI, V29, P9255, DOI 10.1523/JNEUROSCI.1085-09.2009; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 1998, J NEUROSCI, V18, P6444; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Borisyuk A, 2002, J NEUROPHYSIOL, V88, P2134, DOI 10.1152/jn.2002.88.4.2134; Borisyuk A, 2001, NEUROCOMPUTING, V38, P1127, DOI 10.1016/S0925-2312(01)00475-1; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Buss E, 2004, EAR HEARING, V25, P242, DOI 10.1097/01.AUD.0000130796.73809.09; Casseday JH, 2000, J NEUROPHYSIOL, V84, P1475, DOI 10.1152/jn.2000.84.3.1475; Chen JY, 2013, J NEUROSCI, V33, P15915, DOI 10.1523/JNEUROSCI.5088-12.2013; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Ehrlich D, 1997, J NEUROPHYSIOL, V77, P2360, DOI 10.1152/jn.1997.77.5.2360; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fuzessery ZM, 1999, HEARING RES, V137, P137, DOI 10.1016/S0378-5955(99)00133-1; FUZESSERY ZM, 1994, J NEUROPHYSIOL, V72, P1061, DOI 10.1152/jn.1994.72.3.1061; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Fuzessery ZM, 2011, J COMP PHYSIOL A, V197, P615, DOI 10.1007/s00359-010-0554-0; Gittelman JX, 2009, J NEUROSCI, V29, P13030, DOI 10.1523/JNEUROSCI.2477-09.2009; Gordon M, 1998, HEARING RES, V122, P97, DOI 10.1016/S0378-5955(98)00087-2; HEIL P, 1992, HEARING RES, V63, P135, DOI 10.1016/0378-5955(92)90081-W; Hopkins K, 2011, J ACOUST SOC AM, V130, P334, DOI 10.1121/1.3585848; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; LANDFIELD PW, 1977, J GERONTOL, V32, P523, DOI 10.1093/geronj/32.5.523; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; LINDBLOM BE, 1967, J ACOUST SOC AM, V42, P830, DOI 10.1121/1.1910655; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; ORBAN GA, 1985, J NEUROPHYSIOL, V54, P1026, DOI 10.1152/jn.1985.54.4.1026; Razak KA, 2005, J NEUROPHYSIOL, V94, P3573, DOI 10.1152/jn.00816.2004; Razak KA, 2008, J NEUROSCI, V28, P9806, DOI 10.1523/JNEUROSCI.1293-08.2008; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Razak KA, 2007, J NEUROSCI, V27, P1769, DOI 10.1523/JNEUROSCI.3851-06.2007; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Razak KA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00129; Razak KA, 2009, J NEUROPHYSIOL, V102, P1366, DOI 10.1152/jn.00334.2009; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Sadagopan S, 2010, J NEUROSCI, V30, P7314, DOI 10.1523/JNEUROSCI.5072-09.2010; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sanchez JT, 2008, J NEUROSCI, V28, P80, DOI 10.1523/JNEUROSCI.3572-07.2008; Schauer C, 2000, ACOUSTICS SPEECH SIG, P11865; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Stickney GS, 2005, J ACOUST SOC AM, V118, P2412, DOI 10.1121/1.2031967; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; SUGA N, 1965, J PHYSIOL-LONDON, V179, P26, DOI 10.1113/jphysiol.1965.sp007648; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; Trujillo M, 2013, HEARING RES, V298, P80, DOI 10.1016/j.heares.2012.12.013; Trujillo M, 2011, J NEUROPHYSIOL, V106, P2825, DOI 10.1152/jn.00480.2011; Van Hooser SD, 2014, J NEUROPHYSIOL, V111, P2355, DOI 10.1152/jn.00891.2013; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; WHITFIEL.IC, 1965, J NEUROPHYSIOL, V28, P655, DOI 10.1152/jn.1965.28.4.655; Williams AJ, 2010, J NEUROPHYSIOL, V104, P1456, DOI 10.1152/jn.00598.2009; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	68	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115196	10.1371/journal.pone.0115196	http://dx.doi.org/10.1371/journal.pone.0115196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514021	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300040
J	von Lindern, E; Mosler, HJ				von Lindern, Eike; Mosler, Hans-Joachim			Insights into Fisheries Management Practices: Using the Theory of Planned Behavior to Explain Fish Stocking among a Sample of Swiss Anglers	PLOS ONE			English	Article							PAST BEHAVIOR; MISSING DATA; ENHANCEMENT; CONSERVATION; SUSTAINABILITY; ORIENTATION; RESOURCES; EMPHASIS; HABITAT; ENGLAND	Using inadequate management tools often threatens the natural environment. This study focuses on the example of Swiss recreational fishermen (hereafter called "anglers") as recreational fisheries management stakeholders. In recreational fisheries, fish stocking conducted by anglers has been identified as one important factor associated with declining fish catches. We therefore aimed to a) gain insights into why anglers want to maintain fish stocking and b) identify entry points for interventions to promote more pro-ecological management practices. Results (N=349) showed that the majority of anglers think very uncritically about stocking and that they frequently engage in it. We conclude that outcome expectancies and beliefs about risks, in combination with a lack of stocking success controls are the main reasons that anglers retain stocking measures. We suggest that providing anglers with direct experience and feedback about stocking success is suitable to change their intentions regarding stocking and their actual stocking behavior, and thus, to promote more pro-ecological management methods. From a more general perspective, the results of this study are likely to help improve pro-ecological ecosystem management in other domains where problems similar to those in recreational fisheries management might exist.	[von Lindern, Eike; Mosler, Hans-Joachim] Eawag, Environm & Hlth Psychol, Dubendorf, Switzerland		von Lindern, E (corresponding author), Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden.	eike.von_lindern@ibf.uu.se		von Lindern, Eike/0000-0003-3729-8042	Swiss Federal Office for the Environment (FOEN); EAWAG, the Swiss Federal Institute of Aquatic Science and Technology	Swiss Federal Office for the Environment (FOEN); EAWAG, the Swiss Federal Institute of Aquatic Science and Technology	The project was funded by the Swiss Federal Office for the Environment (FOEN) and EAWAG, the Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2011, HUM ECOL REV, V18, P30; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Arlinghaus R, 2005, LIMNOLOGICA, V35, P2, DOI 10.1016/j.limno.2004.10.001; Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Arlinghaus R, 2002, FISH FISH, V3, P261, DOI 10.1046/j.1467-2979.2002.00102.x; Asparouhov T, 2010, MULTIPLE IMPUTATION; Baer J., 2007, GUTE FACHLICHE PRAXI; Bamberg S, 2003, BASIC APPL SOC PSYCH, V25, P175, DOI 10.1207/S15324834BASP2503_01; Burkhardt-Holm P, 2005, ENVIRON SCI TECHNOL, V39, p441A, DOI 10.1021/es053375z; Chao YL, 2011, ENVIRON BEHAV, V43, P53, DOI 10.1177/0013916509350849; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Corral-Verdugo V, 2009, J ENVIRON PSYCHOL, V29, P34, DOI 10.1016/j.jenvp.2008.09.001; Cowx IG, 2004, FISHERIES MANAG ECOL, V11, P145, DOI 10.1111/j.1365-2400.2004.00411.x; Cowx IG, 1999, FISHERIES MANAG ECOL, V6, P21, DOI 10.1046/j.1365-2400.1999.00139.x; Daedlow K, 2011, ANGLER ENV SOCIAL EC, P12; Fielding KS, 2008, J ENVIRON PSYCHOL, V28, P318, DOI 10.1016/j.jenvp.2008.03.003; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Geiser C., 2010, DATENANLYSE MPLUS AN; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Hendry K, 2003, FISH RES, V62, P171, DOI 10.1016/S0165-7836(02)00161-3; Hewlett NR, 2009, FISHERIES MANAG ECOL, V16, P248, DOI 10.1111/j.1365-2400.2009.00671.x; Holzer G, 2003, FISCHEREILICHE BEWIR; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson JR, 2004, AM FISH S S, V44, P121; Jager W, 2007, J SOC ISSUES, V63, P97, DOI 10.1111/j.1540-4560.2007.00498.x; Kaiser FG, 2003, J APPL SOC PSYCHOL, V33, P586, DOI 10.1111/j.1559-1816.2003.tb01914.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lorenzen K, 2008, REV FISH SCI, V16, P10, DOI 10.1080/10641260701790291; Ludtke O, 2007, PSYCHOL RUNDSCH, V58, P103, DOI 10.1026/0033-3042.58.2.103; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; Molony BW, 2003, REV FISH BIOL FISHER, V13, P409, DOI 10.1007/s11160-004-1886-z; Muthen L.K., 2010, MPLUS USERS GUIDE; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Pouta E, 2001, SOC NATUR RESOUR, V14, P93, DOI 10.1080/089419201300000517; Rhodes RE, 2005, PREV MED, V40, P547, DOI 10.1016/j.ypmed.2004.07.016; Rogers MW, 2010, ECOL MODEL, V221, P919, DOI 10.1016/j.ecolmodel.2009.12.016; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schwarzel-Klingenstein J, 1999, ANG SCHW; Smith CL, 1997, FISHERIES, V22, P8, DOI 10.1577/1548-8446(1997)022&lt;0008:CVOCRA&gt;2.0.CO;2; Swiss Federal Office for the Environment FOEN, 2006, FISCHB; van Poorten BT, 2011, P NATL ACAD SCI USA, V108, P12554, DOI 10.1073/pnas.1013919108; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Wahli T, 2002, J FISH DIS, V25, P491, DOI 10.1046/j.1365-2761.2002.00401.x; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Welcomme R. L., 1998, Fisheries Management and Ecology, V5, P351, DOI 10.1046/j.1365-2400.1998.550351.x	48	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115360	10.1371/journal.pone.0115360	http://dx.doi.org/10.1371/journal.pone.0115360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514798	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300054
J	Grewal, N; Thornton, GM; Behzad, H; Sharma, A; Lu, A; Zhang, P; Reid, WD; Granville, DJ; Scott, A				Grewal, Navdeep; Thornton, Gail M.; Behzad, Hayedeh; Sharma, Aishwariya; Lu, Alex; Zhang, Peng; Reid, W. Darlene; Granville, David J.; Scott, Alex			Accumulation of Oxidized LDL in the Tendon Tissues of C57BL/6 or Apolipoprotein E Knock-Out Mice That Consume a High Fat Diet: Potential Impact on Tendon Health	PLOS ONE			English	Article							APOE-DEFICIENT MICE; RISK-FACTOR; ATHEROSCLEROSIS; CELLS; SERUM; HYPERCHOLESTEROLEMIA; TENDINOPATHY; LIPOPROTEINS; INFLAMMATION; CHOLESTEROL	Objective: Clinical studies have suggested an association between dyslipidemia and tendon injuries or chronic tendon pain; the mechanisms underlying this association are not yet known. The objectives of this study were (1) to evaluate the impact of a high fat diet on the function of load-bearing tendons and on the distribution in tendons of oxidized low density lipoprotein (oxLDL), and (2) to examine the effect of oxLDL on tendon fibroblast proliferation and gene expression. Methods: Gene expression (Mmp2, Tgfb1, Col1a1, Col3a1), fat content (Oil Red O staining), oxLDL levels (immunohistochemistry) and tendon biomechanical properties were examined in mice (C57BI/6 or ApoE -/-) receiving a standard or a high fat diet. Human tendon fibroblast proliferation and gene expression (COL1A1, COL3A1, MMP2) were examined following oxLDL exposure. Results: In both types of mice (C57BI/6 or ApoE -/-), consumption of a high fat diet led to a marked increase in oxLDL deposition in the load-bearing extracellular matrix of the tendon. The consumption of a high fat diet also reduced the failure stress and load of the patellar tendon in both mouse types, and increased Mmp2 expression. ApoE -/- mice exhibited more pronounced reductions in tendon function than wild-type mice, and decreased expression of Col1a1 compared to wild type mice. Human tendon fibroblasts responded to oxLDL by increasing their proliferation and their mRNA levels of MMP2, while decreasing their mRNA levels for COL1A1 and COL3A1. Conclusion: The consumption of a high fat diet resulted in deleterious changes in tendon function, and these changes may be explained in part by the effects of oxLDL, which induced a proliferative, matrix-degrading phenotype in human tenocytes.	[Grewal, Navdeep; Behzad, Hayedeh; Sharma, Aishwariya] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Grewal, Navdeep; Behzad, Hayedeh; Sharma, Aishwariya; Lu, Alex; Scott, Alex] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Thornton, Gail M.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Thornton, Gail M.] Univ British Columbia, Fac Med, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Zhang, Peng] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Zhang, Peng] Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Vancouver, BC, Canada; [Reid, W. Darlene] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Granville, David J.] St Pauls Hosp, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of Calgary; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of Toronto; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Scott, A (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	ascott@mail.ubc.ca		Scott, Alex/0000-0003-0366-8404; Reid, W Darlene/0000-0001-9980-8699	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Priority Announcement [126604-1]; Michael Smith Clinical Scholar Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Priority Announcement; Michael Smith Clinical Scholar Award	A. Scott received grant funding from the Canadian Institutes of Health Research (www.cihr.ca), Institute of Musculoskeletal Health and Arthritis Priority Announcement (126604-1) and a Michael Smith Clinical Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Alfredson H, 2003, J ORTHOPAED RES, V21, P970, DOI 10.1016/S0736-0266(03)00107-4; Attia M, 2013, AM J SPORT MED, V41, P908, DOI 10.1177/0363546512473817; Bachem MG, 1999, CLIN CHEM LAB MED, V37, P319, DOI 10.1515/CCLM.1999.054; Beason DP, 2013, J SHOULDER ELB SURG, V22, P681, DOI 10.1016/j.jse.2012.07.008; Beason DP, 2011, J ORTHOP RES, V29, P380, DOI 10.1002/jor.21255; Behzad H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4374; Boivin GP, 2013, BONE JOINT RES, V2, P186, DOI 10.1302/2046-3758.29.2000196; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Gaida JE, 2009, ARTHRIT RHEUM-ARTHR, V61, P840, DOI 10.1002/art.24518; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hirata Y, 2002, J DERMATOL SCI, V30, P248, DOI 10.1016/S0923-1811(02)00112-3; Huebbe P, 2010, MOL NUTR FOOD RES, V54, P623, DOI 10.1002/mnfr.200900398; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Mathiak G, 1999, ARCH ORTHOP TRAUM SU, V119, P280, DOI 10.1007/s004020050410; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozgurtas T, 2003, CLIN CHIM ACTA, V331, P25, DOI 10.1016/S0009-8981(03)00075-5; Pasternak B, 2010, BRIT J SPORT MED, V44, P669, DOI 10.1136/bjsm.2008.049411; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Sereysky JB, 2012, J ORTHOP RES, V30, P965, DOI 10.1002/jor.22012; Sharma A, 2011, J ORTHOP RES, V29, P678, DOI 10.1002/jor.21291; Sommerville LJ, 2012, ATHEROSCLEROSIS, V220, P45, DOI 10.1016/j.atherosclerosis.2011.07.095; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANREE JH, 1995, ATHEROSCLEROSIS, V112, P237, DOI 10.1016/0021-9150(94)05419-J; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582	26	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114214	10.1371/journal.pone.0114214	http://dx.doi.org/10.1371/journal.pone.0114214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502628	gold, Green Published			2022-12-26	WOS:000346375400023
J	Valdivia, K; Jouanno, E; Volff, JN; Galiana-Arnoux, D; Guyomard, R; Helary, L; Mourot, B; Fostier, A; Quillet, E; Guiguen, Y				Valdivia, Karina; Jouanno, Elodie; Volff, Jean-Nicolas; Galiana-Arnoux, Delphine; Guyomard, Rene; Helary, Louise; Mourot, Brigitte; Fostier, Alexis; Quillet, Edwige; Guiguen, Yann			High Temperature Increases the Masculinization Rate of the All-Female (XX) Rainbow Trout "Mal" Population	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; ONCORHYNCHUS-MYKISS; EMBRYONIC-DEVELOPMENT; DETERMINING GENE; DIFFERENTIATION; CORTISOL; FISH; EXPRESSION; GONADS; CARP	Salmonids are generally considered to have a robust genetic sex determination system with a simple male heterogamety (XX/XY). However, spontaneous masculinization of XX females has been found in a rainbow trout population of gynogenetic doubled haploid individuals. The analysis of this masculinization phenotype transmission supported the hypothesis of the involvement of a recessive mutation (termed mal). As temperature effect on sex differentiation has been reported in some salmonid species, in this study we investigated in detail the potential implication of temperature on masculinization in this XX mal-carrying population. Seven families issued from XX mal-carrying parents were exposed from the time of hatching to different rearing water temperatures ((8, 12 and 18 degrees C), and the resulting sex-ratios were confirmed by histological analysis of both gonads. Our results demonstrate that masculinization rates are strongly increased (up to nearly two fold) at the highest temperature treatment (18 degrees C). Interestingly, we also found clear differences between temperatures on the masculinization of the left versus the right gonads with the right gonad consistently more often masculinized than the left one at lower temperatures (8 and 12 degrees C). However, the masculinization rate is also strongly dependent on the genetic background of the XX mal-carrying families. Thus, masculinization in XX mal-carrying rainbow trout is potentially triggered by an interaction between the temperature treatment and a complex genetic background potentially involving some part of the genetic sex differentiation regulatory cascade along with some minor sex-influencing loci. These results indicate that despite its rather strict genetic sex determinism system, rainbow trout sex differentiation can be modulated by temperature, as described in many other fish species.	[Valdivia, Karina; Jouanno, Elodie; Helary, Louise; Mourot, Brigitte; Fostier, Alexis; Guiguen, Yann] INRA, LPGP Fish Physiol & Gen, UR1037, F-35000 Rennes, France; [Volff, Jean-Nicolas; Galiana-Arnoux, Delphine] Univ Claude Bernard Lyon I ENS, CNRS INRA, IGFL, UMR5242, Lyon 07, France; [Guyomard, Rene] INRA, GABI Genet Anim & Biol Integrat, UMR1313, F-78352 Jouy En Josas, France	INRAE; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guiguen, Y (corresponding author), INRA, LPGP Fish Physiol & Gen, UR1037, F-35000 Rennes, France.	yann.guiguen@rennes.inra.fr		Helary, Louise/0000-0002-2481-2113; Guiguen, Yann/0000-0001-5464-6219	French National Research Agency ("Sexytrout" project) [ANR-2008-GENM-031]; Ministere de la Recherche et de l'Enseignement Superieur	French National Research Agency ("Sexytrout" project)(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement Superieur	This work was supported by the French National Research Agency ("Sexytrout" project, ANR-2008-GENM-031). K.V. received a fellowship from the "Ministere de la Recherche et de l'Enseignement Superieur". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelopoulou R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-13; ASHBY KR, 1957, J EMBRYOL EXP MORPH, V5, P225; Azuma T, 2004, AQUACULTURE, V234, P461, DOI 10.1016/j.aquaculture.2003.11.023; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; BARRY TP, 1995, GEN COMP ENDOCR, V97, P57, DOI 10.1006/gcen.1995.1006; Chevassus B., 1979, BULLETIN FRANCAIS DE PISCICULTURE, P18, DOI 10.1051/kmae:1979006; Chevassus Bernard, 1992, Aquatic Living Resources, V5, P325, DOI 10.1051/alr:1992031; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; Craig JK, 1996, CAN J FISH AQUAT SCI, V53, P141, DOI 10.1139/cjfas-53-1-141; Davidson WS, 2009, SEX DEV, V3, P78, DOI 10.1159/000223073; Fuzzen MLM, 2011, GEN COMP ENDOCR, V170, P604, DOI 10.1016/j.ygcen.2010.11.022; Gabe M, 1968, HISTOLOGICAL TECHNIQ; Gabillard JC, 2003, J EXP ZOOL PART A, V298A, P134, DOI 10.1002/jez.a.10280; Guillevic M, 2008, CYBIUM, V32, P99; Hattori RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006548; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; JALABERT B, 1975, ANN BIOL ANIM BIOCH, V15, P19, DOI 10.1051/rnd:19750103; KOMEN J, 1992, DEV GROWTH DIFFER, V34, P535; KWAIN WH, 1975, J FISH RES BOARD CAN, V32, P397, DOI 10.1139/f75-046; Luhmann LM, 2012, SEX DEV, V6, P247, DOI 10.1159/000339705; Magerhans A, 2010, AQUACULTURE, V306, P63, DOI 10.1016/j.aquaculture.2010.05.015; Magerhans A, 2009, AQUACULTURE, V294, P25, DOI 10.1016/j.aquaculture.2009.05.001; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Mittwoch U, 2001, J EXP ZOOL, V290, P484, DOI 10.1002/jez.1091; Hurk R. van den, 1982, Proceedings of the International Symposium on Reproductive Physiology of Fish, Wageningen, the Netherlands, 2-6 August 1982., P69; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Price D.J., 1984, P77; Quillet E, 2002, J HERED, V93, P91, DOI 10.1093/jhered/93.2.91; Quillett E, 2004, J FISH BIOL, V64, P1147, DOI 10.1111/j.1095-8649.2004.00373.x; Ruane NM, 2007, GEN COMP ENDOCR, V150, P473, DOI 10.1016/j.ygcen.2006.11.008; Ruane NM, 2005, GEN COMP ENDOCR, V143, P66, DOI 10.1016/j.ygcen.2005.02.024; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Strussmann CA, 2005, J MORPHOL, V265, P190, DOI 10.1002/jmor.10351; Valdivia K, 2013, SEX DEV, V7, P196, DOI 10.1159/000348435; VANDENHURK R, 1985, GEN COMP ENDOCR, V57, P216, DOI 10.1016/0016-6480(85)90266-7; Vandeputte M, 2006, MOL ECOL NOTES, V6, P265, DOI 10.1111/j.1471-8286.2005.01167.x; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; VANLIMBORGH J, 1968, ARCH ANAT MICROSC MO, V57, P79; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Yamaguchi T, 2012, BIOCHEM BIOPH RES CO, V419, P287, DOI 10.1016/j.bbrc.2012.02.012; Yamaguchi T, 2010, ENDOCRINOLOGY, V151, P3900, DOI 10.1210/en.2010-0228; Yamamoto T. O., 1969, P117; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yu ZH, 1998, INT J ANDROL, V21, P53, DOI 10.1046/j.1365-2605.1998.00088.x	48	25	27	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113355	10.1371/journal.pone.0113355	http://dx.doi.org/10.1371/journal.pone.0113355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501353	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400008
J	Yeh, JH; Huang, CT; Liu, CH; Ruan, SY; Tsai, YJ; Chien, YC; Yang, CY; Huang, CK; Hsu, CL; Kuo, LC; Lee, PL; Ku, SC; Kuo, PH; Yu, CJ				Yeh, Jiann-Horng; Huang, Chun-Ta; Liu, Chia-Hsiung; Ruan, Sheng-Yuan; Tsai, Yi-Ju; Chien, Ying-Chun; Yang, Ching-Yao; Huang, Chun-Kai; Hsu, Chia-Lin; Kuo, Lu-Cheng; Lee, Pei-Lin; Ku, Shih-Chi; Kuo, Ping-Hung; Yu, Chong-Jen		HINT Study Grp	Cautious Application of Pleural N-Terminal Pro-B-Type Natriuretic Peptide in Diagnosis of Congestive Heart Failure Pleural Effusions among Critically Ill Patients	PLOS ONE			English	Article							LIGHTS CRITERIA; CARDIAC ORIGIN; SEVERE SEPSIS; SEPTIC SHOCK; FLUID; BIAS; IDENTIFICATION; METAANALYSIS; ACCURACY; SPECTRUM	Background and Objective: Several studies on diagnostic accuracy of pleural N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) for effusions from congestive heart failure (CHF) conclude that pleural NT-pro-BNP is a useful biomarker with high diagnostic accuracy for distinguishing CHF effusions. However, its applicability in critical care settings remains uncertain and requires further investigations. Methods: NT-proBNP was measured in pleural fluid samples of a prospective cohort of intensive care unit patients with pleural effusions. Receiver operating characteristic curve analysis was performed to determine diagnostic accuracy of pleural NT-proBNP for prediction of CHF effusions. Results: One hundred forty-seven critically ill patients were evaluated, 38 (26%) with CHF effusions and 109 (74%) with non-CHF effusions of various causes. Pleural NT-proBNP levels were significantly elevated in patients with CHF effusions. Pleural NT-pro-BNP demonstrated the area under the curve of 0.87 for diagnosing effusions due to CHF. With a cutoff of 2200 pg/mL, pleural NT-proBNP displayed high sensitivity (89%) but moderate specificity (73%). Notably, 29 (27%) of 109 patients with non-CHF effusions had pleural NT-proBNP levels >2200 pg/mL and these patients were more likely to experience septic shock (18/29 vs. 10/80, P < 0.001) or acute kidney injury (19/29 vs. 9/80, P<0.001). Conclusions: Among critically ill patients, pleural NT-proBNP measurements remain a useful diagnostic aid in evaluation of pleural effusions. However, patients with non-CHF effusions may exhibit high pleural NT-proBNP concentrations if they suffer from septic shock or acute kidney injury. Accordingly, it is suggested that clinical context should be taken into account when interpreting pleural NT-proBNP values in critical care settings.	[Yeh, Jiann-Horng] Shin Kong Wu Ho Mem Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Chun-Ta; Ruan, Sheng-Yuan; Chien, Ying-Chun; Yang, Ching-Yao; Huang, Chun-Kai; Hsu, Chia-Lin; Kuo, Lu-Cheng; Lee, Pei-Lin; Ku, Shih-Chi; Kuo, Ping-Hung; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei 100, Taiwan; [Huang, Chun-Ta; Liu, Chia-Hsiung] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Chia-Hsiung] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [HINT Study Grp] Natl Taiwan Univ Hosp, Taipei 100, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	huangct@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019; Chien, Ying-Chun/M-9595-2016; Ku, Shih-Chi/AAN-5216-2021	Lee, Pei-Lin/0000-0002-6883-9502; Chien, Ying-Chun/0000-0003-0184-323X; HSU, CHIA-LIN/0000-0001-5785-0733; KUO, PING-HUNG/0000-0003-3756-3395; KU, SHIH-CHI/0000-0002-4123-0967; YANG, CHING-YAO/0000-0003-4927-4814; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986; HUANG, CHUN-KAI/0000-0001-7392-6363; Yu, Chong-Jen/0000-0001-5664-9392	Shin Kong Wu Ho-Su Memorial Hospital [SKH-FJU-9718]; National Taiwan University Hospital [NTUH.102-N2297]	Shin Kong Wu Ho-Su Memorial Hospital; National Taiwan University Hospital(National Taiwan University)	This study was supported by the Shin Kong Wu Ho-Su Memorial Hospital (SKH-FJU-9718) (YJT) and the National Taiwan University Hospital (NTUH.102-N2297) (CTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa EK, 2008, CRIT CARE MED, V36, P2322, DOI 10.1097/CCM.0b013e318181040d; Cincin A, 2013, RESP CARE, V58, P313, DOI 10.4187/respcare.01818; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Franz M, 2001, KIDNEY INT, V59, P1928, DOI 10.1046/j.1523-1755.2001.0590051928.x; Han CH, 2008, INTERNAL MED, V47, P1669, DOI 10.2169/internalmedicine.47.1276; Janda S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-58; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Kelly S, 1997, BRIT J RADIOL, V70, P1028, DOI 10.1259/bjr.70.838.9404207; Kolditz M, 2006, EUR RESPIR J, V28, P144, DOI 10.1183/09031936.06.00113205; Liao H, 2008, RESPIROLOGY, V13, P53, DOI 10.1111/j.1440-1843.2007.01191.x; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Long AC, 2010, CHEST, V137, P1369, DOI 10.1378/chest.09-2193; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Ordonez-Llanos J, 2008, AM J CARDIOL, V101, p9A, DOI 10.1016/j.amjcard.2007.11.013; Porcel JM, 2004, AM J MED, V116, P417, DOI 10.1016/j.amjmed.2003.11.008; Porcel JM, 2007, RESPIROLOGY, V12, P654, DOI 10.1111/j.1440-1843.2007.01109.x; Porcel JM, 2013, RESPIROLOGY, V18, P540, DOI 10.1111/resp.12039; Porcel JM, 2009, CHEST, V136, P671, DOI 10.1378/chest.09-0270; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rehman SU, 2008, CARDIOL REV, V16, P240, DOI 10.1097/CRD.0b013e3181815333; Rudiger A, 2006, CRIT CARE MED, V34, P2140, DOI 10.1097/01.CCM.0000229144.97624.90; Tomcsanyi J, 2004, EUR J HEART FAIL, V6, P753, DOI 10.1016/j.ejheart.2003.11.017; Varpula M, 2007, CRIT CARE MED, V35, P1277, DOI 10.1097/01.CCM.0000261893.72811.0F; Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002; Vives M, 1996, CHEST, V109, P1503, DOI 10.1378/chest.109.6.1503; Zhou Q, 2010, HEART, V96, P1207, DOI 10.1136/hrt.2009.188474	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115301	10.1371/journal.pone.0115301	http://dx.doi.org/10.1371/journal.pone.0115301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502236	Green Submitted, gold, Green Published			2022-12-26	WOS:000346375400091
J	Uzunoglu, FG; Dethlefsen, E; Hanssen, A; Wrage, M; Deutsch, L; Harms-Effenberger, K; Vashist, YK; Reeh, M; Sauter, G; Simon, R; Bockhorn, M; Pantel, K; Izbicki, JR; Wikman, H				Uzunoglu, Faik G.; Dethlefsen, Ebba; Hanssen, Annkathrin; Wrage, Michaela; Deutsch, Lena; Harms-Effenberger, Katharina; Vashist, Yogesh K.; Reeh, Matthias; Sauter, Guido; Simon, Ronald; Bockhorn, Maximillian; Pantel, Klaus; Izbicki, Jakob R.; Wikman, Harriet			Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CHROMOSOMAL IMBALANCES; 4Q; HETEROZYGOSITY; CARCINOMA; PATTERNS; STAGE; ADENOCARCINOMA; AMPLIFICATION; PROGRESSION; DELETIONS	This study was performed to assess the prognostic relevance of genomic aberrations at chromosome 4q in NSCLC patients. We have previously identified copy number changes at 4q12-q32 to be significantly associated with the early hematogenous dissemination of non-small cell lung cancer (NSCLC), and now aim to narrow down potential hot-spots within this 107 Mb spanning region. Using eight microsatellite markers at position 4q12-35, allelic imbalance (AI) analyses were performed on a preliminary study cohort (n=86). Positions indicating clinicopathological and prognostic associations in AI analyses were further validated in a larger study cohort using fluorescence in situ hybridization (FISH) in 209 NSCLC patients. Losses at positions 4q21.23 and 4q22.1 were shown to be associated with advanced clinicopathological characteristics as well as with shortened disease free (DFS) and overall survival (OS) (DFS: P=0.019; OS: P=0.002). Multivariate analyses identified the losses of 4q21.23-22.1 to be an independent prognostic marker for both DFS and OS in NSCLC (HR 1.64-2.20, all P<0.04), and especially in squamous cell lung cancer (P<0.05). A case report study of a lung cancer patient further revealed a loss of 4q21.23 in disseminated tumor cells (DTCs). Neither gains at the latter positions, nor genomic aberrations at 4q12, 4q31.2 and 4q35.1, indicated a prognostic relevance. In conclusion, our data indicate that loss at 4q21.23-22.1 in NSCLC is of prognostic relevance in NSCLC patients and thus, includes potential new tumor suppressor genes with clinical relevance.	[Uzunoglu, Faik G.; Deutsch, Lena; Harms-Effenberger, Katharina; Vashist, Yogesh K.; Reeh, Matthias; Bockhorn, Maximillian; Izbicki, Jakob R.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Dethlefsen, Ebba; Hanssen, Annkathrin; Wrage, Michaela; Harms-Effenberger, Katharina; Pantel, Klaus; Wikman, Harriet] Univ Med Ctr Hamburg Eppendorf, Inst Tumour Biol, Hamburg, Germany; [Sauter, Guido; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wikman, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Tumour Biol, Hamburg, Germany.	h.wikman@uke.de	Vashist, Yogesh/ABE-4001-2020; Vashist, Yogesh/AAF-3529-2022; Reeh, Matthias/AAB-6917-2022; Vashist, Yogesh/AFH-9205-2022	Wikman, Harriet/0000-0001-6862-0888	Hamburger Krebsgesellschaft e.V., Hamburg, Germany	Hamburger Krebsgesellschaft e.V., Hamburg, Germany	This work was supported by the Hamburger Krebsgesellschaft e.V., Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Brosens RPM, 2011, CELL ONCOL, V34, P215, DOI 10.1007/s13402-011-0042-8; Danner BC, 2011, ANN THORAC SURG, V92, P1038, DOI 10.1016/j.athoracsur.2011.04.052; Danner BC, 2011, CANCER GENET-NY, V204, P122, DOI 10.1016/j.cancergen.2010.12.003; FONG KM, 1995, CANCER RES, V55, P4268; FONG KM, 1995, CANCER RES, V55, P220; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Li RY, 2007, CLIN CANCER RES, V13, P482, DOI 10.1158/1078-0432.CCR-06-1593; Lin SC, CHROMOSOMAL CHANGES; Luebke AM, 2012, PANCREATOLOGY, V12, P16, DOI 10.1016/j.pan.2011.11.001; Pan HJ, 2005, CANCER RES, V65, P1664, DOI 10.1158/0008-5472.CAN-04-3297; Pantel K, 1994, J Hematother, V3, P165, DOI 10.1089/scd.1.1994.3.165; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Petersen S, 2000, BRIT J CANCER, V82, P65; Pikor LA, 2013, LUNG CANCER, V82, P179, DOI 10.1016/j.lungcan.2013.07.025; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Tai ALS, 2004, CANCER, V100, P1918, DOI 10.1002/cncr.20190; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Wistuba II, 1999, CANCER RES, V59, P1973; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188	26	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113315	10.1371/journal.pone.0113315	http://dx.doi.org/10.1371/journal.pone.0113315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501003	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700007
J	Halwani, R; Al-Kufaidy, R; Vazquez-Tello, A; Pureza, MA; BaHammam, AS; Al-Jahdali, H; Alnassar, SA; Hamid, Q; Al-Muhsen, S				Halwani, Rabih; Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; Pureza, Mary Angeline; BaHammam, Ahmed S.; Al-Jahdali, Hamdan; Alnassar, Sami A.; Hamid, Qutayba; Al-Muhsen, Saleh			IL-17 Enhances Chemotaxis of Primary Human B Cells during Asthma	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AIRWAY INFLAMMATION; RECEPTOR COMPLEX; ALLERGIC-ASTHMA; IGE PRODUCTION; T(H)17 CELLS; BXD2 MICE; P38 MAPK; KAPPA-B; EXPRESSION	IL-17 is a pro-inflammatory mediator that is believed to play a critical role in regulating tissue inflammation during asthma, COPD, as well as other inflammatory disorders. The level of expression of IL-17 has been shown to be upregulated in lung bronchial tissue of asthmatic patients. Several reports have provided further evidence that this cytokine could play a key role in enhancing the migration of inflammatory as well as structural cells of the bronchial lung tissue during asthma and COPD. B cell infiltration to sites of inflammation during inflammatory disorders such as bowel disease, asthma and COPD has been reported. Accordingly, in this study we hypothesized that IL-17 may exert a chemotactic effect on primary B cells during asthma. We observed that B cells from asthmatic patients expressed significantly higher levels of IL-17RA and IL-17RC, compared to those of healthy subjects. Using an in-vitro migration assay, B cells were shown to migrate towards both IL-17A and IL-17F. Interestingly, blocking IL-17A and IL-17F signaling using either anti-IL-17R antibodies or MAP kinase inhibitors prevented in vitro migration of B cell towards IL-17. These observations indicate a direct chemotactic effect of IL-17 cytokines on primary peripheral blood B cells with higher effect being on asthmatic B cells. These findings revealed a key role for IL-17 in enhancing the migration of B cells to the lung tissue during asthma or COPD.	[Halwani, Rabih; Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; Pureza, Mary Angeline; BaHammam, Ahmed S.; Al-Jahdali, Hamdan; Al-Muhsen, Saleh] King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [BaHammam, Ahmed S.] King Saud Univ, Coll Med, Univ Sleep Disorders Ctr, Dept Pulm Med, Riyadh 11461, Saudi Arabia; [Al-Jahdali, Hamdan] King Saud Univ Hlth Sci, Div Pulm, ICU, Dept Med, Riyadh, Saudi Arabia; [Alnassar, Sami A.] King Saud Univ, Coll Med, Div Thorac Surg, Riyadh 11461, Saudi Arabia; [Hamid, Qutayba] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	King Saud University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Saud University; McGill University	Al-Muhsen, S (corresponding author), King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia.	almuhsen@ksu.edu.sa	Halwani, Rabih/AAN-1568-2021; BaHammam, Ahmed Salem/B-9037-2008; BaHammam, Ahmed S/D-7521-2011; Al-muhsen, saleh/E-9315-2014	Halwani, Rabih/0000-0002-6516-7771; BaHammam, Ahmed Salem/0000-0002-1706-6167; BaHammam, Ahmed S/0000-0002-1706-6167; Al-muhsen, saleh/0000-0003-3698-9968	National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia [10-MED1224-02]	National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia(King Saud University)	This work was funded by a grant from the National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia (grant number 10-MED1224-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan LA, 2012, J ALLERGY CLIN IMMUN, V130, P977, DOI 10.1016/j.jaci.2012.04.042; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Beier KC, 2004, J ALLERGY CLIN IMMUN, V114, P775, DOI 10.1016/j.jaci.2004.06.024; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Corneth OBJ, 2014, ARTHRITIS RHEUMATOL, V66, P340, DOI 10.1002/art.38229; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Coyle AJ, 1996, J EXP MED, V183, P1303, DOI 10.1084/jem.183.4.1303; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Gopal R, 2013, MUCOSAL IMMUNOL, V6, P972, DOI 10.1038/mi.2012.135; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Hajoui O, 2004, J ALLERGY CLIN IMMUN, V114, P657, DOI 10.1016/j.jaci.2004.05.034; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Joks R, 2011, RECENT PATENTS INFLA, V5, P221, DOI 10.2174/187221311797264919; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Linden A, 2002, ALLERGY, V57, P769, DOI 10.1034/j.1398-9995.2002.02164.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Sarkar S, 2010, CLIN EXP IMMUNOL, V159, P225, DOI 10.1111/j.1365-2249.2009.04016.x; Scanlon KM, 2011, INT ARCH ALLERGY IMM, V156, P51, DOI 10.1159/000322178; Semper AE, 1995, ADV EXP MED BIOL, V378, P135; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; Tan JQ, 1997, J IMMUNOL, V158, P475; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wu WT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-152; Wuyts WA, 2005, J HEART LUNG TRANSPL, V24, P875, DOI 10.1016/j.healun.2004.05.003; XIA HZ, 1993, BLOOD, V82, P2806; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Ying S, 2001, J ALLERGY CLIN IMMUN, V107, P686, DOI 10.1067/mai.2001.114339; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	55	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114604	10.1371/journal.pone.0114604	http://dx.doi.org/10.1371/journal.pone.0114604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494178	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400057
J	Kurano, M; Tsukamoto, K; Hara, M; Ohkawa, R; Ikeda, H; Yatomi, Y				Kurano, Makoto; Tsukamoto, Kazuhisa; Hara, Masumi; Ohkawa, Ryunosuke; Ikeda, Hitoshi; Yatomi, Yutaka			LDL Receptor and ApoE Are Involved in the Clearance of ApoM-associated Sphingosine 1-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; RESIDUAL CARDIOVASCULAR RISK; APOLIPOPROTEIN-M; ENDOTHELIAL-CELLS; HDL; PLASMA; CHOLESTEROL; S1P; OVEREXPRESSION; METABOLISM	Sphingosine 1-phosphate (S1P) is a vasoactive lipid mediator that is speculated to be involved in various aspects of atherosclerosis. About 70% of circulating plasma S1P is carried on HDL, and several pleiotropic properties of HDL have been ascribed to S1P. In the previous study with human subjects, however, LDL, cholesterol or apoB, but not HDL cholesterol or apoA-I, had a significant positive correlation with the plasma SIP level, suggesting that the metabolic pathway for LDL might have some roles in the metabolism of SIP. In this study, we analyzed the association between LDL, receptor, an important protein in the clearance of LDL, and circulating SIP. We observed that in LDL, receptor-overexpressing mice, the plasma SIP levels as well as apolipoprotein M (apoM), a carrier of SIP, were decreased and that exogenously administered C(17)S1P bound to apoM-containing lipoproteins was cleared more rapidly. Unlike the situation in wild-type mice, LDL, receptor overexpression in apoE-deficient mice did not reduce the plasma SIP or apoM levels, suggesting that apoE might be a ligand for the LDL. receptor during the clearance of these factors. The present findings clarify the novel roles of the LDL receptor and apoL in the clearance of S1P, a multifunctional bioactive phospholipid.	[Kurano, Makoto; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tsukamoto, Kazuhisa] Fukushima Med Univ, Aizu Med Ctr, Dept Metab Diabet & Nephrol, Aizu Wakamatsu, Fukushima 9693482, Japan; [Ohkawa, Ryunosuke; Ikeda, Hitoshi; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, Tokyo 1138655, Japan; [Hara, Masumi] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Med 4,Takatsu Ku, Kawasaki, Kanagawa 2130001, Japan	University of Tokyo; University of Tokyo; Teikyo University	Yatomi, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yatoyuta-tky@umin.ac.jp	Ohkawa, Ryunosuke/C-5402-2017	Ohkawa, Ryunosuke/0000-0002-8584-133X; Yatomi, Yutaka/0000-0003-1719-4297	Japan Society for the Promotion of Science KAKENHI [22249017, 25253040, 25860740]; CREST from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 22249017 and 25253040 (to Y. Y.) and 25860740 (to M. K.) and CREST from the Japan Science and Technology Agency.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Brewer HB, 2011, J CLIN ENDOCR METAB, V96, P1246, DOI 10.1210/jc.2010-0163; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2012, J LIPID RES, V53, P2198, DOI 10.1194/jlr.P023697; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goetzl EJ, 2001, PROSTAG OTH LIPID M, V64, P11, DOI 10.1016/S0090-6980(01)00104-6; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Iacob AO, 2012, CURR OPIN LIPIDOL, V23, P172, DOI 10.1097/MOL.0b013e32835135bd; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Kappelle PJWH, 2010, ATHEROSCLEROSIS, V213, P247, DOI 10.1016/j.atherosclerosis.2010.07.048; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Kurano M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-134; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Rosales C, 2011, ARTERIOSCL THROM VAS, V31, P1834, DOI 10.1161/ATVBAHA.111.224360; Sampson UK, 2012, CURR ATHEROSCLER REP, V14, P1, DOI 10.1007/s11883-011-0219-7; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Schofield JD, 2013, CURR OPIN CARDIOL, V28, P464, DOI 10.1097/HCO.0b013e328362210d; Stewart JE, 1998, INT J BIOCHEM CELL B, V30, P407, DOI 10.1016/S1357-2725(97)00151-9; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006	35	33	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2477	2488		10.1074/jbc.M114.596445	http://dx.doi.org/10.1074/jbc.M114.596445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505264	hybrid, Green Published			2022-12-26	WOS:000348588000049
J	Wei, L; Hao, J; Kaffman, A				Wei, Lan; Hao, Jin; Kaffman, Arie			Early Life Stress Inhibits Expression of Ribosomal RNA in the Developing Hippocampus	PLOS ONE			English	Article							EARLY POSTNATAL LIFE; MATERNAL-CARE; CHILDHOOD MALTREATMENT; BRAIN; MICE; SYMPTOMS; RATS; TRANSCRIPTION; DEPRIVATION; METHYLATION	Children that are exposed to abuse or neglect show abnormal hippocampal function. However, the developmental mechanisms by which early life stress (ELS) impairs normal hippocampal development have not been elucidated. Here we propose that exposure to ELS blunts normal hippocampal growth by inhibiting the availability of ribosomal RNA (rRNA). In support of this hypothesis, we show that the normal mouse hippocampus undergoes a growth-spurt during the second week of life, followed by a gradual decrease in DNA and RNA content that persists into adulthood. This developmental pattern is associated with accelerated ribosomal RNA (rRNA) synthesis during the second week of life, followed by a gradual decline in rRNA levels that continue into adulthood. Levels of DNA methylation at the ribosomal DNA (rDNA) promoter are lower during the second week of life compared to earlier development or adulthood. Exposure to brief daily separation (BDS), a mouse model of early life stress, increased DNA methylation at the ribosomal DNA promoter, decreased rRNA levels, and blunted hippocampal growth during the second week of life. Exposure to acute (3 hrs) maternal separation decreased rRNA and increased DNA methylation at the rDNA proximal promoter, suggesting that exposure to stress early in life can rapidly regulate the availability of rRNA levels in the developing hippocampus. Given the critical role that rRNA plays in supporting normal growth and development, these findings suggest a novel molecular mechanism to explain how stress early in life impairs hippocampus development in the mouse.	[Wei, Lan; Hao, Jin; Kaffman, Arie] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Kaffman, A (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	arie.kaffman@yale.edu			NIMH [R21MH098181, R01MH100078]; DANA foundation Program in Brain and Immuno-imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100078, R21MH098181] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DANA foundation Program in Brain and Immuno-imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH R21MH098181, NIMH R01MH100078, and DANA foundation Program in Brain and Immuno-imaging 2011 (http://www.dana.org/GrantsLanding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BERREBI AS, 1988, BRAIN RES, V438, P216, DOI 10.1016/0006-8993(88)91340-6; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; CAVANAUGH AH, 1983, J BIOL CHEM, V258, P9768; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Denenberg VH, 1981, BRAIN RES, V254, P417; Garrett AS, 2012, DEPRESS ANXIETY, V29, P449, DOI 10.1002/da.21892; Grummt I, 2010, FEBS J, V277, P4626, DOI 10.1111/j.1742-4658.2010.07892.x; Herringa RJ, 2013, P NATL ACAD SCI USA, V110, P19119, DOI 10.1073/pnas.1310766110; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kaffman A, 2012, METHODS MOL BIOL, V829, P3, DOI 10.1007/978-1-61779-458-2_1; Kikusui T, 2006, BEHAV BRAIN RES, V175, P96, DOI 10.1016/j.bbr.2006.08.007; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Parfitt DB, 2004, BRAIN RES, V1016, P111, DOI 10.1016/j.brainres.2004.04.077; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; PAVLIK A, 1980, BRAIN RES, V192, P531, DOI 10.1016/0006-8993(80)90903-8; PAVLIK A, 1979, BRAIN RES, V167, P200, DOI 10.1016/0006-8993(79)90279-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; Ren-Patterson RF, 2006, CELL MOL NEUROBIOL, V26, P755, DOI 10.1007/s10571-006-9048-6; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2005, CELL MOL LIFE SCI, V62, P2067, DOI 10.1007/s00018-005-5110-7; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Szyf M, 2013, CAN J PSYCHIAT, V58, P697, DOI 10.1177/070674371305801208; Wei L, 2012, NEUROPSYCHOPHARMACOL, V37, P567, DOI 10.1038/npp.2011.239; Wei L, 2010, HORM BEHAV, V57, P396, DOI 10.1016/j.yhbeh.2010.01.007; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437	31	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115283	10.1371/journal.pone.0115283	http://dx.doi.org/10.1371/journal.pone.0115283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517398	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600057
J	Fassotte, B; Fischer, C; Durieux, D; Lognay, G; Haubruge, E; Francis, F; Verheggen, FJ				Fassotte, Berenice; Fischer, Christophe; Durieux, Delphine; Lognay, Georges; Haubruge, Eric; Francis, Frederic; Verheggen, Francois J.			First Evidence of a Volatile Sex Pheromone in Lady Beetles	PLOS ONE			English	Article							HARMONIA-AXYRIDIS PALLAS; FEMALE GERMAN-COCKROACH; CALLING BEHAVIOR; CHEMICAL ECOLOGY; MATING-BEHAVIOR; HOST-PLANT; COLEOPTERA; IDENTIFICATION; SEMIOCHEMICALS; ULTRASTRUCTURE	To date, volatile sex pheromones have not been identified in the Coccinellidae family; yet, various studies have suggested that such semiochemicals exist. Here, we collected volatile chemicals released by virgin females of the multicolored Asian lady beetle, Harmonia axyridis (Pallas), which were either allowed or not allowed to feed on aphids. Virgin females in the presence of aphids, exhibited "calling behavior", which is commonly associated with the emission of a sex pheromone in several Coleoptera species. These calling females were found to release a blend of volatile compounds that is involved in the remote attraction (i.e., from a distance) of males. Gas Chromatography-Mass Spectrometry (GC-MS) analyses revealed that (-)-beta-caryophyllene was the major constituent of the volatile blend (ranging from 80 to 86%), with four other chemical components also being present; beta-elemene, methyl-eugenol, alpha-humulene, and alpha-bulnesene. In a second set of experiments, the emission of the five constituents identified from the blend was quantified daily over a 9-day period after exposure to aphids. We found that the quantity of all five chemicals significantly increased across the experimental period. Finally, we evaluated the activity of a synthetic blend of these chemicals by performing bioassays which demonstrated the same attractive effect in males only. The results confirm that female H. axyridis produce a volatile sex pheromone. These findings have potential in the development of more specific and efficient biological pest-control management methods aimed at manipulating the behavior of this invasive lady beetle.	[Fassotte, Berenice; Durieux, Delphine; Haubruge, Eric; Francis, Frederic; Verheggen, Francois J.] Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium; [Fischer, Christophe; Lognay, Georges] Univ Liege, Gembloux Agrobio Tech, Analyt Chem Lab, Unit Anal Qual & Risk, Gembloux, Belgium	University of Liege; University of Liege	Fassotte, B (corresponding author), Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium.	bfassotte@doct.ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476; Verheggen, Francois/0000-0002-5849-1661	"Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium	"Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS)	Berenice Fassotte was financially supported by a PhD grant from the "Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege. Christophe Fischer and Delphine Durieux were financially supported by a PhD grant from the "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; BARBIER R, 1992, INT J INSECT MORPHOL, V21, P223, DOI 10.1016/0020-7322(92)90018-I; Barbour JD, 2006, J INSECT BEHAV, V19, P623, DOI 10.1007/s10905-006-9050-3; Brown AE, 2006, J CHEM ECOL, V32, P2489, DOI 10.1007/s10886-006-9158-0; Carde R.T., 1984, P355; Durieux D, 2010, BIOTECHNOL AGRON SOC, V14, P351; FINNEGAN DE, 1993, J CHEM ECOL, V19, P971, DOI 10.1007/BF00992532; Fischer CY, 2012, J CHEM EDUC, V89, P1611, DOI 10.1021/ed2007907; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Fonseca MG, 2009, J APPL ENTOMOL, V133, P695, DOI 10.1111/j.1439-0418.2009.01424.x; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; GUERIN PM, 1983, J CHEM ECOL, V9, P843, DOI 10.1007/BF00987809; HAMMACK L, 1995, ANN ENTOMOL SOC AM, V88, P562, DOI 10.1093/aesa/88.4.562; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; Hemptinne JL, 1996, ECOL ENTOMOL, V21, P165, DOI 10.1111/j.1365-2311.1996.tb01183.x; Heuskin S, 2010, J PHARMACEUT BIOMED, V53, P962, DOI 10.1016/j.jpba.2010.07.014; Heuskin S, 2009, J CHROMATOGR A, V1216, P2768, DOI 10.1016/j.chroma.2008.09.109; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; KAMM JA, 1986, ENVIRON ENTOMOL, V15, P388, DOI 10.1093/ee/15.2.388; Landolt Peter J., 1997, American Entomologist, V43, P12; LEAL WS, 1993, J CHEM ECOL, V19, P1381, DOI 10.1007/BF00984883; Leroy PD, 2012, INSECT SCI, V19, P372, DOI 10.1111/j.1744-7917.2011.01449.x; LIANG D, 1993, TISSUE CELL, V25, P763, DOI 10.1016/0040-8166(93)90057-R; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; McCornack BP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1001; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; OBATA S, 1991, BEHAVIOUR AND IMPACT OF APHIDOPHAGA, P207; OBATA S, 1987, APPL ENTOMOL ZOOL, V22, P434, DOI 10.1303/aez.22.434; OBATA S, 1987, CAN ENTOMOL, V119, P603, DOI 10.4039/Ent119603-6; OBATA S, 1988, PHYSIOL ENTOMOL, V13, P193, DOI 10.1111/j.1365-3032.1988.tb00923.x; Obata S, 1997, ENTOMOPHAGA, V42, P103, DOI 10.1007/BF02769885; Omkar, 2005, Insect Science, V12, P37, DOI 10.1111/j.1672-9609.2005.00006.x; OSAWA N, 1994, J ETHOL, V12, P63, DOI 10.1007/BF02350081; Paschen MA, 2012, J INSECT BEHAV, V25, P569, DOI 10.1007/s10905-012-9321-0; Pettersson Jan, 2012, P444; QI YT, 1982, J CHEM ECOL, V8, P527, DOI 10.1007/BF00987800; RICHARDS AM, 1980, J AUST ENTOMOL SOC, V19, P26; Rodstein J, 2009, J CHEM ECOL, V35, P590, DOI 10.1007/s10886-009-9623-7; Roy H, 2008, BIOCONTROL, V53, P1, DOI 10.1007/s10526-007-9127-8; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Verheggen FJ, 2007, J CHEM ECOL, V33, P2148, DOI 10.1007/s10886-007-9370-6; VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x; Ward A, 2002, J CHEM ECOL, V28, P515, DOI 10.1023/A:1014535910946; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	46	35	36	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115011	10.1371/journal.pone.0115011	http://dx.doi.org/10.1371/journal.pone.0115011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514321	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300026
J	Gargiulo, P; Banfi, C; Ghilardi, S; Magri, D; Giovannardi, M; Bonomi, A; Salvioni, E; Battaia, E; Filardi, PP; Tremoli, E; Agostoni, P				Gargiulo, Paola; Banfi, Cristina; Ghilardi, Stefania; Magri, Damiano; Giovannardi, Marta; Bonomi, Alice; Salvioni, Elisabetta; Battaia, Elisa; Filardi, Pasquale Perrone; Tremoli, Elena; Agostoni, Piergiuseppe			Surfactant-Derived Proteins as Markers of Alveolar Membrane Damage in Heart Failure	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; LUNG-FUNCTION; PULMONARY SURFACTANT; DIFFUSING-CAPACITY; CAPILLARY BARRIER; PLASMA; RECEPTOR; RAGE; EXERCISE; VENTILATION	Background: In heart failure (HF) alveolar-capillary membrane is abnormal. Surfactant-derived proteins (SPs) and plasma receptor for advanced-glycation-end-products (RAGE) have been proposed as lung damage markers. Methods: Eighty-nine chronic HF and 17 healthy subjects were evaluated by echocardiography, blood parameters, carbon monoxide lung diffusion (DLCO) and cardiopulmonary exercise test. We measured immature SP-B, mature SP-B, SP-A, SP-D and RAGE plasma levels. Results: Immature SP-B (arbitrary units), mature SP-A (ng/ml) and SP-D (ng/ml), but not mature SP-B (ng/ml) and RAGE (pg/ml) levels, were higher in HF than in controls [immature SP-B: 15.6 (13.1, 75th-25th interquartile range) Vs. 11.1 (6.4), p<0.01; SP-A, 29.6 (20.1) Vs. 18.3 (13.5), p=0.01; SP-D: 125 (90) Vs. 78 (58), p<0.01]. Immature SP-B, SP-A, SP-D and RAGE values were related to DLCO, peak oxygen consumption, ventilatory efficiency, and brain natriuretic peptide (BNP), whereas plasma mature SP-B was not. The DLCO Vs. immature SP-B correlation was the strongest one. At multivariate analysis, RAGE was associated to age and creatinine, SP-A to DLCO and BNP, SP-D to BNP, mature SP-B to DLCO and creatinine, and immature SP-B only but strongly to DLCO. Conclusions: Immature SP-B is the most reliable biological marker of alveolar-capillary membrane function in HF.	[Gargiulo, Paola] Inst Diagnost & Nucl Dev, Naples, Italy; [Banfi, Cristina; Ghilardi, Stefania; Giovannardi, Marta; Bonomi, Alice; Salvioni, Elisabetta; Tremoli, Elena; Agostoni, Piergiuseppe] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Milan, Italy; [Magri, Damiano] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy; [Battaia, Elisa] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy; [Filardi, Pasquale Perrone] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Tremoli, Elena] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Centro Cardiologico Monzino; Sapienza University Rome; University of Verona; University of Naples Federico II; University of Milan; University of Milan	Agostoni, P (corresponding author), Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Agostoni, Piergiuseppe/ABG-9556-2020; Salvioni, Elisabetta/ABD-9775-2020; Perrone Filardi, Pasquale/AAC-7590-2022; Gargiulo, Paola/K-6885-2016; Corrà, Ugo/AAF-8322-2020; Banfi, Cristina/G-6362-2018; Bonomi, Alice/AAB-6147-2020; TREMOLI, ELENA/I-8126-2018	Agostoni, Piergiuseppe/0000-0002-8345-6382; Gargiulo, Paola/0000-0003-4622-1725; Corrà, Ugo/0000-0002-9229-3298; Banfi, Cristina/0000-0003-3346-9879; Bonomi, Alice/0000-0001-5409-0791; Salvioni, Elisabetta/0000-0002-8448-7551; Magri, Damiano/0000-0002-0614-2961; TREMOLI, ELENA/0000-0002-0929-6106; GHILARDI, STEFANIA/0000-0001-9971-7965	Italian Ministry of health, Roma, Italy [2600721]	Italian Ministry of health, Roma, Italy	This study was carried out with the support of a grant from the Italian Ministry of health, Roma, Italy (Current research project 2013, BIO 12, ID 2600721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2000, J AM COLL CARDIOL, V36, P1600, DOI 10.1016/S0735-1097(00)00929-3; Agostoni P, 2005, EUR J HEART FAIL, V7, P498, DOI 10.1016/j.ejheart.2004.06.007; Agostoni P, 2011, EUR RESPIR J, V37, P841, DOI 10.1183/09031936.00045910; Agostoni P, 2007, EUR J HEART FAIL, V9, P827, DOI 10.1016/j.ejheart.2007.04.006; Agostoni P, 2006, EUR HEART J, V27, P2538, DOI 10.1093/eurheartj/ehl302; Agostoni P, 2013, RESP PHYSIOL NEUROBI, V188, P223, DOI 10.1016/j.resp.2013.04.005; Agostoni P, 2011, RESP PHYSIOL NEUROBI, V178, P256, DOI 10.1016/j.resp.2011.06.019; Agostoni P, 2010, AM HEART J, V159, P1067, DOI 10.1016/j.ahj.2010.03.034; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSIERES LM, 1995, EUR RESPIR J, V8, P959; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Contini M, 2013, INT J CARDIOL, V168, P2134, DOI 10.1016/j.ijcard.2013.01.277; COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; De Pasquale CG, 2005, CLIN EXP PHARMACOL P, V32, P622, DOI 10.1111/j.0305-1870.2005.04241.x; De Pasquale CG, 2004, CIRCULATION, V110, P1091, DOI 10.1161/01.CIR.0000140260.73611.FA; De Pasquale CG, 2003, CRIT CARE MED, V31, P1060, DOI 10.1097/01.CCM.0000059649.31659.22; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELBORN JS, 1990, EUR HEART J, V11, P75, DOI 10.1093/oxfordjournals.eurheartj.a059596; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Hill J, 2011, EUR HEART J, V32, P1918, DOI 10.1093/eurheartj/ehr124; HUANG YCT, 1994, CHEST, V105, P501, DOI 10.1378/chest.105.2.501; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kobayashi H, 2008, BIOMARKERS, V13, P385, DOI [10.1080/13547500801903651, 10.1080/13547500801903651 ]; Magri D, 2013, RESP MED, V107, P1617, DOI 10.1016/j.rmed.2013.07.019; Magri D, 2009, CIRC-HEART FAIL, V2, P175, DOI 10.1161/CIRCHEARTFAILURE.108.819607; Mukherjee TK, 2008, RESP PHYSIOL NEUROBI, V162, P210, DOI 10.1016/j.resp.2008.07.001; Paolillo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061877; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMEKEL B, 1992, THORAX, V47, P603, DOI 10.1136/thx.47.8.603; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Sorensen GL, 2007, IMMUNOBIOLOGY, V212, P381, DOI 10.1016/j.imbio.2007.01.003; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xie FY, 2013, J CARDIOVASC MED, V14, P461, DOI 10.2459/JCM.0b013e32835dbd24	41	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115030	10.1371/journal.pone.0115030	http://dx.doi.org/10.1371/journal.pone.0115030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514679	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300029
J	Chaves, AJ; Vergara-Alert, J; Busquets, N; Valle, R; Rivas, R; Ramis, A; Darji, A; Majo, N				Chaves, Aida J.; Vergara-Alert, Julia; Busquets, Nuria; Valle, Rosa; Rivas, Raquel; Ramis, Antonio; Darji, Ayub; Majo, Natalia			Neuroinvasion of the Highly Pathogenic Influenza Virus H7N1 Is Caused by Disruption of the Blood Brain Barrier in an Avian Model	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; CENTRAL-NERVOUS-SYSTEM; TIGHT JUNCTION PROTEINS; MICROVASCULAR ENDOTHELIAL-CELLS; A VIRUS; CEREBROSPINAL-FLUID; INFECTED CHICKENS; JAPANESE CHILDREN; CHOROID-PLEXUS; VIRAL ENTRY	Influenza A virus (IAV) causes central nervous system (CNS) lesions in avian and mammalian species, including humans. However, the mechanism used by IAV to invade the brain has not been determined. In the current work, we used chickens infected with a highly pathogenic avian influenza (HPAI) virus as a model to elucidate the mechanism of entry of IAV into the brain. The permeability of the BBB was evaluated in fifteen-day-old H7N1-infected and non-infected chickens using three different methods: (i) detecting Evans blue (EB) extravasation into the brain, (ii) determining the leakage of the serum protein immunoglobulin Y (IgY) into the brain and (iii) assessing the stability of the tight-junction (TJ) proteins zonula occludens-1 and claudin-1 in the chicken brain at 6, 12, 18, 24, 36 and 48 hours post- inoculation (hpi). The onset of the induced viremia was evaluated by quantitative real time RT-PCR (RT-qPCR) at the same time points. Viral RNA was detected from 18 hpi onward in blood samples, whereas IAV antigen was detected at 24 hpi in brain tissue samples. EB and IgY extravasation and loss of integrity of the TJs associated with the presence of viral antigen was first observed at 36 and 48 hpi in the telencephalic pallium and cerebellum. Our data suggest that the mechanism of entry of the H7N1 HPAI into the brain includes infection of the endothelial cells at early stages (24 hpi) with subsequent disruption of the TJs of the BBB and leakage of virus and serum proteins into the adjacent neuroparenchyma.	[Chaves, Aida J.; Vergara-Alert, Julia; Busquets, Nuria; Valle, Rosa; Rivas, Raquel; Ramis, Antonio; Darji, Ayub; Majo, Natalia] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Ramis, Antonio; Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Darji, Ayub] Inst Recerca & Tecnol Agroalimentaries, Barcelona, Spain	IRTA; Autonomous University of Barcelona; IRTA	Majo, N (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	natalia.majo@cresa.uab.cat	Masferrer, Natàlia Majó/AAV-3696-2021; Vergara-Alert, Júlia/I-5010-2015; Busquets, Núria/T-8431-2017	Vergara-Alert, Júlia/0000-0001-7484-444X; Chaves-Hernandez, Aida Jeannette/0000-0002-2856-7418; Majo, Natalia/0000-0003-0189-9751	European Project Specific Target Research Project, Euroflu; EU [5B-CT2007-044098]; Alban Program; European Union [E07D400404CR]	European Project Specific Target Research Project, Euroflu; EU(European Commission); Alban Program; European Union(European Commission)	This work was partially supported by the European Project Specific Target Research Project, Euroflu, and funded by the sixth Framework Program (FP6) of the EU grant 5B-CT2007-044098. Aida J. Chaves was supported by the Alban Program and the European Union Program of High Level Scholarships for Latin America scholarship E07D400404CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; ANDERSON DK, 1975, AM J PHYSIOL, V228, P415, DOI 10.1152/ajplegacy.1975.228.2.415; ANDERSON JR, 1983, J NEUROL SCI, V60, P181, DOI 10.1016/0022-510X(83)90061-8; Beato MS, 2007, VACCINE, V25, P4064, DOI 10.1016/j.vaccine.2007.02.042; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Chaves AJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-106; Chaves AJ, 2011, AVIAN PATHOL, V40, P163, DOI 10.1080/03079457.2011.551874; Christensen JE, 2006, J IMMUNOL, V176, P4235, DOI 10.4049/jimmunol.176.7.4235; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; DAVIDSON F, 2008, AVIAN IMMUNOLOGY; DAVIS LE, 1990, J NEUROL SCI, V97, P221, DOI 10.1016/0022-510X(90)90220-H; Davison F, 2008, AVIAN IMMUNOLOGY, P107, DOI 10.1016/B978-012370634-8.50009-3; del Valle J, 2008, J NEUROSCI METH, V174, P42, DOI 10.1016/j.jneumeth.2008.06.025; DELORME P, 1975, CELL TISSUE RES, V157, P535; FALANGOLA MF, 1995, J NEUROPATH EXP NEUR, V54, P497, DOI 10.1097/00005072-199507000-00003; Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; Fujimoto Y, 2000, EUR J PEDIATR, V159, P319, DOI 10.1007/s004310051280; Ge SJ, 2005, J NEUROSCI RES, V79, P421, DOI 10.1002/jnr.20313; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; HADGE D, 1980, DEV COMP IMMUNOL, V4, P501, DOI 10.1016/S0145-305X(80)80052-8; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kansagra SM, 2011, PEDIATR NEUROL, V45, P400, DOI 10.1016/j.pediatrneurol.2011.09.007; Kaptanoglu E, 2004, J CLIN NEUROSCI, V11, P879, DOI 10.1016/j.jocn.2004.04.005; Kim KJ, 2013, ANN REHABIL MED-ARM, V37, P286, DOI 10.5535/arm.2013.37.2.286; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Kobayashi Y, 1996, J COMP PATHOL, V114, P131, DOI 10.1016/S0021-9975(96)80003-X; Kuang F, 2004, INT J NEUROSCI, V114, P575, DOI 10.1080/00207450490422731; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lin BW, 2000, BRAIN RES, V865, P237, DOI 10.1016/S0006-8993(00)02228-9; Long SS, 2005, ADV EXP MED BIOL, V568, P1; Maclean AG, 2005, J MED PRIMATOL, V34, P237, DOI 10.1111/j.1600-0684.2005.00121.x; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Martin A, 2010, CLIN INFECT DIS, V50, pE50, DOI 10.1086/651501; Maxie GM, 2007, JUBB KENNEDY PALMERS, P393; Mims CA, 1995, MIMS PATHOGENESIS IN, P9; Mims CA, 1995, MIMS PATHOGENESIS IN, P60; MIZUGUCHI M, 1995, J NEUROL NEUROSUR PS, V58, P555, DOI 10.1136/jnnp.58.5.555; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Pelegri C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002; Ravenholt R., 1982, LANCET, V320, P860; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Romero IA, 2000, J VIROL, V74, P6021, DOI 10.1128/JVI.74.13.6021-6030.2000; Rowe T, 2003, AVIAN DIS, V47, P1122, DOI 10.1637/0005-2086-47.s3.1122; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; Ruggieri M, 1998, PEDIATRICS, V101, P112, DOI 10.1542/peds.101.1.112; Ryan G, 2005, J NEUROVIROL, V11, P337, DOI 10.1080/13550280500186445; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Shinya K, 2005, ARCH VIROL, V150, P1653, DOI 10.1007/s00705-005-0539-4; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; SOKRAB TEO, 1988, ACTA NEUROPATHOL, V75, P557, DOI 10.1007/BF00686200; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Suja MS, 2009, CLIN NEUROPATHOL, V28, P113; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; SWAYNE DE, 1989, AVIAN PATHOL, V18, P385, DOI 10.1080/03079458908418613; Swayne DE., 2008, AVIAN INFLUENZA, V1, P87, DOI 10.1002/9780813818634.ch5; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Togashi T, 2004, VIRUS RES, V103, P75, DOI 10.1016/j.virusres.2004.02.016; Togashi T, 2001, INT CONGR SER, V1219, P609, DOI 10.1016/S0531-5131(01)00406-X; Toovey Stephen, 2008, Travel Med Infect Dis, V6, P114, DOI 10.1016/j.tmaid.2008.03.003; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Weitkamp JH, 2004, PEDIATR INFECT DIS J, V23, P259, DOI 10.1097/01.inf.0000115631.99896.41; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Yoshikawa H, 2001, J CHILD NEUROL, V16, P885, DOI 10.1177/088307380101601204	80	15	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115138	10.1371/journal.pone.0115138	http://dx.doi.org/10.1371/journal.pone.0115138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506836	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100053
J	Loera, B; Converso, D; Viotti, S				Loera, Barbara; Converso, Daniela; Viotti, Sara			Evaluating the Psychometric Properties of the Maslach Burnout Inventory-Human Services Survey (MBI-HSS) among Italian Nurses: How Many Factors Must a Researcher Consider?	PLOS ONE			English	Article							FIT INDEXES; VALIDITY; CONSISTENCY; METAANALYSIS; COEFFICIENT; VALIDATION; INVARIANCE; SAMPLE	Background: The Maslach Burnout Inventory (MBI) is the mainstream measure for burnout. However, its psychometric properties have been questioned, and alternative measurement models of the inventory have been suggested. Aims: Different models for the number of items and factors of the MBI-HSS, the version of the Inventory for the Human Service sector, were tested in order to identify the most appropriate model for measuring burnout in Italy. Methods: The study dataset consisted of a sample of 925 nurses. Ten alternative models of burnout were compared using confirmatory factor analysis. The psychometric properties of items and reliability of the MBI-HSS subscales were evaluated. Results: Item malfunctioning may confound the MBI-HSS factor structure. The analysis confirmed the factorial structure of the MBI-HSS with a three-dimensional, 20-item assessment. Conclusions: The factorial structure underlying the MBI-HSS follows Maslach's definition when items are reduced from the original 22 to a 20-item set. Alternative models, either with fewer items or with an increased number of latent dimensions in the burnout structure, do not yield better results to justify redefining the item set or theoretically revising the syndrome construct.	[Loera, Barbara; Converso, Daniela; Viotti, Sara] Univ Turin, Dept Psychol, Turin, Italy	University of Turin	Converso, D (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	daniela.converso@unito.it	Loera, Barbara/AAA-5418-2020; viotti, sara/L-2650-2015; Converso, Daniela/K-6369-2017	viotti, sara/0000-0001-9026-9334; Converso, Daniela/0000-0002-6780-4746; loera, barbara/0000-0002-4210-1796	Fondazione CRT [R.O.L 2624/2011]; Department of Psychology, University of Turin	Fondazione CRT(Fondazione CRT); Department of Psychology, University of Turin	The data collection was originally promoted by an initiative of the local government of Piedmont Region, Italy, started with the project "Organizational well-being in the health sector'' (D.G.R 22-7777) according to the objectives of the healthcare local programme 2007-2010. In the further years the research project was developed and continued with the grant (R.O.L 2624/2011), "Contrasting the malaise and promoting well-being among workers in heath care sector'', funded by Fondazione CRT and Department of Psychology, University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Beckstead JW, 2002, INT J NURS STUD, V39, P785, DOI 10.1016/S0020-7489(02)00012-3; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen KA, 1989, STRUCTURAL EQUATIONS; BOYLE GJ, 1985, BRIT J CLIN PSYCHOL, V24, P45, DOI 10.1111/j.2044-8260.1985.tb01312.x; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Bryant FB, 2012, STRUCT EQU MODELING, V19, P372, DOI 10.1080/10705511.2012.687671; Chao SF, 2011, J INTELL DISABIL RES, V55, P529, DOI 10.1111/j.1365-2788.2011.01413.x; CONVERSO D, 2009, RISORSA UOMO, V15, P241; Cordoba L, 2011, COLOMB MEDICA, V42, P286; Densten IL, 2001, J ORGAN BEHAV, V22, P833, DOI 10.1002/job.115; Gil-Monte PR, 2005, REV SAUDE PUBL, V39, P1, DOI 10.1590/S0034-89102005000100001; GREEN DE, 1991, J SOC BEHAV PERS, V6, P453; Hallberg UE, 2004, EUR J PSYCHOL ASSESS, V20, P320, DOI 10.1027/1015-5759.20.4.320; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; J?reskog K.G., 2018, LISREL 10 WINDOWS CO; JORESKOG KG, 1981, LISREL USERS GUIDE; Kalliath TJ, 2000, WORK STRESS, V14, P35, DOI 10.1080/026783700417212; Kanste Outi, 2006, Nurs Health Sci, V8, P201, DOI 10.1111/j.1442-2018.2006.00283.x; Kim H, 2009, RES SOCIAL WORK PRAC, V19, P325, DOI 10.1177/1049731508318550; Lee HF, 2013, J NURS MANAGE, V21, P648, DOI 10.1111/j.1365-2834.2012.01427.x; Loera B, 2013, PSICOLOGIA SALUTE, V1, P27, DOI DOI 10.3280/PDS2013-001002; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1997, EVALUATING STRESS BO, V3rd ed., P191; Maslach C, 1982, BURNOUT COST CARING; Maslach C.J.S., 1997, MASLACH BURNOUT INVE, V3rd; Meszaros V, 2014, STRESS HEALTH, V30, P82, DOI 10.1002/smi.2481; Oh SH, 2009, CHILD YOUTH SERV REV, V31, P206, DOI 10.1016/j.childyouth.2008.07.012; Olivares Faundez V., 2009, CIENCIA TRABAJO, V11, P160; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Pisanti R, 2013, J ADV NURS, V69, P697, DOI 10.1111/j.1365-2648.2012.06114.x; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Richardsen AM, 2004, J OCCUP ORGAN PSYCH, V77, P377, DOI 10.1348/0963179041752691; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, DOI DOI 10.1037/1072-5245.15.3.235; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Sirigatti S., 1993, ADAPTATION ADJUSTMEN; Sirigatti S., 1992, B PSICOLOGIA APPL, V1, P3; Sirigatti S, 1991, B PSICOLOGIA APPL, V200, P39; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Stefanile C., 1988, B PSICOLOGIA APPL, V187, P29; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vanheule S, 2007, STRESS HEALTH, V23, P87, DOI 10.1002/smi.1124; Viotti Sara, 2012, G Ital Med Lav Ergon, V34, pB52; Wheeler DL, 2011, EDUC PSYCHOL MEAS, V71, P231, DOI 10.1177/0013164410391579; Worley JA, 2008, EDUC PSYCHOL MEAS, V68, P797, DOI 10.1177/0013164408315268; ZERBE WJ, 1987, ACAD MANAGE REV, V12, P250, DOI 10.2307/258533; Ziegler M, 2013, EUR J PSYCHOL ASSESS, V29, P81, DOI 10.1027/1015-5759/a000167	54	82	86	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114987	10.1371/journal.pone.0114987	http://dx.doi.org/10.1371/journal.pone.0114987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25501716	Green Published, gold			2022-12-26	WOS:000346375400066
J	Shearer, TL; Snell, TW; Hay, ME				Shearer, Tonya L.; Snell, Terry W.; Hay, Mark E.			Gene Expression of Corals in Response to Macroalgal Competitors	PLOS ONE			English	Article							BENTHIC ALGAE; MONTASTRAEA-ANNULARIS; ACROPORA-MILLEPORA; CARIBBEAN CORALS; THERMAL-STRESS; CYANOBACTERIA; TEMPERATURE; RESILIENCE; CONTACT; REEFS	As corals decline and macroalgae proliferate on coral reefs, coral-macroalgal competition becomes more frequent and ecologically important. Whether corals are damaged by these interactions depends on susceptibility of the coral and traits of macroalgal competitors. Investigating changes in gene expression of corals and their intracellular symbiotic algae, Symbiodinium, in response to contact with different macroalgae provides insight into the biological processes and cellular pathways affected by competition with macroalgae. We evaluated the gene expression profiles of coral and Symbiodinium genes from two confamilial corals, Acropora millepora and Montipora digitata, after 6 h and 48 h of contact with four common macroalgae that differ in their allelopathic potency to corals. Contacts with macroalgae affected different biological pathways in the more susceptible (A. millepora) versus the more resistant (M. digitata) coral. Genes of coral hosts and of their associated Symbiodinium also responded in species-specific and time-specific ways to each macroalga. Changes in number and expression intensity of affected genes were greater after 6 h compared to 48 h of contact and were greater following contact with Chlorodesmis fastigiata and Amphiroa crassa than following contact with Galaxaura filamentosa or Turbinaria conoides. We documented a divergence in transcriptional responses between two confamilial corals and their associated Symbiodinium, as well as a diversity of dynamic responses within each coral species with respect to the species of macroalgal competitor and the duration of exposure to that competitor. These responses included early initiation of immune processes by Montipora, which is more resistant to damage after long-term macroalgal contact. Activation of the immune response by corals that better resist algal competition is consistent with the hypothesis that some macroalgal effects on corals may be mediated by microbial pathogens.	[Shearer, Tonya L.; Snell, Terry W.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Science Foundation [OCE 0929119]; National Institutes of Health [U01 TW007401-01]; Teasley Endowment to the Georgia Institute of Technology; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [G12-RR03034]; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment to the Georgia Institute of Technology; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by the National Science Foundation (OCE 0929119) (http://www.nsf.gov/div/index.jsp?div-oce), the National Institutes of Health (U01 TW007401-01) (http://www.nih.gov), and the Teasley Endowment to the Georgia Institute of Technology. The Morehouse School of Medicine microarray facility is supported by the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) (G12-RR03034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bay LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061736; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Puill-Stephan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039099; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Shearer TL, 2012, CORAL REEFS, V31, P1177, DOI 10.1007/s00338-012-0943-7; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x	45	6	7	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114525	10.1371/journal.pone.0114525	http://dx.doi.org/10.1371/journal.pone.0114525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500576	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400034
J	Xu, L; Wang, DX; Lu, LL; Jin, L; Liu, JW; Song, DY; Guo, ZW; Xiao, M				Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min			Purification, Cloning, Characterization, and N-Glycosylation Analysis of a Novel beta-Fructosidase from Aspergillus oryzae FS4 Synthesizing Levan- and Neolevan-Type Fructooligosaccharides	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; INVERTASE; FRUCTOSYLTRANSFERASE; THERMOSTABILITY; PROTEIN; FRUCTOFURANOSIDASE; 6-KESTOSE; SUCROSE; CHAIN	beta-Fructosidases are a widespread group of enzymes that catalyze the hydrolysis of terminal fructosyl units from various substrates. These enzymes also exhibit transglycosylation activity when they function with high concentrations of sucrose, which is used to synthesize fructooligosaccharides (FOS) in the food industry. A beta-fructosidase (BfrA) with high transglycosylation activity was purified from Aspergillus oryzae FS4 as a monomeric glycoprotein. Compared with the most extensively studied Aspergillus spp. fructosidases that synthesize inulin-type beta-(2-1)-linked FOS, BfrA has unique transfructosylating property of synthesizing levan- and neolevan-type beta-(2-6)-linked FOS. The coding sequence (bfrAFS4, 1.86 kb) of BfrA was amplified and expressed in Escherichia coli and Pichia pastoris. Both native and recombinant proteins showed transfructosylation and hydrolyzation activities with broad substrate specificity. These proteins could hydrolyze the following linkages: Glc alpha-1, 2-beta Fru; Glc alpha-1, 3-alpha Fru; and Glc alpha-1, 5-beta Fru. Compared with the unglycosylated E. coli-expressed BfrA (E. BfrA), the Nglycosylated native (N. BfrA) and the P. pastoris-expressed BfrA (P. BfrA) were highly stable at a wide pH range (pH 4 to 11), and significantly more thermostable at temperatures up to 50 degrees C with a maximum activity at 55 degrees C. Using sucrose as substrate, the Km and k(cat) values for total activity were 37.19 +/- 5.28 mM and 1.0016 +/- 0.039 x 10(4) s(-1) for N. BfrA. Moreover, 10 of 13 putative N-glycosylation sites were glycosylated on N. BfrA, and N-glycosylation was essential for enzyme thermal stability and optima activity. Thus, BfrA has demonstrated as a well-characterized A. oryzae fructosidase with unique transfructosylating capability of synthesizing levan- and neolevan-type FOS.	[Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Xiao, M (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	minxiao@sdu.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB822102]; National Major Scientific and Technological Special Project for Significant New Drugs Development [2012ZX09502001-005]; National High Technology Research and Development Program of China (863 Program) [2012AA021504]; National Natural Science Foundation of China [31070064, 31301155]; Shandong Provincial Natural Science Foundation, China [ZR2013CQ043]; Independent Innovation Foundation of Shandong University, IIFSDU [2012GN013, 2012TS014]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Major Scientific and Technological Special Project for Significant New Drugs Development; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University, IIFSDU	This work was supported by the Major State Basic Research Development Program of China (973 Program, 2012CB822102) http://www.973.gov.cn/English/Index.aspx, the National Major Scientific and Technological Special Project for Significant New Drugs Development (2012ZX09502001-005), http://www.nmp.gov.cn/, the National High Technology Research and Development Program of China (863 Program, 2012AA021504), http://www.863.gov.cn/, the National Natural Science Foundation of China (31070064, 31301155), http://www.nsfc.gov.cn/publish/portal1/, Shandong Provincial Natural Science Foundation, China (ZR2013CQ043) http://www.sdnsf.gov.cn/portal/, and the Independent Innovation Foundation of Shandong University, IIFSDU (2012GN013, 2012TS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Aslam A, 2013, PAK J BOT, V45, P285; Bao LG, 2001, ARCH BIOCHEM BIOPHYS, V386, P17, DOI 10.1006/abbi.2000.2187; Boer E, 2004, ANTON LEEUW INT J G, V86, P121, DOI 10.1023/B:ANTO.0000036135.69810.df; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Clark SE, 2004, PROTEIN ENG DES SEL, V17, P245, DOI 10.1093/protein/gzh028; Du LQ, 2010, WORLD J MICROB BIOT, V26, P419, DOI 10.1007/s11274-009-0184-2; Farine S, 2001, APPL MICROBIOL BIOT, V55, P55, DOI 10.1007/s002530000493; Fialho MB, 2013, MYCOSCIENCE, V54, P198, DOI 10.1016/j.myc.2012.09.012; Gallagher JA, 2004, J EXP BOT, V55, P557, DOI 10.1093/jxb/erh056; Ghazi I, 2007, J BIOTECHNOL, V128, P204, DOI 10.1016/j.jbiotec.2006.09.017; HASEGAWA M, 1992, EUR J BIOCHEM, V210, P9, DOI 10.1111/j.1432-1033.1992.tb17384.x; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Kilian S, 2002, WORLD J MICROB BIOT, V18, P637, DOI 10.1023/A:1016808015630; Kurakake M, 2010, J AGR FOOD CHEM, V58, P488, DOI 10.1021/jf903303w; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Menendez C, 2013, APPL MICROBIOL BIOT, V97, P1201, DOI 10.1007/s00253-012-4270-2; Mona MR., 2009, AUST J BASIC APPL SC, V3, P1910; MORENO S, 1990, BIOCHEM J, V267, P697, DOI 10.1042/bj2670697; MURAMATSU K, 1994, BIOSCI BIOTECH BIOCH, V58, P1642, DOI 10.1271/bbb.58.1642; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; RODRIGUEZ J, 1995, BIOCHEM J, V306, P235, DOI 10.1042/bj3060235; Rubio MC, 2002, PHYTOCHEMISTRY, V61, P605, DOI 10.1016/S0031-9422(02)00336-9; RUBIO MC, 1995, CURR MICROBIOL, V31, P80, DOI 10.1007/BF00294280; Sangeetha PT, 2005, TRENDS FOOD SCI TECH, V16, P442, DOI 10.1016/j.tifs.2005.05.003; Sangeetha PT, 2005, PROCESS BIOCHEM, V40, P1085, DOI 10.1016/j.procbio.2004.03.009; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Tahiri M, 2003, AM J CLIN NUTR, V77, P449, DOI 10.1093/ajcn/77.2.449; TERASHIMA M, 1994, EUR J BIOCHEM, V226, P249, DOI 10.1111/j.1432-1033.1994.tb20048.x; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x	35	9	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114793	10.1371/journal.pone.0114793	http://dx.doi.org/10.1371/journal.pone.0114793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501957	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400052
J	Berg, A; Patel, S; Gonca, M; David, C; Otterdal, K; Ueland, T; Dalen, I; Kvaloy, JT; Mollnes, TE; Aukrust, P; Langeland, N				Berg, Aase; Patel, Sam; Gonca, Miguel; David, Catarina; Otterdal, Kari; Ueland, Thor; Dalen, Ingvild; Kvaloy, Jan T.; Mollnes, Tom E.; Aukrust, Pal; Langeland, Nina			Cytokine Network in Adults with Falciparum Malaria and HIV-1: Increased IL-8 and IP-10 Levels Are Associated with Disease Severity	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; IMMUNE ACTIVATION; INFECTED ADULTS; CHILDREN; CHEMOKINES; PREVALENCE; PATHOGENESIS; INDIVIDUALS; EXHAUSTION	Background: Co-infection with malaria and HIV increases the severity and mortality of both diseases, but the cytokine responses related to this co-infection are only partially characterised. The aim of this study was to explore cytokine responses in relation to severity and mortality in malaria patients with and without HIV co-infection. Methods: This was a prospective cross-sectional study. Clinical data and blood samples were collected from adults in Mozambique. Plasma was analysed for 21 classical pro-and anti-inflammatory cytokines, including interleukins, interferons, and chemokines. Results: We included 212 in-patients with fever and/or suspected malaria and 56 healthy controls. Falciparum malaria was diagnosed in 131 patients, of whom 70 were co-infected with HIV-1. The malaria patients had marked increases in their cytokine responses compared with the healthy controls. Some of these changes, particularly interleukin 8 (IL-8) and interferon-gamma-inducing protein 10 (IP-10) were strongly associated with falciparum malaria and disease severity. Both these chemokines were markedly increased in patients with falciparum malaria as compared with healthy controls, and raised levels of IL-8 and IP-10 were associated with increased disease severity, even after adjusting for relevant confounders. For IL-8, particularly high levels were found in malaria patients that were co-infected with HIV and in those who died during hospitalization. Interpretations: Our findings underscore the complex role of inflammation during infection with P. falciparum, and suggest a potential pathogenic role for IL-8 and IP-10. However, the correlations do not necessarily mean any causal relationship, and further both clinical and mechanistic research is necessary to elucidate the role of cytokines in pathogenesis and protection during falciparum malaria.	[Berg, Aase] Stavanger Univ Hosp, Dept Med, Stavanger, Norway; [Berg, Aase; Patel, Sam; Gonca, Miguel; David, Catarina] Cent Hosp Maputo, Dept Med, Maputo, Mozambique; [Berg, Aase; Langeland, Nina] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Otterdal, Kari; Ueland, Thor; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Dalen, Ingvild; Kvaloy, Jan T.] Stavanger Univ Hosp, Res Dept, Stavanger, Norway; [Kvaloy, Jan T.] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Mollnes, Tom E.; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Mollnes, Tom E.; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Ueland, Thor; Mollnes, Tom E.; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Mollnes, Tom E.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway; [Mollnes, Tom E.] Res Lab Nordland Hosp, Bodo, Norway; [Mollnes, Tom E.] Univ Tromso, Fac Hlth Sci, Tromso, Norway; [Langeland, Nina] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	Stavanger University Hospital; University of Bergen; University of Oslo; National Hospital Norway; Stavanger University Hospital; Universitetet i Stavanger; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; University of Bergen; Haukeland University Hospital	Berg, A (corresponding author), Stavanger Univ Hosp, Dept Med, Stavanger, Norway.	beaa@sus.no	Berg, Aase/AAS-7666-2020; Mollnes, Tom/ABI-5183-2020	Berg, Aase/0000-0002-6937-3580; 	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Medical Association for Infectious Diseases	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Medical Association for Infectious Diseases	Funding was provided by the Western Norway Regional Health Authority to AB. Economic support was also received from the National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway and the Medical Association for Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Gamra Maha M. M., 2001, Journal of the Egyptian Society of Parasitology, V31, P905; [Anonymous], NORMAS TRATAMENTO MA; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Berg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088257; Berg A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-252; Bostrom S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-109; Brentlinger PE, 2007, ARCH INTERN MED, V167, P1827, DOI 10.1001/archinte.167.17.1827; BURGMANN H, 1995, CLIN IMMUNOL IMMUNOP, V76, P32, DOI 10.1006/clin.1995.1084; Chalwe V, 2012, INT J EPIDEMIOL, V41, P890, DOI 10.1093/ije/dys079; Clark IA, 2000, PARASITOL TODAY, V16, P451, DOI 10.1016/S0169-4758(00)01757-9; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Davenport GC, 2012, AM J HEMATOL, V87, P652, DOI 10.1002/ajh.23200; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Oliveira AM, 2011, AM J TROP MED HYG, V85, P1002, DOI 10.4269/ajtmh.2011.11-0365; Dettling M, 2004, J MULTIVARIATE ANAL, V90, P106, DOI 10.1016/j.jmva.2004.02.012; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Ferrando-Martinez S, 2011, CURR HIV RES, V9, P289, DOI 10.2174/157016211797636008; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Hosmer SW, 2000, APPL LOGISTIC REGRES; Ioannidis LJ, 2014, PARASITOLOGY, V141, P602, DOI 10.1017/S0031182013001984; Iriemenam NC, 2009, AFR HEALTH SCI, V9, P66; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; John CC, 2008, CYTOKINE, V41, P204, DOI 10.1016/j.cyto.2007.12.008; Lourembam SD, 2013, CYTOKINE, V64, P503, DOI 10.1016/j.cyto.2013.08.007; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Mahanta A, 2014, CYTOKINE, V65, P210, DOI 10.1016/j.cyto.2013.11.001; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Ronsholt FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065182; Sinha S, 2010, EUR CYTOKINE NETW, V21, P232, DOI 10.1684/ecn.2010.0208; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; WHO, 2007, HIV AIDS PROGR; World Health Organization, 2011, GUID TREATM MAL	45	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114480	10.1371/journal.pone.0114480	http://dx.doi.org/10.1371/journal.pone.0114480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503583	Green Submitted, Green Published, gold			2022-12-26	WOS:000347146700029
J	Hsu, CC; Wu, PS; Chen, TC; Yu, CW; Tsai, WC; Wu, KQ; Wu, WL; Chen, WH; Chen, HH				Hsu, Chia-Chi; Wu, Pei-Shan; Chen, Tien-Chih; Yu, Chun-Wei; Tsai, Wen-Chieh; Wu, Keqiang; Wu, Wen-Luan; Chen, Wen-Huei; Chen, Hong-Hwa			Histone Acetylation Accompanied with Promoter Sequences Displaying Differential Expression Profiles of B-Class MADS-Box Genes for Phalaenopsis Floral Morphogenesis	PLOS ONE			English	Article							TRANSIENT TRANSFORMATION; EPIGENETIC MAINTENANCE; FLOWER DEVELOPMENT; PROTOPLAST SYSTEM; HOMEOTIC GENES; ORGAN IDENTITY; EVOLUTION; ORCHID; TRANSCRIPTION; ELEMENTS	Five B-class MADS-box genes, including four APETALA3 (AP3)-like PeMADS2 similar to 5 and one PISTILLATA (PI)-like PeMADS6, specify the spectacular flower morphology in orchids. The PI-like PeMADS6 ubiquitously expresses in all floral organs. The four AP3-like genes, resulted from two duplication events, express ubiquitously at floral primordia and early floral organ stages, but show distinct expression profiles at late floral organ primordia and floral bud stages. Here, we isolated the upstream sequences of PeMADS2 similar to 6 and studied the regulatory mechanism for their distinct gene expression. Phylogenetic footprinting analysis of the 1.3-kb upstream sequences of AP3-like PeMADS2 similar to 5 showed that their promoter regions have sufficiently diverged and contributed to their subfunctionalization. The amplified promoter sequences of PeMADS2,6 could drive beta-glucuronidase (GUS) gene expression in all floral organs, similar to their expression at the floral primordia stage. The promoter sequence of PeMADS4, exclusively expressed in lip and column, showed a 1.6 similar to 3-fold higher expression in lip/column than in sepal/petal. Furthermore, we noted a 4.9-fold increase in histone acetylation (H3K9K14ac) in the translation start region of PeMADS4 in lip as compared in petal. All these results suggest that the regulation via the upstream sequences and increased H3K9K14ac level may act synergistically to display distinct expression profiles of the AP3-like genes at late floral organ primordia stage for Phalaenopsis floral morphogenesis.	[Hsu, Chia-Chi; Wu, Pei-Shan; Chen, Tien-Chih; Wu, Wen-Luan; Chen, Hong-Hwa] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Yu, Chun-Wei; Wu, Keqiang] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Chen, Wen-Huei; Chen, Hong-Hwa] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Cheng Kung University	Chen, HH (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	hhchen@mail.ncku.edu.tw	Wu, Keqiang/C-9743-2013	Wu, Keqiang/0000-0002-5791-3594	National Science Council, Taiwan [NSC 102-2811-B-006-022]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (Grant no.: NSC 102-2811-B-006-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Aceto S, 2010, J HERED, V101, P124, DOI 10.1093/jhered/esp082; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Blachutzik JO, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-28; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Bulyk ML, 2004, GENOME BIOL, V5; Burgos-Rivera B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051388; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chuzhanova NA, 2000, GENE, V254, P9, DOI 10.1016/S0378-1119(00)00308-5; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; Denecke J, 2012, PLANT CELL, V24, P1316, DOI 10.1105/tpc.112.096362; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DOLAN JW, 1991, BIOCHIM BIOPHYS ACTA, V1088, P155, DOI 10.1016/0167-4781(91)90051-M; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hill TA, 1998, DEVELOPMENT, V125, P1711; Honma T, 2000, DEVELOPMENT, V127, P2021; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Hsu CT, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-60; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; LI YH, 1994, PLANT CELL REP, V13, P661, DOI 10.1007/BF00231619; Luo M, 2012, J EXP BOT, V63, P3297, DOI 10.1093/jxb/ers059; Mondragon-Palomino M, 2008, TRENDS PLANT SCI, V13, P51, DOI 10.1016/j.tplants.2007.11.007; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Pan ZJ, 2011, PLANT CELL PHYSIOL, V52, P1515, DOI 10.1093/pcp/pcr092; Roudier F, 2009, TRENDS GENET, V25, P511, DOI 10.1016/j.tig.2009.09.013; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; Sambrook J., 2001, MOL CLONING LAB MANU; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; WANG YC, 1988, PLANT MOL BIOL, V11, P433, DOI 10.1007/BF00039024; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weitzman Jonathan B, 2003, J Biol, V2, P9, DOI 10.1186/1475-4924-2-9; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Xu FY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-497; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang SH, 2002, J EXP BOT, V53, P1899, DOI 10.1093/jxb/erf055; Zhang G, 2003, PLANT CELL REP, V21, P860, DOI 10.1007/s00299-003-0585-x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	73	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e106033	10.1371/journal.pone.0106033	http://dx.doi.org/10.1371/journal.pone.0106033			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501842	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700002
J	Wang, GW; Lv, C; Shi, ZR; Zeng, RT; Dong, XY; Zhang, WD; Liu, RH; Shan, L; Shen, YH				Wang, Guo-Wei; Lv, Chao; Shi, Zhi-Ran; Zeng, Ren-Tao; Dong, Xue-Yun; Zhang, Wei-Dong; Liu, Run-Hui; Shan, Lei; Shen, Yun-Heng			Abieslactone Induces Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinomas through the Mitochondrial Pathway and the Generation of Reactive Oxygen Species	PLOS ONE			English	Article							OXIDATIVE STRESS; S-PHASE; BAX ACTIVATION; CANCER; DRUG; TRITERPENOIDS; TRANSLOCATION; PROGRESSION; INHIBITION; MECHANISMS	Abieslactone is a triterpenoid lactone isolated from Abies plants. Previous studies have demonstrated that its derivative abiesenonic acid methyl ester possesses anti-tumor-promoting activity in vitro and in vivo. In the present study, cell viability assay demonstrated that abieslactone had selective cytotoxicity against human hepatoma cell lines. Immunostaining experiments revealed that abieslactone induced HepG2 and SMMC7721 cell apoptosis. Flow cytometry and western blot analysis showed that the apoptosis was associated with cell cycle arrest during the G(1) phase, up-regulation of p53 and p21, and down-regulation of CDK2 and cyclin D1. Furthermore, our results revealed that induction of apoptosis through a mitochondrial pathway led to upregulation of Bax, down-regulation of Bcl-2, mitochondrial release of cytochrome c, reduction of mitochondrial membrane potential (MMP), and activation of caspase cascades (Casp-9 and -3). Activation of caspase cascades also resulted in the cleavage of PARP fragment. Involvement of the caspase apoptosis pathway was confirmed using caspase inhibitor Z-VAD-FMK pretreatment. Recent studies have shown that ROS is upstream of Akt signal in mitochondria-mediated hepatoma cell apoptosis. Our results showed that the accumulation of ROS was detected in HepG2 cells when treated with abieslactone, and ROS scavenger partly blocked the effects of abieslactone-induced HepG2 cell death. In addition, inactivation of total and phosphorylated Akt activities was found to be involved in abieslactone-induced HepG2 cell apoptosis. Therefore, our findings suggested that abieslactone induced G(1) cell cycle arrest and caspase-dependent apoptosis via the mitochondrial pathway and the ROS/Akt pathway in HepG2 cells.	[Wang, Guo-Wei; Zhang, Wei-Dong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Lv, Chao; Shi, Zhi-Ran; Zeng, Ren-Tao; Zhang, Wei-Dong; Liu, Run-Hui; Shan, Lei; Shen, Yun-Heng] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Lv, Chao; Dong, Xue-Yun] Fujian Univ Tradit Chinese Med, Sch Pharm, Fujian 350108, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Fujian University of Traditional Chinese Medicine	Shan, L (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China.	shanleicn@126.com; shenyunheng@hotmail.com	Zhang, Weidong/E-6563-2016	Zhang, Weidong/0000-0002-2433-6823	NCET Foundation; NSFC [81230090]; Shanghai Leading Academic Discipline Project [B906]; Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products [10DZ2251300]; Scientific Foundation of Shanghai China [12401900801, 13401900101]; National Major Project of China [2011ZX09307-002-03]; National Key Technology R&D Program of China [2012BAI29B06]	NCET Foundation; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products; Scientific Foundation of Shanghai China; National Major Project of China; National Key Technology R&D Program of China(National Key Technology R&D Program)	The work was supported by program NCET Foundation, NSFC (81230090), Shanghai Leading Academic Discipline Project (B906), Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products (10DZ2251300), the Scientific Foundation of Shanghai China (12401900801, 13401900101), National Major Project of China (2011ZX09307-002-03) and the National Key Technology R&D Program of China (2012BAI29B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Breitenstein S, 2009, WORLD J SURG, V33, P797, DOI 10.1007/s00268-008-9878-0; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chatterjee S, 2008, TOXICOL LETT, V177, P83, DOI 10.1016/j.toxlet.2007.12.010; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Dong Y, 1997, LIFE SCI, V60, pPL135, DOI 10.1016/S0024-3205(96)00695-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; HOLMES FA, 1991, J NATL CANCER I, V83, P1797, DOI 10.1093/jnci/83.24.1797-a; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kawamori T, 1999, CANCER RES, V59, P597; Lavoie S, 2012, ORG LETT, V14, P1504, DOI 10.1021/ol300237f; Li XG, 2013, CLIN CANCER RES, V19, P2917, DOI 10.1158/1078-0432.CCR-12-3258; Li YL, 2012, TETRAHEDRON, V68, P7763, DOI 10.1016/j.tet.2012.07.047; Li YL, 2012, PHYTOCHEMISTRY, V81, P159, DOI 10.1016/j.phytochem.2012.05.032; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MATSUNAGA S, 1965, CHEM COMMUN, P525, DOI 10.1039/c19650000525; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Oh SH, 2004, BIOCHEM PHARMACOL, V68, P1845, DOI 10.1016/j.bcp.2004.06.021; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Pathak N, 2007, TOXICOL LETT, V169, P95, DOI 10.1016/j.toxlet.2006.12.009; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5; TAKAYASU J, 1990, CANCER LETT, V53, P141, DOI 10.1016/0304-3835(90)90206-D; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Xia JH, 2012, PHYTOCHEMISTRY, V74, P178, DOI 10.1016/j.phytochem.2011.11.011; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang Y, 2013, MOL MED REP, V8, P967, DOI 10.3892/mmr.2013.1640; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018	45	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115151	10.1371/journal.pone.0115151	http://dx.doi.org/10.1371/journal.pone.0115151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502685	gold, Green Submitted, Green Published			2022-12-26	WOS:000347146700095
J	Allmann, S; Mazet, M; Ziebart, N; Bouyssou, G; Fouillen, L; Dupuy, JW; Bonneu, M; Moreau, P; Bringaud, F; Boshart, M				Allmann, Stefan; Mazet, Muriel; Ziebart, Nicole; Bouyssou, Guillaume; Fouillen, Laetitia; Dupuy, Jean-William; Bonneu, Marc; Moreau, Patrick; Bringaud, Frederic; Boshart, Michael			Triacylglycerol Storage in Lipid Droplets in Procyclic Trypanosoma brucei	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LEISHMANIA-MAJOR; BLOOD-STREAM; PHOSPHATE DIKINASE; BETA-OXIDATION; CULTURE FORMS; TSETSE-FLY; METABOLISM; IDENTIFICATION; ORGANELLE	Carbon storage is likely to enable adaptation of trypanosomes to nutritional challenges or bottlenecks during their stage development and migration in the tsetse. Lipid droplets are candidates for this function. This report shows that feeding of T. brucei with oleate results in a 4-5 fold increase in the number of lipid droplets, as quantified by confocal fluorescence microscopy and by flow cytometry of BODIPY 493/503-stained cells. The triacylglycerol (TAG) content also increased 4-5 fold, and labeled oleate is incorporated into TAG. Fatty acid carbon can thus be stored as TAG in lipid droplets under physiological growth conditions in procyclic T. brucei. beta-oxidation has been suggested as a possible catabolic pathway for lipids in T. brucei. A single candidate gene, TFE alpha 1 with coding capacity for a subunit of the trifunctional enzyme complex was identified. TFE alpha 1 is expressed in procyclic T. brucei and present in glycosomal proteomes, Unexpectedly, a TFE alpha 1 gene knock-out mutant still expressed wild-type levels of previously reported NADP-dependent 3-hydroxyacyl-CoA dehydrogenase activity, and therefore, another gene encodes this enzymatic activity. Homozygous Delta tfe alpha 1/Delta tfe alpha 1 null mutant cells show a normal growth rate and an unchanged glycosomal proteome in procyclic T. brucei. The decay kinetics of accumulated lipid droplets upon oleate withdrawal can be fully accounted for by the dilution effect of cell division in wild-type and Delta tfe alpha 1/Delta tfe alpha 1 cells. The absence of net catabolism of stored TAG in procyclic T. brucei, even under strictly glucose-free conditions, does not formally exclude a flux through TAG, in which biosynthesis equals catabolism. Also, the possibility remains that TAG catabolism is completely repressed by other carbon sources in culture media or developmentally activated in post-procyclic stages in the tsetse.	[Allmann, Stefan; Ziebart, Nicole; Boshart, Michael] Univ Munich, Biozentrum, Fak Biol, Martinsried, Germany; [Mazet, Muriel; Bringaud, Frederic] Univ Bordeaux, CNRS, Unite Mixte Rech 5536, Ctr Resonance Magnet Systemes Biol RMSB, Bordeaux, France; [Bouyssou, Guillaume; Fouillen, Laetitia; Moreau, Patrick] Univ Bordeaux, INRA, CNRS, Lab Biogenese Membranaire,Unite Mixte Rech 5200, Villenave Dornon, France; [Dupuy, Jean-William; Bonneu, Marc] Univ Bordeaux, Ctr Genom Fonct, Plateforme Proteome, Bordeaux, France	University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Boshart, M (corresponding author), Univ Munich, Biozentrum, Fak Biol, Martinsried, Germany.	boshart@lmu.de	FOUILLEN, Laetitia/AAV-9710-2020; Dupuy, Jean-William JWD/F-5335-2012; Boshart, Michael/A-2700-2011	FOUILLEN, Laetitia/0000-0002-1204-9296; Dupuy, Jean-William JWD/0000-0002-2448-4797; Boshart, Michael/0000-0002-5070-2663; Moreau, Patrick/0000-0001-9318-3464	University of Munich; Deutsche Forschungsgemeinschaft (DFG) [1100/6-2]; Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC call; Centre National de la Recherche Scientifique (CNRS); Universite of Bordeaux; Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024]; Franco-Bavarian University Cooperation Center (BFHZ/CCUFB)	University of Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC call(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite of Bordeaux; Laboratoire d'Excellence (LabEx) ParaFrap; Franco-Bavarian University Cooperation Center (BFHZ/CCUFB)	Work in Munich was supported by the University of Munich and grants from Deutsche Forschungsgemeinschaft (DFG) 1100/6-2 to MB. Work in Bordeaux was supported by the Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC-2010 call to FB and PM; FB is also supported by the Centre National de la Recherche Scientifique (CNRS), the Universite of Bordeaux, and the Laboratoire d'Excellence (LabEx) ParaFrap ANR-11-LABX-0024. MB and FB have been supported by a research cooperation grant of the Franco-Bavarian University Cooperation Center (BFHZ/CCUFB). DFG: http://www.dfg.de. ANR: http://www.agence-nationale-recherche.fr/. CNRS: http://www.cnrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2004, COMP BIOCHEM PHYS B, V138, P347, DOI 10.1016/j.cbpc.2004.04.017; Allmann S, 2013, J BIOL CHEM; Azema L, 2004, BIOCHEM PHARMACOL, V67, P459, DOI 10.1016/j.bcp.2003.09.005; BERMAN JD, 1987, J PARASITOL, V73, P555, DOI 10.2307/3282136; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; BLUM JJ, 1990, J PROTOZOOL, V37, P505, DOI 10.1111/j.1550-7408.1990.tb01256.x; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; BRUN R, 1979, ACTA TROP, V36, P289; CABIB E, 1973, ANN NY ACAD SCI, V210, P192, DOI 10.1111/j.1749-6632.1973.tb47572.x; Charron AJ, 2002, J CELL SCI, V115, P3049; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; FlorinChristensen M, 1997, MOL BIOCHEM PARASIT, V88, P25, DOI 10.1016/S0166-6851(97)00056-X; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Gassen A, 2012, NUCLEIC ACIDS RES, V40, P10302, DOI 10.1093/nar/gks801; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Igal RA, 1998, J LIPID RES, V39, P31; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Igoillo-Esteve M, 2011, INT J PARASITOL, V41, P429, DOI 10.1016/j.ijpara.2010.11.002; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalo P, 2009, LIPIDS, V44, P169, DOI 10.1007/s11745-008-3247-5; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; LEBER R, 1995, BBA-BIOMEMBRANES, V1234, P119, DOI 10.1016/0005-2736(94)00270-Y; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Listenberger LL, 2007, CURRENT PROTOCOLS CE, V35; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Rotureau B., 2013, CELL MICROBIOL; Rotureau B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00053; STEIGER R F, 1973, Acta Tropica, V30, P64; VAKIRTZI.C, 1972, CAN J BIOCHEM CELL B, V50, P501, DOI 10.1139/o72-068; Venkatesan R, 2013, ACS CHEM BIOL, V8, P1063, DOI 10.1021/cb400007k; VOORHEIS HP, 1980, MOL BIOCHEM PARASIT, V1, P177, DOI 10.1016/0166-6851(80)90016-X; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P311, DOI 10.1007/BF01799383; Wiemer EAC, 1996, MOL BIOCHEM PARASIT, V82, P107, DOI 10.1016/0166-6851(96)02710-7; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; ZOMER AWM, 1995, BBA-LIPID LIPID MET, V1257, P167, DOI 10.1016/0005-2760(95)00066-L	55	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114628	10.1371/journal.pone.0114628	http://dx.doi.org/10.1371/journal.pone.0114628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493940	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400062
J	Wagoner, JA; Sun, T; Lin, L; Hanson, MR				Wagoner, Jessica A.; Sun, Tao; Lin, Lin; Hanson, Maureen R.			Cytidine Deaminase Motifs within the DYW Domain of Two Pentatricopeptide Repeat-containing Proteins Are Required for Site-specific Chloroplast RNA Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Cytidine Deaminase; RNA Editing; Site-directed Mutagenesis; Yeast Two-hybrid Assay; PPR Motif; Pentatricopeptide Protein	ARABIDOPSIS MESOPHYLL PROTOPLASTS; PPR PROTEINS; SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; GENE-EXPRESSION; MESSENGER-RNAS; RECOGNITION; IDENTIFICATION; MITOCHONDRIA; TRANSCRIPT	Background: Pentatricopeptide repeat (PPR) proteins are site-specific RNA editing factors; many have C-terminal motifs of unknown function. Results: Site-directed mutagenesis of two PPR-DYW domains significantly reduces editing efficiency. Conclusion: Residues conserved in cytidine deaminases in the DYW domains are important for editing activity. Significance: This study strengthens the evidence that the DYW domains of PPR proteins carry the deaminase activity necessary for C-to-U modification. In angiosperm organelles, cytidines are converted to uridines by a deamination reaction in the process termed RNA editing. The C targets of editing are recognized by members of the pentatricopeptide repeat (PPR) protein family. Although other members of the editosome have begun to be identified, the enzyme that catalyzes the C-U conversion is still unknown. The DYW motif at the C terminus of many PPR editing factors contains residues conserved with known cytidine deaminase active sites; however, some PPR editing factors lack a DYW motif. Furthermore, in many PPR-DYW editing factors, the truncation of the DYW motif does not affect editing efficiency, so the role of the DYW motif in RNA editing is unclear. Here, a chloroplast PPR-DYW editing factor, quintuple editing factor 1 (QED1), was shown to affect five different plastid editing sites, the greatest number of chloroplast C targets known to be affected by a single PPR protein. Loss of editing at the five sites resulted in stunted growth and accumulation of apparent photodamage. Adding a C-terminal protein tag to QED1 was found to severely inhibit editing function. QED1 and RARE1, another plastid PPR-DYW editing factor, were discovered to require their DYW motifs for efficient editing. To identify specific residues critical for editing, conserved deaminase residues in each PPR protein were mutagenized. The mutant PPR proteins, when expressed in qed1 or rare1 mutant protoplasts, could not complement the editing defect. Therefore, the DYW motif, and specifically, the deaminase residues, of QED1 and RARE1 are required for editing efficiency.	[Wagoner, Jessica A.; Sun, Tao; Lin, Lin; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotechnol Bldg, Ithaca, NY 14853 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058	National Science Foundation (NSF) [MCB-0929423, MCB-1330294]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330294] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) Grants MCB-0929423 and MCB-1330294 (to M. R. H.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Brehme N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00127; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Jakoby MJ, 2006, PLANT PHYSIOL, V141, P1293, DOI 10.1104/pp.106.081406; JEFFERSON RA, 1987, EMBO J, V6, P3901; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; KOLLER B, 1987, CELL, V48, P111, DOI 10.1016/0092-8674(87)90361-8; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Tsugeki R, 1996, PLANT J, V10, P479, DOI 10.1046/j.1365-313X.1996.10030479.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	46	69	73	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2957	2968		10.1074/jbc.M114.622084	http://dx.doi.org/10.1074/jbc.M114.622084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512379	hybrid, Green Published			2022-12-26	WOS:000349310700034
J	Cousijn, J; Koolschijn, PCMP; Zanolie, K; Kleibeuker, SW; Crone, EA				Cousijn, Janna; Koolschijn, P. Cedric M. P.; Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.			The Relation between Gray Matter Morphology and Divergent Thinking in Adolescents and Young Adults	PLOS ONE			English	Article							CORTICAL DEVELOPMENT; CREATIVE COGNITION; PREFRONTAL CORTEX; BRAIN MATURATION; REGIONAL GRAY; VOLUME; MEMORY; SPECIALIZATION; CONNECTIVITY; TRAJECTORIES	Adolescence and early adulthood are developmental time periods during which creative cognition is highly important for adapting to environmental changes. Divergent thinking, which refers to generating novel and useful solutions to open-ended problems, has often been used as a measure of creative cognition. The first goal of this structural neuroimaging study was to elucidate the relationship between gray matter morphology and performance in the verbal (AUT; alternative uses task) and visuo-spatial (CAT; creative ability test) domain of divergent thinking in adolescents and young adults. The second goal was to test if gray matter morphology is related to brain activity during AUT performance. Neural and behavioral data were combined from a cross-sectional study including 25 adolescents aged 15-17 and 20 young adults aged 25-30. Brain-behavior relationships were assessed without a priori location assumptions and within areas that were activated during an AUT-scanner task. Gray matter volume and cortical thickness were not significantly associated with verbal divergent thinking. However, visuo-spatial divergent thinking (CAT originality and fluency) was positively associated with cortical thickness of the right middle temporal gyrus and left brain areas including the superior frontal gyrus and various occipital, parietal, and temporal areas, independently of age. AUT brain activity was not associated with cortical thickness. The results support an important role of a widespread brain network involved in flexible visuo-spatial divergent thinking, providing evidence for a relation between cortical thickness and visuo-spatial divergent thinking in adolescents and young adults. However, studies including visuo-spatial divergent thinking tasks in the scanner are warranted.	[Cousijn, Janna; Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Univ, Brain & Dev Lab, Dept Psychol, Leiden, Netherlands; [Cousijn, Janna] Univ Utrecht, Dept Dev & Expt Psychol, Utrecht, Netherlands; [Koolschijn, P. Cedric M. P.] Univ Amsterdam, Dept Psychol, Dutch Autism & ADHD Res Ctr, Amsterdam, Netherlands; [Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC)	Cousijn, J (corresponding author), Leiden Univ, Brain & Dev Lab, Dept Psychol, Leiden, Netherlands.	j.cousijn@gmail.com		Zanolie, Kiki/0000-0001-6101-1000; Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078; Cousijn, Janna/0000-0002-7699-2582	Netherlands Organisation for Scientific Research (NWO) [400-08-023]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from The Netherlands Organisation for Scientific Research (NWO; open competition program; grant nr. 400-08-023) awarded to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00246; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; Arden R, 2010, BEHAV BRAIN RES, V214, P143, DOI 10.1016/j.bbr.2010.05.015; Aziz-Zadeh L, 2013, SOC COGN AFFECT NEUR, V8, P475, DOI 10.1093/scan/nss021; Baas M, 2014, PERS SOC PSYCHOL B, V40, P1092, DOI 10.1177/0146167214535813; BARRON F, 1981, ANNU REV PSYCHOL, V32, P439, DOI 10.1146/annurev.ps.32.020181.002255; Batey M, 2006, GENET SOC GEN PSYCH, V132, P355, DOI 10.3200/MONO.132.4.355-430; Benedek M, 2013, NEUROIMAGE; Brett M, 2002, NEUROIMAGE; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cousijn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105780; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; CSIKSZENTMIHALYI M, 1977, J YOUTH ADOLESCENCE, V6, P281, DOI 10.1007/BF02138940; Csikszentmihalyi M., 2001, BECOMING ADULT TEENA; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V95, P648, DOI 10.1037/0022-3514.95.3.648; De Dreu CKW, 2014, SOC COGN AFFECT NEUR, V9, P1159, DOI 10.1093/scan/nst094; Dewhurst SA, 2011, PERS INDIV DIFFER, V51, P73, DOI 10.1016/j.paid.2011.03.018; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fink A, 2013, BRAIN STRUCT FUNCT; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; Gansier DA, 2011, NEUROPSYCHOLOGIA, V49, P2527, DOI 10.1016/j.neuropsychologia.2011.05.001; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hartley T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00338; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim KH, 2008, J CREATIVE BEHAV, V42, P106, DOI 10.1002/j.2162-6057.2008.tb01290.x; Kleibeuker SW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00905; Kleibeuker SW, 2013, DEV COGN NEUROS-NETH, V5, P197, DOI 10.1016/j.dcn.2013.03.003; Kleibeuker SW, 2013, DEVELOPMENTAL SCI, V16, P2, DOI 10.1111/j.1467-7687.2012.01176.x; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Leech R., 2013, BRAIN; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Palmiero M, 2010, CREATIVITY RES J, V22, P369, DOI 10.1080/10400419.2010.523396; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Rietzschel EF, 2006, J EXP SOC PSYCHOL, V42, P244, DOI 10.1016/j.jesp.2005.04.005; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Sawyer K, 2011, CREATIVITY RES J, V23, P137, DOI 10.1080/10400419.2011.571191; Scharinger M, 2014, NEUROPSYCHOLOGIA, V53, P75, DOI 10.1016/j.neuropsychologia.2013.09.012; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Stevenson CE, 2014, FRONT HUM N IN PRESS; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tsapkini K, 2011, BRAIN, V134, P3094, DOI 10.1093/brain/awr050; Van Dam A. G., 2006, CAT CREATIEVE AANLEG; Van Wesel F, 2006, CREATIEVE AANLEG TES; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wei DT, 2014, CORTEX, V51, P92, DOI 10.1016/j.cortex.2013.09.004; Witter MP, 2000, HIPPOCAMPUS, V10, P398; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhu FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079272	68	15	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114619	10.1371/journal.pone.0114619	http://dx.doi.org/10.1371/journal.pone.0114619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514366	gold, Green Published			2022-12-26	WOS:000349146300018
J	Hanski, L; Genina, N; Uvell, H; Malinovskaja, K; Gylfe, A; Laaksonen, T; Kolakovic, R; Makila, E; Salonen, J; Hirvonen, J; Elofsson, M; Sandler, N; Vuorela, PM				Hanski, Leena; Genina, Natalja; Uvell, Hanna; Malinovskaja, Kristina; Gylfe, Asa; Laaksonen, Timo; Kolakovic, Ruzica; Makila, Ermei; Salonen, Jarno; Hirvonen, Jouni; Elofsson, Mikael; Sandler, Niklas; Vuorela, Pia M.			Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation	PLOS ONE			English	Article							FAST DISSOLVING FILMS; RED-CLOVER; REPLACEMENT THERAPY; PHENOLIC-COMPOUNDS; CACO-2 CELLS; STRAIN TWAR; IN-VITRO; PNEUMONIAE; TRACHOMATIS; PHARMACOKINETICS	Given the established role of Chlamydia spp. as causative agents of both acute and chronic diseases, search for new antimicrobial agents against these intracellular bacteria is required to promote human health. Isoflavones are naturally occurring phytoestrogens, antioxidants and efflux pump inhibitors, but their therapeutic use is limited by poor water-solubility and intense first-pass metabolism. Here, we report on effects of isoflavones against C. pneumoniae and C. trachomatis and describe buccal permeability and initial formulation development for biochanin A. Biochanin A was the most potent Chlamydia growth inhibitor among the studied isoflavones, ;with an IC50=12 mu M on C. pneumoniae inclusion counts and 6.5 mu M on infectious progeny production, both determined by immunofluorescent staining of infected epithelial cell cultures. Encouraged by the permeation of biochanin A across porcine buccal mucosa without detectable metabolism, oromucosal film formulations were designed and prepared by a solvent casting method. The film formulations showed improved dissolution rate of biochanin A compared to powder or a physical mixture, presumably due to the solubilizing effect of hydrophilic additives and presence of biochanin A in amorphous state. In summary, biochanin A is a potent inhibitor of Chlamydia spp., and the in vitro dissolution results support the use of a buccal formulation to potentially improve its bioavailability in antichlamydial or other pharmaceutical applications.	[Hanski, Leena; Vuorela, Pia M.] Univ Helsinki, Fac Pharm, CDR, Div Pharmaceut Biosci, Helsinki, Finland; [Genina, Natalja; Kolakovic, Ruzica; Sandler, Niklas] Abo Akad Univ, Pharmaceut Sci Lab, Dept Biosci, Turku, Finland; [Uvell, Hanna] Umea Univ, Labs Chem Biol, Umea, Sweden; [Malinovskaja, Kristina; Laaksonen, Timo; Hirvonen, Jouni] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Gylfe, Asa] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Gylfe, Asa; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Gylfe, Asa; Elofsson, Mikael] Umea Univ, Lab Mol Infect Med, Umea, Sweden; [Makila, Ermei; Salonen, Jarno] Univ Turku, Dept Phys & Astron, Lab Ind Phys, Turku, Finland; [Elofsson, Mikael] Umea Univ, Dept Chem, Umea, Sweden	University of Helsinki; Abo Akademi University; Umea University; University of Helsinki; Umea University; Umea University; Umea University; University of Turku; Umea University	Vuorela, PM (corresponding author), Univ Helsinki, Fac Pharm, CDR, Div Pharmaceut Biosci, Helsinki, Finland.	pia.vuorela@helsinki.fi	Hanski, Leena/AAD-5096-2019; Laaksonen, Timo J/C-7141-2009	Hanski, Leena/0000-0002-3121-8542; Genina, Natalja/0000-0002-9947-6900; Hirvonen, Jouni Tapio/0000-0002-5029-1657; Laaksonen, Timo/0000-0002-6699-3004; Elofsson, Mikael/0000-0002-3219-4669; Makila, Ermei/0000-0002-8300-6533	Academy of Finland [252216, 258114, 264988]; Tor, Joe och Pentti Borgs minnesfond grants; Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland; Knut & Alice Wallenberg Foundation; Swedish Research Council; Vinnova	Academy of Finland(Academy of Finland); Tor, Joe och Pentti Borgs minnesfond grants; Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova)	This work has been funded by Academy of Finland grants 252216 (LH), 258114 and 264988 (TL and KM), by Tor, Joe och Pentti Borgs minnesfond grants (LH and PV), as well as by support from the Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland to PV. ME, HU and AG are grateful for financial support from the Knut & Alice Wallenberg Foundation, the Swedish Research Council and Vinnova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvesalo J, 2006, BIOCHEM PHARMACOL, V71, P735, DOI 10.1016/j.bcp.2005.12.006; Alvesalo JKO, 2006, J MED CHEM, V49, P2353, DOI 10.1021/jm051209w; Alvesalo J, 2008, J INFECT DIS, V197, P156, DOI 10.1086/524142; Arya A., 2010, INT J CHEMTECH RES, V2, P576; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Beck VB, 2005, J STEROID BIOCHEM, V94, P499, DOI 10.1016/j.jsbmb.2004.12.038; Bhosai SJ, 2012, CURR OPIN OPHTHALMOL, V23, P288, DOI 10.1097/ICU.0b013e32835438fc; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; CHIRGWIN K, 1989, ANTIMICROB AGENTS CH, V33, P1634, DOI 10.1128/AAC.33.9.1634; Cilurzo F, 2008, EUR J PHARM BIOPHARM, V70, P895, DOI 10.1016/j.ejpb.2008.06.032; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Dean D, 2009, DRUG TODAY, V45, P25; Dinge A, 2008, AAPS PHARMSCITECH, V9, P349, DOI 10.1208/s12249-008-9047-7; Dixit RP, 2009, J CONTROL RELEASE, V139, P94, DOI 10.1016/j.jconrel.2009.06.014; Dornstauder E, 2001, J STEROID BIOCHEM, V78, P67, DOI 10.1016/S0960-0760(01)00075-9; EKMAN MR, 1993, CLIN INFECT DIS, V17, P420, DOI 10.1093/clinids/17.3.420; Gieffers J, 2001, CIRCULATION, V103, P351; Hadfield TL, 1995, MODERN PATHOL, V8, P924; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; Han HK, 2011, INT J PHARMACEUT, V415, P89, DOI 10.1016/j.ijpharm.2011.05.055; Hoffmann EM, 2011, EXPERT OPIN DRUG DEL, V8, P299, DOI 10.1517/17425247.2011.553217; Hu M, 2003, DRUG METAB DISPOS, V31, P924, DOI 10.1124/dmd.31.7.924; Jia XB, 2004, J PHARMACOL EXP THER, V310, P1103, DOI 10.1124/jpet.104.068403; Kabir M.A., 2009, HDB PHARM EXCIPIENTS, P317; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kibbe AH, 2009, HDB PHARM EXCIPIENTS, P208; Krenn L, 2002, J CHROMATOGR B, V777, P123, DOI 10.1016/S1570-0232(02)00079-X; KUO CC, 1990, J INFECT DIS, V162, P755, DOI 10.1093/infdis/162.3.755; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Leinonen M, 2002, LANCET INFECT DIS, V2, P11, DOI 10.1016/S1473-3099(01)00168-2; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Maass M, 1998, J AM COLL CARDIOL, V31, P827, DOI 10.1016/S0735-1097(98)00016-3; Marwaha S, 2014, ANTIMICROB AGENTS CH, V58, P2968, DOI 10.1128/AAC.02015-13; Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023; Morel C, 2003, J AGR FOOD CHEM, V51, P5677, DOI 10.1021/jf0302714; Nicolazzo Joseph A., 2008, V7, P89; Peng SX, 2006, J PHARM SCI-US, V95, P1984, DOI 10.1002/jps.20664; Preis M, 2013, EXPERT OPIN DRUG DEL, V10, P1303, DOI 10.1517/17425247.2013.804058; Salin O, 2011, J AGR FOOD CHEM, V59, P12836, DOI 10.1021/jf2032473; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Shima K, 2011, ANTIMICROB AGENTS CH, V55, P2319, DOI 10.1128/AAC.01655-10; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Steiner C, 2008, BRIT J NUTR, V99, pES78, DOI 10.1017/S0007114508965788; Tammela P, 2004, ARCH BIOCHEM BIOPHYS, V425, P193, DOI 10.1016/j.abb.2004.03.023; Ullah MF, 2009, MOL NUTR FOOD RES, V53, P1376, DOI 10.1002/mnfr.200800547; Ur-Rehman T, 2012, J ANTIBIOT, V65, P397, DOI 10.1038/ja.2012.43; Wei P, 2012, ASIAN PAC J TROP MED, V5, P243, DOI 10.1016/S1995-7645(12)60033-9; Young P. M., 2009, HDB PHARM EXCIPIENTS, P663; Zhang SZ, 2003, PHARMACEUT RES, V20, P1184, DOI 10.1023/A:1025044913766	51	29	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115115	10.1371/journal.pone.0115115	http://dx.doi.org/10.1371/journal.pone.0115115			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514140	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300033
J	Harel, L; Gefen, N; Carmi, O; Orbach, P; Einat, P; Abitbol, G				Harel, Liraz; Gefen, Nir; Carmi, Ofira; Orbach, Pini; Einat, Paz; Abitbol, Guy			Novel Expression Vectors Enabling Induction of Gene Expression by Small-Interfering RNAs and MicroRNAs	PLOS ONE			English	Article							LARGE T-ANTIGEN; DIPHTHERIA-TOXIN; TRANSGENE EXPRESSION; EUKARYOTIC RIBOSOMES; THERAPY; CANCER; EFFICIENCY; CARCINOMA; UPSTREAM; GENOMICS	Small-interfering RNAs and microRNAs are small similar to 21-22 nucleotide long RNAs capable of posttranscriptional suppression of gene expression. The synthetic siRNAs are especially designed to target pre-specified genes and are common molecular biology tools. The miRNAs are endogenous regulators of gene expression found in a wide variety of eukaryotes. miRNAs are currently utilized for diagnostics applications. Therapeutically, various miRNA-antagonizing tools are being explored and miRNAs are also utilized for cell-specific inhibition of the expression of gene therapy vectors harboring target sites for specific miRNAs. Here we show, for the first time, that siRNAs and miRNAs can be harnessed to induce gene expression. We designed special expression vectors in which target sites for artificial siRNAs or endogenous miRNAs are located between the transgene and an Upstream Inhibitory Region (UIR). We hypothesized that cleavage of the mRNA by siRNAs or miRNAs will separate the transgene from the UIR and the resulting uncapped mRNA will be capable of being translated. A UIR composed of seven open reading frames was found to be the most efficient inhibitor of the translation of the downstream transgene. We show that under such a configuration both artificial siRNAs and endogenous miRNAs were capable of inducing transgene expression. We show that using the diphtheria toxin A-chain gene, in combination with target sites for highly expressed miRNAs, specific induction of cell-death can be achieved, setting the stage for application to cancer therapy.	[Harel, Liraz; Gefen, Nir; Carmi, Ofira; Orbach, Pini; Abitbol, Guy] Nanodoc Biotechnol, IL-7403630 Ness Ziona, Israel; [Einat, Paz] Dr Paz Einat Biotechnol Projects & Consulting, IL-74207 Ness Ziona, Israel		Einat, P (corresponding author), Nanodoc Biotechnol, 7 Sapir Str, IL-7403630 Ness Ziona, Israel.	paz@pazeinat.com			Nanodoc Biotechnology	Nanodoc Biotechnology	The research was funded by Nanodoc Biotechnology funds through private funding by Mr. Moshe Arkin, holder of the majority of the shares. Nanodoc Biotechnology provided support in the form of salaries for authors GA, PO, OC, NG, and LH. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders had a role in the decision to publish. PE is employed by "Dr. Paz Einat Biotechnology Projects & Consulting" and has been a paid consultant for the company with a role in experimental design, data analysis and writing the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eliasz S, 2007, ONCOL REV, V1, P131, DOI 10.1007/s12156-007-0015-3; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; GILL DM, 1971, J BIOL CHEM, V246, P1485; Gofrit ON, 2013, J UROL; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lachmann N, 2012, GENE THER, V19, P915, DOI 10.1038/gt.2011.148; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ohana P, 2002, INT J CANCER, V98, P645, DOI 10.1002/ijc.10243; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Ziegelbauer JM, 2014, CURR OPIN VIROL, V7, P33, DOI 10.1016/j.coviro.2014.03.014	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115327	10.1371/journal.pone.0115327	http://dx.doi.org/10.1371/journal.pone.0115327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514749	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300053
J	Leon, G; Sanchez-Ruiloba, L; Perez-Rodriguez, A; Gragera, T; Martinez, N; Hernandez, S; Anta, B; Calero, O; Garcia-Dominguez, CA; Dura, LM; Pena-Jimenez, D; Castro, J; Zarich, N; Sanchez-Gomez, P; Calero, M; Iglesias, T; Oliva, JL; Rojas, JM				Leon, Gonzalo; Sanchez-Ruiloba, Lucia; Perez-Rodriguez, Andrea; Gragera, Teresa; Martinez, Natalia; Hernandez, Silvia; Anta, Berta; Calero, Olga; Garcia-Dominguez, Carlota A.; Dura, Lara M.; Pena-Jimenez, Daniel; Castro, Judit; Zarich, Natasha; Sanchez-Gomez, Pilar; Calero, Miguel; Iglesias, Teresa; Oliva, Jose L.; Rojas, Jose M.			Shoc2/Sur8 Protein Regulates Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; KINASE ACTIVATION; SCAFFOLD PROTEINS; RAS; DIFFERENTIATION; PATHWAY; COMPLEX; CELLS; SUR-8; INHIBITION	The Shoc2 protein has been implicated in the positive regulation of the Ras-ERK pathway by increasing the functional binding interaction between Ras and Raf, leading to increased ERK activity. Here we found that Shoc2 overexpression induced sustained ERK phosphorylation, notably in the case of EGF stimulation, and Shoc2 knockdown inhibited ERK activation. We demonstrate that ectopic overexpression of human Shoc2 in PC12 cells significantly promotes neurite extension in the presence of EGF, a stimulus that induces proliferation rather than differentiation in these cells. Finally, Shoc2 depletion reduces both NGF-induced neurite outgrowth and ERK activation in PC12 cells. Our data indicate that Shoc2 is essential to modulate the Ras-ERK signaling outcome in cell differentiation processes involved in neurite outgrowth.	[Leon, Gonzalo; Perez-Rodriguez, Andrea; Gragera, Teresa; Martinez, Natalia; Hernandez, Silvia; Anta, Berta; Garcia-Dominguez, Carlota A.; Dura, Lara M.; Pena-Jimenez, Daniel; Castro, Judit; Zarich, Natasha; Oliva, Jose L.; Rojas, Jose M.] Inst Salud Carlos III, Unidad Biol Celular, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain; [Sanchez-Ruiloba, Lucia; Iglesias, Teresa] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Sanchez-Ruiloba, Lucia; Calero, Olga; Calero, Miguel; Iglesias, Teresa] CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Olga; Calero, Miguel] Inst Salud Carlos III, Unidad Encefalopatias Espongiformes, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain; [Sanchez-Gomez, Pilar] Inst Salud Carlos III, Unidad Neurooncol, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain	Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Oliva, JL (corresponding author), Inst Salud Carlos III, Unidad Biol Celular, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain.	jloliva@isciii.es; jmrojas@isciii.es	Vacas, Teresa Iglesias/ABF-8663-2020; Rojas, José M/D-3718-2018; Rojas, José M./AAA-3354-2021; LEON ESPINOSA, GONZALO/I-4135-2015; Calero, Miguel/H-5691-2015; Sánchez-Gómez, Pilar/K-8256-2014	Vacas, Teresa Iglesias/0000-0002-4326-9005; Rojas, José M/0000-0002-5383-3482; Rojas, José M./0000-0002-7547-2825; LEON ESPINOSA, GONZALO/0000-0002-9921-2614; Calero, Miguel/0000-0001-5366-3324; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Pena-Jimenez, Daniel/0000-0002-3192-464X; Zarich, Natasha/0000-0003-1058-6191; Sanchez-Ruiloba, Lucia/0000-0001-5418-2290	Ministerio de Educacion y Ciencia (MEC); Fondo de Investigaciones Sanitarias (FIS); CIBERNED [SAF2008-01951]; FIS [PI10/00815, PI12/00775, PI09/0562, PI13/00703]; Comunidad Autonoma de Madrid (CAM) [S-SAL-0202-2006-01]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) [RD12/0036/0027]; Instituto de Salud Carlos III; ISCIII-RETIC [RD06/0020/0003, RD12/0036/0021]; Spanish Association Against Cancer (AECC)	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid (CAM)(Comunidad de Madrid); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer)(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII-RETIC(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC)	GL, TG and LMD were recipients of fellowships from the Ministerio de Educacion y Ciencia (MEC) (to GL, TG), and Fondo de Investigaciones Sanitarias (FIS) (to LMD). LSR held a postdoctoral research contract from CIBERNED. This work was supported by FIS grant (PI10/00815) to JLO; CIBERNED to MC; SAF2008-01951, Comunidad Autonoma de Madrid (CAM) S-SAL-0202-2006-01 and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) to TI; FIS grant PI12/00775 and ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) RD12/0036/0027 from the Instituto de Salud Carlos III to PSG; and FIS grants (PI09/0562 and PI13/00703), ISCIII-RETIC (RD06/0020/0003 and RD12/0036/0021), and the Spanish Association Against Cancer (AECC) to JMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cesarini L, 2009, AM J MED GENET A, V149A, P140, DOI 10.1002/ajmg.a.32488; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ferron SR, 2010, CELL STEM CELL, V7, P367, DOI 10.1016/j.stem.2010.06.021; Galperin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036469; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; Izawa I, 2008, GENES CELLS, V13, P691, DOI 10.1111/j.1365-2443.2008.01198.x; Jeoung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066067; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Kaplan FM, 2012, J BIOL CHEM, V287, P41797, DOI 10.1074/jbc.M112.390906; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li WQ, 2000, GENE DEV, V14, P895; Martinez N, 2007, CELL SIGNAL, V19, P2277, DOI 10.1016/j.cellsig.2007.07.008; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Moon BS, 2011, STEM CELLS, V29, P320, DOI 10.1002/stem.586; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rojas Jose M., 2002, Current Genomics, V3, P295, DOI 10.2174/1389202023350381; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Young LC, 2013, MOL CELL, V52, P679, DOI 10.1016/j.molcel.2013.10.004; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	46	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114837	10.1371/journal.pone.0114837	http://dx.doi.org/10.1371/journal.pone.0114837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514808	Green Published, gold			2022-12-26	WOS:000349146300022
J	Leydon, C; Imaizumi, M; Bartlett, RS; Wang, SF; Thibeault, SL				Leydon, Ciara; Imaizumi, Mitsuyoshi; Bartlett, Rebecca S.; Wang, Sarah F.; Thibeault, Susan L.			Epithelial Cells Are Active Participants in Vocal Fold Wound Healing: An In Vivo Animal Model of Injury	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGF-RECEPTOR; SCAR FORMATION; FACTOR-BETA; TGF-ALPHA; VITRO; REGENERATION; ACTIVATION; EXPRESSION; REPAIR	Vocal fold epithelial cells likely play an important, yet currently poorly defined, role in healing following injury, irritation and inflammation. In the present study, we sought to identify a possible role for growth factors, epidermal growth factor (EGF) and transforming growth factor-beta 1 (TGF beta 1), in epithelial regeneration during wound healing as a necessary first step for uncovering potential signaling mechanisms of vocal fold wound repair and remodeling. Using a rat model, we created unilateral vocal fold injuries and examined the timeline for epithelial healing and regeneration during early and late stages of wound healing using immunohistochemistry (IHC). We observed time-dependent secretion of the proliferation marker, ki67, growth factors EGF and TGF beta 1, as well as activation of the EGF receptor (EGFR), in regenerating epithelium during the acute phase of injury. Ki67, growth factor, and EGFR expression peaked at day 3 post-injury. Presence of cytoplasmic and intercellular EGF and TGF beta 1 staining occurred up to 5 days post-injury, consistent with a role for epithelial cells in synthesizing and secreting these growth factors. To confirm that epithelial cells contributed to the cytokine secretion, we examined epithelial cell growth factor secretion in vitro using polymerase chain reaction (PCR). Cultured pig vocal fold epithelial cells expressed both EGF and TGF beta 1. Our in vivo and in vitro findings indicate that epithelial cells are active participants in the wound healing process. The exact mechanisms underlying their roles in autocrine and paracrine signaling guiding wound healing await study in a controlled, in vitro environment.	[Leydon, Ciara; Imaizumi, Mitsuyoshi; Bartlett, Rebecca S.; Wang, Sarah F.; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Leydon, C (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA.	leydonc@sacredheart.edu	Leydon, Ciara/AAW-7151-2021; Imaizumi, Mitsuyosi/Y-6253-2019		National Institutes of Health National Institute of Deafness and Other Communication Disorders DC [R03 DC011355, R01 DC012773]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011355, R01DC012773] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Deafness and Other Communication Disorders DC; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health National Institute of Deafness and Other Communication Disorders DC R03 DC011355 (CL) and R01 DC012773 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105; Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; Chang Z, 2014, DIS MODEL MECH, V7, P83, DOI 10.1242/dmm.013326; Cohen SM, 2005, ANN OTO RHINOL LARYN, V114, P296, DOI 10.1177/000348940511400408; Dupuit F, 2000, AM J PHYSIOL-LUNG C, V278, pL165, DOI 10.1152/ajplung.2000.278.1.L165; Erickson-DiRenzo E, METHOD PORCINE UNPUB; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P966; Imaizumi I, 2014, LARYNGOSCOP IN PRESS; Ip WK, 2007, IMMUNOLOGY, V122, P532, DOI 10.1111/j.1365-2567.2007.02668.x; Krecicki T, 1999, ORAL ONCOL, V35, P180, DOI 10.1016/S1368-8375(98)00100-6; Krishna P, 2010, LARYNGOSCOPE, V120, P2247, DOI 10.1002/lary.21087; Kutta H, 2002, ANAT EMBRYOL, V205, P315, DOI 10.1007/s00429-002-0255-8; Lee CS, 1996, AUST NZ J SURG, V66, P464, DOI 10.1111/j.1445-2197.1996.tb00783.x; Leydon C, 2013, TISSUE ENG PT A, V19, P2233, DOI [10.1089/ten.tea.2012.0744, 10.1089/ten.TEA.2012.0744]; Leydon C, 2011, J SPEECH LANG HEAR R, V54, P1060, DOI 10.1044/1092-4388(2010/10-0267); Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Ohno S, 2012, LARYNGOSCOPE, V122, P583, DOI 10.1002/lary.22389; Ohno T, 2009, LARYNGOSCOPE, V119, P806, DOI 10.1002/lary.20174; Popovic N, 2009, AM J PHYSIOL-HEART C, V297, pH2044, DOI 10.1152/ajpheart.01015.2008; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; Rousseau B, 2004, ANN OTO RHINOL LARYN, V113, P767, DOI 10.1177/000348940411301001; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Semlali A, 2010, ALLERGY, V65, P1438, DOI 10.1111/j.1398-9995.2010.02376.x; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P684, DOI 10.1177/000348940211100805; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; VAUGHAN TJ, 1992, DEVELOPMENT, V116, P663; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1756; Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346; Znalesniak EB, 2010, CELL PHYSIOL BIOCHEM, V25, P533, DOI 10.1159/000303057	41	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115389	10.1371/journal.pone.0115389	http://dx.doi.org/10.1371/journal.pone.0115389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514022	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300056
J	Lai, YQ; Shi, LW; Lin, Q; Fu, LR; Ha, HM				Lai, Youqun; Shi, Liwan; Lin, Qin; Fu, Lirong; Ha, Huiming			Planning Study of Flattening Filter Free Beams for Volumetric Modulated Arc Therapy in Squamous Cell Carcinoma of the Scalp	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; STEREOTACTIC RADIOTHERAPY; PHOTON BEAMS; IRRADIATION; TOMOTHERAPY; IMRT	Purpose: Flattening filter free (FFF) beams show the potential for a higher dose rate and lower peripheral dose. We investigated the planning study of FFF beams with their role for volumetric modulated arc therapy (VMAT) in squamous cell carcinoma of the scalp. Methods and Materials: One patient with squamous cell carcinoma which had involvement of entire scalp was subjected to VMAT using TrueBeam linear accelerator. As it was a rare skin malignancy, CT data of 7 patients with brain tumors were also included in this study, and their entire scalps were outlined as target volumes. Three VMAT plans were employed with RapidArc form: two half field full-arcs VMAT using 6 MV standard beams (HFF-VMAT-FF), eight half-field quarter-arcs VMAT using 6 MV standard beams (HFQ-VMAT-FF), and HFQ-VMAT using FFF beams (HFQ-VMAT-FFF). Prescribed dose was 25x2 Gy (50 Gy). Plan quality and efficiency were assessed for all plans. Results: There were no statistically significant differences among the three VMAT plans in target volume coverage, conformity, and homogeneity. For HFQ-VMAT-FF plans, there was a significant decrease by 12.6% in the mean dose to the brain compared with HFF-VMAT-FF. By the use of FFF beams, the mean dose to brain in HFQ-VMAT-FFF plans was further decreased by 7.4% compared with HFQ-VMATFF. Beam delivery times were similar for each technique. Conclusions: The HFQ-VMAT-FF plans showed the superiority in dose distributions compared with HFF-VMAT-FF. HFQ-VMAT-FFF plans might provide further normal tissue sparing, particularly in the brain, showing their potential for radiation therapy in squamous cell carcinoma of the scalp.	[Lai, Youqun; Shi, Liwan; Lin, Qin; Fu, Lirong; Ha, Huiming] Xiamen Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China	Xiamen University	Lin, Q (corresponding author), Xiamen Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China.	linqin05@163.com						Alongi F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-171; Della Biancia C, 2011, INT J RADIAT ONCOL, V81, pS908, DOI 10.1016/j.ijrobp.2011.06.1632; Georg D, 2011, MED PHYS, V38, P1280, DOI 10.1118/1.3554643; Hall WA, 2013, J AM COLL RADIOL, V10, P128, DOI 10.1016/j.jacr.2012.06.014; Hrbacek J, 2011, INT J RADIAT ONCOL, V80, P1228, DOI 10.1016/j.ijrobp.2010.09.050; Kuo YC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-76; Lang S, 2013, RADIOTHER ONCOL, V106, P255, DOI 10.1016/j.radonc.2012.12.012; Lu SH, 2012, RADIOTHER ONCOL, V104, P324, DOI 10.1016/j.radonc.2011.11.017; Murao K, 2011, EUR J DERMATOL, V21, P1005, DOI 10.1684/ejd.2011.1520; Ong CL, 2013, INT J RADIAT ONCOL, V86, P743, DOI 10.1016/j.ijrobp.2013.03.038; Ong CL, 2010, RADIOTHER ONCOL, V97, P437, DOI 10.1016/j.radonc.2010.09.027; Pipitone MA, 2006, DERMATOL SURG, V32, P756, DOI 10.1111/j.1524-4725.2006.32153.x; Reggiori G, 2012, MED PHYS, V39, P1112, DOI 10.1118/1.3679858; Ronel DN, 2004, DERMATOL SURG, V30, P446, DOI 10.1111/j.1524-4725.2004.30123.x; Song J., 2014, J NANOMATER, P1; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Stieler F, 2013, RADIOTHER ONCOL, V109, P448, DOI 10.1016/j.radonc.2013.10.017; Wojcicka JB, 2009, RADIOTHER ONCOL, V91, P255, DOI 10.1016/j.radonc.2008.09.022; Yang RJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-515; Zwahlen DR, 2012, INT J RADIAT ONCOL, V83, P1655, DOI 10.1016/j.ijrobp.2011.10.019	20	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114953	10.1371/journal.pone.0114953	http://dx.doi.org/10.1371/journal.pone.0114953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506701	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100036
J	Vassar, RL; Barnea-Goraly, N; Rose, J				Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica			Identification of Neonatal White Matter on DTI: Influence of More Inclusive Thresholds for Atlas Segmentation	PLOS ONE			English	Article							MICROSTRUCTURAL DEVELOPMENT; BRAIN-DEVELOPMENT; HUMAN FETAL; DIFFUSION; MRI; MATURATION; INFANTS; AGE	Purpose: Semi-automated diffusion tensor imaging (DTI) analysis of white matter (WM) microstructure offers a clinically feasible technique to assess neonatal brain development and provide early prognosis, but is limited by variable methods and insufficient evidence regarding optimal parameters. The purpose of this research was to investigate the influence of threshold values on semi-automated, atlas-based brain segmentation in very-low-birth-weight (VLBW) preterm infants at nearterm age. Materials and Methods: DTI scans were analyzed from 45 VLBW preterm neonates at near-term-age with no brain abnormalities evident on MRI. Brain regions were selected with a neonatal brain atlas and threshold values: trace<0.006 mm(2)/s, fractional anisotropy (FA)>0.15, FA>0.20, and FA>0.25. Relative regional volumes, FA, axial diffusivity (AD), and radial diffusivity (RD) were compared for twelve WM regions. Results: Near-term brain regions demonstrated differential effects from segmentation with the three FA thresholds. Regional DTI values and volumes selected in the PLIC, CereP, and RLC varied the least with the application of different FA thresholds. Overall, application of higher FA thresholds significantly reduced brain region volume selected, increased variability, and resulted in higher FA and lower RD values. The lower threshold FA>0.15 selected 78 +/- 21% of original volumes segmented by the atlas, compared to 38 +/- 12% using threshold FA>0.25. Conclusion: Results indicate substantial and differential effects of atlas-based DTI threshold parameters on regional volume and diffusion scalars. A lower, more inclusive FA threshold than typically applied for adults is suggested for consistent analysis of WM regions in neonates.	[Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica] Stanford Univ, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA; [Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica] Stanford Univ, Sch Med, Neonatal Neuroimaging Lab, Stanford, CA 94305 USA; [Barnea-Goraly, Naama] Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Vassar, RL (corresponding author), Stanford Univ, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA.	rvassar@stanford.edu			NIH Clinical and Translational Science Award [1UL1 RR025744]; Lucile Packard Foundation for Children's Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	NIH Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is supported in part by the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (http://www.ncats.nih.gov/research/cts/ctsa/ctsa. html) and by the Lucile Packard Foundation for Children's Health (http://lpfch.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J PEDIATR-US, V156, P882, DOI 10.1016/j.jpeds.2009.12.030; Aeby A, 2013, NEUROIMAGE, V78, P145, DOI 10.1016/j.neuroimage.2013.03.076; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Benini R, 2013, J PEDIATR-US, V162, P369, DOI 10.1016/j.jpeds.2012.07.044; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Heemskerk AM, 2013, AM J NEURORADIOL, V34, P1496, DOI 10.3174/ajnr.A3465; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Lee AY, 2013, PEDIATR RADIOL, V43, P612, DOI 10.1007/s00247-012-2545-5; Loh KB, 2012, EUR RADIOL, V22, P1413, DOI 10.1007/s00330-012-2396-3; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Rose J, 2007, DEV MED CHILD NEUROL, V49, P745, DOI 10.1111/j.1469-8749.2007.00745.x; Rose J, 2014, NEUROIMAGE-CLIN, V5, P169, DOI 10.1016/j.nicl.2014.05.013; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Rose J, 2009, DEV MED CHILD NEUROL, V51, P526, DOI 10.1111/j.1469-8749.2008.03231.x; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Tang X, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003631; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zhang YJ, 2014, NEUROIMAGE, V101, P256, DOI 10.1016/j.neuroimage.2014.07.001	26	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115426	10.1371/journal.pone.0115426	http://dx.doi.org/10.1371/journal.pone.0115426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506943	Green Published, gold			2022-12-26	WOS:000346607100075
J	Wee, CD; Havens, MA; Jodelka, FM; Hastings, ML				Wee, Claribel D.; Havens, Mallory A.; Jodelka, Francine M.; Hastings, Michelle L.			Targeting SR Proteins Improves SMN Expression in Spinal Muscular Atrophy Cells	PLOS ONE			English	Article							MOTOR-NEURON SMN; EXONIC SPLICING ENHANCER; RNA RECOGNITION MOTIFS; MESSENGER-RNA; SINGLE NUCLEOTIDE; SITE SELECTION; STEM-CELLS; HNRNP A1; IN-VIVO; SURVIVAL	Spinal muscular atrophy (SMA) is one of the most common inherited causes of pediatric mortality. SMA is caused by deletions or mutations in the survival of motor neuron 1 (SMN1) gene, which results in SMN protein deficiency. Humans have a centromeric copy of the survival of motor neuron gene, SMN2, which is nearly identical to SMN1. However, SMN2 cannot compensate for the loss of SMN1 because SMN2 has a single-nucleotide difference in exon 7, which negatively affects splicing of the exon. As a result, most mRNA produced from SMN2 lacks exon 7. SMN2 mRNA lacking exon 7 encodes a truncated protein with reduced functionality. Improving SMN2 exon 7 inclusion is a goal of many SMA therapeutic strategies. The identification of regulators of exon 7 inclusion may provide additional therapeutic targets or improve the design of existing strategies. Although a number of regulators of exon 7 inclusion have been identified, the function of most splicing proteins in exon 7 inclusion is unknown. Here, we test the role of SR proteins and hnRNP proteins in SMN2 exon 7 inclusion. Knockdown and overexpression studies reveal that SRSF1, SRSF2, SRSF3, SRSF4, SRSF5, SRSF6, SRSF7, SRSF11, hnRNPA1/B1 and hnRNP U can inhibit exon 7 inclusion. Depletion of two of the most potent inhibitors of exon 7 inclusion, SRSF2 or SRSF3, in cell lines derived from SMA patients, increased SMN2 exon 7 inclusion and SMN protein. Our results identify novel regulators of SMN2 exon 7 inclusion, revealing potential targets for SMA therapeutics.	[Wee, Claribel D.; Havens, Mallory A.; Jodelka, Francine M.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA.	michelle.hastings@rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hastings, Michelle L./0000-0002-4253-9261; Jodelka, Francine/0000-0001-9374-8437	National Institutes of Health [NS069759, 1F31NS076237]; Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NCRR (Health Resources and Service Administration) [S10 OD01662, C76 HF03610-01-00]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069759, F31NS076237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NCRR (Health Resources and Service Administration); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS069759 to M.L.H, 1F31NS076237 to M.A.H., NCRR S10 OD01662 and C76 HF03610-01-00 (Health Resources and Service Administration) to the Midwest Proteome Center at Rosalind Franklin University]; C.D.W. was supported by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship. No individuals employed or contracted by the funders played any role in: study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Baughan TD, 2009, HUM MOL GENET, V18, P1600, DOI 10.1093/hmg/ddp076; Bebee TW, 2010, FRONT BIOSCI-LANDMRK, V15, P1191, DOI 10.2741/3670; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chandler SD, 1997, P NATL ACAD SCI USA, V94, P3596, DOI 10.1073/pnas.94.8.3596; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Cho S, 2014, BIOCH BIOPHYS ACTA; de Araujo MM, 2009, RNA, V15, P515, DOI 10.1261/rna.1273209; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hanamura A, 1998, RNA, V4, P430; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Heinrich B, 2009, J BIOL CHEM, V284, P14303, DOI 10.1074/jbc.M901026200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Irimura Sanae, 2009, Kobe J Med Sci, V54, pE227; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Jong YJ, 2000, J NEUROL SCI, V173, P147, DOI 10.1016/S0022-510X(99)00325-1; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li J, 2008, NEUROCHEM RES, V33, P483, DOI 10.1007/s11064-007-9461-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Mallinjoud P, 2014, GENOME RES, V24, P511, DOI 10.1101/gr.162933.113; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Miyajima H, 2002, J BIOL CHEM, V277, P23271, DOI 10.1074/jbc.M200851200; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Moursy A, 2014, NUCL ACIDS RES; Osman EY, 2014, HUM MOL GENET; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Paz I., 2014, NUCL ACIDS RES; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Porensky PN, 2013, HUM GENE THER, V24, P489, DOI 10.1089/hum.2012.225; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Rigo F, 2012, NAT CHEM BIOL, V8, P555, DOI [10.1038/nchembio.939, 10.1038/NCHEMBIO.939]; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Sivanesan S, 2013, TRANSL NEUROSCI, V4, P1, DOI 10.2478/s13380-013-0109-2; WANG J, 1995, RNA, V1, P335; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yang XM, 2014, NEUROL SCI, V35, P391, DOI 10.1007/s10072-013-1524-4; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Yuo CY, 2008, ANN NEUROL, V63, P26, DOI 10.1002/ana.21241; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	88	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115205	10.1371/journal.pone.0115205	http://dx.doi.org/10.1371/journal.pone.0115205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506695	Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100060
J	Seki, T; Asanuma, K; Asao, R; Nonaka, K; Sasaki, Y; Trejo, JAO; Kurosawa, H; Hirayama, Y; Horikoshi, S; Tomino, Y; Saito, A				Seki, Takuto; Asanuma, Katsuhiko; Asao, Rin; Nonaka, Kanae; Sasaki, Yu; Trejo, Juan Alejandro Oliva; Kurosawa, Hiroyuki; Hirayama, Yoshiaki; Horikoshi, Satoshi; Tomino, Yasuhiko; Saito, Akihiko			Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; HEYMANN NEPHRITIS; TNF-ALPHA; IN-VITRO; INJURY; RECEPTOR; PODOCYTES; PROTEIN; GP330; COMMUNICATION	Background and Objectives: Megalin is highly expressed at the apical membranes of proximal tubular epithelial cells. A urinary full-length megalin (C-megalin) assay is linked to the severity of diabetic nephropathy in type 2 diabetes. This study examined the relationship between levels of urinary C-megalin and histological findings in adult patients with IgA nephropathy (IgAN). Design, Setting, Participants, & Measurements: Urine samples voided in the morning on the day of renal biopsy were obtained from 73 patients with IgAN (29 men and 44 women; mean age, 33 years) and 5 patients with membranous nephropathy (MN). Renal pathologic variables were analyzed using the Oxford classification of IgAN, the Shigematsu classification and the Clinical Guidelines of IgAN in Japan. The levels of urinary C-megalin were measured by sandwich ELISA. Results: Histological analysis based on the Oxford classification revealed that the levels of urinary C-megalin were correlated with mesangial hypercellularity in IgAN patients (OR=1.76, 95% CI: 1.04-3.27, P<0.05). There was a significant correlation between the levels of urinary C-megalin and the severity of chronic extracapillary abnormalities according to the Shigematsu classification in IgAN patients (beta=0.33, P=0.008). The levels of urinary C-megalin were significantly higher in all risk levels of IgAN patients requiring dialysis using the Clinical Guidelines of IgAN in Japan than in the control group. The levels of urinary C-megalin were significantly higher in the high risk and very high risk grades than in the low risk grade (P<0.05). The levels of urinary C-megalin were significantly higher in MN patients compared to the control group. Conclusions: The levels of urinary C-megalin are associated with histological abnormalities in adult IgAN patients. There is a possibility that urinary C-megalin is	[Seki, Takuto; Asanuma, Katsuhiko; Asao, Rin; Nonaka, Kanae; Sasaki, Yu; Trejo, Juan Alejandro Oliva; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Div Nephrol, Tokyo, Japan; [Seki, Takuto; Asanuma, Katsuhiko; Nonaka, Kanae] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan; [Kurosawa, Hiroyuki; Hirayama, Yoshiaki] Denka Seiken Co Ltd, Reagents Dev Dept, Niigata, Japan; [Saito, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Appl Mol Med, Niigata, Japan	Juntendo University; Kyoto University; Denka Company Limited; Niigata University	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp		Asao, Rin/0000-0001-6511-4226	Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Kowa Life Science Foundation [21659217, 23591201]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Kowa Life Science Foundation	This work was supported by research grants from the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, and by a Kowa Life Science Foundation, a Grant for Challenging Exploratory Research (21659217) https://www.jsps.go.jp/english/e-grants/grants01.html and a Grant-in-Aid for Scientific Research (C) (23591201) to KA, https://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; BACHINSKY DR, 1993, AM J PATHOL, V143, P598; Barrett J, 2011, SEMIN NEPHROL, V31, P349, DOI 10.1016/j.semnephrol.2011.06.006; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; BIRK HW, 1991, KIDNEY INT, V40, P823, DOI 10.1038/ki.1991.282; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; KERJASCHKI D, 1987, AM J PATHOL, V129, P183; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2011, ADV OTO-RHINO-LARYNG, V72, P40, DOI 10.1159/000324593; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Lai KN, 2005, KIDNEY INT, V67, pS110, DOI 10.1111/j.1523-1755.2005.09426.x; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Moriyama T, 2011, CLIN EXP NEPHROL, V15, P700, DOI 10.1007/s10157-011-0455-8; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; no author, 2011, Nihon Jinzo Gakkai Shi, V53, P123; Ogasawara S, 2012, DIABETES CARE, V35, P1112, DOI 10.2337/dc11-1684; Peters HPE, 2009, NETH J MED, V67, P54; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Saito A, 2005, NEPHROLOGY, V10, pS26, DOI 10.1111/j.1440-1797.2005.00453.x; Saito A, 2003, J AM SOC NEPHROL, V14, P2025, DOI 10.1097/01.ASN.0000078804.98322.4A; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Shigematsu H, 1997, PATHOL INT, V47, P194, DOI 10.1111/j.1440-1827.1997.tb04480.x; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tanuma A, 2007, NEPHRON PHYSIOL, V107, pP87, DOI 10.1159/000111253; Thrailkill KM, 2009, DIABETES CARE, V32, P1266, DOI 10.2337/dc09-0112; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114400	10.1371/journal.pone.0114400	http://dx.doi.org/10.1371/journal.pone.0114400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502002	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400030
J	Boucquemont, J; Metzger, M; Combe, C; Stengel, B; Leffondre, K				Boucquemont, Julie; Metzger, Marie; Combe, Christian; Stengel, Benedicte; Leffondre, Karen		NephroTest Study Grp	Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?	PLOS ONE			English	Article							STAGE RENAL-DISEASE; COMPETING RISKS; EPIDEMIOLOGY; MORTALITY	Background: In studies investigating risk factors of chronic kidney disease (CKD) progression, one may be interested in estimating factors effects on both a fall of glomerular filtration rate (GFR) below a specific level (i.e., a CKD stage) and death. Such studies have to account for the fact that GFR is measured at intermittent visit only, which implies that progression to the stage of interest is unknown for patients who die before being observed at that stage. Our objective was to compare the results of an illness-death model that handles this uncertainty, with frequently used survival models. Methods: This study included 1,519 patients from the NephroTest cohort with CKD stages 1-4 at baseline (69% males, 59 +/- 15 years, median protein/creatinine ratio [PCR] 27.4 mg/mmol) and subsequent annual measures of GFR (follow-up time 4.3 +/- 2.7 years). Each model was used to estimate the effects of sex, age, PCR, and GFR at baseline on the hazards of progression to CKD stage 5 (GFR < 15 mL/min/1.73 m(2), n = 282 observed) and death (n = 168). Results: For progression to stage 5, there were only minor differences between results from the different models. The differences between results were higher for the hazard of death before or after progression. Our results also suggest that previous findings on the effect of age on end-stage renal disease are more likely due to a strong impact of age on death than to an effect on progression. The probabilities of progression were systematically under-estimated with the survival model as compared with the illness-death model. Conclusions: This study illustrates the advantages of the illness-death model for accurately estimating the effects of risk factors on the hazard of progression and death, and probabilities of progression. It avoids the need to choose arbitrary time-to-event and time-to-censoring, while accounting for both interval censoring and competition by death, using a single analytical model.	[Boucquemont, Julie; Leffondre, Karen] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol & Biostat U897, Bordeaux, France; [Metzger, Marie; Stengel, Benedicte] INSERM, Unit 1018, CESP, Res Ctr Epidemiol & Populat Hlth, Villejuif, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Combe, Christian] Ctr Hosp Univ Bordeaux, Serv Nephrol Transplantat Dialyse, Bordeaux, France; [Combe, Christian] Univ Bordeaux, Unite INSERM 1026, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Leffondre, K (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol & Biostat U897, Bordeaux, France.	karen.leffondre@isped.u-bordeaux2.fr	Karen, Leffondre/AAF-6490-2019; Stengel, Benedicte/G-5730-2015; Combe, Christian/N-3726-2015; Metzger, Marie/K-9772-2018	Karen, Leffondre/0000-0002-1269-8069; Stengel, Benedicte/0000-0001-9469-0804; Combe, Christian/0000-0002-0360-573X; Metzger, Marie/0000-0003-3597-5409	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]; European Community's Seventh Framework Program [HEALTH-F2-2009-241544-SysKid]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); European Community's Seventh Framework Program(European Commission)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR (B. Stengel), French Ministry of Health AOM 09114 (M. Froissart and B. Stengel), INSERM AO 8022LS (B. Stengel), Agence de la Biomedecine R0 8156LL (B. Stengel), AURA (M. Froissart), and Roche 2009-152-447G (M. Froissart). This work was funded by a grant from the European Community's Seventh Framework Program (HEALTH-F2-2009-241544-SysKid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Andersen PK, 2012, STAT MED, V31, P1074, DOI 10.1002/sim.4385; Boucquemont J, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-45; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hoefield RA, 2010, AM J KIDNEY DIS, V56, P1072, DOI 10.1053/j.ajkd.2010.06.010; Joly P, 2002, BIOSTATISTICS, V3, P433, DOI 10.1093/biostatistics/3.3.433; JUCKETT DA, 1993, MECH AGEING DEV, V69, P1, DOI 10.1016/0047-6374(93)90068-3; Kessler M, 2008, NEPHROL THER, V4, P155, DOI 10.1016/j.nephro.2007.11.008; LaMattina JC, 2011, CLIN J AM SOC NEPHRO, V6, P1851, DOI 10.2215/CJN.00650111; Leffondre K, 2015, NEPHROL DIAL TRANSPL, V30, P1237, DOI 10.1093/ndt/gfu320; Leffondre K, 2014, NEPHROL DIAL TRANSPL, V29, P1806, DOI 10.1093/ndt/gft500; Leffondre K, 2013, INT J EPIDEMIOL, V42, P1177, DOI 10.1093/ije/dyt126; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Touraine C., 2013, 1312 U COP DEP BIOST; Touraine C, 2016, STAT METHODS MED RES, V25, P1452, DOI 10.1177/0962280213489234; Van Pottelbergh G, 2012, NEPHROL DIAL TRANSPL, V27, P2297, DOI 10.1093/ndt/gfr659; Weis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081835	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114839	10.1371/journal.pone.0114839	http://dx.doi.org/10.1371/journal.pone.0114839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503256	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700058
J	Fenley, AT; Muddana, HS; Gilson, MK				Fenley, Andrew T.; Muddana, Hari S.; Gilson, Michael K.			Calculation and Visualization of Atomistic Mechanical Stresses in Nanomaterials and Biomolecules	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TENSOR ANALYSIS; MECHANOCHEMISTRY; LEVEL; SYSTEM; FORCE; AMBER; TRANSDUCTION; ALGORITHMS; CHANNEL	Many biomolecules have machine-like functions, and accordingly are discussed in terms of mechanical properties like force and motion. However, the concept of stress, a mechanical property that is of fundamental importance in the study of macroscopic mechanics, is not commonly applied in the biomolecular context. We anticipate that microscopical stress analyses of biomolecules and nanomaterials will provide useful mechanistic insights and help guide molecular design. To enable such applications, we have developed Calculator of Atomistic Mechanical Stress (CAMS), an open-source software package for computing atomic resolution stresses from molecular dynamics (MD) simulations. The software also enables decomposition of stress into contributions from bonded, nonbonded and Generalized Born potential terms. CAMS reads GROMACS topology and trajectory files, which are easily generated from AMBER files as well; and time-varying stresses may be animated and visualized in the VMD viewer. Here, we review relevant theory and present illustrative applications.	[Fenley, Andrew T.; Muddana, Hari S.; Gilson, Michael K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gilson, MK (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	mgilson@ucsd.edu	Muddana, Hari/F-7796-2010		National Institute of General Medical Sciences (NIGMS) [GM61300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061300] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by grant GM61300 from the National Institute of General Medical Sciences (NIGMS) to MKG (http://www.nigms.nih.gov/Pages/default.aspx). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brantley JN, 2013, POLYM INT, V62, P2, DOI 10.1002/pi.4350; Bratzel G, 2012, BIOPOLYMERS, V97, P408, DOI 10.1002/bip.21729; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4; Case DA, 2012, AMBER 12; Chen YP, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166387; CHEUNG KS, 1991, J APPL PHYS, V70, P5688, DOI 10.1063/1.350186; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Costescu BI, 2014, PHYS CHEM CHEM PHYS, V16, P12582, DOI 10.1039/c3cp55341h; Costescu BI, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-5; Delph TJ, 2005, MODEL SIMUL MATER SC, V13, P585, DOI 10.1088/0965-0393/13/4/009; DIBROZOLO FR, 1994, NATURE, V369, P37, DOI 10.1038/369037a0; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; FENLEY AT, 2014, J PHYS CHEM B; Friscic T, 2012, CHEM SOC REV, V41, P3493, DOI 10.1039/c2cs15332g; Ghosh S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907977; Gilson MK, 2010, J CHEM THEORY COMPUT, V6, P637, DOI 10.1021/ct900668k; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gusev AA, 1996, PHYS REV B, V54, P1, DOI 10.1103/PhysRevB.54.1; Hao F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3615290; HARDY RJ, 1982, J CHEM PHYS, V76, P622, DOI 10.1063/1.442714; Hatch HW, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734007; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iozzi MF, 2011, J PHYS CHEM A, V115, P2308, DOI 10.1021/jp109428g; Ishikura T, 2012, CHEM PHYS LETT, V539, P144, DOI 10.1016/j.cplett.2012.05.005; Ivanovskii AL, 2012, RUSS CHEM REV+, V81, P571, DOI 10.1070/RC2012v081n07ABEH004302; James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a; Koike K, 2008, PHYS CHEM CHEM PHYS, V10, P1400, DOI 10.1039/b714618c; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Liang J, 2009, ACS NANO, V3, P1628, DOI 10.1021/nn900294n; Liu B, 2009, J COMPUT THEOR NANOS, V6, P1081, DOI 10.1166/jctn.2009.1148; LUTSKO JF, 1988, J APPL PHYS, V64, P1152, DOI 10.1063/1.341877; MACKERELL AD, 2002, CHARMM THE ENERGY FU; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Noji H, 2011, CHEM SCI, V2, P2086, DOI 10.1039/c1sc00276g; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Orsi M, 2013, FARADAY DISCUSS, V161, P249, DOI 10.1039/c2fd20110k; Palmai Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003444; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rafii-Tabar H, 2004, PHYS REP, V390, P235, DOI 10.1016/j.physrep.2003.10.012; Ribas-Arino J, 2012, CHEM REV, V112, P5412, DOI 10.1021/cr200399q; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sielaff H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0024; Sirk TW, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789961; Sonne J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862624; Sordan R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079663; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000306; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; THEODOROU DN, 1986, MACROMOLECULES, V19, P379, DOI 10.1021/ma00156a026; TSAI DH, 1979, J CHEM PHYS, V70, P1375, DOI 10.1063/1.437577; Valle F, 2007, PHYS LIFE REV, V4, P157, DOI 10.1016/j.plrev.2007.06.001; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velez-Vega C, 2012, J CHEM THEORY COMPUT, V8, P966, DOI 10.1021/ct2006902; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe R, 2013, FEBS LETT, V587, P1030, DOI 10.1016/j.febslet.2013.01.063; Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o; Xiao SB, 2009, BIOPHYS J, V96, P3997, DOI 10.1016/j.bpj.2009.02.052; Zhou M, 2003, P ROY SOC A-MATH PHY, V459, P2347, DOI 10.1098/rspa.2003.1127; Zimmerman JA, 2004, MODEL SIMUL MATER SC, V12, pS319, DOI 10.1088/0965-0393/12/4/S03	74	8	8	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113119	10.1371/journal.pone.0113119	http://dx.doi.org/10.1371/journal.pone.0113119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503996	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700006
J	Kobayashi, CAN; Leite, AL; Peres-Buzalaf, C; Carvalho, JG; Whitford, GM; Everett, ET; Siqueira, WL; Buzalaf, MAR				Kobayashi, Claudia A. N.; Leite, Aline L.; Peres-Buzalaf, Camila; Carvalho, Juliane G.; Whitford, Gary M.; Everett, Eric T.; Siqueira, Walter L.; Buzalaf, Marilia A. R.			Bone Response to Fluoride Exposure Is Influenced by Genetics	PLOS ONE			English	Article							OSTEOPOROSIS; RESORPTION; MINERALIZATION; OSTEOBLASTS; METABOLISM; FLUOROSIS; PROTEINS; RATS; MICE	Genetic factors influence the effects of fluoride (F) on amelogenesis and bone homeostasis but the underlying molecular mechanisms remain undefined. A label-free proteomics approach was employed to identify and evaluate changes in bone protein expression in two mouse strains having different susceptibilities to develop dental fluorosis and to alter bone quality. In vivo bone formation and histomorphometry after F intake were also evaluated and related to the proteome. Resistant 129P3/J and susceptible A/J mice were assigned to three groups given low-F food and water containing 0, 10 or 50 ppmF for 8 weeks. Plasma was evaluated for alkaline phosphatase activity. Femurs, tibiae and lumbar vertebrae were evaluated using micro-CT analysis and mineral apposition rate (MAR) was measured in cortical bone. For quantitative proteomic analysis, bone proteins were extracted and analyzed using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), followed by label-free semi-quantitative differential expression analysis. Alterations in several bone proteins were found among the F treatment groups within each mouse strain and between the strains for each F treatment group (ratio >= 1.5 or <= 0.5; p<0.05). Although F treatment had no significant effects on BMD or bone histomorphometry in either strain, MAR was higher in the 50 ppmF 129P3/J mice than in the 50 ppmF A/J mice treated with 50 ppmF showing that F increased bone formation in a strain-specific manner. Also, F exposure was associated with dose-specific and strain-specific alterations in expression of proteins involved in osteogenesis and osteoclastogenesis. In conclusion, our findings confirm a genetic influence in bone response to F exposure and point to several proteins that may act as targets for the differential F responses in this tissue.	[Kobayashi, Claudia A. N.; Leite, Aline L.; Carvalho, Juliane G.; Buzalaf, Marilia A. R.] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Peres-Buzalaf, Camila] Univ Sagrado Coracao, Ctr Ciencias Saude, Bauru, SP, Brazil; [Whitford, Gary M.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA USA; [Everett, Eric T.] Univ N Carolina, Sch Dent, Carolina Ctr Genome Sci, Dept Pediat Dent, Chapel Hill, NC USA; [Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	Universidade de Sao Paulo; Universidade do Sagrado Coracao; University System of Georgia; Augusta University; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.	mbuzalaf@fob.usp.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Siqueira, Walter/ABE-4069-2021; Siqueira, Walter/ABE-8924-2020; Everett, Eric/AAP-4459-2021; Peres-Buzalaf, Camila/C-5109-2012; Leite, Aline/J-9748-2012	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Siqueira, Walter/0000-0003-1921-3658; Leite, Aline/0000-0002-2112-1309	Sao Paulo State Research Support Foundation (FAPESP) [2008/01449-3]; CNPq [302448/2009-8, 476393/2008-6]; CAPES [2485-09-5]; NSERC [371813]; NIDCR of the National Institutes of Health [R01DE018104]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018104] Funding Source: NIH RePORTER	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIDCR of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Sao Paulo State Research Support Foundation (FAPESP) (grant 2008/01449-3), CNPq (grants 302448/2009-8 and 476393/2008-6), CAPES (grant 2485-09-5), NSERC (grant 371813) and the NIDCR of the National Institutes of Health under award (grant R01DE018104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Balena R, 1998, OSTEOPOROSIS INT, V8, P428, DOI 10.1007/s001980050087; Bera TK, 2001, MOL CELL BIOL, V21, P7020, DOI 10.1128/MCB.21.20.7020-7024.2001; Brun LR, 2010, BIOMED PHARMACOTHER, V64, P1, DOI 10.1016/j.biopha.2008.10.009; Carvalho JG, 2009, J DENT RES, V88, P1054, DOI 10.1177/0022034509347249; Cheng PT, 1995, CELL MATER, V5, P271; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Choubisa S L, 2001, Indian J Environ Health, V43, P177; Darden AG, 1996, J BONE MINER RES, V11, P671; DEQUEKER J, 1993, SCHWEIZ MED WSCHR, V123, P2228; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; ELLIS EM, 1993, P NATL ACAD SCI USA, V90, P10350, DOI 10.1073/pnas.90.21.10350; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Grobler SR, 2009, OPEN DENT J, V3, P48, DOI 10.2174/1874210600903010048; HALL TJ, 1995, BIOCHEM BIOPH RES CO, V207, P280, DOI 10.1006/bbrc.1995.1184; Hamamura K, 2013, J BONE MINER METAB; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Karaoz E, 2004, BIOL TRACE ELEM RES, V102, P199, DOI 10.1385/BTER:102:1-3:199; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Marom R, 2006, J CELL PHYSIOL, V207, P628, DOI 10.1002/jcp.20611; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Mousny M, 2006, BONE, V39, P1283, DOI 10.1016/j.bone.2006.06.006; Moxon L N, 1987, Prog Clin Biol Res, V232, P383; OHTA T, 1995, CALCIFIED TISSUE INT, V56, P390, DOI 10.1007/BF00301608; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Reginster JY, 1998, ANN INTERN MED, V129, P1, DOI 10.7326/0003-4819-129-1-199807010-00001; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Yan D, 2007, BONE, V41, P1036, DOI 10.1016/j.bone.2007.07.018; Yan D, 2011, CELLS TISSUES ORGANS, V194, P261, DOI 10.1159/000324224	36	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114343	10.1371/journal.pone.0114343	http://dx.doi.org/10.1371/journal.pone.0114343			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501567	Green Published, gold			2022-12-26	WOS:000347146700021
J	Schully, KL; Bell, MG; Ward, JM; Keane-Myers, AM				Schully, Kevin L.; Bell, Matthew G.; Ward, Jerrold M.; Keane-Myers, Andrea M.			Oropharyngeal Aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; C57BL/6 MICE; MURINE MODEL; B. THAILANDENSIS; ALLERGIC INFLAMMATION; MOLECULAR-PATTERNS; SEVERE MELIOIDOSIS; GAMMA-INTERFERON; NATURAL-HISTORY; ANIMAL-MODELS	Burkholderia mallei and Burkholderia pseudomallei are potentially lethal pathogens categorized as biothreat agents due, in part, to their ability to be disseminated via aerosol. There are no protective vaccines against these pathogens and treatment options are limited and cumbersome. Since disease severity is greatest when these agents are inhaled, efforts to develop pre- or post- exposure prophylaxis focus largely on inhalation models of infection. Here, we demonstrate a non- invasive and technically simple method for affecting the inhalational challenge of BALB/c mice with B. pseudomallei and B. mallei. In this model, two investigators utilized common laboratory tools such as forceps and a micropipette to conduct and characterize an effective and reproducible inhalational challenge of BALB/c mice with B. mallei and B. pseudomallei. Challenge by oropharyngeal aspiration resulted in acute disease. Additionally, 50% endpoints for B. pseudomallei K96243 and B. mallei ATCC 23344 were nearly identical to published aerosol challenge methods. Furthermore, the pathogens disseminated to all major organs typically targeted by these agents where they proliferated. The pro- inflammatory cytokine production in the proximal and peripheral fluids demonstrated a rapid and robust immune response comparable to previously described murine and human studies. These observations demonstrate that OA is a viable alternative to aerosol exposure.	[Schully, Kevin L.; Bell, Matthew G.; Keane-Myers, Andrea M.] Naval Med Res Ctr Frederick, Frederick, MD 21702 USA; [Ward, Jerrold M.] Global Vet Pathol, Montgomery, MD USA	Naval Medical Research Center (NMRC)	Keane-Myers, AM (corresponding author), Naval Med Res Ctr Frederick, Frederick, MD 21702 USA.	keanemyers@yahoo.com			Defense Advanced Research Projects Agency (DARPA); Defense Threat Reduction Agency (DTRA) [HDTRA1-08-CBDIF-CBT-BAA]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	Funding for this work was provided by The Defense Advanced Research Projects Agency (DARPA). DARPA Order G677/00 and the Defense Threat Reduction Agency (DTRA), HDTRA1-08-CBDIF-CBT-BAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MT, 2012, VACCINE, V30, P4872, DOI 10.1016/j.vaccine.2012.04.078; [Anonymous], 1995, CONTROL COMMUNICABLE; ASHDOWN LR, 1992, AM J TROP MED HYG, V46, P151, DOI 10.4269/ajtmh.1992.46.151; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BOONSAWAT W, 1990, Journal of the Medical Association of Thailand, V73, P345; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2004, AM J TROP MED HYG, V70, P580, DOI 10.4269/ajtmh.2004.70.580; Cheng AC, 2007, INTENS CARE MED, V33, P562, DOI 10.1007/s00134-006-0527-5; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Egger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063432; Fisher NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-117; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Gan YH, 2002, MOL MICROBIOL, V44, P1185, DOI 10.1046/j.1365-2958.2002.02957.x; Gauthier YP, 2001, FEMS IMMUNOL MED MIC, V30, P53, DOI 10.1016/S0928-8244(00)00234-0; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; HOWE C, 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; Koo GC, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-19; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Leakey AK, 1998, MICROB PATHOGENESIS, V24, P269, DOI 10.1006/mpat.1997.0179; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Mandell GL., 1995, PRINCIPLES PRACTICE, P2003; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; McConchie BW, 2006, INFECT IMMUN, V74, P6632, DOI 10.1128/IAI.00720-06; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Norris HH, 2007, J LEUKOCYTE BIOL, V82, P1531, DOI 10.1189/jlb.1106667; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Revelli DA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00164; Rowland CA, 2006, INFECT IMMUN, V74, P5333, DOI 10.1128/IAI.02046-05; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Schell MA, 2008, J BACTERIOL, V190, P2306, DOI 10.1128/JB.01735-07; Schully KL, 2013, RAPID VACCINATION US; Shevchenko MA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-78; Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x; Shields AM, 2012, RHEUMATOLOGY, V51, P780, DOI 10.1093/rheumatology/ker412; Silva EB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00010; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Soffler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043207; Spittler A, 2000, CLIN INFECT DIS, V31, P1338, DOI 10.1086/317499; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Stanton AT, 1921, T 4 C FAR E ASS TROP, V2, P196; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Team R. D. C, 2011, R LANG ENV STAT COMP; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; Utaisincharoen P, 2001, MICROBIOL IMMUNOL, V45, P307, DOI 10.1111/j.1348-0421.2001.tb02623.x; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Waag D, 2005, BIOL WEAPONS DEFENSE, P209; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; West TE, 2012, INT J EXP PATHOL, V93, P421, DOI 10.1111/j.1365-2613.2012.00842.x; West TE, 2010, AM J TROP MED HYG, V83, P1066, DOI 10.4269/ajtmh.2010.10-0306; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	76	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115066	10.1371/journal.pone.0115066	http://dx.doi.org/10.1371/journal.pone.0115066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503969	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700090
J	Bordier, C; Saraux, C; Viblanc, VA; Gachot-Neveu, H; Beaugey, M; Le Maho, Y; Le Bohec, C				Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine			Inter-Annual Variability of Fledgling Sex Ratio in King Penguins	PLOS ONE			English	Article							APTENODYTES-PATAGONICUS; BODY CONDITION; EL-NINO; POPULATION-DYNAMICS; NATURAL-SELECTION; CLIMATE; SURVIVAL; REPRODUCTION; BIRDS; IDENTIFICATION	As the number of breeding pairs depends on the adult sex ratio in a monogamous species with biparental care, investigating sex-ratio variability in natural populations is essential to understand population dynamics. Using 10 years of data (20002009) in a seasonally monogamous seabird, the king penguin (Aptenodytes patagonicus), we investigated the annual sex ratio at fledging, and the potential environmental causes for its variation. Over more than 4000 birds, the annual sex ratio at fledging was highly variable (ranging from 44.4% to 58.3% of males), and on average slightly biased towards males (51.6%). Yearly variation in sex-ratio bias was neither related to density within the colony, nor to global or local oceanographic conditions known to affect both the productivity and accessibility of penguin foraging areas. However, rising sea surface temperature coincided with an increase in fledging sex-ratio variability. Fledging sex ratio was also correlated with difference in body condition between male and female fledglings. When more males were produced in a given year, their body condition was higher (and reciprocally), suggesting that parents might adopt a sex-biased allocation strategy depending on yearly environmental conditions and/or that the effect of environmental parameters on chick condition and survival may be sex-dependent. The initial bias in sex ratio observed at the juvenile stage tended to return to 1:1 equilibrium upon first breeding attempts, as would be expected from Fisher's classic theory of offspring sex-ratio variation.	[Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib 647, Strasbourg, France; [Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine] CNRS, UMR 7178, LIA BioSensib 647, Strasbourg, France; [Saraux, Claire] AgroParisTech ENGREF, Paris, France; [Saraux, Claire] IFREMER, UMR Ecosyst Marin Exploite 212, Sete, France; [Viblanc, Vincent A.] CNRS, UMR 5175, Equipe Ecol Comportementale, Ctr Ecol Fonct & Evolut, Montpellier, France; [Le Bohec, Celine] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Blindern, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Oslo	Bordier, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib 647, Strasbourg, France.	celia.bordier@gmail.com	LE BOHEC, CELINE/AAD-3589-2022; saraux, claire/AAX-8709-2020; Viblanc, Vincent Alexandre/A-7455-2014	saraux, claire/0000-0001-5061-4009; Viblanc, Vincent Alexandre/0000-0002-4953-659X; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais - Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Marie Curie Intra European Fellowship (European Commission) [235962, FP7-PEOPLE-IEF-2008]; AXA Research Fund	Institut Polaire Francais - Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Marie Curie Intra European Fellowship (European Commission)(European CommissionEuropean Commission Joint Research Centre); AXA Research Fund(AXA Research Fund)	This work was supported by the Institut Polaire Francais - Paul-Emile Victor, the Fondation Bettencourt-Schueller, the Fondation des Treilles and the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), grants from the Marie Curie Intra European Fellowship (FP7-PEOPLE-IEF-2008, European Commission; project No 235962) (to C.L.B.) and V.A.V. was supported by a postdoctoral fellowship from the AXA Research Fund during the time of writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JA, 1984, BIOL J LINN SOC, V23, P15, DOI 10.1111/j.1095-8312.1984.tb00802.x; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; Bried J, 1999, AUK, V116, P504; BULL J J, 1988, P96; Caswell, 2000, MATRIX POPULATION MO; CHARNOV E L, 1982; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Dobson FS, 2008, ETHOLOGY, V114, P925, DOI 10.1111/j.1439-0310.2008.01545.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Eichhorn G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1436; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Fahlman A, 2006, POLAR BIOL, V29, P609, DOI 10.1007/s00300-005-0096-z; Fisher RA, 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gauthier-Clerc M, 2002, MAR ECOL PROG SER, V237, P291, DOI 10.3354/meps237291; Gauthier-Clerc M, 2001, ANIM BEHAV, V62, P661, DOI 10.1006/anbe.2001.1803; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Vargas FH, 2007, BIOL CONSERV, V137, P138, DOI 10.1016/j.biocon.2007.02.005; IPCC, 2013, CARBON OTHER BIOGEOC; Kahn NW, 1998, AUK, V115, P1074; Keddar I, 2013, ETHOLOGY, V119, P389, DOI 10.1111/eth.12076; Keyfitz N, 1971, POPULATION FACTS MET; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Le Bohec C, 2007, J ANIM ECOL, V76, P1149, DOI 10.1111/j.1365-2656.2007.01268.x; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lee DE, 2009, J MAMMAL, V90, P1, DOI 10.1644/08-MAMM-A-130.1; Mayr E, 1939, AM NAT, V73, P156, DOI 10.1086/280824; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Moreno J, 1997, AUK, V114, P47, DOI 10.2307/4089064; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nager RG, 2000, BEHAV ECOL SOCIOBIOL, V48, P452, DOI 10.1007/s002650000262; Nesterova AP, 2010, BEHAV ECOL SOCIOBIOL, V64, P1145, DOI 10.1007/s00265-010-0930-3; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Olsson O, 1996, J AVIAN BIOL, V27, P7, DOI 10.2307/3676955; Olsson O, 2002, OECOLOGIA, V132, P509, DOI 10.1007/s00442-002-0985-6; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; Pincemy G, 2010, ETHOLOGY, V116, P1210, DOI 10.1111/j.1439-0310.2010.01835.x; Pincemy G, 2009, ANIM BEHAV, V78, P1247, DOI 10.1016/j.anbehav.2009.07.041; Putz K, 1998, ECOLOGY, V79, P1905, DOI 10.2307/176698; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saraux C, 2012, ANIM BEHAV, V84, P675, DOI 10.1016/j.anbehav.2012.06.024; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sheldon BC, 1998, HEREDITY, V80, P397, DOI 10.1046/j.1365-2540.1998.00374.x; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stier A, 2014, FUNCT ECOL, V28, P601, DOI 10.1111/1365-2435.12204; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Velando A, 2002, BEHAV ECOL, V13, P443, DOI 10.1093/beheco/13.4.443; Veran S, 2009, ECOL LETT, V12, P129, DOI 10.1111/j.1461-0248.2008.01268.x; Viblanc VA, 2014, FUNCT ECOL, V28, P621, DOI 10.1111/1365-2435.12212; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	71	4	4	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114052	10.1371/journal.pone.0114052	http://dx.doi.org/10.1371/journal.pone.0114052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493708	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400027
J	Wayne, PM; Gow, BJ; Costa, MD; Peng, CK; Lipsitz, LA; Hausdorff, JM; Davis, RB; Walsh, JN; Lough, M; Novak, V; Yeh, GY; Ahn, AC; Macklin, EA; Manor, B				Wayne, Peter M.; Gow, Brian J.; Costa, Madalena D.; Peng, C. -K.; Lipsitz, Lewis A.; Hausdorff, Jeffrey M.; Davis, Roger B.; Walsh, Jacquelyn N.; Lough, Matthew; Novak, Vera; Yeh, Gloria Y.; Ahn, Andrew C.; Macklin, Eric A.; Manor, Brad			Complexity-Based Measures Inform Effects of Tai Chi Training on Standing Postural Control: Cross-Sectional and Randomized Trial Studies	PLOS ONE			English	Article							OLDER-ADULTS; BALANCE CONTROL; PHYSIOLOGICAL COMPLEXITY; CHALLENGES INHERENT; MULTISCALE ENTROPY; STABILITY LIMITS; OPEN-LOOP; FALLS; COMMUNITY; DYNAMICS	Background: Diminished control of standing balance, traditionally indicated by greater postural sway magnitude and speed, is associated with falls in older adults. Tai Chi (TC) is a multisystem intervention that reduces fall risk, yet its impact on sway measures vary considerably. We hypothesized that TC improves the integrated function of multiple control systems influencing balance, quantifiable by the multi-scale "complexity'' of postural sway fluctuations. Objectives: To evaluate both traditional and complexity-based measures of sway to characterize the short- and potential long-term effects of TC training on postural control and the relationships between sway measures and physical function in healthy older adults. Methods: A cross-sectional comparison of standing postural sway in healthy TC-nalve and TC-expert (24.5 +/- 12 yrs experience) adults. TC-nalve participants then completed a 6-month, two-arm, wait-list randomized clinical trial of TC training.Postural sway was assessed before and after the training during standing on a force-plate with eyes-open (EO) and eyes-closed (EC). Anterior-posterior (AP) and medio-lateral (ML) sway speed, magnitude, and complexity (quantified by multiscale entropy) were calculated. Single- legged standing time and Timed-Up-and- Go tests characterized physical function. Results: At baseline, compared to TC-nalve adults (n=60, age 64.5 +/- 7.5 yrs), TC-experts (n=27, age 62.8 +/- 7.5 yrs) exhibited greater complexity of sway in the AP EC (P=0.023), ML EO (P, 0.001), and ML EC (P, 0.001) conditions. Traditional measures of sway speed and magnitude were not significantly lower among TC-experts. Intention-to-treat analyses indicated no significant effects of short-term TC training; however, increases in AP EC and ML EC complexity amongst those randomized to TC were positively correlated with practice hours (P=0.044, P=0.018). Long- and short-term TC training were positively associated with physical function. Conclusion: Multiscale entropy offers a complementary approach to traditional COP measures for characterizing sway during quiet standing, and may be more sensitive to the effects of TC in healthy adults.	[Wayne, Peter M.; Gow, Brian J.; Walsh, Jacquelyn N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Osher Ctr Integrat Med, Boston, MA 02115 USA; [Costa, Madalena D.; Peng, C. -K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA; [Costa, Madalena D.; Peng, C. -K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02115 USA; [Peng, C. -K.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Lipsitz, Lewis A.; Novak, Vera; Manor, Brad] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02115 USA; [Lipsitz, Lewis A.; Lough, Matthew] Hebrew SeniorLife, Inst Aging Res, Roslindale, MA USA; [Hausdorff, Jeffrey M.] Tel Aviv Med Ctr & Sch Med, Dept Neurol, Movement Disorders Unit, Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Davis, Roger B.; Yeh, Gloria Y.; Ahn, Andrew C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Novak, Vera] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Ahn, Andrew C.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Macklin, Eric A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Hebrew SeniorLife; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wayne, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Osher Ctr Integrat Med, Boston, MA 02115 USA.	pwayne@partners.org	Peng, Chung-Kang/N-1308-2019; Macklin, Eric A/E-2955-2013	Peng, Chung-Kang/0000-0003-3666-9833; Macklin, Eric A/0000-0003-1618-3502; Gow, Brian/0000-0002-7682-1943	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) [R21 AT005501-01A1]; Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR) [UL1 RR025758]; National Institute on Aging (NIA) [R37-AG25037]; NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R21-DK-084463-02]; National Institutes of Health (NIH)-National Institute on Aging (NIA) [1R01-AG-0287601-A2]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Institutes of Health Award) [8UL1TR000170-05]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (Harvard University); Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT005501] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041785, R00AG030677, R01AG025037] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Institutes of Health Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (Harvard University); Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by grant number R21 AT005501-01A1 from the National Center for Complementary and Alternative Medicine (NCCAM: http://nccam.nih.gov/) at the National Institutes of Health (NIH: http://www.nih.gov/), and from grant number UL1 RR025758 supporting the Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR: http://www.nih.gov/about/almanac/organization/NCRR.htm). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, NCRR, or the NIH. Dr. Lipsitz was supported by grant R37-AG25037 from the National Institute on Aging (NIA: http://www.nia. nih.gov/) and the Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife. Dr. Novak has received grants from the NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: http://www.niddk.nih. gov/) (5R21-DK-084463-02) and the National Institutes of Health (NIH)-National Institute on Aging (NIA: http://www.nia.nih.gov/) (1R01-AG-0287601-A2) unrelated to this study. The work in the SAFE lab was conducted with support from Harvard Catalyst (http://catalyst.harvard.edu/) vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner T., 2006, MEASUREMENT EVALUATI, V8th ed.; Burgener SC, 2008, AM J ALZHEIMERS DIS, V23, P382, DOI 10.1177/1533317508317527; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen YS, 2011, ARCH PHYS MED REHAB, V92, P886, DOI 10.1016/j.apmr.2010.12.043; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Fischer M, 2014, USE PRAGMAT IN PRESS, V21; Gatts Strawberry, 2008, V52, P87, DOI 10.1159/000134289; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Guan HW, 2011, AM J CHINESE MED, V39, P251, DOI 10.1142/S0192415X11008798; Gyllensten AL, 2010, ARCH PHYS MED REHAB, V91, P215, DOI 10.1016/j.apmr.2009.10.009; Hakim RM, 2010, PHYS OCCUP THER GERI, V28, P63, DOI 10.3109/02703181003605861; Harmer PeterA., 2008, V52, P124, DOI 10.1159/000134293; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; HEIL DP, 1995, MED SCI SPORT EXER, V27, P599; Hong YL, 2000, BRIT J SPORT MED, V34, P29, DOI 10.1136/bjsm.34.1.29; JACKSON AS, 1995, MED SCI SPORT EXER, V27, P113; Jacobson BH, 1997, PERCEPT MOTOR SKILL, V84, P27, DOI 10.2466/pms.1997.84.1.27; JUDGE JO, 1993, PHYS THER, V73, P254, DOI 10.1093/ptj/73.4.254; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Li L, 2010, AM J CHINESE MED, V38, P113, DOI 10.1142/S0192415X10007701; Lima BN, 2014, J SPORT SCI MED, V13, P564; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Liu H, 2010, J GERIATR PHYS THER, V33, P103, DOI 10.1097/JPT.0b013e3181eda1c4; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manor B, 2014, J AM GERIAT IN PRESS; Manor B, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-87; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Manson J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-114; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; Pluchino A, 2012, ARCH PHYS MED REHAB, V93, P1138, DOI 10.1016/j.apmr.2012.01.023; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Rubenstein LZ, 2001, ANN INTERN MED, V135, P686, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00007; Sattin RW, 2005, J AM GERIATR SOC, V53, P1168, DOI 10.1111/j.1532-5415.2005.53375.x; Schneider Ellen Caylor, 2010, N C Med J, V71, P547; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Shumway-Cook A, 2006, MOTOR CONTROL TRANSL, V3; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Taylor-Piliae RE, 2014, ARCH PHYS MED REHAB, V95, P816, DOI 10.1016/j.apmr.2014.01.001; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Tousignant M, 2013, DISABIL REHABIL, V35, P1429, DOI 10.3109/09638288.2012.737084; Tsang WW, 2004, ARCH PHYS MED REHAB, V85, P129, DOI 10.1016/j.apmr.2003.02.002; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P648, DOI 10.1249/01.MSS.0000121941.57669.BF; Tsang WWN, 2003, MED SCI SPORT EXER, V35, P1962, DOI 10.1249/01.MSS.0000099110.17311.A2; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P191, DOI 10.1089/acm.2007.7170B; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; Wayne PM, 2013, CONTEMP CLIN TRIALS, V34, P21, DOI 10.1016/j.cct.2012.09.006; Wei Q, 2012, ENTROPY-SWITZ, V14, P2157, DOI 10.3390/e14112157; Wolf SL, 1997, PHYS THER, V77, P371, DOI 10.1093/ptj/77.4.371; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; Wu G, 2002, ARCH PHYS MED REHAB, V83, P1364, DOI 10.1053/apmr.2002.34596; Wu G, 2010, ARCH PHYS MED REHAB, V91, P849, DOI 10.1016/j.apmr.2010.01.024; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	72	43	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114731	10.1371/journal.pone.0114731	http://dx.doi.org/10.1371/journal.pone.0114731			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494333	gold, Green Submitted, Green Published			2022-12-26	WOS:000346611400072
J	Lemieux, E; Cagnol, S; Beaudry, K; Carrier, J; Rivard, N				Lemieux, E.; Cagnol, S.; Beaudry, K.; Carrier, J.; Rivard, N.			Oncogenic KRAS signalling promotes the Wnt/beta-catenin pathway through LRP6 in colorectal cancer	ONCOGENE			English	Article							INTESTINAL EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASES; BETA-CATENIN; TUMOR PROGRESSION; REGULATED KINASE; K-RAS; WNT; TUMORIGENESIS; APC; MUTATIONS	Aberrant regulation of the Wnt/beta-catenin signaling pathway is one of the major causes of colorectal cancer (CRC). Loss-of-function mutations in APC are commonly found in CRC, leading to inappropriate activation of canonical Wnt signaling. Conversely, gain-of-function mutations in KRAS and BRAF genes are detected in up to 60% of CRCs. Whereas KRAS/mitogen-activated protein kinase (MAPK) and canonical Wnt/beta-catenin pathways are critical for intestinal tumorigenesis, mechanisms integrating these two important signaling pathways during CRC development are unknown. Results herein demonstrate that transformation of normal intestinal epithelial cells (IECs) by oncogenic forms of KRAS, BRAF or MEK1 was associated with a marked increase in beta-catenin/TCF4 and c-MYC promoter transcriptional activities and mRNA levels of c-Myc, Axin2 and Lef1. Notably, expression of a dominant-negative mutant of T-Cell Factor 4 (.NTCF4) severely attenuated IEC transformation induced by oncogenic MEK1 and markedly reduced their tumorigenic and metastatic potential in immunocompromised mice. Interestingly, the Frizzled co-receptor LRP6 was phosphorylated in a MEK-dependent manner in transformed IECs and in human CRC cell lines. Expression of LRP6 mutant in which serine/threonine residues in each particular ProlineProlineProlineSerine/ThreonineProline motif were mutated to alanines (LRP6-5A) significantly reduced beta-catenin/TCF4 transcriptional activity. Accordingly, MEK inhibition in human CRC cells significantly diminished beta-catenin/TCF4 transcriptional activity and c-MYC mRNA and protein levels without affecting beta-catenin expression or stability. Lastly, LRP6 phosphorylation was also increased in human colorectal tumors, including adenomas, in comparison with healthy adjacent normal tissues. Our data indicate that oncogenic activation of KRAS/BRAF/MEK signaling stimulates the canonical Wnt/beta-catenin pathway, which in turn promotes intestinal tumor growth and invasion. Moreover, LRP6 phosphorylation by ERK1/2 may provide a unique point of convergence between KRAS/MAPK and Wnt/beta-catenin signalings during oncogenesis.	[Lemieux, E.; Cagnol, S.; Beaudry, K.; Rivard, N.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cell Biol, Sherbrooke, PQ J1E 4K8, Canada; [Carrier, J.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Med, Gastroenterol Serv, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke; University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cell Biol, Canc Res Pavil,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	Nathalie.Rivard@USherbrooke.ca			Canadian Institutes of Health Research [MT-14405]; Canadian Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair(Canada Research Chairs)	We thank Guillaume Arguin and Gerald Bernatchez for technical assistance. The biobank of colorectal cancer specimens was supported by a Team grant on digestive epithelium from the Canadian Institutes of Health Research. This research was supported by a grant from the Canadian Institutes of Health Research Grant to Nathalie Rivard (MT-14405). Etienne Lemieux is a student scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). Nathalie Rivard and Julie C Carrier are members of the FRSQ-Funded Centre de Recherche du CHUS. Nathalie Rivard is a recipient of a Canadian Research Chair in colorectal cancer and inflammatory cell signalling. This research was supported by a grant from the Canadian Institutes of Health Research to NR (MT-14405).	Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Boucher MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG736, DOI 10.1152/ajpgi.00453.2003; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Cagnol S, 2013, ONCOGENE, V32, P564, DOI 10.1038/onc.2012.88; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dasari A, 2010, CLIN CANCER RES, V16, P3811, DOI 10.1158/1078-0432.CCR-09-2283; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Dienstmann R, 2011, ANTI-CANCER AGENT ME, V11, P285, DOI 10.2174/187152011795347469; Eggstein S, 1999, GUT, V44, P834, DOI 10.1136/gut.44.6.834; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fodde R, 2010, J PATHOL, V221, P239, DOI 10.1002/path.2718; Gopalbhai K, 1998, J CELL PHYSIOL, V174, P35, DOI 10.1002/(SICI)1097-4652(199801)174:1<35::AID-JCP5>3.0.CO;2-H; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Komatsu K, 2005, GASTROENTEROLOGY, V129, P577, DOI 10.1053/j.gastro.2005.06.003; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Lee SH, 2004, APMIS, V112, P233, DOI 10.1111/j.1600-0463.2004.apm11204-0502.x; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Luo FJ, 2009, INT J EXP PATHOL, V90, P558, DOI 10.1111/j.1365-2613.2009.00667.x; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Naishiro Y, 2001, CANCER RES, V61, P2751; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Obrador-Hevia A, 2010, J PATHOL, V221, P57, DOI 10.1002/path.2685; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Pretlow TP, 2005, BBA-REV CANCER, V1756, P83, DOI 10.1016/j.bbcan.2005.06.002; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Saucier C, 2010, CANCER METAST BIOL T, V14, P205, DOI 10.1007/978-90-481-8833-8_8; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Taketo MM, 2006, CANCER SCI, V97, P355, DOI 10.1111/j.1349-7006.2006.00190.x; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wang CH, 2013, DEV BIOL, V378, P122, DOI 10.1016/j.ydbio.2013.03.020; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Yuen ST, 2002, CANCER RES, V62, P6451; Zeller E, 2013, ARCH TOXICOL, V87, P611, DOI 10.1007/s00204-013-1035-3	86	106	106	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4914	4927		10.1038/onc.2014.416	http://dx.doi.org/10.1038/onc.2014.416			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25500543	Green Published, hybrid			2022-12-26	WOS:000361693000002
J	Carswell, CL; Sun, JY; Baenziger, JE				Carswell, Casey L.; Sun, Jiayin; Baenziger, John E.			Intramembrane Aromatic Interactions Influence the Lipid Sensitivities of Pentameric Ligand-gated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; TRANSMEMBRANE DOMAIN; CYS-LOOP; STRUCTURAL-CHARACTERIZATION; PROTEIN INTERACTIONS; MOLECULAR-DYNAMICS; PHOSPHATIDIC-ACID; GATING KINETICS; ANIONIC LIPIDS	Although the Torpedo nicotinic acetylcholine receptor (nAChR) reconstituted into phosphatidylcholine (PC) membranes lacking cholesterol and anionic lipids adopts a conformation where agonist binding is uncoupled from channel gating, the underlying mechanism remains to be defined. Here, we examine the mechanism behind lipid-dependent uncoupling by comparing the propensities of two prokaryotic homologs, Gloebacter and Erwinia ligand-gated ion channel (GLIC and ELIC, respectively), to adopt a similar uncoupled conformation. Membrane-reconstituted GLIC and ELIC both exhibit folded structures in the minimal PC membranes that stabilize an uncoupled nAChR. GLIC, with a large number of aromatic interactions at the interface between the outermost transmembrane a-helix, M4, and the adjacent transmembrane a-helices, M1 and M3, retains the ability to flux cations in this uncoupling PC membrane environment. In contrast, ELIC, with a level of aromatic interactions intermediate between that of the nAChR and GLIC, does not undergo agonist-induced channel gating, although it does not exhibit the expected biophysical characteristics of the uncoupled state. Engineering new aromatic interactions at the M4-M1/M3 interface to promote effective M4 interactions with M1/M3, however, increases the stability of the transmembrane domain to restore channel function. Our data provide direct evidence that M4 interactions with M1/M3 are modulated during lipid sensing. Aromatic residues strengthen M4 interactions with M1/M3 to reduce the sensitivities of pentameric ligand-gated ion channels to their surrounding membrane environment.	[Carswell, Casey L.; Sun, Jiayin; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research (CIHR) [111243]; Natural Sciences and Engineering Research Council of Canada [113312]; CIHR Training Program in Neurodegenerative Lipidomics Grant [TGF-96121]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Training Program in Neurodegenerative Lipidomics Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant 111243 and Natural Sciences and Engineering Research Council of Canada Grant 113312, as well as CIHR Training Program in Neurodegenerative Lipidomics Grant TGF-96121.	Antollini SS, 2005, MOL MEMBR BIOL, V22, P471, DOI 10.1080/09687860500367915; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1995, J BIOL CHEM, V270, P29129, DOI 10.1074/jbc.270.49.29129; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Carswell CL, 2008, J BACTERIOL, V190, P5650, DOI 10.1128/JB.00298-08; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2011, BIOCHEM BIOPH RES CO, V407, P456, DOI 10.1016/j.bbrc.2011.03.026; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MARSH D, 1981, BIOCHIM BIOPHYS ACTA, V645, P97, DOI 10.1016/0005-2736(81)90516-2; Methot N, 2001, J BIOL CHEM, V276, P23726, DOI 10.1074/jbc.M102101200; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sturgeon RM, 2010, BIOPHYS J, V98, P989, DOI 10.1016/j.bpj.2009.11.030; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; Tol MB, 2013, J BIOL CHEM, V288, P5756, DOI 10.1074/jbc.M112.422287; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Williamson PTF, 2005, MOL MEMBR BIOL, V22, P485, DOI 10.1080/09687860500370653; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	58	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2496	2507		10.1074/jbc.M114.624395	http://dx.doi.org/10.1074/jbc.M114.624395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25519904	Green Published, hybrid			2022-12-26	WOS:000348588000051
J	Dolcino, M; Lunardi, C; Ottria, A; Tinazzi, E; Patuzzo, G; Puccetti, A				Dolcino, Marzia; Lunardi, Claudio; Ottria, Andrea; Tinazzi, Elisa; Patuzzo, Giuseppe; Puccetti, Antonio			Crossreactive Autoantibodies Directed against Cutaneous and Joint Antigens Are Present in Psoriatic Arthritis	PLOS ONE			English	Article							NEBULIN-RELATED PROTEIN; CLASSIFICATION CRITERIA; N-RAP; PATHOGENESIS; DIAGNOSIS; PROMOTES; GENE	Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease of unknown origin, characterized by erosions and new bone formation. Diagnosis of PsA is mainly clinical and there are no biomarkers available. Moreover in PsA autoantibodies have not been described so far. Indeed an autoimmune origin has been suggested but never proven. Aim of the study was to investigate the possible presence of autoantibodies typically associated with PsA. Methods: We used pooled IgG immunoglobulins derived from 30 patients with PsA to screen a random peptide library in order to identify disease relevant autoantigen peptides. Results: Among the selected peptides, one was recognised by nearly all the patients' sera. The identified peptide (PsA peptide: TNRRGRGSPGAL) shows sequence similarities with skin autoantigens, such as fibrillin 3, a constituent of actin microfibrils, desmocollin 3, a constituent of the desmosomes and keratin 78, a component of epithelial cytoskeleton. Interestingly the PsA peptide shares homology with the nebulin-related anchoring protein (N-RAP), a protein localized in the enthesis (point of insertion of a tendon or ligament to the bone), which represents the first affected site during early PsA. Antibodies affinity purified against the PsA peptide recognize fibrillin, desmocollin, keratin and N-RAP. Moreover antibodies directed against the PsA peptide are detectable in 85% of PsA patients. Such antibodies are not present in healthy donors and are present in 13/100 patients with seroposive rheumatoid arthritis (RA). In seronegative RA these antibodies are detectable only in 3/100 patients. Conclusions: Our results indicate that PsA is characterized by the presence of serum autoantibodies crossreacting with an epitope shared by skin and joint antigens.	[Dolcino, Marzia; Puccetti, Antonio] Inst Giannina Gaslini, Genoa, Italy; [Lunardi, Claudio; Tinazzi, Elisa; Patuzzo, Giuseppe] Univ Verona, Dept Med, I-37100 Verona, Italy; [Ottria, Andrea; Puccetti, Antonio] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Puccetti, A (corresponding author), Inst Giannina Gaslini, Genoa, Italy.	antonio.puccetti@unige.it	Tinazzi, Elisa/AAB-9450-2020	PATUZZO, Giuseppe/0000-0001-8011-0004; Ottria, Andrea/0000-0001-8722-3968				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Butt C, 2005, ANN RHEUM DIS, V64, P114; Davis MR, 2014, MOL GENET METAB, V112, P73, DOI 10.1016/j.ymgme.2013.12.006; Duarte GV, 2012, BEST PRACT RES CL RH, V26, P147, DOI 10.1016/j.berh.2012.01.003; Eder L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0316-4; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; He Z, 2012, SCAND J IMMUNOL, V76, P483, DOI 10.1111/j.1365-3083.2012.02759.x; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2009, J INTERN MED, V265, P250, DOI 10.1111/j.1365-2796.2008.02013.x; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Luo G, 1997, CELL MOTIL CYTOSKEL, V38, P75; Luo G, 1999, BIOCHEMISTRY-US, V38, P6135, DOI 10.1021/bi982395t; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; McGonagle DG, 2012, DERMATOLOGY, V225, P100, DOI 10.1159/000341536; Mease P, 2013, CURR OPIN RHEUMATOL, V25, P287, DOI 10.1097/BOR.0b013e32835fd8d5; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Rahman P, 2005, ANN RHEUM DIS, V64, P1370, DOI 10.1136/ard.2004.031765; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ritchlin C, 2012, J RHEUMATOL, V39, P57, DOI 10.3899/jrheum.120245; Ritchlin CT, 2005, CURR OPIN RHEUMATOL, V17, P406, DOI 10.1097/01.bor.0000167752.93543.76; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Saruta H, 2013, JAMA DERMATOL, V149, P1209, DOI 10.1001/jamadermatol.2013.5244; Stolwijk C, 2012, RHEUM DIS CLIN N AM, V38, P441, DOI 10.1016/j.rdc.2012.09.003; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Villanova F, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-203037; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	31	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115424	10.1371/journal.pone.0115424	http://dx.doi.org/10.1371/journal.pone.0115424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514237	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300058
J	Hall, FS; Sora, I; Hen, R; Uhl, GR				Hall, Frank Scott; Sora, Ichiro; Hen, Rene; Uhl, George R.			Serotonin/Dopamine Interactions in a Hyperactive Mouse: Reduced Serotonin Receptor 1B Activity Reverses Effects of Dopamine Transporter Knockout	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PREPULSE INHIBITION DEFICITS; NUCLEUS ACCUMBENS SEPTI; VENTRAL TEGMENTAL AREA; 5-HT1B RECEPTOR; LOCOMOTOR-ACTIVITY; MICE LACKING; IN-VIVO; 5-HYDROXYTRYPTAMINE(1B) RECEPTORS; AGGRESSIVE-BEHAVIOR	Knockout (KO) mice that lack the dopamine transporter (SL6A3; DAT) display increased locomotion that can be attenuated, under some circumstances, by administration of drugs that normally produce psychostimulant-like effects, such as amphetamine and methylphenidate. These results have led to suggestions that DAT KO mice may model features of attention deficit hyperactivity disorder (ADHD) and that these drugs may act upon serotonin (5-HT) systems to produce these unusual locomotor decreasing effects. Evidence from patterns of brain expression and initial pharmacologic studies led us to use genetic and pharmacologic approaches to examine the influence of altered 5-HT1B receptor activity on hyperactivity in DAT KO mice. Heterozygous 5-HT1B KO and pharmacologic 5-HT1B antagonism both attenuated locomotor hyperactivity in DAT KO mice. Furthermore, DAT KO mice with reduced, but not eliminated, 5-HT1B receptor expression regained cocaine-stimulated locomotion, which was absent in DAT KO mice with normal levels of 5-HT1B receptor expression. Further experiments demonstrated that the degree of habituation to the testing apparatus determined whether cocaine had no effect on locomotion in DAT KO or reduced locomotion, helping to resolve differences among prior reports. These findings of complementation of the locomotor effects of DAT KO by reducing 5-HT1B receptor activity underscore roles for interactions between specific 5-HT receptors and dopamine (DA) systems in basal and cocaine-stimulated locomotion and support evaluation of 5-HT1B antagonists as potential, non-stimulant ADHD therapeutics.	[Hall, Frank Scott] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, Toledo, OH 43606 USA; [Hall, Frank Scott; Uhl, George R.] NIDA, Mol Neurobiol Branch, Intramural Res Program, Baltimore, MD USA; [Sora, Ichiro] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA; [Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Kobe University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Hall, FS (corresponding author), Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	frank.hall@utoledo.edu	Hall, F. Scott/C-3036-2013	Hall, F. Scott/0000-0002-0822-4063	National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA)	National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA)	This research was supported by the National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arime Y, 2012, NEUROPSYCHOPHARMACOL, V37, P2522, DOI 10.1038/npp.2012.114; Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Ase AR, 2008, J CHEM NEUROANAT, V35, P356, DOI 10.1016/j.jchemneu.2008.02.007; Ase AR, 2000, J NEUROCHEM, V75, P2415, DOI 10.1046/j.1471-4159.2000.0752415.x; Ase AR, 2001, J NEUROCHEM, V78, P619, DOI 10.1046/j.1471-4159.2001.00437.x; Banerjee E, 2012, PSYCHIAT RES, V200, P1083, DOI 10.1016/j.psychres.2012.04.003; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; BONHOMME N, 1995, NEUROPHARMACOLOGY, V34, P269, DOI 10.1016/0028-3908(94)00145-I; Boulenguez P, 1996, NEUROPHARMACOLOGY, V35, P1521, DOI 10.1016/S0028-3908(96)00099-8; Bowers BJ, 2000, J NEUROCHEM, V75, P1625, DOI 10.1046/j.1471-4159.2000.0751625.x; CAMERON DL, 1994, J NEUROSCI, V14, P6763; CARTER CJ, 1979, N-S ARCH PHARMACOL, V308, P51, DOI 10.1007/BF00499718; Chaouloff F, 1999, PSYCHOPHARMACOLOGY, V141, P326, DOI 10.1007/s002130050841; Clifton PG, 2003, EUROPEAN J NEUROSCIE, V17; COOK EH, 1995, AM J HUM GENET, V56, P993; CREESE I, 1974, PSYCHOPHARMACOLOGIA, V39, P345, DOI 10.1007/BF00422974; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; CREESE I, 1973, BRAIN RES, V55, P369, DOI 10.1016/0006-8993(73)90302-8; DeDeurwaerdere P, 1997, J NEUROCHEM, V68, P195; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Faccidomo S, 2012, PSYCHOPHARMACOLOGY, V222, P117, DOI 10.1007/s00213-011-2629-1; Fauchey V, 2000, EUR J NEUROSCI, V12, P3415, DOI 10.1046/j.1460-9568.2000.00220.x; Fauchey V, 2000, EUR J NEUROSCI, V12, P19, DOI 10.1046/j.1460-9568.2000.00876.x; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2001, J AM ACAD CHILD PSY, V40, P380, DOI 10.1097/00004583-200103000-00020; GATELY PF, 1985, PSYCHOPHARMACOLOGY, V87, P400, DOI 10.1007/BF00432502; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GLICK SD, 1973, EUR J PHARMACOL, V24, P266, DOI 10.1016/0014-2999(73)90082-4; Hawi Z, 2002, MOL PSYCHIATR, V7, P718, DOI 10.1038/sj.mp.4001048; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Igari M, BEHAV PHARM IN PRESS; Iversen S D, 1977, Adv Biochem Psychopharmacol, V16, P209; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; JOYCE EM, 1983, NEUROPHARMACOLOGY, V22, P1141, DOI 10.1016/0028-3908(83)90051-5; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; KOOB GF, 1978, J COMP PHYSIOL PSYCH, V92, P917, DOI 10.1037/h0077542; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Lucas JJ, 1997, MOL PHARMACOL, V51, P755, DOI 10.1124/mol.51.5.755; Malleret G, 1999, 5 HT1B RECEPTOR KNOC; Matthies S, 2013, J ATTEN DISORD, V17, P176, DOI 10.1177/1087054711428739; MILLER R, 1974, BRAIN RES, V81, P387, DOI 10.1016/0006-8993(74)90957-3; Morikawa H, 2000, MOL PHARMACOL, V58, P1271, DOI 10.1124/mol.58.6.1271; NEILL DB, 1972, PHYSIOL BEHAV, V9, P655, DOI 10.1016/0031-9384(72)90026-1; Neumaier JF, 2002, J NEUROSCI, V22, P10856; O'Dell LE, 2006, J NEUROCHEM, V99, P1363, DOI 10.1111/j.1471-4159.2006.04163.x; O'Dell LE, 2004, J PHARMACOL EXP THER, V311, P711, DOI 10.1124/jpet.104.069278; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Parent M, 2011, J CHEM NEUROANAT, V41, P256, DOI 10.1016/j.jchemneu.2011.04.005; Pentkowski NS, 2012, BIOL PSYCHIAT, V72, P396, DOI 10.1016/j.biopsych.2012.03.024; Pentkowski NS, 2009, ADDICT BIOL, V14, P419, DOI 10.1111/j.1369-1600.2009.00162.x; Pereira DB, 2012, FRONT BIOSCI-LANDMRK, V17, P2740, DOI 10.2741/4083; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ramboz S, 1996, BEHAV BRAIN RES, V73, P305; Ramos-Quiroga JA, 2014, J PSYCHIATR RES, V49, P60, DOI 10.1016/j.jpsychires.2013.10.022; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rocha BA, 1998, NATURE, V393, P175, DOI 10.1038/30259; Sanchez-Mora C, 2013, EUR NEUROPSYCHOPHARM, V23, P1463, DOI 10.1016/j.euroneuro.2013.07.002; Sari Y, 1997, BRAIN RES, V760, P281, DOI 10.1016/S0006-8993(97)00400-9; Sari Y, 1999, NEUROSCIENCE, V88, P899, DOI 10.1016/S0306-4522(98)00256-5; Sarkis EH, 2000, SCIENCE, V287, P2160; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Smoller JW, 2006, BIOL PSYCHIAT, V59, P460, DOI 10.1016/j.biopsych.2005.07.017; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; STECK H, 1954, Ann Med Psychol (Paris), V112, P737; Teicher MH, 2003, J CHILD ADOL PSYCHOP, V13, P41, DOI 10.1089/104454603321666180; TRICKLEBANK MD, 1986, NEUROPHARMACOLOGY, V25, P877, DOI 10.1016/0028-3908(86)90014-6; Uchiumi O, 2013, NEUROPHARMACOLOGY, V64, P348, DOI 10.1016/j.neuropharm.2012.07.016; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; Volkow N D, 2000, Science, V288, P11; Volkow ND, 2002, EUR NEUROPSYCHOPHARM, V12, P557, DOI 10.1016/S0924-977X(02)00104-9; West AR, 1996, SYNAPSE, V23, P20, DOI 10.1002/(SICI)1098-2396(199605)23:1<20::AID-SYN3>3.0.CO;2-J; YADID G, 1994, J PHARMACOL EXP THER, V270, P1158; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yamashita M, 2013, PSYCHOPHARMACOLOGY, V227, P741, DOI 10.1007/s00213-013-3009-9; Zhang X.W., 2010, PLOS ONE, V5	83	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115009	10.1371/journal.pone.0115009	http://dx.doi.org/10.1371/journal.pone.0115009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514162	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300025
J	Lutkenhoff, ES; Rosenberg, M; Chiang, J; Zhang, KY; Pickard, JD; Owen, AM; Monti, MM				Lutkenhoff, Evan S.; Rosenberg, Matthew; Chiang, Jeffrey; Zhang, Kunyu; Pickard, John D.; Owen, Adrian M.; Monti, Martin M.			Optimized Brain Extraction for Pathological Brains (optiBET)	PLOS ONE			English	Article							MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; IMAGE-ANALYSIS; ROBUST; REGISTRATION; FSL	The study of structural and functional magnetic resonance imaging data has greatly benefitted from the development of sophisticated and efficient algorithms aimed at automating and optimizing the analysis of brain data. We address, in the context of the segmentation of brain from non-brain tissue (i.e., brain extraction, also known as skull-stripping), the tension between the increased theoretical and clinical interest in patient data, and the difficulty of conventional algorithms to function optimally in the presence of gross brain pathology. Indeed, because of the reliance of many algorithms on priors derived from healthy volunteers, images with gross pathology can severely affect their ability to correctly trace the boundaries between brain and non-brain tissue, potentially biasing subsequent analysis. We describe and make available an optimized brain extraction script for the pathological brain (optiBET) robust to the presence of pathology. Rather than attempting to trace the boundary between tissues, optiBET performs brain extraction by (i) calculating an initial approximate brain extraction; (ii) employing linear and non-linear registration to project the approximate extraction into the MNI template space; (iii) back-projecting a standard brain-only mask from template space to the subject's original space; and (iv) employing the back-projected brain-only mask to mask-out non-brain tissue. The script results in up to 94% improvement of the quality of extractions over those obtained with conventional software across a large set of severely pathological brains. Since optiBET makes use of freely available algorithms included in FSL, it should be readily employable by anyone having access to such tools.	[Lutkenhoff, Evan S.; Rosenberg, Matthew; Chiang, Jeffrey; Zhang, Kunyu; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 2QQ, England; [Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Monti, Martin M.] Univ Calif Los Angeles, Ronald Reagan Med Ctr, Dept Neurosurg, BIRC, Los Angeles, CA USA	University of California System; University of California Los Angeles; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center	Monti, MM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	monti@psych.ucla.edu	Owen, Adrian M/B-4997-2015; Monti, Martin/G-8352-2011	Monti, Martin/0000-0001-5511-3780; Chiang, Jeffrey/0000-0002-6843-1355	James S. McDonnell Foundation Scholar Award; Medical Research Council [U. 1055.01.002.00007.01, U. 1055.01.002.00001.01]; European Commission ICT Programme [FP7-247919]	James S. McDonnell Foundation Scholar Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission ICT Programme	This work was supported by the James S. McDonnell Foundation Scholar Award, the Medical Research Council (U. 1055.01.002.00007.01 and U. 1055.01.002.00001.01), and the European Commission ICT Programme Project FP7-247919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Friston KJ, 1997, HUMAN BRAIN FUNCTION, P25; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hendrson A, 2004, PARAVIEW GUIDE PARAL; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Monti MM, 2013, HUM BRAIN MAPP, V34, P1245, DOI 10.1002/hbm.21507; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Monti MM, NEUROLOGY IN PRESS; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051	19	123	123	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115551	10.1371/journal.pone.0115551	http://dx.doi.org/10.1371/journal.pone.0115551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514672	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300061
J	Michel, A; Downey, P; Nicolas, JM; Scheller, D				Michel, Anne; Downey, Patrick; Nicolas, Jean-Marie; Scheller, Dieter			Unprecedented Therapeutic Potential with a Combination of A(2A)/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; DOPA-INDUCED DYSKINESIA; GLUTAMATE RECEPTORS; ANIMAL-MODELS; ANTIPARKINSONIAN ACTIONS; MOLECULAR-MECHANISMS; MOTOR FLUCTUATIONS; MARMOSET MODEL; RODENT MODELS; DOUBLE-BLIND	In Parkinson's disease, the long-term use of dopamine replacing agents is associated with the development of motor complications; therefore, there is a need for non-dopaminergic drugs. This study evaluated the potential therapeutic impact of six different NR2B and A(2A) receptor antagonists given either alone or in combination in unilateral 6-OHDA-lesioned rats without (monotherapy) or with (add-on therapy) the co-administration of L-Dopa: Sch-58261+ Merck 22; Sch58261+Co-101244; Preladenant + Merck 22; Preladenant + Radiprodil; Tozadenant + Radiprodil; Istradefylline + Co-101244. Animals given monotherapy were assessed on distance traveled and rearing, whereas those given add-on therapy were assessed on contralateral rotations. Three-way mixed ANOVA were conducted to assess the main effect of each drug separately and to determine whether any interaction between two drugs was additive or synergistic. Additional post hoc analyses were conducted to compare the effect of the combination with the effect of the drugs alone. Motor activity improved significantly and was sustained for longer when the drugs were given in combination than when administered separately at the same dose. Similarly, when tested as add-on treatment to L-Dopa, the combinations resulted in higher levels of contralateral rotation in comparison to the single drugs. Of special interest, the activity observed with some combinations could not be described by a simplistic additive effect and involved more subtle synergistic pharmacological interactions. The combined administration of A(2A)/NR2B-receptor antagonists improved motor behaviour in 6-OHDA rats. Given the proven translatability of this model such a combination may be expected to be effective in improving motor symptoms in patients.	[Michel, Anne; Downey, Patrick; Scheller, Dieter] UCB BioPharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium; [Nicolas, Jean-Marie] UCB BioPharma SPRL, Nonclin Dev, Braine Lalleud, Belgium		Michel, A (corresponding author), UCB BioPharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium.	anne.michel@ucb.com						Acquas E, 1999, BEHAV BRAIN RES, V103, P219, DOI 10.1016/S0166-4328(99)00038-8; Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Aman TK, 2014, J BIOL CHEM; Armentero MT, 2011, PHARMACOL THERAPEUT, V132, P280, DOI 10.1016/j.pharmthera.2011.07.004; Atack JR, 2014, PRECLINICAL MODELS P; Bargiotas P, 2013, NEUROPSYCH DIS TREAT, V9, P1605, DOI 10.2147/NDT.S36693; Barta-Szalai G, 2004, BIOORG MED CHEM LETT, V14, P3953, DOI 10.1016/j.bmcl.2004.05.053; Bibbiani F, 2003, EXP NEUROL, V184, P285, DOI 10.1016/S0014-4886(03)00250-4; Blanchet PJ, 1999, J PHARMACOL EXP THER, V290, P1034; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Haes JU, 2013, CLIN PHARMACOL THER, V93, pS111; Delfino MA, 2004, BEHAV BRAIN RES, V152, P297, DOI 10.1016/j.bbr.2003.10.009; Duty S, 2012, CNS DRUGS, V26, P1017, DOI 10.1007/s40263-012-0016-z; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Fernandez HH, 2010, PARKINSONISM RELAT D, V16, P16, DOI 10.1016/j.parkreldis.2009.06.008; Ferre S, 2001, PARKINSONISM RELAT D, V7, P235, DOI 10.1016/S1353-8020(00)00063-8; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fox SH, 2008, LANCET NEUROL, V7, P927, DOI 10.1016/S1474-4422(08)70214-X; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Gallagher DA, 2007, MOVEMENT DISORD, V22, P1757, DOI 10.1002/mds.21611; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hauber W, 1996, N-S ARCH PHARMACOL, V354, P179; Hauser RA, 2014, LANCET NEUROL, V13, P767, DOI 10.1016/S1474-4422(14)70148-6; Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617; Janhunen S, 2005, EUR J PHARMACOL, V511, P143, DOI 10.1016/j.ejphar.2005.02.017; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Johnson KA, 2009, CNS NEUROL DISORD-DR, V8, P475, DOI 10.2174/187152709789824606; Kelsey JE, 2004, PSYCHOPHARMACOLOGY, V175, P179, DOI 10.1007/s00213-004-1799-5; Kelsey JE, 2009, PSYCHOPHARMACOLOGY, V201, P529, DOI 10.1007/s00213-008-1319-0; Kuppenbender KD, 2000, J COMP NEUROL, V419, P407, DOI 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I; Laloux C, 2012, PHARMACOL RES, V65, P514, DOI 10.1016/j.phrs.2012.02.008; Layton ME, 2011, ACS CHEM NEUROSCI, V2, P352, DOI 10.1021/cn200013d; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Lundblad M, 2003, J NEUROCHEM, V84, P1398, DOI 10.1046/j.1471-4159.2003.01632.x; Marino MJ, 2002, AMINO ACIDS, V23, P185, DOI 10.1007/s00726-001-0127-1; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Michel A., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Mignon L, 2007, PSYCHOPHARMACOLOGY, V192, P49, DOI 10.1007/s00213-006-0680-0; Mihara T, 2007, MODELS PARKINSON S D; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; Nash JE, 1999, EXP NEUROL, V155, P42, DOI 10.1006/exnr.1998.6963; Nash JE, 2004, EXP NEUROL, V188, P471, DOI 10.1016/j.expneurol.2004.05.004; Nash JE, 2000, EXP NEUROL, V165, P136, DOI 10.1006/exnr.2000.7444; Nash JE, 2000, J NEUROSCI, V20, P7782; Neustadt BR, 2007, BIOORG MED CHEM LETT, V17, P1376, DOI 10.1016/j.bmcl.2006.11.083; Nutt JG, 2008, MOVEMENT DISORD, V23, P1860, DOI 10.1002/mds.22169; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088; Pinna A, 2005, EUR J PHARMACOL, V512, P157, DOI 10.1016/j.ejphar.2005.01.057; Pinna A, 2001, SYNAPSE, V39, P233, DOI 10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K; Pinna A, 1996, EUR J NEUROSCI, V8, P1176, DOI 10.1111/j.1460-9568.1996.tb01285.x; Pinna A, 2014, CNSDRUGS; Quiroz C, 2006, J NEUROSCI, V26, P10808, DOI 10.1523/JNEUROSCI.1661-06.2006; Ramirez-Zamora A, 2014, EXPERT REV NEUROTHER, V14, P93, DOI 10.1586/14737175.2014.868306; Rao N, 2008, J CLIN PHARMACOL, V48, P1092, DOI 10.1177/0091270008320924; Schapira AHV, 2005, J NEUROL NEUROSUR PS, V76, P1472, DOI 10.1136/jnnp.2004.035980; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Steece-Collier K, 2000, EXP NEUROL, V163, P239, DOI 10.1006/exnr.2000.7374; Tronci E, 2007, EUR J PHARMACOL, V566, P94, DOI 10.1016/j.ejphar.2007.03.021; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Wessell RH, 2004, NEUROPHARMACOLOGY, V47, P184, DOI 10.1016/j.neuropharm.2004.03.011; Zhou ZL, 1999, J MED CHEM, V42, P2993, DOI 10.1021/jm990246i	74	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114086	10.1371/journal.pone.0114086	http://dx.doi.org/10.1371/journal.pone.0114086			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513815	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300007
J	Papazachariou, L; Demosthenous, P; Pieri, M; Papagregoriou, G; Savva, I; Stavrou, C; Zavros, M; Athanasiou, Y; Ioannou, K; Patsias, C; Panagides, A; Potamitis, C; Demetriou, K; Prikis, M; Hadjigavriel, M; Kkolou, M; Loukaidou, P; Pastelli, A; Michael, A; Lazarou, A; Arsali, M; Damianou, L; Goutziamani, I; Soloukides, A; Yioukas, L; Elia, A; Zouvani, I; Polycarpou, P; Pierides, A; Voskarides, K; Deltas, C				Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Stavrou, Christoforos; Zavros, Michael; Athanasiou, Yiannis; Ioannou, Kyriakos; Patsias, Charalambos; Panagides, Alexia; Potamitis, Costas; Demetriou, Kyproula; Prikis, Marios; Hadjigavriel, Michael; Kkolou, Maria; Loukaidou, Panayiota; Pastelli, Androulla; Michael, Aristos; Lazarou, Akis; Arsali, Maria; Damianou, Loukas; Goutziamani, Ioanna; Soloukides, Andreas; Yioukas, Lakis; Elia, Avraam; Zouvani, Ioanna; Polycarpou, Polycarpos; Pierides, Alkis; Voskarides, Konstantinos; Deltas, Constantinos			Frequency of COL4A3/COL4A4 Mutations amongst Families Segregating Glomerular Microscopic Hematuria and Evidence for Activation of the Unfolded Protein Response. Focal and Segmental Glomerulosclerosis Is a Frequent Development during Ageing	PLOS ONE			English	Article							IV COLLAGEN ALPHA-3; ALPORT SYNDROME; RENAL-FAILURE; COL4A4 GENE; ER STRESS; BENIGN; IDENTIFICATION; CHILDREN; SURVEYOR; DISEASES	Familial glomerular hematuria(s) comprise a genetically heterogeneous group of conditions which include Alport Syndrome (AS) and thin basement membrane nephropathy (TBMN). Here we investigated 57 Greek-Cypriot families presenting glomerular microscopic hematuria (GMH), with or without proteinuria or chronic kidney function decline, but excluded classical AS. We specifically searched the COL4A3/A4 genes and identified 8 heterozygous mutations in 16 families (28,1%). Eight non-related families featured the founder mutation COL4A3-p.(G1334E). Renal biopsies from 8 patients showed TBMN and focal segmental glomerulosclerosis (FSGS). Ten patients (11.5%) reached end-stage kidney disease (ESKD) at ages ranging from 37-69-yo (mean 50,1-yo). Next generation sequencing of the patients who progressed to ESKD failed to reveal a second mutation in any of the COL4A3/A4/A5 genes, supporting that true heterozygosity for COL4A3/A4 mutations predisposes to CRF/ESKD. Although this could be viewed as a milder and late-onset form of autosomal dominant AS, we had no evidence of ultrastructural features or extrarenal manifestations that would justify this diagnosis. Functional studies in cultured podocytes transfected with wild type or mutant COL4A3 chains showed retention of mutant collagens and differential activation of the unfolded protein response (UPR) cascade. This signifies the potential role of the UPR cascade in modulating the final phenotype in patients with collagen IV nephropathies.	[Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, CY-1678 Nicosia, Cyprus; [Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Lab Mol & Med Genet, CY-1678 Nicosia, Cyprus; [Stavrou, Christoforos] Evangelismos Med Ctr, Dept Nephrol, Pafos, Cyprus; [Zavros, Michael; Athanasiou, Yiannis; Ioannou, Kyriakos; Patsias, Charalambos; Panagides, Alexia; Potamitis, Costas; Demetriou, Kyproula; Prikis, Marios] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Hadjigavriel, Michael; Kkolou, Maria; Loukaidou, Panayiota; Pastelli, Androulla] Larnaca Gen Hosp, Dept Nephrol, Larnax, Cyprus; [Michael, Aristos; Lazarou, Akis; Arsali, Maria; Damianou, Loukas; Goutziamani, Ioanna; Soloukides, Andreas] Limassol Gen Hosp, Dept Nephrol, Limassol, Cyprus; [Yioukas, Lakis] Paphos Gen Hosp, Dept Nephrol, Paphos, Cyprus; [Elia, Avraam] Archbishop Makarios III Hosp, Dept Pediat, Nicosia, Cyprus; [Zouvani, Ioanna] Nicosia Gen Hosp, Dept Histopathol, Nicosia, Cyprus; [Polycarpou, Polycarpos] Apollon Private Hosp, Dept Nephrol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus	University of Cyprus; University of Cyprus; Hippocrateon Private Hospital	Pierides, A (corresponding author), Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus.	a.pierides@hippocrateon.com; deltas@ucy.ac.cy	Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/A-4936-2013	Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Papagregoriou, Gregory/0000-0002-2440-9789; Pieri, Myrtani/0000-0002-8883-4434	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project) [NEW INFRASTRUCTURE/STRATEGIC/0308/24]	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project)	This research project was supported by a grant co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project NEW INFRASTRUCTURE/STRATEGIC/0308/24) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Boye E, 1998, AM J HUM GENET, V63, P1329, DOI 10.1086/302106; Buzza M, 2001, KIDNEY INT, V59, P1670, DOI 10.1046/j.1523-1755.2001.0590051670.x; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Deltas C, 2013, NEPHROL DIAL TRANSPL; Deltas C, 2013, NEPHROL DIAL TRANSPL, V28, P2946, DOI 10.1093/ndt/gft253; Demosthenous P, 2012, CLIN GENET, V81, P240, DOI 10.1111/j.1399-0004.2011.01647.x; Erguler K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-16; Fallerini C, 2013, CLIN GENET; Fukuda K, 1997, BIOCHEM BIOPH RES CO, V231, P178, DOI 10.1006/bbrc.1997.6069; Gale DP, 2013, PEDIATR NEPHROL, V28, P1183, DOI 10.1007/s00467-012-2399-y; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gross O, 2014, NEPHROL DIAL TRANSPL, V29, P124, DOI 10.1093/ndt/gfu028; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kashtan CE, 2009, PEDIATR NEPHROL, V24, P1951, DOI 10.1007/s00467-007-0622-z; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kobayashi T, 2010, PEDIATR NEPHROL, V25, P1169, DOI 10.1007/s00467-009-1433-1; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Leinonen A, 1999, KIDNEY INT, V55, P926, DOI 10.1046/j.1523-1755.1999.055003926.x; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Marcocci E, 2009, NEPHROL DIAL TRANSPL, V24, P1464, DOI 10.1093/ndt/gfn681; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miner JH, 2014, KIDNEY INT; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Pierides A, 2013, HIPPOKRATIA, V17, P207; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Rana K, 2005, PEDIATR NEPHROL, V20, P1729, DOI 10.1007/s00467-005-2034-2; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Savige J, 2004, NEPHROLOGY, V9, P52, DOI 10.1111/j.1440-1797.2004.00243.x; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; Taylor J, 2014, ARCH DIS CHILD; Temme J, 2012, KIDNEY INT, V81, P779, DOI 10.1038/ki.2011.452; Tonna S, 2005, SEMIN NEPHROL, V25, P171, DOI 10.1016/j.semnephrol.2005.01.009; Tonna S, 2008, PEDIATR NEPHROL, V23, P2201, DOI 10.1007/s00467-008-0934-7; Tryggvason K, 2006, J AM SOC NEPHROL, V17, P813, DOI 10.1681/ASN.2005070737; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Voskarides K, 2008, PEDIATR NEPHROL, V23, P1373, DOI 10.1007/s00467-008-0804-3; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Voskarides K, 2012, PEDIATR NEPHROL, V27, P675, DOI 10.1007/s00467-011-2084-6; Voskarides K, 2009, J MOL DIAGN, V11, P311, DOI 10.2353/jmoldx.2009.080144; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z	56	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115015	10.1371/journal.pone.0115015	http://dx.doi.org/10.1371/journal.pone.0115015			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514610	gold, Green Published			2022-12-26	WOS:000349146300028
J	Brouwer, M; Coelho, E; Mosse, CD; Brondi, L; Winterton, L; van Leth, F				Brouwer, Miranda; Coelho, Eliana; Mosse, Carla das Dores; Brondi, Luciana; Winterton, Laura; van Leth, Frank			Healthcare Workers' Challenges in the Implementation of Tuberculosis Infection Prevention and Control Measures in Mozambique	PLOS ONE			English	Article							CONTROL KNOWLEDGE	Objective: Healthcare Workers (HCWs) have a higher frequency of TB exposure than the general population and have therefore an occupational TB risk that infection prevention and control (IPC) measures aim to reduce. HCWs are crucial in the implementation of these measures. The objective of the study was to investigate Mozambican HCWs' perceptions of their occupational TB risk and the measures they report using to reduce this risk. In addition, we explored the challenges HCWs encounter while using these TBIPC measures. Methods: Focus group discussion. Analysis according content method. Participants: Four categories of HCWs: auxiliary workers, medical (doctors and clinical officers), nurses and TB program staff. Results: HCWs are aware of their occupational TB risk and use various measures to reduce their risk of infection. HCWs find it challenging to employ measures that minimize such risks and a lack of clear guidelines contributes to these challenges. HCWs' and patient behavior further complicate the use of TBIPC measures. Conclusion: HCWs in Mozambique perceive a high occupational risk of TB infection. They report several challenges using measures to reduce this risk such as shortage of material, lack of clear guidelines, insufficient motivation and inadequate training. Robust training with motivational approaches, alongside supervision and support for HCWs could improve implementation of TBIPC measures. Healthcare management should address the areas for improvement that are beyond the individual HCW's control.	[Brouwer, Miranda] Hlth Alliance Int, Tech Assistance Unit, Maputo, Mozambique; [Coelho, Eliana] Minist Hlth, Maputo, Mozambique; [Mosse, Carla das Dores] Minist Hlth, Prov Directorate, Tete, Mozambique; [Winterton, Laura] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam	Brouwer, M (corresponding author), Hlth Alliance Int, Tech Assistance Unit, Maputo, Mozambique.	brouwer.miranda@gmail.com		van Leth, Frank/0000-0002-5490-8968	United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	This research was part of the activities supported by a grant from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buregyeya E, 2012, J PUBLIC HEALTH-HEID, V20, P599, DOI 10.1007/s10389-012-0503-1; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Hobday RA, 2013, J HOSP INFECT, V84, P271, DOI 10.1016/j.jhin.2013.04.011; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kamulegeya A, 2013, J INFECT DEV COUNTR, V7, P726, DOI 10.3855/jidc.2486; Kanjee Z, 2012, J Infect Public Health, V5, P67, DOI 10.1016/j.jiph.2011.10.008; Ministerio da Saude & Instituto Nacional de Saude, 2009, INQ NAC PREV RISC CO; Ministerio de Saude Direccao Nacional de Saude Publica Programa Nacional de Controlo da Tuberculose, 2010, POL PLAN NAC CONTR I; Ministry of Health National Directorate of Human Resources, 2008, NAT PLAN HLTH HUM RE; Ministry of Health of The Republic of Uganda, UG NAT GUID TUB INF; Mulder C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049649; Robert J, 2013, INFECT CONT HOSP EP, V34, P190, DOI 10.1086/669085; Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262; Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woith W, 2012, INT J TUBERC LUNG D, V16, P1092, DOI 10.5588/ijtld.10.0779; World Health Organization, 2009, POL TB INF CONTR HLT	18	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114364	10.1371/journal.pone.0114364	http://dx.doi.org/10.1371/journal.pone.0114364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25501847	Green Submitted, gold, Green Published			2022-12-26	WOS:000346607100013
J	Kawahara, R; Granato, DC; Carnielli, CM; Cervigne, NK; Oliveria, CE; Martinez, CAR; Yokoo, S; Fonseca, FP; Lopes, M; Santos-Silva, AR; Graner, E; Coletta, RD; Leme, AFP				Kawahara, Rebeca; Granato, Daniela C.; Carnielli, Carolina M.; Cervigne, Nilva K.; Oliveria, Carine E.; Martinez, Cesar A. R.; Yokoo, Sami; Fonseca, Felipe P.; Lopes, Marcio; Santos-Silva, Alan R.; Graner, Edgard; Coletta, Ricardo D.; Paes Leme, Adriana Franco			Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; TUMOR-GROWTH; MOLECULAR-MECHANISMS; BASEMENT-MEMBRANES; CANCER; METASTASIS; EXPRESSION; IDENTIFICATION; ANGIOGENESIS; ADHESION	Oral squamous cell carcinoma is the most common type of cancer in the oral cavity, representing more than 90% of all oral cancers. The characterization of altered molecules in oral cancer is essential to understand molecular mechanisms underlying tumor progression as well as to contribute to cancer biomarker and therapeutic target discovery. Proteoglycans are key molecular effectors of cell surface and pericellular microenvironments, performing multiple functions in cancer. Two of the major basement membrane proteoglycans, agrin and perlecan, were investigated in this study regarding their role in oral cancer. Using real time quantitative PCR (qRT-PCR), we showed that agrin and perlecan are highly expressed in oral squamous cell carcinoma. Interestingly, cell lines originated from distinct sites showed different expression of agrin and perlecan. Enzymatically targeting chondroitin sulfate modification by chondroitinase, oral squamous carcinoma cell line had a reduced ability to adhere to extracellular matrix proteins and increased sensibility to cisplatin. Additionally, knockdown of agrin and perlecan promoted a decrease on cell migration and adhesion, and on resistance of cells to cisplatin. Our study showed, for the first time, a negative regulation on oral cancer-associated events by either targeting chondroitin sulfate content or agrin and perlecan levels.	[Kawahara, Rebeca; Granato, Daniela C.; Carnielli, Carolina M.; Martinez, Cesar A. R.; Yokoo, Sami; Paes Leme, Adriana Franco] CNPEM, Lab Nacl Biociencias, Lab Espectrometria Massas, Campinas, SP, Brazil; [Cervigne, Nilva K.; Oliveria, Carine E.; Fonseca, Felipe P.; Lopes, Marcio; Santos-Silva, Alan R.; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, UNICAMP, Fac Odontol Piracicaba, Piracicaba, Brazil	Universidade Estadual de Campinas	Leme, AFP (corresponding author), CNPEM, Lab Nacl Biociencias, Lab Espectrometria Massas, Campinas, SP, Brazil.	adriana.paesleme@lnbio.cnpem.org.br	Leme, Adriana F Paes/C-9679-2012; Coletta, Ricardo D./B-4909-2015; Santos-Silva, Alan Roger/B-6121-2008; Cervigne, Nilva K/L-1341-2016; Graner, Edgard/K-4411-2012; Santos-Silva, Alan/C-9947-2016; Rivera, César/AFL-7931-2022; Fonseca, Felipe P/C-4158-2012; de Oliveira, Carine Ervolino/I-3087-2013; Graner, Edgard/P-4651-2019; Lopes, Marcio Ajudarte/AAV-1018-2020; Rivera, César/H-6109-2011; Carnielli, Carolina Moretto/V-2739-2019; Kawahara, Rebeca/B-1532-2015	Leme, Adriana F Paes/0000-0001-7959-147X; Coletta, Ricardo D./0000-0001-5285-3046; Santos-Silva, Alan Roger/0000-0003-2040-6617; Cervigne, Nilva K/0000-0002-6129-9136; Graner, Edgard/0000-0002-4737-7935; Santos-Silva, Alan/0000-0003-2040-6617; Rivera, César/0000-0002-5491-4233; Fonseca, Felipe P/0000-0002-6657-4547; Rivera, César/0000-0002-5491-4233; Carnielli, Carolina Moretto/0000-0001-8336-7390; Kawahara, Rebeca/0000-0002-0292-2637; Yokoo, Sami/0000-0003-4658-9319; Ajudarte Lopes, Marcio/0000-0001-6677-0065	FAPESP [2009/54067-3, 2010/19278-0, 2011/22421-2]; CNPq [470549/2011-4, 301702/2011-0, 470268/2013-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP Grants 2009/54067-3, 2010/19278-0, 2011/22421-2, and CNPq Grants 470549/2011-4, 301702/2011-0 and 470268/2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Batmunkh E, 2007, HUM PATHOL, V38, P1508, DOI 10.1016/j.humpath.2007.02.017; Belcher R, 2014, J SURG ONCOL; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chai YD, 2014, HEAD NECK; Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Dasari S., 2014, EUR J PHARM; Eberle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021496; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Feller L., 2012, J CANC THER, V3, P263, DOI [10.4236/jct.2012.34037, DOI 10.4236/JCT.2012.34037]; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; Ida-Yonemochi H, 2002, VIRCHOWS ARCH, V441, P165, DOI 10.1007/s00428-001-0556-y; Ikarashi T, 2004, J ORAL PATHOL MED, V33, P87, DOI 10.1111/j.1600-0714.2004.00026.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; Martin PT, 1997, DEVELOPMENT, V124, P3909; Mishra Mithilesh, 2013, J Oral Maxillofac Pathol, V17, P31, DOI 10.4103/0973-029X.110704; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Pantazaka E, 2014, BBA-GEN SUBJECTS, V1840, P2643, DOI 10.1016/j.bbagen.2014.01.009; Pereira MC, 2007, J CAN DENT ASSOC, V73, P339; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Silva H, 2012, MOL PHARMACEUT, V9, P1795, DOI 10.1021/mp300098t; Somoracz A, 2010, HUM PATHOL, V41, P1310, DOI 10.1016/j.humpath.2009.10.029; Tatrai P, 2006, LAB INVEST, V86, P1149, DOI 10.1038/labinvest.3700475; Teng PN, 2014, BRIT J CANCER, V110, P123, DOI 10.1038/bjc.2013.687; Terp MG, 2012, CANCER GENOM PROTEOM, V9, P265; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Zhang JS, 2011, CARBOHYD RES, V346, P631, DOI 10.1016/j.carres.2011.01.007; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	54	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115004	10.1371/journal.pone.0115004	http://dx.doi.org/10.1371/journal.pone.0115004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506919	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100042
J	Shrestha, B; Sripadi, P; Reschke, BR; Henderson, HD; Powell, MJ; Moody, SA; Vertes, A				Shrestha, Bindesh; Sripadi, Prabhakar; Reschke, Brent R.; Henderson, Holly D.; Powell, Matthew J.; Moody, Sally A.; Vertes, Akos			Subcellular Metabolite and Lipid Analysis of Xenopus laevis Eggs by LAESI Mass Spectrometry	PLOS ONE			English	Article							ABLATION ELECTROSPRAY-IONIZATION; SPERM CHEMOATTRACTANT; SINGLE CELLS; IN-VIVO; OOCYTE; ALLURIN; TISSUE; KEGG	Xenopus laevis eggs are used as a biological model system for studying fertilization and early embryonic development in vertebrates. Most methods used for their molecular analysis require elaborate sample preparation including separate protocols for the water soluble and lipid components. In this study, laser ablation electrospray ionization (LAESI), an ambient ionization technique, was used for direct mass spectrometric analysis of X. laevis eggs and early stage embryos up to five cleavage cycles. Single unfertilized and fertilized eggs, their animal and vegetal poles, and embryos through the 32-cell stage were analyzed. Fifty two small metabolite ions, including glutathione, GABA and amino acids, as well as numerous lipids including 14 fatty acids, 13 lysophosphatidylcholines, 36 phosphatidylcholines and 29 triacylglycerols were putatively identified. Additionally, some proteins, for example thymosin beta 4 (Xen), were also detected. On the subcellular level, the lipid profiles were found to differ between the animal and vegetal poles of the eggs. Radial profiling revealed profound compositional differences between the jelly coat vitelline/plasma membrane and egg cytoplasm. Changes in the metabolic profile of the egg following fertilization, e.g., the decline of polyamine content with the development of the embryo were observed using LAESI-MS. This approach enables the exploration of metabolic and lipid changes during the early stages of embryogenesis.	[Shrestha, Bindesh; Sripadi, Prabhakar; Vertes, Akos] George Washington Univ, Dept Chem, WM Keck Inst Prote Technol & Applicat, Washington, DC 20052 USA; [Moody, Sally A.] George Washington Univ, Dept Anat & Regenerat Biol, Washington, DC USA; [Reschke, Brent R.; Henderson, Holly D.; Powell, Matthew J.] Protea Biosci, Morgantown, WV USA	George Washington University; George Washington University	Vertes, A (corresponding author), George Washington Univ, Dept Chem, WM Keck Inst Prote Technol & Applicat, Washington, DC 20052 USA.	vertes@gwu.edu	Moody, Sally A./AAI-3660-2020; Vertes, Akos/B-7159-2008; Shrestha, Bindesh/B-8821-2008	Moody, Sally A./0000-0003-4192-1087; Vertes, Akos/0000-0001-5186-5352; Shrestha, Bindesh/0000-0002-7595-3506	U.S. National Science Foundation [CHE-1152302, IOS-0817902, MCB-1121711]; George Washington University; Protea Biosciences	U.S. National Science Foundation(National Science Foundation (NSF)); George Washington University; Protea Biosciences	The authors gratefully acknowledge funding by the U.S. National Science Foundation through Grant No. CHE-1152302 to A.V. for the development of single cell and subcellular analysis methods, and through Grant Nos. IOS-0817902 and MCB-1121711 to S.A.M. for studying molecular changes in embryonic development. The George Washington University Selective Excellence Fund also provided financial contribution to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Protea Biosciences provided support in the form of salaries for authors BRR, HDH and MJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEZ T, 1990, DEVELOPMENT, V110, P955; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Elkan ER, 1938, BMJ-BRIT MED J, V4, P1253, DOI 10.1136/bmj.2.4067.1253; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u; Gonzalez-Serrano AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074981; Gurdon JB, 2000, INT J DEV BIOL, V44, P43; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; Hausen P., 1991, EARLY DEV XENOPUS LA; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khokha MK, 2012, GENESIS, V50, P133, DOI 10.1002/dvg.22015; King ML, 2005, BIOL CELL, V97, P19; Koek MM, 2010, ANAL CHEM, V82, P156, DOI 10.1021/ac9015787; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Moody SA, 1999, CELL LINEAGE ANAL XE, P331; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nemes P, 2008, ANAL CHEM, V80, P4575, DOI 10.1021/ac8004082; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; OHLENDORF DH, 1977, J BIOL CHEM, V252, P7992; Olson JH, 2001, P NATL ACAD SCI USA, V98, P11205, DOI 10.1073/pnas.211316798; OSBORNE HB, 1989, BIOCHEM BIOPH RES CO, V158, P520, DOI 10.1016/S0006-291X(89)80080-4; Petcoff DW, 2008, J LIPID RES, V49, P2365, DOI 10.1194/jlr.M800159-JLR200; Sato K-i, 2006, STUDYING FERTILIZATI, P395; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shrestha B, 2014, ANAL CHEM, V86, P4308, DOI 10.1021/ac500007t; Shrestha B, 2010, APPL PHYS A-MATER, V101, P121, DOI 10.1007/s00339-010-5781-2; Shrestha B, 2010, ANALYST, V135, P751, DOI 10.1039/b922854c; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Stith BJ, 2000, J LIPID RES, V41, P1448; Stolee JA, 2012, ANGEW CHEM INT EDIT, V51, P10386, DOI 10.1002/anie.201205436; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; WASSERMAN WJ, 1976, SCIENCE, V191, P1266, DOI 10.1126/science.1083070; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xiang XY, 2005, MOL REPROD DEV, V70, P344, DOI 10.1002/mrd.20201; YUREWICZ EC, 1975, BIOCHEMISTRY-US, V14, P3101, DOI 10.1021/bi00685a010; Zhang JH, 2004, ANAL BIOCHEM, V334, P20, DOI 10.1016/j.ab.2004.07.012	43	29	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115173	10.1371/journal.pone.0115173	http://dx.doi.org/10.1371/journal.pone.0115173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506922	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100054
J	Bressan, MC; Louie, JD; Mikawa, T				Bressan, Michael C.; Louie, Jonathan D.; Mikawa, Takashi			Hemodynamic Forces Regulate Developmental Patterning of Atrial Conduction	PLOS ONE			English	Article							ENDOTHELIN-CONVERTING ENZYME-1; IN-SITU HYBRIDIZATION; MYOSIN HEAVY-CHAIN; CARDIAC CONDUCTION; VENTRICULAR MYOCARDIUM; PURKINJE-FIBERS; ANISOTROPIC CONDUCTION; PROLIFERATIVE STATE; CELL-PROLIFERATION; CHICK-EMBRYO	Anomalous action potential conduction through the atrial chambers of the heart can lead to severe cardiac arrhythmia. To date, however, little is known regarding the mechanisms that pattern proper atrial conduction during development. Here we demonstrate that atrial muscle functionally diversifies into at least two heterogeneous subtypes, thin-walled myocardium and rapidly conducting muscle bundles, during a developmental window just following cardiac looping. During this process, atrial muscle bundles become enriched for the fast conduction markers Cx40 and Nav1.5, similar to the precursors of the fast conduction Purkinje fiber network located within the trabeculae of the ventricles. In contrast to the ventricular trabeculae, however, atrial muscle bundles display an increased proliferation rate when compared to the surrounding myocardium. Interestingly, mechanical loading of the embryonic atrial muscle resulted in an induction of Cx40, Nav1.5 and the cell cycle marker Cyclin D1, while decreasing atrial pressure via in vivo ligation of the vitelline blood vessels results in decreased atrial conduction velocity. Taken together, these data establish a novel model for atrial conduction patterning, whereby hemodynamic stretch coordinately induces proliferation and fast conduction marker expression, which in turn promotes the formation of large diameter muscle bundles to serve as preferential routes of conduction.	[Bressan, Michael C.; Louie, Jonathan D.; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	Takashi.Mikawa@UCSF.edu			National Institute of Health, Heart, Lung, Blood, Institute [R01 HL093566, R01 HL112268, R01 HL078921, 1K99HL122360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL078921, R01HL112268, R01HL078921, R01HL122375, K99HL122360, R01HL093566, T32HL007544, R00HL122360] Funding Source: NIH RePORTER	National Institute of Health, Heart, Lung, Blood, Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institute of Health, Heart, Lung, Blood, Institute, http://www.nhlbi.nih.gov (R01 HL093566, R01 HL112268, R01 HL078921 to TM, and 1K99HL122360 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 1998, J CARDIOVASC ELECTR, V9, P1233, DOI 10.1111/j.1540-8167.1998.tb00097.x; ANDERSON RH, 1981, ANAT REC, V201, P75, DOI 10.1002/ar.1092010110; Aschoff L., 1910, VERH DEUTSCH PATHOL, V14, P3; Bachmann G, 1916, AM J PHYSIOL, V41, P309, DOI 10.1152/ajplegacy.1916.41.3.309; Benes J, 2014, FEBS LETT, V588, P1465, DOI 10.1016/j.febslet.2014.01.032; Berenfeld O, 2004, ANAT REC PART A, V280A, P1053, DOI 10.1002/ar.a.20106; Betts TR, 2002, J CARDIOVASC ELECTR, V13, P1152, DOI 10.1046/j.1540-8167.2002.01152.x; Bressan M, 2014, DEVELOPMENT, V141, P4149, DOI 10.1242/dev.110007; Bressan M, 2013, SCIENCE, V340, P744, DOI 10.1126/science.1232877; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; DECARVALHO AP, 1959, AM J PHYSIOL, V196, P483, DOI 10.1152/ajplegacy.1959.196.3.483; DRAPER M. H., 1959, QUART JOUR EXPTL PHYSIOL, V44, P91; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; FUJII S, 1988, J MEMBRANE BIOL, V101, P209, DOI 10.1007/BF01872836; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145; Hall CE, 2004, DEVELOPMENT, V131, P581, DOI 10.1242/dev.00947; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Hocini M, 1998, J AM COLL CARDIOL, V31, P629, DOI 10.1016/S0735-1097(97)00519-6; HOLSINGE.JW, 1968, ANN SURG, V167, P447, DOI 10.1097/00000658-196804000-00001; Hurtado R, 2006, DEV DYNAM, V235, P2811, DOI 10.1002/dvdy.20909; Jalife Jose, 1997, P357; JAMES TN, 1971, AM J CARDIOL, V28, P414, DOI 10.1016/0002-9149(71)90005-1; JETER JR, 1971, J EMBRYOL EXP MORPH, V25, P405; KAMINO K, 1991, PHYSIOL REV, V71, P53, DOI 10.1152/physrev.1991.71.1.53; KLEBER AG, 2011, NORMAL AND ABNORMAL, DOI DOI 10.1002/CPHY.CP020112; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Lewis T, 1910, HEART-J STUD CIRC, V2, P147; LEWIS T, 1914, SERIES B CONTAINING, V205, P375, DOI DOI 10.2307/92042; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007; Miquerol L, 2013, DEV DYNAM, V242, P665, DOI 10.1002/dvdy.23964; MONCKEBERG JG, 1921, ERGEB ALLG PATH PATH, V19, P328; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Oana S, 1998, BIOL CELL, V90, P605; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Rentschler S, 2001, DEVELOPMENT, V128, P1785; SAFFITZ JE, 1994, CIRC RES, V74, P1065, DOI 10.1161/01.RES.74.6.1065; Sankova B, 2010, AM J PHYSIOL-HEART C, V298, pH1571, DOI 10.1152/ajpheart.00721.2009; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; Sedmera D, 2006, AM J PHYSIOL-HEART C, V291, pH1646, DOI 10.1152/ajpheart.01007.2005; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; SPACH MS, 1982, CIRC RES, V50, P175, DOI 10.1161/01.RES.50.2.175; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; SPACH MS, 1969, CIRC RES, V24, P857, DOI 10.1161/01.RES.24.6.857; Stekelenburg-de Vos S, 2003, J EXP BIOL, V206, P1051, DOI 10.1242/jeb.00216; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Takebayashi-Suzuki K, 2000, DEVELOPMENT, V127, P3523; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Thorel C, 1910, MUNCHEN MED WCHNSCHR, V57, P183; Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203; TRUEX RAYMOND D., 1965, ANN N Y ACAD SCI, V127, P19, DOI 10.1111/j.1749-6632.1965.tb49390.x; VANMIEROP LH, 1967, AM J PHYSIOL, V212, P407, DOI 10.1152/ajplegacy.1967.212.2.407; WAGNER ML, 1966, CIRC RES, V18, P502, DOI 10.1161/01.RES.18.5.502; WENCKEBACH KF, 1907, VIRCHOWS ARCHIV FUR, V1, P1; YAMADA K, 1968, CIRC RES, V22, P707, DOI 10.1161/01.RES.22.6.707; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	64	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115207	10.1371/journal.pone.0115207	http://dx.doi.org/10.1371/journal.pone.0115207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503944	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400082
J	Cheng, Y; Wang, XY; Hu, H; Killiny, N; Xu, JP				Cheng, Yang; Wang, Xue-Yang; Hu, Hao; Killiny, Nabil; Xu, Jia-Ping			A Hypothetical Model of Crossing Bombyx mori Nucleopolyhedrovirus through Its Host Midgut Physical Barrier	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; PHOSPHOGLYCERATE KINASE; DIGESTIVE JUICE; ARGININE KINASE; PROTEIN; VIRUS; BACULOVIRUS; SILKWORM; EXPRESSION; INFECTION	Bombyx mori nucleopolyhedrovirus (BmNPV) is a primary pathogen of silkworm (B. mori) that causes severe economic losses each year. However, the molecular mechanisms of silkworm-BmNPV interactions, especially the silkworm proteins that can interact with the virus, are still largely unknown. In this study, the total and membrane proteins of silkworm midguts were displayed using one-and two-dimensional electrophoresis. A virus overlay assay was used to detect B. mori proteins that specifically bind to BmNPV particles. Twelve proteins were located and identified using mass spectrometry, and the different expression of the corresponding genes in BmNPV susceptible and resistant silkworm strains also indicated their involvement in BmNPV infection. The 12 proteins are grouped based on their potential roles in viral infection, for example, endocytosis, intracellular transportation, and host responses. Based on these results, we hypothesize the following: I) vacuolar ATP synthase catalytic subunit A and subunit B may be implicated in the process of the membrane fusion of virus and the release of the nucleocapsid into cytoplasm; II) actin, enolase and phosphoglycerate kinase are cytoskeleton associated proteins and may play an important role in BmNPV intracellular transportation; III) mitochondrial prohibitin complex protein 2, ganglioside-induced differentiation-associated protein, calreticulin, regucalcin-like isoform X1 and 60 kDa heat shock protein are involved in cell apoptosis regulation during BmNPV infection in larvae midguts; IV) ribosomal P0 may be associated with BmNPV infection by regulating gene expression of BmNPV; V) arginine kinase has a role in the antiviral activities against BmNPV. Our work should prove informative by providing multiple protein targets and a novel direction to investigate the molecular mechanisms of the interactions between silkworms and BmNPV.	[Cheng, Yang; Wang, Xue-Yang; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Hu, Hao; Killiny, Nabil] Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA	Anhui Agricultural University; State University System of Florida; University of Florida	Xu, JP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	jiapingxu@163.com	Xu, Jiaping/T-4327-2019; Wang, Xue-yang/ABB-8298-2021	Cheng, Yang/0000-0003-2126-282X; Xu, Jiaping/0000-0001-9020-7248; Killiny, Nabil/0000-0002-3895-6943	Natural Science Foundation of China [31472148]; National 863 plans projects of China [2011AA100306]; International cooperation project of Anhui province [1403062018]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 plans projects of China(National High Technology Research and Development Program of China); International cooperation project of Anhui province	This work was supported by the Natural Science Foundation of China (31472148), the National 863 plans projects of China (2011AA100306) and International cooperation project of Anhui province (1403062018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandla MD, 1998, PHYTOPATHOLOGY, V88, P98, DOI 10.1094/PHYTO.1998.88.2.98; Bao YY, 2010, INSECT MOL BIOL, V19, P347, DOI 10.1111/j.1365-2583.2010.00993.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLANCHAER MC, 1955, AM J PHYSIOL, V181, P602, DOI 10.1152/ajplegacy.1955.181.3.602; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Cheng Y, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.76; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; DICKERSON HW, 1989, J PROTOZOOL, V36, P159, DOI 10.1111/j.1550-7408.1989.tb01065.x; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao K, 2012, GENE, V497, P208, DOI 10.1016/j.gene.2012.01.037; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Hafren A, 2013, J VIROL, V87, P4302, DOI 10.1128/JVI.03198-12; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Kikkert M, 1998, PHYTOPATHOLOGY, V88, P63, DOI 10.1094/PHYTO.1998.88.1.63; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Li S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026585; Liu ZG, 2009, INT ARCH ALLERGY IMM, V150, P8, DOI 10.1159/000210375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Ma FF, 2014, GENE, V539, P99, DOI 10.1016/j.gene.2014.01.047; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; Matthews JD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-121; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Nakagawa T, 2005, J CELL BIOCHEM, V96, P1274, DOI 10.1002/jcb.20617; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Nanda SK, 2004, ARCH VIROL, V149, P93, DOI 10.1007/s00705-003-0196-4; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponnuvel KM, 2012, ARCH INSECT BIOCHEM, V81, P90, DOI 10.1002/arch.21046; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rattanarojpong T, 2007, PROTEOMICS, V7, P3809, DOI 10.1002/pmic.200700202; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Song JJ, 2008, J GEN VIROL, V89, P2331, DOI 10.1099/vir.0.2008/002352-0; STERN H, 1952, J GEN PHYSIOL, V36, P181, DOI 10.1085/jgp.36.2.181; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Wang HC, 2009, GENE, V430, P38, DOI 10.1016/j.gene.2008.10.021; Watthanasurorot A, 2013, J MOL CELL BIOL, V5, P120, DOI 10.1093/jmcb/mjt005; Wesolowska A, 2013, EXP PARASITOL, V134, P33, DOI 10.1016/j.exppara.2013.01.013; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M; Wu Y, 2013, FEBS LETT, V587, P600, DOI 10.1016/j.febslet.2013.01.072; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xu JP, 2008, AFR J BIOTECHNOL, V7, P3424	54	15	19	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115032	10.1371/journal.pone.0115032	http://dx.doi.org/10.1371/journal.pone.0115032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502928	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400069
J	Sridhara, V; Meyer, AG; Rai, P; Barrick, JE; Ravikumar, P; Segre, D; Wilke, CO				Sridhara, Viswanadham; Meyer, Austin G.; Rai, Piyush; Barrick, Jeffrey E.; Ravikumar, Pradeep; Segre, Daniel; Wilke, Claus O.			Predicting Growth Conditions from Internal Metabolic Fluxes in an In-Silico Model of E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; ASSOCIATION; ADAPTATION; SELECTION; NUTRIENT; MUTANTS; MG1655	A widely studied problem in systems biology is to predict bacterial phenotype from growth conditions, using mechanistic models such as flux balance analysis (FBA). However, the inverse prediction of growth conditions from phenotype is rarely considered. Here we develop a computational framework to carry out this inverse prediction on a computational model of bacterial metabolism. We use FBA to calculate bacterial phenotypes from growth conditions in E. coli, and then we assess how accurately we can predict the original growth conditions from the phenotypes. Prediction is carried out via regularized multinomial regression. Our analysis provides several important physiological and statistical insights. First, we show that by analyzing metabolic end products we can consistently predict growth conditions. Second, prediction is reliable even in the presence of small amounts of impurities. Third, flux through a relatively small number of reactions per growth source (similar to 10) is sufficient for accurate prediction. Fourth, combining the predictions from two separate models, one trained only on carbon sources and one only on nitrogen sources, performs better than models trained to perform joint prediction. Finally, that separate predictions perform better than a more sophisticated joint prediction scheme suggests that carbon and nitrogen utilization pathways, despite jointly affecting cellular growth, may be fairly decoupled in terms of their dependence on specific assortments of molecular precursors.	[Sridhara, Viswanadham; Meyer, Austin G.; Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Meyer, Austin G.; Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Rai, Piyush; Ravikumar, Pradeep] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Boston University; Boston University; University of Texas System; University of Texas Austin	Wilke, CO (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	wilke@austin.utexas.edu	Segre, Daniel/A-1993-2009	Segre, Daniel/0000-0003-4859-1914; Sridhara, Viswanadham/0000-0003-0688-6140; Meyer, Austin/0000-0002-0581-800X	Army Research Office (ARO) [W911NF-12-1-0390]	Army Research Office (ARO)	This project was funded by Army Research Office (ARO) grant W911NF-12-1-0390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; KUPOR SR, 1972, J BIOL CHEM, V247, P1904; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Menendez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014147; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ravikumar P, 2010, ANN STAT, V38, P1287, DOI 10.1214/09-AOS691; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snitkin Evan S, 2008, Genome Inform, V20, P123; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; Wang H, 2012, BIOINFORMATICS, V28, pI619, DOI 10.1093/bioinformatics/bts411; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041	30	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114608	10.1371/journal.pone.0114608	http://dx.doi.org/10.1371/journal.pone.0114608			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502413	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400038
J	Truong, TC; Than, VT; Kim, W				Thoi Cong Truong; Van Thai Than; Kim, Wonyong			Evolutionary Phylodynamics of Korean Noroviruses Reveals a Novel GII.2/GII.10 Recombination Event	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; ACUTE GASTROENTERITIS; OSAKA CITY; MOLECULAR EPIDEMIOLOGY; HUMAN CALICIVIRUSES; OUTBREAKS; CHILDREN; INFECTIONS; SAPOVIRUS; GII	Viral gastroenteritis is the most common causal agent of public health problems worldwide. Noroviruses cause nonbacterial acute gastroenteritis in humans of all ages. In this study, we investigated the occurrence of norovirus infection in children with acute gastroenteritis admitted to university hospitals in South Korea. We also analyzed the genetic diversity of the viruses and identified novel recombination events among the identified viral strains. Of 502 children with acute gastroenteritis admitted to our three hospitals between January 2011 and March 2012, genotyping of human noroviruses was performed in 171 (34%) norovirus-positive samples. Of these samples, 170 (99.5%) were in genogroup II (GII), while only one (0.5%) was in genogroup I (GI). The most common GII strain was the GII.4-2006b variant (n=96, 56.5%), followed by GII.6 (n=23, 13.5%), GII.12 (n=22, 12.9%), GII.3 (n=20, 11.8%), GII.2 (n=6, 3.5%), GII.b (n=2, 1.2%), and GII.10 (n=1, 0.6%). Potential recombination events (polymerase/capsid) were detected in 39 GII strains (22.9%), and the most frequent genotypes were GII.4/GII.12 (n=12, 30.8%), GII.4/GII.6 (n=12, 30.8%), GII.4/GII.3 (n=8, 20.5%), GII.b/GII.3 (n=3, 7.7%), GII.16/GII.2 (n=2, 5.1%), GII.4/GII.2 (n=1, 2.6%), and GII.2/GII.10 (n=1, 2.6%). For the first time, a novel GII.2/GII.10 recombination was detected; we also identified the GII.16/GII.2 strain for the first time in South Korea. Our data provided important insights into new recombination events, which may prove valuable for predicting the emergence of circulating norovirus strains with global epidemic potential.	[Thoi Cong Truong; Van Thai Than; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Than, Van-Thai/GPX-9664-2022; Than, Van Thai/AAX-2106-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013-R1A1A2A10012148]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (2013-R1A1A2A10012148) funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; Dey SK, 2010, VIRUS GENES, V40, P362, DOI 10.1007/s11262-010-0459-6; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green KY, 2000, J INFECT DIS, V181, pS322, DOI 10.1086/315591; Hansman GS, 2004, ARCH VIROL, V149, P1673, DOI 10.1007/s00705-004-0345-4; Huh JW, 2009, J CLIN VIROL, V44, P152, DOI 10.1016/j.jcv.2008.11.016; Ike AC, 2006, J CLIN MICROBIOL, V44, P1262, DOI 10.1128/JCM.44.4.1262-1267.2006; Iritani N, 2002, J MED VIROL, V66, P131, DOI 10.1002/jmv.2121; Iritani N, 2008, J CLIN MICROBIOL, V46, P2406, DOI 10.1128/JCM.01993-07; Iritani N, 2012, J MED VIROL, V84, P517, DOI 10.1002/jmv.23211; Jiang X, 1999, ARCH VIROL, V144, P2377, DOI 10.1007/s007050050651; JUKES T H, 1969, P21; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kim EJ, 2010, FOOD SCI BIOTECHNOL, V19, P1089, DOI 10.1007/s10068-010-0153-4; Kim SH, 2005, J CLIN MICROBIOL, V43, P4836, DOI 10.1128/JCM.43.9.4836-4839.2005; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lee SG, 2011, APPL ENVIRON MICROB, V77, P1466, DOI 10.1128/AEM.01996-10; LEW JF, 1994, J VIROL, V68, P3391, DOI 10.1128/JVI.68.5.3391-3396.1994; Lochridge VP, 2003, VIRUS GENES, V26, P71, DOI 10.1023/A:1022334323013; Lopman BA, 2002, J CLIN VIROL, V24, P137, DOI 10.1016/S1386-6532(01)00243-8; Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084; Phan TG, 2007, J MED VIROL, V79, P1388, DOI 10.1002/jmv.20924; RAY SC, 1998, SIMPLOT WINDOWS VERS; Ruether IGA, 2012, VIRUS GENES, V44, P237, DOI 10.1007/s11262-011-0697-2; Seah Oh,, 2013, Journal of Bacteriology and Virology, V43, P307, DOI 10.4167/jbv.2013.43.4.307; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton Alice C, 2004, Disaster Manag Response, V2, P4, DOI 10.1016/S1540-2487(03)00130-5; Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05; Won YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085063; Wright PJ, 1998, J MED VIROL, V55, P312, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;312::AID-JMV10&gt;3.0.CO;2-G; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009	43	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113966	10.1371/journal.pone.0113966	http://dx.doi.org/10.1371/journal.pone.0113966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500567	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400019
J	van Doorn, KJ; Verbrugghe, W; Wouters, K; Jansens, H; Jorens, PG				van Doorn, Karin Janssen; Verbrugghe, Walter; Wouters, Kristien; Jansens, Hilde; Jorens, Philippe G.			The Duration of Hypotension Determines the Evolution of Bacteremia-Induced Acute Kidney Injury in the Intensive Care Unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; TARGET BLOOD-PRESSURE; SEPTIC SHOCK; SEVERE SEPSIS; HEMODYNAMIC VARIABLES; MANAGEMENT; MORTALITY; MULTICENTER; DEFINITION; PREDICTORS	Background: Exploration of the impact of severe hypotension on the evolution of acute kidney injury in septic patients. Methods and Results: We reviewed the hemodynamic parameters of 137 adults with septic shock and proven blood stream infection in the ICU. Severe hypotension was defined as a mean arterial blood pressure (MAP) <= 65 mmHg. The influence of the duration of severe hypotension on the evolution of acute kidney injury was evaluated according to the RIFLE classification, with day 0 defined as the day of a positive blood stream infection. After bloodstream infection, the probability for a patient to be in Failure was significantly higher than before blood stream infection (OR=1.94, p=0.0276). Patients have a significantly higher risk of evolving to Failure if the duration of severe hypotension is longer (OR=1.02 for each 10 minutes increase in duration of a MAP <65 mmHg, p=0.0472). A cut-off of at least 51 minutes of severe hypotension (<65 mmHg) or at least 5.5 periods of severe hypotension within 1 day identified patients with increased risk to evolve to Failure. Conclusions: There is a significant influence of both the duration and the number of periods of severe hypotension on the evolution to Failure. Blood stream infection has a significantly negative effect on the relationship between severe hypotension and Failure.	[van Doorn, Karin Janssen] Univ Antwerp, Univ Antwerp Hosp, Dept Nephrol Hypertens, B-2020 Antwerp, Belgium; [Verbrugghe, Walter; Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Crit Care Med, B-2020 Antwerp, Belgium; [Wouters, Kristien] Univ Antwerp, Univ Antwerp Hosp, Dept Biostat, B-2020 Antwerp, Belgium; [Jansens, Hilde] Univ Antwerp, Univ Antwerp Hosp, Dept Microbiol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	van Doorn, KJ (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Dept Nephrol Hypertens, B-2020 Antwerp, Belgium.	k.janssenvandoorn@gmail.com	Wouters, Kristien/ADM-4146-2022					Albanese J, 2004, CHEST, V126, P534, DOI 10.1378/chest.126.2.534; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2010, CAN J ANESTH, V57, P999, DOI 10.1007/s12630-010-9376-3; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Barochia AV, 2013, CURR INFECT DIS REP, V15, P385, DOI 10.1007/s11908-013-0351-3; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Beloncle F, 2013, CRIT CARE, V17, DOI 10.1186/cc12543; Boerma EC, 2010, INTENS CARE MED, V36, P2004, DOI 10.1007/s00134-010-1970-x; Correa TD, 2013, CRIT CARE, V17, DOI 10.1186/cc12495; Cruz DN, 2009, CRIT CARE, V13, DOI 10.1186/cc7759; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser MW, 2009, CRIT CARE, V13, DOI 10.1186/cc8167; Dunser MW, 2009, INTENS CARE MED, V35, P1225, DOI 10.1007/s00134-009-1427-2; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Honore PM, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-32; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Kim WY, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.005; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Ledoux D, 2008, INTENS CARE MED, V34, P1873, DOI 10.1007/s00134-008-1187-4; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Nadeau-Fredette AC, 2013, ADV CHRONIC KIDNEY D, V20, P45, DOI 10.1053/j.ackd.2012.09.005; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Poukkanen M, 2013, CRIT CARE, V17, DOI 10.1186/cc13161; Rivers EP, 2012, MINERVA ANESTESIOL, V78, P712; Ronco C, 2013, BLOOD PURIFICAT, V36, P65, DOI 10.1159/000354768; Shih CY, 2006, J THORAC CARDIOV SUR, V131, P632, DOI 10.1016/j.jtcvs.2005.10.052; Simon PM, 2011, SHOCK, V36, P553, DOI 10.1097/SHK.0b013e318235331e; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Srisawat N, 2010, BLOOD PURIFICAT, V29, P300, DOI 10.1159/000280099; Takala J, 2010, CRIT CARE MED, V38, pS613, DOI 10.1097/CCM.0b013e3181f2430c; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226	38	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114312	10.1371/journal.pone.0114312	http://dx.doi.org/10.1371/journal.pone.0114312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504214	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400026
J	Wei, XH; Shen, HC; Ren, JL; Li, XL; Xu, XD; Yang, RM; Lai, LS; Chen, LA; Hu, JA; Liu, WH; Jiang, XQ				Wei, Xinhua; Shen, Huicong; Ren, Jiliang; Li, Xueli; Xu, Xiangdong; Yang, Ruimeng; Lai, Lisha; Chen, Liang; Hu, Jiani; Liu, Wenhua; Jiang, Xinqing			Altered Resting-State Connectivity in College Students with Nonclinical Depressive Symptoms	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL MAGNETIC-RESONANCE; MOOD REGULATING CIRCUIT; DEFAULT-MODE NETWORK; LINE BRAIN ACTIVITY; MAJOR DEPRESSION; BIPOLAR DEPRESSION; EMOTION REGULATION; CINGULATE CORTEX; FMRI	Background: The underlying brain basis of nonclinical depressive symptoms (nCDSs) is largely unknown. Recently, the seed-based functional connectivity (FC) approach for analyzing resting-state fMRI (rs-fMRI) data has been increasingly used to explore the neural basis of depressive disorders. Other than common seed-based FC method using an a priori seed region, we conducted FC analysis based on regions with altered spontaneous activity revealed by the fractional amplitude of low-frequency fluctuations (fALFF) approach. The aim of the present study was to provide novel insight in the underlying mechanism of nCDSs in college students. Methodology/Principal Findings: A total number of 1105 college students were recruited to participant in a survey for assessing depressive symptoms. Subsequently, 17 individuals with nCDSs and 20 healthy controls (HCs) were enrolled to perform MR studies. Alternations of fALFF were identified in the right superior parietal lobule (SPL) and left lingual gyrus, both of which were used as ROIs for further FC analysis. With right SPL, compare with HCs, subjects with nCDSs showed reduced FCs in the bilateral dorsal lateral prefrontal cortex (DLPFC), left inferior frontal gurus (IFG), left premotor cortex (PMC), DMN network [i.e., bilateral precuneus, posterior cingulate cortex (PCC), right supramarginal gyrus (SMG), right parahippocampal gyrus (PHG), bilateral inferior temporal gurus (ITG)] and left cerebellum posterior lobe (CPL). In addition, increased FCs were observed between the left lingual gyrus and right fusiform gyrus as well as in the left precuneus. Conclusion/Significance: Our results indicate the abnormalities of spontaneous activity in the right SPL and left lingual gyrus and their corresponding dysfunction of the brain circuits might be related to the pathophysiology of nCDSs.	[Wei, Xinhua; Ren, Jiliang; Li, Xueli; Xu, Xiangdong; Yang, Ruimeng; Lai, Lisha; Chen, Liang; Jiang, Xinqing] Guangzhou Med Univ, Guangzhou Hosp 1, Dept Radiol, Guangzhou 510180, Guangdong, Peoples R China; [Shen, Huicong] Capital Med Univ, Tiantan Hosp, Dept Radiol, Beijing 100050, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI 48202 USA; [Liu, Wenhua] Guangzhou Med Univ, Fac Hlth Management, Guangzhou 510180, Guangdong, Peoples R China	Guangzhou Medical University; Capital Medical University; Wayne State University; Guangzhou Medical University	Liu, WH (corresponding author), Guangzhou Med Univ, Fac Hlth Management, Guangzhou 510180, Guangdong, Peoples R China.	2394674931@qq.com; weixinhua.hy@gmail.com	; yang, karen/A-4677-2019	Jiang, Xinqing/0000-0003-0773-523X; yang, karen/0000-0002-6065-6197				Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Al-Busaidi Zakiya, 2011, Oman Med J, V26, P235, DOI 10.5001/omj.2011.58; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P248, DOI 10.1080/15622970802465807; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Georgades K, 2006, J AM ACAD CHILD PSY, V45, P936, DOI 10.1097/01.chi.0000223313.25536.47; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hoff GEAJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00650; Ignjatovic-Ristic D, 2012, W INDIAN MED J, V61, P489, DOI 10.7727/wimj.2011.215; Jamison DT., 2006, PRIORITIES HLTH; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Lee M.H., 2012, AJNR AM J NEURORADIO; Liberg B, 2013, J NERV MENT DIS, V201, P885, DOI 10.1097/NMD.0b013e3182a5c2a7; Liu CH, 2012, NEUROSCI LETT, V516, P202, DOI 10.1016/j.neulet.2012.03.083; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Melo-Carrillo A, 2012, J AFFECT DISORDERS, V136, P1098, DOI 10.1016/j.jad.2011.10.040; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Mikolajczyk RT, 2008, CLIN PRACT EPIDEMIOL, V4, P19, DOI DOI 10.1186/1745-0179-4-19; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rogers MA, 2002, J CLIN EXP NEUROPSYC, V24, P101, DOI 10.1076/jcen.24.1.101.974; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tadayonnejad R, 2014, J GERIATR PSYCH NEUR, V27, P5, DOI 10.1177/0891988713516539; Tahmasian M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00639; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Turner JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00137; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Viviani R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00746; Walther S, 2012, J AFFECT DISORDERS, V136, P124, DOI 10.1016/j.jad.2011.08.020; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	67	23	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114603	10.1371/journal.pone.0114603	http://dx.doi.org/10.1371/journal.pone.0114603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502215	gold, Green Submitted, Green Published			2022-12-26	WOS:000346375400037
J	Yoon, YJ; Kim, DK; Yoon, CM; Park, J; Kim, YK; Roh, TY; Gho, YS				Yoon, Yae Jin; Kim, Dae-Kyum; Yoon, Chang Min; Park, Jaesung; Kim, Yoon-Keun; Roh, Tae-Young; Gho, Yong Song			Egr-1 Activation by Cancer-Derived Extracellular Vesicles Promotes Endothelial Cell Migration via ERK1/2 and JNK Signaling Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; MEMBRANE-VESICLES; PROTEOMIC ANALYSIS; ALPHA EXPRESSION; GENE-EXPRESSION; MESSENGER-RNAS; OVARIAN-CANCER; TISSUE FACTOR; UP-REGULATION; TUMOR-GROWTH	Various mammalian cells, including cancer cells, shed extracellular vesicles (EVs), also known as exosomes and microvesicles, into surrounding tissues. These EVs play roles in tumor growth and metastasis by promoting angiogenesis. However, the detailed mechanism of how cancer-derived EVs elicit endothelial cell activation remains unknown. Here, we provide evidence that early growth response-1 (Egr-1) activation in endothelial cells is involved in the angiogenic activity of colorectal cancer cell-derived EVs. Both RNA interference-mediated downregulation of Egr-1 and ERK1/2 or JNK inhibitor significantly blocked EV-mediated Egr-1 activation and endothelial cell migration. Furthermore, lipid raft-mediated endocytosis inhibitor effectively blocked endothelial Egr-1 activation and migration induced by cancer-derived EVs. Our results suggest that Egr-1 activation in endothelial cells may be a key mechanism involved in the angiogenic activity of cancer-derived EVs. These findings will improve our understanding regarding the proangiogenic activities of EVs in diverse pathological conditions including cancer, cardiovascular diseases, and neurodegenerative diseases.	[Yoon, Yae Jin; Roh, Tae-Young] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Kim, Dae-Kyum; Yoon, Chang Min; Roh, Tae-Young; Gho, Yong Song] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, South Korea; [Kim, Yoon-Keun] Ewha Womans Univ, Med Ctr, Ewha Inst Convergence Med, Seoul 158710, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Ewha Womans University	Roh, TY (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.	tyroh@postech.edu; ysgho@postech.ac.kr		Kim, Dae-Kyum/0000-0003-4568-8278; Roh, Tae-Young/0000-0001-5833-0844	Mid-career Researcher Program through NRF grant - MEST [2014023004]; BK21 Plus - Ministry of Education, Korea [10Z20130012243]; National Research Foundation of Korea [2011-0030049]	Mid-career Researcher Program through NRF grant - MEST; BK21 Plus - Ministry of Education, Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2014023004), BK21 Plus (10Z20130012243) funded by the Ministry of Education, Korea, and the National Research Foundation of Korea (2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Choi DS, 2012, J PROTEOME RES, V11, P1144, DOI 10.1021/pr200842h; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Choi DS, 2013, PROTEOMICS; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gho YS, 1999, CANCER RES, V59, P5128; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hao F, 2008, J BIOL CHEM, V283, P26928, DOI 10.1074/jbc.M803071200; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Khachigian LM, 1997, CIRC RES, V81, P457, DOI 10.1161/01.RES.81.4.457; Kim CW, 2002, CANCER RES, V62, P6312; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Shin SY, 2009, J BIOL CHEM, V284, P30583, DOI 10.1074/jbc.M109.010678; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yao HH, 2011, BLOOD, V117, P2538, DOI 10.1182/blood-2010-10-313593	47	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115170	10.1371/journal.pone.0115170	http://dx.doi.org/10.1371/journal.pone.0115170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502753	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400077
J	Howland, B; Stojanovic, D; Gordon, IJ; Manning, AD; Fletcher, D; Lindenmayer, DB				Howland, Brett; Stojanovic, Dejan; Gordon, Iain J.; Manning, Adrian D.; Fletcher, Don; Lindenmayer, David B.			Eaten Out of House and Home: Impacts of Grazing on Ground-Dwelling Reptiles in Australian Grasslands and Grassy Woodlands	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES RICHNESS; LARGE HERBIVORES; WALLABY CREEK; VEGETATION; ECOSYSTEM; HABITAT; MANAGEMENT; LANDSCAPE; DIVERSITY	Large mammalian grazers can alter the biotic and abiotic features of their environment through their impacts on vegetation. Grazing at moderate intensity has been recommended for biodiversity conservation. Few studies, however, have empirically tested the benefits of moderate grazing intensity in systems dominated by native grazers. Here we investigated the relationship between (1) density of native eastern grey kangaroos, Macropus giganteus, and grass structure, and (2) grass structure and reptiles (i.e. abundance, richness, diversity and occurrence) across 18 grassland and grassy Eucalyptus woodland properties in south-eastern Australia. There was a strong negative relationship between kangaroo density and grass structure after controlling for tree canopy cover. We therefore used grass structure as a surrogate for grazing intensity. Changes in grazing intensity (i.e. grass structure) significantly affected reptile abundance, reptile species richness, reptile species diversity, and the occurrence of several ground-dwelling reptiles. Reptile abundance, species richness and diversity were highest where grazing intensity was low. Importantly, no species of reptile was more likely to occur at high grazing intensities. Legless lizards (Delma impar, D. inornata) were more likely to be detected in areas subject to moderate grazing intensity, whereas one species (Hemiergis talbingoensis) was less likely to be detected in areas subject to intense grazing and three species (Menetia greyii, Morethia boulengeri, and Lampropholis delicata) did not appear to be affected by grazing intensity. Our data indicate that to maximize reptile abundance, species richness, species diversity, and occurrence of several individual species of reptile, managers will need to subject different areas of the landscape to moderate and low grazing intensities and limit the occurrence and extent of high grazing.	[Howland, Brett; Stojanovic, Dejan; Gordon, Iain J.; Manning, Adrian D.; Lindenmayer, David B.] ANU Coll Med Biol & Environm, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Gordon, Iain J.] James Hutton Inst, Dundee DD2 5DA, Scotland; [Fletcher, Don] Environm & Sustainable Dev Directorate, Canberra, ACT 2601, Australia	Australian National University; James Hutton Institute	Howland, B (corresponding author), ANU Coll Med Biol & Environm, Fenner Sch Environm & Soc, Frank Fenner Bldg,141 Australian Natl Univ, Canberra, ACT 0200, Australia.	brett.howland@anu.edu.au	Manning, Adrian/AAX-7288-2021; Gordon, Iain/S-8076-2019; Stojanovic, Dejan/AAB-3113-2019; Manning, Adrian/AAG-2949-2019; Lindenmayer, David B/P-7183-2017; Gordon, Iain J/K-8636-2012	Manning, Adrian/0000-0003-0989-9203; Gordon, Iain/0000-0001-9704-0946; Stojanovic, Dejan/0000-0002-1176-3244; Lindenmayer, David B/0000-0002-4766-4088; Gordon, Iain J/0000-0001-9704-0946	Canberra Birds Conservation Fund; Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship; Australian Government's Department of Industry, Innovation, Science, Research and; Australian Government; ARC Future fellowship [FT 100100358]; Tertiary Education Australian Postgraduate Award	Canberra Birds Conservation Fund; Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship; Australian Government's Department of Industry, Innovation, Science, Research and(Australian Government); Australian Government(Australian GovernmentCGIAR); ARC Future fellowship(Australian Research Council); Tertiary Education Australian Postgraduate Award	Financial support was provided by Canberra Birds Conservation Fund to BH (http://cbcf.canberrabirds.org.au), Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship to BH (http://www.bushheritage.org.au) and the Australian Government's Department of Industry, Innovation, Science, Research and Tertiary Education Australian Postgraduate Award to BH (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx). Financial support was provided to BH by the Australian Government for monitoring activities undertaken at a single property used in this research. AM was funded by ARC Future fellowship FT 100100358. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACT Parks Conservation and Lands, 2010, ACT KANG MAN PLAN; Australian Government Bureau of Meteorology, 2014, ANN CLIM SUMM 2009; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Beever EA, 2004, J ARID ENVIRON, V59, P271, DOI 10.1016/j.jaridenv.2003.12.008; Bennett, 2011, REPTILES FROGS AUSTR; Biehl L, 2002, COMPUT GEOSCI-UK, V28, P1153, DOI 10.1016/S0098-3004(02)00033-X; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Booth DT, 2006, ENVIRON MONIT ASSESS, V123, P97, DOI 10.1007/s10661-005-9164-7; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown GW, 2008, WILDLIFE RES, V35, P8, DOI 10.1071/WR07010; Brown GW, 2011, LANDSCAPE URBAN PLAN, V103, P277, DOI 10.1016/j.landurbplan.2011.08.002; Brown GW, 2001, BIODIVERS CONSERV, V10, P161, DOI 10.1023/A:1008919521638; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burrow AL, 2001, J WILDLIFE MANAGE, V65, P645, DOI 10.2307/3803015; Castellano MJ, 2006, J ARID ENVIRON, V66, P87, DOI 10.1016/j.jaridenv.2005.10.016; Caughley G., 1987, P159; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Cooke BD, 2002, WILDLIFE RES, V29, P689, DOI 10.1071/WR02010; COUGHENOUR MB, 2000, GREATER YELLOWSTONE, P209; Crain CM, 2006, BIOSCIENCE, V56, P211; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; Dorrough J, 2004, ECOGRAPHY, V27, P798, DOI 10.1111/j.0906-7590.2004.04004.x; Dorrough J, 2004, AUST J AGR RES, V55, P279, DOI 10.1071/AR03024; Dorrough J, 1999, AUST J ECOL, V24, P614, DOI 10.1046/j.1442-9993.1999.00995.x; Dorrough J, 2012, AUSTRAL ECOLOGY; ESCAVI (Executive Steering Committee for Australian Vegetation Information), 2003, AUSTR VEG ATTR MAN N; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Fletcher D, 2005, POPULATION DYN UNPUB; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Franklin SE, 2002, PROG PHYS GEOG, V26, P173, DOI 10.1191/0309133302pp332ra; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Green DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048410; Grigg GC, 1989, KANGAROOS WALLABIES; Hadden SA, 1996, WILDLIFE RES, V23, P363, DOI 10.1071/WR9960363; Haydock K. P., 1975, AUSTR J EXPT AGR ANI, V15, P66, DOI DOI 10.1071/EA9750663; Hobbs R.J., 2000, TEMPERATE EUCALYPT W; Hobbs RJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P1, DOI 10.1111/j.1466-822X.2004.00130.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; James C, 2003, AUSTRAL ECOL, V28, P137, DOI 10.1046/j.1442-9993.2003.01259.x; JANZEN DH, 1976, AM NAT, V110, P371, DOI 10.1086/283074; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P133; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Joseph Jr FH, 1984, MULTIVARIATE DATA AN; Knowles RL, 1998, AGROFOREST SYST, V43, P109, DOI 10.1023/A:1026463623463; Kohler AE, 2013, CAN J FISH AQUAT SCI, V70, P502, DOI 10.1139/cjfas-2012-0347; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Lee Y, 1996, J ROY STAT SOC B MET, V58, P619; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; Martin TG, 2005, ECOL APPL, V15, P266, DOI 10.1890/03-5400; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McIntyre S, 2003, J APPL ECOL, V40, P445, DOI 10.1046/j.1365-2664.2003.00823.x; McIntyre S., 2010, Cunninghamia, V11, P319; Meers Trevor, 2003, Ecological Management & Restoration, V4, P126, DOI 10.1046/j.1442-8903.2003.00147.x; Michael DR, 2012, WILDLIFE RES, V39, P149, DOI 10.1071/WR11118; Michael DR, 2010, AUSTRAL ECOL, V35, P215, DOI 10.1111/j.1442-9993.2009.02029.x; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Milsom TP, 2000, J APPL ECOL, V37, P706, DOI 10.1046/j.1365-2664.2000.00529.x; Moir ML, 2005, FOREST ECOL MANAG, V217, P294, DOI 10.1016/j.foreco.2005.06.012; Moore RM, 1970, AUSTR GRASSLANDS; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Nasseri NA, 2011, AFR J ECOL, V49, P133, DOI 10.1111/j.1365-2028.2010.01238.x; NEAVE HM, 1989, AUST WILDLIFE RES, V16, P337, DOI 10.1071/WR9890337; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Pitkanen S, 1998, FOREST ECOL MANAG, V112, P121, DOI 10.1016/S0378-1127(98)00319-3; POOLE WE, 1975, AUST J ZOOL, V23, P333, DOI 10.1071/ZO9750333; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; Prober Suzanne M., 2005, Ecological Management & Restoration, V6, P16, DOI 10.1111/j.1442-8903.2005.00215.x; Ripple WJ, 2000, BIOL CONSERV, V95, P361, DOI 10.1016/S0006-3207(00)00014-8; Smith GT, 1996, J APPL ECOL, V33, P1302, DOI 10.2307/2404771; SOUTHWELL C, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P659; SOUTHWELL C, 1987, AUST WILDLIFE RES, V14, P15; Stevens TA, 2010, AUST J ZOOL, V58, P76, DOI 10.1071/ZO09076; TAYLOR RJ, 1983, AUST WILDLIFE RES, V10, P203; TOFT CA, 1985, COPEIA, P1; Tzaros C., 2005, WILDLIFE BOX IRONBAR; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Vandvik V, 2005, J APPL ECOL, V42, P139, DOI 10.1111/j.1365-2664.2005.00982.x; Viggers KL, 2005, J APPL ECOL, V42, P99, DOI 10.1111/j.1365-2664.2005.01001.x; VSN International, 2012, GENSTAT WIND; Wilson S., 2008, COMPLETE GUIDE REPTI; Woinarski JCZ, 2002, AUSTRAL ECOL, V27, P311, DOI 10.1046/j.1442-9993.2002.01182.x; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x	90	73	75	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e105966	10.1371/journal.pone.0105966	http://dx.doi.org/10.1371/journal.pone.0105966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501680	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000347146700001
J	Li, L; Jiao, ZW; Hale, L; Wu, WL; Guo, YB				Li, Lei; Jiao, Ziwei; Hale, Lauren; Wu, Wenliang; Guo, Yanbin			Disruption of Gene pqqA or pqqB Reduces Plant Growth Promotion Activity and Biocontrol of Crown Gall Disease by Rahnella aquatilis HX2	PLOS ONE			English	Article							PHOSPHATE-SOLUBILIZING BACTERIA; PSEUDOMONAS-FLUORESCENS; PYRROLOQUINOLINE QUINONE; BIOLOGICAL-CONTROL; ESCHERICHIA-COLI; GLUCONIC ACID; CLONING; BIOSYNTHESIS; SEQUENCE; EXOPOLYSACCHARIDE	Rahnella aquatilis strain HX2 has the ability to promote maize growth and suppress sunflower crown gall disease caused by Agrobacterium vitis, A. tumefaciens, and A. rhizogenes. Pyrroloquinoline quinone (PQQ), a cofactor of aldose and alcohol dehydrogenases, is required for the synthesis of an antibacterial substance, gluconic acid, by HX2. Mutants of HX2 unable to produce PQQ were obtained by in-frame deletion of either the pqqA or pqqB gene. In this study, we report the independent functions of pqqA and pqqB genes in relation to PQQ synthesis. Interestingly, both the pqqA and pqqB mutants of R. aquatilis eliminated the ability of strain HX2 to produce antibacterial substance, which in turn, reduced the effectiveness of the strain for biological control of sunflower crown gall disease. The mutation also resulted in decreased mineral phosphate solubilization by HX2, which reduced the efficacy of this strain as a biological fertilizer. These functions were restored by complementation with the wild-type pqq gene cluster. Additionally, the phenotypes of HX2 derivatives, including colony morphology, growth dynamic, and pH change of culture medium were impacted to different extents. Our findings suggested that pqqA and pqqB genes individually play important functions in PQQ biosynthesis and are required for antibacterial activity and phosphorous solubilization. These traits are essential for R. aquatilis efficacy as a biological control and plant growth promoting strain. This study enhances our fundamental understanding of the biosynthesis of an environmentally significant cofactor produced by a promising biocontrol and biological fertilizer strain.	[Li, Lei; Wu, Wenliang; Guo, Yanbin] China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Li, Lei; Wu, Wenliang; Guo, Yanbin] China Agr Univ, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China; [Jiao, Ziwei] Yi Li Normal Univ, Coll Chem & Biol Sci, Yining, Xinjiang, Peoples R China; [Hale, Lauren] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	China Agricultural University; China Agricultural University; University of California System; University of California Riverside	Guo, YB (corresponding author), China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	guoyb@cau.edu.cn		Hale, Lauren/0000-0002-2574-2225	National Natural Science Foundation of China [31200386]; Special Fund for Agro-scientific Research in the Public Interest [201303106]; National Key Technology Research and Development Program in Rural Areas [2012BAD15B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology Research and Development Program in Rural Areas	This work was supported by National Natural Science Foundation of China (31200386), Special Fund for Agro-scientific Research in the Public Interest (201303106), and National Key Technology Research and Development Program in Rural Areas (2012BAD15B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; BABUKHAN S, 1995, APPL ENVIRON MICROB, V61, P972, DOI 10.1128/AEM.61.3.972-978.1995; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; BERGE O, 1991, CAN J MICROBIOL, V37, P195, DOI 10.1139/m91-030; Calvo J, 2007, INT J FOOD MICROBIOL, V113, P251, DOI 10.1016/j.ijfoodmicro.2006.07.003; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Chen F, 2009, EUR J PLANT PATHOL, V124, P427, DOI 10.1007/s10658-009-9429-z; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Dey R, 2004, MICROBIOL RES, V159, P371, DOI 10.1016/j.micres.2004.08.004; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; El-Hendawy HH, 2003, FOLIA MICROBIOL, V48, P799, DOI 10.1007/BF02931517; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Ge X, 2013, J BASIC MICROB, V53, P1; GOLDSTEIN AH, 1994, PHOSPHATE IN MICROORGANISMS, P197; GOLDSTEIN AH, 1995, BIOL AGRIC HORTIC, V12, P185, DOI 10.1080/01448765.1995.9754736; GOOSEN N, 1992, J BACTERIOL, V174, P1426, DOI 10.1128/jb.174.4.1426-1427.1992; Guo YB, 2009, APPL ENVIRON MICROB, V75, P6792, DOI 10.1128/AEM.00902-09; Guo YB, 2012, J BACTERIOL, V194, P6646, DOI 10.1128/JB.01769-12; HALDER AK, 1990, J GEN APPL MICROBIOL, V36, P81, DOI 10.2323/jgam.36.81; Hameeda B, 2008, MICROBIOL RES, V163, P234, DOI 10.1016/j.micres.2006.05.009; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JAMES DW, 1986, APPL ENVIRON MICROB, V52, P1183, DOI 10.1128/AEM.52.5.1183-1189.1986; Kaur R, 2006, PHYTOCHEMISTRY, V67, P595, DOI 10.1016/j.phytochem.2005.12.011; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim CH, 2003, CURR MICROBIOL, V47, P457, DOI 10.1007/s00284-003-4068-7; Kim KY, 1998, FEMS MICROBIOL LETT, V159, P121, DOI 10.1111/j.1574-6968.1998.tb12850.x; Kim KY, 1997, FEMS MICROBIOL LETT, V153, P273, DOI 10.1016/S0378-1097(97)00246-2; Kim KY, 1997, BIOL FERT SOILS, V24, P347, DOI 10.1007/s003740050256; KPOMBLEKOUA K, 1994, SOIL SCI, V158, P442, DOI 10.1097/00010694-199415860-00006; Maliha Rashid, 2004, Pakistan Journal of Biological Sciences, V7, P187, DOI 10.3923/pjbs.2004.187.196; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Sahin F, 2004, PLANT SOIL, V265, P123, DOI 10.1007/s11104-005-0334-8; Salomone JY, 1996, MOL PLANT MICROBE IN, V9, P401, DOI 10.1094/MPMI-9-0401; Sambrook J., 2001, MOL CLONING LAB MANU; SCHNIDER U, 1995, APPL ENVIRON MICROB, V61, P3856, DOI 10.1128/AEM.61.11.3856-3864.1995; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Vikram A, 2007, WORLD J MICROB BIOT, V23, P1333, DOI 10.1007/s11274-007-9365-z; Yan Q, 2009, MICROBIOL-SGM, V155, P124, DOI 10.1099/mic.0.020750-0; Yi YM, 2008, WORLD J MICROB BIOT, V24, P1059, DOI 10.1007/s11274-007-9575-4; Zhou HY, 2005, CHINESE SCI BULL, V50, P775, DOI 10.1360/982005-84	48	26	29	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115010	10.1371/journal.pone.0115010	http://dx.doi.org/10.1371/journal.pone.0115010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502691	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700083
J	Suomi, F; Menger, KE; Monteuuis, G; Naumann, U; Kursu, VAS; Shvetsova, A; Kastaniotis, AJ				Suomi, Fumi; Menger, Katja E.; Monteuuis, Geoffray; Naumann, Uta; Kursu, V. A. Samuli; Shvetsova, Antonina; Kastaniotis, Alexander J.			Expression and Evolution of the Non-Canonically Translated Yeast Mitochondrial Acetyl-CoA Carboxylase Hfa1p	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; TRANSFER-RNA-SYNTHETASES; SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; GENE ENCODES; EFFICIENCY; INITIATION; CODON; TRANSFORMATION; RESPIRATION	The Saccharomyces cerevisiae genome encodes two sequence related acetyl-CoA carboxylases, the cytosolic Acc1p and the mitochondrial Hfa1p, required for respiratory function. Several aspects of expression of the HFA1 gene and its evolutionary origin have remained unclear. Here, we determined the HFA1 transcription initiation sites by 5' RACE analysis. Using a novel "Stop codon scanning" approach, we mapped the location of the HFA1 translation initiation site to an upstream AUU codon at position -372 relative to the annotated start codon. This upstream initiation leads to production of a mitochondrial targeting sequence preceding the ACC domains of the protein. In silico analyses of fungal ACC genes revealed conserved "cryptic" upstream mitochondrial targeting sequences in yeast species that have not undergone a whole genome duplication. Our Delta hfa1 baker's yeast mutant phenotype rescue studies using the protoploid Kluyveromyces lactis ACC confirmed functionality of the cryptic upstream mitochondrial targeting signal. These results lend strong experimental support to the hypothesis that the mitochondrial and cytosolic acetyl-CoA carboxylases in S. cerevisiae have evolved from a single gene encoding both the mitochondrial and cytosolic isoforms. Leaning on a cursory survey of a group of genes of our interest, we propose that cryptic 5' upstream mitochondrial targeting sequences may be more abundant in eukaryotes than anticipated thus far.	[Kastaniotis, Alexander J.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu	Kastaniotis, AJ (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	alexander.kastaniotis@oulu.fi		Kastaniotis, Alexander/0000-0003-3624-9214; Menger, Katja/0000-0002-6972-7326; Monteuuis, Geoffray/0000-0001-7193-7771; Suomi, Fumi/0000-0001-8883-3338	Academy of Finland [263776]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland Decision Number 263776 (AJK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1995, BBA-MOL BASIS DIS, V1272, P168, DOI 10.1016/0925-4439(95)00082-8; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bailey LM, 2010, ARCH BIOCHEM BIOPHYS, V496, P45, DOI 10.1016/j.abb.2010.01.015; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; CHEREST H, 1978, MOL GEN GENET, V163, P153, DOI 10.1007/BF00267406; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kaiser C., 1994, METHODS YEAST GENETI; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kostrub CF, 1998, NUCLEIC ACIDS RES, V26, P4783, DOI 10.1093/nar/26.20.4783; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menger K, 2008, STUDY EXPRESSION YEA, V72; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nadeau JH, 1997, GENETICS, V147, P1259; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Ohno S., 1970, EVOLUTION GENE DUPLI; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P7067, DOI 10.1073/pnas.86.18.7067; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Turunen O, 2009, FEMS YEAST RES, V9, P16, DOI 10.1111/j.1567-1364.2008.00451.x; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114738	10.1371/journal.pone.0114738	http://dx.doi.org/10.1371/journal.pone.0114738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503745	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700049
J	Wei, ZH; Spizzo, I; Diep, H; Drummond, GR; Widdop, RE; Vinh, A				Wei, Zihui; Spizzo, Iresha; Diep, Henry; Drummond, Grant R.; Widdop, Robert E.; Vinh, Antony			Differential Phenotypes of Tissue-Infiltrating T Cells during Angiotensin II-Induced Hypertension in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; BLOOD-PRESSURE; KIDNEY INJURY; MACROPHAGE INFILTRATION; LYMPHOCYTE-RESPONSES; VASCULAR DYSFUNCTION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS	Hypertension remains the leading risk factor for cardiovascular disease (CVD). Experimental hypertension is associated with increased T cell infiltration into blood pressure-controlling organs, such as the aorta and kidney; importantly in absence of T cells of the adaptive immune system, experimental hypertension is significantly blunted. However, the function and phenotype of these T cell infiltrates remains speculative and undefined in the setting of hypertension. The current study compared T cell-derived cytokine and reactive oxygen species (ROS) production from normotensive and hypertensive mice. Splenic, blood, aortic, kidney and brain T cells were isolated from C57BL/6J mice following 14-day vehicle or angiotensin (Ang) II (0.7 mg/kg/day,s.c.) infusion. T cell infiltration was increased in aorta, kidney and brain from hypertensive mice. Cytokine analysis in stimulated T cells indicated an overall Th1 pro-inflammatory phenotype, but a similar proportion (flow cytometry) and quantity (cytometric bead array) of IFN-gamma, TNF-alpha, IL-4 and IL-17 between vehicle-and Ang II-treated groups. Strikingly, elevated T cell-derived production of a chemokine, chemokine C-C motif ligand 2 (CCL2), was observed in aorta (similar to 6-fold) and kidney in response to Ang II, but not in brain, spleen or blood. Moreover, T cell-derived ROS production in aorta was elevated similar to 3-fold in Ang II-treated mice (n=7; P<0.05). Ang II-induced hypertension does not affect the overall T cell cytokine profile, but enhanced T cell-derived ROS production and/or leukocyte recruitment due to elevated CCL2, and this effect may be further amplified with increased infiltration of T cells. We have identified a potential hypertension-specific T cell phenotype that may represent a functional contribution of Tcells to the development of hypertension, and likely several other associated vascular disorders.	[Wei, Zihui; Spizzo, Iresha; Diep, Henry; Drummond, Grant R.; Widdop, Robert E.; Vinh, Antony] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Monash University	Vinh, A (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	antony.vinh@monash.edu	; Vinh, Antony/I-1563-2014	Widdop, Robert/0000-0002-6515-0435; Vinh, Antony/0000-0001-8367-6134; Drummond, Grant/0000-0001-8556-9738	Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment [3227/2011]; Heart Foundation of Australia Postdoctoral Fellowship [PF12M6922]	Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment; Heart Foundation of Australia Postdoctoral Fellowship	This work was supported by a Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment Grant (3227/2011). AV was supported by a Heart Foundation of Australia Postdoctoral Fellowship (PF12M6922), while ZW received an Australian Postgraduate Award. None of the funding sources outlined above had any role in study design; collection, analysis and interpretation of data; writing of the report; or in the decision to submit the article for publication.	Abbas A.K., 2011, CELLULAR MOL IMMUNOL; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Berner B, 2000, J RHEUMATOL, V27, P1128; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CATT KJ, 1970, CIRC RES, V27, pI177; CATT KJ, 1971, LANCET, V1, P459; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Choi YK, 2003, PARASITOL RES, V91, P87, DOI 10.1007/s00436-003-0934-2; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; Crowley SD, 2010, AM J PHYSIOL-REG I, V298, pR1089, DOI 10.1152/ajpregu.00373.2009; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; De Miguel C, 2011, AM J PHYSIOL-RENAL, V300, P42; De Miguel C, 2010, AM J PHYSIOL-REG I, V298, pR1136, DOI 10.1152/ajpregu.00298.2009; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gutkowska J, 2011, J HYPERTENS, V29, P1203, DOI 10.1097/HJH.0b013e3283468392; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; Iannone F, 2012, J RHEUMATOL, V39, P1179, DOI 10.3899/jrheum.111125; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Judd E, 2014, J HUM HYPERTENS; Kaly L, 2012, BEST PRACT RES CL RH, V26, P157, DOI 10.1016/j.berh.2012.01.001; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mirkov I, 2012, ACTA PATHOL MICROB C, V121, P211; Ogata H, 1997, J PATHOL, V182, P106; Owen JL, 2007, INT J MOL MED, V20, P129; Owen JL, 2005, CELL IMMUNOL, V235, P122, DOI 10.1016/j.cellimm.2005.08.032; Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Shang FJ, 2012, MOL MED REP, V5, P1491, DOI 10.3892/mmr.2012.852; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Taherzadeh Z, 2010, AM J PHYSIOL-HEART C, V298, P82; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; WHO, 2013, CARD DIS FACTS SHEET	47	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114895	10.1371/journal.pone.0114895	http://dx.doi.org/10.1371/journal.pone.0114895			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501574	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700064
J	Colombo, F; Trombetta, E; Cetrangolo, P; Maggioni, M; Razini, P; De Santis, F; Torrente, Y; Prati, D; Torresani, E; Porretti, L				Colombo, Federico; Trombetta, Elena; Cetrangolo, Paola; Maggioni, Marco; Razini, Paola; De Santis, Francesca; Torrente, Yvan; Prati, Daniele; Torresani, Erminio; Porretti, Laura			Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER; VERAPAMIL; CANCER; CHEMORESISTANCE; SEQUESTRATION; INHIBITION; METABOLISM	Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p<0.01), and that verapamil incubation can revert this resistance, especially if it is administered after drug pre-incubation. The findings of this study demonstrate the involvement of PGP-positive lysosomes in drug sequestration and MDR in HCC cell lines. The possibility of modulating this mechanism using PGP inhibitors could lead to the development of new targeted strategies to enhance HCC treatment.	[Colombo, Federico; Trombetta, Elena; Cetrangolo, Paola; Torresani, Erminio; Porretti, Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Flow Cytometry & Expt Hepatol Serv, Clin Chem & Microbiol Lab, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Pathol Lab, Milan, Italy; [Razini, Paola; De Santis, Francesca; Torrente, Yvan] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Ctr Dino Ferrari,Stem Cell Lab, Milan, Italy; [Prati, Daniele] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Colombo, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Flow Cytometry & Expt Hepatol Serv, Clin Chem & Microbiol Lab, Milan, Italy.	federico.colombo@policlinico.mi.it	Trombetta, Elena/J-5577-2015; Prati, Daniele/P-8215-2019; Colombo, Federico Simone/J-5586-2015; Maggioni, Marco/AAC-4617-2022; De Santis, Francesca/Q-3453-2019; Trombetta, Elena/O-1408-2019; Porretti, Laura/J-6748-2015	Trombetta, Elena/0000-0002-1933-6415; Prati, Daniele/0000-0002-2281-7498; Colombo, Federico Simone/0000-0003-4480-3481; Maggioni, Marco/0000-0001-8603-8998; De Santis, Francesca/0000-0001-5877-0639; Trombetta, Elena/0000-0002-1933-6415; Porretti, Laura/0000-0001-8100-4262	COPEV (Comitato per la Prevenzione dell'Epatite Virale); Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	COPEV (Comitato per la Prevenzione dell'Epatite Virale); Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	This study was supported by grants from COPEV (Comitato per la Prevenzione dell'Epatite Virale; www.copev.it); "5x1000 funds for the year 2011'' Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (www.policlinico.mi.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 2001, CANCER-AM CANCER SOC, V92, P1577, DOI 10.1002/1097-0142(20010915)92:6<1577::AID-CNCR1484>3.0.CO;2-H; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Colombo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021369; Date S, 2012, ANAL SCI, V28, P201, DOI 10.2116/analsci.28.201; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Falasca M, 2012, EXPERT OPIN INV DRUG, V21, P657, DOI 10.1517/13543784.2012.679339; Fan PS, 2012, CELL BIOCHEM BIOPHYS, V62, P59, DOI 10.1007/s12013-011-9259-4; Fodale V, 2011, CANCER J, V17, P89, DOI 10.1097/PPO.0b013e318212dd3d; Goldman SDB, 2009, BIOANALYSIS, V1, P1445, DOI 10.4155/BIO.09.128; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Huang J, 2011, CELL BIOCHEM BIOPHYS, V59, P127, DOI 10.1007/s12013-010-9125-9; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; LEHNERT M, 1991, BLOOD, V77, P348; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma JJ, 2009, ARCH GYNECOL OBSTET, V279, P149, DOI 10.1007/s00404-008-0690-8; Meaney M, 2013, PARASITOLOGY, V140, P1287, DOI 10.1017/S0031182013000759; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; OZOLS RF, 1987, J CLIN ONCOL, V5, P641, DOI 10.1200/JCO.1987.5.4.641; Relling MV, 1996, THER DRUG MONIT, V18, P350, DOI 10.1097/00007691-199608000-00006; Sun ZG, 2010, TUMORI J, V96, P90, DOI 10.1177/030089161009600115; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; Ughachukwu PO, 2012, ANN MED HEALTH SCI R, V2, P191, DOI 10.4103/2141-9248.105671; Wang XB, 2010, ONCOL REP, V23, P211, DOI 10.3892/or_00000625; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Zhu H, 2012, CHINESE MED J-PEKING, V125, P1095, DOI 10.3760/cma.j.issn.0366-6999.2012.06.024	28	31	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114787	10.1371/journal.pone.0114787	http://dx.doi.org/10.1371/journal.pone.0114787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493932	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400076
J	Li, XL; Li, J; Wilson, A; Sipple, J; Schick, J; Pang, QS				Li, Xiaoli; Li, Jie; Wilson, Andrew; Sipple, Jared; Schick, Jonathan; Pang, Qishen			Fancd2 Is Required for Nuclear Retention of Foxo3a in Hematopoietic Stem Cell Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; FOXO; Hematopoietic Stem Cells; Oxidative Stress; Fancd2	CROSS-LINK REPAIR; FANCONI ANEMIA/BRCA PATHWAY; SELF-RENEWAL; OXIDATIVE STRESS; DNA-DAMAGE; TRANSCRIPTION FACTOR; CANCER; MICE; ACTIVATION; INSIGHTS	Background: Maintenance of HSCs is challenged by DNA damage and oxidative stress. Results:Fancd2 deficiency promoted cytoplasmic localization of Foxo3a in HSCs. Re-expression of Fancd2 restored nuclear Foxo3a localization and prevented HSC exhaustion. Conclusion: Fancd2 is required for nuclear retention of Foxo3a and maintaining hematopoietic repopulation of HSCs. Significance: Our results implicate an interaction between FA DNA repair and FOXO3a pathways in HSC maintenance. Functional maintenance of hematopoietic stem cells (HSCs) is constantly challenged by stresses like DNA damage and oxidative stress. Here we show that the Fanconi anemia protein Fancd2 and stress transcriptional factor Foxo3a cooperate to prevent HSC exhaustion in mice. Deletion of both Fancd2 and Foxo3a led to an initial expansion followed by a progressive decline of bone marrow stem and progenitor cells. Limiting dilution transplantation and competitive repopulating experiments demonstrated a dramatic reduction of competitive repopulating units and progressive decline in hematopoietic repopulating ability of double-knockout (dKO) HSCs. Analysis of the transcriptome of dKO HSCs revealed perturbation of multiple pathways implicated in HSC exhaustion. Fancd2 deficiency strongly promoted cytoplasmic localization of Foxo3a in HSCs, and re-expression of Fancd2 completely restored nuclear Foxo3a localization. By co-expressing a constitutively active CA-FOXO3a and WT or a nonubiquitinated Fancd2 in dKO bone marrow stem/progenitor cells, we demonstrated that Fancd2 was required for nuclear retention of CA-FOXO3a and for maintaining hematopoietic repopulation of the HSCs. Collectively, these results implicate a functional interaction between the Fanconi anemia DNA repair and FOXO3a pathways in HSC maintenance.	[Li, Xiaoli; Wilson, Andrew; Sipple, Jared; Schick, Jonathan; Pang, Qishen] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Li, Jie] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California San Diego	Pang, QS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	qishen.pang@cchmc.org	Li, Xiaoli/GYQ-7384-2022; Li, Jie/L-1737-2015	Li, Jie/0000-0002-0590-9817	National Institutes of Health [R01 HL076712, R01 CA157537, T32 HL091805]; Leukemia and Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [R01CA157537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076712, T32HL091805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL076712, R01 CA157537, and T32 HL091805.; Supported by a Leukemia and Lymphoma Scholar award.	Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Haan Gerald, 2002, Methods Mol Med, V63, P143, DOI 10.1385/1-59259-140-X:143; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Prieto-Remon I, 2013, HAEMATOLOGICA, V98, P705, DOI 10.3324/haematol.2012.074187; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tischkowitz M, 2004, BRIT J HAEMATOL, V126, P176, DOI 10.1111/j.1365-2141.2004.05023.x; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson DB, 2014, ANN MED, V46, P353, DOI 10.3109/07853890.2014.915579; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676	39	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2715	2727		10.1074/jbc.M114.619536	http://dx.doi.org/10.1074/jbc.M114.619536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505262	Green Published, hybrid			2022-12-26	WOS:000349310700015
J	Bertero, T; Cottrill, K; Krauszman, A; Lu, Y; Annis, S; Hale, A; Bhat, B; Waxman, AB; Chau, BN; Kuebler, WM; Chan, SY				Bertero, Thomas; Cottrill, Katherine; Krauszman, Adrienn; Lu, Yu; Annis, Sofia; Hale, Andrew; Bhat, Balkrishen; Waxman, Aaron B.; Chau, B. Nelson; Kuebler, Wolfgang M.; Chan, Stephen Y.			The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIVATED RECEPTOR-GAMMA; MOLECULAR PATHOGENESIS; NITRIC-OXIDE; PPAR-GAMMA; ENDOTHELIN-1; EXPRESSION; NETWORKS; HYPOXIA; IMPAIRS	Pulmonary hypertension (PH) is a complex disorder, spanning several known vascular cell types. Recently, we identified the microRNA-130/301 (miR-130/301) family as a regulator of multiple pro-proliferative pathways in PH, but the true breadth of influence of the miR-130/301 family across cell types in PH may be even more extensive. Here, we employed targeted network theory to identify additional pathogenic pathways regulated by miR-130/301, including those involving vasomotor tone. Guided by these predictions, we demonstrated, via gain- and loss-of-function experimentation in vitro and in vivo, that miR-130/301-specific control of the peroxisome proliferator-activated receptor gamma regulates a panel of vasoactive factors communicating between diseased pulmonary vascular endothelial and smooth muscle cells. Of these, the vasoconstrictive factor endothelin-1 serves as an integral point of communication between the miR-130/301-peroxisome proliferator-activated receptor gamma axis in endothelial cells and contractile function in smooth muscle cells. Thus, resulting from an in silico analysis of the architecture of the PH disease gene network coupled with molecular experimentation in vivo, these findings clarify the expanded role of the miR-130/301 family in the global regulation of PH. They further emphasize the importance of molecular cross-talk among the diverse cellular populations involved in PH.	[Bertero, Thomas; Cottrill, Katherine; Lu, Yu; Annis, Sofia; Hale, Andrew; Chan, Stephen Y.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc & Network Med Dept Med, Boston, MA 02115 USA; [Waxman, Aaron B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med,Dept Med, Boston, MA 02115 USA; [Krauszman, Adrienn; Kuebler, Wolfgang M.] Univ Toronto, Keenan Res Ctr Biomed Sci St Michaels, Toronto, ON M5R 0A3, Canada; [Bhat, Balkrishen; Chau, B. Nelson] Regulus Therapeut, San Diego, CA 92127 USA; [Kuebler, Wolfgang M.] Charite, Dept Physiol, D-10717 Berlin, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Isis Pharmaceuticals Inc; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chan, SY (corresponding author), Brigham & Womens Hosp, New Res Bldg,Rm 630N,77 Ave Louis Pasteur, Boston, MA 02115 USA.	sychan@partners.org	Waxman, Aaron/L-7450-2019; Waxman, Aaron/I-8659-2019	Waxman, Aaron/0000-0001-7797-0361; Kuebler, Wolfgang/0000-0003-4100-2961; BERTERO, Thomas/0000-0002-4801-9902; Annis, Sofia/0000-0003-3264-5260	National Institutes of Health [K08HL096834]; McArthur-Radovsky Fund; Lerner Fund; Harris Fund; Watkins Fund; Pulmonary Hypertension Association; Canadian Institutes for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL096834, R01HL124021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McArthur-Radovsky Fund; Lerner Fund(March of Dimes); Harris Fund; Watkins Fund; Pulmonary Hypertension Association; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant K08HL096834 (to S. Y. C.). This work was also supported by the McArthur-Radovsky, Lerner, Harris, and Watkins Funds and the Pulmonary Hypertension Association (to S. Y. C.) and by the Canadian Institutes for Health Research (to W. M. K.).	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bando K, 1997, CIRCULATION, V96, P346; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Din S, 2009, VASC PHARMACOL, V51, P344, DOI 10.1016/j.vph.2009.09.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009; Hakim TS, 2013, RESP PHYSIOL NEUROBI, V189, P93, DOI 10.1016/j.resp.2013.06.028; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000267; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079503; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Markewitz BA, 2001, CARDIOVASC RES, V49, P200, DOI 10.1016/S0008-6363(00)00221-2; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Nagendran J, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300448; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rabinovitch M, 2010, ADV EXP MED BIOL, V661, P447, DOI 10.1007/978-1-60761-500-2_29; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Shimoda LA, 2000, PHYSIOL RES, V49, P549; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang LM, 2012, J CLIN INVEST, V122, P4218, DOI 10.1172/JCI59176; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu WH, 2011, AM J HYPERTENS, V24, P1087, DOI 10.1038/ajh.2011.116	50	73	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2069	2085		10.1074/jbc.M114.617845	http://dx.doi.org/10.1074/jbc.M114.617845			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505270	Green Published, hybrid			2022-12-26	WOS:000348588000014
J	Kamath, VG; Hsiung, CH; Lizenby, ZJ; McKee, EE				Kamath, Vasudeva G.; Hsiung, Chia-Heng; Lizenby, Zachary J.; McKee, Edward E.			Heart Mitochondrial TTP Synthesis and the Compartmentalization of TMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HUMAN-CELLS; THYMIDINE KINASE; DEOXYNUCLEOTIDE POOLS; LIVER-MITOCHONDRIA; DNA MAINTENANCE; MONOPHOSPHATE; METABOLISM; PHOSPHORYLATION; IDENTIFICATION; DEFICIENCY	The primary pathway of TTP synthesis in the heart requires thymidine salvage by mitochondrial thymidine kinase 2 (TK2). However, the compartmentalization of this pathway and the transport of thymidine nucleotides are not well understood. We investigated the metabolism of [H-3] thymidine or [H-3]TMP as precursors of [H-3] TTP in isolated intact or broken mitochondria from the rat heart. The results demonstrated that [H-3] thymidine was readily metabolized by the mitochondrial salvage enzymes to TTP in intact mitochondria. The equivalent addition of [H-3] TMP produced far less [H-3] TTP than the amount observed with [H-3] thymidine as the precursor. Using zidovudine to inhibit TK2, the synthesis of [H-3] TTP from [H-3] TMP was effectively blocked, demonstrating that synthesis of [H-3] TTP from [H-3] TMP arose solely from the dephosphory-synthase pathway that includes deoxyuridine triphosphatelation of [H-3] TMP to [H-3] thymidine. To determine the role of the membrane in TMP metabolism, mitochondrial membranes were disrupted by freezing and thawing. In broken mitochondria, [H-3] thymidine was readily converted to [H-3] TMP, but further phosphorylation was prevented even though the energy charge was well maintained by addition of oligomycin A, phosphocreatine, and creatine phosphokinase. The failure to synthesize TTP in broken mitochondria was not related to a loss of membrane potential or inhibition of the electron transport chain, as confirmed by addition of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone and potassium cyanide, respectively, in intact mitochondria. In summary, these data, taken together, suggest that the thymidine salvage pathway is compartmentalized so that TMP kinase prefers TMP synthesized by TK2 over medium TMP and that this is disrupted in broken mitochondria.	[Kamath, Vasudeva G.; Hsiung, Chia-Heng; Lizenby, Zachary J.; McKee, Edward E.] Cent Michigan Univ, Dept Foundat Sci, Coll Med, Mt Pleasant, MI 48859 USA	Central Michigan University	McKee, EE (corresponding author), Cent Michigan Univ, Dept Foundat Sci, Coll Med, CMU Res Bldg,Rm 119,2630 Denison Dr, Mt Pleasant, MI 48859 USA.	mckee1ee@cmich.edu	Kamath, Vasudeva/AAE-4707-2020	Hsiung, Chia-Heng/0000-0003-3542-587X; McKee, Edward/0000-0002-4467-7668	National Institute of Health [R01/HL096480]; Central Michigan University Office of Research Sponsored Programs summer fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096480] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Michigan University Office of Research Sponsored Programs summer fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grant R01/HL096480. This work was also supported by the Central Michigan University Office of Research Sponsored Programs summer fellowship (to Z. J. L.).	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; Chen YL, 2008, GENES CELLS, V13, P679, DOI 10.1111/j.1365-2443.2008.01197.x; Chimploy K, 2013, J BIOL CHEM, V288, P13145, DOI 10.1074/jbc.M113.461111; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Lynx MD, 2006, BIOCHEM PHARMACOL, V71, P1342, DOI 10.1016/j.bcp.2006.01.003; Mathews CK, 2014, FASEB J, V28, P3832, DOI 10.1096/fj.14-251249; McCann KA, 2012, J NEUROCHEM, V122, P126, DOI 10.1111/j.1471-4159.2012.07765.x; McKee Edward E, 2004, Cardiovasc Toxicol, V4, P155, DOI 10.1385/CT:4:2:155; MCKEE EE, 1990, AM J PHYSIOL, V258, pE492, DOI 10.1152/ajpendo.1990.258.3.E492; Morris GW, 2010, ANTIVIR THER, V15, P587, DOI 10.3851/IMP1567; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Schlattner U, 2015, N-S ARCH PHARMACOL, V388, P271, DOI 10.1007/s00210-014-1047-4; Steeg PS, 2011, N-S ARCH PHARMACOL, V384, P331, DOI 10.1007/s00210-011-0651-9; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6	27	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2034	2041		10.1074/jbc.M114.624213	http://dx.doi.org/10.1074/jbc.M114.624213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505243	hybrid, Green Published			2022-12-26	WOS:000348588000011
J	Mizugishi, K; Inoue, T; Hatayama, H; Bielawski, J; Pierce, JS; Sato, Y; Takaori-Kondo, A; Konishi, I; Yamashita, K				Mizugishi, Kiyomi; Inoue, Takuya; Hatayama, Hiroshi; Bielawski, Jacek; Pierce, Jason S.; Sato, Yukiyasu; Takaori-Kondo, Akifunni; Konishi, Ikuo; Yamashita, Kouhei			Sphingolipid Pathway Regulates Innate Immune Responses at the Fetomaternal Interface during Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE KINASE TYPE-2; KILLER-CELL ACTIVITY; FUNCTIONAL-CHARACTERIZATION; INTRAVENOUS IMMUNOGLOBULIN; NEUTROPHIL ACTIVATION; TRYPTOPHAN CATABOLISM; RECURRENT MISCARRIAGE; MOLECULAR-CLONING; TISSUE FACTOR; FETAL INJURY	For a successful pregnancy, the mother's immune system has to tolerate the semiallogeneic fetus. A deleterious immune attack is avoided by orchestration of cellular, hormonal, and enzymatic factors. However, the precise mechanisms underlying fetomaternal tolerance are not yet completely understood. In this study, we demonstrate that sphingolipid metabolism constitutes a novel signaling pathway that is indispensable for fetomaternal tolerance by regulating innate immune responses at the fetomaternal interface. Perturbation of the sphingolipid pathway by disruption of the sphingosine kinase gene (Sphk) during pregnancy caused unusually high expression of neutrophil chemoattractants, CXCL1 and CXCL2, in the decidua, leading to a massive infiltration of neutrophils into the fetomaternal interface with enhanced oxidative damage, resulting in early fetal death. Sphk-deficient mice also exhibited neutrophilia in the peripheral blood, enhanced generation of granulocytes in the bone marrow, and a decrease in the number of decidual natural killer cells. The blockage of neutrophil influx protected Sphk-deficient mice against pregnancy loss. Notably, a similar result was obtained in human decidual cells, in which Sphk deficiency dramatically increased the secretion of CXCL1 and IL-8. In conclusion, our findings suggest that the sphingolipid metabolic pathway plays a critical role in fetomaternal tolerance by regulating innate immunity at the fetomaternal interface both in mice and humans, and it could provide novel insight into the development of therapeutic strategies to treat idiopathic pregnancy loss in humans.	[Mizugishi, Kiyomi; Takaori-Kondo, Akifunni; Yamashita, Kouhei] Kyoto Univ Hosp, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Mizugishi, Kiyomi] Musashino Univ, Pharmaceut Sci Res Inst, Dept Pharmacotherapy, Tokyo 2028585, Japan; [Inoue, Takuya; Hatayama, Hiroshi] Adachi Hosp, Dept Gynecol & Obstet, Kyoto 6040837, Japan; [Bielawski, Jacek; Pierce, Jason S.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sato, Yukiyasu; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Grad Sch Med, Kyoto 6068507, Japan	Kyoto University; Medical University of South Carolina; Kyoto University	Mizugishi, K (corresponding author), Kyoto Univ Hosp, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kiyomim@kuhp.kyoto-u.ac.jp		Sato, Yukiyasu/0000-0003-4033-1229	Japan Society for the Promotion of Science [21591414, 24591600]; Naito Foundation; Japan Foundation for Pediatric Research; Cell Science Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Japan Foundation for Pediatric Research; Cell Science Research Foundation(Cell Science Research Foundation, Japan)	This work was supported by Grants-in-aid for Scientific Research 21591414 and 24591600 from the Japan Society for the Promotion of Science, the Naito Foundation, the Japan Foundation for Pediatric Research, and the Cell Science Research Foundation (to K. M.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; AOKI K, 1995, LANCET, V345, P1340, DOI 10.1016/S0140-6736(95)92539-2; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Argraves Kelley M, 2010, World J Biol Chem, V1, P291, DOI 10.4331/wjbc.v1.i10.291; Bansal AS, 2012, J REPROD IMMUNOL, V93, P41, DOI 10.1016/j.jri.2011.10.002; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Girardi G, 2011, THROMB RES, V127, pS43, DOI 10.1016/S0049-3848(11)70012-3; HAIMOVICI F, 1991, BIOL REPROD, V44, P69, DOI 10.1095/biolreprod44.1.69; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jaslow CR, 2010, FERTIL STERIL, V93, P1234, DOI 10.1016/j.fertnstert.2009.01.166; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kotlan B, 2006, AM J REPROD IMMUNOL, V55, P331, DOI 10.1111/j.1600-0897.2006.00368.x; Krieg SA, 2012, MOL HUM REPROD, V18, P442, DOI 10.1093/molehr/gas017; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; MUELLERECKHARDT G, 1994, J REPROD IMMUNOL, V27, P95, DOI 10.1016/0165-0378(94)90026-4; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nava VE, 2000, CANCER RES, V60, P4468; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Saini V, 2011, CLIN CHIM ACTA, V412, P702, DOI 10.1016/j.cca.2011.01.002; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; SUFFYS P, 1989, ANTICANCER RES, V9, P167; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; van den Heuvel MJ, 2007, AM J REPROD IMMUNOL, V58, P447, DOI 10.1111/j.1600-0897.2007.00529.x; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Williams PJ, 2009, REPRODUCTION, V138, P177, DOI 10.1530/REP-09-0007; Winger EE, 2011, AM J REPROD IMMUNOL, V66, P394, DOI 10.1111/j.1600-0897.2011.01018.x; Yamada H, 2003, AM J REPROD IMMUNOL, V50, P351, DOI 10.1034/j.1600-0897.2003.00095.x; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang JH, 2013, HUM REPROD, V28, P3026, DOI 10.1093/humrep/det339	53	24	26	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2053	2068		10.1074/jbc.M114.628867	http://dx.doi.org/10.1074/jbc.M114.628867			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505239	Green Published, hybrid			2022-12-26	WOS:000348588000013
J	Basson, A; Swart, R; Jordaan, E; Mazinu, M; Watermeyer, G				Basson, Abigail; Swart, Rina; Jordaan, Esme; Mazinu, Mikateko; Watermeyer, Gillian			The Association between Childhood Environmental Exposures and the Subsequent Development of Crohn's Disease in the Western Cape, South Africa	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN MICROBIOME; SMOKING; EPIDEMIOLOGY; HYGIENE; RISK; PREVALENCE; PREDICTORS; TOWN	Background: Environmental factors during childhood are thought to play a role in the aetiolgy of Crohn's Disease (CD). However the association between age at time of exposure and the subsequent development of CD in South Africa is unknown. Methods: A case control study of all consecutive CD patients seen at 2 large inflammatory bowel disease (IBD) referral centers in the Western Cape, South Africa between September 2011 and January 2013 was performed. Numerous environmental exposures during 3 age intervals; 0-5, 6-10 and 11-18 years were extracted using an investigator administered questionnaire. An agreement analysis was performed to determine the reliability of questionnaire data for all the relevant variables. Results: This study included 194 CD patients and 213 controls. On multiple logistic regression analysis, a number of childhood environmental exposures during the 3 age interval were significantly associated with the risk of developing CD. During the age interval 6-10 years, never having had consumed unpasteurized milk (OR=5.84; 95% CI, 2.73-13.53) and never having a donkey, horse, sheep or cow on the property (OR=2.48; 95% CI, 1.09-5.98) significantly increased the risk of developing future CD. During the age interval 11-18 years, an independent risk-association was identified for; never having consumed unpasteurized milk (OR=2.60; 95% CI, 1.17-6.10) and second-hand cigarette smoke exposure (OR=1.93; 95% CI, 1.13-3.35). Conclusion: This study demonstrates that both limited microbial exposures and exposure to second-hand cigarette smoke during childhood is associated with future development of CD.	[Basson, Abigail; Swart, Rina] Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa; [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Africa, Biostat Unit, Parow, Western Cape, South Africa; [Jordaan, Esme] Univ Western Cape, Stat & Populat Studies Dept, ZA-7535 Bellville, Western Cape, South Africa; [Watermeyer, Gillian] Groote Schuur Hosp, Dept Gastroenterol, ZA-7925 Cape Town, Western Cape, South Africa; [Watermeyer, Gillian] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa	University of the Western Cape; University of the Western Cape; University of Cape Town; University of Cape Town	Basson, A (corresponding author), Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa.	abbasson@uwc.ac.za	; Swart, Elizabeth/O-9619-2014	Basson, Abigail/0000-0002-8369-919X; Swart, Elizabeth/0000-0002-7786-3117	AstraZeneca/South African Gastroenterology Society (SAGES)	AstraZeneca/South African Gastroenterology Society (SAGES)	This research was supported by the 2011 Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. [http://www.sages.co.za/D_AN_ScholTravel.asp]	Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104859; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Bisgaard H, 2014, CLIN EXP ALLERGY, V44, P475, DOI 10.1111/cea.12291; Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328; Chu KM, 2013, INFLAMM BOWEL DIS, V19, P614, DOI 10.1097/MIB.0b013e31827f27f4; Duggan AE, 1998, GUT, V43, P494, DOI 10.1136/gut.43.4.494; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mahid SS, 2007, INFLAMM BOWEL DIS, V13, P431, DOI 10.1002/ibd.20070; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Proal AD, 2013, CURR OPIN RHEUMATOL, V25, P234, DOI 10.1097/BOR.0b013e32835cedbf; Small K, 2008, DEMOGRAPHIC SOCIOECO; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wadee S, 2007, RHEUMATOLOGY, V46, P1487, DOI 10.1093/rheumatology/kem180; WRIGHT JP, 1986, S AFR MED J, V70, P10; WRIGHT JP, 1983, S AFR MED J, V63, P226	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115492	10.1371/journal.pone.0115492	http://dx.doi.org/10.1371/journal.pone.0115492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514591	Green Published, Green Submitted, gold			2022-12-26	WOS:000349146300060
J	Fung, TT; Kashambwa, R; Sato, K; Chiuve, SE; Fuchs, CS; Wu, KN; Giovannucci, E; Ogino, S; Hu, FB; Meyerhardt, JA				Fung, Teresa T.; Kashambwa, Rutendo; Sato, Kaori; Chiuve, Stephanie E.; Fuchs, Charles S.; Wu, Kana; Giovannucci, Edward; Ogino, Shuji; Hu, Frank B.; Meyerhardt, Jeffrey A.			Post Diagnosis Diet Quality and Colorectal Cancer Survival in Women	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; MEDITERRANEAN DIET; PROSPECTIVE COHORT; COLON-CANCER; ALL-CAUSE; RISK; MORTALITY; PATTERNS	Background: Dietary factors are known to influence colorectal cancer (CRC) risk, however, their association with CRC survival is unclear. Therefore, we prospectively examined the association between diet quality scores, dietary patterns and colorectal cancer (CRC) survival. Methods: 1201 women diagnosed with stage I-III CRC between 1986 and 2008, were followed through 2010. Diet was assessed via a food frequency questionnaire administered at least 6 months after diagnosis. We computed the Alternate Healthy Eating Index-2010 (AHEI-2010), alternate Mediterranean Diet score (aMED) and Dietary Approaches to Stop Hypertension score (DASH) and derived two dietary patterns, Western (unhealthy) and prudent (healthy), by principal component analysis for each woman. Results: During follow-up, we documented 435 deaths, including 162 from CRC. After adjusting for potential confounders, only a higher AHEI-2010 score was significantly associated with lower overall mortality (HR comparing extreme quintiles=0.71, 95% CI 0.52-0.98, p trend=0.01) as well as borderline significantly with lower risk of CRC mortality by the trend test (HR Q5 vs Q1=0.72, 95% CI=0.43-1.21, p trend=0.07). When AHEI-2010 components were examined separately, inverse associations for overall mortality were primarily accounted for by moderate alcohol intake (HR comparing abstainers vs 5-15 g/d=1.30, 95% CI=1.05-1.61) and lower intake of sugar sweetened beverages and fruit juices combined (HR for each additional serving=1.11, 95% CI=1.01-1.23). No other diet quality score or dietary pattern was associated with overall or CRC-specific mortality. Conclusion: Higher AHEI-2010 score may be associated with lower overall mortality, moderate alcohol consumption and lower consumption of sugar sweetened beverages and juices combined appeared to account for most of the observed associations.	[Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Kashambwa, Rutendo] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Wu, Kana; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Surg, Boston, MA 02115 USA; [Fuchs, Charles S.; Hu, Frank B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji; Meyerhardt, Jeffrey A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Simmons University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Fung, TT (corresponding author), Simmons Coll, Dept Nutr, Boston, MA 02115 USA.	fung@simmons.edu		Ogino, Shuji/0000-0002-3909-2323; Chiuve, Stephanie/0000-0002-3524-8917	National Institute of Health [CA87969, CA127003, CA149222, CA95589, CA151993, CA169141, CA 118553, UM1CA167552, U54CA155626, UM1 CA167552]; NATIONAL CANCER INSTITUTE [P50CA127003, R01CA149222, R01CA095589, R01CA169141, R01CA118553, P01CA087969, U54CA155626, UM1CA167552, R01CA151993] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is funded by the National Institute of Health research grants CA87969, CA127003, CA149222, CA95589, CA151993, CA169141, CA 118553, UM1CA167552, U54CA155626, UM1 CA167552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Abhari S, 2013, EUR J EPIDEMIOL, V28, P541, DOI 10.1007/s10654-013-9819-6; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bystrom P, 2009, UPSALA J MED SCI, V114, P160, DOI 10.1080/03009730903027172; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cooney RV, 2013, CANCER EPIDEM BIOMAR, V22, P1278, DOI 10.1158/1055-9965.EPI-13-0199; Crozier J, 2006, BRIT J CANCER, V94, P1833, DOI 10.1038/sj.bjc.6603185; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Fung Teresa T, 2013, Curr Nutr Rep, V2, P48; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2005, AM J CLIN NUTR, V82, P163; HENNEKENS CH, 1979, LANCET, V1, P1390; Hoensch H, 2008, WORLD J GASTROENTERO, V14, P2187, DOI 10.3748/wjg.14.2187; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kim EHJ, 2011, NUTR CANCER, V63, P381, DOI 10.1080/01635581.2011.535963; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Leung EYL, 2008, INT J CANCER, V123, P2460, DOI 10.1002/ijc.23811; Lofano Katia, 2013, J Gastrointest Cancer, V44, P1, DOI 10.1007/s12029-012-9425-y; McCullough ML, 2013, J CLIN ONCOL, V31, P2773, DOI 10.1200/JCO.2013.49.1126; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Reedy J, 2008, AM J EPIDEMIOL, V168, P38, DOI 10.1093/aje/kwn097; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schwingshackl L, 2014, INT J CANCER, V135, P1884, DOI 10.1002/ijc.28824; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Walter V, 2014, ANN ONCOL, V25, P1517, DOI 10.1093/annonc/mdu040; Willett W., 2012, NUTR EPIDEMIOLOGY; Wolpin BM, 2008, J CLIN ONCOL, V26, P3222, DOI 10.1200/JCO.2008.16.1943; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923; Yoshida M, 2007, J NUTR, V137, P2121, DOI 10.1093/jn/137.9.2121; Zhu Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002270	39	67	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115377	10.1371/journal.pone.0115377	http://dx.doi.org/10.1371/journal.pone.0115377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506700	Green Published, gold			2022-12-26	WOS:000346607100072
J	Murakami, I; Chaleckis, R; Pluskal, T; Ito, K; Hori, K; Ebe, M; Yanagida, M; Kondoh, H				Murakami, Itsuo; Chaleckis, Romanas; Pluskal, Tomas; Ito, Ken; Hori, Kousuke; Ebe, Masahiro; Yanagida, Mitsuhiro; Kondoh, Hiroshi			Metabolism of Skin-Absorbed Resveratrol into Its Glucuronized Form in Mouse Skin	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE AGENT; LIFE-SPAN; TRANS-RESVERATROL; UDP-GLUCURONOSYLTRANSFERASE; MITOCHONDRIAL-FUNCTION; CALORIE RESTRICTION; HUMAN LIVER; IN-VIVO; CELLS; YEAST	Resveratrol (RESV) is a plant polyphenol, which is thought to have beneficial metabolic effects in laboratory animals as well as in humans. Following oral administration, RESV is immediately catabolized, resulting in low bioavailability. This study compared RESV metabolites and their tissue distribution after oral uptake and skin absorption. Metabolomic analysis of various mouse tissues revealed that RESV can be absorbed and metabolized through skin. We detected sulfated and glucuronidated RESV metabolites, as well as dihydroresveratrol. These metabolites are thought to have lower pharmacological activity than RESV. Similar quantities of most RESV metabolites were observed 4 h after oral or skin administration, except that glucuronidated RESV metabolites were more abundant in skin after topical RESV application than after oral administration. This result is consistent with our finding of glucuronidated RESV metabolites in cultured skin cells. RESV applied to mouse ears significantly suppressed inflammation in the TPA inflammation model. The skin absorption route could be a complementary, potent way to achieve therapeutic effects with RESV.	[Murakami, Itsuo; Chaleckis, Romanas; Ito, Ken; Hori, Kousuke; Kondoh, Hiroshi] Kyoto Univ Hosp, Geriatr Unit, Sakyo Ku, Kyoto 606, Japan; [Chaleckis, Romanas; Pluskal, Tomas; Ebe, Masahiro; Yanagida, Mitsuhiro] Grad Univ OIST, Cell Unit G0, Okinawa Inst Sci & Technol, Okinawa, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University	Kondoh, H (corresponding author), Kyoto Univ Hosp, Geriatr Unit, Sakyo Ku, Kyoto 606, Japan.	myanagid@gmail.com; hkondoh@kuhp.kyoto-u.ac.jp	Chaleckis, Romanas/K-2629-2014; Pluskal, Tomáš/C-6247-2012	Chaleckis, Romanas/0000-0001-8042-1005; Pluskal, Tomáš/0000-0002-6940-3006	Okinawa Intellectual Cluster Program; Japanese government (Monbukagakusho: MEXT) scholarship; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Okinawa Intellectual Cluster Program; Japanese government (Monbukagakusho: MEXT) scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Itsuo Murakami was supported by a postdoctoral fellowship from Okinawa Intellectual Cluster Program. Romanas Chaleckis was supported by Japanese government (Monbukagakusho: MEXT) scholarship. This work was supported in part by grants from the Okinawa Intellectual Cluster Program, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from Japan Science and Technology Agency (to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Aziz MH, 2005, PHOTOCHEM PHOTOBIOL, V81, P25, DOI 10.1562/2004-08-13-RA-274.1; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bralley EE, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-1; Chaleckis R, 2014, MOL BIOSYST, V10, P2538, DOI 10.1039/c4mb00346b; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; De Santi C, 2000, XENOBIOTICA, V30, P1047, DOI 10.1080/00498250010002487; Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001; DURRHEIM H, 1980, J PHARM SCI, V69, P781, DOI 10.1002/jps.2600690709; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hung CF, 2008, BIOL PHARM BULL, V31, P955, DOI 10.1248/bpb.31.955; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jung CM, 2009, FEMS MICROBIOL LETT, V297, P266, DOI 10.1111/j.1574-6968.2009.01691.x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kuehnbaum NL, 2013, CHEM REV, V113, P2437, DOI 10.1021/cr300484s; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Maier-Salamon A, 2008, J PHARM SCI-US, V97, P1615, DOI 10.1002/jps.21057; Maier-Salamon A, 2013, ANN NY ACAD SCI, V1290, P98, DOI 10.1111/nyas.12198; Maier-Salamon A, 2011, DRUG METAB PHARMACOK, V26, P364, DOI 10.2133/dmpk.DMPK-11-RG-006; Martin GM, 2011, FASEB J, V25, P3756, DOI 10.1096/fj.11-1102.ufm; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miksits M, 2010, CANCER LETT, V289, P237, DOI 10.1016/j.canlet.2009.08.020; Mizutani K, 2000, J NUTR SCI VITAMINOL, V46, P78, DOI 10.3177/jnsv.46.78; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Nerurkar Pratibha V, 2008, Cellscience, V4, P82; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reagan-Shaw S, 2004, ONCOGENE, V23, P5151, DOI 10.1038/sj.onc.1207666; Sabolovic N, 2006, BIOPHARM DRUG DISPOS, V27, P181, DOI 10.1002/bdd.498; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Sasaki H, 2008, GERIATR GERONTOL INT, V8, P1, DOI 10.1111/j.1447-0594.2008.00439.x; Scully T, 2012, NATURE, V492, pS2, DOI 10.1038/492S2a; Sumida K, 2013, MOL PHARMACOL, V84, P679, DOI 10.1124/mol.113.088112; Sun Z, 2012, FEBS J, V279, P2381, DOI 10.1111/j.1742-4658.2012.08617.x; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Ung D, 2009, XENOBIOTICA, V39, P72, DOI [10.1080/00498250802604082, 10.1080/00498250802604082 ]; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vanltallie TB, 2003, METABOLISM, V52, P22, DOI 10.1053/S0026-0495(03)00297-X; Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1; WAWRZYNIAK CJ, 1989, MOL CELL BIOL, V9, P4074, DOI 10.1128/MCB.9.9.4074; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Wu Y, 2013, J EUR ACAD DERMATOL, V27, P345, DOI 10.1111/j.1468-3083.2011.04414.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zillich OV, 2013, INT J COSMETIC SCI, V35, P491, DOI 10.1111/ics.12072	64	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115359	10.1371/journal.pone.0115359	http://dx.doi.org/10.1371/journal.pone.0115359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506824	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100069
J	Gao, JL; Weaver, SR; Fua, H; Pan, ZG				Gao, Junling; Weaver, Scott R.; Fua, Hua; Pan, Zhigang			Does Workplace Social Capital Associate with Hazardous Drinking Among Chinese Rural-Urban Migrant Workers?	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; FINNISH PUBLIC-SECTOR; ALCOHOL-USE; SELF-CONTROL; MULTILEVEL ANALYSIS; POLITICAL-ECONOMY; HEALTH-STATUS; SMOKING; STRESS; EMPLOYEES	Background: The present study sought to investigate the associations between workplace social capital and hazardous drinking (HD) among Chinese rural-urban migrant workers (RUMW). Methods: A cross sectional study with a multi-stage stratified sampling procedure was conducted in Shanghai during July 2012 to January 2013. In total, 5,318 RUMWs from 77 workplaces were involved. Work-place social capital was assessed using a validated and psychometrically tested eight-item measure. The Chinese version of Alcohol Use Disorders Identification Test (AUDIT) was used to assess hazardous drinking. Control variables included gender, age, marital status, education level, salary, and current smoking. Multilevel logistic regression analysis was conducted to test whether individual-and workplace-level social capital was associated with hazardous drinking. Results: Overall, the prevalence of HD was 10.6%. After controlling for individual-level socio-demographic and lifestyle variables, compared to workers in the highest quartile of individual-level social capital, the odds of HD for workers in the three bottom quartiles were 1.13(95% CI: 1.04-1.23), 1.17(95% CI: 1.05-1.56) and 1.26(95% CI: 1.13-1.72), respectively. However, contrary to hypothesis, there was no relationship between workplace-level social capital and hazardous drinking. Conclusions: Higher individual-level social capital may protect against HD among Chinese RUMWs. Interventions to build individual social capital among RUMWs in China may help reduce HD among this population.	[Gao, Junling; Fua, Hua] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Weaver, Scott R.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Pan, Zhigang] Fudan Univ, Affiliated Zhongshan Hosp, Dept Gen Med, Shanghai 200433, Peoples R China	Fudan University; University System of Georgia; Georgia State University; Fudan University	Pan, ZG (corresponding author), Fudan Univ, Affiliated Zhongshan Hosp, Dept Gen Med, Shanghai 200433, Peoples R China.	zhigang_pan@163.com	gao, junling/L-7465-2019		Humanity and Social Science Youth Foundation of Ministry of Education of China [13YJCZH043]; National Institute of Minority Health and Health Disparities of the National Institutes of Health [1P20MD004806]	Humanity and Social Science Youth Foundation of Ministry of Education of China; National Institute of Minority Health and Health Disparities of the National Institutes of Health	This work was funded by the Humanity and Social Science Youth Foundation of Ministry of Education of China (Grant No: 13YJCZH043), and partially supported by the National Institute of Minority Health and Health Disparities of the National Institutes of Health (Grant No: 1P20MD004806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allik J, 2004, J CROSS CULT PSYCHOL, V35, P29, DOI 10.1177/0022022103260381; Botchkovar EV, 2013, INT J OFFENDER THER, V57, P357, DOI 10.1177/0306624X11435318; Burnhams NH, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-14; Chen WQ, 2008, J OCCUP HEALTH, V50, P262, DOI 10.1539/joh.L7149; Chen XG, 2011, HUM ORGAN, V70, P22, DOI 10.17730/humo.70.1.k76047734m703500; Chen YY, 2013, HEALTH CARE WOMEN IN, V34, P122, DOI 10.1080/07399332.2011.610535; China National Bureau Statistics, 2001, CHAR CHIN RUR MIGR 2; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Coleman J. S., 1998, FDN SOCIAL THEORY; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cui XB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-979; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Foster DW, 2014, SUBST USE MISUSE, V49, P1340, DOI 10.3109/10826084.2014.901387; Gao J, 2012, CHINESE J HLTH ED, V28, P806, DOI DOI 10.16168/J.CNKI.ISSN.1002; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Gao JL, 2013, PREV MED, V57, P831, DOI 10.1016/j.ypmed.2013.09.009; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; John F. Kennedy School of Government Harvard University, BETTER WORK SOCIAL C; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kawachi I, 2013, GLOBAL PERSPECTIVES; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; [李冰 Li Bing], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P1; Li Q, 2011, ALCOHOL ALCOHOLISM, V46, P416, DOI 10.1093/alcalc/agr012; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; Lin D, 2006, PSYCHOL DEV ED, V22, P52; Ma GuanSheng, 2005, Acta Nutrimenta Sinica, V27, P362; Marchand A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-333; Meng TG, 2014, HEALTH PLACE, V27, P38, DOI 10.1016/j.healthplace.2014.01.009; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; Mowbray O, 2014, AM J DRUG ALCOHOL AB, V40, P181, DOI 10.3109/00952990.2013.860984; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Oksanen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065846; Piquero Alex R, 2002, Crim Behav Ment Health, V12, P135, DOI 10.1002/cbm.492; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Prusak L, 2001, HARVARD BUS REV, V79, P86; Pulkkinen L, 2011, INT J BEHAV DEV, V35, P475, DOI 10.1177/0165025411422993; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Shortt SED, 2004, HEALTH POLICY, V70, P11, DOI 10.1016/j.healthpol.2004.01.007; Suzuki E, 2009, J EPIDEMIOL COMMUN H, V63, P692, DOI 10.1136/jech.2008.082453; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Wang HM, 2009, SOC SCI MED, V68, P133, DOI 10.1016/j.socscimed.2008.09.038; Wang J.C, 2008, MULTILEVEL MODELS ME; Weitzman ER, 2005, J EPIDEMIOL COMMUN H, V59, P303, DOI 10.1136/jech.2004.024711; Weitzman ER, 2000, AM J PUBLIC HEALTH, V90, P1936, DOI 10.2105/AJPH.90.12.1936; World Health Organization, 2011, GLOB STAT REP ALC HL; Yang TZ, 2012, COMMUNITY MENT HLT J, V48, P342, DOI 10.1007/s10597-011-9395-8; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Zaller N, 2014, ALCOHOL ALCOHOLISM, V49, P321, DOI 10.1093/alcalc/agt184	53	11	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115286	10.1371/journal.pone.0115286	http://dx.doi.org/10.1371/journal.pone.0115286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502013	gold, Green Published			2022-12-26	WOS:000346375400090
J	Jamesdaniel, S				Jamesdaniel, Samson			Downstream Targets of Lmo4 Are Modulated by Cisplatin in the Inner Ear of Wistar Rats	PLOS ONE			English	Article							LIM DOMAIN; INDUCED OTOTOXICITY; SIGNAL TRANSDUCER; APOPTOSIS; EXPRESSION; RESPONSES; TRANSCRIPTION; NITRATION; ACTIVATOR; PROTEINS	Lmo4, a transcriptional regulator, appears to be a key player in mediating the cochlear pathology in cisplatin ototoxicity, as it controls cellular responses by modulating the formation of transcriptional complexes. We provided the first evidence of in vivo nitration of Lmo4 in cisplatin ototoxicity. Our data suggested that nitration of Lmo4 and associated decrease in its cochlear expression has the potential to play a pivotal role in cisplatin ototoxicity. However, the Lmo4 interactomes that signal the downstream events in the cochlea are poorly understood. Therefore, custom-made gene arrays were employed to evaluate the modulation of known binding partners or targets of Lmo4, in Wistar rats treated with 16 mg/kg cisplatin. RT-PCR analysis, 3 days post cisplatin treatment, indicated that cisplatin induced up/down regulation of multiple cochlear genes associated with Lmo4 signaling. The cochlear expression of Esr1 was significantly up-regulated by cisplatin treatment, while the expression of Stat3 was down-regulated. Co-treatment with Trolox, an otoprotective antioxidant, attenuated the cisplatin-induced modulation of 5 genes in the cochlea. Consistent with the changes observed at the gene level, immunoblots with anti-Stat3 indicated that cisplatin-induced decrease in cochlear protein levels were attenuated by Trolox co-treatment. These results suggest that cisplatin-induced decreases in the cochlear Lmo4 upon nitration, and associated modulation in the cochlear expression of its binding partners Esr1 and Jak1, probably facilitates the repression of Stat3, a downstream target of Lmo4 implicated in drug mediated apoptosis. Collectively, these findings provide insights on Lmo4 downstream events and indicate a potential role of Jak/Stat transcriptional machinery in relaying the Lmo4 protein signaling in cisplatin-induced ototoxicity.	[Jamesdaniel, Samson] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Jamesdaniel, Samson] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA	Wayne State University; Wayne State University	Jamesdaniel, S (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.	sjamesdaniel@wayne.edu	Jamesdaniel, Samson/ABA-2616-2021	Jamesdaniel, Samson/0000-0002-5269-9007	National Institute on Deafness and other Communication Disorders, National Institutes of Health [5R03DC010225-03]; National Organization for Hearing Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010225] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the National Institute on Deafness and other Communication Disorders, National Institutes of Health (5R03DC010225-03) and by National Organization for Hearing Research (2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charitidi K, 2009, HEARING RES, V252, P71, DOI 10.1016/j.heares.2008.12.009; CHU G, 1994, J BIOL CHEM, V269, P787; Deng M, 2006, GENE EXPR PATTERNS, V6, P857, DOI 10.1016/j.modgep.2006.02.005; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2012, J BIOL CHEM, V287, P18674, DOI 10.1074/jbc.M111.297960; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010; Natal C, 2008, APOPTOSIS, V13, P1356, DOI 10.1007/s10495-008-0263-0; Novotny-Diermayr V, 2005, J BIOL CHEM, V280, P12747, DOI 10.1074/jbc.M500175200; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Schmitt NC, 2009, J NEUROSCI, V29, P3843, DOI 10.1523/JNEUROSCI.5842-08.2009; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Tian YP, 2010, CLIN EXP METASTAS, V27, P455, DOI 10.1007/s10585-010-9332-1; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	26	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115263	10.1371/journal.pone.0115263	http://dx.doi.org/10.1371/journal.pone.0115263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501662	gold, Green Published, Green Submitted			2022-12-26	WOS:000346375400088
J	Jiang, YM; Zhang, CF; Chen, K; Chen, Z; Sun, ZG; Zhang, ZQ; Ding, DB; Ren, SY; Zuo, YF				Jiang, Yanmei; Zhang, Changfu; Chen, Kai; Chen, Zhe; Sun, Zhigang; Zhang, Zhuqing; Ding, Dongbing; Ren, Shuangyi; Zuo, Yunfei			The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELLS; COLORECTAL-CANCER; GRABBING NONINTEGRIN; ENDOTHELIAL-CELLS; TUMOR-MARKERS; LECTIN; ADHESION; PROTEIN; RECOGNIZES	Background: Colon cancer has always been diagnosed at a late stage, which is associated with poor prognosis. The currently used serum tumor markers CEA and CA19-9 display low sensitivity and specificity and may not have diagnostic value in early stage colon cancer. Thus, there is an urgent need to identify novel serum biomarkers for use in the early detection of colon cancer. Methods: In this study, the expression of DC-SIGN and DC-SIGNR in serum was detected by enzyme-linked immunosorbent assay (ELISA). DC-SIGN and DC-SIGNR expression was detected in cancer tissues by immunohistochemistry (IHC). Results: The level of sDC-SIGN was lower in patients than in the healthy controls, while the level of sDC-SIGNR in patients was higher than in the healthy controls. Both sDC-SIGN and sDC-SIGNR had diagnostic significances for cancer patients, and the combined diagnosis of these two markers was higher than both of them alone. Furthermore, there were significant differences between both sDC-SIGN and sDC-SIGNR in stage I/II patients and the healthy controls. Moreover, high sDC-SIGN level was accompanied with the long survival time. Additionally, DC-SIGNR was negative in the cancer foci and matched normal colon tissues but was weakly positive between the cancer foci. DC-SIGN staining was faint in matched normal colon tissues, strong in the tumor stroma and the invasive margin of colon cancer tissues, and negatively correlated with the sDC-SIGN level in serum from the same patient. Interestingly, the percent survival of patients with a DC-SIGN mean density of. 0.001219 (the upper 95% confidence interval of matched normal colon tissues) was higher than for all other patients. Conclusion: DC-SIGN and DC-SIGNR are blood-based molecular markers that can potentially be used for the diagnosis of early stage patients. Moreover, expression of DC-SIGN in serum and cancer tissues may affect the survival time for colon cancer patients.	[Jiang, Yanmei; Zhang, Changfu; Zhang, Zhuqing; Zuo, Yunfei] Dalian Med Univ, Coll Lab Diagnost Med, Dept Clin Biochem, Dalian 116044, Peoples R China; [Chen, Kai; Chen, Zhe; Ding, Dongbing; Ren, Shuangyi] Dalian Med Univ, Affiliated Hosp 2, Dept Surg, Dalian 116023, Peoples R China; [Jiang, Yanmei; Sun, Zhigang] Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Dalian 116011, Peoples R China; [Zhang, Changfu] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian 116011, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zuo, YF (corresponding author), Dalian Med Univ, Coll Lab Diagnost Med, Dept Clin Biochem, Dalian 116044, Peoples R China.	rsydl@aliyun.com; zyf04112002@dlmedu.edu.cn			Chinese National Science Foundation Projects [81372669, 31270867]; Chinese State Key Program in Basic Research [2012CB822103]; Science and Technology Planning Project of Liao Ning province, China [2012225020]; Project of Chinese Ministry of Health [W2012RQ23]	Chinese National Science Foundation Projects; Chinese State Key Program in Basic Research; Science and Technology Planning Project of Liao Ning province, China; Project of Chinese Ministry of Health	This work was supported by Chinese National Science Foundation Projects (81372669, 31270867), the Chinese State Key Program in Basic Research (2012CB822103), the Science and Technology Planning Project of Liao Ning province, China (2012225020), and the Project of Chinese Ministry of Health (W2012RQ23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaria Bhawna, 2013, Cancer Biology Medicine, V10, P148, DOI 10.7497/j.issn.2095-3941.2013.03.005; Caligaris-Cappio F, 2007, BEST PRACT RES CL HA, V20, P385, DOI 10.1016/j.beha.2007.02.005; Dadabayev AR, 2004, CANCER IMMUNOL IMMUN, V53, P978, DOI 10.1007/s00262-004-0548-2; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edge SB, 2010, AJCC CANC STAGING MA; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fan NJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-54; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferroni P, 2010, CANCER-AM CANCER SOC, V116, P2913, DOI 10.1002/cncr.25094; Flamini E, 2006, CLIN CANCER RES, V12, P6985, DOI 10.1158/1078-0432.CCR-06-1931; Gdowski A, 2014, ADV EXP MED BIOL, V807, P33, DOI 10.1007/978-81-322-1777-0_4; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghia P, 2007, CRIT REV ONCOL HEMAT, V64, P234, DOI 10.1016/j.critrevonc.2007.04.008; Gulubova MV, 2012, INT J COLORECTAL DIS, V27, P159, DOI 10.1007/s00384-011-1334-1; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Martinez O, 2005, INT IMMUNOL, V17, P769, DOI 10.1093/intimm/dxh258; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Meyer S, 2007, GLYCOBIOLOGY, V17, P1104, DOI 10.1093/glycob/cwm073; Mori T, 2010, CANCER INVEST, V28, P387, DOI 10.3109/07357900903287055; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Nonaka M, 2014, J IMMUNOL, V192, P1294, DOI 10.4049/jimmunol.1203023; Nonaka M, 2011, J BIOL CHEM, V286, P22403, DOI 10.1074/jbc.M110.215301; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Robbins SL, 2005, ROBBINS COTRAN PATHO, P314; ROULSTON JE, 1990, BRIT J SURG, V77, P961, DOI 10.1002/bjs.1800770903; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008; Tao HQ, 2011, HUM PATHOL, V42, P1401, DOI 10.1016/j.humpath.2010.08.023; THOMSON DMP, 1969, P NATL ACAD SCI USA, V64, P161, DOI 10.1073/pnas.64.1.161; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Zhang ZQ, 2013, BIOCHEM CELL BIOL, V91, P214, DOI 10.1139/bcb-2012-0110; Zuo YF, 2013, GUT, V62, P1169, DOI 10.1136/gutjnl-2011-300593	44	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114748	10.1371/journal.pone.0114748	http://dx.doi.org/10.1371/journal.pone.0114748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504222	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400050
J	Kamae, Y; Uryu, O; Miki, T; Tomioka, K				Kamae, Yuichi; Uryu, Outa; Miki, Taiki; Tomioka, Kenji			The Nuclear Receptor Genes HR3 and E75 Are Required for the Circadian Rhythm in a Primitive Insect	PLOS ONE			English	Article							CRICKET GRYLLUS-BIMACULATUS; REV-ERB-ALPHA; HEMATOPHAGOUS INSECT; DROSOPHILA-CLOCK; EXPRESSION; TRANSCRIPTION; COMPONENT; TIMELESS; REVEALS; VRILLE	Insect circadian rhythms are generated by a circadian clock consisting of transcriptional/translational feedback loops, in which CYCLE and CLOCK are the key elements in activating the transcription of various clock genes such as timeless (tim) and period (per). Although the transcriptional regulation of Clock (Clk) has been profoundly studied, little is known about the regulation of cycle (cyc). Here, we identify the orphan nuclear receptor genes HR3 and E75, which are orthologs of mammalian clock genes, Rora and Rev-erba, respectively, as factors involved in the rhythmic expression of the cyc gene in a primitive insect, the firebrat Thermobia domestica. Our results show that HR3 and E75 are rhythmically expressed, and their normal, rhythmic expression is required for the persistence of locomotor rhythms. Their RNAi considerably altered the rhythmic transcription of not only cyc but also tim. Surprisingly, the RNAi of HR3 revealed the rhythmic expression of Clk, suggesting that this ancestral insect species possesses the mechanisms for rhythmic expression of both cyc and Clk genes. When either HR3 or E75 was knocked down, tim, cyc, and Clk or tim and cyc, respectively, oscillated in phase, suggesting that the two genes play an important role in the regulation of the phase relationship among the clock genes. Interestingly, HR3 and E75 were also found to be involved in the regulation of ecdysis, suggesting that they interconnect the circadian clock and developmental processes.	[Kamae, Yuichi; Uryu, Outa; Tomioka, Kenji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Miki, Taiki] Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Okayama University; Okayama University	Tomioka, K (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	tomioka@cc.okayama-u.ac.jp	Tomioka, Kenji/B-2632-2011	Tomioka, Kenji/0000-0001-7951-8950	Grants-in-Aid for Scientific Research [23370033] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bebas P, 2009, FASEB J, V23, P523, DOI 10.1096/fj.08-113191; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Kamae Y, 2012, J BIOL RHYTHM, V27, P126, DOI 10.1177/0748730411435997; Kamae Y, 2010, J INSECT PHYSIOL, V56, P1291, DOI 10.1016/j.jinsphys.2010.04.012; Meireles ACA, 2006, FEBS LETT, V580, P2, DOI 10.1016/j.febslet.2005.11.031; Meireles ACA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-38; Moriyama Y, 2012, J BIOL RHYTHM, V27, P467, DOI 10.1177/0748730412462207; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Pittendrigh C.S., 1971, BIOCHRONOMETRY, P212; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tong YH, 2004, J BIOL RHYTHM, V19, P113, DOI 10.1177/0748730403262871; Uryu O, 2013, J INSECT PHYSIOL, V59, P697, DOI 10.1016/j.jinsphys.2013.04.011; Uryu O, 2013, J INSECT PHYSIOL, V59, P494, DOI 10.1016/j.jinsphys.2013.02.009	28	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114899	10.1371/journal.pone.0114899	http://dx.doi.org/10.1371/journal.pone.0114899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502221	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700065
J	Mosca, S; Nicosia, MGL; Cacciola, SO; Schena, L				Mosca, Saveria; Nicosia, Maria G. Li Destri; Cacciola, Santa O.; Schena, Leonardo			Molecular Analysis of Colletotrichum Species in the Carposphere and Phyllosphere of Olive	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MULTIPLE SEQUENCE ALIGNMENT; ROSELLINIA-NECATRIX; CAUSAL AGENT; DNA BARCODE; ANTHRACNOSE; DIVERSITY; COMMUNITY; ACUTATUM; REGION	A metagenomic approach based on the use of genus specific primers was developed and utilized to characterize Colletotrichum species associated with the olive phyllosphere and carposphere. Selected markers enabled the specific amplification of almost the entire ITS1-5.8S-ITS2 region of the rDNA and its use as barcode gene. The analysis of different olive samples (green and senescent leaves, floral residues, symptomatic and asymptomatic fruits, and litter leaves and mummies) in three different phenological phases (June, October and December) enabled the detection of 12 genotypes associated with 4 phylotypes identified as C. godetiae, C. acutatum s.s., C. gloeosporioides s. s. and C. kahawae. Another three genotypes were not identified at the level of species but were associated with the species complexes of C. acutatum, C. gloeosporioides and C. boninense sensu lato. Colletotrichum godetiae and C. acutatum s.s. were by far the most abundant while C. gloeosporioides s. s. was detected in a limited number of samples whereas ther phylotypes were rarely found. The high incidence of C. acutatum s. s. represents a novelty for Italy and more generally for the Mediterranean basin since it had been previously reported only in Portugal. As regards to the phenological phase, Colletotrichum species were found in a few samples in June and were diffused on all assessed samples in December. According to data new infections on olive tissues mainly occur in the late fall. Furthermore, Colletotrichum species seem to have a saprophytic behavior on floral olive residues. The method developed in the present study proved to be valuable and its future application may contribute to the study of cycle and aetiology of diseases caused by Colletotrichum species in many different pathosystems.	[Mosca, Saveria; Nicosia, Maria G. Li Destri; Schena, Leonardo] Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy; [Cacciola, Santa O.] Univ Catania, Dipartimento Gest Sistemi Agroalimentari & Ambien, Catania, Italy	Universita Mediterranea di Reggio Calabria; University of Catania	Schena, L (corresponding author), Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy.	lschena@unirc.it	, Santa Olga Cacciola/H-7416-2019; Li Destri Nicosia, Maria Giulia/AGG-0569-2022; Schena, Leonardo/A-7492-2018	Schena, Leonardo/0000-0002-9737-2593; Mosca, Saveria/0000-0003-4985-8641; Li Destri Nicosia, Maria Giulia/0000-0001-5201-0057	Italian Ministry of Education, University and Research (MIUR) [RBFR10PZ4N]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by grant MIURFIRB 2010 (RBFR10PZ4N) from the Italian Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Agosteo GE, 2002, ACTA HORTIC, P713, DOI 10.17660/ActaHortic.2002.586.152; Agosteo GE, 2005, J PLANT PATHOL, V87, P287; [Anonymous], 1899, BULL SOC MYCOL FR; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Cacciola SO, 2012, J PLANT PATHOL, V94, P29; Cai L, 2009, FUNGAL DIVERS, V39, P183; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Carris LM, 2012, PLANT HLTH INSTRUCTO, P1, DOI [10.1094/PHI-I-2012-0426-01, DOI 10.1094/PHI-I-2012-0426-01]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Damm U, 2012, STUD MYCOL, P1, DOI 10.3114/sim0002; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Damm U, 2009, FUNGAL DIVERS, V39, P45; Damm U, 2013, FUNGAL DIVERS, V61, P29, DOI 10.1007/s13225-013-0255-4; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faedda R, 2011, PHYTOPATHOL MEDITERR, V50, P283; Friedl MA, 2012, MICROBIOL-SGM, V158, P69, DOI 10.1099/mic.0.052555-0; Graniti A., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P457, DOI 10.1111/j.1365-2338.1993.tb01353.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindner DL, 2013, ECOL EVOL, V3, P1751, DOI 10.1002/ece3.586; MARTELLI G. P., 1960, Phytopathologia Mediterranea, V1, P31; Martin MP, 1999, EUR J PLANT PATHOL, V105, P733, DOI 10.1023/A:1008785703330; Moral J, 2008, PLANT DIS, V92, P1421, DOI 10.1094/PDIS-92-10-1421; Moral J, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.110913; Moral J, 2009, PLANT DIS, V93, P1028, DOI 10.1094/PDIS-93-10-1028; Moral J, 2012, PHYTOPATHOLOGY, V102, P982, DOI 10.1094/PHYTO-12-11-0344; Moral J, 2009, PHYTOPATHOLOGY, V99, P548, DOI 10.1094/PHYTO-99-5-0548; Peay KG, 2008, BIOSCIENCE, V58, P799, DOI 10.1641/B580907; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruano-Rosa D, 2007, PLANT PATHOL, V56, P251, DOI 10.1111/j.1365-3059.2006.01546.x; Sanzani SM, 2012, POSTHARVEST BIOL TEC, V68, P64, DOI 10.1016/j.postharvbio.2012.02.003; Schena L, 2014, PLANT PATHOL, V63, P437, DOI 10.1111/ppa.12110; Schena L, 2013, J PLANT PATHOL, V95, P7; Schena L, 2002, EUR J PLANT PATHOL, V108, P355, DOI 10.1023/A:1015697813352; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; SERGEEVA V, 2010, PETRIA, V20, P251; Shivas RG, 2009, FUNGAL DIVERS, V39, P111; Sreenivasaprasad S, 2005, MOL PLANT PATHOL, V6, P361, DOI 10.1111/J.1364-3703.2005.00291.X; Talhinhas P, 2011, PLANT PATHOL, V60, P483, DOI 10.1111/j.1365-3059.2010.02397.x; Talhinhas P, 2009, FEMS MICROBIOL LETT, V296, P31, DOI 10.1111/j.1574-6968.2009.01613.x; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Varzea VMP, 2002, PLANT PATHOL, V51, P202; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Yang YL, 2009, FUNGAL DIVERS, V39, P123	55	38	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114031	10.1371/journal.pone.0114031	http://dx.doi.org/10.1371/journal.pone.0114031			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501572	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700013
J	Sun, K; Li, F; Lin, DZ; Qi, YQ; Xu, MT; Li, N; Huang, CL; Ren, M; Li, Y; Yan, L				Sun, Kan; Li, Feng; Lin, Diaozhu; Qi, Yiqin; Xu, Mingtong; Li, Na; Huang, Chulin; Ren, Meng; Li, Yan; Yan, Li			Serum Gamma - Glutamyltransferase Is Associated with Albuminuria: A Population-Based Study	PLOS ONE			English	Article							LOW-GRADE ALBUMINURIA; CHINESE DIABETIC INDIVIDUALS; GLOMERULAR-FILTRATION-RATE; GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; RISK-EVALUATION; HEART-FAILURE; MICROALBUMINURIA; INFLAMMATION	Background: Serum gamma-glutamyltransferase (GGT) is implicated in the pathogenesis of endothelial dysfunction and atherosclerosis. Albuminuria is a marker of endothelial damage and correlated with structural and functional integrity of the vasculature. Our objective was to evaluate the association between serum GGT level and prevalence of albuminuria in a Chinese population. Materials and Methods: We conducted a population-based cross-sectional study in 9,702 subjects aged 40 years or older. Increased urinary albumin excretion was defined according to the urinary albumin-to-creatinine ratio (ACR) ranges greater or equal than 30 mg/g. Low-grade albuminuria was defined according to the highest quartile of ACR in participants without increased urinary albumin excretion. Results: The prevalence of low-grade albuminuria and increased urinary albumin excretion were respectively 23.4% and 6.6% in this population and gradually increased across the sex-specific serum GGT quartiles (all P for trend <0.05). In logistic regression analysis, compared with subjects in the lowest quartile of serum GGT level, the adjusted odds ratios (ORs) in the highest quartile was 1.22 [95% confidence interval (CI), 1.04-1.43] for low-grade albuminuria and 1.55 (95% CI, 1.18-2.04) for increased urinary albumin excretion. In subgroup analysis, significant relationship of serum GGT level with both low-grade albuminuria and increased urinary albumin excretion were detected in women, younger subjects, overweight subjects and in those with hypertension or glomerular filtration rate greater than 90 (all P<0.05). Conclusion: Serum GGT level is associated with urinary albumin excretion in middle-aged and elderly Chinese.	[Sun, Kan; Li, Feng; Lin, Diaozhu; Qi, Yiqin; Xu, Mingtong; Li, Na; Huang, Chulin; Ren, Meng; Li, Yan; Yan, Li] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Li, Y (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	hfxyl@163.net; threefire@126.com			Natural Science Foundation of Guangdong Province, China [10251008901000010]; 5010 Clinical Medical Project of Sun Yat-sen University [2010010]; Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); 5010 Clinical Medical Project of Sun Yat-sen University; Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases	This work was supported by grants from the Natural Science Foundation of Guangdong Province, China (No. 10251008901000010), 5010 Clinical Medical Project of Sun Yat-sen University (No. 2010010) and grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Clausen P, 2001, CIRCULATION, V103, P1869; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Diercks GFH, 2002, CAN J CARDIOL, V18, P525; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Karp DR, 2001, J BIOL CHEM, V276, P3798, DOI 10.1074/jbc.M008484200; Katz DH, 2014, CIRCULATION, V129, P42, DOI 10.1161/CIRCULATIONAHA.113.003429; Lee DH, 2005, CLIN CHEM, V51, P1185, DOI 10.1373/clinchem.2004.045872; Lee DH, 2005, ATHEROSCLEROSIS, V178, P327, DOI 10.1016/j.atherosclerosis.2004.08.027; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin D, 2014, METABOLISM; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nerpin Elisabet, 2012, BMC Res Notes, V5, P537, DOI 10.1186/1756-0500-5-537; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Yamada J, 2006, ATHEROSCLEROSIS, V189, P198, DOI 10.1016/j.atherosclerosis.2005.11.036; Yilmaz MI, 2013, INT UROL NEPHROL, V45, P1071, DOI 10.1007/s11255-012-0354-2	38	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114970	10.1371/journal.pone.0114970	http://dx.doi.org/10.1371/journal.pone.0114970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500578	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700077
J	Liscovitch, N; French, L				Liscovitch, Noa; French, Leon			Differential Co-Expression between alpha-Synuclein and IFN-gamma Signaling Genes across Development and in Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERFERON-GAMMA; HUMAN BRAIN; EXPRESSION; IDENTIFICATION; METAANALYSIS; ASSOCIATION; INVOLVEMENT; ACTIVATION; MUTATION	Expression patterns of the alpha-synuclein gene (SNCA) were studied across anatomy, development, and disease to better characterize its role in the brain. In this postmortem study, negative spatial co-expression between SNCA and 73 interferon-gamma (IFN-gamma) signaling genes was observed across many brain regions. Recent animal studies have demonstrated that IFN-gamma induces loss of dopamine neurons and nigrostriatal degeneration. This opposing pattern between SNCA and IFN-gamma signaling genes increases with age (rho=-0.78). In contrast, a meta-analysis of four microarray experiments representing 126 substantia nigra samples reveals a switch to positive co-expression in Parkinson's disease (p<0.005). Use of genome-wide testing demonstrates this relationship is specific to SNCA (p<0.002). This change in co-expression suggests an immunomodulatory role of SNCA that may provide insight into neurodegeneration. Genes showing similar co-expression patterns have been previously linked to Alzheimer's (ANK1) and Parkinson's disease (UBE2E2, PCMT1, HPRT1 and RIT2).	[Liscovitch, Noa] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [French, Leon] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada	Bar Ilan University; University of Toronto; University Toronto Affiliates; Baycrest	French, L (corresponding author), Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada.	leonfrench@gmail.com			National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	A National Sciences and Engineering Research Council of Canada Postdoctoral fellowship award supports LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, MOVEMENT DISORD, V27, P1104, DOI 10.1002/mds.25035; Attia N, 2007, MOL CELL BIOL, V27, P6093, DOI 10.1128/MCB.00789-07; Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Austin SA, 2011, NEUROCHEM RES, V36, P994, DOI 10.1007/s11064-011-0439-9; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; BAUMEISTER AA, 1985, NEUROSCI BIOBEHAV R, V9, P169, DOI 10.1016/0149-7634(85)90043-0; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chen J, 2015, NEUROBIOL AGING, V36, P394, DOI 10.1016/j.neurobiolaging.2014.08.015; Christopher L, 2014, BRAIN, V137, P2143, DOI 10.1093/brain/awu084; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dinh K, 2009, CYTOKINE, V45, P179, DOI 10.1016/j.cyto.2008.12.004; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Greene JG, 2012, NEUROBIOL DIS, V45, P76, DOI 10.1016/j.nbd.2010.10.022; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Jinnah HA, 2010, BRAIN, V133, P671, DOI 10.1093/brain/awq013; Kalaitzakis ME, 2009, NEUROSCI LETT, V461, P12, DOI 10.1016/j.neulet.2009.05.083; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Keller MF, 2012, HUM MOL GENET, V21, P4996, DOI 10.1093/hmg/dds335; Kim J-H, 2014, EXP NEUROBIOL, V23, P148, DOI DOI 10.5607/EN.2014.23.2.148; Kim SH, 2004, PARKINSONISM RELAT D, V10, pS9, DOI 10.1016/j.parkreldis.2003.11.005; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Markopoulou K, 2014, PARKINSONISM RELAT D, V20, P584, DOI 10.1016/j.parkreldis.2014.02.021; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin ED, 2004, EUR J NEUROSCI, V20, P3085, DOI 10.1111/j.1460-9568.2004.03801.x; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ouazia D, 2014, NEUROSCIENCE, V267, P263, DOI 10.1016/j.neuroscience.2014.03.001; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Ramsey CP, 2010, J NEUROCHEM, V113, P402, DOI 10.1111/j.1471-4159.2010.06605.x; Ritter M, 2005, CYTOKINE, V30, P177, DOI 10.1016/j.cyto.2004.12.013; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Tebow G, 2008, PEDIATRICS, V121, pE1563, DOI 10.1542/peds.2007-2795; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	49	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115029	10.1371/journal.pone.0115029	http://dx.doi.org/10.1371/journal.pone.0115029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493648	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400089
J	Rao, YH; Hao, R; Wang, B; Yao, TP				Rao, Yanhua; Hao, Rui; Wang, Bin; Yao, Tso-Pang			A Mec17-Myosin II Effector Axis Coordinates Microtubule Acetylation and Actin Dynamics to Control Primary Cilium Biogenesis	PLOS ONE			English	Article							ALPHA-TUBULIN ACETYLTRANSFERASE; BARDET-BIEDL-SYNDROME; MYOSIN-II; HEAVY-CHAIN; CILIOGENESIS; TRAFFICKING; MEMBRANE; CELL; PHOSPHORYLATION; MECHANISMS	Primary cilia are specialized, acetylated microtubule-based signaling processes. Cilium assembly is activated by cellular quiescence and requires reconfiguration of microtubules, the actin cytoskeleton, and vesicular trafficking machinery. How these components are coordinated to activate ciliogenesis remains unknown. Here we identify the microtubule acetyltransferase Mec-17 and myosin II motors as the key effectors in primary cilium biogenesis. We found that myosin IIB (Myh10) is required for cilium formation; however, myosin IIA (Myh9) suppresses it. Myh10 binds and antagonizes Myh9 to increase actin dynamics, which facilitates the assembly of the pericentrosomal preciliary complex (PPC) that supplies materials for cilium growth. Importantly, Myh10 expression is upregulated by serum-starvation and this induction requires Mec-17, which is itself accumulated upon cellular quiescence. Pharmacological stimulation of microtubule acetylation also induces Myh10 expression and cilium formation. Thus cellular quiescence induces Mec17 to couple the production of acetylated microtubules and Myh10, whose accumulation overcomes the inhibitory role of Myh9 and initiates ciliogenesis.	[Rao, Yanhua; Hao, Rui; Wang, Bin; Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	tsopang.yao@duke.edu			National Institutes of Health [2R01-NS054022]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by 2R01-NS054022 (National Institutes of Health) to T.-P.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	30	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114087	10.1371/journal.pone.0114087	http://dx.doi.org/10.1371/journal.pone.0114087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494100	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400029
J	Qian, Y; van Meel, E; Flanagan-Steet, H; Yox, A; Steet, R; Kornfeld, S				Qian, Yi; van Meel, Eline; Flanagan-Steet, Heather; Yox, Alex; Steet, Richard; Kornfeld, Stuart			Analysis of Mucolipidosis II/III GNPTAB Missense Mutations Identifies Domains of UDP-GlcNAc: lysosomal Enzyme GlcNAc-1-phosphotransferase Involved in Catalytic Function and Lysosomal Enzyme Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Genetic Disease; Golgi; Lysosomal Storage Disease; Zebrafish; GlcNAc-1-phosphotransferase; Notch Domains; Mannose 6-phosphate; Mucolipidosis II; Mucolipidosis III	PSEUDO-HURLER POLYDYSTROPHY; III ALPHA/BETA; N-ACETYLGLUCOSAMINE; MOLECULAR ANALYSIS; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE; SUBUNIT; GENE; SEROGROUP; PHENOTYPE	Background: Mutations in GNPTAB cause the lysosomal disorders mucolipidosis II and III . Results: All reported missense mutations were studied and showed various consequences on its gene product, GlcNAc-1-phosphotransferase. Conclusion: Domains responsible for catalytic activity and lysosomal hydrolase recognition were identified. Significance: Analysis of patient mutations provided new insight into the functional domains of GlcNAc-1-phosphotransferase. UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system. GNPTAB encodes the and subunits of GlcNAc-1-phosphotransferase, and mutations in this gene cause the lysosomal storage disorders mucolipidosis II and III . Prior investigation of missense mutations in GNPTAB uncovered amino acids in the N-terminal region and within the DMAP domain involved in Golgi retention of GlcNAc-1-phosphotransferase and its ability to specifically recognize lysosomal hydrolases, respectively. Here, we undertook a comprehensive analysis of the remaining missense mutations in GNPTAB reported in mucolipidosis II and III patients using cell- and zebrafish-based approaches. We show that the Stealth domain harbors the catalytic site, as some mutations in these regions greatly impaired the activity of the enzyme without affecting its Golgi localization and proteolytic processing. We also demonstrate a role for the Notch repeat 1 in lysosomal hydrolase recognition, as missense mutations in conserved cysteine residues in this domain do not affect the catalytic activity but impair mannose phosphorylation of certain lysosomal hydrolases. Rescue experiments using mRNA bearing Notch repeat 1 mutations in GNPTAB-deficient zebrafish revealed selective effects on hydrolase recognition that differ from the DMAP mutation. Finally, the mutant R587P, located in the spacer between Notch 2 and DMAP, was partially rescued by overexpression of the subunit, suggesting a role for this region in subunit binding. These studies provide new insight into the functions of the different domains of the and subunits.	[Qian, Yi; van Meel, Eline; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Flanagan-Steet, Heather; Yox, Alex; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Washington University (WUSTL); University System of Georgia; University of Georgia	Steet, R (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu			National Institutes of Health [CA-008759, GM-086524-7]; Yash Gandhi Foundation; National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-008759 (to S. K.) and GM-086524-7 (to R. S.). This work was also supported by grants from the Yash Gandhi Foundation (to S. K. and R. S.) and the National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders (to H. F.-S.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; Braulke T., 2013, I CELL DIS PSEUDO HU; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Cobos PN, 2015, JIMD REP, V15, P123, DOI 10.1007/8904_2014_308; Coutinho MF, 2012, AM J MED GENET A, V158A, P1225, DOI 10.1002/ajmg.a.35295; Cury GK, 2013, GENE, V524, P59, DOI 10.1016/j.gene.2013.03.105; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Encarnacao M, 2009, CLIN GENET, V76, P76, DOI 10.1111/j.1399-0004.2009.01185.x; Fernandez-Marmiesse A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-59; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lam CW, 2007, CLIN CHIM ACTA, V376, P250, DOI 10.1016/j.cca.2006.09.004; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Petrey AC, 2012, DIS MODEL MECH, V5, P177, DOI 10.1242/dmm.008219; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Tappino B, 2009, HUM MUTAT, V30, pE956, DOI 10.1002/humu.21099; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; van Meel E, 2014, P NATL ACAD SCI USA, V111, P3532, DOI 10.1073/pnas.1401417111; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Zarghooni M, 2009, AM J MED GENET A, V149A, P2753, DOI 10.1002/ajmg.a.33134	35	37	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3045	3056		10.1074/jbc.M114.612507	http://dx.doi.org/10.1074/jbc.M114.612507			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505245	Green Published, hybrid			2022-12-26	WOS:000349310700041
J	Barra, NG; Palanivel, R; Denou, E; Chew, MV; Gillgrass, A; Walker, TD; Kong, J; Richards, CD; Jordana, M; Collins, SM; Trigatti, BL; Holloway, AC; Raha, S; Steinberg, GR; Ashkar, AA				Barra, Nicole G.; Palanivel, Rengasamy; Denou, Emmanuel; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Collins, Stephen M.; Trigatti, Bernardo L.; Holloway, Alison C.; Raha, Sandeep; Steinberg, Gregory R.; Ashkar, Ali A.			Interleukin-15 Modulates Adipose Tissue by Altering Mitochondrial Mass and Activity	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSGENIC MICE; NATURAL-KILLER; GUT MICROBIOTA; INTESTINAL MICROBIOTA; NUTRIENT ABSORPTION; INSULIN SENSITIVITY; LIPID OXIDATION; T-CELLS; OBESITY	Interleukin-15 (IL-15) is an immunomodulatory cytokine that affects body mass regulation independent of lymphocytes; however, the underlying mechanism(s) involved remains unknown. In an effort to investigate these mechanisms, we performed metabolic cage studies, assessed intestinal bacterial diversity and macronutrient absorption, and examined adipose mitochondrial activity in cultured adipocytes and in lean IL-15 transgenic (IL-15tg), overweight IL-15 deficient (IL-15-/-), and control C57Bl/6 (B6) mice. Here we show that differences in body weight are not the result of differential activity level, food intake, or respiratory exchange ratio. Although intestinal microbiota differences between obese and lean individuals are known to impact macronutrient absorption, differing gut bacteria profiles in these murine strains does not translate to differences in body weight in colonized germ free animals and macronutrient absorption. Due to its contribution to body weight variation, we examined mitochondrial factors and found that IL-15 treatment in cultured adipocytes resulted in increased mitochondrial membrane potential and decreased lipid deposition. Lastly, IL-15tg mice have significantly elevated mitochondrial activity and mass in adipose tissue compared to B6 and IL15-/- mice. Altogether, these results suggest that IL-15 is involved in adipose tissue regulation and linked to altered mitochondrial function.	[Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Ashkar, Ali A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Ashkar, Ali A.] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Ashkar, Ali A.] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada; [Palanivel, Rengasamy; Denou, Emmanuel; Collins, Stephen M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Palanivel, Rengasamy; Denou, Emmanuel; Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Hamilton, ON, Canada; [Denou, Emmanuel; Collins, Stephen M.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Trigatti, Bernardo L.] McMaster Univ, Atherothrombosis Res Grp, Hamilton, ON, Canada; [Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Raha, Sandeep] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Ashkar, AA (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	ashkara@mcmaster.ca	RENGASAMY, PALANIVEL/GMW-4099-2022; Raha, Sandeep/AAF-3655-2020; Barra, Nicole/ABG-2670-2021	Raha, Sandeep/0000-0001-7307-3292; Barra, Nicole/0000-0002-2605-0845; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X; Richards, Carl/0000-0002-0081-2231; Steinberg, Gregory/0000-0001-5425-8275; Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Almendro V, 2006, BBA-MOL CELL BIOL L, V1761, P37, DOI 10.1016/j.bbalip.2005.12.006; Almendro V, 2008, OBESITY, V16, P285, DOI 10.1038/oby.2007.47; Almendro V, 2009, INT J MOL MED, V24, P453, DOI 10.3892/ijmm_00000252; Alvarez B, 2002, BBA-GEN SUBJECTS, V1570, P33, DOI 10.1016/S0304-4165(02)00148-4; Amengual-Cladera E, 2012, BR J NUTR, P1; Barra NG, 2012, DIABETES OBES METAB, V14, P190, DOI 10.1111/j.1463-1326.2011.01495.x; Barra NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039553; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bruin JE, 2010, ENDOCRINE, V37, P303, DOI 10.1007/s12020-009-9294-8; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Camacho A, 2012, EXP NEUROL, V237, P396, DOI 10.1016/j.expneurol.2012.06.031; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Daniels J, 2006, AM J NURS, V106, P40, DOI 10.1097/00000446-200601000-00028; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kanegane H, 1996, BLOOD, V88, P230; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Kuo JJ, 2012, INT J MOL MED, V30, P673, DOI 10.3892/ijmm.2012.1049; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Pistilli EE, 2013, CYTOKINE, V61, P41, DOI 10.1016/j.cyto.2012.09.025; Pistilli EE, 2011, J CLIN INVEST, V121, P3120, DOI 10.1172/JCI44945; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Quinn LS, 2013, ENDOCRINOLOGY, V154, P232, DOI 10.1210/en.2012-1773; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; QUINN LS, 1995, ENDOCRINOLOGY, V136, P3669, DOI 10.1210/en.136.8.3669; Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Yang CJ, 2012, BIOSCIENCE REP, V32, P465, DOI 10.1042/BSR20120034; Yang HT, 2013, ENDOCRINE, V43, P579, DOI 10.1007/s12020-012-9809-6; Yokoyama S, 2011, J CLIN IMMUNOL, V31, P1038, DOI 10.1007/s10875-011-9586-7; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106	64	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114799	10.1371/journal.pone.0114799	http://dx.doi.org/10.1371/journal.pone.0114799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517731	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600027
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A Small Short-Necked Hupehsuchian from the Lower Triassic of Hubei Province, China	PLOS ONE			English	Article								Hupehsuchia is a group of enigmatic Triassic marine reptiles that is known exclusively from two counties in Hubei Province, China. One of the common features of the group was a modestly long neck with nine to ten cervical vertebrae. We report a new species of Hupehsuchia, Eohupehsuchus brevicollis gen. et sp. nov., which for the first time shows a short neck in this group, with six cervicals. The configuration of the skull roof in Eohupehsuchus is also unique among Hupehsuchia, with narrow frontals and posteriorly shifted parietals, warranting recognition of a new species. The taxon superficially resembles Nanchangosaurus in retaining hupehsuchian plesiomorphies, such as low neural spines and small body size. However, its limbs are well-developed, unlike in Nanchangosaurus, although the latter genus is marginally larger in body length. Thus, the individual is unlikely to be immature. Also, Eohupehsuchus shares a suite of synapomorphies with Hupehsuchus, including the second and third layers of dermal ossicles above the dorsal neural spines. A phylogenetic analysis suggests that the new species is not the most basal hupehsuchian despite its short neck, and instead forms the sister taxon of Hupehsuchidae. Until recently, Hupehsuchia contained only two monotypic genera. Now there are at least four genera among Hupehsuchia, and the undescribed diversity is even higher. The left forelimb of the only specimen is incomplete, ending with broken phalanges distally. The breakage could only have occurred pre-burial. The individual may have been attacked by a predator and escaped, given that scavenging is unlikely.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan 430023, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Lab Orogen Belt & Crustal Evolut, MOE, Dept Geol, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL 60605 USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey Project [1212010611603]; China Geological Survey Projects [1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey Project(China Geological Survey); China Geological Survey Projects(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; GOLOBOFF P, 2000, TNT TREE ANAL USING; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; Motani R, NATURE IN PRESS; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C. c., 1965, Vertebrata Palasiatica, V9, P315; Young CC, 1972, AQUATIC REPTILES TRI, P17; Young CC, 1972, AQUATIC REPTILES TRI, P28	17	13	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115244	10.1371/journal.pone.0115244	http://dx.doi.org/10.1371/journal.pone.0115244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517113	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600056
J	Lounes, N; Cherfa, MA; Le Carrou, G; Bouyoucef, A; Jay, M; Garin-Bastuji, B; Mick, V				Lounes, Nedjma; Cherfa, Moulay-Ali; Le Carrou, Gilles; Bouyoucef, Abdellah; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie			Human Brucellosis in Maghreb: Existence of a Lineage Related to Socio-Historical Connections with Europe	PLOS ONE			English	Article							NORTH-AFRICA; MELITENSIS; PREVALENCE; LOCI; EAST; SPP.; PCR	Despite control/eradication programs, brucellosis, major worldwide zoonosis due to the Brucella genus, is endemic in Northern Africa and remains a major public health problem in the Maghreb region (Algeria/Morocco/Tunisia). Brucella melitensis biovar 3 is mostly involved in human infections and infects mainly small ruminants. Human and animal brucellosis occurrence in the Maghreb seems still underestimated and its epidemiological situation remains hazy. This study summarizes official data, regarding Brucella melitensis infections in Algeria, from 1989 to 2012, with the purpose to provide appropriate insights concerning the epidemiological situation of human and small ruminant brucellosis in Maghreb. Algeria and Europe are closely linked for historical and economical reasons. These historical connections raise the question of their possible impact on the genetic variability of Brucella strains circulating in the Maghreb. Other purpose of this study was to assess the genetic diversity among Maghreb B. melitensis biovar 3 strains, and to investigate their possible epidemiological relationship with European strains, especially with French strains. A total of 90 B. melitensis biovar 3 Maghreb strains isolated over a 25 year-period (1989-2014), mainly from humans, were analysed by MLVA-16. The obtained results were compared with genotypes of European B. melitensis biovar 3 strains. Molecular assays showed that Algerian strains were mainly distributed into two distinct clusters, one Algerian cluster related to European sub-cluster. These results led to suggest the existence of a lineage resulting from socio-historical connections between Algeria and Europe that might have evolved distinctly from the Maghreb autochthonous group. This study provides insights regarding the epidemiological situation of human brucellosis in the Maghreb and is the first molecular investigation regarding B. melitensis biovar 3 strains circulating in the Maghreb.	[Cherfa, Moulay-Ali; Le Carrou, Gilles; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie] Paris Est Univ Anses, EU OIE FAO, Maisons Alfort, France; [Cherfa, Moulay-Ali; Le Carrou, Gilles; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie] Paris Est Univ Anses, Natl Reference Lab Brucellosis, Maisons Alfort, France; [Lounes, Nedjma] Higher Natl Vet Sch ENSV, Algiers, Algeria; [Bouyoucef, Abdellah] Saad Dahleb Univ, Inst Vet Sci, Blida, Algeria	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Saad Dahlab de Blida	Mick, V (corresponding author), Paris Est Univ Anses, EU OIE FAO, Maisons Alfort, France.	virginie.mick@anses.fr	Lounes, Nedjma/AAX-2653-2021	Jay, Maryne/0000-0003-0443-5565; Garin-Bastuji, Bruno/0000-0002-4486-1182				Aggad H., 2006, Eastern Mediterranean Health Journal, V12, P119; Akakpo A., 2009, C OIE, P71; Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Al-Anazi K.A., 2013, BACTERIAL MYCOTIC IN; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; [Anonymous], 2005, JOINT WHO DFID AHP M; BENAISSA R, 1984, DEV BIOL STAND, V56, P727; Benhabyles N, 1992, CIHEAM PUBLICATION, V1; Benkirane A, 2006, SMALL RUMINANT RES, V62, P19, DOI 10.1016/j.smallrumres.2005.07.032; Benkirane A, 2001, REV SCI TECH OIE, V20, P757, DOI 10.20506/rst.20.3.1314; Boudilmi B, 1990, BRUC M GHARD ALG NOV; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Bouzouaia N, 1995, Tunis Med, V73, P443; Calvez D, 2001, 10 INT S VET LAB DIA; Cherif A, 1986, Arch Inst Pasteur Alger, V55, P9; El Hicheri K, 1992, CIHEAM PUBLICATION, V1; El Idrissi AH, 1996, BRUCELLOSE PETITS RU; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Garin-Bastuji B, 2014, EMERG INFECT DIS, V20, P1570, DOI 10.3201/eid2009.131517; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Garofolo G, 2013, J MICROBIOL METH, V92, P103, DOI 10.1016/j.mimet.2012.11.007; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Jiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076332; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lounes N, 2009, RECUEIL ATELIERS EPI, V1, P5; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Nicoletti P, 1982, DIAGNOSTIC VACCINATI, V38; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Verger JM, 1988, TECHNIQUES BRUCELLOS; WHO, 2006, CONTR NEGL ZOON DIS; World Organisation for Animal Health, HAND; Zribi M, 2009, PATHOL BIOL, V57, P349, DOI 10.1016/j.patbio.2008.02.003	40	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115319	10.1371/journal.pone.0115319	http://dx.doi.org/10.1371/journal.pone.0115319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517901	gold, Green Published, Green Submitted			2022-12-26	WOS:000347215600060
J	Asmyhr, MG; Linke, S; Hose, G; Nipperess, DA				Asmyhr, Maria G.; Linke, Simon; Hose, Grant; Nipperess, David A.			Systematic Conservation Planning for Groundwater Ecosystems Using Phylogenetic Diversity	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; RESERVE SELECTION; WATER; DNA; FAUNA; SCALE; MODEL	Aquifer ecosystems provide a range of important services including clean drinking water. These ecosystems, which are largely inaccessible to humans, comprise a distinct invertebrate fauna (stygofauna), which is characterized by narrow distributions, high levels of endemism and cryptic species. Although being under enormous anthropogenic pressure, aquifers have rarely been included in conservation planning because of the general lack of knowledge of species diversity and distribution. Here we use molecular sequence data and phylogenetic diversity as surrogates for stygofauna diversity in aquifers of New South Wales, Australia. We demonstrate how to incorporate these data as conservation features in the systematic conservation planning software Marxan. We designated each branch of the phylogenetic tree as a conservation feature, with the branch length as a surrogate for the number of distinct characters represented by each branch. Two molecular markers (nuclear 18S ribosomal DNA and mitochondrial cytochrome oxidase subunit I) were used to evaluate how marker variability and the resulting tree topology affected the site-selection process. We found that the sites containing the deepest phylogenetic branches were deemed the most irreplaceable by Marxan. By integrating phylogenetic data, we provide a method for including taxonomically undescribed groundwater fauna in systematic conservation planning.	[Asmyhr, Maria G.; Hose, Grant; Nipperess, David A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Linke, Simon] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia	Macquarie University; Griffith University	Nipperess, DA (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	david.nipperess@mq.edu.au	Nipperess, David/H-2707-2019	Hose, Grant/0000-0003-2106-5543; Linke, Simon/0000-0002-1797-3947	Australian Research Council [DP1095200, DE130100565]; Department of Biological Sciences, Macquarie University; Gosford City Council; Linnean Society of New South Wales	Australian Research Council(Australian Research Council); Department of Biological Sciences, Macquarie University(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gosford City Council; Linnean Society of New South Wales	This work was supported by the Australian Research Council (DP1095200 and DE130100565; http://www.arc.gov.au/); the Department of Biological Sciences, Macquarie University (http://www.bio.mq.edu.au/); Gosford City Council (http://www.gosford.nsw.gov.au/) and the Linnean Society of New South Wales (http://linneansocietynsw.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmyhr MG, 2012, INVERTEBR SYST, V26, P583, DOI 10.1071/IS12032; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Billionnet A, 2013, SYST BIOL, V62, P147, DOI 10.1093/sysbio/sys081; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Boulton AJ, 2009, AQUAT CONSERV, V19, P731, DOI 10.1002/aqc.1073; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Davies TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1096, DOI 10.1111/j.1466-8238.2012.00759.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eamus D, 2006, AUST J BOT, V54, P97, DOI 10.1071/BT05031; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Faith Daniel P., 2008, P99; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Diniz JAF, 2012, CONSERV GENET, V13, P1085, DOI 10.1007/s10592-012-0356-8; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Ferreira D, 2007, BIODIVERS CONSERV, V16, P567, DOI 10.1007/s10531-005-0305-7; Game ET, 2008, MARXAN USER MANUAL M; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Guzik MT, 2010, INVERTEBR SYST, V24, P407, DOI 10.1071/IS10038; Hahn HJ, 2006, LIMNOLOGICA, V36, P119, DOI 10.1016/j.limno.2006.02.001; Hancock PJ, 2009, FRESHWATER BIOL, V54, P902, DOI 10.1111/j.1365-2427.2007.01878.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hermoso V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059662; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; Humphreys WF, 2006, AUST J BOT, V54, P115, DOI 10.1071/BT04151; Januchowski-Hartley SR, 2011, BIOL CONSERV, V144, P2499, DOI 10.1016/j.biocon.2011.07.004; Karanovic T, 2013, INVERTEBR SYST, V27, P540, DOI 10.1071/IS12084; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; Michel G, 2009, FRESHWATER BIOL, V54, P861, DOI 10.1111/j.1365-2427.2009.02192.x; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Morris BL, 2003, GROUNDWATER ITS SUSC; Nipperess DA, 2013, METHODS ECOL EVOL, V4, P566, DOI 10.1111/2041-210X.12042; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; REBELO AG, 1992, CONSERV BIOL, V6, P243, DOI 10.1046/j.1523-1739.1992.620243.x; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Segan DB, 2010, BIOL CONSERV, V143, P2, DOI 10.1016/j.biocon.2009.09.014; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Stoch F, 2009, FRESHWATER BIOL, V54, P745, DOI 10.1111/j.1365-2427.2008.02143.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Grelle CEV, 2010, NAT CONSERVACAO, V8, P46, DOI 10.4322/natcon.00801007; Walker PA, 1995, BIODIVERSITY LETT, V2, P132	54	29	32	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115132	10.1371/journal.pone.0115132	http://dx.doi.org/10.1371/journal.pone.0115132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514422	gold, Green Submitted, Green Published			2022-12-26	WOS:000349146300035
J	Bardine, N; Lamers, G; Wacker, S; Donow, C; Knoechel, W; Durston, A				Bardine, Nabila; Lamers, Gerda; Wacker, Stephan; Donow, Cornelia; Knoechel, Walter; Durston, Antony			Vertical Signalling Involves Transmission of Hox Information from Gastrula Mesoderm to Neurectoderm	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL INDUCTION; XENOPUS EMBRYOS; ENGRAILED HOMEOPROTEIN; ANTEROPOSTERIOR AXIS; OTX2 HOMEOPROTEIN; SPEMANN ORGANIZER; RETINAL AXONS; PLANAR; EXPRESSION	Development and patterning of neural tissue in the vertebrate embryo involves a set of molecules and processes whose relationships are not fully understood. Classical embryology revealed a remarkable phenomenon known as vertical signalling, a gastrulation stage mechanism that copies anterior-posterior positional information from mesoderm to prospective neural tissue. Vertical signalling mediates unambiguous copying of complex information from one tissue layer to another. In this study, we report an investigation of this process in recombinates of mesoderm and ectoderm from gastrulae of Xenopus laevis. Our results show that copying of positional information involves non cell autonomous autoregulation of particular Hox genes whose expression is copied from mesoderm to neurectoderm in the gastrula. Furthermore, this information sharing mechanism involves unconventional translocation of the homeoproteins themselves. This conserved primitive mechanism has been known for three decades but has only recently been put into any developmental context. It provides a simple, robust way to pattern the neurectoderm using the Hox pattern already present in the mesoderm during gastrulation. We suggest that this mechanism was selected during evolution to enable unambiguous copying of rather complex information from cell to cell and that it is a key part of the original ancestral mechanism mediating axial patterning by the highly conserved Hox genes.	[Bardine, Nabila; Lamers, Gerda; Durston, Antony] Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Wacker, Stephan; Donow, Cornelia; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89069 Ulm, Germany	Leiden University; Leiden University - Excl LUMC; Ulm University	Bardine, N (corresponding author), Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands.	bardine.nabila@gmail.com; A.J.Durston@gmail.com		Bardine, Nabila/0000-0002-4365-5336				ALTABA ARI, 1992, DEVELOPMENT, V116, P67; Bardine N, 2009, DEV DYNAM, V238, P755, DOI 10.1002/dvdy.21889; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chatelin J, 1996, MECH DEVELOP, V55, P111; Chen YL, 2000, MECH DEVELOP, V90, P53, DOI 10.1016/S0925-4773(99)00229-4; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Di Lullo E, 2011, DEVELOPMENT, V138, P4991, DOI 10.1242/dev.066282; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Fujii H, 2002, DEV BIOL, V252, P15, DOI 10.1006/dbio.2002.0843; Gavalas A, 2000, CURR OPIN GENET DEV, V10, P380, DOI 10.1016/S0959-437X(00)00100-3; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GRUNZ H, 1995, INT J DEV BIOL, V39, P539; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Jansen HJ, 2007, MECH DEVELOP, V124, P668, DOI 10.1016/j.mod.2007.07.004; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Joubin K, 2001, INT J DEV BIOL, V45, P165; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kolm PJ, 1997, COLD SPRING HARB SYM, V62, P511; Layalle S, 2011, DEVELOPMENT, V138, P2315, DOI 10.1242/dev.057059; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P83, DOI 10.1002/jez.1401200104; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Poznanski A, 1997, DEV BIOL, V184, P351, DOI 10.1006/dbio.1996.8500; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Spemann H., 1924, FDN EXPT EMBRYOLOGY, P144; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; VILASPASA FL, 2010, INT J DEV BIOL, V54, P599, DOI DOI 10.1387/IJDB.082705FL; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254	43	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115208	10.1371/journal.pone.0115208	http://dx.doi.org/10.1371/journal.pone.0115208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514127	gold, Green Published			2022-12-26	WOS:000349146300041
J	Chen, JY; Liu, ZJ; Hong, MM; Zhang, HZ; Chen, C; Xiao, MY; Wang, JX; Yao, F; Ba, MC; Liu, JH; Guo, ZK; Zhong, JX				Chen, Jianying; Liu, Zhenjun; Hong, Mian Ming; Zhang, Hongzhe; Chen, Can; Xiao, Mengyuan; Wang, Junxian; Yao, Feng; Ba, Mingchuan; Liu, Jinghu; Guo, Zi-Kuan; Zhong, Jixin			Proangiogenic Compositions of Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells	PLOS ONE			English	Article							IN-VITRO; MATRIX METALLOPROTEINASES; REPERFUSION INJURY; ANGIOGENESIS; ACTIVATION; MECHANISMS; EXOSOMES; THERAPY; BLOOD; VIVO	Introduction & Objective: Microvesicles (MVs) derived from mesenchymal stem cells (MSCs) have been shown to promote angiogenesis. This study was aimed to shed a light on the mechanisms by analyzing the angiogenesis-promoting compositions of MSC-MVs. Also we try to figure out the impact of hypoxia on angiogenesis. Methods: MVs were isolated from the culture supernatants of MSCs under hypoxia/normoxia and serum-deprivation condition. The morphological features of MVs were revealed by an electron microscope and the origin of the MVs was identified by a bead-bound assay. An antibody array was used to analyze the expression of angiogenic cytokines from MVs and the parent MSCs as well. The major candidate factors were screened and the results were validated by immune blotting. Results: MSC-MVs were around 80 nm in diameter. They expressed CD29, CD44, and CD73, but not CD31 and CD45. Antibody array showed that both MSCs and MVs expressed many angiogenesis-promoting biomolecules, including interleukin-6 (IL-6), basic fibroblast growth factors (bFGF), and recptor of urokinase-type plasminogen activator (UPAR). MSC-MVs contained angiogenin, vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1) and the receptor-2 for vascular endothelial growth factor at higher levels than the parent MSCs. Under hypoxic condition most cytokines were expressed in greater quantity than normoxic in MSCs while in MVs there was no significant difference between hypoxic and normoxic conditions except UPAR, Angiogenin, VEGF, IGF, Tie-2/TEK, and IL-6 which were higher in MVs under hypoxic conditions than those in normoxic condition. Conclusion: Upon serum-deprivation condition, MSCs could secrete MVs that contain a variety of factors contributing to their angiogenesis-promoting function. And among them, Angiogenin, VEGF, MCP-1, VEGF R2 might be of greater importance than the other cytokines. Also UPAR, Angiogenin, VEGF, IGF, Tie-2/TEK, IL-6 might be responsible for hypoxia-augmented proangiogenic effects of MVs.	[Chen, Jianying; Liu, Zhenjun; Hong, Mian Ming; Zhang, Hongzhe; Chen, Can; Xiao, Mengyuan; Wang, Junxian; Yao, Feng; Ba, Mingchuan; Liu, Jinghu; Zhong, Jixin] Affiliated Hosp, Guangdong Med Coll, Dept Internal Med, Div Cardiovasc Dis, Zhanjiang, Guangdong, Peoples R China; [Guo, Zi-Kuan] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China; [Zhong, Jixin] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA	Guangdong Medical University; Academy of Military Medical Sciences - China; University System of Maryland; University of Maryland Baltimore	Chen, JY (corresponding author), Affiliated Hosp, Guangdong Med Coll, Dept Internal Med, Div Cardiovasc Dis, Zhanjiang, Guangdong, Peoples R China.	jychen271@126.com; guozk@bmi.ac.cn	Zhong, Jixin/ABE-3768-2020	Zhong, Jixin/0000-0002-3534-7480; Liu, Jinghu/0000-0002-9798-1639	National Natural Science Foundation of China [81370242, 81101553]; Guangdong Natural Science Foundation [S2013010015005]; Science and Technology Planning Project of Guangdong [2009B030801378, 2012B031800224]; Science and Technology Innovation Fund of Guangdong Medical College [STIF201128]; Financial Foundation of Zhanjiang [(2011)79, (2010)174]; American Heart Association [13POST17210033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong; Science and Technology Innovation Fund of Guangdong Medical College; Financial Foundation of Zhanjiang; American Heart Association(American Heart Association)	This study was supported by grants from the National Natural Science Foundation of China (81370242 and 81101553), Guangdong Natural Science Foundation (S2013010015005), Science and Technology Planning Project of Guangdong (2009B030801378 and 2012B031800224), Science and Technology Innovation Fund of Guangdong Medical College (STIF201128), Financial Foundation of Zhanjiang [(2011)79 and (2010)174], and American Heart Association (13POST17210033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, 10.2217/RME.13.4]; Lau CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033037; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Richardson JD, 2013, STEM CELL REV REP, V9, P281, DOI 10.1007/s12015-012-9366-7; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Zhang HC, 2012, STEM CELLS DEV, V21, P3289, DOI 10.1089/scd.2012.0095	28	65	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115316	10.1371/journal.pone.0115316	http://dx.doi.org/10.1371/journal.pone.0115316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514634	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300052
J	Ji, R; Meng, LB; Jiang, X; Kumar, CVMN; Ding, JX; Li, QT; Lu, QX				Ji, Rui; Meng, Lingbin; Jiang, Xin; Kumar, Naresh C. V. M.; Ding, Jixiang; Li, Qiutang; Lu, Qingxian			TAM Receptors Support Neural Stem Cell Survival, Proliferation and Neuronal Differentiation	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TYROSINE KINASES; APOPTOTIC CELLS; NERVOUS-SYSTEM; TRK RECEPTORS; TYRO-3 FAMILY; NEUROTROPHINS; AXL; NGF; MER	Tyro3, Axl and Mertk (TAM) receptor tyrosine kinases play multiple functional roles by either providing intrinsic trophic support for cell growth or regulating the expression of target genes that are important in the homeostatic regulation of immune responses. TAM receptors have been shown to regulate adult hippocampal neurogenesis by negatively regulation of glial cell activation in central nervous system (CNS). In the present study, we further demonstrated that all three TAMreceptors were expressed by cultured primary neural stem cells (NSCs) and played a direct growth trophic role in NSCs proliferation, neuronal differentiation and survival. The cultured primary NSCs lacking TAM receptors exhibited slower growth, reduced proliferation and increased apoptosis as shown by decreased BrdU incorporation and increased TUNEL labeling, than those from the WT NSCs. In addition, the neuronal differentiation and maturation of themutant NSCs were impeded, as characterized by less neuronal differentiation (beta-tubulin III+) and neurite outgrowth than their WT counterparts. To elucidate the underlying mechanism that the TAM receptors play on the differentiating NSCs, we examined the expression profile of neurotrophins and their receptors by real-time qPCR on the total RNAs from hippocampus and primary NSCs; and found that the TKO NSC showed a significant reduction in the expression of both nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), but accompanied by compensational increases in the expression of the TrkA, TrkB, TrkC and p75 receptors. These results suggest that TAM receptors support NSCs survival, proliferation and differentiation by regulating expression of neurotrophins, especially the NGF.	[Ji, Rui; Kumar, Naresh C. V. M.; Li, Qiutang; Lu, Qingxian] Univ Louisville, Dept Ophthalmol & Visual Sci, Sch Med, Louisville, KY 40202 USA; [Ji, Rui; Meng, Lingbin; Lu, Qingxian] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Jiang, Xin] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130021, Peoples R China; [Ding, Jixiang] Univ Louisville, Sch Dent, Birth Defects Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville; Jilin University; University of Louisville	Lu, QX (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Sch Med, Louisville, KY 40202 USA.	q.lu@louisville.edu	Jiang, Xin/AHA-9454-2022	Jiang, Xin/0000-0002-4613-7438	National Institutes of Health, National Eye Institute [R01-EY018830]; NIH, National Eye Institute [R01-EY019891]; NATIONAL EYE INSTITUTE [R01EY018830, R01EY019891] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01-EY018830), National Eye Institute (http://www.nei.nih.gov/) to Q. Lu, and NIH (R01-EY019891), National Eye Institute (http://www.nei.nih.gov/) to Q. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BRADSHAW RA, 1993, TRENDS BIOCHEM SCI, V18, P48, DOI 10.1016/0968-0004(93)90052-O; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gely-Pernot A, 2012, STEM CELLS, V30, P719, DOI 10.1002/stem.1045; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Middleton G, 2001, DEVELOPMENT, V128, P447; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049	39	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115140	10.1371/journal.pone.0115140	http://dx.doi.org/10.1371/journal.pone.0115140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514676	gold, Green Published, Green Submitted			2022-12-26	WOS:000349146300037
J	Pope, L; Hanks, AS; Just, DR; Wansink, B				Pope, Lizzy; Hanks, Andrew S.; Just, David R.; Wansink, Brian			New Year's Res-Illusions: Food Shopping in the New Year Competes with Healthy Intentions	PLOS ONE			English	Article							HOUSEHOLD FOOD; WEIGHT; SUPERMARKET; PURCHASES; RECEIPTS; PATTERNS; ADULTS; FAT	Objective: How do the holidays - and the possible New Year's resolutions that follow - influence a household's purchase patterns of healthier foods versus less healthy foods? This has important implications for both holiday food shopping and post-holiday shopping. Methods: 207 households were recruited to participate in a randomized-controlled trial conducted at two regional-grocery chain locations in upstate New York. Item-level transaction records were tracked over a seven-month period (July 2010 to March 2011). The cooperating grocer's proprietary nutrient-rating system was used to designate "healthy,'' and "less healthy'' items. Calorie data were extracted from online nutritional databases. Expenditures and calories purchased for the holiday period (Thanksgiving-New Year's), and the post-holiday period (New Year's-March), were compared to baseline (July-Thanksgiving) amounts. Results: During the holiday season, household food expenditures increased 15% compared to baseline ($ 105.74 to $ 121.83; p<0.001), with 75% of additional expenditures accounted for by less-healthy items. Consistent with what one would expect from New Year's resolutions, sales of healthy foods increased 29.4% ($ 13.24/week) after the holiday season compared to baseline, and 18.9% ($ 9.26/week) compared to the holiday period. Unfortunately, sales of less-healthy foods remained at holiday levels ($ 72.85/week holiday period vs. $ 72.52/week post-holiday). Calories purchased each week increased 9.3% (450 calories per serving/week) after the New Year compared to the holiday period, and increased 20.2% (890 calories per serving/week) compared to baseline. Conclusions: Despite resolutions to eat more healthfully after New Year's, consumers may adjust to a new "status quo'' of increased less-healthy food purchasing during the holidays, and dubiously fulfill their New Year's resolutions by spending more on healthy foods. Encouraging consumers to substitute healthy items for less-healthy items may be one way for practitioners and public health officials to help consumers fulfill New Year's resolutions, and reverse holiday weight gain.	[Pope, Lizzy; Hanks, Andrew S.; Just, David R.; Wansink, Brian] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Food & Brand Lab, Ithaca, NY USA	Cornell University	Pope, L (corresponding author), Univ Vermont, Dept Nutr & Food Sci, Burlington, VT 05405 USA.	efpope@uvm.edu		Hanks, Andrew/0000-0003-0687-4772	National Institutes of Health (NIH) [1RC1HD063370-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063370] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully acknowledge financial support from the National Institutes of Health (NIH), grant 1RC1HD063370-01. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister R., 2011, WILLPOWER; Cook CM, 2012, AM J CLIN NUTR, V95, P726, DOI 10.3945/ajcn.111.023036; Cullen K, 2007, J AM DIET ASSOC, V107, P1747, DOI 10.1016/j.jada.2007.07.007; Ehrich KR, 2005, J MARKETING RES, V42, P266, DOI 10.1509/jmkr.2005.42.3.266; Fischer LM, 2011, AM J HLTH PROMOT, V26, pe55, DOI DOI 10.4278/AJHP.100709-QUAL-238; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; French SA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-37; French SA, 2008, J AM DIET ASSOC, V108, P2051, DOI 10.1016/j.jada.2008.09.001; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hull HR, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-29; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Khare A, 2009, J PUBLIC POLICY MARK, V28, P234, DOI 10.1509/jppm.28.2.234; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Ogden CL, 2004, MEAN BODY WEIGHT BOD; Rankin JW, 1998, J NUTR EDUC, V30, P81, DOI 10.1016/S0022-3182(98)70284-5; Ransley JK, 2001, PUBLIC HEALTH NUTR, V4, P1279, DOI 10.1079/PHN2001171; Reid R, 1999, J HUM NUTR DIET, V12, P513, DOI 10.1046/j.1365-277x.1999.00205.x; Rossner SM, 2011, OBESITY FACTS, V4, P3, DOI 10.1159/000324861; Spencer R.J., 2013, PUBLIC HEALTH NUTR, V17, P1; Stevenson J, 2013, EUROPEAN J CLIN NUTR; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2014, J MARKETING RES, V36, P380; Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605; Wilcox K, 2009, J CONSUM RES, V36, P380, DOI 10.1086/599219; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	29	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e110561	10.1371/journal.pone.0110561	http://dx.doi.org/10.1371/journal.pone.0110561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514158	Green Published, gold			2022-12-26	WOS:000349146300001
J	Abidin, NZ; Mamat, M; Dangerfield, B; Zulkepli, JH; Baten, MA; Wibowo, A				Abidin, Norhaslinda Zainal; Mamat, Mustafa; Dangerfield, Brian; Zulkepli, Jafri Haji; Baten, Md. Azizul; Wibowo, Antoni			Combating Obesity through Healthy Eating Behavior: A Call for System Dynamics Optimization	PLOS ONE			English	Article							PREVENTION; FOOD; CONSUMPTION; CHILDHOOD; DESIGN; DIET	Poor eating behavior has been identified as one of the core contributory factors of the childhood obesity epidemic. The consequences of obesity on numerous aspects of life are thoroughly explored in the existing literature. For instance, evidence shows that obesity is linked to incidences of diseases such as heart disease, type-2 diabetes, and some cancers, as well as psychosocial problems. To respond to the increasing trends in the UK, in 2008 the government set a target to reverse the prevalence of obesity (POB) back to 2000 levels by 2020. This paper will outline the application of system dynamics (SD) optimization to simulate the effect of changes in the eating behavior of British children (aged 2 to 15 years) on weight and obesity. This study also will identify how long it will take to achieve the government's target. This paper proposed a simulation model called Intervention Childhood Obesity Dynamics (ICOD) by focusing the interrelations between various strands of knowledge in one complex human weight regulation system. The model offers distinct insights into the dynamics by capturing the complex interdependencies from the causal loop and feedback structure, with the intention to better understand how eating behaviors influence children's weight, body mass index (BMI), and POB measurement. This study proposed a set of equations that are revised from the original (baseline) equations. The new functions are constructed using a RAMP function of linear decrement in portion size and number of meal variables from 2013 until 2020 in order to achieve the 2020 desired target. Findings from the optimization analysis revealed that the 2020 target won't be achieved until 2026 at the earliest, six years late. Thus, the model suggested that a longer period may be needed to significantly reduce obesity in this population.	[Abidin, Norhaslinda Zainal; Zulkepli, Jafri Haji; Baten, Md. Azizul; Wibowo, Antoni] Univ Utara Malaysia, Coll Arts & Sci, Sch Quantitat Sci, Sintok, Kedah, Malaysia; [Mamat, Mustafa] Univ Malaysia Terengganu, Fac Sci & Technol, Dept Math, Kuala Terengganu, Terengganu, Malaysia; [Dangerfield, Brian] Univ Bristol, Sch Econ Finance & Management, Dept Management, Bristol, Avon, England	Universiti Utara Malaysia; Universiti Malaysia Terengganu; University of Bristol	Abidin, NZ (corresponding author), Univ Utara Malaysia, Coll Arts & Sci, Sch Quantitat Sci, Sintok, Kedah, Malaysia.	nhaslinda@uum.edu.my	Mamat, Mustafa/AAF-7716-2019; Zulkepli, Jafri/AAY-2849-2020; Abidin, Norhaslinda Zainal/AAY-1335-2021	Baten, Md. Azizul/0000-0001-9786-6369; Dangerfield, Brian/0000-0003-2435-2169	Universiti Malaysia Terengganu (UMT) under the Fundamental Research Grant Scheme (FRGS) [59256]	Universiti Malaysia Terengganu (UMT) under the Fundamental Research Grant Scheme (FRGS)	The authors wish to thank Universiti Malaysia Terengganu (UMT) for the financial support in conducting the research, provided under the Fundamental Research Grant Scheme (FRGS) with grant number: 59256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid TK, 2003, MED SCI SPORT EXER, V35, P400, DOI 10.1249/01.MSS.0000053659.32126.2D; [Anonymous], 2013, OB OV; Bazin E, 2011, THESIS U SALFORD; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Campbell K, 2001, Obes Rev, V2, P149, DOI 10.1046/j.1467-789x.2001.00035.x; Coyle RG, 1985, SYST DYNAM REV, V1, P81, DOI 10.1002/sdr.4260010107; Dangerfield B, 1996, J OPER RES SOC, V47, P405, DOI 10.2307/3010583; Dangerfield BC, 2011, ONL P 29 INT SYST DY; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Duggan J, 2008, SYST DYNAM REV, V24, P97, DOI 10.1002/sdr.393; Forrester J.W., 1961, IND DYNAMICS; Forrester JW, 2007, SYST DYNAM REV, V23, P345, DOI 10.1002/sdr.382; HOMER J, 2004, DIABETES SYSTEM MODE; Homer J, 2006, ONL P 24 INT SYST DY; INFORMS Computing Society, 2013, NAT MATH PROGR; KELOHARJU R, 1989, J OPER RES SOC, V40, P221, DOI 10.1057/jors.1989.33; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lebcir M., 2006, HLTH CARE MANAGEMENT; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Meyers RA, 2009, ENCY COMPLEXITY SYST; Mohapatra PKJ, 1985, SYST DYNAM REV, V1, P63, DOI 10.1002/sdr.4260010106; Neumark-Sztainer D, 2003, PREV MED, V37, P41, DOI 10.1016/S0091-7435(03)00057-4; NHS, 2011, HLTH SURV ENGL 2009; NHS, 2011, STAT OB PHYS ACT DIE; Norhaslinda Zainal Abidin, 2012, THESIS U SALFORD; Northstone K, 2012, J EPIDEMIOL COMMUN H, V66, P624, DOI 10.1136/jech.2010.111955; Rennie KL, 2005, BEST PRACT RES CL EN, V19, P343, DOI 10.1016/j.beem.2005.04.003; Senge P.M., 1980, SYSTEM DYNAMICS TIMS, V14, P209; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Theodore RF, 2009, INTELLIGENCE, V37, P506, DOI 10.1016/j.intell.2009.07.001; Townshend JRP, 2000, J OPER RES SOC, V51, P812, DOI 10.2307/253962; VENSIM, 2010, VENT SYST; Wolstenholme EF, 1987, SYST DYNAM REV, V3, P102, DOI 10.1002/sdr.4260030203; Young LR, 2007, J PUBLIC HEALTH POL, V28, P238, DOI 10.1057/palgrave.jphp.3200127	40	22	22	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114135	10.1371/journal.pone.0114135	http://dx.doi.org/10.1371/journal.pone.0114135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25502170	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000346607100008
J	Boesjes, M; Bloks, VW; Hageman, J; Bos, T; van Dijk, TH; Havinga, R; Wolters, H; Jonker, JW; Kuipers, F; Groen, AK				Boesjes, Marije; Bloks, Vincent W.; Hageman, Jurre; Bos, Trijnie; van Dijk, Theo H.; Havinga, Rick; Wolters, Henk; Jonker, Johan W.; Kuipers, Folkert; Groen, Albert K.			Hepatic Farnesoid X-Receptor Isoforms alpha 2 and alpha 4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice	PLOS ONE			English	Article							TRANSINTESTINAL CHOLESTEROL EXCRETION; GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR; ADENOASSOCIATED VIRUS; ACID SYNTHESIS; FEEDBACK-REGULATION; DEFICIENT MICE; FXR; EXPRESSION; LIVER	The nuclear receptor FXR acts as an intracellular bile salt sensor that regulates synthesis and transport of bile salts within their enterohepatic circulation. In addition, FXR is involved in control of a variety of crucial metabolic pathways. Four FXR splice variants are known, i.e. FXR alpha 1-4. Although these isoforms show differences in spatial and temporal expression patterns as well as in transcriptional activity, the physiological relevance hereof has remained elusive. We have evaluated specific roles of hepatic FXR alpha 2 and FXR alpha 4 by stably expressing these isoforms using liver-specific self-complementary adeno-associated viral vectors in total body FXR knock-out mice. The hepatic gene expression profile of the FXR knock-out mice was largely normalized by both isoforms. Yet, differential effects were also apparent; FXR alpha 2 was more effective in reducing elevated HDL levels and transrepressed hepatic expression of Cyp8b1, the regulator of cholate synthesis. The latter coincided with a switch in hydrophobicity of the bile salt pool. Furthermore, FXR alpha 2-transduction caused an increased neutral sterol excretion compared to FXR alpha 4 without affecting intestinal cholesterol absorption. Our data show, for the first time, that hepatic FXR alpha 2 and FXR alpha 4 differentially modulate bile salt and lipoprotein metabolism in mice.	[Boesjes, Marije; Bloks, Vincent W.; Hageman, Jurre; Bos, Trijnie; van Dijk, Theo H.; Havinga, Rick; Wolters, Henk; Jonker, Johan W.; Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Boesjes, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	m.boesjes@umcg.nl	Jonker, Johan W./ABE-6853-2020; Bloks, Vincent Walter/A-7609-2012	Jonker, Johan W./0000-0002-3919-5437; Bloks, Vincent Walter/0000-0001-6493-7482; Kuipers, Folkert/0000-0003-2518-737X	Top Institute Pharma, The Netherlands [T2-110]	Top Institute Pharma, The Netherlands(Netherlands Government)	Supported within the framework of Top Institute Pharma, The Netherlands, project T2-110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; Anakk S, 2010, J CLIN INVEST; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottcher CFJ, 2011, ANAL CHIM ACTA, V1961, P203; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chen WL, 2003, GENE, V313, P71, DOI 10.1016/S0378-1119(03)00631-0; Claudel T, 2002, J CLIN INVEST, V109, P961; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gautier T, 2013, J LIPID RES; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Hoeke MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088011; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Kemper JK, 2011, BBA-MOL BASIS DIS, V1812, P842, DOI 10.1016/j.bbadis.2010.11.011; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kuipers F, 1996, HEPATOLOGY, V24, P241; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Martinez-Becerra P, 2012, PHARMACOL RES, V66, P419, DOI 10.1016/j.phrs.2012.07.005; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Montenegro-Miranda PS, 2011, HUM GENE THER, V22, P605, DOI 10.1089/hum.2010.222; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rosenzweig M, 2001, BLOOD, V97, P1951, DOI 10.1182/blood.V97.7.1951; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Seppen J, 2006, MOL THER, V13, P1085, DOI 10.1016/j.ymthe.2006.01.014; Sirvent A, 2004, FEBS LETT, V566, P173, DOI 10.1016/j.febslet.2004.04.026; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Stroeve JH, 2010, LAB INVEST; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vaquero J, 2013, BIOCHEM PHARMACOL, V86, P926, DOI 10.1016/j.bcp.2013.07.022; Vrins CLJ, 2010, WORLD J GASTROENTERO, V16, P5953, DOI 10.3748/wjg.v16.i47.5953; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Woollett LA, 2006, GUT, V55, P197, DOI 10.1136/gut.2005.069906; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006	56	20	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115028	10.1371/journal.pone.0115028	http://dx.doi.org/10.1371/journal.pone.0115028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506828	gold, Green Published, Green Submitted			2022-12-26	WOS:000346607100045
J	Du, JY; Reznikov, LR; Welsh, MJ				Du, Jianyang; Reznikov, Leah R.; Welsh, Michael J.			Expression and Activity of Acid-Sensing Ion Channels in the Mouse Anterior Pituitary	PLOS ONE			English	Article							RAT HIPPOCAMPAL-NEURONS; SENSORY NEURONS; NA+ CHANNEL; SYNAPTIC PLASTICITY; ACTIVATED CURRENTS; EVOKED CURRENTS; GATED CHANNELS; CELLS; H+; ISCHEMIA	Acid sensing ion channels (ASICs) are proton-gated cation channels that are expressed in the nervous system and play an important role in fear learning and memory. The function of ASICs in the pituitary, an endocrine gland that contributes to emotions, is unknown. We sought to investigate which ASIC subunits were present in the pituitary and found mRNA expression for all ASIC isoforms, including ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and ASIC4. We also observed acid-evoked ASIC-like currents in isolated anterior pituitary cells that were absent in mice lacking ASIC1a. The biophysical properties and the responses to PcTx1, amiloride, Ca2+ and Zn2+ suggested that ASIC currents were mediated predominantly by heteromultimeric channels that contained ASIC1a and ASIC2a or ASIC2b. ASIC currents were also sensitive to FMRFamide (Phe-Met-Arg-Phe amide), suggesting that FMRFamide-like compounds might endogenously regulate pituitary ASICs. To determine whether ASICs might regulate pituitary cell function, we applied low pH and found that it increased the intracellular Ca2+ concentration. These data suggest that ASIC channels are present and functionally active in anterior pituitary cells and may therefore influence their function.	[Du, Jianyang; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Du, Jianyang; Reznikov, Leah R.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Du, JY (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	jianyang-du@uiowa.edu	Reznikov, Leah R./J-4314-2019	Reznikov, Leah R./0000-0002-4074-9070; Welsh, Michael/0000-0002-1646-6206	Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119560] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Howard Hughes Medical Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CH, 2009, J PHYSIOL-LONDON, V587, P1727, DOI 10.1113/jphysiol.2008.166918; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Dhingra A, 2008, J COMP NEUROL, V510, P484, DOI 10.1002/cne.21807; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Graeff Frederico Guilherme, 2010, Psychol. Neurosci., V3, P3, DOI 10.3922/j.psns.2010.1.002; Grunder S, 2000, NEUROREPORT, V11, P1607; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jiang Q, 2010, NEUROSCIENCE, V169, P574, DOI 10.1016/j.neuroscience.2010.05.043; Jiang Q, 2009, NEUROSCIENCE, V162, P55, DOI 10.1016/j.neuroscience.2009.04.029; Li MH, 2014, J GEN PHYSIOL, V143, P719, DOI 10.1085/jgp.201310990; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Stojilkovic SS, 2010, ENDOCR REV, V31, P845, DOI 10.1210/er.2010-0005; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Ukena K, 2001, NEUROSCI LETT, V300, P153, DOI 10.1016/S0304-3940(01)01583-X; Van Goor F, 2001, MOL ENDOCRINOL, V15, P1222, DOI 10.1210/me.15.7.1222; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Weng XC, 2004, NEUROSCI RES, V50, P493, DOI 10.1016/j.neures.2004.09.001; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamazaki M, 2012, NEUROSCI LETT, V526, P29, DOI 10.1016/j.neulet.2012.07.063; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029; Zorec R, 1996, TRENDS ENDOCRIN MET, V7, P384, DOI 10.1016/S1043-2760(96)00169-5	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115310	10.1371/journal.pone.0115310	http://dx.doi.org/10.1371/journal.pone.0115310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506946	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100067
J	Guo, ZL; Zhang, H; Lin, SJ				Guo, Zhiling; Zhang, Huan; Lin, Senjie			Light-Promoted Rhodopsin Expression and Starvation Survival in the Marine Dinoflagellate Oxyrrhis marina	PLOS ONE			English	Article							PROTON PUMP; MICROBIAL RHODOPSINS; GRAZING RESPONSES; GENE SEQUENCE; IDENTIFICATION; BACTERIAL; PROTEIN; GROWTH; RNA; XANTHORHODOPSIN	The discovery of microbial rhodopsins in marine proteobacteria changed the dogma that photosynthesis is the only pathway to use the solar energy for biological utilization in the marine environment. Although homologs of these rhodopsins have been identified in dinoflagellates, the diversity of the encoding genes and their physiological roles remain unexplored. As an initial step toward addressing the gap, we conducted high-throughput transcriptome sequencing on Oxyrrhis marina to retrieve rhodopsin transcripts, rapid amplification of cDNA ends to isolate full-length cDNAs of dominant representatives, and quantitative reverse-transcription PCR to investigate their expression under varying conditions. Our phylogenetic analyses showed that O. marina contained both the proton-pumping type (PR) and sensory type (SR) rhodopsins, and the transcriptome data showed that the PR type dominated over the SR type. We compared rhodopsin gene expression for cultures kept under light: dark cycle and continuous darkness in a time course of 24 days without feeding. Although both types of rhodopsin were expressed under the two conditions, the expression levels of PR were much higher than SR, consistent with the transcriptomic data. Furthermore, relative to cultures kept in the dark, rhodopsin expression levels and cell survival rate were both higher in cultures grown in the light. This is the first report of light-dependent promotion of starvation survival and concomitant promotion of PR expression in a eukaryote. While direct evidence needs to come from functional test on rhodopsins in vitro or gene knockout/knockdown experiments, our results suggest that the proton-pumping rhodopsin might be responsible for the light-enhanced survival of O. marina, as previously demonstrated in bacteria.	[Guo, Zhiling; Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Guo, Zhiling] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao 266100, Shandong, Peoples R China; [Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China	University of Connecticut; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Ocean University of China; Xiamen University	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016; Guo, Zhiling/AAJ-6843-2020	Guo, Zhiling/0000-0001-9549-2164	National Science Foundation of the US grant [1212392]; National Science Foundation of China [41129001, 41176091, 41330959]; National Science of China overseas collaboration Fund [41129001]; Gordon and Betty Moore Foundation [2637]	National Science Foundation of the US grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science of China overseas collaboration Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by the National Science Foundation of the US grant 1212392 and National Science Foundation of China (41129001, 41176091, 41330959) (http://www.nsfc.gov.cn/), and National Science of China overseas collaboration Fund (41129001). Transcriptome sequencing was supported by the Gordon and Betty Moore Foundation through Grant #2637 to the National Center for Genome Resource (NCGR). Samples MMETSP0451 and MMETSP0452 were sequenced at NCGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Atamna-Ismaeel N, 2012, ENVIRON MICROBIOL, V14, P140, DOI 10.1111/j.1462-2920.2011.02554.x; Balashov SP, 2007, CELL MOL LIFE SCI, V64, P2323, DOI 10.1007/s00018-007-7167-y; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BARSANTI L, 1993, VISION RES, V33, P2043, DOI 10.1016/0042-6989(93)90002-E; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; CARON DA, 1993, MICROBIAL ECOL, V25, P93, DOI 10.1007/BF00182132; ENGLANDER JJ, 1977, NATURE, V265, P658, DOI 10.1038/265658a0; Feinstein TN, 2002, J PHYCOL, V38, P659, DOI 10.1046/j.1529-8817.2002.01175.x; Feng S, 2013, ISME J, V7, P2206, DOI 10.1038/ismej.2013.97; Finkel OM, 2013, ISME J, V7, P448, DOI 10.1038/ismej.2012.112; Frassanito AM, 2010, CELL MOL LIFE SCI, V67, P965, DOI 10.1007/s00018-009-0225-x; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Graul RC, 1997, PHARMACEUT RES, V14, P1533, DOI 10.1023/A:1012166015402; GUALTIERI P, 1992, BIOCHIM BIOPHYS ACTA, V1117, P55, DOI 10.1016/0304-4165(92)90162-N; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Zhiling, 2013, Microorganisms, V1, P33; Hartz AJ, 2011, J EUKARYOT MICROBIOL, V58, P171, DOI 10.1111/j.1550-7408.2011.00529.x; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Idnurm A, 2001, GENOME, V44, P167, DOI 10.1139/gen-44-2-167; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Jeong HJ, 2008, J EUKARYOT MICROBIOL, V55, P271, DOI 10.1111/j.1550-7408.2008.00336.x; Kikukawa T., 2012, MOL PHOTOCHEMISTRY V, P89; Kuo RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060826; Li AS, 2000, J PHYCOL, V36, P33, DOI 10.1046/j.1529-8817.2000.98076.x; Lin S, 2010, P 13 INT C HARMF ALG, P166; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lowe CD, 2011, J PLANKTON RES, V33, P555, DOI 10.1093/plankt/fbq110; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moreno-Paz M, 2006, ENVIRON MICROBIOL, V8, P1064, DOI 10.1111/j.1462-2920.2006.00998.x; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Ruiz-Gonzalez MX, 2004, J MOL EVOL, V58, P348, DOI 10.1007/s00239-003-2557-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Skovgaard A, 1996, MAR ECOL PROG SER, V143, P247, DOI 10.3354/meps143247; Slamovits CH, 2011, J PLANKTON RES, V33, P591, DOI 10.1093/plankt/fbq153; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMIOKA H, 1986, BIOCHEM BIOPH RES CO, V139, P389, DOI 10.1016/S0006-291X(86)80003-1; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036961; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-34; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021; Zhang H, 2013, PROTIST, V164, P510, DOI 10.1016/j.protis.2013.04.002	65	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114941	10.1371/journal.pone.0114941	http://dx.doi.org/10.1371/journal.pone.0114941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506945	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100035
J	Chiarella, E; Carra, G; Scicchitano, S; Codispoti, B; Mega, T; Lupia, M; Pelaggi, D; Marafioti, MG; Aloisio, A; Giordano, M; Nappo, G; Spoleti, CB; Grillone, T; Giovannone, ED; Spina, R; Bernaudo, F; Moore, MAS; Bond, HM; Mesuraca, M; Morrone, G				Chiarella, Emanuela; Carra, Giovanna; Scicchitano, Stefania; Codispoti, Bruna; Mega, Tiziana; Lupia, Michela; Pelaggi, Daniela; Marafioti, Maria G.; Aloisio, Annamaria; Giordano, Marco; Nappo, Giovanna; Spoleti, Cristina B.; Grillone, Teresa; Giovannone, Emilia D.; Spina, Raffaella; Bernaudo, Francesca; Moore, Malcolm A. S.; Bond, Heather M.; Mesuraca, Maria; Morrone, Giovanni			UMG Lenti: Novel Lentiviral Vectors for Efficient Transgene- and Reporter Gene Expression in Human Early Hematopoietic Progenitors	PLOS ONE			English	Article							HUMAN CD34(+) CELLS; FINGER PROTEIN 521; SELF-RENEWAL; STEM-CELLS; CONSTITUTIVE ACTIVATION; ENFORCED EXPRESSION; DIFFERENTIATION; PROMOTES; LEUKEMIA; PROLIFERATION	Lentiviral vectors are widely used to investigate the biological properties of regulatory proteins and/or of leukaemia-associated oncogenes by stably enforcing their expression in hematopoietic stem and progenitor cells. In these studies it is critical to be able to monitor and/or sort the infected cells, typically via fluorescent proteins encoded by the modified viral genome. The most popular strategy to ensure co-expression of transgene and reporter gene is to insert between these cDNAs an IRES element, thus generating bi-cistronic mRNAs whose transcription is driven by a single promoter. However, while the product of the gene located upstream of the IRES is generally abundantly expressed, the translation of the downstream cDNA (typically encoding the reporter protein) is often inconsistent, which hinders the detection and the isolation of transduced cells. To overcome these limitations, we developed novel lentiviral dual-promoter vectors (named UMG-LV5 and -LV6) where transgene expression is driven by the potent UBC promoter and that of the reporter protein, EGFP, by the minimal regulatory element of the WASP gene. These vectors, harboring two distinct transgenes, were tested in a variety of human haematopoietic cell lines as well as in primary human CD34(+) cells in comparison with the FUIGW vector that contains the expression cassette UBC-transgene-IRES-EGFP. In these experiments both UMG-LV5 and UMG-LV6 yielded moderately lower transgene expression than FUIGW, but dramatically higher levels of EGFP, thereby allowing the easy distinction between transduced and non-transduced cells. An additional construct was produced, in which the cDNA encoding the reporter protein is upstream, and the transgene downstream of the IRES sequence. This vector, named UMG-LV11, proved able to promote abundant expression of both transgene product and EGFP in all cells tested. The UMG-LVs represent therefore useful vectors for gene transfer-based studies in hematopoietic stem and progenitor cells, as well as in non-hematopoietic cells.	[Chiarella, Emanuela; Carra, Giovanna; Scicchitano, Stefania; Codispoti, Bruna; Mega, Tiziana; Lupia, Michela; Pelaggi, Daniela; Marafioti, Maria G.; Aloisio, Annamaria; Giordano, Marco; Nappo, Giovanna; Spoleti, Cristina B.; Grillone, Teresa; Spina, Raffaella; Bernaudo, Francesca; Bond, Heather M.; Mesuraca, Maria; Morrone, Giovanni] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, I-88100 Catanzaro, Italy; [Giovannone, Emilia D.] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Mol Oncol Lab, I-88100 Catanzaro, Italy; [Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, New York, NY 10065 USA	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Memorial Sloan Kettering Cancer Center	Mesuraca, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, I-88100 Catanzaro, Italy.	mes@unicz.it; morrone@unicz.it	Carrà, Giovanna/ABF-4205-2020; Chiarella, Emanuela/H-4665-2018; Scicchitano, Stefania/AAG-4643-2021; Giordano, Marco/AAO-6102-2020; Lupia, Michela/AAP-2653-2020; Morrone, Giovanni/A-7202-2008	Carrà, Giovanna/0000-0002-6263-6800; Chiarella, Emanuela/0000-0002-8314-715X; Giordano, Marco/0000-0001-6335-0030; Morrone, Giovanni/0000-0002-1978-340X; GIOVANNONE, EMILIA DORA/0000-0002-3549-1415; Bond, Heather Mandy/0000-0003-4033-2985; Codispoti, Bruna/0000-0001-8802-3546; MESURACA, Maria/0000-0002-5455-168X; Scicchitano, Stefania/0000-0002-3566-7214	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN); Associazione Italiana per la Ricerca sul Cancro (AIRC); Gar-Reichman Cancer Research Institute Fund; Rudin Foundation; AIRC post-doctoral fellowship; Molecular Oncology Programme; POR Calabria FSE [1007-2013]; Prometeo training fellowship [PON01_2834];  [PON01_2834 Prometeo];  [PON03PE_00009_2 ICaRe]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Gar-Reichman Cancer Research Institute Fund; Rudin Foundation; AIRC post-doctoral fellowship(Fondazione AIRC per la ricerca sul cancro); Molecular Oncology Programme; POR Calabria FSE(Regione Calabria); Prometeo training fellowship; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN) to GM and HMB; Associazione Italiana per la Ricerca sul Cancro (AIRC) to GM; PON01_2834 Prometeo to GM; PON03PE_00009_2 ICaRe to GM; Gar-Reichman Cancer Research Institute Fund and Rudin Foundation to MASM; AIRC post-doctoral fellowship to TM; PhD fellowships from the Molecular Oncology Programme to FB, BC, EC, ML, GN, RS and SS; POR Calabria FSE 1007-2013 "HEMMAS" post-doctoral fellowship to MG; PON01_2834 Prometeo training fellowship to MGM, AA, CBS and TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Chung KY, 2005, BLOOD, V105, P77, DOI 10.1182/blood-2003-12-4445; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Giordano V, 1997, J IMMUNOL, V158, P4097; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kiviranta R, 2013, J EXP MED, V210, P969, DOI 10.1084/jem.20121187; La Rocca R, 2009, J IMMUNOL, V182, P4529, DOI 10.4049/jimmunol.0802109; Leuci V, 2009, STEM CELLS, V27, P2815, DOI 10.1002/stem.224; Logan AC, 2002, CURR OPIN BIOTECH, V13, P429, DOI 10.1016/S0958-1669(02)00346-4; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Mesuraca M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/318793; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Petrella A, 1998, BLOOD, V91, P4554, DOI 10.1182/blood.V91.12.4554.412k26_4554_4560; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Scherr Michaela, 2002, Current Gene Therapy, V2, P45, DOI 10.2174/1566523023348237; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Spina R, 2013, ONCOTARGET, V4, P1280, DOI 10.18632/oncotarget.1176; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Ye Q, 2004, LEUKEMIA, V18, P777, DOI 10.1038/sj.leu.2403291; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7	37	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114795	10.1371/journal.pone.0114795	http://dx.doi.org/10.1371/journal.pone.0114795			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502183	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400053
J	Swaminathan, B; Goikuria, H; Vega, R; Rodriguez-Antigudad, A; Medina, AL; Freijo, MD; Vandenbroeck, K; Alloza, I				Swaminathan, Bhairavi; Goikuria, Haize; Vega, Reyes; Rodriguez-Antiguedad, Alfredo; Lopez Medina, Antonio; del Mar Freijo, Maria; Vandenbroeck, Koen; Alloza, Iraide			Autophagic Marker MAP1LC3B Expression Levels Are Associated with Carotid Atherosclerosis Symptomatology	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE PROTEIN; PLAQUE; HMGB1; ATHEROGENESIS; INFLAMMATION; DISEASES; AREAS	Objectives: The mechanism by which atheroma plaque becomes unstable is not completely understood to date but analysis of differentially expressed genes in stable versus unstable plaques may provide clues. This will be crucial toward disclosing the mechanistic basis of plaque instability, and may help to identify prognostic biomarkers for ischaemic events. The objective of our study was to identify differences in expression levels of 59 selected genes between symptomatic patients (unstable plaques) and asymptomatic patients (stable plaques). Methods: 80 carotid plaques obtained by carotid endarterectomy and classified as symptomatic (>70% stenosis) or asymptomatic (>80% stenosis) were used in this study. The expression levels of 59 genes were quantified by qPCR on RNA extracted from the carotid plaques obtained by endarterectomy and analyzed by means of various bioinformatic tools. Results: Several genes associated with autophagy pathways displayed differential expression levels between asymptomatic and symptomatic (i.e. MAP1LC3B, RAB24, EVA1A). In particular, mRNA levels of MAP1LC3B, an autophagic marker, showed a 5-fold decrease in symptomatic samples, which was confirmed in protein blots. Immune system-related factors and endoplasmic reticulum-associated markers (i.e. ERP27, ITPR1, ERO1LB, TIMP1, IL12B) emerged as differently expressed genes between asymptomatic and symptomatic patients. Conclusions: Carotid atherosclerotic plaques in which MAP1LC3B is underexpressed would not be able to benefit from MAP1LC3B-associated autophagy. This may lead to accumulation of dead cells at lesion site with subsequent plaque destabilization leading to cerebrovascular events. Identified biomarkers and network interactions may represent novel targets for development of treatments against plaque destabilization and thus for the prevention of cerebrovascular events.	[Swaminathan, Bhairavi; Goikuria, Haize; Vandenbroeck, Koen; Alloza, Iraide] Univ Basque Country, Fac Med & Odontol, Dept Neurosci, Leioa, Spain; [Vandenbroeck, Koen; Alloza, Iraide] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Goikuria, Haize; Vandenbroeck, Koen; Alloza, Iraide] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Vega, Reyes; Rodriguez-Antiguedad, Alfredo; Lopez Medina, Antonio; del Mar Freijo, Maria] Basurto Hosp, Dept Neurol, Bilbao, Spain	University of Basque Country; Basque Foundation for Science; Basurto Hospital	Alloza, I (corresponding author), Univ Basque Country, Fac Med & Odontol, Dept Neurosci, Leioa, Spain.	iraide.alloza@ehu.es	Vandenbroeck, Koen/D-6845-2012; Rodriguez-Antigüedad, Alfredo/AAT-1760-2021	Vandenbroeck, Koen/0000-0002-6967-6485; Alloza, Iraide/0000-0002-8949-7732; Rodriguez-Antiguedad, Alfredo/0000-0001-5975-725X	Basque Government (Proyectos de Investigacion Sanitaria) [2008111024]; Basque Government (Grupos de Investigacion del Sistema Universitario Vasco) [IT512-10]	Basque Government (Proyectos de Investigacion Sanitaria)(Basque Government); Basque Government (Grupos de Investigacion del Sistema Universitario Vasco)(Basque Government)	This work was supported by grants from the Basque Government (Proyectos de Investigacion Sanitaria; ref. 2008111024) (http://www.osasun.ejgv.euskadi.net) and from the Basque Government (Grupos de Investigacion del Sistema Universitario Vasco; ref. IT512-10 (http://www.hezkuntza.ejgv.euskadi.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; de Souza AWS, 2012, AUTOIMMUN REV, V11, P909, DOI 10.1016/j.autrev.2012.03.007; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083119; Duan XH, 2009, BIOCHEM BIOPH RES CO, V387, P694, DOI 10.1016/j.bbrc.2009.07.085; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hennerici MG, 2004, CEREBROVASC DIS, V17, P17, DOI 10.1159/000075300; Ijas P, 2007, ARTERIOSCL THROM VAS, V27, P154, DOI 10.1161/01.ATV.0000251991.64617.e7; Kowala M C, 1997, Adv Pharmacol, V37, P299; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Li L, 2012, EXP NEUROL, V234, P181, DOI 10.1016/j.expneurol.2011.12.038; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malaud E, 2014, ATHEROSCLEROSIS, V233, P551, DOI 10.1016/j.atherosclerosis.2013.12.019; Martinet W, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0321-1; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mehta TA, 2005, EUR J VASC ENDOVASC, V29, P395, DOI 10.1016/j.ejvs.2005.01.005; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; Munafo DB, 2002, TRAFFIC, V3, P472, DOI 10.1034/j.1600-0854.2002.30704.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Paschen W, 1996, MED HYPOTHESES, V47, P283, DOI 10.1016/S0306-9877(96)90068-7; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Saksi J, 2011, J MOL MED, V89, P1015, DOI 10.1007/s00109-011-0773-z; Schrijvers DM, 2011, ARTERIOSCL THROM VAS, V31, P2787, DOI 10.1161/ATVBAHA.111.224899; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stenina OI, 2008, CIRC RES, V103, P1053, DOI 10.1161/CIRCRESAHA.108.188870; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang L, 2007, APOPTOSIS, V12, P1489, DOI 10.1007/s10495-007-0073-9; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005	49	28	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115176	10.1371/journal.pone.0115176	http://dx.doi.org/10.1371/journal.pone.0115176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503069	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400079
J	Xu, X; Variyam, JN; Zhao, ZX; Chaloupka, FJ				Xu, Xin; Variyam, Jayachandran N.; Zhao, Zhenxiang; Chaloupka, Frank J.			Relative Food Prices and Obesity in US Metropolitan Areas: 1976-2001	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY ENERGY DENSITY; ADULT OBESITY; TIME-SERIES; PHYSICAL-ACTIVITY; PANEL-DATA; ENVIRONMENT; PREVALENCE; WEIGHT; CONSUMPTION	This study investigates the impact of food price on obesity, by exploring the co-occurrence of obesity growth with relative food price reduction between 1976 and 2001. Analyses control for female labor participation and metropolitan outlet densities that might affect body weight. Both the first-difference and fixed effects approaches provide consistent evidence suggesting that relative food prices have substantial impacts on obesity and such impacts were more pronounced among the low-educated. These findings imply that relative food price reductions during the time period could plausibly explain about 18% of the increase in obesity among the U.S. adults in metropolitan areas.	[Xu, Xin; Zhao, Zhenxiang] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA; [Variyam, Jayachandran N.] USDA, Econ Res Serv, Food Econ Div, Washington, DE USA; [Chaloupka, Frank J.] Univ Illinois, Natl Bur Econ Res, Inst Hlth Res & Policy, Dept Econ, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Agriculture (USDA); National Bureau of Economic Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xu, X (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	xxu11@uic.edu		Xu, Xin/0000-0002-5219-499X; Variyam, Jayachandran/0000-0001-5358-2209	United States Department of Agriculture-Economic Research Service Cooperative Agreement [58-4000-9-0047]	United States Department of Agriculture-Economic Research Service Cooperative Agreement	Research for this study was supported by United States Department of Agriculture-Economic Research Service Cooperative Agreement No. 58-4000-9-0047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Antman F, 2007, ECON DEV CULT CHANGE, V56, P125, DOI 10.1086/520561; Auld MC, 2009, ECONOMICA, V76, P719, DOI 10.1111/j.1468-0335.2008.00709.x; Beydoun MA, 2008, SOC SCI MED, V66, P2218, DOI 10.1016/j.socscimed.2008.01.018; Beydoun MA, 2011, J NUTR, V141, P304, DOI 10.3945/jn.110.132613; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; BLUNDELL R, 1993, J ECONOMETRICS, V59, P137, DOI 10.1016/0304-4076(93)90043-5; Brown M. G., 2008, Journal of Agricultural and Applied Economics, V40, P593; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; CORNWELL C, 1994, REV ECON STAT, V76, P360, DOI 10.2307/2109893; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Dalton M, 2013, OBESITY FACTS, V6, P348, DOI 10.1159/000354599; Dargay JM, 1999, J TRANSP ECON POLICY, V33, P287; DEATON A, 1985, J ECONOMETRICS, V30, P109, DOI 10.1016/0304-4076(85)90134-4; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gardes F, 2005, J BUS ECON STAT, V23, P242, DOI 10.1198/073500104000000587; Gelbach J., 2007, 261 COLL LAW; Goldman D., 2011, FOOD PRICES DYNAMICS; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Grossman M, 2014, ECON HUM BIOL, V12, P4, DOI 10.1016/j.ehb.2013.10.003; Gustafson A, 2012, J COMMUN HEALTH, V37, P897, DOI 10.1007/s10900-011-9524-x; Han E, 2011, PUBLIC HEALTH, V125, P129, DOI 10.1016/j.puhe.2010.11.014; Han EN, 2013, CONTEMP ECON POLICY, V31, P528, DOI 10.1111/j.1465-7287.2012.00322.x; Heshmati A, 1997, J AGR ECON, V48, P22, DOI 10.1111/j.1477-9552.1997.tb01128.x; Inagami S, 2006, AM J PREV MED, V31, P10, DOI 10.1016/j.amepre.2006.03.019; Jeffery RW, 2007, DIABETES, V56, P2673, DOI 10.2337/db07-1029; Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039; Jue JJS, 2012, PREV MED, V55, P629, DOI 10.1016/j.ypmed.2012.10.009; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Lakdawalla D, 2005, AM ECON REV, V95, P253, DOI 10.1257/000282805774670266; Maddock J, 2004, AM J HEALTH PROMOT, V19, P137, DOI 10.4278/0890-1171-19.2.137; Meng Y, 2014, J HLTH EC; Meyer KA, 2014, JAMA INTERN MED, V174, P434, DOI 10.1001/jamainternmed.2013.13922; Mijkovic D, 2008, AGR ECON-BLACKWELL, V38, P375, DOI 10.1111/j.1574-0862.2008.00307.x; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; MOFFITT R, 1993, J ECONOMETRICS, V59, P99, DOI 10.1016/0304-4076(93)90041-3; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morrissey TW, 2014, PEDIATRICS, V133, P422, DOI 10.1542/peds.2013-1963; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Powell LM, 2011, AM J AGR ECON, V93, P378, DOI 10.1093/ajae/aaq106; Powell LM, 2009, J HEALTH ECON, V28, P963, DOI 10.1016/j.jhealeco.2009.06.009; Powell LM, 2009, ECON HUM BIOL, V7, P64, DOI 10.1016/j.ehb.2009.01.004; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Powell LM, 2006, ADV HEALTH ECON HEAL, V17, P23, DOI 10.1016/S0731-2199(06)17002-8; Richards TJ, 2007, CONTEMP ECON POLICY, V25, P309, DOI 10.1111/j.1465-7287.2007.00047.x; Schroeter C, 2008, J HEALTH ECON, V27, P45, DOI 10.1016/j.jhealeco.2007.04.001; Smith T.A., 2010, TAXING CALORIC SWEET; Stafford M, 2007, SOC SCI MED, V65, P1882, DOI 10.1016/j.socscimed.2007.05.042; Sturm R, 2008, PUBLIC HEALTH, V122, P1140, DOI 10.1016/j.puhe.2008.04.001; Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007; Sturm R, 2011, PUBLIC HEALTH, V125, P136, DOI 10.1016/j.puhe.2010.11.016; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; VERBEEK M, 1993, J ECONOMETRICS, V59, P125, DOI 10.1016/0304-4076(93)90042-4; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zheng Y. Q., 2008, Journal of Agricultural and Applied Economics, V40, P837; Zheng YQ, 2010, APPL ECON, V42, P1601, DOI 10.1080/00036840701721570	69	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114707	10.1371/journal.pone.0114707	http://dx.doi.org/10.1371/journal.pone.0114707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502888	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400045
J	Lv, MM; Zhu, XY; Wang, H; Wang, F; Guan, WX				Lv, Mengmeng; Zhu, Xingya; Wang, Hao; Wang, Feng; Guan, Wenxian			Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-3; DISEASE RISK MARKERS; SKIN TUMOR PROMOTION; C-REACTIVE PROTEIN; PROSTATE-CANCER; ENERGY RESTRICTION; WEIGHT-LOSS; MAMMARY CARCINOGENESIS	Background: The role of dietary restriction regimens such as caloric restriction, ketogenic diet and intermittent fasting in development of cancers has been detected via abundant preclinical experiments. However, the conclusions are controversial. We aim to review the relevant animal studies systematically and provide assistance for further clinical studies. Methods: Literatures on associations between dietary restriction and cancer published in PubMed in recent twenty years were comprehensively searched. Animal model, tumor type, feeding regimen, study length, sample size, major outcome, conclusion, quality assessment score and the interferential step of cancer were extracted from each eligible study. We analyzed the tumor incidence rates from 21 studies about caloric restriction. Results: Fifty-nine studies were involved in our system review. The involved studies explored roles of dietary restriction during initiation, progression and metastasis of cancer. About 90.9% of the relevant studies showed that caloric restriction plays an anti-cancer role, with the pooled OR (95% CI) of 0.20 (0.12, 0.34) relative to controls. Ketogenic diet was also positively associated with cancer, which was indicated by eight of the nine studies. However, 37.5% of the related studies obtained a negative conclusion that intermittent fasting was not significantly preventive against cancer. Conclusions: Caloric restriction and ketogenic diet are effective against cancer in animal experiments while the role of intermittent fasting is doubtful and still needs exploration. More clinical experiments are needed and more suitable patterns for humans should be investigated.	[Lv, Mengmeng] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Lv, Mengmeng] Nanjing Med Univ, Clin Sch 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Xingya] Nanjing Med Univ, Gulou Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhu, Xingya; Wang, Hao; Wang, Feng; Guan, Wenxian] Nanjing Univ, Nanjing Gulou Hosp, Coll Med, Dept Gastrointestinal Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Guan, WX (corresponding author), Nanjing Univ, Nanjing Gulou Hosp, Coll Med, Dept Gastrointestinal Surg, Nanjing 210008, Jiangsu, Peoples R China.	guanwx810@126.com						Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Birt DF, 1997, CARCINOGENESIS, V18, P2107, DOI 10.1093/carcin/18.11.2107; Blando J, 2011, CANCER PREV RES, V4, P2002, DOI 10.1158/1940-6207.CAPR-11-0182; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Bonorden MJL, 2009, NUTR CANCER, V61, P265, DOI 10.1080/01635580802419798; Buschemeyer WC, 2010, PROSTATE, V70, P1037, DOI 10.1002/pros.21136; Carver DK, 2011, CANCER PREV RES, V4, P562, DOI 10.1158/1940-6207.CAPR-10-0294; Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581; Cleary MP, 2007, EXP BIOL MED, V232, P70; Cleary Margot P, 2011, J Carcinog, V10, P21, DOI 10.4103/1477-3163.85181; Coffer PJ, 2009, CELL RES, V19, P797, DOI 10.1038/cr.2009.81; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; Dirx MJM, 2003, INT J CANCER, V106, P766, DOI 10.1002/ijc.11277; Dogan S, 2010, ONCOL LETT, V1, P167, DOI 10.3892/ol_00000031; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; Dunn SE, 1997, CANCER RES, V57, P4667; ENGELMAN RW, 1994, CANCER RES, V54, P5724; Eslami S, 2012, BIOIMPACTS, V2, P213, DOI 10.5681/bi.2012.028; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Freedland SJ, 2008, PROSTATE, V68, P11, DOI 10.1002/pros.20683; Galet C, 2013, INT J MOL SCI, V14, P13782, DOI 10.3390/ijms140713782; Gillette CA, 1997, CARCINOGENESIS, V18, P1183, DOI 10.1093/carcin/18.6.1183; Golan T, 2011, ONCOLOGY-NY, V25, P518; Harvey AE, 2013, MOL CARCINOGEN, V52, P997, DOI 10.1002/mc.21940; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973; Hursting SD, 1997, CANCER RES, V57, P2843; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092; JAMES SJ, 1994, CANCER RES, V54, P5508; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Jiang YS, 2013, J NEURO-ONCOL, V114, P25, DOI 10.1007/s11060-013-1154-y; Kandori H, 2005, CANCER SCI, V96, P221, DOI 10.1111/j.1349-7006.2005.00041.x; Lanza-Jacoby S, 2013, EXP BIOL MED, V238, P787, DOI 10.1177/1535370213493727; Lashinger LM, 2011, CANCER PREV RES, V4, P1041, DOI 10.1158/1940-6207.CAPR-11-0023; Lashinger LM, 2011, CANCER PREV RES, V4, P1030, DOI 10.1158/1940-6207.CAPR-11-0027; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Mai V, 2003, CANCER RES, V63, P1752; Maroon J, 2013, J CHILD NEUROL, V28, P1002, DOI 10.1177/0883073813488670; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Martin-Montalvo A, 2011, ONCOGENE, V30, P505, DOI 10.1038/onc.2010.492; Mason C, 2013, CANCER EPIDEM BIOMAR, V22, P1457, DOI 10.1158/1055-9965.EPI-13-0337; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; McCormick DL, 2007, NUTR CANCER, V57, P194, DOI 10.1080/01635580701277494; Mizuno NK, 2013, CANCER PREV RES, V6, P540, DOI 10.1158/1940-6207.CAPR-13-0033; Moore T, 2012, CANCER PREV RES, V5, P1236, DOI 10.1158/1940-6207.CAPR-12-0234; Mulrooney TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018085; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Nogueira LM, 2012, ENDOCR-RELAT CANCER, V19, P57, DOI 10.1530/ERC-11-0213; Ong KR, 2009, CANCER PREV RES, V2, P720, DOI 10.1158/1940-6207.CAPR-09-0008; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Pape-Ansorge KA, 2002, NUTR CANCER, V44, P161, DOI 10.1207/S15327914NC4402_07; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Rocha NS, 2002, TERATOGEN CARCIN MUT, V22, P129, DOI 10.1002/tcm.10005; Rogozina OP, 2013, BREAST CANCER RES TR, V138, P395, DOI 10.1007/s10549-013-2464-7; Rowlands MA, 2012, CANCER RES, V72, P503, DOI 10.1158/0008-5472.CAN-11-1601; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Saleh AD, 2013, CELL CYCLE, V12, P1955, DOI 10.4161/cc.25016; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Seyfried BTN, 2009, J CANCER RES THER, V5, P7, DOI 10.4103/0973-1482.55134; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shelton LM, 2010, ASN NEURO, V2, DOI 10.1042/AN20100002; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Simone BA, 2013, FUTURE ONCOL, V9, P959, DOI [10.2217/fon.13.31, 10.2217/FON.13.31]; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stewart JW, 2005, CARCINOGENESIS, V26, P1077, DOI 10.1093/carcin/bgi051; Suttie AW, 2005, TOXICOL PATHOL, V33, P386, DOI 10.1080/01926230590930272; Tagliaferro AR, 1996, J NUTR, V126, P1398, DOI 10.1093/jn/126.5.1398; Thomas JA, 2010, PROSTATE CANCER P D, V13, P350, DOI 10.1038/pcan.2010.24; Thompson HJ, 2004, CANCER RES, V64, P5643, DOI 10.1158/0008-5472.CAN-04-0787; Tomasi C, 1999, CARCINOGENESIS, V20, P1979, DOI 10.1093/carcin/20.10.1979; Tomita Mariko, 2012, J Carcinog, V11, P10, DOI 10.4103/1477-3163.99176; Tsao JL, 2002, CARCINOGENESIS, V23, P1807, DOI 10.1093/carcin/23.11.1807; van Ginhoven TM, 2010, J SURG ONCOL, V102, P348, DOI 10.1002/jso.21649; VonTungeln LS, 1996, CANCER LETT, V104, P133, DOI 10.1016/0304-3835(96)04232-2; Wang T, 2011, CANCER EPIDEM BIOMAR, V20, P971, DOI 10.1158/1055-9965.EPI-10-1222; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Wright JL, 2013, PROSTATE, V73, P1345, DOI 10.1002/pros.22682; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071	88	122	123	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115147	10.1371/journal.pone.0115147	http://dx.doi.org/10.1371/journal.pone.0115147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502434	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700093
J	Rihani, A; De Wilde, B; Zeka, F; Laureys, G; Francotte, N; Tonini, GP; Coco, S; Versteeg, R; Noguera, R; Schulte, JH; Eggert, A; Stallings, RL; Speleman, F; Vandesompele, J; Van Maerken, T				Rihani, Ali; De Wilde, Bram; Zeka, Fjoralba; Laureys, Genevieve; Francotte, Nadine; Tonini, Gian Paolo; Coco, Simona; Versteeg, Rogier; Noguera, Rosa; Schulte, Johannes H.; Eggert, Angelika; Stallings, Raymond L.; Speleman, Frank; Vandesompele, Jo; Van Maerken, Tom			CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients	PLOS ONE			English	Article							CANCER; P53; CASPASE-8; SUSCEPTIBILITY; PROGRESSION; GENOTYPE; PATHWAY; GENES	Background: Neuroblastoma is a pediatric cancer that exhibits a wide clinical spectrum ranging from spontaneous regression in low-risk patients to fatal disease in high-risk patients. The identification of single nucleotide polymorphisms (SNPs) may help explain the heterogeneity of neuroblastoma and assist in identifying patients at higher risk for poor survival. SNPs in the TP53 pathway are of special importance, as several studies have reported associations between TP53 pathway SNPs and cancer. Of note, less than 2% of neuroblastoma tumors have a TP53 mutation at diagnosis. Patients and Methods: We selected 21 of the most frequently studied SNPs in the TP53 pathway and evaluated their association with outcome in 500 neuroblastoma patients using TaqMan allelic discrimination assays. Results and Conclusion: We investigated the impact of 21 SNPs on overall survival, event-free survival, age at diagnosis, MYCN status, and stage of the disease in 500 neuroblastoma patients. A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse overall and event-free survival in patients with MYCN-amplified neuroblastoma tumors.	[Rihani, Ali; De Wilde, Bram; Zeka, Fjoralba; Speleman, Frank; Vandesompele, Jo; Van Maerken, Tom] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium; [Francotte, Nadine] CHC, Dept Pediat Hemato Oncol, SUHOPL, Serv Univ Hemato Oncol Pediat, St Nicolas, Belgium; [Tonini, Gian Paolo] Univ Padua, Fdn Citta Speranza, Pediat Res Inst, Dept Womens & Childrens Hlth,Neuroblastoma Lab,On, Padua, Italy; [Coco, Simona] Univ San Martino, Azienda Osped, IRCCS, IST Ist Nazl Ric Cancro,Lung Canc Unit, Genoa, Italy; [Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Noguera, Rosa] Univ Valencia, Sch Med, Dept Pathol, Valencia, Spain; [Schulte, Johannes H.] German Canc Consortium DKTK, Heidelberg, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schulte, Johannes H.] German Canc Res Ctr, Heidelberg, Germany; [Schulte, Johannes H.; Eggert, Angelika] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany; [Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Stallings, Raymond L.] Natl childrens Res Ctr, Dublin, Ireland	Ghent University; Ghent University; Ghent University Hospital; Fondazione Citta della Speranza; University of Padua; University of Genoa; IRCCS AOU San Martino IST; University of Amsterdam; Academic Medical Center Amsterdam; University of Valencia; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Duisburg Essen; Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Trinity College Dublin	Van Maerken, T (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.	Tom.VanMaerken@UGent.be	Stallings, Raymond/A-7213-2008; Rihani, Ali/R-6608-2019; Schulte, Johannes H./V-2474-2018; speleman, frank/AAR-5184-2020; Coco, Simona/J-6051-2016; Eggert, Angelika/AAE-6907-2022; Vandesompele, Jo/W-3411-2018; laureys, genevieve/AAG-2390-2021; Versteeg, Rogier/AAQ-1765-2020	Rihani, Ali/0000-0002-6176-0519; speleman, frank/0000-0002-6628-8559; Coco, Simona/0000-0002-5296-4325; Eggert, Angelika/0000-0003-3476-8184; Vandesompele, Jo/0000-0001-6274-0184; De Wilde, Bram/0000-0003-0213-1322; Schulte, Johannes Hubertus/0000-0003-0671-1201; Versteeg, Rogier/0000-0001-7172-0388	Ghent University research fund (BOF) [01D02210]; FWO [12B9912N]; FIS [PI10/15]; RTICC [RD06/0020/0102, RD12/0036/0020]; Instituto Carlos III Madrid ERDF, Spain; BOF; Childhood Cancer Fund; National Cancer Plan of the Belgian State [29]	Ghent University research fund (BOF)(Ghent University); FWO(FWO); FIS(Instituto de Salud Carlos III); RTICC(Instituto de Salud Carlos III); Instituto Carlos III Madrid ERDF, Spain; BOF; Childhood Cancer Fund; National Cancer Plan of the Belgian State	AR is supported by a PhD fellowship from the Ghent University research fund (BOF; 01D02210). TVM is a postdoctoral fellow of the FWO (12B9912N). RN is supported by FIS (contract PI10/15) and RTICC (contracts RD06/0020/0102; RD12/0036/0020), Instituto Carlos III Madrid & ERDF, Spain. Italian Neuroblastoma Foundation supported the Italian samples collection and preparation. This work was supported by the BOF, the FWO, the Childhood Cancer Fund, and the National Cancer Plan of the Belgian State (Action 29). The study sponsors have no role in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dai ZY, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-24; Decock A, 2011, EPIGENETICS-US, V6, P962, DOI 10.4161/epi.6.8.16516; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kamimatsuse A, 2009, PEDIATR BLOOD CANCER, V52, P777, DOI 10.1002/pbc.21977; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Paulin FEM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-281; Perfumo C, 2008, EUR J CANCER, V44, P2634, DOI 10.1016/j.ejca.2008.08.018; Perfumo C, 2009, PEDIATR BLOOD CANCER, V53, P576, DOI 10.1002/pbc.22132; Rihani A, 2014, PEDIATR BLOOD CANCER, V61, P1867, DOI 10.1002/pbc.24927; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stupack DG, 2013, CANCER LETT, V332, P133, DOI 10.1016/j.canlet.2010.07.022; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Teitz T, 2013, CANCER RES, V73, P4086, DOI 10.1158/0008-5472.CAN-12-2681; Tweddle DA, 2001, CANCER RES, V61, P8; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; van Noesel MM, 2003, CANCER LETT, V197, P165, DOI 10.1016/S0304-3835(03)00101-0; Vazquez A, 2010, CANCER RES, V70, P172, DOI 10.1158/0008-5472.CAN-09-2218; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114696	10.1371/journal.pone.0114696	http://dx.doi.org/10.1371/journal.pone.0114696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502557	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700045
J	Kang, HB; Ahn, KS; Oh, SR; Kim, JW				Kang, Ho-Bum; Ahn, Kyung-Seop; Oh, Sei-Ryang; Kim, Jae Wha			Genkwadaphnin Induces IFN-gamma via PKD1/NF-kappa B/STAT1 Dependent Pathway in NK-92 Cells	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSES; INTERFERON-GAMMA; NK-CELLS; DAPHNE-GENKWA; ACTIVATING RECEPTORS; DIRECT STIMULATION; VIRUS-INFECTION; IL-18; MACROPHAGES	The flower buds of Daphne genkwa Sieb. et Zucc. have been used as a traditional Chinese medicine although their functional mechanisms have not been discovered yet. We have studied the potential effects of the plant extracts on natural killer (NK) cell activation, and isolated an active fraction. Genkwadaphnin (GD-1) displayed a potent efficacy to induce IFN-gamma transcription in NK cells with concentration-and time-dependent manners. GD-1 treatment triggered the phosphorylation of PKD1, a member of PKC family, MEK and ERK, resulting in IKK activation to induce I kappa B degradation, and the nuclear localization of p65, an NF-kappa B subunit, which regulates IFN-gamma transcription. GD-1 effect on IFN-gamma production was blocked by the addition of Rottlerin, a PKC inhibitor, CID 755673, a PKD inhibitor, or Bay11-7082, an IKK alpha inhibitor. The nuclear localization of p65 was also inhibited by the kinase inhibitors. Secreted IFN-gamma activates STAT1 phosphorylation as autocrine-loops to sustain its secretion. GD-1 induced the phosphorylation of STAT1 probably through the increase of IFN-gamma. STAT1 inhibitor also abrogated the sustained IFN-gamma secretion. These results suggest that GD-1 is involved in the activation of PKD1 and/or ERK pathway, which activate NK-kappa B triggering IFN-gamma production. As positive feedback loops, secreted IFN-gamma activates STAT1 and elongates its production in NK-92 cells.	[Kang, Ho-Bum; Kim, Jae Wha] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Ahn, Kyung-Seop; Oh, Sei-Ryang] Korea Res Inst Biosci & Biotechnol, Immune Modulator Res Ctr, Cheongwon Gun, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea.	wjkim@kribb.re.kr			Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program [KCS3021413]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2102R1A1A2043799]; Small & Medium Business Administration of Korea [SCE0101312]	Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Small & Medium Business Administration of Korea	Funding for this work came from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (KCS3021413, https://www.kribb.re.kr/eng/, JWK) and grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2102R1A1A2043799, http://www.nrf.re.kr/nrf_eng_cms/, JWK) and Small & Medium Business Administration of Korea (SCE0101312, http://www.smba.go.kr/eng/index.do, JWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Carnaud C, 1999, J IMMUNOL, V163, P4647; Carson WE, 2001, EUR J IMMUNOL, V31, P3016, DOI 10.1002/1521-4141(2001010)31:10<3016::AID-IMMU3016>3.0.CO;2-J; Cederarv M, 2009, IMMUNOBIOLOGY, V214, P331, DOI 10.1016/j.imbio.2008.10.009; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Golab J, 2000, IMMUNOL LETT, V72, P153, DOI 10.1016/S0165-2478(00)00178-4; HALL IH, 1982, J PHARM SCI, V71, P1263, DOI 10.1002/jps.2600711120; Huang Kenneth H, 2006, J Immune Based Ther Vaccines, V4, P7, DOI 10.1186/1476-8518-4-7; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jennings P, 2009, J IMMUNOL, V182, P2879, DOI 10.4049/jimmunol.0803220; Jo SK, 2012, BIOMOL THER, V20, P513, DOI 10.4062/biomolther.2012.20.6.513; Kakugawa S, 2009, J VIROL, V83, P2510, DOI 10.1128/JVI.02416-08; Lee MMK, 2009, J LEUKOCYTE BIOL, V86, P1319, DOI 10.1189/jlb.0209052; Li HS, 2012, RES INTEGR TRADIT CH, V4, P93; Li SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-159; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Montoya CJ, 2006, CLIN IMMUNOL, V120, P138, DOI 10.1016/j.clim.2006.02.008; Munder M, 2001, IMMUNOL LETT, V75, P159, DOI 10.1016/S0165-2478(00)00288-1; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Otani T, 1999, CELL IMMUNOL, V198, P111, DOI 10.1006/cimm.1999.1589; Page KM, 2008, J LEUKOCYTE BIOL, V83, P1267, DOI 10.1189/jlb.1107745; Parihar R, 2002, J CLIN INVEST, V110, P983, DOI 10.1172/JCI200215950; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; PERUSSIA B, 1983, J EXP MED, V158, P2058, DOI 10.1084/jem.158.6.2058; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1997, SEMIN ONCOL, V24, pS9; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; STRATOWA C, 1995, IMMUNOBIOLOGY, V193, P293, DOI 10.1016/S0171-2985(11)80558-9; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tassi I, 2008, BLOOD, V112, P4109, DOI 10.1182/blood-2008-02-139527; Tong QY, 2012, J EMERG TRADIT CHIN, V21, P1166; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zeng KW, 2013, TOXICOL APPL PHARM, V273, P159, DOI 10.1016/j.taap.2013.08.028; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P128, DOI 10.1016/j.intimp.2006.07.011	52	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115146	10.1371/journal.pone.0115146	http://dx.doi.org/10.1371/journal.pone.0115146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517939	Green Published, gold, Green Submitted			2022-12-26	WOS:000347215600045
J	Lu, XB; Huang, W				Lu, Xibin; Huang, Wei			PiggyBac Mediated Multiplex Gene Transfer in Mouse Embryonic Stem Cell	PLOS ONE			English	Article							FIBROBLAST FEEDER LAYERS; GERM-LINE TRANSMISSION; HOMOLOGOUS RECOMBINATION; PLURIPOTENTIAL CELLS; SLEEPING-BEAUTY; TRANSGENIC MICE; TRANSPOSON; EXPRESSION; DIFFERENTIATION; BACULOVIRUSES	PiggyBac system has been shown to have a high efficiency to mediate gene transfer. However, there are no reports on its efficiency to mediate multiplex transgenes in mouse embryonic stem cells. Here we first established an immortalized feeder cell line by introducing four antibiotic resistance genes simultaneously into the original SNL 76/7 feeder cell line utilizing the PiggyBac system. This is the feeder cell line with the most diverse types of antibiotic resistance genes reported so far, which will enable researchers to perform simultaneous multiplex gene transfer or gene targeting experiments in ES cells. With such feeder cell line, we were able to quantitatively characterize the transposition efficiency of PiggyBac system in mouse ES cells using five transposons carrying different inducible fluorescence proteins and antibiotic resistance genes, and the efficiency ranged from about 2% for one transposon to 0.5% for five transposons. The highly efficient multiplex gene transfer mediated by PiggyBac will no doubt provide researchers with more choices in biomedical research and development.	[Lu, Xibin; Huang, Wei] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Huang, Wei] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Peoples R China	University of Hong Kong; Southern University of Science & Technology	Huang, W (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	huang.w@sustc.edu.cn	Huang, Wei/AAW-1423-2021		Research Grants Council of Hong Kong General Research Fund [767711]; National Natural Science Foundation of China Fund [31270887]; Shenzhen Commission of Science and Innovation Fund [ZDSYS20140509142721429]	Research Grants Council of Hong Kong General Research Fund(Hong Kong Research Grants Council); National Natural Science Foundation of China Fund(National Natural Science Foundation of China (NSFC)); Shenzhen Commission of Science and Innovation Fund	This work is supported by a Research Grants Council of Hong Kong General Research Fund (No. 767711), a National Natural Science Foundation of China Fund (No. 31270887) and a Shenzhen Commission of Science and Innovation Fund (ZDSYS20140509142721429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Iuchi S, 2006, DIFFERENTIATION, V74, P160, DOI 10.1111/j.1432-0436.2006.00067.x; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, BIOL RES, V6; JOHNSON KA, 1995, NUCLEIC ACIDS RES, V23, P1273, DOI 10.1093/nar/23.7.1273; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kim J, 2008, STEM CELLS, V26, P2516, DOI 10.1634/stemcells.2008-0379; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Linnell ER, 2001, MAMM GENOME, V12, P169, DOI 10.1007/s003350010238; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mossine VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085494; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan CY, 2010, J GENET GENOMICS, V37, P241, DOI 10.1016/S1673-8527(09)60042-4; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	41	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115072	10.1371/journal.pone.0115072	http://dx.doi.org/10.1371/journal.pone.0115072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517991	Green Submitted, gold, Green Published			2022-12-26	WOS:000347215600039
J	Niu, XY; Lu, C; Xiao, C; Zhang, ZG; Jiang, M; He, D; Bian, YQ; Zhang, G; Bian, ZX; Lu, AP				Niu, Xuyan; Lu, Cheng; Xiao, Cheng; Zhang, Zhiguo; Jiang, Miao; He, Dan; Bian, Yanqin; Zhang, Ge; Bian, Zhaoxiang; Lu, Aiping			The Shared Crosstalk of Multiple Pathways Involved in the Inflammation between Rheumatoid Arthritis and Coronary Artery Disease Based on a Digital Gene Expression Profile	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK-FACTORS; CELL CO-STIMULATION; PERIPHERAL-BLOOD; HEART-DISEASE; ACCELERATED ATHEROSCLEROSIS; TRANSCRIPTOME ANALYSIS; SYSTEMIC INFLAMMATION; COMMON DISEASES; MICROARRAY	Rheumatoid arthritis (RA) and coronary artery disease (CAD) are both complex inflammatory diseases, and an increased prevalence of CAD and a high rate of mortality have been observed in RA patients. But the molecular mechanism of inflammation that is shared between the two disorders is unclear. High-throughput techniques, such as transcriptome analysis, are becoming important tools for genetic biomarker discovery in highly complex biological samples, which is critical for the diagnosis, prognosis, and treatment of disease. In the present study, we reported one type of transcriptome analysis method: digital gene expression profiling of peripheral blood mononuclear cells of 10 RA patients, 10 CAD patients and 10 healthy people. In all, 213 and 152 differently expressed genes (DEGs) were identified in RA patients compared with normal controls (RA vs. normal) and CAD patients compared with normal controls (CAD vs. normal), respectively, with 73 shared DEGs between them. Using this technique in combination with Ingenuity Pathways Analysis software, the effects on inflammation of four shared canonical pathways, three shared activated predicted upstream regulators and three shared molecular interaction networks were identified and explored. These shared molecular mechanisms may provide the genetic basis and potential targets for optimizing the application of current drugs to more effectively treat these diseases simultaneously and for preventing one when the other is diagnosed.	[Niu, Xuyan; Lu, Cheng; Jiang, Miao; Lu, Aiping] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Beijing 100029, Peoples R China; [Zhang, Zhiguo] China Acad Chinese Med Sci, Inst Basic Theory, Beijing 100700, Peoples R China; [He, Dan; Bian, Yanqin; Lu, Aiping] Shanghai Municipal Educ Commiss, E Inst Chinese Tradit Internal Med, Shanghai 201203, Peoples R China; [Zhang, Ge; Bian, Zhaoxiang; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China-Japan Friendship Hospital; China Academy of Chinese Medical Sciences; Institute of Basic Theory for Chinese Medicine, CACMS; Shanghai Municipal Education Commission (SHMEC); Hong Kong Baptist University	Lu, AP (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China.	lap64067611@126.com	Zhang, Ge/K-9118-2019; Xiao, Cheng/AAM-7764-2020	Zhang, Ge/0000-0002-7807-7695; 	International cooperation project of Ministry of science and technology [2014DFA31490]; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University [RC-IRMS/12-13/02]; Research Committee of Hong Kong Baptist University [FRG2/12-13/027]; Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation [20118450201]	International cooperation project of Ministry of science and technology; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University; Research Committee of Hong Kong Baptist University; Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation	This study was supported by (1) International cooperation project of Ministry of science and technology (Project ID: 2014DFA31490) to Cheng Xiao, (2) Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University (Project ID: RC-IRMS/12-13/02), Research Committee of Hong Kong Baptist University (Project ID: FRG2/12-13/027) to Ge Zhang, and (3) Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation (Project ID: 20118450201) to Aiping Lu.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bili A, 2014, ARTHRIT CARE RES, V66, P355, DOI 10.1002/acr.22166; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Crowson CS, 2013, AM HEART J, V166, P622, DOI 10.1016/j.ahj.2013.07.010; Cunha TM, 2008, BRIT J PHARMACOL, V154, P460, DOI 10.1038/bjp.2008.94; Cynthia S, 2013, AM HEART J, V166, p[622, e621]; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dessein PH, 2013, MEDIATORS INFLAMM; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Farzaneh-Far A, 2005, INT J CLIN PRACT, V59, P823, DOI 10.1111/j.1742-1241.2005.00489.x; Ferrari R, 1999, PHARMACOL RES, V40, P97, DOI 10.1006/phrs.1998.0463; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Javed Q, 2013, HEART LUNG CIRC, V22, P323, DOI 10.1016/j.hlc.2012.12.002; Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169; Kaiser C, 2012, RHEUMATOL INT, V32, P295, DOI 10.1007/s00296-011-2096-3; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Korhonen R, 2009, BASIC CLIN PHARMACOL, V104, P276, DOI 10.1111/j.1742-7843.2009.00375.x; Krintus M, 2014, CRIT REV CLIN LAB SC, V11, P1; Kriszbacher I, 2005, NEW ENGL J MED, V353, P429; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Li JY, 2013, CARDIOLOGY, V124, P53, DOI 10.1159/000345772; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Ljung L, 2012, ARTHRITIS RHEUM-US, V64, P42, DOI 10.1002/art.30654; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Min SH, 2010, BIOCHEM BIOPH RES CO, V391, P1080, DOI 10.1016/j.bbrc.2009.12.025; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nguyen CM, 2012, PHARMACOECONOMICS, V30, P575, DOI 10.2165/11594990-000000000-00000; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Nordang GBN, 2013, RHEUMATOLOGY, V52, P1973, DOI 10.1093/rheumatology/ket252; Nuhrenberg TG, 2013, J CARDIOVASC TRANSL, V6, P81, DOI 10.1007/s12265-012-9420-5; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Rodriguez-Lopez J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1849; Sarzi-Puttini P, 2010, AUTOIMMUN REV, V9, P849, DOI 10.1016/j.autrev.2010.08.002; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stavropoulos-Kalinoglou A, 2009, ANN RHEUM DIS, V68, P242, DOI 10.1136/ard.2008.095596; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang Weihong, 2007, BMC Cardiovasc Disord, V7, P30, DOI 10.1186/1471-2261-7-30; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; UNEMORI EN, 1993, J BIOL CHEM, V268, P1338; Wang XD, 2013, BONE, V52, P111, DOI 10.1016/j.bone.2012.09.018; Yonezawa K, 2012, KOBE J MED SCI, V58, pE128, DOI DOI 10.24546/81005037	69	11	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113659	10.1371/journal.pone.0113659	http://dx.doi.org/10.1371/journal.pone.0113659			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514790	Green Published, gold			2022-12-26	WOS:000349146300006
J	Soderquist, P; Norrstrom, J; Elmberg, J; Guillemain, M; Gunnarsson, G				Soderquist, Par; Norrstrom, Joanna; Elmberg, Johan; Guillemain, Matthieu; Gunnarsson, Gunnar			Wild Mallards Have More "Goose-Like" Bills Than Their Ancestors: A Case of Anthropogenic Influence?	PLOS ONE			English	Article							GAME-FARM MALLARDS; DABBLING DUCKS; ANAS-PLATYRHYNCHOS; LAMELLAR DENSITY; MATE PREFERENCE; BODY LENGTH; MORPHOLOGY; HYBRIDIZATION; ECOMORPHOLOGY; CONSEQUENCES	Wild populations of the world's most common dabbling duck, the mallard (Anas platyrhynchos), run the risk of genetic introgression by farmed conspecifics released for hunting purposes. We tested whether bill morphology of free-living birds has changed since large-scale releases of farmed mallards started. Three groups of mallards from Sweden, Norway and Finland were compared: historical wild (before large-scale releases started), present-day wild, and present-day farmed. Higher density of bill lamellae was observed in historical wild mallards (only males). Farmed mallards had wider bills than present-day and historical wild ones. Present-day wild and farmed mallards also had higher and shorter bills than historical wild mallards. Present-day mallards thus tend to have more "goose-like" bills (wider, higher, and shorter) than their ancestors. Our study suggests that surviving released mallards affect morphological traits in wild population by introgression. We discuss how such anthropogenic impact may lead to a maladapted and genetically compromised wild mallard population. Our study system has bearing on other taxa where large-scale releases of conspecifics with 'alien genes' may cause a cryptic invasive process that nevertheless has fitness consequences for individual birds.	[Soderquist, Par; Norrstrom, Joanna; Elmberg, Johan; Gunnarsson, Gunnar] Kristianstad Univ, Div Nat Sci, SE-29188 Kristianstad, Sweden; [Soderquist, Par] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, SE-90183 Umea, Sweden; [Guillemain, Matthieu] CNERA Avifaune Migratrice, Off Natl Chasse & Faune Sauvage, F-13200 Arles, France	Kristianstad University; Swedish University of Agricultural Sciences	Soderquist, P (corresponding author), Kristianstad Univ, Div Nat Sci, SE-29188 Kristianstad, Sweden.	par.soderquist@hkr.se			Swedish Environmental Protection Agency [V-205-09]	Swedish Environmental Protection Agency	Funding provided by V-205-09 The Swedish Environmental Protection Agency, http://www.naturvardsverket.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champagnon J., 2011, THESIS U MONTPELLIER; Champagnon J, 2011, EUROPEAN J WILDLIFE, V58, P1; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Champagnon J, 2010, BIRD STUDY, V57, P344, DOI 10.1080/00063657.2010.486028; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CHENG KM, 1979, ANIM BEHAV, V27, P417, DOI 10.1016/0003-3472(79)90177-5; CHENG KM, 1978, ANIM BEHAV, V26, P996, DOI 10.1016/0003-3472(78)90088-X; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Deceuninck B., 2014, SYNTHESE DENOMBREMEN; Delany S, 2006, WATERBIRD POPULATION; DESFORGES MF, 1976, ANIM BEHAV, V24, P391, DOI 10.1016/S0003-3472(76)80049-8; DESFORGES MF, 1975, ANIM BEHAV, V23, P692, DOI 10.1016/0003-3472(75)90145-1; Elmberg Johan, 2009, Wildfowl, P9; Gille U, 1999, CONDOR, V101, P710, DOI 10.2307/1370207; Greenwood RJ., 1975, PRAIRIE NAT, V7, P9; Guay P. -J., 2014, Pacific Conservation Biology, V20, P41; Guay PJ, 2008, CONDOR, V110, P276, DOI 10.1525/cond.2008.8424; Guillemain M, 2002, OIKOS, V98, P547, DOI 10.1034/j.1600-0706.2002.980321.x; Guillemain M., 1999, Wildfowl, V50, P123; Guillemain M, 2010, AMBIO, V39, P170, DOI 10.1007/s13280-010-0020-9; Gunnarsson G, 2011, AMBIO, V40, P338, DOI 10.1007/s13280-010-0117-1; Gurd DB, 2007, AM NAT, V169, P334, DOI 10.1086/510924; Gurd DB, 2005, THESIS SIMON FRASER; KEHOE FP, 1987, CAN J ZOOL, V65, P1818, DOI 10.1139/z87-275; KOOLOOS JGM, 1989, ZOOMORPHOLOGY, V108, P269, DOI 10.1007/BF00312160; Kraus RHS, 2013, MOL ECOL, V22, P41, DOI 10.1111/mec.12098; Laikre L, 2006, AMBIO, V35, P255, DOI 10.1579/05-A-060R.1; Lockwood JL, 2007, INVASION ECOLOGY; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Mondain-Monval J-Y, 2000, FAUNE SAUVAGE, V251, P124; Moore SJ, 2006, BIRD CONSERV INT, V16, P253, DOI 10.1017/S0959270906000396; NUDDS TD, 1984, CAN J ZOOL, V62, P2009, DOI 10.1139/z84-294; NUDDS TD, 1994, OIKOS, V69, P295, DOI 10.2307/3546150; NUDDS TD, 1984, CAN J ZOOL, V62, P2002, DOI 10.1139/z84-293; Nudds TD, 2000, OIKOS, V91, P583, DOI 10.1034/j.1600-0706.2000.910321.x; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Ottosson U., 2012, FAGLARNA I SVERIGE A; Pehrsson O, 1982, VILTNYTT, V16, P23; POYSA H, 1983, ORNIS SCAND, V14, P317, DOI 10.2307/3676325; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Rhymer J.M., 2006, ACTA ZOOLOGICAL SINI, V52, P583, DOI DOI 10.1146/annurev.ecolsys.27.1.83; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Tolkamp CR, 1993, THESIS U GUELPH; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilson RE, 2008, WILSON J ORNITHOL, V120, P390, DOI 10.1676/07-040.1	46	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115143	10.1371/journal.pone.0115143	http://dx.doi.org/10.1371/journal.pone.0115143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514789	Green Submitted, Green Published, gold			2022-12-26	WOS:000349146300038
J	Thibodeau, JF; Holterman, CE; Burger, D; Read, NC; Reudelhuber, TL; Kennedy, CRJ				Thibodeau, Jean-Francois; Holterman, Chet E.; Burger, Dylan; Read, Naomi C.; Reudelhuber, Timothy L.; Kennedy, Christopher R. J.			A Novel Mouse Model of Advanced Diabetic Kidney Disease	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; ANGIOTENSIN-II; RAS BLOCKADE; NEPHROPATHY; HYPERTENSION; RENIN; MICE; INHIBITION; DEFICIENCY; EXPRESSION	Currently available rodent models exhibit characteristics of early diabetic nephropathy (DN) such as hyperfiltration, mesangial expansion, and albuminuria yet features of late DN (hypertension, GFR decline, tubulointerstitial fibrosis) are absent or require a significant time investment for full phenotype development. Accordingly, the aim of the present study was to develop a mouse model of advanced DN with hypertension superimposed (HD mice). Mice transgenic for human renin cDNA under the control of the transthyretin promoter (TTRhRen) were employed as a model of angiotensin-dependent hypertension. Diabetes was induced in TTRhRen mice through low dose streptozotocin (HD-STZ mice) or by intercrossing with OVE26 diabetic mice (HD-OVE mice). Both HD-STZ and HD-OVE mice displayed more pronounced increases in urinary albumin levels as compared with their diabetic littermates. Additionally, HD mice displayed renal hypertrophy, advanced glomerular scarring and evidence of tubulointerstitial fibrosis. Both HD-OVE and HD-STZ mice showed evidence of GFR decline as FITC-inulin clearance was decreased compared to hyperfiltering STZ and OVE mice. Taken together our results suggest that HD mice represent a robust model of type I DN that recapitulates key features of human disease which may be significant in studying the pathogenesis of DN and in the assessment of putative therapeutics.	[Thibodeau, Jean-Francois; Holterman, Chet E.; Burger, Dylan; Read, Naomi C.; Kennedy, Christopher R. J.] Ottawa Hosp, Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada; [Thibodeau, Jean-Francois; Burger, Dylan; Read, Naomi C.; Kennedy, Christopher R. J.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Reudelhuber, Timothy L.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Kennedy, CRJ (corresponding author), Ottawa Hosp, Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada.	ckennedy@uottawa.ca	Burger, Dylan/ABD-2727-2020; Thibodeau, Jean-Francois/AAC-6752-2019	Burger, Dylan/0000-0003-3951-2911; Thibodeau, Jean-Francois/0000-0002-9322-4868; Holterman, Chet/0000-0002-9002-6073	Ontario Graduate Scholarship; Heart & Stroke/Pfizer Canada Fellowship; Canadian Institutes of Health Research	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Heart & Stroke/Pfizer Canada Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	J-F.T. is a recipient of an Ontario Graduate Scholarship. D. B. is a recipient of a Heart & Stroke/Pfizer Canada Fellowship. C.RJ.K. is the guarantor of this study. Funding was also received from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brezniceanu ML, 2007, KIDNEY INT, V71, P912, DOI 10.1038/sj.ki.5002188; Brosius FC, 2013, CURR OPIN NEPHROL HY, V22, P17, DOI 10.1097/MNH.0b013e32835b3766; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Burger D, 2014, CLIN SCI LOND; Caron KMI, 2005, PHYSIOL GENOMICS, V20, P203, DOI 10.1152/physiolgenomics.00221.2004; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Conway BR, 2011, J AM SOC NEPHROLOGY; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Fletcher Sarah J, 2012, Front Endocrinol (Lausanne), V3, P166, DOI 10.3389/fendo.2012.00166; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Soler MJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/616313; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kobori H, 2012, J INVESTIG MED; Lo CS, 2012, AM J PHYSIOL-RENAL, V302, pF840, DOI 10.1152/ajprenal.00340.2011; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Powell DW, 2013, LIFE SCI, V93, P257, DOI 10.1016/j.lfs.2013.06.016; Prescott G, 2000, PHYSIOL GENOMICS, V4, P67, DOI 10.1152/physiolgenomics.2000.4.1.67; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Redon J, 2012, J AM COLL CARDIOL, V59, P74, DOI 10.1016/j.jacc.2011.09.040; Reiser J, 2007, CURR HYPERTENS REP, V9, P403, DOI 10.1007/s11906-007-0074-7; Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060; Remuzzi Giuseppe, 2005, Kidney Int Suppl, pS57; Singh R, 1999, DIABETES, V48, P2066, DOI 10.2337/diabetes.48.10.2066; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Touyz RM, 2005, HYPERTENSION, V45, P530, DOI 10.1161/01.HYP.0000158845.49943.5e; Zhang MZ, 2011, AM J PHYSL RENAL PHY; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248	37	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113459	10.1371/journal.pone.0113459	http://dx.doi.org/10.1371/journal.pone.0113459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514595	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300004
J	Mohan, H; Ramesh, N; Mortazavi, S; Le, A; Iwakura, H; Unniappan, S				Mohan, Haneesha; Ramesh, Naresh; Mortazavi, Sima; Le, Anthony; Iwakura, Hiroshi; Unniappan, Suraj			Nutrients Differentially Regulate Nucleobindin-2/Nesfatin-1 In Vitro in Cultured Stomach Ghrelinoma (MGN3-1) Cells and In Vivo in Male Mice	PLOS ONE			English	Article							SECRETION; NESFATIN-1; INSULIN; EXPRESSION; GLUCAGON; PROTEIN; CLONING; GPR120; GPR40	Nesfatin-1 is secreted, meal-responsive anorexigenic peptide encoded in the precursor nucleobindin-2 [NUCB2]. Circulating nesfatin-1 increases post- prandially, but the dietary components that modulate NUCB2/nesfatin-1 remain unknown. We hypothesized that carbohydrate, fat and protein differentially regulate tissue specific expression of nesfatin-1. NUCB2, prohormone convertases and nesfatin-1 were detected in mouse stomach ghrelinoma [MGN3-1] cells. NUCB2 mRNA and protein were also detected in mouse liver, and small and large intestines. MGN3-1 cells were treated with glucose, fatty acids or amino acids. Male C57BL/6 mice were chronically fed high fat, high carbohydrate and high protein diets for 17 weeks. Quantitative PCR and nesfatin-1 assays were used to determine nesfatin-1 at mRNA and protein levels. Glucose stimulated NUCB2 mRNA expression in MGN3-1 cells. L-Tryptophan also increased NUCB2 mRNA expression and ghrelin mRNA expression, and nesfatin-1 secretion. Oleic acid inhibited NUCB2 mRNA expression, while ghrelin mRNA expression and secretion was enhanced. NUCB2 mRNA expression was significantly lower in the liver of mice fed a high protein diet compared to mice fed other diets. Chronic intake of high fat diet caused a significant reduction in NUCB2 mRNA in the stomach, while high protein and high fat diet caused similar suppression of NUCB2 mRNA in the large intestine. No differences in serum nesfatin-1 levels were found in mice at 7 a. m, at the commencement of the light phase. High carbohydrate diet fed mice showed significantly elevated nesfatin-1 levels at 1 p.m. Serum nesfatin-1 was significantly lower in mice fed high fat, protein or carbohydrate compared to the controls at 7 p.m, just prior to the dark phase. Mice that received a bolus of high fat had significantly elevated nesfatin-1/ NUCB2 at all time points tested post-gavage, compared to control mice and mice fed other diets. Our results for the first time indicate that nesfatin-1 is modulated by nutrients.	[Mohan, Haneesha; Ramesh, Naresh; Mortazavi, Sima; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Le, Anthony] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Iwakura, Hiroshi] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Sakyo Ku, Kyoto, Japan	University of Saskatchewan; York University - Canada; Kyoto University	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada.	suraj.unniappan@usask.ca		Iwakura, Hiroshi/0000-0001-8033-0736	Canadian Insitutes of Health Research (CIHR); Saskatchewan Health Research Foundation	Canadian Insitutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation	This research is funded by an open operating grant from the Canadian Insitutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html) and an Establishment Grant from the Saskatchewan Health Research Foundation (http:// shrf.ca/). SU is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders have no role in the research or manuscript preparation.	Al Massadi O, 2010, J ENDOCRINOL INVEST, V33, P599, DOI 10.1007/BF03346655; BARNIKOLWATANABE S, 1994, BIOL CHEM H-S, V375, P497, DOI 10.1515/bchm3.1994.375.8.497; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Broglio F, 2004, CLIN ENDOCRINOL, V61, P503, DOI 10.1111/j.1365-2265.2004.02121.x; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2011, J ENDOCRINOL, V208, pR9, DOI 10.1530/JOE-10-0492; Gonzalez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015201; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Koliaki Chrysi, 2010, Int J Pept, V2010, DOI 10.1155/2010/710852; Krause W J, 2000, Prog Histochem Cytochem, V35, P259; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Mohan H, 2012, REGUL PEPTIDES, V175, P61, DOI 10.1016/j.regpep.2012.02.006; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Stengel A, 2012, PEPTIDES, V35, P143, DOI 10.1016/j.peptides.2012.03.015; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Varricchio E, 2013, ACTA HISTOCHEM; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064882; Xia ZF, 2012, AM J PHYSIOL-GASTR L, V303, pG570, DOI 10.1152/ajpgi.00178.2012; Zhang AQ, 2010, WORLD J GASTROENTERO, V16, P1735, DOI 10.3748/wjg.v16.i14.1735; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115102	10.1371/journal.pone.0115102	http://dx.doi.org/10.1371/journal.pone.0115102			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506938	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100051
J	Okazaki, Y; Furuhashi, M; Tanaka, M; Mita, T; Fuseya, T; Ishimura, S; Watanabe, Y; Hoshina, K; Akasaka, H; Ohnishi, H; Yoshida, H; Saitoh, S; Shimamoto, K; Miura, T				Okazaki, Yusuke; Furuhashi, Masato; Tanaka, Marenao; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Watanabe, Yuki; Hoshina, Kyoko; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Shimamoto, Kazuaki; Miura, Tetsuji			Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction	PLOS ONE			English	Article							LIVER-TYPE; METABOLIC SYNDROME; APOLIPOPROTEIN-E; BIOMARKER; OBESITY; KIDNEY; HEART; AP2; DETERIORATION; DEFICIENT	Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2) is expressed in not only adipocytes and macrophages but also peritubular capillaries in the normal kidney. We recently demonstrated that ectopic expression of FABP4, but not FABP1 known as liver FABP (L-FABP), in the glomerulus is associated with progression of proteinuria and renal dysfunction. However, urinary excretion of FABP4 has not been investigated. Methods: Subjects who participated in the Tanno-Sobetsu Study, a study with a population-based cohort design, in 2011 (n=392, male/female: 166/226) were enrolled. Urinary FABP4 (U-FABP4) and urinary albumin-to-creatinine ratio (UACR) were measured. Change in estimated glomerular filtration rate (eGFR) was followed up one year later. Results: In 93 (23.7%) of the 392 subjects, U-FABP4 level was below the sensitivity of the assay. Subjects with undetectable U-FABP4 were younger and had lower UACR and higher eGFR levels than subjects with measurable U-FABP4. U-FABP4 level was positively correlated with age, systolic blood pressure and levels of serum FABP4 (S-FABP4), triglycerides, hemoglobin A1c (HbA1c), urinary FABP1 (U-FABP1) and UACR (r=0.360, p<0.001). Age, S-FABP4, U-FABP1 and UACR were independent predictors of U-FABP4. On the other hand, systolic blood pressure, HbA1c and U-FABP4 were independently correlated with UACR. Reduction in eGFR after one year was significantly larger in a group with the highest tertile of baseline U-FABP4 than a group with the lowest tertile. Conclusions: Urinary FABP4 level is independently correlated with level of albuminuria and possibly predicts yearly decline of eGFR. U-FABP4 would be a novel biomarker of glomerular damage.	[Okazaki, Yusuke; Furuhashi, Masato; Tanaka, Marenao; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Watanabe, Yuki; Hoshina, Kyoko; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Dept Nursing, Div Med & Behav Subjects, Sapporo, Hokkaido, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Furuhashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Furuhashi, Masato/AAT-5518-2021; Marenao, Tanaka/ABA-4054-2020	Furuhashi, Masato/0000-0002-0145-3541; Tanaka, Marenao/0000-0002-6575-9996; Ohnishi, Hirofumi/0000-0002-5873-6438	JSPS KAKENHI; Takeda Science Foundation; Ono Medical Research Foundation; Akiyama Life Science Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Diabetes Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Akiyama Life Science Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Diabetes Foundation	M.F. has been supported by grants from JSPS KAKENHI, Takeda Science Foundation, Ono Medical Research Foundation, Akiyama Life Science Foundation, Suhara Memorial Foundation, Takeda Medical Research Foundation, and Japan Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Furuhashi M, 2014, HYPERTENS R IN PRESS; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Gilkeson GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064650; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.01835.x; Lee MYK, 2007, ARTERIOSCL THROM VAS, V27, P2443, DOI 10.1161/ATVBAHA.107.141705; Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x; MAATMAN RGHJ, 1992, BIOCHEM J, V288, P285, DOI 10.1042/bj2880285; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Mou S, 2012, CLIN CHIM ACTA, V413, P187, DOI 10.1016/j.cca.2011.09.018; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Tanaka M, 2014, NEPHRON CLIN PRACT, V128, P345, DOI 10.1159/000368412; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170	42	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115429	10.1371/journal.pone.0115429	http://dx.doi.org/10.1371/journal.pone.0115429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506691	Green Published, gold, Green Submitted			2022-12-26	WOS:000346607100076
J	Vaarala, O; Vuorela, A; Partinen, M; Baumann, M; Freitag, TL; Meri, S; Saavalainen, P; Jauhiainen, M; Soliymani, R; Kirjavainen, T; Olsen, P; Saarenpaa-Heikkila, O; Rouvinen, J; Roivainen, M; Nohynek, H; Jokinen, J; Julkunen, I; Kilpi, T				Vaarala, Outi; Vuorela, Arja; Partinen, Markku; Baumann, Marc; Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi; Jauhiainen, Matti; Soliymani, Rabah; Kirjavainen, Turkka; Olsen, Paivi; Saarenpaa-Heikkila, Outi; Rouvinen, Juha; Roivainen, Merja; Nohynek, Hanna; Jokinen, Jukka; Julkunen, Ilkka; Kilpi, Terhi			Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk	PLOS ONE			English	Article							VACCINATION; ANTIBODIES; CHILDREN; PROTEIN; CELLS	Background: Narcolepsy results from immune-mediated destruction of hypocretin secreting neurons in hypothalamus, however the triggers and disease mechanisms are poorly understood. Vaccine-attributable risk of narcolepsy reported so far with the AS03 adjuvanted H1N1 vaccination Pandemrix has been manifold compared to the AS03 adjuvanted Arepanrix, which contained differently produced H1N1 viral antigen preparation. Hence, antigenic differences and antibody response to these vaccines were investigated. Methods and Findings: Increased circulating IgG-antibody levels to Pandemrix H1N1 antigen were found in 47 children with Pandemrix-associated narcolepsy when compared to 57 healthy children vaccinated with Pandemrix. H1N1 antigen of Arepanrix inhibited poorly these antibodies indicating antigenic difference between Arepanrix and Pandemrix. High-resolution gel electrophoresis quantitation and mass spectrometry identification analyses revealed higher amounts of structurally altered viral nucleoprotein (NP) in Pandemrix. Increased antibody levels to hemagglutinin (HA) and NP, particularly to detergent treated NP, was seen in narcolepsy. Higher levels of antibodies to NP were found in children with DQB1*06:02 risk allele and in DQB1*06:02 transgenic mice immunized with Pandemrix when compared to controls. Conclusions: This work identified 1) higher amounts of structurally altered viral NP in Pandemrix than in Arepanrix, 2) detergent-induced antigenic changes of viral NP, that are recognized by antibodies from children with narcolepsy, and 3) increased antibody response to NP in association of DQB1*06:02 risk allele of narcolepsy. These findings provide a link between Pandemrix and narcolepsy. Although detailed mechanisms of Pandemrix in narcolepsy remain elusive, our results move the focus from adjuvant(s) onto the H1N1 viral proteins.	[Vaarala, Outi; Vuorela, Arja; Nohynek, Hanna; Jokinen, Jukka; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Vitalmed Res Ctr Helsinki, Helsinki Sleep Clin, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Baumann, Marc; Soliymani, Rabah] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Meilahti Clin Prote Core Facil, Helsinki, Finland; [Baumann, Marc; Soliymani, Rabah] Univ Helsinki, NeuroMed Res Program, Helsinki, Finland; [Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi] Univ Helsinki, Res Program Unit, Helsinki, Finland; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Biomedicum, Publ Hlth Genom Res Unit, Helsinki, Finland; [Kirjavainen, Turkka] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat, Helsinki, Finland; [Olsen, Paivi] Oulu Univ Hosp, Dept Child Neurol, Oulu, Finland; [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Rouvinen, Juha] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Rouvinen, Juha] Univ Eastern Finland, Bioctr Kuopio, Joensuu, Finland; [Roivainen, Merja; Julkunen, Ilkka] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Julkunen, Ilkka] Univ Turku, Dept Virol, Turku, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Tampere University; Tampere University Hospital; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Turku	Vaarala, O (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland.	outi.vaarala@helsinki.fi	Saavalainen, Päivi M/E-8621-2011	Rouvinen, Juha/0000-0003-1843-5718; Baumann, Marc/0000-0002-2991-889X; Meri, Seppo/0000-0001-9142-501X; Freitag, Tobias/0000-0001-5971-2991; Soliymani, Rabah/0000-0003-0184-3352; Vuorela, Arja/0000-0001-9987-1903; Kirjavainen, Turkka/0000-0002-0043-5093; Partinen, Markku/0000-0002-8182-9368	National Institute for Health and Welfare (THL), Academy of Finland [260603]; Ministry of Social Affairs and Health, Finland	National Institute for Health and Welfare (THL), Academy of Finland; Ministry of Social Affairs and Health, Finland	The following organizations funded the study: National Institute for Health and Welfare (THL), Academy of Finland (260603) and Ministry of Social Affairs and Health, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Billiard M, 1989, SLEEP RES, V18, P201; Choe YJ, 2012, VACCINE, V30, P7439, DOI 10.1016/j.vaccine.2012.10.030; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; European Medicines Agency, EMA6910372013 CHMP; European Medicines Agency, ASS REP IMM DIFF PAN; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayward SL, 2006, J IMMUNOL, V176, P7715, DOI 10.4049/jimmunol.176.12.7715; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Hermeling S, 2003, PHARM RES, V20, P1903, DOI 10.1023/B:PHAM.0000008034.61317.02; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lind A, 2014, J AUTOIMMUN, V50, P99, DOI 10.1016/j.jaut.2014.01.031; Melen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068402; Mikk ML, 2014, HUM IMMUNOL, V75, P65, DOI 10.1016/j.humimm.2013.09.008; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; Nohynek H, 2012, PLOS ONE, V7; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Prokudina EN, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-37; Samoilovich E, 2003, J MED VIROL, V71, P274, DOI 10.1002/jmv.10480; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h	30	70	71	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114361	10.1371/journal.pone.0114361	http://dx.doi.org/10.1371/journal.pone.0114361			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25501681	Green Published, gold			2022-12-26	WOS:000346607100012
J	Chiku, K; Nihira, T; Suzuki, E; Nishimoto, M; Kitaoka, M; Ohtsubo, K; Nakai, H				Chiku, Kazuhiro; Nihira, Takanori; Suzuki, Erika; Nishimoto, Mamoru; Kitaoka, Motomitsu; Ohtsubo, Ken'ichi; Nakai, Hiroyuki			Discovery of Two beta-1,2-Mannoside Phosphorylases Showing Different Chain-Length Specificities from Thermoanaerobacter sp X-514	PLOS ONE			English	Article							CANDIDA-ALBICANS; 4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE; BETA-1,2-LINKED OLIGOMANNOSIDES; GLYCOSIDE PHOSPHORYLASES; ENZYMATIC-SYNTHESIS; RUMINOCOCCUS-ALBUS; ESCHERICHIA-COLI; IDENTIFICATION; PROTEIN; MANNAN	We characterized Teth514_1788 and Teth514_1789, belonging to glycoside hydrolase family 130, from Thermoanaerobacter sp. X-514. These two enzymes catalyzed the synthesis of 1,2-beta-oligomannan using beta-1,2-mannobiose and Dmannose as the optimal acceptors, respectively, in the presence of the donor alpha-Dmannose 1-phosphate. Kinetic analysis of the phosphorolytic reaction toward 1,2-beta-oligomannan revealed that these enzymes followed a typical sequential Bi Bi mechanism. The kinetic parameters of the phosphorolysis of 1,2-beta-oligomannan indicate that Teth514_1788 and Teth514_1789 prefer 1,2-beta-oligomannans containing a DP >= 3 and beta-1,2-Man(2), respectively. These results indicate that the two enzymes are novel inverting phosphorylases that exhibit distinct chain-length specificities toward 1,2-beta-oligomannan. Here, we propose 1,2-beta-oligomannan: phosphate alpha-D-mannosyltransferase as the systematic name and 1,2 beta- oligomannan phosphorylase as the short name for Teth514_1788 and beta-1,2-mannobiose: phosphate alpha-D-mannosyltransferase as the systematic name and beta-1-,2-mannobiosephosphorylase as the short name for Teth514_1789.	[Chiku, Kazuhiro; Nihira, Takanori; Suzuki, Erika; Ohtsubo, Ken'ichi; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 95021, Japan; [Nishimoto, Mamoru; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakai, H (corresponding author), Niigata Univ, Fac Agr, Niigata 95021, Japan.	nakai@agr.niigata-u.ac.jp	Ohtsubo, Kenichi/AAW-1700-2020; Chiku, Kazuhiro/O-3055-2018; Kitaoka, Motomitsu/R-1536-2019	Ohtsubo, Kenichi/0000-0001-9354-3087; Chiku, Kazuhiro/0000-0001-6857-8894; Kitaoka, Motomitsu/0000-0002-0083-1838	JSPS; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by JSPS's program "Grant-in-Aid for Research Activity Start-up", MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology, Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and Grant for Promotion of Niigata University Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BEYNON LM, 1995, CARBOHYD RES, V272, P231, DOI 10.1016/0008-6215(95)00095-B; CHENG CC, 1979, CARBOHYD RES, V73, P169; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; EKWALL E, 1982, J MED MICROBIOL, V15, P173, DOI 10.1099/00222615-15-2-173; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gerber-Lemaire S, 2009, SPR CARB CH, V35, P13, DOI 10.1039/b905496k; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Hemme CL, 2010, J BACTERIOL, V192, P6494, DOI 10.1128/JB.01064-10; Jaito N, 2014, BIOSCI BIOTECH BIOCH, V78, P263, DOI 10.1080/09168451.2014.882760; Jouault T, 1998, J INFECT DIS, V178, P792, DOI 10.1086/515361; JOUAULT T, 1995, INFECT IMMUN, V63, P2378, DOI 10.1128/IAI.63.6.2378-2381.1995; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Liu Y, 2014, CARBOHYDR R IN PRESS; Lombard V, 2014, NUCL ACIDS IN PRESS; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; MURAO S, 1985, AGR BIOL CHEM TOKYO, V49, P2113, DOI 10.1080/00021369.1985.10867024; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nihira T, 2014, J APPL GLYCOSC, V2, P59, DOI [10.5458/jag.jag.JAG-2013_013, DOI 10.5458/JAG.JAG.JAG-2013_013]; Nihira T., 2013, J APPL GLYCOSCI, V60, P137; Nihira T, 2014, J APPL GLYC IN PRESS; Nihira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086548; Nihira T, 2013, FEBS LETT, V587, P3382, DOI 10.1016/j.febslet.2013.08.038; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; PREVIATO JO, 1982, EXP PARASITOL, V53, P170, DOI 10.1016/0014-4894(82)90058-3; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Sawangwan T, 2009, ORG BIOMOL CHEM, V7, P4267, DOI 10.1039/b912621j; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Suzuki M, 2009, NEW BIOTECHNOL, V26, P137, DOI 10.1016/j.nbt.2009.07.004	51	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114882	10.1371/journal.pone.0114882	http://dx.doi.org/10.1371/journal.pone.0114882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500577	Green Published, gold, Green Submitted			2022-12-26	WOS:000346375400058
J	Roh, JY; Song, BG; Park, WI; Shin, EH; Park, C; Park, MY; Chang, KS; Lee, WG; Lee, HI; Shin, EH				Roh, Jong Yul; Song, Bong Gu; Park, Won Il; Shin, Eun Hee; Park, Chan; Park, Mi-Yeoun; Chang, Kyu Sik; Lee, Wook Gyo; Lee, Hee Il; Shin, E-Hyun			Coincidence between Geographical Distribution of Leptotrombidium scutellare and Scrub Typhus Incidence in South Korea	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; RELATIVE ABUNDANCE; ENDEMIC AREA; TROMBICULIDAE; VECTORS; ACARI; TRANSMISSION; RODENTS	To clarify the geographical distribution of scrub typhus vectors in Korea, a survey of larval trombiculid mites was conducted from 2005 to 2007 by collecting wild small mammals twice a year (spring and autumn) at 24 sites nationwide. A total of 67,325 mites representing 4 genera and 14 species were collected from 783 trapped rodents, corresponding to a chigger index (number of chigger mites per rodent) of 86.0. The predominant mite species were Leptotrombidium pallidum (52.6%), Leptotrombiduim scutellare (27.1%), Leptotrombidium palpale (8.2%), Leptotrombidium orientale (5.6%), and Neotrombicula tamiyai (1.7%). However, the proportions of L. scutellare in southern areas, including endemic provinces such as Jeollabuk-Do (34.3%), Jeollanam-Do (49.0%), and Gyeongsangnam-Do (88%), were relatively higher than in central Korean regions where L. pallidum was predominant. In autumn, the ratio of L. scutellare increased to 42% while the ratio of L. pallidum decreased. The geographical distribution map of the L. scutellare chigger index was identical to the incidence pattern of scrub typhus, whereas those of overall mites and L. pallidum showed no relationship with case incidence patterns. Distribution mapping analysis shows an identical geographical distribution of L. scutellare and epidemic incidence of scrub typhus in South Korea. L. pallidum could be another vector at all other parts of the Korean peninsula, including the eastern and northern regions that have a low level of scrub typhus incidence.	[Roh, Jong Yul; Song, Bong Gu; Park, Won Il; Shin, Eun Hee; Park, Mi-Yeoun; Chang, Kyu Sik; Lee, Wook Gyo; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea; [Park, Chan] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Arboviruses, Cheongju, South Korea; [Lee, Hee Il] Korea Natl Inst Hlth, Div Biosafety Evaluat & Control, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Division of Biosafety Evaluation & Control	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019; Shin, Eun-Hee/D-5757-2012		Korea Centers for Disease Control and Prevention under the budget for health promotion [4800-4851-300]	Korea Centers for Disease Control and Prevention under the budget for health promotion	This work was supported by Korea Centers for Disease Control and Prevention under the budget for health promotion (No. 4800-4851-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang Woo-Hyun, 1995, Journal of Korean Medical Science, V10, P227; Frances SP, 1999, J MED ENTOMOL, V36, P869, DOI 10.1093/jmedent/36.6.869; KCDC, 2012, NAT NOT DIS SURV SYS; Kim HC, 2010, KOREAN J PARASITOL, V48, P237, DOI 10.3347/kjp.2010.48.3.237; Kuo CC, 2011, MED VET ENTOMOL, V25, P169, DOI 10.1111/j.1365-2915.2010.00941.x; Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; Lee IY, 2009, KOREAN J PARASITOL, V47, P381, DOI 10.3347/kjp.2009.47.4.381; Lee SH, 2012, KOREAN J PARASITOL, V50, P327, DOI 10.3347/kjp.2012.50.4.327; Phasomkusolsil S, 2009, J MED ENTOMOL, V46, P1442, DOI 10.1603/033.046.0628; REE H-I, 1990, Korean Journal of Systematic Zoology, V6, P57; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Ree Han-Il, 1997, Korean Journal of Parasitology, V35, P171, DOI 10.3347/kjp.1997.35.3.171; Ree Han-Il, 1997, Medical Entomology and Zoology, V48, P197; Ree Han-Il, 1992, Korean Journal of Parasitology, V30, P341, DOI 10.3347/kjp.1992.30.4.341; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Takahashi M, 2004, J MED ENTOMOL, V41, P107, DOI 10.1603/0022-2585-41.1.107; TAKAHASHI M, 1988, JPN J EXP MED, V58, P213	18	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113193	10.1371/journal.pone.0113193	http://dx.doi.org/10.1371/journal.pone.0113193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500568	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400006
J	Jaratlerdsiri, W; Deakin, J; Godinez, MR; Shan, X; Peterson, DG; Marthey, S; Lyons, E; McCarthy, FM; Isberg, SR; Higgins, DP; Chong, AY; St John, J; Glenn, TC; Ray, DA; Gongora, J				Jaratlerdsiri, Weerachai; Deakin, Janine; Godinez, Ricardo M.; Shan, Xueyan; Peterson, Daniel G.; Marthey, Sylvain; Lyons, Eric; McCarthy, Fiona M.; Isberg, Sally R.; Higgins, Damien P.; Chong, Amanda Y.; St John, John; Glenn, Travis C.; Ray, David A.; Gongora, Jaime			Comparative Genome Analyses Reveal Distinct Structure in the Saltwater Crocodile MHC	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I REGION; CLASS-IIB; GENES; EVOLUTION; DUPLICATION; SEQUENCE; CHICKEN; ORGANIZATION; POLYMORPHISM	The major histocompatibility complex (MHC) is a dynamic genome region with an essential role in the adaptive immunity of vertebrates, especially antigen presentation. The MHC is generally divided into subregions (classes I, II and III) containing genes of similar function across species, but with different gene number and organisation. Crocodylia (crocodilians) are widely distributed and represent an evolutionary distinct group among higher vertebrates, but the genomic organisation of MHC within this lineage has been largely unexplored. Here, we studied the MHC region of the saltwater crocodile (Crocodylus porosus) and compared it with that of other taxa. We characterised genomic clusters encompassing MHC class I and class II genes in the saltwater crocodile based on sequencing of bacterial artificial chromosomes. Six gene clusters spanning similar to 452 kb were identified to contain nine MHC class I genes, six MHC class II genes, three TAP genes, and a TRIM gene. These MHC class I and class II genes were in separate scaffold regions and were greater in length (2- 6 times longer) than their counterparts in well- studied fowl B loci, suggesting that the compaction of avian MHC occurred after the crocodilianavian split. Comparative analyses between the saltwater crocodile MHC and that from the alligator and gharial showed large syntenic areas (>80% identity) with similar gene order. Comparisons with other vertebrates showed that the saltwater crocodile had MHC class I genes located along with TAP, consistent with birds studied. Linkage between MHC class I and TRIM39 observed in the saltwater crocodile resembled MHC in eutherians compared, but absent in avian MHC, suggesting that the saltwater crocodile MHC appears to have gene organisation intermediate between these two lineages. These observations suggest that the structure of the saltwater crocodile MHC, and other crocodilians, can help determine the MHC that was present in the ancestors of archosaurs.	[Jaratlerdsiri, Weerachai; Isberg, Sally R.; Higgins, Damien P.; Chong, Amanda Y.; Gongora, Jaime] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Deakin, Janine] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Deakin, Janine] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Godinez, Ricardo M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Shan, Xueyan; Ray, David A.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Peterson, Daniel G.; Ray, David A.] Mississippi State Univ, IGBB, Mississippi State, MS 39762 USA; [Marthey, Sylvain] INRA, UMR 1313, F-78352 Jouy En Josas, France; [Lyons, Eric] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [McCarthy, Fiona M.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA; [Isberg, Sally R.] Ctr Crocodile Res, Noonamah, NT 0837, Australia; [St John, John] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Godinez, Ricardo M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Sydney; Australian National University; University of Canberra; Harvard University; Mississippi State University; Mississippi State University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; University of Arizona; University of California System; University of California Santa Cruz; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School	Gongora, J (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	jaime.gongora@sydney.edu.au	Deakin, Janine/A-1941-2008; Glenn, Travis C/A-2390-2008; Higgins, Damien P/A-9601-2011; Jaratlerdsiri, Weerachai/ABE-3372-2021	Deakin, Janine/0000-0002-1259-3531; Glenn, Travis C/0000-0001-7725-3637; Lyons, Eric/0000-0002-3348-8845; Jaratlerdsiri, Weerachai/0000-0001-9100-1807; Peterson, Daniel/0000-0002-0274-5968; Higgins, Damien/0000-0003-1215-6523; Gongora, Jaime/0000-0003-2215-656X; Ray, David/0000-0002-3340-3987; Chong, Amanda/0000-0003-4919-2632; Isberg, Sally/0000-0002-8895-2414	Rural Industries Research and Development Corporation grant [PRJ-002461]; US National Science Foundation [MCB-1052500, MCB-0841821]; Direct For Biological Sciences [0841821] Funding Source: National Science Foundation	Rural Industries Research and Development Corporation grant(Rural Industries R&D Corp); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was partially supported by a Rural Industries Research and Development Corporation grant (http://www.rirdc.gov.au/; PRJ-002461 to SRI JG). Funding for the C. porosus, A. mississippiensis, and G. gangeticus genome drafts was provided, in part, by the US National Science Foundation (http://www.nsf.gov/; MCB-1052500 and MCB-0841821 to DAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou C, 2003, HUM MOL GENET, V12, P3025, DOI 10.1093/hmg/ddg317; Amadou C, 1999, IMMUNOGENETICS, V49, P362, DOI 10.1007/s002510050507; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Brown TA, 2002, SEQUENCING GENOMES G; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burri R, 2008, MOL BIOL EVOL, V25, P1180, DOI 10.1093/molbev/msn065; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Clark MS, 2001, IMMUNOGENETICS, V52, P174, DOI 10.1007/s002510000285; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Ferreri GC, 2004, CYTOGENET GENOME RES, V107, P115, DOI 10.1159/000079580; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; Ganapathy G, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-11; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; Green RE, SCIENCE; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Hughes AL, 2008, MOL BIOL EVOL, V25, P2681, DOI 10.1093/molbev/msn207; Jaratlerdsiri W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087534; Jaratlerdsiri W, 2014, IMMUNOGENETICS, V66, P53, DOI 10.1007/s00251-013-0746-1; Jaratlerdsiri W, 2012, IMMUNOGENETICS, V64, P825, DOI 10.1007/s00251-012-0637-x; Jerome Mariette, 2011, BMC Res Notes, V4, P149, DOI 10.1186/1756-0500-4-149; KASAHARA M, 1993, EUR J IMMUNOL, V23, P2160, DOI 10.1002/eji.1830230917; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Kaufman J, 2013, MOL IMMUNOL, V55, P159, DOI 10.1016/j.molimm.2012.10.030; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kitts P, 2002, NCBI HDB; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Kulski JK, 1999, J MOL EVOL, V49, P84, DOI 10.1007/PL00006537; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kuroda N, 2002, IMMUNOGENETICS, V54, P418, DOI 10.1007/s00251-002-0473-5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd Mark, 1999, Bulletin of the Association of Reptilian and Amphibian Veterinarians, V9, P12; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lukacs MF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-251; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Promerova M, 2009, IMMUNOGENETICS, V61, P451, DOI 10.1007/s00251-009-0375-x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Sambrook JG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-152; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Sato A, 2011, MOL BIOL EVOL, V28, P1943, DOI 10.1093/molbev/msr015; Schut E, 2011, IMMUNOGENETICS, V63, P531, DOI 10.1007/s00251-011-0532-x; Shan X, 2009, BMC GENOMICS, V10, P59; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Siddle HV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-421; Siddle HV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-310; SNELL GD, 1992, SCAND J IMMUNOL, V36, P513; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Walker BA, 2005, IMMUNOGENETICS, V57, P232, DOI 10.1007/s00251-005-0786-2; Wan QH, 2013, CELL RES, V23, P1091, DOI 10.1038/cr.2013.104; Wang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-553; Westerdahl H, 2004, HEREDITY, V92, P534, DOI 10.1038/sj.hdy.6800450; Wilming LG, 2013, SEQUENCING COMP ANAL; Yap MW, 2012, TRIM RBCC PROTEINS; Ye Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032154; Yuhki N, 2007, J HERED, V98, P390, DOI 10.1093/jhered/esm056; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; Zhan X, 2014, GIGASCIENCE, DOI [10.5524/101006., DOI 10.5524/101006.]; Zhang G, 2014, GIGASCIENCE, DOI [10.5524/101013, DOI 10.5524/101013.]; Zheng J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	93	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114631	10.1371/journal.pone.0114631	http://dx.doi.org/10.1371/journal.pone.0114631			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503521	Green Published, gold			2022-12-26	WOS:000347146700036
J	Marchio, A; Bertani, S; Rojas, TR; Doimi, F; Terris, B; Deharo, E; Dejean, A; Ruiz, E; Pineau, P				Marchio, Agnes; Bertani, Stephane; Rojas, Teresa Rojas; Doimi, Franco; Terris, Benoit; Deharo, Eric; Dejean, Anne; Ruiz, Eloy; Pineau, Pascal			A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							ALPHA-FETOPROTEIN GENE; FREQUENT SOMATIC MUTATIONS; BETA-CATENIN MUTATIONS; TUMOR-SUPPRESSOR GENE; CANCER STEM-CELLS; LIVER-CANCER; LATIN-AMERICA; EXPRESSION; HEPATITIS; EXPOSURE	Hepatocellular carcinoma usually afflicts individuals in their later years following longstanding liver disease. In Peru, hepatocellular carcinoma exists in a unique clinical presentation, which affects patients around age 25 with a normal, healthy liver. In order to deepen our understanding of the molecular processes ongoing in Peruvian liver tumors, mutation spectrum analysis was carried out on hepatocellular carcinomas from 80 Peruvian patients. Sequencing analysis focused on nine genes typically altered during liver carcinogenesis, i.e. ARID2, AXIN1, BRAF, CTNNB1, NFE2L2, H/K/N-RAS, and TP53. We also assessed the transcription level of factors involved in the control of the alpha-fetoprotein expression and the Hippo signaling pathway that controls contact inhibition in metazoans. The mutation spectrum of Peruvian patients was unique with a major class of alterations represented by Insertions/Deletions. There were no changes at hepatocellular carcinoma-associated mutation hotspots in more than half of the specimens analyzed. Furthermore, our findings support the theory of a consistent collapse in the Hippo axis, as well as an expression of the stemness factor NANOG in high alpha-fetoprotein-expressing hepatocellular carcinomas. These results confirm the specificity of Peruvian hepatocellular carcinoma at the molecular genetic level. The present study emphasizes the necessity to widen cancer research to include historically neglected patients from South America, and more broadly the Global South, where cancer genetics and tumor presentation are divergent from canonical neoplasms.	[Marchio, Agnes; Dejean, Anne; Pineau, Pascal] Inst Pasteur, Unite Org Nucl & Oncogenese, Paris, France; [Bertani, Stephane; Dejean, Anne; Pineau, Pascal] INSERM, U993, Paris, France; [Bertani, Stephane; Deharo, Eric] Univ Toulouse 3, UPS, PHARMADEV UMR152, F-31062 Toulouse, France; [Bertani, Stephane] Inst Rech Dev, PHARMADEV UMR152, Lima, Peru; [Rojas, Teresa Rojas] Aix Marseille Univ, Ctr Epidemiol & St Publ Armees, SESSTIM INSERM IRD AMU UMR192, Marseille, France; [Doimi, Franco] Inst Nacl Enfermedades Neoplasicas, Dept Patol Banco Tejidos Tumor, Lima, Peru; [Terris, Benoit] Hop Cochin, AP HP, Serv Anat & Cytol Pathol, F-75674 Paris, France; [Deharo, Eric] Inst Rech Dev, PHARMADEV UMR152, Viangchan, Laos; [Ruiz, Eloy] Inst Nacl Enfermedades Neoplasicas, Dept Cirugia Abdomen, Lima, Peru	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Instituto Nacional de Enfermedades Neoplasicas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Instituto Nacional de Enfermedades Neoplasicas	Pineau, P (corresponding author), Inst Pasteur, Unite Org Nucl & Oncogenese, Paris, France.	pascal.pineau@pasteur.fr	Pineau, Pascal/AAP-5614-2020; Deharo, Eric/I-6026-2015; Rojas, Teresa/E-3057-2016; Bertani, Stephane/B-1250-2013; Dejean, Anne/L-5145-2018; Terris, Benoit/P-1497-2017	Pineau, Pascal/0000-0002-9407-1592; Deharo, Eric/0000-0002-5664-9517; Bertani, Stephane/0000-0002-0398-9745; Rojas, Teresa/0000-0003-1536-3675	French National League against Cancer; Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan) [ENV201408]; Young Teams Associated to IRD Program (INCAnCER); Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad [BECA-1-P-155-13]	French National League against Cancer; Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan); Young Teams Associated to IRD Program (INCAnCER); Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad	This work was funded by the French National League against Cancer (team label LNCC) and Odyssey-RE; SB and ED (PI) were supported by the Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan) (ENV201408); FD (PI) and ER were supported by the Young Teams Associated to IRD Program (INCAnCER); TRR was a recipient of a doctoral fellowship from the Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad (BECA-1-P-155-13). The funders had no role in study design, data collection and analysis, decision	American Joint Committee on Cancer, 2002, AM JOINT COMM CANC S; BECKER FF, 1975, CANCER RES, V35, P1510; Bei R, 2011, CURR MOL MED, V11, P564, DOI 10.2174/156652411800615162; Bertani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067756; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; BOISJOYEUX B, 1995, J BIOL CHEM, V270, P10204, DOI 10.1074/jbc.270.17.10204; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bryant-Greenwood PK, 1998, FETAL DIAGN THER, V13, P46, DOI 10.1159/000020801; Cabezas César, 2007, Rev. perú. med. exp. salud publica, V24, P378; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Di Bisceglie AM, 2004, GASTROENTEROLOGY, V127, pS104, DOI 10.1053/j.gastro.2004.09.022; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fassio E, 2010, ANN HEPATOL, V9, P63, DOI 10.1016/S1665-2681(19)31681-3; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garcia-Diaz M, 2006, TRENDS BIOCHEM SCI, V31, P206, DOI 10.1016/j.tibs.2006.02.004; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2; Greenblatt MS, 1996, CANCER RES, V56, P2130; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Indacochea Sonia, 1997, Rev Gastroenterol Peru, V17, P56; Kenney J.F., 1962, MATH STAT, V3rd ed., P101; KEW M, 1974, GUT, V15, P814, DOI 10.1136/gut.15.10.814; Kew M C, 1995, Trop Gastroenterol, V16, P11; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; KOROPATNICK J, 1988, J BIOCHEM TOXICOL, V3, P159, DOI 10.1002/jbt.2570030304; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; LOGRIECO A, 1993, MYCOPATHOLOGIA, V122, P185, DOI 10.1007/BF01103480; MACNAB GM, 1976, BRIT J CANCER, V33, P544, DOI 10.1038/bjc.1976.86; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Marcos LA, 2009, J HELMINTHOL, V83, P23, DOI 10.1017/S0022149X08067205; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Nuttall KL, 2000, MED HYPOTHESES, V54, P498, DOI 10.1054/mehy.1999.0884; O'Connor ML, 2014, CANCER LETT, V344, P180, DOI 10.1016/j.canlet.2013.11.012; OBrien JE, 1997, OBSTET GYNECOL, V89, P355, DOI 10.1016/S0029-7844(96)00524-8; Peterson ML, 2011, SEMIN CANCER BIOL, V21, P21, DOI 10.1016/j.semcancer.2011.01.001; Pineau P, 2008, MUTAT RES-GEN TOX EN, V653, P6, DOI 10.1016/j.mrgentox.2008.01.012; Ruiz Eloy, 1998, Rev Gastroenterol Peru, V18, P199; Ruiz Eloy, 2007, Rev. gastroenterol. Perú, V27, P223; Sandoval JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073006; SCOTT RJ, 1989, CANCER RES, V49, P6085; Sell S, 1998, PATHOLOGY, V30, P34, DOI 10.1080/00313029800169645; SHUIN T, 1994, CANCER RES, V54, P2852; SIZARET P, 1975, ANN NY ACAD SCI, V259, P136, DOI 10.1111/j.1749-6632.1975.tb25410.x; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; SMALLEY SR, 1988, CANCER-AM CANCER SOC, V62, P1414, DOI 10.1002/1097-0142(19881001)62:7<1414::AID-CNCR2820620729>3.0.CO;2-7; SOLT DB, 1983, CANCER RES, V43, P188; Spear BT, 1999, SEMIN CANCER BIOL, V9, P109, DOI 10.1006/scbi.1998.0087; Sun C, 2013, INT J BIOCHEM CELL B, V45, P1099, DOI 10.1016/j.biocel.2013.02.017; Szymanska K, 2009, CANCER EPIDEM BIOMAR, V18, P1638, DOI 10.1158/1055-9965.EPI-08-1102; Tanase AM, 2015, J EXPO SCI ENV EPID, V25, P256, DOI 10.1038/jes.2014.16; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trevisani F, 2010, DIGEST LIVER DIS, V42, P341, DOI 10.1016/j.dld.2009.09.002; Tsang YT, 2013, J PATHOL, V231, P449, DOI 10.1002/path.4252; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tsoulfas G, 2012, ANZ J SURG, V82, P510, DOI 10.1111/j.1445-2197.2012.06079.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; VOGEL CL, 1970, LANCET, V2, P621; Wang J, 2009, CANCER INFORM, V7, P199; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Wilkening S, 2007, CARCINOGENESIS, V28, P2262, DOI 10.1093/carcin/bgm191; Yacoub C, 2012, SCI WORLD J, P1, DOI 10.1100/2012/732519; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100	72	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114912	10.1371/journal.pone.0114912	http://dx.doi.org/10.1371/journal.pone.0114912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502816	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700070
J	Meyers, DJ; Hood, ME; Stopka, TJ				Meyers, David J.; Hood, Maria Elena; Stopka, Thomas J.			HIV and Hepatitis C Mortality in Massachusetts, 2002-2011: Spatial Cluster and Trend Analysis of HIV and HCV Using Multiple Cause of Death	PLOS ONE			English	Article								Background: Infectious diseases, while associated with a much smaller proportion of deaths than they were 50 years ago, still play a significant role in mortality across the state of Massachusetts. Most analysis of infectious disease mortality in the state only take into account the underlying cause of death, rather than contributing causes of death, which may not capture the full extent of mortality trends for infectious diseases such as HIV and the Hepatitis C virus (HCV). Methods: In this study we sought to evaluate current trends in infectious disease mortality across the state using a multiple cause of death methodology. We performed a mortality trend analysis, identified spatial clusters of disease using a 5-step geoprocessing approach and examined spatial-temporal clustering trends in infectious disease mortality in Massachusetts from 2002-2011, with a focus on HIV/AIDS and HCV. Results: Significant clusters of high infectious disease mortality in space and time throughout the state were detected through both spatial and space time cluster analysis. The most significant clusters occurred in Springfield, Worcester, South Boston, the Merrimack Valley, and New Bedford with other smaller clusters detected across the state. Multiple cause of death mortality rates were much higher than underlying cause mortality alone, and significant disparities existed across race and age groups. Conclusions: We found that our multi-method analyses, which focused on contributing causes of death, were more robust than analyses that focused on underlying cause of death alone. Our results may be used to inform public health resource allocation for infectious disease prevention and treatment programs, provide novel insight into the current state of infectious disease mortality throughout the state, and benefited from approaches that may more accurately document mortality trends.	[Meyers, David J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Meyers, David J.; Stopka, Thomas J.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Hood, Maria Elena] Massachusetts Dept Publ Hlth, Off Data Management & Outcomes Assessment, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Department of Public Health; Tufts University; Massachusetts Department of Public Health	Meyers, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	dmeyers@hsph.harvard.edu	Meyers, David J/AFI-1703-2022; Stopka, Thomas/GSN-6831-2022	Meyers, David J/0000-0002-4081-1751; 	Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health; Department of Public Health and Community Medicine at the Tufts University School of Medicine	Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health; Department of Public Health and Community Medicine at the Tufts University School of Medicine	The authors would like to thank Christine Rioux, Kenneth Chui, and Brandon Olsen for additional guidance on the manuscript. This work was supported in kind by the Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health and the Department of Public Health and Community Medicine at the Tufts University School of Medicine.	Burra T, 2002, CAN GEOGR-GEOGR CAN, V46, P160, DOI 10.1111/j.1541-0064.2002.tb00737.x; Ed Hsu Chiehwen, 2004, Int J Health Geogr, V3, P4; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gundogdu IB, 2010, SAFETY SCI, V48, P763, DOI 10.1016/j.ssci.2010.02.016; HOOD M, 2013, MASSACHUSETTS DEATHS; KANJALA C, 2010, GLOB HLTH ACTION, V3; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; MACKENBACH JP, 1995, AM J EPIDEMIOL, V141, P466, DOI 10.1093/oxfordjournals.aje.a117449; Mahajan R, 2014, CLIN INFECT DIS, V58, P1055, DOI 10.1093/cid/ciu077; MANTON KG, 1980, GERONTOLOGIST, V20, P480, DOI 10.1093/geront/20.4.480; *MASSGIS, 2014, ADMINISTRATION AND F; *MDPH, 2011, AM J TRANSPLANT, V11, P1535, DOI DOI 10.1111/J.1600-6143.2011.03659.X; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; MJ A, 1994, GASTROENTEROL CLIN N, V23, P437; Nkhoma Ella T, 2004, Int J Health Geogr, V3, P25, DOI 10.1186/1476-072X-3-25; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; Rosenberg PS, 1998, JAMA-J AM MED ASSOC, V279, P1894, DOI 10.1001/jama.279.23.1894; Sabel CE, 2007, SOC SCI MED, V65, P43, DOI 10.1016/j.socscimed.2007.02.040; Stopka TJ, 2014, AM J PUBLIC HEALTH, V104, pS183, DOI 10.2105/AJPH.2013.301769	20	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114822	10.1371/journal.pone.0114822	http://dx.doi.org/10.1371/journal.pone.0114822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502820	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700056
J	Xu, JF; Yang, GH; Pan, XH; Zhang, SJ; Zhao, C; Qiu, BS; Gu, HF; Hong, JF; Cao, L; Chen, Y; Xia, B; Bi, Q; Wang, YP				Xu, Ji-Feng; Yang, Guang-hai; Pan, Xiao-Hong; Zhang, Shui-Jun; Zhao, Chen; Qiu, Bin-Song; Gu, Hai-Feng; Hong, Jian-Fei; Cao, Li; Chen, Yu; Xia, Bing; Bi, Qin; Wang, Ya-Ping			Altered MicroRNA Expression Profile in Exosomes during Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HUMAN SALIVA; IN-VITRO; MICROVESICLES; MECHANISM; WNT; MICROPARTICLES; INHIBITION; SECRETION; PROTEINS; TARGETS	The physiological role of microRNAs (miRNAs) in osteoblast differentiation remains elusive. Exosomal miRNAs isolated from human bone marrow-derived mesenchymal stem cells (BMSCs) culture were profiled using miRNA arrays containing probes for 894 human matured miRNAs. Seventy-nine miRNAs (similar to 8.84%) could be detected in exosomes isolated from BMSC culture supernatants when normalized to endogenous control genes RNU44. Among them, nine exosomal miRNAs were up regulated and 4 miRNAs were under regulated significantly (Relative fold >2, p<0.05) when compared with the values at 0 day with maximum changes at 1 to 7 days. Five miRNAs (miR-199b, miR-218, miR-148a, miR-135b, and miR-221) were further validated and differentially expressed in the individual exosomal samples from hBMSCs cultured at different time points. Bioinformatic analysis by DIANA-mirPath demonstrated that RNA degradation, mRNA surveillance pathway, Wnt signaling pathway, RNA transport were the most prominent pathways enriched in quantiles with differential exosomal miRNA patterns related to osteogenic differentiation. These data demonstrated exosomal miRNA is a regulator of osteoblast differentiation.	[Xu, Ji-Feng; Zhang, Shui-Jun; Zhao, Chen; Qiu, Bin-Song; Gu, Hai-Feng; Hong, Jian-Fei; Cao, Li; Chen, Yu; Xia, Bing; Bi, Qin] Zhejiang Prov Peoples Hosp, Dept Orthoped & Joint Surg, Hangzhou 310014, Zhejiang, Peoples R China; [Pan, Xiao-Hong; Wang, Ya-Ping] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310009, Zhejiang, Peoples R China; [Yang, Guang-hai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430022, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University; Huazhong University of Science & Technology	Xu, JF (corresponding author), Zhejiang Prov Peoples Hosp, Dept Orthoped & Joint Surg, Hangzhou 310014, Zhejiang, Peoples R China.	xu_jifeng@hotmail.com; wangypzju@163.com			Medical Scientific Research Foundation of Zhejiang Province, China [2013KYB031]; National Natural Science Foundation of China [81200113]; Fundamental Research Funds for the Central Universities [2014FZA7014]	Medical Scientific Research Foundation of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by Medical Scientific Research Foundation of Zhejiang Province, China (Grant No. 2013KYB031), National Natural Science Foundation of China (Grant No. 81200113), the Fundamental Research Funds for the Central Universities (Grant No. 2014FZA7014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen M, 2012, SEMIN THROMB HEMOST, V38, P102, DOI 10.1055/s-0031-1300956; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bakhshandeh B, 2012, BIOTECHNOL LETT, V34, P1579, DOI 10.1007/s10529-012-0934-3; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen TS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-47; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; Johansson SM, 2008, IMMUNOLOGY, V123, P491, DOI 10.1111/j.1365-2567.2007.02714.x; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vimalraj S, 2013, CURR ISSUES MOL BIOL, V15, P7; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Xu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079752; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang WB, 2014, BONE, V58, P59, DOI 10.1016/j.bone.2013.09.015; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	57	152	181	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114627	10.1371/journal.pone.0114627	http://dx.doi.org/10.1371/journal.pone.0114627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503309	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700035
J	von Oheimb, G; Hardtle, W; Eckstein, D; Engelke, HH; Hehnke, T; Wagner, B; Fichtner, A				von Oheimb, Goddert; Haerdtle, Werner; Eckstein, Dieter; Engelke, Hans-Hermann; Hehnke, Timo; Wagner, Bettina; Fichtner, Andreas			Does Forest Continuity Enhance the Resilience of Trees to Environmental Change?	PLOS ONE			English	Article							QUERCUS-PETRAEA LIEBL.; FAGUS-SYLVATICA L.; LAND-USE; BEECH FORESTS; RADIAL GROWTH; SOIL CARBON; RING WIDTH; OAK; CLIMATE; NITROGEN	There is ample evidence that continuously existing forests and afforestations on previously agricultural land differ with regard to ecosystem functions and services such as carbon sequestration, nutrient cycling and biodiversity. However, no studies have so far been conducted on possible long-term ( >100 years) impacts on tree growth caused by differences in the ecological continuity of forest stands. In the present study we analysed the variation in tree-ring width of sessile oak (Quercus petraea (Matt.) Liebl.) trees (mean age 115-136 years) due to different land-use histories (continuously existing forests, afforestations both on arable land and on heathland). We also analysed the relation of growth patterns to soil nutrient stores and to climatic parameters (temperature, precipitation). Tree rings formed between 1896 and 2005 were widest in trees afforested on arable land. This can be attributed to higher nitrogen and phosphorous availability and indicates that former fertilisation may continue to affect the nutritional status of forest soils for more than one century after those activities have ceased. Moreover, these trees responded more strongly to environmental changes-as shown by a higher mean sensitivity of the tree-ring widths-than trees of continuously existing forests. However, the impact of climatic parameters on the variability in tree-ring width was generally small, but trees on former arable land showed the highest susceptibility to annually changing climatic conditions. We assume that incompletely developed humus horizons as well as differences in the edaphon are responsible for the more sensitive response of oak trees of recent forests (former arable land and former heathland) to variation in environmental conditions. We conclude that forests characterised by a long ecological continuity may be better adapted to global change than recent forest ecosystems.	[von Oheimb, Goddert] Tech Univ Dresden, Inst Gen Ecol & Environm Protect, D-01737 Tharandt, Germany; [Haerdtle, Werner; Hehnke, Timo; Fichtner, Andreas] Leuphana Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany; [Eckstein, Dieter] Univ Hamburg, Ctr Wood Sci, D-21031 Hamburg, Germany; [Engelke, Hans-Hermann] Niedersachsen State Forestry Dept, Forestry Dept Sellhorn, D-29646 Bispingen, Germany; [Wagner, Bettina] Univ Gottingen, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany	Technische Universitat Dresden; Leuphana University Luneburg; University of Hamburg; University of Gottingen	von Oheimb, G (corresponding author), Tech Univ Dresden, Inst Gen Ecol & Environm Protect, Pienner Str 7, D-01737 Tharandt, Germany.	Goddert_v_Oheimb@tu-dresden.de	von Oheimb, Goddert/O-9483-2015; Fichtner, Andreas/AAP-3188-2021; Haerdtle, Werner/B-2568-2016	von Oheimb, Goddert/0000-0001-7408-425X; Fichtner, Andreas/0000-0003-0499-4893; Hardtle, Werner/0000-0002-5599-5792				Assmann T, 1999, BIODIVERS CONSERV, V8, P1499, DOI 10.1023/A:1008974413376; Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Baeten L, 2011, PLANT ECOL, V212, P901, DOI 10.1007/s11258-010-9876-9; Baeten L, 2010, OECOLOGIA, V163, P1021, DOI 10.1007/s00442-010-1599-z; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Bauhus J, 2010, ECOSYSTEM GOODS SERV, P96, DOI [10.4324/9781849776417, DOI 10.4324/9781849776417]; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Becker M, 1996, ANN SCI FOREST, V53, P585, DOI 10.1051/forest:19960237; Berges L, 2005, ANN FOREST SCI, V62, P391, DOI 10.1051/forest:2005035; Berges L, 2008, FOREST ECOL MANAG, V255, P567, DOI 10.1016/j.foreco.2007.09.027; Broadmeadow MSJ, 2000, NEW PHYTOL, V146, P437, DOI 10.1046/j.1469-8137.2000.00665.x; Brunet J, 1998, J ECOL, V86, P429, DOI 10.1046/j.1365-2745.1998.00269.x; Burton J, 2010, J SOIL SEDIMENT, V10, P1267, DOI 10.1007/s11368-010-0238-y; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Compton JE, 1998, OECOLOGIA, V116, P536, DOI 10.1007/s004420050619; Cufar K, 2008, TREE-RING RES, V64, P3, DOI 10.3959/2007-12.1; De Schrijver A, 2012, OECOLOGIA, V169, P221, DOI 10.1007/s00442-011-2185-8; Deans JD, 1996, FORESTRY, V69, P5, DOI 10.1093/forestry/69.1.5; Dittmar C, 2003, FOREST ECOL MANAG, V173, P63, DOI 10.1016/S0378-1127(01)00816-7; Drobyshev I, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008033; ECKSTEIN D, 1974, ANGEW BOT, V48, P371; Fang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061461; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Fraterrigo JM, 2006, ECOLOGY, V87, P570, DOI 10.1890/05-0638; Friedrichs DA, 2009, TREE PHYSIOL, V29, P39, DOI 10.1093/treephys/tpn003; Fritts H.C, 1976, TREE RINGS CLIMATE; Goodale CL, 2001, ECOL APPL, V11, P253, DOI 10.1890/1051-0761(2001)011[0253:TLTEOL]2.0.CO;2; Gotmark F, 2005, FOREST ECOL MANAG, V214, P142, DOI 10.1016/j.foreco.2005.04.001; Greiffenhagen A, 2006, GEODERMA, V132, P182, DOI 10.1016/j.geoderma.2005.05.006; Hardtle W, 2014, ECOL INDIC, V45, P45, DOI 10.1016/j.ecolind.2014.03.015; Hardtle W, 2013, ECOSYSTEMS, V16, P1413, DOI 10.1007/s10021-013-9692-x; Hardtle W, 2013, PLANT ECOL, V214, P1147, DOI 10.1007/s11258-013-0239-1; Hardtle W, 2004, FLORA, V199, P134, DOI 10.1078/0367-2530-00142; HEIL GW, 2007, ENV EFFECTS AFFOREST, P1; Hejcman M, 2013, ECOSYSTEMS, V16, P652, DOI 10.1007/s10021-013-9638-3; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Kint V, 2012, EUR J FOREST RES, V131, P609, DOI 10.1007/s10342-011-0535-z; Koerner W, 1999, OECOLOGIA, V121, P421, DOI 10.1007/s004420050947; Lang AC, 2014, J APPL ECOL, V51, P224, DOI 10.1111/1365-2664.12157; Lebourgeois F, 2004, ANN FOREST SCI, V61, P361, DOI 10.1051/forest:2004029; Leuschner C, 2001, FOREST ECOL MANAG, V149, P33, DOI 10.1016/S0378-1127(00)00543-0; Leuschner C, 2014, ECOSYSTEMS, V17, P497, DOI 10.1007/s10021-013-9738-0; Leuschner C, 2013, FOREST ECOL MANAG, V310, P405, DOI 10.1016/j.foreco.2013.08.043; Leuzinger S, 2005, TREE PHYSIOL, V25, P641, DOI 10.1093/treephys/25.6.641; Mattingly WB, 2013, OECOLOGIA, V172, P1147, DOI 10.1007/s00442-012-2568-5; Merian P, 2011, PLANT ECOL, V212, P1855, DOI 10.1007/s11258-011-9959-2; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; MUYS B, 1992, SOIL BIOL BIOCHEM, V24, P1459, DOI 10.1016/0038-0717(92)90133-I; Niemeyer T, 2005, APPL VEG SCI, V8, P183, DOI 10.1111/j.1654-109X.2005.tb00644.x; Norden B, 2001, BIODIVERS CONSERV, V10, P779, DOI 10.1023/A:1016675103935; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Potthast K, 2012, BIOGEOCHEMISTRY, V111, P151, DOI 10.1007/s10533-011-9626-7; RIO MD, PLANT BIOL IN PRESS, DOI DOI 10.1111/P1B.12029; Seidel D, 2013, FOREST ECOL MANAG, V310, P366, DOI 10.1016/j.foreco.2013.08.058; Sidorova OV, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000473; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; Sparling G. P., 1997, P97; Speer J.H., 2010, FUNDAMENTALS TREE RI; Stan AB, 2010, DENDROCHRONOLOGIA, V28, P135, DOI 10.1016/j.dendro.2009.10.003; Thomas FM, 2000, PLANT ECOL, V147, P95, DOI 10.1023/A:1009841921261; Thomas FM, 2002, FOREST PATHOL, V32, P277, DOI 10.1046/j.1439-0329.2002.00291.x; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; von Oheimb G, 2008, FOREST ECOL MANAG, V255, P1984, DOI 10.1016/j.foreco.2007.12.021; Wang W, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002484; Wazny T., 1991, Dendrochronologia, P35; WESTPHAL C, 2001, BERICHTE FORSCHUNGSZ, V174, P1	70	17	17	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113507	10.1371/journal.pone.0113507	http://dx.doi.org/10.1371/journal.pone.0113507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494042	Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400014
J	Henkels, KM; Mallets, ER; Dennis, PB; Gomez-Cambronero, J				Henkels, Karen M.; Mallets, Elizabeth R.; Dennis, Patrick B.; Gomez-Cambronero, Julian			S6K is a morphogenic protein with a mechanism involving Filamin-A phosphorylation and phosphatidic acid binding	FASEB JOURNAL			English	Article						cytoskeleton signaling; cell morphology; morphogenesis; breast cancer; cell invasion	ACTIN CYTOSKELETON; CELL-MIGRATION; IN-VITRO; KINASE; MTOR; SITE	Change of cell shape in vivo plays many roles that are central to life itself, such as embryonic development, inflammation, wound healing, and pathologic processes such as cancer metastasis. Nonetheless, the spatiotemporal mechanisms that control the concerted regulation of cell shape remain understudied. Here, we show that ribosomal S6K, which is normally considered a protein involved in protein translation, is a morphogenic protein. Its presence in cells alters the overall organization of the cell surface and cell circularity [(4 pi x area)/(perimeter)(2)] from 0.47 +/- 60.06 units in mock-treated cells to 0.09 +/- 6 0.03 units in S6K-overexpressing macrophages causing stellation and arborization of cell shape. This effect was partially reversed in cells expressing a kinase-inactive S6K mutant and was fully reversed in cells silenced with small interference RNA. Equally important is that S6K is itself regulated by phospholipids, specifically phosphatidic acid, whereby 300 nM 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), but not the control 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), binds directly to S6K and causes an similar to 2.9-fold increase in S6K catalytic activity. This was followed by an increase in Filamin A (FLNA) functionality as measured by phospho-FLNA (S-2152) expression and by a subsequent elevation of actin nucleation. This reliance of S6K on phosphatidic acid (PA), a curvature-inducing phospholipid, explained the extra-large perimeter of cells that overexpressed S6K. Furthermore, the diversity of the response to S6K in several unrelated cell types (fibroblasts, leukocytes, and invasive cancer cells) that we report here indicates the existence of an underlying common mechanism inmammalian cells. This new signaling set, PA-S6K-FLNA-actin, sheds light for the first time into the morphogenic pathway of cytoskeletal structures that are crucial for adhesion and cell locomotion during inflammation and metastasis.	[Henkels, Karen M.; Mallets, Elizabeth R.; Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Dennis, Patrick B.] US Air Force, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA	Wright State University Dayton; United States Department of Defense; United States Air Force	Gomez-Cambronero, J (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [HL056653-14]; American Heart Association [13GRNT17230097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge Dr. Francisco Alvarez (Emory University) for helpful discussions on cell morphology and Marium Husain and Francis Speranza for technical contribution on the transfection efficiency/cell viability assay and actin polymerization and phagocytosis experiments, respectively. This work was supported by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant HL056653-14, and the American Heart Association Grant 13GRNT17230097.	Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; Cretel E, 2008, CELL MOL BIOENG, V1, P5, DOI 10.1007/s12195-008-0009-7; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Lee A, 2000, DEV DYNAM, V217, P257, DOI 10.1002/(SICI)1097-0177(200003)217:3<257::AID-DVDY4>3.0.CO;2-5; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; PATA I, 1992, GENE, V121, P387, DOI 10.1016/0378-1119(92)90149-J; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sato Makoto, 2005, Anatomical Science International, V80, P19; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Tweedy L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02606; WANG E, 1979, J CELL BIOL, V83, P320, DOI 10.1083/jcb.83.2.320; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	26	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1299	1313		10.1096/fj.14-260992	http://dx.doi.org/10.1096/fj.14-260992			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25512366	Green Published			2022-12-26	WOS:000354115000018
J	Wigington, CP; Jung, J; Rye, EA; Belauret, SL; Philpot, AM; Feng, Y; Santangelo, PJ; Corbett, AH				Wigington, Callie P.; Jung, Jeenah; Rye, Emily A.; Belauret, Sara L.; Philpot, Akahne M.; Feng, Yue; Santangelo, Philip J.; Corbett, Anita H.			Post-transcriptional Regulation of Programmed Cell Death 4 (PDCD4) mRNA by the RNA-binding Proteins Human Antigen R (HuR) and T-cell Intracellular Antigen 1 (TIA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PDCD4; INITIATION-FACTOR 4A; BREAST-CANCER CELLS; AU-RICH ELEMENT; GENE-EXPRESSION; TRANSFORMATION SUPPRESSOR; TRANSLATIONAL SILENCER; ARGININE METHYLATION; SPLICING REGULATOR; PROXIMITY LIGATION	Post-transcriptional processing of mRNA transcripts plays a critical role in establishing the gene expression profile of a cell. Such processing events are mediated by a host of factors, including RNA-binding proteins and microRNAs. A number of critical cellular pathways are subject to regulation at multiple levels that allow fine-tuning of key biological responses. Programmed cell death 4 (PDCD4) is a tumor suppressor and an important modulator of mRNA translation that is regulated by a number of mechanisms, most notably as a target of the on comiR, miR-21. Here, we provide evidence for post-transcriptional regulation of PDCD4 by the RNA-binding proteins, HuR and TIA1. Complementary approaches reveal binding of both HuR and TIA1 to the PDCD4 transcript. Consistent with a model where RNA-binding proteins modulate the PDCD4 transcript, knockdown of HuR and/or TIA1 results in a significant decrease in steady-state PDCD4 mRNA and protein levels. However, fractionation experiments suggest that the mode of regulation of the PDCD4 transcript likely differs in the cytoplasm and the nucleus as the pool of PDCD4 mRNA present in the cytoplasm is more stable than the nuclear pool of PDCD4 transcript. We observe a competitive mode of binding between HuR and TIA1 on the PDCD4 transcript in the cytoplasm, suggesting that these two factors dynamically interact with one another as well as the PDCD4 transcript to maintain tight control of PDCD4 levels. Overall, this study reveals an additional set of regulatory interactions that modulate the expression of PDCD4, a key pro-apoptotic factor, and also reveals new insights into how HuR and TIA1 functions are integrated to achieve such regulation.	[Wigington, Callie P.; Rye, Emily A.; Philpot, Akahne M.; Corbett, Anita H.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Wigington, Callie P.; Rye, Emily A.] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Jung, Jeenah; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Jung, Jeenah; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30332 USA; [Belauret, Sara L.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30322 USA; [Philpot, Akahne M.] Winship Canc Inst, Summer Scholars Res Program, Atlanta, GA 30332 USA; [Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021	Corbett, Anita/0000-0002-0461-6895; Feng, Yue/0000-0002-7905-2182	National Institutes of Health [R01 GM058728, R01 GM094198, R21 CA147922, F31 CA168321, T32 GM008367]; NATIONAL CANCER INSTITUTE [F31CA168321, R21CA147922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, T32GM008169, T32GM008367, R01GM094198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM058728 (to A. H. C.), R01 GM094198 and R21 CA147922 (to P. J. S.), and F31 CA168321 and T32 GM008367 (to C. P. W.).	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2014, NUCLEIC ACIDS RES, V42, P10099, DOI 10.1093/nar/gku686; Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Abe R, 1996, NUCLEIC ACIDS RES, V24, P4895, DOI 10.1093/nar/24.24.4895; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Fan H, 2007, EUR J GASTROEN HEPAT, V19, P952, DOI 10.1097/MEG.0b013e3282c3a89e; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fay MM, 2014, J BIOL CHEM, V289, P17541, DOI 10.1074/jbc.M113.541300; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; HURWITZ J, 1962, P NATL ACAD SCI USA, V48, P1222, DOI 10.1073/pnas.48.7.1222; Irier HA, 2009, J NEUROCHEM, V109, P584, DOI 10.1111/j.1471-4159.2009.05992.x; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Jung J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks837; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim J, 2014, CELL DEATH DIFFER, V21, P481, DOI 10.1038/cdd.2013.171; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leupold JH, 2012, BIOSCIENCE REP, V32, P281, DOI 10.1042/BSR20110045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Santangelo PJ, 2012, METHOD ENZYMOL, V505, P383, DOI 10.1016/B978-0-12-388448-0.00028-0; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Subramaniam K, 2010, CANCER LETT, V297, P259, DOI 10.1016/j.canlet.2010.05.019; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Vikhreva PN, 2014, BBA-GENE REGUL MECH, V1839, P43, DOI 10.1016/j.bbagrm.2013.12.001; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang H, 2011, ACTA CRYSTALLOGR F, V67, P546, DOI 10.1107/S1744309110052930; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	94	39	40	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3468	3487		10.1074/jbc.M114.631937	http://dx.doi.org/10.1074/jbc.M114.631937			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519906	Green Published, hybrid			2022-12-26	WOS:000349456000022
J	Wang, RR; You, JX				Wang, Ranran; You, Jianxin			Mechanistic Analysis of the Role of Bromodomain-containing Protein 4 (BRD4) in BRD4-NUT Oncoprotein-induced Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyltransferase; Bromodomain-containing Protein 4 (BRD4); E1A Binding Protein p300 (P300); Transcription Elongation Factor; Transcription Factor; BRD4-NUT; NUT Midline Carcinoma; Transcriptional Activation	NUT MIDLINE CARCINOMA; PAPILLOMAVIRUS E2 PROTEIN; ACETYLATED CHROMATIN; SELECTIVE-INHIBITION; BET BROMODOMAINS; GENE-EXPRESSION; S-PHASE; DIFFERENTIATION; PROGRESSION; TARGET	Background: NUT midline carcinoma is an aggressive cancer typically caused by the formation of the BRD4-NUT fusion oncoprotein. Results: BRD4-NUT-stimulated histone hyperacetylation recruits BRD4 and associated transcription factors to activate gene expression. Conclusion:BRD4-NUT perturbs normal gene expression to trigger oncogenic events in NMC. Significance: Breaking BRD4-NUT interaction with histone acetyltransferases is an excellent strategy to abrogate the BRD4-NUT oncogenic activities. NUT midline carcinoma (NMC) is a rare but highly aggressive cancer typically caused by the translocation t(15;19), which results in the formation of the BRD4-NUT fusion oncoprotein. Previous studies have demonstrated that fusion of the NUT protein with the double bromodomains of BRD4 may significantly alter the cellular gene expression profile to contribute to NMC tumorigenesis. However, the mechanistic details of this BRD4-NUT function remain poorly understood. In this study, we examined the NUT function in transcriptional regulation by targeting it to a LacO transgene array integrated in U2OS 2-6-3 cells, which allow us to visualize how NUT alters the in situ gene transcription dynamic. Using this system, we demonstrated that the NUT protein tethered to the LacO locus recruits p300/CREB-binding protein (CBP), induces histone hyperacetylation, and enriches BRD4 to the transgene array chromatin foci. We also discovered that, in BRD4-NUT expressed in NMC cells, the NUT moiety of the fusion protein anchored to chromatin by the double bromodomains also stimulates histone hyperacetylation, which causes BRD4 to bind tighter to chromatin. Consequently, multiple BRD4-interacting factors are recruited to the NUT-associated chromatin locus to activate in situ transgene expression. This gene transcription function was repressed by either expression of a dominant negative inhibitor of the p300-NUT interaction or treatment with (+)-JQ1, which dissociates BRD4 from the LacO chromatin locus. Our data support a model in which BRD4-NUT-stimulated histone hyperacetylation recruits additional BRD4 and interacting partners to support transcriptional activation, which underlies the BRD4-NUT oncogenic mechanism in NMC.	[Wang, Ranran; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	National Institutes of Health [R01CA148768, R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA148768, R01CA142723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768 and R01CA142723.	Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; French CA, 2014, CANCER DISCOV, V4, P928, DOI 10.1158/2159-8290.CD-14-0014; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Grayson AR, 2014, ONCOGENE, V33, P1736, DOI 10.1038/onc.2013.126; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Li J, 2014, VIRUSES-BASEL, V6, P319, DOI 10.3390/v6010319; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Wang RR, 2014, CANCER RES, V74, P3332, DOI 10.1158/0008-5472.CAN-13-2658; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	34	42	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2744	2758		10.1074/jbc.M114.600759	http://dx.doi.org/10.1074/jbc.M114.600759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512383	Green Published, hybrid			2022-12-26	WOS:000349310700017
J	Chang, HT; Hu, C; Chiu, YL; Peng, NJ; Liu, RS				Chang, Hong-Tai; Hu, Chin; Chiu, Yu-Li; Peng, Nan-Jing; Liu, Ren-Shyan			Role of 2-[F-18] Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography in the Post-Therapy Surveillance of Breast Cancer	PLOS ONE			English	Article							TUMOR-MARKERS; FOLLOW-UP; FDG-PET; CLINICAL IMPACT; CA 15-3; RECURRENT; MANAGEMENT; DIAGNOSIS	Purpose: To evaluate the usefulness of 2-[F-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the early detection of breast cancer tumor recurrences and its role in post-therapy surveillance. Methods: FDG-PET/CT was performed on patients with increased serum CA 15-3 levels and/or clinical/radiologic suspicion of recurrence. A group of asymptomatic patients who underwent FDG-PET/CT in the post-therapy surveillance of breast cancer served as the controls. The results were analyzed based on the patients' histological data, other imaging modalities and/or clinical follow-up. Recurrence was defined as evidence of recurrent lesions within 12 months of the FDG-PET/CT scan. Results: Based on elevated serum CA15-3 levels (n=31) and clinical/radiologic suspicion (n=40), 71 scans were performed due to suspected recurrence, whereas 69 scans were performed for asymptomatic follow-up. The sensitivity and specificity of FDG-PET/CT were 87.5% and 87.1% in the patients with suspected recurrence and 77.8% and 91.7% in the asymptomatic patients. The positive predictive value in the patients with suspected recurrence (mainly due to elevated serum CA 15-3 levels) was higher than that in asymptomatic patients (P=0.013). Recurrences were proven in 56.3% (40/71) of the patients with suspected recurrence and in 13% (9/69) of the asymptomatic patients (P < 0.001). FDG-PET/CT resulted in changes in the planned management in 49.3% (35/71) of the patients with suspected recurrence and 10.1% (7/69) of the asymptomatic patients (P < 0.001). After follow-up, 77.5% (55/71) of the patients with suspicious recurrences and 97.1% (67/69) of the asymptomatic patients were surviving at the end of the study (P < 0.001). Conclusions: FDG-PET/CT was able to detect recurrence, and the results altered the intended patient management in the post-therapy surveillance of breast cancer. FDG-PET/CT should be used as a priority in patients with increased serum CA 15-3 levels, or with clinical/radiologic suspicion of recurrence, and might be useful for asymptomatic patients.	[Chang, Hong-Tai] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Hu, Chin; Chiu, Yu-Li; Peng, Nan-Jing] Kaohsiung Vet Gen Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Peng, Nan-Jing; Liu, Ren-Shyan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Peng, NJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Nucl Med, Kaohsiung, Taiwan.	njpeng@vghks.gov.tw						Bensouda Y, 2009, B CANCER, V96, P923, DOI 10.1684/bdc.2009.0919; Chang KJ, 2008, J ONCOLOGY SOC, V24, P85; Constantinidou A, 2011, ANN ONCOL, V22, P307, DOI 10.1093/annonc/mdq343; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Eubank WB, 2004, AM J ROENTGENOL, V183, P479, DOI 10.2214/ajr.183.2.1830479; Evangelista L, 2011, EUR J NUCL MED MOL I, V38, P293, DOI 10.1007/s00259-010-1626-7; Grahek D, 2004, EUR J NUCL MED MOL I, V31, P179, DOI 10.1007/s00259-003-1348-1; Grassetto G, 2011, EUR J RADIOL, V80, P828, DOI 10.1016/j.ejrad.2010.04.029; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Haug AR, 2007, J COMPUT ASSIST TOMO, V31, P629, DOI 10.1097/01.rct.0000284394.83696.42; Hillner BE, 2008, J CLIN ONCOL, V26, P2155, DOI 10.1200/JCO.2007.14.5631; Isasi CR, 2005, BREAST CANCER RES TR, V90, P105, DOI 10.1007/s10549-004-3291-7; Kokko R, 2002, EUR J CANCER, V38, P1189, DOI 10.1016/S0959-8049(01)00429-4; Kostakoglu L, 2003, RADIOGRAPHICS, V23, P315, DOI 10.1148/rg.232025705; Liu CS, 2002, JPN J CLIN ONCOL, V32, P244, DOI 10.1093/jjco/hyf052; Manohar K, 2012, NUCL MED COMMUN, V33, P591, DOI 10.1097/MNM.0b013e3283516716; Mariani L, 2009, BIOMARKERS, V14, P130, DOI 10.1080/13547500902770090; Pennant M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14500; Porika M, 2010, ASIAN PAC J CANCER P, V11, P157; Radan L, 2006, CANCER-AM CANCER SOC, V107, P2545, DOI 10.1002/cncr.22292; Ruibal A, 1986, INT J BIOL MARKER, V3, P159; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Suarez M, 2002, Q J NUCL MED, V46, P113; Tietz N. W., 1999, TIETZ TXB CLIN CHEM; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143	26	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115127	10.1371/journal.pone.0115127	http://dx.doi.org/10.1371/journal.pone.0115127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517451	Green Published, Green Submitted, gold			2022-12-26	WOS:000347215600042
J	Winter, G; Cordente, AG; Curtin, C				Winter, Gal; Cordente, Antonio G.; Curtin, Chris			Formation of Hydrogen Sulfide from Cysteine in Saccharomyces cerevisiae BY4742: Genome Wide Screen Reveals a Central Role of the Vacuole	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; FUNCTIONAL-CHARACTERIZATION; GAMMA-CYSTATHIONASE; SULFUR-COMPOUNDS; YEAST; H2S; GENE; GLUTATHIONE; BIOGENESIS; METABOLISM	Discoveries on the toxic effects of cysteine accumulation and, particularly, recent findings on the many physiological roles of one of the products of cysteine catabolism, hydrogen sulfide (H2S), are highlighting the importance of this amino acid and sulfur metabolism in a range of cellular activities. It is also highlighting how little we know about this critical part of cellular metabolism. In the work described here, a genome-wide screen using a deletion collection of Saccharomyces cerevisiae revealed a surprising set of genes associated with this process. In addition, the yeast vacuole, not previously associated with cysteine catabolism, emerged as an important compartment for cysteine degradation. Most prominent among the vacuole-related mutants were those involved in vacuole acidification; we identified each of the eight subunits of a vacuole acidification sub-complex (V-1 of the yeast V-ATPase) as essential for cysteine degradation. Other functions identified included translation, RNA processing, folate-derived one-carbon metabolism, and mitochondrial iron-sulfur homeostasis. This work identified for the first time cellular factors affecting the fundamental process of cysteine catabolism. Results obtained significantly contribute to the understanding of this process and may provide insight into the underlying cause of cysteine accumulation and H2S generation in eukaryotes.	[Winter, Gal] Univ Western Sydney, Coll Hlth & Sci, Sch Biomed & Hlth Sci, Parramatta, NSW, Australia; [Winter, Gal; Cordente, Antonio G.; Curtin, Chris] Australian Wine Res Inst, Adelaide, SA, Australia; [Winter, Gal] Univ Queensland, Ctr Microbial Electrosynthesis CEMES, Brisbane, Qld, Australia	Western Sydney University; Australian Wine Research Institute; University of Queensland	Winter, G (corresponding author), Univ Western Sydney, Coll Hlth & Sci, Sch Biomed & Hlth Sci, Parramatta, NSW, Australia.	g.winter@uq.edu.au		Winter, Gal/0000-0003-3789-395X; Cordente, Toni/0000-0001-9166-9073	Laffort Australia; Australia's grape growers and winemakers through Grape and Wine Research and Development Corporation; Australian Government; Australian Wine Research Institute	Laffort Australia; Australia's grape growers and winemakers through Grape and Wine Research and Development Corporation(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); Australian Wine Research Institute	This study was funded by Laffort Australia. Gal Winter was a PhD student at the University of Western Sydney and The Australian Wine Research Institute. Antonio G. Cordente and Chris Curtin are employed by The Australian Wine Research Institute. The Australian Wine Research Institute is supported by Australia's grape growers and winemakers through their investment agency the Grape and Wine Research and Development Corporation, with matching funds from the Australian Government. The funder had no role articulated in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Australian Wine Research Institute provided support in the form of salaries for authors AGC and CC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are in the "author contributions" section.	ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Arita A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-524; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Balk J, 2004, CHEMBIOCHEM, V5, P1044, DOI 10.1002/cbic.200400061; BARTON AB, 1993, YEAST, V9, P363, DOI 10.1002/yea.320090406; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Bengtsson L, 1999, J GEOPHYS RES-ATMOS, V104, P3865, DOI 10.1029/1998JD200046; Brachmann CB, 1998, YEAST, V14, P115; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; DERIKX PJL, 1990, APPL ENVIRON MICROB, V56, P176, DOI 10.1128/AEM.56.1.176-180.1990; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kim HS, 2009, FEMS YEAST RES, V9, P713, DOI 10.1111/j.1567-1364.2009.00516.x; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Linderholm AL, 2008, APPL ENVIRON MICROB, V74, P1418, DOI 10.1128/AEM.01758-07; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; Ono B, 1996, YEAST, V12, P1153, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1153::AID-YEA16>3.0.CO;2-2; ONO BI, 1991, YEAST, V7, P843, DOI 10.1002/yea.320070809; Park SK, 2008, J MICROBIOL BIOTECHN, V18, P1550; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; R Core Team, 2018, R LANG ENV STAT COMP; Roberts RL, 2003, P NATL ACAD SCI USA, V100, P6634, DOI 10.1073/pnas.1132022100; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Sherman F, 1986, LAB COURSE MANUAL ME; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Suzuki T, 2011, J BIOSCI BIOENG, V112, P107, DOI 10.1016/j.jbiosc.2011.04.007; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; WALTERS DW, 1986, J BIOL CHEM, V261, P5372; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Winter G, 2011, AUST J GRAPE WINE R, V17, P285, DOI 10.1111/j.1755-0238.2011.00127.x; Winter G, 2012, J MICROBIOL METH, V91, P165, DOI 10.1016/j.mimet.2012.08.003; Winter G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-36; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	62	14	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113869	10.1371/journal.pone.0113869	http://dx.doi.org/10.1371/journal.pone.0113869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517415	gold, Green Published			2022-12-26	WOS:000347215600009
J	Mack, SG; Cook, DJ; Dhurjati, P; Butchbach, MER				Mack, Sean G.; Cook, Daniel J.; Dhurjati, Prasad; Butchbach, Matthew E. R.			Systems Biology Investigation of cAMP Modulation to Increase SMN Levels for the Treatment of Spinal Muscular Atrophy	PLOS ONE			English	Article							MOTOR-NEURON PROTEIN; COPY NUMBER; MESSENGER-RNA; 2,4-DIAMINOQUINAZOLINE DERIVATIVES; SACCHAROMYCES-CEREVISIAE; SINGLE NUCLEOTIDE; DETERMINING GENE; PATIENT CELLS; MOUSE MODEL; SURVIVAL	Spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide, is an autosomal recessive disorder caused by the loss of SMN1 (survival motor neuron 1), which encodes the protein SMN. The loss of SMN1 causes a deficiency in SMN protein levels leading to motor neuron cell death in the anterior horn of the spinal cord. SMN2, however, can also produce some functional SMN to partially compensate for loss of SMN1 in SMA suggesting increasing transcription of SMN2 as a potential therapy to treat patients with SMA. A cAMP response element was identified on the SMN2 promoter, implicating cAMP activation as a step in the transcription of SMN2. Therefore, we investigated the effects of modulating the cAMP signaling cascade on SMN production in vitro and in silico. SMA patient fibroblasts were treated with the cAMP signaling modulators rolipram, salbutamol, dbcAMP, epinephrine and forskolin. All of the modulators tested were able to increase gem formation, a marker for SMN protein in the nucleus, in a dose-dependent manner. We then derived two possible mathematical models simulating the regulation of SMN2 expression by cAMP signaling. Both models fit well with our experimental data. In silico treatment of SMA fibroblasts simultaneously with two different cAMP modulators resulted in an additive increase in gem formation. This study shows how a systems biology approach can be used to develop potential therapeutic targets for treating SMA.	[Mack, Sean G.; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Appl Clin Gen, Wilmington, DE 19803 USA; [Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Pediat Res, Wilmington, DE USA; [Mack, Sean G.; Cook, Daniel J.; Dhurjati, Prasad] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA; [Butchbach, Matthew E. R.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Butchbach, Matthew E. R.] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; University of Delaware; University of Delaware; Jefferson University	Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Appl Clin Gen, Wilmington, DE 19803 USA.	butchbach@nemoursresearch.org		Butchbach, Matthew/0000-0003-2912-6400	Nemours Foundation; University of Delaware Undergraduate Research Program; Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE) programs of the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	Nemours Foundation; University of Delaware Undergraduate Research Program; Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE) programs of the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Nemours Foundation (M.E.R.B.), the University of Delaware Undergraduate Research Program (S.G.M.) and the Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE; grant number P20GM103464 to M.E.R.B.) programs of the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Biondi O, 2010, J NEUROSCI, V30, P11288, DOI 10.1523/JNEUROSCI.1764-10.2010; Branchu J, 2013, J NEUROSCI, V33, P4280, DOI 10.1523/JNEUROSCI.2728-12.2013; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Cusco I, 2002, BJOG-INT J OBSTET GY, V109, P1244, DOI 10.1016/S1470-0328(02)02983-X; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Dhurjati P, 2008, CAN J CHEM ENG, V86, P127, DOI 10.1002/cjce.20025; Elsheikh B, 2009, MUSCLE NERVE, V40, P652, DOI 10.1002/mus.21350; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleppe R, 2011, CURR TOP MED CHEM, V11, P1393, DOI 10.2174/156802611795589629; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lunn MR, 2004, CHEM BIOL, V11, P1489, DOI 10.1016/j.chembiol.2004.08.024; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; Majumder S, 2004, J BIOL CHEM, V279, P14803, DOI 10.1074/jbc.M308225200; Mattis VB, 2008, J NEUROSCI METH, V175, P36, DOI 10.1016/j.jneumeth.2008.07.024; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; Mattis VB, 2009, HUM MOL GENET, V18, P3906, DOI 10.1093/hmg/ddp333; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SCUDIERO DA, 1986, MUTAT RES, V159, P125, DOI 10.1016/0027-5107(86)90121-1; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Tiziano FD, 2007, NEUROMUSCULAR DISORD, V17, P400, DOI 10.1016/j.nmd.2007.02.006; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Williamson T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-70; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wu CY, 2011, BBA-PROTEINS PROTEOM, V1814, P1134, DOI 10.1016/j.bbapap.2011.04.015; Xiao JB, 2011, J MED CHEM, V54, P6215, DOI 10.1021/jm200497t; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858	56	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115473	10.1371/journal.pone.0115473	http://dx.doi.org/10.1371/journal.pone.0115473			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514431	Green Published, gold, Green Submitted			2022-12-26	WOS:000349146300059
J	Nath, J; Guy, A; Smith, TB; Cobbold, M; Inston, NG; Hodson, J; Tennant, DA; Ludwig, C; Ready, AR				Nath, Jay; Guy, Alison; Smith, Thomas B.; Cobbold, Mark; Inston, Nicholas G.; Hodson, James; Tennant, Daniel A.; Ludwig, Christian; Ready, Andrew R.			Metabolomic Perfusate Analysis during Kidney Machine Perfusion: The Pig Provides an Appropriate Model for Human Studies	PLOS ONE			English	Article							COLD-STORAGE; PULSATILE PERFUSION; BRAIN-DEATH; PRESERVATION; TRANSPLANTATION; DONOR; MANAGEMENT; LIVER; RISK; PUMP	Introduction: Hypothermic machine perfusion offers great promise in kidney transplantation and experimental studies are needed to establish the optimal conditions for this to occur. Pig kidneys are considered to be a good model for this purpose and share many properties with human organs. However it is not established whether the metabolism of pig kidneys in such hypothermic hypoxic conditions is comparable to human organs. Methods: Standard criteria human (n = 12) and porcine (n = 10) kidneys underwent HMP using the LifePort Kidney Transporter 1.0 (Organ Recovery Systems) using KPS-1 solution. Perfusate was sampled at 45 minutes and 4 hours of perfusion and metabolomic analysis performed using 1-D H-1-NMR spectroscopy. Results: There was no inter-species difference in the number of metabolites identified. Of the 30 metabolites analysed, 16 (53.3%) were present in comparable concentrations in the pig and human kidney perfusates. The rate of change of concentration for 3-Hydroxybutyrate was greater for human kidneys (p<0.001). For the other 29 metabolites (96.7%), there was no difference in the rate of change of concentration between pig and human samples. Conclusions: Whilst there are some differences between pig and human kidneys during HMP they appear to be metabolically similar and the pig seems to be a valid model for human studies.	[Nath, Jay; Guy, Alison; Inston, Nicholas G.; Ready, Andrew R.] Univ Hosp Birmingham, Dept Renal Surg, Birmingham, W Midlands, England; [Nath, Jay; Guy, Alison; Smith, Thomas B.; Cobbold, Mark] Univ Birmingham, Dept Immun & Infect, Birmingham, W Midlands, England; [Hodson, James] Univ Hosp Birmingham, Wolfson Comp Lab, Birmingham, W Midlands, England; [Ludwig, Christian] Univ Birmingham, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England; [Nath, Jay; Tennant, Daniel A.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Nath, J (corresponding author), Univ Hosp Birmingham, Dept Renal Surg, Birmingham, W Midlands, England.	J.Nath@bham.ac.uk	Nath, Jay/K-1437-2019; Tennant, Daniel/ABE-8145-2021	Tennant, Daniel/0000-0003-0499-2732; Hodson, James/0000-0003-3487-0090	University Hospital Birmingham Charities [Dkaarcde 17496]	University Hospital Birmingham Charities	University Hospital Birmingham Charities 60,000 pound Grant number Dkaarcde 17496. Organ Recovery Systems, Donation of Lifeport machine (value circa 25,000) pound.	Bagul A, 2008, BRIT J SURG, V95, P111, DOI 10.1002/bjs.5909; Barklin A, 2008, ACTA ANAESTH SCAND, V52, P628, DOI 10.1111/j.1399-6576.2008.01606.x; Bon D, 2014, TRANSPLANTATION; Bugge JF, 2009, ACTA ANAESTH SCAND, V53, P1239, DOI 10.1111/j.1399-6576.2009.02064.x; Cannon RM, 2013, J AM COLL SURGEONS, V216, P625, DOI 10.1016/j.jamcollsurg.2012.12.025; Fuller BJ, 2007, CRYOBIOLOGY, V54, P129, DOI 10.1016/j.cryobiol.2007.01.003; GARBER AJ, 1974, J CLIN INVEST, V54, P981, DOI 10.1172/JCI107839; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; GRAMM HJ, 1992, TRANSPLANTATION, V54, P851, DOI 10.1097/00007890-199211000-00016; Guy AJ, 2014, TRANSPLANTATION; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Henry SD, 2012, AM J TRANSPLANT, V12, P2477, DOI 10.1111/j.1600-6143.2012.04086.x; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KOUNDAKJIAN PP, 1970, BIOCHEM J, V119, P49, DOI 10.1042/bj1190049; Kozaki K, 2000, TRANSPLANT P, V32, P164, DOI 10.1016/S0041-1345(99)00896-9; Kwiatkowski A, 2007, AM J TRANSPLANT, V7, P1942, DOI 10.1111/j.1600-6143.2007.01877.x; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lodhi SA, 2012, AM J TRANSPLANT, V12, P2774, DOI 10.1111/j.1600-6143.2012.04179.x; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Matsuno N, 2000, TRANSPLANT P, V32, P173, DOI 10.1016/S0041-1345(99)00919-7; Matsuokaa L, 2006, AM J TRANSPLANT, V6, P1473, DOI 10.1111/j.1600-6143.2006.01323.x; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Polyak MMR, 2000, TRANSPLANTATION, V69, P249, DOI 10.1097/00007890-200001270-00010; POWNER DJ, 1990, CRIT CARE MED, V18, P702; SACHS DH, 1994, VET IMMUNOL IMMUNOP, V43, P185, DOI 10.1016/0165-2427(94)90135-X; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Sellers MT, 2000, CLIN TRANSPLANT, V14, P543, DOI 10.1034/j.1399-0012.2000.140605.x; Shah AP, 2008, TRANSPLANTATION, V86, P1006, DOI 10.1097/TP.0b013e318187b978; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Suarez JF, 1999, TRANSPLANT P, V31, P2292, DOI 10.1016/S0041-1345(99)00345-0; Swindle MM, 2012, FUTURE MED CHEM, V4, P1771, DOI [10.4155/FMC.12.113, 10.4155/fmc.12.113]; Wight JP, 2003, CLIN TRANSPLANT, V17, P293, DOI 10.1034/j.1399-0012.2003.00077.x; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103	35	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114818	10.1371/journal.pone.0114818	http://dx.doi.org/10.1371/journal.pone.0114818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502759	Green Published, Green Submitted, gold			2022-12-26	WOS:000346375400056
J	Srinivasan, DG; Abdelhady, A; Stern, DL				Srinivasan, Dayalan G.; Abdelhady, Ahmed; Stern, David L.			Gene Expression Analysis of Parthenogenetic Embryonic Development of the Pea Aphid, Acyrthosiphon pisum, Suggests That Aphid Parthenogenesis Evolved from Meiotic Oogenesis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PERSICAE SULZER HEMIPTERA; SPO11 HOMOLOG; POTATO APHID; MEIOSIS; RECOMBINATION; MOUSE; DNA; CHROMOSOME; ELEMENT	Aphids exhibit a form of phenotypic plasticity, called polyphenism, in which genetically identical females reproduce sexually during one part of the life cycle and asexually (via parthenogenesis) during the remainder of the life cycle. The molecular basis for aphid parthenogenesis is unknown. Cytological observations of aphid parthenogenesis suggest that asexual oogenesis evolved either through a modification of meiosis or from a mitotic process. As a test of these alternatives, we assessed the expression levels and expression patterns of canonical meiotic recombination and germline genes in the sexual and asexual ovaries of the pea aphid, Acyrthosiphon pisum. We observed expression of all meiosis genes in similar patterns in asexual and sexual ovaries, with the exception that some genes encoding Argonaute-family members were not expressed in sexual ovaries. In addition, we observed that asexual aphid tissues accumulated unspliced transcripts of Spo11, whereas sexual aphid tissues accumulated primarily spliced transcripts. In situ hybridization revealed Spo11 transcript in sexual germ cells and undetectable levels of Spo11 transcript in asexual germ cells. We also found that an obligately asexual strain of pea aphid produced little spliced Spo11 transcript. Together, these results suggest that parthenogenetic oogenesis evolved from a meiosis-like, and not a mitosis-like, process and that the aphid reproductive polyphenism may involve a modification of Spo11 gene activity.	[Srinivasan, Dayalan G.; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Srinivasan, Dayalan G.; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Srinivasan, Dayalan G.; Abdelhady, Ahmed] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Rowan University	Srinivasan, DG (corresponding author), Princeton Univ, Howard Hughes Med Inst, Guyot Hall, Princeton, NJ 08544 USA.	srinivasan@rowan.edu		Stern, David/0000-0002-1847-6483	National Institutes of Health NRSA Postdoctoral Fellowship [GM077928]; David and Lucille Packard Foundation Fellowship in Science or Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077928] Funding Source: NIH RePORTER	National Institutes of Health NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucille Packard Foundation Fellowship in Science or Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A National Institutes of Health NRSA Postdoctoral Fellowship (GM077928) to DGS (grants.nih.gov/training/nrsa.htm), and a David and Lucille Packard Foundation Fellowship in Science or Engineering to DLS (www.packard.org) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; BAKER BS, 1978, GENETICS, V90, P531; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; BLACKMAN RL, 1978, INT J INSECT MORPHOL, V7, P33, DOI 10.1016/S0020-7322(78)80013-0; Blackman RL, 1987, WORLD CROP PESTS A, P164; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; BUNING J, 1985, J MORPHOL, V186, P209, DOI 10.1002/jmor.1051860206; COVITZ PA, 1994, GENETICS, V138, P577; Cromie GA, 2007, TRENDS CELL BIOL, V17, P448, DOI 10.1016/j.tcb.2007.07.007; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Guikema JEJ, 2008, J IMMUNOL, V181, P8450, DOI 10.4049/jimmunol.181.12.8450; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Hales DF, 2002, GENET RES, V79, P203, DOI 10.1017/S0016672302005657; Hales DF, 2002, GENET RES, V79, P119, DOI 10.1017/S001667230100550X; Hansen D, 2006, CURR TOP DEV BIOL, V76, P185, DOI 10.1016/S0070-2153(06)76006-9; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Liao Z, 2010, ARCH INSECT BIOCHEM, V74, P91, DOI 10.1002/arch.20362; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028051; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Metzler-Guillemain C, 2000, CHROMOSOMA, V109, P133, DOI 10.1007/s004120050421; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; MIZUNO K, 1992, GENE, V119, P293, DOI 10.1016/0378-1119(92)90286-X; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; PRINZ S, 1995, NUCLEIC ACIDS RES, V23, P3449, DOI 10.1093/nar/23.17.3449; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Riparbelli MG, 2005, DEV BIOL, V278, P220, DOI 10.1016/j.ydbio.2004.11.009; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sage J, 1999, MECH DEVELOP, V80, P29, DOI 10.1016/S0925-4773(98)00191-9; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Santucci-Darmanin S, 1999, MAMM GENOME, V10, P423, DOI 10.1007/s003359901016; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Shigenobu S, 2010, INSECT MOL BIOL, V19, P23, DOI 10.1111/j.1365-2583.2009.00946.x; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wei QY, 1997, PATHOBIOLOGY, V65, P293, DOI 10.1159/000164141; West-Eberhard Mary Jane, 2003, pi; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x	58	11	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115099	10.1371/journal.pone.0115099	http://dx.doi.org/10.1371/journal.pone.0115099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501006	Green Submitted, Green Published, gold			2022-12-26	WOS:000346375400071
J	Mikami, Y; Matsuzaki, H; Horie, M; Noguchi, S; Jo, T; Narumoto, O; Kohyama, T; Takizawa, H; Nagase, T; Yamauchi, Y				Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Kohyama, Tadashi; Takizawa, Hajime; Nagase, Takahide; Yamauchi, Yasuhiro			Lymphotoxin beta Receptor Signaling Induces IL-8 Production in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; SEVERE ASTHMA; NEUTROPHILIC INFLAMMATION; ENDOTHELIAL-CELLS; TNF SUPERFAMILY; FAMILY-MEMBER; LIGHT; EXPRESSION; PATHWAYS	Asthma-related mortality has been decreasing due to inhaled corticosteroid use, but severe asthma remains a major clinical problem. One characteristic of severe asthma is resistance to steroid therapy, which is related to neutrophilic inflammation. Recently, the tumor necrosis factor superfamily member (TNFSF) 14/LIGHT has been recognized as a key mediator in severe asthmatic airway inflammation. However, the profiles and intracellular mechanisms of cytokine/chemokine production induced in cells by LIGHT are poorly understood. We aimed to elucidate the molecular mechanism of LIGHT-induced cytokine/chemokine production by bronchial epithelial cells. Human bronchial epithelial cells express lymphotoxin beta receptor (LT beta R), but not herpesvirus entry mediator, which are receptors for LIGHT. LIGHT induced various cytokines/chemokines, such as interleukin (IL)-6, oncostatin M, monocyte chemotactic protein-1, growth-regulated protein alpha and IL-8. Specific siRNA for LT beta R attenuated IL-6 and IL-8 production by BEAS-2B and normal human bronchial epithelial cells. LIGHT activated intracellular signaling, such as mitogen-activated protein kinase and nuclear factor-kappa B (NF-kappa B) signaling. LIGHT also induced luciferase activity of NF-kappa B response element, but not of activator protein-1 or serum response element. Specific inhibitors of phosphorylation of extracellular signal-regulated kinase (Erk) and that of inhibitor kappa B attenuated IL-8 production, suggesting that LIGHT-LT beta R signaling induces IL-8 production via the Erk and NF-kappa B pathways. LIGHT, via LT beta R signaling, may contribute to exacerbation of airway neutrophilic inflammation through cytokine and chemokine production by bronchial epithelial cells.	[Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Nagase, Takahide; Yamauchi, Yasuhiro] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Kohyama, Tadashi] Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med, Sagamihara, Kanagawa, Japan; [Takizawa, Hajime] Kyorin Univ, Dept Resp Med, Tokyo, Japan	University of Tokyo; Teikyo University; Kyorin University	Yamauchi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan.	YAMAUCHIY-INT@h.u-tokyo.ac.jp		MIKAMI, YU/0000-0003-3262-2958	Japan Society for the Promotion of Science [24591125]; Grants-in-Aid for Scientific Research [24591125] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Research Project Number: 24591125) [http://www.jsps.go.jp/jgrantsinaid/index.html] to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Cheung Timothy C, 2009, Recent Pat DNA Gene Seq, V3, P177; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Duhen T, 2004, EUR J IMMUNOL, V34, P3534, DOI 10.1002/eji.200425598; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Feng EZ, 2013, EXP THER MED, V6, P747, DOI 10.3892/etm.2013.1192; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Godaly G, 1997, INFECT IMMUN, V65, P3451, DOI 10.1128/IAI.65.8.3451-3456.1997; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Ishida S, 2008, J RHEUMATOL, V35, P960; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Mikami Y, 2012, BIOCHEM BIOPH RES CO, V428, P451, DOI 10.1016/j.bbrc.2012.10.097; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Nakagome K, 2012, INT ARCH ALLERGY IMM, V158, P96, DOI 10.1159/000337801; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Plant SR, 2007, J NEUROSCI, V27, P7429, DOI 10.1523/JNEUROSCI.1307-07.2007; Robins S, 2011, AM J RESP CELL MOL, V45, P984, DOI 10.1165/rcmb.2010-0450OC; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Shi JX, 2012, AM J PHYSIOL-LUNG C, V302, pL793, DOI 10.1152/ajplung.00339.2011; Snelgrove RJ, 2011, EUR J PHARMACOL, V667, P1, DOI 10.1016/j.ejphar.2011.05.073; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takata M, 2001, BRIT J PHARMACOL, V134, P753, DOI 10.1038/sj.bjp.0704305; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Wang J, 2002, EUR J IMMUNOL, V32, P1969, DOI 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	42	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114791	10.1371/journal.pone.0114791	http://dx.doi.org/10.1371/journal.pone.0114791			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501580	Green Published, Green Submitted, gold			2022-12-26	WOS:000347146700053
J	Tahiri-Alaoui, A; Zhao, YG; Sadigh, Y; Popplestone, J; Kgosana, L; Smith, LP; Nair, V				Tahiri-Alaoui, Abdessamad; Zhao, Yuguang; Sadigh, Yashar; Popplestone, James; Kgosana, Lydia; Smith, Lorraine P.; Nair, Venugopal			Poly(A) Binding Protein 1 Enhances Cap-Independent Translation Initiation of Neurovirulence Factor from Avian Herpesvirus	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; EUKARYOTIC MESSENGER-RNA; POLY(A)-BINDING PROTEIN; CELL-LINE; C-MYC; IDENTIFICATION; INFECTION; ABUNDANCE; SEQUENCE; PABP	Poly(A) binding protein 1 (PABP1) plays a central role in mRNA translation and stability and is a target by many viruses in diverse manners. We report a novel viral translational control strategy involving the recruitment of PABP1 to the 5' leader internal ribosome entry site (5L IRES) of an immediate-early (IE) bicistronic mRNA that encodes the neurovirulence protein (pp14) from the avian herpesvirus Marek's disease virus serotype 1 (MDV1). We provide evidence for the interaction between an internal poly(A) sequence within the 5L IRES and PABP1 which may occur concomitantly with the recruitment of PABP1 to the poly(A) tail. RNA interference and reverse genetic mutagenesis results show that a subset of virally encoded-microRNAs (miRNAs) targets the inhibitor of PABP1, known as paip2, and therefore plays an indirect role in PABP1 recruitment strategy by increasing the available pool of active PABP1. We propose a model that may offer a mechanistic explanation for the cap-independent enhancement of the activity of the 5L IRES by recruitment of a bona fide initiation protein to the 5' end of the message and that is, from the affinity binding data, still compatible with the formation of 'closed loop' structure of mRNA.	[Tahiri-Alaoui, Abdessamad; Sadigh, Yashar; Popplestone, James; Kgosana, Lydia; Smith, Lorraine P.; Nair, Venugopal] Pirbright Inst, Woking, Surrey, England; [Zhao, Yuguang] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Wellcome Centre for Human Genetics	Tahiri-Alaoui, A (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.	abdou.tahiri-alaoui@pirbright.ac.uk; venugopal.nair@pirbright.ac.uk	Nair, Venugopal/D-4447-2016; Sadigh, Yashar/AAL-2996-2020	Nair, Venugopal/0000-0002-8255-516X; Sadigh, Yashar/0000-0003-1892-1361	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H010696/1]; BBSRC [BBS/E/I/00001651, BB/H010696/1, BBS/E/I/00001704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001704, BB/H010696/1, BBS/E/I/00001651] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (BBSRC, grant number BB/H010696/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina ZA, 2014, NUCLEIC ACIDS RES, V42, P9461, DOI 10.1093/nar/gku599; AKIYAMA Y, 1974, BIKEN J, V17, P105; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Bradrick SS, 2007, RNA, V13, P1582, DOI 10.1261/rna.556107; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dobrikova E, 2010, J VIROL, V84, P270, DOI 10.1128/JVI.01740-09; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Gudkov AT, 2005, BIOTECHNOL BIOENG, V91, P468, DOI 10.1002/bit.20525; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jarosinski K, 2007, P NATL ACAD SCI USA, V104, P20025, DOI 10.1073/pnas.0706295104; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; McKinney C, 2012, P NATL ACAD SCI USA, V109, P5627, DOI 10.1073/pnas.1202829109; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morgan R, 2008, J VIROL, V82, P12213, DOI 10.1128/JVI.01722-08; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Perez C, 2011, J VIROL, V85, P156, DOI 10.1128/JVI.01778-10; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Salaun C, 2010, J VIROL, V84, P8539, DOI 10.1128/JVI.00668-10; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Tahiri-Alaoui A, 2013, AVIAN DIS, V57, P387, DOI 10.1637/10322-080912-Reg.1; Tahiri-Alaoui A, 2009, J VIROL, V83, P12769, DOI 10.1128/JVI.01010-09; Tahiri-Alaoui A, 2009, J VIROL, V83, P5846, DOI 10.1128/JVI.02602-08; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Thoma C, 2008, RNA, V14, P1579, DOI 10.1261/rna.1043908; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Xu HT, 2008, J VIROL METHODS, V149, P201, DOI 10.1016/j.jviromet.2008.02.005; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhao YG, 2010, METHODS MOL BIOL, V634, P53, DOI 10.1007/978-1-60761-652-8_4; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114466	10.1371/journal.pone.0114466	http://dx.doi.org/10.1371/journal.pone.0114466			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503397	gold, Green Published, Green Submitted			2022-12-26	WOS:000347146700028
J	Zhao, CJ; Liu, XY; Yang, D				Zhao, Chenjing; Liu, Xingyue; Yang, Ding			Wing Base Structural Data Support the Sister Relationship of Megaloptera and Neuroptera (Insecta: Neuropterida)	PLOS ONE			English	Article							PHYLOGENY; HOLOMETABOLA; MORPHOLOGY; SCLERITES; POSITION; HOMOLOGY	The phylogenetic status and the monophyly of the holometabolous insect order Megaloptera has been an often disputed and long unresolved problem. The present study attempts to infer phylogenetic relationships among three orders, Megaloptera, Neuroptera, and Raphidioptera, within the superorder Neuropterida, based on wing base structure. Cladistic analyses were carried out based on morphological data from both the fore- and hindwing base. A sister relationship between Megaloptera and Neuroptera was recovered, and the monophyly of Megaloptera was corroborated. The division of the order Megaloptera, the traditional higher classification, into Corydalidae (Corydalinae + Chauliodinae) and Sialidae, was also supported by our wing base data analyses.	[Zhao, Chenjing; Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	China Agricultural University	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xingyue_liu@yahoo.com; dyangcau@126.com	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of China [31322051, 31320103902]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	The research described is supported by the National Natural Science Foundation of China (31322051, 31320103902) and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPOCK H., 1991, RAPHIDIOPTEREN ERDE; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock U, 2012, ARTHROPOD SYST PHYLO, V70, P119; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Beutel RG, 2008, EUR J ENTOMOL, V105, P917, DOI 10.14411/eje.2008.119; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Buning J, 2005, DEV GENES EVOL, V215, P597, DOI 10.1007/s00427-005-0017-8; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; CONTRERASRAMOS A, 1998, T SAY PUBLICATIONS E; Elliott J.M., 1996, Freshwater Biological Association Scientific Publication, V54, P1; Friedrich F, 2010, CLADISTICS, V26, P579, DOI 10.1111/j.1096-0031.2010.00305.x; Goloboff P. A., 1999, NONA VERSION 2 0 COM; Goloboff P, 2008, CLADISTICS, V24, P91; Grimaldi David, 2005, pi; HAMILTON K G A, 1971, Journal of the Kansas Entomological Society, V44, P421; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Hornschemeyer T, 2002, ZOOL SCR, V31, P17, DOI 10.1046/j.0300-3256.2001.00086.x; Hunefeld F, 2012, MITT DEUT GES ALLGEM, V18, P53; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Kukalova-Peck J., 1991, INSECTS AUSTR, VI, P141; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Liu XY, 2013, SYST ENTOMOL, V38, P543, DOI 10.1111/syen.12009; MARDEN JH, 1995, NATURE, V377, P332, DOI 10.1038/377332a0; MARDEN JH, 1994, SCIENCE, V266, P427, DOI 10.1126/science.266.5184.427; MATSUDA R, 1970, MEM ENTOMOL SOC CAN, P1; Ninomiya T, 2009, SYST ENTOMOL, V34, P334, DOI 10.1111/j.1365-3113.2008.00455.x; Nixon K.C., 2002, WINCLADA VER 1 00 08; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Rieppel O, 2002, BIOL J LINN SOC, V75, P59, DOI 10.1046/j.1095-8312.2002.00006.x; Snodgrass RE, 1935, PRINCIPLES INSECT MO; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yang D, 2010, INSECTA, V51; Yoshizawa K, 2001, SYST ENTOMOL, V26, P1, DOI 10.1046/j.1365-3113.2001.00133.x; Yoshizawa K, 2007, ARTHROPOD STRUCT DEV, V36, P277, DOI 10.1016/j.asd.2007.05.004; Yoshizawa K, 2007, SYST ENTOMOL, V32, P197, DOI 10.1111/j.1365-3113.2007.00379.x; Yoshizawa Kazunori, 2005, Insecta Matsumurana, V62, P1; Yoshizawa K, 2012, ENTOMOL SCI, V15, P408, DOI 10.1111/j.1479-8298.2012.00528.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	47	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114695	10.1371/journal.pone.0114695	http://dx.doi.org/10.1371/journal.pone.0114695			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502404	Green Published, gold, Green Submitted			2022-12-26	WOS:000347146700044
J	Lazarin, GA; Hawthorne, F; Collins, NS; Platt, EA; Evans, EA; Haque, IS				Lazarin, Gabriel A.; Hawthorne, Felicia; Collins, Nicholas S.; Platt, Elizabeth A.; Evans, Eric A.; Haque, Imran S.			Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels	PLOS ONE			English	Article								Professional guidelines dictate that disease severity is a key criterion for carrier screening. Expanded carrier screening, which tests for hundreds to thousands of mutations simultaneously, requires an objective, systematic means of describing a given disease's severity to build screening panels. We hypothesized that diseases with characteristics deemed to be of highest impact would likewise be rated as most severe, and diseases with characteristics of lower impact would be rated as less severe. We describe a pilot test of this hypothesis in which we surveyed 192 health care professionals to determine the impact of specific disease phenotypic characteristics on perceived severity, and asked the same group to rate the severity of selected inherited diseases. The results support the hypothesis: we identified four "Tiers'' of disease characteristics (1-4). Based on these responses, we developed an algorithm that, based on the combination of characteristics normally seen in an affected individual, classifies the disease as Profound, Severe, Moderate, or Mild. This algorithm allows simple classification of disease severity that is replicable and not labor intensive.	[Lazarin, Gabriel A.; Hawthorne, Felicia; Collins, Nicholas S.; Platt, Elizabeth A.; Evans, Eric A.; Haque, Imran S.] Counsyl, San Francisco, CA 94080 USA		Lazarin, GA (corresponding author), Counsyl, San Francisco, CA 94080 USA.	gabriel@counsyl.com			Counsyl, a molecular genetics laboratory	Counsyl, a molecular genetics laboratory	This study was funded by Counsyl, a molecular genetics laboratory that performs carrier screening. Study design, data collection and analysis, and manuscript preparation were all completed by the authors who are currently, or were, employees at Counsyl.	Amos J, 2006, TECHNICAL STANDARDS; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Fedick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059722; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991; Schrijver I, 2005, J MOL DIAGN, V7, P375, DOI 10.1016/S1525-1578(10)60567-3; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	11	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114391	10.1371/journal.pone.0114391	http://dx.doi.org/10.1371/journal.pone.0114391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494330	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400044
J	Redding, DW; Mazel, F; Mooers, AO				Redding, David W.; Mazel, Florent; Mooers, Arne O.			Measuring Evolutionary Isolation for Conservation	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; SHAPLEY VALUE; TAXONOMY; AGONY	Conservation planning needs to account for limited resources when choosing those species on which to focus attention and resources. Currently, funding is biased to small sections of the tree of life, such as raptors and carnivores. One new approach for increasing the diversity of species under consideration considers how many close relatives a species has in its evolutionary tree. At least eleven different ways to measure this characteristic on phylogenies for the purposes of setting species-specific priorities for conservation have been proposed. We find that there is much redundancy within the current set, with three pairs of metrics being essentially identical. Non-redundant metrics represent different trade-offs between the unique evolutionary history represented by a species verses its average distance to all other species. Depending on which metric is used, species priority lists can differ as much as 85% for the top 100 species. We call for some consensus on the theory behind these metrics and suggest that all future developments are compared to the current published set, and offer scripts to aid such comparisons.	[Redding, David W.; Mooers, Arne O.] Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada; [Redding, David W.] UCL, Dept Genet Evolut & Environm, Ctr Biodivers Ecol & Conservat, London, England; [Mazel, Florent] Lab Ecol Alpine, Grenoble, France	Simon Fraser University; University of London; University College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Redding, DW (corresponding author), Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada.	dwredding@gmail.com	Redding, David/M-1766-2019; Mazel, Florent/AFN-6012-2022	Redding, David/0000-0001-8615-1798; Mazel, Florent/0000-0003-0572-9901	Ecosystem Services for Poverty Alleviation (ESPA) programme [NE-J001570-1]; Systematics Society Systematics Research Fund (DWR); NSERC Canada; European Research Council TEEMBIO Seventh Framework Programme [281422]; DFG [FZT 118]; sDiv	Ecosystem Services for Poverty Alleviation (ESPA) programme; Systematics Society Systematics Research Fund (DWR); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Research Council TEEMBIO Seventh Framework Programme; DFG(German Research Foundation (DFG)); sDiv	This work was supported by Ecosystem Services for Poverty Alleviation (ESPA) programme project no. (NE-J001570-1); Systematics Society Systematics Research Fund (DWR); NSERC Canada (AOM); The European Research Council TEEMBIO Seventh Framework Programme grant agreement no. 281422 (FM); and sDiv, the Synthesis Centre for Biodiversity Sciences (DFG FZT 118) (DWR, FM, AOM). The funders had no role in study design, data col<SUP>l</SUP>ection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, NATURE, V348, P493, DOI 10.1038/348493c0; AmphibiaWeb, 2013, INF AMPH BIOL CONS; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; CROZIER RH, 1992, BIOL CONSERV, V61, P11, DOI 10.1016/0006-3207(92)91202-4; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fay JJ, 1983, US FED REG, V48, P43098; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Haake CJ, 2008, J MATH BIOL, V56, P479, DOI 10.1007/s00285-007-0126-2; Hartmann K, 2013, J MATH BIOL, V67, P1163, DOI 10.1007/s00285-012-0585-y; Huang JX, 2011, J THEOR BIOL, V276, P99, DOI 10.1016/j.jtbi.2011.01.037; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2014, CURR BIOL, V24, P1; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Maechler M., 2013, CLUSTER CLUSTER ANAL; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Nixon Kevin C., 1992, P216; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; R Core Team, 2021, R LANGUAGE ENV STAT; Red List of Endangered Species, 2012, RED LIST END SPEC; Redding, 2003, THESIS U E ANGLIA NO; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricotta C, 2007, ACTA BIOTHEOR, V55, P23, DOI 10.1007/s10441-007-9008-7; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Volkmann L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088945; Waldron A, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas1221370110, DOI 10.1073/PNAS1221370110]; Wilson D. E., 2005, MAMMAL SPECIES WORLD	36	40	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113490	10.1371/journal.pone.0113490	http://dx.doi.org/10.1371/journal.pone.0113490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493934	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400013
J	Adams, J; Light, R				Adams, Jimi; Light, Ryan			Mapping Interdisciplinary Fields: Efficiencies, Gaps and Redundancies in HIV/AIDS Research	PLOS ONE			English	Article								While interdisciplinarity continues to increase in popularity among funders and other scientific organizations, its potential to promote scientific advances remains under-examined. For HIV/AIDS research, we examine the dynamics of disciplinary integration (or lack thereof) providing insight into a field's knowledge base and those questions that remain unresolved. Drawing on the complete histories of two interdisciplinary journals, we construct bibliographic coupling networks based on overlapping citations to identify segregation into research clusters and estimate topic models of research content. We then compare how readily those bibliographic coupling clusters account for the structuring of topics covered within the field as it evolves over two decades. These comparisons challenge one-dimensional and/or cross-sectional approaches to interdisciplinarity. Some topics are increasingly coordinated across disciplinary boundaries (e. g., vaccine development); others remain relatively segmented into disconnected disciplinary domains for the full period (e. g., drug resistance). This divergence indicates heterogeneity in interdisciplinarity and emphasizes the need for critical approaches to studying the organization of science.	[Adams, Jimi] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Light, Ryan] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of Colorado System; University of Colorado Denver; University of Oregon	Adams, J (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA.	jimi.adams@ucdenver.edu	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1992, ASA P STAT GRAPH SEC; [Anonymous], PREP FUT HIV AIDS AF; [Anonymous], CULTURAL BOUNDARIES; [Anonymous], 2012, AIDS 30 HIST; [Anonymous], SCI SCI SCI2 TOOL; Bettencourt LMA, 2008, SCIENTOMETRICS, V75, P495, DOI 10.1007/s11192-007-1888-4; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crane D., 1972, INVISIBLE COLL DIFFU; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Garfield E, 2001, BIBLIOGRAPHIC COUPLI; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Jacobs J., 2013, DEFENSE DISCIPLINES; Jacobs JA, 2009, ANNU REV SOCIOL, V35, P43, DOI 10.1146/annurev-soc-070308-115954; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Knorr-Cetina K., 1999, EPISTEMIC CULTURES S; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Manton KG, 2009, P NATL ACAD SCI USA, V106, P10981, DOI 10.1073/pnas.0905104106; Moody James, 2006, AM SOCIOL, V37, P67; National Academy of Sciences, 2005, FAC INT RES; National Institutes of Health, 2007, NIH NEWS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Steyvers M, 2007, HDB LATENT SEMANTIC; Wilbur W John, 2002, Pac Symp Biocomput, P386; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680	38	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115092	10.1371/journal.pone.0115092	http://dx.doi.org/10.1371/journal.pone.0115092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506703	Green Published, Green Submitted, gold			2022-12-26	WOS:000346607100048
J	Clutterbuck, S; Adams, J; Nettle, D				Clutterbuck, Stephanie; Adams, Jean; Nettle, Daniel			Childhood Adversity Accelerates Intended Reproductive Timing in Adolescent Girls without Increasing Interest in Infants	PLOS ONE			English	Article							SEX-DIFFERENCES; FATHER ABSENCE; EVOLUTIONARY-THEORY; LIFE-HISTORY; BABY SCHEMA; AGE; RESPONSIVENESS; YOUNG; MENARCHE; BABIES	Women experiencing greater childhood adversity exhibit faster reproductive trajectories. One possible psychological mechanism underlying this phenomenon is an increased interest in infants. Interest in infants is thought to be an adaptation important for successful rearing as it motivates the acquisition of caretaking skills. We investigated the relationships between childhood adversity, intended reproductive timing and interest in infants in a sample of English adolescent girls. Specifically we sought to investigate the relationship between 1) childhood adversity and intended reproductive timing; 2) childhood adversity and interest in infants; and 3) intended reproductive timing and interest in infants. Additionally we explored different methods of measuring interest in infants using self-reported fondness for babies, a forced choice adult versus infant paper-based preference task and a novel computer based attention task using adult and infant stimuli. In total 357 girls aged nine to 14 years participated in the study, which took place in schools. Participants completed the two interest in infants tasks before moving on to a childhood adversity questionnaire. Girls with more childhood adversity reported earlier ideal ages at parenthood. We found some evidence that, contrary to our predictions, girls with less childhood adversity were more interested in infants. There was no relationship between intended reproductive timing and interest in infants. The different measurements for interest in infants were only weakly related, if at all, highlighting the complexity of measuring this construct. Our findings suggest that rather than interest in infants being a mechanism for the effect of childhood adversity on early reproductive timing it might instead be an indicator of future reproductive strategies.	[Clutterbuck, Stephanie; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Clutterbuck, S (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	p.clutterbuck@ncl.ac.uk	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	North Tyneside Council [001]; Birtch Control Trust of the Galton Institute [001]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	North Tyneside Council; Birtch Control Trust of the Galton Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was partly funded from two sources: 1. The North Tyneside Council. Grant Number: 001 URL: http://www.northtyneside.gov.uk/, and 2. The Birtch Control Trust of the Galton Institute. Grant Number: 001 URL: http://www.galtoninstitute.org.uk/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 2001, CROSS-CULT RES, V35, P263, DOI 10.1177/106939710103500301; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; BERMAN PW, 1975, SEX ROLES, V1, P311; BERMAN PW, 1978, CHILD DEV, V49, P917, DOI 10.2307/1128272; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BLAKEMORE JEO, 1981, CHILD DEV, V52, P386; BLAKEMORE JEO, 1985, SEX ROLES, V13, P405, DOI 10.1007/BF00287951; Blell M, 2008, J BIOSOC SCI, V40, P563, DOI 10.1017/S0021932007002696; Bottino MN, 2012, J AFFECT DISORDERS, V142, P219, DOI 10.1016/j.jad.2012.04.030; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Duchowski A, 2007, EYE TRACKING METHODO, V373; Elliott D. S., 1985, EXPLAINING DELINQUEN; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; FELDMAN SS, 1979, CHILD DEV, V50, P942, DOI 10.2307/1129318; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FELDMAN SS, 1977, DEV PSYCHOL, V13, P675, DOI 10.1037/0012-1649.13.6.675; FRODI AM, 1984, SEX ROLES, V10, P639; FRODI AM, 1978, CHILD DEV, V49, P1182, DOI 10.2307/1128758; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138; Kim K, 1998, J ADOLESCENCE, V21, P231, DOI 10.1006/jado.1998.0149; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maestripieri D, 2004, DEVELOPMENTAL SCI, V7, P560, DOI 10.1111/j.1467-7687.2004.00380.x; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Maestripieri D, 2006, DEV REV, V26, P120, DOI 10.1016/j.dr.2006.02.006; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLennan D., 2011, ENGLISH INDICES DEPR; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; Nettle D., 2010, P R SOC B, V278, P1721, DOI DOI 10.1098/RSPB.2010.1726.PMID:21068037; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012690; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Romans SE, 2003, PSYCHOL MED, V33, P933, DOI 10.1017/S0033291703007530; Russell ST, 2002, J RES ADOLESCENCE, V12, P305, DOI 10.1111/1532-7795.00035; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Sprengelmeyer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065844; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Wellings K, 1999, REV REPROD, V4, P184, DOI 10.1530/revreprod/4.3.184; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	58	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85013	10.1371/journal.pone.0085013	http://dx.doi.org/10.1371/journal.pone.0085013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25506703	Green Submitted, Green Published, gold			2022-12-26	WOS:000330236000007
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-26	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-26	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-26	WOS:000333355300008
